data_2lja_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2lja _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 0.667 0 N-CA-C 112.458 0.54 . . . . 0.0 112.458 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -80.55 78.9 7.24 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 120.9 0.381 . . . . 0.0 110.95 -177.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 53.6 m 68.65 95.5 0.07 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.032 -0.985 . . . . 0.0 111.899 176.613 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 33.9 p90 -98.1 165.99 11.63 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.416 178.067 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' SER . . . . . 0.479 ' HA ' ' HA ' ' A' ' 24' ' ' SER . 25.0 m -142.51 120.43 12.02 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.896 -0.409 . . . . 0.0 109.896 175.664 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . 0.419 ' CE2' ' HA ' ' A' ' 94' ' ' MET . 57.8 m-85 -128.19 161.72 54.62 Favored Pre-proline 0 C--N 1.324 -0.528 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.45 -177.407 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.44 ' HD2' ' O ' ' A' ' 93' ' ' HIS . 2.7 Cg_endo -86.18 124.95 2.54 Favored 'Trans proline' 0 N--CA 1.454 -0.846 0 C-N-CA 122.476 2.117 . . . . 0.0 112.567 174.008 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . 0.477 ' HB3' ' HB3' ' A' ' 21' ' ' LYS . 4.0 t70 -69.56 159.03 34.12 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.529 -0.759 . . . . 0.0 109.122 171.971 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.759 HG13 HG13 ' A' ' 82' ' ' VAL . 18.5 mm -40.94 -49.71 0.67 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.401 0 O-C-N 124.558 1.161 . . . . 0.0 112.898 -176.585 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 4.8 p30 -69.55 -16.49 63.43 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-O 121.126 0.488 . . . . 0.0 110.974 -174.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 107.73 33.83 2.98 Favored Glycine 0 N--CA 1.444 -0.781 0 CA-C-N 115.802 -0.636 . . . . 0.0 111.663 -177.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.823 ' HZ3' HG23 ' A' ' 23' ' ' VAL . 48.2 tttm -102.32 128.99 48.64 Favored 'General case' 0 CA--C 1.515 -0.381 0 C-N-CA 120.402 -0.519 . . . . 0.0 111.188 -177.617 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 8.3 m -64.75 104.88 0.89 Allowed 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 109.527 -0.546 . . . . 0.0 109.527 170.429 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.823 HG23 ' HZ3' ' A' ' 21' ' ' LYS . 41.6 t -111.79 118.46 57.65 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 176.067 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' SER . . . . . 0.479 ' HA ' ' HA ' ' A' ' 14' ' ' SER . 89.6 p -100.48 -173.81 2.5 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.563 -175.762 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.583 HD13 ' O ' ' A' ' 25' ' ' LEU . 1.5 tm? -82.35 -1.02 48.47 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 176.219 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -95.99 -21.69 17.85 Favored 'General case' 0 CA--C 1.51 -0.563 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 -178.482 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -65.7 -22.38 66.61 Favored 'General case' 0 N--CA 1.437 -1.09 0 CA-C-N 113.755 -1.566 . . . . 0.0 110.208 173.354 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.629 HD11 HG23 ' A' ' 67' ' ' VAL . 37.1 mt -112.37 -15.67 13.08 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-N 115.407 -0.815 . . . . 0.0 111.008 -177.009 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.442 ' HB2' ' O ' ' A' ' 25' ' ' LEU . 62.2 tttp -69.75 133.38 47.4 Favored 'General case' 0 N--CA 1.445 -0.693 0 CA-C-N 115.694 -0.684 . . . . 0.0 111.455 -171.174 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 119.19 -18.9 10.2 Favored Glycine 0 N--CA 1.45 -0.387 0 N-CA-C 111.172 -0.771 . . . . 0.0 111.172 -176.896 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.594 ' HB3' ' NE2' ' A' ' 65' ' ' HIS . 24.5 ttmm -140.18 147.47 40.16 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 179.241 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.54 ' HB2' ' O ' ' A' ' 63' ' ' ASP . 81.8 m-85 -54.0 140.76 30.32 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-O 121.119 0.485 . . . . 0.0 111.659 -176.261 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 5.1 mp -112.18 132.25 61.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.634 -177.111 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 85.5 t80 -115.58 116.54 28.33 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 172.595 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.607 ' HB ' ' HB ' ' A' ' 113' ' ' ILE . 67.9 mt -103.33 109.73 27.81 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 CA-C-O 120.999 0.428 . . . . 0.0 110.671 -177.937 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.55 ' HA ' ' O ' ' A' ' 111' ' ' ARG . 5.7 p-10 -105.57 158.31 16.78 Favored 'General case' 0 C--N 1.316 -0.858 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 173.238 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.45 HG21 HG23 ' A' ' 106' ' ' ILE . 52.6 t -103.26 136.68 34.84 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.806 0 C-N-CA 120.485 -0.486 . . . . 0.0 111.447 179.068 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' TRP . . . . . 0.649 ' CZ2' ' HB2' ' A' ' 91' ' ' GLN . 0.2 OUTLIER -128.5 141.77 51.28 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 -179.95 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.516 ' HB3' HD12 ' A' ' 109' ' ' ILE . . . -146.15 158.11 43.86 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 112.445 0.535 . . . . 0.0 112.445 -176.67 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -76.35 -46.22 28.49 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.798 -0.637 . . . . 0.0 109.559 175.917 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 5.3 p-90 -80.77 -1.16 41.76 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 114.885 -1.052 . . . . 0.0 111.687 -175.352 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 43.6 t -95.31 110.89 22.84 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.252 0.549 . . . . 0.0 110.127 177.596 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . 0.408 ' N ' ' CD ' ' A' ' 44' ' ' PRO . . . -85.31 -43.97 6.4 Favored Glycine 0 CA--C 1.528 0.859 0 CA-C-O 118.967 -0.907 . . . . 0.0 113.727 176.352 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.408 ' CD ' ' N ' ' A' ' 43' ' ' GLY . 71.2 Cg_exo -53.03 -38.34 80.07 Favored 'Trans proline' 0 C--N 1.362 1.274 0 C-N-CA 122.584 2.189 . . . . 0.0 113.221 -176.835 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . 0.679 ' O ' ' HG ' ' A' ' 49' ' ' LEU . 29.8 p -58.95 -32.51 69.67 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.8 0.333 . . . . 0.0 111.021 -179.653 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.55 ' HG2' HD12 ' A' ' 49' ' ' LEU . 52.0 mtt85 -69.38 -8.18 44.17 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.757 -176.412 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -78.26 -27.81 57.09 Favored Glycine 0 N--CA 1.444 -0.774 0 C-N-CA 120.53 -0.843 . . . . 0.0 111.658 175.687 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . 0.466 ' OE2' ' HD3' ' A' ' 128' ' ' ARG . 15.7 pt-20 -114.53 -8.03 12.78 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 111.695 0.257 . . . . 0.0 111.695 -177.687 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.679 ' HG ' ' O ' ' A' ' 45' ' ' CYS . 68.8 mt -55.18 -47.13 99.27 Favored Pre-proline 0 CA--C 1.537 0.442 0 N-CA-C 112.248 0.462 . . . . 0.0 112.248 178.22 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.476 ' HD3' ' HB2' ' A' ' 49' ' ' LEU . 53.6 Cg_exo -54.97 -37.46 93.59 Favored 'Trans proline' 0 C--N 1.355 0.905 0 C-N-CA 121.688 1.592 . . . . 0.0 111.944 172.552 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -73.51 -28.64 62.01 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.619 179.544 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 8.2 tt -64.59 -39.62 94.06 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.009 -0.737 . . . . 0.0 109.009 175.096 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . 0.485 ' HZ1' ' HB3' ' A' ' 53' ' ' LYS . 4.5 mmmp? -63.83 -46.99 82.58 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.486 174.59 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.456 ' CD ' ' HZ2' ' A' ' 58' ' ' LYS . 0.3 OUTLIER -53.09 -43.56 66.9 Favored 'General case' 0 C--O 1.222 -0.348 0 O-C-N 123.565 0.541 . . . . 0.0 111.082 173.944 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.465 HD23 ' HE2' ' A' ' 138' ' ' PHE . 21.7 tp -59.51 -44.42 93.13 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.951 0.405 . . . . 0.0 110.474 178.572 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.41 ' OE1' ' HD2' ' A' ' 66' ' ' PHE . 10.1 tp10 -65.5 -55.96 15.03 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.022 179.906 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 29.9 mt-10 -72.75 -19.24 61.41 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.561 -172.534 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . 0.456 ' HZ2' ' CD ' ' A' ' 54' ' ' GLU . 18.1 ttmm -82.37 -31.6 29.65 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.139 0.495 . . . . 0.0 110.044 174.326 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.444 ' O ' ' HD2' ' A' ' 62' ' ' LYS . 25.8 m-85 -103.9 12.95 33.74 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.657 -0.702 . . . . 0.0 111.166 -178.552 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -47.16 113.8 0.74 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.077 0.465 . . . . 0.0 111.819 178.673 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 115.01 -12.19 20.11 Favored Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 120.88 -0.676 . . . . 0.0 112.254 -178.192 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . 0.635 ' H ' ' HD2' ' A' ' 62' ' ' LYS . 0.0 OUTLIER -65.9 169.48 6.61 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-O 121.405 0.621 . . . . 0.0 111.599 -178.397 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . 0.564 ' CG ' ' HG3' ' A' ' 31' ' ' LYS . 4.6 t70 -94.77 55.77 1.93 Allowed 'General case' 0 C--N 1.318 -0.773 0 CA-C-O 121.367 0.604 . . . . 0.0 109.992 178.786 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.418 ' HB ' ' HG2' ' A' ' 62' ' ' LYS . 4.0 mp -145.99 134.09 15.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.571 -0.74 . . . . 0.0 109.752 -178.698 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' HIS . . . . . 0.594 ' NE2' ' HB3' ' A' ' 31' ' ' LYS . 88.4 m-70 -101.55 120.81 40.88 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.511 -0.552 . . . . 0.0 109.511 173.623 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . 0.552 ' O ' ' HB ' ' A' ' 90' ' ' ILE . 63.5 m-85 -83.32 108.93 16.85 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 171.163 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.629 HG23 HD11 ' A' ' 28' ' ' LEU . 44.2 t -120.77 105.16 16.38 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.696 -174.188 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' SER . . . . . 0.522 ' HA ' ' O ' ' A' ' 36' ' ' ASP . 13.3 m -88.09 124.53 33.87 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.531 -179.191 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 55.7 tp -110.0 129.98 55.6 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.777 0.322 . . . . 0.0 110.453 177.655 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' SER . . . . . 0.498 ' O ' ' HB3' ' A' ' 94' ' ' MET . 1.0 OUTLIER -112.09 122.41 47.68 Favored 'General case' 0 C--O 1.221 -0.396 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.721 -175.147 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 12.9 t -85.41 9.31 15.97 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.403 177.674 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . 0.513 ' OD1' ' HA ' ' A' ' 39' ' ' ALA . 3.0 m-20 -64.56 136.47 57.06 Favored 'General case' 0 CA--C 1.516 -0.343 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.592 -178.013 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . 0.507 ' HZ1' HG23 ' A' ' 96' ' ' THR . 18.2 ttmm -82.83 -33.72 27.09 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-O 121.254 0.549 . . . . 0.0 109.846 177.451 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . 0.499 ' HB2' ' HB1' ' A' ' 77' ' ' ALA . 0.9 OUTLIER -77.9 85.84 4.14 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.477 -0.783 . . . . 0.0 111.217 -179.641 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.429 ' HB2' ' CE1' ' A' ' 93' ' ' HIS . 18.0 tttm -62.54 -62.95 1.39 Allowed 'General case' 0 C--O 1.218 -0.553 0 C-N-CA 120.024 -0.67 . . . . 0.0 111.782 -179.649 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.432 ' HA ' ' HD2' ' A' ' 76' ' ' LYS . 42.2 tptt -53.23 -37.7 62.29 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 123.279 0.362 . . . . 0.0 111.777 -174.445 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.499 ' HB1' ' HB2' ' A' ' 74' ' ' ASN . . . -66.47 -38.08 86.54 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.565 0.698 . . . . 0.0 110.466 177.217 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' TRP . . . . . 0.455 ' HZ3' HH22 ' A' ' 46' ' ' ARG . 7.5 t-105 -80.58 -41.89 23.25 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.313 -0.858 . . . . 0.0 111.229 -176.271 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . 0.721 ' HB2' HG21 ' A' ' 18' ' ' ILE . 1.4 pt-20 -62.44 -39.11 92.27 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-O 120.711 0.291 . . . . 0.0 110.754 179.927 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 3.8 p30 -75.15 -28.55 60.18 Favored 'General case' 0 CA--C 1.518 -0.259 0 C-N-CA 119.784 -0.766 . . . . 0.0 109.65 177.188 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' MET . . . . . 0.501 ' HG3' ' OD2' ' A' ' 85' ' ' ASP . 9.9 tpt -64.72 -51.97 59.57 Favored 'General case' 0 C--O 1.209 -1.068 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.362 176.822 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.759 HG13 HG13 ' A' ' 18' ' ' ILE . 3.2 p -61.24 -30.6 48.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 C-N-CA 120.744 -0.382 . . . . 0.0 110.746 178.869 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 71.8 m -64.41 -38.09 89.8 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.264 0.554 . . . . 0.0 110.08 173.471 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . 0.451 ' HZ2' ' HB2' ' A' ' 84' ' ' LYS . 3.1 ttmp? -77.55 -44.77 27.47 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.421 -0.809 . . . . 0.0 110.381 179.865 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . 0.714 ' HB3' ' HG ' ' A' ' 87' ' ' LEU . 1.2 m-20 -69.57 -16.37 63.4 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 114.68 -1.146 . . . . 0.0 111.007 179.949 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 18.8 mm-40 59.53 31.12 20.78 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-N 115.764 -0.653 . . . . 0.0 112.468 178.585 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.714 ' HG ' ' HB3' ' A' ' 85' ' ' ASP . 58.6 mt -85.01 39.84 0.78 Allowed 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.279 -177.739 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . 0.434 ' HD2' ' N ' ' A' ' 88' ' ' LYS . 0.1 OUTLIER -65.56 150.53 48.25 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-O 121.407 0.623 . . . . 0.0 112.491 -178.801 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 166.4 -134.82 3.42 Favored Glycine 0 C--O 1.229 -0.172 0 N-CA-C 109.861 -1.296 . . . . 0.0 109.861 -172.587 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.552 ' HB ' ' O ' ' A' ' 66' ' ' PHE . 48.0 mm -111.22 114.09 46.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 170.073 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . 0.649 ' HB2' ' CZ2' ' A' ' 38' ' ' TRP . 0.4 OUTLIER -141.88 146.78 36.16 Favored 'General case' 0 C--N 1.314 -0.948 0 N-CA-C 113.232 0.827 . . . . 0.0 113.232 -168.643 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.626 HD12 ' HB ' ' A' ' 23' ' ' VAL . 2.5 mm? -134.13 153.86 51.57 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 114.853 -1.067 . . . . 0.0 110.581 179.161 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' HIS . . . . . 0.44 ' O ' ' HD2' ' A' ' 16' ' ' PRO . 25.5 t-80 -129.43 125.07 35.66 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.907 -179.724 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' MET . . . . . 0.538 ' SD ' ' HA ' ' A' ' 98' ' ' ARG . 24.5 ttm -76.26 -85.3 0.05 Allowed 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.38 -0.827 . . . . 0.0 110.313 179.393 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . 0.499 ' HA2' ' O ' ' A' ' 72' ' ' ASP . . . 117.78 -74.03 0.29 Allowed Glycine 0 N--CA 1.443 -0.869 0 C-N-CA 120.1 -1.048 . . . . 0.0 113.417 177.865 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' THR . . . . . 0.507 HG23 ' HZ1' ' A' ' 73' ' ' LYS . 14.8 m -135.67 -8.12 2.16 Favored 'General case' 0 C--N 1.316 -0.861 0 C-N-CA 120.557 -0.457 . . . . 0.0 111.618 -174.956 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . 0.462 ' CG ' ' HG3' ' A' ' 94' ' ' MET . 8.2 p-10 -89.97 48.21 1.55 Allowed 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.883 0.849 . . . . 0.0 110.083 -176.091 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . 0.538 ' HA ' ' SD ' ' A' ' 94' ' ' MET . 0.0 OUTLIER -75.91 20.52 0.18 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.133 -0.94 . . . . 0.0 112.614 -172.342 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 9.9 m -70.18 -30.17 67.23 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 171.24 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' PHE . . . . . 0.477 ' CZ ' ' HE2' ' A' ' 104' ' ' TYR . 1.3 t80 -73.59 -25.73 60.48 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.23 -0.895 . . . . 0.0 109.53 177.898 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' MET . . . . . 0.528 ' HB3' ' O ' ' A' ' 98' ' ' ARG . 13.4 tpt -58.81 -52.34 66.15 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 114.769 -1.105 . . . . 0.0 109.745 175.578 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 67.9 m-20 -73.38 -26.7 61.1 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.579 -0.737 . . . . 0.0 111.318 179.486 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -60.72 -26.82 67.45 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-O 121.025 0.44 . . . . 0.0 111.062 -179.224 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' TYR . . . . . 0.49 ' HB2' HG13 ' A' ' 106' ' ' ILE . 49.4 m-85 -108.52 -3.32 18.19 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.478 178.365 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 7.7 mp 60.36 32.19 20.59 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.147 0.499 . . . . 0.0 110.316 -174.547 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . 0.563 HG22 ' HB2' ' A' ' 111' ' ' ARG . 79.0 mt -64.2 131.14 29.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.737 176.505 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 16.3 t-20 -157.59 161.02 38.69 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 178.421 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 81.35 -60.88 4.67 Favored Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 121.242 -0.504 . . . . 0.0 112.991 178.092 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . 0.516 HD12 ' HB3' ' A' ' 39' ' ' ALA . 44.3 mt 72.08 131.04 0.04 OUTLIER Pre-proline 0 CA--C 1.535 0.371 0 C-N-CA 122.971 0.508 . . . . 0.0 110.399 -176.22 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . 0.424 ' HB3' ' O ' ' A' ' 37' ' ' VAL . 2.2 Cg_endo -84.15 145.89 48.9 Favored 'Cis proline' 0 N--CA 1.461 -0.384 0 C-N-CA 124.153 -1.186 . . . . 0.0 112.963 0.3 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . 0.61 ' HD2' ' N ' ' A' ' 112' ' ' PHE . 0.0 OUTLIER -97.34 141.67 30.14 Favored 'General case' 0 N--CA 1.446 -0.626 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 173.093 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . 0.61 ' N ' ' HD2' ' A' ' 111' ' ' ARG . 0.7 OUTLIER -104.04 117.86 35.3 Favored 'General case' 0 C--N 1.324 -0.537 0 O-C-N 124.024 0.827 . . . . 0.0 111.714 -177.792 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.607 ' HB ' ' HB ' ' A' ' 35' ' ' ILE . 77.4 mt -129.22 149.41 33.65 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.428 0 C-N-CA 122.359 0.263 . . . . 0.0 110.38 177.106 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.476 HD23 ' HE1' ' A' ' 126' ' ' MET . 21.4 tp -137.12 139.84 41.5 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.583 0.23 . . . . 0.0 110.621 178.041 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . 0.487 ' HG ' ' HA ' ' A' ' 121' ' ' ILE . 1.0 OUTLIER -135.8 156.64 48.49 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.897 0.379 . . . . 0.0 110.207 -179.105 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . 0.554 ' HB3' ' HB2' ' A' ' 120' ' ' LYS . 23.0 t70 -73.04 160.74 31.58 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.571 -0.74 . . . . 0.0 110.786 176.91 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . 0.4 HH11 ' HD3' ' A' ' 117' ' ' ARG . 75.0 mtt-85 -44.81 -39.94 5.72 Favored 'General case' 0 N--CA 1.466 0.345 0 O-C-N 124.536 1.147 . . . . 0.0 112.18 179.838 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . 0.492 ' HB3' ' HG2' ' A' ' 120' ' ' LYS . 25.1 t70 -63.43 -23.55 67.45 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.335 0.588 . . . . 0.0 111.151 -178.03 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . 0.543 ' HA3' HD11 ' A' ' 25' ' ' LEU . . . 105.54 19.84 10.09 Favored Glycine 0 N--CA 1.432 -1.571 0 N-CA-C 110.001 -1.24 . . . . 0.0 110.001 -169.376 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . 0.554 ' HB2' ' HB3' ' A' ' 116' ' ' ASP . 32.8 mmtm -91.85 107.97 19.59 Favored 'General case' 0 C--O 1.221 -0.447 0 C-N-CA 120.71 -0.396 . . . . 0.0 111.207 -175.128 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . 0.487 ' HA ' ' HG ' ' A' ' 115' ' ' LEU . 3.5 mp -47.18 113.02 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 O-C-N 123.55 0.531 . . . . 0.0 110.651 177.553 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 38.5 mm -94.34 -53.79 7.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 115.678 -0.692 . . . . 0.0 109.773 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 6.1 m -127.04 114.46 17.81 Favored 'General case' 0 N--CA 1.446 -0.653 0 CA-C-N 115.504 -0.771 . . . . 0.0 109.911 179.832 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . 0.516 ' O ' HG12 ' A' ' 113' ' ' ILE . . . -65.0 -32.13 73.71 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 109.446 -0.576 . . . . 0.0 109.446 174.89 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 12.4 p-10 -127.33 106.92 9.54 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.08 -0.964 . . . . 0.0 109.019 173.586 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' MET . . . . . 0.476 ' HE1' HD23 ' A' ' 114' ' ' LEU . 14.1 tpt -99.55 -101.3 0.23 Allowed 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.077 -175.469 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' THR . . . . . 0.693 ' HB ' ' HB ' ' A' ' 134' ' ' THR . 0.2 OUTLIER -155.17 122.73 5.65 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.916 0.389 . . . . 0.0 110.885 -179.236 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . 0.466 ' HD3' ' OE2' ' A' ' 48' ' ' GLU . 30.1 ttm-85 -49.29 140.84 12.4 Favored Pre-proline 0 C--N 1.326 -0.454 0 CA-C-N 115.153 -0.931 . . . . 0.0 111.421 176.632 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -54.74 -38.77 91.58 Favored 'Trans proline' 0 C--N 1.35 0.615 0 C-N-CA 122.797 2.331 . . . . 0.0 113.14 178.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' SER . . . . . 0.406 ' HB2' ' CB ' ' A' ' 48' ' ' GLU . 36.4 t -72.51 -2.22 18.88 Favored 'General case' 0 CA--C 1.535 0.395 0 N-CA-C 111.657 0.243 . . . . 0.0 111.657 177.981 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . 0.475 ' O ' HG23 ' A' ' 134' ' ' THR . 9.5 t70 -94.45 115.16 64.95 Favored Pre-proline 0 C--N 1.326 -0.417 0 N-CA-C 109.716 -0.476 . . . . 0.0 109.716 179.204 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -56.71 -25.46 60.38 Favored 'Trans proline' 0 N--CA 1.473 0.268 0 C-N-CA 123.041 2.494 . . . . 0.0 113.602 -176.425 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . 0.511 ' HB2' ' HZ1' ' A' ' 133' ' ' LYS . 9.7 mtmp? -70.02 -20.36 63.27 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 121.328 -0.149 . . . . 0.0 111.017 -177.984 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' THR . . . . . 0.693 ' HB ' ' HB ' ' A' ' 127' ' ' THR . 1.6 t -72.67 -40.7 66.11 Favored 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 177.348 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . 0.616 ' HA ' ' CD2' ' A' ' 138' ' ' PHE . . . -62.85 -41.53 99.4 Favored 'General case' 0 N--CA 1.453 -0.324 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.14 176.885 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -55.74 -42.34 75.24 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.417 -0.81 . . . . 0.0 110.649 175.014 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . 0.861 ' HE2' ' HA ' ' A' ' 137' ' ' LYS . 10.0 mmpt? -63.35 -42.8 98.93 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.144 179.559 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . 0.616 ' CD2' ' HA ' ' A' ' 135' ' ' ALA . 11.2 m-85 -57.88 -54.27 48.8 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-O 120.838 0.352 . . . . 0.0 110.366 -179.866 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 49.8 m-20 -56.34 -46.16 80.05 Favored 'General case' 0 C--O 1.223 -0.301 0 CA-C-N 115.918 -0.583 . . . . 0.0 109.966 179.743 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 28.7 tt0 -57.65 -55.22 37.62 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.544 -0.753 . . . . 0.0 111.987 -177.897 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 4.6 pp -68.54 -20.12 64.54 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-O 120.722 0.296 . . . . 0.0 111.673 -174.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 95.7 mt . . . . . 0 C--N 1.327 -0.372 0 CA-C-O 120.789 0.328 . . . . 0.0 110.489 175.424 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . 0.445 ' HB3' HD12 ' A' ' 121' ' ' ILE . . . . . . . . 0 N--CA 1.469 0.522 0 CA-C-O 121.086 0.47 . . . . 0.0 111.654 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -82.91 75.69 9.79 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.764 -179.214 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' SER . . . . . 0.493 ' HA ' ' HB3' ' A' ' 25' ' ' LEU . 15.9 m 68.74 79.0 0.21 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.004 -0.998 . . . . 0.0 111.482 176.433 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 23.6 p90 -101.3 -179.53 4.06 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.744 179.134 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 21.0 t -142.37 132.09 24.1 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 109.338 -0.616 . . . . 0.0 109.338 177.537 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . 0.505 ' HB3' ' HB3' ' A' ' 92' ' ' LEU . 12.9 m-85 -138.42 154.67 73.77 Favored Pre-proline 0 C--N 1.326 -0.456 0 CA-C-O 120.608 0.242 . . . . 0.0 111.433 -176.873 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -85.09 127.89 3.55 Favored 'Trans proline' 0 N--CA 1.457 -0.652 0 C-N-CA 123.196 2.597 . . . . 0.0 113.165 179.444 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . 0.682 ' HB3' ' HB3' ' A' ' 21' ' ' LYS . 0.5 OUTLIER -72.53 161.63 30.54 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.167 -0.924 . . . . 0.0 109.746 170.815 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.5 HD13 ' CG1' ' A' ' 82' ' ' VAL . 1.4 tt -46.59 -40.37 4.45 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 O-C-N 124.032 0.832 . . . . 0.0 112.083 -175.95 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . 0.475 ' ND2' HG22 ' A' ' 18' ' ' ILE . 27.9 m-80 -79.53 9.93 4.41 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.228 -175.439 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 77.19 25.81 63.13 Favored Glycine 0 N--CA 1.445 -0.706 0 N-CA-C 110.758 -0.937 . . . . 0.0 110.758 -174.753 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.682 ' HB3' ' HB3' ' A' ' 17' ' ' ASP . 8.0 ttpm? -94.86 106.94 18.96 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.427 -0.386 . . . . 0.0 110.328 -174.694 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 24.7 m -69.29 111.54 5.27 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.154 -178.225 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.578 ' HB ' HD11 ' A' ' 92' ' ' LEU . 47.7 t -115.82 133.86 60.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 116.139 -0.482 . . . . 0.0 109.862 178.352 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 97.7 p -101.74 160.49 14.42 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.35 -178.434 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.548 HD13 ' HG ' ' A' ' 28' ' ' LEU . 20.8 tp -75.17 0.52 16.07 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.164 0.507 . . . . 0.0 109.961 175.45 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -75.68 -25.97 57.21 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.827 -179.734 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -74.87 -21.51 59.2 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-O 122.68 1.229 . . . . 0.0 108.87 177.137 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.548 ' HG ' HD13 ' A' ' 25' ' ' LEU . 3.9 mm? -82.7 -7.4 59.65 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 113.581 -1.645 . . . . 0.0 111.542 -170.941 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.755 ' HA ' ' O ' ' A' ' 117' ' ' ARG . 2.6 mptp? -73.65 175.92 6.7 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.239 0.542 . . . . 0.0 111.272 179.423 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 84.19 -44.51 3.34 Favored Glycine 0 N--CA 1.449 -0.49 0 CA-C-N 115.775 -0.648 . . . . 0.0 112.437 177.814 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.746 ' HD3' ' HA ' ' A' ' 63' ' ' ASP . 66.1 mttm -121.33 164.93 16.25 Favored 'General case' 0 C--N 1.323 -0.577 0 C-N-CA 122.226 0.211 . . . . 0.0 110.582 -177.848 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 44.1 m-85 -67.21 151.75 46.97 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.779 0.323 . . . . 0.0 111.24 -177.609 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.758 HD12 ' HA2' ' A' ' 119' ' ' GLY . 53.4 mt -121.5 132.63 70.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-O 120.832 0.349 . . . . 0.0 111.202 -174.623 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 86.0 t80 -121.37 125.35 46.74 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 109.071 -0.715 . . . . 0.0 109.071 172.74 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.536 HG12 ' HB ' ' A' ' 67' ' ' VAL . 64.2 mt -114.44 134.47 57.28 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-O 120.955 0.407 . . . . 0.0 110.718 -177.877 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.535 ' HA ' ' O ' ' A' ' 111' ' ' ARG . 24.3 t0 -126.68 158.55 36.12 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.372 -0.831 . . . . 0.0 109.0 177.121 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.576 ' HA ' ' O ' ' A' ' 69' ' ' LEU . 59.2 t -105.74 111.47 35.09 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.904 0 C-N-CA 120.228 -0.589 . . . . 0.0 110.816 173.164 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' TRP . . . . . 0.65 ' CZ2' ' HB2' ' A' ' 91' ' ' GLN . 0.6 OUTLIER -95.22 133.27 39.28 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.275 178.716 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.559 ' HA ' ' OD1' ' A' ' 72' ' ' ASP . . . -146.85 163.02 37.42 Favored 'General case' 0 N--CA 1.464 0.266 0 N-CA-C 111.7 0.259 . . . . 0.0 111.7 -175.722 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' THR . . . . . 0.698 ' HB ' ' CE3' ' A' ' 78' ' ' TRP . 8.2 t -98.34 -35.72 10.22 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-O 120.885 0.374 . . . . 0.0 110.762 176.693 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 22.6 p-90 -86.39 16.27 4.66 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.164 0.507 . . . . 0.0 110.547 -178.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' CYS . . . . . 0.782 ' SG ' ' HB3' ' A' ' 45' ' ' CYS . 14.8 p -75.37 -56.55 4.6 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.611 -0.722 . . . . 0.0 111.791 -175.775 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 98.15 -99.37 2.19 Favored Glycine 0 CA--C 1.521 0.424 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.101 -176.161 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -55.32 -28.35 62.23 Favored 'Trans proline' 0 C--N 1.352 0.714 0 C-N-CA 123.331 2.688 . . . . 0.0 113.274 -179.635 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . 0.83 ' HB2' ' HD3' ' A' ' 110' ' ' PRO . 18.2 t -57.57 -22.85 47.34 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-O 120.979 0.419 . . . . 0.0 111.428 179.425 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.534 ' HA ' ' CD1' ' A' ' 49' ' ' LEU . 33.0 mtp-105 -70.9 -15.67 62.63 Favored 'General case' 0 C--N 1.324 -0.5 0 C-N-CA 120.577 -0.449 . . . . 0.0 111.301 -178.748 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -84.23 -12.97 75.1 Favored Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 120.678 -0.772 . . . . 0.0 111.67 176.08 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . 0.651 ' HB3' ' HB2' ' A' ' 129' ' ' PRO . 0.5 OUTLIER -91.51 -26.34 18.83 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.135 0.493 . . . . 0.0 109.884 -179.342 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.787 HD23 HD12 ' A' ' 52' ' ' LEU . 54.9 mt -51.53 -45.27 90.77 Favored Pre-proline 0 CA--C 1.536 0.406 0 CA-C-N 115.315 -0.857 . . . . 0.0 113.147 -176.664 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.534 ' HD2' ' N ' ' A' ' 49' ' ' LEU . 10.3 Cg_endo -54.2 -36.42 85.79 Favored 'Trans proline' 0 C--N 1.354 0.818 0 C-N-CA 121.683 1.589 . . . . 0.0 112.048 174.426 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . 0.521 ' HA ' ' HB2' ' A' ' 54' ' ' GLU . . . -82.21 -22.44 35.93 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.329 0.585 . . . . 0.0 110.106 -178.443 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.787 HD12 HD23 ' A' ' 49' ' ' LEU . 27.3 mt -64.74 -37.26 86.99 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.423 -0.808 . . . . 0.0 110.156 175.423 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . 0.449 ' HE3' ' HB3' ' A' ' 53' ' ' LYS . 10.2 mtpp -75.2 -40.21 59.44 Favored 'General case' 0 CA--C 1.517 -0.322 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.951 173.567 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.597 ' CD ' ' HZ1' ' A' ' 58' ' ' LYS . 6.4 mm-40 -47.16 -50.38 20.65 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.538 -0.755 . . . . 0.0 110.678 173.213 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 73.6 mt -59.01 -55.35 36.3 Favored 'General case' 0 N--CA 1.446 -0.631 0 CA-C-N 115.592 -0.731 . . . . 0.0 111.072 176.261 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.601 ' OE2' ' HB3' ' A' ' 88' ' ' LYS . 37.7 tt0 -45.01 -60.64 1.98 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.477 -0.783 . . . . 0.0 112.558 179.776 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 61.5 mt-10 -74.42 -31.99 62.5 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 111.96 0.356 . . . . 0.0 111.96 -169.86 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . 0.597 ' HZ1' ' CD ' ' A' ' 54' ' ' GLU . 49.5 mttp -78.38 -40.67 35.54 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.131 0.491 . . . . 0.0 111.081 -178.169 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.564 ' HB2' ' HE2' ' A' ' 66' ' ' PHE . 73.2 m-85 -102.78 8.43 39.38 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.497 -173.915 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . 0.48 ' HB2' ' O ' ' A' ' 56' ' ' GLU . . . -59.53 131.41 50.85 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.657 172.156 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 77.13 11.01 85.95 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.962 -0.637 . . . . 0.0 113.027 176.147 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 33.5 mmtm -89.13 -136.11 0.11 Allowed 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.966 -0.383 . . . . 0.0 109.966 177.624 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . 0.746 ' HA ' ' HD3' ' A' ' 31' ' ' LYS . 4.6 t0 -120.02 42.14 3.01 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 121.542 0.687 . . . . 0.0 109.778 179.008 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.413 HG23 ' HB3' ' A' ' 59' ' ' TYR . 7.3 tp -148.81 151.21 13.35 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 115.083 -0.962 . . . . 0.0 109.868 -171.624 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' HIS . . . . . 0.578 ' NE2' ' HB2' ' A' ' 31' ' ' LYS . 80.9 m-70 -126.99 137.8 53.16 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 175.128 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . 0.564 ' HE2' ' HB2' ' A' ' 59' ' ' TYR . 91.0 m-85 -110.43 109.98 20.57 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 120.624 0.249 . . . . 0.0 110.415 178.714 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.536 ' HB ' HG12 ' A' ' 35' ' ' ILE . 49.8 t -109.1 109.26 27.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.156 -177.115 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 50.2 m -91.68 114.0 26.41 Favored 'General case' 0 C--N 1.316 -0.884 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 174.144 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.576 ' O ' ' HA ' ' A' ' 37' ' ' VAL . 66.7 tp -109.83 130.02 55.57 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.555 -0.293 . . . . 0.0 110.266 178.649 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' SER . . . . . 0.558 ' O ' ' HB3' ' A' ' 94' ' ' MET . 1.8 t -109.02 119.23 38.94 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 111.93 0.344 . . . . 0.0 111.93 -173.758 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' CYS . . . . . 0.555 ' HB3' ' SD ' ' A' ' 101' ' ' MET . 33.6 m -88.14 19.29 3.76 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.519 177.368 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . 0.563 ' OD2' HG23 ' A' ' 40' ' ' THR . 2.2 m-20 -73.33 113.99 11.04 Favored 'General case' 0 CA--C 1.515 -0.403 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.705 -178.54 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . 0.522 ' HA ' ' O ' ' A' ' 95' ' ' GLY . 47.3 tttm -71.63 -17.53 62.26 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-O 121.155 0.502 . . . . 0.0 110.312 177.812 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 4.6 m-20 -83.83 91.31 7.52 Favored 'General case' 0 CA--C 1.515 -0.392 0 N-CA-C 109.025 -0.731 . . . . 0.0 109.025 175.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.652 ' HZ2' ' HG3' ' A' ' 79' ' ' GLU . 13.0 tmtt? -64.98 -65.09 0.72 Allowed 'General case' 0 C--N 1.322 -0.629 0 C-N-CA 120.066 -0.654 . . . . 0.0 110.984 -176.69 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 11.1 tmtt? -52.24 -45.66 65.41 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.2 -0.909 . . . . 0.0 111.195 -176.357 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.683 ' HA ' ' ND2' ' A' ' 80' ' ' ASN . . . -61.77 -38.69 88.96 Favored 'General case' 0 C--O 1.246 0.881 0 CA-C-O 121.572 0.701 . . . . 0.0 110.644 -177.281 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' TRP . . . . . 0.698 ' CE3' ' HB ' ' A' ' 40' ' ' THR . 4.7 t-105 -70.14 -47.55 61.24 Favored 'General case' 0 N--CA 1.438 -1.042 0 CA-C-N 115.099 -0.955 . . . . 0.0 110.634 -176.798 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . 0.652 ' HG3' ' HZ2' ' A' ' 75' ' ' LYS . 4.0 mm-40 -47.25 -44.78 23.13 Favored 'General case' 0 C--O 1.236 0.355 0 O-C-N 123.418 0.449 . . . . 0.0 111.774 175.347 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . 0.683 ' ND2' ' HA ' ' A' ' 77' ' ' ALA . 1.8 m-80 -59.83 -50.84 72.21 Favored 'General case' 0 CA--C 1.518 -0.288 0 C-N-CA 120.196 -0.601 . . . . 0.0 110.468 179.501 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' MET . . . . . 0.4 ' HE3' ' HB2' ' A' ' 81' ' ' MET . 23.1 ttm -64.27 -42.32 96.49 Favored 'General case' 0 C--N 1.332 -0.156 0 N-CA-C 112.578 0.585 . . . . 0.0 112.578 -173.016 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.516 HG11 ' O ' ' A' ' 78' ' ' TRP . 1.3 p -62.45 -37.43 78.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 C-N-CA 120.061 -0.656 . . . . 0.0 110.714 177.884 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 32.8 m -70.74 -35.75 72.82 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.221 0.534 . . . . 0.0 110.532 178.427 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 22.0 tttm -73.4 -52.29 14.31 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.721 -0.672 . . . . 0.0 111.571 -178.554 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -85.81 6.74 26.71 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.444 -0.798 . . . . 0.0 111.899 -173.404 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 89.8 mt-30 57.84 38.34 27.16 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 122.927 0.491 . . . . 0.0 111.605 175.237 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.636 HD21 HD22 ' A' ' 49' ' ' LEU . 44.4 mt -73.72 111.48 8.91 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.515 -177.08 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . 0.69 ' HZ3' ' HB3' ' A' ' 88' ' ' LYS . 3.9 mmmp? -105.51 -157.1 0.6 Allowed 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 112.537 0.569 . . . . 0.0 112.537 -177.346 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 97.04 176.76 34.89 Favored Glycine 0 N--CA 1.447 -0.591 0 N-CA-C 110.507 -1.037 . . . . 0.0 110.507 -169.254 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 63.0 mt -83.22 110.94 18.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 N-CA-C 107.065 -1.457 . . . . 0.0 107.065 169.873 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . 0.65 ' HB2' ' CZ2' ' A' ' 38' ' ' TRP . 1.3 pt20 -122.78 123.21 40.52 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-O 121.666 0.746 . . . . 0.0 112.837 -164.114 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.578 HD11 ' HB ' ' A' ' 23' ' ' VAL . 2.5 mm? -121.23 149.93 42.12 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 114.937 -1.029 . . . . 0.0 109.318 178.272 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 16.1 t-80 -120.33 135.23 55.08 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-O 121.642 0.734 . . . . 0.0 111.589 -176.113 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' MET . . . . . 0.78 ' HG3' ' HB2' ' A' ' 97' ' ' ASP . 25.7 ttm -103.21 91.96 4.31 Favored 'General case' 0 N--CA 1.442 -0.871 0 CA-C-N 114.391 -1.277 . . . . 0.0 108.16 178.933 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . 0.522 ' O ' ' HA ' ' A' ' 73' ' ' LYS . . . -57.76 -55.19 31.86 Favored Glycine 0 C--N 1.318 -0.426 0 CA-C-N 115.169 -0.923 . . . . 0.0 113.807 -175.256 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 10.9 m -146.94 13.0 1.12 Allowed 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 122.064 0.935 . . . . 0.0 109.49 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . 0.78 ' HB2' ' HG3' ' A' ' 94' ' ' MET . 0.7 OUTLIER -81.56 31.83 0.35 Allowed 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 114.838 -1.074 . . . . 0.0 110.462 -175.471 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . 0.528 ' HA ' ' SD ' ' A' ' 94' ' ' MET . 0.0 OUTLIER -67.52 0.03 3.42 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 113.362 0.875 . . . . 0.0 113.362 -170.619 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' THR . . . . . 0.451 ' HA ' ' NH2' ' A' ' 98' ' ' ARG . 10.4 m -66.01 -19.23 65.79 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.66 0.743 . . . . 0.0 109.568 172.806 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 16.4 t80 -79.55 -24.14 42.34 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 115.317 -0.856 . . . . 0.0 110.135 177.773 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' MET . . . . . 0.555 ' SD ' ' HB3' ' A' ' 71' ' ' CYS . 88.6 mtp -60.17 -48.12 83.06 Favored 'General case' 0 CA--C 1.515 -0.395 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 174.357 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 67.5 m-20 -56.04 -40.89 74.17 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.224 -0.898 . . . . 0.0 111.088 176.577 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -63.25 -28.64 70.17 Favored 'General case' 0 N--CA 1.462 0.131 0 CA-C-N 116.198 -0.455 . . . . 0.0 112.075 -176.058 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' TYR . . . . . 0.944 ' HB3' HG21 ' A' ' 106' ' ' ILE . 2.8 m-85 -107.49 -6.36 17.08 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 111.937 0.347 . . . . 0.0 111.937 -178.602 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 3.4 mm? 57.94 33.06 22.77 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-O 121.425 0.631 . . . . 0.0 110.269 -174.049 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . 0.944 HG21 ' HB3' ' A' ' 104' ' ' TYR . 32.9 pt -88.93 36.18 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.248 -177.854 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 5.0 p-10 -67.28 -28.34 67.94 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.962 0.41 . . . . 0.0 110.376 179.266 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -92.06 103.5 3.06 Favored Glycine 0 N--CA 1.444 -0.769 0 N-CA-C 111.106 -0.798 . . . . 0.0 111.106 175.608 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . 0.453 ' HA ' ' C ' ' A' ' 110' ' ' PRO . 34.3 pt -110.79 153.46 43.69 Favored Pre-proline 0 C--N 1.324 -0.501 0 O-C-N 123.315 0.068 . . . . 0.0 110.943 -178.131 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . 0.83 ' HD3' ' HB2' ' A' ' 45' ' ' CYS . 42.2 Cg_endo -68.98 150.5 88.26 Favored 'Cis proline' 0 C--N 1.35 0.654 0 C-N-CA 123.547 -1.439 . . . . 0.0 112.428 0.982 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . 0.578 ' HG3' HG23 ' A' ' 106' ' ' ILE . 0.0 OUTLIER -114.52 127.9 56.05 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.209 -177.215 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . 0.531 ' HB2' ' HB3' ' A' ' 126' ' ' MET . 0.2 OUTLIER -102.47 114.35 28.48 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 114.701 -1.136 . . . . 0.0 110.608 -177.504 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 86.8 mt -130.75 143.51 40.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 120.85 0.357 . . . . 0.0 111.119 -178.244 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 48.2 tp -124.05 134.63 53.37 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.032 178.762 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . 0.454 ' N ' HD13 ' A' ' 115' ' ' LEU . 1.6 mp -134.36 160.47 37.84 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.225 0.536 . . . . 0.0 110.615 -177.341 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . 0.486 ' HB2' HD13 ' A' ' 122' ' ' ILE . 28.5 t70 -77.17 167.96 20.87 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.193 -0.912 . . . . 0.0 110.351 177.288 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . 0.755 ' O ' ' HA ' ' A' ' 29' ' ' LYS . 81.9 mtt-85 -47.97 -37.66 15.06 Favored 'General case' 0 C--N 1.327 -0.382 0 O-C-N 124.402 1.064 . . . . 0.0 112.446 -177.524 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . 0.547 ' HA ' ' HG3' ' A' ' 29' ' ' LYS . 25.4 t0 -76.84 -0.1 22.77 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.532 0.682 . . . . 0.0 111.244 -178.922 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . 0.758 ' HA2' HD12 ' A' ' 33' ' ' ILE . . . 82.86 24.53 52.64 Favored Glycine 0 N--CA 1.431 -1.678 0 N-CA-C 110.058 -1.217 . . . . 0.0 110.058 -171.523 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . 0.46 ' HB2' ' HB3' ' A' ' 116' ' ' ASP . 44.9 mmtm -92.73 106.22 18.23 Favored 'General case' 0 C--O 1.222 -0.371 0 C-N-CA 120.601 -0.439 . . . . 0.0 111.466 -178.047 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . 0.445 HD12 ' HB3' ' A' ' 10' ' ' ALA . 4.4 mp -41.51 117.58 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.397 0 CA-C-N 115.416 -0.811 . . . . 0.0 112.273 -177.95 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' ILE . . . . . 0.486 HD13 ' HB2' ' A' ' 116' ' ' ASP . 45.6 mm -98.95 -43.62 11.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 115.392 -0.822 . . . . 0.0 109.313 176.288 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 16.2 m -135.6 114.32 11.9 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.305 -0.861 . . . . 0.0 109.917 178.428 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -77.49 -12.38 59.95 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.24 0.543 . . . . 0.0 110.555 179.681 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 6.5 t30 -143.65 98.58 3.27 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.186 -0.915 . . . . 0.0 108.573 175.686 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' MET . . . . . 0.697 ' HE2' ' HD3' ' A' ' 137' ' ' LYS . 17.6 tpt -77.79 -86.6 0.06 Allowed 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.649 -174.546 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 8.4 m -155.87 -73.01 0.11 Allowed 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.945 0.402 . . . . 0.0 110.055 -178.889 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . 0.742 ' HB3' ' HB2' ' A' ' 131' ' ' ASP . 44.9 ttt180 -178.35 143.17 0.45 Allowed Pre-proline 0 N--CA 1.44 -0.955 0 CA-C-N 115.508 -0.769 . . . . 0.0 109.159 -179.226 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . 0.651 ' HB2' ' HB3' ' A' ' 48' ' ' GLU . 57.3 Cg_exo -52.72 -45.45 40.35 Favored 'Trans proline' 0 C--N 1.346 0.431 0 C-N-CA 122.577 2.185 . . . . 0.0 112.856 178.405 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' SER . . . . . 0.525 ' HB3' ' HA ' ' A' ' 48' ' ' GLU . 31.2 p -96.22 5.7 50.43 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 112.279 0.474 . . . . 0.0 112.279 -176.717 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . 0.787 ' OD1' ' HG2' ' A' ' 133' ' ' LYS . 11.3 t70 -89.3 128.43 51.36 Favored Pre-proline 0 C--O 1.235 0.312 0 C-N-CA 120.101 -0.64 . . . . 0.0 110.469 -178.658 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . 0.615 ' O ' ' HG3' ' A' ' 136' ' ' GLU . 82.6 Cg_exo -46.92 -41.23 25.71 Favored 'Trans proline' 0 C--N 1.344 0.325 0 C-N-CA 124.048 3.165 . . . . 0.0 114.944 -178.042 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . 0.787 ' HG2' ' OD1' ' A' ' 131' ' ' ASP . 27.7 mmtm -53.61 -37.71 63.29 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-O 121.209 0.528 . . . . 0.0 110.194 -172.097 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' THR . . . . . 0.714 HG23 ' CZ ' ' A' ' 138' ' ' PHE . 4.9 m -59.31 -59.62 5.16 Favored 'General case' 0 N--CA 1.446 -0.642 0 CA-C-N 115.23 -0.895 . . . . 0.0 110.657 178.0 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . 0.529 ' HA ' ' CD2' ' A' ' 138' ' ' PHE . . . -61.54 -41.21 97.0 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.862 -179.626 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . 0.615 ' HG3' ' O ' ' A' ' 132' ' ' PRO . 19.9 mt-10 -66.92 -28.77 68.57 Favored 'General case' 0 CA--C 1.514 -0.423 0 CA-C-O 121.409 0.623 . . . . 0.0 110.511 -177.154 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . 0.697 ' HD3' ' HE2' ' A' ' 126' ' ' MET . 60.8 tttp -75.06 -31.23 61.2 Favored 'General case' 0 C--N 1.317 -0.848 0 CA-C-N 115.298 -0.865 . . . . 0.0 111.024 177.119 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . 0.714 ' CZ ' HG23 ' A' ' 134' ' ' THR . 12.2 m-30 -62.08 -41.06 97.79 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 173.69 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' ASN . . . . . 0.414 ' HB2' ' O ' ' A' ' 136' ' ' GLU . 5.7 m-20 -57.48 -53.15 61.37 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.02 -0.991 . . . . 0.0 110.157 172.901 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . 0.531 ' HB3' ' O ' ' A' ' 137' ' ' LYS . 8.0 tt0 -43.07 -51.55 5.75 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 123.14 0.576 . . . . 0.0 111.958 171.392 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . 0.536 ' HG ' ' O ' ' A' ' 137' ' ' LYS . 94.2 mt -58.34 -37.92 76.14 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.9 -178.112 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 11.2 mp . . . . . 0 C--N 1.329 -0.296 0 CA-C-O 120.89 0.376 . . . . 0.0 111.163 -179.764 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.235 0.322 0 CA-C-O 121.054 0.454 . . . . 0.0 111.121 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -155.24 101.45 2.22 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.98 177.83 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' SER . . . . . 0.456 ' HA ' HD23 ' A' ' 25' ' ' LEU . 36.9 m 65.01 103.85 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.474 0 CA-C-O 121.398 0.618 . . . . 0.0 112.128 178.128 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 36.5 p90 -125.81 171.03 11.02 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.426 178.487 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 30.7 m -140.91 129.21 22.34 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.899 -0.408 . . . . 0.0 109.899 178.227 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 45.8 m-85 -144.46 158.06 54.82 Favored Pre-proline 0 C--N 1.327 -0.372 0 CA-C-O 120.612 0.244 . . . . 0.0 110.841 -177.599 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_endo -87.09 128.5 2.71 Favored 'Trans proline' 0 N--CA 1.455 -0.751 0 C-N-CA 123.028 2.485 . . . . 0.0 113.023 178.882 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . 1.144 ' HB3' ' HB3' ' A' ' 21' ' ' LYS . 0.8 OUTLIER -66.32 162.77 19.5 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.409 -0.814 . . . . 0.0 109.735 170.687 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.854 HG13 HG11 ' A' ' 82' ' ' VAL . 24.5 mm -44.23 -45.43 2.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 O-C-N 124.27 0.981 . . . . 0.0 112.392 -177.367 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 33.2 m-80 -79.54 2.98 20.18 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.674 -172.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 87.5 35.79 9.17 Favored Glycine 0 N--CA 1.448 -0.557 0 N-CA-C 110.574 -1.011 . . . . 0.0 110.574 -174.526 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 1.144 ' HB3' ' HB3' ' A' ' 17' ' ' ASP . 35.5 ttmt -100.92 107.33 18.8 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.209 -0.495 . . . . 0.0 110.412 -174.835 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 25.2 m -74.34 105.73 5.64 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 120.924 0.392 . . . . 0.0 110.976 -177.137 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.548 ' HB ' HD13 ' A' ' 92' ' ' LEU . 45.8 t -117.99 138.07 49.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 116.064 -0.517 . . . . 0.0 109.668 179.192 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 80.3 p -113.6 156.5 23.55 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 116.316 -0.402 . . . . 0.0 109.93 179.263 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.503 ' O ' ' HB2' ' A' ' 29' ' ' LYS . 34.4 tp -70.42 -9.69 57.09 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.16 177.543 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -80.96 -26.98 36.2 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.494 177.288 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -74.15 -34.72 63.94 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.548 0.69 . . . . 0.0 110.107 175.795 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.472 HD12 HG22 ' A' ' 90' ' ' ILE . 66.6 mt -91.78 0.44 57.49 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.322 -0.854 . . . . 0.0 110.557 179.226 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.503 ' HB2' ' O ' ' A' ' 25' ' ' LEU . 60.2 tttp -74.54 150.63 39.69 Favored 'General case' 0 N--CA 1.443 -0.808 0 CA-C-N 115.134 -0.939 . . . . 0.0 110.633 -176.504 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 94.65 5.41 61.51 Favored Glycine 0 N--CA 1.447 -0.601 0 N-CA-C 110.576 -1.01 . . . . 0.0 110.576 -175.128 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 1.063 ' HD2' ' HA ' ' A' ' 63' ' ' ASP . 11.0 tppt? -146.0 151.44 37.78 Favored 'General case' 0 N--CA 1.446 -0.646 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 -177.982 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 61.3 m-85 -65.92 151.28 47.11 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 120.985 -0.286 . . . . 0.0 110.652 179.793 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.539 ' HB ' ' HB2' ' A' ' 115' ' ' LEU . 46.1 mm -127.08 125.86 67.13 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.975 -176.068 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . 0.434 ' CE2' ' HB2' ' A' ' 36' ' ' ASP . 59.0 t80 -105.43 112.01 24.95 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 170.554 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.548 ' HB ' ' HB ' ' A' ' 113' ' ' ILE . 40.3 mt -92.14 120.72 41.82 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-O 121.298 0.57 . . . . 0.0 110.461 179.77 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.539 ' O ' ' HA ' ' A' ' 68' ' ' SER . 15.9 t70 -120.24 125.03 47.11 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 115.133 -0.94 . . . . 0.0 109.231 178.919 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.504 HG13 HG22 ' A' ' 109' ' ' ILE . 21.5 t -82.5 113.92 22.53 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.913 0 C-N-CA 119.817 -0.753 . . . . 0.0 110.717 -178.981 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' TRP . . . . . 0.602 ' O ' ' HB2' ' A' ' 70' ' ' SER . 0.5 OUTLIER -108.95 135.82 49.5 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.268 -0.878 . . . . 0.0 108.926 -177.967 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.608 ' HB2' ' HB3' ' A' ' 42' ' ' CYS . . . -145.04 172.36 13.17 Favored 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 120.433 -0.507 . . . . 0.0 111.96 -176.919 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -89.18 -43.17 11.21 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.661 0.743 . . . . 0.0 109.855 176.95 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' TRP . . . . . 0.511 ' CH2' HD11 ' A' ' 109' ' ' ILE . 11.1 p-90 -88.39 12.35 14.43 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 114.957 -1.02 . . . . 0.0 111.233 -176.056 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' CYS . . . . . 0.76 ' SG ' ' HB3' ' A' ' 45' ' ' CYS . 28.3 p -79.33 -17.86 53.68 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.154 -178.792 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 57.49 -107.06 0.88 Allowed Glycine 0 CA--C 1.522 0.508 0 CA-C-N 116.057 -0.519 . . . . 0.0 113.829 177.258 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_exo -51.6 -25.77 20.73 Favored 'Trans proline' 0 C--N 1.353 0.776 0 C-N-CA 123.746 2.964 . . . . 0.0 113.688 -177.348 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . 0.76 ' HB3' ' SG ' ' A' ' 42' ' ' CYS . 7.0 t -52.95 -30.68 36.11 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-O 120.844 0.354 . . . . 0.0 111.3 176.838 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.565 ' HA ' ' HG ' ' A' ' 49' ' ' LEU . 64.9 mtp180 -68.15 -11.42 59.14 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.835 -0.62 . . . . 0.0 111.677 -175.679 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -69.56 -33.23 71.75 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.919 -0.658 . . . . 0.0 112.595 179.802 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . 0.548 ' OE2' ' HD3' ' A' ' 128' ' ' ARG . 28.0 mt-10 -93.6 -9.0 39.55 Favored 'General case' 0 C--N 1.328 -0.366 0 O-C-N 122.738 -0.272 . . . . 0.0 111.061 -177.561 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.604 ' HB3' HD21 ' A' ' 87' ' ' LEU . 81.4 mt -55.52 -46.69 99.68 Favored Pre-proline 0 C--N 1.326 -0.426 0 CA-C-N 116.558 -0.292 . . . . 0.0 111.455 179.331 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.983 ' HA ' ' HE3' ' A' ' 53' ' ' LYS . 51.5 Cg_exo -55.34 -43.95 53.56 Favored 'Trans proline' 0 C--N 1.356 0.956 0 C-N-CA 121.635 1.556 . . . . 0.0 111.895 170.781 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -69.02 -24.29 64.19 Favored 'General case' 0 N--CA 1.462 0.138 0 CA-C-O 121.13 0.49 . . . . 0.0 110.686 -174.483 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 8.7 tt -68.42 -39.28 81.65 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.486 -0.779 . . . . 0.0 109.252 178.015 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . 0.983 ' HE3' ' HA ' ' A' ' 50' ' ' PRO . 8.4 mtmp? -62.84 -51.48 66.88 Favored 'General case' 0 CA--C 1.519 -0.248 0 CA-C-O 121.73 0.776 . . . . 0.0 109.375 177.302 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -57.82 -37.81 74.48 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 114.977 -1.01 . . . . 0.0 111.205 179.347 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.476 HD23 ' HE2' ' A' ' 138' ' ' PHE . 12.9 tp -73.98 -40.7 62.79 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.543 -0.299 . . . . 0.0 110.64 179.583 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.634 ' HG3' ' O ' ' A' ' 53' ' ' LYS . 0.0 OUTLIER -66.24 -39.52 89.6 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.711 -0.222 . . . . 0.0 110.473 -177.496 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 51.5 mt-10 -76.44 -28.27 56.53 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.009 0.433 . . . . 0.0 110.73 -179.255 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 63.7 tttm -70.21 -31.36 68.76 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.862 176.489 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.458 ' HB3' HD12 ' A' ' 64' ' ' ILE . 88.0 m-85 -112.17 5.71 18.65 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 112.0 0.37 . . . . 0.0 112.0 -176.099 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -62.93 142.97 58.11 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.618 175.687 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 95.11 -14.24 65.59 Favored Glycine 0 N--CA 1.446 -0.673 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.054 -179.743 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . 0.736 ' HE2' ' HB3' ' A' ' 142' ' ' LEU . 18.7 mmmt -104.13 -169.86 1.69 Allowed 'General case' 0 N--CA 1.448 -0.532 0 CA-C-O 121.271 0.558 . . . . 0.0 111.463 178.859 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . 1.063 ' HA ' ' HD2' ' A' ' 31' ' ' LYS . 28.0 m-20 -87.91 34.12 0.72 Allowed 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 113.401 0.889 . . . . 0.0 113.401 -165.848 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.458 HD12 ' HB3' ' A' ' 59' ' ' TYR . 27.6 pt -140.57 135.8 35.27 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-O 120.786 0.327 . . . . 0.0 110.639 176.213 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' HIS . . . . . 0.487 ' HB2' HD11 ' A' ' 33' ' ' ILE . 39.2 m-70 -109.61 144.25 38.2 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.074 175.889 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . 0.44 ' HE2' HD22 ' A' ' 55' ' ' LEU . 59.8 m-85 -100.78 114.6 28.53 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 173.468 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.638 ' HA ' ' O ' ' A' ' 90' ' ' ILE . 58.2 t -123.35 115.07 44.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-O 120.974 0.416 . . . . 0.0 111.125 -175.315 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' SER . . . . . 0.539 ' HA ' ' O ' ' A' ' 36' ' ' ASP . 50.9 m -96.48 131.15 43.37 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.688 179.01 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.432 ' O ' ' HA ' ' A' ' 37' ' ' VAL . 84.8 mt -120.9 139.03 53.78 Favored 'General case' 0 N--CA 1.468 0.47 0 N-CA-C 110.51 -0.182 . . . . 0.0 110.51 178.062 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' SER . . . . . 0.602 ' HB2' ' O ' ' A' ' 38' ' ' TRP . 0.8 OUTLIER -123.69 129.94 51.88 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 112.5 0.556 . . . . 0.0 112.5 -174.374 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 4.8 p -93.65 23.03 4.95 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.301 173.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . 0.483 ' OD1' ' HA ' ' A' ' 39' ' ' ALA . 3.0 m-20 -79.47 108.02 12.68 Favored 'General case' 0 N--CA 1.467 0.382 0 O-C-N 122.339 -0.226 . . . . 0.0 111.013 -177.389 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 16.2 ptpt -68.12 -20.95 64.96 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 120.979 0.418 . . . . 0.0 110.658 178.09 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . 0.514 ' HB2' ' HB2' ' A' ' 77' ' ' ALA . 1.0 OUTLIER -79.42 69.09 5.61 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.394 174.122 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 11.9 tttt -58.73 -51.24 70.8 Favored 'General case' 0 C--O 1.218 -0.564 0 CA-C-N 116.63 -0.259 . . . . 0.0 111.649 -174.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.652 ' HA ' ' OE2' ' A' ' 79' ' ' GLU . 0.2 OUTLIER -58.11 -44.37 87.65 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 120.811 0.339 . . . . 0.0 110.442 -177.478 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.514 ' HB2' ' HB2' ' A' ' 74' ' ' ASN . . . -62.37 -43.29 99.18 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.683 0.754 . . . . 0.0 110.567 178.285 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' TRP . . . . . 0.457 ' O ' HG12 ' A' ' 82' ' ' VAL . 3.9 t-105 -73.34 -45.76 53.29 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 115.159 -0.928 . . . . 0.0 111.268 -176.731 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . 0.652 ' OE2' ' HA ' ' A' ' 76' ' ' LYS . 0.6 OUTLIER -62.79 -35.29 79.39 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.001 -175.026 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 4.6 p30 -78.03 -33.51 51.06 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 119.657 -0.817 . . . . 0.0 110.339 178.772 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 45.4 tpp -61.96 -51.92 66.12 Favored 'General case' 0 C--O 1.222 -0.391 0 N-CA-C 111.462 0.171 . . . . 0.0 111.462 176.572 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.854 HG11 HG13 ' A' ' 18' ' ' ILE . 2.4 p -59.17 -37.03 66.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 C-N-CA 120.828 -0.349 . . . . 0.0 110.628 177.817 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 91.8 m -61.53 -39.09 89.8 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-O 120.894 0.378 . . . . 0.0 110.694 175.724 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . 0.451 ' O ' ' HD2' ' A' ' 84' ' ' LYS . 0.2 OUTLIER -75.91 -44.94 37.85 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 179.717 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . 0.464 ' CG ' HH21 ' A' ' 46' ' ' ARG . 1.8 m-20 -69.6 -19.92 63.64 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.466 -0.788 . . . . 0.0 111.702 -176.387 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 73.1 mt-30 60.08 58.93 2.53 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-O 121.531 0.681 . . . . 0.0 110.936 176.853 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.604 HD21 ' HB3' ' A' ' 49' ' ' LEU . 81.9 mt -86.31 134.14 33.76 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.458 -0.792 . . . . 0.0 111.132 -177.068 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . 0.569 ' HB3' ' OE2' ' A' ' 56' ' ' GLU . 11.7 mmmm -91.93 -168.99 2.14 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.934 177.249 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 84.49 160.25 31.35 Favored Glycine 0 N--CA 1.447 -0.612 0 C-N-CA 121.098 -0.573 . . . . 0.0 112.336 -177.436 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.638 ' O ' ' HA ' ' A' ' 67' ' ' VAL . 53.8 mt -77.68 113.0 16.29 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 175.405 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . 0.6 ' HB2' ' CZ2' ' A' ' 38' ' ' TRP . 1.6 pt20 -124.14 123.12 39.61 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-O 121.439 0.637 . . . . 0.0 112.074 -167.452 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.548 HD13 ' HB ' ' A' ' 23' ' ' VAL . 2.8 mm? -120.6 167.51 12.34 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.391 -0.822 . . . . 0.0 109.621 178.276 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 20.6 t-80 -138.66 126.89 22.82 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-O 121.201 0.524 . . . . 0.0 111.36 -173.084 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' MET . . . . . 0.624 ' HE2' ' HB2' ' A' ' 101' ' ' MET . 37.1 ttp -88.57 -67.05 0.86 Allowed 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 114.989 -1.005 . . . . 0.0 109.4 176.683 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . 0.425 ' HA2' ' O ' ' A' ' 72' ' ' ASP . . . 84.07 -77.5 2.11 Favored Glycine 0 N--CA 1.442 -0.901 0 C-N-CA 120.74 -0.743 . . . . 0.0 114.069 172.951 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 5.6 p -84.93 -19.57 32.0 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 113.247 0.832 . . . . 0.0 113.247 -169.75 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -101.54 154.77 18.55 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 119.723 -0.791 . . . . 0.0 111.023 -178.172 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . 0.464 ' HA ' ' HB3' ' A' ' 101' ' ' MET . 0.0 OUTLIER -140.66 9.05 2.19 Favored 'General case' 0 N--CA 1.446 -0.643 0 CA-C-N 115.511 -0.768 . . . . 0.0 109.789 173.083 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 4.5 m -78.32 -36.31 46.55 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.246 0.546 . . . . 0.0 109.793 178.426 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 70.5 t80 -74.78 -30.5 61.46 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 174.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' MET . . . . . 0.68 ' HG2' HG13 ' A' ' 106' ' ' ILE . 1.6 tmt? -64.2 -38.02 89.55 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 114.453 -1.249 . . . . 0.0 109.977 172.034 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -65.72 -44.44 86.05 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.468 -0.787 . . . . 0.0 110.483 177.61 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -62.88 -21.24 65.85 Favored 'General case' 0 CA--C 1.528 0.132 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.882 -177.604 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 6.3 m-30 -100.39 -3.1 31.77 Favored 'General case' 0 C--O 1.237 0.419 0 CA-C-N 116.418 -0.355 . . . . 0.0 111.002 179.645 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 95.4 mt 59.05 25.94 14.49 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.108 -179.168 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . 0.68 HG13 ' HG2' ' A' ' 101' ' ' MET . 30.4 pt -86.64 66.14 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-O 121.664 0.745 . . . . 0.0 111.01 -177.693 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . 0.58 ' HA ' ' HE2' ' A' ' 101' ' ' MET . 44.2 t-20 -81.51 -59.72 2.52 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.364 -0.834 . . . . 0.0 109.81 179.786 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -82.93 90.2 1.53 Allowed Glycine 0 N--CA 1.446 -0.673 0 C-N-CA 120.634 -0.794 . . . . 0.0 111.482 176.931 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . 0.511 HD11 ' CH2' ' A' ' 41' ' ' TRP . 46.5 pt -91.33 158.23 41.32 Favored Pre-proline 0 C--N 1.326 -0.448 0 N-CA-C 110.655 -0.128 . . . . 0.0 110.655 179.89 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . 0.747 ' HD3' ' HB2' ' A' ' 45' ' ' CYS . 40.9 Cg_endo -65.84 153.98 79.98 Favored 'Cis proline' 0 C--N 1.35 0.605 0 C-N-CA 124.006 -1.248 . . . . 0.0 113.691 1.939 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . 0.494 ' HG3' ' HA ' ' A' ' 106' ' ' ILE . 0.0 OUTLIER -125.8 138.14 53.82 Favored 'General case' 0 N--CA 1.446 -0.668 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.017 -179.302 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . 0.778 ' HD2' ' HB2' ' A' ' 128' ' ' ARG . 0.1 OUTLIER -102.05 117.53 34.99 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.358 -0.837 . . . . 0.0 110.633 -177.74 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.548 ' HB ' ' HB ' ' A' ' 35' ' ' ILE . 92.7 mt -131.15 145.13 35.87 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.283 0 CA-C-O 120.87 0.367 . . . . 0.0 111.128 -178.065 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.417 ' C ' HD12 ' A' ' 115' ' ' LEU . 42.0 tp -125.61 141.65 51.92 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.332 -0.395 . . . . 0.0 109.943 178.193 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . 0.657 ' HG ' ' HA ' ' A' ' 121' ' ' ILE . 3.0 mp -134.87 153.98 51.84 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.061 0.458 . . . . 0.0 110.587 -178.018 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 27.8 t0 -79.72 166.49 21.74 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.221 -0.9 . . . . 0.0 110.765 178.596 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . 0.408 ' HA ' ' O ' ' A' ' 31' ' ' LYS . 5.6 mtm180 -53.57 -26.42 21.42 Favored 'General case' 0 N--CA 1.466 0.348 0 O-C-N 124.437 1.085 . . . . 0.0 111.956 -178.8 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -69.31 -16.72 63.61 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.302 0.573 . . . . 0.0 110.549 178.89 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 93.0 24.44 22.65 Favored Glycine 0 N--CA 1.436 -1.353 0 N-CA-C 109.762 -1.335 . . . . 0.0 109.762 -169.893 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . 0.4 ' HD2' ' HA ' ' A' ' 120' ' ' LYS . 24.6 mmmt -111.7 114.34 27.29 Favored 'General case' 0 C--O 1.221 -0.403 0 N-CA-C 112.235 0.457 . . . . 0.0 112.235 -172.507 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . 0.657 ' HA ' ' HG ' ' A' ' 115' ' ' LEU . 4.1 mp -42.74 116.01 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 O-C-N 123.972 0.795 . . . . 0.0 111.761 178.576 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' ILE . . . . . 0.413 ' H ' ' HA ' ' A' ' 115' ' ' LEU . 69.3 mt -87.84 -47.69 15.52 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-N 115.21 -0.904 . . . . 0.0 108.726 174.94 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 15.1 m -128.52 114.53 16.87 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-N 115.003 -0.999 . . . . 0.0 109.944 179.631 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -70.98 -21.66 62.29 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.103 0.478 . . . . 0.0 110.577 178.509 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 6.9 t30 -139.57 101.53 4.24 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.539 -0.755 . . . . 0.0 109.009 176.399 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 13.1 tpt -105.48 -127.04 0.24 Allowed 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.2 -175.891 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 2.0 p -145.08 136.61 25.28 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 110.134 -0.321 . . . . 0.0 110.134 -178.062 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . 0.778 ' HB2' ' HD2' ' A' ' 112' ' ' PHE . 14.8 ttt180 -94.68 152.55 39.92 Favored Pre-proline 0 CA--C 1.535 0.401 0 CA-C-O 119.242 -0.408 . . . . 0.0 110.854 -177.978 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . 0.674 ' HD2' ' CG ' ' A' ' 128' ' ' ARG . 47.0 Cg_exo -24.4 -39.72 0.02 OUTLIER 'Trans proline' 0 C--N 1.366 1.469 1 C-N-CA 126.32 4.68 . . . . 0.0 117.275 175.771 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' SER . . . . . 0.505 ' HG ' ' CD ' ' A' ' 48' ' ' GLU . 66.6 m -50.33 -29.85 10.79 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-N 118.526 0.603 . . . . 0.0 111.129 175.302 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -92.2 121.36 66.77 Favored Pre-proline 0 C--N 1.323 -0.571 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.536 175.519 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . 0.467 ' O ' ' HG3' ' A' ' 136' ' ' GLU . 59.9 Cg_endo -72.16 -23.73 20.93 Favored 'Trans proline' 0 N--CA 1.462 -0.346 0 C-N-CA 122.492 2.128 . . . . 0.0 112.322 179.664 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . 0.47 ' HA ' ' HD3' ' A' ' 133' ' ' LYS . 57.3 mmtt -63.09 -30.25 71.45 Favored 'General case' 0 CA--C 1.518 -0.259 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.878 -177.771 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' THR . . . . . 0.764 HG21 ' CZ ' ' A' ' 138' ' ' PHE . 3.0 m -59.11 -54.81 42.83 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.742 -0.663 . . . . 0.0 109.718 175.234 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . 0.582 ' HA ' ' CD2' ' A' ' 138' ' ' PHE . . . -59.99 -43.56 95.09 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-N 115.67 -0.695 . . . . 0.0 112.045 177.817 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . 0.467 ' HG3' ' O ' ' A' ' 132' ' ' PRO . 50.8 mt-10 -55.72 -52.01 65.38 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-O 122.025 0.917 . . . . 0.0 110.269 177.47 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . 0.658 ' HE3' HD21 ' A' ' 141' ' ' LEU . 52.3 tptt -54.53 -40.63 68.83 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 113.956 -1.475 . . . . 0.0 111.319 179.113 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . 0.764 ' CZ ' HG21 ' A' ' 134' ' ' THR . 19.5 m-30 -55.49 -47.69 75.77 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 116.63 -0.259 . . . . 0.0 110.582 177.105 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 39.5 m-20 -54.18 -55.03 31.86 Favored 'General case' 0 CA--C 1.521 -0.162 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 -179.254 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . 0.592 ' CD ' ' HZ3' ' A' ' 137' ' ' LYS . 8.8 tt0 -48.87 -57.71 5.99 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.403 -0.817 . . . . 0.0 111.968 174.95 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . 0.658 HD21 ' HE3' ' A' ' 137' ' ' LYS . 90.2 mt -60.89 -37.3 81.74 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.799 -174.477 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . 0.736 ' HB3' ' HE2' ' A' ' 62' ' ' LYS . 89.2 mt . . . . . 0 C--N 1.323 -0.56 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.144 -178.387 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . 0.641 ' HA ' ' HZ ' ' A' ' 100' ' ' PHE . . . . . . . . 0 N--CA 1.47 0.542 0 N-CA-C 112.667 0.618 . . . . 0.0 112.667 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -56.67 -32.54 65.51 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 112.87 0.693 . . . . 0.0 112.87 -172.895 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 31.1 m -147.68 86.56 1.6 Allowed 'General case' 0 C--N 1.316 -0.873 0 CA-C-O 121.128 0.489 . . . . 0.0 111.362 179.188 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . 0.468 ' CE2' HD22 ' A' ' 25' ' ' LEU . 47.9 p90 -105.57 163.15 12.89 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 172.712 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' SER . . . . . 0.419 ' HA ' ' HA ' ' A' ' 24' ' ' SER . 14.0 m -139.71 122.03 15.99 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 109.805 -0.442 . . . . 0.0 109.805 178.852 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . 0.413 ' HA ' ' HD3' ' A' ' 16' ' ' PRO . 19.6 m-85 -137.11 149.32 65.84 Favored Pre-proline 0 C--N 1.327 -0.393 0 CA-C-O 120.678 0.275 . . . . 0.0 110.744 -177.262 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.46 ' HD2' ' O ' ' A' ' 93' ' ' HIS . 9.2 Cg_exo -72.35 124.37 9.87 Favored 'Trans proline' 0 N--CA 1.456 -0.678 0 C-N-CA 122.473 2.115 . . . . 0.0 112.54 178.02 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . 0.865 ' HB3' ' HB3' ' A' ' 21' ' ' LYS . 0.2 OUTLIER -68.97 162.95 25.65 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.132 -0.94 . . . . 0.0 109.765 172.769 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.633 HD11 HG12 ' A' ' 82' ' ' VAL . 0.8 OUTLIER -44.78 -43.42 2.49 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 O-C-N 124.147 0.904 . . . . 0.0 112.171 -177.227 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . 0.505 ' ND2' HG23 ' A' ' 18' ' ' ILE . 21.8 m-80 -77.42 1.2 19.82 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.144 -175.349 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 85.84 30.61 23.08 Favored Glycine 0 N--CA 1.446 -0.663 0 N-CA-C 110.682 -0.967 . . . . 0.0 110.682 -173.626 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.865 ' HB3' ' HB3' ' A' ' 17' ' ' ASP . 2.0 ttmp? -98.09 116.04 29.48 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.481 -0.36 . . . . 0.0 110.902 -172.933 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 25.6 m -70.38 104.78 2.81 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 120.867 0.365 . . . . 0.0 110.905 178.799 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.433 ' HB ' ' CD2' ' A' ' 92' ' ' LEU . 61.0 t -121.32 146.16 26.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 178.741 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' SER . . . . . 0.419 ' HA ' ' HA ' ' A' ' 14' ' ' SER . 86.7 p -121.52 -173.96 2.75 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 109.985 -0.376 . . . . 0.0 109.985 -178.666 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.685 ' O ' ' HB2' ' A' ' 29' ' ' LYS . 15.0 tp -98.84 0.69 44.78 Favored 'General case' 0 C--N 1.32 -0.685 0 C-N-CA 120.16 -0.616 . . . . 0.0 109.951 173.881 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -85.99 -32.71 21.37 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.398 -179.06 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -77.01 -17.98 58.47 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.367 0.603 . . . . 0.0 110.117 176.104 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 85.8 mt -100.12 -5.31 28.06 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.602 -0.727 . . . . 0.0 110.429 176.859 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.685 ' HB2' ' O ' ' A' ' 25' ' ' LEU . 58.4 tttm -81.7 140.98 34.0 Favored 'General case' 0 N--CA 1.443 -0.79 0 CA-C-N 115.582 -0.735 . . . . 0.0 110.705 -172.338 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 115.63 -13.58 17.88 Favored Glycine 0 N--CA 1.452 -0.239 0 N-CA-C 111.326 -0.71 . . . . 0.0 111.326 -175.389 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.501 ' HG3' ' OD1' ' A' ' 63' ' ' ASP . 25.0 ttmm -132.27 153.1 50.99 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 177.129 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.648 ' HB2' HG23 ' A' ' 64' ' ' ILE . 24.7 m-85 -51.92 141.85 16.78 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 118.328 0.513 . . . . 0.0 110.916 -176.491 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.571 HG21 HD13 ' A' ' 25' ' ' LEU . 67.3 mt -119.27 122.29 68.72 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.74 -174.545 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . 0.523 ' OH ' ' HG3' ' A' ' 128' ' ' ARG . 30.2 t80 -114.99 134.66 54.99 Favored 'General case' 0 C--N 1.316 -0.863 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 173.94 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.61 ' HA ' ' O ' ' A' ' 67' ' ' VAL . 82.1 mt -130.26 129.88 65.3 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.047 -176.651 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.62 ' O ' ' HA ' ' A' ' 68' ' ' SER . 4.6 p30 -130.6 160.29 34.64 Favored 'General case' 0 C--O 1.217 -0.614 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.418 172.71 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.536 ' HB ' ' HA ' ' A' ' 110' ' ' PRO . 47.8 t -95.56 137.94 22.44 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 CA-C-O 121.087 0.47 . . . . 0.0 111.779 -178.429 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' TRP . . . . . 0.926 ' HZ3' HG21 ' A' ' 82' ' ' VAL . 0.6 OUTLIER -122.34 132.91 54.62 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 174.244 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -148.43 154.14 39.48 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 120.767 -0.373 . . . . 0.0 111.655 -176.727 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' THR . . . . . 0.672 ' HB ' ' CE3' ' A' ' 78' ' ' TRP . 4.1 t -92.93 -28.68 16.31 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 121.203 -0.199 . . . . 0.0 110.785 173.516 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 11.5 p-90 -81.69 -8.32 59.69 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.939 0.4 . . . . 0.0 110.417 179.537 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' CYS . . . . . 0.535 ' HB3' ' SG ' ' A' ' 45' ' ' CYS . 47.7 t -86.35 -71.33 0.55 Allowed 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 173.099 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 112.21 -77.53 0.24 Allowed Glycine 0 C--O 1.227 -0.293 0 C-N-CA 120.532 -0.842 . . . . 0.0 113.239 176.87 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.535 ' HD2' ' O ' ' A' ' 42' ' ' CYS . 9.7 Cg_endo -52.38 -31.79 49.08 Favored 'Trans proline' 0 C--N 1.353 0.815 0 C-N-CA 123.182 2.588 . . . . 0.0 112.431 -178.636 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . 0.569 ' HB3' ' HD3' ' A' ' 110' ' ' PRO . 26.9 p -61.41 -17.0 52.21 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.688 -179.899 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.475 ' HA ' HD23 ' A' ' 49' ' ' LEU . 61.7 mtp180 -83.27 -19.4 36.41 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.814 0.34 . . . . 0.0 111.075 -177.48 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -83.77 -7.68 85.5 Favored Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.479 -176.705 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -95.58 -10.44 29.55 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.513 0.197 . . . . 0.0 111.152 -177.283 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.958 ' HG ' ' HB3' ' A' ' 87' ' ' LEU . 4.2 mm? -55.25 -44.85 99.85 Favored Pre-proline 0 CA--C 1.538 0.487 0 CA-C-N 116.649 -0.251 . . . . 0.0 111.505 176.709 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.661 ' O ' ' HG2' ' A' ' 54' ' ' GLU . 76.0 Cg_exo -52.68 -37.37 75.1 Favored 'Trans proline' 0 C--N 1.357 0.981 0 C-N-CA 121.816 1.677 . . . . 0.0 112.131 170.606 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -71.51 -19.84 62.14 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.35 0.595 . . . . 0.0 110.704 -178.071 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 8.1 tt -72.88 -45.69 56.85 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.568 -0.742 . . . . 0.0 109.692 -179.83 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . 0.504 ' HG3' ' N ' ' A' ' 54' ' ' GLU . 7.9 ptmm? -63.89 -42.04 97.57 Favored 'General case' 0 C--O 1.226 -0.15 0 N-CA-C 109.878 -0.415 . . . . 0.0 109.878 177.704 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.661 ' HG2' ' O ' ' A' ' 50' ' ' PRO . 55.2 mm-40 -51.22 -49.75 60.44 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-O 121.64 0.733 . . . . 0.0 110.224 177.932 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.708 HD13 ' HD2' ' A' ' 59' ' ' TYR . 0.2 OUTLIER -66.7 -39.21 87.98 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.068 -0.969 . . . . 0.0 110.755 -179.021 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 14.2 tp10 -61.23 -57.66 11.51 Favored 'General case' 0 N--CA 1.447 -0.591 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.045 -177.207 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 -67.97 -25.42 65.42 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 111.744 0.276 . . . . 0.0 111.744 -176.113 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . 0.492 ' HD3' ' CE2' ' A' ' 59' ' ' TYR . 63.4 tttt -67.7 -34.12 76.25 Favored 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 120.759 -0.376 . . . . 0.0 110.51 174.064 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.708 ' HD2' HD13 ' A' ' 55' ' ' LEU . 68.3 m-85 -119.81 25.17 10.15 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.426 -176.327 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -49.63 116.51 1.79 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.059 0.457 . . . . 0.0 111.972 178.143 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 105.11 -0.73 40.96 Favored Glycine 0 N--CA 1.453 -0.214 0 C-N-CA 120.945 -0.645 . . . . 0.0 112.451 179.504 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . 0.803 ' HG2' HG12 ' A' ' 64' ' ' ILE . 0.0 OUTLIER -67.32 174.9 2.98 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.523 0.678 . . . . 0.0 112.422 -178.299 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . 0.501 ' OD1' ' HG3' ' A' ' 31' ' ' LYS . 32.3 t70 -101.28 51.45 0.85 Allowed 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.905 -177.317 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.803 HG12 ' HG2' ' A' ' 62' ' ' LYS . 19.4 pt -146.8 165.57 7.3 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.401 0 N-CA-C 110.113 -0.329 . . . . 0.0 110.113 177.546 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' HIS . . . . . 0.475 ' NE2' ' HB3' ' A' ' 31' ' ' LYS . 85.2 m-70 -122.9 140.42 52.99 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 175.922 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . 0.68 ' O ' ' HB ' ' A' ' 90' ' ' ILE . 79.6 m-85 -102.01 103.18 13.78 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 172.381 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.61 ' O ' ' HA ' ' A' ' 35' ' ' ILE . 39.0 t -119.12 113.6 41.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-O 120.967 0.413 . . . . 0.0 111.11 -175.465 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' SER . . . . . 0.62 ' HA ' ' O ' ' A' ' 36' ' ' ASP . 0.7 OUTLIER -93.95 131.96 38.88 Favored 'General case' 0 C--N 1.317 -0.824 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 177.521 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.536 ' CD2' ' HB2' ' A' ' 92' ' ' LEU . 73.2 mt -118.2 137.7 52.83 Favored 'General case' 0 N--CA 1.468 0.463 0 O-C-N 122.072 -0.392 . . . . 0.0 110.426 176.918 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' SER . . . . . 0.552 ' HB2' ' O ' ' A' ' 38' ' ' TRP . 1.3 t -118.06 123.5 45.81 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.188 0.518 . . . . 0.0 112.029 -176.209 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 49.7 t -89.85 14.14 12.75 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.75 176.417 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . 0.55 ' O ' ' HA2' ' A' ' 95' ' ' GLY . 0.9 OUTLIER -65.53 133.11 50.53 Favored 'General case' 0 CA--C 1.516 -0.362 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 -178.292 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . 0.486 ' HB2' ' NZ ' ' A' ' 73' ' ' LYS . 1.0 OUTLIER -87.45 -24.94 23.99 Favored 'General case' 0 C--N 1.316 -0.872 0 C-N-CA 120.084 -0.646 . . . . 0.0 110.571 -177.646 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . 0.497 ' HB2' ' HB3' ' A' ' 77' ' ' ALA . 0.7 OUTLIER -84.12 78.97 9.67 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.343 176.175 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.453 ' HZ2' ' CD ' ' A' ' 79' ' ' GLU . 10.2 tttt -61.63 -56.58 18.31 Favored 'General case' 0 C--O 1.221 -0.443 0 C-N-CA 120.826 -0.35 . . . . 0.0 111.741 -173.763 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.551 ' HA ' ' OE1' ' A' ' 79' ' ' GLU . 17.3 tppt? -57.09 -40.62 77.32 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 111.882 0.327 . . . . 0.0 111.882 -177.903 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.497 ' HB3' ' HB2' ' A' ' 74' ' ' ASN . . . -62.79 -41.2 99.16 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.827 0.823 . . . . 0.0 110.188 177.393 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' TRP . . . . . 0.672 ' CE3' ' HB ' ' A' ' 40' ' ' THR . 5.2 t-105 -74.31 -47.57 33.81 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 114.698 -1.137 . . . . 0.0 111.202 -176.802 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . 0.551 ' OE1' ' HA ' ' A' ' 76' ' ' LYS . 3.3 pt-20 -64.57 -35.52 81.24 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.938 -174.782 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 3.6 p30 -74.94 -37.13 62.07 Favored 'General case' 0 CA--C 1.523 -0.081 0 C-N-CA 119.995 -0.682 . . . . 0.0 110.114 179.053 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 34.4 ttm -64.1 -50.52 67.98 Favored 'General case' 0 C--O 1.219 -0.552 0 C-N-CA 120.65 -0.42 . . . . 0.0 110.784 175.914 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.926 HG21 ' HZ3' ' A' ' 38' ' ' TRP . 12.5 p -63.18 -23.23 32.75 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-O 121.086 0.469 . . . . 0.0 111.005 -178.158 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' THR . . . . . 0.563 ' OG1' HD13 ' A' ' 18' ' ' ILE . 88.2 m -76.38 -46.82 25.65 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.566 -0.288 . . . . 0.0 110.453 171.98 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.32 -42.36 88.32 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.337 0.589 . . . . 0.0 110.384 -178.286 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -74.51 -5.61 43.66 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.186 -0.915 . . . . 0.0 111.282 -179.824 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 47.7 mt-30 63.52 17.74 10.57 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 115.867 -0.606 . . . . 0.0 112.368 174.556 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.958 ' HB3' ' HG ' ' A' ' 49' ' ' LEU . 29.2 mt -74.67 93.78 2.6 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.96 -0.385 . . . . 0.0 109.96 -179.986 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 9.0 mmtm -110.07 -178.84 3.62 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 113.006 0.743 . . . . 0.0 113.006 -176.261 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 130.88 -165.02 23.08 Favored Glycine 0 N--CA 1.449 -0.448 0 N-CA-C 109.71 -1.356 . . . . 0.0 109.71 -172.117 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.68 ' HB ' ' O ' ' A' ' 66' ' ' PHE . 60.9 mt -85.02 112.14 21.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 118.054 0.927 . . . . 0.0 108.508 172.808 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . 0.58 ' HB2' ' CZ2' ' A' ' 38' ' ' TRP . 2.1 pt20 -142.01 113.26 7.6 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 121.457 0.646 . . . . 0.0 111.69 -170.647 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.536 ' HB2' ' CD2' ' A' ' 69' ' ' LEU . 77.5 mt -110.42 154.23 23.87 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.495 -0.775 . . . . 0.0 109.902 -179.75 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' HIS . . . . . 0.46 ' O ' ' HD2' ' A' ' 16' ' ' PRO . 35.4 t-80 -121.93 126.81 49.47 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-O 121.455 0.645 . . . . 0.0 111.134 -175.254 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 28.2 ttp -91.12 -72.62 0.57 Allowed 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 114.801 -1.09 . . . . 0.0 109.923 178.197 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . 0.55 ' HA2' ' O ' ' A' ' 72' ' ' ASP . . . 86.48 -75.26 2.26 Favored Glycine 0 N--CA 1.446 -0.648 0 C-N-CA 120.601 -0.809 . . . . 0.0 114.24 173.863 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -90.42 -34.59 15.57 Favored 'General case' 0 C--N 1.315 -0.928 0 N-CA-C 112.126 0.417 . . . . 0.0 112.126 -174.556 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -92.75 54.91 2.32 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.717 -163.833 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . 0.4 ' HD3' ' C ' ' A' ' 98' ' ' ARG . 0.0 OUTLIER -67.71 4.94 0.94 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.952 -0.567 . . . . 0.0 112.405 -176.812 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 9.4 t -66.74 -19.44 65.75 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.126 0.489 . . . . 0.0 109.76 174.887 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' PHE . . . . . 0.641 ' HZ ' ' HA ' ' A' ' 10' ' ' ALA . 10.5 t80 -77.28 -23.87 51.09 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.174 177.652 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 93.6 mmm -62.41 -48.12 81.11 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 174.761 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -62.25 -22.49 66.03 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 115.405 -0.816 . . . . 0.0 111.649 176.603 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -70.42 -24.06 62.85 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.697 0.284 . . . . 0.0 111.115 179.544 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' TYR . . . . . 0.547 ' HB2' HD12 ' A' ' 106' ' ' ILE . 47.2 m-85 -106.28 -11.31 16.06 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.802 176.561 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 7.2 mp 67.14 14.59 9.83 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 115.61 -0.723 . . . . 0.0 112.071 179.181 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . 1.054 ' HB ' ' HG3' ' A' ' 111' ' ' ARG . 0.2 OUTLIER -82.84 149.95 4.45 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.428 0 CA-C-O 120.933 0.397 . . . . 0.0 110.804 -179.926 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 5.1 p30 -127.37 -57.65 1.29 Allowed 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.435 -179.289 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -76.38 116.1 4.62 Favored Glycine 0 N--CA 1.447 -0.601 0 C-N-CA 120.966 -0.635 . . . . 0.0 112.587 -179.389 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . 0.438 ' HB ' ' HA ' ' A' ' 110' ' ' PRO . 40.2 pt -102.65 153.62 38.05 Favored Pre-proline 0 C--N 1.326 -0.441 0 N-CA-C 110.43 -0.211 . . . . 0.0 110.43 176.344 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . 0.569 ' HD3' ' HB3' ' A' ' 45' ' ' CYS . 49.5 Cg_endo -71.61 133.94 30.69 Favored 'Cis proline' 0 C--N 1.343 0.288 0 C-N-CA 123.175 -1.594 . . . . 0.0 113.236 1.312 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . 1.054 ' HG3' ' HB ' ' A' ' 106' ' ' ILE . 0.0 OUTLIER -95.22 146.41 24.35 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 173.975 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . 0.542 ' CE1' ' HB2' ' A' ' 128' ' ' ARG . 9.7 m-85 -119.35 119.44 34.0 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 -177.495 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 91.7 mt -131.13 138.19 53.96 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-O 121.015 0.436 . . . . 0.0 110.975 -177.283 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.691 HD21 HD13 ' A' ' 141' ' ' LEU . 30.6 tp -119.47 133.09 55.86 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.631 -0.713 . . . . 0.0 109.471 177.738 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . 0.423 ' N ' HD13 ' A' ' 115' ' ' LEU . 0.7 OUTLIER -133.74 155.33 49.96 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.206 0.527 . . . . 0.0 110.61 -178.003 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . 0.626 ' HB3' ' HB2' ' A' ' 120' ' ' LYS . 17.6 t70 -71.21 166.82 20.71 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.176 -0.92 . . . . 0.0 110.804 176.76 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . 0.406 ' N ' ' CG ' ' A' ' 116' ' ' ASP . 69.4 mtt85 -51.55 -32.15 27.1 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 124.281 1.033 . . . . 0.0 112.974 -178.09 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . 0.691 ' HB3' ' HD3' ' A' ' 120' ' ' LYS . 25.4 t70 -81.25 4.48 20.24 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-O 121.474 0.654 . . . . 0.0 110.474 179.45 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 81.31 23.11 59.38 Favored Glycine 0 N--CA 1.438 -1.207 0 N-CA-C 110.466 -1.054 . . . . 0.0 110.466 -173.832 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . 0.691 ' HD3' ' HB3' ' A' ' 118' ' ' ASP . 19.8 mmmt -81.27 106.69 13.45 Favored 'General case' 0 CA--C 1.51 -0.566 0 C-N-CA 120.646 -0.422 . . . . 0.0 110.864 -176.028 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 3.6 mp -47.05 106.58 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.315 -0.916 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.822 178.189 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 39.3 mm -88.34 -47.21 15.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 115.51 -0.768 . . . . 0.0 109.661 -179.75 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 13.6 m -144.95 114.64 7.26 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.721 178.576 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -74.52 -24.13 58.93 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.621 0.724 . . . . 0.0 109.782 174.774 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . 0.741 ' HA ' ' NH1' ' A' ' 111' ' ' ARG . 53.6 t30 -110.4 85.04 2.03 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.487 -0.779 . . . . 0.0 109.329 175.485 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' MET . . . . . 0.611 ' HG2' ' HB2' ' A' ' 114' ' ' LEU . 3.3 tpt -113.54 -166.91 1.13 Allowed 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 107.813 -1.18 . . . . 0.0 107.813 179.026 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' THR . . . . . 0.576 ' O ' HG23 ' A' ' 134' ' ' THR . 2.1 p -132.11 161.53 33.07 Favored 'General case' 0 C--N 1.316 -0.882 0 N-CA-C 109.684 -0.487 . . . . 0.0 109.684 179.864 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . 0.626 ' CG ' ' HD2' ' A' ' 129' ' ' PRO . 19.2 ttt180 -86.76 158.01 54.23 Favored Pre-proline 0 C--N 1.316 -0.887 0 N-CA-C 109.795 -0.446 . . . . 0.0 109.795 179.387 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . 0.626 ' HD2' ' CG ' ' A' ' 128' ' ' ARG . 49.3 Cg_exo -42.81 -23.66 0.35 Allowed 'Trans proline' 0 C--N 1.356 0.945 0 C-N-CA 123.468 2.779 . . . . 0.0 113.908 170.906 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -55.85 -31.91 63.17 Favored 'General case' 0 CA--C 1.529 0.143 0 CA-C-O 121.092 0.472 . . . . 0.0 110.691 175.325 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 11.1 t0 -101.67 127.83 30.4 Favored Pre-proline 0 C--O 1.237 0.439 0 CA-C-N 115.852 -0.613 . . . . 0.0 109.92 179.51 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -58.35 -26.81 78.93 Favored 'Trans proline' 0 C--N 1.347 0.464 0 C-N-CA 123.299 2.666 . . . . 0.0 114.047 -178.385 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 42.3 mttp -56.15 -42.25 76.7 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-O 121.457 0.646 . . . . 0.0 110.842 -177.451 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' THR . . . . . 0.576 HG23 ' O ' ' A' ' 127' ' ' THR . 0.1 OUTLIER -69.14 -43.07 75.08 Favored 'General case' 0 N--CA 1.443 -0.821 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.539 178.883 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . 0.526 ' HA ' ' CD2' ' A' ' 138' ' ' PHE . . . -56.78 -46.92 81.22 Favored 'General case' 0 C--O 1.238 0.478 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.618 179.259 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . 0.647 ' HA ' ' OD1' ' A' ' 139' ' ' ASN . 14.7 pt-20 -71.15 -23.75 62.13 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.621 -179.559 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . 0.623 ' O ' ' HB3' ' A' ' 140' ' ' GLU . 60.9 tttp -79.28 -26.9 42.25 Favored 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 120.422 -0.511 . . . . 0.0 111.023 173.313 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . 0.587 ' HD2' HD11 ' A' ' 55' ' ' LEU . 21.5 m-85 -65.15 -43.2 92.57 Favored 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 120.469 -0.492 . . . . 0.0 110.213 177.138 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' ASN . . . . . 0.647 ' OD1' ' HA ' ' A' ' 136' ' ' GLU . 2.0 p-10 -70.01 -32.18 70.22 Favored 'General case' 0 C--O 1.224 -0.264 0 C-N-CA 120.006 -0.678 . . . . 0.0 110.128 175.099 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . 0.623 ' HB3' ' O ' ' A' ' 137' ' ' LYS . 4.4 tt0 -51.23 -55.13 19.69 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-O 120.823 0.344 . . . . 0.0 110.657 169.371 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . 0.691 HD13 HD21 ' A' ' 114' ' ' LEU . 90.1 mt -58.42 -36.26 73.34 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.533 -178.918 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . 0.496 ' HG ' ' O ' ' A' ' 138' ' ' PHE . 86.9 mt . . . . . 0 C--N 1.327 -0.382 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.2 -179.671 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 0.708 0 CA-C-O 121.125 0.488 . . . . 0.0 111.592 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -80.92 73.75 7.93 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.649 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' SER . . . . . 0.545 ' HA ' ' HB3' ' A' ' 25' ' ' LEU . 18.1 m 71.79 90.47 0.09 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.151 -0.931 . . . . 0.0 111.103 178.644 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 33.6 p90 -105.69 163.51 12.64 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.509 179.031 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' SER . . . . . 0.402 ' HA ' ' HA ' ' A' ' 24' ' ' SER . 11.9 p -137.45 128.27 27.18 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.276 -0.42 . . . . 0.0 109.902 178.053 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . 0.418 ' HA ' ' HD3' ' A' ' 16' ' ' PRO . 36.3 m-85 -140.91 149.63 56.78 Favored Pre-proline 0 C--N 1.326 -0.427 0 CA-C-N 116.532 -0.304 . . . . 0.0 110.248 -177.016 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.647 ' HA ' ' O ' ' A' ' 21' ' ' LYS . 3.8 Cg_exo -75.23 124.91 8.82 Favored 'Trans proline' 0 N--CA 1.453 -0.885 0 C-N-CA 122.201 1.934 . . . . 0.0 112.726 179.677 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . 0.739 ' HB3' ' HB3' ' A' ' 21' ' ' LYS . 0.0 OUTLIER -64.89 162.01 17.2 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.38 -0.827 . . . . 0.0 109.05 170.732 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.548 ' CG1' ' HA ' ' A' ' 79' ' ' GLU . 9.6 tp -62.42 -25.95 39.19 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.242 -171.656 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . 0.483 ' HB2' ' OD2' ' A' ' 17' ' ' ASP . 0.9 OUTLIER -80.85 4.98 17.4 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.127 177.253 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 78.89 49.54 6.4 Favored Glycine 0 N--CA 1.449 -0.451 0 N-CA-C 110.809 -0.917 . . . . 0.0 110.809 -176.258 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.739 ' HB3' ' HB3' ' A' ' 17' ' ' ASP . 0.0 OUTLIER -114.84 140.85 48.61 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.531 -0.335 . . . . 0.0 110.521 -173.63 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 19.6 m -90.62 99.07 12.17 Favored 'General case' 0 C--N 1.318 -0.762 0 C-N-CA 120.512 -0.475 . . . . 0.0 110.078 178.207 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.414 ' HB ' ' CD2' ' A' ' 92' ' ' LEU . 48.7 t -115.34 137.79 47.78 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 116.069 -0.514 . . . . 0.0 109.735 -179.756 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' SER . . . . . 0.402 ' HA ' ' HA ' ' A' ' 14' ' ' SER . 59.7 p -122.55 169.52 10.93 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.964 -175.786 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.78 HD12 HD13 ' A' ' 28' ' ' LEU . 32.5 tp -66.74 -16.1 64.0 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.026 174.87 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -62.4 -39.74 94.22 Favored 'General case' 0 C--N 1.333 -0.123 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.948 179.75 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -61.16 -33.81 74.02 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-O 121.772 0.796 . . . . 0.0 110.226 174.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.78 HD13 HD12 ' A' ' 25' ' ' LEU . 33.4 mt -79.64 -15.02 58.36 Favored 'General case' 0 N--CA 1.445 -0.688 0 CA-C-N 115.0 -1.0 . . . . 0.0 111.684 -173.008 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.663 ' HA ' ' O ' ' A' ' 117' ' ' ARG . 1.7 mptm? -66.46 160.83 24.11 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.392 0.615 . . . . 0.0 111.881 178.198 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 84.32 -14.83 43.25 Favored Glycine 0 N--CA 1.45 -0.374 0 CA-C-N 115.464 -0.789 . . . . 0.0 112.29 178.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.572 ' HG3' ' CG ' ' A' ' 63' ' ' ASP . 24.5 ttmm -144.15 143.15 30.96 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 109.311 -0.625 . . . . 0.0 109.311 -176.507 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 63.0 m-85 -56.2 155.04 7.11 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-O 120.681 0.277 . . . . 0.0 111.276 -177.689 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.545 HD13 ' HA2' ' A' ' 119' ' ' GLY . 43.3 mt -128.11 135.39 62.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-O 120.74 0.305 . . . . 0.0 111.565 -171.913 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . 0.52 ' HB2' HD13 ' A' ' 64' ' ' ILE . 88.1 t80 -120.04 116.47 25.79 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 173.532 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.528 ' HA ' ' O ' ' A' ' 67' ' ' VAL . 28.9 mm -101.7 132.21 48.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.566 -179.299 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.566 ' HA ' ' O ' ' A' ' 111' ' ' ARG . 1.2 t70 -140.77 162.76 34.65 Favored 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 176.992 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.546 ' HB ' ' HA ' ' A' ' 110' ' ' PRO . 46.8 t -102.06 131.22 50.5 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.919 0 C-N-CA 120.212 -0.595 . . . . 0.0 111.45 176.736 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' TRP . . . . . 0.668 ' CE3' ' HZ2' ' A' ' 78' ' ' TRP . 0.9 OUTLIER -126.14 132.75 51.78 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-O 120.822 0.344 . . . . 0.0 110.128 179.325 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.532 ' HB1' ' SG ' ' A' ' 42' ' ' CYS . . . -148.68 168.74 22.06 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-N 116.688 -0.233 . . . . 0.0 110.85 178.013 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' THR . . . . . 0.584 ' HB ' ' CE3' ' A' ' 78' ' ' TRP . 9.6 t -92.08 -18.68 23.24 Favored 'General case' 0 C--O 1.233 0.235 0 C-N-CA 120.868 -0.333 . . . . 0.0 111.667 179.265 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 1.5 p-90 -90.41 -13.46 34.9 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.788 0.328 . . . . 0.0 111.712 -177.44 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' CYS . . . . . 0.532 ' SG ' ' HB1' ' A' ' 39' ' ' ALA . 5.9 p -88.34 94.99 10.02 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.014 0.435 . . . . 0.0 110.515 177.723 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -54.17 -58.3 13.42 Favored Glycine 0 CA--C 1.524 0.647 0 CA-C-N 115.43 -0.804 . . . . 0.0 113.967 -179.309 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -53.95 -38.41 86.32 Favored 'Trans proline' 0 C--N 1.354 0.83 0 C-N-CA 122.721 2.28 . . . . 0.0 112.68 -178.31 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . 0.802 ' HB2' ' HD3' ' A' ' 110' ' ' PRO . 36.7 t -59.07 -38.54 79.69 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.184 0.516 . . . . 0.0 110.689 178.888 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.515 ' HA ' ' HG ' ' A' ' 49' ' ' LEU . 39.3 mtp180 -70.9 -15.83 62.64 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.911 -176.322 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -77.91 -26.48 60.28 Favored Glycine 0 N--CA 1.445 -0.701 0 C-N-CA 120.754 -0.736 . . . . 0.0 111.769 177.119 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . 0.638 ' HB3' ' HB3' ' A' ' 130' ' ' SER . 14.2 pt-20 -107.03 0.99 24.01 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.841 0.353 . . . . 0.0 111.5 -179.854 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.539 ' N ' ' HD2' ' A' ' 50' ' ' PRO . 68.4 mt -59.94 -45.8 98.16 Favored Pre-proline 0 CA--C 1.537 0.456 0 CA-C-N 116.531 -0.304 . . . . 0.0 111.288 172.992 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.539 ' HD2' ' N ' ' A' ' 49' ' ' LEU . 11.9 Cg_endo -57.53 -35.16 98.89 Favored 'Trans proline' 0 C--N 1.356 0.965 0 C-N-CA 121.761 1.641 . . . . 0.0 111.913 171.323 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . 0.559 ' HA ' ' HG2' ' A' ' 54' ' ' GLU . . . -67.3 -23.43 65.65 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-O 121.079 0.466 . . . . 0.0 110.806 179.042 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 10.0 tt -69.88 -34.08 73.08 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.944 -0.571 . . . . 0.0 109.554 176.073 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . 0.49 ' HB3' ' O ' ' A' ' 50' ' ' PRO . 11.3 tttm -65.54 -46.71 78.5 Favored 'General case' 0 N--CA 1.425 -1.675 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 172.402 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.559 ' HG2' ' HA ' ' A' ' 51' ' ' ALA . 24.4 mm-40 -52.6 -44.65 66.11 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.05 -0.977 . . . . 0.0 110.001 176.688 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 47.8 mt -57.15 -53.55 56.8 Favored 'General case' 0 N--CA 1.452 -0.375 0 CA-C-N 115.433 -0.803 . . . . 0.0 111.249 175.418 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -48.87 -58.86 4.16 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.204 -0.907 . . . . 0.0 111.848 -179.052 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -71.11 -27.69 63.77 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 111.828 0.306 . . . . 0.0 111.828 -176.49 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 33.5 tttm -66.12 -25.04 66.81 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-O 121.01 0.433 . . . . 0.0 109.911 175.185 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.705 ' HD1' ' HG3' ' A' ' 62' ' ' LYS . 53.1 m-85 -124.26 18.34 9.06 Favored 'General case' 0 N--CA 1.453 -0.284 0 N-CA-C 112.766 0.654 . . . . 0.0 112.766 -176.522 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -62.03 110.23 1.52 Allowed 'General case' 0 C--N 1.323 -0.543 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 169.595 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 113.74 -13.27 22.57 Favored Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 120.802 -0.713 . . . . 0.0 111.758 -175.215 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . 0.738 ' HD2' ' HG ' ' A' ' 142' ' ' LEU . 28.7 mmtp -84.82 -170.38 3.09 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-O 121.416 0.627 . . . . 0.0 110.809 177.418 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . 0.572 ' CG ' ' HG3' ' A' ' 31' ' ' LYS . 16.9 t70 -116.95 82.96 1.89 Allowed 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.417 -179.217 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.52 HD13 ' HB2' ' A' ' 34' ' ' TYR . 17.2 tt -157.97 141.94 7.05 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.535 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.342 177.211 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' HIS . . . . . 0.516 ' NE2' ' HB3' ' A' ' 31' ' ' LYS . 84.5 m-70 -103.52 108.58 19.89 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 109.176 -0.676 . . . . 0.0 109.176 171.258 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 89.6 m-85 -78.78 103.54 8.79 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 172.783 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.695 ' HA ' ' O ' ' A' ' 90' ' ' ILE . 41.2 t -127.79 117.87 47.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-O 120.797 0.332 . . . . 0.0 111.068 -174.501 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' SER . . . . . 0.514 ' HA ' ' O ' ' A' ' 36' ' ' ASP . 8.3 m -109.16 147.37 32.61 Favored 'General case' 0 C--N 1.318 -0.768 0 C-N-CA 120.687 -0.405 . . . . 0.0 110.597 178.03 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.52 HD11 ' HB2' ' A' ' 92' ' ' LEU . 3.8 mm? -110.96 132.91 53.81 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.476 178.355 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 27.5 t -112.95 117.33 31.78 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.106 0.479 . . . . 0.0 111.693 -179.118 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 71.7 m -91.81 33.24 1.05 Allowed 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.247 172.791 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . 0.523 ' OD2' HG22 ' A' ' 40' ' ' THR . 0.4 OUTLIER -75.62 126.41 30.95 Favored 'General case' 0 CA--C 1.512 -0.514 0 C-N-CA 120.155 -0.618 . . . . 0.0 110.446 178.07 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . 0.533 ' H ' ' HE3' ' A' ' 73' ' ' LYS . 0.0 OUTLIER -78.13 -14.56 59.43 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.224 -178.887 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . 0.518 ' N ' ' HD2' ' A' ' 73' ' ' LYS . 0.6 OUTLIER -101.19 68.95 1.26 Allowed 'General case' 0 CA--C 1.512 -0.51 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 179.283 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.594 ' O ' ' HG3' ' A' ' 79' ' ' GLU . 11.8 tmtt? -54.66 -53.13 58.8 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.616 -173.779 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.443 ' HA ' ' CD ' ' A' ' 79' ' ' GLU . 18.2 tptp -52.87 -53.74 44.66 Favored 'General case' 0 C--N 1.327 -0.376 0 O-C-N 123.321 0.388 . . . . 0.0 110.847 179.018 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.584 ' HA ' ' ND2' ' A' ' 80' ' ' ASN . . . -56.53 -36.67 69.49 Favored 'General case' 0 C--O 1.24 0.565 0 CA-C-O 121.517 0.675 . . . . 0.0 110.505 179.358 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' TRP . . . . . 0.668 ' HZ2' ' CE3' ' A' ' 38' ' ' TRP . 8.0 t-105 -68.64 -34.21 75.35 Favored 'General case' 0 N--CA 1.435 -1.216 0 CA-C-N 114.807 -1.088 . . . . 0.0 110.606 -178.02 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . 0.594 ' HG3' ' O ' ' A' ' 75' ' ' LYS . 52.7 mt-10 -53.66 -51.35 63.46 Favored 'General case' 0 CA--C 1.515 -0.39 0 CA-C-O 121.482 0.658 . . . . 0.0 110.822 173.766 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . 0.584 ' ND2' ' HA ' ' A' ' 77' ' ' ALA . 0.7 OUTLIER -66.23 -33.57 76.06 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.253 -0.885 . . . . 0.0 111.188 -173.282 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' MET . . . . . 0.403 ' HE3' HD12 ' A' ' 87' ' ' LEU . 1.4 tmt? -63.87 -59.12 4.92 Favored 'General case' 0 CA--C 1.517 -0.314 0 C-N-CA 120.849 -0.34 . . . . 0.0 111.306 177.731 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.556 HG21 ' HB2' ' A' ' 87' ' ' LEU . 5.7 p -58.52 -28.65 36.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-O 121.066 0.46 . . . . 0.0 110.873 -176.27 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 27.8 m -76.23 -40.43 52.12 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.927 -0.578 . . . . 0.0 110.954 176.902 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . 0.508 ' C ' ' HE2' ' A' ' 84' ' ' LYS . 0.0 OUTLIER -73.69 -49.0 27.92 Favored 'General case' 0 N--CA 1.456 -0.16 0 CA-C-O 121.338 0.589 . . . . 0.0 109.656 -178.096 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -76.27 0.49 19.09 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.129 -0.941 . . . . 0.0 111.211 -173.427 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 27.5 mt-30 61.41 34.21 18.34 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-N 115.79 -0.641 . . . . 0.0 112.575 168.853 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.556 ' HB2' HG21 ' A' ' 82' ' ' VAL . 72.0 mt -67.34 151.44 47.46 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.193 0.521 . . . . 0.0 111.548 -176.662 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 22.0 mmtm -117.75 -168.03 1.43 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.562 176.482 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 82.65 170.58 45.76 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 121.151 -0.547 . . . . 0.0 112.743 -177.719 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.695 ' O ' ' HA ' ' A' ' 67' ' ' VAL . 62.9 mt -85.64 112.11 21.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 N-CA-C 108.509 -0.922 . . . . 0.0 108.509 175.064 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . 0.657 ' HB3' ' CZ2' ' A' ' 38' ' ' TRP . 11.6 mm-40 -119.28 109.95 16.43 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-O 121.139 0.495 . . . . 0.0 111.181 -169.452 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.52 ' HB2' HD11 ' A' ' 69' ' ' LEU . 61.2 mt -106.55 149.46 27.12 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.465 0.65 . . . . 0.0 110.725 -177.64 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' HIS . . . . . 0.602 ' CE1' ' HA2' ' A' ' 95' ' ' GLY . 17.2 t-80 -119.95 111.59 18.11 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.662 -177.011 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 1.4 ttp -61.95 -49.64 75.3 Favored 'General case' 0 N--CA 1.448 -0.574 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.442 179.102 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . 0.602 ' HA2' ' CE1' ' A' ' 93' ' ' HIS . . . 118.68 -109.59 1.77 Allowed Glycine 0 N--CA 1.44 -1.076 0 CA-C-N 115.335 -0.848 . . . . 0.0 111.212 -177.997 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 1.7 m -126.94 24.17 6.48 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-O 120.731 0.3 . . . . 0.0 110.591 -179.255 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -87.32 142.65 27.73 Favored 'General case' 0 C--O 1.236 0.375 0 C-N-CA 119.656 -0.818 . . . . 0.0 111.276 -176.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . 0.775 ' HA ' ' HB2' ' A' ' 101' ' ' MET . 8.0 tpt180 -127.34 -3.42 6.19 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.039 -0.982 . . . . 0.0 110.163 178.057 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 1.5 m -66.49 -41.17 89.34 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 176.207 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' PHE . . . . . 0.402 ' CZ ' ' HE2' ' A' ' 104' ' ' TYR . 6.1 t80 -83.11 -24.34 32.66 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.433 -0.803 . . . . 0.0 109.707 176.298 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' MET . . . . . 0.775 ' HB2' ' HA ' ' A' ' 98' ' ' ARG . 0.0 OUTLIER -64.39 -55.49 20.69 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.432 -0.803 . . . . 0.0 109.078 178.125 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . 0.482 ' CG ' ' HE ' ' A' ' 98' ' ' ARG . 7.8 m-20 -65.02 -25.3 67.79 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.907 174.826 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -59.97 -32.24 70.64 Favored 'General case' 0 N--CA 1.466 0.33 0 N-CA-C 112.02 0.378 . . . . 0.0 112.02 -176.399 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' TYR . . . . . 0.402 ' HE2' ' CZ ' ' A' ' 100' ' ' PHE . 23.4 m-85 -101.04 8.55 42.89 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.619 0.247 . . . . 0.0 111.386 179.299 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 3.5 mm? 61.18 21.03 11.52 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.211 -179.831 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . 0.583 HG12 ' O ' ' A' ' 101' ' ' MET . 15.3 pt -79.98 150.55 4.91 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 176.013 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . 0.458 ' ND2' HH22 ' A' ' 98' ' ' ARG . 12.1 t-20 -160.82 -64.34 0.06 Allowed 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 -179.798 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -77.28 78.8 1.4 Allowed Glycine 0 N--CA 1.449 -0.498 0 N-CA-C 111.061 -0.815 . . . . 0.0 111.061 174.359 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . 0.553 ' HB ' ' HA ' ' A' ' 110' ' ' PRO . 2.8 pp -75.68 161.1 77.48 Favored Pre-proline 0 C--N 1.323 -0.572 0 CA-C-N 115.719 -0.241 . . . . 0.0 111.546 -175.366 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . 0.802 ' HD3' ' HB2' ' A' ' 45' ' ' CYS . 40.1 Cg_endo -68.72 164.21 76.73 Favored 'Cis proline' 0 C--N 1.35 0.633 0 C-N-CA 124.029 -1.238 . . . . 0.0 113.504 0.983 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . 0.566 ' O ' ' HA ' ' A' ' 36' ' ' ASP . 0.0 OUTLIER -129.54 137.59 50.85 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.728 -0.669 . . . . 0.0 109.43 179.314 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . 0.42 ' H ' ' HD3' ' A' ' 111' ' ' ARG . 0.2 OUTLIER -105.55 115.47 30.3 Favored 'General case' 0 C--N 1.323 -0.583 0 O-C-N 124.712 1.257 . . . . 0.0 111.413 -172.157 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.491 ' HB ' ' HB ' ' A' ' 35' ' ' ILE . 79.3 mt -131.16 146.15 34.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 120.936 0.398 . . . . 0.0 110.903 -178.956 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 42.0 tp -128.89 135.6 49.28 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.148 178.382 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . 0.491 ' N ' HD13 ' A' ' 115' ' ' LEU . 1.3 mp -135.51 161.13 36.34 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.368 0.604 . . . . 0.0 110.892 -178.216 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . 0.848 ' HB3' ' HB2' ' A' ' 120' ' ' LYS . 17.8 t70 -74.22 165.35 25.31 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 114.874 -1.057 . . . . 0.0 110.443 175.728 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . 0.663 ' O ' ' HA ' ' A' ' 29' ' ' LYS . 53.8 mtt-85 -46.71 -39.35 11.35 Favored 'General case' 0 C--N 1.33 -0.271 0 O-C-N 124.308 1.005 . . . . 0.0 112.423 -178.562 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . 0.588 ' HA ' ' HG3' ' A' ' 29' ' ' LYS . 14.6 t0 -83.92 16.77 2.65 Favored 'General case' 0 C--O 1.237 0.423 0 CA-C-O 121.154 0.502 . . . . 0.0 111.253 -177.623 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . 0.545 ' HA2' HD13 ' A' ' 33' ' ' ILE . . . 72.85 25.26 74.32 Favored Glycine 0 N--CA 1.435 -1.416 0 C-N-CA 120.417 -0.897 . . . . 0.0 110.869 -175.712 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . 0.848 ' HB2' ' HB3' ' A' ' 116' ' ' ASP . 40.3 mmtm -85.7 104.17 15.17 Favored 'General case' 0 C--O 1.22 -0.462 0 C-N-CA 120.378 -0.529 . . . . 0.0 111.458 -179.196 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . 0.455 ' HA ' ' HG ' ' A' ' 115' ' ' LEU . 3.8 mp -44.81 113.22 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.678 -179.053 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 46.0 mm -95.75 -44.25 12.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.664 -0.698 . . . . 0.0 109.597 177.855 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 14.6 m -142.29 114.82 8.48 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.485 -0.78 . . . . 0.0 110.086 177.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -78.06 -6.9 56.05 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.043 0.449 . . . . 0.0 110.832 179.276 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 5.9 t30 -150.81 100.59 2.83 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.83 -0.623 . . . . 0.0 109.416 179.456 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' MET . . . . . 0.599 ' HG2' HG23 ' A' ' 134' ' ' THR . 43.9 tpp -89.67 -91.04 0.14 Allowed 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 111.935 0.346 . . . . 0.0 111.935 -176.76 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' THR . . . . . 0.544 ' O ' ' HG2' ' A' ' 128' ' ' ARG . 0.0 OUTLIER -152.67 -70.21 0.15 Allowed 'General case' 0 CA--C 1.531 0.235 0 N-CA-C 112.322 0.49 . . . . 0.0 112.322 -178.326 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . 0.544 ' HG2' ' O ' ' A' ' 127' ' ' THR . 3.5 mmt180 175.99 140.13 0.21 Allowed Pre-proline 0 N--CA 1.467 0.393 0 C-N-CA 124.351 1.06 . . . . 0.0 109.299 -173.474 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . 0.407 ' HG3' ' OD2' ' A' ' 36' ' ' ASP . 46.0 Cg_exo -56.44 -37.33 97.38 Favored 'Trans proline' 0 C--N 1.342 0.23 0 C-N-CA 122.339 2.026 . . . . 0.0 111.874 171.522 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' SER . . . . . 0.638 ' HB3' ' HB3' ' A' ' 48' ' ' GLU . 13.3 p -78.06 -25.67 47.83 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.821 179.663 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . 0.507 ' OD2' ' HB2' ' A' ' 133' ' ' LYS . 29.7 t70 -78.49 117.6 67.31 Favored Pre-proline 0 C--N 1.327 -0.406 0 CA-C-O 120.832 0.348 . . . . 0.0 110.724 -175.336 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . 0.58 ' O ' ' HG2' ' A' ' 136' ' ' GLU . 49.6 Cg_exo -56.6 -29.49 79.47 Favored 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 123.469 2.78 . . . . 0.0 113.73 -175.233 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . 0.703 ' O ' ' HG2' ' A' ' 137' ' ' LYS . 0.0 OUTLIER -54.48 -35.36 62.99 Favored 'General case' 0 N--CA 1.456 -0.152 0 CA-C-O 120.578 0.227 . . . . 0.0 110.688 -177.824 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' THR . . . . . 0.599 HG23 ' HG2' ' A' ' 126' ' ' MET . 4.6 m -60.69 -48.81 80.13 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.482 0.658 . . . . 0.0 110.666 178.399 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . 0.61 ' HA ' ' CD2' ' A' ' 138' ' ' PHE . . . -61.78 -43.36 99.0 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.315 -0.857 . . . . 0.0 111.106 -178.228 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . 0.58 ' HG2' ' O ' ' A' ' 132' ' ' PRO . 10.8 mm-40 -72.05 -23.97 61.45 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.546 -177.279 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . 0.703 ' HG2' ' O ' ' A' ' 133' ' ' LYS . 17.8 mmtm -56.07 -49.77 72.85 Favored 'General case' 0 CA--C 1.515 -0.369 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 167.901 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . 0.61 ' CD2' ' HA ' ' A' ' 135' ' ' ALA . 7.0 m-30 -55.26 -36.91 66.58 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-N 115.163 -0.926 . . . . 0.0 110.57 -178.746 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' ASN . . . . . 0.541 ' ND2' ' HA ' ' A' ' 136' ' ' GLU . 72.8 m-20 -58.13 -56.41 22.38 Favored 'General case' 0 C--N 1.332 -0.179 0 C-N-CA 120.686 -0.406 . . . . 0.0 110.693 175.839 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -44.73 -59.91 2.28 Favored 'General case' 0 C--N 1.342 0.258 0 O-C-N 123.615 0.572 . . . . 0.0 111.675 178.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . 0.459 HD13 ' O ' ' A' ' 137' ' ' LYS . 8.5 mp -50.69 -37.8 43.33 Favored 'General case' 0 CA--C 1.531 0.226 0 N-CA-C 112.595 0.591 . . . . 0.0 112.595 178.86 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . 0.738 ' HG ' ' HD2' ' A' ' 62' ' ' LYS . 3.8 mm? . . . . . 0 C--N 1.327 -0.401 0 CA-C-O 120.623 0.249 . . . . 0.0 111.623 179.264 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.455 -0.181 0 CA-C-O 121.136 0.493 . . . . 0.0 110.489 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -156.2 -43.44 0.08 Allowed 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.291 -0.868 . . . . 0.0 110.768 -179.35 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 23.5 p -149.91 33.49 0.68 Allowed 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 115.165 -0.925 . . . . 0.0 110.628 -178.256 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . 0.417 ' HB2' ' CE2' ' A' ' 15' ' ' TYR . 27.5 p90 -63.18 150.11 43.73 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.252 -177.278 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' SER . . . . . 0.404 ' HA ' ' HA ' ' A' ' 24' ' ' SER . 15.9 m -137.06 127.53 26.7 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 178.047 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . 0.417 ' CE2' ' HB2' ' A' ' 13' ' ' PHE . 77.6 m-85 -138.34 156.93 73.34 Favored Pre-proline 0 C--N 1.326 -0.436 0 CA-C-O 120.752 0.311 . . . . 0.0 111.356 -175.399 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.467 ' HD2' ' O ' ' A' ' 93' ' ' HIS . 1.6 Cg_endo -83.53 126.77 4.2 Favored 'Trans proline' 0 N--CA 1.459 -0.556 0 C-N-CA 123.183 2.588 . . . . 0.0 113.85 -178.488 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . 1.022 ' HB3' ' HB3' ' A' ' 21' ' ' LYS . 0.4 OUTLIER -65.08 166.14 9.99 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 114.88 -1.055 . . . . 0.0 109.584 169.47 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.571 ' HB ' ' HB2' ' A' ' 79' ' ' GLU . 40.0 pt -48.74 -33.36 5.01 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 C-N-CA 123.561 0.744 . . . . 0.0 112.803 -175.169 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 36.8 m-80 -83.7 -3.1 57.5 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.776 0.322 . . . . 0.0 111.599 -177.48 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 89.83 29.25 16.19 Favored Glycine 0 N--CA 1.45 -0.377 0 N-CA-C 110.212 -1.155 . . . . 0.0 110.212 -171.21 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 1.022 ' HB3' ' HB3' ' A' ' 17' ' ' ASP . 19.1 ttmt -92.23 111.74 23.42 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 114.872 -0.664 . . . . 0.0 110.639 -172.921 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 20.3 m -70.58 112.54 6.91 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 120.796 0.331 . . . . 0.0 111.376 -177.755 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.499 ' HB ' HD21 ' A' ' 92' ' ' LEU . 59.9 t -124.3 145.57 31.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 177.107 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' SER . . . . . 0.404 ' HA ' ' HA ' ' A' ' 14' ' ' SER . 94.5 p -122.01 -175.46 3.12 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.084 0.468 . . . . 0.0 110.904 -175.784 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.453 ' O ' ' HB2' ' A' ' 29' ' ' LYS . 30.8 tp -93.68 -0.32 56.11 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.072 175.479 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.423 ' O ' ' HB3' ' A' ' 29' ' ' LYS . . . -88.94 -35.41 16.48 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.004 -179.196 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 3.9 p30 -78.18 -22.87 47.99 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.448 0.642 . . . . 0.0 110.062 176.7 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 85.7 mt -89.66 -8.79 51.69 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.105 175.311 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.453 ' HB2' ' O ' ' A' ' 25' ' ' LEU . 48.3 tttp -76.45 140.29 41.21 Favored 'General case' 0 N--CA 1.446 -0.654 0 CA-C-N 115.48 -0.782 . . . . 0.0 111.177 -176.254 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 110.54 2.32 29.16 Favored Glycine 0 N--CA 1.449 -0.481 0 N-CA-C 111.382 -0.687 . . . . 0.0 111.382 -177.153 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.584 ' HG3' ' CG ' ' A' ' 63' ' ' ASP . 24.6 ttmm -152.43 149.91 29.08 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 109.076 -0.712 . . . . 0.0 109.076 -179.758 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.45 ' HB2' ' O ' ' A' ' 63' ' ' ASP . 39.3 m-85 -49.11 144.92 4.53 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-O 121.044 0.45 . . . . 0.0 111.889 -177.307 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.48 ' HB ' ' HB2' ' A' ' 115' ' ' LEU . 35.3 mm -121.53 122.69 67.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.985 -177.234 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 78.6 t80 -116.96 112.01 20.4 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 108.782 -0.822 . . . . 0.0 108.782 171.701 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.706 ' HB ' ' CG2' ' A' ' 113' ' ' ILE . 78.8 mt -105.35 129.4 58.24 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 C-N-CA 120.563 -0.455 . . . . 0.0 110.446 -177.023 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.499 ' HA ' ' O ' ' A' ' 111' ' ' ARG . 1.8 t70 -123.34 159.72 28.26 Favored 'General case' 0 C--N 1.314 -0.938 0 N-CA-C 108.798 -0.815 . . . . 0.0 108.798 178.06 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.461 HG11 HG23 ' A' ' 109' ' ' ILE . 58.9 t -104.59 112.79 39.6 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.953 0 C-N-CA 120.258 -0.577 . . . . 0.0 110.49 176.24 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' TRP . . . . . 0.592 ' CD2' ' HZ2' ' A' ' 78' ' ' TRP . 0.6 OUTLIER -101.98 132.64 47.7 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.235 -176.055 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.428 ' HA ' ' OD1' ' A' ' 72' ' ' ASP . . . -147.05 156.25 42.87 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.885 -178.21 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' THR . . . . . 0.701 ' HB ' ' CE3' ' A' ' 78' ' ' TRP . 14.6 t -99.14 -23.46 15.23 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 120.898 -0.321 . . . . 0.0 110.808 175.418 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 8.8 p-90 -84.08 -8.0 59.23 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.076 0.465 . . . . 0.0 110.831 -179.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 42.5 t -91.99 105.29 17.57 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 175.713 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . 0.402 ' N ' ' HD2' ' A' ' 44' ' ' PRO . . . -54.74 -61.68 7.05 Favored Glycine 0 CA--C 1.524 0.641 0 CA-C-N 115.712 -0.676 . . . . 0.0 113.837 -178.424 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.402 ' HD2' ' N ' ' A' ' 43' ' ' GLY . 12.3 Cg_endo -55.76 -34.33 90.66 Favored 'Trans proline' 0 C--N 1.352 0.755 0 C-N-CA 122.901 2.401 . . . . 0.0 112.66 -177.415 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . 0.694 ' O ' ' HG ' ' A' ' 49' ' ' LEU . 49.6 t -53.08 -39.75 63.57 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.178 179.481 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.676 HH12 ' HH2' ' A' ' 78' ' ' TRP . 20.1 mmm180 -65.92 -20.76 66.33 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.585 -174.409 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -80.56 -40.18 13.26 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.84 -0.695 . . . . 0.0 113.383 -174.126 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -95.72 -6.36 39.98 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 117.077 0.438 . . . . 0.0 111.604 -174.424 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.694 ' HG ' ' O ' ' A' ' 45' ' ' CYS . 39.7 mt -56.96 -47.42 99.12 Favored Pre-proline 0 C--N 1.327 -0.376 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.926 175.868 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.513 ' O ' ' HG2' ' A' ' 54' ' ' GLU . 75.4 Cg_exo -51.6 -40.39 64.14 Favored 'Trans proline' 0 C--N 1.358 1.051 0 C-N-CA 121.972 1.781 . . . . 0.0 112.113 173.906 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -69.86 -27.45 64.85 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.431 0.634 . . . . 0.0 110.695 -178.418 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.581 HD22 ' HE3' ' A' ' 88' ' ' LYS . 3.6 tt -73.36 -33.2 64.94 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.506 -0.77 . . . . 0.0 109.214 176.247 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . 0.852 ' HE2' HD21 ' A' ' 87' ' ' LEU . 85.0 mttt -64.61 -50.37 67.44 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 108.933 -0.765 . . . . 0.0 108.933 174.905 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.513 ' HG2' ' O ' ' A' ' 50' ' ' PRO . 33.1 mm-40 -51.82 -41.75 62.0 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-N 114.822 -1.081 . . . . 0.0 110.836 175.797 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.585 HD23 ' CE2' ' A' ' 138' ' ' PHE . 17.6 tp -61.29 -44.41 97.26 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.05 -0.977 . . . . 0.0 111.057 -178.624 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.561 ' OE1' ' HB2' ' A' ' 88' ' ' LYS . 24.4 tt0 -65.17 -36.53 84.5 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-N 116.61 -0.268 . . . . 0.0 111.306 -178.192 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 17.2 mm-40 -54.07 -54.41 39.83 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.579 0.704 . . . . 0.0 109.832 173.851 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . 0.493 ' HE3' ' CZ ' ' A' ' 59' ' ' TYR . 32.6 tttp -53.81 -33.88 57.47 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 114.58 -1.191 . . . . 0.0 112.333 177.334 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.493 ' CZ ' ' HE3' ' A' ' 58' ' ' LYS . 84.9 m-85 -111.16 16.95 20.78 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 112.335 0.494 . . . . 0.0 112.335 -175.88 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -64.1 131.68 48.22 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.868 0.366 . . . . 0.0 110.64 176.552 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 68.68 44.7 69.53 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.922 -0.656 . . . . 0.0 112.176 -179.506 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 40.2 mmtm -128.51 -154.11 0.61 Allowed 'General case' 0 N--CA 1.45 -0.432 0 CA-C-O 120.981 0.419 . . . . 0.0 109.981 177.2 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . 0.584 ' CG ' ' HG3' ' A' ' 31' ' ' LYS . 10.4 t70 -111.77 69.46 0.69 Allowed 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 116.182 -0.463 . . . . 0.0 109.799 177.022 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.555 HG13 ' O ' ' A' ' 63' ' ' ASP . 15.1 mt -151.89 139.32 13.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.274 178.437 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' HIS . . . . . 0.498 ' NE2' ' HB3' ' A' ' 31' ' ' LYS . 92.0 m-70 -114.92 111.3 20.96 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.49 -0.777 . . . . 0.0 109.949 173.406 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . 0.5 ' HE1' HD22 ' A' ' 55' ' ' LEU . 89.4 m-85 -81.9 103.66 11.71 Favored 'General case' 0 C--N 1.318 -0.782 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 171.179 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.62 ' HA ' ' O ' ' A' ' 90' ' ' ILE . 41.9 t -116.28 122.12 69.03 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.436 -176.242 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' SER . . . . . 0.771 ' HB2' ' HG2' ' A' ' 91' ' ' GLN . 50.7 m -110.54 134.94 51.93 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 116.544 -0.298 . . . . 0.0 110.932 -178.707 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.483 HD13 ' HB2' ' A' ' 92' ' ' LEU . 4.5 mm? -115.75 139.45 50.14 Favored 'General case' 0 N--CA 1.471 0.598 0 N-CA-C 110.081 -0.34 . . . . 0.0 110.081 175.6 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 3.5 t -118.11 124.87 49.08 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 112.926 0.713 . . . . 0.0 112.926 -172.882 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 10.6 m -87.1 13.07 10.03 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.876 174.217 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . 0.585 ' O ' ' HA2' ' A' ' 95' ' ' GLY . 1.0 OUTLIER -71.45 136.31 47.58 Favored 'General case' 0 CA--C 1.516 -0.331 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 -178.476 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . 0.469 ' H ' ' HG2' ' A' ' 73' ' ' LYS . 0.4 OUTLIER -99.98 -18.84 16.85 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-O 121.481 0.657 . . . . 0.0 110.034 178.92 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . 0.584 ' HB2' ' HB3' ' A' ' 77' ' ' ALA . 0.8 OUTLIER -80.8 61.05 4.3 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.026 -0.988 . . . . 0.0 109.785 174.369 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 9.5 tttt -50.67 -53.79 28.31 Favored 'General case' 0 C--O 1.222 -0.35 0 N-CA-C 112.647 0.61 . . . . 0.0 112.647 -171.177 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.501 ' HA ' ' OE1' ' A' ' 79' ' ' GLU . 40.3 tptt -61.7 -42.3 98.74 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.842 0.353 . . . . 0.0 110.989 -177.149 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.584 ' HB3' ' HB2' ' A' ' 74' ' ' ASN . . . -63.84 -33.76 76.4 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 121.746 0.784 . . . . 0.0 110.119 176.927 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' TRP . . . . . 0.701 ' CE3' ' HB ' ' A' ' 40' ' ' THR . 9.7 t-105 -76.72 -50.21 14.17 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 114.797 -1.092 . . . . 0.0 111.555 -177.463 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . 0.571 ' HB2' ' HB ' ' A' ' 18' ' ' ILE . 4.1 pt-20 -60.38 -34.44 73.9 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-O 121.198 0.523 . . . . 0.0 110.357 -176.255 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . 0.614 ' O ' ' HD3' ' A' ' 84' ' ' LYS . 3.4 p30 -79.42 -29.97 42.15 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 119.67 -0.812 . . . . 0.0 110.668 177.622 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 13.6 tpt -61.4 -47.56 85.26 Favored 'General case' 0 C--O 1.225 -0.235 0 O-C-N 122.437 -0.164 . . . . 0.0 111.175 175.374 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.569 HG21 ' HB2' ' A' ' 87' ' ' LEU . 0.2 OUTLIER -61.1 -36.15 70.55 Favored 'Isoleucine or valine' 0 C--O 1.232 0.164 0 C-N-CA 120.386 -0.526 . . . . 0.0 110.17 175.602 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 76.3 m -61.51 -41.93 98.04 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.289 174.863 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . 0.614 ' HD3' ' O ' ' A' ' 80' ' ' ASN . 1.9 mptm? -72.9 -46.92 50.08 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-O 121.092 0.472 . . . . 0.0 110.912 179.684 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -66.03 -25.81 67.23 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.287 -0.869 . . . . 0.0 111.01 -176.477 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 29.2 mm-40 64.59 72.8 0.44 Allowed 'General case' 0 C--O 1.234 0.287 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.561 -175.843 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.852 HD21 ' HE2' ' A' ' 53' ' ' LYS . 89.8 mt -92.99 -179.46 5.11 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.05 177.007 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . 0.581 ' HE3' HD22 ' A' ' 52' ' ' LEU . 0.0 OUTLIER -145.74 173.62 11.93 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 112.534 0.568 . . . . 0.0 112.534 -171.424 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 78.4 -170.71 54.95 Favored Glycine 0 N--CA 1.452 -0.24 0 CA-C-N 115.593 -0.731 . . . . 0.0 112.856 178.883 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.62 ' O ' ' HA ' ' A' ' 67' ' ' VAL . 5.0 mp -89.66 112.1 24.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 177.219 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . 0.771 ' HG2' ' HB2' ' A' ' 68' ' ' SER . 21.8 mt-30 -123.11 111.02 16.03 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-O 121.475 0.655 . . . . 0.0 111.061 -174.561 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.499 HD21 ' HB ' ' A' ' 23' ' ' VAL . 55.2 mt -105.98 164.36 12.02 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 114.979 -1.009 . . . . 0.0 109.668 -178.238 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' HIS . . . . . 0.467 ' O ' ' HD2' ' A' ' 16' ' ' PRO . 17.7 t-80 -131.46 124.67 30.67 Favored 'General case' 0 C--N 1.313 -1.015 0 CA-C-O 120.936 0.398 . . . . 0.0 111.357 -171.577 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 24.0 ttp -79.94 -58.02 3.37 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.241 179.39 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . 0.585 ' HA2' ' O ' ' A' ' 72' ' ' ASP . . . 101.34 -93.88 1.18 Allowed Glycine 0 N--CA 1.444 -0.789 0 C-N-CA 120.304 -0.951 . . . . 0.0 113.549 174.212 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 4.6 p -109.09 8.63 26.17 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 112.84 0.682 . . . . 0.0 112.84 -172.067 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -102.21 153.11 20.27 Favored 'General case' 0 CA--C 1.517 -0.309 0 C-N-CA 119.811 -0.756 . . . . 0.0 109.962 177.269 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.14 6.93 3.37 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.965 -0.561 . . . . 0.0 109.608 173.462 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 6.9 m -76.54 -32.7 58.39 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.044 -176.038 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 59.5 t80 -74.6 -37.49 62.85 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.546 -0.752 . . . . 0.0 111.014 178.938 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 5.2 ppp? -77.4 -26.17 51.52 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 176.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -68.05 -29.92 69.01 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.427 -0.806 . . . . 0.0 109.965 172.876 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -63.25 -18.61 63.74 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-N 115.991 -0.549 . . . . 0.0 111.37 179.181 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 72.3 m-85 -97.36 -5.43 36.43 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-O 120.837 0.351 . . . . 0.0 110.078 178.511 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 87.1 mt 60.19 17.04 6.55 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 115.35 -0.841 . . . . 0.0 111.345 179.349 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 11.1 tp -73.7 -45.15 51.29 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.35 0 N-CA-C 112.566 0.58 . . . . 0.0 112.566 -172.573 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 9.0 t30 67.66 -62.64 0.33 Allowed 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 123.158 0.583 . . . . 0.0 111.613 -176.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -91.77 111.05 3.95 Favored Glycine 0 N--CA 1.447 -0.579 0 C-N-CA 121.183 -0.532 . . . . 0.0 112.575 -176.537 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . 0.524 ' HB ' ' HA ' ' A' ' 110' ' ' PRO . 43.2 pt -85.1 158.28 58.63 Favored Pre-proline 0 C--N 1.322 -0.595 0 N-CA-C 110.434 -0.21 . . . . 0.0 110.434 176.81 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . 0.524 ' HA ' ' HB ' ' A' ' 109' ' ' ILE . 3.0 Cg_exo -74.31 158.69 98.61 Favored 'Cis proline' 0 C--N 1.348 0.53 0 C-N-CA 124.132 -1.195 . . . . 0.0 113.426 1.473 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . 0.697 ' HD2' ' N ' ' A' ' 112' ' ' PHE . 0.1 OUTLIER -113.32 140.41 48.04 Favored 'General case' 0 N--CA 1.442 -0.874 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 175.979 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . 0.697 ' N ' ' HD2' ' A' ' 111' ' ' ARG . 4.2 m-85 -115.44 132.41 56.63 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 108.609 -0.885 . . . . 0.0 108.609 -177.953 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.706 ' CG2' ' HB ' ' A' ' 35' ' ' ILE . 7.5 tt -147.53 156.77 9.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 118.492 0.587 . . . . 0.0 111.278 -177.846 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 35.3 tp -136.29 132.56 35.89 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.837 0.351 . . . . 0.0 110.495 177.754 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . 0.535 ' HG ' ' HA ' ' A' ' 121' ' ' ILE . 2.5 mp -130.97 151.54 51.26 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 178.979 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . 0.427 ' N ' HG13 ' A' ' 122' ' ' ILE . 9.7 t70 -73.1 164.56 26.51 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.965 -0.561 . . . . 0.0 109.792 179.044 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . 0.513 ' HG2' ' HA ' ' A' ' 31' ' ' LYS . 3.9 mtm180 -47.32 -33.96 6.27 Favored 'General case' 0 C--N 1.323 -0.554 0 O-C-N 124.519 1.137 . . . . 0.0 112.271 -179.645 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -71.24 -6.03 36.58 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.215 -177.883 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 84.69 22.61 52.95 Favored Glycine 0 N--CA 1.441 -1.027 0 N-CA-C 110.006 -1.238 . . . . 0.0 110.006 -172.542 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 30.4 mmtp -102.75 111.13 23.31 Favored 'General case' 0 CA--C 1.518 -0.287 0 CA-C-N 115.521 -0.339 . . . . 0.0 111.267 -174.107 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . 0.535 ' HA ' ' HG ' ' A' ' 115' ' ' LEU . 3.8 mp -41.4 115.08 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 O-C-N 124.196 0.935 . . . . 0.0 111.817 179.883 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' ILE . . . . . 0.445 ' H ' ' HA ' ' A' ' 115' ' ' LEU . 63.8 mt -83.72 -41.5 16.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 175.92 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 49.4 m -146.55 125.36 12.66 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 114.843 -1.072 . . . . 0.0 109.164 176.091 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -61.34 -31.56 71.43 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-O 121.046 0.45 . . . . 0.0 111.584 -176.189 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 10.9 t30 -138.35 113.83 9.61 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.917 -0.583 . . . . 0.0 109.468 174.554 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' MET . . . . . 0.459 ' HG3' ' H ' ' A' ' 127' ' ' THR . 7.7 tpt -93.91 -148.03 0.26 Allowed 'General case' 0 C--N 1.317 -0.833 0 N-CA-C 108.917 -0.771 . . . . 0.0 108.917 -179.401 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' THR . . . . . 0.459 ' H ' ' HG3' ' A' ' 126' ' ' MET . 1.1 p -135.94 143.09 44.72 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-O 120.707 0.289 . . . . 0.0 110.928 -177.497 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . 0.45 ' HA ' ' CD1' ' A' ' 112' ' ' PHE . 9.2 ptp180 -40.65 154.49 0.21 Allowed Pre-proline 0 C--N 1.327 -0.408 0 N-CA-C 113.536 0.939 . . . . 0.0 113.536 176.353 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_exo -54.81 -34.02 83.45 Favored 'Trans proline' 0 C--N 1.348 0.505 0 C-N-CA 123.503 2.802 . . . . 0.0 113.135 178.178 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 16.3 m -76.16 -1.86 28.29 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.655 -178.254 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . 0.438 ' HA ' ' HD3' ' A' ' 132' ' ' PRO . 9.8 t70 -90.3 124.82 61.99 Favored Pre-proline 0 C--N 1.324 -0.511 0 N-CA-C 109.974 -0.38 . . . . 0.0 109.974 178.757 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . 0.438 ' HD3' ' HA ' ' A' ' 131' ' ' ASP . 43.5 Cg_exo -58.77 -35.71 98.2 Favored 'Trans proline' 0 C--N 1.344 0.325 0 C-N-CA 123.173 2.582 . . . . 0.0 113.414 -177.827 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . 0.593 ' HB2' ' HZ1' ' A' ' 133' ' ' LYS . 10.0 mtmp? -62.88 -34.42 77.34 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-O 121.082 0.467 . . . . 0.0 111.031 -177.036 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' THR . . . . . 0.54 HG22 ' CZ ' ' A' ' 138' ' ' PHE . 0.3 OUTLIER -69.64 -51.49 34.39 Favored 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 109.765 -0.457 . . . . 0.0 109.765 177.168 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . 0.475 ' HA ' ' CD2' ' A' ' 138' ' ' PHE . . . -54.96 -49.95 70.14 Favored 'General case' 0 C--O 1.24 0.553 0 CA-C-N 115.605 -0.725 . . . . 0.0 112.25 179.653 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . 0.536 ' HG3' ' N ' ' A' ' 137' ' ' LYS . 2.0 pt-20 -60.57 -41.44 94.64 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-O 120.978 0.418 . . . . 0.0 110.268 -179.56 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . 0.536 ' N ' ' HG3' ' A' ' 136' ' ' GLU . 0.0 OUTLIER -66.53 -33.15 75.03 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.76 -177.217 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . 0.585 ' CE2' HD23 ' A' ' 55' ' ' LEU . 20.5 m-85 -58.52 -52.54 65.2 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.336 175.008 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 56.6 m-20 -57.47 -54.55 45.59 Favored 'General case' 0 N--CA 1.464 0.26 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 177.718 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 23.3 tt0 -49.91 -60.5 2.86 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 114.798 -1.092 . . . . 0.0 113.204 179.868 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 84.7 mt -67.43 -28.89 68.27 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-O 120.644 0.259 . . . . 0.0 111.616 -173.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 66.8 tp . . . . . 0 C--N 1.325 -0.485 0 CA-C-O 121.335 0.588 . . . . 0.0 109.737 175.202 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.326 0 CA-C-O 121.554 0.692 . . . . 0.0 110.068 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -139.59 91.7 2.51 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.402 -0.817 . . . . 0.0 110.969 -178.355 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' SER . . . . . 1.008 ' HA ' ' HB3' ' A' ' 25' ' ' LEU . 67.2 m 59.06 77.09 0.32 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.702 -0.681 . . . . 0.0 112.105 178.154 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 31.4 p90 -82.3 -178.98 7.25 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.569 177.324 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' SER . . . . . 0.457 ' HA ' ' HA ' ' A' ' 24' ' ' SER . 23.2 t -142.53 134.64 27.36 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 175.469 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . 0.404 ' HA ' ' HD3' ' A' ' 16' ' ' PRO . 36.4 m-85 -146.07 150.3 41.55 Favored Pre-proline 0 C--N 1.325 -0.472 0 N-CA-C 109.999 -0.371 . . . . 0.0 109.999 179.835 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.404 ' HD3' ' HA ' ' A' ' 15' ' ' TYR . 3.9 Cg_exo -76.64 125.3 8.14 Favored 'Trans proline' 0 N--CA 1.455 -0.778 0 C-N-CA 122.458 2.106 . . . . 0.0 112.14 178.351 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . 0.784 ' HB3' ' HB3' ' A' ' 21' ' ' LYS . 0.0 OUTLIER -60.76 163.49 5.57 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.709 -0.678 . . . . 0.0 109.62 172.051 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.499 HG12 HG11 ' A' ' 82' ' ' VAL . 10.5 tp -61.33 -25.52 36.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.817 -170.9 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . 0.481 ' HB2' ' OD2' ' A' ' 17' ' ' ASP . 0.9 OUTLIER -81.88 -5.37 58.19 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 120.932 0.396 . . . . 0.0 110.779 178.064 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 93.42 37.38 5.61 Favored Glycine 0 N--CA 1.447 -0.576 0 N-CA-C 110.888 -0.885 . . . . 0.0 110.888 -175.6 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.784 ' HB3' ' HB3' ' A' ' 17' ' ' ASP . 3.2 ttmp? -108.37 111.48 23.42 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.709 0.29 . . . . 0.0 110.89 -173.449 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 16.7 m -70.49 109.14 4.64 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 120.87 0.366 . . . . 0.0 111.095 -179.257 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.508 ' HB ' HD23 ' A' ' 92' ' ' LEU . 39.4 t -126.48 152.78 34.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 178.355 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' SER . . . . . 0.457 ' HA ' ' HA ' ' A' ' 14' ' ' SER . 93.8 p -122.67 176.35 6.0 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.186 0.517 . . . . 0.0 110.718 -179.973 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 1.008 ' HB3' ' HA ' ' A' ' 12' ' ' SER . 21.0 tp -95.77 15.08 21.17 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 121.761 0.791 . . . . 0.0 108.882 173.435 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.507 ' HA ' ' CE ' ' A' ' 29' ' ' LYS . . . -100.05 -35.0 9.85 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 114.915 -1.038 . . . . 0.0 110.503 177.282 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -81.26 -17.7 48.54 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.458 177.69 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 72.4 mt -91.25 22.79 3.63 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.72 -179.911 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.507 ' CE ' ' HA ' ' A' ' 26' ' ' ALA . 1.1 mptp? -70.43 -169.64 0.32 Allowed 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 121.308 0.575 . . . . 0.0 111.348 176.469 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 89.23 -47.67 3.34 Favored Glycine 0 N--CA 1.45 -0.372 0 CA-C-N 115.83 -0.623 . . . . 0.0 112.616 173.328 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.686 ' HD3' ' HA ' ' A' ' 63' ' ' ASP . 72.6 mttt -127.05 167.72 15.56 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 110.0 -0.37 . . . . 0.0 110.0 -178.311 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 97.6 m-85 -64.95 154.12 38.47 Favored 'General case' 0 C--N 1.327 -0.4 0 O-C-N 123.197 0.311 . . . . 0.0 110.798 -176.579 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.447 HD12 ' HA2' ' A' ' 119' ' ' GLY . 4.6 mp -120.26 124.61 72.95 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-O 120.706 0.289 . . . . 0.0 110.475 -179.543 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 84.4 t80 -107.45 116.23 31.58 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 109.006 -0.738 . . . . 0.0 109.006 172.339 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.553 ' HA ' ' O ' ' A' ' 67' ' ' VAL . 67.8 mt -102.81 116.77 47.14 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.697 -178.239 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -109.93 158.82 17.82 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.503 -0.772 . . . . 0.0 109.14 174.112 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.463 ' HB ' ' HA ' ' A' ' 110' ' ' PRO . 57.5 t -101.25 125.55 55.21 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 C-N-CA 120.34 -0.544 . . . . 0.0 110.852 172.996 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' TRP . . . . . 0.638 ' CZ2' ' HB2' ' A' ' 91' ' ' GLN . 1.0 OUTLIER -118.95 135.11 54.77 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.04 -0.527 . . . . 0.0 109.778 -178.973 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.459 ' HA ' ' OD1' ' A' ' 72' ' ' ASP . . . -146.63 165.23 30.18 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.683 -0.235 . . . . 0.0 111.307 179.943 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' THR . . . . . 0.807 ' HB ' ' CE3' ' A' ' 78' ' ' TRP . 12.3 t -99.87 -29.55 12.53 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.946 0.403 . . . . 0.0 110.572 173.069 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 19.4 p-90 -80.42 11.15 3.84 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.117 0.484 . . . . 0.0 110.956 -179.138 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' CYS . . . . . 0.749 ' SG ' ' HB3' ' A' ' 45' ' ' CYS . 29.2 p -104.35 172.1 6.98 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.649 -177.044 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -123.03 -70.52 0.24 Allowed Glycine 0 N--CA 1.448 -0.549 0 CA-C-N 115.857 -0.611 . . . . 0.0 112.252 177.218 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -55.28 -35.53 91.56 Favored 'Trans proline' 0 C--N 1.351 0.676 0 C-N-CA 122.991 2.461 . . . . 0.0 112.882 178.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . 0.749 ' HB3' ' SG ' ' A' ' 42' ' ' CYS . 8.4 t -59.02 -34.41 71.86 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.872 0.368 . . . . 0.0 111.097 177.209 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.54 ' HA ' HD12 ' A' ' 49' ' ' LEU . 32.4 mtp180 -73.5 -4.66 35.17 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.33 -177.218 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -83.95 -19.73 60.71 Favored Glycine 0 N--CA 1.447 -0.62 0 C-N-CA 120.788 -0.72 . . . . 0.0 111.842 176.473 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . 0.541 ' OE2' ' HD3' ' A' ' 128' ' ' ARG . 42.1 mm-40 -84.21 -16.87 41.78 Favored 'General case' 0 CA--C 1.515 -0.384 0 N-CA-C 110.401 -0.222 . . . . 0.0 110.401 -177.823 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.56 ' HB2' ' HD3' ' A' ' 50' ' ' PRO . 5.7 mp -45.44 -53.5 18.3 Favored Pre-proline 0 C--N 1.326 -0.424 0 CA-C-N 115.935 -0.575 . . . . 0.0 112.278 -178.744 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.56 ' HD3' ' HB2' ' A' ' 49' ' ' LEU . 31.7 Cg_exo -64.13 -37.55 41.38 Favored 'Trans proline' 0 C--N 1.353 0.799 0 C-N-CA 121.885 1.723 . . . . 0.0 112.842 175.868 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -77.34 -27.97 52.95 Favored 'General case' 0 CA--C 1.52 -0.193 0 CA-C-O 121.248 0.546 . . . . 0.0 110.6 -172.752 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 6.1 tt -64.13 -41.71 97.1 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 177.802 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . 0.503 ' HZ3' ' CD ' ' A' ' 56' ' ' GLU . 27.0 mmtm -70.64 -40.07 73.29 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.582 -0.735 . . . . 0.0 111.454 -179.731 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -51.72 -53.64 37.06 Favored 'General case' 0 N--CA 1.455 -0.189 0 CA-C-O 121.341 0.591 . . . . 0.0 110.947 172.928 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.414 HD12 ' HE2' ' A' ' 138' ' ' PHE . 47.3 mt -61.5 -52.27 65.2 Favored 'General case' 0 N--CA 1.447 -0.611 0 CA-C-N 115.452 -0.795 . . . . 0.0 110.902 177.109 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.503 ' CD ' ' HZ3' ' A' ' 53' ' ' LYS . 31.9 tt0 -45.09 -60.16 2.24 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 114.65 -1.159 . . . . 0.0 112.519 -179.308 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -69.7 -36.18 75.71 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-O 120.976 0.417 . . . . 0.0 111.045 -174.664 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . 0.56 ' HB2' ' NZ ' ' A' ' 58' ' ' LYS . 0.7 OUTLIER -69.24 -35.2 75.9 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.21 0.528 . . . . 0.0 111.028 -175.482 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 83.3 m-85 -111.03 9.29 22.11 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.058 -178.285 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . 0.419 ' HB1' ' O ' ' A' ' 56' ' ' GLU . . . -56.02 128.61 36.13 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.663 178.355 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 81.86 -4.16 76.26 Favored Glycine 0 N--CA 1.449 -0.44 0 CA-C-N 115.652 -0.704 . . . . 0.0 113.386 174.231 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . 0.582 ' HD3' ' N ' ' A' ' 62' ' ' LYS . 0.0 OUTLIER -76.66 -89.8 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 117.104 0.452 . . . . 0.0 111.142 -174.896 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . 0.686 ' HA ' ' HD3' ' A' ' 31' ' ' LYS . 10.9 p-10 -139.07 6.07 2.36 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.635 -175.463 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 16.0 tt -128.8 147.26 33.25 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-O 121.443 0.64 . . . . 0.0 112.623 -168.662 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 87.8 m-70 -112.86 125.8 54.76 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.203 -0.908 . . . . 0.0 108.807 170.697 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . 0.601 ' O ' ' HB ' ' A' ' 90' ' ' ILE . 96.4 m-85 -90.94 112.44 24.32 Favored 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 109.176 -0.675 . . . . 0.0 109.176 173.153 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.553 ' O ' ' HA ' ' A' ' 35' ' ' ILE . 45.9 t -123.58 106.32 17.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.662 -175.086 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' SER . . . . . 0.427 ' HB3' ' CD1' ' A' ' 38' ' ' TRP . 15.0 m -88.11 139.55 30.39 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.107 179.069 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 61.4 tp -122.36 124.11 42.93 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-O 120.774 0.321 . . . . 0.0 110.459 176.868 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 1.2 t -104.62 122.05 44.82 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.691 0.758 . . . . 0.0 112.509 -173.219 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 4.2 m -86.81 11.19 13.82 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 114.956 -1.02 . . . . 0.0 111.539 177.05 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . 0.509 ' O ' ' HA2' ' A' ' 95' ' ' GLY . 1.6 m-20 -69.07 125.76 27.67 Favored 'General case' 0 N--CA 1.464 0.266 0 N-CA-C 110.452 -0.203 . . . . 0.0 110.452 -176.521 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 86.0 tttt -76.27 -32.05 58.61 Favored 'General case' 0 C--N 1.321 -0.633 0 C-N-CA 120.344 -0.542 . . . . 0.0 109.708 175.343 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . 0.528 ' HB2' ' HB2' ' A' ' 77' ' ' ALA . 0.8 OUTLIER -76.21 71.23 2.92 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.481 -0.781 . . . . 0.0 110.856 177.771 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.516 ' O ' ' HG3' ' A' ' 79' ' ' GLU . 12.0 tmtt? -57.16 -56.61 19.57 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 120.992 -0.283 . . . . 0.0 111.596 -175.423 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.497 ' HA ' ' CD ' ' A' ' 79' ' ' GLU . 2.2 tptp -52.15 -57.44 9.61 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.097 -179.543 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.528 ' HB2' ' HB2' ' A' ' 74' ' ' ASN . . . -52.96 -31.59 41.39 Favored 'General case' 0 C--O 1.237 0.425 0 CA-C-O 121.356 0.598 . . . . 0.0 110.898 -179.766 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' TRP . . . . . 0.807 ' CE3' ' HB ' ' A' ' 40' ' ' THR . 2.1 t-105 -76.91 -34.63 57.69 Favored 'General case' 0 N--CA 1.442 -0.856 0 CA-C-N 115.146 -0.933 . . . . 0.0 110.546 -176.756 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . 0.516 ' HG3' ' O ' ' A' ' 75' ' ' LYS . 29.9 mt-10 -51.19 -52.43 44.41 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-O 121.573 0.702 . . . . 0.0 110.326 172.496 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . 0.43 ' ND2' ' O ' ' A' ' 76' ' ' LYS . 1.2 m-80 -64.17 -41.19 97.23 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.25 -0.886 . . . . 0.0 110.747 -175.987 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' MET . . . . . 0.487 ' HG2' ' OG1' ' A' ' 40' ' ' THR . 14.4 tpt -67.29 -49.14 65.42 Favored 'General case' 0 N--CA 1.447 -0.601 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.938 -177.766 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.621 ' CG2' ' HZ3' ' A' ' 38' ' ' TRP . 7.5 p -61.35 -30.89 48.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 121.068 0.461 . . . . 0.0 110.788 -179.543 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 45.8 m -74.61 -39.1 62.36 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.534 178.035 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . 0.915 ' HB3' ' HZ3' ' A' ' 84' ' ' LYS . 0.0 OUTLIER -74.08 -33.71 63.73 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 121.329 0.585 . . . . 0.0 109.843 179.48 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -82.81 4.29 25.98 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.216 -0.902 . . . . 0.0 111.329 -179.428 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 26.6 mt-30 60.38 28.24 17.86 Favored 'General case' 0 N--CA 1.47 0.545 0 N-CA-C 112.668 0.618 . . . . 0.0 112.668 171.904 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.562 ' HB2' HG23 ' A' ' 82' ' ' VAL . 97.6 mt -89.43 104.09 16.67 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 121.003 0.43 . . . . 0.0 111.523 -176.916 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . 0.551 ' HA ' ' HE3' ' A' ' 88' ' ' LYS . 0.0 OUTLIER -106.95 -167.15 1.24 Allowed 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.031 172.515 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 109.44 -159.58 13.94 Favored Glycine 0 N--CA 1.452 -0.259 0 N-CA-C 111.023 -0.831 . . . . 0.0 111.023 -176.122 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.601 ' HB ' ' O ' ' A' ' 66' ' ' PHE . 62.9 mt -95.15 112.27 27.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 175.007 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . 0.638 ' HB2' ' CZ2' ' A' ' 38' ' ' TRP . 1.9 pt20 -139.14 123.04 17.73 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-O 121.348 0.594 . . . . 0.0 111.389 -173.098 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.508 HD23 ' HB ' ' A' ' 23' ' ' VAL . 70.4 mt -113.91 152.23 31.1 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.449 -0.796 . . . . 0.0 109.939 179.788 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' HIS . . . . . 0.447 ' CE1' ' HG3' ' A' ' 75' ' ' LYS . 20.6 t-80 -120.75 126.52 50.37 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.905 -177.416 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' MET . . . . . 0.428 ' SD ' ' HA ' ' A' ' 98' ' ' ARG . 18.6 ttp -84.13 -66.48 0.89 Allowed 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.227 -0.897 . . . . 0.0 110.61 178.567 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . 0.509 ' HA2' ' O ' ' A' ' 72' ' ' ASP . . . 108.56 -109.96 2.96 Favored Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 120.528 -0.844 . . . . 0.0 112.083 -178.29 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 8.9 t -112.45 11.18 19.84 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 120.727 0.299 . . . . 0.0 111.111 -177.147 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -97.5 46.46 1.03 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.126 0.489 . . . . 0.0 110.357 -175.371 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . 0.443 ' N ' ' HD3' ' A' ' 98' ' ' ARG . 0.0 OUTLIER -77.51 18.45 0.43 Allowed 'General case' 0 CA--C 1.52 -0.174 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.782 -172.812 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 5.2 m -61.0 -24.35 66.09 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 108.358 -0.979 . . . . 0.0 108.358 168.768 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 12.0 t80 -75.56 -29.93 59.52 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-N 114.766 -1.106 . . . . 0.0 110.118 176.172 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 71.2 mtp -63.08 -54.06 43.83 Favored 'General case' 0 CA--C 1.514 -0.42 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 171.307 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -57.16 -33.15 67.14 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.082 -0.963 . . . . 0.0 111.246 179.404 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -60.27 -39.82 88.19 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.793 0.33 . . . . 0.0 111.087 178.019 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' TYR . . . . . 0.46 ' HB2' HG13 ' A' ' 106' ' ' ILE . 42.9 m-85 -93.3 3.34 55.8 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.481 179.661 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 95.4 mt 65.47 22.02 11.85 Favored 'General case' 0 N--CA 1.464 0.242 0 O-C-N 123.755 0.659 . . . . 0.0 110.817 -176.234 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . 0.896 HG12 ' HG3' ' A' ' 111' ' ' ARG . 51.2 mt -71.08 112.5 6.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.627 176.036 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 50.9 t-20 -112.61 -68.85 0.9 Allowed 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 172.826 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -82.24 111.28 3.33 Favored Glycine 0 N--CA 1.446 -0.693 0 C-N-CA 120.83 -0.7 . . . . 0.0 111.802 178.5 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . 0.565 ' HB ' ' HA ' ' A' ' 110' ' ' PRO . 34.5 pt -85.82 158.54 56.27 Favored Pre-proline 0 C--N 1.321 -0.633 0 N-CA-C 110.484 -0.191 . . . . 0.0 110.484 178.51 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . 0.565 ' HA ' ' HB ' ' A' ' 109' ' ' ILE . 86.8 Cg_endo -81.1 158.86 83.62 Favored 'Cis proline' 0 C--N 1.345 0.37 0 C-N-CA 123.768 -1.346 . . . . 0.0 113.391 1.995 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . 0.896 ' HG3' HG12 ' A' ' 106' ' ' ILE . 0.0 OUTLIER -108.58 148.45 30.3 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 108.712 -0.848 . . . . 0.0 108.712 173.215 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . 0.537 ' CE1' ' HB3' ' A' ' 128' ' ' ARG . 0.5 OUTLIER -119.11 116.72 26.96 Favored 'General case' 0 C--N 1.324 -0.532 0 O-C-N 123.96 0.788 . . . . 0.0 109.088 -175.008 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 91.6 mt -135.6 143.67 35.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 120.812 0.339 . . . . 0.0 111.261 -177.332 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.538 ' HB2' ' HG3' ' A' ' 126' ' ' MET . 39.3 tp -124.99 138.07 54.23 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.275 178.36 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . 0.587 ' HG ' ' HA ' ' A' ' 121' ' ' ILE . 3.2 mp -131.97 153.45 50.31 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.079 -177.324 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . 0.526 ' HB2' HD13 ' A' ' 122' ' ' ILE . 37.4 t0 -68.37 166.81 15.87 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.564 -0.744 . . . . 0.0 110.212 177.308 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . 0.569 ' HA ' ' O ' ' A' ' 31' ' ' LYS . 8.3 mtm180 -48.87 -27.77 3.29 Favored 'General case' 0 N--CA 1.465 0.314 0 O-C-N 124.447 1.092 . . . . 0.0 112.615 -177.445 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . 0.424 ' HA ' ' HG3' ' A' ' 29' ' ' LYS . 33.0 t70 -83.44 2.31 37.3 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.478 0.656 . . . . 0.0 111.076 -178.835 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . 0.447 ' HA2' HD12 ' A' ' 33' ' ' ILE . . . 76.06 29.13 59.25 Favored Glycine 0 N--CA 1.434 -1.438 0 N-CA-C 110.247 -1.141 . . . . 0.0 110.247 -171.968 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . 0.4 ' HD3' ' HA ' ' A' ' 120' ' ' LYS . 41.0 mmtm -101.28 112.13 24.55 Favored 'General case' 0 C--O 1.222 -0.356 0 C-N-CA 120.794 -0.363 . . . . 0.0 111.791 -178.856 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . 0.587 ' HA ' ' HG ' ' A' ' 115' ' ' LEU . 3.9 mp -41.7 117.54 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 O-C-N 123.888 0.742 . . . . 0.0 112.327 -177.508 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' ILE . . . . . 0.526 HD13 ' HB2' ' A' ' 116' ' ' ASP . 35.6 mm -100.3 -44.54 11.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 115.345 -0.843 . . . . 0.0 109.555 175.983 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 15.9 m -135.2 114.47 12.36 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.503 -0.772 . . . . 0.0 110.343 178.716 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -81.53 -13.22 58.35 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.161 0.505 . . . . 0.0 110.606 179.439 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 3.4 p-10 -128.24 83.69 2.18 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.54 -0.755 . . . . 0.0 110.486 178.14 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' MET . . . . . 0.538 ' HG3' ' HB2' ' A' ' 114' ' ' LEU . 46.4 mmm -94.48 -165.13 1.26 Allowed 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.442 177.784 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' THR . . . . . 0.406 HG21 ' NZ ' ' A' ' 133' ' ' LYS . 6.2 p -120.86 141.75 50.29 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.627 179.268 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . 0.541 ' HD3' ' OE2' ' A' ' 48' ' ' GLU . 13.0 ptp180 -48.96 154.28 1.31 Allowed Pre-proline 0 C--N 1.327 -0.385 0 CA-C-N 115.514 -0.766 . . . . 0.0 112.84 177.664 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_exo -51.58 -36.16 59.21 Favored 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 123.447 2.765 . . . . 0.0 113.627 177.275 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' SER . . . . . 0.424 ' HG ' ' CD ' ' A' ' 48' ' ' GLU . 18.8 m -72.79 -7.67 51.78 Favored 'General case' 0 N--CA 1.462 0.153 0 CA-C-O 120.935 0.398 . . . . 0.0 111.643 -178.784 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -90.51 121.39 68.44 Favored Pre-proline 0 C--N 1.327 -0.41 0 N-CA-C 109.751 -0.463 . . . . 0.0 109.751 179.668 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . 0.434 ' O ' ' HG2' ' A' ' 136' ' ' GLU . 51.9 Cg_exo -57.45 -31.73 92.15 Favored 'Trans proline' 0 C--N 1.343 0.284 0 C-N-CA 122.976 2.451 . . . . 0.0 113.268 -178.096 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . 0.514 ' HZ2' ' HB2' ' A' ' 133' ' ' LYS . 9.7 mtmp? -66.44 -19.24 65.74 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.846 0.355 . . . . 0.0 110.98 -176.908 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' THR . . . . . 0.632 HG21 ' CZ ' ' A' ' 138' ' ' PHE . 3.8 m -68.12 -51.25 48.34 Favored 'General case' 0 N--CA 1.447 -0.584 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 173.786 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . 0.639 ' HA ' ' CD2' ' A' ' 138' ' ' PHE . . . -59.96 -38.61 83.01 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.67 -0.696 . . . . 0.0 110.576 175.515 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . 0.434 ' HG2' ' O ' ' A' ' 132' ' ' PRO . 5.9 mm-40 -56.15 -41.62 75.71 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.203 177.111 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . 0.577 ' O ' ' HG ' ' A' ' 141' ' ' LEU . 21.3 ttmm -72.44 -26.33 61.8 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.56 -0.291 . . . . 0.0 111.043 179.745 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . 0.639 ' CD2' ' HA ' ' A' ' 135' ' ' ALA . 10.7 m-30 -66.27 -42.76 88.01 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 173.908 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 76.7 m-20 -58.62 -45.7 88.63 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.583 -0.735 . . . . 0.0 109.341 173.672 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . 0.532 ' HB3' ' O ' ' A' ' 137' ' ' LYS . 24.9 tt0 -50.79 -51.72 47.91 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 115.266 -0.879 . . . . 0.0 111.661 174.196 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . 0.577 ' HG ' ' O ' ' A' ' 137' ' ' LYS . 95.2 mt -58.05 -44.46 87.46 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.472 -178.399 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 81.0 mt . . . . . 0 C--N 1.328 -0.347 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.478 179.336 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 0.603 0 N-CA-C 112.225 0.454 . . . . 0.0 112.225 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -76.09 82.61 2.93 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.76 -177.491 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' SER . . . . . 0.483 ' HA ' ' HB3' ' A' ' 25' ' ' LEU . 37.8 m 69.5 43.34 1.03 Allowed 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 114.674 -1.148 . . . . 0.0 111.267 174.759 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 55.7 p90 -68.06 161.98 25.6 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.606 177.909 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' SER . . . . . 0.541 ' HA ' ' HA ' ' A' ' 24' ' ' SER . 5.2 p -134.7 129.16 34.33 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.655 179.26 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . 0.427 ' OH ' ' HB2' ' A' ' 100' ' ' PHE . 24.6 m-85 -140.44 141.13 24.62 Favored Pre-proline 0 C--N 1.326 -0.414 0 CA-C-O 120.842 0.353 . . . . 0.0 111.119 178.709 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 63.3 Cg_endo -75.25 125.59 9.26 Favored 'Trans proline' 0 N--CA 1.461 -0.388 0 C-N-CA 122.399 2.066 . . . . 0.0 113.481 -177.442 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -69.35 159.13 33.73 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.131 -0.94 . . . . 0.0 109.252 170.379 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.532 HG13 ' OE1' ' A' ' 79' ' ' GLU . 2.6 tt -44.43 -44.56 2.37 Favored 'Isoleucine or valine' 0 C--O 1.24 0.567 0 O-C-N 124.445 1.091 . . . . 0.0 112.221 -176.207 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 43.8 m-80 -65.89 -12.93 58.29 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.375 -176.422 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 97.14 32.15 6.56 Favored Glycine 0 N--CA 1.444 -0.817 0 N-CA-C 111.248 -0.741 . . . . 0.0 111.248 -176.615 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.427 ' NZ ' HG23 ' A' ' 23' ' ' VAL . 23.4 ttpp -106.68 121.11 43.68 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 120.667 -0.413 . . . . 0.0 110.36 -176.815 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 14.1 m -63.0 99.32 0.16 Allowed 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.964 0.412 . . . . 0.0 110.385 176.65 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.427 HG23 ' NZ ' ' A' ' 21' ' ' LYS . 97.0 t -99.82 113.76 36.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 178.098 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' SER . . . . . 0.541 ' HA ' ' HA ' ' A' ' 14' ' ' SER . 14.7 m -105.4 177.0 4.98 Favored 'General case' 0 C--N 1.311 -1.069 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.159 -179.218 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.53 ' O ' ' HB2' ' A' ' 29' ' ' LYS . 2.9 tm? -53.87 -38.0 64.27 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.619 178.718 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -89.66 10.13 24.36 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 112.287 0.477 . . . . 0.0 112.287 -176.596 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -87.43 -27.77 22.52 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-O 121.481 0.658 . . . . 0.0 110.319 -179.187 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.461 HD11 ' CD1' ' A' ' 33' ' ' ILE . 0.9 OUTLIER -132.88 15.91 4.27 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.487 -0.778 . . . . 0.0 110.592 -178.928 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.53 ' HB2' ' O ' ' A' ' 25' ' ' LEU . 17.1 tttt -67.02 150.47 49.18 Favored 'General case' 0 C--N 1.313 -0.979 0 CA-C-N 114.197 -1.365 . . . . 0.0 111.301 -177.063 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 113.49 -18.48 20.32 Favored Glycine 0 N--CA 1.448 -0.565 0 N-CA-C 111.193 -0.763 . . . . 0.0 111.193 -178.85 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.761 ' HD2' ' HA ' ' A' ' 63' ' ' ASP . 72.8 mmtt -117.11 154.72 30.53 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 179.218 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 69.4 m-85 -66.05 121.45 15.16 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 177.365 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.461 ' CD1' HD11 ' A' ' 28' ' ' LEU . 41.8 mm -94.6 115.73 34.14 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.896 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.73 -175.099 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . 0.665 ' HE2' ' HA ' ' A' ' 129' ' ' PRO . 59.4 t80 -107.01 111.23 23.62 Favored 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 173.755 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.551 ' HA ' ' O ' ' A' ' 67' ' ' VAL . 59.5 mt -97.01 132.6 41.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-O 121.152 0.501 . . . . 0.0 111.656 -173.392 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.478 ' O ' ' HA ' ' A' ' 68' ' ' SER . 5.3 p-10 -122.99 159.64 27.92 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.262 -0.881 . . . . 0.0 109.034 174.142 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.414 HG22 HG21 ' A' ' 106' ' ' ILE . 85.4 t -103.51 133.32 47.76 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.788 0 C-N-CA 120.5 -0.48 . . . . 0.0 110.805 174.078 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' TRP . . . . . 0.652 ' HZ3' HG22 ' A' ' 82' ' ' VAL . 0.9 OUTLIER -126.51 137.25 53.35 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.136 -0.483 . . . . 0.0 109.889 -178.303 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.554 ' HA ' ' OD1' ' A' ' 72' ' ' ASP . . . -145.55 164.68 30.91 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.64 -0.255 . . . . 0.0 110.666 177.665 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' THR . . . . . 0.699 ' HB ' ' CE3' ' A' ' 78' ' ' TRP . 4.9 t -81.55 -23.71 37.03 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.336 0.588 . . . . 0.0 109.671 172.822 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 12.7 p-90 -97.62 19.25 13.83 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.358 -0.837 . . . . 0.0 110.231 177.824 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' CYS . . . . . 0.647 ' SG ' ' HB3' ' A' ' 45' ' ' CYS . 24.8 p -78.27 -26.46 47.16 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.107 -177.437 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 66.47 -111.73 4.37 Favored Glycine 0 CA--C 1.519 0.337 0 CA-C-N 116.066 -0.515 . . . . 0.0 113.346 178.534 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -54.58 -28.16 54.24 Favored 'Trans proline' 0 C--N 1.351 0.666 0 C-N-CA 123.461 2.774 . . . . 0.0 113.292 -177.726 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . 0.647 ' HB3' ' SG ' ' A' ' 42' ' ' CYS . 30.7 t -52.6 -30.88 33.56 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.414 177.147 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.49 HH21 ' CG ' ' A' ' 85' ' ' ASP . 46.0 mtp180 -58.75 -21.42 55.46 Favored 'General case' 0 C--O 1.223 -0.292 0 N-CA-C 111.911 0.337 . . . . 0.0 111.911 -178.782 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -70.96 -23.88 77.64 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.829 -0.7 . . . . 0.0 112.831 -178.118 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . 0.429 ' HB3' ' HB2' ' A' ' 130' ' ' SER . 35.7 mt-10 -99.3 -18.43 17.57 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.761 0.28 . . . . 0.0 111.317 -176.978 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.685 ' HB3' HD23 ' A' ' 87' ' ' LEU . 3.6 mm? -57.54 -43.91 99.21 Favored Pre-proline 0 C--N 1.325 -0.486 0 N-CA-C 112.911 0.708 . . . . 0.0 112.911 -179.166 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.513 ' HD2' ' N ' ' A' ' 49' ' ' LEU . 12.3 Cg_endo -58.48 -37.89 92.61 Favored 'Trans proline' 0 C--N 1.351 0.706 0 C-N-CA 121.275 1.317 . . . . 0.0 111.027 170.684 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -73.33 -19.09 61.1 Favored 'General case' 0 CA--C 1.519 -0.212 0 CA-C-O 121.415 0.626 . . . . 0.0 109.796 -176.638 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.44 ' O ' HD22 ' A' ' 52' ' ' LEU . 5.8 tt -65.13 -38.02 89.32 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-N 115.107 -0.951 . . . . 0.0 108.74 174.421 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . 0.657 ' O ' ' HG2' ' A' ' 57' ' ' GLU . 8.9 mtmp? -59.01 -60.95 3.05 Favored 'General case' 0 CA--C 1.505 -0.783 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 171.809 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -45.17 -42.44 9.12 Favored 'General case' 0 C--O 1.224 -0.274 0 O-C-N 124.577 1.173 . . . . 0.0 111.256 -178.698 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.429 ' HB3' ' CE1' ' A' ' 66' ' ' PHE . 39.9 mt -61.41 -57.81 10.75 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.352 175.698 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 18.2 tp10 -65.45 -35.28 80.43 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.42 -174.391 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.657 ' HG2' ' O ' ' A' ' 53' ' ' LYS . 9.4 pt-20 -80.49 -29.05 37.36 Favored 'General case' 0 CA--C 1.532 0.25 0 O-C-N 121.906 -0.496 . . . . 0.0 111.141 179.4 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 75.9 tttt -63.36 -44.53 94.54 Favored 'General case' 0 C--O 1.237 0.426 0 CA-C-O 121.923 0.868 . . . . 0.0 109.11 170.484 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 61.2 m-85 -99.92 14.86 29.01 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.008 -0.997 . . . . 0.0 111.308 -176.414 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . 0.456 ' HB3' ' HA ' ' A' ' 57' ' ' GLU . . . -57.66 126.44 27.38 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.037 170.584 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 85.43 -6.05 81.31 Favored Glycine 0 N--CA 1.445 -0.721 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.126 -179.151 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 30.7 mmtm -88.51 -155.67 0.34 Allowed 'General case' 0 CA--C 1.515 -0.374 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 178.89 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . 0.761 ' HA ' ' HD2' ' A' ' 31' ' ' LYS . 36.1 m-20 -111.67 28.45 8.74 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 115.824 -0.626 . . . . 0.0 112.641 -175.793 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 4.7 mp -131.86 146.57 33.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-O 120.527 0.203 . . . . 0.0 110.799 179.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' HIS . . . . . 0.502 ' CD2' ' HB2' ' A' ' 31' ' ' LYS . 56.8 m-70 -124.91 145.65 49.72 Favored 'General case' 0 CA--C 1.514 -0.425 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 170.094 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . 0.429 ' CE1' ' HB3' ' A' ' 55' ' ' LEU . 77.0 m-85 -110.37 105.92 15.09 Favored 'General case' 0 C--N 1.315 -0.914 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 172.521 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.551 ' O ' ' HA ' ' A' ' 35' ' ' ILE . 48.0 t -112.63 114.07 45.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 115.374 -0.83 . . . . 0.0 111.232 -170.172 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' SER . . . . . 0.478 ' HA ' ' O ' ' A' ' 36' ' ' ASP . 3.6 m -88.26 150.64 23.15 Favored 'General case' 0 C--N 1.314 -0.935 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.584 -179.379 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.473 HD11 ' HB2' ' A' ' 94' ' ' MET . 61.1 tp -133.92 121.62 21.96 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.984 0.421 . . . . 0.0 110.531 175.092 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' SER . . . . . 0.474 ' O ' ' HB3' ' A' ' 94' ' ' MET . 0.7 OUTLIER -105.28 120.34 41.31 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.395 0.617 . . . . 0.0 112.379 -172.783 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' CYS . . . . . 0.492 ' HB3' ' HE3' ' A' ' 94' ' ' MET . 1.8 p -85.87 13.62 7.16 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.483 -0.78 . . . . 0.0 111.702 175.83 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . 0.574 ' OD2' HG22 ' A' ' 40' ' ' THR . 2.6 m-20 -69.56 115.28 8.63 Favored 'General case' 0 CA--C 1.511 -0.537 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 -179.511 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -67.83 -28.86 67.92 Favored 'General case' 0 C--N 1.318 -0.763 0 C-N-CA 120.093 -0.643 . . . . 0.0 110.209 -179.924 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . 0.715 ' ND2' ' HB3' ' A' ' 77' ' ' ALA . 1.0 OUTLIER -77.27 116.28 17.75 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 171.73 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.674 ' HE2' ' CD ' ' A' ' 79' ' ' GLU . 19.9 tttt -81.45 -64.39 1.2 Allowed 'General case' 0 C--N 1.319 -0.745 0 C-N-CA 119.804 -0.759 . . . . 0.0 110.847 171.839 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.861 ' HE2' ' HA ' ' A' ' 76' ' ' LYS . 0.4 OUTLIER -44.25 -56.67 3.96 Favored 'General case' 0 N--CA 1.464 0.246 0 N-CA-C 113.383 0.883 . . . . 0.0 113.383 -172.057 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.811 ' HA ' ' ND2' ' A' ' 80' ' ' ASN . . . -61.28 -27.59 68.58 Favored 'General case' 0 C--O 1.242 0.689 0 CA-C-O 121.51 0.671 . . . . 0.0 111.233 -176.75 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' TRP . . . . . 0.699 ' CE3' ' HB ' ' A' ' 40' ' ' THR . 3.1 t-105 -81.61 -43.0 19.22 Favored 'General case' 0 N--CA 1.435 -1.188 0 CA-C-N 115.373 -0.83 . . . . 0.0 110.192 -173.921 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . 0.674 ' CD ' ' HE2' ' A' ' 75' ' ' LYS . 6.0 mm-40 -49.34 -43.54 43.9 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-O 121.012 0.434 . . . . 0.0 110.747 171.649 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . 0.811 ' ND2' ' HA ' ' A' ' 77' ' ' ALA . 7.2 m-20 -56.93 -54.32 47.98 Favored 'General case' 0 CA--C 1.517 -0.315 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.583 179.269 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 37.5 ttm -64.61 -46.17 83.77 Favored 'General case' 0 C--O 1.223 -0.301 0 CA-C-N 116.248 -0.433 . . . . 0.0 112.073 -174.895 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.652 HG22 ' HZ3' ' A' ' 38' ' ' TRP . 5.7 p -63.44 -28.25 44.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 C-N-CA 120.622 -0.431 . . . . 0.0 111.407 -178.162 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 36.7 m -81.72 -34.95 30.27 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 120.87 0.367 . . . . 0.0 110.69 177.642 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 24.9 ttmm -77.48 -44.22 29.61 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.109 0.48 . . . . 0.0 111.059 -177.547 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . 0.749 ' HB3' ' HG ' ' A' ' 87' ' ' LEU . 5.4 t0 -77.36 -1.67 31.16 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.185 -0.916 . . . . 0.0 110.943 -176.247 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 48.3 mt-30 65.25 19.83 11.78 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 115.673 -0.694 . . . . 0.0 112.21 175.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.749 ' HG ' ' HB3' ' A' ' 85' ' ' ASP . 17.3 mt -74.03 87.81 1.87 Allowed 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.131 -179.119 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 4.2 mmpm? -101.76 -177.85 3.55 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 112.537 0.569 . . . . 0.0 112.537 -175.739 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 122.71 -176.23 16.53 Favored Glycine 0 N--CA 1.448 -0.545 0 N-CA-C 109.554 -1.418 . . . . 0.0 109.554 -171.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.538 ' O ' ' HA ' ' A' ' 67' ' ' VAL . 60.6 mt -83.34 112.7 21.3 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 118.063 0.932 . . . . 0.0 108.681 175.481 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . 0.483 ' HB2' ' CZ2' ' A' ' 38' ' ' TRP . 2.1 pt20 -137.98 110.71 7.61 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-O 121.834 0.826 . . . . 0.0 112.085 -168.565 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.421 HD21 ' HB ' ' A' ' 23' ' ' VAL . 26.0 mt -97.51 142.11 29.74 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.146 -0.934 . . . . 0.0 110.272 -177.83 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' HIS . . . . . 0.438 ' CE1' ' HG3' ' A' ' 75' ' ' LYS . 29.7 t-80 -110.56 117.04 32.47 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-O 121.35 0.595 . . . . 0.0 110.599 -179.643 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' MET . . . . . 0.615 ' SD ' ' HA ' ' A' ' 98' ' ' ARG . 13.6 ttp -79.81 -63.67 1.36 Allowed 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 114.964 -1.016 . . . . 0.0 110.482 -179.891 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . 0.53 ' HA2' ' O ' ' A' ' 72' ' ' ASP . . . 71.36 -79.1 0.55 Allowed Glycine 0 C--O 1.236 0.268 0 C-N-CA 120.967 -0.635 . . . . 0.0 114.466 174.463 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 1.3 p -88.72 -35.52 16.69 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-O 120.819 0.342 . . . . 0.0 111.57 -175.329 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -92.52 57.18 2.88 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.809 -166.793 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . 0.615 ' HA ' ' SD ' ' A' ' 94' ' ' MET . 0.0 OUTLIER -70.82 10.28 0.54 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.12 -0.946 . . . . 0.0 112.698 -172.888 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 8.6 m -73.6 -19.14 60.95 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 120.964 0.411 . . . . 0.0 111.079 -179.587 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' PHE . . . . . 0.427 ' HB2' ' OH ' ' A' ' 15' ' ' TYR . 3.2 t80 -79.63 -43.37 22.97 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 120.898 -0.321 . . . . 0.0 110.713 -178.459 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' MET . . . . . 0.52 ' HA ' HD12 ' A' ' 106' ' ' ILE . 5.1 ppp? -69.23 -24.91 64.07 Favored 'General case' 0 C--N 1.332 -0.178 0 N-CA-C 109.176 -0.676 . . . . 0.0 109.176 175.383 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . 0.409 ' HB2' ' NH1' ' A' ' 98' ' ' ARG . 11.4 t70 -66.41 -50.98 61.62 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.132 -0.94 . . . . 0.0 110.423 173.904 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -64.6 -18.94 65.36 Favored 'General case' 0 N--CA 1.461 0.095 0 CA-C-N 115.758 -0.655 . . . . 0.0 112.072 -175.29 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 46.1 m-85 -108.45 2.43 22.33 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 111.844 0.313 . . . . 0.0 111.844 -179.319 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 8.8 tp 59.35 26.41 15.27 Favored 'General case' 0 C--N 1.328 -0.361 0 O-C-N 123.507 0.504 . . . . 0.0 110.423 -179.351 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . 0.65 HG12 ' HG3' ' A' ' 111' ' ' ARG . 69.9 mt -60.21 101.46 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.328 0 CA-C-N 115.673 -0.694 . . . . 0.0 111.456 178.769 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 8.7 p30 -134.21 148.88 50.95 Favored 'General case' 0 C--N 1.317 -0.808 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 173.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 76.3 84.91 0.41 Allowed Glycine 0 N--CA 1.446 -0.671 0 C-N-CA 120.469 -0.872 . . . . 0.0 111.775 -176.079 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . 0.43 HG22 ' HA ' ' A' ' 110' ' ' PRO . 40.1 mt -69.57 139.16 88.84 Favored Pre-proline 0 C--N 1.325 -0.481 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 177.603 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . 0.491 ' HG3' ' SG ' ' A' ' 45' ' ' CYS . 10.0 Cg_endo -93.11 140.39 8.36 Favored 'Cis proline' 0 N--CA 1.459 -0.521 0 C-N-CA 124.455 -1.061 . . . . 0.0 113.974 0.952 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . 0.65 ' HG3' HG12 ' A' ' 106' ' ' ILE . 0.0 OUTLIER -83.82 144.18 29.45 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 172.933 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . 0.531 ' HD1' ' H ' ' A' ' 126' ' ' MET . 0.9 OUTLIER -118.7 116.83 27.38 Favored 'General case' 0 C--N 1.323 -0.547 0 O-C-N 123.724 0.64 . . . . 0.0 110.792 -176.788 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.473 ' HB ' ' HB ' ' A' ' 35' ' ' ILE . 83.0 mt -130.99 149.56 33.66 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.299 0 CA-C-N 116.703 -0.226 . . . . 0.0 110.908 -177.917 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.415 ' C ' HD11 ' A' ' 115' ' ' LEU . 62.4 tp -128.54 138.07 52.06 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.618 -0.265 . . . . 0.0 110.57 178.941 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . 0.555 ' HG ' ' HA ' ' A' ' 121' ' ' ILE . 2.0 mp -135.19 152.1 51.26 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-O 121.334 0.588 . . . . 0.0 110.623 179.108 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . 0.421 ' N ' HG13 ' A' ' 122' ' ' ILE . 7.6 t70 -69.73 160.85 30.91 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 114.872 -1.058 . . . . 0.0 110.645 175.952 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . 0.444 ' HA ' ' O ' ' A' ' 31' ' ' LYS . 58.7 mtt-85 -48.51 -37.41 17.5 Favored 'General case' 0 N--CA 1.474 0.728 0 O-C-N 124.267 0.979 . . . . 0.0 111.368 -178.368 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . 0.634 ' HB3' ' HG3' ' A' ' 120' ' ' LYS . 29.1 t0 -67.82 -13.01 61.78 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 114.515 -1.221 . . . . 0.0 111.121 -177.069 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . 0.524 ' HA3' HD11 ' A' ' 25' ' ' LEU . . . 93.63 23.78 22.71 Favored Glycine 0 N--CA 1.439 -1.112 0 N-CA-C 110.553 -1.019 . . . . 0.0 110.553 -172.132 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . 0.634 ' HG3' ' HB3' ' A' ' 118' ' ' ASP . 36.6 mtmm -103.72 106.75 17.35 Favored 'General case' 0 C--O 1.223 -0.333 0 C-N-CA 120.564 -0.454 . . . . 0.0 111.365 -174.619 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . 0.555 ' HA ' ' HG ' ' A' ' 115' ' ' LEU . 3.3 mp -42.16 116.57 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 O-C-N 123.909 0.755 . . . . 0.0 111.692 -178.982 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' ILE . . . . . 0.422 ' H ' ' HA ' ' A' ' 115' ' ' LEU . 57.4 mt -89.04 -38.74 11.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 115.346 -0.843 . . . . 0.0 108.902 177.082 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 14.9 m -148.15 126.77 12.49 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.492 -0.776 . . . . 0.0 110.197 -179.812 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -74.24 -14.95 61.0 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-O 121.336 0.589 . . . . 0.0 110.593 178.53 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . 0.449 ' HA ' ' O ' ' A' ' 112' ' ' PHE . 5.1 p-10 -149.42 126.83 11.5 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.054 -0.975 . . . . 0.0 108.598 173.613 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' MET . . . . . 0.531 ' H ' ' HD1' ' A' ' 112' ' ' PHE . 15.9 tpt -108.95 -87.34 0.5 Allowed 'General case' 0 C--N 1.321 -0.653 0 C-N-CA 120.804 -0.358 . . . . 0.0 111.567 -176.941 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 7.6 p -141.61 -77.85 0.27 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.269 0.557 . . . . 0.0 110.774 -175.013 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . 0.886 ' HB3' ' HB2' ' A' ' 131' ' ' ASP . 43.3 ttm-85 -172.31 141.04 1.09 Allowed Pre-proline 0 N--CA 1.443 -0.807 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 177.5 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . 0.665 ' HA ' ' HE2' ' A' ' 34' ' ' TYR . 5.7 Cg_exo -38.48 -52.46 1.98 Allowed 'Trans proline' 0 C--N 1.348 0.551 0 C-N-CA 123.746 2.964 . . . . 0.0 113.455 -179.242 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' SER . . . . . 0.429 ' HB2' ' HB3' ' A' ' 48' ' ' GLU . 36.1 t -109.01 26.16 10.94 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 111.734 0.272 . . . . 0.0 111.734 -177.378 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . 0.886 ' HB2' ' HB3' ' A' ' 128' ' ' ARG . 11.1 t0 -73.64 119.69 77.29 Favored Pre-proline 0 C--O 1.237 0.43 0 C-N-CA 120.108 -0.637 . . . . 0.0 109.458 176.598 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . 0.413 ' O ' ' HG2' ' A' ' 136' ' ' GLU . 51.5 Cg_exo -55.12 -33.08 82.61 Favored 'Trans proline' 0 C--N 1.349 0.579 0 C-N-CA 123.495 2.797 . . . . 0.0 113.737 -175.034 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 38.3 mttp -57.82 -45.86 85.55 Favored 'General case' 0 CA--C 1.519 -0.227 0 CA-C-O 121.33 0.586 . . . . 0.0 109.912 -177.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -63.36 -47.54 81.66 Favored 'General case' 0 N--CA 1.448 -0.538 0 CA-C-N 115.033 -0.985 . . . . 0.0 111.116 -178.881 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . 0.665 ' HA ' ' CD2' ' A' ' 138' ' ' PHE . . . -59.61 -50.75 72.67 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.606 -0.725 . . . . 0.0 111.072 -173.895 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . 0.685 ' O ' ' HB2' ' A' ' 139' ' ' ASN . 22.7 mm-40 -76.21 -23.16 54.6 Favored 'General case' 0 C--N 1.312 -1.028 0 CA-C-O 121.857 0.837 . . . . 0.0 110.084 -175.175 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . 1.017 ' HA ' ' HE3' ' A' ' 137' ' ' LYS . 0.1 OUTLIER -65.45 -39.34 91.9 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 115.522 -0.763 . . . . 0.0 109.655 170.995 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . 0.665 ' CD2' ' HA ' ' A' ' 135' ' ' ALA . 15.0 m-85 -55.59 -36.55 67.02 Favored 'General case' 0 N--CA 1.464 0.265 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 172.637 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' ASN . . . . . 0.685 ' HB2' ' O ' ' A' ' 136' ' ' GLU . 94.2 m-20 -51.16 -59.72 3.88 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.148 174.113 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -61.55 -36.12 79.7 Favored 'General case' 0 N--CA 1.463 0.179 0 C-N-CA 120.656 -0.418 . . . . 0.0 111.486 -179.262 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . 0.487 ' HG ' ' O ' ' A' ' 137' ' ' LYS . 96.9 mt -61.48 -27.82 68.85 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.897 0.38 . . . . 0.0 110.841 178.348 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 41.7 tp . . . . . 0 C--N 1.326 -0.438 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.597 178.172 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.227 -0.117 0 CA-C-O 120.913 0.387 . . . . 0.0 111.759 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -89.6 -20.69 23.42 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.306 0.575 . . . . 0.0 110.36 177.817 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' SER . . . . . 0.563 ' HA ' ' HB3' ' A' ' 25' ' ' LEU . 67.6 m -161.24 91.43 0.86 Allowed 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.373 -0.83 . . . . 0.0 109.914 178.482 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . 0.496 ' CE2' HD22 ' A' ' 25' ' ' LEU . 25.4 p90 -103.55 178.81 4.45 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.655 -179.79 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' SER . . . . . 0.451 ' HA ' ' HA ' ' A' ' 24' ' ' SER . 25.1 p -142.35 119.72 11.6 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.119 -0.492 . . . . 0.0 109.948 176.578 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . 0.558 ' HB2' HD23 ' A' ' 92' ' ' LEU . 28.3 m-85 -134.8 155.3 79.48 Favored Pre-proline 0 C--N 1.324 -0.53 0 CA-C-N 116.652 -0.249 . . . . 0.0 110.675 -179.15 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -83.37 124.84 3.77 Favored 'Trans proline' 0 N--CA 1.453 -0.864 0 C-N-CA 122.016 1.811 . . . . 0.0 112.896 176.19 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . 0.995 ' HB3' ' HB3' ' A' ' 21' ' ' LYS . 0.9 OUTLIER -61.47 162.29 8.29 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.077 -0.965 . . . . 0.0 109.173 168.662 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.61 HD11 HG13 ' A' ' 82' ' ' VAL . 0.7 OUTLIER -42.46 -45.08 1.1 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.452 0 O-C-N 123.975 0.797 . . . . 0.0 112.072 -176.644 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . 0.504 ' ND2' HG21 ' A' ' 18' ' ' ILE . 28.9 m-80 -77.23 8.54 3.92 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.825 -173.967 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 81.54 25.22 54.58 Favored Glycine 0 N--CA 1.449 -0.442 0 N-CA-C 110.769 -0.932 . . . . 0.0 110.769 -175.022 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.995 ' HB3' ' HB3' ' A' ' 17' ' ' ASP . 1.4 ttmp? -89.96 107.39 19.09 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.435 -0.383 . . . . 0.0 110.473 -173.744 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 23.6 m -67.37 108.29 2.72 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.84 -179.648 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 57.5 t -123.89 133.07 70.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 116.021 -0.536 . . . . 0.0 109.683 179.846 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' SER . . . . . 0.451 ' HA ' ' HA ' ' A' ' 14' ' ' SER . 26.5 p -104.46 171.27 7.42 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.128 0.489 . . . . 0.0 110.031 178.6 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.563 ' HB3' ' HA ' ' A' ' 12' ' ' SER . 20.9 tp -91.18 11.86 21.95 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 121.257 0.551 . . . . 0.0 109.608 176.725 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.552 ' HA ' ' HD3' ' A' ' 29' ' ' LYS . . . -103.29 -25.63 13.25 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 -176.09 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 62.5 m-20 -70.29 -11.79 61.14 Favored 'General case' 0 N--CA 1.436 -1.154 0 CA-C-N 114.05 -1.432 . . . . 0.0 110.797 177.538 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 79.4 mt -110.3 3.19 19.67 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.575 -0.739 . . . . 0.0 112.317 -170.582 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.552 ' HD3' ' HA ' ' A' ' 26' ' ' ALA . 1.3 mptm? -61.98 150.07 38.97 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.192 0.52 . . . . 0.0 111.041 178.462 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 98.55 5.92 56.63 Favored Glycine 0 N--CA 1.445 -0.73 0 C-N-CA 120.807 -0.711 . . . . 0.0 111.731 -179.826 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.814 ' HD3' ' HA ' ' A' ' 63' ' ' ASP . 7.5 ttmm -161.79 148.39 13.99 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.958 -0.386 . . . . 0.0 109.958 179.45 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.485 ' HB2' ' O ' ' A' ' 63' ' ' ASP . 40.6 m-85 -56.28 149.57 16.14 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-O 121.266 0.555 . . . . 0.0 112.365 -173.765 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.672 ' HB ' ' HB2' ' A' ' 115' ' ' LEU . 31.4 mm -118.94 135.65 58.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 115.593 -0.731 . . . . 0.0 110.611 -176.139 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 87.8 t80 -123.32 112.08 17.18 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 109.583 -0.525 . . . . 0.0 109.583 172.197 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.689 ' HB ' ' HB ' ' A' ' 113' ' ' ILE . 39.4 mm -100.8 116.99 45.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.26 179.445 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -117.14 158.56 24.04 Favored 'General case' 0 C--N 1.315 -0.925 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 176.612 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.522 HG12 ' CG2' ' A' ' 109' ' ' ILE . 32.6 t -107.86 112.07 38.6 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.009 0 C-N-CA 120.171 -0.612 . . . . 0.0 109.888 175.315 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' TRP . . . . . 0.701 ' CE3' ' HZ2' ' A' ' 78' ' ' TRP . 0.9 OUTLIER -109.92 134.15 52.4 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 115.575 -0.739 . . . . 0.0 109.174 -175.461 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.529 ' HB3' ' HB3' ' A' ' 42' ' ' CYS . . . -147.07 165.62 29.36 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 116.477 -0.329 . . . . 0.0 110.702 -177.123 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' THR . . . . . 0.674 ' HB ' ' CE3' ' A' ' 78' ' ' TRP . 9.8 t -89.02 -24.96 22.22 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.271 0.558 . . . . 0.0 109.698 173.824 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 13.4 p-90 -94.86 8.81 41.49 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.108 179.782 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' CYS . . . . . 0.607 ' SG ' ' HB3' ' A' ' 45' ' ' CYS . 17.5 p -88.54 148.28 24.19 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 175.311 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -92.18 -65.69 1.12 Allowed Glycine 0 N--CA 1.448 -0.527 0 C-N-CA 120.277 -0.963 . . . . 0.0 113.087 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -56.12 -51.82 8.64 Favored 'Trans proline' 0 C--N 1.35 0.655 0 C-N-CA 122.743 2.295 . . . . 0.0 112.865 -175.328 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . 0.607 ' HB3' ' SG ' ' A' ' 42' ' ' CYS . 35.1 t -63.11 -39.75 95.61 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.874 0.369 . . . . 0.0 110.325 -175.846 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.516 ' HA ' ' HG ' ' A' ' 49' ' ' LEU . 62.3 ttt180 -71.14 -27.89 63.88 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.493 179.252 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -79.73 -37.75 22.13 Favored Glycine 0 N--CA 1.447 -0.609 0 C-N-CA 120.69 -0.767 . . . . 0.0 111.945 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . 0.536 ' OE2' ' HD3' ' A' ' 128' ' ' ARG . 35.5 mt-10 -90.16 10.1 25.8 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 122.976 -0.132 . . . . 0.0 111.27 -178.495 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.633 ' O ' ' HG3' ' A' ' 53' ' ' LYS . 41.0 mt -46.23 -52.17 29.57 Favored Pre-proline 0 N--CA 1.468 0.465 0 N-CA-C 112.419 0.526 . . . . 0.0 112.419 -179.725 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.525 ' HD2' ' N ' ' A' ' 49' ' ' LEU . 10.3 Cg_endo -54.26 -41.33 77.1 Favored 'Trans proline' 0 C--N 1.355 0.876 0 C-N-CA 122.035 1.823 . . . . 0.0 112.46 179.077 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -80.46 -26.65 38.18 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.379 0.609 . . . . 0.0 110.172 -177.204 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 7.9 tt -66.71 -43.7 83.62 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.424 -0.807 . . . . 0.0 108.884 175.585 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . 0.633 ' HG3' ' O ' ' A' ' 49' ' ' LEU . 88.5 mttt -57.83 -48.58 79.36 Favored 'General case' 0 CA--C 1.516 -0.335 0 O-C-N 123.589 0.556 . . . . 0.0 110.345 177.424 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.46 ' CD ' ' HZ3' ' A' ' 58' ' ' LYS . 0.5 OUTLIER -44.86 -59.09 2.72 Favored 'General case' 0 N--CA 1.452 -0.329 0 O-C-N 124.06 0.85 . . . . 0.0 111.018 175.16 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 60.1 mt -59.99 -51.71 68.48 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.27 177.789 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -44.14 -59.58 2.27 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 114.582 -1.19 . . . . 0.0 112.528 -179.056 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.555 ' HG2' ' O ' ' A' ' 53' ' ' LYS . 6.1 pt-20 -82.75 -29.27 29.82 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 112.154 0.427 . . . . 0.0 112.154 -173.868 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . 0.516 ' HE3' ' HE1' ' A' ' 59' ' ' TYR . 32.4 ttpt -68.68 -36.65 78.78 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.236 0.541 . . . . 0.0 110.229 178.316 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.722 ' HB3' HD11 ' A' ' 64' ' ' ILE . 41.7 m-85 -99.45 -1.0 39.66 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.371 -178.857 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -63.83 142.09 58.53 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.538 -0.541 . . . . 0.0 109.538 169.19 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 84.86 9.72 80.33 Favored Glycine 0 N--CA 1.448 -0.521 0 C-N-CA 120.494 -0.86 . . . . 0.0 112.555 179.712 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . 0.53 ' HD2' HD23 ' A' ' 142' ' ' LEU . 39.8 mmtm -100.61 -160.72 0.81 Allowed 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 174.532 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . 0.814 ' HA ' ' HD3' ' A' ' 31' ' ' LYS . 2.6 t70 -90.66 52.04 2.11 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-O 121.271 0.558 . . . . 0.0 110.019 -179.688 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.722 HD11 ' HB3' ' A' ' 59' ' ' TYR . 9.2 pt -151.73 156.63 5.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 115.525 -0.761 . . . . 0.0 110.396 -178.418 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' HIS . . . . . 0.651 ' NE2' ' HB3' ' A' ' 31' ' ' LYS . 95.0 m-70 -126.28 113.64 17.21 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.165 -0.47 . . . . 0.0 109.779 175.397 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 88.7 m-85 -76.77 103.8 6.93 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 172.783 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.617 ' HB ' HD11 ' A' ' 35' ' ' ILE . 23.1 t -121.26 104.78 15.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 116.162 -0.472 . . . . 0.0 109.789 -178.928 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 6.8 m -99.28 144.7 28.1 Favored 'General case' 0 C--N 1.313 -1.015 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.508 -177.063 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.421 HD23 ' HB2' ' A' ' 92' ' ' LEU . 78.5 mt -122.95 124.1 42.43 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-O 120.696 0.284 . . . . 0.0 111.49 177.564 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' SER . . . . . 0.432 ' HA ' ' O ' ' A' ' 38' ' ' TRP . 40.6 m -96.0 119.71 34.98 Favored 'General case' 0 N--CA 1.464 0.272 0 N-CA-C 112.542 0.571 . . . . 0.0 112.542 -179.49 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' CYS . . . . . 0.639 ' HG ' HG21 ' A' ' 109' ' ' ILE . 7.4 p -92.64 28.53 1.99 Allowed 'General case' 0 C--N 1.313 -1.008 0 CA-C-O 121.198 0.523 . . . . 0.0 110.118 175.03 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . 0.507 ' OD2' HG21 ' A' ' 40' ' ' THR . 2.1 m-20 -81.77 112.79 19.25 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.312 178.255 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . 0.431 ' HB3' ' HB ' ' A' ' 96' ' ' THR . 8.8 ptmm? -67.98 -28.6 67.58 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.078 0.466 . . . . 0.0 111.127 178.994 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -87.32 75.83 9.22 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 109.608 -0.515 . . . . 0.0 109.608 179.556 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.422 ' O ' ' HG2' ' A' ' 79' ' ' GLU . 8.5 tttm -55.06 -64.01 0.97 Allowed 'General case' 0 C--O 1.217 -0.655 0 CA-C-N 115.849 -0.614 . . . . 0.0 112.45 -175.711 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 64.2 tttp -43.94 -50.17 8.24 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 112.258 0.466 . . . . 0.0 112.258 -177.605 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.694 ' HA ' ' ND2' ' A' ' 80' ' ' ASN . . . -58.75 -41.6 86.91 Favored 'General case' 0 C--O 1.246 0.905 0 CA-C-O 122.142 0.972 . . . . 0.0 110.341 179.769 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' TRP . . . . . 0.701 ' HZ2' ' CE3' ' A' ' 38' ' ' TRP . 10.0 t-105 -65.55 -49.98 66.87 Favored 'General case' 0 C--N 1.312 -1.056 0 CA-C-N 114.012 -1.449 . . . . 0.0 110.988 -178.97 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . 0.461 ' OE1' HG13 ' A' ' 18' ' ' ILE . 6.1 mm-40 -47.4 -44.07 24.12 Favored 'General case' 0 C--O 1.234 0.276 0 N-CA-C 112.069 0.396 . . . . 0.0 112.069 175.678 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . 0.712 ' O ' ' HG2' ' A' ' 84' ' ' LYS . 1.9 m-80 -60.64 -46.85 88.75 Favored 'General case' 0 CA--C 1.514 -0.41 0 C-N-CA 120.326 -0.55 . . . . 0.0 110.288 -179.243 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' MET . . . . . 0.45 ' SD ' ' HZ3' ' A' ' 78' ' ' TRP . 19.0 ttt -63.07 -47.79 81.44 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 120.41 -0.516 . . . . 0.0 111.993 -177.214 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.61 HG13 HD11 ' A' ' 18' ' ' ILE . 7.2 p -64.17 -28.48 44.99 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 C-N-CA 120.308 -0.557 . . . . 0.0 111.41 -177.54 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' THR . . . . . 0.422 HG23 HD13 ' A' ' 18' ' ' ILE . 5.0 p -81.17 -21.89 39.37 Favored 'General case' 0 N--CA 1.444 -0.749 0 O-C-N 121.941 -0.475 . . . . 0.0 111.757 176.406 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . 0.712 ' HG2' ' O ' ' A' ' 80' ' ' ASN . 27.1 mmtm -84.73 -38.39 19.75 Favored 'General case' 0 CA--C 1.519 -0.237 0 CA-C-O 121.249 0.547 . . . . 0.0 110.597 178.195 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . 0.418 ' CG ' ' HZ3' ' A' ' 53' ' ' LYS . 36.5 t70 -80.15 -22.76 41.67 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.241 -0.891 . . . . 0.0 110.305 179.393 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 26.4 mt-30 66.54 76.46 0.3 Allowed 'General case' 0 C--O 1.234 0.268 0 CA-C-N 115.188 -0.914 . . . . 0.0 111.96 177.085 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.519 ' HB2' HG23 ' A' ' 82' ' ' VAL . 89.4 mt -103.85 133.09 49.42 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.426 -0.806 . . . . 0.0 109.065 173.658 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . 0.521 ' HZ3' ' HB3' ' A' ' 57' ' ' GLU . 0.0 OUTLIER -134.73 157.97 45.34 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.349 0.595 . . . . 0.0 111.96 -175.499 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 124.91 -132.75 8.24 Favored Glycine 0 N--CA 1.447 -0.626 0 N-CA-C 110.224 -1.15 . . . . 0.0 110.224 -173.278 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 57.7 mt -112.03 108.02 24.45 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 173.414 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . 0.62 ' HB3' ' CZ2' ' A' ' 38' ' ' TRP . 7.0 mm-40 -129.04 103.75 7.18 Favored 'General case' 0 N--CA 1.445 -0.708 0 N-CA-C 109.926 -0.398 . . . . 0.0 109.926 -175.828 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.558 HD23 ' HB2' ' A' ' 15' ' ' TYR . 5.1 mp -103.29 151.36 22.79 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-O 121.493 0.663 . . . . 0.0 110.87 -175.765 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 16.7 t-80 -120.77 119.59 33.17 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-N 115.613 -0.722 . . . . 0.0 110.425 -176.912 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' MET . . . . . 0.416 ' HE3' ' HE1' ' A' ' 101' ' ' MET . 33.7 ttm -71.78 -75.78 0.12 Allowed 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.433 -0.803 . . . . 0.0 110.129 176.363 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 134.94 -95.15 0.26 Allowed Glycine 0 N--CA 1.442 -0.95 0 N-CA-C 111.114 -0.794 . . . . 0.0 111.114 -174.181 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' THR . . . . . 0.431 ' HB ' ' HB3' ' A' ' 73' ' ' LYS . 9.2 t -150.49 25.61 0.77 Allowed 'General case' 0 C--N 1.313 -0.981 0 CA-C-O 121.834 0.826 . . . . 0.0 109.287 177.831 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -81.55 72.61 8.6 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 114.86 -1.063 . . . . 0.0 109.766 -179.092 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . 0.556 ' HA ' ' HG3' ' A' ' 101' ' ' MET . 7.4 mmm180 -69.36 -10.91 60.03 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.724 -173.298 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 7.6 m -58.24 -36.81 73.76 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.165 0.507 . . . . 0.0 109.927 175.262 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 24.8 t80 -81.74 -25.43 35.38 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.184 178.782 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' MET . . . . . 0.556 ' HG3' ' HA ' ' A' ' 98' ' ' ARG . 1.3 mmt -58.92 -51.44 70.04 Favored 'General case' 0 CA--C 1.519 -0.245 0 CA-C-O 121.265 0.555 . . . . 0.0 109.507 175.451 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -77.02 -23.03 52.19 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.406 -0.815 . . . . 0.0 110.538 -177.793 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -64.8 -26.93 68.55 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-O 121.12 0.486 . . . . 0.0 111.043 176.931 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' TYR . . . . . 0.525 ' HB3' HG23 ' A' ' 106' ' ' ILE . 0.3 OUTLIER -96.38 -4.11 42.47 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.296 174.875 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 93.5 mt 58.59 32.21 21.91 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.356 -172.301 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . 0.984 HG21 HD13 ' A' ' 113' ' ' ILE . 40.8 pt -114.43 31.96 1.52 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.333 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.356 -178.622 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 15.3 p30 -56.47 -29.74 62.09 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.469 -0.787 . . . . 0.0 111.82 -178.699 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -89.48 108.95 3.54 Favored Glycine 0 N--CA 1.448 -0.525 0 C-N-CA 121.02 -0.61 . . . . 0.0 111.61 174.077 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . 0.639 HG21 ' HG ' ' A' ' 71' ' ' CYS . 2.5 pp -100.43 153.81 37.54 Favored Pre-proline 0 C--N 1.325 -0.466 0 CA-C-O 120.344 0.116 . . . . 0.0 110.767 -177.528 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . 0.426 ' HG3' ' HB2' ' A' ' 42' ' ' CYS . 2.7 Cg_exo -76.82 152.51 95.43 Favored 'Cis proline' 0 C--N 1.344 0.326 0 C-N-CA 123.899 -1.292 . . . . 0.0 111.966 -0.068 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . 0.743 HH11 HG22 ' A' ' 106' ' ' ILE . 0.0 OUTLIER -125.17 138.45 54.14 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.365 0.603 . . . . 0.0 110.966 -179.0 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . 0.587 ' HD1' ' H ' ' A' ' 126' ' ' MET . 0.2 OUTLIER -106.74 114.97 29.39 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 114.341 -1.3 . . . . 0.0 110.354 -176.548 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.984 HD13 HG21 ' A' ' 106' ' ' ILE . 61.6 mt -123.57 142.54 39.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-O 120.858 0.361 . . . . 0.0 110.754 -178.483 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 23.0 tp -129.23 135.14 48.42 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.996 -0.547 . . . . 0.0 109.655 177.662 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . 0.672 ' HB2' ' HB ' ' A' ' 33' ' ' ILE . 2.0 mp -132.57 153.44 51.0 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.878 0.37 . . . . 0.0 110.495 -177.054 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . 0.466 ' HB3' ' HB2' ' A' ' 120' ' ' LYS . 27.9 t0 -68.93 166.1 18.58 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.468 -0.787 . . . . 0.0 110.261 177.276 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . 0.517 ' HA ' ' C ' ' A' ' 31' ' ' LYS . 9.2 mtm180 -49.39 -27.64 4.28 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 124.335 1.054 . . . . 0.0 112.733 -177.076 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . 0.556 ' HB3' ' HG3' ' A' ' 120' ' ' LYS . 30.6 t70 -83.32 -0.97 52.1 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.257 0.551 . . . . 0.0 110.965 -178.784 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 81.26 22.5 60.61 Favored Glycine 0 N--CA 1.439 -1.16 0 N-CA-C 110.203 -1.159 . . . . 0.0 110.203 -170.513 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . 0.556 ' HG3' ' HB3' ' A' ' 118' ' ' ASP . 56.5 mttp -88.56 107.4 18.88 Favored 'General case' 0 C--O 1.223 -0.325 0 C-N-CA 120.478 -0.489 . . . . 0.0 111.052 -178.267 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . 0.459 ' HA ' ' HG ' ' A' ' 115' ' ' LEU . 19.5 mt -42.74 116.27 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-O 121.725 0.774 . . . . 0.0 112.332 179.251 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' ILE . . . . . 0.441 HD13 ' HB2' ' A' ' 116' ' ' ASP . 39.2 mm -97.87 -50.87 10.94 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.927 0 CA-C-N 114.283 -1.326 . . . . 0.0 109.203 177.163 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 14.6 m -129.44 114.21 15.87 Favored 'General case' 0 N--CA 1.446 -0.664 0 CA-C-N 115.22 -0.9 . . . . 0.0 110.113 179.305 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -68.05 -20.38 64.97 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 121.807 0.813 . . . . 0.0 109.496 174.046 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 7.4 p30 -141.46 122.07 14.23 Favored 'General case' 0 N--CA 1.447 -0.586 0 CA-C-N 114.523 -1.217 . . . . 0.0 108.25 171.291 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' MET . . . . . 0.587 ' H ' ' HD1' ' A' ' 112' ' ' PHE . 17.3 tpt -92.76 -80.66 0.37 Allowed 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.915 -176.664 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 4.2 m -155.44 -61.91 0.11 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.576 -0.284 . . . . 0.0 110.48 179.605 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . 1.078 ' HB3' ' HB2' ' A' ' 131' ' ' ASP . 0.0 OUTLIER -179.82 142.1 0.35 Allowed Pre-proline 0 N--CA 1.453 -0.314 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 -176.467 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . 0.576 ' HD2' ' HG2' ' A' ' 128' ' ' ARG . 1.5 Cg_endo -43.19 -49.0 7.58 Favored 'Trans proline' 0 C--N 1.351 0.671 0 C-N-CA 123.431 2.754 . . . . 0.0 113.353 -178.626 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 25.3 t -113.24 29.72 7.76 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.821 0.343 . . . . 0.0 111.196 -177.561 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . 1.078 ' HB2' ' HB3' ' A' ' 128' ' ' ARG . 11.2 t70 -84.88 135.94 39.39 Favored Pre-proline 0 C--N 1.328 -0.341 0 C-N-CA 120.389 -0.525 . . . . 0.0 110.426 -179.975 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 80.8 Cg_exo -48.24 -37.82 32.34 Favored 'Trans proline' 0 C--N 1.344 0.303 0 C-N-CA 123.231 2.621 . . . . 0.0 113.258 176.66 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 28.9 mmtm -56.98 -36.22 70.1 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-O 120.866 0.365 . . . . 0.0 111.711 -177.336 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' THR . . . . . 0.674 HG23 ' CZ ' ' A' ' 138' ' ' PHE . 2.4 m -64.51 -51.19 64.22 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.284 0.564 . . . . 0.0 109.69 177.244 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . 0.658 ' HA ' ' CD2' ' A' ' 138' ' ' PHE . . . -61.56 -41.01 96.75 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.583 -0.735 . . . . 0.0 111.542 177.576 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -53.5 -52.1 60.67 Favored 'General case' 0 CA--C 1.511 -0.531 0 CA-C-O 121.44 0.638 . . . . 0.0 110.458 176.882 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . 0.717 ' HE2' ' HA ' ' A' ' 137' ' ' LYS . 0.3 OUTLIER -48.93 -46.56 43.26 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 114.333 -1.303 . . . . 0.0 111.261 175.614 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . 0.674 ' CZ ' HG23 ' A' ' 134' ' ' THR . 5.9 m-85 -63.1 -53.77 48.29 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 120.889 0.376 . . . . 0.0 109.991 178.4 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 94.2 m-20 -50.9 -50.12 58.04 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.789 -179.886 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . 0.551 ' CD ' ' HZ2' ' A' ' 137' ' ' LYS . 2.1 tt0 -49.41 -54.47 17.35 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.648 -0.705 . . . . 0.0 112.133 178.17 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . 0.543 ' HG ' ' O ' ' A' ' 138' ' ' PHE . 3.2 pp -69.35 -19.38 63.85 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 120.953 -0.299 . . . . 0.0 111.206 -174.842 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . 0.53 HD23 ' HD2' ' A' ' 62' ' ' LYS . 8.2 mp . . . . . 0 C--N 1.331 -0.215 0 CA-C-O 120.907 0.384 . . . . 0.0 110.56 173.418 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.359 0 CA-C-O 121.542 0.687 . . . . 0.0 110.499 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -138.77 99.22 3.74 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 115.131 -0.94 . . . . 0.0 110.216 -179.752 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 49.0 m 64.7 80.02 0.24 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.405 -0.816 . . . . 0.0 111.454 179.463 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 53.5 p90 -96.08 155.32 16.81 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.116 178.014 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 5.4 p -142.1 112.92 7.35 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 120.98 0.419 . . . . 0.0 110.147 177.307 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . 0.526 ' HB2' HD11 ' A' ' 92' ' ' LEU . 35.8 m-85 -135.75 149.7 69.69 Favored Pre-proline 0 C--N 1.326 -0.431 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.413 -176.38 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -87.07 131.37 3.11 Favored 'Trans proline' 0 N--CA 1.452 -0.946 0 C-N-CA 122.528 2.152 . . . . 0.0 113.23 179.808 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . 0.46 ' HB3' ' HB3' ' A' ' 21' ' ' LYS . 12.1 t70 -67.95 154.49 41.49 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 114.958 -1.019 . . . . 0.0 108.63 170.403 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -53.21 -32.93 19.75 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.6 0 O-C-N 124.018 0.824 . . . . 0.0 110.883 -179.391 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 43.7 m-80 -76.29 -1.77 28.23 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 121.089 0.471 . . . . 0.0 110.82 179.051 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 86.05 42.11 6.83 Favored Glycine 0 N--CA 1.446 -0.647 0 CA-C-N 115.739 -0.664 . . . . 0.0 112.172 -179.619 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.653 ' HZ2' HG23 ' A' ' 23' ' ' VAL . 56.8 tttm -107.71 124.2 49.66 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 120.173 -0.611 . . . . 0.0 111.252 -179.453 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 19.4 m -66.49 107.38 2.04 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.29 -0.414 . . . . 0.0 109.945 172.652 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.653 HG23 ' HZ2' ' A' ' 21' ' ' LYS . 91.6 t -116.35 117.32 55.1 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-O 120.996 0.427 . . . . 0.0 109.909 178.342 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 17.6 m -122.77 179.47 4.62 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.288 -178.15 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.401 HD11 ' HA3' ' A' ' 119' ' ' GLY . 52.7 tp -56.4 -42.28 77.7 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.924 0.393 . . . . 0.0 111.027 -179.287 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -82.27 15.91 2.24 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.86 -177.793 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -102.18 -17.08 16.14 Favored 'General case' 0 CA--C 1.517 -0.294 0 N-CA-C 107.692 -1.225 . . . . 0.0 107.692 178.319 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -117.22 -20.81 9.07 Favored 'General case' 0 N--CA 1.445 -0.723 0 CA-C-N 113.973 -1.467 . . . . 0.0 110.494 -179.323 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 58.3 tttm -61.71 132.07 52.0 Favored 'General case' 0 N--CA 1.446 -0.662 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.273 -173.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 120.5 -8.59 11.03 Favored Glycine 0 N--CA 1.451 -0.328 0 N-CA-C 110.61 -0.996 . . . . 0.0 110.61 -174.496 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.707 ' HD3' ' HA ' ' A' ' 63' ' ' ASP . 25.2 ttmm -155.63 154.96 32.44 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 -178.784 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.445 ' HB2' ' O ' ' A' ' 63' ' ' ASP . 61.8 m-85 -59.07 147.1 36.12 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-O 121.094 0.473 . . . . 0.0 111.601 -174.482 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.541 HD12 ' HA2' ' A' ' 119' ' ' GLY . 40.0 mt -124.45 134.77 65.83 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.439 -175.633 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . 0.408 ' HE2' ' HB3' ' A' ' 36' ' ' ASP . 80.3 t80 -121.79 130.71 53.61 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 173.177 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.546 ' HA ' ' O ' ' A' ' 67' ' ' VAL . 62.5 mt -115.2 110.76 33.1 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-O 121.093 0.473 . . . . 0.0 110.577 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.558 ' O ' ' HA ' ' A' ' 68' ' ' SER . 7.1 p-10 -110.34 158.97 17.87 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-N 115.5 -0.773 . . . . 0.0 109.063 175.257 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.492 ' O ' ' HB3' ' A' ' 110' ' ' PRO . 85.5 t -102.88 126.68 57.09 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.806 0 C-N-CA 120.144 -0.622 . . . . 0.0 111.119 176.598 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' TRP . . . . . 0.594 ' CE3' ' HZ2' ' A' ' 78' ' ' TRP . 0.7 OUTLIER -113.31 130.49 56.25 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 109.368 -0.605 . . . . 0.0 109.368 177.958 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -150.19 167.47 26.81 Favored 'General case' 0 C--N 1.328 -0.354 0 O-C-N 122.362 -0.211 . . . . 0.0 111.039 -178.497 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' THR . . . . . 0.582 HG22 ' OD2' ' A' ' 72' ' ' ASP . 13.8 t -108.85 -33.63 6.89 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 120.696 -0.401 . . . . 0.0 110.694 174.313 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' TRP . . . . . 0.687 ' HE1' ' HA ' ' A' ' 72' ' ' ASP . 65.6 p-90 -73.94 -9.24 58.44 Favored 'General case' 0 C--N 1.343 0.291 0 C-N-CA 120.319 -0.552 . . . . 0.0 111.002 178.489 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 25.5 t -63.55 -57.57 9.72 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.102 -179.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 107.28 -85.18 0.41 Allowed Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.642 -0.789 . . . . 0.0 112.493 -176.712 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_exo -53.42 -28.63 45.04 Favored 'Trans proline' 0 C--N 1.354 0.818 0 C-N-CA 123.134 2.556 . . . . 0.0 112.727 179.277 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 42.4 t -54.13 -29.15 44.06 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.055 176.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 54.8 mtp180 -83.65 -26.23 30.08 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-O 120.903 0.382 . . . . 0.0 110.695 -179.701 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -80.52 -36.67 22.65 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.865 -0.683 . . . . 0.0 111.689 -179.335 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 21.3 mt-10 -90.23 10.36 24.95 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.292 0.568 . . . . 0.0 109.985 177.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.545 ' N ' ' HD2' ' A' ' 50' ' ' PRO . 20.2 tp -69.05 -45.99 30.24 Favored Pre-proline 0 N--CA 1.441 -0.89 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.869 -177.936 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.545 ' HD2' ' N ' ' A' ' 49' ' ' LEU . 11.7 Cg_endo -56.83 -22.28 44.59 Favored 'Trans proline' 0 C--N 1.351 0.698 0 C-N-CA 121.565 1.51 . . . . 0.0 111.363 171.379 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -85.05 -31.38 23.44 Favored 'General case' 0 CA--C 1.515 -0.386 0 CA-C-O 121.924 0.869 . . . . 0.0 108.895 -179.233 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 6.0 tt -69.94 -48.07 59.88 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-N 114.443 -1.253 . . . . 0.0 108.573 178.228 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . 0.617 ' HZ1' ' HB3' ' A' ' 53' ' ' LYS . 7.6 mtpm? -58.83 -49.37 77.99 Favored 'General case' 0 C--O 1.225 -0.193 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.751 179.119 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.482 ' CD ' ' HZ3' ' A' ' 58' ' ' LYS . 0.6 OUTLIER -46.03 -56.37 5.64 Favored 'General case' 0 C--N 1.332 -0.16 0 O-C-N 123.514 0.509 . . . . 0.0 111.586 176.397 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.595 HD23 ' HE2' ' A' ' 138' ' ' PHE . 38.8 tp -66.95 -48.7 67.75 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.255 -178.392 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.538 ' CD ' ' HZ2' ' A' ' 88' ' ' LYS . 5.9 tm-20 -59.03 -55.1 39.47 Favored 'General case' 0 N--CA 1.448 -0.553 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.563 -175.998 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.992 ' HG2' ' HZ1' ' A' ' 88' ' ' LYS . 38.2 mt-10 -70.12 -30.43 67.62 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.724 0.297 . . . . 0.0 111.244 -174.73 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . 0.482 ' HZ3' ' CD ' ' A' ' 54' ' ' GLU . 34.3 ttmt -69.96 -41.77 74.07 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-O 121.198 0.523 . . . . 0.0 110.665 179.237 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 17.2 m-85 -100.3 7.82 44.12 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.473 -177.032 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -65.11 136.19 56.41 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.258 -0.428 . . . . 0.0 109.941 173.245 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 82.61 1.52 90.53 Favored Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.407 179.187 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . 0.44 ' O ' ' HD3' ' A' ' 31' ' ' LYS . 34.8 mmtm -90.59 -154.16 0.33 Allowed 'General case' 0 CA--C 1.515 -0.395 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 176.601 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . 0.707 ' HA ' ' HD3' ' A' ' 31' ' ' LYS . 2.6 t70 -95.1 47.26 1.14 Allowed 'General case' 0 C--N 1.318 -0.762 0 CA-C-O 121.35 0.595 . . . . 0.0 110.344 179.153 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 13.3 tt -155.16 135.31 4.18 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.721 0 CA-C-N 115.582 -0.735 . . . . 0.0 109.961 178.038 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' HIS . . . . . 0.654 ' NE2' ' HB3' ' A' ' 31' ' ' LYS . 75.3 m-70 -105.0 114.27 28.38 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 176.911 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . 0.444 ' CZ ' ' HG ' ' A' ' 55' ' ' LEU . 73.6 m-85 -78.4 104.81 9.23 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 172.442 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.546 ' O ' ' HA ' ' A' ' 35' ' ' ILE . 48.4 t -117.49 104.46 16.42 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.884 -178.359 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' SER . . . . . 0.558 ' HA ' ' O ' ' A' ' 36' ' ' ASP . 23.3 p -89.26 146.03 25.0 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.169 -179.8 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.478 ' O ' HG12 ' A' ' 37' ' ' VAL . 64.8 tp -124.12 126.84 46.87 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 109.689 -0.486 . . . . 0.0 109.689 176.77 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' SER . . . . . 0.464 ' HB3' ' HA ' ' A' ' 93' ' ' HIS . 19.3 t -103.94 109.03 20.62 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.435 0.636 . . . . 0.0 112.29 -174.301 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 6.8 m -81.02 25.11 0.48 Allowed 'General case' 0 C--N 1.314 -0.974 0 CA-C-N 115.067 -0.969 . . . . 0.0 110.188 169.553 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . 0.687 ' HA ' ' HE1' ' A' ' 41' ' ' TRP . 2.9 t70 -72.79 129.74 38.89 Favored 'General case' 0 CA--C 1.51 -0.578 0 C-N-CA 119.899 -0.72 . . . . 0.0 110.174 -178.646 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . 0.501 ' HZ3' ' HB3' ' A' ' 73' ' ' LYS . 3.0 ttpm? -88.02 -11.95 45.81 Favored 'General case' 0 C--N 1.313 -0.979 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.338 -177.856 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 -104.39 60.04 0.71 Allowed 'General case' 0 CA--C 1.51 -0.595 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 -176.779 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.643 ' O ' ' HG2' ' A' ' 79' ' ' GLU . 64.9 tttt -47.75 -51.33 22.59 Favored 'General case' 0 C--O 1.221 -0.414 0 O-C-N 123.644 0.59 . . . . 0.0 112.447 -170.029 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.404 ' O ' ' ND2' ' A' ' 80' ' ' ASN . 23.6 tptm -48.3 -54.24 14.45 Favored 'General case' 0 C--O 1.245 0.855 0 CA-C-N 116.735 -0.211 . . . . 0.0 110.456 -179.999 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.526 ' HA ' HD22 ' A' ' 80' ' ' ASN . . . -61.27 -39.86 91.95 Favored 'General case' 0 N--CA 1.452 -0.355 0 O-C-N 123.972 0.795 . . . . 0.0 110.034 -178.844 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' TRP . . . . . 0.594 ' HZ2' ' CE3' ' A' ' 38' ' ' TRP . 9.3 t-105 -61.43 -58.51 7.88 Favored 'General case' 0 N--CA 1.437 -1.088 0 CA-C-N 114.96 -1.018 . . . . 0.0 112.263 -179.458 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . 0.643 ' HG2' ' O ' ' A' ' 75' ' ' LYS . 3.3 mm-40 -52.25 -48.04 65.43 Favored 'General case' 0 C--O 1.236 0.39 0 N-CA-C 112.426 0.528 . . . . 0.0 112.426 -175.669 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . 0.526 HD22 ' HA ' ' A' ' 77' ' ' ALA . 8.4 p30 -71.16 -28.82 64.53 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 118.859 -1.136 . . . . 0.0 110.852 -178.159 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 15.3 ttt -68.19 -47.81 66.93 Favored 'General case' 0 C--O 1.222 -0.359 0 C-N-CA 120.978 -0.289 . . . . 0.0 111.542 177.518 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.544 HG23 ' HB2' ' A' ' 87' ' ' LEU . 0.2 OUTLIER -58.69 -37.9 68.44 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.313 0 C-N-CA 120.429 -0.509 . . . . 0.0 110.205 178.72 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 25.3 m -67.34 -33.31 74.97 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.81 177.376 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 21.0 tttm -80.25 -49.97 10.86 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.699 -177.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 52.8 m-20 -84.37 6.79 21.78 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.633 -0.712 . . . . 0.0 111.406 -173.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 89.7 mt-30 64.28 41.72 5.8 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 115.72 -0.673 . . . . 0.0 112.745 171.007 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.544 ' HB2' HG23 ' A' ' 82' ' ' VAL . 7.9 mp -83.95 82.11 8.49 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 120.758 -0.377 . . . . 0.0 110.218 176.036 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . 0.992 ' HZ1' ' HG2' ' A' ' 57' ' ' GLU . 0.0 OUTLIER -95.79 171.53 8.59 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.594 -0.276 . . . . 0.0 111.676 -179.852 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 128.07 -139.74 11.3 Favored Glycine 0 N--CA 1.452 -0.258 0 N-CA-C 110.286 -1.126 . . . . 0.0 110.286 -175.795 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 63.8 mt -111.44 109.05 27.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 N-CA-C 107.935 -1.135 . . . . 0.0 107.935 168.408 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . 0.508 ' HB3' ' CZ2' ' A' ' 38' ' ' TRP . 3.5 mm100 -127.73 100.22 5.87 Favored 'General case' 0 N--CA 1.442 -0.85 0 CA-C-O 120.838 0.351 . . . . 0.0 110.953 -167.669 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.526 HD11 ' HB2' ' A' ' 15' ' ' TYR . 27.0 mt -97.22 140.58 31.49 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 120.817 0.342 . . . . 0.0 110.787 -177.133 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' HIS . . . . . 0.551 ' CE1' ' HG3' ' A' ' 75' ' ' LYS . 30.0 t-80 -114.53 120.63 40.88 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 120.864 0.364 . . . . 0.0 110.896 178.301 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 19.7 ttp -79.0 -55.83 4.84 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.74 -0.664 . . . . 0.0 109.999 176.553 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . 0.446 ' HA2' ' NE2' ' A' ' 93' ' ' HIS . . . 111.19 -119.33 5.14 Favored Glycine 0 N--CA 1.438 -1.178 0 C-N-CA 120.557 -0.83 . . . . 0.0 111.879 -179.465 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 8.9 t -109.85 21.71 16.55 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-O 120.555 0.217 . . . . 0.0 110.994 -175.28 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -90.84 134.17 34.65 Favored 'General case' 0 CA--C 1.515 -0.383 0 C-N-CA 119.699 -0.8 . . . . 0.0 109.74 179.9 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . 0.554 ' HA ' ' HG3' ' A' ' 101' ' ' MET . 0.0 OUTLIER -113.71 6.08 16.69 Favored 'General case' 0 C--N 1.32 -0.676 0 C-N-CA 120.361 -0.536 . . . . 0.0 110.699 176.689 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 4.0 m -71.0 -39.68 72.29 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.373 -178.611 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 27.7 t80 -82.24 -30.61 30.65 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.585 -176.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' MET . . . . . 0.554 ' HG3' ' HA ' ' A' ' 98' ' ' ARG . 4.7 ppp? -74.68 -20.92 59.67 Favored 'General case' 0 C--N 1.332 -0.168 0 C-N-CA 120.144 -0.622 . . . . 0.0 109.495 177.554 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -68.0 -42.81 80.18 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.41 -0.814 . . . . 0.0 109.8 172.331 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -64.46 -16.99 63.4 Favored 'General case' 0 CA--C 1.529 0.158 0 CA-C-N 115.674 -0.694 . . . . 0.0 111.815 -177.621 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 9.0 m-85 -108.28 -2.32 19.35 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.402 178.212 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 7.8 mp 55.34 37.64 29.18 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.812 -176.793 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . 0.846 HG12 ' HG3' ' A' ' 111' ' ' ARG . 60.8 mt -59.41 106.51 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.006 177.906 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 7.1 m120 -73.79 -66.18 0.74 Allowed 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.626 0.727 . . . . 0.0 109.938 178.483 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -135.14 145.82 17.88 Favored Glycine 0 N--CA 1.438 -1.216 0 CA-C-N 114.971 -1.013 . . . . 0.0 111.12 178.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . 0.451 HG21 HG13 ' A' ' 37' ' ' VAL . 40.2 pt -100.53 154.3 37.26 Favored Pre-proline 0 C--N 1.316 -0.85 0 N-CA-C 110.34 -0.244 . . . . 0.0 110.34 179.736 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . 0.492 ' HB3' ' O ' ' A' ' 37' ' ' VAL . 15.9 Cg_exo -69.1 131.73 19.34 Favored 'Cis proline' 0 C--N 1.348 0.515 0 C-N-CA 123.973 -1.261 . . . . 0.0 113.54 0.656 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . 0.846 ' HG3' HG12 ' A' ' 106' ' ' ILE . 0.0 OUTLIER -82.26 160.3 22.99 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 175.215 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . 0.427 ' HD2' ' HB2' ' A' ' 128' ' ' ARG . 0.2 OUTLIER -130.45 114.43 15.52 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.76 -0.654 . . . . 0.0 109.958 -177.445 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.499 ' HB ' ' HB ' ' A' ' 35' ' ' ILE . 81.5 mt -134.44 142.88 39.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-O 120.735 0.303 . . . . 0.0 111.142 -176.306 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.477 ' HB2' ' SD ' ' A' ' 126' ' ' MET . 41.2 tp -127.13 140.41 52.28 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.262 178.689 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . 0.462 ' HB2' ' HB ' ' A' ' 33' ' ' ILE . 1.9 mp -133.29 150.0 51.91 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.302 0.572 . . . . 0.0 110.042 178.152 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . 0.605 ' HB3' ' HB2' ' A' ' 120' ' ' LYS . 14.1 t70 -70.29 164.3 24.7 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.029 -0.987 . . . . 0.0 110.604 178.905 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . 0.408 ' HA ' ' C ' ' A' ' 31' ' ' LYS . 84.5 mtt180 -48.13 -38.09 17.05 Favored 'General case' 0 N--CA 1.464 0.247 0 O-C-N 124.198 0.936 . . . . 0.0 112.613 -178.63 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -80.54 9.77 5.61 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.638 0.256 . . . . 0.0 111.607 -178.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . 0.541 ' HA2' HD12 ' A' ' 33' ' ' ILE . . . 79.04 28.81 53.34 Favored Glycine 0 N--CA 1.445 -0.744 0 N-CA-C 111.244 -0.743 . . . . 0.0 111.244 -176.988 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . 0.605 ' HB2' ' HB3' ' A' ' 116' ' ' ASP . 32.4 mtmm -99.47 104.29 16.11 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 120.674 -0.411 . . . . 0.0 110.742 -175.147 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . 0.432 ' HA ' ' HG ' ' A' ' 115' ' ' LEU . 4.0 mp -43.65 111.57 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-O 121.31 0.576 . . . . 0.0 111.396 -178.286 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' ILE . . . . . 0.413 ' H ' ' HA ' ' A' ' 115' ' ' LEU . 58.7 mt -85.59 -41.3 15.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 115.337 -0.847 . . . . 0.0 109.18 178.921 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 17.3 m -149.72 115.44 5.6 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.416 -0.811 . . . . 0.0 110.299 -179.522 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -69.92 -15.22 63.03 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.348 0.594 . . . . 0.0 110.307 174.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 18.1 p-10 -139.95 102.77 4.48 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.313 -0.858 . . . . 0.0 110.066 174.24 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' MET . . . . . 0.477 ' SD ' ' HB2' ' A' ' 114' ' ' LEU . 20.8 ttp -107.97 -133.4 0.33 Allowed 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.036 -0.529 . . . . 0.0 109.676 178.602 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 6.3 p -124.69 138.07 54.32 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 110.149 -0.315 . . . . 0.0 110.149 177.328 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . 0.447 ' CG ' ' HD2' ' A' ' 129' ' ' PRO . 37.9 ttm180 -67.78 147.36 98.59 Favored Pre-proline 0 C--N 1.325 -0.475 0 CA-C-N 116.198 -0.455 . . . . 0.0 109.874 177.565 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . 0.447 ' HD2' ' CG ' ' A' ' 128' ' ' ARG . 2.9 Cg_endo -42.62 -25.82 0.54 Allowed 'Trans proline' 0 C--N 1.356 0.966 0 C-N-CA 124.119 3.213 . . . . 0.0 114.226 177.095 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 1.4 m -57.76 -26.05 61.32 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 122.723 0.409 . . . . 0.0 111.708 178.432 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . 0.494 ' OD1' ' HG3' ' A' ' 133' ' ' LYS . 21.1 t0 -99.05 124.88 43.76 Favored Pre-proline 0 C--N 1.329 -0.32 0 N-CA-C 109.938 -0.393 . . . . 0.0 109.938 179.511 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 28.7 Cg_endo -61.0 -18.11 55.73 Favored 'Trans proline' 0 C--N 1.347 0.489 0 C-N-CA 123.273 2.648 . . . . 0.0 113.788 -178.081 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . 0.494 ' HG3' ' OD1' ' A' ' 131' ' ' ASP . 48.6 mttp -58.2 -23.93 57.31 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-O 120.833 0.349 . . . . 0.0 110.605 178.843 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 36.2 p -58.39 -59.32 5.53 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.235 175.494 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -56.75 -47.17 80.66 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.917 -177.907 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -56.63 -39.9 74.47 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.44 -0.8 . . . . 0.0 111.15 -179.633 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . 0.501 ' O ' ' HG ' ' A' ' 141' ' ' LEU . 75.5 tttt -74.08 -34.09 63.88 Favored 'General case' 0 N--CA 1.451 -0.396 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.883 -179.271 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . 0.595 ' HE2' HD23 ' A' ' 55' ' ' LEU . 11.1 m-30 -64.43 -40.22 95.33 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 109.689 -0.486 . . . . 0.0 109.689 177.747 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 75.6 m-20 -58.17 -45.74 86.96 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.69 -0.686 . . . . 0.0 109.66 174.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -60.58 -48.07 83.39 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.067 177.467 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . 0.501 ' HG ' ' O ' ' A' ' 137' ' ' LYS . 95.5 mt -56.38 -45.59 80.46 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.776 -179.402 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . 0.508 HD13 ' HB2' ' A' ' 63' ' ' ASP . 60.0 tp . . . . . 0 C--N 1.33 -0.278 0 CA-C-O 121.201 0.524 . . . . 0.0 110.811 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . 0.434 ' HA ' ' CZ ' ' A' ' 100' ' ' PHE . . . . . . . . 0 N--CA 1.455 -0.191 0 CA-C-O 121.308 0.575 . . . . 0.0 109.884 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -128.38 13.24 6.56 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.344 -0.844 . . . . 0.0 110.535 -178.644 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 35.6 p -143.16 18.34 1.92 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.13 0.491 . . . . 0.0 110.852 -179.747 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 49.5 p90 -73.81 149.64 41.54 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.055 -0.521 . . . . 0.0 111.008 -176.958 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' SER . . . . . 0.448 ' HA ' ' HA ' ' A' ' 24' ' ' SER . 39.1 m -142.22 117.23 9.98 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.773 -0.649 . . . . 0.0 109.377 176.811 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . 0.516 ' HB2' HD21 ' A' ' 92' ' ' LEU . 57.5 m-85 -128.32 145.68 56.64 Favored Pre-proline 0 C--N 1.323 -0.55 0 CA-C-O 120.851 0.357 . . . . 0.0 111.236 -176.321 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.403 ' HD2' ' O ' ' A' ' 93' ' ' HIS . 63.2 Cg_endo -76.07 125.39 8.58 Favored 'Trans proline' 0 N--CA 1.459 -0.553 0 C-N-CA 122.434 2.089 . . . . 0.0 113.449 -179.029 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . 0.656 ' HB3' ' HB3' ' A' ' 21' ' ' LYS . 3.3 t70 -64.15 157.36 25.79 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.044 -0.98 . . . . 0.0 108.528 168.007 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.504 HD12 ' CG1' ' A' ' 82' ' ' VAL . 3.4 tt -50.06 -39.04 15.41 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.519 0 O-C-N 123.959 0.787 . . . . 0.0 111.561 -173.867 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 37.8 m-80 -75.61 3.8 8.87 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.474 -175.407 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 82.59 37.77 13.42 Favored Glycine 0 N--CA 1.445 -0.719 0 N-CA-C 111.186 -0.765 . . . . 0.0 111.186 -176.739 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.656 ' HB3' ' HB3' ' A' ' 17' ' ' ASP . 4.2 tmmt? -110.72 120.9 43.92 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.723 0.297 . . . . 0.0 110.333 -177.786 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 26.0 m -70.68 101.66 2.11 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-O 120.956 0.407 . . . . 0.0 110.917 -177.039 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.506 ' HB ' HD22 ' A' ' 92' ' ' LEU . 41.5 t -92.61 109.26 21.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 175.703 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' SER . . . . . 0.448 ' HA ' ' HA ' ' A' ' 14' ' ' SER . 57.4 p -106.16 175.86 5.36 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.204 -177.956 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.466 HD13 ' HA3' ' A' ' 119' ' ' GLY . 2.9 tm? -58.42 -33.7 69.98 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 109.662 -0.496 . . . . 0.0 109.662 176.098 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -74.32 -25.86 59.81 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.735 -178.456 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -69.17 -32.47 71.82 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-O 121.523 0.678 . . . . 0.0 110.472 -179.556 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.663 HD13 HG22 ' A' ' 67' ' ' VAL . 68.9 mt -100.35 -8.6 23.17 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.56 -0.745 . . . . 0.0 110.902 -178.623 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 56.1 tttp -70.75 138.45 50.49 Favored 'General case' 0 N--CA 1.443 -0.813 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.219 -173.874 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 109.22 -3.64 31.4 Favored Glycine 0 N--CA 1.446 -0.656 0 N-CA-C 111.203 -0.759 . . . . 0.0 111.203 -176.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.628 ' HD3' ' HA ' ' A' ' 63' ' ' ASP . 21.6 ttmm -154.1 150.25 27.98 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 -179.486 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.474 ' HB2' ' O ' ' A' ' 63' ' ' ASP . 29.1 m-85 -59.99 148.68 34.53 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 121.145 0.498 . . . . 0.0 111.667 -175.829 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.459 ' HB ' ' HB2' ' A' ' 115' ' ' LEU . 55.3 mt -123.39 128.12 74.59 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.772 -175.602 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 91.7 t80 -118.16 110.19 17.29 Favored 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 108.72 -0.845 . . . . 0.0 108.72 173.395 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.541 ' HB ' ' HB ' ' A' ' 113' ' ' ILE . 68.0 mt -97.48 126.03 50.45 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-O 121.06 0.457 . . . . 0.0 111.135 -175.455 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.446 ' HA ' ' O ' ' A' ' 111' ' ' ARG . 3.2 p30 -113.04 159.33 19.27 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 173.18 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.499 HG21 HG21 ' A' ' 106' ' ' ILE . 61.6 t -105.05 131.19 54.83 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.933 0 C-N-CA 120.36 -0.536 . . . . 0.0 111.055 173.427 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' TRP . . . . . 0.661 ' HZ3' HG21 ' A' ' 82' ' ' VAL . 0.4 OUTLIER -125.05 134.17 52.63 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-O 120.748 0.308 . . . . 0.0 110.718 -179.014 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -147.74 162.04 40.01 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 116.646 -0.252 . . . . 0.0 110.588 178.377 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' THR . . . . . 0.714 ' HB ' ' CE3' ' A' ' 78' ' ' TRP . 12.2 t -99.6 -10.12 22.41 Favored 'General case' 0 N--CA 1.462 0.136 0 C-N-CA 120.537 -0.465 . . . . 0.0 111.528 179.845 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' TRP . . . . . 0.439 ' HE1' ' HA ' ' A' ' 72' ' ' ASP . 9.7 p-90 -99.02 15.88 24.37 Favored 'General case' 0 CA--C 1.51 -0.595 0 CA-C-O 122.56 1.171 . . . . 0.0 108.025 -177.381 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' CYS . . . . . 0.57 ' SG ' HD11 ' A' ' 109' ' ' ILE . 99.6 m -123.18 135.95 54.54 Favored 'General case' 0 N--CA 1.429 -1.505 0 CA-C-N 113.267 -1.788 . . . . 0.0 109.398 -178.212 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . 0.631 ' H ' ' HD2' ' A' ' 44' ' ' PRO . . . -101.92 -49.86 1.22 Allowed Glycine 0 CA--C 1.525 0.671 0 CA-C-O 119.203 -0.776 . . . . 0.0 113.879 -177.945 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.631 ' HD2' ' H ' ' A' ' 43' ' ' GLY . 10.5 Cg_endo -53.38 -34.6 71.77 Favored 'Trans proline' 0 C--N 1.357 1.022 0 C-N-CA 122.8 2.333 . . . . 0.0 112.826 -176.661 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . 0.638 ' O ' ' HG ' ' A' ' 49' ' ' LEU . 18.4 p -58.42 -34.06 70.37 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.109 179.547 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.489 ' HG2' HD11 ' A' ' 49' ' ' LEU . 33.8 mtt85 -72.01 -8.01 52.04 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.787 -174.811 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -74.79 -33.87 54.49 Favored Glycine 0 N--CA 1.446 -0.677 0 C-N-CA 120.428 -0.892 . . . . 0.0 111.979 177.262 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . 0.531 ' OE1' ' HD3' ' A' ' 128' ' ' ARG . 7.4 pt-20 -112.69 -0.49 15.05 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 112.198 0.444 . . . . 0.0 112.198 -177.478 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.638 ' HG ' ' O ' ' A' ' 45' ' ' CYS . 34.7 mt -55.05 -49.6 91.26 Favored Pre-proline 0 N--CA 1.468 0.443 0 N-CA-C 112.29 0.478 . . . . 0.0 112.29 177.069 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.553 ' HD3' ' HB2' ' A' ' 49' ' ' LEU . 77.2 Cg_exo -52.72 -44.33 48.73 Favored 'Trans proline' 0 C--N 1.357 1.016 0 C-N-CA 121.901 1.734 . . . . 0.0 112.161 176.483 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -73.61 -31.09 63.38 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.235 0.54 . . . . 0.0 110.563 -178.037 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.443 ' O ' ' HB2' ' A' ' 55' ' ' LEU . 6.5 tt -64.1 -53.44 49.7 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.264 -0.88 . . . . 0.0 109.885 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . 0.681 ' O ' ' HG3' ' A' ' 57' ' ' GLU . 17.7 pttp -60.97 -39.64 90.36 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.121 179.71 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.47 ' HG3' ' O ' ' A' ' 50' ' ' PRO . 18.3 mt-10 -68.6 -29.06 67.5 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.469 -178.915 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.494 HD11 ' HB3' ' A' ' 129' ' ' PRO . 12.6 mt -59.32 -47.17 86.39 Favored 'General case' 0 N--CA 1.448 -0.55 0 N-CA-C 109.753 -0.462 . . . . 0.0 109.753 172.044 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 1.021 ' HG2' ' HA2' ' A' ' 89' ' ' GLY . 8.2 tp10 -65.18 -43.49 91.48 Favored 'General case' 0 C--O 1.218 -0.591 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.2 177.498 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.681 ' HG3' ' O ' ' A' ' 53' ' ' LYS . 37.1 mt-10 -61.42 -22.57 65.13 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.126 0.489 . . . . 0.0 110.776 179.773 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 63.2 tttp -85.45 -39.46 17.49 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.668 177.197 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 83.1 m-85 -110.48 18.29 19.92 Favored 'General case' 0 C--O 1.235 0.339 0 N-CA-C 111.859 0.318 . . . . 0.0 111.859 -173.556 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . 0.408 ' HA ' ' OE2' ' A' ' 56' ' ' GLU . . . -56.48 117.16 3.58 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.914 -177.315 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 75.65 -3.5 49.01 Favored Glycine 0 N--CA 1.45 -0.428 0 CA-C-N 115.768 -0.651 . . . . 0.0 113.237 175.848 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . 0.542 ' HA ' ' HD3' ' A' ' 62' ' ' LYS . 30.4 mmtm -66.56 -80.87 0.04 OUTLIER 'General case' 0 CA--C 1.515 -0.394 0 CA-C-O 120.956 0.408 . . . . 0.0 110.561 -178.082 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . 0.628 ' HA ' ' HD3' ' A' ' 31' ' ' LYS . 14.5 t0 -156.87 28.89 0.31 Allowed 'General case' 0 C--N 1.313 -0.983 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.904 170.343 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 5.3 mp -142.53 133.89 24.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 115.888 -0.596 . . . . 0.0 109.528 178.667 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' HIS . . . . . 0.5 ' NE2' ' HB3' ' A' ' 31' ' ' LYS . 99.4 m-70 -107.21 116.43 31.91 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 109.241 -0.652 . . . . 0.0 109.241 172.312 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . 0.561 ' HB2' ' HB2' ' A' ' 56' ' ' GLU . 76.4 m-85 -87.85 103.32 15.54 Favored 'General case' 0 C--N 1.316 -0.866 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 174.286 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.714 ' HA ' ' O ' ' A' ' 90' ' ' ILE . 47.3 t -111.39 110.33 31.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 115.505 -0.77 . . . . 0.0 111.348 -169.641 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' SER . . . . . 0.402 ' HB3' ' CG ' ' A' ' 38' ' ' TRP . 14.0 m -88.25 125.26 34.56 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 115.531 -0.758 . . . . 0.0 110.489 -179.642 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.452 HD11 ' HB2' ' A' ' 94' ' ' MET . 55.1 tp -113.57 121.19 43.46 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 122.784 0.433 . . . . 0.0 110.358 178.84 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' SER . . . . . 0.462 ' HB2' ' CD1' ' A' ' 38' ' ' TRP . 10.2 t -109.15 116.9 32.82 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 112.488 0.551 . . . . 0.0 112.488 -174.188 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 42.8 t -86.09 21.93 1.87 Allowed 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.208 173.907 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . 0.605 ' OD2' HG22 ' A' ' 40' ' ' THR . 5.4 t70 -66.51 131.48 46.13 Favored 'General case' 0 CA--C 1.513 -0.465 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 179.63 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . 0.589 ' HZ3' ' HB3' ' A' ' 73' ' ' LYS . 3.7 ttpm? -82.63 -14.19 55.16 Favored 'General case' 0 C--N 1.315 -0.91 0 C-N-CA 120.427 -0.509 . . . . 0.0 110.642 -177.561 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . 0.512 ' HB2' ' HB3' ' A' ' 77' ' ' ALA . 0.2 OUTLIER -109.06 83.32 1.73 Allowed 'General case' 0 CA--C 1.51 -0.574 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 -176.766 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.641 ' HE2' ' CD ' ' A' ' 79' ' ' GLU . 18.0 tttt -56.41 -60.7 3.15 Favored 'General case' 0 C--O 1.22 -0.459 0 C-N-CA 120.742 -0.383 . . . . 0.0 111.346 -172.513 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.644 ' HB2' ' HZ3' ' A' ' 76' ' ' LYS . 4.4 ttmp? -46.9 -43.99 19.32 Favored 'General case' 0 C--O 1.239 0.545 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.474 179.59 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.512 ' HB3' ' HB2' ' A' ' 74' ' ' ASN . . . -64.84 -38.56 91.38 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-O 121.347 0.594 . . . . 0.0 110.019 -177.804 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' TRP . . . . . 0.714 ' CE3' ' HB ' ' A' ' 40' ' ' THR . 5.6 t-105 -69.49 -47.71 63.01 Favored 'General case' 0 N--CA 1.44 -0.938 0 CA-C-N 115.015 -0.993 . . . . 0.0 111.515 -178.759 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . 0.641 ' CD ' ' HE2' ' A' ' 75' ' ' LYS . 4.4 mm-40 -48.43 -54.01 15.69 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-O 121.165 0.507 . . . . 0.0 111.756 177.018 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . 0.501 HD22 ' HA ' ' A' ' 77' ' ' ALA . 9.2 p30 -72.88 -23.17 60.69 Favored 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 119.482 -0.887 . . . . 0.0 110.858 -176.518 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' MET . . . . . 0.559 ' HG2' ' OG1' ' A' ' 40' ' ' THR . 10.9 tpt -70.02 -48.45 57.99 Favored 'General case' 0 C--O 1.21 -0.979 0 CA-C-O 119.488 -0.291 . . . . 0.0 111.242 176.152 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.661 HG21 ' HZ3' ' A' ' 38' ' ' TRP . 2.3 p -62.92 -25.34 38.23 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 C-N-CA 120.474 -0.491 . . . . 0.0 110.355 177.79 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 29.7 m -64.32 -36.65 84.81 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-O 121.189 0.518 . . . . 0.0 110.294 171.611 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 80.6 mttt -82.88 -45.79 13.79 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.573 179.119 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . 0.513 ' OD2' ' HG3' ' A' ' 81' ' ' MET . 1.2 m-20 -64.55 -23.09 67.15 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 114.881 -1.054 . . . . 0.0 110.665 179.2 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 51.4 mt-30 57.59 61.62 2.4 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 115.517 -0.765 . . . . 0.0 111.483 178.298 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.556 ' HB2' HG23 ' A' ' 82' ' ' VAL . 79.3 mt -100.21 113.17 25.64 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.612 -178.709 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . 0.539 ' HB2' ' HB2' ' A' ' 53' ' ' LYS . 11.8 mmmm -86.49 178.98 6.93 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.234 178.36 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . 1.021 ' HA2' ' HG2' ' A' ' 56' ' ' GLU . . . 105.19 -177.84 23.29 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.825 -0.702 . . . . 0.0 112.538 178.138 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.714 ' O ' ' HA ' ' A' ' 67' ' ' VAL . 45.6 mm -86.75 113.61 24.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 175.638 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . 0.568 ' HB2' ' CZ2' ' A' ' 38' ' ' TRP . 1.8 pt20 -130.72 142.11 50.41 Favored 'General case' 0 C--N 1.309 -1.162 0 C-N-CA 120.321 -0.551 . . . . 0.0 111.713 -170.207 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.516 HD21 ' HB2' ' A' ' 15' ' ' TYR . 1.0 OUTLIER -145.01 156.26 43.84 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.677 178.756 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' HIS . . . . . 0.553 ' CE1' ' HG3' ' A' ' 75' ' ' LYS . 19.0 t-80 -117.53 138.57 51.81 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-O 121.422 0.63 . . . . 0.0 111.471 -175.06 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' MET . . . . . 0.745 ' SD ' ' HA ' ' A' ' 98' ' ' ARG . 27.1 ttm -98.25 -76.68 0.52 Allowed 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 114.973 -1.012 . . . . 0.0 109.902 177.771 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . 0.49 ' HA2' ' O ' ' A' ' 72' ' ' ASP . . . 80.64 -85.41 1.36 Allowed Glycine 0 N--CA 1.447 -0.608 0 C-N-CA 121.065 -0.588 . . . . 0.0 113.207 178.474 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 7.6 p -82.47 -25.61 33.39 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 120.942 0.401 . . . . 0.0 112.063 -173.635 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . 0.494 ' HB2' ' HG3' ' A' ' 94' ' ' MET . 4.0 m-20 -87.85 38.05 0.82 Allowed 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.55 -173.307 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . 0.745 ' HA ' ' SD ' ' A' ' 94' ' ' MET . 0.0 OUTLIER -64.69 -12.42 46.36 Favored 'General case' 0 C--O 1.222 -0.35 0 N-CA-C 112.532 0.568 . . . . 0.0 112.532 -171.327 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 4.8 m -58.75 -20.61 51.02 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.385 0.612 . . . . 0.0 110.742 177.85 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' PHE . . . . . 0.434 ' CZ ' ' HA ' ' A' ' 10' ' ' ALA . 36.0 t80 -81.15 -32.0 33.87 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.096 179.932 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' MET . . . . . 0.671 ' HG3' ' O ' ' A' ' 98' ' ' ARG . 4.2 ppp? -77.08 -31.26 55.89 Favored 'General case' 0 C--O 1.235 0.321 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 177.919 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -59.84 -39.68 85.97 Favored 'General case' 0 CA--C 1.52 -0.177 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.145 170.875 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -62.96 -23.88 67.63 Favored 'General case' 0 N--CA 1.462 0.148 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.451 -178.617 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 48.0 m-85 -100.38 -4.81 28.29 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.304 178.817 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 3.4 mm? 59.61 32.4 21.53 Favored 'General case' 0 C--O 1.234 0.271 0 O-C-N 123.417 0.448 . . . . 0.0 110.818 -176.874 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . 0.51 HG12 ' HG3' ' A' ' 111' ' ' ARG . 68.4 mt -65.8 88.95 0.1 OUTLIER 'Isoleucine or valine' 0 C--O 1.225 -0.221 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.179 177.316 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 31.1 m-80 -98.52 -13.8 20.3 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.125 0.488 . . . . 0.0 110.342 176.18 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -122.43 115.06 2.63 Favored Glycine 0 N--CA 1.442 -0.945 0 C-N-CA 120.571 -0.823 . . . . 0.0 112.192 -177.58 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . 0.57 HD11 ' SG ' ' A' ' 42' ' ' CYS . 32.0 mt -97.2 131.39 27.59 Favored Pre-proline 0 C--N 1.32 -0.676 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 174.37 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . 0.413 ' HD3' ' HA ' ' A' ' 45' ' ' CYS . 1.4 Cg_endo -82.73 151.23 71.89 Favored 'Cis proline' 0 N--CA 1.459 -0.539 0 C-N-CA 123.769 -1.346 . . . . 0.0 112.935 1.729 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . 0.51 ' HG3' HG12 ' A' ' 106' ' ' ILE . 0.0 OUTLIER -102.77 140.18 37.38 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 173.596 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . 0.655 ' CE1' ' HB3' ' A' ' 128' ' ' ARG . 0.0 OUTLIER -105.1 118.03 35.51 Favored 'General case' 0 C--N 1.327 -0.371 0 O-C-N 124.102 0.876 . . . . 0.0 110.174 -175.102 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.541 ' HB ' ' HB ' ' A' ' 35' ' ' ILE . 90.8 mt -132.81 148.62 31.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.65 0.262 . . . . 0.0 110.904 -178.737 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 42.5 tp -132.1 139.22 48.4 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.504 -0.316 . . . . 0.0 110.674 179.706 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . 0.588 ' HG ' ' HA ' ' A' ' 121' ' ' ILE . 2.3 mp -136.09 153.83 51.2 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 178.768 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . 0.517 ' HB2' HD12 ' A' ' 122' ' ' ILE . 24.2 t70 -76.94 163.68 26.5 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.648 178.409 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 63.3 mtt180 -51.49 -30.05 18.71 Favored 'General case' 0 N--CA 1.464 0.256 0 O-C-N 124.354 1.034 . . . . 0.0 111.748 178.692 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -64.82 -17.86 64.61 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.077 0.465 . . . . 0.0 110.759 178.378 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . 0.466 ' HA3' HD13 ' A' ' 25' ' ' LEU . . . 93.97 25.16 17.99 Favored Glycine 0 N--CA 1.438 -1.173 0 N-CA-C 110.187 -1.165 . . . . 0.0 110.187 -172.438 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . 0.411 ' HA ' ' HD3' ' A' ' 120' ' ' LYS . 30.3 mmtp -112.56 116.77 30.74 Favored 'General case' 0 C--O 1.223 -0.297 0 C-N-CA 120.304 -0.558 . . . . 0.0 112.097 -172.991 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . 0.588 ' HA ' ' HG ' ' A' ' 115' ' ' LEU . 3.8 mp -44.38 119.5 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.27 0 CA-C-N 115.436 -0.802 . . . . 0.0 111.984 179.698 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' ILE . . . . . 0.517 HD12 ' HB2' ' A' ' 116' ' ' ASP . 45.5 mm -98.62 -41.02 9.82 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-N 115.301 -0.863 . . . . 0.0 109.335 175.727 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 16.4 m -137.2 115.83 12.08 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.393 -0.821 . . . . 0.0 110.41 179.07 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -74.23 -16.01 60.97 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.06 0.457 . . . . 0.0 110.821 178.091 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 6.1 t30 -146.83 100.6 3.34 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.762 -0.654 . . . . 0.0 109.398 177.059 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' MET . . . . . 0.404 ' HG2' ' H ' ' A' ' 127' ' ' THR . 12.4 ttt -101.21 -139.0 0.34 Allowed 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.192 -177.978 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' THR . . . . . 0.404 ' H ' ' HG2' ' A' ' 126' ' ' MET . 1.0 OUTLIER -124.96 127.25 46.75 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-O 121.039 0.447 . . . . 0.0 111.003 -175.733 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . 0.655 ' HB3' ' CE1' ' A' ' 112' ' ' PHE . 11.6 ptp180 -51.28 153.91 3.23 Favored Pre-proline 0 N--CA 1.468 0.473 0 N-CA-C 113.414 0.894 . . . . 0.0 113.414 178.778 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . 0.528 ' HD2' ' OE2' ' A' ' 48' ' ' GLU . 51.9 Cg_exo -55.69 -27.39 60.86 Favored 'Trans proline' 0 C--N 1.35 0.656 0 C-N-CA 123.575 2.85 . . . . 0.0 113.557 177.193 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 130' ' ' SER . . . . . 0.507 ' OG ' ' HB3' ' A' ' 48' ' ' GLU . 67.9 m -62.95 -20.64 65.43 Favored 'General case' 0 N--CA 1.462 0.132 0 CA-C-O 120.919 0.39 . . . . 0.0 111.301 176.912 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . 0.432 ' OD2' ' HB2' ' A' ' 133' ' ' LYS . 7.3 t70 -85.32 122.1 73.73 Favored Pre-proline 0 C--N 1.325 -0.484 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.708 178.774 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . 0.405 ' O ' ' HG3' ' A' ' 136' ' ' GLU . 30.5 Cg_exo -63.97 -30.01 66.84 Favored 'Trans proline' 0 C--N 1.343 0.252 0 C-N-CA 122.922 2.415 . . . . 0.0 112.675 179.921 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . 0.611 ' HZ3' ' CD ' ' A' ' 136' ' ' GLU . 26.7 mmmt -61.64 -37.64 84.76 Favored 'General case' 0 CA--C 1.519 -0.219 0 CA-C-O 121.007 0.432 . . . . 0.0 110.391 -176.801 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 134' ' ' THR . . . . . 0.723 HG21 ' CZ ' ' A' ' 138' ' ' PHE . 5.2 m -61.66 -53.25 58.66 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.238 176.255 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . 0.544 ' HA ' ' CD2' ' A' ' 138' ' ' PHE . . . -54.93 -46.52 74.94 Favored 'General case' 0 C--O 1.242 0.672 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.183 176.925 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . 0.611 ' CD ' ' HZ3' ' A' ' 133' ' ' LYS . 48.8 mt-10 -54.39 -55.74 25.61 Favored 'General case' 0 CA--C 1.509 -0.625 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.169 176.551 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . 0.594 ' HE2' ' HA ' ' A' ' 137' ' ' LYS . 0.1 OUTLIER -43.79 -42.88 5.81 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 114.221 -1.354 . . . . 0.0 111.774 179.825 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . 0.723 ' CZ ' HG21 ' A' ' 134' ' ' THR . 13.6 m-85 -63.74 -60.73 2.93 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-O 120.774 0.321 . . . . 0.0 110.921 179.961 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 11.0 p30 -68.86 -23.7 64.26 Favored 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 120.313 -0.555 . . . . 0.0 110.989 -174.387 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . 0.572 ' CD ' ' HZ2' ' A' ' 137' ' ' LYS . 13.2 tt0 -60.47 -51.81 67.87 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.054 0.454 . . . . 0.0 110.454 173.568 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . 0.52 ' HG ' ' O ' ' A' ' 137' ' ' LYS . 88.6 mt -64.56 -30.01 71.03 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.147 -177.906 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 4.4 mm? . . . . . 0 C--N 1.327 -0.377 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.428 178.048 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.444 -0.735 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -69.43 59.77 0.13 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 114.861 -1.063 . . . . 0.0 113.641 -172.445 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' SER . . . . . 0.51 ' HA ' ' HB3' ' A' ' 25' ' ' LEU . 26.4 m 53.58 33.4 16.3 Favored 'General case' 0 N--CA 1.465 0.28 0 N-CA-C 112.767 0.655 . . . . 0.0 112.767 170.493 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 34.7 p90 -60.77 147.92 40.82 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.893 0.378 . . . . 0.0 110.747 179.084 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' SER . . . . . 0.489 ' HA ' ' HA ' ' A' ' 24' ' ' SER . 28.2 t -139.81 117.96 11.93 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.111 -0.495 . . . . 0.0 109.707 -179.293 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . 0.414 ' CD1' ' HA ' ' A' ' 94' ' ' MET . 92.1 m-85 -138.78 155.14 73.38 Favored Pre-proline 0 C--N 1.323 -0.562 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.322 -176.976 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -81.19 125.89 5.39 Favored 'Trans proline' 0 N--CA 1.454 -0.85 0 C-N-CA 122.015 1.81 . . . . 0.0 112.116 175.469 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . 0.496 ' HA ' ' HA ' ' A' ' 92' ' ' LEU . 12.5 t70 -62.32 152.95 32.36 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.196 -0.911 . . . . 0.0 108.894 172.127 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.642 HG23 ' HG3' ' A' ' 91' ' ' GLN . 12.1 tt -58.67 -25.81 29.63 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.435 0 O-C-N 123.781 0.675 . . . . 0.0 111.301 -178.287 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 44.7 m-80 -79.35 -2.17 40.32 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.321 0.582 . . . . 0.0 110.053 176.47 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 86.82 40.64 7.06 Favored Glycine 0 N--CA 1.447 -0.583 0 CA-C-N 115.401 -0.818 . . . . 0.0 112.371 179.244 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.557 ' HZ1' HG23 ' A' ' 23' ' ' VAL . 62.0 tttm -113.84 117.22 30.84 Favored 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 120.372 -0.531 . . . . 0.0 111.027 179.989 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 17.7 m -64.45 108.84 1.75 Allowed 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 109.938 -0.393 . . . . 0.0 109.938 174.384 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.557 HG23 ' HZ1' ' A' ' 21' ' ' LYS . 99.6 t -119.83 125.5 74.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-O 121.011 0.434 . . . . 0.0 110.201 -179.829 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' SER . . . . . 0.489 ' HA ' ' HA ' ' A' ' 14' ' ' SER . 57.3 p -113.19 176.6 4.95 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 115.731 -0.668 . . . . 0.0 109.426 177.57 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.51 ' HB3' ' HA ' ' A' ' 12' ' ' SER . 2.7 tm? -60.98 -30.39 70.24 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 176.908 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -72.11 -24.42 61.47 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.66 -0.246 . . . . 0.0 111.325 -179.896 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -73.18 -21.75 60.61 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-O 121.924 0.868 . . . . 0.0 109.616 177.798 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.476 HD11 HG21 ' A' ' 67' ' ' VAL . 32.9 mt -104.5 -21.02 13.51 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-N 115.073 -0.967 . . . . 0.0 110.742 -179.492 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 52.9 tttp -71.41 149.32 46.06 Favored 'General case' 0 N--CA 1.445 -0.688 0 CA-C-N 115.459 -0.792 . . . . 0.0 110.909 -173.542 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 91.81 10.21 61.76 Favored Glycine 0 N--CA 1.452 -0.295 0 N-CA-C 111.066 -0.814 . . . . 0.0 111.066 -175.198 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.816 ' HD3' ' HA ' ' A' ' 63' ' ' ASP . 13.1 ttmm -162.12 157.48 23.35 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 108.196 -1.038 . . . . 0.0 108.196 179.73 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.521 ' CD2' HD11 ' A' ' 141' ' ' LEU . 82.3 m-85 -66.17 143.51 57.23 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 118.287 0.494 . . . . 0.0 110.808 -178.641 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.869 HD12 HD11 ' A' ' 115' ' ' LEU . 3.6 mp -126.04 146.37 31.95 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.226 0 CA-C-O 120.811 0.339 . . . . 0.0 110.561 -179.55 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . 0.723 ' HD1' ' HB3' ' A' ' 114' ' ' LEU . 75.2 t80 -129.7 121.64 27.35 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 173.224 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.678 HD13 ' HB ' ' A' ' 67' ' ' VAL . 25.9 mm -109.96 110.9 33.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 N-CA-C 112.156 0.428 . . . . 0.0 112.156 -173.253 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.563 ' O ' ' HA ' ' A' ' 68' ' ' SER . 33.7 m-20 -99.04 158.21 15.82 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 169.549 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.503 HG11 HG21 ' A' ' 109' ' ' ILE . 40.5 t -103.67 112.18 36.19 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.859 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 171.066 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' TRP . . . . . 0.795 ' CZ3' HG21 ' A' ' 82' ' ' VAL . 0.6 OUTLIER -103.29 132.55 49.46 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 -177.298 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.46 ' HB3' ' SG ' ' A' ' 42' ' ' CYS . . . -148.22 174.7 11.72 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.505 -0.316 . . . . 0.0 110.762 -178.551 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' THR . . . . . 0.531 ' HB ' ' CE3' ' A' ' 78' ' ' TRP . 5.9 t -104.27 -30.3 10.23 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 120.975 0.417 . . . . 0.0 110.379 171.618 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 21.0 p-90 -85.59 7.36 23.45 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.549 -178.108 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' CYS . . . . . 0.548 ' SG ' ' HB3' ' A' ' 45' ' ' CYS . 5.7 p -87.55 -2.21 58.47 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.677 -0.238 . . . . 0.0 111.41 -179.068 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . 0.572 ' O ' ' HG2' ' A' ' 46' ' ' ARG . . . 64.94 -108.35 2.3 Favored Glycine 0 CA--C 1.523 0.579 0 N-CA-C 114.773 0.669 . . . . 0.0 114.773 171.736 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.429 ' HD2' ' O ' ' A' ' 42' ' ' CYS . 9.6 Cg_endo -50.75 -23.15 10.86 Favored 'Trans proline' 0 C--N 1.356 0.96 0 C-N-CA 124.342 3.361 . . . . 0.0 113.541 -174.647 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . 0.721 ' HB2' ' HD3' ' A' ' 110' ' ' PRO . 47.1 t -52.19 -15.97 0.71 Allowed 'General case' 0 C--N 1.323 -0.55 0 O-C-N 124.071 0.857 . . . . 0.0 112.924 178.533 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.572 ' HG2' ' O ' ' A' ' 43' ' ' GLY . 24.7 mmm180 -71.02 -6.64 40.49 Favored 'General case' 0 N--CA 1.448 -0.574 0 O-C-N 121.806 -0.559 . . . . 0.0 110.467 -179.43 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.444 ' O ' ' HD2' ' A' ' 50' ' ' PRO . . . -84.13 -23.44 51.87 Favored Glycine 0 N--CA 1.446 -0.643 0 CA-C-N 115.818 -0.628 . . . . 0.0 112.95 -178.478 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . 0.533 ' HG3' ' HB3' ' A' ' 129' ' ' PRO . 2.0 mp0 -83.01 -4.49 58.38 Favored 'General case' 0 CA--C 1.516 -0.333 0 CA-C-N 117.2 0.5 . . . . 0.0 110.524 -179.379 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.773 ' HG ' HD23 ' A' ' 87' ' ' LEU . 7.3 mp -43.96 -55.23 9.61 Favored Pre-proline 0 CA--C 1.536 0.432 0 N-CA-C 112.487 0.551 . . . . 0.0 112.487 177.09 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.474 ' HD3' ' HB2' ' A' ' 49' ' ' LEU . 43.5 Cg_exo -58.45 -42.89 50.64 Favored 'Trans proline' 0 C--N 1.355 0.909 0 C-N-CA 121.874 1.716 . . . . 0.0 112.185 175.047 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -69.49 -21.75 63.66 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-O 121.476 0.655 . . . . 0.0 110.411 -174.226 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.538 HD11 HD21 ' A' ' 87' ' ' LEU . 7.6 tt -70.14 -55.44 9.4 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 114.974 -1.012 . . . . 0.0 108.643 178.673 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . 0.694 ' HB3' ' NZ ' ' A' ' 53' ' ' LYS . 1.8 mtpm? -52.63 -63.01 1.28 Allowed 'General case' 0 C--O 1.219 -0.508 0 CA-C-N 115.503 -0.771 . . . . 0.0 111.365 175.826 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -52.39 -39.45 60.86 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 113.302 0.853 . . . . 0.0 113.302 -173.146 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.425 ' O ' ' HB2' ' A' ' 58' ' ' LYS . 14.4 mt -67.49 -44.77 77.69 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.174 0.512 . . . . 0.0 110.622 174.43 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -57.39 -42.68 82.68 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.145 -0.934 . . . . 0.0 111.582 176.538 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.617 ' HG2' ' O ' ' A' ' 53' ' ' LYS . 16.0 mm-40 -53.47 -52.01 60.88 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-O 121.714 0.768 . . . . 0.0 109.287 175.74 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . 0.465 ' HB3' ' HE3' ' A' ' 58' ' ' LYS . 10.4 mmmt -53.01 -58.12 8.07 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-N 114.504 -1.225 . . . . 0.0 112.439 178.804 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.554 ' HB2' ' HE2' ' A' ' 66' ' ' PHE . 96.0 m-85 -106.71 21.6 17.23 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.047 -0.524 . . . . 0.0 112.322 -166.537 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -61.59 120.79 11.26 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.603 173.75 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 72.26 33.81 61.5 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.946 -0.645 . . . . 0.0 112.866 177.141 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . 0.496 ' HB3' HD11 ' A' ' 142' ' ' LEU . 40.1 mmtm -109.03 -164.91 0.97 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.154 0.502 . . . . 0.0 110.128 175.623 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . 0.816 ' HA ' ' HD3' ' A' ' 31' ' ' LYS . 3.7 t70 -89.87 54.95 2.99 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-O 121.792 0.806 . . . . 0.0 109.497 179.362 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.433 HG23 ' HB2' ' A' ' 62' ' ' LYS . 6.8 tp -157.0 129.98 1.15 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 CA-C-N 115.061 -0.972 . . . . 0.0 109.774 -178.114 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' HIS . . . . . 0.462 ' NE2' ' HB3' ' A' ' 31' ' ' LYS . 68.0 m-70 -103.3 106.58 17.13 Favored 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 175.773 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . 0.554 ' HE2' ' HB2' ' A' ' 59' ' ' TYR . 61.0 m-85 -79.01 103.13 8.74 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 171.082 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.678 ' HB ' HD13 ' A' ' 35' ' ' ILE . 29.6 t -122.26 126.53 74.4 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.476 -175.196 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' SER . . . . . 0.563 ' HA ' ' O ' ' A' ' 36' ' ' ASP . 37.1 m -114.05 134.3 54.96 Favored 'General case' 0 C--N 1.311 -1.066 0 CA-C-N 116.106 -0.497 . . . . 0.0 109.855 177.191 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.502 HD22 ' HB2' ' A' ' 92' ' ' LEU . 26.6 mt -110.53 132.78 53.88 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 110.006 -0.368 . . . . 0.0 110.006 177.116 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' SER . . . . . 0.466 ' O ' ' HB3' ' A' ' 94' ' ' MET . 0.9 OUTLIER -105.15 117.89 35.14 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.008 0.432 . . . . 0.0 111.348 -176.882 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 34.8 m -88.39 15.7 7.43 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.773 179.61 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . 0.53 ' OD2' HG22 ' A' ' 40' ' ' THR . 1.3 m-20 -71.73 135.52 46.81 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.249 -0.648 . . . . 0.0 109.249 -179.867 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . 0.414 ' O ' ' HD3' ' A' ' 73' ' ' LYS . 1.5 tmtp? -89.04 -30.1 18.95 Favored 'General case' 0 C--N 1.318 -0.784 0 C-N-CA 119.918 -0.713 . . . . 0.0 109.464 177.62 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . 0.501 ' HB2' ' HB3' ' A' ' 77' ' ' ALA . 0.8 OUTLIER -72.53 68.18 0.79 Allowed 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.135 -0.939 . . . . 0.0 110.434 174.127 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.478 ' O ' ' HG2' ' A' ' 79' ' ' GLU . 9.4 tttm -51.8 -64.5 0.79 Allowed 'General case' 0 C--O 1.22 -0.482 0 N-CA-C 112.489 0.551 . . . . 0.0 112.489 -175.984 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 51.9 tttm -49.77 -49.18 49.39 Favored 'General case' 0 C--N 1.329 -0.297 0 O-C-N 123.162 0.289 . . . . 0.0 111.204 -176.793 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.65 ' HA ' ' ND2' ' A' ' 80' ' ' ASN . . . -52.29 -44.05 64.79 Favored 'General case' 0 C--O 1.244 0.802 0 CA-C-O 121.886 0.85 . . . . 0.0 110.359 178.478 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' TRP . . . . . 0.564 ' CH2' HG23 ' A' ' 82' ' ' VAL . 6.8 t-105 -66.92 -51.13 59.08 Favored 'General case' 0 N--CA 1.437 -1.114 0 CA-C-N 114.278 -1.328 . . . . 0.0 111.048 -179.438 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . 0.519 ' OE1' HG13 ' A' ' 18' ' ' ILE . 5.3 mm-40 -46.22 -47.08 17.99 Favored 'General case' 0 CA--C 1.537 0.459 0 N-CA-C 111.87 0.322 . . . . 0.0 111.87 176.189 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . 0.65 ' ND2' ' HA ' ' A' ' 77' ' ' ALA . 0.6 OUTLIER -60.33 -49.23 78.42 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 120.823 -0.351 . . . . 0.0 110.526 -177.738 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 22.5 ttm -59.47 -48.47 81.53 Favored 'General case' 0 N--CA 1.466 0.341 0 N-CA-C 112.433 0.531 . . . . 0.0 112.433 -175.756 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.795 HG21 ' CZ3' ' A' ' 38' ' ' TRP . 0.9 OUTLIER -67.25 -26.05 35.24 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 C-N-CA 120.158 -0.617 . . . . 0.0 110.918 -178.046 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 90.6 m -72.78 -37.0 67.74 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.294 -0.412 . . . . 0.0 109.986 174.646 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . 0.409 ' HB3' ' HE3' ' A' ' 84' ' ' LYS . 1.2 tmmt? -71.26 -41.38 70.16 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.375 0.607 . . . . 0.0 110.018 177.513 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 15.6 m-20 -83.67 -1.72 54.64 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.225 -0.898 . . . . 0.0 111.881 -177.349 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 45.3 mt-30 62.0 23.63 13.95 Favored 'General case' 0 N--CA 1.468 0.466 0 N-CA-C 112.727 0.64 . . . . 0.0 112.727 172.074 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.773 HD23 ' HG ' ' A' ' 49' ' ' LEU . 94.1 mt -73.61 117.46 15.4 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 110.236 -0.283 . . . . 0.0 110.236 178.796 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . 0.564 ' HA ' ' HE3' ' A' ' 88' ' ' LYS . 0.0 OUTLIER -119.61 -168.08 1.53 Allowed 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.693 -0.23 . . . . 0.0 111.581 177.314 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 112.75 -163.23 12.17 Favored Glycine 0 N--CA 1.451 -0.35 0 N-CA-C 110.241 -1.144 . . . . 0.0 110.241 -173.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.648 ' O ' ' HA ' ' A' ' 67' ' ' VAL . 52.5 mt -92.72 111.67 24.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 173.679 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . 0.687 ' HB2' ' CZ2' ' A' ' 38' ' ' TRP . 1.0 OUTLIER -143.24 103.59 4.15 Favored 'General case' 0 C--N 1.311 -1.086 0 CA-C-O 121.598 0.713 . . . . 0.0 111.789 -168.934 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.502 ' HB2' HD22 ' A' ' 69' ' ' LEU . 20.6 mt -96.79 151.28 19.81 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.275 -0.875 . . . . 0.0 110.622 -175.846 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 37.3 t-80 -113.47 127.87 56.25 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.081 178.847 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' MET . . . . . 0.466 ' HB3' ' O ' ' A' ' 70' ' ' SER . 35.9 ttm -81.06 -83.14 0.11 Allowed 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 115.053 -0.976 . . . . 0.0 110.279 -179.682 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 131.2 -83.72 0.31 Allowed Glycine 0 N--CA 1.444 -0.79 0 C-N-CA 120.396 -0.907 . . . . 0.0 112.245 -178.19 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 1.7 m -137.72 4.63 2.59 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.583 0.706 . . . . 0.0 109.964 179.472 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -87.16 53.03 2.68 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.248 -0.887 . . . . 0.0 110.448 -172.485 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . 0.472 ' HB3' ' OD1' ' A' ' 102' ' ' ASP . 4.0 mtm180 -63.35 -8.94 9.96 Favored 'General case' 0 CA--C 1.512 -0.5 0 N-CA-C 112.542 0.571 . . . . 0.0 112.542 -172.924 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' THR . . . . . 0.431 ' O ' ' HB1' ' A' ' 103' ' ' ALA . 5.4 m -38.4 -33.09 0.09 Allowed 'General case' 0 C--N 1.313 -0.988 0 O-C-N 124.146 0.904 . . . . 0.0 112.376 179.197 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 80.2 t80 -81.27 -39.21 25.63 Favored 'General case' 0 CA--C 1.532 0.281 0 N-CA-C 112.356 0.502 . . . . 0.0 112.356 -179.822 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' MET . . . . . 0.473 ' HE1' ' HA ' ' A' ' 107' ' ' ASN . 24.9 ptm -78.66 -34.02 46.63 Favored 'General case' 0 CA--C 1.52 -0.185 0 C-N-CA 120.107 -0.637 . . . . 0.0 109.592 -177.268 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . 0.472 ' OD1' ' HB3' ' A' ' 98' ' ' ARG . 2.5 m-20 -75.57 -21.62 57.71 Favored 'General case' 0 N--CA 1.447 -0.604 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.186 176.581 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . 0.431 ' HB1' ' O ' ' A' ' 99' ' ' THR . . . -64.95 -29.57 70.51 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-O 121.063 0.459 . . . . 0.0 110.701 174.88 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 59.7 m-85 -96.96 2.35 51.46 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.519 177.796 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 95.6 mt 65.89 5.21 3.33 Favored 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 113.386 0.884 . . . . 0.0 113.386 173.164 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . 0.547 ' CG1' ' HG3' ' A' ' 111' ' ' ARG . 1.2 pp -97.34 88.83 1.88 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.575 0 CA-C-O 121.509 0.671 . . . . 0.0 112.194 -179.277 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . 0.473 ' HA ' ' HE1' ' A' ' 101' ' ' MET . 4.0 p-10 -77.1 -11.73 59.85 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.609 -0.723 . . . . 0.0 109.812 175.642 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -89.75 98.56 2.46 Favored Glycine 0 N--CA 1.445 -0.716 0 CA-C-N 115.445 -0.798 . . . . 0.0 111.621 177.357 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . 0.59 ' HB ' ' HA ' ' A' ' 110' ' ' PRO . 34.2 pt -104.88 162.79 18.72 Favored Pre-proline 0 C--N 1.321 -0.641 0 N-CA-C 110.088 -0.338 . . . . 0.0 110.088 179.823 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . 0.721 ' HD3' ' HB2' ' A' ' 45' ' ' CYS . 39.6 Cg_endo -70.11 143.74 75.39 Favored 'Cis proline' 0 C--N 1.349 0.567 0 C-N-CA 124.158 -1.184 . . . . 0.0 113.559 1.63 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . 0.547 ' HG3' ' CG1' ' A' ' 106' ' ' ILE . 0.0 OUTLIER -117.51 136.49 53.21 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.625 -0.716 . . . . 0.0 109.081 177.295 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . 0.557 ' CD2' ' HA ' ' A' ' 127' ' ' THR . 1.4 m-85 -105.7 117.23 33.5 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.789 -176.173 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.474 HG23 ' N ' ' A' ' 114' ' ' LEU . 24.4 mm -128.53 164.0 31.61 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 N-CA-C 108.144 -1.058 . . . . 0.0 108.144 177.137 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.739 HD21 ' HG2' ' A' ' 126' ' ' MET . 1.8 pt? -158.45 154.24 26.5 Favored 'General case' 0 C--N 1.316 -0.882 0 C-N-CA 120.573 -0.451 . . . . 0.0 110.978 173.455 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . 0.869 HD11 HD12 ' A' ' 33' ' ' ILE . 0.0 OUTLIER -138.17 150.98 47.29 Favored 'General case' 0 N--CA 1.448 -0.569 0 CA-C-O 122.329 1.062 . . . . 0.0 113.377 -173.788 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 12.8 t0 -69.19 163.73 24.24 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 113.174 -1.83 . . . . 0.0 109.782 176.328 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . 0.475 ' HA ' ' O ' ' A' ' 31' ' ' LYS . 31.1 mtm180 -48.39 -28.05 2.99 Favored 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 124.503 1.121 . . . . 0.0 113.272 -174.877 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 26.6 t0 -82.52 -5.13 58.56 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.104 0.478 . . . . 0.0 111.44 -177.314 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 89.34 16.6 57.0 Favored Glycine 0 N--CA 1.441 -0.986 0 N-CA-C 110.013 -1.235 . . . . 0.0 110.013 -171.241 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 4.9 tttm -90.27 147.21 23.67 Favored 'General case' 0 C--O 1.204 -1.327 0 CA-C-N 115.034 -0.583 . . . . 0.0 110.766 -175.522 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 3.8 mp -67.76 130.47 33.03 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.668 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.03 -174.775 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' ILE . . . . . 0.555 ' HB ' ' HG ' ' A' ' 114' ' ' LEU . 37.4 mm -100.53 -56.4 5.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 171.122 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' SER . . . . . 0.455 ' HB3' ' CD2' ' A' ' 114' ' ' LEU . 42.9 t -135.14 142.72 46.22 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.481 174.375 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . 0.461 ' HA ' ' CD1' ' A' ' 113' ' ' ILE . . . -112.55 23.48 13.51 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.425 -0.807 . . . . 0.0 109.429 176.018 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 4.1 p-10 -161.67 38.63 0.13 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.349 -0.841 . . . . 0.0 110.108 -179.913 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' MET . . . . . 0.739 ' HG2' HD21 ' A' ' 114' ' ' LEU . 2.2 tpt -71.7 -168.72 0.37 Allowed 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 115.762 -0.654 . . . . 0.0 111.206 -176.949 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' THR . . . . . 0.557 ' HA ' ' CD2' ' A' ' 112' ' ' PHE . 4.1 m -161.0 120.79 2.67 Favored 'General case' 0 C--O 1.223 -0.312 0 N-CA-C 110.108 -0.33 . . . . 0.0 110.108 -174.867 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . 0.55 ' HB2' ' OH ' ' A' ' 34' ' ' TYR . 21.8 ttt85 -88.94 -62.94 0.21 Allowed Pre-proline 0 CA--C 1.498 -1.039 0 CA-C-O 117.846 -1.073 . . . . 0.0 113.401 178.491 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . 0.533 ' HB3' ' HG3' ' A' ' 48' ' ' GLU . 1.0 OUTLIER -37.96 79.04 0.0 OUTLIER 'Trans proline' 0 C--N 1.372 1.784 0 C-N-CA 124.352 3.368 . . . . 0.0 113.814 -158.648 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 130' ' ' SER . . . . . 0.471 ' N ' ' O ' ' A' ' 128' ' ' ARG . 43.5 p 54.73 26.72 7.86 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 114.299 -1.319 . . . . 0.0 110.67 -179.47 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . 0.494 ' CG ' ' HZ1' ' A' ' 133' ' ' LYS . 13.8 t70 -70.76 123.56 89.4 Favored Pre-proline 0 C--O 1.236 0.355 0 CA-C-N 115.513 -0.767 . . . . 0.0 111.041 -178.648 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_endo -63.92 -37.51 43.66 Favored 'Trans proline' 0 N--CA 1.46 -0.459 0 C-N-CA 122.505 2.136 . . . . 0.0 112.881 -178.343 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . 0.494 ' HZ1' ' CG ' ' A' ' 131' ' ' ASP . 26.1 mtmm -54.3 -50.11 68.09 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-O 121.599 0.714 . . . . 0.0 110.113 -177.036 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 134' ' ' THR . . . . . 0.644 HG21 ' CZ ' ' A' ' 138' ' ' PHE . 13.8 m -78.76 -35.52 44.47 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 114.977 -1.01 . . . . 0.0 111.221 -174.494 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . 0.726 ' HA ' ' CD2' ' A' ' 138' ' ' PHE . . . -62.31 -40.7 97.16 Favored 'General case' 0 C--O 1.242 0.658 0 CA-C-O 121.167 0.508 . . . . 0.0 110.372 178.269 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . 0.536 ' HA ' ' ND2' ' A' ' 139' ' ' ASN . 7.1 mm-40 -65.19 -41.4 94.6 Favored 'General case' 0 N--CA 1.447 -0.614 0 CA-C-N 115.254 -0.885 . . . . 0.0 111.062 176.486 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . 0.954 ' HE2' ' HA ' ' A' ' 137' ' ' LYS . 9.1 mmpt? -55.79 -41.71 74.51 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.554 175.975 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . 0.726 ' CD2' ' HA ' ' A' ' 135' ' ' ALA . 15.3 m-85 -56.81 -60.37 3.66 Favored 'General case' 0 N--CA 1.463 0.2 0 O-C-N 123.181 0.301 . . . . 0.0 110.783 178.556 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 139' ' ' ASN . . . . . 0.536 ' ND2' ' HA ' ' A' ' 136' ' ' GLU . 11.7 p30 -69.49 -27.03 64.85 Favored 'General case' 0 C--O 1.224 -0.249 0 C-N-CA 120.602 -0.439 . . . . 0.0 111.506 -173.326 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 21.7 tt0 -63.18 -60.66 3.13 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.597 0.237 . . . . 0.0 111.464 177.092 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . 0.702 ' HG ' ' O ' ' A' ' 137' ' ' LYS . 3.0 pp -69.85 -19.86 63.43 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-O 120.845 0.355 . . . . 0.0 111.417 -175.69 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . 0.496 HD11 ' HB3' ' A' ' 62' ' ' LYS . 0.8 OUTLIER . . . . . 0 C--N 1.325 -0.494 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.065 175.039 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.463 0.187 0 CA-C-O 119.857 -0.116 . . . . 0.0 111.181 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . 11.97 74.54 0.01 OUTLIER 'General case' 0 N--CA 1.479 0.994 0 O-C-N 125.061 1.475 . . . . 0.0 113.807 -178.21 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' SER . . . . . 1.011 ' HA ' ' HB3' ' A' ' 25' ' ' LEU . 68.5 m 62.35 84.14 0.14 Allowed 'General case' 0 CA--C 1.534 0.362 0 CA-C-O 121.593 0.711 . . . . 0.0 111.354 -175.778 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 16.3 p90 -99.84 175.17 5.88 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.403 -0.817 . . . . 0.0 110.419 178.528 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 13.8 p -142.75 123.26 14.02 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.514 0.197 . . . . 0.0 110.57 178.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . 0.584 ' HB2' HD11 ' A' ' 92' ' ' LEU . 80.5 m-85 -134.65 150.05 72.51 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.655 -0.248 . . . . 0.0 110.483 179.24 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.401 ' HD2' ' O ' ' A' ' 93' ' ' HIS . 3.1 Cg_exo -80.83 124.85 5.21 Favored 'Trans proline' 0 N--CA 1.457 -0.636 0 C-N-CA 122.581 2.187 . . . . 0.0 112.805 178.638 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . 0.676 ' HB3' ' HB3' ' A' ' 21' ' ' LYS . 4.8 t70 -70.36 159.93 33.24 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.32 -0.855 . . . . 0.0 109.123 171.136 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.592 HD13 ' CG1' ' A' ' 82' ' ' VAL . 1.5 tt -50.24 -35.57 12.08 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.512 0 O-C-N 123.68 0.613 . . . . 0.0 111.651 -176.187 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 34.5 m-80 -77.54 11.93 1.83 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.411 -177.384 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 70.56 32.16 67.77 Favored Glycine 0 CA--C 1.505 -0.55 0 N-CA-C 110.335 -1.106 . . . . 0.0 110.335 -175.582 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.676 ' HB3' ' HB3' ' A' ' 17' ' ' ASP . 8.2 ttpm? -103.52 109.25 20.83 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.048 -0.576 . . . . 0.0 110.519 -173.997 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 20.9 m -65.19 106.94 1.42 Allowed 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.756 178.515 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.509 HG12 HG21 ' A' ' 90' ' ' ILE . 63.3 t -112.95 127.99 69.92 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 N-CA-C 109.176 -0.676 . . . . 0.0 109.176 179.028 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' SER . . . . . 0.459 ' C ' ' H ' ' A' ' 26' ' ' ALA . 92.9 p -122.62 165.01 17.16 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.535 0.683 . . . . 0.0 111.757 -173.193 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 1.011 ' HB3' ' HA ' ' A' ' 12' ' ' SER . 20.8 tp -85.35 33.15 0.55 Allowed 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.894 0.854 . . . . 0.0 109.311 175.385 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.459 ' H ' ' C ' ' A' ' 24' ' ' SER . . . -118.73 -41.37 2.8 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 114.505 -1.225 . . . . 0.0 109.745 174.155 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -79.1 -31.77 44.37 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.337 0.589 . . . . 0.0 109.937 173.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.594 HD12 HG21 ' A' ' 67' ' ' VAL . 75.9 mt -78.97 -18.46 53.67 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.217 174.862 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.5 ' HB2' ' O ' ' A' ' 25' ' ' LEU . 44.7 tttp -71.48 131.66 43.63 Favored 'General case' 0 N--CA 1.444 -0.729 0 CA-C-N 115.317 -0.856 . . . . 0.0 110.817 -175.336 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 117.17 -8.74 15.8 Favored Glycine 0 N--CA 1.448 -0.512 0 N-CA-C 110.79 -0.924 . . . . 0.0 110.79 -174.655 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.432 ' C ' ' HA ' ' A' ' 117' ' ' ARG . 24.9 ttmm -143.47 147.94 35.3 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 179.637 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 54.9 m-85 -54.01 144.66 18.59 Favored 'General case' 0 N--CA 1.47 0.543 0 N-CA-C 112.562 0.578 . . . . 0.0 112.562 -174.223 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.503 HG13 HD13 ' A' ' 25' ' ' LEU . 39.2 mm -120.73 133.93 65.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.562 -0.745 . . . . 0.0 110.99 -175.04 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . 0.466 ' OH ' ' HD3' ' A' ' 129' ' ' PRO . 80.1 t80 -120.67 118.98 31.5 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 172.253 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.592 ' HB ' ' HB ' ' A' ' 113' ' ' ILE . 75.1 mt -99.98 126.78 53.39 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 N-CA-C 110.138 -0.319 . . . . 0.0 110.138 179.399 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.528 ' O ' ' HA ' ' A' ' 68' ' ' SER . 11.8 t70 -129.9 124.91 34.3 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.23 -178.924 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.404 HG13 HG22 ' A' ' 109' ' ' ILE . 26.5 t -81.78 121.77 35.63 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.913 0 C-N-CA 120.557 -0.457 . . . . 0.0 110.423 -179.598 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' TRP . . . . . 0.668 ' CE3' ' HZ2' ' A' ' 78' ' ' TRP . 0.7 OUTLIER -121.74 133.41 54.93 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.161 -0.472 . . . . 0.0 109.896 -176.618 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.512 ' HA ' ' OD1' ' A' ' 72' ' ' ASP . . . -148.27 158.28 44.0 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.577 -177.482 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' THR . . . . . 0.624 ' HB ' ' CE3' ' A' ' 78' ' ' TRP . 11.1 t -94.89 -25.59 16.52 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.114 0.483 . . . . 0.0 110.611 175.111 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 14.9 p-90 -87.78 13.32 10.86 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.079 -177.742 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' CYS . . . . . 0.446 ' SG ' ' HB2' ' A' ' 45' ' ' CYS . 14.9 t -86.24 -60.69 1.93 Allowed 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.09 175.92 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 110.92 -91.37 0.61 Allowed Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.641 -179.269 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -53.62 -28.87 48.11 Favored 'Trans proline' 0 C--N 1.35 0.638 0 C-N-CA 123.302 2.668 . . . . 0.0 113.066 -178.59 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . 0.586 ' HG ' ' HG3' ' A' ' 110' ' ' PRO . 42.2 t -51.64 -30.05 20.09 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.66 178.594 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.55 ' HA ' ' HG ' ' A' ' 49' ' ' LEU . 55.8 mtp180 -65.44 -30.58 71.39 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.451 -0.341 . . . . 0.0 111.686 -176.592 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -68.9 -26.39 74.66 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.652 -0.785 . . . . 0.0 112.49 -176.65 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . 0.443 ' OE2' ' HG2' ' A' ' 128' ' ' ARG . 14.6 mt-10 -94.49 -12.24 28.06 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.594 0.235 . . . . 0.0 111.005 -176.94 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.637 ' O ' ' HG3' ' A' ' 53' ' ' LYS . 73.2 mt -49.75 -49.19 74.74 Favored Pre-proline 0 C--N 1.331 -0.239 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.948 -178.598 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.54 ' HD3' ' HB2' ' A' ' 49' ' ' LEU . 71.3 Cg_exo -50.83 -37.82 56.04 Favored 'Trans proline' 0 C--N 1.357 1.003 0 C-N-CA 122.184 1.923 . . . . 0.0 112.767 176.984 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . 0.499 ' O ' ' HB2' ' A' ' 55' ' ' LEU . . . -75.14 -25.4 58.36 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-O 121.617 0.722 . . . . 0.0 110.504 -176.114 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 6.8 tt -79.02 -48.34 14.6 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.0 -1.0 . . . . 0.0 108.419 -177.155 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . 0.732 ' HB3' ' HG2' ' A' ' 88' ' ' LYS . 81.9 mttt -51.59 -55.71 17.67 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-N 114.655 -1.157 . . . . 0.0 109.909 176.893 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.464 ' HG2' ' O ' ' A' ' 50' ' ' PRO . 9.6 mm-40 -73.58 -23.32 59.93 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 114.074 -1.421 . . . . 0.0 112.55 -171.185 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.499 ' HB2' ' O ' ' A' ' 51' ' ' ALA . 0.4 OUTLIER -73.35 -34.0 65.4 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 120.302 -0.559 . . . . 0.0 109.588 176.408 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.447 ' OE2' ' HB2' ' A' ' 66' ' ' PHE . 5.1 tp10 -68.14 -37.13 80.74 Favored 'General case' 0 C--O 1.217 -0.63 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 175.686 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.453 ' HG2' ' O ' ' A' ' 53' ' ' LYS . 7.1 mm-40 -54.04 -53.96 45.8 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.391 0.615 . . . . 0.0 110.451 175.492 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 34.4 ttpt -55.57 -35.41 65.74 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.369 -0.832 . . . . 0.0 110.903 177.755 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.452 ' CZ ' ' HB2' ' A' ' 138' ' ' PHE . 38.3 m-85 -102.91 12.29 36.32 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 113.109 0.781 . . . . 0.0 113.109 -176.114 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -65.09 123.63 20.0 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 120.878 0.371 . . . . 0.0 110.352 176.516 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 83.52 7.68 85.94 Favored Glycine 0 N--CA 1.448 -0.541 0 C-N-CA 120.826 -0.702 . . . . 0.0 112.782 178.195 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 34.2 mmtm -89.92 -153.47 0.29 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.194 0.521 . . . . 0.0 109.821 177.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -106.75 62.39 0.63 Allowed 'General case' 0 C--N 1.316 -0.878 0 CA-C-O 121.571 0.701 . . . . 0.0 110.021 176.853 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 17.8 tt -157.35 163.98 1.21 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.787 0 CA-C-N 115.12 -0.945 . . . . 0.0 109.174 177.503 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 96.8 m-70 -139.25 114.97 10.01 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 174.453 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . 0.447 ' HB2' ' OE2' ' A' ' 56' ' ' GLU . 12.5 m-85 -80.47 103.0 10.04 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 171.998 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.594 HG21 HD12 ' A' ' 28' ' ' LEU . 46.8 t -115.82 104.54 16.9 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 CA-C-N 115.332 -0.849 . . . . 0.0 109.739 -176.566 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' SER . . . . . 0.528 ' HA ' ' O ' ' A' ' 36' ' ' ASP . 28.9 m -88.1 148.26 24.54 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.531 -178.132 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.41 HD12 ' HB2' ' A' ' 94' ' ' MET . 63.7 tp -126.73 119.9 28.07 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 120.839 0.352 . . . . 0.0 110.664 178.139 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' SER . . . . . 0.492 ' HB3' ' HA ' ' A' ' 93' ' ' HIS . 3.4 t -100.74 119.05 38.05 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.228 0.537 . . . . 0.0 112.095 -174.552 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 18.7 m -90.76 15.34 11.33 Favored 'General case' 0 C--N 1.31 -1.121 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.816 177.864 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . 0.512 ' OD1' ' HA ' ' A' ' 39' ' ' ALA . 2.4 m-20 -68.2 127.26 32.25 Favored 'General case' 0 CA--C 1.516 -0.344 0 CA-C-O 121.049 0.452 . . . . 0.0 110.663 -177.957 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 38.5 ttmt -79.01 -31.65 44.81 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 121.413 0.625 . . . . 0.0 109.323 175.335 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . 0.51 ' HB2' ' HB2' ' A' ' 77' ' ' ALA . 0.8 OUTLIER -80.36 68.59 6.59 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.175 -0.92 . . . . 0.0 110.25 177.45 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.548 ' HG3' ' CE1' ' A' ' 93' ' ' HIS . 33.0 tttt -58.91 -49.54 77.43 Favored 'General case' 0 C--O 1.223 -0.338 0 C-N-CA 120.936 -0.306 . . . . 0.0 111.462 -173.862 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 64.7 tttp -52.43 -56.04 17.77 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 110.343 -0.243 . . . . 0.0 110.343 179.273 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.648 ' HA ' ' ND2' ' A' ' 80' ' ' ASN . . . -51.45 -35.66 40.63 Favored 'General case' 0 C--O 1.242 0.678 0 CA-C-O 122.03 0.919 . . . . 0.0 110.933 177.011 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' TRP . . . . . 0.668 ' HZ2' ' CE3' ' A' ' 38' ' ' TRP . 14.8 t-105 -74.25 -51.05 16.5 Favored 'General case' 0 N--CA 1.431 -1.377 0 CA-C-N 114.434 -1.257 . . . . 0.0 111.828 -173.045 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . 0.495 ' HG2' ' O ' ' A' ' 75' ' ' LYS . 4.8 mm-40 -49.61 -41.06 41.17 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-O 121.082 0.468 . . . . 0.0 110.485 176.849 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . 0.648 ' ND2' ' HA ' ' A' ' 77' ' ' ALA . 6.0 m-20 -56.87 -54.26 48.53 Favored 'General case' 0 CA--C 1.518 -0.261 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.706 177.795 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' MET . . . . . 0.539 ' SD ' ' HZ3' ' A' ' 78' ' ' TRP . 16.6 ttt -61.09 -48.42 81.75 Favored 'General case' 0 C--O 1.223 -0.316 0 N-CA-C 112.358 0.503 . . . . 0.0 112.358 -175.435 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.592 ' CG1' HD13 ' A' ' 18' ' ' ILE . 0.9 OUTLIER -60.91 -34.79 60.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 C-N-CA 120.386 -0.526 . . . . 0.0 111.069 -178.478 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 25.5 m -73.41 -29.79 62.82 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.106 0.479 . . . . 0.0 110.574 176.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 51.3 tttp -81.3 -41.97 21.33 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.179 0.514 . . . . 0.0 111.043 -177.905 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -77.24 -21.04 54.38 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.239 -0.891 . . . . 0.0 110.084 -176.126 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 17.8 mm-40 63.99 79.52 0.26 Allowed 'General case' 0 C--O 1.233 0.192 0 CA-C-N 115.375 -0.83 . . . . 0.0 111.229 -179.885 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.659 HD23 ' HE2' ' A' ' 53' ' ' LYS . 49.4 mt -96.55 140.93 30.45 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.422 -0.808 . . . . 0.0 111.001 179.402 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . 0.732 ' HG2' ' HB3' ' A' ' 53' ' ' LYS . 30.6 mmtp -95.47 174.28 7.09 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.234 -0.439 . . . . 0.0 109.821 179.341 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . 0.419 ' CA ' ' HG2' ' A' ' 56' ' ' GLU . . . 86.33 -164.83 36.84 Favored Glycine 0 CA--C 1.517 0.184 0 C-N-CA 120.927 -0.654 . . . . 0.0 113.432 174.418 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.509 HG21 HG12 ' A' ' 23' ' ' VAL . 64.2 mt -103.51 113.45 40.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 178.297 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . 0.616 ' HB3' ' CZ2' ' A' ' 38' ' ' TRP . 8.1 mm100 -117.23 104.83 11.57 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 120.892 0.377 . . . . 0.0 111.022 -169.624 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.584 HD11 ' HB2' ' A' ' 15' ' ' TYR . 34.9 mt -100.04 147.94 25.07 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.146 0.498 . . . . 0.0 111.111 -176.51 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' HIS . . . . . 0.548 ' CE1' ' HG3' ' A' ' 75' ' ' LYS . 28.1 t-80 -115.08 127.86 55.87 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.144 0.497 . . . . 0.0 111.086 179.759 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' MET . . . . . 0.491 ' HB3' ' O ' ' A' ' 70' ' ' SER . 24.1 ttm -77.32 -74.95 0.22 Allowed 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.294 -0.866 . . . . 0.0 109.93 176.167 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . 0.41 ' N ' ' HG2' ' A' ' 94' ' ' MET . . . 78.67 101.96 0.21 Allowed Glycine 0 N--CA 1.445 -0.734 0 C-N-CA 120.755 -0.735 . . . . 0.0 113.135 -179.689 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 64.9 p 61.17 16.29 7.08 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 114.221 1.193 . . . . 0.0 114.221 170.098 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -123.99 54.47 1.33 Allowed 'General case' 0 CA--C 1.518 -0.265 0 CA-C-O 121.502 0.667 . . . . 0.0 110.096 174.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . 0.47 ' HB2' ' SD ' ' A' ' 101' ' ' MET . 0.1 OUTLIER -77.3 5.62 8.26 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.27 -0.877 . . . . 0.0 111.911 -170.433 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 2.8 m -61.0 -29.95 70.0 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.294 0.569 . . . . 0.0 110.529 177.42 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 27.3 t80 -73.94 -24.83 59.71 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.567 -179.14 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' MET . . . . . 0.47 ' SD ' ' HB2' ' A' ' 98' ' ' ARG . 83.2 mtp -61.7 -51.58 67.8 Favored 'General case' 0 CA--C 1.515 -0.402 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 174.059 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -62.03 -25.36 67.61 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 114.649 -1.16 . . . . 0.0 111.424 -177.696 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -65.84 -28.97 69.37 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-O 121.074 0.464 . . . . 0.0 110.877 178.1 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 61.9 m-85 -109.27 10.81 25.61 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.495 179.766 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 95.4 mt 64.72 15.51 9.81 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.1 -177.24 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . 0.882 HG12 ' HG3' ' A' ' 111' ' ' ARG . 61.2 mt -67.03 112.92 2.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.271 175.111 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 16.2 t-20 -124.96 -53.85 1.63 Allowed 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 176.346 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -92.19 115.02 4.7 Favored Glycine 0 N--CA 1.442 -0.915 0 CA-C-N 115.29 -0.868 . . . . 0.0 111.979 178.339 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . 0.526 ' CG2' ' HA ' ' A' ' 110' ' ' PRO . 41.9 mt -77.7 142.97 66.59 Favored Pre-proline 0 C--N 1.321 -0.655 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 175.383 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . 0.586 ' HG3' ' HG ' ' A' ' 45' ' ' CYS . 1.0 OUTLIER -86.13 170.67 42.16 Favored 'Cis proline' 0 C--N 1.348 0.553 0 C-N-CA 124.775 -0.927 . . . . 0.0 113.853 1.087 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . 0.882 ' HG3' HG12 ' A' ' 106' ' ' ILE . 0.0 OUTLIER -134.79 133.82 40.23 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.477 -0.783 . . . . 0.0 108.897 179.413 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . 0.488 ' CE1' ' HB2' ' A' ' 128' ' ' ARG . 0.0 OUTLIER -102.33 117.05 33.91 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 123.365 0.415 . . . . 0.0 110.502 -175.604 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.592 ' HB ' ' HB ' ' A' ' 35' ' ' ILE . 82.1 mt -129.16 141.81 45.64 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.326 0 CA-C-O 120.708 0.29 . . . . 0.0 111.004 179.559 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 40.4 tp -130.31 139.21 50.72 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.5 -179.775 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . 0.451 HD11 ' N ' ' A' ' 115' ' ' LEU . 0.8 OUTLIER -136.03 155.77 49.73 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.04 0.447 . . . . 0.0 110.54 179.673 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . 0.67 ' HB3' ' HB2' ' A' ' 120' ' ' LYS . 19.2 t70 -71.94 162.55 29.29 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.221 -0.899 . . . . 0.0 110.568 176.684 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . 0.432 ' HA ' ' C ' ' A' ' 31' ' ' LYS . 33.0 mtt180 -46.53 -40.2 12.21 Favored 'General case' 0 N--CA 1.462 0.136 0 O-C-N 124.43 1.081 . . . . 0.0 111.895 -178.611 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . 0.841 ' HB3' ' HG3' ' A' ' 120' ' ' LYS . 38.4 t70 -66.09 -18.87 65.62 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.36 0.6 . . . . 0.0 111.173 -177.448 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 104.26 16.96 16.93 Favored Glycine 0 N--CA 1.436 -1.344 0 N-CA-C 110.288 -1.125 . . . . 0.0 110.288 -170.151 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . 0.841 ' HG3' ' HB3' ' A' ' 118' ' ' ASP . 60.0 mttm -86.03 107.35 17.75 Favored 'General case' 0 C--O 1.219 -0.528 0 C-N-CA 120.805 -0.358 . . . . 0.0 111.115 -173.929 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . 0.413 ' HA ' ' HG ' ' A' ' 115' ' ' LEU . 3.9 mp -48.18 111.67 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-O 121.02 0.438 . . . . 0.0 110.797 177.725 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 45.5 mm -95.48 -50.38 11.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 115.659 -0.7 . . . . 0.0 109.9 -179.508 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 19.9 m -125.99 114.59 18.67 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.212 -177.86 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -72.08 -16.98 62.03 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.13 0.491 . . . . 0.0 110.091 176.694 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . 0.421 ' HA ' ' O ' ' A' ' 112' ' ' PHE . 7.7 t30 -149.8 101.18 3.03 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.299 -0.864 . . . . 0.0 109.159 173.909 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 12.6 tpt -91.48 -125.2 0.08 Allowed 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 -178.761 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 127' ' ' THR . . . . . 0.458 ' OG1' ' HB ' ' A' ' 134' ' ' THR . 0.0 OUTLIER -140.82 131.72 26.01 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.879 0.371 . . . . 0.0 110.48 178.399 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . 0.617 ' HD2' ' HD2' ' A' ' 129' ' ' PRO . 17.7 tpt180 -51.52 138.03 30.83 Favored Pre-proline 0 C--N 1.323 -0.56 0 CA-C-N 115.252 -0.885 . . . . 0.0 111.073 176.04 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . 0.617 ' HD2' ' HD2' ' A' ' 128' ' ' ARG . 68.8 Cg_exo -48.49 -21.48 3.34 Favored 'Trans proline' 0 C--N 1.351 0.664 0 C-N-CA 123.496 2.797 . . . . 0.0 113.747 174.074 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 130' ' ' SER . . . . . 0.429 ' OG ' ' HB3' ' A' ' 48' ' ' GLU . 4.4 m -61.11 -28.06 68.82 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.762 0.315 . . . . 0.0 111.035 176.774 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . 0.647 ' OD1' ' HG2' ' A' ' 133' ' ' LYS . 24.1 t0 -100.64 117.35 62.93 Favored Pre-proline 0 N--CA 1.453 -0.321 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.162 179.736 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . 0.592 ' O ' ' HG2' ' A' ' 136' ' ' GLU . 14.1 Cg_endo -56.98 -21.18 40.19 Favored 'Trans proline' 0 CA--C 1.53 0.315 0 C-N-CA 123.196 2.597 . . . . 0.0 114.018 179.736 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . 0.647 ' HG2' ' OD1' ' A' ' 131' ' ' ASP . 31.1 mmtm -48.15 -55.31 10.68 Favored 'General case' 0 N--CA 1.474 0.73 0 CA-C-O 121.066 0.46 . . . . 0.0 110.724 -177.528 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 134' ' ' THR . . . . . 0.458 ' HB ' ' OG1' ' A' ' 127' ' ' THR . 15.1 t -65.15 -41.15 95.02 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.233 -0.894 . . . . 0.0 110.755 -175.069 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . 0.572 ' HA ' ' CD2' ' A' ' 138' ' ' PHE . . . -64.24 -47.87 78.0 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-O 121.402 0.62 . . . . 0.0 110.758 -176.801 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . 0.592 ' HG2' ' O ' ' A' ' 132' ' ' PRO . 8.6 mm-40 -77.12 -22.86 52.02 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-O 121.465 0.65 . . . . 0.0 109.821 -176.2 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . 0.573 ' O ' ' HG ' ' A' ' 141' ' ' LEU . 0.1 OUTLIER -57.68 -39.17 76.48 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.15 -0.932 . . . . 0.0 109.441 168.659 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . 0.572 ' CD2' ' HA ' ' A' ' 135' ' ' ALA . 9.3 m-85 -66.76 -40.59 88.31 Favored 'General case' 0 N--CA 1.462 0.15 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.373 177.596 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 139' ' ' ASN . . . . . 0.48 ' ND2' ' HA ' ' A' ' 136' ' ' GLU . 92.6 m-20 -47.53 -53.76 13.52 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 175.758 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . 0.541 ' CD ' ' HZ1' ' A' ' 137' ' ' LYS . 21.8 tt0 -53.85 -48.42 70.0 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.287 -0.869 . . . . 0.0 111.472 179.111 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . 0.573 ' HG ' ' O ' ' A' ' 137' ' ' LYS . 83.4 mt -58.32 -29.35 65.84 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.899 -176.688 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 10.0 mp . . . . . 0 C--N 1.327 -0.412 0 CA-C-N 116.678 -0.237 . . . . 0.0 111.442 -179.756 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . 0.433 ' HB1' HD11 ' A' ' 121' ' ' ILE . . . . . . . . 0 N--CA 1.471 0.584 0 N-CA-C 112.823 0.675 . . . . 0.0 112.823 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -76.2 69.35 2.73 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 112.281 0.474 . . . . 0.0 112.281 -175.598 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 42.5 m 62.6 102.86 0.03 OUTLIER 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 113.188 0.811 . . . . 0.0 113.188 172.042 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . 0.489 ' CE1' HD12 ' A' ' 25' ' ' LEU . 38.7 p90 -105.58 129.91 53.74 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.137 -0.483 . . . . 0.0 109.943 173.985 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 3.4 m -121.82 111.76 17.52 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.395 -177.841 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 63.9 m-85 -134.79 151.63 76.07 Favored Pre-proline 0 C--N 1.322 -0.597 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.605 -175.885 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -76.41 125.81 8.63 Favored 'Trans proline' 0 N--CA 1.46 -0.497 0 C-N-CA 122.569 2.18 . . . . 0.0 112.587 178.966 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . 0.544 ' HA ' ' HA ' ' A' ' 92' ' ' LEU . 10.5 t70 -70.51 159.16 34.79 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.484 -0.78 . . . . 0.0 108.926 172.114 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.536 HG13 HG13 ' A' ' 82' ' ' VAL . 0.0 OUTLIER -55.8 -25.64 19.01 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.487 0 O-C-N 123.722 0.639 . . . . 0.0 111.55 -176.947 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 42.8 m-80 -72.65 2.42 6.55 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.137 0.494 . . . . 0.0 110.91 176.065 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 73.67 36.35 53.73 Favored Glycine 0 N--CA 1.446 -0.639 0 N-CA-C 110.835 -0.906 . . . . 0.0 110.835 -179.501 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.832 ' HZ2' ' HB2' ' A' ' 21' ' ' LYS . 0.1 OUTLIER -119.56 134.07 55.39 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 110.273 -0.269 . . . . 0.0 110.273 -175.045 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 7.0 m -80.11 107.83 13.22 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-O 120.868 0.366 . . . . 0.0 110.619 -177.326 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.476 ' HB ' HD23 ' A' ' 92' ' ' LEU . 62.0 t -108.4 141.7 22.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 115.871 -0.604 . . . . 0.0 109.69 -179.969 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 82.3 p -120.53 -173.71 2.64 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 120.867 0.365 . . . . 0.0 110.716 -176.895 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.645 ' O ' ' HB2' ' A' ' 29' ' ' LYS . 65.0 tp -78.73 -26.52 44.72 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.465 -179.716 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -84.76 -30.58 24.54 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 112.8 0.667 . . . . 0.0 112.8 -169.709 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 3.4 p30 -81.04 -15.5 55.94 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.171 0.51 . . . . 0.0 110.849 -175.796 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 18.8 tp -118.36 21.87 12.42 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.756 0.788 . . . . 0.0 109.319 178.007 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.645 ' HB2' ' O ' ' A' ' 25' ' ' LEU . 57.6 tttm -94.18 163.27 13.52 Favored 'General case' 0 N--CA 1.44 -0.957 0 CA-C-N 114.813 -1.085 . . . . 0.0 109.961 -178.45 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 114.49 -31.33 6.45 Favored Glycine 0 CA--C 1.509 -0.301 0 C-N-CA 120.591 -0.814 . . . . 0.0 111.669 177.734 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 1.022 ' HD3' ' HA ' ' A' ' 63' ' ' ASP . 65.2 mttm -119.36 165.55 14.16 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 109.662 -0.496 . . . . 0.0 109.662 174.822 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 81.5 m-85 -60.89 149.15 37.18 Favored 'General case' 0 C--N 1.329 -0.311 0 O-C-N 123.323 0.39 . . . . 0.0 110.639 -177.87 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 71.1 mt -124.5 132.18 71.7 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 CA-C-O 120.853 0.359 . . . . 0.0 110.807 -174.737 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 88.3 t80 -117.12 121.05 40.19 Favored 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 173.013 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.516 ' HB ' ' HB ' ' A' ' 113' ' ' ILE . 57.1 mt -105.58 118.83 53.78 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-O 121.171 0.51 . . . . 0.0 110.736 -178.286 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -106.41 156.87 18.08 Favored 'General case' 0 C--N 1.316 -0.849 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 172.3 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.481 HG12 ' O ' ' A' ' 69' ' ' LEU . 62.0 t -110.46 112.1 39.08 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.877 0 C-N-CA 120.034 -0.666 . . . . 0.0 110.22 174.161 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' TRP . . . . . 0.651 ' CZ2' ' HB2' ' A' ' 91' ' ' GLN . 0.2 OUTLIER -98.02 132.86 43.2 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.097 -0.956 . . . . 0.0 109.516 -177.257 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.576 ' HA ' ' OD1' ' A' ' 72' ' ' ASP . . . -147.58 155.09 41.49 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.664 -178.714 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' THR . . . . . 0.662 ' HB ' ' CE3' ' A' ' 78' ' ' TRP . 13.3 t -100.34 -28.41 12.97 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.781 0.324 . . . . 0.0 110.704 174.601 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 18.5 p-90 -81.31 11.03 4.69 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.785 -177.053 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' CYS . . . . . 0.777 ' HB3' ' SG ' ' A' ' 45' ' ' CYS . 44.5 t -91.55 -61.03 1.73 Allowed 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 109.912 -0.403 . . . . 0.0 109.912 174.854 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 111.0 -83.68 0.33 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.597 -179.629 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_exo -54.19 -26.86 44.32 Favored 'Trans proline' 0 C--N 1.351 0.704 0 C-N-CA 123.188 2.592 . . . . 0.0 112.854 179.463 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . 0.777 ' SG ' ' HB3' ' A' ' 42' ' ' CYS . 23.1 p -51.47 -35.49 40.1 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.399 176.797 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.552 ' HA ' HD12 ' A' ' 49' ' ' LEU . 33.6 mtp180 -67.9 -12.3 60.41 Favored 'General case' 0 N--CA 1.456 -0.157 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.21 -175.698 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -80.37 -19.93 67.93 Favored Glycine 0 N--CA 1.446 -0.654 0 C-N-CA 120.648 -0.786 . . . . 0.0 111.369 175.437 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 24.6 mt-10 -99.34 -12.81 19.97 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-O 120.606 0.241 . . . . 0.0 110.615 -179.282 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.552 HD12 ' HA ' ' A' ' 46' ' ' ARG . 7.5 mp -51.89 -48.57 87.52 Favored Pre-proline 0 CA--C 1.536 0.436 0 CA-C-N 116.561 -0.29 . . . . 0.0 111.701 172.279 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -57.04 -35.84 99.07 Favored 'Trans proline' 0 C--N 1.355 0.896 0 C-N-CA 121.791 1.661 . . . . 0.0 111.937 171.601 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . 0.449 ' O ' ' HB2' ' A' ' 54' ' ' GLU . . . -72.0 -26.03 62.06 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-O 121.234 0.54 . . . . 0.0 110.574 -179.1 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 87.3 mt -67.6 -33.67 75.47 Favored 'General case' 0 N--CA 1.444 -0.74 0 CA-C-N 115.858 -0.61 . . . . 0.0 109.67 174.225 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 5.5 mtpm? -70.36 -39.19 74.76 Favored 'General case' 0 CA--C 1.519 -0.236 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.166 175.005 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.449 ' HB2' ' O ' ' A' ' 51' ' ' ALA . 28.1 mm-40 -50.7 -50.82 54.18 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.755 -0.657 . . . . 0.0 109.669 172.9 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 62.8 mt -62.23 -53.12 59.74 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.976 175.409 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 26.4 tt0 -43.41 -59.84 1.96 Allowed 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 114.575 -1.193 . . . . 0.0 112.427 179.522 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -78.67 -29.04 45.41 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 120.777 0.322 . . . . 0.0 111.598 -172.666 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 65.5 tttm -70.48 -27.69 64.41 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.884 0.374 . . . . 0.0 110.831 178.62 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.41 ' HB2' ' HE2' ' A' ' 66' ' ' PHE . 68.4 m-85 -122.58 13.7 10.13 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.46 -0.336 . . . . 0.0 111.845 -176.343 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -60.07 132.09 52.85 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.217 172.392 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 69.36 46.37 56.87 Favored Glycine 0 N--CA 1.447 -0.599 0 C-N-CA 120.854 -0.689 . . . . 0.0 112.169 -179.702 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 40.3 mmtm -126.6 -164.42 1.33 Allowed 'General case' 0 N--CA 1.45 -0.451 0 CA-C-O 121.216 0.531 . . . . 0.0 110.313 174.859 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . 1.022 ' HA ' ' HD3' ' A' ' 31' ' ' LYS . 0.1 OUTLIER -97.85 44.32 1.04 Allowed 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.639 -0.71 . . . . 0.0 110.805 -179.41 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 18.2 tt -144.45 149.27 17.49 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.761 0 CA-C-N 114.929 -1.032 . . . . 0.0 109.761 -177.036 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' HIS . . . . . 0.545 ' NE2' ' HB2' ' A' ' 31' ' ' LYS . 89.4 m-70 -124.25 121.34 34.78 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 109.918 -0.401 . . . . 0.0 109.918 178.287 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . 0.41 ' HE2' ' HB2' ' A' ' 59' ' ' TYR . 91.8 m-85 -88.65 111.31 21.78 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 173.585 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.506 ' O ' ' HA ' ' A' ' 35' ' ' ILE . 27.4 t -118.58 109.37 26.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.459 -175.83 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' SER . . . . . 0.403 ' HB3' ' CD1' ' A' ' 38' ' ' TRP . 10.9 m -88.07 143.73 26.91 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-N 115.918 -0.583 . . . . 0.0 109.856 178.844 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.481 ' O ' HG12 ' A' ' 37' ' ' VAL . 62.7 tp -131.88 124.0 28.63 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 174.652 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' SER . . . . . 0.556 ' O ' ' HB3' ' A' ' 94' ' ' MET . 1.3 t -108.15 119.61 39.98 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.076 0.465 . . . . 0.0 112.046 -173.957 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 2.4 p -87.06 17.6 4.1 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.749 -0.659 . . . . 0.0 110.806 177.214 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . 0.585 ' OD2' HG22 ' A' ' 40' ' ' THR . 1.9 m-20 -69.64 121.3 16.86 Favored 'General case' 0 CA--C 1.515 -0.4 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.011 179.496 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 45.9 tttm -75.91 -25.86 56.42 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-O 121.146 0.498 . . . . 0.0 110.062 -179.874 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . 0.494 ' HB2' ' HB3' ' A' ' 77' ' ' ALA . 0.2 OUTLIER -78.7 96.87 5.67 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.747 -0.66 . . . . 0.0 109.788 174.027 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.545 ' O ' ' HG2' ' A' ' 79' ' ' GLU . 11.4 tmtt? -71.41 -66.33 0.64 Allowed 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 120.446 -0.502 . . . . 0.0 112.038 -173.863 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 36.0 ttpt -58.3 -43.28 88.04 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 121.009 -0.277 . . . . 0.0 110.819 -173.044 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.572 ' HA ' ' ND2' ' A' ' 80' ' ' ASN . . . -52.22 -38.82 59.09 Favored 'General case' 0 C--O 1.246 0.879 0 CA-C-O 121.86 0.838 . . . . 0.0 111.277 178.716 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' TRP . . . . . 0.662 ' CE3' ' HB ' ' A' ' 40' ' ' THR . 16.2 t-105 -79.02 -42.53 26.31 Favored 'General case' 0 N--CA 1.44 -0.959 0 CA-C-N 115.151 -0.931 . . . . 0.0 111.045 -173.175 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . 0.545 ' HG2' ' O ' ' A' ' 75' ' ' LYS . 3.8 mm-40 -51.97 -40.72 61.33 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-O 121.473 0.654 . . . . 0.0 110.248 175.748 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . 0.572 ' ND2' ' HA ' ' A' ' 77' ' ' ALA . 7.2 m-20 -59.25 -54.07 51.02 Favored 'General case' 0 CA--C 1.513 -0.446 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.257 177.858 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 28.6 ttm -61.37 -45.99 92.05 Favored 'General case' 0 C--O 1.219 -0.507 0 CA-C-N 116.02 -0.536 . . . . 0.0 112.235 -174.209 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.564 ' CG2' ' HZ3' ' A' ' 38' ' ' TRP . 3.9 p -61.57 -32.82 54.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 C-N-CA 120.07 -0.652 . . . . 0.0 111.016 179.519 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 58.9 m -63.75 -40.34 96.48 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.979 0.419 . . . . 0.0 110.239 175.886 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 12.8 mptt -81.13 -29.96 34.66 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.495 -179.396 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . 0.408 ' CG ' HH21 ' A' ' 46' ' ' ARG . 1.5 m-20 -77.6 -6.8 55.02 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.142 0.496 . . . . 0.0 110.975 178.529 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 84.7 mt-30 66.18 18.26 10.92 Favored 'General case' 0 N--CA 1.468 0.43 0 N-CA-C 113.271 0.841 . . . . 0.0 113.271 170.357 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.531 ' HB2' HG21 ' A' ' 82' ' ' VAL . 71.0 mt -64.14 143.18 58.07 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.558 0.218 . . . . 0.0 110.89 -179.926 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 24.6 mmtm -123.15 -166.91 1.52 Allowed 'General case' 0 N--CA 1.451 -0.382 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.934 176.367 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 92.2 -157.01 23.83 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 121.002 -0.618 . . . . 0.0 111.685 -178.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 50.1 mm -107.26 117.48 53.12 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 N-CA-C 108.933 -0.766 . . . . 0.0 108.933 175.631 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . 0.651 ' HB2' ' CZ2' ' A' ' 38' ' ' TRP . 0.6 OUTLIER -135.2 102.59 5.23 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-O 121.916 0.865 . . . . 0.0 111.724 -169.4 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.544 ' HA ' ' HA ' ' A' ' 17' ' ' ASP . 38.6 mt -91.73 142.2 27.86 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 114.806 -1.088 . . . . 0.0 110.588 -175.982 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 23.2 t-80 -111.82 116.07 30.07 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-O 121.37 0.605 . . . . 0.0 110.443 179.544 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' MET . . . . . 0.734 ' SD ' ' HA ' ' A' ' 98' ' ' ARG . 10.7 ttm -69.47 -52.28 28.1 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.048 -0.978 . . . . 0.0 111.073 -178.899 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . 0.413 ' HA2' ' O ' ' A' ' 72' ' ' ASP . . . 77.86 -86.7 1.07 Allowed Glycine 0 N--CA 1.448 -0.557 0 C-N-CA 120.628 -0.796 . . . . 0.0 113.243 175.781 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 5.1 m -120.7 -5.45 9.7 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 120.843 0.354 . . . . 0.0 111.112 -176.173 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . 0.53 ' O ' ' HG3' ' A' ' 94' ' ' MET . 13.0 t70 -98.46 72.65 2.07 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 120.056 -0.657 . . . . 0.0 109.719 -177.907 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . 0.734 ' HA ' ' SD ' ' A' ' 94' ' ' MET . 0.0 OUTLIER -82.62 31.31 0.41 Allowed 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.384 -175.462 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 3.0 m -65.67 -43.45 89.31 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.489 179.837 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -71.73 -36.58 70.53 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.247 177.3 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' MET . . . . . 0.526 ' HG3' ' O ' ' A' ' 106' ' ' ILE . 15.1 ttt -56.08 -45.11 79.47 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.568 -0.742 . . . . 0.0 109.982 173.95 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . 0.48 ' HB2' ' CZ ' ' A' ' 98' ' ' ARG . 21.9 t70 -69.07 -49.56 56.29 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.242 -0.89 . . . . 0.0 110.919 179.462 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -69.01 -21.71 64.12 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.957 -0.565 . . . . 0.0 112.344 -171.512 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 25.8 m-85 -109.08 2.63 21.28 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 111.752 0.279 . . . . 0.0 111.752 -178.441 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 9.0 mp 59.39 27.27 16.34 Favored 'General case' 0 N--CA 1.466 0.334 0 O-C-N 123.47 0.481 . . . . 0.0 111.09 -177.968 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . 0.526 ' O ' ' HG3' ' A' ' 101' ' ' MET . 53.6 mt -66.7 77.85 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.271 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.71 174.084 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 61.2 t30 -109.19 -46.47 3.57 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 175.427 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -77.77 91.95 1.1 Allowed Glycine 0 N--CA 1.446 -0.639 0 CA-C-N 115.455 -0.793 . . . . 0.0 111.222 174.575 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . 0.455 HD11 ' HB2' ' A' ' 42' ' ' CYS . 2.4 pp -103.34 151.57 38.6 Favored Pre-proline 0 C--N 1.322 -0.609 0 CA-C-N 115.963 -0.118 . . . . 0.0 111.094 -178.829 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . 0.541 ' HD3' ' HB3' ' A' ' 45' ' ' CYS . 30.0 Cg_endo -68.51 153.49 89.39 Favored 'Cis proline' 0 C--N 1.349 0.573 0 C-N-CA 123.725 -1.365 . . . . 0.0 113.623 1.115 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . 0.465 ' H ' ' HB ' ' A' ' 37' ' ' VAL . 0.0 OUTLIER -113.57 144.41 42.93 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.727 -0.669 . . . . 0.0 109.519 -177.526 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . 0.639 ' HD2' ' HD3' ' A' ' 129' ' ' PRO . 0.9 OUTLIER -112.66 114.52 27.17 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.835 -177.873 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.516 ' HB ' ' HB ' ' A' ' 35' ' ' ILE . 85.6 mt -128.57 141.97 45.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.854 0.359 . . . . 0.0 110.801 -178.796 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 41.2 tp -126.48 136.45 52.64 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.172 179.097 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . 0.512 ' N ' HD12 ' A' ' 115' ' ' LEU . 0.7 OUTLIER -136.27 156.7 48.29 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.397 0.618 . . . . 0.0 110.553 -178.175 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . 0.629 ' HB3' ' HB2' ' A' ' 120' ' ' LYS . 9.6 t70 -77.96 168.2 20.28 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 114.88 -1.055 . . . . 0.0 111.351 177.722 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . 0.48 ' HA ' ' O ' ' A' ' 31' ' ' LYS . 88.1 mtt-85 -45.88 -40.55 10.15 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 124.569 1.148 . . . . 0.0 113.115 179.911 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . 0.756 ' HB2' ' HG3' ' A' ' 120' ' ' LYS . 40.2 m-20 -78.34 5.19 11.03 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.576 0.227 . . . . 0.0 111.502 -178.461 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . 0.418 ' HA3' HD13 ' A' ' 25' ' ' LEU . . . 80.63 26.6 53.71 Favored Glycine 0 N--CA 1.44 -1.09 0 N-CA-C 110.521 -1.032 . . . . 0.0 110.521 -173.268 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . 0.756 ' HG3' ' HB2' ' A' ' 118' ' ' ASP . 33.9 mtmm -94.17 103.98 16.01 Favored 'General case' 0 C--O 1.223 -0.332 0 C-N-CA 120.574 -0.45 . . . . 0.0 110.468 -173.511 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . 0.433 HD11 ' HB1' ' A' ' 10' ' ' ALA . 2.7 mp -45.0 112.72 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 115.566 -0.743 . . . . 0.0 111.651 -178.47 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' ILE . . . . . 0.417 HD12 ' HB2' ' A' ' 116' ' ' ASP . 46.3 mm -89.5 -40.1 12.83 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-N 115.216 -0.902 . . . . 0.0 109.126 176.504 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 14.8 m -142.66 117.49 9.9 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.338 -0.847 . . . . 0.0 110.497 178.237 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . 0.497 ' O ' HG12 ' A' ' 113' ' ' ILE . . . -68.29 -27.16 66.07 Favored 'General case' 0 C--N 1.334 -0.103 0 CA-C-O 121.409 0.623 . . . . 0.0 109.75 175.453 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 3.9 p-10 -136.82 109.25 7.37 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.044 -0.98 . . . . 0.0 108.646 171.103 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 126' ' ' MET . . . . . 0.509 ' HE3' ' HA ' ' A' ' 134' ' ' THR . 27.9 ttt -83.17 -87.83 0.1 Allowed 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.518 -174.728 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -137.03 -75.76 0.42 Allowed 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.574 -0.285 . . . . 0.0 111.579 -178.266 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . 0.901 ' HB3' ' HB2' ' A' ' 131' ' ' ASP . 3.6 tmm_? 177.88 139.06 0.24 Allowed Pre-proline 0 N--CA 1.453 -0.297 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 -178.128 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . 0.639 ' HD3' ' HD2' ' A' ' 112' ' ' PHE . 85.1 Cg_exo -48.65 -44.8 29.81 Favored 'Trans proline' 0 C--N 1.349 0.554 0 C-N-CA 122.869 2.379 . . . . 0.0 113.617 -176.649 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 130' ' ' SER . . . . . 0.63 ' HB3' ' NH1' ' A' ' 128' ' ' ARG . 43.8 t -107.1 26.83 9.66 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.063 0.459 . . . . 0.0 110.863 -178.719 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . 0.901 ' HB2' ' HB3' ' A' ' 128' ' ' ARG . 13.6 t70 -92.09 134.06 29.25 Favored Pre-proline 0 C--N 1.325 -0.496 0 N-CA-C 109.781 -0.451 . . . . 0.0 109.781 177.686 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . 0.612 ' O ' ' HG3' ' A' ' 136' ' ' GLU . 18.8 Cg_endo -58.22 -40.87 72.51 Favored 'Trans proline' 0 C--N 1.343 0.269 0 C-N-CA 122.748 2.299 . . . . 0.0 113.142 -178.867 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 36.0 mtmm -61.17 -27.44 68.41 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 121.048 0.451 . . . . 0.0 110.69 -175.05 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 134' ' ' THR . . . . . 0.694 HG21 ' CZ ' ' A' ' 138' ' ' PHE . 1.3 m -60.94 -57.18 13.74 Favored 'General case' 0 N--CA 1.447 -0.595 0 CA-C-N 115.73 -0.668 . . . . 0.0 109.464 173.772 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . 0.624 ' HA ' ' CD2' ' A' ' 138' ' ' PHE . . . -60.09 -42.73 95.26 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.011 -0.995 . . . . 0.0 111.696 178.599 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . 0.612 ' HG3' ' O ' ' A' ' 132' ' ' PRO . 38.6 mt-10 -54.18 -52.45 61.15 Favored 'General case' 0 CA--C 1.512 -0.516 0 CA-C-O 121.382 0.61 . . . . 0.0 110.534 179.177 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . 0.501 ' O ' ' HB3' ' A' ' 140' ' ' GLU . 5.8 tmtm? -55.24 -43.61 74.73 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-N 114.792 -1.094 . . . . 0.0 111.148 -178.747 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . 0.694 ' CZ ' HG21 ' A' ' 134' ' ' THR . 14.8 m-85 -53.68 -60.54 3.18 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.07 -0.513 . . . . 0.0 111.44 177.674 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 139' ' ' ASN . . . . . 0.448 HD21 ' N ' ' A' ' 140' ' ' GLU . 0.3 OUTLIER -72.28 -17.37 61.88 Favored 'General case' 0 C--O 1.224 -0.287 0 C-N-CA 120.423 -0.511 . . . . 0.0 111.2 -175.491 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . 0.501 ' HB3' ' O ' ' A' ' 137' ' ' LYS . 3.8 tt0 -59.21 -57.44 13.0 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.736 171.351 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . 0.444 ' HG ' ' O ' ' A' ' 138' ' ' PHE . 4.5 pp -71.53 -19.58 62.15 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.965 -177.31 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 95.7 mt . . . . . 0 C--N 1.328 -0.361 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.424 174.064 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.119 0 CA-C-O 121.107 0.48 . . . . 0.0 110.153 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -159.79 117.31 2.64 Favored 'General case' 0 N--CA 1.447 -0.585 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.66 -175.526 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' SER . . . . . 0.592 ' H ' HD22 ' A' ' 25' ' ' LEU . 47.3 m 67.04 36.01 4.37 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.235 -0.893 . . . . 0.0 112.141 171.954 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 37.5 p90 -66.06 163.87 16.53 Favored 'General case' 0 N--CA 1.463 0.208 0 N-CA-C 110.093 -0.336 . . . . 0.0 110.093 174.672 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' SER . . . . . 0.424 ' HA ' ' HA ' ' A' ' 24' ' ' SER . 16.2 t -142.36 128.0 19.16 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 120.865 0.364 . . . . 0.0 110.802 179.843 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . 0.45 ' O ' HD22 ' A' ' 92' ' ' LEU . 75.7 m-85 -141.83 159.65 58.82 Favored Pre-proline 0 C--N 1.327 -0.402 0 CA-C-N 115.874 -0.603 . . . . 0.0 109.81 178.942 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.663 ' HA ' ' O ' ' A' ' 21' ' ' LYS . 85.9 Cg_endo -88.44 134.16 2.85 Favored 'Trans proline' 0 N--CA 1.459 -0.549 0 C-N-CA 122.557 2.172 . . . . 0.0 113.996 -178.896 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . 0.488 ' HA ' ' O ' ' A' ' 91' ' ' GLN . 8.3 m-20 -69.1 168.62 13.55 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.054 171.203 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.572 HD12 HG13 ' A' ' 82' ' ' VAL . 1.9 tt -41.69 -40.36 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 O-C-N 124.563 1.164 . . . . 0.0 112.238 175.539 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 40.4 m-80 -68.54 -3.99 13.59 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.484 -177.086 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 79.14 33.63 35.57 Favored Glycine 0 N--CA 1.442 -0.931 0 N-CA-C 110.561 -1.016 . . . . 0.0 110.561 -174.389 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.663 ' O ' ' HA ' ' A' ' 16' ' ' PRO . 15.9 tppt? -110.43 126.73 54.62 Favored 'General case' 0 C--O 1.22 -0.48 0 CA-C-N 115.607 -0.297 . . . . 0.0 110.853 -173.952 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 18.8 m -84.44 106.86 16.35 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.974 -174.392 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.4 ' HB ' HD21 ' A' ' 92' ' ' LEU . 71.7 t -112.81 144.65 20.07 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 115.646 -0.706 . . . . 0.0 109.748 179.837 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' SER . . . . . 0.424 ' HA ' ' HA ' ' A' ' 14' ' ' SER . 95.7 p -113.98 162.01 16.96 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.912 -178.928 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.592 HD22 ' H ' ' A' ' 12' ' ' SER . 53.9 tp -66.98 -16.89 64.64 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.761 178.33 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -74.56 -18.95 60.51 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.825 0.345 . . . . 0.0 110.815 179.408 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -76.86 -39.1 52.33 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.629 0.728 . . . . 0.0 109.749 175.37 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.563 HD13 HG23 ' A' ' 67' ' ' VAL . 24.0 mt -84.69 -7.83 59.08 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 114.853 -1.067 . . . . 0.0 110.152 -179.402 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 32.9 tttp -73.78 130.2 39.48 Favored 'General case' 0 N--CA 1.439 -1.019 0 CA-C-N 114.847 -1.07 . . . . 0.0 110.496 -178.131 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 128.2 -31.14 3.72 Favored Glycine 0 N--CA 1.445 -0.747 0 N-CA-C 110.305 -1.118 . . . . 0.0 110.305 -173.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.842 ' HD3' ' HA ' ' A' ' 63' ' ' ASP . 61.4 mttm -122.56 174.31 7.15 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.526 -0.337 . . . . 0.0 110.154 175.518 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.94 ' HB2' HG23 ' A' ' 64' ' ' ILE . 92.4 m-85 -69.16 150.97 46.93 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 110.189 -0.3 . . . . 0.0 110.189 179.767 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.532 HD12 ' HA2' ' A' ' 119' ' ' GLY . 5.3 mp -124.59 134.47 66.69 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-O 120.79 0.328 . . . . 0.0 110.619 178.945 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 60.9 t80 -118.58 114.46 22.83 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 171.677 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.494 ' HA ' ' O ' ' A' ' 67' ' ' VAL . 67.4 mt -103.13 114.32 42.4 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 CA-C-O 121.134 0.493 . . . . 0.0 110.755 -177.791 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.466 ' O ' ' HA ' ' A' ' 68' ' ' SER . 5.5 p-10 -110.98 158.43 18.79 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 115.549 -0.75 . . . . 0.0 109.365 174.394 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.415 HG13 ' CG2' ' A' ' 109' ' ' ILE . 59.7 t -102.33 130.08 52.77 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.822 0 C-N-CA 120.779 -0.368 . . . . 0.0 110.421 178.359 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' TRP . . . . . 0.619 ' CZ2' ' HB2' ' A' ' 91' ' ' GLN . 0.6 OUTLIER -122.31 134.34 54.66 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 -179.223 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.529 ' HB1' ' HB3' ' A' ' 42' ' ' CYS . . . -145.03 162.23 37.47 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.548 -179.689 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' THR . . . . . 0.75 ' HB ' ' CE3' ' A' ' 78' ' ' TRP . 8.8 t -88.05 -22.19 24.34 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.226 0.536 . . . . 0.0 110.02 175.338 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' TRP . . . . . 0.483 ' HZ2' ' HG ' ' A' ' 71' ' ' CYS . 19.0 p-90 -96.71 18.0 15.3 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.674 -0.694 . . . . 0.0 109.848 176.045 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' CYS . . . . . 0.671 ' SG ' ' HB3' ' A' ' 45' ' ' CYS . 23.9 p -76.15 -19.38 58.53 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.542 -0.754 . . . . 0.0 111.089 -177.572 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 47.65 -98.31 0.01 OUTLIER Glycine 0 C--N 1.338 0.645 0 O-C-N 124.12 0.887 . . . . 0.0 114.261 176.602 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 81.6 Cg_exo -51.19 -26.11 19.02 Favored 'Trans proline' 0 C--N 1.354 0.821 0 C-N-CA 123.623 2.882 . . . . 0.0 113.502 178.217 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . 0.671 ' HB3' ' SG ' ' A' ' 42' ' ' CYS . 42.1 t -67.33 -41.14 85.75 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.286 0.565 . . . . 0.0 110.003 174.599 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.581 ' HA ' ' HG ' ' A' ' 49' ' ' LEU . 28.6 ttt-85 -67.49 -23.19 65.45 Favored 'General case' 0 N--CA 1.44 -0.953 0 CA-C-N 115.177 -0.92 . . . . 0.0 111.901 -173.487 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -63.2 -25.93 68.78 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.727 -0.749 . . . . 0.0 111.953 179.831 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . 0.444 ' CD ' ' HE ' ' A' ' 128' ' ' ARG . 47.9 mt-10 -109.78 24.56 12.88 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 111.708 0.262 . . . . 0.0 111.708 -179.934 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.581 ' HG ' ' HA ' ' A' ' 46' ' ' ARG . 34.6 mt -59.29 -42.7 94.34 Favored Pre-proline 0 C--N 1.328 -0.369 0 C-N-CA 120.692 -0.403 . . . . 0.0 110.543 170.625 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.431 ' HD3' ' HB2' ' A' ' 49' ' ' LEU . 76.2 Cg_exo -51.94 -38.91 69.7 Favored 'Trans proline' 0 C--N 1.36 1.139 0 C-N-CA 122.02 1.813 . . . . 0.0 112.108 169.386 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -74.72 -26.76 60.03 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.146 0.498 . . . . 0.0 110.675 179.948 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 6.5 tt -67.01 -44.01 81.42 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 173.487 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . 0.587 ' HB3' ' HZ2' ' A' ' 53' ' ' LYS . 3.1 mmmp? -60.98 -42.63 98.74 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.558 176.353 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -47.76 -58.58 4.14 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.786 173.662 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.568 ' HG ' ' CZ ' ' A' ' 66' ' ' PHE . 18.0 tp -62.79 -44.24 96.68 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.538 -0.755 . . . . 0.0 110.479 179.169 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 23.7 tt0 -49.46 -60.41 2.87 Favored 'General case' 0 C--N 1.331 -0.212 0 C-N-CA 123.853 0.861 . . . . 0.0 111.876 -179.597 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 32.1 mt-10 -73.03 -35.51 66.77 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.767 -172.797 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 43.6 mtpt -68.14 -38.31 82.01 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.005 0.431 . . . . 0.0 111.609 179.714 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.618 ' HB3' HD13 ' A' ' 64' ' ' ILE . 51.7 m-85 -107.13 10.41 30.12 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.897 -175.769 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -70.45 150.3 46.35 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 109.773 -0.455 . . . . 0.0 109.773 170.478 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 68.72 38.78 86.12 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.574 178.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . 0.656 ' HB2' HG12 ' A' ' 64' ' ' ILE . 47.6 mmtm -119.67 -163.53 1.0 Allowed 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.233 0.539 . . . . 0.0 109.933 176.154 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . 0.842 ' HA ' ' HD3' ' A' ' 31' ' ' LYS . 0.6 OUTLIER -92.49 36.62 1.0 Allowed 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 115.265 -0.879 . . . . 0.0 110.127 178.165 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.94 HG23 ' HB2' ' A' ' 32' ' ' TYR . 30.4 pt -141.8 167.38 16.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.543 -174.507 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' HIS . . . . . 0.666 ' NE2' ' HB2' ' A' ' 31' ' ' LYS . 63.2 m-70 -136.45 119.03 15.93 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.172 -0.467 . . . . 0.0 109.919 177.02 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . 0.568 ' CZ ' ' HG ' ' A' ' 55' ' ' LEU . 11.8 m-85 -79.5 118.71 21.61 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 170.016 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.563 HG23 HD13 ' A' ' 28' ' ' LEU . 25.4 t -127.59 103.94 11.37 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-O 121.138 0.494 . . . . 0.0 110.707 -175.279 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' SER . . . . . 0.466 ' HA ' ' O ' ' A' ' 36' ' ' ASP . 16.1 m -88.56 129.21 35.53 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-N 115.536 -0.757 . . . . 0.0 110.039 178.613 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.482 ' CD2' ' HB2' ' A' ' 92' ' ' LEU . 54.4 mt -114.33 132.21 56.27 Favored 'General case' 0 N--CA 1.465 0.303 0 O-C-N 122.147 -0.346 . . . . 0.0 110.287 174.988 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 1.4 t -112.34 120.33 41.35 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.17 0.51 . . . . 0.0 112.327 -174.586 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' CYS . . . . . 0.483 ' HG ' ' HZ2' ' A' ' 41' ' ' TRP . 4.7 p -88.76 18.49 4.69 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.842 177.014 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . 0.53 ' OD2' HG22 ' A' ' 40' ' ' THR . 2.1 m-20 -72.34 136.55 46.2 Favored 'General case' 0 CA--C 1.519 -0.25 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.231 -179.497 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 51.4 tptt -79.16 -37.97 37.11 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 121.228 0.537 . . . . 0.0 110.045 177.936 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . 0.507 ' HB2' ' HB1' ' A' ' 77' ' ' ALA . 0.6 OUTLIER -79.42 82.96 5.49 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.759 -179.846 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.51 ' HB2' ' CE1' ' A' ' 93' ' ' HIS . 10.0 tttt -64.38 -51.9 60.96 Favored 'General case' 0 C--N 1.323 -0.545 0 C-N-CA 120.968 -0.293 . . . . 0.0 111.396 -177.129 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.489 ' HD3' ' C ' ' A' ' 76' ' ' LYS . 3.1 tmtm? -58.98 -51.27 70.79 Favored 'General case' 0 N--CA 1.444 -0.757 0 CA-C-N 116.103 -0.499 . . . . 0.0 109.715 -174.922 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.671 ' HA ' ' ND2' ' A' ' 80' ' ' ASN . . . -56.36 -38.48 71.46 Favored 'General case' 0 C--O 1.243 0.72 0 CA-C-O 121.959 0.885 . . . . 0.0 110.926 178.455 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' TRP . . . . . 0.75 ' CE3' ' HB ' ' A' ' 40' ' ' THR . 11.7 t-105 -75.83 -43.86 43.84 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 114.963 -1.017 . . . . 0.0 111.757 -174.169 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . 0.526 ' HB2' HG13 ' A' ' 18' ' ' ILE . 4.0 pt-20 -60.49 -27.92 67.96 Favored 'General case' 0 CA--C 1.542 0.647 0 CA-C-O 121.047 0.451 . . . . 0.0 109.914 179.422 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . 0.671 ' ND2' ' HA ' ' A' ' 77' ' ' ALA . 8.9 m-20 -63.12 -52.98 60.42 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-O 120.795 0.331 . . . . 0.0 110.145 171.862 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 54.8 tpp -56.45 -47.84 78.28 Favored 'General case' 0 CA--C 1.518 -0.288 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.991 -175.83 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.577 ' HB ' ' HZ3' ' A' ' 38' ' ' TRP . 1.6 p -61.16 -34.1 58.98 Favored 'Isoleucine or valine' 0 C--O 1.237 0.401 0 CA-C-O 120.939 0.4 . . . . 0.0 110.847 178.737 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 90.5 m -64.63 -42.53 95.41 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.82 0.343 . . . . 0.0 110.467 174.896 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . 0.887 ' HB3' ' HZ3' ' A' ' 84' ' ' LYS . 0.0 OUTLIER -76.79 -37.95 54.88 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.008 -176.535 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 55.8 m-20 -83.02 -0.1 47.31 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.49 -177.95 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 27.4 mt-30 66.08 11.56 7.87 Favored 'General case' 0 N--CA 1.467 0.391 0 N-CA-C 113.69 0.996 . . . . 0.0 113.69 170.724 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.548 ' HB2' HG22 ' A' ' 82' ' ' VAL . 84.9 mt -64.63 126.32 27.51 Favored 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 110.323 -0.251 . . . . 0.0 110.323 178.582 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 21.6 mmtm -123.33 -161.98 1.01 Allowed 'General case' 0 N--CA 1.45 -0.427 0 CA-C-O 120.768 0.318 . . . . 0.0 111.799 -179.217 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 96.13 -156.58 21.34 Favored Glycine 0 N--CA 1.448 -0.535 0 N-CA-C 111.416 -0.674 . . . . 0.0 111.416 -177.579 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.521 ' O ' ' HA ' ' A' ' 67' ' ' VAL . 45.8 mm -93.29 116.46 34.49 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 174.529 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . 0.619 ' HB2' ' CZ2' ' A' ' 38' ' ' TRP . 1.9 pt20 -141.64 95.17 2.78 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-O 121.813 0.816 . . . . 0.0 111.83 -168.854 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.482 ' HB2' ' CD2' ' A' ' 69' ' ' LEU . 37.9 mt -94.43 157.11 16.16 Favored 'General case' 0 N--CA 1.442 -0.844 0 CA-C-N 114.779 -1.101 . . . . 0.0 110.421 -176.647 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' HIS . . . . . 0.51 ' CE1' ' HB2' ' A' ' 75' ' ' LYS . 21.9 t-80 -123.98 127.17 47.53 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-N 115.498 -0.774 . . . . 0.0 110.248 -177.684 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' MET . . . . . 0.622 ' HG3' ' HB2' ' A' ' 97' ' ' ASP . 30.2 ttm -81.58 -65.93 0.95 Allowed 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 114.96 -1.018 . . . . 0.0 110.764 -177.289 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 106.53 -94.18 0.92 Allowed Glycine 0 N--CA 1.446 -0.688 0 C-N-CA 120.492 -0.861 . . . . 0.0 112.664 179.772 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -117.75 0.42 11.99 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 120.81 0.338 . . . . 0.0 111.399 -176.279 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . 0.622 ' HB2' ' HG3' ' A' ' 94' ' ' MET . 3.9 m-20 -83.89 41.55 0.81 Allowed 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.008 0.433 . . . . 0.0 110.658 -174.294 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.9 -6.74 9.04 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.789 -0.641 . . . . 0.0 112.399 -172.264 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 16.7 m -70.24 -19.27 63.15 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.347 0.594 . . . . 0.0 110.17 176.625 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 52.8 t80 -74.21 -37.94 63.72 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.839 -0.618 . . . . 0.0 109.463 175.069 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' MET . . . . . 0.456 ' HE1' HG23 ' A' ' 106' ' ' ILE . 71.4 mmm -63.37 -42.74 98.88 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 173.353 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -58.7 -47.5 84.33 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 114.422 -1.263 . . . . 0.0 110.701 178.711 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -67.85 -12.76 61.29 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.721 -177.503 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 7.7 m-85 -105.64 6.82 32.36 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.021 179.918 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 3.7 mm? 62.57 25.39 15.11 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.812 -179.097 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . 0.732 HG12 ' HG3' ' A' ' 111' ' ' ARG . 58.9 mt -83.61 86.3 2.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.004 174.267 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 13.9 m120 -84.76 -51.41 6.81 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.045 177.274 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -107.73 130.67 10.23 Favored Glycine 0 N--CA 1.441 -1.019 0 CA-C-N 115.448 -0.796 . . . . 0.0 111.676 -179.933 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . 0.447 ' HB ' ' HA ' ' A' ' 110' ' ' PRO . 2.9 pp -98.98 154.95 37.09 Favored Pre-proline 0 C--N 1.319 -0.751 0 N-CA-C 110.43 -0.211 . . . . 0.0 110.43 177.988 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . 0.625 ' HG3' ' SG ' ' A' ' 45' ' ' CYS . 71.8 Cg_endo -82.89 149.5 67.82 Favored 'Cis proline' 0 N--CA 1.46 -0.449 0 C-N-CA 123.523 -1.449 . . . . 0.0 113.036 0.199 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . 0.732 ' HG3' HG12 ' A' ' 106' ' ' ILE . 0.0 OUTLIER -103.99 153.17 21.15 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.902 -0.59 . . . . 0.0 109.658 177.657 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 11.9 m-85 -119.72 127.69 53.09 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 108.89 -0.782 . . . . 0.0 108.89 -178.231 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.414 ' HB ' ' HB ' ' A' ' 35' ' ' ILE . 89.6 mt -138.26 144.8 29.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-O 120.685 0.279 . . . . 0.0 110.764 -175.769 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 28.5 tp -128.58 139.78 52.12 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 109.879 -0.415 . . . . 0.0 109.879 178.494 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . 0.658 ' HG ' ' HA ' ' A' ' 121' ' ' ILE . 2.1 mp -133.75 158.83 42.33 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 109.947 -0.39 . . . . 0.0 109.947 -177.796 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . 0.523 ' OD2' ' HB2' ' A' ' 120' ' ' LYS . 3.9 p30 -86.12 175.31 8.6 Favored 'General case' 0 CA--C 1.516 -0.349 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.023 177.73 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . 0.59 ' HA ' ' O ' ' A' ' 31' ' ' LYS . 21.9 mtp85 -58.17 -26.98 63.42 Favored 'General case' 0 N--CA 1.465 0.298 0 O-C-N 124.36 1.038 . . . . 0.0 112.384 -173.124 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -76.29 -6.91 53.56 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.529 0.68 . . . . 0.0 109.356 -179.239 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . 0.532 ' HA2' HD12 ' A' ' 33' ' ' ILE . . . 89.47 23.48 33.85 Favored Glycine 0 N--CA 1.434 -1.463 0 N-CA-C 110.319 -1.113 . . . . 0.0 110.319 -174.857 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . 0.523 ' HB2' ' OD2' ' A' ' 116' ' ' ASP . 10.1 mmmm -102.96 118.38 36.7 Favored 'General case' 0 C--O 1.223 -0.295 0 C-N-CA 119.792 -0.763 . . . . 0.0 112.045 -172.96 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . 0.658 ' HA ' ' HG ' ' A' ' 115' ' ' LEU . 3.6 mp -46.79 114.69 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.55 -0.75 . . . . 0.0 111.681 178.618 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 40.0 mm -92.68 -44.4 13.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 115.229 -0.896 . . . . 0.0 109.659 176.519 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 20.8 m -127.63 114.79 17.83 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.386 -0.824 . . . . 0.0 110.024 177.774 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -72.31 -17.72 61.84 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.074 0.464 . . . . 0.0 110.774 178.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 7.2 t30 -142.3 98.84 3.39 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.62 -0.718 . . . . 0.0 109.828 175.969 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 126' ' ' MET . . . . . 0.461 ' HG3' ' H ' ' A' ' 127' ' ' THR . 7.7 tpt -92.73 -150.49 0.27 Allowed 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 178.135 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 127' ' ' THR . . . . . 0.613 ' OG1' ' HB ' ' A' ' 134' ' ' THR . 1.3 p -133.37 131.47 40.09 Favored 'General case' 0 N--CA 1.446 -0.642 0 CA-C-O 121.593 0.711 . . . . 0.0 112.356 -175.053 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . 0.444 ' HE ' ' CD ' ' A' ' 48' ' ' GLU . 34.4 ttt85 -31.89 139.2 0.2 Allowed Pre-proline 0 N--CA 1.471 0.588 0 CA-C-N 113.753 -1.567 . . . . 0.0 113.316 170.169 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_exo -40.54 -39.96 3.09 Favored 'Trans proline' 0 C--N 1.352 0.727 0 C-N-CA 124.682 3.588 . . . . 0.0 115.338 179.028 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -72.36 -7.0 47.27 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 112.22 0.452 . . . . 0.0 112.22 -175.589 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . 0.543 ' O ' HG23 ' A' ' 134' ' ' THR . 4.5 t70 -85.18 130.09 53.28 Favored Pre-proline 0 C--N 1.324 -0.542 0 CA-C-O 120.829 0.347 . . . . 0.0 110.887 178.468 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -68.6 -22.77 37.56 Favored 'Trans proline' 0 C--N 1.343 0.239 0 C-N-CA 122.648 2.232 . . . . 0.0 113.111 -179.907 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . 0.614 ' HA ' ' HG2' ' A' ' 136' ' ' GLU . 0.8 OUTLIER -73.76 -35.38 64.99 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.114 0.483 . . . . 0.0 110.7 -175.87 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 134' ' ' THR . . . . . 0.613 ' HB ' ' OG1' ' A' ' 127' ' ' THR . 4.2 t -71.2 -40.25 71.3 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 176.048 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . 0.503 ' HA ' ' CD2' ' A' ' 138' ' ' PHE . . . -62.48 -49.12 76.63 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 115.78 -0.645 . . . . 0.0 111.462 179.162 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . 0.614 ' HG2' ' HA ' ' A' ' 133' ' ' LYS . 5.2 pt-20 -58.91 -38.22 78.43 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 121.215 0.531 . . . . 0.0 109.818 179.56 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . 0.55 ' O ' ' HG ' ' A' ' 141' ' ' LEU . 0.0 OUTLIER -65.4 -41.52 93.55 Favored 'General case' 0 N--CA 1.448 -0.547 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.014 -177.913 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . 0.503 ' CD2' ' HA ' ' A' ' 135' ' ' ALA . 15.3 m-85 -54.5 -52.48 61.81 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-O 121.012 0.434 . . . . 0.0 109.996 176.524 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 66.2 m-20 -59.37 -50.42 74.02 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.01 179.32 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -52.04 -56.25 15.55 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.242 -0.89 . . . . 0.0 112.768 179.547 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . 0.55 ' HG ' ' O ' ' A' ' 137' ' ' LYS . 4.1 pp -68.87 -21.8 64.24 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 120.816 0.341 . . . . 0.0 111.336 -175.962 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.326 -0.427 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 175.22 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.234 0.257 0 CA-C-O 121.284 0.564 . . . . 0.0 109.672 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -154.47 -34.7 0.1 Allowed 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.49 -0.777 . . . . 0.0 111.193 -178.836 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 22.8 t -169.54 153.42 5.11 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 178.521 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . 0.427 ' CD2' ' HZ ' ' A' ' 100' ' ' PHE . 52.3 p90 -154.98 152.82 30.14 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-O 120.81 0.338 . . . . 0.0 110.938 179.405 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 19.3 m -143.75 106.56 4.47 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 169.701 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . 0.785 ' HB2' HD12 ' A' ' 92' ' ' LEU . 24.8 m-85 -128.35 154.7 79.13 Favored Pre-proline 0 C--N 1.325 -0.483 0 CA-C-N 116.762 -0.199 . . . . 0.0 110.963 -174.716 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -81.89 125.43 4.79 Favored 'Trans proline' 0 CA--C 1.532 0.386 0 C-N-CA 122.6 2.2 . . . . 0.0 113.87 -178.479 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . 0.667 ' HB3' ' HB3' ' A' ' 21' ' ' LYS . 0.4 OUTLIER -69.53 163.62 25.01 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.009 -0.996 . . . . 0.0 109.918 171.212 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.629 HD13 HG11 ' A' ' 82' ' ' VAL . 0.9 OUTLIER -43.85 -44.99 1.94 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.662 0 O-C-N 123.858 0.724 . . . . 0.0 112.252 -177.883 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . 0.478 ' ND2' HG21 ' A' ' 18' ' ' ILE . 29.2 m-80 -77.24 3.81 12.0 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.495 -174.792 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 83.62 32.57 24.31 Favored Glycine 0 N--CA 1.446 -0.683 0 N-CA-C 110.662 -0.975 . . . . 0.0 110.662 -174.289 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.667 ' HB3' ' HB3' ' A' ' 17' ' ' ASP . 8.0 ttpm? -104.94 105.97 16.25 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.758 0.313 . . . . 0.0 110.796 -174.549 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 19.3 m -67.68 117.33 9.46 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.147 -179.935 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.45 HG12 HD23 ' A' ' 92' ' ' LEU . 7.1 p -117.77 143.49 28.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 115.939 -0.573 . . . . 0.0 109.475 177.396 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 60.4 p -122.48 -173.19 2.63 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.02 0.438 . . . . 0.0 110.579 -175.621 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 64.8 tp -85.91 -19.89 29.83 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.775 177.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.873 ' HA ' ' HD3' ' A' ' 29' ' ' LYS . . . -78.46 -35.23 46.97 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.568 -0.287 . . . . 0.0 111.423 -172.593 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -78.24 -11.79 59.95 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.36 0.6 . . . . 0.0 110.543 179.783 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.504 HD11 HG23 ' A' ' 67' ' ' VAL . 92.8 mt -92.78 -9.18 41.46 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.632 177.324 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.873 ' HD3' ' HA ' ' A' ' 26' ' ' ALA . 13.4 mtpp -75.98 153.59 36.44 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.266 0.555 . . . . 0.0 111.537 -179.07 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 101.7 -3.12 52.96 Favored Glycine 0 N--CA 1.45 -0.385 0 CA-C-N 115.357 -0.838 . . . . 0.0 111.747 -178.227 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.613 ' HB3' ' NE2' ' A' ' 65' ' ' HIS . 24.2 ttmm -157.97 145.89 18.62 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 -179.108 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.427 ' HB2' ' O ' ' A' ' 63' ' ' ASP . 34.6 m-85 -53.63 149.37 8.28 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-O 120.906 0.384 . . . . 0.0 111.424 -177.861 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.453 HD12 ' HA2' ' A' ' 119' ' ' GLY . 55.1 mt -125.28 138.69 53.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.554 -175.581 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 59.4 t80 -127.45 123.74 36.75 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 174.677 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.587 ' HB ' ' HB ' ' A' ' 113' ' ' ILE . 66.4 mt -109.59 123.13 65.23 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-O 121.074 0.464 . . . . 0.0 111.189 -177.028 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.426 ' HA ' ' O ' ' A' ' 111' ' ' ARG . 4.7 p-10 -116.37 159.32 22.13 Favored 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 173.216 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.49 HG11 HG21 ' A' ' 109' ' ' ILE . 60.7 t -105.22 115.47 47.13 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.839 0 C-N-CA 120.203 -0.599 . . . . 0.0 111.235 176.241 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' TRP . . . . . 0.628 ' HZ3' HG23 ' A' ' 82' ' ' VAL . 0.6 OUTLIER -98.12 132.79 43.36 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 179.358 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.574 ' HA ' ' OD1' ' A' ' 72' ' ' ASP . . . -147.05 152.99 39.47 Favored 'General case' 0 C--O 1.236 0.368 0 N-CA-C 112.268 0.47 . . . . 0.0 112.268 -173.837 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' THR . . . . . 0.526 HG23 ' SD ' ' A' ' 81' ' ' MET . 0.5 OUTLIER -83.68 -48.06 10.56 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.703 0.763 . . . . 0.0 110.182 176.561 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 17.4 p-90 -81.73 20.08 0.99 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 114.654 -1.157 . . . . 0.0 112.283 -171.309 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' CYS . . . . . 0.684 ' HB3' ' SG ' ' A' ' 45' ' ' CYS . 40.5 t -88.39 -64.03 1.21 Allowed 'General case' 0 C--N 1.322 -0.613 0 C-N-CA 120.541 -0.464 . . . . 0.0 110.38 -179.672 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 108.46 -84.1 0.36 Allowed Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.611 -0.804 . . . . 0.0 112.232 -178.736 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_exo -53.91 -22.6 24.69 Favored 'Trans proline' 0 C--N 1.352 0.736 0 C-N-CA 123.244 2.63 . . . . 0.0 112.946 177.57 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . 0.684 ' SG ' ' HB3' ' A' ' 42' ' ' CYS . 26.3 p -52.45 -31.87 36.84 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.26 177.843 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.573 ' HA ' ' HG ' ' A' ' 49' ' ' LEU . 64.9 mtp180 -72.91 -14.39 61.46 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.121 -175.617 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -84.26 -25.56 43.43 Favored Glycine 0 N--CA 1.448 -0.535 0 N-CA-C 111.244 -0.742 . . . . 0.0 111.244 174.484 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -87.12 -20.95 26.34 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.952 -0.388 . . . . 0.0 109.952 -179.186 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.672 ' HB2' ' HD3' ' A' ' 50' ' ' PRO . 79.4 mt -52.74 -50.61 80.09 Favored Pre-proline 0 CA--C 1.534 0.365 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.4 -179.225 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.672 ' HD3' ' HB2' ' A' ' 49' ' ' LEU . 52.8 Cg_exo -57.73 -34.91 98.85 Favored 'Trans proline' 0 C--N 1.355 0.875 0 C-N-CA 121.905 1.737 . . . . 0.0 112.552 173.476 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -75.48 -31.82 60.36 Favored 'General case' 0 N--CA 1.454 -0.236 0 CA-C-O 121.274 0.559 . . . . 0.0 109.889 -176.948 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 6.9 tt -68.0 -40.2 83.09 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.326 -0.852 . . . . 0.0 108.934 177.097 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . 0.862 ' HA ' ' HG2' ' A' ' 56' ' ' GLU . 12.3 mtpp -60.13 -43.99 95.27 Favored 'General case' 0 CA--C 1.517 -0.298 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.857 176.198 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.577 ' O ' ' HB2' ' A' ' 58' ' ' LYS . 23.5 mm-40 -50.2 -47.82 54.53 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.814 173.365 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 6.0 mp -66.27 -51.77 54.14 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 111.873 0.324 . . . . 0.0 111.873 179.074 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.862 ' HG2' ' HA ' ' A' ' 53' ' ' LYS . 10.2 pt-20 -58.11 -46.48 85.49 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 120.571 0.224 . . . . 0.0 111.436 -173.964 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.696 ' HG3' ' HG3' ' A' ' 56' ' ' GLU . 62.4 mt-10 -80.88 -25.53 37.55 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.819 0.342 . . . . 0.0 111.024 -174.173 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . 0.577 ' HB2' ' O ' ' A' ' 54' ' ' GLU . 16.2 ttmm -75.84 -34.53 60.09 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.343 0.592 . . . . 0.0 110.25 178.099 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.459 ' HD1' ' HG3' ' A' ' 62' ' ' LYS . 97.9 m-85 -108.63 8.54 27.09 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.488 -176.45 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -60.9 112.08 1.91 Allowed 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 170.467 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 111.27 -8.42 28.81 Favored Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 120.641 -0.79 . . . . 0.0 111.822 -177.763 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . 0.459 ' HG3' ' HD1' ' A' ' 59' ' ' TYR . 45.8 mmtm -84.65 -157.72 0.3 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.465 0.65 . . . . 0.0 109.892 176.371 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . 0.513 ' CG ' ' HG3' ' A' ' 31' ' ' LYS . 9.1 t70 -108.46 75.1 0.96 Allowed 'General case' 0 C--N 1.314 -0.955 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.026 176.387 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 17.1 tt -157.4 143.54 9.22 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.64 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.01 178.084 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' HIS . . . . . 0.613 ' NE2' ' HB3' ' A' ' 31' ' ' LYS . 93.1 m-70 -111.14 108.94 18.79 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 171.663 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 73.3 m-85 -77.05 107.75 9.63 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 173.211 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.545 HG13 HD22 ' A' ' 92' ' ' LEU . 98.1 t -120.28 104.68 15.83 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-N 115.211 -0.904 . . . . 0.0 110.843 -173.086 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' SER . . . . . 0.708 ' HB2' ' HG2' ' A' ' 91' ' ' GLN . 11.0 m -91.25 130.97 37.06 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.815 178.152 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.693 HD13 ' HB2' ' A' ' 94' ' ' MET . 62.3 tp -121.66 131.95 54.38 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 110.05 -0.352 . . . . 0.0 110.05 177.537 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' SER . . . . . 0.418 ' HB2' ' O ' ' A' ' 38' ' ' TRP . 1.7 t -112.89 120.78 42.6 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.318 0.58 . . . . 0.0 112.297 -173.013 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 9.9 m -82.71 9.61 9.27 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.58 -0.736 . . . . 0.0 111.398 175.251 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . 0.682 ' O ' ' HA2' ' A' ' 95' ' ' GLY . 2.2 m-20 -66.02 132.81 49.43 Favored 'General case' 0 CA--C 1.517 -0.307 0 CA-C-O 120.917 0.389 . . . . 0.0 111.766 -174.78 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 21.0 ttpp -76.12 -30.63 58.29 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 121.367 0.603 . . . . 0.0 110.051 175.16 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -84.62 105.32 15.34 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 108.933 -0.766 . . . . 0.0 108.933 -179.949 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 14.3 tttt -78.01 -57.25 3.9 Favored 'General case' 0 C--N 1.319 -0.735 0 C-N-CA 118.834 -1.146 . . . . 0.0 111.055 177.996 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.671 ' HA ' ' OE2' ' A' ' 79' ' ' GLU . 12.5 ttmm -55.56 -50.41 70.13 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 112.535 0.568 . . . . 0.0 112.535 -175.298 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -60.58 -33.2 72.36 Favored 'General case' 0 CA--C 1.522 -0.104 0 CA-C-O 121.545 0.688 . . . . 0.0 110.297 -178.09 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' TRP . . . . . 0.564 ' CZ2' ' CE3' ' A' ' 38' ' ' TRP . 10.9 t-105 -80.47 -43.88 20.14 Favored 'General case' 0 N--CA 1.442 -0.827 0 CA-C-N 115.236 -0.893 . . . . 0.0 110.937 -178.285 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . 0.671 ' OE2' ' HA ' ' A' ' 76' ' ' LYS . 1.3 pt-20 -64.09 -36.51 84.25 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.405 -178.953 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . 0.476 HD21 ' N ' ' A' ' 81' ' ' MET . 0.2 OUTLIER -78.11 -27.61 48.43 Favored 'General case' 0 C--N 1.332 -0.189 0 C-N-CA 120.111 -0.636 . . . . 0.0 110.636 178.652 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' MET . . . . . 0.526 ' SD ' HG23 ' A' ' 40' ' ' THR . 19.5 ttt -68.17 -50.06 56.86 Favored 'General case' 0 C--O 1.218 -0.605 0 C-N-CA 121.031 -0.268 . . . . 0.0 111.021 173.946 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.629 HG11 HD13 ' A' ' 18' ' ' ILE . 5.6 p -59.91 -31.99 48.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 C-N-CA 120.306 -0.558 . . . . 0.0 110.598 179.491 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 60.5 m -67.25 -41.47 85.53 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-O 120.952 0.406 . . . . 0.0 110.762 173.734 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 51.2 tptt -70.0 -46.19 65.65 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.912 179.738 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . 0.417 ' CG ' HH21 ' A' ' 46' ' ' ARG . 0.9 OUTLIER -73.85 -8.62 56.75 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.184 -0.916 . . . . 0.0 111.045 179.511 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 88.0 mt-30 61.56 32.82 18.61 Favored 'General case' 0 C--O 1.238 0.454 0 N-CA-C 113.328 0.862 . . . . 0.0 113.328 169.388 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.553 ' HB2' HG22 ' A' ' 82' ' ' VAL . 75.9 mt -67.86 152.37 45.68 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.632 0.253 . . . . 0.0 110.582 177.85 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . 0.435 ' HB2' ' OE1' ' A' ' 56' ' ' GLU . 28.9 mmtm -125.03 -162.46 1.1 Allowed 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.998 178.352 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 86.53 -155.29 28.01 Favored Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 120.918 -0.658 . . . . 0.0 111.944 -178.797 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 63.0 mt -109.98 110.94 34.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 176.342 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . 0.708 ' HG2' ' HB2' ' A' ' 68' ' ' SER . 21.9 mt-30 -128.53 111.57 13.39 Favored 'General case' 0 N--CA 1.441 -0.883 0 CA-C-O 121.33 0.586 . . . . 0.0 111.131 -175.541 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.785 HD12 ' HB2' ' A' ' 15' ' ' TYR . 0.4 OUTLIER -109.1 146.08 34.63 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.238 -179.0 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 18.9 t-80 -110.27 119.14 38.28 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.783 -175.585 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' MET . . . . . 0.693 ' HB2' HD13 ' A' ' 69' ' ' LEU . 26.2 ttp -83.11 -56.88 3.53 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 114.929 -1.032 . . . . 0.0 110.838 -177.343 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . 0.682 ' HA2' ' O ' ' A' ' 72' ' ' ASP . . . 86.78 -90.43 1.67 Allowed Glycine 0 N--CA 1.445 -0.703 0 C-N-CA 120.214 -0.993 . . . . 0.0 113.296 176.126 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 1.7 p -103.56 -20.24 14.09 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 112.33 0.493 . . . . 0.0 112.33 -174.125 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -93.09 54.15 2.09 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-O 121.185 0.517 . . . . 0.0 111.033 -165.627 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . 0.676 ' HA ' ' SD ' ' A' ' 94' ' ' MET . 0.0 OUTLIER -81.24 40.26 0.55 Allowed 'General case' 0 CA--C 1.516 -0.363 0 N-CA-C 112.845 0.683 . . . . 0.0 112.845 -172.243 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 7.3 t -60.9 -17.71 52.3 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 169.77 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' PHE . . . . . 0.427 ' HZ ' ' CD2' ' A' ' 13' ' ' PHE . 2.8 m-85 -72.91 -37.14 67.34 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-N 115.218 -0.901 . . . . 0.0 111.377 174.392 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' MET . . . . . 0.898 ' HA ' ' HB ' ' A' ' 106' ' ' ILE . 83.8 mtp -63.67 -48.47 77.06 Favored 'General case' 0 CA--C 1.517 -0.313 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 178.717 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -62.77 -37.87 88.37 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.824 -0.625 . . . . 0.0 111.112 177.053 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -71.68 -47.35 54.76 Favored 'General case' 0 N--CA 1.463 0.197 0 N-CA-C 112.367 0.506 . . . . 0.0 112.367 -175.071 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' TYR . . . . . 0.677 ' HB2' HG12 ' A' ' 106' ' ' ILE . 67.3 m-85 -96.95 0.48 49.0 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 112.069 0.396 . . . . 0.0 112.069 -174.491 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 9.6 mp 64.57 26.34 13.28 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.309 0.576 . . . . 0.0 110.006 -173.104 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . 0.898 ' HB ' ' HA ' ' A' ' 101' ' ' MET . 33.8 mm -55.67 108.96 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.155 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.188 172.933 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 48.5 t-20 -139.65 -66.61 0.45 Allowed 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 178.328 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -72.03 100.1 0.91 Allowed Glycine 0 N--CA 1.446 -0.699 0 C-N-CA 120.62 -0.8 . . . . 0.0 111.188 174.366 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . 0.49 HG21 HG11 ' A' ' 37' ' ' VAL . 2.7 pp -106.2 154.22 39.81 Favored Pre-proline 0 C--N 1.323 -0.587 0 C-N-CA 121.544 -0.062 . . . . 0.0 110.986 -178.74 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . 0.485 ' C ' ' HA ' ' A' ' 109' ' ' ILE . 22.7 Cg_exo -65.52 138.38 36.19 Favored 'Cis proline' 0 C--N 1.349 0.561 0 C-N-CA 124.224 -1.156 . . . . 0.0 113.392 1.016 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . 0.471 ' HD3' ' H ' ' A' ' 112' ' ' PHE . 0.0 OUTLIER -96.1 150.49 20.44 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.842 -0.617 . . . . 0.0 109.56 178.46 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . 0.562 ' HB2' ' HB2' ' A' ' 126' ' ' MET . 0.1 OUTLIER -116.35 114.36 24.2 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.279 -0.873 . . . . 0.0 110.583 -174.97 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.638 HD13 HD13 ' A' ' 106' ' ' ILE . 67.6 mt -128.86 144.46 38.04 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.354 0 CA-C-O 120.819 0.343 . . . . 0.0 111.064 -179.187 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 45.6 tp -128.71 134.08 48.35 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.064 -0.516 . . . . 0.0 109.987 176.717 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . 0.489 HD22 HG13 ' A' ' 121' ' ' ILE . 0.4 OUTLIER -135.47 152.69 51.6 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.453 0.644 . . . . 0.0 110.601 -178.959 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . 0.806 ' HB3' ' HB2' ' A' ' 120' ' ' LYS . 43.0 t0 -70.61 164.5 24.79 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 114.735 -1.12 . . . . 0.0 110.36 179.707 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . 0.407 ' HA ' ' O ' ' A' ' 31' ' ' LYS . 40.0 mtm180 -51.56 -20.99 2.19 Favored 'General case' 0 C--N 1.323 -0.578 0 C-N-CA 124.589 1.155 . . . . 0.0 113.515 -173.98 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . 0.517 ' HB3' ' HG3' ' A' ' 120' ' ' LYS . 26.6 t70 -96.91 1.9 51.02 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-O 121.471 0.653 . . . . 0.0 110.262 -175.966 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . 0.453 ' HA2' HD12 ' A' ' 33' ' ' ILE . . . 88.17 16.93 58.46 Favored Glycine 0 N--CA 1.44 -1.034 0 N-CA-C 110.504 -1.038 . . . . 0.0 110.504 -171.752 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . 0.806 ' HB2' ' HB3' ' A' ' 116' ' ' ASP . 6.2 mtpm? -85.02 102.85 13.53 Favored 'General case' 0 C--O 1.221 -0.419 0 C-N-CA 121.047 -0.261 . . . . 0.0 110.953 -175.955 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . 0.489 HG13 HD22 ' A' ' 115' ' ' LEU . 4.1 mp -45.8 115.94 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 O-C-N 123.728 0.643 . . . . 0.0 111.561 -176.546 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 122' ' ' ILE . . . . . 0.422 ' H ' ' HA ' ' A' ' 115' ' ' LEU . 56.3 mt -89.77 -39.27 12.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 178.404 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 123' ' ' SER . . . . . 0.416 ' HG ' ' C ' ' A' ' 122' ' ' ILE . 17.1 m -154.4 125.11 7.07 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.369 -0.832 . . . . 0.0 109.77 176.932 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . 0.435 ' O ' HG12 ' A' ' 113' ' ' ILE . . . -72.5 -18.74 61.64 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.33 0.586 . . . . 0.0 110.21 177.982 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 16.2 p-10 -142.03 121.69 13.41 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.402 -0.817 . . . . 0.0 110.445 176.668 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 126' ' ' MET . . . . . 0.562 ' HB2' ' HB2' ' A' ' 112' ' ' PHE . 92.3 mmm -95.65 -117.86 0.11 Allowed 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.048 174.197 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 127' ' ' THR . . . . . 0.596 ' HB ' ' CG ' ' A' ' 131' ' ' ASP . 4.0 m -132.36 -50.38 0.93 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.877 0.37 . . . . 0.0 110.768 -179.482 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . 0.96 ' HB3' ' HB3' ' A' ' 131' ' ' ASP . 46.9 ttt180 -165.76 151.18 8.05 Favored Pre-proline 0 N--CA 1.444 -0.746 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 -178.674 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 20.5 Cg_exo -64.98 7.78 0.25 Allowed 'Trans proline' 0 CA--C 1.532 0.417 0 C-N-CA 122.141 1.894 . . . . 0.0 112.797 175.589 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 130' ' ' SER . . . . . 0.443 ' H ' ' C ' ' A' ' 128' ' ' ARG . 11.4 p -158.77 21.15 0.21 Allowed 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 111.808 0.299 . . . . 0.0 111.808 -178.895 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . 0.96 ' HB3' ' HB3' ' A' ' 128' ' ' ARG . 1.2 p30 -75.97 152.76 84.64 Favored Pre-proline 0 N--CA 1.444 -0.77 0 O-C-N 122.151 -0.343 . . . . 0.0 110.412 179.7 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -65.65 -28.01 52.69 Favored 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.842 2.361 . . . . 0.0 114.042 -175.028 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . 0.79 ' HA ' ' HG2' ' A' ' 136' ' ' GLU . 36.0 mttm -79.24 -28.92 42.48 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.019 0.437 . . . . 0.0 111.041 -176.289 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 134' ' ' THR . . . . . 0.692 HG21 ' CZ ' ' A' ' 138' ' ' PHE . 96.9 m -71.89 -38.82 69.92 Favored 'General case' 0 C--N 1.317 -0.838 0 N-CA-C 109.611 -0.514 . . . . 0.0 109.611 171.48 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . 0.423 ' HA ' ' CD2' ' A' ' 138' ' ' PHE . . . -61.59 -49.8 75.16 Favored 'General case' 0 C--O 1.236 0.39 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.659 174.742 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . 0.79 ' HG2' ' HA ' ' A' ' 133' ' ' LYS . 11.9 pt-20 -63.65 -28.32 69.83 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 120.961 0.41 . . . . 0.0 110.111 179.104 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . 0.629 ' O ' ' HG ' ' A' ' 141' ' ' LEU . 0.7 OUTLIER -60.09 -48.27 82.41 Favored 'General case' 0 N--CA 1.446 -0.654 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.406 175.866 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . 0.692 ' CZ ' HG21 ' A' ' 134' ' ' THR . 8.6 m-85 -54.46 -47.12 73.31 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.012 177.566 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 85.3 m-20 -56.63 -47.71 79.12 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.262 177.147 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -60.15 -43.01 96.08 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.553 179.103 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . 0.629 ' HG ' ' O ' ' A' ' 137' ' ' LYS . 94.0 mt -57.39 -44.82 84.84 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.409 -178.646 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 10.0 mp . . . . . 0 C--N 1.327 -0.408 0 CA-C-O 120.819 0.342 . . . . 0.0 111.032 -179.667 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . 0.689 ' HA ' ' CE1' ' A' ' 100' ' ' PHE . . . . . . . . 0 N--CA 1.466 0.342 0 CA-C-O 121.042 0.449 . . . . 0.0 111.839 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.634 ' HB1' ' HE3' ' A' ' 120' ' ' LYS . . . -89.77 -6.07 56.33 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.582 -175.142 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 50.1 m -158.12 129.83 6.77 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.557 179.908 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . 0.44 ' CE2' HD11 ' A' ' 25' ' ' LEU . 52.4 p90 -157.65 159.46 37.01 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.481 -0.327 . . . . 0.0 110.295 176.451 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' SER . . . . . 0.542 ' HA ' ' HA ' ' A' ' 24' ' ' SER . 19.2 m -142.46 124.97 15.71 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.215 -0.448 . . . . 0.0 109.801 177.785 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 77.7 m-85 -139.25 154.18 71.8 Favored Pre-proline 0 C--N 1.326 -0.425 0 CA-C-O 120.516 0.198 . . . . 0.0 110.869 -178.002 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.467 ' HA ' ' O ' ' A' ' 21' ' ' LYS . 6.8 Cg_endo -85.15 127.93 3.53 Favored 'Trans proline' 0 N--CA 1.452 -0.92 0 C-N-CA 122.478 2.118 . . . . 0.0 112.928 179.437 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . 0.501 ' HA ' ' O ' ' A' ' 91' ' ' GLN . 11.7 t70 -67.18 154.65 40.74 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 169.409 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.47 HD11 ' CG1' ' A' ' 82' ' ' VAL . 5.9 tt -52.06 -33.3 16.26 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.435 0 O-C-N 123.729 0.643 . . . . 0.0 111.431 -176.338 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 40.3 m-80 -69.09 -9.68 53.88 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.027 -179.627 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 92.93 36.83 5.9 Favored Glycine 0 N--CA 1.446 -0.656 0 CA-C-N 115.802 -0.636 . . . . 0.0 111.802 -179.382 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.467 ' O ' ' HA ' ' A' ' 16' ' ' PRO . 62.3 tttm -107.04 121.79 45.18 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 120.573 -0.451 . . . . 0.0 110.617 -178.306 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 12.9 m -67.35 99.76 0.76 Allowed 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 109.651 -0.5 . . . . 0.0 109.651 173.566 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.434 HG22 ' HZ1' ' A' ' 21' ' ' LYS . 96.6 t -107.57 115.43 48.77 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-N 115.888 -0.596 . . . . 0.0 109.905 -178.77 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' SER . . . . . 0.542 ' HA ' ' HA ' ' A' ' 14' ' ' SER . 77.9 p -98.75 171.08 8.32 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 115.878 -0.601 . . . . 0.0 109.712 179.411 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.488 HD21 ' O ' ' A' ' 119' ' ' GLY . 27.0 tp -66.99 -22.27 65.92 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.087 0.47 . . . . 0.0 110.435 177.113 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -79.94 -31.48 40.01 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.092 176.593 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.413 ' OD2' HG11 ' A' ' 23' ' ' VAL . 20.6 t70 -66.69 -21.95 66.09 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 115.511 -0.768 . . . . 0.0 110.005 176.813 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.599 HD11 HG21 ' A' ' 67' ' ' VAL . 96.0 mt -105.96 3.22 28.17 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.456 -0.793 . . . . 0.0 111.779 -179.446 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.457 ' HG2' ' HA ' ' A' ' 118' ' ' ASP . 18.8 mtpt -75.08 162.01 28.91 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 121.377 0.608 . . . . 0.0 112.063 -177.6 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 113.84 -41.82 2.1 Favored Glycine 0 N--CA 1.447 -0.6 0 CA-C-N 115.332 -0.849 . . . . 0.0 111.459 179.809 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.471 ' O ' ' HA ' ' A' ' 117' ' ' ARG . 60.7 mttm -125.79 165.4 18.72 Favored 'General case' 0 N--CA 1.447 -0.623 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 177.48 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -63.68 134.82 56.08 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 177.667 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.443 HD11 ' HA2' ' A' ' 119' ' ' GLY . 5.0 mp -102.49 132.31 48.82 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.914 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 179.289 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 18.6 t80 -113.49 107.61 16.05 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 174.711 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.703 ' HA ' ' O ' ' A' ' 67' ' ' VAL . 62.6 mt -91.56 120.45 40.64 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.746 -176.251 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.476 ' O ' ' HA ' ' A' ' 68' ' ' SER . 3.8 t70 -118.13 125.96 51.28 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 177.176 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.555 ' HA ' ' O ' ' A' ' 69' ' ' LEU . 42.5 t -79.49 112.38 17.46 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.761 0 CA-C-O 121.507 0.67 . . . . 0.0 111.57 -175.572 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' TRP . . . . . 0.579 ' HZ3' ' CG2' ' A' ' 82' ' ' VAL . 0.8 OUTLIER -101.36 134.31 44.64 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.092 -0.958 . . . . 0.0 109.629 178.651 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -146.54 170.46 16.85 Favored 'General case' 0 C--N 1.321 -0.661 0 O-C-N 122.072 -0.393 . . . . 0.0 110.316 -179.592 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' THR . . . . . 0.69 ' HB ' ' CE3' ' A' ' 78' ' ' TRP . 8.8 t -91.05 1.44 57.08 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.508 0.671 . . . . 0.0 110.109 178.369 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 8.4 p-90 -126.6 17.93 7.47 Favored 'General case' 0 N--CA 1.448 -0.568 0 CA-C-N 115.613 -0.721 . . . . 0.0 111.411 -179.237 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 26.4 p -105.83 108.36 19.83 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-O 121.302 0.572 . . . . 0.0 109.973 175.764 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . 0.439 ' N ' ' HD2' ' A' ' 44' ' ' PRO . . . -72.56 -62.83 3.09 Favored Glycine 0 CA--C 1.525 0.71 0 CA-C-N 115.563 -0.744 . . . . 0.0 114.446 -174.502 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.439 ' HD2' ' N ' ' A' ' 43' ' ' GLY . 10.4 Cg_endo -52.1 -32.53 49.64 Favored 'Trans proline' 0 C--N 1.356 0.936 0 C-N-CA 123.523 2.815 . . . . 0.0 113.687 -171.364 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . 0.669 ' HB2' ' CG ' ' A' ' 110' ' ' PRO . 37.1 t -57.37 -31.17 65.51 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.657 -177.544 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.476 ' HA ' ' HG ' ' A' ' 49' ' ' LEU . 1.7 mpt_? -63.96 -43.29 96.26 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 112.478 0.548 . . . . 0.0 112.478 -172.501 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -69.17 -8.32 58.48 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.89 -0.671 . . . . 0.0 113.291 -174.82 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . 0.446 ' CD ' ' HE ' ' A' ' 128' ' ' ARG . 24.4 mt-10 -119.21 3.62 11.36 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.649 0.261 . . . . 0.0 111.14 -177.719 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.546 ' HB2' ' HD3' ' A' ' 50' ' ' PRO . 87.2 mt -53.97 -46.88 98.45 Favored Pre-proline 0 CA--C 1.534 0.354 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.451 176.584 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.546 ' HD3' ' HB2' ' A' ' 49' ' ' LEU . 75.0 Cg_exo -51.34 -44.22 44.62 Favored 'Trans proline' 0 C--N 1.358 1.07 0 C-N-CA 121.93 1.753 . . . . 0.0 111.994 172.518 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -69.92 -32.42 70.69 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.024 0.44 . . . . 0.0 110.942 -176.329 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 7.6 tt -63.94 -50.44 68.67 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.344 -178.34 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . 0.575 ' O ' ' HG3' ' A' ' 57' ' ' GLU . 24.9 pttm -71.56 -30.14 65.53 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 120.38 -0.528 . . . . 0.0 110.586 -177.398 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -68.28 -37.98 81.24 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-O 121.017 0.437 . . . . 0.0 110.795 177.028 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.46 HD21 ' O ' ' A' ' 129' ' ' PRO . 14.7 tp -63.78 -40.11 95.87 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 177.469 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -64.39 -47.65 78.41 Favored 'General case' 0 N--CA 1.443 -0.785 0 CA-C-N 115.987 -0.551 . . . . 0.0 109.934 177.931 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.575 ' HG3' ' O ' ' A' ' 53' ' ' LYS . 42.1 mt-10 -50.2 -40.1 46.09 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-O 121.199 0.523 . . . . 0.0 110.942 178.533 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . 0.795 ' HE3' ' CE2' ' A' ' 59' ' ' TYR . 34.6 ttpt -73.11 -43.03 62.28 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.532 -0.758 . . . . 0.0 112.327 -177.159 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.795 ' CE2' ' HE3' ' A' ' 58' ' ' LYS . 97.6 m-85 -102.66 -2.5 28.18 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 112.561 0.578 . . . . 0.0 112.561 -172.279 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -57.66 122.75 13.53 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.09 0.471 . . . . 0.0 111.61 179.755 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 99.58 -20.71 48.43 Favored Glycine 0 N--CA 1.445 -0.716 0 CA-C-N 115.536 -0.757 . . . . 0.0 113.263 174.036 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . 0.52 ' N ' ' HD2' ' A' ' 62' ' ' LYS . 10.8 mptt -78.69 -97.57 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 117.204 0.502 . . . . 0.0 111.657 -176.25 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . 0.419 ' HB3' HD22 ' A' ' 142' ' ' LEU . 12.3 p-10 -119.68 -3.4 10.32 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.537 -0.301 . . . . 0.0 111.73 -173.029 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.451 HG12 ' N ' ' A' ' 65' ' ' HIS . 16.7 tt -144.64 164.65 13.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-O 120.731 0.3 . . . . 0.0 111.086 -170.893 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' HIS . . . . . 0.451 ' N ' HG12 ' A' ' 64' ' ' ILE . 0.1 OUTLIER -156.83 141.36 16.74 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.111 171.497 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 74.9 m-85 -94.67 132.27 39.58 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.223 0.535 . . . . 0.0 110.983 -174.257 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.703 ' O ' ' HA ' ' A' ' 35' ' ' ILE . 56.9 t -132.52 118.57 35.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.176 -178.401 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' SER . . . . . 0.476 ' HA ' ' O ' ' A' ' 36' ' ' ASP . 49.7 m -88.38 136.51 32.95 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.542 -179.692 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.555 ' O ' ' HA ' ' A' ' 37' ' ' VAL . 64.2 tp -121.84 128.93 52.19 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 110.304 -0.258 . . . . 0.0 110.304 177.279 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' SER . . . . . 0.449 ' HB2' ' CD1' ' A' ' 38' ' ' TRP . 44.2 t -109.7 114.87 28.83 Favored 'General case' 0 C--O 1.216 -0.684 0 N-CA-C 112.102 0.408 . . . . 0.0 112.102 -172.901 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 3.3 m -84.64 21.49 1.51 Allowed 'General case' 0 C--N 1.312 -1.048 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.805 175.672 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -71.76 143.95 49.4 Favored 'General case' 0 CA--C 1.515 -0.396 0 C-N-CA 120.069 -0.652 . . . . 0.0 109.916 178.372 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . 0.95 ' HB3' ' HZ1' ' A' ' 73' ' ' LYS . 0.0 OUTLIER -96.68 -15.23 21.57 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.179 -177.277 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . 0.514 ' HB2' ' HB2' ' A' ' 77' ' ' ALA . 0.0 OUTLIER -104.2 79.84 1.65 Allowed 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 -177.736 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.536 ' HA ' ' CE1' ' A' ' 93' ' ' HIS . 21.1 tttm -51.6 -63.5 1.11 Allowed 'General case' 0 CA--C 1.513 -0.451 0 N-CA-C 112.782 0.66 . . . . 0.0 112.782 -173.544 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 26.3 tptp -46.51 -51.46 15.32 Favored 'General case' 0 C--N 1.323 -0.556 0 O-C-N 123.431 0.457 . . . . 0.0 110.726 -178.359 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.686 ' HA ' ' ND2' ' A' ' 80' ' ' ASN . . . -58.95 -42.81 90.72 Favored 'General case' 0 C--O 1.239 0.551 0 CA-C-O 121.198 0.523 . . . . 0.0 110.826 179.619 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' TRP . . . . . 0.69 ' CE3' ' HB ' ' A' ' 40' ' ' THR . 6.9 t-105 -64.35 -51.98 60.65 Favored 'General case' 0 N--CA 1.435 -1.188 0 CA-C-N 115.51 -0.768 . . . . 0.0 112.489 -179.94 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . 0.481 ' CD ' ' HE2' ' A' ' 75' ' ' LYS . 19.2 mm-40 -48.14 -40.1 22.71 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-O 120.948 0.404 . . . . 0.0 111.39 178.278 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . 0.686 ' ND2' ' HA ' ' A' ' 77' ' ' ALA . 3.6 m-20 -60.66 -50.19 74.52 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-O 120.846 0.355 . . . . 0.0 110.614 177.146 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 16.2 tpt -63.5 -37.7 88.29 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 112.164 0.431 . . . . 0.0 112.164 -175.183 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.579 ' CG2' ' HZ3' ' A' ' 38' ' ' TRP . 0.6 OUTLIER -68.58 -36.9 76.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 C-N-CA 119.965 -0.694 . . . . 0.0 111.13 179.053 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 12.7 t -78.69 -21.39 48.28 Favored 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 120.127 -0.629 . . . . 0.0 110.512 178.051 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 60.9 tttp -80.94 -53.68 6.24 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-O 120.973 0.416 . . . . 0.0 110.379 177.537 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -77.29 -20.04 55.59 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.143 -177.204 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 26.5 mt-30 65.16 78.42 0.28 Allowed 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 115.147 -0.933 . . . . 0.0 112.244 177.304 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.519 HD12 ' HA ' ' A' ' 82' ' ' VAL . 5.5 mp -104.45 118.42 36.57 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.116 -0.947 . . . . 0.0 108.61 174.101 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 72.9 mmtt -103.04 179.17 4.35 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 112.706 0.632 . . . . 0.0 112.706 -177.323 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 105.84 179.17 23.63 Favored Glycine 0 N--CA 1.45 -0.383 0 CA-C-N 115.096 -0.956 . . . . 0.0 111.172 -175.972 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.472 ' O ' ' HA ' ' A' ' 67' ' ' VAL . 63.4 mt -76.82 116.36 19.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 173.242 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . 0.555 ' HB2' ' CZ2' ' A' ' 38' ' ' TRP . 3.0 pt20 -136.81 107.42 6.54 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 121.793 0.806 . . . . 0.0 112.646 -166.075 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.43 ' CD2' ' HB ' ' A' ' 23' ' ' VAL . 21.9 mt -99.15 144.31 28.43 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.012 -0.994 . . . . 0.0 110.117 -178.618 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' HIS . . . . . 0.536 ' CE1' ' HA ' ' A' ' 75' ' ' LYS . 10.3 t-160 -115.83 131.34 56.97 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 121.69 0.757 . . . . 0.0 111.334 178.725 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' MET . . . . . 0.768 ' HG3' ' HB2' ' A' ' 97' ' ' ASP . 34.4 ttp -108.84 90.2 3.22 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 114.059 -1.428 . . . . 0.0 108.491 179.626 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . 0.513 ' O ' ' HA ' ' A' ' 73' ' ' LYS . . . -64.25 -65.53 2.96 Favored Glycine 0 C--N 1.318 -0.45 0 CA-C-N 115.319 -0.855 . . . . 0.0 113.513 -173.387 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 7.4 p -121.02 7.19 10.32 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-O 121.438 0.637 . . . . 0.0 110.393 -178.135 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . 0.768 ' HB2' ' HG3' ' A' ' 94' ' ' MET . 0.6 OUTLIER -90.56 12.73 17.86 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.32 -0.854 . . . . 0.0 110.663 -170.998 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . 0.684 ' HA ' ' SD ' ' A' ' 94' ' ' MET . 0.0 OUTLIER -72.19 14.03 0.26 Allowed 'General case' 0 C--O 1.222 -0.356 0 N-CA-C 113.068 0.766 . . . . 0.0 113.068 -170.704 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 9.8 t -70.52 -21.98 62.68 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 169.234 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' PHE . . . . . 0.689 ' CE1' ' HA ' ' A' ' 10' ' ' ALA . 88.9 t80 -79.31 -24.42 42.85 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.52 -0.764 . . . . 0.0 109.653 174.255 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' MET . . . . . 0.642 ' HB3' ' O ' ' A' ' 98' ' ' ARG . 14.8 tpt -59.69 -38.14 80.76 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.321 -0.854 . . . . 0.0 110.177 175.102 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 78.6 m-20 -65.21 -21.43 66.75 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.6 -0.727 . . . . 0.0 111.401 179.207 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -66.29 -14.52 62.13 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-O 120.592 0.234 . . . . 0.0 111.502 178.465 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' TYR . . . . . 0.431 ' C ' ' H ' ' A' ' 106' ' ' ILE . 65.5 m-85 -95.69 -13.27 24.38 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 110.195 -0.298 . . . . 0.0 110.195 176.427 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 98.3 mt 71.17 -24.36 0.17 Allowed 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 123.791 0.836 . . . . 0.0 112.864 176.811 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . 0.431 ' H ' ' C ' ' A' ' 104' ' ' TYR . 14.4 mt -98.1 93.72 3.43 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-O 120.875 0.369 . . . . 0.0 110.721 -175.871 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . 0.51 ' HA ' ' HE3' ' A' ' 101' ' ' MET . 67.0 t30 -82.62 -1.33 50.65 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.857 -178.282 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -81.46 98.46 1.89 Allowed Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.802 -0.713 . . . . 0.0 111.742 177.813 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . 0.571 ' HB ' ' HA ' ' A' ' 110' ' ' PRO . 44.8 pt -104.56 161.11 23.83 Favored Pre-proline 0 C--N 1.325 -0.475 0 CA-C-N 116.473 0.137 . . . . 0.0 111.062 -177.156 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . 0.669 ' CG ' ' HB2' ' A' ' 45' ' ' CYS . 23.4 Cg_exo -64.26 134.44 18.44 Favored 'Cis proline' 0 C--N 1.35 0.657 0 C-N-CA 123.928 -1.28 . . . . 0.0 113.178 0.89 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . 0.934 ' HE ' ' HA ' ' A' ' 111' ' ' ARG . 0.0 OUTLIER -102.28 141.78 34.57 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-N 116.246 -0.434 . . . . 0.0 109.964 174.263 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -113.93 113.74 25.25 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.301 -0.863 . . . . 0.0 108.739 -174.949 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.457 ' HB ' ' HB ' ' A' ' 35' ' ' ILE . 81.0 mt -123.97 138.16 54.58 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-O 121.249 0.547 . . . . 0.0 111.488 -173.024 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.466 ' HG ' HD13 ' A' ' 122' ' ' ILE . 58.8 tp -112.96 134.31 54.53 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 115.415 -0.811 . . . . 0.0 109.062 175.916 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . 0.477 ' N ' HD13 ' A' ' 115' ' ' LEU . 2.3 mp -131.58 147.04 52.49 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 -179.831 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 23.6 t0 -65.75 164.8 13.91 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.119 176.409 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . 0.471 ' HA ' ' O ' ' A' ' 31' ' ' LYS . 0.6 OUTLIER -53.84 -21.71 8.18 Favored 'General case' 0 N--CA 1.471 0.586 0 O-C-N 124.2 0.937 . . . . 0.0 112.376 -176.15 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . 0.497 ' HB3' ' HG2' ' A' ' 120' ' ' LYS . 6.0 t70 -88.46 6.21 38.75 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.557 0.694 . . . . 0.0 110.075 -178.974 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . 0.488 ' O ' HD21 ' A' ' 25' ' ' LEU . . . 75.82 24.78 68.76 Favored Glycine 0 N--CA 1.437 -1.26 0 N-CA-C 110.833 -0.907 . . . . 0.0 110.833 -173.859 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . 0.634 ' HE3' ' HB1' ' A' ' 11' ' ' ALA . 43.6 mmtm -99.76 106.35 18.24 Favored 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 120.317 -0.553 . . . . 0.0 111.351 -175.803 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . 0.403 ' HA ' ' HG ' ' A' ' 115' ' ' LEU . 3.0 mp -39.84 115.78 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 114.852 -1.067 . . . . 0.0 112.419 -177.648 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 122' ' ' ILE . . . . . 0.466 HD13 ' HG ' ' A' ' 114' ' ' LEU . 57.4 mt -86.88 -41.14 14.58 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 114.957 -1.02 . . . . 0.0 108.797 173.978 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 19.8 m -153.53 121.55 6.09 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.444 179.019 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -79.19 -17.03 55.66 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-O 121.488 0.661 . . . . 0.0 110.497 177.407 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 45.6 t30 -128.26 98.83 5.21 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 108.477 -0.935 . . . . 0.0 108.477 174.457 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 17.1 tpt -100.77 -97.43 0.26 Allowed 'General case' 0 C--N 1.322 -0.616 0 C-N-CA 120.696 -0.402 . . . . 0.0 111.409 -174.999 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 127' ' ' THR . . . . . 0.557 ' O ' ' HB2' ' A' ' 128' ' ' ARG . 3.4 p -152.01 -73.81 0.14 Allowed 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 111.534 0.198 . . . . 0.0 111.534 -173.42 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . 0.598 ' HD2' ' HD2' ' A' ' 129' ' ' PRO . 20.2 tpt180 157.0 136.27 0.0 OUTLIER Pre-proline 0 N--CA 1.456 -0.151 0 C-N-CA 124.196 0.999 . . . . 0.0 108.514 -172.424 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . 0.598 ' HD2' ' HD2' ' A' ' 128' ' ' ARG . 84.2 Cg_exo -49.45 -44.13 35.91 Favored 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 122.285 1.99 . . . . 0.0 112.6 172.166 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -78.6 3.03 17.34 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 112.263 0.468 . . . . 0.0 112.263 -177.54 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -89.23 123.76 66.34 Favored Pre-proline 0 C--O 1.236 0.363 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 177.291 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -55.43 -37.06 95.14 Favored 'Trans proline' 0 C--N 1.342 0.236 0 C-N-CA 123.345 2.696 . . . . 0.0 113.653 -176.069 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . 0.521 ' HA ' ' HG2' ' A' ' 136' ' ' GLU . 36.4 mtmm -61.11 -33.21 73.01 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 121.357 0.598 . . . . 0.0 110.964 -175.367 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 134' ' ' THR . . . . . 0.576 HG22 ' CZ ' ' A' ' 138' ' ' PHE . 0.2 OUTLIER -67.13 -53.05 34.26 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.885 176.843 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . 0.474 ' HA ' ' CD2' ' A' ' 138' ' ' PHE . . . -60.64 -47.3 86.84 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.41 -0.814 . . . . 0.0 111.555 -178.999 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . 0.521 ' HG2' ' HA ' ' A' ' 133' ' ' LYS . 12.9 pt-20 -63.29 -30.39 71.54 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.395 -178.205 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . 1.049 ' HA ' ' HE3' ' A' ' 137' ' ' LYS . 0.4 OUTLIER -65.43 -44.64 86.71 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-N 116.573 -0.285 . . . . 0.0 110.405 177.709 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . 0.576 ' CZ ' HG22 ' A' ' 134' ' ' THR . 7.2 m-85 -60.51 -57.58 12.14 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-O 121.056 0.455 . . . . 0.0 110.694 -179.708 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 139' ' ' ASN . . . . . 0.453 ' C ' HD21 ' A' ' 139' ' ' ASN . 0.3 OUTLIER -67.68 -18.28 64.88 Favored 'General case' 0 C--O 1.222 -0.354 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.811 -175.514 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . 0.518 ' CD ' ' HZ3' ' A' ' 137' ' ' LYS . 24.6 tt0 -66.35 -50.36 63.81 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 172.595 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . 0.465 ' HG ' ' O ' ' A' ' 137' ' ' LYS . 60.8 mt -61.17 -33.55 73.61 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.659 -179.783 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . 0.419 HD22 ' HB3' ' A' ' 63' ' ' ASP . 94.6 mt . . . . . 0 C--N 1.328 -0.365 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.255 178.896 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 0.589 0 CA-C-O 120.696 0.284 . . . . 0.0 111.161 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.41 ' HA ' ' HE3' ' A' ' 120' ' ' LYS . . . -70.55 -29.3 65.72 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.977 0.418 . . . . 0.0 110.683 176.926 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 26.6 t -164.75 83.56 0.4 Allowed 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.244 -0.889 . . . . 0.0 109.906 176.396 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 41.1 p90 -101.43 164.46 11.76 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.416 179.985 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' SER . . . . . 0.519 ' HA ' ' HA ' ' A' ' 24' ' ' SER . 20.2 m -142.24 126.03 17.05 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 109.905 -0.406 . . . . 0.0 109.905 178.258 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . 0.403 ' HA ' ' HD3' ' A' ' 16' ' ' PRO . 59.2 m-85 -141.04 144.96 37.03 Favored Pre-proline 0 C--N 1.325 -0.465 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.834 -178.602 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.447 ' HA ' ' O ' ' A' ' 21' ' ' LYS . 4.2 Cg_exo -77.68 125.65 7.64 Favored 'Trans proline' 0 N--CA 1.461 -0.412 0 C-N-CA 122.87 2.38 . . . . 0.0 113.018 -179.846 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . 0.592 ' HA ' ' HA ' ' A' ' 92' ' ' LEU . 11.2 t70 -65.37 158.42 26.63 Favored 'General case' 0 C--O 1.238 0.457 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 172.228 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.468 HG12 HG13 ' A' ' 82' ' ' VAL . 11.0 tp -55.03 -27.38 19.16 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 O-C-N 123.669 0.606 . . . . 0.0 112.248 -170.281 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . 0.539 HD22 ' HB2' ' A' ' 21' ' ' LYS . 3.3 p-10 -78.78 -13.27 59.9 Favored 'General case' 0 N--CA 1.456 -0.16 0 CA-C-O 121.2 0.524 . . . . 0.0 110.189 -178.177 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 104.36 31.61 4.57 Favored Glycine 0 N--CA 1.445 -0.732 0 CA-C-N 115.712 -0.676 . . . . 0.0 112.154 -177.29 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.539 ' HB2' HD22 ' A' ' 19' ' ' ASN . 62.3 tttt -101.9 115.03 29.64 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 120.439 -0.504 . . . . 0.0 110.805 179.354 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 14.7 m -64.83 99.69 0.35 Allowed 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 120.892 0.377 . . . . 0.0 110.157 174.579 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 92.9 t -103.3 119.16 51.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.46 -178.457 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' SER . . . . . 0.519 ' HA ' ' HA ' ' A' ' 14' ' ' SER . 88.2 p -97.45 171.51 8.34 Favored 'General case' 0 C--N 1.316 -0.878 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 177.082 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.451 ' O ' ' HB2' ' A' ' 29' ' ' LYS . 37.8 tp -63.83 -24.66 67.84 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.72 0.295 . . . . 0.0 111.128 179.709 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -75.61 -24.85 56.57 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.533 -0.303 . . . . 0.0 111.013 -179.312 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -66.33 -25.07 66.65 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-O 121.489 0.661 . . . . 0.0 110.326 179.839 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.645 HD12 HG23 ' A' ' 90' ' ' ILE . 85.7 mt -122.75 15.66 10.18 Favored 'General case' 0 N--CA 1.449 -0.52 0 CA-C-N 115.663 -0.699 . . . . 0.0 111.237 -177.145 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.49 ' HE2' ' O ' ' A' ' 118' ' ' ASP . 61.1 tttm -83.82 157.51 22.01 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.572 -175.38 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 114.72 -34.65 4.78 Favored Glycine 0 N--CA 1.449 -0.433 0 C-N-CA 120.756 -0.735 . . . . 0.0 111.73 179.383 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.743 ' HD3' ' HA ' ' A' ' 63' ' ' ASP . 63.6 mttm -120.52 170.03 9.79 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.733 -0.233 . . . . 0.0 110.683 177.67 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 87.3 m-85 -65.81 155.56 35.87 Favored 'General case' 0 C--N 1.329 -0.296 0 O-C-N 123.298 0.374 . . . . 0.0 110.272 178.52 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.559 ' HB ' ' HB2' ' A' ' 115' ' ' LEU . 70.9 mt -129.38 140.68 48.52 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-O 120.87 0.366 . . . . 0.0 111.163 -175.684 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 93.3 t80 -125.56 110.69 14.15 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 174.001 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.587 ' HA ' ' O ' ' A' ' 67' ' ' VAL . 59.2 mt -98.01 130.03 47.35 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.07 -176.346 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.445 ' O ' ' HA ' ' A' ' 68' ' ' SER . 5.7 p-10 -116.38 150.33 37.92 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.761 -0.654 . . . . 0.0 109.519 174.762 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 38.2 t -102.65 130.55 52.47 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.801 0 C-N-CA 120.487 -0.485 . . . . 0.0 110.148 174.927 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' TRP . . . . . 0.655 ' CZ2' ' HB2' ' A' ' 91' ' ' GLN . 0.6 OUTLIER -132.66 135.81 46.07 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.771 -0.65 . . . . 0.0 109.623 -173.569 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.444 ' HB3' ' SG ' ' A' ' 42' ' ' CYS . . . -147.06 161.7 40.31 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 122.257 -0.277 . . . . 0.0 111.092 178.664 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' THR . . . . . 0.695 ' HB ' ' CE3' ' A' ' 78' ' ' TRP . 3.0 t -85.52 -4.84 59.28 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.012 0.434 . . . . 0.0 110.925 178.025 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 10.2 p-90 -115.86 16.51 16.23 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.442 -176.855 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' CYS . . . . . 0.444 ' SG ' ' HB3' ' A' ' 39' ' ' ALA . 19.8 p -120.93 95.46 4.71 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.228 0.537 . . . . 0.0 110.755 178.675 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -63.39 -51.12 57.07 Favored Glycine 0 CA--C 1.527 0.805 0 CA-C-O 119.184 -0.787 . . . . 0.0 113.894 -179.778 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -54.45 -38.7 89.71 Favored 'Trans proline' 0 C--N 1.357 0.999 0 C-N-CA 122.483 2.122 . . . . 0.0 112.632 -179.111 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . 0.497 ' SG ' ' HB3' ' A' ' 110' ' ' PRO . 16.8 t -59.01 -40.86 86.25 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.303 0.573 . . . . 0.0 110.634 177.35 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.593 ' HA ' ' CD1' ' A' ' 49' ' ' LEU . 23.2 ttt180 -72.57 -3.74 26.49 Favored 'General case' 0 N--CA 1.447 -0.621 0 CA-C-N 115.309 -0.859 . . . . 0.0 111.409 -175.847 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -66.59 -48.36 63.03 Favored Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 121.055 -0.593 . . . . 0.0 112.693 179.857 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . 0.53 ' OE1' ' HB2' ' A' ' 128' ' ' ARG . 11.9 pt-20 -115.29 17.28 16.64 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 112.179 0.437 . . . . 0.0 112.179 -176.441 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.933 HD11 HD22 ' A' ' 87' ' ' LEU . 37.7 mt -52.41 -50.72 78.32 Favored Pre-proline 0 C--N 1.324 -0.54 0 N-CA-C 112.248 0.462 . . . . 0.0 112.248 175.987 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.518 ' HD2' ' N ' ' A' ' 49' ' ' LEU . 10.3 Cg_endo -55.2 -36.08 92.46 Favored 'Trans proline' 0 C--N 1.356 0.96 0 C-N-CA 122.0 1.8 . . . . 0.0 112.305 176.601 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -71.87 -23.29 61.48 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.021 0.439 . . . . 0.0 111.08 -178.707 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 6.7 tt -70.01 -44.09 70.04 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 177.532 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . 0.558 ' HD2' ' N ' ' A' ' 53' ' ' LYS . 3.2 mptp? -68.82 -40.02 79.71 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.396 177.638 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.603 ' O ' ' HG3' ' A' ' 58' ' ' LYS . 0.2 OUTLIER -48.2 -49.37 33.17 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.395 0.617 . . . . 0.0 110.72 168.568 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.595 HD21 ' HE2' ' A' ' 138' ' ' PHE . 21.7 tp -60.11 -40.03 88.27 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.151 176.97 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.583 ' HG2' ' CG ' ' A' ' 66' ' ' PHE . 44.4 mt-10 -57.67 -48.45 79.46 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.527 -0.76 . . . . 0.0 111.332 178.137 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -61.13 -36.84 80.83 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.846 0.355 . . . . 0.0 110.954 -179.703 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . 0.603 ' HG3' ' O ' ' A' ' 54' ' ' GLU . 53.1 mttm -62.47 -43.8 97.93 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-O 121.41 0.624 . . . . 0.0 110.535 177.387 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 96.1 m-85 -101.93 16.38 26.14 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.434 -175.126 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -64.7 135.57 56.02 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.118 172.749 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 80.75 9.37 86.44 Favored Glycine 0 N--CA 1.449 -0.487 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.762 178.985 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 37.7 mmtm -94.7 -151.59 0.33 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.345 0.593 . . . . 0.0 110.164 177.764 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . 0.743 ' HA ' ' HD3' ' A' ' 31' ' ' LYS . 4.0 t70 -111.82 64.89 0.62 Allowed 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.731 -0.668 . . . . 0.0 109.789 178.517 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 19.9 tt -156.53 156.28 4.68 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.446 0 CA-C-N 115.857 -0.611 . . . . 0.0 110.537 -175.035 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' HIS . . . . . 0.73 ' NE2' ' HB2' ' A' ' 31' ' ' LYS . 81.1 m-70 -134.97 115.05 13.1 Favored 'General case' 0 CA--C 1.515 -0.377 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 175.631 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . 0.583 ' CG ' ' HG2' ' A' ' 56' ' ' GLU . 71.0 m-85 -79.67 118.95 21.96 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 172.05 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.587 ' O ' ' HA ' ' A' ' 35' ' ' ILE . 40.5 t -128.94 111.36 22.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.674 -174.256 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' SER . . . . . 0.525 ' HB3' ' CD1' ' A' ' 38' ' ' TRP . 8.2 m -87.81 146.97 25.36 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.145 179.655 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.476 ' HA ' ' O ' ' A' ' 92' ' ' LEU . 7.2 mp -131.45 122.78 26.81 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-O 120.762 0.315 . . . . 0.0 110.338 171.81 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 14.7 t -110.09 114.62 28.28 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.135 0.493 . . . . 0.0 112.106 -175.782 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 64.0 m -79.19 19.09 0.59 Allowed 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.328 175.798 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -61.58 152.72 29.72 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-O 120.676 0.274 . . . . 0.0 110.79 176.428 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 21.9 pttp -108.06 -21.99 12.58 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.182 -178.351 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -100.88 67.97 1.26 Allowed 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 -179.087 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.53 ' O ' ' HG3' ' A' ' 79' ' ' GLU . 9.7 tttt -48.06 -52.78 18.76 Favored 'General case' 0 C--N 1.331 -0.237 0 O-C-N 123.782 0.676 . . . . 0.0 112.795 -168.606 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.46 ' O ' ' ND2' ' A' ' 80' ' ' ASN . 35.1 tptt -52.67 -50.03 64.06 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 123.397 0.435 . . . . 0.0 110.646 -179.067 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.556 ' HA ' ' ND2' ' A' ' 80' ' ' ASN . . . -58.15 -37.53 74.84 Favored 'General case' 0 C--O 1.245 0.834 0 CA-C-O 121.492 0.663 . . . . 0.0 110.405 -179.152 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' TRP . . . . . 0.695 ' CE3' ' HB ' ' A' ' 40' ' ' THR . 5.8 t-105 -68.41 -35.94 78.39 Favored 'General case' 0 N--CA 1.438 -1.03 0 CA-C-N 115.051 -0.977 . . . . 0.0 110.306 -178.642 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . 0.53 ' HG3' ' O ' ' A' ' 75' ' ' LYS . 55.9 mt-10 -51.07 -48.85 61.5 Favored 'General case' 0 CA--C 1.52 -0.189 0 CA-C-O 121.328 0.585 . . . . 0.0 110.965 173.435 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . 0.556 ' ND2' ' HA ' ' A' ' 77' ' ' ALA . 2.7 m-80 -64.85 -42.76 94.63 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.544 -175.504 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' MET . . . . . 0.429 ' SD ' ' HZ3' ' A' ' 78' ' ' TRP . 34.8 ttm -66.82 -47.25 72.59 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 119.892 -0.723 . . . . 0.0 111.667 -177.844 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.541 ' CG2' ' HZ3' ' A' ' 38' ' ' TRP . 4.4 p -62.18 -32.39 54.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 C-N-CA 120.49 -0.484 . . . . 0.0 110.93 179.947 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 89.3 m -70.72 -40.72 72.63 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.707 178.406 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . 0.53 ' HD3' ' O ' ' A' ' 80' ' ' ASN . 1.3 mptm? -81.78 -32.47 31.36 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.579 -0.282 . . . . 0.0 111.394 -175.866 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . 0.499 ' HB3' HD12 ' A' ' 87' ' ' LEU . 1.2 t0 -81.71 -3.77 54.54 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.438 0.637 . . . . 0.0 110.164 -179.718 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . 0.506 ' HA ' ' OE1' ' A' ' 86' ' ' GLN . 13.6 mm-40 68.88 16.77 8.81 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 115.017 -0.992 . . . . 0.0 113.444 172.757 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.933 HD22 HD11 ' A' ' 49' ' ' LEU . 10.6 mp -66.58 103.81 1.15 Allowed 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 110.326 -0.25 . . . . 0.0 110.326 173.867 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 43.6 mmtm -108.72 -178.8 3.69 Favored 'General case' 0 C--N 1.323 -0.548 0 O-C-N 122.431 -0.168 . . . . 0.0 110.698 176.168 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 122.2 -153.24 16.82 Favored Glycine 0 N--CA 1.452 -0.278 0 N-CA-C 110.762 -0.935 . . . . 0.0 110.762 -177.069 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.645 HG23 HD12 ' A' ' 28' ' ' LEU . 48.5 mm -104.67 116.03 47.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 N-CA-C 108.369 -0.974 . . . . 0.0 108.369 171.356 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . 0.655 ' HB2' ' CZ2' ' A' ' 38' ' ' TRP . 2.2 pt20 -141.41 100.19 3.73 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-O 122.099 0.952 . . . . 0.0 112.57 -165.55 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.592 ' HA ' ' HA ' ' A' ' 17' ' ' ASP . 22.9 mt -89.89 149.29 22.69 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 114.623 -1.171 . . . . 0.0 110.366 -176.93 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' HIS . . . . . 0.407 ' O ' ' HD2' ' A' ' 16' ' ' PRO . 15.0 t-80 -121.11 134.14 55.24 Favored 'General case' 0 C--N 1.31 -1.132 0 CA-C-N 115.585 -0.734 . . . . 0.0 109.402 177.619 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' MET . . . . . 0.579 ' SD ' ' HA ' ' A' ' 98' ' ' ARG . 48.3 ttm -78.98 -83.8 0.09 Allowed 'General case' 0 N--CA 1.435 -1.203 0 CA-C-N 115.302 -0.863 . . . . 0.0 110.349 -175.423 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 125.08 42.11 0.34 Allowed Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.102 -1.047 . . . . 0.0 113.045 178.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' THR . . . . . 0.438 ' C ' ' H ' ' A' ' 98' ' ' ARG . 3.7 m 78.03 0.35 2.72 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 123.021 0.528 . . . . 0.0 111.378 -179.329 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -79.3 34.75 0.26 Allowed 'General case' 0 N--CA 1.467 0.409 0 CA-C-O 121.405 0.622 . . . . 0.0 109.52 178.577 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . 0.579 ' HA ' ' SD ' ' A' ' 94' ' ' MET . 0.1 OUTLIER -76.24 20.24 0.21 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.4 -0.818 . . . . 0.0 112.773 -167.106 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 14.3 m -70.38 -24.3 62.93 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.732 0.777 . . . . 0.0 108.916 169.832 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 17.1 t80 -75.83 -23.95 55.78 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.367 -0.833 . . . . 0.0 109.506 175.354 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' MET . . . . . 0.477 ' HB3' ' O ' ' A' ' 98' ' ' ARG . 16.6 tpt -64.43 -33.77 76.63 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.482 -0.781 . . . . 0.0 109.407 175.035 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 46.1 m-20 -70.55 -22.73 62.57 Favored 'General case' 0 N--CA 1.461 0.104 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.819 177.177 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -71.73 -14.59 62.06 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.892 0.377 . . . . 0.0 111.013 -179.004 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' TYR . . . . . 0.592 ' O ' ' HG ' ' A' ' 105' ' ' LEU . 65.1 m-85 -96.47 -4.06 42.26 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 174.563 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.592 ' HG ' ' O ' ' A' ' 104' ' ' TYR . 2.9 pp 51.52 14.37 0.26 Allowed 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 125.108 1.363 . . . . 0.0 113.605 178.818 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . 0.565 ' HB ' ' CG ' ' A' ' 111' ' ' ARG . 17.2 mm -120.1 95.27 3.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 N-CA-C 109.025 -0.732 . . . . 0.0 109.025 172.665 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . 0.503 ' ND2' HH22 ' A' ' 98' ' ' ARG . 4.6 m-20 -86.32 20.49 2.37 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.903 -173.067 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -113.76 123.42 6.11 Favored Glycine 0 N--CA 1.447 -0.629 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.06 -179.626 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . 0.459 ' CG2' ' HA ' ' A' ' 110' ' ' PRO . 21.8 mt -87.85 137.45 31.69 Favored Pre-proline 0 C--N 1.325 -0.469 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 176.838 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . 0.51 ' HG2' ' CZ ' ' A' ' 112' ' ' PHE . 95.1 Cg_endo -88.96 144.2 19.84 Favored 'Cis proline' 0 N--CA 1.456 -0.681 0 C-N-CA 123.522 -1.449 . . . . 0.0 113.496 1.188 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . 0.565 ' CG ' ' HB ' ' A' ' 106' ' ' ILE . 0.0 OUTLIER -100.2 133.25 44.88 Favored 'General case' 0 N--CA 1.444 -0.761 0 N-CA-C 108.879 -0.786 . . . . 0.0 108.879 172.587 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . 0.577 ' CZ ' ' HB3' ' A' ' 128' ' ' ARG . 13.1 m-85 -102.44 124.84 48.72 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 108.52 -0.919 . . . . 0.0 108.52 179.616 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.582 ' HB ' ' HB ' ' A' ' 35' ' ' ILE . 74.7 mt -133.46 147.07 31.15 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-O 120.981 0.419 . . . . 0.0 111.135 -175.276 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 37.1 tp -127.76 135.99 50.89 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.923 -0.581 . . . . 0.0 109.725 179.108 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . 0.559 ' HB2' ' HB ' ' A' ' 33' ' ' ILE . 2.8 mp -133.81 154.87 50.7 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 179.264 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . 0.405 ' HB3' HD13 ' A' ' 122' ' ' ILE . 2.7 p30 -84.92 178.1 7.72 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.664 -179.956 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . 0.542 ' HG2' ' HA ' ' A' ' 31' ' ' LYS . 79.7 mtt180 -58.82 -20.48 50.89 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 114.538 -1.21 . . . . 0.0 112.927 -174.434 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . 0.49 ' O ' ' HE2' ' A' ' 29' ' ' LYS . 22.4 t70 -85.27 1.77 46.84 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.741 0.781 . . . . 0.0 109.137 179.506 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 77.87 25.08 63.07 Favored Glycine 0 N--CA 1.431 -1.7 0 N-CA-C 110.221 -1.151 . . . . 0.0 110.221 -173.366 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . 0.41 ' HE3' ' HA ' ' A' ' 11' ' ' ALA . 46.1 mmtm -108.45 120.8 43.47 Favored 'General case' 0 C--O 1.22 -0.451 0 C-N-CA 119.246 -0.982 . . . . 0.0 112.326 -172.369 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . 0.545 ' HA ' ' HG ' ' A' ' 115' ' ' LEU . 33.3 mt -42.62 117.83 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-N 115.079 -0.964 . . . . 0.0 113.159 -179.363 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 122' ' ' ILE . . . . . 0.405 HD13 ' HB3' ' A' ' 116' ' ' ASP . 59.4 mt -93.0 -37.13 8.18 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.828 0 CA-C-N 113.863 -1.517 . . . . 0.0 108.862 174.286 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 11.1 m -146.61 115.58 6.92 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.406 -0.815 . . . . 0.0 110.44 179.346 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -69.41 -30.47 68.44 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.52 0.676 . . . . 0.0 109.429 172.647 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . 0.422 ' HA ' ' NH1' ' A' ' 111' ' ' ARG . 11.0 t30 -111.07 95.77 5.74 Favored 'General case' 0 N--CA 1.449 -0.519 0 CA-C-N 115.245 -0.888 . . . . 0.0 109.675 175.985 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 126' ' ' MET . . . . . 0.543 ' HE3' ' HD3' ' A' ' 137' ' ' LYS . 10.5 tpt -105.98 -175.72 2.87 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 107.742 -1.206 . . . . 0.0 107.742 177.592 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 127' ' ' THR . . . . . 0.499 ' H ' ' HG3' ' A' ' 126' ' ' MET . 4.1 p -115.95 139.07 50.61 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-O 121.441 0.638 . . . . 0.0 112.387 -173.025 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . 0.577 ' HB3' ' CZ ' ' A' ' 112' ' ' PHE . 0.0 OUTLIER -41.2 146.84 0.48 Allowed Pre-proline 0 N--CA 1.468 0.452 0 CA-C-N 114.472 -1.24 . . . . 0.0 113.558 171.593 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 26.0 Cg_endo -61.85 -31.35 85.12 Favored 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 123.464 2.776 . . . . 0.0 113.293 -178.593 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 130' ' ' SER . . . . . 0.425 ' HB3' ' CZ ' ' A' ' 128' ' ' ARG . 47.1 t -74.93 -2.38 26.75 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.698 0.285 . . . . 0.0 111.164 -179.125 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . 0.463 ' HB2' ' CD ' ' A' ' 128' ' ' ARG . 14.5 t70 -91.59 129.25 43.39 Favored Pre-proline 0 C--N 1.327 -0.377 0 N-CA-C 110.059 -0.349 . . . . 0.0 110.059 176.289 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -67.85 -26.59 38.11 Favored 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 122.774 2.316 . . . . 0.0 113.414 -176.668 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . 0.552 ' O ' ' HG3' ' A' ' 137' ' ' LYS . 13.7 mmmm -70.44 -28.92 65.41 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.862 0.363 . . . . 0.0 110.238 -178.48 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 134' ' ' THR . . . . . 0.774 HG23 ' CZ ' ' A' ' 138' ' ' PHE . 2.8 m -59.04 -50.91 72.27 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.662 -0.699 . . . . 0.0 109.899 175.004 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . 0.609 ' HA ' ' CD2' ' A' ' 138' ' ' PHE . . . -56.41 -43.78 79.7 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.288 -0.869 . . . . 0.0 111.383 176.567 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 7.6 mt-10 -54.8 -49.16 71.63 Favored 'General case' 0 CA--C 1.516 -0.364 0 CA-C-O 121.316 0.579 . . . . 0.0 110.724 177.793 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . 0.552 ' HG3' ' O ' ' A' ' 133' ' ' LYS . 39.3 mtpt -55.63 -41.65 73.84 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.239 -0.892 . . . . 0.0 111.142 -179.705 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . 0.774 ' CZ ' HG23 ' A' ' 134' ' ' THR . 13.7 m-85 -61.36 -61.2 2.72 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.728 179.35 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 139' ' ' ASN . . . . . 0.514 HD21 ' N ' ' A' ' 140' ' ' GLU . 0.3 OUTLIER -69.43 -18.91 63.78 Favored 'General case' 0 C--O 1.224 -0.285 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.819 -172.711 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . 0.514 ' N ' HD21 ' A' ' 139' ' ' ASN . 36.1 tt0 -75.39 -51.07 13.98 Favored 'General case' 0 C--N 1.321 -0.64 0 C-N-CA 120.97 -0.292 . . . . 0.0 110.688 175.616 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . 0.4 ' HG ' ' O ' ' A' ' 137' ' ' LYS . 89.3 mt -66.92 -27.11 67.22 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.318 -177.562 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 96.9 mt . . . . . 0 C--N 1.325 -0.485 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.653 177.031 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . 0.556 ' HA ' ' CZ ' ' A' ' 100' ' ' PHE . . . . . . . . 0 N--CA 1.47 0.537 0 CA-C-O 120.812 0.339 . . . . 0.0 111.312 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.42 ' O ' HD21 ' A' ' 25' ' ' LEU . . . -74.89 -11.65 60.18 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.223 178.971 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' SER . . . . . 0.696 ' HA ' ' HB3' ' A' ' 25' ' ' LEU . 18.3 p -159.67 93.36 1.09 Allowed 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.857 174.427 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 38.2 p90 -97.76 159.85 14.68 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.437 174.8 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 13.2 p -134.59 115.18 13.56 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.642 0.258 . . . . 0.0 111.117 -178.908 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 65.3 m-85 -138.88 159.62 66.32 Favored Pre-proline 0 N--CA 1.465 0.288 0 CA-C-N 116.451 -0.34 . . . . 0.0 111.3 -177.487 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 79.4 Cg_endo -84.86 134.15 5.23 Favored 'Trans proline' 0 C--N 1.351 0.676 0 C-N-CA 122.683 2.255 . . . . 0.0 113.406 177.895 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . 0.514 ' HB3' ' HB3' ' A' ' 21' ' ' LYS . 7.4 t70 -80.0 160.12 26.0 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 114.826 -1.079 . . . . 0.0 109.428 174.96 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.406 HD12 HG22 ' A' ' 82' ' ' VAL . 2.2 tt -46.94 -38.19 4.0 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 O-C-N 124.151 0.907 . . . . 0.0 112.105 -178.392 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 45.0 m-80 -71.82 -13.2 61.62 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.097 0.475 . . . . 0.0 111.056 -178.389 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 95.28 34.43 6.11 Favored Glycine 0 N--CA 1.446 -0.654 0 N-CA-C 110.949 -0.86 . . . . 0.0 110.949 -175.027 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.596 ' HZ3' HG23 ' A' ' 23' ' ' VAL . 25.7 tptp -106.08 131.05 53.82 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.121 0.486 . . . . 0.0 111.012 -176.241 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 7.6 m -80.76 99.06 8.05 Favored 'General case' 0 C--N 1.314 -0.97 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 179.618 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.596 ' HB ' HD13 ' A' ' 92' ' ' LEU . 25.2 t -109.43 134.52 51.22 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-O 121.321 0.581 . . . . 0.0 109.728 178.848 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 13.7 m -122.52 166.47 14.75 Favored 'General case' 0 C--N 1.306 -1.287 0 CA-C-N 115.59 -0.732 . . . . 0.0 109.184 178.334 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.696 ' HB3' ' HA ' ' A' ' 12' ' ' SER . 19.6 tp -66.35 -22.51 66.26 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.083 0.468 . . . . 0.0 110.298 179.472 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.468 ' HA ' ' HB2' ' A' ' 29' ' ' LYS . . . -91.29 0.69 57.48 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.746 175.583 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -91.73 -33.44 15.02 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 179.415 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.672 HD12 HG21 ' A' ' 90' ' ' ILE . 76.9 mt -105.37 10.3 33.47 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.635 176.166 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.468 ' HB2' ' HA ' ' A' ' 26' ' ' ALA . 64.0 tttt -65.94 148.13 52.28 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 115.443 -0.799 . . . . 0.0 111.12 -176.825 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 121.04 -23.59 7.68 Favored Glycine 0 N--CA 1.447 -0.622 0 N-CA-C 111.185 -0.766 . . . . 0.0 111.185 -177.092 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.514 ' HD3' ' HA ' ' A' ' 63' ' ' ASP . 43.7 mttm -128.49 166.72 18.23 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 109.527 -0.546 . . . . 0.0 109.527 177.574 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.877 ' HB2' HG23 ' A' ' 64' ' ' ILE . 67.9 m-85 -66.55 144.87 56.18 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.83 0.348 . . . . 0.0 110.54 -179.644 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 47.0 mm -117.13 128.67 74.45 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-N 116.301 -0.408 . . . . 0.0 110.838 -176.31 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 84.6 t80 -110.57 121.54 45.57 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 171.774 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.702 ' HB ' ' HB ' ' A' ' 113' ' ' ILE . 54.5 mt -107.78 128.59 62.91 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-O 120.905 0.383 . . . . 0.0 110.569 -178.995 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.431 ' O ' ' HA ' ' A' ' 68' ' ' SER . 4.5 t70 -132.77 141.62 48.6 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 176.693 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.51 ' HA ' ' O ' ' A' ' 69' ' ' LEU . 39.1 t -89.5 112.82 24.94 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 C-N-CA 120.531 -0.468 . . . . 0.0 111.675 -176.289 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' TRP . . . . . 0.678 ' CZ2' ' HB2' ' A' ' 91' ' ' GLN . 0.7 OUTLIER -102.72 132.91 48.54 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.642 -0.708 . . . . 0.0 109.353 178.905 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -147.71 164.57 33.15 Favored 'General case' 0 N--CA 1.464 0.252 0 N-CA-C 111.689 0.255 . . . . 0.0 111.689 -175.03 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' THR . . . . . 0.586 HG22 ' OD2' ' A' ' 72' ' ' ASP . 4.2 t -99.22 -33.08 10.9 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-O 120.856 0.36 . . . . 0.0 110.794 172.037 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 21.2 p-90 -82.94 21.21 1.07 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.158 0.504 . . . . 0.0 110.531 -178.947 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' CYS . . . . . 0.809 ' SG ' ' HB3' ' A' ' 45' ' ' CYS . 12.7 p -87.51 -69.88 0.66 Allowed 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.35 -176.649 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . 0.439 ' N ' ' SG ' ' A' ' 42' ' ' CYS . . . 110.35 -92.36 0.68 Allowed Glycine 0 N--CA 1.448 -0.565 0 C-N-CA 121.111 -0.566 . . . . 0.0 111.949 -175.511 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.419 ' HD2' ' O ' ' A' ' 42' ' ' CYS . 12.2 Cg_endo -55.97 -29.57 74.11 Favored 'Trans proline' 0 C--N 1.349 0.602 0 C-N-CA 123.464 2.776 . . . . 0.0 112.747 -178.65 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . 0.991 ' HB2' ' HD3' ' A' ' 110' ' ' PRO . 43.6 t -54.33 -33.49 59.04 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.729 -0.669 . . . . 0.0 111.445 178.978 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.522 ' HA ' ' HG ' ' A' ' 49' ' ' LEU . 56.8 mtp180 -68.31 -18.0 64.4 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.712 0.291 . . . . 0.0 110.937 -176.396 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -82.02 -22.47 59.28 Favored Glycine 0 N--CA 1.448 -0.512 0 C-N-CA 120.713 -0.756 . . . . 0.0 111.865 177.135 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -104.63 -5.67 21.19 Favored 'General case' 0 C--N 1.329 -0.313 0 O-C-N 122.783 -0.245 . . . . 0.0 111.043 179.488 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.717 HD12 HD13 ' A' ' 87' ' ' LEU . 65.0 mt -53.64 -48.04 94.54 Favored Pre-proline 0 C--O 1.235 0.295 0 CA-C-N 116.677 -0.238 . . . . 0.0 110.975 174.401 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.681 ' O ' ' HG2' ' A' ' 54' ' ' GLU . 54.2 Cg_exo -54.57 -40.91 81.68 Favored 'Trans proline' 0 C--N 1.356 0.949 0 C-N-CA 121.824 1.682 . . . . 0.0 112.029 171.724 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -69.29 -31.56 70.14 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-O 121.26 0.552 . . . . 0.0 110.571 -176.728 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 6.6 tt -67.04 -48.25 68.89 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.364 -0.834 . . . . 0.0 109.916 -179.395 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . 0.56 ' O ' ' HG3' ' A' ' 57' ' ' GLU . 6.2 ptmm? -67.58 -32.45 73.21 Favored 'General case' 0 C--N 1.333 -0.134 0 C-N-CA 121.009 -0.276 . . . . 0.0 110.48 -179.909 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.681 ' HG2' ' O ' ' A' ' 50' ' ' PRO . 51.6 mm-40 -59.51 -47.38 85.76 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.904 0.383 . . . . 0.0 110.394 176.493 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.417 ' CD1' ' HA ' ' A' ' 129' ' ' PRO . 29.6 mt -61.9 -53.41 56.17 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.683 175.598 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.549 ' HA ' ' CD2' ' A' ' 66' ' ' PHE . 4.5 tm-20 -44.7 -59.87 2.29 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 114.872 -1.058 . . . . 0.0 112.039 179.957 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.56 ' HG3' ' O ' ' A' ' 53' ' ' LYS . 20.1 mt-10 -71.78 -35.6 70.08 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.77 0.319 . . . . 0.0 111.664 -173.082 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . 0.402 ' HD3' ' CE2' ' A' ' 59' ' ' TYR . 83.5 tttt -67.09 -39.48 86.78 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.224 0.535 . . . . 0.0 110.771 -178.875 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.438 ' HB3' HD13 ' A' ' 64' ' ' ILE . 96.9 m-85 -105.32 10.27 33.58 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.241 -176.141 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -68.19 157.41 35.47 Favored 'General case' 0 C--O 1.239 0.516 0 CA-C-O 120.795 0.331 . . . . 0.0 110.427 172.215 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 77.9 8.49 87.3 Favored Glycine 0 N--CA 1.447 -0.633 0 C-N-CA 120.98 -0.629 . . . . 0.0 112.583 178.421 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . 0.497 ' HB2' HG12 ' A' ' 64' ' ' ILE . 43.6 mmtm -98.77 -161.17 0.85 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.129 0.49 . . . . 0.0 110.029 177.99 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . 0.514 ' HA ' ' HD3' ' A' ' 31' ' ' LYS . 21.5 m-20 -91.16 32.69 1.01 Allowed 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 115.352 -0.84 . . . . 0.0 110.556 179.267 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.877 HG23 ' HB2' ' A' ' 32' ' ' TYR . 31.7 pt -141.67 165.59 18.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.129 -176.955 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 87.1 m-70 -136.44 137.72 40.73 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 175.118 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . 0.549 ' CD2' ' HA ' ' A' ' 56' ' ' GLU . 93.4 m-85 -94.69 110.11 21.98 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.624 -0.51 . . . . 0.0 109.624 174.172 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.597 ' O ' ' HA ' ' A' ' 35' ' ' ILE . 57.1 t -116.81 106.17 19.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.713 -175.581 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' SER . . . . . 0.431 ' HA ' ' O ' ' A' ' 36' ' ' ASP . 34.5 m -88.96 133.41 34.33 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.171 177.302 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.51 ' O ' ' HA ' ' A' ' 37' ' ' VAL . 79.2 mt -117.24 135.18 53.99 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.735 0.302 . . . . 0.0 110.42 176.712 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' SER . . . . . 0.426 ' O ' ' HB3' ' A' ' 94' ' ' MET . 1.4 t -113.87 120.73 41.73 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.279 -0.418 . . . . 0.0 111.63 -176.247 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 1.8 p -89.14 16.4 7.27 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.908 177.142 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . 0.586 ' OD2' HG22 ' A' ' 40' ' ' THR . 1.4 m-20 -68.23 132.75 47.69 Favored 'General case' 0 CA--C 1.518 -0.266 0 N-CA-C 109.919 -0.4 . . . . 0.0 109.919 178.923 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 38.7 ttpt -76.85 -35.37 57.55 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-O 121.18 0.514 . . . . 0.0 109.862 177.86 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . 0.517 ' HB2' ' HB1' ' A' ' 77' ' ' ALA . 0.9 OUTLIER -74.29 102.07 4.23 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.538 -0.755 . . . . 0.0 110.216 176.553 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 10.8 tttt -78.19 -55.68 5.07 Favored 'General case' 0 C--N 1.319 -0.732 0 C-N-CA 120.521 -0.472 . . . . 0.0 111.282 -178.343 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 47.4 tptt -60.43 -48.6 81.04 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.254 -174.986 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.517 ' HB1' ' HB2' ' A' ' 74' ' ' ASN . . . -58.31 -36.38 73.27 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.972 178.714 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' TRP . . . . . 0.509 ' O ' HG12 ' A' ' 82' ' ' VAL . 12.2 t-105 -76.9 -48.6 17.8 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.197 -177.714 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . 0.417 ' O ' HG13 ' A' ' 82' ' ' VAL . 4.6 pt-20 -62.15 -32.91 73.57 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-O 120.938 0.399 . . . . 0.0 110.919 -176.326 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . 0.528 HD21 ' N ' ' A' ' 81' ' ' MET . 0.2 OUTLIER -79.99 -27.3 39.64 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 119.717 -0.793 . . . . 0.0 111.149 177.866 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' MET . . . . . 0.528 ' N ' HD21 ' A' ' 80' ' ' ASN . 15.4 ttt -65.91 -48.47 71.32 Favored 'General case' 0 C--O 1.22 -0.495 0 C-N-CA 120.45 -0.5 . . . . 0.0 111.068 173.481 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.603 HG23 ' HB2' ' A' ' 87' ' ' LEU . 0.6 OUTLIER -58.88 -37.59 67.83 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 C-N-CA 120.408 -0.517 . . . . 0.0 110.518 177.832 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 58.7 m -63.33 -41.96 98.94 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.84 175.241 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 1.3 tmtp? -71.81 -45.17 62.4 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.435 -178.873 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -72.36 -10.91 60.4 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.461 -0.79 . . . . 0.0 111.627 -178.026 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 22.5 mt-30 67.67 49.27 0.98 Allowed 'General case' 0 N--CA 1.464 0.267 0 O-C-N 123.517 0.511 . . . . 0.0 111.855 173.731 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.717 HD13 HD12 ' A' ' 49' ' ' LEU . 21.2 mt -104.67 130.66 52.66 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 176.687 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . 0.584 ' C ' ' HD3' ' A' ' 88' ' ' LYS . 0.0 OUTLIER -135.53 165.51 25.35 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.8 0.333 . . . . 0.0 111.847 -179.112 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 140.3 -142.08 12.1 Favored Glycine 0 N--CA 1.449 -0.448 0 N-CA-C 109.998 -1.241 . . . . 0.0 109.998 -176.208 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.672 HG21 HD12 ' A' ' 28' ' ' LEU . 45.9 mm -108.79 113.18 43.39 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 169.792 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . 0.678 ' HB2' ' CZ2' ' A' ' 38' ' ' TRP . 1.7 pt20 -141.48 104.17 4.53 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-O 121.836 0.827 . . . . 0.0 112.207 -169.33 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.596 HD13 ' HB ' ' A' ' 23' ' ' VAL . 3.0 mm? -99.04 163.31 12.63 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 114.905 -1.043 . . . . 0.0 110.766 -177.439 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 25.2 t-80 -131.68 121.73 24.78 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.93 -174.95 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' MET . . . . . 0.426 ' HB3' ' O ' ' A' ' 70' ' ' SER . 25.3 ttm -73.07 -61.11 1.93 Allowed 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 114.901 -1.045 . . . . 0.0 110.697 -179.169 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 95.04 -101.62 2.74 Favored Glycine 0 N--CA 1.446 -0.671 0 C-N-CA 120.661 -0.78 . . . . 0.0 112.712 178.14 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 19.2 p -110.91 16.68 21.12 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 111.884 0.327 . . . . 0.0 111.884 -175.508 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -102.06 48.18 0.88 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.051 0.453 . . . . 0.0 110.452 -179.133 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -68.55 -6.82 27.54 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.516 -174.471 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 28.9 m -64.49 -30.99 72.02 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.113 0.482 . . . . 0.0 110.025 173.082 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' PHE . . . . . 0.556 ' CZ ' ' HA ' ' A' ' 10' ' ' ALA . 20.5 t80 -74.2 -36.79 64.01 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 176.442 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' MET . . . . . 0.677 ' HG3' HG13 ' A' ' 106' ' ' ILE . 12.9 ttt -59.07 -45.55 90.53 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.063 -0.971 . . . . 0.0 110.311 172.138 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -67.09 -35.14 79.15 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.985 179.733 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -61.26 -38.19 85.8 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-O 120.997 0.427 . . . . 0.0 111.167 -179.504 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 39.7 m-85 -87.44 -7.66 57.41 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.533 179.316 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 80.0 mt 61.05 30.49 19.56 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.956 -179.696 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . 0.677 HG13 ' HG3' ' A' ' 101' ' ' MET . 22.9 pt -77.79 77.79 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 121.685 0.755 . . . . 0.0 110.901 179.008 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 17.6 p-10 -88.28 -54.26 4.29 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.613 -0.721 . . . . 0.0 111.542 -177.878 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -81.53 63.22 4.39 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 121.103 -0.57 . . . . 0.0 112.379 -176.559 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . 0.587 ' HA ' ' C ' ' A' ' 110' ' ' PRO . 44.9 pt -71.43 147.46 92.72 Favored Pre-proline 0 C--N 1.324 -0.509 0 N-CA-C 110.496 -0.187 . . . . 0.0 110.496 -179.363 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . 0.991 ' HD3' ' HB2' ' A' ' 45' ' ' CYS . 24.9 Cg_endo -62.57 136.05 19.57 Favored 'Cis proline' 0 C--N 1.348 0.52 0 C-N-CA 124.013 -1.245 . . . . 0.0 113.168 2.096 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . 0.574 ' HG3' ' HA ' ' A' ' 106' ' ' ILE . 0.0 OUTLIER -113.15 141.5 46.85 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.41 -0.814 . . . . 0.0 109.764 -177.708 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . 0.49 ' O ' ' HA ' ' A' ' 125' ' ' ASN . 0.3 OUTLIER -97.95 124.99 42.65 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 114.935 -1.03 . . . . 0.0 112.116 -173.657 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.702 ' HB ' ' HB ' ' A' ' 35' ' ' ILE . 85.6 mt -136.01 148.2 27.87 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.487 0 CA-C-O 120.737 0.303 . . . . 0.0 110.8 178.442 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 33.5 tp -137.77 137.8 38.61 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 116.62 -0.264 . . . . 0.0 110.335 179.411 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . 0.535 ' N ' HD13 ' A' ' 115' ' ' LEU . 0.3 OUTLIER -135.58 156.26 49.15 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-O 121.504 0.669 . . . . 0.0 111.41 -178.723 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . 0.686 ' HB3' ' HB2' ' A' ' 120' ' ' LYS . 11.2 t70 -75.77 162.67 27.99 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 114.572 -1.194 . . . . 0.0 110.876 179.695 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . 0.471 ' HA ' ' O ' ' A' ' 31' ' ' LYS . 17.0 mtm180 -49.94 -32.67 15.39 Favored 'General case' 0 N--CA 1.47 0.555 0 O-C-N 124.513 1.133 . . . . 0.0 112.703 -177.408 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . 0.72 ' HB3' ' HG3' ' A' ' 120' ' ' LYS . 19.8 t70 -77.97 -5.58 51.67 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-O 121.256 0.55 . . . . 0.0 110.948 -178.512 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 90.55 21.77 36.28 Favored Glycine 0 N--CA 1.438 -1.191 0 N-CA-C 110.459 -1.056 . . . . 0.0 110.459 -171.138 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . 0.72 ' HG3' ' HB3' ' A' ' 118' ' ' ASP . 35.9 mttp -87.22 105.29 17.11 Favored 'General case' 0 CA--C 1.515 -0.375 0 C-N-CA 120.304 -0.558 . . . . 0.0 110.342 -176.074 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . 0.418 HG13 ' CD2' ' A' ' 115' ' ' LEU . 3.6 mp -47.23 108.61 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-O 121.147 0.498 . . . . 0.0 110.669 178.353 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 122' ' ' ILE . . . . . 0.424 ' H ' ' HA ' ' A' ' 115' ' ' LEU . 48.2 mt -83.56 -51.6 14.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 -177.952 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 15.0 m -136.01 126.3 26.51 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.189 -0.914 . . . . 0.0 109.988 -178.665 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -74.02 -18.74 60.81 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.386 0.612 . . . . 0.0 109.803 176.616 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . 0.49 ' HA ' ' O ' ' A' ' 112' ' ' PHE . 3.9 p30 -140.18 118.09 11.78 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.106 -0.952 . . . . 0.0 109.995 174.617 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 126' ' ' MET . . . . . 0.443 ' H ' ' HD1' ' A' ' 112' ' ' PHE . 15.9 tpt -110.94 -115.82 0.31 Allowed 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.686 -0.688 . . . . 0.0 109.859 179.084 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 127' ' ' THR . . . . . 0.422 ' HB ' ' HB3' ' A' ' 131' ' ' ASP . 3.3 p -145.76 139.91 26.79 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 122.379 0.272 . . . . 0.0 110.321 178.571 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 65.7 mtt180 -62.87 161.5 28.96 Favored Pre-proline 0 N--CA 1.468 0.458 0 N-CA-C 112.876 0.695 . . . . 0.0 112.876 179.924 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . 0.417 ' HA ' ' CD1' ' A' ' 55' ' ' LEU . 1.9 Cg_endo -49.47 -31.25 23.26 Favored 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 123.862 3.041 . . . . 0.0 113.165 170.499 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 22.7 t -74.08 -26.34 60.32 Favored 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 111.543 0.201 . . . . 0.0 111.543 -179.264 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . 0.422 ' HB3' ' HB ' ' A' ' 127' ' ' THR . 8.7 t70 -81.9 128.1 69.78 Favored Pre-proline 0 C--N 1.331 -0.22 0 C-N-CA 120.236 -0.585 . . . . 0.0 110.734 179.64 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . 0.422 ' HD3' ' HA ' ' A' ' 131' ' ' ASP . 31.4 Cg_exo -61.86 -25.01 77.85 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 123.233 2.622 . . . . 0.0 113.671 -178.714 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . 0.548 ' O ' ' HB2' ' A' ' 137' ' ' LYS . 45.5 mmtm -61.04 -34.81 75.45 Favored 'General case' 0 CA--C 1.516 -0.357 0 CA-C-O 120.674 0.273 . . . . 0.0 110.926 -178.288 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 134' ' ' THR . . . . . 0.63 HG23 ' CZ ' ' A' ' 138' ' ' PHE . 1.2 m -59.56 -52.58 64.96 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.99 -0.55 . . . . 0.0 109.792 177.018 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . 0.534 ' HA ' ' CD2' ' A' ' 138' ' ' PHE . . . -60.44 -47.08 87.66 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.242 -0.89 . . . . 0.0 111.891 -179.481 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . 0.532 ' HG2' ' HA ' ' A' ' 133' ' ' LYS . 12.5 pt-20 -73.14 -23.19 60.43 Favored 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 120.444 -0.502 . . . . 0.0 110.852 -176.177 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . 0.548 ' HB2' ' O ' ' A' ' 133' ' ' LYS . 4.1 tmtm? -66.24 -43.01 87.76 Favored 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 109.492 -0.558 . . . . 0.0 109.492 175.855 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . 0.63 ' CZ ' HG23 ' A' ' 134' ' ' THR . 9.9 m-85 -56.37 -50.59 71.11 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.817 -0.629 . . . . 0.0 109.484 174.459 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 85.9 m-20 -54.66 -46.42 74.0 Favored 'General case' 0 C--O 1.222 -0.383 0 CA-C-N 115.795 -0.639 . . . . 0.0 109.881 176.984 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -53.88 -48.78 69.73 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.441 179.28 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . 0.525 HD22 ' HE3' ' A' ' 137' ' ' LYS . 91.1 mt -58.48 -45.93 87.68 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.451 -177.594 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 2.9 mm? . . . . . 0 C--N 1.327 -0.399 0 CA-C-O 120.898 0.38 . . . . 0.0 111.053 -178.603 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . 0.481 ' HB2' ' HZ ' ' A' ' 100' ' ' PHE . . . . . . . . 0 C--O 1.231 0.11 0 N-CA-C 110.482 -0.192 . . . . 0.0 110.482 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . 63.05 -69.36 0.07 Allowed 'General case' 0 N--CA 1.468 0.449 0 O-C-N 124.294 0.996 . . . . 0.0 111.996 -178.875 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 50.5 m -156.23 109.72 2.7 Favored 'General case' 0 C--N 1.311 -1.095 0 CA-C-N 115.223 -0.899 . . . . 0.0 109.615 179.938 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . 0.405 ' H ' ' HB2' ' A' ' 25' ' ' LEU . 12.7 p90 -124.57 176.43 6.53 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.753 -177.514 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' SER . . . . . 0.539 ' HA ' ' HA ' ' A' ' 24' ' ' SER . 3.1 p -142.03 122.75 14.29 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.301 177.63 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 45.5 m-85 -132.09 145.67 58.38 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-O 120.819 0.342 . . . . 0.0 111.609 -177.685 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.555 ' HA ' ' O ' ' A' ' 21' ' ' LYS . 78.3 Cg_endo -81.69 128.19 5.92 Favored 'Trans proline' 0 N--CA 1.46 -0.48 0 C-N-CA 122.817 2.345 . . . . 0.0 113.931 179.692 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . 0.496 ' HB3' ' HB3' ' A' ' 21' ' ' LYS . 1.3 t70 -71.26 161.16 31.54 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 114.89 -1.05 . . . . 0.0 109.321 169.789 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.497 HG22 HG13 ' A' ' 82' ' ' VAL . 29.9 pt -46.76 -38.18 3.79 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.358 0 O-C-N 124.165 0.915 . . . . 0.0 112.849 -174.158 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 42.3 m-80 -75.88 -13.23 60.26 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-O 120.984 0.421 . . . . 0.0 111.357 -176.159 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 103.17 23.64 8.41 Favored Glycine 0 N--CA 1.449 -0.456 0 N-CA-C 111.182 -0.767 . . . . 0.0 111.182 -174.318 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.851 ' HE3' HG22 ' A' ' 23' ' ' VAL . 19.8 tptt -90.23 137.65 32.17 Favored 'General case' 0 C--O 1.219 -0.523 0 CA-C-O 121.081 0.467 . . . . 0.0 110.545 -176.063 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.495 ' N ' ' HD2' ' A' ' 21' ' ' LYS . 52.2 m -91.32 99.98 12.86 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-O 121.023 0.439 . . . . 0.0 110.163 -177.181 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.851 HG22 ' HE3' ' A' ' 21' ' ' LYS . 41.5 t -104.35 113.82 42.32 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 115.707 -0.679 . . . . 0.0 109.475 178.156 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' SER . . . . . 0.539 ' HA ' ' HA ' ' A' ' 14' ' ' SER . 7.1 m -105.98 173.34 6.35 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.249 -177.984 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.523 HD13 ' HA3' ' A' ' 119' ' ' GLY . 3.4 tm? -59.01 -45.23 91.2 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.058 179.035 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -72.08 -17.9 61.96 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.973 0.416 . . . . 0.0 111.076 -177.851 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -73.8 -28.68 61.76 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.92 -0.582 . . . . 0.0 109.815 -178.91 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.483 HD11 HG22 ' A' ' 90' ' ' ILE . 97.6 mt -111.54 -1.18 15.91 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.316 179.25 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 85.2 tttt -67.51 146.29 54.09 Favored 'General case' 0 N--CA 1.448 -0.543 0 CA-C-O 121.104 0.478 . . . . 0.0 111.497 -174.119 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 116.9 -20.5 11.64 Favored Glycine 0 N--CA 1.445 -0.746 0 N-CA-C 111.139 -0.785 . . . . 0.0 111.139 -177.309 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.473 ' HB3' ' N ' ' A' ' 64' ' ' ILE . 64.3 mttm -126.11 149.38 48.98 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.727 -0.237 . . . . 0.0 110.656 178.746 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.538 ' CE1' ' HA ' ' A' ' 116' ' ' ASP . 22.4 m-85 -61.57 119.66 9.05 Favored 'General case' 0 CA--C 1.516 -0.341 0 CA-C-O 120.75 0.31 . . . . 0.0 110.707 -179.978 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 68.6 mt -100.29 115.35 41.39 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.921 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.057 -174.673 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 81.7 t80 -92.03 120.71 32.92 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 108.669 -0.864 . . . . 0.0 108.669 170.953 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.595 ' HA ' ' O ' ' A' ' 67' ' ' VAL . 49.8 mt -107.73 122.64 62.32 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-O 120.985 0.421 . . . . 0.0 110.616 -178.802 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.505 ' O ' ' HA ' ' A' ' 68' ' ' SER . 1.9 t70 -120.06 159.47 24.72 Favored 'General case' 0 C--N 1.315 -0.926 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 174.432 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.517 HG12 HG21 ' A' ' 109' ' ' ILE . 42.9 t -102.32 114.55 42.11 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.98 0 C-N-CA 119.651 -0.819 . . . . 0.0 111.822 178.882 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' TRP . . . . . 0.633 ' CE3' ' HZ2' ' A' ' 78' ' ' TRP . 0.8 OUTLIER -102.62 134.44 45.98 Favored 'General case' 0 C--O 1.225 -0.198 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 -179.994 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.621 ' HB1' ' SG ' ' A' ' 42' ' ' CYS . . . -146.94 164.68 32.15 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 112.285 0.476 . . . . 0.0 112.285 -175.474 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' THR . . . . . 0.418 HG22 ' SD ' ' A' ' 81' ' ' MET . 1.4 m -78.64 -30.82 46.59 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.519 0.676 . . . . 0.0 110.383 178.117 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' TRP . . . . . 0.58 ' CH2' HD12 ' A' ' 109' ' ' ILE . 9.4 p-90 -106.48 21.83 16.8 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.234 -0.894 . . . . 0.0 112.116 -172.486 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' CYS . . . . . 0.621 ' SG ' ' HB1' ' A' ' 39' ' ' ALA . 25.7 p -116.99 88.98 3.01 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.477 0.656 . . . . 0.0 109.972 173.434 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -56.79 -53.97 40.05 Favored Glycine 0 CA--C 1.524 0.644 0 CA-C-N 115.486 -0.779 . . . . 0.0 113.912 -178.0 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 78.2 Cg_exo -52.41 -35.91 67.26 Favored 'Trans proline' 0 C--N 1.357 0.992 0 C-N-CA 122.818 2.345 . . . . 0.0 113.144 -178.333 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . 0.719 ' HB2' ' HD3' ' A' ' 110' ' ' PRO . 51.2 t -57.21 -30.82 64.88 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 121.041 0.448 . . . . 0.0 111.308 -177.564 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.495 ' HA ' HD12 ' A' ' 49' ' ' LEU . 41.9 mtp-105 -74.67 0.25 15.74 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.114 -0.493 . . . . 0.0 111.298 -174.162 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -84.45 -40.24 8.53 Favored Glycine 0 N--CA 1.446 -0.65 0 N-CA-C 111.539 -0.625 . . . . 0.0 111.539 174.22 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . 0.435 ' CD ' ' HE ' ' A' ' 128' ' ' ARG . 4.4 pm0 -93.92 -8.28 40.63 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 111.531 0.197 . . . . 0.0 111.531 -179.447 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.601 ' HB2' ' HD3' ' A' ' 50' ' ' PRO . 48.6 mt -54.97 -51.47 79.17 Favored Pre-proline 0 CA--C 1.535 0.374 0 N-CA-C 111.773 0.286 . . . . 0.0 111.773 177.473 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.601 ' HD3' ' HB2' ' A' ' 49' ' ' LEU . 50.8 Cg_exo -57.77 -38.08 94.21 Favored 'Trans proline' 0 C--N 1.357 1.007 0 C-N-CA 122.007 1.805 . . . . 0.0 112.077 175.574 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -70.01 -33.26 71.78 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.009 0.433 . . . . 0.0 110.775 -179.921 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 9.3 tt -66.56 -48.67 68.93 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.59 -177.759 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . 0.57 ' O ' ' HG3' ' A' ' 57' ' ' GLU . 12.4 ptmm? -62.58 -42.59 99.65 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 109.97 -0.381 . . . . 0.0 109.97 177.676 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -62.91 -34.47 77.51 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.323 179.687 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 18.2 mt -60.89 -48.02 83.74 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.931 175.42 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.447 ' HB2' ' HB2' ' A' ' 66' ' ' PHE . 7.8 tp10 -63.19 -41.78 99.23 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.572 -0.74 . . . . 0.0 109.999 178.615 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.57 ' HG3' ' O ' ' A' ' 53' ' ' LYS . 35.9 mt-10 -66.94 -21.38 65.98 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.827 177.627 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 61.7 tttp -86.21 -43.71 12.76 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.582 -179.267 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 80.3 m-85 -95.45 0.52 53.38 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 112.097 0.406 . . . . 0.0 112.097 -174.062 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -58.31 111.78 1.33 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.113 0.483 . . . . 0.0 110.829 176.349 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 150.69 -36.07 0.92 Allowed Glycine 0 N--CA 1.445 -0.718 0 N-CA-C 111.234 -0.746 . . . . 0.0 111.234 -178.597 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . 0.522 ' HB3' HD22 ' A' ' 142' ' ' LEU . 2.2 mmmm -103.12 -160.64 0.79 Allowed 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.104 0.478 . . . . 0.0 110.695 175.93 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . 0.442 ' H ' ' HB3' ' A' ' 62' ' ' LYS . 23.0 m-20 -97.92 79.15 2.61 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 116.024 -0.534 . . . . 0.0 111.884 -174.988 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.571 ' HB ' HD21 ' A' ' 142' ' ' LEU . 14.7 tt -154.03 156.93 4.81 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 115.59 -0.732 . . . . 0.0 109.613 176.725 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' HIS . . . . . 0.447 ' CE1' ' HD2' ' A' ' 31' ' ' LYS . 47.6 m-70 -143.61 142.59 31.11 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 109.893 -0.41 . . . . 0.0 109.893 175.857 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . 0.447 ' HB2' ' HB2' ' A' ' 56' ' ' GLU . 87.5 m-85 -109.88 102.93 11.65 Favored 'General case' 0 C--N 1.314 -0.96 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 172.28 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.61 HG23 ' HB ' ' A' ' 90' ' ' ILE . 51.1 t -119.68 125.98 74.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 115.134 -0.939 . . . . 0.0 110.72 -171.85 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' SER . . . . . 0.53 ' HB2' ' OE1' ' A' ' 91' ' ' GLN . 21.2 m -107.31 140.59 39.98 Favored 'General case' 0 C--N 1.312 -1.061 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.261 176.951 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 57.4 tp -117.76 133.52 55.85 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.089 179.388 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' SER . . . . . 0.429 ' O ' ' HB3' ' A' ' 94' ' ' MET . 1.6 t -109.81 116.9 32.5 Favored 'General case' 0 C--O 1.221 -0.446 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.845 -172.303 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 42.6 m -85.55 19.85 2.27 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 120.827 0.346 . . . . 0.0 111.1 177.937 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . 0.554 ' OD1' ' HA ' ' A' ' 39' ' ' ALA . 3.6 m-20 -73.95 147.83 42.72 Favored 'General case' 0 CA--C 1.517 -0.321 0 CA-C-O 121.261 0.553 . . . . 0.0 111.41 -177.228 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . 0.478 ' HB2' ' HE3' ' A' ' 73' ' ' LYS . 28.1 ttmt -95.38 -32.61 12.85 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 115.415 -0.812 . . . . 0.0 109.912 177.734 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -78.86 73.74 5.4 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.703 -0.681 . . . . 0.0 109.722 -178.319 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.431 ' HZ1' ' CD ' ' A' ' 79' ' ' GLU . 10.5 tttt -58.55 -50.8 72.46 Favored 'General case' 0 C--N 1.323 -0.575 0 C-N-CA 120.71 -0.396 . . . . 0.0 111.437 -175.116 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.441 ' HA ' ' OE1' ' A' ' 79' ' ' GLU . 1.6 tmtt? -57.49 -48.01 80.39 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.695 -177.795 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -67.38 -38.44 84.72 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-O 121.475 0.655 . . . . 0.0 110.126 -177.545 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' TRP . . . . . 0.633 ' HZ2' ' CE3' ' A' ' 38' ' ' TRP . 13.8 t-105 -71.28 -47.65 55.62 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 115.1 -0.955 . . . . 0.0 111.412 -178.348 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . 0.441 ' OE1' ' HA ' ' A' ' 76' ' ' LYS . 3.1 pt-20 -62.23 -37.04 83.87 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-O 120.631 0.253 . . . . 0.0 111.405 -175.547 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 6.0 p30 -77.45 -31.29 53.72 Favored 'General case' 0 C--N 1.332 -0.181 0 C-N-CA 119.413 -0.915 . . . . 0.0 110.301 179.581 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' MET . . . . . 0.418 ' SD ' HG22 ' A' ' 40' ' ' THR . 16.3 ttt -64.67 -46.86 80.64 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.632 -0.258 . . . . 0.0 111.497 176.661 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.584 HG22 ' HB2' ' A' ' 87' ' ' LEU . 1.0 OUTLIER -60.44 -36.74 71.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 C-N-CA 120.373 -0.531 . . . . 0.0 110.389 175.982 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 31.3 m -64.13 -38.11 89.89 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.641 177.046 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . 0.484 ' HA ' ' HD3' ' A' ' 84' ' ' LYS . 35.3 mmtm -74.03 -47.44 36.89 Favored 'General case' 0 CA--C 1.519 -0.222 0 CA-C-O 121.214 0.531 . . . . 0.0 111.385 178.213 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -72.74 -8.12 53.89 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.319 -0.855 . . . . 0.0 111.918 -178.442 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 49.9 mt-30 69.23 26.06 5.52 Favored 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 112.634 0.605 . . . . 0.0 112.634 169.91 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.584 ' HB2' HG22 ' A' ' 82' ' ' VAL . 18.8 mt -67.77 108.54 3.0 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.719 0.295 . . . . 0.0 110.393 -178.091 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . 0.404 ' HB2' ' HE2' ' A' ' 53' ' ' LYS . 39.7 mmtm -95.87 -177.44 4.03 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.388 -178.68 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 96.56 -162.57 22.44 Favored Glycine 0 N--CA 1.448 -0.556 0 N-CA-C 111.017 -0.833 . . . . 0.0 111.017 -174.632 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.61 ' HB ' HG23 ' A' ' 67' ' ' VAL . 49.4 mm -97.31 113.62 32.22 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 117.435 0.618 . . . . 0.0 109.693 176.885 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . 0.582 ' HB3' ' CZ2' ' A' ' 38' ' ' TRP . 60.4 mm-40 -123.98 106.77 10.67 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.45 -173.965 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 41.7 mt -104.67 145.61 30.09 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.095 -175.636 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' HIS . . . . . 0.527 ' O ' ' HD2' ' A' ' 16' ' ' PRO . 26.7 t-80 -113.22 139.76 48.52 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-O 121.502 0.668 . . . . 0.0 111.383 -177.929 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' MET . . . . . 0.608 ' HG3' ' HB2' ' A' ' 97' ' ' ASP . 27.1 ttm -107.72 94.18 4.94 Favored 'General case' 0 N--CA 1.442 -0.849 0 CA-C-N 114.905 -1.043 . . . . 0.0 108.629 179.075 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -68.93 78.12 0.28 Allowed Glycine 0 C--N 1.315 -0.592 0 CA-C-N 115.122 -0.945 . . . . 0.0 113.599 -178.669 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' THR . . . . . 0.44 ' C ' ' H ' ' A' ' 98' ' ' ARG . 5.3 m 71.87 5.13 5.27 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 123.148 0.579 . . . . 0.0 111.674 174.337 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . 0.608 ' HB2' ' HG3' ' A' ' 94' ' ' MET . 13.2 m-20 -79.02 32.06 0.21 Allowed 'General case' 0 N--CA 1.466 0.331 0 CA-C-O 121.036 0.446 . . . . 0.0 110.011 178.743 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . 0.592 ' HA ' ' SD ' ' A' ' 94' ' ' MET . 0.0 OUTLIER -78.59 14.06 1.41 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.129 -0.487 . . . . 0.0 112.225 -169.589 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -66.43 -28.09 68.34 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 168.082 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' PHE . . . . . 0.481 ' HZ ' ' HB2' ' A' ' 10' ' ' ALA . 55.1 t80 -70.95 -38.92 72.85 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.011 -0.995 . . . . 0.0 109.283 172.928 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' MET . . . . . 0.512 ' HG3' HG13 ' A' ' 106' ' ' ILE . 11.5 ttt -57.25 -44.9 84.29 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.296 -0.866 . . . . 0.0 110.333 172.702 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -67.61 -33.54 75.2 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.43 -0.805 . . . . 0.0 111.189 179.327 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -73.93 -39.91 63.45 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.925 0.393 . . . . 0.0 111.4 -179.589 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' TYR . . . . . 0.585 ' HB3' HG22 ' A' ' 106' ' ' ILE . 2.4 m-85 -83.64 -5.12 59.1 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.745 -178.917 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 93.8 mt 63.51 20.78 12.43 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.292 177.92 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . 0.595 HG21 ' HG3' ' A' ' 111' ' ' ARG . 39.0 pt -77.99 59.38 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 CA-C-O 121.586 0.708 . . . . 0.0 110.871 178.399 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 9.8 p30 -86.82 -38.5 16.77 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.928 179.505 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -85.12 76.72 2.18 Favored Glycine 0 N--CA 1.447 -0.6 0 N-CA-C 111.41 -0.676 . . . . 0.0 111.41 176.416 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . 0.58 HD12 ' CH2' ' A' ' 41' ' ' TRP . 23.0 pt -94.78 156.46 38.18 Favored Pre-proline 0 C--N 1.323 -0.57 0 CA-C-N 115.973 -0.114 . . . . 0.0 110.955 -177.742 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . 0.719 ' HD3' ' HB2' ' A' ' 45' ' ' CYS . 29.2 Cg_endo -61.52 147.57 51.01 Favored 'Cis proline' 0 C--N 1.349 0.583 0 C-N-CA 124.348 -1.105 . . . . 0.0 114.049 2.117 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . 0.595 ' HG3' HG21 ' A' ' 106' ' ' ILE . 0.0 OUTLIER -118.54 137.87 52.92 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 179.125 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . 0.454 ' CD1' ' HA ' ' A' ' 128' ' ' ARG . 0.9 OUTLIER -103.2 120.96 41.7 Favored 'General case' 0 C--N 1.329 -0.285 0 O-C-N 123.908 0.755 . . . . 0.0 110.066 -175.366 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 87.3 mt -136.93 147.62 27.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-O 120.656 0.265 . . . . 0.0 110.307 -179.971 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.477 ' HB2' ' HG2' ' A' ' 126' ' ' MET . 54.7 tp -129.24 137.49 51.12 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.508 0.194 . . . . 0.0 110.546 -179.936 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . 0.747 ' HG ' ' HA ' ' A' ' 121' ' ' ILE . 4.7 mp -129.56 151.12 50.52 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.127 0.489 . . . . 0.0 110.379 179.324 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . 0.538 ' HA ' ' CE1' ' A' ' 32' ' ' TYR . 22.4 t70 -70.88 164.33 25.58 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.243 -0.89 . . . . 0.0 110.205 176.564 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 76.4 mtp180 -49.77 -31.71 12.18 Favored 'General case' 0 N--CA 1.466 0.369 0 O-C-N 124.068 0.855 . . . . 0.0 111.858 179.683 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . 0.466 ' HB3' ' HG2' ' A' ' 120' ' ' LYS . 6.4 t70 -71.77 -4.29 26.86 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.164 -178.906 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . 0.523 ' HA3' HD13 ' A' ' 25' ' ' LEU . . . 79.49 30.54 44.52 Favored Glycine 0 N--CA 1.439 -1.154 0 N-CA-C 110.286 -1.126 . . . . 0.0 110.286 -171.757 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . 0.466 ' HG2' ' HB3' ' A' ' 118' ' ' ASP . 40.6 mmtm -110.65 110.43 21.11 Favored 'General case' 0 CA--C 1.516 -0.333 0 C-N-CA 120.707 -0.397 . . . . 0.0 111.536 -175.418 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . 0.747 ' HA ' ' HG ' ' A' ' 115' ' ' LEU . 3.3 mp -42.15 112.22 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 115.272 -0.876 . . . . 0.0 111.94 -179.145 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 122' ' ' ILE . . . . . 0.498 HD11 ' HB2' ' A' ' 116' ' ' ASP . 27.3 mm -87.68 -46.8 15.94 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-N 115.275 -0.875 . . . . 0.0 109.281 176.096 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 12.4 m -134.7 114.4 12.66 Favored 'General case' 0 N--CA 1.447 -0.622 0 CA-C-N 115.142 -0.935 . . . . 0.0 110.03 179.559 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -76.12 -16.04 59.97 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.77 0.795 . . . . 0.0 109.714 175.735 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 12.2 p-10 -124.17 87.62 2.76 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 114.679 -1.146 . . . . 0.0 109.728 175.264 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 126' ' ' MET . . . . . 0.654 ' HE2' HG22 ' A' ' 134' ' ' THR . 5.0 tpt -94.44 -170.18 2.21 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 108.936 -0.764 . . . . 0.0 108.936 -180.0 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 127' ' ' THR . . . . . 0.542 ' HB ' ' OG1' ' A' ' 134' ' ' THR . 3.7 m -117.7 138.98 51.64 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 110.205 -0.295 . . . . 0.0 110.205 -177.914 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . 0.454 ' HA ' ' CD1' ' A' ' 112' ' ' PHE . 49.1 ttt180 -32.32 136.63 0.25 Allowed Pre-proline 0 C--O 1.237 0.401 0 C-N-CA 124.36 1.064 . . . . 0.0 112.686 173.314 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_exo -50.56 -40.21 54.99 Favored 'Trans proline' 0 C--N 1.347 0.474 0 C-N-CA 123.731 2.954 . . . . 0.0 113.479 -178.016 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 8.8 p -84.27 18.2 2.27 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 112.219 0.452 . . . . 0.0 112.219 -175.716 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . 0.438 ' HA ' ' HD3' ' A' ' 132' ' ' PRO . 15.2 t70 -97.99 131.05 27.32 Favored Pre-proline 0 C--N 1.328 -0.328 0 C-N-CA 120.582 -0.447 . . . . 0.0 110.003 175.893 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . 0.438 ' HD3' ' HA ' ' A' ' 131' ' ' ASP . 56.5 Cg_exo -53.91 -35.43 80.09 Favored 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 123.139 2.56 . . . . 0.0 113.56 -177.988 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 35.5 mtmm -68.13 -36.48 79.77 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.046 0.451 . . . . 0.0 110.16 -178.33 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 134' ' ' THR . . . . . 0.68 HG21 ' CZ ' ' A' ' 138' ' ' PHE . 1.3 m -65.58 -48.54 71.97 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.128 178.26 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . 0.534 ' HA ' ' CD2' ' A' ' 138' ' ' PHE . . . -58.31 -46.77 85.51 Favored 'General case' 0 C--O 1.237 0.418 0 CA-C-N 115.494 -0.776 . . . . 0.0 112.099 -179.713 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -71.0 -24.33 62.36 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.832 0.348 . . . . 0.0 110.701 -178.567 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . 0.533 ' O ' ' HG ' ' A' ' 141' ' ' LEU . 44.6 tptt -65.95 -41.14 91.65 Favored 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 109.611 -0.514 . . . . 0.0 109.611 175.189 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . 0.68 ' CZ ' HG21 ' A' ' 134' ' ' THR . 12.1 m-85 -58.84 -51.87 68.16 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.504 177.726 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 19.3 p30 -69.95 -24.19 63.3 Favored 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 120.392 -0.523 . . . . 0.0 111.351 -175.35 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 51.0 tt0 -67.67 -48.51 66.42 Favored 'General case' 0 N--CA 1.45 -0.453 0 CA-C-O 120.826 0.346 . . . . 0.0 110.573 172.226 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . 0.533 ' HG ' ' O ' ' A' ' 137' ' ' LYS . 86.9 mt -64.4 -35.05 79.63 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.972 -178.163 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . 0.571 HD21 ' HB ' ' A' ' 64' ' ' ILE . 79.1 mt . . . . . 0 C--N 1.326 -0.444 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.228 -179.395 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.651 ' HB2' ' HA2' ' A' ' 6' ' ' GLY . 2.0 mpt? . . . . . 0 N--CA 1.482 1.165 0 N-CA-C 110.24 -0.281 . . . . 0.0 110.24 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 10.6 m -50.23 144.66 6.94 Favored 'General case' 0 C--O 1.24 0.569 0 N-CA-C 112.488 0.551 . . . . 0.0 112.488 -176.144 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER 73.46 -67.46 0.26 Allowed 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 115.134 -0.939 . . . . 0.0 109.43 -176.553 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 12.3 ptm180 -175.73 -38.0 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.81 -0.632 . . . . 0.0 109.375 174.407 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 3.3 m -89.97 -78.35 0.37 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.969 -0.56 . . . . 0.0 109.64 176.826 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . 0.651 ' HA2' ' HB2' ' A' ' 1' ' ' MET . . . 174.6 47.12 0.05 OUTLIER Glycine 0 N--CA 1.447 -0.599 0 N-CA-C 111.536 -0.626 . . . . 0.0 111.536 179.378 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 67.8 m-20 -104.09 137.26 19.18 Favored Pre-proline 0 C--N 1.325 -0.499 0 CA-C-O 120.61 0.243 . . . . 0.0 110.532 -175.832 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 69.8 Cg_endo -79.76 113.61 3.07 Favored 'Trans proline' 0 N--CA 1.458 -0.613 0 C-N-CA 122.698 2.266 . . . . 0.0 111.589 176.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.495 ' HB3' ' HE1' ' A' ' 100' ' ' PHE . 43.6 m -151.85 156.62 40.52 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.365 -177.477 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . 73.76 -34.97 0.3 Allowed 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 123.863 0.865 . . . . 0.0 112.458 175.847 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.401 ' H ' ' C ' ' A' ' 9' ' ' SER . . . -80.55 78.9 7.24 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 120.9 0.381 . . . . 0.0 110.95 -177.958 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 53.6 m 68.65 95.5 0.07 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.032 -0.985 . . . . 0.0 111.899 176.613 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 33.9 p90 -98.1 165.99 11.63 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.416 178.067 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' SER . . . . . 0.479 ' HA ' ' HA ' ' A' ' 24' ' ' SER . 25.0 m -142.51 120.43 12.02 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.896 -0.409 . . . . 0.0 109.896 175.664 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . 0.419 ' CE2' ' HA ' ' A' ' 94' ' ' MET . 57.8 m-85 -128.19 161.72 54.62 Favored Pre-proline 0 C--N 1.324 -0.528 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.45 -177.407 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.44 ' HD2' ' O ' ' A' ' 93' ' ' HIS . 2.7 Cg_endo -86.18 124.95 2.54 Favored 'Trans proline' 0 N--CA 1.454 -0.846 0 C-N-CA 122.476 2.117 . . . . 0.0 112.567 174.008 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . 0.477 ' HB3' ' HB3' ' A' ' 21' ' ' LYS . 4.0 t70 -69.56 159.03 34.12 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.529 -0.759 . . . . 0.0 109.122 171.971 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.759 HG13 HG13 ' A' ' 82' ' ' VAL . 18.5 mm -40.94 -49.71 0.67 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.401 0 O-C-N 124.558 1.161 . . . . 0.0 112.898 -176.585 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 4.8 p30 -69.55 -16.49 63.43 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-O 121.126 0.488 . . . . 0.0 110.974 -174.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 107.73 33.83 2.98 Favored Glycine 0 N--CA 1.444 -0.781 0 CA-C-N 115.802 -0.636 . . . . 0.0 111.663 -177.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.823 ' HZ3' HG23 ' A' ' 23' ' ' VAL . 48.2 tttm -102.32 128.99 48.64 Favored 'General case' 0 CA--C 1.515 -0.381 0 C-N-CA 120.402 -0.519 . . . . 0.0 111.188 -177.617 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 8.3 m -64.75 104.88 0.89 Allowed 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 109.527 -0.546 . . . . 0.0 109.527 170.429 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.823 HG23 ' HZ3' ' A' ' 21' ' ' LYS . 41.6 t -111.79 118.46 57.65 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 176.067 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' SER . . . . . 0.479 ' HA ' ' HA ' ' A' ' 14' ' ' SER . 89.6 p -100.48 -173.81 2.5 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.563 -175.762 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.583 HD13 ' O ' ' A' ' 25' ' ' LEU . 1.5 tm? -82.35 -1.02 48.47 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 176.219 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -95.99 -21.69 17.85 Favored 'General case' 0 CA--C 1.51 -0.563 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 -178.482 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -65.7 -22.38 66.61 Favored 'General case' 0 N--CA 1.437 -1.09 0 CA-C-N 113.755 -1.566 . . . . 0.0 110.208 173.354 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.629 HD11 HG23 ' A' ' 67' ' ' VAL . 37.1 mt -112.37 -15.67 13.08 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-N 115.407 -0.815 . . . . 0.0 111.008 -177.009 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.442 ' HB2' ' O ' ' A' ' 25' ' ' LEU . 62.2 tttp -69.75 133.38 47.4 Favored 'General case' 0 N--CA 1.445 -0.693 0 CA-C-N 115.694 -0.684 . . . . 0.0 111.455 -171.174 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 119.19 -18.9 10.2 Favored Glycine 0 N--CA 1.45 -0.387 0 N-CA-C 111.172 -0.771 . . . . 0.0 111.172 -176.896 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.594 ' HB3' ' NE2' ' A' ' 65' ' ' HIS . 24.5 ttmm -140.18 147.47 40.16 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 179.241 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.54 ' HB2' ' O ' ' A' ' 63' ' ' ASP . 81.8 m-85 -54.0 140.76 30.32 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-O 121.119 0.485 . . . . 0.0 111.659 -176.261 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 5.1 mp -112.18 132.25 61.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.634 -177.111 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 85.5 t80 -115.58 116.54 28.33 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 172.595 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.607 ' HB ' ' HB ' ' A' ' 113' ' ' ILE . 67.9 mt -103.33 109.73 27.81 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 CA-C-O 120.999 0.428 . . . . 0.0 110.671 -177.937 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.55 ' HA ' ' O ' ' A' ' 111' ' ' ARG . 5.7 p-10 -105.57 158.31 16.78 Favored 'General case' 0 C--N 1.316 -0.858 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 173.238 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.45 HG21 HG23 ' A' ' 106' ' ' ILE . 52.6 t -103.26 136.68 34.84 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.806 0 C-N-CA 120.485 -0.486 . . . . 0.0 111.447 179.068 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' TRP . . . . . 0.649 ' CZ2' ' HB2' ' A' ' 91' ' ' GLN . 0.2 OUTLIER -128.5 141.77 51.28 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 -179.95 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.516 ' HB3' HD12 ' A' ' 109' ' ' ILE . . . -146.15 158.11 43.86 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 112.445 0.535 . . . . 0.0 112.445 -176.67 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -76.35 -46.22 28.49 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.798 -0.637 . . . . 0.0 109.559 175.917 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 5.3 p-90 -80.77 -1.16 41.76 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 114.885 -1.052 . . . . 0.0 111.687 -175.352 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 43.6 t -95.31 110.89 22.84 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.252 0.549 . . . . 0.0 110.127 177.596 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . 0.408 ' N ' ' CD ' ' A' ' 44' ' ' PRO . . . -85.31 -43.97 6.4 Favored Glycine 0 CA--C 1.528 0.859 0 CA-C-O 118.967 -0.907 . . . . 0.0 113.727 176.352 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.408 ' CD ' ' N ' ' A' ' 43' ' ' GLY . 71.2 Cg_exo -53.03 -38.34 80.07 Favored 'Trans proline' 0 C--N 1.362 1.274 0 C-N-CA 122.584 2.189 . . . . 0.0 113.221 -176.835 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . 0.679 ' O ' ' HG ' ' A' ' 49' ' ' LEU . 29.8 p -58.95 -32.51 69.67 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.8 0.333 . . . . 0.0 111.021 -179.653 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.55 ' HG2' HD12 ' A' ' 49' ' ' LEU . 52.0 mtt85 -69.38 -8.18 44.17 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.757 -176.412 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -78.26 -27.81 57.09 Favored Glycine 0 N--CA 1.444 -0.774 0 C-N-CA 120.53 -0.843 . . . . 0.0 111.658 175.687 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.466 ' OE2' ' HD3' ' A' ' 128' ' ' ARG . 15.7 pt-20 -114.53 -8.03 12.78 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 111.695 0.257 . . . . 0.0 111.695 -177.687 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.679 ' HG ' ' O ' ' A' ' 45' ' ' CYS . 68.8 mt -55.18 -47.13 99.27 Favored Pre-proline 0 CA--C 1.537 0.442 0 N-CA-C 112.248 0.462 . . . . 0.0 112.248 178.22 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.476 ' HD3' ' HB2' ' A' ' 49' ' ' LEU . 53.6 Cg_exo -54.97 -37.46 93.59 Favored 'Trans proline' 0 C--N 1.355 0.905 0 C-N-CA 121.688 1.592 . . . . 0.0 111.944 172.552 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -73.51 -28.64 62.01 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.619 179.544 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 8.2 tt -64.59 -39.62 94.06 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.009 -0.737 . . . . 0.0 109.009 175.096 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.485 ' HZ1' ' HB3' ' A' ' 53' ' ' LYS . 4.5 mmmp? -63.83 -46.99 82.58 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.486 174.59 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.456 ' CD ' ' HZ2' ' A' ' 58' ' ' LYS . 0.3 OUTLIER -53.09 -43.56 66.9 Favored 'General case' 0 C--O 1.222 -0.348 0 O-C-N 123.565 0.541 . . . . 0.0 111.082 173.944 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.465 HD23 ' HE2' ' A' ' 138' ' ' PHE . 21.7 tp -59.51 -44.42 93.13 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.951 0.405 . . . . 0.0 110.474 178.572 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.41 ' OE1' ' HD2' ' A' ' 66' ' ' PHE . 10.1 tp10 -65.5 -55.96 15.03 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.022 179.906 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 29.9 mt-10 -72.75 -19.24 61.41 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.561 -172.534 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . 0.456 ' HZ2' ' CD ' ' A' ' 54' ' ' GLU . 18.1 ttmm -82.37 -31.6 29.65 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.139 0.495 . . . . 0.0 110.044 174.326 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.444 ' O ' ' HD2' ' A' ' 62' ' ' LYS . 25.8 m-85 -103.9 12.95 33.74 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.657 -0.702 . . . . 0.0 111.166 -178.552 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -47.16 113.8 0.74 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.077 0.465 . . . . 0.0 111.819 178.673 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 115.01 -12.19 20.11 Favored Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 120.88 -0.676 . . . . 0.0 112.254 -178.192 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.635 ' H ' ' HD2' ' A' ' 62' ' ' LYS . 0.0 OUTLIER -65.9 169.48 6.61 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-O 121.405 0.621 . . . . 0.0 111.599 -178.397 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.564 ' CG ' ' HG3' ' A' ' 31' ' ' LYS . 4.6 t70 -94.77 55.77 1.93 Allowed 'General case' 0 C--N 1.318 -0.773 0 CA-C-O 121.367 0.604 . . . . 0.0 109.992 178.786 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.418 ' HB ' ' HG2' ' A' ' 62' ' ' LYS . 4.0 mp -145.99 134.09 15.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.571 -0.74 . . . . 0.0 109.752 -178.698 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' HIS . . . . . 0.594 ' NE2' ' HB3' ' A' ' 31' ' ' LYS . 88.4 m-70 -101.55 120.81 40.88 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.511 -0.552 . . . . 0.0 109.511 173.623 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . 0.552 ' O ' ' HB ' ' A' ' 90' ' ' ILE . 63.5 m-85 -83.32 108.93 16.85 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 171.163 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.629 HG23 HD11 ' A' ' 28' ' ' LEU . 44.2 t -120.77 105.16 16.38 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.696 -174.188 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' SER . . . . . 0.522 ' HA ' ' O ' ' A' ' 36' ' ' ASP . 13.3 m -88.09 124.53 33.87 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.531 -179.191 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 55.7 tp -110.0 129.98 55.6 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.777 0.322 . . . . 0.0 110.453 177.655 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' SER . . . . . 0.498 ' O ' ' HB3' ' A' ' 94' ' ' MET . 1.0 OUTLIER -112.09 122.41 47.68 Favored 'General case' 0 C--O 1.221 -0.396 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.721 -175.147 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 12.9 t -85.41 9.31 15.97 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.403 177.674 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.513 ' OD1' ' HA ' ' A' ' 39' ' ' ALA . 3.0 m-20 -64.56 136.47 57.06 Favored 'General case' 0 CA--C 1.516 -0.343 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.592 -178.013 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.507 ' HZ1' HG23 ' A' ' 96' ' ' THR . 18.2 ttmm -82.83 -33.72 27.09 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-O 121.254 0.549 . . . . 0.0 109.846 177.451 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . 0.499 ' HB2' ' HB1' ' A' ' 77' ' ' ALA . 0.9 OUTLIER -77.9 85.84 4.14 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.477 -0.783 . . . . 0.0 111.217 -179.641 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.429 ' HB2' ' CE1' ' A' ' 93' ' ' HIS . 18.0 tttm -62.54 -62.95 1.39 Allowed 'General case' 0 C--O 1.218 -0.553 0 C-N-CA 120.024 -0.67 . . . . 0.0 111.782 -179.649 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.432 ' HA ' ' HD2' ' A' ' 76' ' ' LYS . 42.2 tptt -53.23 -37.7 62.29 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 123.279 0.362 . . . . 0.0 111.777 -174.445 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.499 ' HB1' ' HB2' ' A' ' 74' ' ' ASN . . . -66.47 -38.08 86.54 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.565 0.698 . . . . 0.0 110.466 177.217 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' TRP . . . . . 0.455 ' HZ3' HH22 ' A' ' 46' ' ' ARG . 7.5 t-105 -80.58 -41.89 23.25 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.313 -0.858 . . . . 0.0 111.229 -176.271 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.721 ' HB2' HG21 ' A' ' 18' ' ' ILE . 1.4 pt-20 -62.44 -39.11 92.27 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-O 120.711 0.291 . . . . 0.0 110.754 179.927 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 3.8 p30 -75.15 -28.55 60.18 Favored 'General case' 0 CA--C 1.518 -0.259 0 C-N-CA 119.784 -0.766 . . . . 0.0 109.65 177.188 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' MET . . . . . 0.501 ' HG3' ' OD2' ' A' ' 85' ' ' ASP . 9.9 tpt -64.72 -51.97 59.57 Favored 'General case' 0 C--O 1.209 -1.068 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.362 176.822 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.759 HG13 HG13 ' A' ' 18' ' ' ILE . 3.2 p -61.24 -30.6 48.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 C-N-CA 120.744 -0.382 . . . . 0.0 110.746 178.869 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 71.8 m -64.41 -38.09 89.8 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.264 0.554 . . . . 0.0 110.08 173.471 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . 0.451 ' HZ2' ' HB2' ' A' ' 84' ' ' LYS . 3.1 ttmp? -77.55 -44.77 27.47 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.421 -0.809 . . . . 0.0 110.381 179.865 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . 0.714 ' HB3' ' HG ' ' A' ' 87' ' ' LEU . 1.2 m-20 -69.57 -16.37 63.4 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 114.68 -1.146 . . . . 0.0 111.007 179.949 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 18.8 mm-40 59.53 31.12 20.78 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-N 115.764 -0.653 . . . . 0.0 112.468 178.585 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.714 ' HG ' ' HB3' ' A' ' 85' ' ' ASP . 58.6 mt -85.01 39.84 0.78 Allowed 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.279 -177.739 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.434 ' HD2' ' N ' ' A' ' 88' ' ' LYS . 0.1 OUTLIER -65.56 150.53 48.25 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-O 121.407 0.623 . . . . 0.0 112.491 -178.801 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 166.4 -134.82 3.42 Favored Glycine 0 C--O 1.229 -0.172 0 N-CA-C 109.861 -1.296 . . . . 0.0 109.861 -172.587 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.552 ' HB ' ' O ' ' A' ' 66' ' ' PHE . 48.0 mm -111.22 114.09 46.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 170.073 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . 0.649 ' HB2' ' CZ2' ' A' ' 38' ' ' TRP . 0.4 OUTLIER -141.88 146.78 36.16 Favored 'General case' 0 C--N 1.314 -0.948 0 N-CA-C 113.232 0.827 . . . . 0.0 113.232 -168.643 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.626 HD12 ' HB ' ' A' ' 23' ' ' VAL . 2.5 mm? -134.13 153.86 51.57 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 114.853 -1.067 . . . . 0.0 110.581 179.161 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' HIS . . . . . 0.44 ' O ' ' HD2' ' A' ' 16' ' ' PRO . 25.5 t-80 -129.43 125.07 35.66 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.907 -179.724 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' MET . . . . . 0.538 ' SD ' ' HA ' ' A' ' 98' ' ' ARG . 24.5 ttm -76.26 -85.3 0.05 Allowed 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.38 -0.827 . . . . 0.0 110.313 179.393 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . 0.499 ' HA2' ' O ' ' A' ' 72' ' ' ASP . . . 117.78 -74.03 0.29 Allowed Glycine 0 N--CA 1.443 -0.869 0 C-N-CA 120.1 -1.048 . . . . 0.0 113.417 177.865 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' THR . . . . . 0.507 HG23 ' HZ1' ' A' ' 73' ' ' LYS . 14.8 m -135.67 -8.12 2.16 Favored 'General case' 0 C--N 1.316 -0.861 0 C-N-CA 120.557 -0.457 . . . . 0.0 111.618 -174.956 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . 0.462 ' CG ' ' HG3' ' A' ' 94' ' ' MET . 8.2 p-10 -89.97 48.21 1.55 Allowed 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.883 0.849 . . . . 0.0 110.083 -176.091 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . 0.538 ' HA ' ' SD ' ' A' ' 94' ' ' MET . 0.0 OUTLIER -75.91 20.52 0.18 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.133 -0.94 . . . . 0.0 112.614 -172.342 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 9.9 m -70.18 -30.17 67.23 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 171.24 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . 0.495 ' HE1' ' HB3' ' A' ' 9' ' ' SER . 1.3 t80 -73.59 -25.73 60.48 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.23 -0.895 . . . . 0.0 109.53 177.898 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' MET . . . . . 0.528 ' HB3' ' O ' ' A' ' 98' ' ' ARG . 13.4 tpt -58.81 -52.34 66.15 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 114.769 -1.105 . . . . 0.0 109.745 175.578 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 67.9 m-20 -73.38 -26.7 61.1 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.579 -0.737 . . . . 0.0 111.318 179.486 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -60.72 -26.82 67.45 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-O 121.025 0.44 . . . . 0.0 111.062 -179.224 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' TYR . . . . . 0.49 ' HB2' HG13 ' A' ' 106' ' ' ILE . 49.4 m-85 -108.52 -3.32 18.19 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.478 178.365 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 7.7 mp 60.36 32.19 20.59 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.147 0.499 . . . . 0.0 110.316 -174.547 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . 0.563 HG22 ' HB2' ' A' ' 111' ' ' ARG . 79.0 mt -64.2 131.14 29.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.737 176.505 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 16.3 t-20 -157.59 161.02 38.69 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 178.421 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 81.35 -60.88 4.67 Favored Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 121.242 -0.504 . . . . 0.0 112.991 178.092 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . 0.516 HD12 ' HB3' ' A' ' 39' ' ' ALA . 44.3 mt 72.08 131.04 0.04 OUTLIER Pre-proline 0 CA--C 1.535 0.371 0 C-N-CA 122.971 0.508 . . . . 0.0 110.399 -176.22 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . 0.424 ' HB3' ' O ' ' A' ' 37' ' ' VAL . 2.2 Cg_endo -84.15 145.89 48.9 Favored 'Cis proline' 0 N--CA 1.461 -0.384 0 C-N-CA 124.153 -1.186 . . . . 0.0 112.963 0.3 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . 0.61 ' HD2' ' N ' ' A' ' 112' ' ' PHE . 0.0 OUTLIER -97.34 141.67 30.14 Favored 'General case' 0 N--CA 1.446 -0.626 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 173.093 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . 0.61 ' N ' ' HD2' ' A' ' 111' ' ' ARG . 0.7 OUTLIER -104.04 117.86 35.3 Favored 'General case' 0 C--N 1.324 -0.537 0 O-C-N 124.024 0.827 . . . . 0.0 111.714 -177.792 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.607 ' HB ' ' HB ' ' A' ' 35' ' ' ILE . 77.4 mt -129.22 149.41 33.65 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.428 0 C-N-CA 122.359 0.263 . . . . 0.0 110.38 177.106 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.476 HD23 ' HE1' ' A' ' 126' ' ' MET . 21.4 tp -137.12 139.84 41.5 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.583 0.23 . . . . 0.0 110.621 178.041 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.487 ' HG ' ' HA ' ' A' ' 121' ' ' ILE . 1.0 OUTLIER -135.8 156.64 48.49 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.897 0.379 . . . . 0.0 110.207 -179.105 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . 0.554 ' HB3' ' HB2' ' A' ' 120' ' ' LYS . 23.0 t70 -73.04 160.74 31.58 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.571 -0.74 . . . . 0.0 110.786 176.91 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . 0.4 HH11 ' HD3' ' A' ' 117' ' ' ARG . 75.0 mtt-85 -44.81 -39.94 5.72 Favored 'General case' 0 N--CA 1.466 0.345 0 O-C-N 124.536 1.147 . . . . 0.0 112.18 179.838 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . 0.492 ' HB3' ' HG2' ' A' ' 120' ' ' LYS . 25.1 t70 -63.43 -23.55 67.45 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.335 0.588 . . . . 0.0 111.151 -178.03 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . 0.543 ' HA3' HD11 ' A' ' 25' ' ' LEU . . . 105.54 19.84 10.09 Favored Glycine 0 N--CA 1.432 -1.571 0 N-CA-C 110.001 -1.24 . . . . 0.0 110.001 -169.376 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . 0.554 ' HB2' ' HB3' ' A' ' 116' ' ' ASP . 32.8 mmtm -91.85 107.97 19.59 Favored 'General case' 0 C--O 1.221 -0.447 0 C-N-CA 120.71 -0.396 . . . . 0.0 111.207 -175.128 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . 0.487 ' HA ' ' HG ' ' A' ' 115' ' ' LEU . 3.5 mp -47.18 113.02 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 O-C-N 123.55 0.531 . . . . 0.0 110.651 177.553 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 38.5 mm -94.34 -53.79 7.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 115.678 -0.692 . . . . 0.0 109.773 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 6.1 m -127.04 114.46 17.81 Favored 'General case' 0 N--CA 1.446 -0.653 0 CA-C-N 115.504 -0.771 . . . . 0.0 109.911 179.832 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . 0.516 ' O ' HG12 ' A' ' 113' ' ' ILE . . . -65.0 -32.13 73.71 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 109.446 -0.576 . . . . 0.0 109.446 174.89 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 12.4 p-10 -127.33 106.92 9.54 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.08 -0.964 . . . . 0.0 109.019 173.586 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' MET . . . . . 0.476 ' HE1' HD23 ' A' ' 114' ' ' LEU . 14.1 tpt -99.55 -101.3 0.23 Allowed 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.077 -175.469 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' THR . . . . . 0.693 ' HB ' ' HB ' ' A' ' 134' ' ' THR . 0.2 OUTLIER -155.17 122.73 5.65 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.916 0.389 . . . . 0.0 110.885 -179.236 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . 0.466 ' HD3' ' OE2' ' A' ' 48' ' ' GLU . 30.1 ttm-85 -49.29 140.84 12.4 Favored Pre-proline 0 C--N 1.326 -0.454 0 CA-C-N 115.153 -0.931 . . . . 0.0 111.421 176.632 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -54.74 -38.77 91.58 Favored 'Trans proline' 0 C--N 1.35 0.615 0 C-N-CA 122.797 2.331 . . . . 0.0 113.14 178.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' SER . . . . . 0.406 ' HB2' ' CB ' ' A' ' 48' ' ' GLU . 36.4 t -72.51 -2.22 18.88 Favored 'General case' 0 CA--C 1.535 0.395 0 N-CA-C 111.657 0.243 . . . . 0.0 111.657 177.981 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . 0.475 ' O ' HG23 ' A' ' 134' ' ' THR . 9.5 t70 -94.45 115.16 64.95 Favored Pre-proline 0 C--N 1.326 -0.417 0 N-CA-C 109.716 -0.476 . . . . 0.0 109.716 179.204 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -56.71 -25.46 60.38 Favored 'Trans proline' 0 N--CA 1.473 0.268 0 C-N-CA 123.041 2.494 . . . . 0.0 113.602 -176.425 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . 0.511 ' HB2' ' HZ1' ' A' ' 133' ' ' LYS . 9.7 mtmp? -70.02 -20.36 63.27 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 121.328 -0.149 . . . . 0.0 111.017 -177.984 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' THR . . . . . 0.693 ' HB ' ' HB ' ' A' ' 127' ' ' THR . 1.6 t -72.67 -40.7 66.11 Favored 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 177.348 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . 0.616 ' HA ' ' CD2' ' A' ' 138' ' ' PHE . . . -62.85 -41.53 99.4 Favored 'General case' 0 N--CA 1.453 -0.324 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.14 176.885 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -55.74 -42.34 75.24 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.417 -0.81 . . . . 0.0 110.649 175.014 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . 0.861 ' HE2' ' HA ' ' A' ' 137' ' ' LYS . 10.0 mmpt? -63.35 -42.8 98.93 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.144 179.559 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . 0.616 ' CD2' ' HA ' ' A' ' 135' ' ' ALA . 11.2 m-85 -57.88 -54.27 48.8 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-O 120.838 0.352 . . . . 0.0 110.366 -179.866 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 49.8 m-20 -56.34 -46.16 80.05 Favored 'General case' 0 C--O 1.223 -0.301 0 CA-C-N 115.918 -0.583 . . . . 0.0 109.966 179.743 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . 0.639 ' HB2' ' HE2' ' A' ' 149' ' ' HIS . 28.7 tt0 -57.65 -55.22 37.62 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.544 -0.753 . . . . 0.0 111.987 -177.897 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 4.6 pp -68.54 -20.12 64.54 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-O 120.722 0.296 . . . . 0.0 111.673 -174.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 95.7 mt -89.37 -11.87 42.02 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.789 0.328 . . . . 0.0 110.489 175.424 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 71.79 30.11 66.47 Favored Glycine 0 N--CA 1.449 -0.495 0 N-CA-C 110.72 -0.952 . . . . 0.0 110.72 -176.046 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . 0.454 ' O ' ' HG ' ' A' ' 144' ' ' LEU . 58.1 tp -88.81 16.76 6.35 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 114.559 -0.821 . . . . 0.0 110.617 -174.741 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . 0.733 ' HB3' ' HA ' ' A' ' 148' ' ' HIS . 47.4 mt-10 -79.99 131.31 35.78 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.322 -178.786 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . 0.406 ' C ' ' H ' ' A' ' 148' ' ' HIS . . . -76.49 73.7 1.81 Allowed Glycine 0 N--CA 1.454 -0.125 0 N-CA-C 110.661 -0.976 . . . . 0.0 110.661 174.035 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' HIS . . . . . 0.461 ' HD1' ' C ' ' A' ' 152' ' ' HIS . 7.1 t-160 77.2 -40.38 0.35 Allowed 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 124.197 0.999 . . . . 0.0 108.637 -167.21 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' HIS . . . . . 0.733 ' HA ' ' HB3' ' A' ' 145' ' ' GLU . 0.1 OUTLIER -171.84 166.41 6.43 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.399 -0.819 . . . . 0.0 109.188 167.934 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . 0.639 ' HE2' ' HB2' ' A' ' 140' ' ' GLU . 37.2 m80 -34.23 -63.54 0.28 Allowed 'General case' 0 N--CA 1.477 0.878 0 O-C-N 124.275 0.984 . . . . 0.0 112.5 -176.896 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 68.9 m-70 -102.49 112.43 25.15 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 177.02 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 59.4 t-80 -45.34 103.59 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.269 0 O-C-N 124.453 1.096 . . . . 0.0 113.214 -167.052 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' HIS . . . . . 0.461 ' C ' ' HD1' ' A' ' 147' ' ' HIS . 53.3 t60 . . . . . 0 C--O 1.245 0.862 0 CA-C-N 115.087 -0.96 . . . . 0.0 108.693 172.864 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.537 ' HG3' ' HG ' ' A' ' 3' ' ' LEU . 11.2 tpt . . . . . 0 N--CA 1.483 1.221 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 25.9 t -59.85 -34.06 72.62 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-O 120.998 0.428 . . . . 0.0 110.336 177.03 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.537 ' HG ' ' HG3' ' A' ' 1' ' ' MET . 2.8 pp -87.06 26.82 1.1 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.358 0.599 . . . . 0.0 110.448 176.188 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 17.7 tpp180 68.0 -87.82 0.03 OUTLIER 'General case' 0 C--O 1.233 0.19 0 CA-C-N 115.12 -0.945 . . . . 0.0 111.318 -176.866 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 69.9 p 40.75 -93.16 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.576 0 O-C-N 124.271 0.982 . . . . 0.0 111.731 -170.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -162.61 -78.6 0.03 OUTLIER Glycine 0 N--CA 1.442 -0.934 0 N-CA-C 111.159 -0.776 . . . . 0.0 111.159 176.554 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 27.9 p-10 -73.85 153.86 89.08 Favored Pre-proline 0 C--N 1.323 -0.578 0 CA-C-O 120.892 0.377 . . . . 0.0 110.686 -179.802 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 7.2 Cg_endo -86.53 107.37 0.79 Allowed 'Trans proline' 0 N--CA 1.453 -0.895 0 C-N-CA 122.901 2.401 . . . . 0.0 111.346 172.434 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.449 ' HA ' ' HE1' ' A' ' 100' ' ' PHE . 16.6 m -96.25 111.36 23.45 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.272 -178.8 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.445 ' HB3' HD12 ' A' ' 121' ' ' ILE . . . 73.94 -40.22 0.45 Allowed 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 123.595 0.758 . . . . 0.0 111.654 179.402 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.411 ' H ' ' C ' ' A' ' 9' ' ' SER . . . -82.91 75.69 9.79 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.764 -179.214 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.493 ' HA ' ' HB3' ' A' ' 25' ' ' LEU . 15.9 m 68.74 79.0 0.21 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.004 -0.998 . . . . 0.0 111.482 176.433 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 23.6 p90 -101.3 -179.53 4.06 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.744 179.134 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 21.0 t -142.37 132.09 24.1 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 109.338 -0.616 . . . . 0.0 109.338 177.537 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . 0.505 ' HB3' ' HB3' ' A' ' 92' ' ' LEU . 12.9 m-85 -138.42 154.67 73.77 Favored Pre-proline 0 C--N 1.326 -0.456 0 CA-C-O 120.608 0.242 . . . . 0.0 111.433 -176.873 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -85.09 127.89 3.55 Favored 'Trans proline' 0 N--CA 1.457 -0.652 0 C-N-CA 123.196 2.597 . . . . 0.0 113.165 179.444 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . 0.682 ' HB3' ' HB3' ' A' ' 21' ' ' LYS . 0.5 OUTLIER -72.53 161.63 30.54 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.167 -0.924 . . . . 0.0 109.746 170.815 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.5 HD13 ' CG1' ' A' ' 82' ' ' VAL . 1.4 tt -46.59 -40.37 4.45 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 O-C-N 124.032 0.832 . . . . 0.0 112.083 -175.95 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . 0.475 ' ND2' HG22 ' A' ' 18' ' ' ILE . 27.9 m-80 -79.53 9.93 4.41 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.228 -175.439 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 77.19 25.81 63.13 Favored Glycine 0 N--CA 1.445 -0.706 0 N-CA-C 110.758 -0.937 . . . . 0.0 110.758 -174.753 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.682 ' HB3' ' HB3' ' A' ' 17' ' ' ASP . 8.0 ttpm? -94.86 106.94 18.96 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.427 -0.386 . . . . 0.0 110.328 -174.694 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 24.7 m -69.29 111.54 5.27 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.154 -178.225 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.578 ' HB ' HD11 ' A' ' 92' ' ' LEU . 47.7 t -115.82 133.86 60.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 116.139 -0.482 . . . . 0.0 109.862 178.352 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 97.7 p -101.74 160.49 14.42 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.35 -178.434 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.548 HD13 ' HG ' ' A' ' 28' ' ' LEU . 20.8 tp -75.17 0.52 16.07 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.164 0.507 . . . . 0.0 109.961 175.45 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -75.68 -25.97 57.21 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.827 -179.734 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -74.87 -21.51 59.2 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-O 122.68 1.229 . . . . 0.0 108.87 177.137 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.548 ' HG ' HD13 ' A' ' 25' ' ' LEU . 3.9 mm? -82.7 -7.4 59.65 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 113.581 -1.645 . . . . 0.0 111.542 -170.941 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.755 ' HA ' ' O ' ' A' ' 117' ' ' ARG . 2.6 mptp? -73.65 175.92 6.7 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.239 0.542 . . . . 0.0 111.272 179.423 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 84.19 -44.51 3.34 Favored Glycine 0 N--CA 1.449 -0.49 0 CA-C-N 115.775 -0.648 . . . . 0.0 112.437 177.814 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.746 ' HD3' ' HA ' ' A' ' 63' ' ' ASP . 66.1 mttm -121.33 164.93 16.25 Favored 'General case' 0 C--N 1.323 -0.577 0 C-N-CA 122.226 0.211 . . . . 0.0 110.582 -177.848 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 44.1 m-85 -67.21 151.75 46.97 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.779 0.323 . . . . 0.0 111.24 -177.609 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.758 HD12 ' HA2' ' A' ' 119' ' ' GLY . 53.4 mt -121.5 132.63 70.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-O 120.832 0.349 . . . . 0.0 111.202 -174.623 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 86.0 t80 -121.37 125.35 46.74 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 109.071 -0.715 . . . . 0.0 109.071 172.74 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.536 HG12 ' HB ' ' A' ' 67' ' ' VAL . 64.2 mt -114.44 134.47 57.28 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-O 120.955 0.407 . . . . 0.0 110.718 -177.877 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.535 ' HA ' ' O ' ' A' ' 111' ' ' ARG . 24.3 t0 -126.68 158.55 36.12 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.372 -0.831 . . . . 0.0 109.0 177.121 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.576 ' HA ' ' O ' ' A' ' 69' ' ' LEU . 59.2 t -105.74 111.47 35.09 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.904 0 C-N-CA 120.228 -0.589 . . . . 0.0 110.816 173.164 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' TRP . . . . . 0.65 ' CZ2' ' HB2' ' A' ' 91' ' ' GLN . 0.6 OUTLIER -95.22 133.27 39.28 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.275 178.716 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.559 ' HA ' ' OD1' ' A' ' 72' ' ' ASP . . . -146.85 163.02 37.42 Favored 'General case' 0 N--CA 1.464 0.266 0 N-CA-C 111.7 0.259 . . . . 0.0 111.7 -175.722 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' THR . . . . . 0.698 ' HB ' ' CE3' ' A' ' 78' ' ' TRP . 8.2 t -98.34 -35.72 10.22 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-O 120.885 0.374 . . . . 0.0 110.762 176.693 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 22.6 p-90 -86.39 16.27 4.66 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.164 0.507 . . . . 0.0 110.547 -178.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . 0.782 ' SG ' ' HB3' ' A' ' 45' ' ' CYS . 14.8 p -75.37 -56.55 4.6 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.611 -0.722 . . . . 0.0 111.791 -175.775 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 98.15 -99.37 2.19 Favored Glycine 0 CA--C 1.521 0.424 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.101 -176.161 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -55.32 -28.35 62.23 Favored 'Trans proline' 0 C--N 1.352 0.714 0 C-N-CA 123.331 2.688 . . . . 0.0 113.274 -179.635 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . 0.83 ' HB2' ' HD3' ' A' ' 110' ' ' PRO . 18.2 t -57.57 -22.85 47.34 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-O 120.979 0.419 . . . . 0.0 111.428 179.425 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.534 ' HA ' ' CD1' ' A' ' 49' ' ' LEU . 33.0 mtp-105 -70.9 -15.67 62.63 Favored 'General case' 0 C--N 1.324 -0.5 0 C-N-CA 120.577 -0.449 . . . . 0.0 111.301 -178.748 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -84.23 -12.97 75.1 Favored Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 120.678 -0.772 . . . . 0.0 111.67 176.08 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.651 ' HB3' ' HB2' ' A' ' 129' ' ' PRO . 0.5 OUTLIER -91.51 -26.34 18.83 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.135 0.493 . . . . 0.0 109.884 -179.342 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.787 HD23 HD12 ' A' ' 52' ' ' LEU . 54.9 mt -51.53 -45.27 90.77 Favored Pre-proline 0 CA--C 1.536 0.406 0 CA-C-N 115.315 -0.857 . . . . 0.0 113.147 -176.664 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.534 ' HD2' ' N ' ' A' ' 49' ' ' LEU . 10.3 Cg_endo -54.2 -36.42 85.79 Favored 'Trans proline' 0 C--N 1.354 0.818 0 C-N-CA 121.683 1.589 . . . . 0.0 112.048 174.426 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.521 ' HA ' ' HB2' ' A' ' 54' ' ' GLU . . . -82.21 -22.44 35.93 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.329 0.585 . . . . 0.0 110.106 -178.443 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.787 HD12 HD23 ' A' ' 49' ' ' LEU . 27.3 mt -64.74 -37.26 86.99 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.423 -0.808 . . . . 0.0 110.156 175.423 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.449 ' HE3' ' HB3' ' A' ' 53' ' ' LYS . 10.2 mtpp -75.2 -40.21 59.44 Favored 'General case' 0 CA--C 1.517 -0.322 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.951 173.567 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.597 ' CD ' ' HZ1' ' A' ' 58' ' ' LYS . 6.4 mm-40 -47.16 -50.38 20.65 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.538 -0.755 . . . . 0.0 110.678 173.213 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 73.6 mt -59.01 -55.35 36.3 Favored 'General case' 0 N--CA 1.446 -0.631 0 CA-C-N 115.592 -0.731 . . . . 0.0 111.072 176.261 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.601 ' OE2' ' HB3' ' A' ' 88' ' ' LYS . 37.7 tt0 -45.01 -60.64 1.98 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.477 -0.783 . . . . 0.0 112.558 179.776 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 61.5 mt-10 -74.42 -31.99 62.5 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 111.96 0.356 . . . . 0.0 111.96 -169.86 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . 0.597 ' HZ1' ' CD ' ' A' ' 54' ' ' GLU . 49.5 mttp -78.38 -40.67 35.54 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.131 0.491 . . . . 0.0 111.081 -178.169 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.564 ' HB2' ' HE2' ' A' ' 66' ' ' PHE . 73.2 m-85 -102.78 8.43 39.38 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.497 -173.915 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . 0.48 ' HB2' ' O ' ' A' ' 56' ' ' GLU . . . -59.53 131.41 50.85 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.657 172.156 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 77.13 11.01 85.95 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.962 -0.637 . . . . 0.0 113.027 176.147 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 33.5 mmtm -89.13 -136.11 0.11 Allowed 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.966 -0.383 . . . . 0.0 109.966 177.624 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.746 ' HA ' ' HD3' ' A' ' 31' ' ' LYS . 4.6 t0 -120.02 42.14 3.01 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 121.542 0.687 . . . . 0.0 109.778 179.008 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.413 HG23 ' HB3' ' A' ' 59' ' ' TYR . 7.3 tp -148.81 151.21 13.35 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 115.083 -0.962 . . . . 0.0 109.868 -171.624 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' HIS . . . . . 0.578 ' NE2' ' HB2' ' A' ' 31' ' ' LYS . 80.9 m-70 -126.99 137.8 53.16 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 175.128 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . 0.564 ' HE2' ' HB2' ' A' ' 59' ' ' TYR . 91.0 m-85 -110.43 109.98 20.57 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 120.624 0.249 . . . . 0.0 110.415 178.714 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.536 ' HB ' HG12 ' A' ' 35' ' ' ILE . 49.8 t -109.1 109.26 27.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.156 -177.115 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 50.2 m -91.68 114.0 26.41 Favored 'General case' 0 C--N 1.316 -0.884 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 174.144 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.576 ' O ' ' HA ' ' A' ' 37' ' ' VAL . 66.7 tp -109.83 130.02 55.57 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.555 -0.293 . . . . 0.0 110.266 178.649 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' SER . . . . . 0.558 ' O ' ' HB3' ' A' ' 94' ' ' MET . 1.8 t -109.02 119.23 38.94 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 111.93 0.344 . . . . 0.0 111.93 -173.758 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' CYS . . . . . 0.555 ' HB3' ' SD ' ' A' ' 101' ' ' MET . 33.6 m -88.14 19.29 3.76 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.519 177.368 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.563 ' OD2' HG23 ' A' ' 40' ' ' THR . 2.2 m-20 -73.33 113.99 11.04 Favored 'General case' 0 CA--C 1.515 -0.403 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.705 -178.54 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.522 ' HA ' ' O ' ' A' ' 95' ' ' GLY . 47.3 tttm -71.63 -17.53 62.26 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-O 121.155 0.502 . . . . 0.0 110.312 177.812 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 4.6 m-20 -83.83 91.31 7.52 Favored 'General case' 0 CA--C 1.515 -0.392 0 N-CA-C 109.025 -0.731 . . . . 0.0 109.025 175.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.652 ' HZ2' ' HG3' ' A' ' 79' ' ' GLU . 13.0 tmtt? -64.98 -65.09 0.72 Allowed 'General case' 0 C--N 1.322 -0.629 0 C-N-CA 120.066 -0.654 . . . . 0.0 110.984 -176.69 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 11.1 tmtt? -52.24 -45.66 65.41 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.2 -0.909 . . . . 0.0 111.195 -176.357 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.683 ' HA ' ' ND2' ' A' ' 80' ' ' ASN . . . -61.77 -38.69 88.96 Favored 'General case' 0 C--O 1.246 0.881 0 CA-C-O 121.572 0.701 . . . . 0.0 110.644 -177.281 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' TRP . . . . . 0.698 ' CE3' ' HB ' ' A' ' 40' ' ' THR . 4.7 t-105 -70.14 -47.55 61.24 Favored 'General case' 0 N--CA 1.438 -1.042 0 CA-C-N 115.099 -0.955 . . . . 0.0 110.634 -176.798 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.652 ' HG3' ' HZ2' ' A' ' 75' ' ' LYS . 4.0 mm-40 -47.25 -44.78 23.13 Favored 'General case' 0 C--O 1.236 0.355 0 O-C-N 123.418 0.449 . . . . 0.0 111.774 175.347 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . 0.683 ' ND2' ' HA ' ' A' ' 77' ' ' ALA . 1.8 m-80 -59.83 -50.84 72.21 Favored 'General case' 0 CA--C 1.518 -0.288 0 C-N-CA 120.196 -0.601 . . . . 0.0 110.468 179.501 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' MET . . . . . 0.4 ' HE3' ' HB2' ' A' ' 81' ' ' MET . 23.1 ttm -64.27 -42.32 96.49 Favored 'General case' 0 C--N 1.332 -0.156 0 N-CA-C 112.578 0.585 . . . . 0.0 112.578 -173.016 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.516 HG11 ' O ' ' A' ' 78' ' ' TRP . 1.3 p -62.45 -37.43 78.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 C-N-CA 120.061 -0.656 . . . . 0.0 110.714 177.884 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 32.8 m -70.74 -35.75 72.82 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.221 0.534 . . . . 0.0 110.532 178.427 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 22.0 tttm -73.4 -52.29 14.31 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.721 -0.672 . . . . 0.0 111.571 -178.554 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -85.81 6.74 26.71 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.444 -0.798 . . . . 0.0 111.899 -173.404 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 89.8 mt-30 57.84 38.34 27.16 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 122.927 0.491 . . . . 0.0 111.605 175.237 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.636 HD21 HD22 ' A' ' 49' ' ' LEU . 44.4 mt -73.72 111.48 8.91 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.515 -177.08 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.69 ' HZ3' ' HB3' ' A' ' 88' ' ' LYS . 3.9 mmmp? -105.51 -157.1 0.6 Allowed 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 112.537 0.569 . . . . 0.0 112.537 -177.346 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 97.04 176.76 34.89 Favored Glycine 0 N--CA 1.447 -0.591 0 N-CA-C 110.507 -1.037 . . . . 0.0 110.507 -169.254 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 63.0 mt -83.22 110.94 18.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 N-CA-C 107.065 -1.457 . . . . 0.0 107.065 169.873 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . 0.65 ' HB2' ' CZ2' ' A' ' 38' ' ' TRP . 1.3 pt20 -122.78 123.21 40.52 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-O 121.666 0.746 . . . . 0.0 112.837 -164.114 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.578 HD11 ' HB ' ' A' ' 23' ' ' VAL . 2.5 mm? -121.23 149.93 42.12 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 114.937 -1.029 . . . . 0.0 109.318 178.272 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 16.1 t-80 -120.33 135.23 55.08 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-O 121.642 0.734 . . . . 0.0 111.589 -176.113 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' MET . . . . . 0.78 ' HG3' ' HB2' ' A' ' 97' ' ' ASP . 25.7 ttm -103.21 91.96 4.31 Favored 'General case' 0 N--CA 1.442 -0.871 0 CA-C-N 114.391 -1.277 . . . . 0.0 108.16 178.933 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . 0.522 ' O ' ' HA ' ' A' ' 73' ' ' LYS . . . -57.76 -55.19 31.86 Favored Glycine 0 C--N 1.318 -0.426 0 CA-C-N 115.169 -0.923 . . . . 0.0 113.807 -175.256 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 10.9 m -146.94 13.0 1.12 Allowed 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 122.064 0.935 . . . . 0.0 109.49 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . 0.78 ' HB2' ' HG3' ' A' ' 94' ' ' MET . 0.7 OUTLIER -81.56 31.83 0.35 Allowed 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 114.838 -1.074 . . . . 0.0 110.462 -175.471 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . 0.528 ' HA ' ' SD ' ' A' ' 94' ' ' MET . 0.0 OUTLIER -67.52 0.03 3.42 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 113.362 0.875 . . . . 0.0 113.362 -170.619 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' THR . . . . . 0.451 ' HA ' ' NH2' ' A' ' 98' ' ' ARG . 10.4 m -66.01 -19.23 65.79 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.66 0.743 . . . . 0.0 109.568 172.806 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . 0.449 ' HE1' ' HA ' ' A' ' 9' ' ' SER . 16.4 t80 -79.55 -24.14 42.34 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 115.317 -0.856 . . . . 0.0 110.135 177.773 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' MET . . . . . 0.555 ' SD ' ' HB3' ' A' ' 71' ' ' CYS . 88.6 mtp -60.17 -48.12 83.06 Favored 'General case' 0 CA--C 1.515 -0.395 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 174.357 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 67.5 m-20 -56.04 -40.89 74.17 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.224 -0.898 . . . . 0.0 111.088 176.577 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -63.25 -28.64 70.17 Favored 'General case' 0 N--CA 1.462 0.131 0 CA-C-N 116.198 -0.455 . . . . 0.0 112.075 -176.058 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' TYR . . . . . 0.944 ' HB3' HG21 ' A' ' 106' ' ' ILE . 2.8 m-85 -107.49 -6.36 17.08 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 111.937 0.347 . . . . 0.0 111.937 -178.602 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 3.4 mm? 57.94 33.06 22.77 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-O 121.425 0.631 . . . . 0.0 110.269 -174.049 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . 0.944 HG21 ' HB3' ' A' ' 104' ' ' TYR . 32.9 pt -88.93 36.18 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.248 -177.854 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 5.0 p-10 -67.28 -28.34 67.94 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.962 0.41 . . . . 0.0 110.376 179.266 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -92.06 103.5 3.06 Favored Glycine 0 N--CA 1.444 -0.769 0 N-CA-C 111.106 -0.798 . . . . 0.0 111.106 175.608 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . 0.453 ' HA ' ' C ' ' A' ' 110' ' ' PRO . 34.3 pt -110.79 153.46 43.69 Favored Pre-proline 0 C--N 1.324 -0.501 0 O-C-N 123.315 0.068 . . . . 0.0 110.943 -178.131 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . 0.83 ' HD3' ' HB2' ' A' ' 45' ' ' CYS . 42.2 Cg_endo -68.98 150.5 88.26 Favored 'Cis proline' 0 C--N 1.35 0.654 0 C-N-CA 123.547 -1.439 . . . . 0.0 112.428 0.982 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . 0.578 ' HG3' HG23 ' A' ' 106' ' ' ILE . 0.0 OUTLIER -114.52 127.9 56.05 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.209 -177.215 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . 0.531 ' HB2' ' HB3' ' A' ' 126' ' ' MET . 0.2 OUTLIER -102.47 114.35 28.48 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 114.701 -1.136 . . . . 0.0 110.608 -177.504 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 86.8 mt -130.75 143.51 40.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 120.85 0.357 . . . . 0.0 111.119 -178.244 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 48.2 tp -124.05 134.63 53.37 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.032 178.762 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.454 ' N ' HD13 ' A' ' 115' ' ' LEU . 1.6 mp -134.36 160.47 37.84 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.225 0.536 . . . . 0.0 110.615 -177.341 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . 0.486 ' HB2' HD13 ' A' ' 122' ' ' ILE . 28.5 t70 -77.17 167.96 20.87 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.193 -0.912 . . . . 0.0 110.351 177.288 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . 0.755 ' O ' ' HA ' ' A' ' 29' ' ' LYS . 81.9 mtt-85 -47.97 -37.66 15.06 Favored 'General case' 0 C--N 1.327 -0.382 0 O-C-N 124.402 1.064 . . . . 0.0 112.446 -177.524 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . 0.547 ' HA ' ' HG3' ' A' ' 29' ' ' LYS . 25.4 t0 -76.84 -0.1 22.77 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.532 0.682 . . . . 0.0 111.244 -178.922 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . 0.758 ' HA2' HD12 ' A' ' 33' ' ' ILE . . . 82.86 24.53 52.64 Favored Glycine 0 N--CA 1.431 -1.678 0 N-CA-C 110.058 -1.217 . . . . 0.0 110.058 -171.523 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . 0.46 ' HB2' ' HB3' ' A' ' 116' ' ' ASP . 44.9 mmtm -92.73 106.22 18.23 Favored 'General case' 0 C--O 1.222 -0.371 0 C-N-CA 120.601 -0.439 . . . . 0.0 111.466 -178.047 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . 0.445 HD12 ' HB3' ' A' ' 10' ' ' ALA . 4.4 mp -41.51 117.58 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.397 0 CA-C-N 115.416 -0.811 . . . . 0.0 112.273 -177.95 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' ILE . . . . . 0.486 HD13 ' HB2' ' A' ' 116' ' ' ASP . 45.6 mm -98.95 -43.62 11.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 115.392 -0.822 . . . . 0.0 109.313 176.288 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 16.2 m -135.6 114.32 11.9 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.305 -0.861 . . . . 0.0 109.917 178.428 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -77.49 -12.38 59.95 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.24 0.543 . . . . 0.0 110.555 179.681 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 6.5 t30 -143.65 98.58 3.27 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.186 -0.915 . . . . 0.0 108.573 175.686 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' MET . . . . . 0.697 ' HE2' ' HD3' ' A' ' 137' ' ' LYS . 17.6 tpt -77.79 -86.6 0.06 Allowed 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.649 -174.546 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 8.4 m -155.87 -73.01 0.11 Allowed 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.945 0.402 . . . . 0.0 110.055 -178.889 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . 0.742 ' HB3' ' HB2' ' A' ' 131' ' ' ASP . 44.9 ttt180 -178.35 143.17 0.45 Allowed Pre-proline 0 N--CA 1.44 -0.955 0 CA-C-N 115.508 -0.769 . . . . 0.0 109.159 -179.226 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . 0.651 ' HB2' ' HB3' ' A' ' 48' ' ' GLU . 57.3 Cg_exo -52.72 -45.45 40.35 Favored 'Trans proline' 0 C--N 1.346 0.431 0 C-N-CA 122.577 2.185 . . . . 0.0 112.856 178.405 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' SER . . . . . 0.525 ' HB3' ' HA ' ' A' ' 48' ' ' GLU . 31.2 p -96.22 5.7 50.43 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 112.279 0.474 . . . . 0.0 112.279 -176.717 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . 0.787 ' OD1' ' HG2' ' A' ' 133' ' ' LYS . 11.3 t70 -89.3 128.43 51.36 Favored Pre-proline 0 C--O 1.235 0.312 0 C-N-CA 120.101 -0.64 . . . . 0.0 110.469 -178.658 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . 0.615 ' O ' ' HG3' ' A' ' 136' ' ' GLU . 82.6 Cg_exo -46.92 -41.23 25.71 Favored 'Trans proline' 0 C--N 1.344 0.325 0 C-N-CA 124.048 3.165 . . . . 0.0 114.944 -178.042 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . 0.787 ' HG2' ' OD1' ' A' ' 131' ' ' ASP . 27.7 mmtm -53.61 -37.71 63.29 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-O 121.209 0.528 . . . . 0.0 110.194 -172.097 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' THR . . . . . 0.714 HG23 ' CZ ' ' A' ' 138' ' ' PHE . 4.9 m -59.31 -59.62 5.16 Favored 'General case' 0 N--CA 1.446 -0.642 0 CA-C-N 115.23 -0.895 . . . . 0.0 110.657 178.0 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . 0.529 ' HA ' ' CD2' ' A' ' 138' ' ' PHE . . . -61.54 -41.21 97.0 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.862 -179.626 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . 0.885 ' HB3' ' HA3' ' A' ' 146' ' ' GLY . 19.9 mt-10 -66.92 -28.77 68.57 Favored 'General case' 0 CA--C 1.514 -0.423 0 CA-C-O 121.409 0.623 . . . . 0.0 110.511 -177.154 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . 0.697 ' HD3' ' HE2' ' A' ' 126' ' ' MET . 60.8 tttp -75.06 -31.23 61.2 Favored 'General case' 0 C--N 1.317 -0.848 0 CA-C-N 115.298 -0.865 . . . . 0.0 111.024 177.119 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . 0.714 ' CZ ' HG23 ' A' ' 134' ' ' THR . 12.2 m-30 -62.08 -41.06 97.79 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 173.69 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . 0.414 ' HB2' ' O ' ' A' ' 136' ' ' GLU . 5.7 m-20 -57.48 -53.15 61.37 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.02 -0.991 . . . . 0.0 110.157 172.901 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . 0.531 ' HB3' ' O ' ' A' ' 137' ' ' LYS . 8.0 tt0 -43.07 -51.55 5.75 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 123.14 0.576 . . . . 0.0 111.958 171.392 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . 0.536 ' HG ' ' O ' ' A' ' 137' ' ' LYS . 94.2 mt -58.34 -37.92 76.14 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.9 -178.112 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 11.2 mp -84.95 -7.16 59.27 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.89 0.376 . . . . 0.0 111.163 -179.764 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 89.44 6.16 71.2 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 121.132 -0.556 . . . . 0.0 111.799 179.284 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 65.5 tp -86.71 -25.75 24.6 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.483 -0.359 . . . . 0.0 110.405 -179.458 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . 0.557 ' HB3' ' CE1' ' A' ' 147' ' ' HIS . 3.2 tt0 58.5 154.29 0.02 OUTLIER 'General case' 0 N--CA 1.452 -0.333 0 N-CA-C 114.524 1.305 . . . . 0.0 114.524 -177.8 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . 0.885 ' HA3' ' HB3' ' A' ' 136' ' ' GLU . . . -86.35 98.74 2.35 Favored Glycine 0 N--CA 1.444 -0.823 0 N-CA-C 110.252 -1.139 . . . . 0.0 110.252 169.682 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' HIS . . . . . 0.557 ' CE1' ' HB3' ' A' ' 145' ' ' GLU . 4.5 m-70 -82.22 28.31 0.45 Allowed 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 112.319 0.489 . . . . 0.0 112.319 -171.616 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' HIS . . . . . 0.584 ' HB2' ' OE1' ' A' ' 136' ' ' GLU . 0.0 OUTLIER -57.43 -30.32 64.88 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.288 0.566 . . . . 0.0 110.673 176.809 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 37.8 p-80 -126.76 21.53 6.98 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.343 -0.844 . . . . 0.0 109.687 -179.42 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 2.9 t-80 -126.23 103.99 7.98 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 -176.305 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 29.5 m170 -75.48 -0.47 20.28 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 111.848 0.314 . . . . 0.0 111.848 -174.554 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 25.3 t60 . . . . . 0 C--O 1.245 0.839 0 CA-C-O 118.149 -0.929 . . . . 0.0 109.136 173.795 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 85.8 mmm . . . . . 0 N--CA 1.481 1.109 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 14.6 m -66.73 117.41 8.83 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 123.281 0.363 . . . . 0.0 110.408 178.738 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 80.1 mt -149.86 102.33 3.12 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-N 116.328 -0.397 . . . . 0.0 110.651 179.107 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -166.25 28.71 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.31 0.576 . . . . 0.0 109.87 175.233 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' SER . . . . . 0.62 ' HB2' ' O ' ' A' ' 7' ' ' ASN . 2.0 m -146.54 -179.11 6.54 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 -179.06 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -67.2 -20.18 70.93 Favored Glycine 0 C--N 1.331 0.271 0 N-CA-C 110.898 -0.881 . . . . 0.0 110.898 171.034 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . 0.62 ' O ' ' HB2' ' A' ' 5' ' ' SER . 41.7 m-80 -125.64 158.53 64.61 Favored Pre-proline 0 C--N 1.326 -0.432 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 173.332 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_exo -54.24 -35.88 84.46 Favored 'Trans proline' 0 CA--C 1.533 0.472 0 C-N-CA 122.5 2.134 . . . . 0.0 113.035 178.351 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 9.2 m -73.66 -172.79 1.32 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.083 0.468 . . . . 0.0 111.456 -178.389 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . 64.81 24.15 12.77 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-N 115.651 -0.704 . . . . 0.0 111.121 -179.104 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -155.24 101.45 2.22 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.98 177.83 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.456 ' HA ' HD23 ' A' ' 25' ' ' LEU . 36.9 m 65.01 103.85 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.474 0 CA-C-O 121.398 0.618 . . . . 0.0 112.128 178.128 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 36.5 p90 -125.81 171.03 11.02 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.426 178.487 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 30.7 m -140.91 129.21 22.34 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.899 -0.408 . . . . 0.0 109.899 178.227 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 45.8 m-85 -144.46 158.06 54.82 Favored Pre-proline 0 C--N 1.327 -0.372 0 CA-C-O 120.612 0.244 . . . . 0.0 110.841 -177.599 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_endo -87.09 128.5 2.71 Favored 'Trans proline' 0 N--CA 1.455 -0.751 0 C-N-CA 123.028 2.485 . . . . 0.0 113.023 178.882 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . 1.144 ' HB3' ' HB3' ' A' ' 21' ' ' LYS . 0.8 OUTLIER -66.32 162.77 19.5 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.409 -0.814 . . . . 0.0 109.735 170.687 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.854 HG13 HG11 ' A' ' 82' ' ' VAL . 24.5 mm -44.23 -45.43 2.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 O-C-N 124.27 0.981 . . . . 0.0 112.392 -177.367 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 33.2 m-80 -79.54 2.98 20.18 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.674 -172.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 87.5 35.79 9.17 Favored Glycine 0 N--CA 1.448 -0.557 0 N-CA-C 110.574 -1.011 . . . . 0.0 110.574 -174.526 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 1.144 ' HB3' ' HB3' ' A' ' 17' ' ' ASP . 35.5 ttmt -100.92 107.33 18.8 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.209 -0.495 . . . . 0.0 110.412 -174.835 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 25.2 m -74.34 105.73 5.64 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 120.924 0.392 . . . . 0.0 110.976 -177.137 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.548 ' HB ' HD13 ' A' ' 92' ' ' LEU . 45.8 t -117.99 138.07 49.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 116.064 -0.517 . . . . 0.0 109.668 179.192 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 80.3 p -113.6 156.5 23.55 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 116.316 -0.402 . . . . 0.0 109.93 179.263 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.503 ' O ' ' HB2' ' A' ' 29' ' ' LYS . 34.4 tp -70.42 -9.69 57.09 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.16 177.543 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -80.96 -26.98 36.2 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.494 177.288 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -74.15 -34.72 63.94 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.548 0.69 . . . . 0.0 110.107 175.795 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.472 HD12 HG22 ' A' ' 90' ' ' ILE . 66.6 mt -91.78 0.44 57.49 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.322 -0.854 . . . . 0.0 110.557 179.226 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.503 ' HB2' ' O ' ' A' ' 25' ' ' LEU . 60.2 tttp -74.54 150.63 39.69 Favored 'General case' 0 N--CA 1.443 -0.808 0 CA-C-N 115.134 -0.939 . . . . 0.0 110.633 -176.504 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 94.65 5.41 61.51 Favored Glycine 0 N--CA 1.447 -0.601 0 N-CA-C 110.576 -1.01 . . . . 0.0 110.576 -175.128 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 1.063 ' HD2' ' HA ' ' A' ' 63' ' ' ASP . 11.0 tppt? -146.0 151.44 37.78 Favored 'General case' 0 N--CA 1.446 -0.646 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 -177.982 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 61.3 m-85 -65.92 151.28 47.11 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 120.985 -0.286 . . . . 0.0 110.652 179.793 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.539 ' HB ' ' HB2' ' A' ' 115' ' ' LEU . 46.1 mm -127.08 125.86 67.13 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.975 -176.068 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . 0.434 ' CE2' ' HB2' ' A' ' 36' ' ' ASP . 59.0 t80 -105.43 112.01 24.95 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 170.554 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.548 ' HB ' ' HB ' ' A' ' 113' ' ' ILE . 40.3 mt -92.14 120.72 41.82 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-O 121.298 0.57 . . . . 0.0 110.461 179.77 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.539 ' O ' ' HA ' ' A' ' 68' ' ' SER . 15.9 t70 -120.24 125.03 47.11 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 115.133 -0.94 . . . . 0.0 109.231 178.919 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.504 HG13 HG22 ' A' ' 109' ' ' ILE . 21.5 t -82.5 113.92 22.53 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.913 0 C-N-CA 119.817 -0.753 . . . . 0.0 110.717 -178.981 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' TRP . . . . . 0.602 ' O ' ' HB2' ' A' ' 70' ' ' SER . 0.5 OUTLIER -108.95 135.82 49.5 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.268 -0.878 . . . . 0.0 108.926 -177.967 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.608 ' HB2' ' HB3' ' A' ' 42' ' ' CYS . . . -145.04 172.36 13.17 Favored 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 120.433 -0.507 . . . . 0.0 111.96 -176.919 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -89.18 -43.17 11.21 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.661 0.743 . . . . 0.0 109.855 176.95 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . 0.511 ' CH2' HD11 ' A' ' 109' ' ' ILE . 11.1 p-90 -88.39 12.35 14.43 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 114.957 -1.02 . . . . 0.0 111.233 -176.056 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . 0.76 ' SG ' ' HB3' ' A' ' 45' ' ' CYS . 28.3 p -79.33 -17.86 53.68 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.154 -178.792 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 57.49 -107.06 0.88 Allowed Glycine 0 CA--C 1.522 0.508 0 CA-C-N 116.057 -0.519 . . . . 0.0 113.829 177.258 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_exo -51.6 -25.77 20.73 Favored 'Trans proline' 0 C--N 1.353 0.776 0 C-N-CA 123.746 2.964 . . . . 0.0 113.688 -177.348 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . 0.76 ' HB3' ' SG ' ' A' ' 42' ' ' CYS . 7.0 t -52.95 -30.68 36.11 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-O 120.844 0.354 . . . . 0.0 111.3 176.838 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.565 ' HA ' ' HG ' ' A' ' 49' ' ' LEU . 64.9 mtp180 -68.15 -11.42 59.14 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.835 -0.62 . . . . 0.0 111.677 -175.679 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -69.56 -33.23 71.75 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.919 -0.658 . . . . 0.0 112.595 179.802 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.548 ' OE2' ' HD3' ' A' ' 128' ' ' ARG . 28.0 mt-10 -93.6 -9.0 39.55 Favored 'General case' 0 C--N 1.328 -0.366 0 O-C-N 122.738 -0.272 . . . . 0.0 111.061 -177.561 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.604 ' HB3' HD21 ' A' ' 87' ' ' LEU . 81.4 mt -55.52 -46.69 99.68 Favored Pre-proline 0 C--N 1.326 -0.426 0 CA-C-N 116.558 -0.292 . . . . 0.0 111.455 179.331 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.983 ' HA ' ' HE3' ' A' ' 53' ' ' LYS . 51.5 Cg_exo -55.34 -43.95 53.56 Favored 'Trans proline' 0 C--N 1.356 0.956 0 C-N-CA 121.635 1.556 . . . . 0.0 111.895 170.781 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -69.02 -24.29 64.19 Favored 'General case' 0 N--CA 1.462 0.138 0 CA-C-O 121.13 0.49 . . . . 0.0 110.686 -174.483 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 8.7 tt -68.42 -39.28 81.65 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.486 -0.779 . . . . 0.0 109.252 178.015 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.983 ' HE3' ' HA ' ' A' ' 50' ' ' PRO . 8.4 mtmp? -62.84 -51.48 66.88 Favored 'General case' 0 CA--C 1.519 -0.248 0 CA-C-O 121.73 0.776 . . . . 0.0 109.375 177.302 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -57.82 -37.81 74.48 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 114.977 -1.01 . . . . 0.0 111.205 179.347 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.476 HD23 ' HE2' ' A' ' 138' ' ' PHE . 12.9 tp -73.98 -40.7 62.79 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.543 -0.299 . . . . 0.0 110.64 179.583 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.634 ' HG3' ' O ' ' A' ' 53' ' ' LYS . 0.0 OUTLIER -66.24 -39.52 89.6 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.711 -0.222 . . . . 0.0 110.473 -177.496 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 51.5 mt-10 -76.44 -28.27 56.53 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.009 0.433 . . . . 0.0 110.73 -179.255 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 63.7 tttm -70.21 -31.36 68.76 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.862 176.489 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.458 ' HB3' HD12 ' A' ' 64' ' ' ILE . 88.0 m-85 -112.17 5.71 18.65 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 112.0 0.37 . . . . 0.0 112.0 -176.099 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -62.93 142.97 58.11 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.618 175.687 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 95.11 -14.24 65.59 Favored Glycine 0 N--CA 1.446 -0.673 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.054 -179.743 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.736 ' HE2' ' HB3' ' A' ' 142' ' ' LEU . 18.7 mmmt -104.13 -169.86 1.69 Allowed 'General case' 0 N--CA 1.448 -0.532 0 CA-C-O 121.271 0.558 . . . . 0.0 111.463 178.859 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 1.063 ' HA ' ' HD2' ' A' ' 31' ' ' LYS . 28.0 m-20 -87.91 34.12 0.72 Allowed 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 113.401 0.889 . . . . 0.0 113.401 -165.848 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.458 HD12 ' HB3' ' A' ' 59' ' ' TYR . 27.6 pt -140.57 135.8 35.27 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-O 120.786 0.327 . . . . 0.0 110.639 176.213 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' HIS . . . . . 0.487 ' HB2' HD11 ' A' ' 33' ' ' ILE . 39.2 m-70 -109.61 144.25 38.2 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.074 175.889 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . 0.44 ' HE2' HD22 ' A' ' 55' ' ' LEU . 59.8 m-85 -100.78 114.6 28.53 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 173.468 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.638 ' HA ' ' O ' ' A' ' 90' ' ' ILE . 58.2 t -123.35 115.07 44.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-O 120.974 0.416 . . . . 0.0 111.125 -175.315 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' SER . . . . . 0.539 ' HA ' ' O ' ' A' ' 36' ' ' ASP . 50.9 m -96.48 131.15 43.37 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.688 179.01 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.432 ' O ' ' HA ' ' A' ' 37' ' ' VAL . 84.8 mt -120.9 139.03 53.78 Favored 'General case' 0 N--CA 1.468 0.47 0 N-CA-C 110.51 -0.182 . . . . 0.0 110.51 178.062 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' SER . . . . . 0.602 ' HB2' ' O ' ' A' ' 38' ' ' TRP . 0.8 OUTLIER -123.69 129.94 51.88 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 112.5 0.556 . . . . 0.0 112.5 -174.374 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 4.8 p -93.65 23.03 4.95 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.301 173.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.483 ' OD1' ' HA ' ' A' ' 39' ' ' ALA . 3.0 m-20 -79.47 108.02 12.68 Favored 'General case' 0 N--CA 1.467 0.382 0 O-C-N 122.339 -0.226 . . . . 0.0 111.013 -177.389 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 16.2 ptpt -68.12 -20.95 64.96 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 120.979 0.418 . . . . 0.0 110.658 178.09 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . 0.514 ' HB2' ' HB2' ' A' ' 77' ' ' ALA . 1.0 OUTLIER -79.42 69.09 5.61 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.394 174.122 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 11.9 tttt -58.73 -51.24 70.8 Favored 'General case' 0 C--O 1.218 -0.564 0 CA-C-N 116.63 -0.259 . . . . 0.0 111.649 -174.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.652 ' HA ' ' OE2' ' A' ' 79' ' ' GLU . 0.2 OUTLIER -58.11 -44.37 87.65 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 120.811 0.339 . . . . 0.0 110.442 -177.478 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.514 ' HB2' ' HB2' ' A' ' 74' ' ' ASN . . . -62.37 -43.29 99.18 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.683 0.754 . . . . 0.0 110.567 178.285 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' TRP . . . . . 0.457 ' O ' HG12 ' A' ' 82' ' ' VAL . 3.9 t-105 -73.34 -45.76 53.29 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 115.159 -0.928 . . . . 0.0 111.268 -176.731 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.652 ' OE2' ' HA ' ' A' ' 76' ' ' LYS . 0.6 OUTLIER -62.79 -35.29 79.39 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.001 -175.026 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 4.6 p30 -78.03 -33.51 51.06 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 119.657 -0.817 . . . . 0.0 110.339 178.772 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 45.4 tpp -61.96 -51.92 66.12 Favored 'General case' 0 C--O 1.222 -0.391 0 N-CA-C 111.462 0.171 . . . . 0.0 111.462 176.572 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.854 HG11 HG13 ' A' ' 18' ' ' ILE . 2.4 p -59.17 -37.03 66.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 C-N-CA 120.828 -0.349 . . . . 0.0 110.628 177.817 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 91.8 m -61.53 -39.09 89.8 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-O 120.894 0.378 . . . . 0.0 110.694 175.724 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . 0.451 ' O ' ' HD2' ' A' ' 84' ' ' LYS . 0.2 OUTLIER -75.91 -44.94 37.85 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 179.717 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . 0.464 ' CG ' HH21 ' A' ' 46' ' ' ARG . 1.8 m-20 -69.6 -19.92 63.64 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.466 -0.788 . . . . 0.0 111.702 -176.387 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 73.1 mt-30 60.08 58.93 2.53 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-O 121.531 0.681 . . . . 0.0 110.936 176.853 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.604 HD21 ' HB3' ' A' ' 49' ' ' LEU . 81.9 mt -86.31 134.14 33.76 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.458 -0.792 . . . . 0.0 111.132 -177.068 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.569 ' HB3' ' OE2' ' A' ' 56' ' ' GLU . 11.7 mmmm -91.93 -168.99 2.14 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.934 177.249 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 84.49 160.25 31.35 Favored Glycine 0 N--CA 1.447 -0.612 0 C-N-CA 121.098 -0.573 . . . . 0.0 112.336 -177.436 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.638 ' O ' ' HA ' ' A' ' 67' ' ' VAL . 53.8 mt -77.68 113.0 16.29 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 175.405 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . 0.6 ' HB2' ' CZ2' ' A' ' 38' ' ' TRP . 1.6 pt20 -124.14 123.12 39.61 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-O 121.439 0.637 . . . . 0.0 112.074 -167.452 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.548 HD13 ' HB ' ' A' ' 23' ' ' VAL . 2.8 mm? -120.6 167.51 12.34 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.391 -0.822 . . . . 0.0 109.621 178.276 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 20.6 t-80 -138.66 126.89 22.82 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-O 121.201 0.524 . . . . 0.0 111.36 -173.084 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' MET . . . . . 0.624 ' HE2' ' HB2' ' A' ' 101' ' ' MET . 37.1 ttp -88.57 -67.05 0.86 Allowed 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 114.989 -1.005 . . . . 0.0 109.4 176.683 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . 0.425 ' HA2' ' O ' ' A' ' 72' ' ' ASP . . . 84.07 -77.5 2.11 Favored Glycine 0 N--CA 1.442 -0.901 0 C-N-CA 120.74 -0.743 . . . . 0.0 114.069 172.951 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 5.6 p -84.93 -19.57 32.0 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 113.247 0.832 . . . . 0.0 113.247 -169.75 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -101.54 154.77 18.55 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 119.723 -0.791 . . . . 0.0 111.023 -178.172 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . 0.464 ' HA ' ' HB3' ' A' ' 101' ' ' MET . 0.0 OUTLIER -140.66 9.05 2.19 Favored 'General case' 0 N--CA 1.446 -0.643 0 CA-C-N 115.511 -0.768 . . . . 0.0 109.789 173.083 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 4.5 m -78.32 -36.31 46.55 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.246 0.546 . . . . 0.0 109.793 178.426 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 70.5 t80 -74.78 -30.5 61.46 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 174.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' MET . . . . . 0.68 ' HG2' HG13 ' A' ' 106' ' ' ILE . 1.6 tmt? -64.2 -38.02 89.55 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 114.453 -1.249 . . . . 0.0 109.977 172.034 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -65.72 -44.44 86.05 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.468 -0.787 . . . . 0.0 110.483 177.61 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -62.88 -21.24 65.85 Favored 'General case' 0 CA--C 1.528 0.132 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.882 -177.604 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 6.3 m-30 -100.39 -3.1 31.77 Favored 'General case' 0 C--O 1.237 0.419 0 CA-C-N 116.418 -0.355 . . . . 0.0 111.002 179.645 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 95.4 mt 59.05 25.94 14.49 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.108 -179.168 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . 0.68 HG13 ' HG2' ' A' ' 101' ' ' MET . 30.4 pt -86.64 66.14 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-O 121.664 0.745 . . . . 0.0 111.01 -177.693 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . 0.58 ' HA ' ' HE2' ' A' ' 101' ' ' MET . 44.2 t-20 -81.51 -59.72 2.52 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.364 -0.834 . . . . 0.0 109.81 179.786 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -82.93 90.2 1.53 Allowed Glycine 0 N--CA 1.446 -0.673 0 C-N-CA 120.634 -0.794 . . . . 0.0 111.482 176.931 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . 0.511 HD11 ' CH2' ' A' ' 41' ' ' TRP . 46.5 pt -91.33 158.23 41.32 Favored Pre-proline 0 C--N 1.326 -0.448 0 N-CA-C 110.655 -0.128 . . . . 0.0 110.655 179.89 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . 0.747 ' HD3' ' HB2' ' A' ' 45' ' ' CYS . 40.9 Cg_endo -65.84 153.98 79.98 Favored 'Cis proline' 0 C--N 1.35 0.605 0 C-N-CA 124.006 -1.248 . . . . 0.0 113.691 1.939 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . 0.494 ' HG3' ' HA ' ' A' ' 106' ' ' ILE . 0.0 OUTLIER -125.8 138.14 53.82 Favored 'General case' 0 N--CA 1.446 -0.668 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.017 -179.302 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . 0.778 ' HD2' ' HB2' ' A' ' 128' ' ' ARG . 0.1 OUTLIER -102.05 117.53 34.99 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.358 -0.837 . . . . 0.0 110.633 -177.74 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.548 ' HB ' ' HB ' ' A' ' 35' ' ' ILE . 92.7 mt -131.15 145.13 35.87 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.283 0 CA-C-O 120.87 0.367 . . . . 0.0 111.128 -178.065 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.417 ' C ' HD12 ' A' ' 115' ' ' LEU . 42.0 tp -125.61 141.65 51.92 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.332 -0.395 . . . . 0.0 109.943 178.193 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.657 ' HG ' ' HA ' ' A' ' 121' ' ' ILE . 3.0 mp -134.87 153.98 51.84 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.061 0.458 . . . . 0.0 110.587 -178.018 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 27.8 t0 -79.72 166.49 21.74 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.221 -0.9 . . . . 0.0 110.765 178.596 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . 0.408 ' HA ' ' O ' ' A' ' 31' ' ' LYS . 5.6 mtm180 -53.57 -26.42 21.42 Favored 'General case' 0 N--CA 1.466 0.348 0 O-C-N 124.437 1.085 . . . . 0.0 111.956 -178.8 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -69.31 -16.72 63.61 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.302 0.573 . . . . 0.0 110.549 178.89 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 93.0 24.44 22.65 Favored Glycine 0 N--CA 1.436 -1.353 0 N-CA-C 109.762 -1.335 . . . . 0.0 109.762 -169.893 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . 0.4 ' HD2' ' HA ' ' A' ' 120' ' ' LYS . 24.6 mmmt -111.7 114.34 27.29 Favored 'General case' 0 C--O 1.221 -0.403 0 N-CA-C 112.235 0.457 . . . . 0.0 112.235 -172.507 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . 0.657 ' HA ' ' HG ' ' A' ' 115' ' ' LEU . 4.1 mp -42.74 116.01 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 O-C-N 123.972 0.795 . . . . 0.0 111.761 178.576 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' ILE . . . . . 0.413 ' H ' ' HA ' ' A' ' 115' ' ' LEU . 69.3 mt -87.84 -47.69 15.52 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-N 115.21 -0.904 . . . . 0.0 108.726 174.94 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 15.1 m -128.52 114.53 16.87 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-N 115.003 -0.999 . . . . 0.0 109.944 179.631 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -70.98 -21.66 62.29 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.103 0.478 . . . . 0.0 110.577 178.509 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 6.9 t30 -139.57 101.53 4.24 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.539 -0.755 . . . . 0.0 109.009 176.399 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 13.1 tpt -105.48 -127.04 0.24 Allowed 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.2 -175.891 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 2.0 p -145.08 136.61 25.28 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 110.134 -0.321 . . . . 0.0 110.134 -178.062 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . 0.778 ' HB2' ' HD2' ' A' ' 112' ' ' PHE . 14.8 ttt180 -94.68 152.55 39.92 Favored Pre-proline 0 CA--C 1.535 0.401 0 CA-C-O 119.242 -0.408 . . . . 0.0 110.854 -177.978 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . 0.674 ' HD2' ' CG ' ' A' ' 128' ' ' ARG . 47.0 Cg_exo -24.4 -39.72 0.02 OUTLIER 'Trans proline' 0 C--N 1.366 1.469 1 C-N-CA 126.32 4.68 . . . . 0.0 117.275 175.771 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' SER . . . . . 0.505 ' HG ' ' CD ' ' A' ' 48' ' ' GLU . 66.6 m -50.33 -29.85 10.79 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-N 118.526 0.603 . . . . 0.0 111.129 175.302 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -92.2 121.36 66.77 Favored Pre-proline 0 C--N 1.323 -0.571 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.536 175.519 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . 0.467 ' O ' ' HG3' ' A' ' 136' ' ' GLU . 59.9 Cg_endo -72.16 -23.73 20.93 Favored 'Trans proline' 0 N--CA 1.462 -0.346 0 C-N-CA 122.492 2.128 . . . . 0.0 112.322 179.664 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . 0.47 ' HA ' ' HD3' ' A' ' 133' ' ' LYS . 57.3 mmtt -63.09 -30.25 71.45 Favored 'General case' 0 CA--C 1.518 -0.259 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.878 -177.771 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' THR . . . . . 0.764 HG21 ' CZ ' ' A' ' 138' ' ' PHE . 3.0 m -59.11 -54.81 42.83 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.742 -0.663 . . . . 0.0 109.718 175.234 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . 0.582 ' HA ' ' CD2' ' A' ' 138' ' ' PHE . . . -59.99 -43.56 95.09 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-N 115.67 -0.695 . . . . 0.0 112.045 177.817 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . 0.467 ' HG3' ' O ' ' A' ' 132' ' ' PRO . 50.8 mt-10 -55.72 -52.01 65.38 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-O 122.025 0.917 . . . . 0.0 110.269 177.47 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . 0.658 ' HE3' HD21 ' A' ' 141' ' ' LEU . 52.3 tptt -54.53 -40.63 68.83 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 113.956 -1.475 . . . . 0.0 111.319 179.113 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . 0.764 ' CZ ' HG21 ' A' ' 134' ' ' THR . 19.5 m-30 -55.49 -47.69 75.77 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 116.63 -0.259 . . . . 0.0 110.582 177.105 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . 0.6 ' HB3' ' HG3' ' A' ' 145' ' ' GLU . 39.5 m-20 -54.18 -55.03 31.86 Favored 'General case' 0 CA--C 1.521 -0.162 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 -179.254 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . 0.592 ' CD ' ' HZ3' ' A' ' 137' ' ' LYS . 8.8 tt0 -48.87 -57.71 5.99 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.403 -0.817 . . . . 0.0 111.968 174.95 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . 0.658 HD21 ' HE3' ' A' ' 137' ' ' LYS . 90.2 mt -60.89 -37.3 81.74 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.799 -174.477 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . 0.736 ' HB3' ' HE2' ' A' ' 62' ' ' LYS . 89.2 mt -79.14 -11.35 59.97 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.144 -178.387 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 86.9 19.67 55.47 Favored Glycine 0 N--CA 1.449 -0.454 0 N-CA-C 111.528 -0.629 . . . . 0.0 111.528 178.713 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 9.5 tt -80.15 -40.15 27.96 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 -179.594 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . 0.6 ' HG3' ' HB3' ' A' ' 139' ' ' ASN . 34.6 mt-10 -107.9 -171.56 1.89 Allowed 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.812 177.077 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 78.56 -119.59 5.16 Favored Glycine 0 N--CA 1.447 -0.614 0 C-N-CA 121.002 -0.618 . . . . 0.0 112.258 178.751 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 70.0 m80 -87.45 54.99 3.33 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.306 0.574 . . . . 0.0 110.594 -177.073 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 12.3 t60 -93.65 -5.4 48.73 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.006 -179.312 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -101.84 140.59 35.91 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.344 179.313 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 17.4 p80 -163.4 127.56 2.86 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.209 178.845 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 84.6 t60 -127.41 140.74 51.97 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 120.859 0.361 . . . . 0.0 110.799 -176.303 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 15.5 m170 . . . . . 0 C--O 1.242 0.661 0 CA-C-O 118.46 -0.781 . . . . 0.0 109.937 175.531 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.8 mtt . . . . . 0 N--CA 1.48 1.052 0 N-CA-C 110.164 -0.31 . . . . 0.0 110.164 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.736 ' HA ' ' HA ' ' A' ' 8' ' ' PRO . 27.9 m -78.83 131.54 36.51 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 109.738 -0.467 . . . . 0.0 109.738 175.876 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.545 HD22 ' H ' ' A' ' 3' ' ' LEU . 2.8 mm? -55.36 -58.36 8.05 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.988 0.423 . . . . 0.0 110.326 179.915 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 57.0 mtt180 -138.76 -68.75 0.44 Allowed 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 109.287 -0.635 . . . . 0.0 109.287 174.34 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 50.5 m -149.31 144.37 26.42 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.55 -0.75 . . . . 0.0 109.423 176.169 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 128.32 -94.16 0.37 Allowed Glycine 0 N--CA 1.447 -0.619 0 C-N-CA 120.811 -0.709 . . . . 0.0 111.84 -179.43 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . 0.931 ' HB2' ' HB3' ' A' ' 11' ' ' ALA . 78.7 m-20 -130.1 151.13 77.83 Favored Pre-proline 0 C--N 1.326 -0.451 0 N-CA-C 109.823 -0.436 . . . . 0.0 109.823 177.465 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.736 ' HA ' ' HA ' ' A' ' 2' ' ' SER . 9.7 Cg_exo -72.21 -62.61 0.04 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.368 0 C-N-CA 122.559 2.173 . . . . 0.0 111.484 174.084 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 16.2 m -102.08 165.39 11.19 Favored 'General case' 0 N--CA 1.447 -0.611 0 CA-C-N 115.952 -0.567 . . . . 0.0 109.897 179.296 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.641 ' HA ' ' HZ ' ' A' ' 100' ' ' PHE . . . 75.76 -44.65 0.52 Allowed 'General case' 0 N--CA 1.47 0.542 0 O-C-N 124.065 0.853 . . . . 0.0 112.667 174.896 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.931 ' HB3' ' HB2' ' A' ' 7' ' ' ASN . . . -56.67 -32.54 65.51 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 112.87 0.693 . . . . 0.0 112.87 -172.895 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 31.1 m -147.68 86.56 1.6 Allowed 'General case' 0 C--N 1.316 -0.873 0 CA-C-O 121.128 0.489 . . . . 0.0 111.362 179.188 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . 0.468 ' CE2' HD22 ' A' ' 25' ' ' LEU . 47.9 p90 -105.57 163.15 12.89 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 172.712 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' SER . . . . . 0.419 ' HA ' ' HA ' ' A' ' 24' ' ' SER . 14.0 m -139.71 122.03 15.99 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 109.805 -0.442 . . . . 0.0 109.805 178.852 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . 0.413 ' HA ' ' HD3' ' A' ' 16' ' ' PRO . 19.6 m-85 -137.11 149.32 65.84 Favored Pre-proline 0 C--N 1.327 -0.393 0 CA-C-O 120.678 0.275 . . . . 0.0 110.744 -177.262 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.46 ' HD2' ' O ' ' A' ' 93' ' ' HIS . 9.2 Cg_exo -72.35 124.37 9.87 Favored 'Trans proline' 0 N--CA 1.456 -0.678 0 C-N-CA 122.473 2.115 . . . . 0.0 112.54 178.02 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . 0.865 ' HB3' ' HB3' ' A' ' 21' ' ' LYS . 0.2 OUTLIER -68.97 162.95 25.65 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.132 -0.94 . . . . 0.0 109.765 172.769 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.633 HD11 HG12 ' A' ' 82' ' ' VAL . 0.8 OUTLIER -44.78 -43.42 2.49 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 O-C-N 124.147 0.904 . . . . 0.0 112.171 -177.227 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . 0.505 ' ND2' HG23 ' A' ' 18' ' ' ILE . 21.8 m-80 -77.42 1.2 19.82 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.144 -175.349 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 85.84 30.61 23.08 Favored Glycine 0 N--CA 1.446 -0.663 0 N-CA-C 110.682 -0.967 . . . . 0.0 110.682 -173.626 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.865 ' HB3' ' HB3' ' A' ' 17' ' ' ASP . 2.0 ttmp? -98.09 116.04 29.48 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.481 -0.36 . . . . 0.0 110.902 -172.933 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 25.6 m -70.38 104.78 2.81 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 120.867 0.365 . . . . 0.0 110.905 178.799 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.433 ' HB ' ' CD2' ' A' ' 92' ' ' LEU . 61.0 t -121.32 146.16 26.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 178.741 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' SER . . . . . 0.419 ' HA ' ' HA ' ' A' ' 14' ' ' SER . 86.7 p -121.52 -173.96 2.75 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 109.985 -0.376 . . . . 0.0 109.985 -178.666 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.685 ' O ' ' HB2' ' A' ' 29' ' ' LYS . 15.0 tp -98.84 0.69 44.78 Favored 'General case' 0 C--N 1.32 -0.685 0 C-N-CA 120.16 -0.616 . . . . 0.0 109.951 173.881 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -85.99 -32.71 21.37 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.398 -179.06 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -77.01 -17.98 58.47 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.367 0.603 . . . . 0.0 110.117 176.104 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 85.8 mt -100.12 -5.31 28.06 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.602 -0.727 . . . . 0.0 110.429 176.859 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.685 ' HB2' ' O ' ' A' ' 25' ' ' LEU . 58.4 tttm -81.7 140.98 34.0 Favored 'General case' 0 N--CA 1.443 -0.79 0 CA-C-N 115.582 -0.735 . . . . 0.0 110.705 -172.338 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 115.63 -13.58 17.88 Favored Glycine 0 N--CA 1.452 -0.239 0 N-CA-C 111.326 -0.71 . . . . 0.0 111.326 -175.389 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.501 ' HG3' ' OD1' ' A' ' 63' ' ' ASP . 25.0 ttmm -132.27 153.1 50.99 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 177.129 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.648 ' HB2' HG23 ' A' ' 64' ' ' ILE . 24.7 m-85 -51.92 141.85 16.78 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 118.328 0.513 . . . . 0.0 110.916 -176.491 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.571 HG21 HD13 ' A' ' 25' ' ' LEU . 67.3 mt -119.27 122.29 68.72 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.74 -174.545 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . 0.523 ' OH ' ' HG3' ' A' ' 128' ' ' ARG . 30.2 t80 -114.99 134.66 54.99 Favored 'General case' 0 C--N 1.316 -0.863 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 173.94 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.61 ' HA ' ' O ' ' A' ' 67' ' ' VAL . 82.1 mt -130.26 129.88 65.3 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.047 -176.651 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.62 ' O ' ' HA ' ' A' ' 68' ' ' SER . 4.6 p30 -130.6 160.29 34.64 Favored 'General case' 0 C--O 1.217 -0.614 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.418 172.71 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.536 ' HB ' ' HA ' ' A' ' 110' ' ' PRO . 47.8 t -95.56 137.94 22.44 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 CA-C-O 121.087 0.47 . . . . 0.0 111.779 -178.429 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' TRP . . . . . 0.926 ' HZ3' HG21 ' A' ' 82' ' ' VAL . 0.6 OUTLIER -122.34 132.91 54.62 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 174.244 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -148.43 154.14 39.48 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 120.767 -0.373 . . . . 0.0 111.655 -176.727 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' THR . . . . . 0.672 ' HB ' ' CE3' ' A' ' 78' ' ' TRP . 4.1 t -92.93 -28.68 16.31 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 121.203 -0.199 . . . . 0.0 110.785 173.516 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 11.5 p-90 -81.69 -8.32 59.69 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.939 0.4 . . . . 0.0 110.417 179.537 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . 0.535 ' HB3' ' SG ' ' A' ' 45' ' ' CYS . 47.7 t -86.35 -71.33 0.55 Allowed 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 173.099 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 112.21 -77.53 0.24 Allowed Glycine 0 C--O 1.227 -0.293 0 C-N-CA 120.532 -0.842 . . . . 0.0 113.239 176.87 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.535 ' HD2' ' O ' ' A' ' 42' ' ' CYS . 9.7 Cg_endo -52.38 -31.79 49.08 Favored 'Trans proline' 0 C--N 1.353 0.815 0 C-N-CA 123.182 2.588 . . . . 0.0 112.431 -178.636 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . 0.569 ' HB3' ' HD3' ' A' ' 110' ' ' PRO . 26.9 p -61.41 -17.0 52.21 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.688 -179.899 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.475 ' HA ' HD23 ' A' ' 49' ' ' LEU . 61.7 mtp180 -83.27 -19.4 36.41 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.814 0.34 . . . . 0.0 111.075 -177.48 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -83.77 -7.68 85.5 Favored Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.479 -176.705 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -95.58 -10.44 29.55 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.513 0.197 . . . . 0.0 111.152 -177.283 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.958 ' HG ' ' HB3' ' A' ' 87' ' ' LEU . 4.2 mm? -55.25 -44.85 99.85 Favored Pre-proline 0 CA--C 1.538 0.487 0 CA-C-N 116.649 -0.251 . . . . 0.0 111.505 176.709 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.661 ' O ' ' HG2' ' A' ' 54' ' ' GLU . 76.0 Cg_exo -52.68 -37.37 75.1 Favored 'Trans proline' 0 C--N 1.357 0.981 0 C-N-CA 121.816 1.677 . . . . 0.0 112.131 170.606 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -71.51 -19.84 62.14 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.35 0.595 . . . . 0.0 110.704 -178.071 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 8.1 tt -72.88 -45.69 56.85 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.568 -0.742 . . . . 0.0 109.692 -179.83 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.504 ' HG3' ' N ' ' A' ' 54' ' ' GLU . 7.9 ptmm? -63.89 -42.04 97.57 Favored 'General case' 0 C--O 1.226 -0.15 0 N-CA-C 109.878 -0.415 . . . . 0.0 109.878 177.704 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.661 ' HG2' ' O ' ' A' ' 50' ' ' PRO . 55.2 mm-40 -51.22 -49.75 60.44 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-O 121.64 0.733 . . . . 0.0 110.224 177.932 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.708 HD13 ' HD2' ' A' ' 59' ' ' TYR . 0.2 OUTLIER -66.7 -39.21 87.98 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.068 -0.969 . . . . 0.0 110.755 -179.021 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 14.2 tp10 -61.23 -57.66 11.51 Favored 'General case' 0 N--CA 1.447 -0.591 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.045 -177.207 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 -67.97 -25.42 65.42 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 111.744 0.276 . . . . 0.0 111.744 -176.113 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . 0.492 ' HD3' ' CE2' ' A' ' 59' ' ' TYR . 63.4 tttt -67.7 -34.12 76.25 Favored 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 120.759 -0.376 . . . . 0.0 110.51 174.064 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.708 ' HD2' HD13 ' A' ' 55' ' ' LEU . 68.3 m-85 -119.81 25.17 10.15 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.426 -176.327 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -49.63 116.51 1.79 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.059 0.457 . . . . 0.0 111.972 178.143 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 105.11 -0.73 40.96 Favored Glycine 0 N--CA 1.453 -0.214 0 C-N-CA 120.945 -0.645 . . . . 0.0 112.451 179.504 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.803 ' HG2' HG12 ' A' ' 64' ' ' ILE . 0.0 OUTLIER -67.32 174.9 2.98 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.523 0.678 . . . . 0.0 112.422 -178.299 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.501 ' OD1' ' HG3' ' A' ' 31' ' ' LYS . 32.3 t70 -101.28 51.45 0.85 Allowed 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.905 -177.317 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.803 HG12 ' HG2' ' A' ' 62' ' ' LYS . 19.4 pt -146.8 165.57 7.3 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.401 0 N-CA-C 110.113 -0.329 . . . . 0.0 110.113 177.546 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' HIS . . . . . 0.475 ' NE2' ' HB3' ' A' ' 31' ' ' LYS . 85.2 m-70 -122.9 140.42 52.99 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 175.922 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . 0.68 ' O ' ' HB ' ' A' ' 90' ' ' ILE . 79.6 m-85 -102.01 103.18 13.78 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 172.381 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.61 ' O ' ' HA ' ' A' ' 35' ' ' ILE . 39.0 t -119.12 113.6 41.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-O 120.967 0.413 . . . . 0.0 111.11 -175.465 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' SER . . . . . 0.62 ' HA ' ' O ' ' A' ' 36' ' ' ASP . 0.7 OUTLIER -93.95 131.96 38.88 Favored 'General case' 0 C--N 1.317 -0.824 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 177.521 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.536 ' CD2' ' HB2' ' A' ' 92' ' ' LEU . 73.2 mt -118.2 137.7 52.83 Favored 'General case' 0 N--CA 1.468 0.463 0 O-C-N 122.072 -0.392 . . . . 0.0 110.426 176.918 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' SER . . . . . 0.552 ' HB2' ' O ' ' A' ' 38' ' ' TRP . 1.3 t -118.06 123.5 45.81 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.188 0.518 . . . . 0.0 112.029 -176.209 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 49.7 t -89.85 14.14 12.75 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.75 176.417 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.55 ' O ' ' HA2' ' A' ' 95' ' ' GLY . 0.9 OUTLIER -65.53 133.11 50.53 Favored 'General case' 0 CA--C 1.516 -0.362 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 -178.292 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.486 ' HB2' ' NZ ' ' A' ' 73' ' ' LYS . 1.0 OUTLIER -87.45 -24.94 23.99 Favored 'General case' 0 C--N 1.316 -0.872 0 C-N-CA 120.084 -0.646 . . . . 0.0 110.571 -177.646 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . 0.497 ' HB2' ' HB3' ' A' ' 77' ' ' ALA . 0.7 OUTLIER -84.12 78.97 9.67 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.343 176.175 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.453 ' HZ2' ' CD ' ' A' ' 79' ' ' GLU . 10.2 tttt -61.63 -56.58 18.31 Favored 'General case' 0 C--O 1.221 -0.443 0 C-N-CA 120.826 -0.35 . . . . 0.0 111.741 -173.763 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.551 ' HA ' ' OE1' ' A' ' 79' ' ' GLU . 17.3 tppt? -57.09 -40.62 77.32 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 111.882 0.327 . . . . 0.0 111.882 -177.903 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.497 ' HB3' ' HB2' ' A' ' 74' ' ' ASN . . . -62.79 -41.2 99.16 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.827 0.823 . . . . 0.0 110.188 177.393 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' TRP . . . . . 0.672 ' CE3' ' HB ' ' A' ' 40' ' ' THR . 5.2 t-105 -74.31 -47.57 33.81 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 114.698 -1.137 . . . . 0.0 111.202 -176.802 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.551 ' OE1' ' HA ' ' A' ' 76' ' ' LYS . 3.3 pt-20 -64.57 -35.52 81.24 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.938 -174.782 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 3.6 p30 -74.94 -37.13 62.07 Favored 'General case' 0 CA--C 1.523 -0.081 0 C-N-CA 119.995 -0.682 . . . . 0.0 110.114 179.053 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 34.4 ttm -64.1 -50.52 67.98 Favored 'General case' 0 C--O 1.219 -0.552 0 C-N-CA 120.65 -0.42 . . . . 0.0 110.784 175.914 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.926 HG21 ' HZ3' ' A' ' 38' ' ' TRP . 12.5 p -63.18 -23.23 32.75 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-O 121.086 0.469 . . . . 0.0 111.005 -178.158 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' THR . . . . . 0.563 ' OG1' HD13 ' A' ' 18' ' ' ILE . 88.2 m -76.38 -46.82 25.65 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.566 -0.288 . . . . 0.0 110.453 171.98 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.32 -42.36 88.32 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.337 0.589 . . . . 0.0 110.384 -178.286 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -74.51 -5.61 43.66 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.186 -0.915 . . . . 0.0 111.282 -179.824 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 47.7 mt-30 63.52 17.74 10.57 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 115.867 -0.606 . . . . 0.0 112.368 174.556 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.958 ' HB3' ' HG ' ' A' ' 49' ' ' LEU . 29.2 mt -74.67 93.78 2.6 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.96 -0.385 . . . . 0.0 109.96 -179.986 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 9.0 mmtm -110.07 -178.84 3.62 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 113.006 0.743 . . . . 0.0 113.006 -176.261 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 130.88 -165.02 23.08 Favored Glycine 0 N--CA 1.449 -0.448 0 N-CA-C 109.71 -1.356 . . . . 0.0 109.71 -172.117 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.68 ' HB ' ' O ' ' A' ' 66' ' ' PHE . 60.9 mt -85.02 112.14 21.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 118.054 0.927 . . . . 0.0 108.508 172.808 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . 0.58 ' HB2' ' CZ2' ' A' ' 38' ' ' TRP . 2.1 pt20 -142.01 113.26 7.6 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 121.457 0.646 . . . . 0.0 111.69 -170.647 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.536 ' HB2' ' CD2' ' A' ' 69' ' ' LEU . 77.5 mt -110.42 154.23 23.87 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.495 -0.775 . . . . 0.0 109.902 -179.75 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' HIS . . . . . 0.46 ' O ' ' HD2' ' A' ' 16' ' ' PRO . 35.4 t-80 -121.93 126.81 49.47 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-O 121.455 0.645 . . . . 0.0 111.134 -175.254 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 28.2 ttp -91.12 -72.62 0.57 Allowed 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 114.801 -1.09 . . . . 0.0 109.923 178.197 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . 0.55 ' HA2' ' O ' ' A' ' 72' ' ' ASP . . . 86.48 -75.26 2.26 Favored Glycine 0 N--CA 1.446 -0.648 0 C-N-CA 120.601 -0.809 . . . . 0.0 114.24 173.863 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -90.42 -34.59 15.57 Favored 'General case' 0 C--N 1.315 -0.928 0 N-CA-C 112.126 0.417 . . . . 0.0 112.126 -174.556 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -92.75 54.91 2.32 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.717 -163.833 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . 0.4 ' HD3' ' C ' ' A' ' 98' ' ' ARG . 0.0 OUTLIER -67.71 4.94 0.94 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.952 -0.567 . . . . 0.0 112.405 -176.812 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 9.4 t -66.74 -19.44 65.75 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.126 0.489 . . . . 0.0 109.76 174.887 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . 0.641 ' HZ ' ' HA ' ' A' ' 10' ' ' ALA . 10.5 t80 -77.28 -23.87 51.09 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.174 177.652 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 93.6 mmm -62.41 -48.12 81.11 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 174.761 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -62.25 -22.49 66.03 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 115.405 -0.816 . . . . 0.0 111.649 176.603 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -70.42 -24.06 62.85 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.697 0.284 . . . . 0.0 111.115 179.544 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' TYR . . . . . 0.547 ' HB2' HD12 ' A' ' 106' ' ' ILE . 47.2 m-85 -106.28 -11.31 16.06 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.802 176.561 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 7.2 mp 67.14 14.59 9.83 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 115.61 -0.723 . . . . 0.0 112.071 179.181 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . 1.054 ' HB ' ' HG3' ' A' ' 111' ' ' ARG . 0.2 OUTLIER -82.84 149.95 4.45 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.428 0 CA-C-O 120.933 0.397 . . . . 0.0 110.804 -179.926 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 5.1 p30 -127.37 -57.65 1.29 Allowed 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.435 -179.289 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -76.38 116.1 4.62 Favored Glycine 0 N--CA 1.447 -0.601 0 C-N-CA 120.966 -0.635 . . . . 0.0 112.587 -179.389 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . 0.438 ' HB ' ' HA ' ' A' ' 110' ' ' PRO . 40.2 pt -102.65 153.62 38.05 Favored Pre-proline 0 C--N 1.326 -0.441 0 N-CA-C 110.43 -0.211 . . . . 0.0 110.43 176.344 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . 0.569 ' HD3' ' HB3' ' A' ' 45' ' ' CYS . 49.5 Cg_endo -71.61 133.94 30.69 Favored 'Cis proline' 0 C--N 1.343 0.288 0 C-N-CA 123.175 -1.594 . . . . 0.0 113.236 1.312 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . 1.054 ' HG3' ' HB ' ' A' ' 106' ' ' ILE . 0.0 OUTLIER -95.22 146.41 24.35 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 173.975 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . 0.542 ' CE1' ' HB2' ' A' ' 128' ' ' ARG . 9.7 m-85 -119.35 119.44 34.0 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 -177.495 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 91.7 mt -131.13 138.19 53.96 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-O 121.015 0.436 . . . . 0.0 110.975 -177.283 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.691 HD21 HD13 ' A' ' 141' ' ' LEU . 30.6 tp -119.47 133.09 55.86 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.631 -0.713 . . . . 0.0 109.471 177.738 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.423 ' N ' HD13 ' A' ' 115' ' ' LEU . 0.7 OUTLIER -133.74 155.33 49.96 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.206 0.527 . . . . 0.0 110.61 -178.003 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . 0.626 ' HB3' ' HB2' ' A' ' 120' ' ' LYS . 17.6 t70 -71.21 166.82 20.71 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.176 -0.92 . . . . 0.0 110.804 176.76 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . 0.406 ' N ' ' CG ' ' A' ' 116' ' ' ASP . 69.4 mtt85 -51.55 -32.15 27.1 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 124.281 1.033 . . . . 0.0 112.974 -178.09 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . 0.691 ' HB3' ' HD3' ' A' ' 120' ' ' LYS . 25.4 t70 -81.25 4.48 20.24 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-O 121.474 0.654 . . . . 0.0 110.474 179.45 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 81.31 23.11 59.38 Favored Glycine 0 N--CA 1.438 -1.207 0 N-CA-C 110.466 -1.054 . . . . 0.0 110.466 -173.832 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . 0.691 ' HD3' ' HB3' ' A' ' 118' ' ' ASP . 19.8 mmmt -81.27 106.69 13.45 Favored 'General case' 0 CA--C 1.51 -0.566 0 C-N-CA 120.646 -0.422 . . . . 0.0 110.864 -176.028 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 3.6 mp -47.05 106.58 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.315 -0.916 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.822 178.189 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 39.3 mm -88.34 -47.21 15.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 115.51 -0.768 . . . . 0.0 109.661 -179.75 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 13.6 m -144.95 114.64 7.26 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.721 178.576 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -74.52 -24.13 58.93 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.621 0.724 . . . . 0.0 109.782 174.774 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . 0.741 ' HA ' ' NH1' ' A' ' 111' ' ' ARG . 53.6 t30 -110.4 85.04 2.03 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.487 -0.779 . . . . 0.0 109.329 175.485 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' MET . . . . . 0.611 ' HG2' ' HB2' ' A' ' 114' ' ' LEU . 3.3 tpt -113.54 -166.91 1.13 Allowed 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 107.813 -1.18 . . . . 0.0 107.813 179.026 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' THR . . . . . 0.576 ' O ' HG23 ' A' ' 134' ' ' THR . 2.1 p -132.11 161.53 33.07 Favored 'General case' 0 C--N 1.316 -0.882 0 N-CA-C 109.684 -0.487 . . . . 0.0 109.684 179.864 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . 0.626 ' CG ' ' HD2' ' A' ' 129' ' ' PRO . 19.2 ttt180 -86.76 158.01 54.23 Favored Pre-proline 0 C--N 1.316 -0.887 0 N-CA-C 109.795 -0.446 . . . . 0.0 109.795 179.387 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . 0.626 ' HD2' ' CG ' ' A' ' 128' ' ' ARG . 49.3 Cg_exo -42.81 -23.66 0.35 Allowed 'Trans proline' 0 C--N 1.356 0.945 0 C-N-CA 123.468 2.779 . . . . 0.0 113.908 170.906 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -55.85 -31.91 63.17 Favored 'General case' 0 CA--C 1.529 0.143 0 CA-C-O 121.092 0.472 . . . . 0.0 110.691 175.325 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 11.1 t0 -101.67 127.83 30.4 Favored Pre-proline 0 C--O 1.237 0.439 0 CA-C-N 115.852 -0.613 . . . . 0.0 109.92 179.51 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -58.35 -26.81 78.93 Favored 'Trans proline' 0 C--N 1.347 0.464 0 C-N-CA 123.299 2.666 . . . . 0.0 114.047 -178.385 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 42.3 mttp -56.15 -42.25 76.7 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-O 121.457 0.646 . . . . 0.0 110.842 -177.451 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' THR . . . . . 0.576 HG23 ' O ' ' A' ' 127' ' ' THR . 0.1 OUTLIER -69.14 -43.07 75.08 Favored 'General case' 0 N--CA 1.443 -0.821 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.539 178.883 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . 0.526 ' HA ' ' CD2' ' A' ' 138' ' ' PHE . . . -56.78 -46.92 81.22 Favored 'General case' 0 C--O 1.238 0.478 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.618 179.259 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . 0.647 ' HA ' ' OD1' ' A' ' 139' ' ' ASN . 14.7 pt-20 -71.15 -23.75 62.13 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.621 -179.559 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . 0.623 ' O ' ' HB3' ' A' ' 140' ' ' GLU . 60.9 tttp -79.28 -26.9 42.25 Favored 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 120.422 -0.511 . . . . 0.0 111.023 173.313 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . 0.587 ' HD2' HD11 ' A' ' 55' ' ' LEU . 21.5 m-85 -65.15 -43.2 92.57 Favored 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 120.469 -0.492 . . . . 0.0 110.213 177.138 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . 0.647 ' OD1' ' HA ' ' A' ' 136' ' ' GLU . 2.0 p-10 -70.01 -32.18 70.22 Favored 'General case' 0 C--O 1.224 -0.264 0 C-N-CA 120.006 -0.678 . . . . 0.0 110.128 175.099 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . 0.623 ' HB3' ' O ' ' A' ' 137' ' ' LYS . 4.4 tt0 -51.23 -55.13 19.69 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-O 120.823 0.344 . . . . 0.0 110.657 169.371 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . 0.691 HD13 HD21 ' A' ' 114' ' ' LEU . 90.1 mt -58.42 -36.26 73.34 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.533 -178.918 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . 0.496 ' HG ' ' O ' ' A' ' 138' ' ' PHE . 86.9 mt -77.32 -18.51 57.41 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.2 -179.671 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 86.05 13.83 68.19 Favored Glycine 0 N--CA 1.45 -0.417 0 N-CA-C 110.749 -0.94 . . . . 0.0 110.749 -175.625 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 37.4 tp -97.86 37.45 1.4 Allowed 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 -178.128 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . 0.455 ' HG2' ' HA ' ' A' ' 140' ' ' GLU . 0.0 OUTLIER -54.57 138.25 41.38 Favored 'General case' 0 N--CA 1.445 -0.71 0 CA-C-N 114.663 -1.153 . . . . 0.0 113.69 -176.325 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -115.2 -2.4 21.76 Favored Glycine 0 N--CA 1.446 -0.697 0 CA-C-N 114.797 -1.092 . . . . 0.0 112.283 -177.546 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 36.2 m80 -83.23 -2.29 55.2 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.25 0.547 . . . . 0.0 109.597 177.194 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 44.5 t-80 -78.01 110.33 12.85 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.551 -0.749 . . . . 0.0 111.478 -176.364 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 1.6 t60 -113.99 162.41 16.46 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 175.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 49.0 t-80 -101.3 108.87 20.62 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.783 0.325 . . . . 0.0 111.348 -178.162 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 78.4 t60 -124.36 -1.37 8.13 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.522 0.677 . . . . 0.0 109.223 172.026 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 26.8 t-80 . . . . . 0 C--O 1.244 0.786 0 CA-C-N 115.185 -0.916 . . . . 0.0 109.109 178.829 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 54.3 ttm . . . . . 0 N--CA 1.482 1.173 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 13.2 m -141.1 -175.41 4.31 Favored 'General case' 0 C--N 1.324 -0.523 0 O-C-N 123.21 0.319 . . . . 0.0 110.208 -175.518 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.84 HD13 ' H ' ' A' ' 3' ' ' LEU . 0.0 OUTLIER -79.53 13.16 2.12 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.293 0.568 . . . . 0.0 111.088 178.799 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . 0.494 ' HG3' ' O ' ' A' ' 7' ' ' ASN . 19.1 tpt180 -145.93 105.35 3.94 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.648 -0.705 . . . . 0.0 109.898 -173.848 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 15.6 m -75.4 140.31 42.87 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.013 176.856 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 87.23 54.15 2.64 Favored Glycine 0 N--CA 1.449 -0.44 0 N-CA-C 110.821 -0.912 . . . . 0.0 110.821 -174.783 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . 0.494 ' O ' ' HG3' ' A' ' 4' ' ' ARG . 10.1 m-20 68.26 141.18 0.07 OUTLIER Pre-proline 0 N--CA 1.467 0.394 0 C-N-CA 123.307 0.643 . . . . 0.0 111.162 -174.382 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.421 ' HD3' ' HA ' ' A' ' 7' ' ' ASN . 25.2 Cg_exo -62.66 -15.81 48.79 Favored 'Trans proline' 0 CA--C 1.527 0.149 0 C-N-CA 123.001 2.467 . . . . 0.0 112.651 -176.82 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.405 ' C ' ' H ' ' A' ' 11' ' ' ALA . 19.7 m 67.98 99.62 0.05 Allowed 'General case' 0 N--CA 1.464 0.233 0 O-C-N 123.784 0.677 . . . . 0.0 111.58 175.861 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . 73.72 -42.08 0.51 Allowed 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 123.991 0.917 . . . . 0.0 111.592 179.125 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.405 ' H ' ' C ' ' A' ' 9' ' ' SER . . . -80.92 73.75 7.93 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.649 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.545 ' HA ' ' HB3' ' A' ' 25' ' ' LEU . 18.1 m 71.79 90.47 0.09 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.151 -0.931 . . . . 0.0 111.103 178.644 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 33.6 p90 -105.69 163.51 12.64 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.509 179.031 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' SER . . . . . 0.402 ' HA ' ' HA ' ' A' ' 24' ' ' SER . 11.9 p -137.45 128.27 27.18 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.276 -0.42 . . . . 0.0 109.902 178.053 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . 0.418 ' HA ' ' HD3' ' A' ' 16' ' ' PRO . 36.3 m-85 -140.91 149.63 56.78 Favored Pre-proline 0 C--N 1.326 -0.427 0 CA-C-N 116.532 -0.304 . . . . 0.0 110.248 -177.016 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.647 ' HA ' ' O ' ' A' ' 21' ' ' LYS . 3.8 Cg_exo -75.23 124.91 8.82 Favored 'Trans proline' 0 N--CA 1.453 -0.885 0 C-N-CA 122.201 1.934 . . . . 0.0 112.726 179.677 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . 0.739 ' HB3' ' HB3' ' A' ' 21' ' ' LYS . 0.0 OUTLIER -64.89 162.01 17.2 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.38 -0.827 . . . . 0.0 109.05 170.732 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.548 ' CG1' ' HA ' ' A' ' 79' ' ' GLU . 9.6 tp -62.42 -25.95 39.19 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.242 -171.656 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . 0.483 ' HB2' ' OD2' ' A' ' 17' ' ' ASP . 0.9 OUTLIER -80.85 4.98 17.4 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.127 177.253 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 78.89 49.54 6.4 Favored Glycine 0 N--CA 1.449 -0.451 0 N-CA-C 110.809 -0.917 . . . . 0.0 110.809 -176.258 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.739 ' HB3' ' HB3' ' A' ' 17' ' ' ASP . 0.0 OUTLIER -114.84 140.85 48.61 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.531 -0.335 . . . . 0.0 110.521 -173.63 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 19.6 m -90.62 99.07 12.17 Favored 'General case' 0 C--N 1.318 -0.762 0 C-N-CA 120.512 -0.475 . . . . 0.0 110.078 178.207 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.414 ' HB ' ' CD2' ' A' ' 92' ' ' LEU . 48.7 t -115.34 137.79 47.78 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 116.069 -0.514 . . . . 0.0 109.735 -179.756 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' SER . . . . . 0.402 ' HA ' ' HA ' ' A' ' 14' ' ' SER . 59.7 p -122.55 169.52 10.93 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.964 -175.786 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.78 HD12 HD13 ' A' ' 28' ' ' LEU . 32.5 tp -66.74 -16.1 64.0 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.026 174.87 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -62.4 -39.74 94.22 Favored 'General case' 0 C--N 1.333 -0.123 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.948 179.75 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -61.16 -33.81 74.02 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-O 121.772 0.796 . . . . 0.0 110.226 174.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.78 HD13 HD12 ' A' ' 25' ' ' LEU . 33.4 mt -79.64 -15.02 58.36 Favored 'General case' 0 N--CA 1.445 -0.688 0 CA-C-N 115.0 -1.0 . . . . 0.0 111.684 -173.008 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.663 ' HA ' ' O ' ' A' ' 117' ' ' ARG . 1.7 mptm? -66.46 160.83 24.11 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.392 0.615 . . . . 0.0 111.881 178.198 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 84.32 -14.83 43.25 Favored Glycine 0 N--CA 1.45 -0.374 0 CA-C-N 115.464 -0.789 . . . . 0.0 112.29 178.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.572 ' HG3' ' CG ' ' A' ' 63' ' ' ASP . 24.5 ttmm -144.15 143.15 30.96 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 109.311 -0.625 . . . . 0.0 109.311 -176.507 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 63.0 m-85 -56.2 155.04 7.11 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-O 120.681 0.277 . . . . 0.0 111.276 -177.689 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.545 HD13 ' HA2' ' A' ' 119' ' ' GLY . 43.3 mt -128.11 135.39 62.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-O 120.74 0.305 . . . . 0.0 111.565 -171.913 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . 0.52 ' HB2' HD13 ' A' ' 64' ' ' ILE . 88.1 t80 -120.04 116.47 25.79 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 173.532 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.528 ' HA ' ' O ' ' A' ' 67' ' ' VAL . 28.9 mm -101.7 132.21 48.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.566 -179.299 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.566 ' HA ' ' O ' ' A' ' 111' ' ' ARG . 1.2 t70 -140.77 162.76 34.65 Favored 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 176.992 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.546 ' HB ' ' HA ' ' A' ' 110' ' ' PRO . 46.8 t -102.06 131.22 50.5 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.919 0 C-N-CA 120.212 -0.595 . . . . 0.0 111.45 176.736 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' TRP . . . . . 0.668 ' CE3' ' HZ2' ' A' ' 78' ' ' TRP . 0.9 OUTLIER -126.14 132.75 51.78 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-O 120.822 0.344 . . . . 0.0 110.128 179.325 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.532 ' HB1' ' SG ' ' A' ' 42' ' ' CYS . . . -148.68 168.74 22.06 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-N 116.688 -0.233 . . . . 0.0 110.85 178.013 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' THR . . . . . 0.584 ' HB ' ' CE3' ' A' ' 78' ' ' TRP . 9.6 t -92.08 -18.68 23.24 Favored 'General case' 0 C--O 1.233 0.235 0 C-N-CA 120.868 -0.333 . . . . 0.0 111.667 179.265 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 1.5 p-90 -90.41 -13.46 34.9 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.788 0.328 . . . . 0.0 111.712 -177.44 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . 0.532 ' SG ' ' HB1' ' A' ' 39' ' ' ALA . 5.9 p -88.34 94.99 10.02 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.014 0.435 . . . . 0.0 110.515 177.723 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -54.17 -58.3 13.42 Favored Glycine 0 CA--C 1.524 0.647 0 CA-C-N 115.43 -0.804 . . . . 0.0 113.967 -179.309 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -53.95 -38.41 86.32 Favored 'Trans proline' 0 C--N 1.354 0.83 0 C-N-CA 122.721 2.28 . . . . 0.0 112.68 -178.31 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . 0.802 ' HB2' ' HD3' ' A' ' 110' ' ' PRO . 36.7 t -59.07 -38.54 79.69 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.184 0.516 . . . . 0.0 110.689 178.888 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.515 ' HA ' ' HG ' ' A' ' 49' ' ' LEU . 39.3 mtp180 -70.9 -15.83 62.64 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.911 -176.322 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -77.91 -26.48 60.28 Favored Glycine 0 N--CA 1.445 -0.701 0 C-N-CA 120.754 -0.736 . . . . 0.0 111.769 177.119 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.638 ' HB3' ' HB3' ' A' ' 130' ' ' SER . 14.2 pt-20 -107.03 0.99 24.01 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.841 0.353 . . . . 0.0 111.5 -179.854 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.539 ' N ' ' HD2' ' A' ' 50' ' ' PRO . 68.4 mt -59.94 -45.8 98.16 Favored Pre-proline 0 CA--C 1.537 0.456 0 CA-C-N 116.531 -0.304 . . . . 0.0 111.288 172.992 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.539 ' HD2' ' N ' ' A' ' 49' ' ' LEU . 11.9 Cg_endo -57.53 -35.16 98.89 Favored 'Trans proline' 0 C--N 1.356 0.965 0 C-N-CA 121.761 1.641 . . . . 0.0 111.913 171.323 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.559 ' HA ' ' HG2' ' A' ' 54' ' ' GLU . . . -67.3 -23.43 65.65 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-O 121.079 0.466 . . . . 0.0 110.806 179.042 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 10.0 tt -69.88 -34.08 73.08 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.944 -0.571 . . . . 0.0 109.554 176.073 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.49 ' HB3' ' O ' ' A' ' 50' ' ' PRO . 11.3 tttm -65.54 -46.71 78.5 Favored 'General case' 0 N--CA 1.425 -1.675 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 172.402 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.559 ' HG2' ' HA ' ' A' ' 51' ' ' ALA . 24.4 mm-40 -52.6 -44.65 66.11 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.05 -0.977 . . . . 0.0 110.001 176.688 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 47.8 mt -57.15 -53.55 56.8 Favored 'General case' 0 N--CA 1.452 -0.375 0 CA-C-N 115.433 -0.803 . . . . 0.0 111.249 175.418 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -48.87 -58.86 4.16 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.204 -0.907 . . . . 0.0 111.848 -179.052 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -71.11 -27.69 63.77 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 111.828 0.306 . . . . 0.0 111.828 -176.49 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 33.5 tttm -66.12 -25.04 66.81 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-O 121.01 0.433 . . . . 0.0 109.911 175.185 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.705 ' HD1' ' HG3' ' A' ' 62' ' ' LYS . 53.1 m-85 -124.26 18.34 9.06 Favored 'General case' 0 N--CA 1.453 -0.284 0 N-CA-C 112.766 0.654 . . . . 0.0 112.766 -176.522 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -62.03 110.23 1.52 Allowed 'General case' 0 C--N 1.323 -0.543 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 169.595 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 113.74 -13.27 22.57 Favored Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 120.802 -0.713 . . . . 0.0 111.758 -175.215 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.738 ' HD2' ' HG ' ' A' ' 142' ' ' LEU . 28.7 mmtp -84.82 -170.38 3.09 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-O 121.416 0.627 . . . . 0.0 110.809 177.418 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.572 ' CG ' ' HG3' ' A' ' 31' ' ' LYS . 16.9 t70 -116.95 82.96 1.89 Allowed 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.417 -179.217 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.52 HD13 ' HB2' ' A' ' 34' ' ' TYR . 17.2 tt -157.97 141.94 7.05 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.535 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.342 177.211 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' HIS . . . . . 0.516 ' NE2' ' HB3' ' A' ' 31' ' ' LYS . 84.5 m-70 -103.52 108.58 19.89 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 109.176 -0.676 . . . . 0.0 109.176 171.258 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 89.6 m-85 -78.78 103.54 8.79 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 172.783 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.695 ' HA ' ' O ' ' A' ' 90' ' ' ILE . 41.2 t -127.79 117.87 47.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-O 120.797 0.332 . . . . 0.0 111.068 -174.501 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' SER . . . . . 0.514 ' HA ' ' O ' ' A' ' 36' ' ' ASP . 8.3 m -109.16 147.37 32.61 Favored 'General case' 0 C--N 1.318 -0.768 0 C-N-CA 120.687 -0.405 . . . . 0.0 110.597 178.03 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.52 HD11 ' HB2' ' A' ' 92' ' ' LEU . 3.8 mm? -110.96 132.91 53.81 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.476 178.355 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 27.5 t -112.95 117.33 31.78 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.106 0.479 . . . . 0.0 111.693 -179.118 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 71.7 m -91.81 33.24 1.05 Allowed 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.247 172.791 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.523 ' OD2' HG22 ' A' ' 40' ' ' THR . 0.4 OUTLIER -75.62 126.41 30.95 Favored 'General case' 0 CA--C 1.512 -0.514 0 C-N-CA 120.155 -0.618 . . . . 0.0 110.446 178.07 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.533 ' H ' ' HE3' ' A' ' 73' ' ' LYS . 0.0 OUTLIER -78.13 -14.56 59.43 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.224 -178.887 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . 0.518 ' N ' ' HD2' ' A' ' 73' ' ' LYS . 0.6 OUTLIER -101.19 68.95 1.26 Allowed 'General case' 0 CA--C 1.512 -0.51 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 179.283 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.594 ' O ' ' HG3' ' A' ' 79' ' ' GLU . 11.8 tmtt? -54.66 -53.13 58.8 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.616 -173.779 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.443 ' HA ' ' CD ' ' A' ' 79' ' ' GLU . 18.2 tptp -52.87 -53.74 44.66 Favored 'General case' 0 C--N 1.327 -0.376 0 O-C-N 123.321 0.388 . . . . 0.0 110.847 179.018 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.584 ' HA ' ' ND2' ' A' ' 80' ' ' ASN . . . -56.53 -36.67 69.49 Favored 'General case' 0 C--O 1.24 0.565 0 CA-C-O 121.517 0.675 . . . . 0.0 110.505 179.358 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' TRP . . . . . 0.668 ' HZ2' ' CE3' ' A' ' 38' ' ' TRP . 8.0 t-105 -68.64 -34.21 75.35 Favored 'General case' 0 N--CA 1.435 -1.216 0 CA-C-N 114.807 -1.088 . . . . 0.0 110.606 -178.02 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.594 ' HG3' ' O ' ' A' ' 75' ' ' LYS . 52.7 mt-10 -53.66 -51.35 63.46 Favored 'General case' 0 CA--C 1.515 -0.39 0 CA-C-O 121.482 0.658 . . . . 0.0 110.822 173.766 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . 0.584 ' ND2' ' HA ' ' A' ' 77' ' ' ALA . 0.7 OUTLIER -66.23 -33.57 76.06 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.253 -0.885 . . . . 0.0 111.188 -173.282 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' MET . . . . . 0.403 ' HE3' HD12 ' A' ' 87' ' ' LEU . 1.4 tmt? -63.87 -59.12 4.92 Favored 'General case' 0 CA--C 1.517 -0.314 0 C-N-CA 120.849 -0.34 . . . . 0.0 111.306 177.731 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.556 HG21 ' HB2' ' A' ' 87' ' ' LEU . 5.7 p -58.52 -28.65 36.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-O 121.066 0.46 . . . . 0.0 110.873 -176.27 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 27.8 m -76.23 -40.43 52.12 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.927 -0.578 . . . . 0.0 110.954 176.902 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . 0.508 ' C ' ' HE2' ' A' ' 84' ' ' LYS . 0.0 OUTLIER -73.69 -49.0 27.92 Favored 'General case' 0 N--CA 1.456 -0.16 0 CA-C-O 121.338 0.589 . . . . 0.0 109.656 -178.096 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -76.27 0.49 19.09 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.129 -0.941 . . . . 0.0 111.211 -173.427 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 27.5 mt-30 61.41 34.21 18.34 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-N 115.79 -0.641 . . . . 0.0 112.575 168.853 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.556 ' HB2' HG21 ' A' ' 82' ' ' VAL . 72.0 mt -67.34 151.44 47.46 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.193 0.521 . . . . 0.0 111.548 -176.662 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 22.0 mmtm -117.75 -168.03 1.43 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.562 176.482 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 82.65 170.58 45.76 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 121.151 -0.547 . . . . 0.0 112.743 -177.719 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.695 ' O ' ' HA ' ' A' ' 67' ' ' VAL . 62.9 mt -85.64 112.11 21.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 N-CA-C 108.509 -0.922 . . . . 0.0 108.509 175.064 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . 0.657 ' HB3' ' CZ2' ' A' ' 38' ' ' TRP . 11.6 mm-40 -119.28 109.95 16.43 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-O 121.139 0.495 . . . . 0.0 111.181 -169.452 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.52 ' HB2' HD11 ' A' ' 69' ' ' LEU . 61.2 mt -106.55 149.46 27.12 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.465 0.65 . . . . 0.0 110.725 -177.64 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' HIS . . . . . 0.602 ' CE1' ' HA2' ' A' ' 95' ' ' GLY . 17.2 t-80 -119.95 111.59 18.11 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.662 -177.011 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 1.4 ttp -61.95 -49.64 75.3 Favored 'General case' 0 N--CA 1.448 -0.574 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.442 179.102 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . 0.602 ' HA2' ' CE1' ' A' ' 93' ' ' HIS . . . 118.68 -109.59 1.77 Allowed Glycine 0 N--CA 1.44 -1.076 0 CA-C-N 115.335 -0.848 . . . . 0.0 111.212 -177.997 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 1.7 m -126.94 24.17 6.48 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-O 120.731 0.3 . . . . 0.0 110.591 -179.255 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -87.32 142.65 27.73 Favored 'General case' 0 C--O 1.236 0.375 0 C-N-CA 119.656 -0.818 . . . . 0.0 111.276 -176.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . 0.775 ' HA ' ' HB2' ' A' ' 101' ' ' MET . 8.0 tpt180 -127.34 -3.42 6.19 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.039 -0.982 . . . . 0.0 110.163 178.057 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 1.5 m -66.49 -41.17 89.34 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 176.207 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . 0.402 ' CZ ' ' HE2' ' A' ' 104' ' ' TYR . 6.1 t80 -83.11 -24.34 32.66 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.433 -0.803 . . . . 0.0 109.707 176.298 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' MET . . . . . 0.775 ' HB2' ' HA ' ' A' ' 98' ' ' ARG . 0.0 OUTLIER -64.39 -55.49 20.69 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.432 -0.803 . . . . 0.0 109.078 178.125 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . 0.482 ' CG ' ' HE ' ' A' ' 98' ' ' ARG . 7.8 m-20 -65.02 -25.3 67.79 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.907 174.826 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -59.97 -32.24 70.64 Favored 'General case' 0 N--CA 1.466 0.33 0 N-CA-C 112.02 0.378 . . . . 0.0 112.02 -176.399 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' TYR . . . . . 0.402 ' HE2' ' CZ ' ' A' ' 100' ' ' PHE . 23.4 m-85 -101.04 8.55 42.89 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.619 0.247 . . . . 0.0 111.386 179.299 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 3.5 mm? 61.18 21.03 11.52 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.211 -179.831 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . 0.583 HG12 ' O ' ' A' ' 101' ' ' MET . 15.3 pt -79.98 150.55 4.91 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 176.013 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . 0.458 ' ND2' HH22 ' A' ' 98' ' ' ARG . 12.1 t-20 -160.82 -64.34 0.06 Allowed 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 -179.798 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -77.28 78.8 1.4 Allowed Glycine 0 N--CA 1.449 -0.498 0 N-CA-C 111.061 -0.815 . . . . 0.0 111.061 174.359 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . 0.553 ' HB ' ' HA ' ' A' ' 110' ' ' PRO . 2.8 pp -75.68 161.1 77.48 Favored Pre-proline 0 C--N 1.323 -0.572 0 CA-C-N 115.719 -0.241 . . . . 0.0 111.546 -175.366 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . 0.802 ' HD3' ' HB2' ' A' ' 45' ' ' CYS . 40.1 Cg_endo -68.72 164.21 76.73 Favored 'Cis proline' 0 C--N 1.35 0.633 0 C-N-CA 124.029 -1.238 . . . . 0.0 113.504 0.983 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . 0.566 ' O ' ' HA ' ' A' ' 36' ' ' ASP . 0.0 OUTLIER -129.54 137.59 50.85 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.728 -0.669 . . . . 0.0 109.43 179.314 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . 0.42 ' H ' ' HD3' ' A' ' 111' ' ' ARG . 0.2 OUTLIER -105.55 115.47 30.3 Favored 'General case' 0 C--N 1.323 -0.583 0 O-C-N 124.712 1.257 . . . . 0.0 111.413 -172.157 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.491 ' HB ' ' HB ' ' A' ' 35' ' ' ILE . 79.3 mt -131.16 146.15 34.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 120.936 0.398 . . . . 0.0 110.903 -178.956 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 42.0 tp -128.89 135.6 49.28 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.148 178.382 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.491 ' N ' HD13 ' A' ' 115' ' ' LEU . 1.3 mp -135.51 161.13 36.34 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.368 0.604 . . . . 0.0 110.892 -178.216 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . 0.848 ' HB3' ' HB2' ' A' ' 120' ' ' LYS . 17.8 t70 -74.22 165.35 25.31 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 114.874 -1.057 . . . . 0.0 110.443 175.728 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . 0.663 ' O ' ' HA ' ' A' ' 29' ' ' LYS . 53.8 mtt-85 -46.71 -39.35 11.35 Favored 'General case' 0 C--N 1.33 -0.271 0 O-C-N 124.308 1.005 . . . . 0.0 112.423 -178.562 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . 0.588 ' HA ' ' HG3' ' A' ' 29' ' ' LYS . 14.6 t0 -83.92 16.77 2.65 Favored 'General case' 0 C--O 1.237 0.423 0 CA-C-O 121.154 0.502 . . . . 0.0 111.253 -177.623 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . 0.545 ' HA2' HD13 ' A' ' 33' ' ' ILE . . . 72.85 25.26 74.32 Favored Glycine 0 N--CA 1.435 -1.416 0 C-N-CA 120.417 -0.897 . . . . 0.0 110.869 -175.712 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . 0.848 ' HB2' ' HB3' ' A' ' 116' ' ' ASP . 40.3 mmtm -85.7 104.17 15.17 Favored 'General case' 0 C--O 1.22 -0.462 0 C-N-CA 120.378 -0.529 . . . . 0.0 111.458 -179.196 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . 0.455 ' HA ' ' HG ' ' A' ' 115' ' ' LEU . 3.8 mp -44.81 113.22 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.678 -179.053 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 46.0 mm -95.75 -44.25 12.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.664 -0.698 . . . . 0.0 109.597 177.855 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 14.6 m -142.29 114.82 8.48 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.485 -0.78 . . . . 0.0 110.086 177.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -78.06 -6.9 56.05 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.043 0.449 . . . . 0.0 110.832 179.276 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 5.9 t30 -150.81 100.59 2.83 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.83 -0.623 . . . . 0.0 109.416 179.456 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' MET . . . . . 0.599 ' HG2' HG23 ' A' ' 134' ' ' THR . 43.9 tpp -89.67 -91.04 0.14 Allowed 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 111.935 0.346 . . . . 0.0 111.935 -176.76 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' THR . . . . . 0.544 ' O ' ' HG2' ' A' ' 128' ' ' ARG . 0.0 OUTLIER -152.67 -70.21 0.15 Allowed 'General case' 0 CA--C 1.531 0.235 0 N-CA-C 112.322 0.49 . . . . 0.0 112.322 -178.326 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . 0.544 ' HG2' ' O ' ' A' ' 127' ' ' THR . 3.5 mmt180 175.99 140.13 0.21 Allowed Pre-proline 0 N--CA 1.467 0.393 0 C-N-CA 124.351 1.06 . . . . 0.0 109.299 -173.474 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . 0.407 ' HG3' ' OD2' ' A' ' 36' ' ' ASP . 46.0 Cg_exo -56.44 -37.33 97.38 Favored 'Trans proline' 0 C--N 1.342 0.23 0 C-N-CA 122.339 2.026 . . . . 0.0 111.874 171.522 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' SER . . . . . 0.638 ' HB3' ' HB3' ' A' ' 48' ' ' GLU . 13.3 p -78.06 -25.67 47.83 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.821 179.663 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . 0.507 ' OD2' ' HB2' ' A' ' 133' ' ' LYS . 29.7 t70 -78.49 117.6 67.31 Favored Pre-proline 0 C--N 1.327 -0.406 0 CA-C-O 120.832 0.348 . . . . 0.0 110.724 -175.336 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . 0.58 ' O ' ' HG2' ' A' ' 136' ' ' GLU . 49.6 Cg_exo -56.6 -29.49 79.47 Favored 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 123.469 2.78 . . . . 0.0 113.73 -175.233 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . 0.703 ' O ' ' HG2' ' A' ' 137' ' ' LYS . 0.0 OUTLIER -54.48 -35.36 62.99 Favored 'General case' 0 N--CA 1.456 -0.152 0 CA-C-O 120.578 0.227 . . . . 0.0 110.688 -177.824 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' THR . . . . . 0.599 HG23 ' HG2' ' A' ' 126' ' ' MET . 4.6 m -60.69 -48.81 80.13 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.482 0.658 . . . . 0.0 110.666 178.399 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . 0.61 ' HA ' ' CD2' ' A' ' 138' ' ' PHE . . . -61.78 -43.36 99.0 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.315 -0.857 . . . . 0.0 111.106 -178.228 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . 0.58 ' HG2' ' O ' ' A' ' 132' ' ' PRO . 10.8 mm-40 -72.05 -23.97 61.45 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.546 -177.279 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . 0.703 ' HG2' ' O ' ' A' ' 133' ' ' LYS . 17.8 mmtm -56.07 -49.77 72.85 Favored 'General case' 0 CA--C 1.515 -0.369 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 167.901 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . 0.61 ' CD2' ' HA ' ' A' ' 135' ' ' ALA . 7.0 m-30 -55.26 -36.91 66.58 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-N 115.163 -0.926 . . . . 0.0 110.57 -178.746 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . 0.541 ' ND2' ' HA ' ' A' ' 136' ' ' GLU . 72.8 m-20 -58.13 -56.41 22.38 Favored 'General case' 0 C--N 1.332 -0.179 0 C-N-CA 120.686 -0.406 . . . . 0.0 110.693 175.839 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -44.73 -59.91 2.28 Favored 'General case' 0 C--N 1.342 0.258 0 O-C-N 123.615 0.572 . . . . 0.0 111.675 178.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . 0.459 HD13 ' O ' ' A' ' 137' ' ' LYS . 8.5 mp -50.69 -37.8 43.33 Favored 'General case' 0 CA--C 1.531 0.226 0 N-CA-C 112.595 0.591 . . . . 0.0 112.595 178.86 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . 0.738 ' HG ' ' HD2' ' A' ' 62' ' ' LYS . 3.8 mm? -79.3 -29.2 42.34 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.623 0.249 . . . . 0.0 111.623 179.264 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 98.13 27.27 8.89 Favored Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 120.949 -0.643 . . . . 0.0 112.297 178.789 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . 0.601 HD21 ' HZ1' ' A' ' 62' ' ' LYS . 50.4 tp -75.25 -32.28 61.04 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.037 0.446 . . . . 0.0 110.46 -177.621 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 4.4 mp0 -54.76 -34.92 63.21 Favored 'General case' 0 C--O 1.238 0.449 0 CA-C-N 115.287 -0.869 . . . . 0.0 110.88 178.477 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 64.45 8.4 31.67 Favored Glycine 0 C--N 1.32 -0.335 0 CA-C-N 114.097 -1.41 . . . . 0.0 112.525 -178.791 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 74.4 m80 -151.5 -57.18 0.15 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.216 0.531 . . . . 0.0 109.587 -175.766 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' HIS . . . . . 0.524 ' O ' ' HB2' ' A' ' 149' ' ' HIS . 67.5 t60 -76.62 92.32 3.49 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.602 -0.727 . . . . 0.0 111.272 -178.514 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . 0.524 ' HB2' ' O ' ' A' ' 148' ' ' HIS . 4.5 t-160 172.41 -80.53 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 115.408 -0.815 . . . . 0.0 108.911 170.235 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 17.0 t60 65.33 -65.95 0.15 Allowed 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 123.651 0.78 . . . . 0.0 111.427 -179.837 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 54.1 t-80 -153.8 99.5 2.29 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 109.934 -0.395 . . . . 0.0 109.934 177.222 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' HIS . . . . . 0.401 ' HB3' ' CD2' ' A' ' 149' ' ' HIS . 11.0 t-80 . . . . . 0 C--N 1.318 -0.77 0 CA-C-O 118.175 -0.917 . . . . 0.0 109.268 179.545 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 58.1 tpp . . . . . 0 N--CA 1.479 0.99 0 CA-C-O 120.792 0.329 . . . . 0.0 110.219 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 14.8 m -96.2 86.23 4.19 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.006 0.431 . . . . 0.0 109.93 179.385 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 88.5 mt -67.47 112.68 4.79 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.646 -0.706 . . . . 0.0 111.063 -178.492 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 5.9 ptp180 -117.52 6.86 12.57 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.539 -0.755 . . . . 0.0 109.547 178.494 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 8.0 m -141.03 129.56 22.62 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-N 115.039 -0.982 . . . . 0.0 109.243 -178.838 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 109.1 -133.23 11.53 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.756 -0.735 . . . . 0.0 111.381 -178.164 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 25.1 p-10 -114.93 149.79 43.06 Favored Pre-proline 0 C--N 1.325 -0.482 0 CA-C-N 116.994 0.397 . . . . 0.0 110.429 176.769 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 14.1 Cg_exo -68.16 146.72 71.12 Favored 'Trans proline' 0 N--CA 1.464 -0.219 0 C-N-CA 122.801 2.334 . . . . 0.0 112.279 179.521 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 51.0 m -103.12 174.01 6.05 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.18 -0.463 . . . . 0.0 109.968 176.524 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -76.45 71.08 3.09 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.136 0.493 . . . . 0.0 110.489 178.784 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -156.2 -43.44 0.08 Allowed 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.291 -0.868 . . . . 0.0 110.768 -179.35 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 23.5 p -149.91 33.49 0.68 Allowed 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 115.165 -0.925 . . . . 0.0 110.628 -178.256 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . 0.417 ' HB2' ' CE2' ' A' ' 15' ' ' TYR . 27.5 p90 -63.18 150.11 43.73 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.252 -177.278 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' SER . . . . . 0.404 ' HA ' ' HA ' ' A' ' 24' ' ' SER . 15.9 m -137.06 127.53 26.7 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 178.047 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . 0.417 ' CE2' ' HB2' ' A' ' 13' ' ' PHE . 77.6 m-85 -138.34 156.93 73.34 Favored Pre-proline 0 C--N 1.326 -0.436 0 CA-C-O 120.752 0.311 . . . . 0.0 111.356 -175.399 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.467 ' HD2' ' O ' ' A' ' 93' ' ' HIS . 1.6 Cg_endo -83.53 126.77 4.2 Favored 'Trans proline' 0 N--CA 1.459 -0.556 0 C-N-CA 123.183 2.588 . . . . 0.0 113.85 -178.488 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . 1.022 ' HB3' ' HB3' ' A' ' 21' ' ' LYS . 0.4 OUTLIER -65.08 166.14 9.99 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 114.88 -1.055 . . . . 0.0 109.584 169.47 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.571 ' HB ' ' HB2' ' A' ' 79' ' ' GLU . 40.0 pt -48.74 -33.36 5.01 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 C-N-CA 123.561 0.744 . . . . 0.0 112.803 -175.169 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 36.8 m-80 -83.7 -3.1 57.5 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.776 0.322 . . . . 0.0 111.599 -177.48 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 89.83 29.25 16.19 Favored Glycine 0 N--CA 1.45 -0.377 0 N-CA-C 110.212 -1.155 . . . . 0.0 110.212 -171.21 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 1.022 ' HB3' ' HB3' ' A' ' 17' ' ' ASP . 19.1 ttmt -92.23 111.74 23.42 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 114.872 -0.664 . . . . 0.0 110.639 -172.921 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 20.3 m -70.58 112.54 6.91 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 120.796 0.331 . . . . 0.0 111.376 -177.755 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.499 ' HB ' HD21 ' A' ' 92' ' ' LEU . 59.9 t -124.3 145.57 31.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 177.107 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' SER . . . . . 0.404 ' HA ' ' HA ' ' A' ' 14' ' ' SER . 94.5 p -122.01 -175.46 3.12 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.084 0.468 . . . . 0.0 110.904 -175.784 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.453 ' O ' ' HB2' ' A' ' 29' ' ' LYS . 30.8 tp -93.68 -0.32 56.11 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.072 175.479 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.423 ' O ' ' HB3' ' A' ' 29' ' ' LYS . . . -88.94 -35.41 16.48 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.004 -179.196 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 3.9 p30 -78.18 -22.87 47.99 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.448 0.642 . . . . 0.0 110.062 176.7 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 85.7 mt -89.66 -8.79 51.69 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.105 175.311 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.453 ' HB2' ' O ' ' A' ' 25' ' ' LEU . 48.3 tttp -76.45 140.29 41.21 Favored 'General case' 0 N--CA 1.446 -0.654 0 CA-C-N 115.48 -0.782 . . . . 0.0 111.177 -176.254 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 110.54 2.32 29.16 Favored Glycine 0 N--CA 1.449 -0.481 0 N-CA-C 111.382 -0.687 . . . . 0.0 111.382 -177.153 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.584 ' HG3' ' CG ' ' A' ' 63' ' ' ASP . 24.6 ttmm -152.43 149.91 29.08 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 109.076 -0.712 . . . . 0.0 109.076 -179.758 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.45 ' HB2' ' O ' ' A' ' 63' ' ' ASP . 39.3 m-85 -49.11 144.92 4.53 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-O 121.044 0.45 . . . . 0.0 111.889 -177.307 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.48 ' HB ' ' HB2' ' A' ' 115' ' ' LEU . 35.3 mm -121.53 122.69 67.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.985 -177.234 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 78.6 t80 -116.96 112.01 20.4 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 108.782 -0.822 . . . . 0.0 108.782 171.701 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.706 ' HB ' ' CG2' ' A' ' 113' ' ' ILE . 78.8 mt -105.35 129.4 58.24 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 C-N-CA 120.563 -0.455 . . . . 0.0 110.446 -177.023 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.499 ' HA ' ' O ' ' A' ' 111' ' ' ARG . 1.8 t70 -123.34 159.72 28.26 Favored 'General case' 0 C--N 1.314 -0.938 0 N-CA-C 108.798 -0.815 . . . . 0.0 108.798 178.06 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.461 HG11 HG23 ' A' ' 109' ' ' ILE . 58.9 t -104.59 112.79 39.6 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.953 0 C-N-CA 120.258 -0.577 . . . . 0.0 110.49 176.24 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' TRP . . . . . 0.592 ' CD2' ' HZ2' ' A' ' 78' ' ' TRP . 0.6 OUTLIER -101.98 132.64 47.7 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.235 -176.055 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.428 ' HA ' ' OD1' ' A' ' 72' ' ' ASP . . . -147.05 156.25 42.87 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.885 -178.21 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' THR . . . . . 0.701 ' HB ' ' CE3' ' A' ' 78' ' ' TRP . 14.6 t -99.14 -23.46 15.23 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 120.898 -0.321 . . . . 0.0 110.808 175.418 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 8.8 p-90 -84.08 -8.0 59.23 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.076 0.465 . . . . 0.0 110.831 -179.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 42.5 t -91.99 105.29 17.57 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 175.713 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . 0.402 ' N ' ' HD2' ' A' ' 44' ' ' PRO . . . -54.74 -61.68 7.05 Favored Glycine 0 CA--C 1.524 0.641 0 CA-C-N 115.712 -0.676 . . . . 0.0 113.837 -178.424 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.402 ' HD2' ' N ' ' A' ' 43' ' ' GLY . 12.3 Cg_endo -55.76 -34.33 90.66 Favored 'Trans proline' 0 C--N 1.352 0.755 0 C-N-CA 122.901 2.401 . . . . 0.0 112.66 -177.415 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . 0.694 ' O ' ' HG ' ' A' ' 49' ' ' LEU . 49.6 t -53.08 -39.75 63.57 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.178 179.481 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.676 HH12 ' HH2' ' A' ' 78' ' ' TRP . 20.1 mmm180 -65.92 -20.76 66.33 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.585 -174.409 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -80.56 -40.18 13.26 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.84 -0.695 . . . . 0.0 113.383 -174.126 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -95.72 -6.36 39.98 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 117.077 0.438 . . . . 0.0 111.604 -174.424 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.694 ' HG ' ' O ' ' A' ' 45' ' ' CYS . 39.7 mt -56.96 -47.42 99.12 Favored Pre-proline 0 C--N 1.327 -0.376 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.926 175.868 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.513 ' O ' ' HG2' ' A' ' 54' ' ' GLU . 75.4 Cg_exo -51.6 -40.39 64.14 Favored 'Trans proline' 0 C--N 1.358 1.051 0 C-N-CA 121.972 1.781 . . . . 0.0 112.113 173.906 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -69.86 -27.45 64.85 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.431 0.634 . . . . 0.0 110.695 -178.418 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.581 HD22 ' HE3' ' A' ' 88' ' ' LYS . 3.6 tt -73.36 -33.2 64.94 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.506 -0.77 . . . . 0.0 109.214 176.247 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.852 ' HE2' HD21 ' A' ' 87' ' ' LEU . 85.0 mttt -64.61 -50.37 67.44 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 108.933 -0.765 . . . . 0.0 108.933 174.905 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.513 ' HG2' ' O ' ' A' ' 50' ' ' PRO . 33.1 mm-40 -51.82 -41.75 62.0 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-N 114.822 -1.081 . . . . 0.0 110.836 175.797 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.585 HD23 ' CE2' ' A' ' 138' ' ' PHE . 17.6 tp -61.29 -44.41 97.26 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.05 -0.977 . . . . 0.0 111.057 -178.624 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.561 ' OE1' ' HB2' ' A' ' 88' ' ' LYS . 24.4 tt0 -65.17 -36.53 84.5 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-N 116.61 -0.268 . . . . 0.0 111.306 -178.192 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 17.2 mm-40 -54.07 -54.41 39.83 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.579 0.704 . . . . 0.0 109.832 173.851 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . 0.493 ' HE3' ' CZ ' ' A' ' 59' ' ' TYR . 32.6 tttp -53.81 -33.88 57.47 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 114.58 -1.191 . . . . 0.0 112.333 177.334 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.493 ' CZ ' ' HE3' ' A' ' 58' ' ' LYS . 84.9 m-85 -111.16 16.95 20.78 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 112.335 0.494 . . . . 0.0 112.335 -175.88 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -64.1 131.68 48.22 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.868 0.366 . . . . 0.0 110.64 176.552 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 68.68 44.7 69.53 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.922 -0.656 . . . . 0.0 112.176 -179.506 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 40.2 mmtm -128.51 -154.11 0.61 Allowed 'General case' 0 N--CA 1.45 -0.432 0 CA-C-O 120.981 0.419 . . . . 0.0 109.981 177.2 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.584 ' CG ' ' HG3' ' A' ' 31' ' ' LYS . 10.4 t70 -111.77 69.46 0.69 Allowed 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 116.182 -0.463 . . . . 0.0 109.799 177.022 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.555 HG13 ' O ' ' A' ' 63' ' ' ASP . 15.1 mt -151.89 139.32 13.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.274 178.437 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' HIS . . . . . 0.498 ' NE2' ' HB3' ' A' ' 31' ' ' LYS . 92.0 m-70 -114.92 111.3 20.96 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.49 -0.777 . . . . 0.0 109.949 173.406 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . 0.5 ' HE1' HD22 ' A' ' 55' ' ' LEU . 89.4 m-85 -81.9 103.66 11.71 Favored 'General case' 0 C--N 1.318 -0.782 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 171.179 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.62 ' HA ' ' O ' ' A' ' 90' ' ' ILE . 41.9 t -116.28 122.12 69.03 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.436 -176.242 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' SER . . . . . 0.771 ' HB2' ' HG2' ' A' ' 91' ' ' GLN . 50.7 m -110.54 134.94 51.93 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 116.544 -0.298 . . . . 0.0 110.932 -178.707 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.483 HD13 ' HB2' ' A' ' 92' ' ' LEU . 4.5 mm? -115.75 139.45 50.14 Favored 'General case' 0 N--CA 1.471 0.598 0 N-CA-C 110.081 -0.34 . . . . 0.0 110.081 175.6 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 3.5 t -118.11 124.87 49.08 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 112.926 0.713 . . . . 0.0 112.926 -172.882 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 10.6 m -87.1 13.07 10.03 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.876 174.217 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.585 ' O ' ' HA2' ' A' ' 95' ' ' GLY . 1.0 OUTLIER -71.45 136.31 47.58 Favored 'General case' 0 CA--C 1.516 -0.331 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 -178.476 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.469 ' H ' ' HG2' ' A' ' 73' ' ' LYS . 0.4 OUTLIER -99.98 -18.84 16.85 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-O 121.481 0.657 . . . . 0.0 110.034 178.92 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . 0.584 ' HB2' ' HB3' ' A' ' 77' ' ' ALA . 0.8 OUTLIER -80.8 61.05 4.3 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.026 -0.988 . . . . 0.0 109.785 174.369 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 9.5 tttt -50.67 -53.79 28.31 Favored 'General case' 0 C--O 1.222 -0.35 0 N-CA-C 112.647 0.61 . . . . 0.0 112.647 -171.177 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.501 ' HA ' ' OE1' ' A' ' 79' ' ' GLU . 40.3 tptt -61.7 -42.3 98.74 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.842 0.353 . . . . 0.0 110.989 -177.149 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.584 ' HB3' ' HB2' ' A' ' 74' ' ' ASN . . . -63.84 -33.76 76.4 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 121.746 0.784 . . . . 0.0 110.119 176.927 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' TRP . . . . . 0.701 ' CE3' ' HB ' ' A' ' 40' ' ' THR . 9.7 t-105 -76.72 -50.21 14.17 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 114.797 -1.092 . . . . 0.0 111.555 -177.463 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.571 ' HB2' ' HB ' ' A' ' 18' ' ' ILE . 4.1 pt-20 -60.38 -34.44 73.9 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-O 121.198 0.523 . . . . 0.0 110.357 -176.255 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . 0.614 ' O ' ' HD3' ' A' ' 84' ' ' LYS . 3.4 p30 -79.42 -29.97 42.15 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 119.67 -0.812 . . . . 0.0 110.668 177.622 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 13.6 tpt -61.4 -47.56 85.26 Favored 'General case' 0 C--O 1.225 -0.235 0 O-C-N 122.437 -0.164 . . . . 0.0 111.175 175.374 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.569 HG21 ' HB2' ' A' ' 87' ' ' LEU . 0.2 OUTLIER -61.1 -36.15 70.55 Favored 'Isoleucine or valine' 0 C--O 1.232 0.164 0 C-N-CA 120.386 -0.526 . . . . 0.0 110.17 175.602 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 76.3 m -61.51 -41.93 98.04 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.289 174.863 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . 0.614 ' HD3' ' O ' ' A' ' 80' ' ' ASN . 1.9 mptm? -72.9 -46.92 50.08 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-O 121.092 0.472 . . . . 0.0 110.912 179.684 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -66.03 -25.81 67.23 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.287 -0.869 . . . . 0.0 111.01 -176.477 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 29.2 mm-40 64.59 72.8 0.44 Allowed 'General case' 0 C--O 1.234 0.287 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.561 -175.843 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.852 HD21 ' HE2' ' A' ' 53' ' ' LYS . 89.8 mt -92.99 -179.46 5.11 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.05 177.007 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.581 ' HE3' HD22 ' A' ' 52' ' ' LEU . 0.0 OUTLIER -145.74 173.62 11.93 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 112.534 0.568 . . . . 0.0 112.534 -171.424 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 78.4 -170.71 54.95 Favored Glycine 0 N--CA 1.452 -0.24 0 CA-C-N 115.593 -0.731 . . . . 0.0 112.856 178.883 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.62 ' O ' ' HA ' ' A' ' 67' ' ' VAL . 5.0 mp -89.66 112.1 24.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 177.219 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . 0.771 ' HG2' ' HB2' ' A' ' 68' ' ' SER . 21.8 mt-30 -123.11 111.02 16.03 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-O 121.475 0.655 . . . . 0.0 111.061 -174.561 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.499 HD21 ' HB ' ' A' ' 23' ' ' VAL . 55.2 mt -105.98 164.36 12.02 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 114.979 -1.009 . . . . 0.0 109.668 -178.238 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' HIS . . . . . 0.467 ' O ' ' HD2' ' A' ' 16' ' ' PRO . 17.7 t-80 -131.46 124.67 30.67 Favored 'General case' 0 C--N 1.313 -1.015 0 CA-C-O 120.936 0.398 . . . . 0.0 111.357 -171.577 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 24.0 ttp -79.94 -58.02 3.37 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.241 179.39 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . 0.585 ' HA2' ' O ' ' A' ' 72' ' ' ASP . . . 101.34 -93.88 1.18 Allowed Glycine 0 N--CA 1.444 -0.789 0 C-N-CA 120.304 -0.951 . . . . 0.0 113.549 174.212 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 4.6 p -109.09 8.63 26.17 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 112.84 0.682 . . . . 0.0 112.84 -172.067 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -102.21 153.11 20.27 Favored 'General case' 0 CA--C 1.517 -0.309 0 C-N-CA 119.811 -0.756 . . . . 0.0 109.962 177.269 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.14 6.93 3.37 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.965 -0.561 . . . . 0.0 109.608 173.462 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 6.9 m -76.54 -32.7 58.39 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.044 -176.038 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 59.5 t80 -74.6 -37.49 62.85 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.546 -0.752 . . . . 0.0 111.014 178.938 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 5.2 ppp? -77.4 -26.17 51.52 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 176.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -68.05 -29.92 69.01 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.427 -0.806 . . . . 0.0 109.965 172.876 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -63.25 -18.61 63.74 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-N 115.991 -0.549 . . . . 0.0 111.37 179.181 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 72.3 m-85 -97.36 -5.43 36.43 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-O 120.837 0.351 . . . . 0.0 110.078 178.511 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 87.1 mt 60.19 17.04 6.55 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 115.35 -0.841 . . . . 0.0 111.345 179.349 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 11.1 tp -73.7 -45.15 51.29 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.35 0 N-CA-C 112.566 0.58 . . . . 0.0 112.566 -172.573 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 9.0 t30 67.66 -62.64 0.33 Allowed 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 123.158 0.583 . . . . 0.0 111.613 -176.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -91.77 111.05 3.95 Favored Glycine 0 N--CA 1.447 -0.579 0 C-N-CA 121.183 -0.532 . . . . 0.0 112.575 -176.537 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . 0.524 ' HB ' ' HA ' ' A' ' 110' ' ' PRO . 43.2 pt -85.1 158.28 58.63 Favored Pre-proline 0 C--N 1.322 -0.595 0 N-CA-C 110.434 -0.21 . . . . 0.0 110.434 176.81 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . 0.524 ' HA ' ' HB ' ' A' ' 109' ' ' ILE . 3.0 Cg_exo -74.31 158.69 98.61 Favored 'Cis proline' 0 C--N 1.348 0.53 0 C-N-CA 124.132 -1.195 . . . . 0.0 113.426 1.473 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . 0.697 ' HD2' ' N ' ' A' ' 112' ' ' PHE . 0.1 OUTLIER -113.32 140.41 48.04 Favored 'General case' 0 N--CA 1.442 -0.874 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 175.979 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . 0.697 ' N ' ' HD2' ' A' ' 111' ' ' ARG . 4.2 m-85 -115.44 132.41 56.63 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 108.609 -0.885 . . . . 0.0 108.609 -177.953 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.706 ' CG2' ' HB ' ' A' ' 35' ' ' ILE . 7.5 tt -147.53 156.77 9.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 118.492 0.587 . . . . 0.0 111.278 -177.846 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 35.3 tp -136.29 132.56 35.89 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.837 0.351 . . . . 0.0 110.495 177.754 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.535 ' HG ' ' HA ' ' A' ' 121' ' ' ILE . 2.5 mp -130.97 151.54 51.26 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 178.979 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . 0.427 ' N ' HG13 ' A' ' 122' ' ' ILE . 9.7 t70 -73.1 164.56 26.51 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.965 -0.561 . . . . 0.0 109.792 179.044 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . 0.513 ' HG2' ' HA ' ' A' ' 31' ' ' LYS . 3.9 mtm180 -47.32 -33.96 6.27 Favored 'General case' 0 C--N 1.323 -0.554 0 O-C-N 124.519 1.137 . . . . 0.0 112.271 -179.645 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -71.24 -6.03 36.58 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.215 -177.883 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 84.69 22.61 52.95 Favored Glycine 0 N--CA 1.441 -1.027 0 N-CA-C 110.006 -1.238 . . . . 0.0 110.006 -172.542 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 30.4 mmtp -102.75 111.13 23.31 Favored 'General case' 0 CA--C 1.518 -0.287 0 CA-C-N 115.521 -0.339 . . . . 0.0 111.267 -174.107 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . 0.535 ' HA ' ' HG ' ' A' ' 115' ' ' LEU . 3.8 mp -41.4 115.08 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 O-C-N 124.196 0.935 . . . . 0.0 111.817 179.883 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' ILE . . . . . 0.445 ' H ' ' HA ' ' A' ' 115' ' ' LEU . 63.8 mt -83.72 -41.5 16.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 175.92 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 49.4 m -146.55 125.36 12.66 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 114.843 -1.072 . . . . 0.0 109.164 176.091 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -61.34 -31.56 71.43 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-O 121.046 0.45 . . . . 0.0 111.584 -176.189 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 10.9 t30 -138.35 113.83 9.61 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.917 -0.583 . . . . 0.0 109.468 174.554 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' MET . . . . . 0.459 ' HG3' ' H ' ' A' ' 127' ' ' THR . 7.7 tpt -93.91 -148.03 0.26 Allowed 'General case' 0 C--N 1.317 -0.833 0 N-CA-C 108.917 -0.771 . . . . 0.0 108.917 -179.401 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' THR . . . . . 0.459 ' H ' ' HG3' ' A' ' 126' ' ' MET . 1.1 p -135.94 143.09 44.72 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-O 120.707 0.289 . . . . 0.0 110.928 -177.497 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . 0.45 ' HA ' ' CD1' ' A' ' 112' ' ' PHE . 9.2 ptp180 -40.65 154.49 0.21 Allowed Pre-proline 0 C--N 1.327 -0.408 0 N-CA-C 113.536 0.939 . . . . 0.0 113.536 176.353 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_exo -54.81 -34.02 83.45 Favored 'Trans proline' 0 C--N 1.348 0.505 0 C-N-CA 123.503 2.802 . . . . 0.0 113.135 178.178 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 16.3 m -76.16 -1.86 28.29 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.655 -178.254 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . 0.438 ' HA ' ' HD3' ' A' ' 132' ' ' PRO . 9.8 t70 -90.3 124.82 61.99 Favored Pre-proline 0 C--N 1.324 -0.511 0 N-CA-C 109.974 -0.38 . . . . 0.0 109.974 178.757 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . 0.438 ' HD3' ' HA ' ' A' ' 131' ' ' ASP . 43.5 Cg_exo -58.77 -35.71 98.2 Favored 'Trans proline' 0 C--N 1.344 0.325 0 C-N-CA 123.173 2.582 . . . . 0.0 113.414 -177.827 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . 0.593 ' HB2' ' HZ1' ' A' ' 133' ' ' LYS . 10.0 mtmp? -62.88 -34.42 77.34 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-O 121.082 0.467 . . . . 0.0 111.031 -177.036 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' THR . . . . . 0.54 HG22 ' CZ ' ' A' ' 138' ' ' PHE . 0.3 OUTLIER -69.64 -51.49 34.39 Favored 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 109.765 -0.457 . . . . 0.0 109.765 177.168 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . 0.475 ' HA ' ' CD2' ' A' ' 138' ' ' PHE . . . -54.96 -49.95 70.14 Favored 'General case' 0 C--O 1.24 0.553 0 CA-C-N 115.605 -0.725 . . . . 0.0 112.25 179.653 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . 0.536 ' HG3' ' N ' ' A' ' 137' ' ' LYS . 2.0 pt-20 -60.57 -41.44 94.64 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-O 120.978 0.418 . . . . 0.0 110.268 -179.56 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . 0.536 ' N ' ' HG3' ' A' ' 136' ' ' GLU . 0.0 OUTLIER -66.53 -33.15 75.03 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.76 -177.217 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . 0.585 ' CE2' HD23 ' A' ' 55' ' ' LEU . 20.5 m-85 -58.52 -52.54 65.2 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.336 175.008 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . 0.822 ' HB3' ' HG3' ' A' ' 145' ' ' GLU . 56.6 m-20 -57.47 -54.55 45.59 Favored 'General case' 0 N--CA 1.464 0.26 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 177.718 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 23.3 tt0 -49.91 -60.5 2.86 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 114.798 -1.092 . . . . 0.0 113.204 179.868 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 84.7 mt -67.43 -28.89 68.27 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-O 120.644 0.259 . . . . 0.0 111.616 -173.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . 0.403 HD21 ' HB2' ' A' ' 144' ' ' LEU . 66.8 tp -76.19 -21.77 56.1 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.335 0.588 . . . . 0.0 109.737 175.202 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 78.22 25.14 62.17 Favored Glycine 0 N--CA 1.445 -0.749 0 N-CA-C 110.588 -1.005 . . . . 0.0 110.588 -176.562 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . 0.403 ' HB2' HD21 ' A' ' 142' ' ' LEU . 9.7 tt -73.47 -35.05 65.64 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-N 114.782 -0.709 . . . . 0.0 109.727 -176.461 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . 0.822 ' HG3' ' HB3' ' A' ' 139' ' ' ASN . 50.6 mt-10 -81.64 96.97 7.67 Favored 'General case' 0 N--CA 1.444 -0.732 0 CA-C-O 121.605 0.717 . . . . 0.0 110.709 178.683 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -74.9 64.66 2.29 Favored Glycine 0 C--N 1.311 -0.808 0 CA-C-N 114.693 -1.139 . . . . 0.0 110.848 175.175 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 11.9 t-80 -78.67 34.96 0.23 Allowed 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 122.83 0.452 . . . . 0.0 111.93 -170.756 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 22.5 p-80 -143.88 137.61 28.01 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.849 -0.426 . . . . 0.0 109.849 178.493 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 13.9 p-80 -58.92 115.73 3.31 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-O 121.121 0.486 . . . . 0.0 110.078 177.591 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 60.3 t60 -81.6 85.23 6.58 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.739 -0.664 . . . . 0.0 112.45 -170.042 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 34.6 t-80 -99.0 -8.55 25.21 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 106.713 -1.588 . . . . 0.0 106.713 161.374 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 32.0 p80 . . . . . 0 C--O 1.243 0.716 0 CA-C-N 113.536 -1.666 . . . . 0.0 108.057 173.217 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.443 ' SD ' ' N ' ' A' ' 1' ' ' MET . 1.4 mpt? . . . . . 0 N--CA 1.48 1.057 0 N-CA-C 109.901 -0.407 . . . . 0.0 109.901 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 22.3 t -174.11 101.03 0.1 Allowed 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 178.197 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 6.4 mp -96.28 84.38 3.74 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 120.954 0.407 . . . . 0.0 110.553 -176.76 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 35.2 mtp180 -73.69 -3.94 31.34 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.032 0.444 . . . . 0.0 110.698 178.834 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 10.3 p -91.83 -4.51 54.78 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.487 175.855 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -145.36 -85.54 0.07 OUTLIER Glycine 0 N--CA 1.447 -0.582 0 C-N-CA 120.883 -0.675 . . . . 0.0 112.041 -179.207 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . 0.424 ' HA ' ' HD3' ' A' ' 8' ' ' PRO . 45.8 m-80 -134.64 145.59 55.58 Favored Pre-proline 0 C--N 1.327 -0.388 0 N-CA-C 110.409 -0.219 . . . . 0.0 110.409 -179.157 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.424 ' HD3' ' HA ' ' A' ' 7' ' ' ASN . 21.3 Cg_exo -65.55 158.22 54.23 Favored 'Trans proline' 0 N--CA 1.464 -0.223 0 C-N-CA 122.924 2.416 . . . . 0.0 111.975 178.182 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 16.6 m -114.28 166.74 11.34 Favored 'General case' 0 N--CA 1.445 -0.707 0 CA-C-N 116.073 -0.512 . . . . 0.0 109.793 -179.254 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -77.81 72.99 4.38 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.554 0.692 . . . . 0.0 110.068 178.169 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -139.59 91.7 2.51 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.402 -0.817 . . . . 0.0 110.969 -178.355 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 1.008 ' HA ' ' HB3' ' A' ' 25' ' ' LEU . 67.2 m 59.06 77.09 0.32 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.702 -0.681 . . . . 0.0 112.105 178.154 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 31.4 p90 -82.3 -178.98 7.25 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.569 177.324 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' SER . . . . . 0.457 ' HA ' ' HA ' ' A' ' 24' ' ' SER . 23.2 t -142.53 134.64 27.36 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 175.469 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . 0.404 ' HA ' ' HD3' ' A' ' 16' ' ' PRO . 36.4 m-85 -146.07 150.3 41.55 Favored Pre-proline 0 C--N 1.325 -0.472 0 N-CA-C 109.999 -0.371 . . . . 0.0 109.999 179.835 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.404 ' HD3' ' HA ' ' A' ' 15' ' ' TYR . 3.9 Cg_exo -76.64 125.3 8.14 Favored 'Trans proline' 0 N--CA 1.455 -0.778 0 C-N-CA 122.458 2.106 . . . . 0.0 112.14 178.351 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . 0.784 ' HB3' ' HB3' ' A' ' 21' ' ' LYS . 0.0 OUTLIER -60.76 163.49 5.57 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.709 -0.678 . . . . 0.0 109.62 172.051 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.499 HG12 HG11 ' A' ' 82' ' ' VAL . 10.5 tp -61.33 -25.52 36.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.817 -170.9 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . 0.481 ' HB2' ' OD2' ' A' ' 17' ' ' ASP . 0.9 OUTLIER -81.88 -5.37 58.19 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 120.932 0.396 . . . . 0.0 110.779 178.064 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 93.42 37.38 5.61 Favored Glycine 0 N--CA 1.447 -0.576 0 N-CA-C 110.888 -0.885 . . . . 0.0 110.888 -175.6 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.784 ' HB3' ' HB3' ' A' ' 17' ' ' ASP . 3.2 ttmp? -108.37 111.48 23.42 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.709 0.29 . . . . 0.0 110.89 -173.449 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 16.7 m -70.49 109.14 4.64 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 120.87 0.366 . . . . 0.0 111.095 -179.257 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.508 ' HB ' HD23 ' A' ' 92' ' ' LEU . 39.4 t -126.48 152.78 34.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 178.355 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' SER . . . . . 0.457 ' HA ' ' HA ' ' A' ' 14' ' ' SER . 93.8 p -122.67 176.35 6.0 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.186 0.517 . . . . 0.0 110.718 -179.973 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 1.008 ' HB3' ' HA ' ' A' ' 12' ' ' SER . 21.0 tp -95.77 15.08 21.17 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 121.761 0.791 . . . . 0.0 108.882 173.435 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.507 ' HA ' ' CE ' ' A' ' 29' ' ' LYS . . . -100.05 -35.0 9.85 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 114.915 -1.038 . . . . 0.0 110.503 177.282 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -81.26 -17.7 48.54 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.458 177.69 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 72.4 mt -91.25 22.79 3.63 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.72 -179.911 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.507 ' CE ' ' HA ' ' A' ' 26' ' ' ALA . 1.1 mptp? -70.43 -169.64 0.32 Allowed 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 121.308 0.575 . . . . 0.0 111.348 176.469 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 89.23 -47.67 3.34 Favored Glycine 0 N--CA 1.45 -0.372 0 CA-C-N 115.83 -0.623 . . . . 0.0 112.616 173.328 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.686 ' HD3' ' HA ' ' A' ' 63' ' ' ASP . 72.6 mttt -127.05 167.72 15.56 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 110.0 -0.37 . . . . 0.0 110.0 -178.311 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 97.6 m-85 -64.95 154.12 38.47 Favored 'General case' 0 C--N 1.327 -0.4 0 O-C-N 123.197 0.311 . . . . 0.0 110.798 -176.579 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.447 HD12 ' HA2' ' A' ' 119' ' ' GLY . 4.6 mp -120.26 124.61 72.95 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-O 120.706 0.289 . . . . 0.0 110.475 -179.543 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 84.4 t80 -107.45 116.23 31.58 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 109.006 -0.738 . . . . 0.0 109.006 172.339 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.553 ' HA ' ' O ' ' A' ' 67' ' ' VAL . 67.8 mt -102.81 116.77 47.14 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.697 -178.239 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -109.93 158.82 17.82 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.503 -0.772 . . . . 0.0 109.14 174.112 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.463 ' HB ' ' HA ' ' A' ' 110' ' ' PRO . 57.5 t -101.25 125.55 55.21 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 C-N-CA 120.34 -0.544 . . . . 0.0 110.852 172.996 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' TRP . . . . . 0.638 ' CZ2' ' HB2' ' A' ' 91' ' ' GLN . 1.0 OUTLIER -118.95 135.11 54.77 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.04 -0.527 . . . . 0.0 109.778 -178.973 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.459 ' HA ' ' OD1' ' A' ' 72' ' ' ASP . . . -146.63 165.23 30.18 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.683 -0.235 . . . . 0.0 111.307 179.943 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' THR . . . . . 0.807 ' HB ' ' CE3' ' A' ' 78' ' ' TRP . 12.3 t -99.87 -29.55 12.53 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.946 0.403 . . . . 0.0 110.572 173.069 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 19.4 p-90 -80.42 11.15 3.84 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.117 0.484 . . . . 0.0 110.956 -179.138 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . 0.749 ' SG ' ' HB3' ' A' ' 45' ' ' CYS . 29.2 p -104.35 172.1 6.98 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.649 -177.044 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -123.03 -70.52 0.24 Allowed Glycine 0 N--CA 1.448 -0.549 0 CA-C-N 115.857 -0.611 . . . . 0.0 112.252 177.218 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -55.28 -35.53 91.56 Favored 'Trans proline' 0 C--N 1.351 0.676 0 C-N-CA 122.991 2.461 . . . . 0.0 112.882 178.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . 0.749 ' HB3' ' SG ' ' A' ' 42' ' ' CYS . 8.4 t -59.02 -34.41 71.86 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.872 0.368 . . . . 0.0 111.097 177.209 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.54 ' HA ' HD12 ' A' ' 49' ' ' LEU . 32.4 mtp180 -73.5 -4.66 35.17 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.33 -177.218 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -83.95 -19.73 60.71 Favored Glycine 0 N--CA 1.447 -0.62 0 C-N-CA 120.788 -0.72 . . . . 0.0 111.842 176.473 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.541 ' OE2' ' HD3' ' A' ' 128' ' ' ARG . 42.1 mm-40 -84.21 -16.87 41.78 Favored 'General case' 0 CA--C 1.515 -0.384 0 N-CA-C 110.401 -0.222 . . . . 0.0 110.401 -177.823 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.56 ' HB2' ' HD3' ' A' ' 50' ' ' PRO . 5.7 mp -45.44 -53.5 18.3 Favored Pre-proline 0 C--N 1.326 -0.424 0 CA-C-N 115.935 -0.575 . . . . 0.0 112.278 -178.744 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.56 ' HD3' ' HB2' ' A' ' 49' ' ' LEU . 31.7 Cg_exo -64.13 -37.55 41.38 Favored 'Trans proline' 0 C--N 1.353 0.799 0 C-N-CA 121.885 1.723 . . . . 0.0 112.842 175.868 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -77.34 -27.97 52.95 Favored 'General case' 0 CA--C 1.52 -0.193 0 CA-C-O 121.248 0.546 . . . . 0.0 110.6 -172.752 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 6.1 tt -64.13 -41.71 97.1 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 177.802 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.503 ' HZ3' ' CD ' ' A' ' 56' ' ' GLU . 27.0 mmtm -70.64 -40.07 73.29 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.582 -0.735 . . . . 0.0 111.454 -179.731 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -51.72 -53.64 37.06 Favored 'General case' 0 N--CA 1.455 -0.189 0 CA-C-O 121.341 0.591 . . . . 0.0 110.947 172.928 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.414 HD12 ' HE2' ' A' ' 138' ' ' PHE . 47.3 mt -61.5 -52.27 65.2 Favored 'General case' 0 N--CA 1.447 -0.611 0 CA-C-N 115.452 -0.795 . . . . 0.0 110.902 177.109 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.503 ' CD ' ' HZ3' ' A' ' 53' ' ' LYS . 31.9 tt0 -45.09 -60.16 2.24 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 114.65 -1.159 . . . . 0.0 112.519 -179.308 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -69.7 -36.18 75.71 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-O 120.976 0.417 . . . . 0.0 111.045 -174.664 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . 0.56 ' HB2' ' NZ ' ' A' ' 58' ' ' LYS . 0.7 OUTLIER -69.24 -35.2 75.9 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.21 0.528 . . . . 0.0 111.028 -175.482 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 83.3 m-85 -111.03 9.29 22.11 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.058 -178.285 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . 0.419 ' HB1' ' O ' ' A' ' 56' ' ' GLU . . . -56.02 128.61 36.13 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.663 178.355 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 81.86 -4.16 76.26 Favored Glycine 0 N--CA 1.449 -0.44 0 CA-C-N 115.652 -0.704 . . . . 0.0 113.386 174.231 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.582 ' HD3' ' N ' ' A' ' 62' ' ' LYS . 0.0 OUTLIER -76.66 -89.8 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 117.104 0.452 . . . . 0.0 111.142 -174.896 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.686 ' HA ' ' HD3' ' A' ' 31' ' ' LYS . 10.9 p-10 -139.07 6.07 2.36 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.635 -175.463 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 16.0 tt -128.8 147.26 33.25 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-O 121.443 0.64 . . . . 0.0 112.623 -168.662 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 87.8 m-70 -112.86 125.8 54.76 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.203 -0.908 . . . . 0.0 108.807 170.697 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . 0.601 ' O ' ' HB ' ' A' ' 90' ' ' ILE . 96.4 m-85 -90.94 112.44 24.32 Favored 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 109.176 -0.675 . . . . 0.0 109.176 173.153 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.553 ' O ' ' HA ' ' A' ' 35' ' ' ILE . 45.9 t -123.58 106.32 17.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.662 -175.086 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' SER . . . . . 0.427 ' HB3' ' CD1' ' A' ' 38' ' ' TRP . 15.0 m -88.11 139.55 30.39 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.107 179.069 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 61.4 tp -122.36 124.11 42.93 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-O 120.774 0.321 . . . . 0.0 110.459 176.868 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 1.2 t -104.62 122.05 44.82 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.691 0.758 . . . . 0.0 112.509 -173.219 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 4.2 m -86.81 11.19 13.82 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 114.956 -1.02 . . . . 0.0 111.539 177.05 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.509 ' O ' ' HA2' ' A' ' 95' ' ' GLY . 1.6 m-20 -69.07 125.76 27.67 Favored 'General case' 0 N--CA 1.464 0.266 0 N-CA-C 110.452 -0.203 . . . . 0.0 110.452 -176.521 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 86.0 tttt -76.27 -32.05 58.61 Favored 'General case' 0 C--N 1.321 -0.633 0 C-N-CA 120.344 -0.542 . . . . 0.0 109.708 175.343 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . 0.528 ' HB2' ' HB2' ' A' ' 77' ' ' ALA . 0.8 OUTLIER -76.21 71.23 2.92 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.481 -0.781 . . . . 0.0 110.856 177.771 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.516 ' O ' ' HG3' ' A' ' 79' ' ' GLU . 12.0 tmtt? -57.16 -56.61 19.57 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 120.992 -0.283 . . . . 0.0 111.596 -175.423 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.497 ' HA ' ' CD ' ' A' ' 79' ' ' GLU . 2.2 tptp -52.15 -57.44 9.61 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.097 -179.543 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.528 ' HB2' ' HB2' ' A' ' 74' ' ' ASN . . . -52.96 -31.59 41.39 Favored 'General case' 0 C--O 1.237 0.425 0 CA-C-O 121.356 0.598 . . . . 0.0 110.898 -179.766 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' TRP . . . . . 0.807 ' CE3' ' HB ' ' A' ' 40' ' ' THR . 2.1 t-105 -76.91 -34.63 57.69 Favored 'General case' 0 N--CA 1.442 -0.856 0 CA-C-N 115.146 -0.933 . . . . 0.0 110.546 -176.756 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.516 ' HG3' ' O ' ' A' ' 75' ' ' LYS . 29.9 mt-10 -51.19 -52.43 44.41 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-O 121.573 0.702 . . . . 0.0 110.326 172.496 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . 0.43 ' ND2' ' O ' ' A' ' 76' ' ' LYS . 1.2 m-80 -64.17 -41.19 97.23 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.25 -0.886 . . . . 0.0 110.747 -175.987 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' MET . . . . . 0.487 ' HG2' ' OG1' ' A' ' 40' ' ' THR . 14.4 tpt -67.29 -49.14 65.42 Favored 'General case' 0 N--CA 1.447 -0.601 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.938 -177.766 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.621 ' CG2' ' HZ3' ' A' ' 38' ' ' TRP . 7.5 p -61.35 -30.89 48.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 121.068 0.461 . . . . 0.0 110.788 -179.543 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 45.8 m -74.61 -39.1 62.36 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.534 178.035 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . 0.915 ' HB3' ' HZ3' ' A' ' 84' ' ' LYS . 0.0 OUTLIER -74.08 -33.71 63.73 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 121.329 0.585 . . . . 0.0 109.843 179.48 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -82.81 4.29 25.98 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.216 -0.902 . . . . 0.0 111.329 -179.428 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 26.6 mt-30 60.38 28.24 17.86 Favored 'General case' 0 N--CA 1.47 0.545 0 N-CA-C 112.668 0.618 . . . . 0.0 112.668 171.904 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.562 ' HB2' HG23 ' A' ' 82' ' ' VAL . 97.6 mt -89.43 104.09 16.67 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 121.003 0.43 . . . . 0.0 111.523 -176.916 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.551 ' HA ' ' HE3' ' A' ' 88' ' ' LYS . 0.0 OUTLIER -106.95 -167.15 1.24 Allowed 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.031 172.515 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 109.44 -159.58 13.94 Favored Glycine 0 N--CA 1.452 -0.259 0 N-CA-C 111.023 -0.831 . . . . 0.0 111.023 -176.122 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.601 ' HB ' ' O ' ' A' ' 66' ' ' PHE . 62.9 mt -95.15 112.27 27.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 175.007 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . 0.638 ' HB2' ' CZ2' ' A' ' 38' ' ' TRP . 1.9 pt20 -139.14 123.04 17.73 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-O 121.348 0.594 . . . . 0.0 111.389 -173.098 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.508 HD23 ' HB ' ' A' ' 23' ' ' VAL . 70.4 mt -113.91 152.23 31.1 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.449 -0.796 . . . . 0.0 109.939 179.788 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' HIS . . . . . 0.447 ' CE1' ' HG3' ' A' ' 75' ' ' LYS . 20.6 t-80 -120.75 126.52 50.37 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.905 -177.416 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' MET . . . . . 0.428 ' SD ' ' HA ' ' A' ' 98' ' ' ARG . 18.6 ttp -84.13 -66.48 0.89 Allowed 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.227 -0.897 . . . . 0.0 110.61 178.567 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . 0.509 ' HA2' ' O ' ' A' ' 72' ' ' ASP . . . 108.56 -109.96 2.96 Favored Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 120.528 -0.844 . . . . 0.0 112.083 -178.29 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 8.9 t -112.45 11.18 19.84 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 120.727 0.299 . . . . 0.0 111.111 -177.147 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -97.5 46.46 1.03 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.126 0.489 . . . . 0.0 110.357 -175.371 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . 0.443 ' N ' ' HD3' ' A' ' 98' ' ' ARG . 0.0 OUTLIER -77.51 18.45 0.43 Allowed 'General case' 0 CA--C 1.52 -0.174 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.782 -172.812 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 5.2 m -61.0 -24.35 66.09 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 108.358 -0.979 . . . . 0.0 108.358 168.768 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 12.0 t80 -75.56 -29.93 59.52 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-N 114.766 -1.106 . . . . 0.0 110.118 176.172 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 71.2 mtp -63.08 -54.06 43.83 Favored 'General case' 0 CA--C 1.514 -0.42 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 171.307 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -57.16 -33.15 67.14 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.082 -0.963 . . . . 0.0 111.246 179.404 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -60.27 -39.82 88.19 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.793 0.33 . . . . 0.0 111.087 178.019 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' TYR . . . . . 0.46 ' HB2' HG13 ' A' ' 106' ' ' ILE . 42.9 m-85 -93.3 3.34 55.8 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.481 179.661 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 95.4 mt 65.47 22.02 11.85 Favored 'General case' 0 N--CA 1.464 0.242 0 O-C-N 123.755 0.659 . . . . 0.0 110.817 -176.234 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . 0.896 HG12 ' HG3' ' A' ' 111' ' ' ARG . 51.2 mt -71.08 112.5 6.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.627 176.036 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 50.9 t-20 -112.61 -68.85 0.9 Allowed 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 172.826 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -82.24 111.28 3.33 Favored Glycine 0 N--CA 1.446 -0.693 0 C-N-CA 120.83 -0.7 . . . . 0.0 111.802 178.5 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . 0.565 ' HB ' ' HA ' ' A' ' 110' ' ' PRO . 34.5 pt -85.82 158.54 56.27 Favored Pre-proline 0 C--N 1.321 -0.633 0 N-CA-C 110.484 -0.191 . . . . 0.0 110.484 178.51 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . 0.565 ' HA ' ' HB ' ' A' ' 109' ' ' ILE . 86.8 Cg_endo -81.1 158.86 83.62 Favored 'Cis proline' 0 C--N 1.345 0.37 0 C-N-CA 123.768 -1.346 . . . . 0.0 113.391 1.995 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . 0.896 ' HG3' HG12 ' A' ' 106' ' ' ILE . 0.0 OUTLIER -108.58 148.45 30.3 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 108.712 -0.848 . . . . 0.0 108.712 173.215 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . 0.537 ' CE1' ' HB3' ' A' ' 128' ' ' ARG . 0.5 OUTLIER -119.11 116.72 26.96 Favored 'General case' 0 C--N 1.324 -0.532 0 O-C-N 123.96 0.788 . . . . 0.0 109.088 -175.008 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 91.6 mt -135.6 143.67 35.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 120.812 0.339 . . . . 0.0 111.261 -177.332 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.538 ' HB2' ' HG3' ' A' ' 126' ' ' MET . 39.3 tp -124.99 138.07 54.23 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.275 178.36 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.587 ' HG ' ' HA ' ' A' ' 121' ' ' ILE . 3.2 mp -131.97 153.45 50.31 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.079 -177.324 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . 0.526 ' HB2' HD13 ' A' ' 122' ' ' ILE . 37.4 t0 -68.37 166.81 15.87 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.564 -0.744 . . . . 0.0 110.212 177.308 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . 0.569 ' HA ' ' O ' ' A' ' 31' ' ' LYS . 8.3 mtm180 -48.87 -27.77 3.29 Favored 'General case' 0 N--CA 1.465 0.314 0 O-C-N 124.447 1.092 . . . . 0.0 112.615 -177.445 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . 0.424 ' HA ' ' HG3' ' A' ' 29' ' ' LYS . 33.0 t70 -83.44 2.31 37.3 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.478 0.656 . . . . 0.0 111.076 -178.835 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . 0.447 ' HA2' HD12 ' A' ' 33' ' ' ILE . . . 76.06 29.13 59.25 Favored Glycine 0 N--CA 1.434 -1.438 0 N-CA-C 110.247 -1.141 . . . . 0.0 110.247 -171.968 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . 0.4 ' HD3' ' HA ' ' A' ' 120' ' ' LYS . 41.0 mmtm -101.28 112.13 24.55 Favored 'General case' 0 C--O 1.222 -0.356 0 C-N-CA 120.794 -0.363 . . . . 0.0 111.791 -178.856 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . 0.587 ' HA ' ' HG ' ' A' ' 115' ' ' LEU . 3.9 mp -41.7 117.54 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 O-C-N 123.888 0.742 . . . . 0.0 112.327 -177.508 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' ILE . . . . . 0.526 HD13 ' HB2' ' A' ' 116' ' ' ASP . 35.6 mm -100.3 -44.54 11.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 115.345 -0.843 . . . . 0.0 109.555 175.983 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 15.9 m -135.2 114.47 12.36 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.503 -0.772 . . . . 0.0 110.343 178.716 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -81.53 -13.22 58.35 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.161 0.505 . . . . 0.0 110.606 179.439 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 3.4 p-10 -128.24 83.69 2.18 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.54 -0.755 . . . . 0.0 110.486 178.14 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' MET . . . . . 0.538 ' HG3' ' HB2' ' A' ' 114' ' ' LEU . 46.4 mmm -94.48 -165.13 1.26 Allowed 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.442 177.784 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' THR . . . . . 0.406 HG21 ' NZ ' ' A' ' 133' ' ' LYS . 6.2 p -120.86 141.75 50.29 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.627 179.268 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . 0.541 ' HD3' ' OE2' ' A' ' 48' ' ' GLU . 13.0 ptp180 -48.96 154.28 1.31 Allowed Pre-proline 0 C--N 1.327 -0.385 0 CA-C-N 115.514 -0.766 . . . . 0.0 112.84 177.664 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_exo -51.58 -36.16 59.21 Favored 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 123.447 2.765 . . . . 0.0 113.627 177.275 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' SER . . . . . 0.424 ' HG ' ' CD ' ' A' ' 48' ' ' GLU . 18.8 m -72.79 -7.67 51.78 Favored 'General case' 0 N--CA 1.462 0.153 0 CA-C-O 120.935 0.398 . . . . 0.0 111.643 -178.784 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -90.51 121.39 68.44 Favored Pre-proline 0 C--N 1.327 -0.41 0 N-CA-C 109.751 -0.463 . . . . 0.0 109.751 179.668 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . 0.434 ' O ' ' HG2' ' A' ' 136' ' ' GLU . 51.9 Cg_exo -57.45 -31.73 92.15 Favored 'Trans proline' 0 C--N 1.343 0.284 0 C-N-CA 122.976 2.451 . . . . 0.0 113.268 -178.096 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . 0.514 ' HZ2' ' HB2' ' A' ' 133' ' ' LYS . 9.7 mtmp? -66.44 -19.24 65.74 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.846 0.355 . . . . 0.0 110.98 -176.908 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' THR . . . . . 0.632 HG21 ' CZ ' ' A' ' 138' ' ' PHE . 3.8 m -68.12 -51.25 48.34 Favored 'General case' 0 N--CA 1.447 -0.584 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 173.786 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . 0.639 ' HA ' ' CD2' ' A' ' 138' ' ' PHE . . . -59.96 -38.61 83.01 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.67 -0.696 . . . . 0.0 110.576 175.515 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . 0.434 ' HG2' ' O ' ' A' ' 132' ' ' PRO . 5.9 mm-40 -56.15 -41.62 75.71 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.203 177.111 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . 0.577 ' O ' ' HG ' ' A' ' 141' ' ' LEU . 21.3 ttmm -72.44 -26.33 61.8 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.56 -0.291 . . . . 0.0 111.043 179.745 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . 0.639 ' CD2' ' HA ' ' A' ' 135' ' ' ALA . 10.7 m-30 -66.27 -42.76 88.01 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 173.908 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 76.7 m-20 -58.62 -45.7 88.63 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.583 -0.735 . . . . 0.0 109.341 173.672 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . 0.532 ' HB3' ' O ' ' A' ' 137' ' ' LYS . 24.9 tt0 -50.79 -51.72 47.91 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 115.266 -0.879 . . . . 0.0 111.661 174.196 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . 0.577 ' HG ' ' O ' ' A' ' 137' ' ' LYS . 95.2 mt -58.05 -44.46 87.46 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.472 -178.399 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 81.0 mt -73.12 -10.82 60.19 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.478 179.336 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 82.4 19.39 64.41 Favored Glycine 0 N--CA 1.447 -0.594 0 N-CA-C 111.196 -0.762 . . . . 0.0 111.196 -179.271 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . 0.477 ' O ' ' HG ' ' A' ' 144' ' ' LEU . 52.4 tp -89.63 22.79 2.88 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.563 0.697 . . . . 0.0 109.907 -178.55 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -59.11 146.23 39.43 Favored 'General case' 0 N--CA 1.44 -0.932 0 CA-C-O 121.569 0.7 . . . . 0.0 111.67 177.323 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 96.84 -17.74 58.74 Favored Glycine 0 N--CA 1.443 -0.885 0 N-CA-C 110.115 -1.194 . . . . 0.0 110.115 -167.563 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER 75.5 -70.22 0.15 Allowed 'General case' 0 N--CA 1.465 0.31 0 C-N-CA 123.966 0.907 . . . . 0.0 111.173 172.59 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 78.0 m-70 -146.17 14.86 1.31 Allowed 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.299 176.633 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . 0.406 ' CG ' ' H ' ' A' ' 150' ' ' HIS . 8.1 p80 -170.62 -73.15 0.02 OUTLIER 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.823 175.456 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' HIS . . . . . 0.406 ' H ' ' CG ' ' A' ' 149' ' ' HIS . 0.0 OUTLIER 176.01 139.65 0.06 Allowed 'General case' 0 N--CA 1.464 0.259 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 -178.494 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 4.6 p80 -99.24 -2.12 37.42 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-O 121.325 0.583 . . . . 0.0 109.652 174.098 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.242 0.668 0 CA-C-N 114.726 -1.125 . . . . 0.0 108.288 176.769 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.452 ' N ' ' SD ' ' A' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.481 1.103 0 N-CA-C 110.103 -0.332 . . . . 0.0 110.103 . . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 12.9 m -104.87 -66.82 0.94 Allowed 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.274 -179.393 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.631 HD22 ' H ' ' A' ' 3' ' ' LEU . 2.3 pt? -73.36 145.11 46.16 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.023 -0.535 . . . . 0.0 109.914 177.584 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 17.7 ptt180 -171.83 -44.26 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.39 -176.44 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 17.1 m -81.4 100.85 9.48 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.456 179.473 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 133.65 -104.09 0.52 Allowed Glycine 0 N--CA 1.447 -0.608 0 C-N-CA 120.882 -0.675 . . . . 0.0 112.087 178.889 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -128.01 146.02 57.58 Favored Pre-proline 0 C--N 1.324 -0.529 0 N-CA-C 110.246 -0.279 . . . . 0.0 110.246 179.246 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_endo -82.75 93.11 0.89 Allowed 'Trans proline' 0 N--CA 1.456 -0.682 0 C-N-CA 122.885 2.39 . . . . 0.0 112.148 177.269 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.407 ' C ' ' H ' ' A' ' 11' ' ' ALA . 16.3 m -84.5 95.63 8.87 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.632 -178.514 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . 74.75 -37.89 0.37 Allowed 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 123.751 0.82 . . . . 0.0 112.225 176.355 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.407 ' H ' ' C ' ' A' ' 9' ' ' SER . . . -76.09 82.61 2.93 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.76 -177.491 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.483 ' HA ' ' HB3' ' A' ' 25' ' ' LEU . 37.8 m 69.5 43.34 1.03 Allowed 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 114.674 -1.148 . . . . 0.0 111.267 174.759 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 55.7 p90 -68.06 161.98 25.6 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.606 177.909 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' SER . . . . . 0.541 ' HA ' ' HA ' ' A' ' 24' ' ' SER . 5.2 p -134.7 129.16 34.33 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.655 179.26 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . 0.427 ' OH ' ' HB2' ' A' ' 100' ' ' PHE . 24.6 m-85 -140.44 141.13 24.62 Favored Pre-proline 0 C--N 1.326 -0.414 0 CA-C-O 120.842 0.353 . . . . 0.0 111.119 178.709 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 63.3 Cg_endo -75.25 125.59 9.26 Favored 'Trans proline' 0 N--CA 1.461 -0.388 0 C-N-CA 122.399 2.066 . . . . 0.0 113.481 -177.442 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -69.35 159.13 33.73 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.131 -0.94 . . . . 0.0 109.252 170.379 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.532 HG13 ' OE1' ' A' ' 79' ' ' GLU . 2.6 tt -44.43 -44.56 2.37 Favored 'Isoleucine or valine' 0 C--O 1.24 0.567 0 O-C-N 124.445 1.091 . . . . 0.0 112.221 -176.207 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 43.8 m-80 -65.89 -12.93 58.29 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.375 -176.422 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 97.14 32.15 6.56 Favored Glycine 0 N--CA 1.444 -0.817 0 N-CA-C 111.248 -0.741 . . . . 0.0 111.248 -176.615 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.427 ' NZ ' HG23 ' A' ' 23' ' ' VAL . 23.4 ttpp -106.68 121.11 43.68 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 120.667 -0.413 . . . . 0.0 110.36 -176.815 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 14.1 m -63.0 99.32 0.16 Allowed 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.964 0.412 . . . . 0.0 110.385 176.65 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.427 HG23 ' NZ ' ' A' ' 21' ' ' LYS . 97.0 t -99.82 113.76 36.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 178.098 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' SER . . . . . 0.541 ' HA ' ' HA ' ' A' ' 14' ' ' SER . 14.7 m -105.4 177.0 4.98 Favored 'General case' 0 C--N 1.311 -1.069 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.159 -179.218 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.53 ' O ' ' HB2' ' A' ' 29' ' ' LYS . 2.9 tm? -53.87 -38.0 64.27 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.619 178.718 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -89.66 10.13 24.36 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 112.287 0.477 . . . . 0.0 112.287 -176.596 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -87.43 -27.77 22.52 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-O 121.481 0.658 . . . . 0.0 110.319 -179.187 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.461 HD11 ' CD1' ' A' ' 33' ' ' ILE . 0.9 OUTLIER -132.88 15.91 4.27 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.487 -0.778 . . . . 0.0 110.592 -178.928 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.53 ' HB2' ' O ' ' A' ' 25' ' ' LEU . 17.1 tttt -67.02 150.47 49.18 Favored 'General case' 0 C--N 1.313 -0.979 0 CA-C-N 114.197 -1.365 . . . . 0.0 111.301 -177.063 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 113.49 -18.48 20.32 Favored Glycine 0 N--CA 1.448 -0.565 0 N-CA-C 111.193 -0.763 . . . . 0.0 111.193 -178.85 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.761 ' HD2' ' HA ' ' A' ' 63' ' ' ASP . 72.8 mmtt -117.11 154.72 30.53 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 179.218 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 69.4 m-85 -66.05 121.45 15.16 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 177.365 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.461 ' CD1' HD11 ' A' ' 28' ' ' LEU . 41.8 mm -94.6 115.73 34.14 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.896 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.73 -175.099 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . 0.665 ' HE2' ' HA ' ' A' ' 129' ' ' PRO . 59.4 t80 -107.01 111.23 23.62 Favored 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 173.755 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.551 ' HA ' ' O ' ' A' ' 67' ' ' VAL . 59.5 mt -97.01 132.6 41.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-O 121.152 0.501 . . . . 0.0 111.656 -173.392 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.478 ' O ' ' HA ' ' A' ' 68' ' ' SER . 5.3 p-10 -122.99 159.64 27.92 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.262 -0.881 . . . . 0.0 109.034 174.142 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.414 HG22 HG21 ' A' ' 106' ' ' ILE . 85.4 t -103.51 133.32 47.76 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.788 0 C-N-CA 120.5 -0.48 . . . . 0.0 110.805 174.078 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' TRP . . . . . 0.652 ' HZ3' HG22 ' A' ' 82' ' ' VAL . 0.9 OUTLIER -126.51 137.25 53.35 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.136 -0.483 . . . . 0.0 109.889 -178.303 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.554 ' HA ' ' OD1' ' A' ' 72' ' ' ASP . . . -145.55 164.68 30.91 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.64 -0.255 . . . . 0.0 110.666 177.665 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' THR . . . . . 0.699 ' HB ' ' CE3' ' A' ' 78' ' ' TRP . 4.9 t -81.55 -23.71 37.03 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.336 0.588 . . . . 0.0 109.671 172.822 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 12.7 p-90 -97.62 19.25 13.83 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.358 -0.837 . . . . 0.0 110.231 177.824 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . 0.647 ' SG ' ' HB3' ' A' ' 45' ' ' CYS . 24.8 p -78.27 -26.46 47.16 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.107 -177.437 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 66.47 -111.73 4.37 Favored Glycine 0 CA--C 1.519 0.337 0 CA-C-N 116.066 -0.515 . . . . 0.0 113.346 178.534 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -54.58 -28.16 54.24 Favored 'Trans proline' 0 C--N 1.351 0.666 0 C-N-CA 123.461 2.774 . . . . 0.0 113.292 -177.726 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . 0.647 ' HB3' ' SG ' ' A' ' 42' ' ' CYS . 30.7 t -52.6 -30.88 33.56 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.414 177.147 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.49 HH21 ' CG ' ' A' ' 85' ' ' ASP . 46.0 mtp180 -58.75 -21.42 55.46 Favored 'General case' 0 C--O 1.223 -0.292 0 N-CA-C 111.911 0.337 . . . . 0.0 111.911 -178.782 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -70.96 -23.88 77.64 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.829 -0.7 . . . . 0.0 112.831 -178.118 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.429 ' HB3' ' HB2' ' A' ' 130' ' ' SER . 35.7 mt-10 -99.3 -18.43 17.57 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.761 0.28 . . . . 0.0 111.317 -176.978 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.685 ' HB3' HD23 ' A' ' 87' ' ' LEU . 3.6 mm? -57.54 -43.91 99.21 Favored Pre-proline 0 C--N 1.325 -0.486 0 N-CA-C 112.911 0.708 . . . . 0.0 112.911 -179.166 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.513 ' HD2' ' N ' ' A' ' 49' ' ' LEU . 12.3 Cg_endo -58.48 -37.89 92.61 Favored 'Trans proline' 0 C--N 1.351 0.706 0 C-N-CA 121.275 1.317 . . . . 0.0 111.027 170.684 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -73.33 -19.09 61.1 Favored 'General case' 0 CA--C 1.519 -0.212 0 CA-C-O 121.415 0.626 . . . . 0.0 109.796 -176.638 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.44 ' O ' HD22 ' A' ' 52' ' ' LEU . 5.8 tt -65.13 -38.02 89.32 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-N 115.107 -0.951 . . . . 0.0 108.74 174.421 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.657 ' O ' ' HG2' ' A' ' 57' ' ' GLU . 8.9 mtmp? -59.01 -60.95 3.05 Favored 'General case' 0 CA--C 1.505 -0.783 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 171.809 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -45.17 -42.44 9.12 Favored 'General case' 0 C--O 1.224 -0.274 0 O-C-N 124.577 1.173 . . . . 0.0 111.256 -178.698 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.429 ' HB3' ' CE1' ' A' ' 66' ' ' PHE . 39.9 mt -61.41 -57.81 10.75 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.352 175.698 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 18.2 tp10 -65.45 -35.28 80.43 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.42 -174.391 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.657 ' HG2' ' O ' ' A' ' 53' ' ' LYS . 9.4 pt-20 -80.49 -29.05 37.36 Favored 'General case' 0 CA--C 1.532 0.25 0 O-C-N 121.906 -0.496 . . . . 0.0 111.141 179.4 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 75.9 tttt -63.36 -44.53 94.54 Favored 'General case' 0 C--O 1.237 0.426 0 CA-C-O 121.923 0.868 . . . . 0.0 109.11 170.484 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 61.2 m-85 -99.92 14.86 29.01 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.008 -0.997 . . . . 0.0 111.308 -176.414 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . 0.456 ' HB3' ' HA ' ' A' ' 57' ' ' GLU . . . -57.66 126.44 27.38 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.037 170.584 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 85.43 -6.05 81.31 Favored Glycine 0 N--CA 1.445 -0.721 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.126 -179.151 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 30.7 mmtm -88.51 -155.67 0.34 Allowed 'General case' 0 CA--C 1.515 -0.374 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 178.89 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.761 ' HA ' ' HD2' ' A' ' 31' ' ' LYS . 36.1 m-20 -111.67 28.45 8.74 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 115.824 -0.626 . . . . 0.0 112.641 -175.793 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 4.7 mp -131.86 146.57 33.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-O 120.527 0.203 . . . . 0.0 110.799 179.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' HIS . . . . . 0.502 ' CD2' ' HB2' ' A' ' 31' ' ' LYS . 56.8 m-70 -124.91 145.65 49.72 Favored 'General case' 0 CA--C 1.514 -0.425 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 170.094 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . 0.429 ' CE1' ' HB3' ' A' ' 55' ' ' LEU . 77.0 m-85 -110.37 105.92 15.09 Favored 'General case' 0 C--N 1.315 -0.914 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 172.521 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.551 ' O ' ' HA ' ' A' ' 35' ' ' ILE . 48.0 t -112.63 114.07 45.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 115.374 -0.83 . . . . 0.0 111.232 -170.172 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' SER . . . . . 0.478 ' HA ' ' O ' ' A' ' 36' ' ' ASP . 3.6 m -88.26 150.64 23.15 Favored 'General case' 0 C--N 1.314 -0.935 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.584 -179.379 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.473 HD11 ' HB2' ' A' ' 94' ' ' MET . 61.1 tp -133.92 121.62 21.96 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.984 0.421 . . . . 0.0 110.531 175.092 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' SER . . . . . 0.474 ' O ' ' HB3' ' A' ' 94' ' ' MET . 0.7 OUTLIER -105.28 120.34 41.31 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.395 0.617 . . . . 0.0 112.379 -172.783 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' CYS . . . . . 0.492 ' HB3' ' HE3' ' A' ' 94' ' ' MET . 1.8 p -85.87 13.62 7.16 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.483 -0.78 . . . . 0.0 111.702 175.83 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.574 ' OD2' HG22 ' A' ' 40' ' ' THR . 2.6 m-20 -69.56 115.28 8.63 Favored 'General case' 0 CA--C 1.511 -0.537 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 -179.511 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -67.83 -28.86 67.92 Favored 'General case' 0 C--N 1.318 -0.763 0 C-N-CA 120.093 -0.643 . . . . 0.0 110.209 -179.924 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . 0.715 ' ND2' ' HB3' ' A' ' 77' ' ' ALA . 1.0 OUTLIER -77.27 116.28 17.75 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 171.73 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.674 ' HE2' ' CD ' ' A' ' 79' ' ' GLU . 19.9 tttt -81.45 -64.39 1.2 Allowed 'General case' 0 C--N 1.319 -0.745 0 C-N-CA 119.804 -0.759 . . . . 0.0 110.847 171.839 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.861 ' HE2' ' HA ' ' A' ' 76' ' ' LYS . 0.4 OUTLIER -44.25 -56.67 3.96 Favored 'General case' 0 N--CA 1.464 0.246 0 N-CA-C 113.383 0.883 . . . . 0.0 113.383 -172.057 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.811 ' HA ' ' ND2' ' A' ' 80' ' ' ASN . . . -61.28 -27.59 68.58 Favored 'General case' 0 C--O 1.242 0.689 0 CA-C-O 121.51 0.671 . . . . 0.0 111.233 -176.75 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' TRP . . . . . 0.699 ' CE3' ' HB ' ' A' ' 40' ' ' THR . 3.1 t-105 -81.61 -43.0 19.22 Favored 'General case' 0 N--CA 1.435 -1.188 0 CA-C-N 115.373 -0.83 . . . . 0.0 110.192 -173.921 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.674 ' CD ' ' HE2' ' A' ' 75' ' ' LYS . 6.0 mm-40 -49.34 -43.54 43.9 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-O 121.012 0.434 . . . . 0.0 110.747 171.649 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . 0.811 ' ND2' ' HA ' ' A' ' 77' ' ' ALA . 7.2 m-20 -56.93 -54.32 47.98 Favored 'General case' 0 CA--C 1.517 -0.315 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.583 179.269 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 37.5 ttm -64.61 -46.17 83.77 Favored 'General case' 0 C--O 1.223 -0.301 0 CA-C-N 116.248 -0.433 . . . . 0.0 112.073 -174.895 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.652 HG22 ' HZ3' ' A' ' 38' ' ' TRP . 5.7 p -63.44 -28.25 44.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 C-N-CA 120.622 -0.431 . . . . 0.0 111.407 -178.162 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 36.7 m -81.72 -34.95 30.27 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 120.87 0.367 . . . . 0.0 110.69 177.642 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 24.9 ttmm -77.48 -44.22 29.61 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.109 0.48 . . . . 0.0 111.059 -177.547 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . 0.749 ' HB3' ' HG ' ' A' ' 87' ' ' LEU . 5.4 t0 -77.36 -1.67 31.16 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.185 -0.916 . . . . 0.0 110.943 -176.247 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 48.3 mt-30 65.25 19.83 11.78 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 115.673 -0.694 . . . . 0.0 112.21 175.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.749 ' HG ' ' HB3' ' A' ' 85' ' ' ASP . 17.3 mt -74.03 87.81 1.87 Allowed 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.131 -179.119 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 4.2 mmpm? -101.76 -177.85 3.55 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 112.537 0.569 . . . . 0.0 112.537 -175.739 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 122.71 -176.23 16.53 Favored Glycine 0 N--CA 1.448 -0.545 0 N-CA-C 109.554 -1.418 . . . . 0.0 109.554 -171.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.538 ' O ' ' HA ' ' A' ' 67' ' ' VAL . 60.6 mt -83.34 112.7 21.3 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 118.063 0.932 . . . . 0.0 108.681 175.481 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . 0.483 ' HB2' ' CZ2' ' A' ' 38' ' ' TRP . 2.1 pt20 -137.98 110.71 7.61 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-O 121.834 0.826 . . . . 0.0 112.085 -168.565 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.421 HD21 ' HB ' ' A' ' 23' ' ' VAL . 26.0 mt -97.51 142.11 29.74 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.146 -0.934 . . . . 0.0 110.272 -177.83 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' HIS . . . . . 0.438 ' CE1' ' HG3' ' A' ' 75' ' ' LYS . 29.7 t-80 -110.56 117.04 32.47 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-O 121.35 0.595 . . . . 0.0 110.599 -179.643 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' MET . . . . . 0.615 ' SD ' ' HA ' ' A' ' 98' ' ' ARG . 13.6 ttp -79.81 -63.67 1.36 Allowed 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 114.964 -1.016 . . . . 0.0 110.482 -179.891 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . 0.53 ' HA2' ' O ' ' A' ' 72' ' ' ASP . . . 71.36 -79.1 0.55 Allowed Glycine 0 C--O 1.236 0.268 0 C-N-CA 120.967 -0.635 . . . . 0.0 114.466 174.463 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 1.3 p -88.72 -35.52 16.69 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-O 120.819 0.342 . . . . 0.0 111.57 -175.329 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -92.52 57.18 2.88 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.809 -166.793 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . 0.615 ' HA ' ' SD ' ' A' ' 94' ' ' MET . 0.0 OUTLIER -70.82 10.28 0.54 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.12 -0.946 . . . . 0.0 112.698 -172.888 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 8.6 m -73.6 -19.14 60.95 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 120.964 0.411 . . . . 0.0 111.079 -179.587 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . 0.427 ' HB2' ' OH ' ' A' ' 15' ' ' TYR . 3.2 t80 -79.63 -43.37 22.97 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 120.898 -0.321 . . . . 0.0 110.713 -178.459 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' MET . . . . . 0.52 ' HA ' HD12 ' A' ' 106' ' ' ILE . 5.1 ppp? -69.23 -24.91 64.07 Favored 'General case' 0 C--N 1.332 -0.178 0 N-CA-C 109.176 -0.676 . . . . 0.0 109.176 175.383 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . 0.409 ' HB2' ' NH1' ' A' ' 98' ' ' ARG . 11.4 t70 -66.41 -50.98 61.62 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.132 -0.94 . . . . 0.0 110.423 173.904 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -64.6 -18.94 65.36 Favored 'General case' 0 N--CA 1.461 0.095 0 CA-C-N 115.758 -0.655 . . . . 0.0 112.072 -175.29 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 46.1 m-85 -108.45 2.43 22.33 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 111.844 0.313 . . . . 0.0 111.844 -179.319 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 8.8 tp 59.35 26.41 15.27 Favored 'General case' 0 C--N 1.328 -0.361 0 O-C-N 123.507 0.504 . . . . 0.0 110.423 -179.351 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . 0.65 HG12 ' HG3' ' A' ' 111' ' ' ARG . 69.9 mt -60.21 101.46 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.328 0 CA-C-N 115.673 -0.694 . . . . 0.0 111.456 178.769 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 8.7 p30 -134.21 148.88 50.95 Favored 'General case' 0 C--N 1.317 -0.808 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 173.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 76.3 84.91 0.41 Allowed Glycine 0 N--CA 1.446 -0.671 0 C-N-CA 120.469 -0.872 . . . . 0.0 111.775 -176.079 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . 0.43 HG22 ' HA ' ' A' ' 110' ' ' PRO . 40.1 mt -69.57 139.16 88.84 Favored Pre-proline 0 C--N 1.325 -0.481 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 177.603 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . 0.491 ' HG3' ' SG ' ' A' ' 45' ' ' CYS . 10.0 Cg_endo -93.11 140.39 8.36 Favored 'Cis proline' 0 N--CA 1.459 -0.521 0 C-N-CA 124.455 -1.061 . . . . 0.0 113.974 0.952 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . 0.65 ' HG3' HG12 ' A' ' 106' ' ' ILE . 0.0 OUTLIER -83.82 144.18 29.45 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 172.933 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . 0.531 ' HD1' ' H ' ' A' ' 126' ' ' MET . 0.9 OUTLIER -118.7 116.83 27.38 Favored 'General case' 0 C--N 1.323 -0.547 0 O-C-N 123.724 0.64 . . . . 0.0 110.792 -176.788 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.473 ' HB ' ' HB ' ' A' ' 35' ' ' ILE . 83.0 mt -130.99 149.56 33.66 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.299 0 CA-C-N 116.703 -0.226 . . . . 0.0 110.908 -177.917 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.415 ' C ' HD11 ' A' ' 115' ' ' LEU . 62.4 tp -128.54 138.07 52.06 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.618 -0.265 . . . . 0.0 110.57 178.941 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.555 ' HG ' ' HA ' ' A' ' 121' ' ' ILE . 2.0 mp -135.19 152.1 51.26 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-O 121.334 0.588 . . . . 0.0 110.623 179.108 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . 0.421 ' N ' HG13 ' A' ' 122' ' ' ILE . 7.6 t70 -69.73 160.85 30.91 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 114.872 -1.058 . . . . 0.0 110.645 175.952 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . 0.444 ' HA ' ' O ' ' A' ' 31' ' ' LYS . 58.7 mtt-85 -48.51 -37.41 17.5 Favored 'General case' 0 N--CA 1.474 0.728 0 O-C-N 124.267 0.979 . . . . 0.0 111.368 -178.368 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . 0.634 ' HB3' ' HG3' ' A' ' 120' ' ' LYS . 29.1 t0 -67.82 -13.01 61.78 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 114.515 -1.221 . . . . 0.0 111.121 -177.069 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . 0.524 ' HA3' HD11 ' A' ' 25' ' ' LEU . . . 93.63 23.78 22.71 Favored Glycine 0 N--CA 1.439 -1.112 0 N-CA-C 110.553 -1.019 . . . . 0.0 110.553 -172.132 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . 0.634 ' HG3' ' HB3' ' A' ' 118' ' ' ASP . 36.6 mtmm -103.72 106.75 17.35 Favored 'General case' 0 C--O 1.223 -0.333 0 C-N-CA 120.564 -0.454 . . . . 0.0 111.365 -174.619 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . 0.555 ' HA ' ' HG ' ' A' ' 115' ' ' LEU . 3.3 mp -42.16 116.57 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 O-C-N 123.909 0.755 . . . . 0.0 111.692 -178.982 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' ILE . . . . . 0.422 ' H ' ' HA ' ' A' ' 115' ' ' LEU . 57.4 mt -89.04 -38.74 11.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 115.346 -0.843 . . . . 0.0 108.902 177.082 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 14.9 m -148.15 126.77 12.49 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.492 -0.776 . . . . 0.0 110.197 -179.812 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -74.24 -14.95 61.0 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-O 121.336 0.589 . . . . 0.0 110.593 178.53 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . 0.449 ' HA ' ' O ' ' A' ' 112' ' ' PHE . 5.1 p-10 -149.42 126.83 11.5 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.054 -0.975 . . . . 0.0 108.598 173.613 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' MET . . . . . 0.531 ' H ' ' HD1' ' A' ' 112' ' ' PHE . 15.9 tpt -108.95 -87.34 0.5 Allowed 'General case' 0 C--N 1.321 -0.653 0 C-N-CA 120.804 -0.358 . . . . 0.0 111.567 -176.941 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 7.6 p -141.61 -77.85 0.27 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.269 0.557 . . . . 0.0 110.774 -175.013 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . 0.886 ' HB3' ' HB2' ' A' ' 131' ' ' ASP . 43.3 ttm-85 -172.31 141.04 1.09 Allowed Pre-proline 0 N--CA 1.443 -0.807 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 177.5 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . 0.665 ' HA ' ' HE2' ' A' ' 34' ' ' TYR . 5.7 Cg_exo -38.48 -52.46 1.98 Allowed 'Trans proline' 0 C--N 1.348 0.551 0 C-N-CA 123.746 2.964 . . . . 0.0 113.455 -179.242 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' SER . . . . . 0.429 ' HB2' ' HB3' ' A' ' 48' ' ' GLU . 36.1 t -109.01 26.16 10.94 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 111.734 0.272 . . . . 0.0 111.734 -177.378 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . 0.886 ' HB2' ' HB3' ' A' ' 128' ' ' ARG . 11.1 t0 -73.64 119.69 77.29 Favored Pre-proline 0 C--O 1.237 0.43 0 C-N-CA 120.108 -0.637 . . . . 0.0 109.458 176.598 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . 0.413 ' O ' ' HG2' ' A' ' 136' ' ' GLU . 51.5 Cg_exo -55.12 -33.08 82.61 Favored 'Trans proline' 0 C--N 1.349 0.579 0 C-N-CA 123.495 2.797 . . . . 0.0 113.737 -175.034 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 38.3 mttp -57.82 -45.86 85.55 Favored 'General case' 0 CA--C 1.519 -0.227 0 CA-C-O 121.33 0.586 . . . . 0.0 109.912 -177.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -63.36 -47.54 81.66 Favored 'General case' 0 N--CA 1.448 -0.538 0 CA-C-N 115.033 -0.985 . . . . 0.0 111.116 -178.881 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . 0.665 ' HA ' ' CD2' ' A' ' 138' ' ' PHE . . . -59.61 -50.75 72.67 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.606 -0.725 . . . . 0.0 111.072 -173.895 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . 0.685 ' O ' ' HB2' ' A' ' 139' ' ' ASN . 22.7 mm-40 -76.21 -23.16 54.6 Favored 'General case' 0 C--N 1.312 -1.028 0 CA-C-O 121.857 0.837 . . . . 0.0 110.084 -175.175 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . 1.017 ' HA ' ' HE3' ' A' ' 137' ' ' LYS . 0.1 OUTLIER -65.45 -39.34 91.9 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 115.522 -0.763 . . . . 0.0 109.655 170.995 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . 0.665 ' CD2' ' HA ' ' A' ' 135' ' ' ALA . 15.0 m-85 -55.59 -36.55 67.02 Favored 'General case' 0 N--CA 1.464 0.265 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 172.637 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . 0.685 ' HB2' ' O ' ' A' ' 136' ' ' GLU . 94.2 m-20 -51.16 -59.72 3.88 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.148 174.113 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . 0.451 ' HB2' ' OE2' ' A' ' 145' ' ' GLU . 33.8 tt0 -61.55 -36.12 79.7 Favored 'General case' 0 N--CA 1.463 0.179 0 C-N-CA 120.656 -0.418 . . . . 0.0 111.486 -179.262 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . 0.487 ' HG ' ' O ' ' A' ' 137' ' ' LYS . 96.9 mt -61.48 -27.82 68.85 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.897 0.38 . . . . 0.0 110.841 178.348 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 41.7 tp -93.06 -18.08 23.07 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.597 178.172 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 97.78 22.05 17.07 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 121.179 -0.534 . . . . 0.0 111.88 -177.913 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 8.6 tt -89.56 -34.39 16.37 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.775 -0.213 . . . . 0.0 111.321 -175.7 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . 0.451 ' OE2' ' HB2' ' A' ' 140' ' ' GLU . 23.5 mt-10 -64.96 108.61 1.84 Allowed 'General case' 0 CA--C 1.516 -0.331 0 CA-C-O 121.784 0.802 . . . . 0.0 111.061 -179.694 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -84.23 66.13 3.95 Favored Glycine 0 C--N 1.312 -0.792 0 CA-C-N 114.682 -1.145 . . . . 0.0 112.053 -179.172 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 38.3 m170 -68.25 105.02 1.98 Allowed 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.849 0.357 . . . . 0.0 110.159 179.241 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 36.7 m80 -126.57 116.44 21.06 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.414 -179.087 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 31.0 t-80 -156.48 90.78 1.19 Allowed 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.088 177.826 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 45.4 t60 -146.05 6.07 1.01 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.938 0.399 . . . . 0.0 110.793 178.456 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 6.5 t60 -83.21 -33.73 26.06 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 109.333 -0.618 . . . . 0.0 109.333 177.484 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 61.7 t-80 . . . . . 0 C--O 1.24 0.583 0 CA-C-N 115.083 -0.962 . . . . 0.0 109.058 177.013 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.3 mpp? . . . . . 0 N--CA 1.483 1.183 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 25.0 m -92.8 134.44 35.06 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.931 0.396 . . . . 0.0 110.417 179.844 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.422 HD22 ' N ' ' A' ' 3' ' ' LEU . 2.1 pt? -134.19 171.54 14.1 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.064 -179.726 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . 0.462 ' HD2' ' N ' ' A' ' 4' ' ' ARG . 8.6 mpt_? -88.34 19.89 3.56 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.206 0.526 . . . . 0.0 110.548 -176.097 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 17.7 m -148.44 26.42 0.95 Allowed 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.643 -0.708 . . . . 0.0 109.737 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -159.44 -150.71 5.91 Favored Glycine 0 N--CA 1.446 -0.672 0 C-N-CA 120.633 -0.794 . . . . 0.0 112.514 -176.833 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 3.9 m-20 -82.96 150.42 61.64 Favored Pre-proline 0 C--N 1.323 -0.559 0 CA-C-O 120.943 0.401 . . . . 0.0 111.591 -175.331 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -80.38 -155.34 0.06 OUTLIER 'Trans proline' 0 C--N 1.346 0.441 0 C-N-CA 123.222 2.615 . . . . 0.0 111.879 175.102 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 19.2 p -149.58 -171.04 3.79 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.722 0.296 . . . . 0.0 110.726 -179.909 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -75.0 4.45 6.61 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.759 -178.403 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -89.6 -20.69 23.42 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.306 0.575 . . . . 0.0 110.36 177.817 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.563 ' HA ' ' HB3' ' A' ' 25' ' ' LEU . 67.6 m -161.24 91.43 0.86 Allowed 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.373 -0.83 . . . . 0.0 109.914 178.482 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . 0.496 ' CE2' HD22 ' A' ' 25' ' ' LEU . 25.4 p90 -103.55 178.81 4.45 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.655 -179.79 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' SER . . . . . 0.451 ' HA ' ' HA ' ' A' ' 24' ' ' SER . 25.1 p -142.35 119.72 11.6 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.119 -0.492 . . . . 0.0 109.948 176.578 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . 0.558 ' HB2' HD23 ' A' ' 92' ' ' LEU . 28.3 m-85 -134.8 155.3 79.48 Favored Pre-proline 0 C--N 1.324 -0.53 0 CA-C-N 116.652 -0.249 . . . . 0.0 110.675 -179.15 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -83.37 124.84 3.77 Favored 'Trans proline' 0 N--CA 1.453 -0.864 0 C-N-CA 122.016 1.811 . . . . 0.0 112.896 176.19 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . 0.995 ' HB3' ' HB3' ' A' ' 21' ' ' LYS . 0.9 OUTLIER -61.47 162.29 8.29 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.077 -0.965 . . . . 0.0 109.173 168.662 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.61 HD11 HG13 ' A' ' 82' ' ' VAL . 0.7 OUTLIER -42.46 -45.08 1.1 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.452 0 O-C-N 123.975 0.797 . . . . 0.0 112.072 -176.644 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . 0.504 ' ND2' HG21 ' A' ' 18' ' ' ILE . 28.9 m-80 -77.23 8.54 3.92 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.825 -173.967 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 81.54 25.22 54.58 Favored Glycine 0 N--CA 1.449 -0.442 0 N-CA-C 110.769 -0.932 . . . . 0.0 110.769 -175.022 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.995 ' HB3' ' HB3' ' A' ' 17' ' ' ASP . 1.4 ttmp? -89.96 107.39 19.09 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.435 -0.383 . . . . 0.0 110.473 -173.744 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 23.6 m -67.37 108.29 2.72 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.84 -179.648 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 57.5 t -123.89 133.07 70.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 116.021 -0.536 . . . . 0.0 109.683 179.846 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' SER . . . . . 0.451 ' HA ' ' HA ' ' A' ' 14' ' ' SER . 26.5 p -104.46 171.27 7.42 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.128 0.489 . . . . 0.0 110.031 178.6 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.563 ' HB3' ' HA ' ' A' ' 12' ' ' SER . 20.9 tp -91.18 11.86 21.95 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 121.257 0.551 . . . . 0.0 109.608 176.725 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.552 ' HA ' ' HD3' ' A' ' 29' ' ' LYS . . . -103.29 -25.63 13.25 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 -176.09 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 62.5 m-20 -70.29 -11.79 61.14 Favored 'General case' 0 N--CA 1.436 -1.154 0 CA-C-N 114.05 -1.432 . . . . 0.0 110.797 177.538 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 79.4 mt -110.3 3.19 19.67 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.575 -0.739 . . . . 0.0 112.317 -170.582 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.552 ' HD3' ' HA ' ' A' ' 26' ' ' ALA . 1.3 mptm? -61.98 150.07 38.97 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.192 0.52 . . . . 0.0 111.041 178.462 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 98.55 5.92 56.63 Favored Glycine 0 N--CA 1.445 -0.73 0 C-N-CA 120.807 -0.711 . . . . 0.0 111.731 -179.826 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.814 ' HD3' ' HA ' ' A' ' 63' ' ' ASP . 7.5 ttmm -161.79 148.39 13.99 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.958 -0.386 . . . . 0.0 109.958 179.45 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.485 ' HB2' ' O ' ' A' ' 63' ' ' ASP . 40.6 m-85 -56.28 149.57 16.14 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-O 121.266 0.555 . . . . 0.0 112.365 -173.765 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.672 ' HB ' ' HB2' ' A' ' 115' ' ' LEU . 31.4 mm -118.94 135.65 58.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 115.593 -0.731 . . . . 0.0 110.611 -176.139 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 87.8 t80 -123.32 112.08 17.18 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 109.583 -0.525 . . . . 0.0 109.583 172.197 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.689 ' HB ' ' HB ' ' A' ' 113' ' ' ILE . 39.4 mm -100.8 116.99 45.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.26 179.445 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -117.14 158.56 24.04 Favored 'General case' 0 C--N 1.315 -0.925 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 176.612 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.522 HG12 ' CG2' ' A' ' 109' ' ' ILE . 32.6 t -107.86 112.07 38.6 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.009 0 C-N-CA 120.171 -0.612 . . . . 0.0 109.888 175.315 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' TRP . . . . . 0.701 ' CE3' ' HZ2' ' A' ' 78' ' ' TRP . 0.9 OUTLIER -109.92 134.15 52.4 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 115.575 -0.739 . . . . 0.0 109.174 -175.461 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.529 ' HB3' ' HB3' ' A' ' 42' ' ' CYS . . . -147.07 165.62 29.36 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 116.477 -0.329 . . . . 0.0 110.702 -177.123 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' THR . . . . . 0.674 ' HB ' ' CE3' ' A' ' 78' ' ' TRP . 9.8 t -89.02 -24.96 22.22 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.271 0.558 . . . . 0.0 109.698 173.824 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 13.4 p-90 -94.86 8.81 41.49 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.108 179.782 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . 0.607 ' SG ' ' HB3' ' A' ' 45' ' ' CYS . 17.5 p -88.54 148.28 24.19 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 175.311 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -92.18 -65.69 1.12 Allowed Glycine 0 N--CA 1.448 -0.527 0 C-N-CA 120.277 -0.963 . . . . 0.0 113.087 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -56.12 -51.82 8.64 Favored 'Trans proline' 0 C--N 1.35 0.655 0 C-N-CA 122.743 2.295 . . . . 0.0 112.865 -175.328 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . 0.607 ' HB3' ' SG ' ' A' ' 42' ' ' CYS . 35.1 t -63.11 -39.75 95.61 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.874 0.369 . . . . 0.0 110.325 -175.846 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.516 ' HA ' ' HG ' ' A' ' 49' ' ' LEU . 62.3 ttt180 -71.14 -27.89 63.88 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.493 179.252 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -79.73 -37.75 22.13 Favored Glycine 0 N--CA 1.447 -0.609 0 C-N-CA 120.69 -0.767 . . . . 0.0 111.945 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.536 ' OE2' ' HD3' ' A' ' 128' ' ' ARG . 35.5 mt-10 -90.16 10.1 25.8 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 122.976 -0.132 . . . . 0.0 111.27 -178.495 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.633 ' O ' ' HG3' ' A' ' 53' ' ' LYS . 41.0 mt -46.23 -52.17 29.57 Favored Pre-proline 0 N--CA 1.468 0.465 0 N-CA-C 112.419 0.526 . . . . 0.0 112.419 -179.725 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.525 ' HD2' ' N ' ' A' ' 49' ' ' LEU . 10.3 Cg_endo -54.26 -41.33 77.1 Favored 'Trans proline' 0 C--N 1.355 0.876 0 C-N-CA 122.035 1.823 . . . . 0.0 112.46 179.077 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -80.46 -26.65 38.18 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.379 0.609 . . . . 0.0 110.172 -177.204 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 7.9 tt -66.71 -43.7 83.62 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.424 -0.807 . . . . 0.0 108.884 175.585 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.633 ' HG3' ' O ' ' A' ' 49' ' ' LEU . 88.5 mttt -57.83 -48.58 79.36 Favored 'General case' 0 CA--C 1.516 -0.335 0 O-C-N 123.589 0.556 . . . . 0.0 110.345 177.424 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.46 ' CD ' ' HZ3' ' A' ' 58' ' ' LYS . 0.5 OUTLIER -44.86 -59.09 2.72 Favored 'General case' 0 N--CA 1.452 -0.329 0 O-C-N 124.06 0.85 . . . . 0.0 111.018 175.16 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 60.1 mt -59.99 -51.71 68.48 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.27 177.789 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -44.14 -59.58 2.27 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 114.582 -1.19 . . . . 0.0 112.528 -179.056 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.555 ' HG2' ' O ' ' A' ' 53' ' ' LYS . 6.1 pt-20 -82.75 -29.27 29.82 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 112.154 0.427 . . . . 0.0 112.154 -173.868 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . 0.516 ' HE3' ' HE1' ' A' ' 59' ' ' TYR . 32.4 ttpt -68.68 -36.65 78.78 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.236 0.541 . . . . 0.0 110.229 178.316 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.722 ' HB3' HD11 ' A' ' 64' ' ' ILE . 41.7 m-85 -99.45 -1.0 39.66 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.371 -178.857 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -63.83 142.09 58.53 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.538 -0.541 . . . . 0.0 109.538 169.19 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 84.86 9.72 80.33 Favored Glycine 0 N--CA 1.448 -0.521 0 C-N-CA 120.494 -0.86 . . . . 0.0 112.555 179.712 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.53 ' HD2' HD23 ' A' ' 142' ' ' LEU . 39.8 mmtm -100.61 -160.72 0.81 Allowed 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 174.532 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.814 ' HA ' ' HD3' ' A' ' 31' ' ' LYS . 2.6 t70 -90.66 52.04 2.11 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-O 121.271 0.558 . . . . 0.0 110.019 -179.688 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.722 HD11 ' HB3' ' A' ' 59' ' ' TYR . 9.2 pt -151.73 156.63 5.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 115.525 -0.761 . . . . 0.0 110.396 -178.418 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' HIS . . . . . 0.651 ' NE2' ' HB3' ' A' ' 31' ' ' LYS . 95.0 m-70 -126.28 113.64 17.21 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.165 -0.47 . . . . 0.0 109.779 175.397 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 88.7 m-85 -76.77 103.8 6.93 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 172.783 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.617 ' HB ' HD11 ' A' ' 35' ' ' ILE . 23.1 t -121.26 104.78 15.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 116.162 -0.472 . . . . 0.0 109.789 -178.928 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 6.8 m -99.28 144.7 28.1 Favored 'General case' 0 C--N 1.313 -1.015 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.508 -177.063 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.421 HD23 ' HB2' ' A' ' 92' ' ' LEU . 78.5 mt -122.95 124.1 42.43 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-O 120.696 0.284 . . . . 0.0 111.49 177.564 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' SER . . . . . 0.432 ' HA ' ' O ' ' A' ' 38' ' ' TRP . 40.6 m -96.0 119.71 34.98 Favored 'General case' 0 N--CA 1.464 0.272 0 N-CA-C 112.542 0.571 . . . . 0.0 112.542 -179.49 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' CYS . . . . . 0.639 ' HG ' HG21 ' A' ' 109' ' ' ILE . 7.4 p -92.64 28.53 1.99 Allowed 'General case' 0 C--N 1.313 -1.008 0 CA-C-O 121.198 0.523 . . . . 0.0 110.118 175.03 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.507 ' OD2' HG21 ' A' ' 40' ' ' THR . 2.1 m-20 -81.77 112.79 19.25 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.312 178.255 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.431 ' HB3' ' HB ' ' A' ' 96' ' ' THR . 8.8 ptmm? -67.98 -28.6 67.58 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.078 0.466 . . . . 0.0 111.127 178.994 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -87.32 75.83 9.22 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 109.608 -0.515 . . . . 0.0 109.608 179.556 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.422 ' O ' ' HG2' ' A' ' 79' ' ' GLU . 8.5 tttm -55.06 -64.01 0.97 Allowed 'General case' 0 C--O 1.217 -0.655 0 CA-C-N 115.849 -0.614 . . . . 0.0 112.45 -175.711 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 64.2 tttp -43.94 -50.17 8.24 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 112.258 0.466 . . . . 0.0 112.258 -177.605 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.694 ' HA ' ' ND2' ' A' ' 80' ' ' ASN . . . -58.75 -41.6 86.91 Favored 'General case' 0 C--O 1.246 0.905 0 CA-C-O 122.142 0.972 . . . . 0.0 110.341 179.769 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' TRP . . . . . 0.701 ' HZ2' ' CE3' ' A' ' 38' ' ' TRP . 10.0 t-105 -65.55 -49.98 66.87 Favored 'General case' 0 C--N 1.312 -1.056 0 CA-C-N 114.012 -1.449 . . . . 0.0 110.988 -178.97 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.461 ' OE1' HG13 ' A' ' 18' ' ' ILE . 6.1 mm-40 -47.4 -44.07 24.12 Favored 'General case' 0 C--O 1.234 0.276 0 N-CA-C 112.069 0.396 . . . . 0.0 112.069 175.678 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . 0.712 ' O ' ' HG2' ' A' ' 84' ' ' LYS . 1.9 m-80 -60.64 -46.85 88.75 Favored 'General case' 0 CA--C 1.514 -0.41 0 C-N-CA 120.326 -0.55 . . . . 0.0 110.288 -179.243 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' MET . . . . . 0.45 ' SD ' ' HZ3' ' A' ' 78' ' ' TRP . 19.0 ttt -63.07 -47.79 81.44 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 120.41 -0.516 . . . . 0.0 111.993 -177.214 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.61 HG13 HD11 ' A' ' 18' ' ' ILE . 7.2 p -64.17 -28.48 44.99 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 C-N-CA 120.308 -0.557 . . . . 0.0 111.41 -177.54 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' THR . . . . . 0.422 HG23 HD13 ' A' ' 18' ' ' ILE . 5.0 p -81.17 -21.89 39.37 Favored 'General case' 0 N--CA 1.444 -0.749 0 O-C-N 121.941 -0.475 . . . . 0.0 111.757 176.406 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . 0.712 ' HG2' ' O ' ' A' ' 80' ' ' ASN . 27.1 mmtm -84.73 -38.39 19.75 Favored 'General case' 0 CA--C 1.519 -0.237 0 CA-C-O 121.249 0.547 . . . . 0.0 110.597 178.195 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . 0.418 ' CG ' ' HZ3' ' A' ' 53' ' ' LYS . 36.5 t70 -80.15 -22.76 41.67 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.241 -0.891 . . . . 0.0 110.305 179.393 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 26.4 mt-30 66.54 76.46 0.3 Allowed 'General case' 0 C--O 1.234 0.268 0 CA-C-N 115.188 -0.914 . . . . 0.0 111.96 177.085 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.519 ' HB2' HG23 ' A' ' 82' ' ' VAL . 89.4 mt -103.85 133.09 49.42 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.426 -0.806 . . . . 0.0 109.065 173.658 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.521 ' HZ3' ' HB3' ' A' ' 57' ' ' GLU . 0.0 OUTLIER -134.73 157.97 45.34 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.349 0.595 . . . . 0.0 111.96 -175.499 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 124.91 -132.75 8.24 Favored Glycine 0 N--CA 1.447 -0.626 0 N-CA-C 110.224 -1.15 . . . . 0.0 110.224 -173.278 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 57.7 mt -112.03 108.02 24.45 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 173.414 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . 0.62 ' HB3' ' CZ2' ' A' ' 38' ' ' TRP . 7.0 mm-40 -129.04 103.75 7.18 Favored 'General case' 0 N--CA 1.445 -0.708 0 N-CA-C 109.926 -0.398 . . . . 0.0 109.926 -175.828 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.558 HD23 ' HB2' ' A' ' 15' ' ' TYR . 5.1 mp -103.29 151.36 22.79 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-O 121.493 0.663 . . . . 0.0 110.87 -175.765 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 16.7 t-80 -120.77 119.59 33.17 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-N 115.613 -0.722 . . . . 0.0 110.425 -176.912 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' MET . . . . . 0.416 ' HE3' ' HE1' ' A' ' 101' ' ' MET . 33.7 ttm -71.78 -75.78 0.12 Allowed 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.433 -0.803 . . . . 0.0 110.129 176.363 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 134.94 -95.15 0.26 Allowed Glycine 0 N--CA 1.442 -0.95 0 N-CA-C 111.114 -0.794 . . . . 0.0 111.114 -174.181 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' THR . . . . . 0.431 ' HB ' ' HB3' ' A' ' 73' ' ' LYS . 9.2 t -150.49 25.61 0.77 Allowed 'General case' 0 C--N 1.313 -0.981 0 CA-C-O 121.834 0.826 . . . . 0.0 109.287 177.831 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -81.55 72.61 8.6 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 114.86 -1.063 . . . . 0.0 109.766 -179.092 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . 0.556 ' HA ' ' HG3' ' A' ' 101' ' ' MET . 7.4 mmm180 -69.36 -10.91 60.03 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.724 -173.298 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 7.6 m -58.24 -36.81 73.76 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.165 0.507 . . . . 0.0 109.927 175.262 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 24.8 t80 -81.74 -25.43 35.38 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.184 178.782 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' MET . . . . . 0.556 ' HG3' ' HA ' ' A' ' 98' ' ' ARG . 1.3 mmt -58.92 -51.44 70.04 Favored 'General case' 0 CA--C 1.519 -0.245 0 CA-C-O 121.265 0.555 . . . . 0.0 109.507 175.451 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -77.02 -23.03 52.19 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.406 -0.815 . . . . 0.0 110.538 -177.793 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -64.8 -26.93 68.55 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-O 121.12 0.486 . . . . 0.0 111.043 176.931 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' TYR . . . . . 0.525 ' HB3' HG23 ' A' ' 106' ' ' ILE . 0.3 OUTLIER -96.38 -4.11 42.47 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.296 174.875 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 93.5 mt 58.59 32.21 21.91 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.356 -172.301 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . 0.984 HG21 HD13 ' A' ' 113' ' ' ILE . 40.8 pt -114.43 31.96 1.52 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.333 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.356 -178.622 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 15.3 p30 -56.47 -29.74 62.09 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.469 -0.787 . . . . 0.0 111.82 -178.699 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -89.48 108.95 3.54 Favored Glycine 0 N--CA 1.448 -0.525 0 C-N-CA 121.02 -0.61 . . . . 0.0 111.61 174.077 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . 0.639 HG21 ' HG ' ' A' ' 71' ' ' CYS . 2.5 pp -100.43 153.81 37.54 Favored Pre-proline 0 C--N 1.325 -0.466 0 CA-C-O 120.344 0.116 . . . . 0.0 110.767 -177.528 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . 0.426 ' HG3' ' HB2' ' A' ' 42' ' ' CYS . 2.7 Cg_exo -76.82 152.51 95.43 Favored 'Cis proline' 0 C--N 1.344 0.326 0 C-N-CA 123.899 -1.292 . . . . 0.0 111.966 -0.068 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . 0.743 HH11 HG22 ' A' ' 106' ' ' ILE . 0.0 OUTLIER -125.17 138.45 54.14 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.365 0.603 . . . . 0.0 110.966 -179.0 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . 0.587 ' HD1' ' H ' ' A' ' 126' ' ' MET . 0.2 OUTLIER -106.74 114.97 29.39 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 114.341 -1.3 . . . . 0.0 110.354 -176.548 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.984 HD13 HG21 ' A' ' 106' ' ' ILE . 61.6 mt -123.57 142.54 39.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-O 120.858 0.361 . . . . 0.0 110.754 -178.483 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 23.0 tp -129.23 135.14 48.42 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.996 -0.547 . . . . 0.0 109.655 177.662 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.672 ' HB2' ' HB ' ' A' ' 33' ' ' ILE . 2.0 mp -132.57 153.44 51.0 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.878 0.37 . . . . 0.0 110.495 -177.054 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . 0.466 ' HB3' ' HB2' ' A' ' 120' ' ' LYS . 27.9 t0 -68.93 166.1 18.58 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.468 -0.787 . . . . 0.0 110.261 177.276 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . 0.517 ' HA ' ' C ' ' A' ' 31' ' ' LYS . 9.2 mtm180 -49.39 -27.64 4.28 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 124.335 1.054 . . . . 0.0 112.733 -177.076 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . 0.556 ' HB3' ' HG3' ' A' ' 120' ' ' LYS . 30.6 t70 -83.32 -0.97 52.1 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.257 0.551 . . . . 0.0 110.965 -178.784 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 81.26 22.5 60.61 Favored Glycine 0 N--CA 1.439 -1.16 0 N-CA-C 110.203 -1.159 . . . . 0.0 110.203 -170.513 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . 0.556 ' HG3' ' HB3' ' A' ' 118' ' ' ASP . 56.5 mttp -88.56 107.4 18.88 Favored 'General case' 0 C--O 1.223 -0.325 0 C-N-CA 120.478 -0.489 . . . . 0.0 111.052 -178.267 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . 0.459 ' HA ' ' HG ' ' A' ' 115' ' ' LEU . 19.5 mt -42.74 116.27 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-O 121.725 0.774 . . . . 0.0 112.332 179.251 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' ILE . . . . . 0.441 HD13 ' HB2' ' A' ' 116' ' ' ASP . 39.2 mm -97.87 -50.87 10.94 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.927 0 CA-C-N 114.283 -1.326 . . . . 0.0 109.203 177.163 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 14.6 m -129.44 114.21 15.87 Favored 'General case' 0 N--CA 1.446 -0.664 0 CA-C-N 115.22 -0.9 . . . . 0.0 110.113 179.305 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -68.05 -20.38 64.97 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 121.807 0.813 . . . . 0.0 109.496 174.046 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 7.4 p30 -141.46 122.07 14.23 Favored 'General case' 0 N--CA 1.447 -0.586 0 CA-C-N 114.523 -1.217 . . . . 0.0 108.25 171.291 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' MET . . . . . 0.587 ' H ' ' HD1' ' A' ' 112' ' ' PHE . 17.3 tpt -92.76 -80.66 0.37 Allowed 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.915 -176.664 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 4.2 m -155.44 -61.91 0.11 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.576 -0.284 . . . . 0.0 110.48 179.605 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . 1.078 ' HB3' ' HB2' ' A' ' 131' ' ' ASP . 0.0 OUTLIER -179.82 142.1 0.35 Allowed Pre-proline 0 N--CA 1.453 -0.314 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 -176.467 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . 0.576 ' HD2' ' HG2' ' A' ' 128' ' ' ARG . 1.5 Cg_endo -43.19 -49.0 7.58 Favored 'Trans proline' 0 C--N 1.351 0.671 0 C-N-CA 123.431 2.754 . . . . 0.0 113.353 -178.626 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 25.3 t -113.24 29.72 7.76 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.821 0.343 . . . . 0.0 111.196 -177.561 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . 1.078 ' HB2' ' HB3' ' A' ' 128' ' ' ARG . 11.2 t70 -84.88 135.94 39.39 Favored Pre-proline 0 C--N 1.328 -0.341 0 C-N-CA 120.389 -0.525 . . . . 0.0 110.426 -179.975 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 80.8 Cg_exo -48.24 -37.82 32.34 Favored 'Trans proline' 0 C--N 1.344 0.303 0 C-N-CA 123.231 2.621 . . . . 0.0 113.258 176.66 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 28.9 mmtm -56.98 -36.22 70.1 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-O 120.866 0.365 . . . . 0.0 111.711 -177.336 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' THR . . . . . 0.674 HG23 ' CZ ' ' A' ' 138' ' ' PHE . 2.4 m -64.51 -51.19 64.22 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.284 0.564 . . . . 0.0 109.69 177.244 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . 0.658 ' HA ' ' CD2' ' A' ' 138' ' ' PHE . . . -61.56 -41.01 96.75 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.583 -0.735 . . . . 0.0 111.542 177.576 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -53.5 -52.1 60.67 Favored 'General case' 0 CA--C 1.511 -0.531 0 CA-C-O 121.44 0.638 . . . . 0.0 110.458 176.882 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . 0.717 ' HE2' ' HA ' ' A' ' 137' ' ' LYS . 0.3 OUTLIER -48.93 -46.56 43.26 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 114.333 -1.303 . . . . 0.0 111.261 175.614 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . 0.674 ' CZ ' HG23 ' A' ' 134' ' ' THR . 5.9 m-85 -63.1 -53.77 48.29 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 120.889 0.376 . . . . 0.0 109.991 178.4 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . 0.423 ' C ' ' H ' ' A' ' 145' ' ' GLU . 94.2 m-20 -50.9 -50.12 58.04 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.789 -179.886 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . 0.551 ' CD ' ' HZ2' ' A' ' 137' ' ' LYS . 2.1 tt0 -49.41 -54.47 17.35 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.648 -0.705 . . . . 0.0 112.133 178.17 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . 0.543 ' HG ' ' O ' ' A' ' 138' ' ' PHE . 3.2 pp -69.35 -19.38 63.85 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 120.953 -0.299 . . . . 0.0 111.206 -174.842 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . 0.53 HD23 ' HD2' ' A' ' 62' ' ' LYS . 8.2 mp -82.64 -16.9 46.58 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.907 0.384 . . . . 0.0 110.56 173.418 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 94.14 8.47 60.17 Favored Glycine 0 N--CA 1.45 -0.387 0 N-CA-C 111.603 -0.599 . . . . 0.0 111.603 -178.135 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 60.7 tp -90.33 -52.11 5.09 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.476 -0.362 . . . . 0.0 110.258 -178.886 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . 0.423 ' H ' ' C ' ' A' ' 139' ' ' ASN . 2.6 mt-10 60.14 -76.36 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.446 0 O-C-N 124.348 1.03 . . . . 0.0 112.346 179.33 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 145.03 24.42 0.12 Allowed Glycine 0 C--N 1.306 -1.109 0 CA-C-N 113.771 -1.559 . . . . 0.0 109.696 -171.708 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 6.4 p-80 -58.04 118.13 5.09 Favored 'General case' 0 N--CA 1.458 -0.032 0 CA-C-O 121.388 0.613 . . . . 0.0 111.338 -177.062 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 14.8 t60 -102.29 2.48 37.0 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.589 -0.732 . . . . 0.0 109.554 -179.14 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 2.9 m-70 -133.52 141.29 47.68 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.648 -178.561 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 39.4 t-80 65.43 -98.97 0.06 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.109 -0.95 . . . . 0.0 111.902 172.383 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 70.1 t60 171.66 145.13 0.03 OUTLIER 'General case' 0 C--O 1.232 0.174 0 N-CA-C 109.754 -0.461 . . . . 0.0 109.754 -171.911 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 4.9 t60 . . . . . 0 C--O 1.241 0.642 0 N-CA-C 107.88 -1.156 . . . . 0.0 107.88 169.674 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.419 ' HG2' ' HB3' ' A' ' 8' ' ' PRO . 26.8 ptm . . . . . 0 N--CA 1.48 1.031 0 N-CA-C 110.262 -0.273 . . . . 0.0 110.262 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 23.0 m 68.71 -76.2 0.06 Allowed 'General case' 0 CA--C 1.532 0.275 0 O-C-N 124.111 0.882 . . . . 0.0 112.311 173.79 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.67 ' H ' HD23 ' A' ' 3' ' ' LEU . 1.8 pt? -82.65 110.25 17.55 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.902 0.382 . . . . 0.0 110.33 -178.949 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 27.1 mtm180 69.26 -170.68 0.18 Allowed 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 115.254 -0.885 . . . . 0.0 110.247 -179.037 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 34.4 m -111.2 93.29 4.4 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 174.44 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 167.74 -136.25 4.02 Favored Glycine 0 N--CA 1.446 -0.635 0 C-N-CA 120.531 -0.843 . . . . 0.0 112.689 -178.369 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . 0.448 ' HA ' ' HD3' ' A' ' 8' ' ' PRO . 4.7 p-10 -70.86 148.35 94.65 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-O 120.975 0.416 . . . . 0.0 111.874 -174.459 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.448 ' HD3' ' HA ' ' A' ' 7' ' ' ASN . 4.4 Cg_exo -74.32 165.93 30.69 Favored 'Trans proline' 0 C--O 1.234 0.279 0 C-N-CA 123.198 2.598 . . . . 0.0 111.708 175.089 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.506 ' HB2' HD13 ' A' ' 3' ' ' LEU . 66.2 m -156.15 176.09 13.12 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.559 -0.291 . . . . 0.0 110.481 179.0 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -77.61 76.29 4.14 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.542 0.687 . . . . 0.0 110.499 178.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -138.77 99.22 3.74 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 115.131 -0.94 . . . . 0.0 110.216 -179.752 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 49.0 m 64.7 80.02 0.24 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.405 -0.816 . . . . 0.0 111.454 179.463 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 53.5 p90 -96.08 155.32 16.81 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.116 178.014 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 5.4 p -142.1 112.92 7.35 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 120.98 0.419 . . . . 0.0 110.147 177.307 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . 0.526 ' HB2' HD11 ' A' ' 92' ' ' LEU . 35.8 m-85 -135.75 149.7 69.69 Favored Pre-proline 0 C--N 1.326 -0.431 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.413 -176.38 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -87.07 131.37 3.11 Favored 'Trans proline' 0 N--CA 1.452 -0.946 0 C-N-CA 122.528 2.152 . . . . 0.0 113.23 179.808 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . 0.46 ' HB3' ' HB3' ' A' ' 21' ' ' LYS . 12.1 t70 -67.95 154.49 41.49 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 114.958 -1.019 . . . . 0.0 108.63 170.403 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -53.21 -32.93 19.75 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.6 0 O-C-N 124.018 0.824 . . . . 0.0 110.883 -179.391 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 43.7 m-80 -76.29 -1.77 28.23 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 121.089 0.471 . . . . 0.0 110.82 179.051 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 86.05 42.11 6.83 Favored Glycine 0 N--CA 1.446 -0.647 0 CA-C-N 115.739 -0.664 . . . . 0.0 112.172 -179.619 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.653 ' HZ2' HG23 ' A' ' 23' ' ' VAL . 56.8 tttm -107.71 124.2 49.66 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 120.173 -0.611 . . . . 0.0 111.252 -179.453 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 19.4 m -66.49 107.38 2.04 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.29 -0.414 . . . . 0.0 109.945 172.652 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.653 HG23 ' HZ2' ' A' ' 21' ' ' LYS . 91.6 t -116.35 117.32 55.1 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-O 120.996 0.427 . . . . 0.0 109.909 178.342 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 17.6 m -122.77 179.47 4.62 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.288 -178.15 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.401 HD11 ' HA3' ' A' ' 119' ' ' GLY . 52.7 tp -56.4 -42.28 77.7 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.924 0.393 . . . . 0.0 111.027 -179.287 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -82.27 15.91 2.24 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.86 -177.793 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -102.18 -17.08 16.14 Favored 'General case' 0 CA--C 1.517 -0.294 0 N-CA-C 107.692 -1.225 . . . . 0.0 107.692 178.319 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -117.22 -20.81 9.07 Favored 'General case' 0 N--CA 1.445 -0.723 0 CA-C-N 113.973 -1.467 . . . . 0.0 110.494 -179.323 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 58.3 tttm -61.71 132.07 52.0 Favored 'General case' 0 N--CA 1.446 -0.662 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.273 -173.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 120.5 -8.59 11.03 Favored Glycine 0 N--CA 1.451 -0.328 0 N-CA-C 110.61 -0.996 . . . . 0.0 110.61 -174.496 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.707 ' HD3' ' HA ' ' A' ' 63' ' ' ASP . 25.2 ttmm -155.63 154.96 32.44 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 -178.784 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.445 ' HB2' ' O ' ' A' ' 63' ' ' ASP . 61.8 m-85 -59.07 147.1 36.12 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-O 121.094 0.473 . . . . 0.0 111.601 -174.482 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.541 HD12 ' HA2' ' A' ' 119' ' ' GLY . 40.0 mt -124.45 134.77 65.83 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.439 -175.633 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . 0.408 ' HE2' ' HB3' ' A' ' 36' ' ' ASP . 80.3 t80 -121.79 130.71 53.61 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 173.177 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.546 ' HA ' ' O ' ' A' ' 67' ' ' VAL . 62.5 mt -115.2 110.76 33.1 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-O 121.093 0.473 . . . . 0.0 110.577 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.558 ' O ' ' HA ' ' A' ' 68' ' ' SER . 7.1 p-10 -110.34 158.97 17.87 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-N 115.5 -0.773 . . . . 0.0 109.063 175.257 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.492 ' O ' ' HB3' ' A' ' 110' ' ' PRO . 85.5 t -102.88 126.68 57.09 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.806 0 C-N-CA 120.144 -0.622 . . . . 0.0 111.119 176.598 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' TRP . . . . . 0.594 ' CE3' ' HZ2' ' A' ' 78' ' ' TRP . 0.7 OUTLIER -113.31 130.49 56.25 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 109.368 -0.605 . . . . 0.0 109.368 177.958 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -150.19 167.47 26.81 Favored 'General case' 0 C--N 1.328 -0.354 0 O-C-N 122.362 -0.211 . . . . 0.0 111.039 -178.497 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' THR . . . . . 0.582 HG22 ' OD2' ' A' ' 72' ' ' ASP . 13.8 t -108.85 -33.63 6.89 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 120.696 -0.401 . . . . 0.0 110.694 174.313 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . 0.687 ' HE1' ' HA ' ' A' ' 72' ' ' ASP . 65.6 p-90 -73.94 -9.24 58.44 Favored 'General case' 0 C--N 1.343 0.291 0 C-N-CA 120.319 -0.552 . . . . 0.0 111.002 178.489 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 25.5 t -63.55 -57.57 9.72 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.102 -179.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 107.28 -85.18 0.41 Allowed Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.642 -0.789 . . . . 0.0 112.493 -176.712 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_exo -53.42 -28.63 45.04 Favored 'Trans proline' 0 C--N 1.354 0.818 0 C-N-CA 123.134 2.556 . . . . 0.0 112.727 179.277 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 42.4 t -54.13 -29.15 44.06 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.055 176.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 54.8 mtp180 -83.65 -26.23 30.08 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-O 120.903 0.382 . . . . 0.0 110.695 -179.701 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -80.52 -36.67 22.65 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.865 -0.683 . . . . 0.0 111.689 -179.335 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 21.3 mt-10 -90.23 10.36 24.95 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.292 0.568 . . . . 0.0 109.985 177.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.545 ' N ' ' HD2' ' A' ' 50' ' ' PRO . 20.2 tp -69.05 -45.99 30.24 Favored Pre-proline 0 N--CA 1.441 -0.89 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.869 -177.936 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.545 ' HD2' ' N ' ' A' ' 49' ' ' LEU . 11.7 Cg_endo -56.83 -22.28 44.59 Favored 'Trans proline' 0 C--N 1.351 0.698 0 C-N-CA 121.565 1.51 . . . . 0.0 111.363 171.379 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -85.05 -31.38 23.44 Favored 'General case' 0 CA--C 1.515 -0.386 0 CA-C-O 121.924 0.869 . . . . 0.0 108.895 -179.233 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 6.0 tt -69.94 -48.07 59.88 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-N 114.443 -1.253 . . . . 0.0 108.573 178.228 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.617 ' HZ1' ' HB3' ' A' ' 53' ' ' LYS . 7.6 mtpm? -58.83 -49.37 77.99 Favored 'General case' 0 C--O 1.225 -0.193 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.751 179.119 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.482 ' CD ' ' HZ3' ' A' ' 58' ' ' LYS . 0.6 OUTLIER -46.03 -56.37 5.64 Favored 'General case' 0 C--N 1.332 -0.16 0 O-C-N 123.514 0.509 . . . . 0.0 111.586 176.397 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.595 HD23 ' HE2' ' A' ' 138' ' ' PHE . 38.8 tp -66.95 -48.7 67.75 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.255 -178.392 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.538 ' CD ' ' HZ2' ' A' ' 88' ' ' LYS . 5.9 tm-20 -59.03 -55.1 39.47 Favored 'General case' 0 N--CA 1.448 -0.553 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.563 -175.998 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.992 ' HG2' ' HZ1' ' A' ' 88' ' ' LYS . 38.2 mt-10 -70.12 -30.43 67.62 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.724 0.297 . . . . 0.0 111.244 -174.73 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . 0.482 ' HZ3' ' CD ' ' A' ' 54' ' ' GLU . 34.3 ttmt -69.96 -41.77 74.07 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-O 121.198 0.523 . . . . 0.0 110.665 179.237 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 17.2 m-85 -100.3 7.82 44.12 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.473 -177.032 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -65.11 136.19 56.41 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.258 -0.428 . . . . 0.0 109.941 173.245 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 82.61 1.52 90.53 Favored Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.407 179.187 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.44 ' O ' ' HD3' ' A' ' 31' ' ' LYS . 34.8 mmtm -90.59 -154.16 0.33 Allowed 'General case' 0 CA--C 1.515 -0.395 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 176.601 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.707 ' HA ' ' HD3' ' A' ' 31' ' ' LYS . 2.6 t70 -95.1 47.26 1.14 Allowed 'General case' 0 C--N 1.318 -0.762 0 CA-C-O 121.35 0.595 . . . . 0.0 110.344 179.153 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 13.3 tt -155.16 135.31 4.18 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.721 0 CA-C-N 115.582 -0.735 . . . . 0.0 109.961 178.038 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' HIS . . . . . 0.654 ' NE2' ' HB3' ' A' ' 31' ' ' LYS . 75.3 m-70 -105.0 114.27 28.38 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 176.911 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . 0.444 ' CZ ' ' HG ' ' A' ' 55' ' ' LEU . 73.6 m-85 -78.4 104.81 9.23 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 172.442 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.546 ' O ' ' HA ' ' A' ' 35' ' ' ILE . 48.4 t -117.49 104.46 16.42 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.884 -178.359 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' SER . . . . . 0.558 ' HA ' ' O ' ' A' ' 36' ' ' ASP . 23.3 p -89.26 146.03 25.0 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.169 -179.8 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.478 ' O ' HG12 ' A' ' 37' ' ' VAL . 64.8 tp -124.12 126.84 46.87 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 109.689 -0.486 . . . . 0.0 109.689 176.77 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' SER . . . . . 0.464 ' HB3' ' HA ' ' A' ' 93' ' ' HIS . 19.3 t -103.94 109.03 20.62 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.435 0.636 . . . . 0.0 112.29 -174.301 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 6.8 m -81.02 25.11 0.48 Allowed 'General case' 0 C--N 1.314 -0.974 0 CA-C-N 115.067 -0.969 . . . . 0.0 110.188 169.553 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.687 ' HA ' ' HE1' ' A' ' 41' ' ' TRP . 2.9 t70 -72.79 129.74 38.89 Favored 'General case' 0 CA--C 1.51 -0.578 0 C-N-CA 119.899 -0.72 . . . . 0.0 110.174 -178.646 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.501 ' HZ3' ' HB3' ' A' ' 73' ' ' LYS . 3.0 ttpm? -88.02 -11.95 45.81 Favored 'General case' 0 C--N 1.313 -0.979 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.338 -177.856 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 -104.39 60.04 0.71 Allowed 'General case' 0 CA--C 1.51 -0.595 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 -176.779 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.643 ' O ' ' HG2' ' A' ' 79' ' ' GLU . 64.9 tttt -47.75 -51.33 22.59 Favored 'General case' 0 C--O 1.221 -0.414 0 O-C-N 123.644 0.59 . . . . 0.0 112.447 -170.029 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.404 ' O ' ' ND2' ' A' ' 80' ' ' ASN . 23.6 tptm -48.3 -54.24 14.45 Favored 'General case' 0 C--O 1.245 0.855 0 CA-C-N 116.735 -0.211 . . . . 0.0 110.456 -179.999 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.526 ' HA ' HD22 ' A' ' 80' ' ' ASN . . . -61.27 -39.86 91.95 Favored 'General case' 0 N--CA 1.452 -0.355 0 O-C-N 123.972 0.795 . . . . 0.0 110.034 -178.844 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' TRP . . . . . 0.594 ' HZ2' ' CE3' ' A' ' 38' ' ' TRP . 9.3 t-105 -61.43 -58.51 7.88 Favored 'General case' 0 N--CA 1.437 -1.088 0 CA-C-N 114.96 -1.018 . . . . 0.0 112.263 -179.458 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.643 ' HG2' ' O ' ' A' ' 75' ' ' LYS . 3.3 mm-40 -52.25 -48.04 65.43 Favored 'General case' 0 C--O 1.236 0.39 0 N-CA-C 112.426 0.528 . . . . 0.0 112.426 -175.669 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . 0.526 HD22 ' HA ' ' A' ' 77' ' ' ALA . 8.4 p30 -71.16 -28.82 64.53 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 118.859 -1.136 . . . . 0.0 110.852 -178.159 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 15.3 ttt -68.19 -47.81 66.93 Favored 'General case' 0 C--O 1.222 -0.359 0 C-N-CA 120.978 -0.289 . . . . 0.0 111.542 177.518 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.544 HG23 ' HB2' ' A' ' 87' ' ' LEU . 0.2 OUTLIER -58.69 -37.9 68.44 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.313 0 C-N-CA 120.429 -0.509 . . . . 0.0 110.205 178.72 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 25.3 m -67.34 -33.31 74.97 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.81 177.376 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 21.0 tttm -80.25 -49.97 10.86 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.699 -177.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 52.8 m-20 -84.37 6.79 21.78 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.633 -0.712 . . . . 0.0 111.406 -173.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 89.7 mt-30 64.28 41.72 5.8 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 115.72 -0.673 . . . . 0.0 112.745 171.007 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.544 ' HB2' HG23 ' A' ' 82' ' ' VAL . 7.9 mp -83.95 82.11 8.49 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 120.758 -0.377 . . . . 0.0 110.218 176.036 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.992 ' HZ1' ' HG2' ' A' ' 57' ' ' GLU . 0.0 OUTLIER -95.79 171.53 8.59 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.594 -0.276 . . . . 0.0 111.676 -179.852 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 128.07 -139.74 11.3 Favored Glycine 0 N--CA 1.452 -0.258 0 N-CA-C 110.286 -1.126 . . . . 0.0 110.286 -175.795 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 63.8 mt -111.44 109.05 27.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 N-CA-C 107.935 -1.135 . . . . 0.0 107.935 168.408 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . 0.508 ' HB3' ' CZ2' ' A' ' 38' ' ' TRP . 3.5 mm100 -127.73 100.22 5.87 Favored 'General case' 0 N--CA 1.442 -0.85 0 CA-C-O 120.838 0.351 . . . . 0.0 110.953 -167.669 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.526 HD11 ' HB2' ' A' ' 15' ' ' TYR . 27.0 mt -97.22 140.58 31.49 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 120.817 0.342 . . . . 0.0 110.787 -177.133 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' HIS . . . . . 0.551 ' CE1' ' HG3' ' A' ' 75' ' ' LYS . 30.0 t-80 -114.53 120.63 40.88 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 120.864 0.364 . . . . 0.0 110.896 178.301 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 19.7 ttp -79.0 -55.83 4.84 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.74 -0.664 . . . . 0.0 109.999 176.553 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . 0.446 ' HA2' ' NE2' ' A' ' 93' ' ' HIS . . . 111.19 -119.33 5.14 Favored Glycine 0 N--CA 1.438 -1.178 0 C-N-CA 120.557 -0.83 . . . . 0.0 111.879 -179.465 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 8.9 t -109.85 21.71 16.55 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-O 120.555 0.217 . . . . 0.0 110.994 -175.28 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -90.84 134.17 34.65 Favored 'General case' 0 CA--C 1.515 -0.383 0 C-N-CA 119.699 -0.8 . . . . 0.0 109.74 179.9 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . 0.554 ' HA ' ' HG3' ' A' ' 101' ' ' MET . 0.0 OUTLIER -113.71 6.08 16.69 Favored 'General case' 0 C--N 1.32 -0.676 0 C-N-CA 120.361 -0.536 . . . . 0.0 110.699 176.689 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 4.0 m -71.0 -39.68 72.29 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.373 -178.611 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 27.7 t80 -82.24 -30.61 30.65 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.585 -176.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' MET . . . . . 0.554 ' HG3' ' HA ' ' A' ' 98' ' ' ARG . 4.7 ppp? -74.68 -20.92 59.67 Favored 'General case' 0 C--N 1.332 -0.168 0 C-N-CA 120.144 -0.622 . . . . 0.0 109.495 177.554 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -68.0 -42.81 80.18 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.41 -0.814 . . . . 0.0 109.8 172.331 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -64.46 -16.99 63.4 Favored 'General case' 0 CA--C 1.529 0.158 0 CA-C-N 115.674 -0.694 . . . . 0.0 111.815 -177.621 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 9.0 m-85 -108.28 -2.32 19.35 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.402 178.212 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 7.8 mp 55.34 37.64 29.18 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.812 -176.793 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . 0.846 HG12 ' HG3' ' A' ' 111' ' ' ARG . 60.8 mt -59.41 106.51 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.006 177.906 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 7.1 m120 -73.79 -66.18 0.74 Allowed 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.626 0.727 . . . . 0.0 109.938 178.483 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -135.14 145.82 17.88 Favored Glycine 0 N--CA 1.438 -1.216 0 CA-C-N 114.971 -1.013 . . . . 0.0 111.12 178.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . 0.451 HG21 HG13 ' A' ' 37' ' ' VAL . 40.2 pt -100.53 154.3 37.26 Favored Pre-proline 0 C--N 1.316 -0.85 0 N-CA-C 110.34 -0.244 . . . . 0.0 110.34 179.736 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . 0.492 ' HB3' ' O ' ' A' ' 37' ' ' VAL . 15.9 Cg_exo -69.1 131.73 19.34 Favored 'Cis proline' 0 C--N 1.348 0.515 0 C-N-CA 123.973 -1.261 . . . . 0.0 113.54 0.656 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . 0.846 ' HG3' HG12 ' A' ' 106' ' ' ILE . 0.0 OUTLIER -82.26 160.3 22.99 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 175.215 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . 0.427 ' HD2' ' HB2' ' A' ' 128' ' ' ARG . 0.2 OUTLIER -130.45 114.43 15.52 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.76 -0.654 . . . . 0.0 109.958 -177.445 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.499 ' HB ' ' HB ' ' A' ' 35' ' ' ILE . 81.5 mt -134.44 142.88 39.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-O 120.735 0.303 . . . . 0.0 111.142 -176.306 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.477 ' HB2' ' SD ' ' A' ' 126' ' ' MET . 41.2 tp -127.13 140.41 52.28 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.262 178.689 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.462 ' HB2' ' HB ' ' A' ' 33' ' ' ILE . 1.9 mp -133.29 150.0 51.91 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.302 0.572 . . . . 0.0 110.042 178.152 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . 0.605 ' HB3' ' HB2' ' A' ' 120' ' ' LYS . 14.1 t70 -70.29 164.3 24.7 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.029 -0.987 . . . . 0.0 110.604 178.905 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . 0.408 ' HA ' ' C ' ' A' ' 31' ' ' LYS . 84.5 mtt180 -48.13 -38.09 17.05 Favored 'General case' 0 N--CA 1.464 0.247 0 O-C-N 124.198 0.936 . . . . 0.0 112.613 -178.63 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -80.54 9.77 5.61 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.638 0.256 . . . . 0.0 111.607 -178.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . 0.541 ' HA2' HD12 ' A' ' 33' ' ' ILE . . . 79.04 28.81 53.34 Favored Glycine 0 N--CA 1.445 -0.744 0 N-CA-C 111.244 -0.743 . . . . 0.0 111.244 -176.988 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . 0.605 ' HB2' ' HB3' ' A' ' 116' ' ' ASP . 32.4 mtmm -99.47 104.29 16.11 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 120.674 -0.411 . . . . 0.0 110.742 -175.147 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . 0.432 ' HA ' ' HG ' ' A' ' 115' ' ' LEU . 4.0 mp -43.65 111.57 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-O 121.31 0.576 . . . . 0.0 111.396 -178.286 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' ILE . . . . . 0.413 ' H ' ' HA ' ' A' ' 115' ' ' LEU . 58.7 mt -85.59 -41.3 15.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 115.337 -0.847 . . . . 0.0 109.18 178.921 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 17.3 m -149.72 115.44 5.6 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.416 -0.811 . . . . 0.0 110.299 -179.522 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -69.92 -15.22 63.03 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.348 0.594 . . . . 0.0 110.307 174.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 18.1 p-10 -139.95 102.77 4.48 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.313 -0.858 . . . . 0.0 110.066 174.24 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' MET . . . . . 0.477 ' SD ' ' HB2' ' A' ' 114' ' ' LEU . 20.8 ttp -107.97 -133.4 0.33 Allowed 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.036 -0.529 . . . . 0.0 109.676 178.602 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 6.3 p -124.69 138.07 54.32 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 110.149 -0.315 . . . . 0.0 110.149 177.328 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . 0.447 ' CG ' ' HD2' ' A' ' 129' ' ' PRO . 37.9 ttm180 -67.78 147.36 98.59 Favored Pre-proline 0 C--N 1.325 -0.475 0 CA-C-N 116.198 -0.455 . . . . 0.0 109.874 177.565 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . 0.447 ' HD2' ' CG ' ' A' ' 128' ' ' ARG . 2.9 Cg_endo -42.62 -25.82 0.54 Allowed 'Trans proline' 0 C--N 1.356 0.966 0 C-N-CA 124.119 3.213 . . . . 0.0 114.226 177.095 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 1.4 m -57.76 -26.05 61.32 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 122.723 0.409 . . . . 0.0 111.708 178.432 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . 0.494 ' OD1' ' HG3' ' A' ' 133' ' ' LYS . 21.1 t0 -99.05 124.88 43.76 Favored Pre-proline 0 C--N 1.329 -0.32 0 N-CA-C 109.938 -0.393 . . . . 0.0 109.938 179.511 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 28.7 Cg_endo -61.0 -18.11 55.73 Favored 'Trans proline' 0 C--N 1.347 0.489 0 C-N-CA 123.273 2.648 . . . . 0.0 113.788 -178.081 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . 0.494 ' HG3' ' OD1' ' A' ' 131' ' ' ASP . 48.6 mttp -58.2 -23.93 57.31 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-O 120.833 0.349 . . . . 0.0 110.605 178.843 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 36.2 p -58.39 -59.32 5.53 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.235 175.494 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -56.75 -47.17 80.66 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.917 -177.907 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -56.63 -39.9 74.47 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.44 -0.8 . . . . 0.0 111.15 -179.633 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . 0.501 ' O ' ' HG ' ' A' ' 141' ' ' LEU . 75.5 tttt -74.08 -34.09 63.88 Favored 'General case' 0 N--CA 1.451 -0.396 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.883 -179.271 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . 0.595 ' HE2' HD23 ' A' ' 55' ' ' LEU . 11.1 m-30 -64.43 -40.22 95.33 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 109.689 -0.486 . . . . 0.0 109.689 177.747 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 75.6 m-20 -58.17 -45.74 86.96 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.69 -0.686 . . . . 0.0 109.66 174.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -60.58 -48.07 83.39 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.067 177.467 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . 0.501 ' HG ' ' O ' ' A' ' 137' ' ' LYS . 95.5 mt -56.38 -45.59 80.46 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.776 -179.402 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . 0.508 HD13 ' HB2' ' A' ' 63' ' ' ASP . 60.0 tp -67.71 -23.28 65.26 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.201 0.524 . . . . 0.0 110.811 -179.973 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 95.27 23.81 18.45 Favored Glycine 0 N--CA 1.442 -0.924 0 C-N-CA 120.719 -0.753 . . . . 0.0 111.383 -176.904 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 55.6 tp -82.26 -68.66 0.68 Allowed 'General case' 0 N--CA 1.446 -0.632 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 175.822 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 8.2 mm-40 -70.4 -22.44 62.74 Favored 'General case' 0 CA--C 1.505 -0.756 0 CA-C-O 122.086 0.946 . . . . 0.0 110.704 172.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -71.77 64.9 1.16 Allowed Glycine 0 C--N 1.305 -1.145 0 CA-C-N 113.974 -1.466 . . . . 0.0 110.078 166.272 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 88.9 m-70 -74.8 44.44 0.22 Allowed 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 122.754 0.421 . . . . 0.0 111.014 -174.544 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 27.3 p80 -78.97 48.43 0.84 Allowed 'General case' 0 N--CA 1.466 0.348 0 N-CA-C 112.366 0.506 . . . . 0.0 112.366 -173.486 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -166.7 174.36 8.78 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-N 116.46 -0.336 . . . . 0.0 110.718 175.594 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 15.2 t-80 66.97 22.39 10.08 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 123.509 0.723 . . . . 0.0 111.444 176.543 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 34.3 p-80 -166.94 -173.58 2.41 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 110.14 -0.318 . . . . 0.0 110.14 176.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 84.5 t60 . . . . . 0 C--O 1.246 0.914 0 CA-C-O 118.555 -0.736 . . . . 0.0 110.133 178.922 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.1 ptt? . . . . . 0 N--CA 1.481 1.125 0 CA-C-O 120.794 0.331 . . . . 0.0 111.035 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 18.7 p -154.88 178.29 10.33 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 110.153 -0.314 . . . . 0.0 110.153 -178.565 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 6.9 mp -71.96 98.28 2.02 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 176.204 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 38.9 ttm180 -62.46 -37.78 87.24 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.119 -175.704 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 37.1 m -110.89 101.49 10.08 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.33 -179.476 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . 0.402 ' O ' ' HB2' ' A' ' 7' ' ' ASN . . . 113.4 -39.37 2.86 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.552 177.693 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . 0.402 ' HB2' ' O ' ' A' ' 6' ' ' GLY . 53.5 m-80 68.41 162.91 0.14 Allowed Pre-proline 0 N--CA 1.469 0.493 0 C-N-CA 122.919 0.488 . . . . 0.0 110.789 -175.978 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -57.01 110.97 0.67 Allowed 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.008 1.806 . . . . 0.0 111.149 175.792 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.409 ' HA ' ' OG ' ' A' ' 12' ' ' SER . 5.5 m -70.23 -5.9 30.79 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.285 0.564 . . . . 0.0 111.775 -172.546 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.434 ' HA ' ' CZ ' ' A' ' 100' ' ' PHE . . . -79.0 -11.06 60.0 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 115.417 -0.81 . . . . 0.0 109.884 178.391 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -128.38 13.24 6.56 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.344 -0.844 . . . . 0.0 110.535 -178.644 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.409 ' OG ' ' HA ' ' A' ' 9' ' ' SER . 35.6 p -143.16 18.34 1.92 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.13 0.491 . . . . 0.0 110.852 -179.747 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 49.5 p90 -73.81 149.64 41.54 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.055 -0.521 . . . . 0.0 111.008 -176.958 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' SER . . . . . 0.448 ' HA ' ' HA ' ' A' ' 24' ' ' SER . 39.1 m -142.22 117.23 9.98 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.773 -0.649 . . . . 0.0 109.377 176.811 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . 0.516 ' HB2' HD21 ' A' ' 92' ' ' LEU . 57.5 m-85 -128.32 145.68 56.64 Favored Pre-proline 0 C--N 1.323 -0.55 0 CA-C-O 120.851 0.357 . . . . 0.0 111.236 -176.321 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.403 ' HD2' ' O ' ' A' ' 93' ' ' HIS . 63.2 Cg_endo -76.07 125.39 8.58 Favored 'Trans proline' 0 N--CA 1.459 -0.553 0 C-N-CA 122.434 2.089 . . . . 0.0 113.449 -179.029 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . 0.656 ' HB3' ' HB3' ' A' ' 21' ' ' LYS . 3.3 t70 -64.15 157.36 25.79 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.044 -0.98 . . . . 0.0 108.528 168.007 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.504 HD12 ' CG1' ' A' ' 82' ' ' VAL . 3.4 tt -50.06 -39.04 15.41 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.519 0 O-C-N 123.959 0.787 . . . . 0.0 111.561 -173.867 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 37.8 m-80 -75.61 3.8 8.87 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.474 -175.407 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 82.59 37.77 13.42 Favored Glycine 0 N--CA 1.445 -0.719 0 N-CA-C 111.186 -0.765 . . . . 0.0 111.186 -176.739 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.656 ' HB3' ' HB3' ' A' ' 17' ' ' ASP . 4.2 tmmt? -110.72 120.9 43.92 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.723 0.297 . . . . 0.0 110.333 -177.786 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 26.0 m -70.68 101.66 2.11 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-O 120.956 0.407 . . . . 0.0 110.917 -177.039 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.506 ' HB ' HD22 ' A' ' 92' ' ' LEU . 41.5 t -92.61 109.26 21.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 175.703 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' SER . . . . . 0.448 ' HA ' ' HA ' ' A' ' 14' ' ' SER . 57.4 p -106.16 175.86 5.36 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.204 -177.956 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.466 HD13 ' HA3' ' A' ' 119' ' ' GLY . 2.9 tm? -58.42 -33.7 69.98 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 109.662 -0.496 . . . . 0.0 109.662 176.098 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -74.32 -25.86 59.81 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.735 -178.456 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -69.17 -32.47 71.82 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-O 121.523 0.678 . . . . 0.0 110.472 -179.556 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.663 HD13 HG22 ' A' ' 67' ' ' VAL . 68.9 mt -100.35 -8.6 23.17 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.56 -0.745 . . . . 0.0 110.902 -178.623 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 56.1 tttp -70.75 138.45 50.49 Favored 'General case' 0 N--CA 1.443 -0.813 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.219 -173.874 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 109.22 -3.64 31.4 Favored Glycine 0 N--CA 1.446 -0.656 0 N-CA-C 111.203 -0.759 . . . . 0.0 111.203 -176.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.628 ' HD3' ' HA ' ' A' ' 63' ' ' ASP . 21.6 ttmm -154.1 150.25 27.98 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 -179.486 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.474 ' HB2' ' O ' ' A' ' 63' ' ' ASP . 29.1 m-85 -59.99 148.68 34.53 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 121.145 0.498 . . . . 0.0 111.667 -175.829 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.459 ' HB ' ' HB2' ' A' ' 115' ' ' LEU . 55.3 mt -123.39 128.12 74.59 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.772 -175.602 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 91.7 t80 -118.16 110.19 17.29 Favored 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 108.72 -0.845 . . . . 0.0 108.72 173.395 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.541 ' HB ' ' HB ' ' A' ' 113' ' ' ILE . 68.0 mt -97.48 126.03 50.45 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-O 121.06 0.457 . . . . 0.0 111.135 -175.455 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.446 ' HA ' ' O ' ' A' ' 111' ' ' ARG . 3.2 p30 -113.04 159.33 19.27 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 173.18 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.499 HG21 HG21 ' A' ' 106' ' ' ILE . 61.6 t -105.05 131.19 54.83 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.933 0 C-N-CA 120.36 -0.536 . . . . 0.0 111.055 173.427 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' TRP . . . . . 0.661 ' HZ3' HG21 ' A' ' 82' ' ' VAL . 0.4 OUTLIER -125.05 134.17 52.63 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-O 120.748 0.308 . . . . 0.0 110.718 -179.014 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -147.74 162.04 40.01 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 116.646 -0.252 . . . . 0.0 110.588 178.377 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' THR . . . . . 0.714 ' HB ' ' CE3' ' A' ' 78' ' ' TRP . 12.2 t -99.6 -10.12 22.41 Favored 'General case' 0 N--CA 1.462 0.136 0 C-N-CA 120.537 -0.465 . . . . 0.0 111.528 179.845 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . 0.439 ' HE1' ' HA ' ' A' ' 72' ' ' ASP . 9.7 p-90 -99.02 15.88 24.37 Favored 'General case' 0 CA--C 1.51 -0.595 0 CA-C-O 122.56 1.171 . . . . 0.0 108.025 -177.381 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . 0.57 ' SG ' HD11 ' A' ' 109' ' ' ILE . 99.6 m -123.18 135.95 54.54 Favored 'General case' 0 N--CA 1.429 -1.505 0 CA-C-N 113.267 -1.788 . . . . 0.0 109.398 -178.212 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . 0.631 ' H ' ' HD2' ' A' ' 44' ' ' PRO . . . -101.92 -49.86 1.22 Allowed Glycine 0 CA--C 1.525 0.671 0 CA-C-O 119.203 -0.776 . . . . 0.0 113.879 -177.945 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.631 ' HD2' ' H ' ' A' ' 43' ' ' GLY . 10.5 Cg_endo -53.38 -34.6 71.77 Favored 'Trans proline' 0 C--N 1.357 1.022 0 C-N-CA 122.8 2.333 . . . . 0.0 112.826 -176.661 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . 0.638 ' O ' ' HG ' ' A' ' 49' ' ' LEU . 18.4 p -58.42 -34.06 70.37 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.109 179.547 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.489 ' HG2' HD11 ' A' ' 49' ' ' LEU . 33.8 mtt85 -72.01 -8.01 52.04 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.787 -174.811 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -74.79 -33.87 54.49 Favored Glycine 0 N--CA 1.446 -0.677 0 C-N-CA 120.428 -0.892 . . . . 0.0 111.979 177.262 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.531 ' OE1' ' HD3' ' A' ' 128' ' ' ARG . 7.4 pt-20 -112.69 -0.49 15.05 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 112.198 0.444 . . . . 0.0 112.198 -177.478 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.638 ' HG ' ' O ' ' A' ' 45' ' ' CYS . 34.7 mt -55.05 -49.6 91.26 Favored Pre-proline 0 N--CA 1.468 0.443 0 N-CA-C 112.29 0.478 . . . . 0.0 112.29 177.069 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.553 ' HD3' ' HB2' ' A' ' 49' ' ' LEU . 77.2 Cg_exo -52.72 -44.33 48.73 Favored 'Trans proline' 0 C--N 1.357 1.016 0 C-N-CA 121.901 1.734 . . . . 0.0 112.161 176.483 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -73.61 -31.09 63.38 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.235 0.54 . . . . 0.0 110.563 -178.037 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.443 ' O ' ' HB2' ' A' ' 55' ' ' LEU . 6.5 tt -64.1 -53.44 49.7 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.264 -0.88 . . . . 0.0 109.885 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.681 ' O ' ' HG3' ' A' ' 57' ' ' GLU . 17.7 pttp -60.97 -39.64 90.36 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.121 179.71 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.47 ' HG3' ' O ' ' A' ' 50' ' ' PRO . 18.3 mt-10 -68.6 -29.06 67.5 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.469 -178.915 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.494 HD11 ' HB3' ' A' ' 129' ' ' PRO . 12.6 mt -59.32 -47.17 86.39 Favored 'General case' 0 N--CA 1.448 -0.55 0 N-CA-C 109.753 -0.462 . . . . 0.0 109.753 172.044 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 1.021 ' HG2' ' HA2' ' A' ' 89' ' ' GLY . 8.2 tp10 -65.18 -43.49 91.48 Favored 'General case' 0 C--O 1.218 -0.591 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.2 177.498 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.681 ' HG3' ' O ' ' A' ' 53' ' ' LYS . 37.1 mt-10 -61.42 -22.57 65.13 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.126 0.489 . . . . 0.0 110.776 179.773 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 63.2 tttp -85.45 -39.46 17.49 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.668 177.197 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 83.1 m-85 -110.48 18.29 19.92 Favored 'General case' 0 C--O 1.235 0.339 0 N-CA-C 111.859 0.318 . . . . 0.0 111.859 -173.556 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . 0.408 ' HA ' ' OE2' ' A' ' 56' ' ' GLU . . . -56.48 117.16 3.58 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.914 -177.315 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 75.65 -3.5 49.01 Favored Glycine 0 N--CA 1.45 -0.428 0 CA-C-N 115.768 -0.651 . . . . 0.0 113.237 175.848 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.542 ' HA ' ' HD3' ' A' ' 62' ' ' LYS . 30.4 mmtm -66.56 -80.87 0.04 OUTLIER 'General case' 0 CA--C 1.515 -0.394 0 CA-C-O 120.956 0.408 . . . . 0.0 110.561 -178.082 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.628 ' HA ' ' HD3' ' A' ' 31' ' ' LYS . 14.5 t0 -156.87 28.89 0.31 Allowed 'General case' 0 C--N 1.313 -0.983 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.904 170.343 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 5.3 mp -142.53 133.89 24.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 115.888 -0.596 . . . . 0.0 109.528 178.667 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' HIS . . . . . 0.5 ' NE2' ' HB3' ' A' ' 31' ' ' LYS . 99.4 m-70 -107.21 116.43 31.91 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 109.241 -0.652 . . . . 0.0 109.241 172.312 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . 0.561 ' HB2' ' HB2' ' A' ' 56' ' ' GLU . 76.4 m-85 -87.85 103.32 15.54 Favored 'General case' 0 C--N 1.316 -0.866 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 174.286 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.714 ' HA ' ' O ' ' A' ' 90' ' ' ILE . 47.3 t -111.39 110.33 31.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 115.505 -0.77 . . . . 0.0 111.348 -169.641 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' SER . . . . . 0.402 ' HB3' ' CG ' ' A' ' 38' ' ' TRP . 14.0 m -88.25 125.26 34.56 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 115.531 -0.758 . . . . 0.0 110.489 -179.642 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.452 HD11 ' HB2' ' A' ' 94' ' ' MET . 55.1 tp -113.57 121.19 43.46 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 122.784 0.433 . . . . 0.0 110.358 178.84 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' SER . . . . . 0.462 ' HB2' ' CD1' ' A' ' 38' ' ' TRP . 10.2 t -109.15 116.9 32.82 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 112.488 0.551 . . . . 0.0 112.488 -174.188 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 42.8 t -86.09 21.93 1.87 Allowed 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.208 173.907 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.605 ' OD2' HG22 ' A' ' 40' ' ' THR . 5.4 t70 -66.51 131.48 46.13 Favored 'General case' 0 CA--C 1.513 -0.465 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 179.63 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.589 ' HZ3' ' HB3' ' A' ' 73' ' ' LYS . 3.7 ttpm? -82.63 -14.19 55.16 Favored 'General case' 0 C--N 1.315 -0.91 0 C-N-CA 120.427 -0.509 . . . . 0.0 110.642 -177.561 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . 0.512 ' HB2' ' HB3' ' A' ' 77' ' ' ALA . 0.2 OUTLIER -109.06 83.32 1.73 Allowed 'General case' 0 CA--C 1.51 -0.574 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 -176.766 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.641 ' HE2' ' CD ' ' A' ' 79' ' ' GLU . 18.0 tttt -56.41 -60.7 3.15 Favored 'General case' 0 C--O 1.22 -0.459 0 C-N-CA 120.742 -0.383 . . . . 0.0 111.346 -172.513 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.644 ' HB2' ' HZ3' ' A' ' 76' ' ' LYS . 4.4 ttmp? -46.9 -43.99 19.32 Favored 'General case' 0 C--O 1.239 0.545 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.474 179.59 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.512 ' HB3' ' HB2' ' A' ' 74' ' ' ASN . . . -64.84 -38.56 91.38 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-O 121.347 0.594 . . . . 0.0 110.019 -177.804 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' TRP . . . . . 0.714 ' CE3' ' HB ' ' A' ' 40' ' ' THR . 5.6 t-105 -69.49 -47.71 63.01 Favored 'General case' 0 N--CA 1.44 -0.938 0 CA-C-N 115.015 -0.993 . . . . 0.0 111.515 -178.759 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.641 ' CD ' ' HE2' ' A' ' 75' ' ' LYS . 4.4 mm-40 -48.43 -54.01 15.69 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-O 121.165 0.507 . . . . 0.0 111.756 177.018 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . 0.501 HD22 ' HA ' ' A' ' 77' ' ' ALA . 9.2 p30 -72.88 -23.17 60.69 Favored 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 119.482 -0.887 . . . . 0.0 110.858 -176.518 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' MET . . . . . 0.559 ' HG2' ' OG1' ' A' ' 40' ' ' THR . 10.9 tpt -70.02 -48.45 57.99 Favored 'General case' 0 C--O 1.21 -0.979 0 CA-C-O 119.488 -0.291 . . . . 0.0 111.242 176.152 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.661 HG21 ' HZ3' ' A' ' 38' ' ' TRP . 2.3 p -62.92 -25.34 38.23 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 C-N-CA 120.474 -0.491 . . . . 0.0 110.355 177.79 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 29.7 m -64.32 -36.65 84.81 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-O 121.189 0.518 . . . . 0.0 110.294 171.611 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 80.6 mttt -82.88 -45.79 13.79 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.573 179.119 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . 0.513 ' OD2' ' HG3' ' A' ' 81' ' ' MET . 1.2 m-20 -64.55 -23.09 67.15 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 114.881 -1.054 . . . . 0.0 110.665 179.2 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 51.4 mt-30 57.59 61.62 2.4 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 115.517 -0.765 . . . . 0.0 111.483 178.298 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.556 ' HB2' HG23 ' A' ' 82' ' ' VAL . 79.3 mt -100.21 113.17 25.64 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.612 -178.709 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.539 ' HB2' ' HB2' ' A' ' 53' ' ' LYS . 11.8 mmmm -86.49 178.98 6.93 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.234 178.36 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . 1.021 ' HA2' ' HG2' ' A' ' 56' ' ' GLU . . . 105.19 -177.84 23.29 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.825 -0.702 . . . . 0.0 112.538 178.138 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.714 ' O ' ' HA ' ' A' ' 67' ' ' VAL . 45.6 mm -86.75 113.61 24.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 175.638 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . 0.568 ' HB2' ' CZ2' ' A' ' 38' ' ' TRP . 1.8 pt20 -130.72 142.11 50.41 Favored 'General case' 0 C--N 1.309 -1.162 0 C-N-CA 120.321 -0.551 . . . . 0.0 111.713 -170.207 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.516 HD21 ' HB2' ' A' ' 15' ' ' TYR . 1.0 OUTLIER -145.01 156.26 43.84 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.677 178.756 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' HIS . . . . . 0.553 ' CE1' ' HG3' ' A' ' 75' ' ' LYS . 19.0 t-80 -117.53 138.57 51.81 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-O 121.422 0.63 . . . . 0.0 111.471 -175.06 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' MET . . . . . 0.745 ' SD ' ' HA ' ' A' ' 98' ' ' ARG . 27.1 ttm -98.25 -76.68 0.52 Allowed 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 114.973 -1.012 . . . . 0.0 109.902 177.771 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . 0.49 ' HA2' ' O ' ' A' ' 72' ' ' ASP . . . 80.64 -85.41 1.36 Allowed Glycine 0 N--CA 1.447 -0.608 0 C-N-CA 121.065 -0.588 . . . . 0.0 113.207 178.474 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 7.6 p -82.47 -25.61 33.39 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 120.942 0.401 . . . . 0.0 112.063 -173.635 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . 0.494 ' HB2' ' HG3' ' A' ' 94' ' ' MET . 4.0 m-20 -87.85 38.05 0.82 Allowed 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.55 -173.307 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . 0.745 ' HA ' ' SD ' ' A' ' 94' ' ' MET . 0.0 OUTLIER -64.69 -12.42 46.36 Favored 'General case' 0 C--O 1.222 -0.35 0 N-CA-C 112.532 0.568 . . . . 0.0 112.532 -171.327 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 4.8 m -58.75 -20.61 51.02 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.385 0.612 . . . . 0.0 110.742 177.85 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . 0.434 ' CZ ' ' HA ' ' A' ' 10' ' ' ALA . 36.0 t80 -81.15 -32.0 33.87 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.096 179.932 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' MET . . . . . 0.671 ' HG3' ' O ' ' A' ' 98' ' ' ARG . 4.2 ppp? -77.08 -31.26 55.89 Favored 'General case' 0 C--O 1.235 0.321 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 177.919 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -59.84 -39.68 85.97 Favored 'General case' 0 CA--C 1.52 -0.177 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.145 170.875 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -62.96 -23.88 67.63 Favored 'General case' 0 N--CA 1.462 0.148 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.451 -178.617 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 48.0 m-85 -100.38 -4.81 28.29 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.304 178.817 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 3.4 mm? 59.61 32.4 21.53 Favored 'General case' 0 C--O 1.234 0.271 0 O-C-N 123.417 0.448 . . . . 0.0 110.818 -176.874 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . 0.51 HG12 ' HG3' ' A' ' 111' ' ' ARG . 68.4 mt -65.8 88.95 0.1 OUTLIER 'Isoleucine or valine' 0 C--O 1.225 -0.221 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.179 177.316 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 31.1 m-80 -98.52 -13.8 20.3 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.125 0.488 . . . . 0.0 110.342 176.18 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -122.43 115.06 2.63 Favored Glycine 0 N--CA 1.442 -0.945 0 C-N-CA 120.571 -0.823 . . . . 0.0 112.192 -177.58 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . 0.57 HD11 ' SG ' ' A' ' 42' ' ' CYS . 32.0 mt -97.2 131.39 27.59 Favored Pre-proline 0 C--N 1.32 -0.676 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 174.37 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . 0.413 ' HD3' ' HA ' ' A' ' 45' ' ' CYS . 1.4 Cg_endo -82.73 151.23 71.89 Favored 'Cis proline' 0 N--CA 1.459 -0.539 0 C-N-CA 123.769 -1.346 . . . . 0.0 112.935 1.729 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . 0.51 ' HG3' HG12 ' A' ' 106' ' ' ILE . 0.0 OUTLIER -102.77 140.18 37.38 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 173.596 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . 0.655 ' CE1' ' HB3' ' A' ' 128' ' ' ARG . 0.0 OUTLIER -105.1 118.03 35.51 Favored 'General case' 0 C--N 1.327 -0.371 0 O-C-N 124.102 0.876 . . . . 0.0 110.174 -175.102 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.541 ' HB ' ' HB ' ' A' ' 35' ' ' ILE . 90.8 mt -132.81 148.62 31.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.65 0.262 . . . . 0.0 110.904 -178.737 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 42.5 tp -132.1 139.22 48.4 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.504 -0.316 . . . . 0.0 110.674 179.706 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.588 ' HG ' ' HA ' ' A' ' 121' ' ' ILE . 2.3 mp -136.09 153.83 51.2 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 178.768 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . 0.517 ' HB2' HD12 ' A' ' 122' ' ' ILE . 24.2 t70 -76.94 163.68 26.5 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.648 178.409 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 63.3 mtt180 -51.49 -30.05 18.71 Favored 'General case' 0 N--CA 1.464 0.256 0 O-C-N 124.354 1.034 . . . . 0.0 111.748 178.692 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -64.82 -17.86 64.61 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.077 0.465 . . . . 0.0 110.759 178.378 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . 0.466 ' HA3' HD13 ' A' ' 25' ' ' LEU . . . 93.97 25.16 17.99 Favored Glycine 0 N--CA 1.438 -1.173 0 N-CA-C 110.187 -1.165 . . . . 0.0 110.187 -172.438 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . 0.411 ' HA ' ' HD3' ' A' ' 120' ' ' LYS . 30.3 mmtp -112.56 116.77 30.74 Favored 'General case' 0 C--O 1.223 -0.297 0 C-N-CA 120.304 -0.558 . . . . 0.0 112.097 -172.991 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . 0.588 ' HA ' ' HG ' ' A' ' 115' ' ' LEU . 3.8 mp -44.38 119.5 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.27 0 CA-C-N 115.436 -0.802 . . . . 0.0 111.984 179.698 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' ILE . . . . . 0.517 HD12 ' HB2' ' A' ' 116' ' ' ASP . 45.5 mm -98.62 -41.02 9.82 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-N 115.301 -0.863 . . . . 0.0 109.335 175.727 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 16.4 m -137.2 115.83 12.08 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.393 -0.821 . . . . 0.0 110.41 179.07 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -74.23 -16.01 60.97 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.06 0.457 . . . . 0.0 110.821 178.091 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 6.1 t30 -146.83 100.6 3.34 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.762 -0.654 . . . . 0.0 109.398 177.059 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' MET . . . . . 0.404 ' HG2' ' H ' ' A' ' 127' ' ' THR . 12.4 ttt -101.21 -139.0 0.34 Allowed 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.192 -177.978 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' THR . . . . . 0.404 ' H ' ' HG2' ' A' ' 126' ' ' MET . 1.0 OUTLIER -124.96 127.25 46.75 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-O 121.039 0.447 . . . . 0.0 111.003 -175.733 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . 0.655 ' HB3' ' CE1' ' A' ' 112' ' ' PHE . 11.6 ptp180 -51.28 153.91 3.23 Favored Pre-proline 0 N--CA 1.468 0.473 0 N-CA-C 113.414 0.894 . . . . 0.0 113.414 178.778 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . 0.528 ' HD2' ' OE2' ' A' ' 48' ' ' GLU . 51.9 Cg_exo -55.69 -27.39 60.86 Favored 'Trans proline' 0 C--N 1.35 0.656 0 C-N-CA 123.575 2.85 . . . . 0.0 113.557 177.193 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' SER . . . . . 0.507 ' OG ' ' HB3' ' A' ' 48' ' ' GLU . 67.9 m -62.95 -20.64 65.43 Favored 'General case' 0 N--CA 1.462 0.132 0 CA-C-O 120.919 0.39 . . . . 0.0 111.301 176.912 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . 0.432 ' OD2' ' HB2' ' A' ' 133' ' ' LYS . 7.3 t70 -85.32 122.1 73.73 Favored Pre-proline 0 C--N 1.325 -0.484 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.708 178.774 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . 0.405 ' O ' ' HG3' ' A' ' 136' ' ' GLU . 30.5 Cg_exo -63.97 -30.01 66.84 Favored 'Trans proline' 0 C--N 1.343 0.252 0 C-N-CA 122.922 2.415 . . . . 0.0 112.675 179.921 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . 0.611 ' HZ3' ' CD ' ' A' ' 136' ' ' GLU . 26.7 mmmt -61.64 -37.64 84.76 Favored 'General case' 0 CA--C 1.519 -0.219 0 CA-C-O 121.007 0.432 . . . . 0.0 110.391 -176.801 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' THR . . . . . 0.723 HG21 ' CZ ' ' A' ' 138' ' ' PHE . 5.2 m -61.66 -53.25 58.66 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.238 176.255 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . 0.544 ' HA ' ' CD2' ' A' ' 138' ' ' PHE . . . -54.93 -46.52 74.94 Favored 'General case' 0 C--O 1.242 0.672 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.183 176.925 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . 0.611 ' CD ' ' HZ3' ' A' ' 133' ' ' LYS . 48.8 mt-10 -54.39 -55.74 25.61 Favored 'General case' 0 CA--C 1.509 -0.625 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.169 176.551 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . 0.594 ' HE2' ' HA ' ' A' ' 137' ' ' LYS . 0.1 OUTLIER -43.79 -42.88 5.81 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 114.221 -1.354 . . . . 0.0 111.774 179.825 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . 0.723 ' CZ ' HG21 ' A' ' 134' ' ' THR . 13.6 m-85 -63.74 -60.73 2.93 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-O 120.774 0.321 . . . . 0.0 110.921 179.961 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . 0.459 ' HB2' ' HB3' ' A' ' 144' ' ' LEU . 11.0 p30 -68.86 -23.7 64.26 Favored 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 120.313 -0.555 . . . . 0.0 110.989 -174.387 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . 0.572 ' CD ' ' HZ2' ' A' ' 137' ' ' LYS . 13.2 tt0 -60.47 -51.81 67.87 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.054 0.454 . . . . 0.0 110.454 173.568 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . 0.52 ' HG ' ' O ' ' A' ' 137' ' ' LYS . 88.6 mt -64.56 -30.01 71.03 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.147 -177.906 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -82.16 -16.09 51.02 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.428 178.048 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 74.74 36.34 48.3 Favored Glycine 0 N--CA 1.45 -0.401 0 N-CA-C 110.705 -0.958 . . . . 0.0 110.705 -178.039 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . 0.459 ' HB3' ' HB2' ' A' ' 139' ' ' ASN . 49.8 tp -106.63 12.46 29.32 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 114.862 -0.669 . . . . 0.0 110.32 -173.527 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . 0.41 ' HB2' ' CD2' ' A' ' 147' ' ' HIS . 0.0 OUTLIER -104.33 -32.77 8.91 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.516 0.674 . . . . 0.0 111.315 -179.492 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 99.67 7.0 54.23 Favored Glycine 0 C--N 1.315 -0.622 0 CA-C-N 114.827 -1.079 . . . . 0.0 113.262 175.773 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 147' ' ' HIS . . . . . 0.41 ' CD2' ' HB2' ' A' ' 145' ' ' GLU . 13.6 m-70 -95.55 56.48 1.81 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 117.428 0.614 . . . . 0.0 109.72 -176.99 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 19.6 p80 -73.25 63.72 0.75 Allowed 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 115.693 -0.685 . . . . 0.0 112.449 -174.714 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 23.8 t60 51.56 86.95 0.03 OUTLIER 'General case' 0 C--O 1.234 0.286 0 C-N-CA 124.034 0.934 . . . . 0.0 112.623 174.13 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 42.9 t-80 -62.74 108.97 1.28 Allowed 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.232 176.205 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 25.7 p80 -121.0 13.69 11.38 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.964 0.412 . . . . 0.0 110.367 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 41.6 t-80 . . . . . 0 C--O 1.242 0.691 0 CA-C-N 115.49 -0.777 . . . . 0.0 109.083 179.034 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 10.9 tpt . . . . . 0 N--CA 1.48 1.043 0 N-CA-C 110.023 -0.362 . . . . 0.0 110.023 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.463 ' HB2' HD21 ' A' ' 3' ' ' LEU . 1.2 m -57.9 -49.01 78.19 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.749 -174.77 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.488 ' O ' ' HG3' ' A' ' 4' ' ' ARG . 3.1 mm? -81.8 -4.03 55.38 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.353 -176.674 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . 0.488 ' HG3' ' O ' ' A' ' 3' ' ' LEU . 0.3 OUTLIER 37.08 -102.66 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 123.647 0.779 . . . . 0.0 112.365 -172.311 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 12.2 p -134.37 19.37 3.66 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.133 0.492 . . . . 0.0 110.387 179.328 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 142.53 73.78 0.03 OUTLIER Glycine 0 N--CA 1.448 -0.51 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.346 -178.022 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . 0.443 ' HA ' ' HD3' ' A' ' 8' ' ' PRO . 8.5 t30 -156.17 144.11 14.22 Favored Pre-proline 0 C--N 1.325 -0.479 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 178.207 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.443 ' HD3' ' HA ' ' A' ' 7' ' ' ASN . 39.6 Cg_exo -60.81 -67.17 0.05 OUTLIER 'Trans proline' 0 C--N 1.343 0.257 0 C-N-CA 123.047 2.498 . . . . 0.0 112.103 -176.39 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.788 ' HA ' HD13 ' A' ' 121' ' ' ILE . 18.3 m 57.88 -162.41 0.21 Allowed 'General case' 0 N--CA 1.453 -0.299 0 CA-C-O 121.803 0.811 . . . . 0.0 111.592 175.124 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -86.9 78.13 9.1 Favored 'General case' 0 C--N 1.314 -0.948 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 169.845 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -69.43 59.77 0.13 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 114.861 -1.063 . . . . 0.0 113.641 -172.445 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.51 ' HA ' ' HB3' ' A' ' 25' ' ' LEU . 26.4 m 53.58 33.4 16.3 Favored 'General case' 0 N--CA 1.465 0.28 0 N-CA-C 112.767 0.655 . . . . 0.0 112.767 170.493 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 34.7 p90 -60.77 147.92 40.82 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.893 0.378 . . . . 0.0 110.747 179.084 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' SER . . . . . 0.489 ' HA ' ' HA ' ' A' ' 24' ' ' SER . 28.2 t -139.81 117.96 11.93 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.111 -0.495 . . . . 0.0 109.707 -179.293 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . 0.414 ' CD1' ' HA ' ' A' ' 94' ' ' MET . 92.1 m-85 -138.78 155.14 73.38 Favored Pre-proline 0 C--N 1.323 -0.562 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.322 -176.976 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -81.19 125.89 5.39 Favored 'Trans proline' 0 N--CA 1.454 -0.85 0 C-N-CA 122.015 1.81 . . . . 0.0 112.116 175.469 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . 0.496 ' HA ' ' HA ' ' A' ' 92' ' ' LEU . 12.5 t70 -62.32 152.95 32.36 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.196 -0.911 . . . . 0.0 108.894 172.127 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.642 HG23 ' HG3' ' A' ' 91' ' ' GLN . 12.1 tt -58.67 -25.81 29.63 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.435 0 O-C-N 123.781 0.675 . . . . 0.0 111.301 -178.287 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 44.7 m-80 -79.35 -2.17 40.32 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.321 0.582 . . . . 0.0 110.053 176.47 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 86.82 40.64 7.06 Favored Glycine 0 N--CA 1.447 -0.583 0 CA-C-N 115.401 -0.818 . . . . 0.0 112.371 179.244 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.557 ' HZ1' HG23 ' A' ' 23' ' ' VAL . 62.0 tttm -113.84 117.22 30.84 Favored 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 120.372 -0.531 . . . . 0.0 111.027 179.989 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 17.7 m -64.45 108.84 1.75 Allowed 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 109.938 -0.393 . . . . 0.0 109.938 174.384 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.557 HG23 ' HZ1' ' A' ' 21' ' ' LYS . 99.6 t -119.83 125.5 74.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-O 121.011 0.434 . . . . 0.0 110.201 -179.829 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' SER . . . . . 0.489 ' HA ' ' HA ' ' A' ' 14' ' ' SER . 57.3 p -113.19 176.6 4.95 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 115.731 -0.668 . . . . 0.0 109.426 177.57 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.51 ' HB3' ' HA ' ' A' ' 12' ' ' SER . 2.7 tm? -60.98 -30.39 70.24 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 176.908 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -72.11 -24.42 61.47 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.66 -0.246 . . . . 0.0 111.325 -179.896 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -73.18 -21.75 60.61 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-O 121.924 0.868 . . . . 0.0 109.616 177.798 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.476 HD11 HG21 ' A' ' 67' ' ' VAL . 32.9 mt -104.5 -21.02 13.51 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-N 115.073 -0.967 . . . . 0.0 110.742 -179.492 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 52.9 tttp -71.41 149.32 46.06 Favored 'General case' 0 N--CA 1.445 -0.688 0 CA-C-N 115.459 -0.792 . . . . 0.0 110.909 -173.542 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 91.81 10.21 61.76 Favored Glycine 0 N--CA 1.452 -0.295 0 N-CA-C 111.066 -0.814 . . . . 0.0 111.066 -175.198 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.816 ' HD3' ' HA ' ' A' ' 63' ' ' ASP . 13.1 ttmm -162.12 157.48 23.35 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 108.196 -1.038 . . . . 0.0 108.196 179.73 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.521 ' CD2' HD11 ' A' ' 141' ' ' LEU . 82.3 m-85 -66.17 143.51 57.23 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 118.287 0.494 . . . . 0.0 110.808 -178.641 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.869 HD12 HD11 ' A' ' 115' ' ' LEU . 3.6 mp -126.04 146.37 31.95 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.226 0 CA-C-O 120.811 0.339 . . . . 0.0 110.561 -179.55 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . 0.723 ' HD1' ' HB3' ' A' ' 114' ' ' LEU . 75.2 t80 -129.7 121.64 27.35 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 173.224 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.678 HD13 ' HB ' ' A' ' 67' ' ' VAL . 25.9 mm -109.96 110.9 33.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 N-CA-C 112.156 0.428 . . . . 0.0 112.156 -173.253 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.563 ' O ' ' HA ' ' A' ' 68' ' ' SER . 33.7 m-20 -99.04 158.21 15.82 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 169.549 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.503 HG11 HG21 ' A' ' 109' ' ' ILE . 40.5 t -103.67 112.18 36.19 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.859 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 171.066 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' TRP . . . . . 0.795 ' CZ3' HG21 ' A' ' 82' ' ' VAL . 0.6 OUTLIER -103.29 132.55 49.46 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 -177.298 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.46 ' HB3' ' SG ' ' A' ' 42' ' ' CYS . . . -148.22 174.7 11.72 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.505 -0.316 . . . . 0.0 110.762 -178.551 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' THR . . . . . 0.531 ' HB ' ' CE3' ' A' ' 78' ' ' TRP . 5.9 t -104.27 -30.3 10.23 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 120.975 0.417 . . . . 0.0 110.379 171.618 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 21.0 p-90 -85.59 7.36 23.45 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.549 -178.108 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . 0.548 ' SG ' ' HB3' ' A' ' 45' ' ' CYS . 5.7 p -87.55 -2.21 58.47 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.677 -0.238 . . . . 0.0 111.41 -179.068 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . 0.572 ' O ' ' HG2' ' A' ' 46' ' ' ARG . . . 64.94 -108.35 2.3 Favored Glycine 0 CA--C 1.523 0.579 0 N-CA-C 114.773 0.669 . . . . 0.0 114.773 171.736 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.429 ' HD2' ' O ' ' A' ' 42' ' ' CYS . 9.6 Cg_endo -50.75 -23.15 10.86 Favored 'Trans proline' 0 C--N 1.356 0.96 0 C-N-CA 124.342 3.361 . . . . 0.0 113.541 -174.647 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . 0.721 ' HB2' ' HD3' ' A' ' 110' ' ' PRO . 47.1 t -52.19 -15.97 0.71 Allowed 'General case' 0 C--N 1.323 -0.55 0 O-C-N 124.071 0.857 . . . . 0.0 112.924 178.533 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.572 ' HG2' ' O ' ' A' ' 43' ' ' GLY . 24.7 mmm180 -71.02 -6.64 40.49 Favored 'General case' 0 N--CA 1.448 -0.574 0 O-C-N 121.806 -0.559 . . . . 0.0 110.467 -179.43 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.444 ' O ' ' HD2' ' A' ' 50' ' ' PRO . . . -84.13 -23.44 51.87 Favored Glycine 0 N--CA 1.446 -0.643 0 CA-C-N 115.818 -0.628 . . . . 0.0 112.95 -178.478 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.533 ' HG3' ' HB3' ' A' ' 129' ' ' PRO . 2.0 mp0 -83.01 -4.49 58.38 Favored 'General case' 0 CA--C 1.516 -0.333 0 CA-C-N 117.2 0.5 . . . . 0.0 110.524 -179.379 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.773 ' HG ' HD23 ' A' ' 87' ' ' LEU . 7.3 mp -43.96 -55.23 9.61 Favored Pre-proline 0 CA--C 1.536 0.432 0 N-CA-C 112.487 0.551 . . . . 0.0 112.487 177.09 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.474 ' HD3' ' HB2' ' A' ' 49' ' ' LEU . 43.5 Cg_exo -58.45 -42.89 50.64 Favored 'Trans proline' 0 C--N 1.355 0.909 0 C-N-CA 121.874 1.716 . . . . 0.0 112.185 175.047 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -69.49 -21.75 63.66 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-O 121.476 0.655 . . . . 0.0 110.411 -174.226 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.538 HD11 HD21 ' A' ' 87' ' ' LEU . 7.6 tt -70.14 -55.44 9.4 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 114.974 -1.012 . . . . 0.0 108.643 178.673 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.694 ' HB3' ' NZ ' ' A' ' 53' ' ' LYS . 1.8 mtpm? -52.63 -63.01 1.28 Allowed 'General case' 0 C--O 1.219 -0.508 0 CA-C-N 115.503 -0.771 . . . . 0.0 111.365 175.826 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -52.39 -39.45 60.86 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 113.302 0.853 . . . . 0.0 113.302 -173.146 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.425 ' O ' ' HB2' ' A' ' 58' ' ' LYS . 14.4 mt -67.49 -44.77 77.69 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.174 0.512 . . . . 0.0 110.622 174.43 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -57.39 -42.68 82.68 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.145 -0.934 . . . . 0.0 111.582 176.538 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.617 ' HG2' ' O ' ' A' ' 53' ' ' LYS . 16.0 mm-40 -53.47 -52.01 60.88 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-O 121.714 0.768 . . . . 0.0 109.287 175.74 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . 0.465 ' HB3' ' HE3' ' A' ' 58' ' ' LYS . 10.4 mmmt -53.01 -58.12 8.07 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-N 114.504 -1.225 . . . . 0.0 112.439 178.804 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.554 ' HB2' ' HE2' ' A' ' 66' ' ' PHE . 96.0 m-85 -106.71 21.6 17.23 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.047 -0.524 . . . . 0.0 112.322 -166.537 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -61.59 120.79 11.26 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.603 173.75 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 72.26 33.81 61.5 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.946 -0.645 . . . . 0.0 112.866 177.141 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.496 ' HB3' HD11 ' A' ' 142' ' ' LEU . 40.1 mmtm -109.03 -164.91 0.97 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.154 0.502 . . . . 0.0 110.128 175.623 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.816 ' HA ' ' HD3' ' A' ' 31' ' ' LYS . 3.7 t70 -89.87 54.95 2.99 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-O 121.792 0.806 . . . . 0.0 109.497 179.362 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.433 HG23 ' HB2' ' A' ' 62' ' ' LYS . 6.8 tp -157.0 129.98 1.15 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 CA-C-N 115.061 -0.972 . . . . 0.0 109.774 -178.114 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' HIS . . . . . 0.462 ' NE2' ' HB3' ' A' ' 31' ' ' LYS . 68.0 m-70 -103.3 106.58 17.13 Favored 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 175.773 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . 0.554 ' HE2' ' HB2' ' A' ' 59' ' ' TYR . 61.0 m-85 -79.01 103.13 8.74 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 171.082 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.678 ' HB ' HD13 ' A' ' 35' ' ' ILE . 29.6 t -122.26 126.53 74.4 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.476 -175.196 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' SER . . . . . 0.563 ' HA ' ' O ' ' A' ' 36' ' ' ASP . 37.1 m -114.05 134.3 54.96 Favored 'General case' 0 C--N 1.311 -1.066 0 CA-C-N 116.106 -0.497 . . . . 0.0 109.855 177.191 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.502 HD22 ' HB2' ' A' ' 92' ' ' LEU . 26.6 mt -110.53 132.78 53.88 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 110.006 -0.368 . . . . 0.0 110.006 177.116 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' SER . . . . . 0.466 ' O ' ' HB3' ' A' ' 94' ' ' MET . 0.9 OUTLIER -105.15 117.89 35.14 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.008 0.432 . . . . 0.0 111.348 -176.882 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 34.8 m -88.39 15.7 7.43 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.773 179.61 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.53 ' OD2' HG22 ' A' ' 40' ' ' THR . 1.3 m-20 -71.73 135.52 46.81 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.249 -0.648 . . . . 0.0 109.249 -179.867 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.414 ' O ' ' HD3' ' A' ' 73' ' ' LYS . 1.5 tmtp? -89.04 -30.1 18.95 Favored 'General case' 0 C--N 1.318 -0.784 0 C-N-CA 119.918 -0.713 . . . . 0.0 109.464 177.62 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . 0.501 ' HB2' ' HB3' ' A' ' 77' ' ' ALA . 0.8 OUTLIER -72.53 68.18 0.79 Allowed 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.135 -0.939 . . . . 0.0 110.434 174.127 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.478 ' O ' ' HG2' ' A' ' 79' ' ' GLU . 9.4 tttm -51.8 -64.5 0.79 Allowed 'General case' 0 C--O 1.22 -0.482 0 N-CA-C 112.489 0.551 . . . . 0.0 112.489 -175.984 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 51.9 tttm -49.77 -49.18 49.39 Favored 'General case' 0 C--N 1.329 -0.297 0 O-C-N 123.162 0.289 . . . . 0.0 111.204 -176.793 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.65 ' HA ' ' ND2' ' A' ' 80' ' ' ASN . . . -52.29 -44.05 64.79 Favored 'General case' 0 C--O 1.244 0.802 0 CA-C-O 121.886 0.85 . . . . 0.0 110.359 178.478 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' TRP . . . . . 0.564 ' CH2' HG23 ' A' ' 82' ' ' VAL . 6.8 t-105 -66.92 -51.13 59.08 Favored 'General case' 0 N--CA 1.437 -1.114 0 CA-C-N 114.278 -1.328 . . . . 0.0 111.048 -179.438 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.519 ' OE1' HG13 ' A' ' 18' ' ' ILE . 5.3 mm-40 -46.22 -47.08 17.99 Favored 'General case' 0 CA--C 1.537 0.459 0 N-CA-C 111.87 0.322 . . . . 0.0 111.87 176.189 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . 0.65 ' ND2' ' HA ' ' A' ' 77' ' ' ALA . 0.6 OUTLIER -60.33 -49.23 78.42 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 120.823 -0.351 . . . . 0.0 110.526 -177.738 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 22.5 ttm -59.47 -48.47 81.53 Favored 'General case' 0 N--CA 1.466 0.341 0 N-CA-C 112.433 0.531 . . . . 0.0 112.433 -175.756 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.795 HG21 ' CZ3' ' A' ' 38' ' ' TRP . 0.9 OUTLIER -67.25 -26.05 35.24 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 C-N-CA 120.158 -0.617 . . . . 0.0 110.918 -178.046 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 90.6 m -72.78 -37.0 67.74 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.294 -0.412 . . . . 0.0 109.986 174.646 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . 0.409 ' HB3' ' HE3' ' A' ' 84' ' ' LYS . 1.2 tmmt? -71.26 -41.38 70.16 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.375 0.607 . . . . 0.0 110.018 177.513 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 15.6 m-20 -83.67 -1.72 54.64 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.225 -0.898 . . . . 0.0 111.881 -177.349 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 45.3 mt-30 62.0 23.63 13.95 Favored 'General case' 0 N--CA 1.468 0.466 0 N-CA-C 112.727 0.64 . . . . 0.0 112.727 172.074 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.773 HD23 ' HG ' ' A' ' 49' ' ' LEU . 94.1 mt -73.61 117.46 15.4 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 110.236 -0.283 . . . . 0.0 110.236 178.796 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.564 ' HA ' ' HE3' ' A' ' 88' ' ' LYS . 0.0 OUTLIER -119.61 -168.08 1.53 Allowed 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.693 -0.23 . . . . 0.0 111.581 177.314 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 112.75 -163.23 12.17 Favored Glycine 0 N--CA 1.451 -0.35 0 N-CA-C 110.241 -1.144 . . . . 0.0 110.241 -173.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.648 ' O ' ' HA ' ' A' ' 67' ' ' VAL . 52.5 mt -92.72 111.67 24.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 173.679 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . 0.687 ' HB2' ' CZ2' ' A' ' 38' ' ' TRP . 1.0 OUTLIER -143.24 103.59 4.15 Favored 'General case' 0 C--N 1.311 -1.086 0 CA-C-O 121.598 0.713 . . . . 0.0 111.789 -168.934 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.502 ' HB2' HD22 ' A' ' 69' ' ' LEU . 20.6 mt -96.79 151.28 19.81 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.275 -0.875 . . . . 0.0 110.622 -175.846 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 37.3 t-80 -113.47 127.87 56.25 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.081 178.847 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' MET . . . . . 0.466 ' HB3' ' O ' ' A' ' 70' ' ' SER . 35.9 ttm -81.06 -83.14 0.11 Allowed 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 115.053 -0.976 . . . . 0.0 110.279 -179.682 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 131.2 -83.72 0.31 Allowed Glycine 0 N--CA 1.444 -0.79 0 C-N-CA 120.396 -0.907 . . . . 0.0 112.245 -178.19 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 1.7 m -137.72 4.63 2.59 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.583 0.706 . . . . 0.0 109.964 179.472 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -87.16 53.03 2.68 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.248 -0.887 . . . . 0.0 110.448 -172.485 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . 0.472 ' HB3' ' OD1' ' A' ' 102' ' ' ASP . 4.0 mtm180 -63.35 -8.94 9.96 Favored 'General case' 0 CA--C 1.512 -0.5 0 N-CA-C 112.542 0.571 . . . . 0.0 112.542 -172.924 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' THR . . . . . 0.431 ' O ' ' HB1' ' A' ' 103' ' ' ALA . 5.4 m -38.4 -33.09 0.09 Allowed 'General case' 0 C--N 1.313 -0.988 0 O-C-N 124.146 0.904 . . . . 0.0 112.376 179.197 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 80.2 t80 -81.27 -39.21 25.63 Favored 'General case' 0 CA--C 1.532 0.281 0 N-CA-C 112.356 0.502 . . . . 0.0 112.356 -179.822 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' MET . . . . . 0.473 ' HE1' ' HA ' ' A' ' 107' ' ' ASN . 24.9 ptm -78.66 -34.02 46.63 Favored 'General case' 0 CA--C 1.52 -0.185 0 C-N-CA 120.107 -0.637 . . . . 0.0 109.592 -177.268 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . 0.472 ' OD1' ' HB3' ' A' ' 98' ' ' ARG . 2.5 m-20 -75.57 -21.62 57.71 Favored 'General case' 0 N--CA 1.447 -0.604 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.186 176.581 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . 0.431 ' HB1' ' O ' ' A' ' 99' ' ' THR . . . -64.95 -29.57 70.51 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-O 121.063 0.459 . . . . 0.0 110.701 174.88 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 59.7 m-85 -96.96 2.35 51.46 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.519 177.796 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 95.6 mt 65.89 5.21 3.33 Favored 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 113.386 0.884 . . . . 0.0 113.386 173.164 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . 0.547 ' CG1' ' HG3' ' A' ' 111' ' ' ARG . 1.2 pp -97.34 88.83 1.88 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.575 0 CA-C-O 121.509 0.671 . . . . 0.0 112.194 -179.277 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . 0.473 ' HA ' ' HE1' ' A' ' 101' ' ' MET . 4.0 p-10 -77.1 -11.73 59.85 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.609 -0.723 . . . . 0.0 109.812 175.642 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -89.75 98.56 2.46 Favored Glycine 0 N--CA 1.445 -0.716 0 CA-C-N 115.445 -0.798 . . . . 0.0 111.621 177.357 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . 0.59 ' HB ' ' HA ' ' A' ' 110' ' ' PRO . 34.2 pt -104.88 162.79 18.72 Favored Pre-proline 0 C--N 1.321 -0.641 0 N-CA-C 110.088 -0.338 . . . . 0.0 110.088 179.823 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . 0.721 ' HD3' ' HB2' ' A' ' 45' ' ' CYS . 39.6 Cg_endo -70.11 143.74 75.39 Favored 'Cis proline' 0 C--N 1.349 0.567 0 C-N-CA 124.158 -1.184 . . . . 0.0 113.559 1.63 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . 0.547 ' HG3' ' CG1' ' A' ' 106' ' ' ILE . 0.0 OUTLIER -117.51 136.49 53.21 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.625 -0.716 . . . . 0.0 109.081 177.295 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . 0.557 ' CD2' ' HA ' ' A' ' 127' ' ' THR . 1.4 m-85 -105.7 117.23 33.5 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.789 -176.173 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.474 HG23 ' N ' ' A' ' 114' ' ' LEU . 24.4 mm -128.53 164.0 31.61 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 N-CA-C 108.144 -1.058 . . . . 0.0 108.144 177.137 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.739 HD21 ' HG2' ' A' ' 126' ' ' MET . 1.8 pt? -158.45 154.24 26.5 Favored 'General case' 0 C--N 1.316 -0.882 0 C-N-CA 120.573 -0.451 . . . . 0.0 110.978 173.455 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.869 HD11 HD12 ' A' ' 33' ' ' ILE . 0.0 OUTLIER -138.17 150.98 47.29 Favored 'General case' 0 N--CA 1.448 -0.569 0 CA-C-O 122.329 1.062 . . . . 0.0 113.377 -173.788 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 12.8 t0 -69.19 163.73 24.24 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 113.174 -1.83 . . . . 0.0 109.782 176.328 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . 0.475 ' HA ' ' O ' ' A' ' 31' ' ' LYS . 31.1 mtm180 -48.39 -28.05 2.99 Favored 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 124.503 1.121 . . . . 0.0 113.272 -174.877 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 26.6 t0 -82.52 -5.13 58.56 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.104 0.478 . . . . 0.0 111.44 -177.314 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 89.34 16.6 57.0 Favored Glycine 0 N--CA 1.441 -0.986 0 N-CA-C 110.013 -1.235 . . . . 0.0 110.013 -171.241 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 4.9 tttm -90.27 147.21 23.67 Favored 'General case' 0 C--O 1.204 -1.327 0 CA-C-N 115.034 -0.583 . . . . 0.0 110.766 -175.522 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . 0.788 HD13 ' HA ' ' A' ' 9' ' ' SER . 3.8 mp -67.76 130.47 33.03 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.668 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.03 -174.775 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' ILE . . . . . 0.555 ' HB ' ' HG ' ' A' ' 114' ' ' LEU . 37.4 mm -100.53 -56.4 5.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 171.122 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' SER . . . . . 0.455 ' HB3' ' CD2' ' A' ' 114' ' ' LEU . 42.9 t -135.14 142.72 46.22 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.481 174.375 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . 0.461 ' HA ' ' CD1' ' A' ' 113' ' ' ILE . . . -112.55 23.48 13.51 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.425 -0.807 . . . . 0.0 109.429 176.018 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 4.1 p-10 -161.67 38.63 0.13 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.349 -0.841 . . . . 0.0 110.108 -179.913 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' MET . . . . . 0.739 ' HG2' HD21 ' A' ' 114' ' ' LEU . 2.2 tpt -71.7 -168.72 0.37 Allowed 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 115.762 -0.654 . . . . 0.0 111.206 -176.949 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' THR . . . . . 0.557 ' HA ' ' CD2' ' A' ' 112' ' ' PHE . 4.1 m -161.0 120.79 2.67 Favored 'General case' 0 C--O 1.223 -0.312 0 N-CA-C 110.108 -0.33 . . . . 0.0 110.108 -174.867 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . 0.55 ' HB2' ' OH ' ' A' ' 34' ' ' TYR . 21.8 ttt85 -88.94 -62.94 0.21 Allowed Pre-proline 0 CA--C 1.498 -1.039 0 CA-C-O 117.846 -1.073 . . . . 0.0 113.401 178.491 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . 0.533 ' HB3' ' HG3' ' A' ' 48' ' ' GLU . 1.0 OUTLIER -37.96 79.04 0.0 OUTLIER 'Trans proline' 0 C--N 1.372 1.784 0 C-N-CA 124.352 3.368 . . . . 0.0 113.814 -158.648 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' SER . . . . . 0.471 ' N ' ' O ' ' A' ' 128' ' ' ARG . 43.5 p 54.73 26.72 7.86 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 114.299 -1.319 . . . . 0.0 110.67 -179.47 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . 0.494 ' CG ' ' HZ1' ' A' ' 133' ' ' LYS . 13.8 t70 -70.76 123.56 89.4 Favored Pre-proline 0 C--O 1.236 0.355 0 CA-C-N 115.513 -0.767 . . . . 0.0 111.041 -178.648 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_endo -63.92 -37.51 43.66 Favored 'Trans proline' 0 N--CA 1.46 -0.459 0 C-N-CA 122.505 2.136 . . . . 0.0 112.881 -178.343 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . 0.494 ' HZ1' ' CG ' ' A' ' 131' ' ' ASP . 26.1 mtmm -54.3 -50.11 68.09 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-O 121.599 0.714 . . . . 0.0 110.113 -177.036 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' THR . . . . . 0.644 HG21 ' CZ ' ' A' ' 138' ' ' PHE . 13.8 m -78.76 -35.52 44.47 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 114.977 -1.01 . . . . 0.0 111.221 -174.494 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . 0.726 ' HA ' ' CD2' ' A' ' 138' ' ' PHE . . . -62.31 -40.7 97.16 Favored 'General case' 0 C--O 1.242 0.658 0 CA-C-O 121.167 0.508 . . . . 0.0 110.372 178.269 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . 0.536 ' HA ' ' ND2' ' A' ' 139' ' ' ASN . 7.1 mm-40 -65.19 -41.4 94.6 Favored 'General case' 0 N--CA 1.447 -0.614 0 CA-C-N 115.254 -0.885 . . . . 0.0 111.062 176.486 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . 0.954 ' HE2' ' HA ' ' A' ' 137' ' ' LYS . 9.1 mmpt? -55.79 -41.71 74.51 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.554 175.975 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . 0.726 ' CD2' ' HA ' ' A' ' 135' ' ' ALA . 15.3 m-85 -56.81 -60.37 3.66 Favored 'General case' 0 N--CA 1.463 0.2 0 O-C-N 123.181 0.301 . . . . 0.0 110.783 178.556 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . 0.568 ' OD1' ' HA ' ' A' ' 145' ' ' GLU . 11.7 p30 -69.49 -27.03 64.85 Favored 'General case' 0 C--O 1.224 -0.249 0 C-N-CA 120.602 -0.439 . . . . 0.0 111.506 -173.326 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 21.7 tt0 -63.18 -60.66 3.13 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.597 0.237 . . . . 0.0 111.464 177.092 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . 0.702 ' HG ' ' O ' ' A' ' 137' ' ' LYS . 3.0 pp -69.85 -19.86 63.43 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-O 120.845 0.355 . . . . 0.0 111.417 -175.69 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . 0.496 HD11 ' HB3' ' A' ' 62' ' ' LYS . 0.8 OUTLIER -81.46 -21.38 38.82 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.065 175.039 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 73.57 27.51 67.33 Favored Glycine 0 N--CA 1.448 -0.548 0 N-CA-C 110.304 -1.118 . . . . 0.0 110.304 -176.231 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . 0.401 ' HG ' ' O ' ' A' ' 144' ' ' LEU . 42.5 tp -109.66 27.15 9.85 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 114.308 -0.946 . . . . 0.0 108.987 -174.265 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . 0.568 ' HA ' ' OD1' ' A' ' 139' ' ' ASN . 51.3 mt-10 -54.31 -71.3 0.08 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 114.505 -1.225 . . . . 0.0 113.748 -173.659 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 78.73 -80.77 1.43 Allowed Glycine 0 C--N 1.31 -0.893 0 N-CA-C 109.424 -1.471 . . . . 0.0 109.424 -165.295 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 147' ' ' HIS . . . . . 0.48 ' HE2' ' CD ' ' A' ' 136' ' ' GLU . 9.3 m170 63.92 -60.14 0.19 Allowed 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 115.061 1.504 . . . . 0.0 115.061 167.721 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 47.9 t-80 -70.96 75.94 0.64 Allowed 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 112.391 0.515 . . . . 0.0 112.391 -169.287 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 21.3 t-80 54.08 76.11 0.25 Allowed 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 115.561 -0.745 . . . . 0.0 111.994 173.663 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 150' ' ' HIS . . . . . 0.435 ' O ' ' HB3' ' A' ' 151' ' ' HIS . 52.4 m-70 -137.94 90.78 2.52 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.389 -0.368 . . . . 0.0 110.994 175.954 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 151' ' ' HIS . . . . . 0.435 ' HB3' ' O ' ' A' ' 150' ' ' HIS . 16.9 p80 172.19 -38.69 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.488 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 175.429 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 66.0 t-80 . . . . . 0 C--O 1.242 0.682 0 N-CA-C 107.598 -1.26 . . . . 0.0 107.598 178.458 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.737 ' HA ' ' O ' ' A' ' 11' ' ' ALA . 67.7 mtm . . . . . 0 N--CA 1.48 1.074 0 N-CA-C 109.999 -0.371 . . . . 0.0 109.999 . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.407 ' H ' ' HB3' ' A' ' 11' ' ' ALA . 16.8 t -140.99 156.77 45.99 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 179.888 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.668 HD23 ' HG3' ' A' ' 8' ' ' PRO . 2.6 pt? -137.73 161.47 36.43 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 120.712 0.291 . . . . 0.0 110.353 -177.837 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 63.4 mmt-85 -117.06 -19.37 9.77 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 172.396 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 19.0 t -173.03 153.75 2.63 Favored 'General case' 0 N--CA 1.451 -0.397 0 CA-C-N 115.399 -0.819 . . . . 0.0 108.979 178.324 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 76.89 -92.4 1.02 Allowed Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 120.917 -0.658 . . . . 0.0 112.722 178.721 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . 0.413 ' HA ' ' HD3' ' A' ' 8' ' ' PRO . 9.1 p30 -154.74 151.43 23.46 Favored Pre-proline 0 C--N 1.325 -0.473 0 N-CA-C 110.419 -0.215 . . . . 0.0 110.419 -176.766 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.668 ' HG3' HD23 ' A' ' 3' ' ' LEU . 3.1 Cg_exo -74.31 106.87 2.32 Favored 'Trans proline' 0 N--CA 1.462 -0.363 0 C-N-CA 122.649 2.233 . . . . 0.0 111.753 177.24 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 1.6 p -104.9 104.0 13.68 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.142 -177.586 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.623 ' O ' ' HG2' ' A' ' 1' ' ' MET . . . 70.53 -75.66 0.07 Allowed 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 115.134 -0.939 . . . . 0.0 111.181 178.762 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.737 ' O ' ' HA ' ' A' ' 1' ' ' MET . . . 11.97 74.54 0.01 OUTLIER 'General case' 0 N--CA 1.479 0.994 0 O-C-N 125.061 1.475 . . . . 0.0 113.807 -178.21 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 1.011 ' HA ' ' HB3' ' A' ' 25' ' ' LEU . 68.5 m 62.35 84.14 0.14 Allowed 'General case' 0 CA--C 1.534 0.362 0 CA-C-O 121.593 0.711 . . . . 0.0 111.354 -175.778 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 16.3 p90 -99.84 175.17 5.88 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.403 -0.817 . . . . 0.0 110.419 178.528 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 13.8 p -142.75 123.26 14.02 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.514 0.197 . . . . 0.0 110.57 178.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . 0.584 ' HB2' HD11 ' A' ' 92' ' ' LEU . 80.5 m-85 -134.65 150.05 72.51 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.655 -0.248 . . . . 0.0 110.483 179.24 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.401 ' HD2' ' O ' ' A' ' 93' ' ' HIS . 3.1 Cg_exo -80.83 124.85 5.21 Favored 'Trans proline' 0 N--CA 1.457 -0.636 0 C-N-CA 122.581 2.187 . . . . 0.0 112.805 178.638 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . 0.676 ' HB3' ' HB3' ' A' ' 21' ' ' LYS . 4.8 t70 -70.36 159.93 33.24 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.32 -0.855 . . . . 0.0 109.123 171.136 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.592 HD13 ' CG1' ' A' ' 82' ' ' VAL . 1.5 tt -50.24 -35.57 12.08 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.512 0 O-C-N 123.68 0.613 . . . . 0.0 111.651 -176.187 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 34.5 m-80 -77.54 11.93 1.83 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.411 -177.384 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 70.56 32.16 67.77 Favored Glycine 0 CA--C 1.505 -0.55 0 N-CA-C 110.335 -1.106 . . . . 0.0 110.335 -175.582 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.676 ' HB3' ' HB3' ' A' ' 17' ' ' ASP . 8.2 ttpm? -103.52 109.25 20.83 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.048 -0.576 . . . . 0.0 110.519 -173.997 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 20.9 m -65.19 106.94 1.42 Allowed 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.756 178.515 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.509 HG12 HG21 ' A' ' 90' ' ' ILE . 63.3 t -112.95 127.99 69.92 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 N-CA-C 109.176 -0.676 . . . . 0.0 109.176 179.028 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' SER . . . . . 0.459 ' C ' ' H ' ' A' ' 26' ' ' ALA . 92.9 p -122.62 165.01 17.16 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.535 0.683 . . . . 0.0 111.757 -173.193 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 1.011 ' HB3' ' HA ' ' A' ' 12' ' ' SER . 20.8 tp -85.35 33.15 0.55 Allowed 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.894 0.854 . . . . 0.0 109.311 175.385 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.459 ' H ' ' C ' ' A' ' 24' ' ' SER . . . -118.73 -41.37 2.8 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 114.505 -1.225 . . . . 0.0 109.745 174.155 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -79.1 -31.77 44.37 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.337 0.589 . . . . 0.0 109.937 173.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.594 HD12 HG21 ' A' ' 67' ' ' VAL . 75.9 mt -78.97 -18.46 53.67 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.217 174.862 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.5 ' HB2' ' O ' ' A' ' 25' ' ' LEU . 44.7 tttp -71.48 131.66 43.63 Favored 'General case' 0 N--CA 1.444 -0.729 0 CA-C-N 115.317 -0.856 . . . . 0.0 110.817 -175.336 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 117.17 -8.74 15.8 Favored Glycine 0 N--CA 1.448 -0.512 0 N-CA-C 110.79 -0.924 . . . . 0.0 110.79 -174.655 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.432 ' C ' ' HA ' ' A' ' 117' ' ' ARG . 24.9 ttmm -143.47 147.94 35.3 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 179.637 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 54.9 m-85 -54.01 144.66 18.59 Favored 'General case' 0 N--CA 1.47 0.543 0 N-CA-C 112.562 0.578 . . . . 0.0 112.562 -174.223 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.503 HG13 HD13 ' A' ' 25' ' ' LEU . 39.2 mm -120.73 133.93 65.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.562 -0.745 . . . . 0.0 110.99 -175.04 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . 0.466 ' OH ' ' HD3' ' A' ' 129' ' ' PRO . 80.1 t80 -120.67 118.98 31.5 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 172.253 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.592 ' HB ' ' HB ' ' A' ' 113' ' ' ILE . 75.1 mt -99.98 126.78 53.39 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 N-CA-C 110.138 -0.319 . . . . 0.0 110.138 179.399 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.528 ' O ' ' HA ' ' A' ' 68' ' ' SER . 11.8 t70 -129.9 124.91 34.3 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.23 -178.924 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.404 HG13 HG22 ' A' ' 109' ' ' ILE . 26.5 t -81.78 121.77 35.63 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.913 0 C-N-CA 120.557 -0.457 . . . . 0.0 110.423 -179.598 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' TRP . . . . . 0.668 ' CE3' ' HZ2' ' A' ' 78' ' ' TRP . 0.7 OUTLIER -121.74 133.41 54.93 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.161 -0.472 . . . . 0.0 109.896 -176.618 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.512 ' HA ' ' OD1' ' A' ' 72' ' ' ASP . . . -148.27 158.28 44.0 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.577 -177.482 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' THR . . . . . 0.624 ' HB ' ' CE3' ' A' ' 78' ' ' TRP . 11.1 t -94.89 -25.59 16.52 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.114 0.483 . . . . 0.0 110.611 175.111 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 14.9 p-90 -87.78 13.32 10.86 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.079 -177.742 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . 0.446 ' SG ' ' HB2' ' A' ' 45' ' ' CYS . 14.9 t -86.24 -60.69 1.93 Allowed 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.09 175.92 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 110.92 -91.37 0.61 Allowed Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.641 -179.269 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -53.62 -28.87 48.11 Favored 'Trans proline' 0 C--N 1.35 0.638 0 C-N-CA 123.302 2.668 . . . . 0.0 113.066 -178.59 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . 0.586 ' HG ' ' HG3' ' A' ' 110' ' ' PRO . 42.2 t -51.64 -30.05 20.09 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.66 178.594 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.55 ' HA ' ' HG ' ' A' ' 49' ' ' LEU . 55.8 mtp180 -65.44 -30.58 71.39 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.451 -0.341 . . . . 0.0 111.686 -176.592 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -68.9 -26.39 74.66 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.652 -0.785 . . . . 0.0 112.49 -176.65 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.443 ' OE2' ' HG2' ' A' ' 128' ' ' ARG . 14.6 mt-10 -94.49 -12.24 28.06 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.594 0.235 . . . . 0.0 111.005 -176.94 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.637 ' O ' ' HG3' ' A' ' 53' ' ' LYS . 73.2 mt -49.75 -49.19 74.74 Favored Pre-proline 0 C--N 1.331 -0.239 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.948 -178.598 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.54 ' HD3' ' HB2' ' A' ' 49' ' ' LEU . 71.3 Cg_exo -50.83 -37.82 56.04 Favored 'Trans proline' 0 C--N 1.357 1.003 0 C-N-CA 122.184 1.923 . . . . 0.0 112.767 176.984 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.499 ' O ' ' HB2' ' A' ' 55' ' ' LEU . . . -75.14 -25.4 58.36 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-O 121.617 0.722 . . . . 0.0 110.504 -176.114 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 6.8 tt -79.02 -48.34 14.6 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.0 -1.0 . . . . 0.0 108.419 -177.155 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.732 ' HB3' ' HG2' ' A' ' 88' ' ' LYS . 81.9 mttt -51.59 -55.71 17.67 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-N 114.655 -1.157 . . . . 0.0 109.909 176.893 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.464 ' HG2' ' O ' ' A' ' 50' ' ' PRO . 9.6 mm-40 -73.58 -23.32 59.93 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 114.074 -1.421 . . . . 0.0 112.55 -171.185 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.499 ' HB2' ' O ' ' A' ' 51' ' ' ALA . 0.4 OUTLIER -73.35 -34.0 65.4 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 120.302 -0.559 . . . . 0.0 109.588 176.408 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.447 ' OE2' ' HB2' ' A' ' 66' ' ' PHE . 5.1 tp10 -68.14 -37.13 80.74 Favored 'General case' 0 C--O 1.217 -0.63 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 175.686 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.453 ' HG2' ' O ' ' A' ' 53' ' ' LYS . 7.1 mm-40 -54.04 -53.96 45.8 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.391 0.615 . . . . 0.0 110.451 175.492 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 34.4 ttpt -55.57 -35.41 65.74 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.369 -0.832 . . . . 0.0 110.903 177.755 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.452 ' CZ ' ' HB2' ' A' ' 138' ' ' PHE . 38.3 m-85 -102.91 12.29 36.32 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 113.109 0.781 . . . . 0.0 113.109 -176.114 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -65.09 123.63 20.0 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 120.878 0.371 . . . . 0.0 110.352 176.516 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 83.52 7.68 85.94 Favored Glycine 0 N--CA 1.448 -0.541 0 C-N-CA 120.826 -0.702 . . . . 0.0 112.782 178.195 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 34.2 mmtm -89.92 -153.47 0.29 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.194 0.521 . . . . 0.0 109.821 177.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -106.75 62.39 0.63 Allowed 'General case' 0 C--N 1.316 -0.878 0 CA-C-O 121.571 0.701 . . . . 0.0 110.021 176.853 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 17.8 tt -157.35 163.98 1.21 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.787 0 CA-C-N 115.12 -0.945 . . . . 0.0 109.174 177.503 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 96.8 m-70 -139.25 114.97 10.01 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 174.453 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . 0.447 ' HB2' ' OE2' ' A' ' 56' ' ' GLU . 12.5 m-85 -80.47 103.0 10.04 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 171.998 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.594 HG21 HD12 ' A' ' 28' ' ' LEU . 46.8 t -115.82 104.54 16.9 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 CA-C-N 115.332 -0.849 . . . . 0.0 109.739 -176.566 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' SER . . . . . 0.528 ' HA ' ' O ' ' A' ' 36' ' ' ASP . 28.9 m -88.1 148.26 24.54 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.531 -178.132 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.41 HD12 ' HB2' ' A' ' 94' ' ' MET . 63.7 tp -126.73 119.9 28.07 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 120.839 0.352 . . . . 0.0 110.664 178.139 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' SER . . . . . 0.492 ' HB3' ' HA ' ' A' ' 93' ' ' HIS . 3.4 t -100.74 119.05 38.05 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.228 0.537 . . . . 0.0 112.095 -174.552 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 18.7 m -90.76 15.34 11.33 Favored 'General case' 0 C--N 1.31 -1.121 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.816 177.864 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.512 ' OD1' ' HA ' ' A' ' 39' ' ' ALA . 2.4 m-20 -68.2 127.26 32.25 Favored 'General case' 0 CA--C 1.516 -0.344 0 CA-C-O 121.049 0.452 . . . . 0.0 110.663 -177.957 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 38.5 ttmt -79.01 -31.65 44.81 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 121.413 0.625 . . . . 0.0 109.323 175.335 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . 0.51 ' HB2' ' HB2' ' A' ' 77' ' ' ALA . 0.8 OUTLIER -80.36 68.59 6.59 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.175 -0.92 . . . . 0.0 110.25 177.45 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.548 ' HG3' ' CE1' ' A' ' 93' ' ' HIS . 33.0 tttt -58.91 -49.54 77.43 Favored 'General case' 0 C--O 1.223 -0.338 0 C-N-CA 120.936 -0.306 . . . . 0.0 111.462 -173.862 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 64.7 tttp -52.43 -56.04 17.77 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 110.343 -0.243 . . . . 0.0 110.343 179.273 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.648 ' HA ' ' ND2' ' A' ' 80' ' ' ASN . . . -51.45 -35.66 40.63 Favored 'General case' 0 C--O 1.242 0.678 0 CA-C-O 122.03 0.919 . . . . 0.0 110.933 177.011 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' TRP . . . . . 0.668 ' HZ2' ' CE3' ' A' ' 38' ' ' TRP . 14.8 t-105 -74.25 -51.05 16.5 Favored 'General case' 0 N--CA 1.431 -1.377 0 CA-C-N 114.434 -1.257 . . . . 0.0 111.828 -173.045 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.495 ' HG2' ' O ' ' A' ' 75' ' ' LYS . 4.8 mm-40 -49.61 -41.06 41.17 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-O 121.082 0.468 . . . . 0.0 110.485 176.849 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . 0.648 ' ND2' ' HA ' ' A' ' 77' ' ' ALA . 6.0 m-20 -56.87 -54.26 48.53 Favored 'General case' 0 CA--C 1.518 -0.261 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.706 177.795 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' MET . . . . . 0.539 ' SD ' ' HZ3' ' A' ' 78' ' ' TRP . 16.6 ttt -61.09 -48.42 81.75 Favored 'General case' 0 C--O 1.223 -0.316 0 N-CA-C 112.358 0.503 . . . . 0.0 112.358 -175.435 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.592 ' CG1' HD13 ' A' ' 18' ' ' ILE . 0.9 OUTLIER -60.91 -34.79 60.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 C-N-CA 120.386 -0.526 . . . . 0.0 111.069 -178.478 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 25.5 m -73.41 -29.79 62.82 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.106 0.479 . . . . 0.0 110.574 176.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 51.3 tttp -81.3 -41.97 21.33 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.179 0.514 . . . . 0.0 111.043 -177.905 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -77.24 -21.04 54.38 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.239 -0.891 . . . . 0.0 110.084 -176.126 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 17.8 mm-40 63.99 79.52 0.26 Allowed 'General case' 0 C--O 1.233 0.192 0 CA-C-N 115.375 -0.83 . . . . 0.0 111.229 -179.885 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.659 HD23 ' HE2' ' A' ' 53' ' ' LYS . 49.4 mt -96.55 140.93 30.45 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.422 -0.808 . . . . 0.0 111.001 179.402 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.732 ' HG2' ' HB3' ' A' ' 53' ' ' LYS . 30.6 mmtp -95.47 174.28 7.09 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.234 -0.439 . . . . 0.0 109.821 179.341 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . 0.419 ' CA ' ' HG2' ' A' ' 56' ' ' GLU . . . 86.33 -164.83 36.84 Favored Glycine 0 CA--C 1.517 0.184 0 C-N-CA 120.927 -0.654 . . . . 0.0 113.432 174.418 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.509 HG21 HG12 ' A' ' 23' ' ' VAL . 64.2 mt -103.51 113.45 40.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 178.297 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . 0.616 ' HB3' ' CZ2' ' A' ' 38' ' ' TRP . 8.1 mm100 -117.23 104.83 11.57 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 120.892 0.377 . . . . 0.0 111.022 -169.624 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.584 HD11 ' HB2' ' A' ' 15' ' ' TYR . 34.9 mt -100.04 147.94 25.07 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.146 0.498 . . . . 0.0 111.111 -176.51 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' HIS . . . . . 0.548 ' CE1' ' HG3' ' A' ' 75' ' ' LYS . 28.1 t-80 -115.08 127.86 55.87 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.144 0.497 . . . . 0.0 111.086 179.759 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' MET . . . . . 0.491 ' HB3' ' O ' ' A' ' 70' ' ' SER . 24.1 ttm -77.32 -74.95 0.22 Allowed 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.294 -0.866 . . . . 0.0 109.93 176.167 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . 0.41 ' N ' ' HG2' ' A' ' 94' ' ' MET . . . 78.67 101.96 0.21 Allowed Glycine 0 N--CA 1.445 -0.734 0 C-N-CA 120.755 -0.735 . . . . 0.0 113.135 -179.689 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 64.9 p 61.17 16.29 7.08 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 114.221 1.193 . . . . 0.0 114.221 170.098 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -123.99 54.47 1.33 Allowed 'General case' 0 CA--C 1.518 -0.265 0 CA-C-O 121.502 0.667 . . . . 0.0 110.096 174.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . 0.47 ' HB2' ' SD ' ' A' ' 101' ' ' MET . 0.1 OUTLIER -77.3 5.62 8.26 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.27 -0.877 . . . . 0.0 111.911 -170.433 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 2.8 m -61.0 -29.95 70.0 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.294 0.569 . . . . 0.0 110.529 177.42 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 27.3 t80 -73.94 -24.83 59.71 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.567 -179.14 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' MET . . . . . 0.47 ' SD ' ' HB2' ' A' ' 98' ' ' ARG . 83.2 mtp -61.7 -51.58 67.8 Favored 'General case' 0 CA--C 1.515 -0.402 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 174.059 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -62.03 -25.36 67.61 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 114.649 -1.16 . . . . 0.0 111.424 -177.696 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -65.84 -28.97 69.37 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-O 121.074 0.464 . . . . 0.0 110.877 178.1 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 61.9 m-85 -109.27 10.81 25.61 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.495 179.766 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 95.4 mt 64.72 15.51 9.81 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.1 -177.24 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . 0.882 HG12 ' HG3' ' A' ' 111' ' ' ARG . 61.2 mt -67.03 112.92 2.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.271 175.111 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 16.2 t-20 -124.96 -53.85 1.63 Allowed 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 176.346 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -92.19 115.02 4.7 Favored Glycine 0 N--CA 1.442 -0.915 0 CA-C-N 115.29 -0.868 . . . . 0.0 111.979 178.339 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . 0.526 ' CG2' ' HA ' ' A' ' 110' ' ' PRO . 41.9 mt -77.7 142.97 66.59 Favored Pre-proline 0 C--N 1.321 -0.655 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 175.383 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . 0.586 ' HG3' ' HG ' ' A' ' 45' ' ' CYS . 1.0 OUTLIER -86.13 170.67 42.16 Favored 'Cis proline' 0 C--N 1.348 0.553 0 C-N-CA 124.775 -0.927 . . . . 0.0 113.853 1.087 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . 0.882 ' HG3' HG12 ' A' ' 106' ' ' ILE . 0.0 OUTLIER -134.79 133.82 40.23 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.477 -0.783 . . . . 0.0 108.897 179.413 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . 0.488 ' CE1' ' HB2' ' A' ' 128' ' ' ARG . 0.0 OUTLIER -102.33 117.05 33.91 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 123.365 0.415 . . . . 0.0 110.502 -175.604 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.592 ' HB ' ' HB ' ' A' ' 35' ' ' ILE . 82.1 mt -129.16 141.81 45.64 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.326 0 CA-C-O 120.708 0.29 . . . . 0.0 111.004 179.559 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 40.4 tp -130.31 139.21 50.72 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.5 -179.775 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.451 HD11 ' N ' ' A' ' 115' ' ' LEU . 0.8 OUTLIER -136.03 155.77 49.73 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.04 0.447 . . . . 0.0 110.54 179.673 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . 0.67 ' HB3' ' HB2' ' A' ' 120' ' ' LYS . 19.2 t70 -71.94 162.55 29.29 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.221 -0.899 . . . . 0.0 110.568 176.684 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . 0.432 ' HA ' ' C ' ' A' ' 31' ' ' LYS . 33.0 mtt180 -46.53 -40.2 12.21 Favored 'General case' 0 N--CA 1.462 0.136 0 O-C-N 124.43 1.081 . . . . 0.0 111.895 -178.611 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . 0.841 ' HB3' ' HG3' ' A' ' 120' ' ' LYS . 38.4 t70 -66.09 -18.87 65.62 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.36 0.6 . . . . 0.0 111.173 -177.448 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 104.26 16.96 16.93 Favored Glycine 0 N--CA 1.436 -1.344 0 N-CA-C 110.288 -1.125 . . . . 0.0 110.288 -170.151 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . 0.841 ' HG3' ' HB3' ' A' ' 118' ' ' ASP . 60.0 mttm -86.03 107.35 17.75 Favored 'General case' 0 C--O 1.219 -0.528 0 C-N-CA 120.805 -0.358 . . . . 0.0 111.115 -173.929 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . 0.413 ' HA ' ' HG ' ' A' ' 115' ' ' LEU . 3.9 mp -48.18 111.67 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-O 121.02 0.438 . . . . 0.0 110.797 177.725 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 45.5 mm -95.48 -50.38 11.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 115.659 -0.7 . . . . 0.0 109.9 -179.508 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 19.9 m -125.99 114.59 18.67 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.212 -177.86 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -72.08 -16.98 62.03 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.13 0.491 . . . . 0.0 110.091 176.694 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . 0.421 ' HA ' ' O ' ' A' ' 112' ' ' PHE . 7.7 t30 -149.8 101.18 3.03 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.299 -0.864 . . . . 0.0 109.159 173.909 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 12.6 tpt -91.48 -125.2 0.08 Allowed 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 -178.761 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' THR . . . . . 0.458 ' OG1' ' HB ' ' A' ' 134' ' ' THR . 0.0 OUTLIER -140.82 131.72 26.01 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.879 0.371 . . . . 0.0 110.48 178.399 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . 0.617 ' HD2' ' HD2' ' A' ' 129' ' ' PRO . 17.7 tpt180 -51.52 138.03 30.83 Favored Pre-proline 0 C--N 1.323 -0.56 0 CA-C-N 115.252 -0.885 . . . . 0.0 111.073 176.04 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . 0.617 ' HD2' ' HD2' ' A' ' 128' ' ' ARG . 68.8 Cg_exo -48.49 -21.48 3.34 Favored 'Trans proline' 0 C--N 1.351 0.664 0 C-N-CA 123.496 2.797 . . . . 0.0 113.747 174.074 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' SER . . . . . 0.429 ' OG ' ' HB3' ' A' ' 48' ' ' GLU . 4.4 m -61.11 -28.06 68.82 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.762 0.315 . . . . 0.0 111.035 176.774 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . 0.647 ' OD1' ' HG2' ' A' ' 133' ' ' LYS . 24.1 t0 -100.64 117.35 62.93 Favored Pre-proline 0 N--CA 1.453 -0.321 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.162 179.736 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . 0.592 ' O ' ' HG2' ' A' ' 136' ' ' GLU . 14.1 Cg_endo -56.98 -21.18 40.19 Favored 'Trans proline' 0 CA--C 1.53 0.315 0 C-N-CA 123.196 2.597 . . . . 0.0 114.018 179.736 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . 0.647 ' HG2' ' OD1' ' A' ' 131' ' ' ASP . 31.1 mmtm -48.15 -55.31 10.68 Favored 'General case' 0 N--CA 1.474 0.73 0 CA-C-O 121.066 0.46 . . . . 0.0 110.724 -177.528 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' THR . . . . . 0.458 ' HB ' ' OG1' ' A' ' 127' ' ' THR . 15.1 t -65.15 -41.15 95.02 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.233 -0.894 . . . . 0.0 110.755 -175.069 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . 0.572 ' HA ' ' CD2' ' A' ' 138' ' ' PHE . . . -64.24 -47.87 78.0 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-O 121.402 0.62 . . . . 0.0 110.758 -176.801 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . 0.592 ' HG2' ' O ' ' A' ' 132' ' ' PRO . 8.6 mm-40 -77.12 -22.86 52.02 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-O 121.465 0.65 . . . . 0.0 109.821 -176.2 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . 0.573 ' O ' ' HG ' ' A' ' 141' ' ' LEU . 0.1 OUTLIER -57.68 -39.17 76.48 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.15 -0.932 . . . . 0.0 109.441 168.659 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . 0.572 ' CD2' ' HA ' ' A' ' 135' ' ' ALA . 9.3 m-85 -66.76 -40.59 88.31 Favored 'General case' 0 N--CA 1.462 0.15 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.373 177.596 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . 0.586 ' HB3' ' HG3' ' A' ' 145' ' ' GLU . 92.6 m-20 -47.53 -53.76 13.52 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 175.758 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . 0.541 ' CD ' ' HZ1' ' A' ' 137' ' ' LYS . 21.8 tt0 -53.85 -48.42 70.0 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.287 -0.869 . . . . 0.0 111.472 179.111 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . 0.573 ' HG ' ' O ' ' A' ' 137' ' ' LYS . 83.4 mt -58.32 -29.35 65.84 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.899 -176.688 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 10.0 mp -102.16 -5.66 24.16 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.678 -0.237 . . . . 0.0 111.442 -179.756 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 72.63 28.56 67.13 Favored Glycine 0 C--N 1.329 0.152 0 N-CA-C 110.827 -0.909 . . . . 0.0 110.827 -176.749 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . 0.503 HD22 ' OD1' ' A' ' 139' ' ' ASN . 26.9 tp -76.14 -31.58 58.67 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 114.77 -0.715 . . . . 0.0 110.837 -173.139 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . 0.586 ' HG3' ' HB3' ' A' ' 139' ' ' ASN . 0.0 OUTLIER -86.4 -29.9 22.54 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.793 0.806 . . . . 0.0 110.372 178.477 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -76.93 28.79 1.6 Allowed Glycine 0 C--N 1.317 -0.484 0 CA-C-N 114.061 -1.427 . . . . 0.0 113.992 -174.93 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 18.9 p-80 -76.03 61.53 1.54 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.709 0.766 . . . . 0.0 110.232 176.263 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 12.3 m170 -92.0 100.0 12.73 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.69 -0.687 . . . . 0.0 109.573 -176.523 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 7.3 p80 -61.85 142.15 57.53 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.054 0.454 . . . . 0.0 111.367 -176.483 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 46.7 m80 -129.01 116.12 18.84 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.052 -0.522 . . . . 0.0 109.592 177.134 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 23.0 m170 69.39 103.6 0.06 Allowed 'General case' 0 N--CA 1.468 0.472 0 O-C-N 123.947 0.779 . . . . 0.0 111.503 -177.115 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 56.0 t-80 . . . . . 0 C--O 1.245 0.823 0 CA-C-O 118.318 -0.849 . . . . 0.0 109.515 177.98 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.5 mmt . . . . . 0 N--CA 1.479 0.986 0 N-CA-C 109.535 -0.543 . . . . 0.0 109.535 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 6.4 m -77.92 69.91 4.21 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.573 -0.528 . . . . 0.0 109.573 176.702 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 43.7 tp 69.52 -58.24 0.52 Allowed 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 115.268 -0.878 . . . . 0.0 110.367 -172.131 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 90.7 mtm180 -117.75 -179.72 3.82 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.115 -0.493 . . . . 0.0 109.706 176.913 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 16.3 m -78.4 -9.35 59.25 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.375 0.607 . . . . 0.0 110.577 178.183 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -165.85 143.85 8.74 Favored Glycine 0 N--CA 1.444 -0.788 0 N-CA-C 110.137 -1.185 . . . . 0.0 110.137 177.752 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . 0.561 ' HB3' ' HB1' ' A' ' 103' ' ' ALA . 8.9 m120 64.81 108.84 0.03 OUTLIER Pre-proline 0 N--CA 1.469 0.515 0 CA-C-O 121.171 0.51 . . . . 0.0 110.349 -177.094 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_exo -68.59 -75.34 0.01 OUTLIER 'Trans proline' 0 C--N 1.331 -0.362 0 C-N-CA 122.882 2.388 . . . . 0.0 112.367 -176.886 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 48.7 m 68.04 111.77 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.309 0 O-C-N 123.631 0.582 . . . . 0.0 111.271 -177.538 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.433 ' HB1' HD11 ' A' ' 121' ' ' ILE . . . 71.89 -40.95 0.49 Allowed 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 123.465 0.706 . . . . 0.0 112.823 178.077 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -76.2 69.35 2.73 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 112.281 0.474 . . . . 0.0 112.281 -175.598 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 42.5 m 62.6 102.86 0.03 OUTLIER 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 113.188 0.811 . . . . 0.0 113.188 172.042 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . 0.489 ' CE1' HD12 ' A' ' 25' ' ' LEU . 38.7 p90 -105.58 129.91 53.74 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.137 -0.483 . . . . 0.0 109.943 173.985 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 3.4 m -121.82 111.76 17.52 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.395 -177.841 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 63.9 m-85 -134.79 151.63 76.07 Favored Pre-proline 0 C--N 1.322 -0.597 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.605 -175.885 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -76.41 125.81 8.63 Favored 'Trans proline' 0 N--CA 1.46 -0.497 0 C-N-CA 122.569 2.18 . . . . 0.0 112.587 178.966 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . 0.544 ' HA ' ' HA ' ' A' ' 92' ' ' LEU . 10.5 t70 -70.51 159.16 34.79 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.484 -0.78 . . . . 0.0 108.926 172.114 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.536 HG13 HG13 ' A' ' 82' ' ' VAL . 0.0 OUTLIER -55.8 -25.64 19.01 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.487 0 O-C-N 123.722 0.639 . . . . 0.0 111.55 -176.947 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 42.8 m-80 -72.65 2.42 6.55 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.137 0.494 . . . . 0.0 110.91 176.065 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 73.67 36.35 53.73 Favored Glycine 0 N--CA 1.446 -0.639 0 N-CA-C 110.835 -0.906 . . . . 0.0 110.835 -179.501 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.832 ' HZ2' ' HB2' ' A' ' 21' ' ' LYS . 0.1 OUTLIER -119.56 134.07 55.39 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 110.273 -0.269 . . . . 0.0 110.273 -175.045 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 7.0 m -80.11 107.83 13.22 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-O 120.868 0.366 . . . . 0.0 110.619 -177.326 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.476 ' HB ' HD23 ' A' ' 92' ' ' LEU . 62.0 t -108.4 141.7 22.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 115.871 -0.604 . . . . 0.0 109.69 -179.969 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 82.3 p -120.53 -173.71 2.64 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 120.867 0.365 . . . . 0.0 110.716 -176.895 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.645 ' O ' ' HB2' ' A' ' 29' ' ' LYS . 65.0 tp -78.73 -26.52 44.72 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.465 -179.716 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -84.76 -30.58 24.54 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 112.8 0.667 . . . . 0.0 112.8 -169.709 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 3.4 p30 -81.04 -15.5 55.94 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.171 0.51 . . . . 0.0 110.849 -175.796 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 18.8 tp -118.36 21.87 12.42 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.756 0.788 . . . . 0.0 109.319 178.007 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.645 ' HB2' ' O ' ' A' ' 25' ' ' LEU . 57.6 tttm -94.18 163.27 13.52 Favored 'General case' 0 N--CA 1.44 -0.957 0 CA-C-N 114.813 -1.085 . . . . 0.0 109.961 -178.45 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 114.49 -31.33 6.45 Favored Glycine 0 CA--C 1.509 -0.301 0 C-N-CA 120.591 -0.814 . . . . 0.0 111.669 177.734 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 1.022 ' HD3' ' HA ' ' A' ' 63' ' ' ASP . 65.2 mttm -119.36 165.55 14.16 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 109.662 -0.496 . . . . 0.0 109.662 174.822 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 81.5 m-85 -60.89 149.15 37.18 Favored 'General case' 0 C--N 1.329 -0.311 0 O-C-N 123.323 0.39 . . . . 0.0 110.639 -177.87 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 71.1 mt -124.5 132.18 71.7 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 CA-C-O 120.853 0.359 . . . . 0.0 110.807 -174.737 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 88.3 t80 -117.12 121.05 40.19 Favored 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 173.013 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.516 ' HB ' ' HB ' ' A' ' 113' ' ' ILE . 57.1 mt -105.58 118.83 53.78 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-O 121.171 0.51 . . . . 0.0 110.736 -178.286 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -106.41 156.87 18.08 Favored 'General case' 0 C--N 1.316 -0.849 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 172.3 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.481 HG12 ' O ' ' A' ' 69' ' ' LEU . 62.0 t -110.46 112.1 39.08 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.877 0 C-N-CA 120.034 -0.666 . . . . 0.0 110.22 174.161 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' TRP . . . . . 0.651 ' CZ2' ' HB2' ' A' ' 91' ' ' GLN . 0.2 OUTLIER -98.02 132.86 43.2 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.097 -0.956 . . . . 0.0 109.516 -177.257 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.576 ' HA ' ' OD1' ' A' ' 72' ' ' ASP . . . -147.58 155.09 41.49 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.664 -178.714 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' THR . . . . . 0.662 ' HB ' ' CE3' ' A' ' 78' ' ' TRP . 13.3 t -100.34 -28.41 12.97 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.781 0.324 . . . . 0.0 110.704 174.601 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 18.5 p-90 -81.31 11.03 4.69 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.785 -177.053 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . 0.777 ' HB3' ' SG ' ' A' ' 45' ' ' CYS . 44.5 t -91.55 -61.03 1.73 Allowed 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 109.912 -0.403 . . . . 0.0 109.912 174.854 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 111.0 -83.68 0.33 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.597 -179.629 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_exo -54.19 -26.86 44.32 Favored 'Trans proline' 0 C--N 1.351 0.704 0 C-N-CA 123.188 2.592 . . . . 0.0 112.854 179.463 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . 0.777 ' SG ' ' HB3' ' A' ' 42' ' ' CYS . 23.1 p -51.47 -35.49 40.1 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.399 176.797 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.552 ' HA ' HD12 ' A' ' 49' ' ' LEU . 33.6 mtp180 -67.9 -12.3 60.41 Favored 'General case' 0 N--CA 1.456 -0.157 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.21 -175.698 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -80.37 -19.93 67.93 Favored Glycine 0 N--CA 1.446 -0.654 0 C-N-CA 120.648 -0.786 . . . . 0.0 111.369 175.437 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 24.6 mt-10 -99.34 -12.81 19.97 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-O 120.606 0.241 . . . . 0.0 110.615 -179.282 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.552 HD12 ' HA ' ' A' ' 46' ' ' ARG . 7.5 mp -51.89 -48.57 87.52 Favored Pre-proline 0 CA--C 1.536 0.436 0 CA-C-N 116.561 -0.29 . . . . 0.0 111.701 172.279 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -57.04 -35.84 99.07 Favored 'Trans proline' 0 C--N 1.355 0.896 0 C-N-CA 121.791 1.661 . . . . 0.0 111.937 171.601 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.449 ' O ' ' HB2' ' A' ' 54' ' ' GLU . . . -72.0 -26.03 62.06 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-O 121.234 0.54 . . . . 0.0 110.574 -179.1 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 87.3 mt -67.6 -33.67 75.47 Favored 'General case' 0 N--CA 1.444 -0.74 0 CA-C-N 115.858 -0.61 . . . . 0.0 109.67 174.225 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 5.5 mtpm? -70.36 -39.19 74.76 Favored 'General case' 0 CA--C 1.519 -0.236 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.166 175.005 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.449 ' HB2' ' O ' ' A' ' 51' ' ' ALA . 28.1 mm-40 -50.7 -50.82 54.18 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.755 -0.657 . . . . 0.0 109.669 172.9 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 62.8 mt -62.23 -53.12 59.74 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.976 175.409 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 26.4 tt0 -43.41 -59.84 1.96 Allowed 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 114.575 -1.193 . . . . 0.0 112.427 179.522 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -78.67 -29.04 45.41 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 120.777 0.322 . . . . 0.0 111.598 -172.666 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 65.5 tttm -70.48 -27.69 64.41 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.884 0.374 . . . . 0.0 110.831 178.62 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.41 ' HB2' ' HE2' ' A' ' 66' ' ' PHE . 68.4 m-85 -122.58 13.7 10.13 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.46 -0.336 . . . . 0.0 111.845 -176.343 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -60.07 132.09 52.85 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.217 172.392 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 69.36 46.37 56.87 Favored Glycine 0 N--CA 1.447 -0.599 0 C-N-CA 120.854 -0.689 . . . . 0.0 112.169 -179.702 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 40.3 mmtm -126.6 -164.42 1.33 Allowed 'General case' 0 N--CA 1.45 -0.451 0 CA-C-O 121.216 0.531 . . . . 0.0 110.313 174.859 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 1.022 ' HA ' ' HD3' ' A' ' 31' ' ' LYS . 0.1 OUTLIER -97.85 44.32 1.04 Allowed 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.639 -0.71 . . . . 0.0 110.805 -179.41 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 18.2 tt -144.45 149.27 17.49 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.761 0 CA-C-N 114.929 -1.032 . . . . 0.0 109.761 -177.036 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' HIS . . . . . 0.545 ' NE2' ' HB2' ' A' ' 31' ' ' LYS . 89.4 m-70 -124.25 121.34 34.78 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 109.918 -0.401 . . . . 0.0 109.918 178.287 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . 0.41 ' HE2' ' HB2' ' A' ' 59' ' ' TYR . 91.8 m-85 -88.65 111.31 21.78 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 173.585 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.506 ' O ' ' HA ' ' A' ' 35' ' ' ILE . 27.4 t -118.58 109.37 26.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.459 -175.83 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' SER . . . . . 0.403 ' HB3' ' CD1' ' A' ' 38' ' ' TRP . 10.9 m -88.07 143.73 26.91 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-N 115.918 -0.583 . . . . 0.0 109.856 178.844 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.481 ' O ' HG12 ' A' ' 37' ' ' VAL . 62.7 tp -131.88 124.0 28.63 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 174.652 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' SER . . . . . 0.556 ' O ' ' HB3' ' A' ' 94' ' ' MET . 1.3 t -108.15 119.61 39.98 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.076 0.465 . . . . 0.0 112.046 -173.957 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 2.4 p -87.06 17.6 4.1 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.749 -0.659 . . . . 0.0 110.806 177.214 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.585 ' OD2' HG22 ' A' ' 40' ' ' THR . 1.9 m-20 -69.64 121.3 16.86 Favored 'General case' 0 CA--C 1.515 -0.4 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.011 179.496 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 45.9 tttm -75.91 -25.86 56.42 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-O 121.146 0.498 . . . . 0.0 110.062 -179.874 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . 0.494 ' HB2' ' HB3' ' A' ' 77' ' ' ALA . 0.2 OUTLIER -78.7 96.87 5.67 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.747 -0.66 . . . . 0.0 109.788 174.027 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.545 ' O ' ' HG2' ' A' ' 79' ' ' GLU . 11.4 tmtt? -71.41 -66.33 0.64 Allowed 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 120.446 -0.502 . . . . 0.0 112.038 -173.863 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 36.0 ttpt -58.3 -43.28 88.04 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 121.009 -0.277 . . . . 0.0 110.819 -173.044 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.572 ' HA ' ' ND2' ' A' ' 80' ' ' ASN . . . -52.22 -38.82 59.09 Favored 'General case' 0 C--O 1.246 0.879 0 CA-C-O 121.86 0.838 . . . . 0.0 111.277 178.716 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' TRP . . . . . 0.662 ' CE3' ' HB ' ' A' ' 40' ' ' THR . 16.2 t-105 -79.02 -42.53 26.31 Favored 'General case' 0 N--CA 1.44 -0.959 0 CA-C-N 115.151 -0.931 . . . . 0.0 111.045 -173.175 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.545 ' HG2' ' O ' ' A' ' 75' ' ' LYS . 3.8 mm-40 -51.97 -40.72 61.33 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-O 121.473 0.654 . . . . 0.0 110.248 175.748 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . 0.572 ' ND2' ' HA ' ' A' ' 77' ' ' ALA . 7.2 m-20 -59.25 -54.07 51.02 Favored 'General case' 0 CA--C 1.513 -0.446 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.257 177.858 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 28.6 ttm -61.37 -45.99 92.05 Favored 'General case' 0 C--O 1.219 -0.507 0 CA-C-N 116.02 -0.536 . . . . 0.0 112.235 -174.209 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.564 ' CG2' ' HZ3' ' A' ' 38' ' ' TRP . 3.9 p -61.57 -32.82 54.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 C-N-CA 120.07 -0.652 . . . . 0.0 111.016 179.519 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 58.9 m -63.75 -40.34 96.48 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.979 0.419 . . . . 0.0 110.239 175.886 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 12.8 mptt -81.13 -29.96 34.66 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.495 -179.396 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . 0.408 ' CG ' HH21 ' A' ' 46' ' ' ARG . 1.5 m-20 -77.6 -6.8 55.02 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.142 0.496 . . . . 0.0 110.975 178.529 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 84.7 mt-30 66.18 18.26 10.92 Favored 'General case' 0 N--CA 1.468 0.43 0 N-CA-C 113.271 0.841 . . . . 0.0 113.271 170.357 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.531 ' HB2' HG21 ' A' ' 82' ' ' VAL . 71.0 mt -64.14 143.18 58.07 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.558 0.218 . . . . 0.0 110.89 -179.926 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 24.6 mmtm -123.15 -166.91 1.52 Allowed 'General case' 0 N--CA 1.451 -0.382 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.934 176.367 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 92.2 -157.01 23.83 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 121.002 -0.618 . . . . 0.0 111.685 -178.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 50.1 mm -107.26 117.48 53.12 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 N-CA-C 108.933 -0.766 . . . . 0.0 108.933 175.631 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . 0.651 ' HB2' ' CZ2' ' A' ' 38' ' ' TRP . 0.6 OUTLIER -135.2 102.59 5.23 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-O 121.916 0.865 . . . . 0.0 111.724 -169.4 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.544 ' HA ' ' HA ' ' A' ' 17' ' ' ASP . 38.6 mt -91.73 142.2 27.86 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 114.806 -1.088 . . . . 0.0 110.588 -175.982 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 23.2 t-80 -111.82 116.07 30.07 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-O 121.37 0.605 . . . . 0.0 110.443 179.544 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' MET . . . . . 0.734 ' SD ' ' HA ' ' A' ' 98' ' ' ARG . 10.7 ttm -69.47 -52.28 28.1 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.048 -0.978 . . . . 0.0 111.073 -178.899 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . 0.413 ' HA2' ' O ' ' A' ' 72' ' ' ASP . . . 77.86 -86.7 1.07 Allowed Glycine 0 N--CA 1.448 -0.557 0 C-N-CA 120.628 -0.796 . . . . 0.0 113.243 175.781 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 5.1 m -120.7 -5.45 9.7 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 120.843 0.354 . . . . 0.0 111.112 -176.173 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . 0.53 ' O ' ' HG3' ' A' ' 94' ' ' MET . 13.0 t70 -98.46 72.65 2.07 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 120.056 -0.657 . . . . 0.0 109.719 -177.907 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . 0.734 ' HA ' ' SD ' ' A' ' 94' ' ' MET . 0.0 OUTLIER -82.62 31.31 0.41 Allowed 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.384 -175.462 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 3.0 m -65.67 -43.45 89.31 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.489 179.837 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -71.73 -36.58 70.53 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.247 177.3 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' MET . . . . . 0.526 ' HG3' ' O ' ' A' ' 106' ' ' ILE . 15.1 ttt -56.08 -45.11 79.47 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.568 -0.742 . . . . 0.0 109.982 173.95 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . 0.48 ' HB2' ' CZ ' ' A' ' 98' ' ' ARG . 21.9 t70 -69.07 -49.56 56.29 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.242 -0.89 . . . . 0.0 110.919 179.462 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . 0.561 ' HB1' ' HB3' ' A' ' 7' ' ' ASN . . . -69.01 -21.71 64.12 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.957 -0.565 . . . . 0.0 112.344 -171.512 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 25.8 m-85 -109.08 2.63 21.28 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 111.752 0.279 . . . . 0.0 111.752 -178.441 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 9.0 mp 59.39 27.27 16.34 Favored 'General case' 0 N--CA 1.466 0.334 0 O-C-N 123.47 0.481 . . . . 0.0 111.09 -177.968 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . 0.526 ' O ' ' HG3' ' A' ' 101' ' ' MET . 53.6 mt -66.7 77.85 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.271 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.71 174.084 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 61.2 t30 -109.19 -46.47 3.57 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 175.427 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -77.77 91.95 1.1 Allowed Glycine 0 N--CA 1.446 -0.639 0 CA-C-N 115.455 -0.793 . . . . 0.0 111.222 174.575 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . 0.455 HD11 ' HB2' ' A' ' 42' ' ' CYS . 2.4 pp -103.34 151.57 38.6 Favored Pre-proline 0 C--N 1.322 -0.609 0 CA-C-N 115.963 -0.118 . . . . 0.0 111.094 -178.829 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . 0.541 ' HD3' ' HB3' ' A' ' 45' ' ' CYS . 30.0 Cg_endo -68.51 153.49 89.39 Favored 'Cis proline' 0 C--N 1.349 0.573 0 C-N-CA 123.725 -1.365 . . . . 0.0 113.623 1.115 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . 0.465 ' H ' ' HB ' ' A' ' 37' ' ' VAL . 0.0 OUTLIER -113.57 144.41 42.93 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.727 -0.669 . . . . 0.0 109.519 -177.526 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . 0.639 ' HD2' ' HD3' ' A' ' 129' ' ' PRO . 0.9 OUTLIER -112.66 114.52 27.17 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.835 -177.873 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.516 ' HB ' ' HB ' ' A' ' 35' ' ' ILE . 85.6 mt -128.57 141.97 45.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.854 0.359 . . . . 0.0 110.801 -178.796 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 41.2 tp -126.48 136.45 52.64 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.172 179.097 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.512 ' N ' HD12 ' A' ' 115' ' ' LEU . 0.7 OUTLIER -136.27 156.7 48.29 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.397 0.618 . . . . 0.0 110.553 -178.175 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . 0.629 ' HB3' ' HB2' ' A' ' 120' ' ' LYS . 9.6 t70 -77.96 168.2 20.28 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 114.88 -1.055 . . . . 0.0 111.351 177.722 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . 0.48 ' HA ' ' O ' ' A' ' 31' ' ' LYS . 88.1 mtt-85 -45.88 -40.55 10.15 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 124.569 1.148 . . . . 0.0 113.115 179.911 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . 0.756 ' HB2' ' HG3' ' A' ' 120' ' ' LYS . 40.2 m-20 -78.34 5.19 11.03 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.576 0.227 . . . . 0.0 111.502 -178.461 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . 0.418 ' HA3' HD13 ' A' ' 25' ' ' LEU . . . 80.63 26.6 53.71 Favored Glycine 0 N--CA 1.44 -1.09 0 N-CA-C 110.521 -1.032 . . . . 0.0 110.521 -173.268 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . 0.756 ' HG3' ' HB2' ' A' ' 118' ' ' ASP . 33.9 mtmm -94.17 103.98 16.01 Favored 'General case' 0 C--O 1.223 -0.332 0 C-N-CA 120.574 -0.45 . . . . 0.0 110.468 -173.511 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . 0.433 HD11 ' HB1' ' A' ' 10' ' ' ALA . 2.7 mp -45.0 112.72 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 115.566 -0.743 . . . . 0.0 111.651 -178.47 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' ILE . . . . . 0.417 HD12 ' HB2' ' A' ' 116' ' ' ASP . 46.3 mm -89.5 -40.1 12.83 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-N 115.216 -0.902 . . . . 0.0 109.126 176.504 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 14.8 m -142.66 117.49 9.9 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.338 -0.847 . . . . 0.0 110.497 178.237 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . 0.497 ' O ' HG12 ' A' ' 113' ' ' ILE . . . -68.29 -27.16 66.07 Favored 'General case' 0 C--N 1.334 -0.103 0 CA-C-O 121.409 0.623 . . . . 0.0 109.75 175.453 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 3.9 p-10 -136.82 109.25 7.37 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.044 -0.98 . . . . 0.0 108.646 171.103 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' MET . . . . . 0.509 ' HE3' ' HA ' ' A' ' 134' ' ' THR . 27.9 ttt -83.17 -87.83 0.1 Allowed 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.518 -174.728 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -137.03 -75.76 0.42 Allowed 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.574 -0.285 . . . . 0.0 111.579 -178.266 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . 0.901 ' HB3' ' HB2' ' A' ' 131' ' ' ASP . 3.6 tmm_? 177.88 139.06 0.24 Allowed Pre-proline 0 N--CA 1.453 -0.297 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 -178.128 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . 0.639 ' HD3' ' HD2' ' A' ' 112' ' ' PHE . 85.1 Cg_exo -48.65 -44.8 29.81 Favored 'Trans proline' 0 C--N 1.349 0.554 0 C-N-CA 122.869 2.379 . . . . 0.0 113.617 -176.649 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' SER . . . . . 0.63 ' HB3' ' NH1' ' A' ' 128' ' ' ARG . 43.8 t -107.1 26.83 9.66 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.063 0.459 . . . . 0.0 110.863 -178.719 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . 0.901 ' HB2' ' HB3' ' A' ' 128' ' ' ARG . 13.6 t70 -92.09 134.06 29.25 Favored Pre-proline 0 C--N 1.325 -0.496 0 N-CA-C 109.781 -0.451 . . . . 0.0 109.781 177.686 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . 0.612 ' O ' ' HG3' ' A' ' 136' ' ' GLU . 18.8 Cg_endo -58.22 -40.87 72.51 Favored 'Trans proline' 0 C--N 1.343 0.269 0 C-N-CA 122.748 2.299 . . . . 0.0 113.142 -178.867 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 36.0 mtmm -61.17 -27.44 68.41 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 121.048 0.451 . . . . 0.0 110.69 -175.05 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' THR . . . . . 0.694 HG21 ' CZ ' ' A' ' 138' ' ' PHE . 1.3 m -60.94 -57.18 13.74 Favored 'General case' 0 N--CA 1.447 -0.595 0 CA-C-N 115.73 -0.668 . . . . 0.0 109.464 173.772 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . 0.624 ' HA ' ' CD2' ' A' ' 138' ' ' PHE . . . -60.09 -42.73 95.26 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.011 -0.995 . . . . 0.0 111.696 178.599 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . 0.612 ' HG3' ' O ' ' A' ' 132' ' ' PRO . 38.6 mt-10 -54.18 -52.45 61.15 Favored 'General case' 0 CA--C 1.512 -0.516 0 CA-C-O 121.382 0.61 . . . . 0.0 110.534 179.177 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . 0.501 ' O ' ' HB3' ' A' ' 140' ' ' GLU . 5.8 tmtm? -55.24 -43.61 74.73 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-N 114.792 -1.094 . . . . 0.0 111.148 -178.747 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . 0.694 ' CZ ' HG21 ' A' ' 134' ' ' THR . 14.8 m-85 -53.68 -60.54 3.18 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.07 -0.513 . . . . 0.0 111.44 177.674 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . 0.577 ' HB2' ' HB3' ' A' ' 144' ' ' LEU . 0.3 OUTLIER -72.28 -17.37 61.88 Favored 'General case' 0 C--O 1.224 -0.287 0 C-N-CA 120.423 -0.511 . . . . 0.0 111.2 -175.491 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . 0.501 ' HB3' ' O ' ' A' ' 137' ' ' LYS . 3.8 tt0 -59.21 -57.44 13.0 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.736 171.351 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . 0.444 ' HG ' ' O ' ' A' ' 138' ' ' PHE . 4.5 pp -71.53 -19.58 62.15 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.965 -177.31 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 95.7 mt -81.05 -18.5 46.48 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.424 174.064 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 73.91 40.03 45.2 Favored Glycine 0 N--CA 1.45 -0.389 0 N-CA-C 110.848 -0.901 . . . . 0.0 110.848 -178.63 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . 0.577 ' HB3' ' HB2' ' A' ' 139' ' ' ASN . 46.9 tp -117.38 20.39 13.63 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 114.882 -0.659 . . . . 0.0 110.398 -173.361 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -88.9 -32.37 17.76 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.332 0.587 . . . . 0.0 110.174 179.712 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -64.23 100.4 0.4 Allowed Glycine 0 C--N 1.317 -0.503 0 CA-C-N 114.659 -1.155 . . . . 0.0 112.46 179.613 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 28.0 m170 -110.85 145.23 38.6 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 110.489 -0.189 . . . . 0.0 110.489 -178.23 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER 65.36 129.94 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.701 0 O-C-N 124.455 1.097 . . . . 0.0 110.779 -173.841 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 9.6 p80 -68.43 153.94 42.79 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.873 -175.026 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 43.7 p-80 -148.02 121.14 8.87 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.095 -179.849 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 7.8 t-160 -103.62 79.26 1.66 Allowed 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 120.988 0.423 . . . . 0.0 110.028 179.763 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 55.6 t-80 . . . . . 0 C--O 1.243 0.728 0 CA-C-N 115.224 -0.898 . . . . 0.0 109.053 -178.726 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 93.6 mtp . . . . . 0 N--CA 1.482 1.14 0 CA-C-O 120.296 0.093 . . . . 0.0 110.76 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 50.8 m 61.93 -164.28 0.25 Allowed 'General case' 0 N--CA 1.463 0.176 0 O-C-N 123.587 0.554 . . . . 0.0 109.9 -174.916 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.428 ' HB3' ' HA ' ' A' ' 8' ' ' PRO . 92.6 mt 56.43 93.85 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.516 0 CA-C-O 121.357 0.599 . . . . 0.0 112.374 173.133 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 4.4 ptp180 -151.48 -171.46 3.94 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.959 -177.083 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 29.5 m 60.15 31.78 20.67 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-O 121.606 0.717 . . . . 0.0 110.113 -175.7 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 173.73 -97.35 0.11 Allowed Glycine 0 N--CA 1.444 -0.821 0 CA-C-N 115.131 -0.941 . . . . 0.0 111.316 -178.734 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 15.0 t-20 -155.2 142.76 13.98 Favored Pre-proline 0 C--N 1.325 -0.481 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 178.904 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.428 ' HA ' ' HB3' ' A' ' 3' ' ' LEU . 12.2 Cg_exo -70.95 -25.23 23.34 Favored 'Trans proline' 0 N--CA 1.466 -0.135 0 C-N-CA 123.194 2.596 . . . . 0.0 112.688 -178.675 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 28.8 m -90.12 15.32 10.44 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.315 0.578 . . . . 0.0 110.863 -178.269 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -89.14 28.72 1.16 Allowed 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.153 178.879 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -159.79 117.31 2.64 Favored 'General case' 0 N--CA 1.447 -0.585 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.66 -175.526 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.592 ' H ' HD22 ' A' ' 25' ' ' LEU . 47.3 m 67.04 36.01 4.37 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.235 -0.893 . . . . 0.0 112.141 171.954 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 37.5 p90 -66.06 163.87 16.53 Favored 'General case' 0 N--CA 1.463 0.208 0 N-CA-C 110.093 -0.336 . . . . 0.0 110.093 174.672 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' SER . . . . . 0.424 ' HA ' ' HA ' ' A' ' 24' ' ' SER . 16.2 t -142.36 128.0 19.16 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 120.865 0.364 . . . . 0.0 110.802 179.843 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . 0.45 ' O ' HD22 ' A' ' 92' ' ' LEU . 75.7 m-85 -141.83 159.65 58.82 Favored Pre-proline 0 C--N 1.327 -0.402 0 CA-C-N 115.874 -0.603 . . . . 0.0 109.81 178.942 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.663 ' HA ' ' O ' ' A' ' 21' ' ' LYS . 85.9 Cg_endo -88.44 134.16 2.85 Favored 'Trans proline' 0 N--CA 1.459 -0.549 0 C-N-CA 122.557 2.172 . . . . 0.0 113.996 -178.896 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . 0.488 ' HA ' ' O ' ' A' ' 91' ' ' GLN . 8.3 m-20 -69.1 168.62 13.55 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.054 171.203 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.572 HD12 HG13 ' A' ' 82' ' ' VAL . 1.9 tt -41.69 -40.36 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 O-C-N 124.563 1.164 . . . . 0.0 112.238 175.539 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 40.4 m-80 -68.54 -3.99 13.59 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.484 -177.086 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 79.14 33.63 35.57 Favored Glycine 0 N--CA 1.442 -0.931 0 N-CA-C 110.561 -1.016 . . . . 0.0 110.561 -174.389 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.663 ' O ' ' HA ' ' A' ' 16' ' ' PRO . 15.9 tppt? -110.43 126.73 54.62 Favored 'General case' 0 C--O 1.22 -0.48 0 CA-C-N 115.607 -0.297 . . . . 0.0 110.853 -173.952 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 18.8 m -84.44 106.86 16.35 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.974 -174.392 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.4 ' HB ' HD21 ' A' ' 92' ' ' LEU . 71.7 t -112.81 144.65 20.07 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 115.646 -0.706 . . . . 0.0 109.748 179.837 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' SER . . . . . 0.424 ' HA ' ' HA ' ' A' ' 14' ' ' SER . 95.7 p -113.98 162.01 16.96 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.912 -178.928 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.592 HD22 ' H ' ' A' ' 12' ' ' SER . 53.9 tp -66.98 -16.89 64.64 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.761 178.33 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -74.56 -18.95 60.51 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.825 0.345 . . . . 0.0 110.815 179.408 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -76.86 -39.1 52.33 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.629 0.728 . . . . 0.0 109.749 175.37 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.563 HD13 HG23 ' A' ' 67' ' ' VAL . 24.0 mt -84.69 -7.83 59.08 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 114.853 -1.067 . . . . 0.0 110.152 -179.402 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 32.9 tttp -73.78 130.2 39.48 Favored 'General case' 0 N--CA 1.439 -1.019 0 CA-C-N 114.847 -1.07 . . . . 0.0 110.496 -178.131 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 128.2 -31.14 3.72 Favored Glycine 0 N--CA 1.445 -0.747 0 N-CA-C 110.305 -1.118 . . . . 0.0 110.305 -173.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.842 ' HD3' ' HA ' ' A' ' 63' ' ' ASP . 61.4 mttm -122.56 174.31 7.15 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.526 -0.337 . . . . 0.0 110.154 175.518 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.94 ' HB2' HG23 ' A' ' 64' ' ' ILE . 92.4 m-85 -69.16 150.97 46.93 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 110.189 -0.3 . . . . 0.0 110.189 179.767 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.532 HD12 ' HA2' ' A' ' 119' ' ' GLY . 5.3 mp -124.59 134.47 66.69 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-O 120.79 0.328 . . . . 0.0 110.619 178.945 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 60.9 t80 -118.58 114.46 22.83 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 171.677 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.494 ' HA ' ' O ' ' A' ' 67' ' ' VAL . 67.4 mt -103.13 114.32 42.4 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 CA-C-O 121.134 0.493 . . . . 0.0 110.755 -177.791 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.466 ' O ' ' HA ' ' A' ' 68' ' ' SER . 5.5 p-10 -110.98 158.43 18.79 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 115.549 -0.75 . . . . 0.0 109.365 174.394 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.415 HG13 ' CG2' ' A' ' 109' ' ' ILE . 59.7 t -102.33 130.08 52.77 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.822 0 C-N-CA 120.779 -0.368 . . . . 0.0 110.421 178.359 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' TRP . . . . . 0.619 ' CZ2' ' HB2' ' A' ' 91' ' ' GLN . 0.6 OUTLIER -122.31 134.34 54.66 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 -179.223 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.529 ' HB1' ' HB3' ' A' ' 42' ' ' CYS . . . -145.03 162.23 37.47 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.548 -179.689 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' THR . . . . . 0.75 ' HB ' ' CE3' ' A' ' 78' ' ' TRP . 8.8 t -88.05 -22.19 24.34 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.226 0.536 . . . . 0.0 110.02 175.338 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . 0.483 ' HZ2' ' HG ' ' A' ' 71' ' ' CYS . 19.0 p-90 -96.71 18.0 15.3 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.674 -0.694 . . . . 0.0 109.848 176.045 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . 0.671 ' SG ' ' HB3' ' A' ' 45' ' ' CYS . 23.9 p -76.15 -19.38 58.53 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.542 -0.754 . . . . 0.0 111.089 -177.572 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 47.65 -98.31 0.01 OUTLIER Glycine 0 C--N 1.338 0.645 0 O-C-N 124.12 0.887 . . . . 0.0 114.261 176.602 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 81.6 Cg_exo -51.19 -26.11 19.02 Favored 'Trans proline' 0 C--N 1.354 0.821 0 C-N-CA 123.623 2.882 . . . . 0.0 113.502 178.217 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . 0.671 ' HB3' ' SG ' ' A' ' 42' ' ' CYS . 42.1 t -67.33 -41.14 85.75 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.286 0.565 . . . . 0.0 110.003 174.599 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.581 ' HA ' ' HG ' ' A' ' 49' ' ' LEU . 28.6 ttt-85 -67.49 -23.19 65.45 Favored 'General case' 0 N--CA 1.44 -0.953 0 CA-C-N 115.177 -0.92 . . . . 0.0 111.901 -173.487 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -63.2 -25.93 68.78 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.727 -0.749 . . . . 0.0 111.953 179.831 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.444 ' CD ' ' HE ' ' A' ' 128' ' ' ARG . 47.9 mt-10 -109.78 24.56 12.88 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 111.708 0.262 . . . . 0.0 111.708 -179.934 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.581 ' HG ' ' HA ' ' A' ' 46' ' ' ARG . 34.6 mt -59.29 -42.7 94.34 Favored Pre-proline 0 C--N 1.328 -0.369 0 C-N-CA 120.692 -0.403 . . . . 0.0 110.543 170.625 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.431 ' HD3' ' HB2' ' A' ' 49' ' ' LEU . 76.2 Cg_exo -51.94 -38.91 69.7 Favored 'Trans proline' 0 C--N 1.36 1.139 0 C-N-CA 122.02 1.813 . . . . 0.0 112.108 169.386 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -74.72 -26.76 60.03 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.146 0.498 . . . . 0.0 110.675 179.948 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 6.5 tt -67.01 -44.01 81.42 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 173.487 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.587 ' HB3' ' HZ2' ' A' ' 53' ' ' LYS . 3.1 mmmp? -60.98 -42.63 98.74 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.558 176.353 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -47.76 -58.58 4.14 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.786 173.662 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.568 ' HG ' ' CZ ' ' A' ' 66' ' ' PHE . 18.0 tp -62.79 -44.24 96.68 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.538 -0.755 . . . . 0.0 110.479 179.169 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 23.7 tt0 -49.46 -60.41 2.87 Favored 'General case' 0 C--N 1.331 -0.212 0 C-N-CA 123.853 0.861 . . . . 0.0 111.876 -179.597 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 32.1 mt-10 -73.03 -35.51 66.77 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.767 -172.797 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 43.6 mtpt -68.14 -38.31 82.01 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.005 0.431 . . . . 0.0 111.609 179.714 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.618 ' HB3' HD13 ' A' ' 64' ' ' ILE . 51.7 m-85 -107.13 10.41 30.12 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.897 -175.769 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -70.45 150.3 46.35 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 109.773 -0.455 . . . . 0.0 109.773 170.478 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 68.72 38.78 86.12 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.574 178.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.656 ' HB2' HG12 ' A' ' 64' ' ' ILE . 47.6 mmtm -119.67 -163.53 1.0 Allowed 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.233 0.539 . . . . 0.0 109.933 176.154 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.842 ' HA ' ' HD3' ' A' ' 31' ' ' LYS . 0.6 OUTLIER -92.49 36.62 1.0 Allowed 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 115.265 -0.879 . . . . 0.0 110.127 178.165 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.94 HG23 ' HB2' ' A' ' 32' ' ' TYR . 30.4 pt -141.8 167.38 16.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.543 -174.507 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' HIS . . . . . 0.666 ' NE2' ' HB2' ' A' ' 31' ' ' LYS . 63.2 m-70 -136.45 119.03 15.93 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.172 -0.467 . . . . 0.0 109.919 177.02 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . 0.568 ' CZ ' ' HG ' ' A' ' 55' ' ' LEU . 11.8 m-85 -79.5 118.71 21.61 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 170.016 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.563 HG23 HD13 ' A' ' 28' ' ' LEU . 25.4 t -127.59 103.94 11.37 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-O 121.138 0.494 . . . . 0.0 110.707 -175.279 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' SER . . . . . 0.466 ' HA ' ' O ' ' A' ' 36' ' ' ASP . 16.1 m -88.56 129.21 35.53 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-N 115.536 -0.757 . . . . 0.0 110.039 178.613 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.482 ' CD2' ' HB2' ' A' ' 92' ' ' LEU . 54.4 mt -114.33 132.21 56.27 Favored 'General case' 0 N--CA 1.465 0.303 0 O-C-N 122.147 -0.346 . . . . 0.0 110.287 174.988 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 1.4 t -112.34 120.33 41.35 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.17 0.51 . . . . 0.0 112.327 -174.586 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' CYS . . . . . 0.483 ' HG ' ' HZ2' ' A' ' 41' ' ' TRP . 4.7 p -88.76 18.49 4.69 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.842 177.014 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.53 ' OD2' HG22 ' A' ' 40' ' ' THR . 2.1 m-20 -72.34 136.55 46.2 Favored 'General case' 0 CA--C 1.519 -0.25 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.231 -179.497 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 51.4 tptt -79.16 -37.97 37.11 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 121.228 0.537 . . . . 0.0 110.045 177.936 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . 0.507 ' HB2' ' HB1' ' A' ' 77' ' ' ALA . 0.6 OUTLIER -79.42 82.96 5.49 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.759 -179.846 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.51 ' HB2' ' CE1' ' A' ' 93' ' ' HIS . 10.0 tttt -64.38 -51.9 60.96 Favored 'General case' 0 C--N 1.323 -0.545 0 C-N-CA 120.968 -0.293 . . . . 0.0 111.396 -177.129 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.489 ' HD3' ' C ' ' A' ' 76' ' ' LYS . 3.1 tmtm? -58.98 -51.27 70.79 Favored 'General case' 0 N--CA 1.444 -0.757 0 CA-C-N 116.103 -0.499 . . . . 0.0 109.715 -174.922 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.671 ' HA ' ' ND2' ' A' ' 80' ' ' ASN . . . -56.36 -38.48 71.46 Favored 'General case' 0 C--O 1.243 0.72 0 CA-C-O 121.959 0.885 . . . . 0.0 110.926 178.455 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' TRP . . . . . 0.75 ' CE3' ' HB ' ' A' ' 40' ' ' THR . 11.7 t-105 -75.83 -43.86 43.84 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 114.963 -1.017 . . . . 0.0 111.757 -174.169 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.526 ' HB2' HG13 ' A' ' 18' ' ' ILE . 4.0 pt-20 -60.49 -27.92 67.96 Favored 'General case' 0 CA--C 1.542 0.647 0 CA-C-O 121.047 0.451 . . . . 0.0 109.914 179.422 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . 0.671 ' ND2' ' HA ' ' A' ' 77' ' ' ALA . 8.9 m-20 -63.12 -52.98 60.42 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-O 120.795 0.331 . . . . 0.0 110.145 171.862 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 54.8 tpp -56.45 -47.84 78.28 Favored 'General case' 0 CA--C 1.518 -0.288 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.991 -175.83 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.577 ' HB ' ' HZ3' ' A' ' 38' ' ' TRP . 1.6 p -61.16 -34.1 58.98 Favored 'Isoleucine or valine' 0 C--O 1.237 0.401 0 CA-C-O 120.939 0.4 . . . . 0.0 110.847 178.737 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 90.5 m -64.63 -42.53 95.41 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.82 0.343 . . . . 0.0 110.467 174.896 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . 0.887 ' HB3' ' HZ3' ' A' ' 84' ' ' LYS . 0.0 OUTLIER -76.79 -37.95 54.88 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.008 -176.535 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 55.8 m-20 -83.02 -0.1 47.31 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.49 -177.95 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 27.4 mt-30 66.08 11.56 7.87 Favored 'General case' 0 N--CA 1.467 0.391 0 N-CA-C 113.69 0.996 . . . . 0.0 113.69 170.724 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.548 ' HB2' HG22 ' A' ' 82' ' ' VAL . 84.9 mt -64.63 126.32 27.51 Favored 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 110.323 -0.251 . . . . 0.0 110.323 178.582 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 21.6 mmtm -123.33 -161.98 1.01 Allowed 'General case' 0 N--CA 1.45 -0.427 0 CA-C-O 120.768 0.318 . . . . 0.0 111.799 -179.217 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 96.13 -156.58 21.34 Favored Glycine 0 N--CA 1.448 -0.535 0 N-CA-C 111.416 -0.674 . . . . 0.0 111.416 -177.579 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.521 ' O ' ' HA ' ' A' ' 67' ' ' VAL . 45.8 mm -93.29 116.46 34.49 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 174.529 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . 0.619 ' HB2' ' CZ2' ' A' ' 38' ' ' TRP . 1.9 pt20 -141.64 95.17 2.78 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-O 121.813 0.816 . . . . 0.0 111.83 -168.854 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.482 ' HB2' ' CD2' ' A' ' 69' ' ' LEU . 37.9 mt -94.43 157.11 16.16 Favored 'General case' 0 N--CA 1.442 -0.844 0 CA-C-N 114.779 -1.101 . . . . 0.0 110.421 -176.647 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' HIS . . . . . 0.51 ' CE1' ' HB2' ' A' ' 75' ' ' LYS . 21.9 t-80 -123.98 127.17 47.53 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-N 115.498 -0.774 . . . . 0.0 110.248 -177.684 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' MET . . . . . 0.622 ' HG3' ' HB2' ' A' ' 97' ' ' ASP . 30.2 ttm -81.58 -65.93 0.95 Allowed 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 114.96 -1.018 . . . . 0.0 110.764 -177.289 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 106.53 -94.18 0.92 Allowed Glycine 0 N--CA 1.446 -0.688 0 C-N-CA 120.492 -0.861 . . . . 0.0 112.664 179.772 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -117.75 0.42 11.99 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 120.81 0.338 . . . . 0.0 111.399 -176.279 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . 0.622 ' HB2' ' HG3' ' A' ' 94' ' ' MET . 3.9 m-20 -83.89 41.55 0.81 Allowed 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.008 0.433 . . . . 0.0 110.658 -174.294 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.9 -6.74 9.04 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.789 -0.641 . . . . 0.0 112.399 -172.264 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 16.7 m -70.24 -19.27 63.15 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.347 0.594 . . . . 0.0 110.17 176.625 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 52.8 t80 -74.21 -37.94 63.72 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.839 -0.618 . . . . 0.0 109.463 175.069 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' MET . . . . . 0.456 ' HE1' HG23 ' A' ' 106' ' ' ILE . 71.4 mmm -63.37 -42.74 98.88 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 173.353 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -58.7 -47.5 84.33 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 114.422 -1.263 . . . . 0.0 110.701 178.711 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -67.85 -12.76 61.29 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.721 -177.503 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 7.7 m-85 -105.64 6.82 32.36 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.021 179.918 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 3.7 mm? 62.57 25.39 15.11 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.812 -179.097 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . 0.732 HG12 ' HG3' ' A' ' 111' ' ' ARG . 58.9 mt -83.61 86.3 2.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.004 174.267 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 13.9 m120 -84.76 -51.41 6.81 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.045 177.274 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -107.73 130.67 10.23 Favored Glycine 0 N--CA 1.441 -1.019 0 CA-C-N 115.448 -0.796 . . . . 0.0 111.676 -179.933 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . 0.447 ' HB ' ' HA ' ' A' ' 110' ' ' PRO . 2.9 pp -98.98 154.95 37.09 Favored Pre-proline 0 C--N 1.319 -0.751 0 N-CA-C 110.43 -0.211 . . . . 0.0 110.43 177.988 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . 0.625 ' HG3' ' SG ' ' A' ' 45' ' ' CYS . 71.8 Cg_endo -82.89 149.5 67.82 Favored 'Cis proline' 0 N--CA 1.46 -0.449 0 C-N-CA 123.523 -1.449 . . . . 0.0 113.036 0.199 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . 0.732 ' HG3' HG12 ' A' ' 106' ' ' ILE . 0.0 OUTLIER -103.99 153.17 21.15 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.902 -0.59 . . . . 0.0 109.658 177.657 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 11.9 m-85 -119.72 127.69 53.09 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 108.89 -0.782 . . . . 0.0 108.89 -178.231 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.414 ' HB ' ' HB ' ' A' ' 35' ' ' ILE . 89.6 mt -138.26 144.8 29.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-O 120.685 0.279 . . . . 0.0 110.764 -175.769 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 28.5 tp -128.58 139.78 52.12 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 109.879 -0.415 . . . . 0.0 109.879 178.494 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.658 ' HG ' ' HA ' ' A' ' 121' ' ' ILE . 2.1 mp -133.75 158.83 42.33 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 109.947 -0.39 . . . . 0.0 109.947 -177.796 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . 0.523 ' OD2' ' HB2' ' A' ' 120' ' ' LYS . 3.9 p30 -86.12 175.31 8.6 Favored 'General case' 0 CA--C 1.516 -0.349 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.023 177.73 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . 0.59 ' HA ' ' O ' ' A' ' 31' ' ' LYS . 21.9 mtp85 -58.17 -26.98 63.42 Favored 'General case' 0 N--CA 1.465 0.298 0 O-C-N 124.36 1.038 . . . . 0.0 112.384 -173.124 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -76.29 -6.91 53.56 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.529 0.68 . . . . 0.0 109.356 -179.239 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . 0.532 ' HA2' HD12 ' A' ' 33' ' ' ILE . . . 89.47 23.48 33.85 Favored Glycine 0 N--CA 1.434 -1.463 0 N-CA-C 110.319 -1.113 . . . . 0.0 110.319 -174.857 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . 0.523 ' HB2' ' OD2' ' A' ' 116' ' ' ASP . 10.1 mmmm -102.96 118.38 36.7 Favored 'General case' 0 C--O 1.223 -0.295 0 C-N-CA 119.792 -0.763 . . . . 0.0 112.045 -172.96 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . 0.658 ' HA ' ' HG ' ' A' ' 115' ' ' LEU . 3.6 mp -46.79 114.69 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.55 -0.75 . . . . 0.0 111.681 178.618 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 40.0 mm -92.68 -44.4 13.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 115.229 -0.896 . . . . 0.0 109.659 176.519 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 20.8 m -127.63 114.79 17.83 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.386 -0.824 . . . . 0.0 110.024 177.774 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -72.31 -17.72 61.84 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.074 0.464 . . . . 0.0 110.774 178.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 7.2 t30 -142.3 98.84 3.39 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.62 -0.718 . . . . 0.0 109.828 175.969 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' MET . . . . . 0.461 ' HG3' ' H ' ' A' ' 127' ' ' THR . 7.7 tpt -92.73 -150.49 0.27 Allowed 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 178.135 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' THR . . . . . 0.613 ' OG1' ' HB ' ' A' ' 134' ' ' THR . 1.3 p -133.37 131.47 40.09 Favored 'General case' 0 N--CA 1.446 -0.642 0 CA-C-O 121.593 0.711 . . . . 0.0 112.356 -175.053 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . 0.444 ' HE ' ' CD ' ' A' ' 48' ' ' GLU . 34.4 ttt85 -31.89 139.2 0.2 Allowed Pre-proline 0 N--CA 1.471 0.588 0 CA-C-N 113.753 -1.567 . . . . 0.0 113.316 170.169 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_exo -40.54 -39.96 3.09 Favored 'Trans proline' 0 C--N 1.352 0.727 0 C-N-CA 124.682 3.588 . . . . 0.0 115.338 179.028 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -72.36 -7.0 47.27 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 112.22 0.452 . . . . 0.0 112.22 -175.589 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . 0.543 ' O ' HG23 ' A' ' 134' ' ' THR . 4.5 t70 -85.18 130.09 53.28 Favored Pre-proline 0 C--N 1.324 -0.542 0 CA-C-O 120.829 0.347 . . . . 0.0 110.887 178.468 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -68.6 -22.77 37.56 Favored 'Trans proline' 0 C--N 1.343 0.239 0 C-N-CA 122.648 2.232 . . . . 0.0 113.111 -179.907 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . 0.614 ' HA ' ' HG2' ' A' ' 136' ' ' GLU . 0.8 OUTLIER -73.76 -35.38 64.99 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.114 0.483 . . . . 0.0 110.7 -175.87 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' THR . . . . . 0.613 ' HB ' ' OG1' ' A' ' 127' ' ' THR . 4.2 t -71.2 -40.25 71.3 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 176.048 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . 0.503 ' HA ' ' CD2' ' A' ' 138' ' ' PHE . . . -62.48 -49.12 76.63 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 115.78 -0.645 . . . . 0.0 111.462 179.162 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . 0.614 ' HG2' ' HA ' ' A' ' 133' ' ' LYS . 5.2 pt-20 -58.91 -38.22 78.43 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 121.215 0.531 . . . . 0.0 109.818 179.56 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . 0.55 ' O ' ' HG ' ' A' ' 141' ' ' LEU . 0.0 OUTLIER -65.4 -41.52 93.55 Favored 'General case' 0 N--CA 1.448 -0.547 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.014 -177.913 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . 0.503 ' CD2' ' HA ' ' A' ' 135' ' ' ALA . 15.3 m-85 -54.5 -52.48 61.81 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-O 121.012 0.434 . . . . 0.0 109.996 176.524 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . 0.553 ' HB3' ' HG3' ' A' ' 145' ' ' GLU . 66.2 m-20 -59.37 -50.42 74.02 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.01 179.32 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -52.04 -56.25 15.55 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.242 -0.89 . . . . 0.0 112.768 179.547 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . 0.55 ' HG ' ' O ' ' A' ' 137' ' ' LYS . 4.1 pp -68.87 -21.8 64.24 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 120.816 0.341 . . . . 0.0 111.336 -175.962 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -78.22 -18.82 54.92 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 175.22 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 87.17 17.72 58.7 Favored Glycine 0 N--CA 1.446 -0.644 0 N-CA-C 111.005 -0.838 . . . . 0.0 111.005 -178.066 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 9.8 tt -80.97 -39.17 26.41 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-N 115.201 -0.499 . . . . 0.0 109.664 -179.355 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . 0.553 ' HG3' ' HB3' ' A' ' 139' ' ' ASN . 30.7 mt-10 -101.67 -172.03 2.08 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.248 179.544 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 127.66 63.76 0.13 Allowed Glycine 0 N--CA 1.444 -0.769 0 N-CA-C 111.119 -0.792 . . . . 0.0 111.119 -177.403 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 46.2 t-80 -76.46 64.88 2.23 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-O 121.29 0.567 . . . . 0.0 111.32 -174.682 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 41.6 t60 -135.57 7.31 3.28 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 108.558 -0.904 . . . . 0.0 108.558 172.875 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . 0.406 ' HD1' ' C ' ' A' ' 152' ' ' HIS . 16.5 m170 -104.55 -179.87 4.07 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 114.928 -1.033 . . . . 0.0 109.146 179.038 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 50.9 m-70 -110.22 2.6 19.39 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.803 0.335 . . . . 0.0 111.414 -179.407 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 58.2 m-70 -152.67 -63.67 0.16 Allowed 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 173.954 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 152' ' ' HIS . . . . . 0.406 ' C ' ' HD1' ' A' ' 149' ' ' HIS . 53.0 t-80 . . . . . 0 C--O 1.25 1.091 0 CA-C-O 117.454 -1.26 . . . . 0.0 107.689 173.272 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.492 ' H1 ' ' HB1' ' A' ' 11' ' ' ALA . 93.1 mtp . . . . . 0 N--CA 1.481 1.112 0 N-CA-C 110.007 -0.368 . . . . 0.0 110.007 . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 9.9 m -83.9 120.55 26.22 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.808 -0.441 . . . . 0.0 109.808 177.041 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -76.44 73.93 3.19 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.117 0.484 . . . . 0.0 110.762 -178.822 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 35.1 tpt85 -109.21 -22.66 11.99 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.256 177.287 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 13.2 p -79.48 -25.17 41.92 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.997 -178.459 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 88.38 -6.14 83.91 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.797 -0.716 . . . . 0.0 111.652 -178.008 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . 0.463 ' N ' HD21 ' A' ' 7' ' ' ASN . 0.8 OUTLIER -97.03 156.1 36.74 Favored Pre-proline 0 C--N 1.325 -0.48 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 178.865 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.568 ' HG2' HG21 ' A' ' 99' ' ' THR . 2.3 Cg_endo -48.31 -56.01 3.53 Favored 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 123.39 2.727 . . . . 0.0 112.892 -177.34 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 13.7 m 61.28 -171.25 0.15 Allowed 'General case' 0 C--O 1.233 0.184 0 CA-C-O 121.475 0.655 . . . . 0.0 111.158 176.96 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.459 ' HB2' ' HG3' ' A' ' 1' ' ' MET . . . -79.28 68.64 5.33 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.937 -0.574 . . . . 0.0 109.672 174.18 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.492 ' HB1' ' H1 ' ' A' ' 1' ' ' MET . . . -154.47 -34.7 0.1 Allowed 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.49 -0.777 . . . . 0.0 111.193 -178.836 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 22.8 t -169.54 153.42 5.11 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 178.521 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . 0.427 ' CD2' ' HZ ' ' A' ' 100' ' ' PHE . 52.3 p90 -154.98 152.82 30.14 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-O 120.81 0.338 . . . . 0.0 110.938 179.405 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 19.3 m -143.75 106.56 4.47 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 169.701 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . 0.785 ' HB2' HD12 ' A' ' 92' ' ' LEU . 24.8 m-85 -128.35 154.7 79.13 Favored Pre-proline 0 C--N 1.325 -0.483 0 CA-C-N 116.762 -0.199 . . . . 0.0 110.963 -174.716 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -81.89 125.43 4.79 Favored 'Trans proline' 0 CA--C 1.532 0.386 0 C-N-CA 122.6 2.2 . . . . 0.0 113.87 -178.479 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . 0.667 ' HB3' ' HB3' ' A' ' 21' ' ' LYS . 0.4 OUTLIER -69.53 163.62 25.01 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.009 -0.996 . . . . 0.0 109.918 171.212 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.629 HD13 HG11 ' A' ' 82' ' ' VAL . 0.9 OUTLIER -43.85 -44.99 1.94 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.662 0 O-C-N 123.858 0.724 . . . . 0.0 112.252 -177.883 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . 0.478 ' ND2' HG21 ' A' ' 18' ' ' ILE . 29.2 m-80 -77.24 3.81 12.0 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.495 -174.792 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 83.62 32.57 24.31 Favored Glycine 0 N--CA 1.446 -0.683 0 N-CA-C 110.662 -0.975 . . . . 0.0 110.662 -174.289 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.667 ' HB3' ' HB3' ' A' ' 17' ' ' ASP . 8.0 ttpm? -104.94 105.97 16.25 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.758 0.313 . . . . 0.0 110.796 -174.549 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 19.3 m -67.68 117.33 9.46 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.147 -179.935 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.45 HG12 HD23 ' A' ' 92' ' ' LEU . 7.1 p -117.77 143.49 28.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 115.939 -0.573 . . . . 0.0 109.475 177.396 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 60.4 p -122.48 -173.19 2.63 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.02 0.438 . . . . 0.0 110.579 -175.621 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 64.8 tp -85.91 -19.89 29.83 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.775 177.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.873 ' HA ' ' HD3' ' A' ' 29' ' ' LYS . . . -78.46 -35.23 46.97 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.568 -0.287 . . . . 0.0 111.423 -172.593 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -78.24 -11.79 59.95 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.36 0.6 . . . . 0.0 110.543 179.783 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.504 HD11 HG23 ' A' ' 67' ' ' VAL . 92.8 mt -92.78 -9.18 41.46 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.632 177.324 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.873 ' HD3' ' HA ' ' A' ' 26' ' ' ALA . 13.4 mtpp -75.98 153.59 36.44 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.266 0.555 . . . . 0.0 111.537 -179.07 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 101.7 -3.12 52.96 Favored Glycine 0 N--CA 1.45 -0.385 0 CA-C-N 115.357 -0.838 . . . . 0.0 111.747 -178.227 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.613 ' HB3' ' NE2' ' A' ' 65' ' ' HIS . 24.2 ttmm -157.97 145.89 18.62 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 -179.108 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.427 ' HB2' ' O ' ' A' ' 63' ' ' ASP . 34.6 m-85 -53.63 149.37 8.28 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-O 120.906 0.384 . . . . 0.0 111.424 -177.861 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.453 HD12 ' HA2' ' A' ' 119' ' ' GLY . 55.1 mt -125.28 138.69 53.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.554 -175.581 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 59.4 t80 -127.45 123.74 36.75 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 174.677 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.587 ' HB ' ' HB ' ' A' ' 113' ' ' ILE . 66.4 mt -109.59 123.13 65.23 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-O 121.074 0.464 . . . . 0.0 111.189 -177.028 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.426 ' HA ' ' O ' ' A' ' 111' ' ' ARG . 4.7 p-10 -116.37 159.32 22.13 Favored 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 173.216 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.49 HG11 HG21 ' A' ' 109' ' ' ILE . 60.7 t -105.22 115.47 47.13 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.839 0 C-N-CA 120.203 -0.599 . . . . 0.0 111.235 176.241 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' TRP . . . . . 0.628 ' HZ3' HG23 ' A' ' 82' ' ' VAL . 0.6 OUTLIER -98.12 132.79 43.36 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 179.358 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.574 ' HA ' ' OD1' ' A' ' 72' ' ' ASP . . . -147.05 152.99 39.47 Favored 'General case' 0 C--O 1.236 0.368 0 N-CA-C 112.268 0.47 . . . . 0.0 112.268 -173.837 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' THR . . . . . 0.526 HG23 ' SD ' ' A' ' 81' ' ' MET . 0.5 OUTLIER -83.68 -48.06 10.56 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.703 0.763 . . . . 0.0 110.182 176.561 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 17.4 p-90 -81.73 20.08 0.99 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 114.654 -1.157 . . . . 0.0 112.283 -171.309 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . 0.684 ' HB3' ' SG ' ' A' ' 45' ' ' CYS . 40.5 t -88.39 -64.03 1.21 Allowed 'General case' 0 C--N 1.322 -0.613 0 C-N-CA 120.541 -0.464 . . . . 0.0 110.38 -179.672 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 108.46 -84.1 0.36 Allowed Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.611 -0.804 . . . . 0.0 112.232 -178.736 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_exo -53.91 -22.6 24.69 Favored 'Trans proline' 0 C--N 1.352 0.736 0 C-N-CA 123.244 2.63 . . . . 0.0 112.946 177.57 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . 0.684 ' SG ' ' HB3' ' A' ' 42' ' ' CYS . 26.3 p -52.45 -31.87 36.84 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.26 177.843 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.573 ' HA ' ' HG ' ' A' ' 49' ' ' LEU . 64.9 mtp180 -72.91 -14.39 61.46 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.121 -175.617 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -84.26 -25.56 43.43 Favored Glycine 0 N--CA 1.448 -0.535 0 N-CA-C 111.244 -0.742 . . . . 0.0 111.244 174.484 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -87.12 -20.95 26.34 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.952 -0.388 . . . . 0.0 109.952 -179.186 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.672 ' HB2' ' HD3' ' A' ' 50' ' ' PRO . 79.4 mt -52.74 -50.61 80.09 Favored Pre-proline 0 CA--C 1.534 0.365 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.4 -179.225 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.672 ' HD3' ' HB2' ' A' ' 49' ' ' LEU . 52.8 Cg_exo -57.73 -34.91 98.85 Favored 'Trans proline' 0 C--N 1.355 0.875 0 C-N-CA 121.905 1.737 . . . . 0.0 112.552 173.476 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -75.48 -31.82 60.36 Favored 'General case' 0 N--CA 1.454 -0.236 0 CA-C-O 121.274 0.559 . . . . 0.0 109.889 -176.948 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 6.9 tt -68.0 -40.2 83.09 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.326 -0.852 . . . . 0.0 108.934 177.097 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.862 ' HA ' ' HG2' ' A' ' 56' ' ' GLU . 12.3 mtpp -60.13 -43.99 95.27 Favored 'General case' 0 CA--C 1.517 -0.298 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.857 176.198 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.577 ' O ' ' HB2' ' A' ' 58' ' ' LYS . 23.5 mm-40 -50.2 -47.82 54.53 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.814 173.365 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 6.0 mp -66.27 -51.77 54.14 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 111.873 0.324 . . . . 0.0 111.873 179.074 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.862 ' HG2' ' HA ' ' A' ' 53' ' ' LYS . 10.2 pt-20 -58.11 -46.48 85.49 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 120.571 0.224 . . . . 0.0 111.436 -173.964 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.696 ' HG3' ' HG3' ' A' ' 56' ' ' GLU . 62.4 mt-10 -80.88 -25.53 37.55 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.819 0.342 . . . . 0.0 111.024 -174.173 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . 0.577 ' HB2' ' O ' ' A' ' 54' ' ' GLU . 16.2 ttmm -75.84 -34.53 60.09 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.343 0.592 . . . . 0.0 110.25 178.099 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.459 ' HD1' ' HG3' ' A' ' 62' ' ' LYS . 97.9 m-85 -108.63 8.54 27.09 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.488 -176.45 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -60.9 112.08 1.91 Allowed 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 170.467 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 111.27 -8.42 28.81 Favored Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 120.641 -0.79 . . . . 0.0 111.822 -177.763 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.459 ' HG3' ' HD1' ' A' ' 59' ' ' TYR . 45.8 mmtm -84.65 -157.72 0.3 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.465 0.65 . . . . 0.0 109.892 176.371 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.513 ' CG ' ' HG3' ' A' ' 31' ' ' LYS . 9.1 t70 -108.46 75.1 0.96 Allowed 'General case' 0 C--N 1.314 -0.955 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.026 176.387 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 17.1 tt -157.4 143.54 9.22 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.64 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.01 178.084 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' HIS . . . . . 0.613 ' NE2' ' HB3' ' A' ' 31' ' ' LYS . 93.1 m-70 -111.14 108.94 18.79 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 171.663 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 73.3 m-85 -77.05 107.75 9.63 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 173.211 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.545 HG13 HD22 ' A' ' 92' ' ' LEU . 98.1 t -120.28 104.68 15.83 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-N 115.211 -0.904 . . . . 0.0 110.843 -173.086 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' SER . . . . . 0.708 ' HB2' ' HG2' ' A' ' 91' ' ' GLN . 11.0 m -91.25 130.97 37.06 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.815 178.152 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.693 HD13 ' HB2' ' A' ' 94' ' ' MET . 62.3 tp -121.66 131.95 54.38 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 110.05 -0.352 . . . . 0.0 110.05 177.537 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' SER . . . . . 0.418 ' HB2' ' O ' ' A' ' 38' ' ' TRP . 1.7 t -112.89 120.78 42.6 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.318 0.58 . . . . 0.0 112.297 -173.013 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 9.9 m -82.71 9.61 9.27 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.58 -0.736 . . . . 0.0 111.398 175.251 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.682 ' O ' ' HA2' ' A' ' 95' ' ' GLY . 2.2 m-20 -66.02 132.81 49.43 Favored 'General case' 0 CA--C 1.517 -0.307 0 CA-C-O 120.917 0.389 . . . . 0.0 111.766 -174.78 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 21.0 ttpp -76.12 -30.63 58.29 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 121.367 0.603 . . . . 0.0 110.051 175.16 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -84.62 105.32 15.34 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 108.933 -0.766 . . . . 0.0 108.933 -179.949 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 14.3 tttt -78.01 -57.25 3.9 Favored 'General case' 0 C--N 1.319 -0.735 0 C-N-CA 118.834 -1.146 . . . . 0.0 111.055 177.996 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.671 ' HA ' ' OE2' ' A' ' 79' ' ' GLU . 12.5 ttmm -55.56 -50.41 70.13 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 112.535 0.568 . . . . 0.0 112.535 -175.298 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -60.58 -33.2 72.36 Favored 'General case' 0 CA--C 1.522 -0.104 0 CA-C-O 121.545 0.688 . . . . 0.0 110.297 -178.09 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' TRP . . . . . 0.564 ' CZ2' ' CE3' ' A' ' 38' ' ' TRP . 10.9 t-105 -80.47 -43.88 20.14 Favored 'General case' 0 N--CA 1.442 -0.827 0 CA-C-N 115.236 -0.893 . . . . 0.0 110.937 -178.285 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.671 ' OE2' ' HA ' ' A' ' 76' ' ' LYS . 1.3 pt-20 -64.09 -36.51 84.25 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.405 -178.953 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . 0.476 HD21 ' N ' ' A' ' 81' ' ' MET . 0.2 OUTLIER -78.11 -27.61 48.43 Favored 'General case' 0 C--N 1.332 -0.189 0 C-N-CA 120.111 -0.636 . . . . 0.0 110.636 178.652 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' MET . . . . . 0.526 ' SD ' HG23 ' A' ' 40' ' ' THR . 19.5 ttt -68.17 -50.06 56.86 Favored 'General case' 0 C--O 1.218 -0.605 0 C-N-CA 121.031 -0.268 . . . . 0.0 111.021 173.946 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.629 HG11 HD13 ' A' ' 18' ' ' ILE . 5.6 p -59.91 -31.99 48.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 C-N-CA 120.306 -0.558 . . . . 0.0 110.598 179.491 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 60.5 m -67.25 -41.47 85.53 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-O 120.952 0.406 . . . . 0.0 110.762 173.734 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 51.2 tptt -70.0 -46.19 65.65 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.912 179.738 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . 0.417 ' CG ' HH21 ' A' ' 46' ' ' ARG . 0.9 OUTLIER -73.85 -8.62 56.75 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.184 -0.916 . . . . 0.0 111.045 179.511 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 88.0 mt-30 61.56 32.82 18.61 Favored 'General case' 0 C--O 1.238 0.454 0 N-CA-C 113.328 0.862 . . . . 0.0 113.328 169.388 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.553 ' HB2' HG22 ' A' ' 82' ' ' VAL . 75.9 mt -67.86 152.37 45.68 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.632 0.253 . . . . 0.0 110.582 177.85 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.435 ' HB2' ' OE1' ' A' ' 56' ' ' GLU . 28.9 mmtm -125.03 -162.46 1.1 Allowed 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.998 178.352 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 86.53 -155.29 28.01 Favored Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 120.918 -0.658 . . . . 0.0 111.944 -178.797 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 63.0 mt -109.98 110.94 34.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 176.342 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . 0.708 ' HG2' ' HB2' ' A' ' 68' ' ' SER . 21.9 mt-30 -128.53 111.57 13.39 Favored 'General case' 0 N--CA 1.441 -0.883 0 CA-C-O 121.33 0.586 . . . . 0.0 111.131 -175.541 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.785 HD12 ' HB2' ' A' ' 15' ' ' TYR . 0.4 OUTLIER -109.1 146.08 34.63 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.238 -179.0 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 18.9 t-80 -110.27 119.14 38.28 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.783 -175.585 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' MET . . . . . 0.693 ' HB2' HD13 ' A' ' 69' ' ' LEU . 26.2 ttp -83.11 -56.88 3.53 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 114.929 -1.032 . . . . 0.0 110.838 -177.343 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . 0.682 ' HA2' ' O ' ' A' ' 72' ' ' ASP . . . 86.78 -90.43 1.67 Allowed Glycine 0 N--CA 1.445 -0.703 0 C-N-CA 120.214 -0.993 . . . . 0.0 113.296 176.126 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 1.7 p -103.56 -20.24 14.09 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 112.33 0.493 . . . . 0.0 112.33 -174.125 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -93.09 54.15 2.09 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-O 121.185 0.517 . . . . 0.0 111.033 -165.627 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . 0.676 ' HA ' ' SD ' ' A' ' 94' ' ' MET . 0.0 OUTLIER -81.24 40.26 0.55 Allowed 'General case' 0 CA--C 1.516 -0.363 0 N-CA-C 112.845 0.683 . . . . 0.0 112.845 -172.243 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' THR . . . . . 0.568 HG21 ' HG2' ' A' ' 8' ' ' PRO . 7.3 t -60.9 -17.71 52.3 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 169.77 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . 0.427 ' HZ ' ' CD2' ' A' ' 13' ' ' PHE . 2.8 m-85 -72.91 -37.14 67.34 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-N 115.218 -0.901 . . . . 0.0 111.377 174.392 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' MET . . . . . 0.898 ' HA ' ' HB ' ' A' ' 106' ' ' ILE . 83.8 mtp -63.67 -48.47 77.06 Favored 'General case' 0 CA--C 1.517 -0.313 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 178.717 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -62.77 -37.87 88.37 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.824 -0.625 . . . . 0.0 111.112 177.053 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -71.68 -47.35 54.76 Favored 'General case' 0 N--CA 1.463 0.197 0 N-CA-C 112.367 0.506 . . . . 0.0 112.367 -175.071 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' TYR . . . . . 0.677 ' HB2' HG12 ' A' ' 106' ' ' ILE . 67.3 m-85 -96.95 0.48 49.0 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 112.069 0.396 . . . . 0.0 112.069 -174.491 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 9.6 mp 64.57 26.34 13.28 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.309 0.576 . . . . 0.0 110.006 -173.104 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . 0.898 ' HB ' ' HA ' ' A' ' 101' ' ' MET . 33.8 mm -55.67 108.96 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.155 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.188 172.933 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 48.5 t-20 -139.65 -66.61 0.45 Allowed 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 178.328 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -72.03 100.1 0.91 Allowed Glycine 0 N--CA 1.446 -0.699 0 C-N-CA 120.62 -0.8 . . . . 0.0 111.188 174.366 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . 0.49 HG21 HG11 ' A' ' 37' ' ' VAL . 2.7 pp -106.2 154.22 39.81 Favored Pre-proline 0 C--N 1.323 -0.587 0 C-N-CA 121.544 -0.062 . . . . 0.0 110.986 -178.74 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . 0.485 ' C ' ' HA ' ' A' ' 109' ' ' ILE . 22.7 Cg_exo -65.52 138.38 36.19 Favored 'Cis proline' 0 C--N 1.349 0.561 0 C-N-CA 124.224 -1.156 . . . . 0.0 113.392 1.016 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . 0.471 ' HD3' ' H ' ' A' ' 112' ' ' PHE . 0.0 OUTLIER -96.1 150.49 20.44 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.842 -0.617 . . . . 0.0 109.56 178.46 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . 0.562 ' HB2' ' HB2' ' A' ' 126' ' ' MET . 0.1 OUTLIER -116.35 114.36 24.2 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.279 -0.873 . . . . 0.0 110.583 -174.97 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.638 HD13 HD13 ' A' ' 106' ' ' ILE . 67.6 mt -128.86 144.46 38.04 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.354 0 CA-C-O 120.819 0.343 . . . . 0.0 111.064 -179.187 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 45.6 tp -128.71 134.08 48.35 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.064 -0.516 . . . . 0.0 109.987 176.717 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.489 HD22 HG13 ' A' ' 121' ' ' ILE . 0.4 OUTLIER -135.47 152.69 51.6 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.453 0.644 . . . . 0.0 110.601 -178.959 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . 0.806 ' HB3' ' HB2' ' A' ' 120' ' ' LYS . 43.0 t0 -70.61 164.5 24.79 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 114.735 -1.12 . . . . 0.0 110.36 179.707 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . 0.407 ' HA ' ' O ' ' A' ' 31' ' ' LYS . 40.0 mtm180 -51.56 -20.99 2.19 Favored 'General case' 0 C--N 1.323 -0.578 0 C-N-CA 124.589 1.155 . . . . 0.0 113.515 -173.98 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . 0.517 ' HB3' ' HG3' ' A' ' 120' ' ' LYS . 26.6 t70 -96.91 1.9 51.02 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-O 121.471 0.653 . . . . 0.0 110.262 -175.966 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . 0.453 ' HA2' HD12 ' A' ' 33' ' ' ILE . . . 88.17 16.93 58.46 Favored Glycine 0 N--CA 1.44 -1.034 0 N-CA-C 110.504 -1.038 . . . . 0.0 110.504 -171.752 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . 0.806 ' HB2' ' HB3' ' A' ' 116' ' ' ASP . 6.2 mtpm? -85.02 102.85 13.53 Favored 'General case' 0 C--O 1.221 -0.419 0 C-N-CA 121.047 -0.261 . . . . 0.0 110.953 -175.955 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . 0.489 HG13 HD22 ' A' ' 115' ' ' LEU . 4.1 mp -45.8 115.94 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 O-C-N 123.728 0.643 . . . . 0.0 111.561 -176.546 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' ILE . . . . . 0.422 ' H ' ' HA ' ' A' ' 115' ' ' LEU . 56.3 mt -89.77 -39.27 12.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 178.404 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' SER . . . . . 0.416 ' HG ' ' C ' ' A' ' 122' ' ' ILE . 17.1 m -154.4 125.11 7.07 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.369 -0.832 . . . . 0.0 109.77 176.932 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . 0.435 ' O ' HG12 ' A' ' 113' ' ' ILE . . . -72.5 -18.74 61.64 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.33 0.586 . . . . 0.0 110.21 177.982 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 16.2 p-10 -142.03 121.69 13.41 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.402 -0.817 . . . . 0.0 110.445 176.668 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' MET . . . . . 0.562 ' HB2' ' HB2' ' A' ' 112' ' ' PHE . 92.3 mmm -95.65 -117.86 0.11 Allowed 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.048 174.197 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' THR . . . . . 0.596 ' HB ' ' CG ' ' A' ' 131' ' ' ASP . 4.0 m -132.36 -50.38 0.93 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.877 0.37 . . . . 0.0 110.768 -179.482 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . 0.96 ' HB3' ' HB3' ' A' ' 131' ' ' ASP . 46.9 ttt180 -165.76 151.18 8.05 Favored Pre-proline 0 N--CA 1.444 -0.746 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 -178.674 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 20.5 Cg_exo -64.98 7.78 0.25 Allowed 'Trans proline' 0 CA--C 1.532 0.417 0 C-N-CA 122.141 1.894 . . . . 0.0 112.797 175.589 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' SER . . . . . 0.443 ' H ' ' C ' ' A' ' 128' ' ' ARG . 11.4 p -158.77 21.15 0.21 Allowed 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 111.808 0.299 . . . . 0.0 111.808 -178.895 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . 0.96 ' HB3' ' HB3' ' A' ' 128' ' ' ARG . 1.2 p30 -75.97 152.76 84.64 Favored Pre-proline 0 N--CA 1.444 -0.77 0 O-C-N 122.151 -0.343 . . . . 0.0 110.412 179.7 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -65.65 -28.01 52.69 Favored 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.842 2.361 . . . . 0.0 114.042 -175.028 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . 0.79 ' HA ' ' HG2' ' A' ' 136' ' ' GLU . 36.0 mttm -79.24 -28.92 42.48 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.019 0.437 . . . . 0.0 111.041 -176.289 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 134' ' ' THR . . . . . 0.692 HG21 ' CZ ' ' A' ' 138' ' ' PHE . 96.9 m -71.89 -38.82 69.92 Favored 'General case' 0 C--N 1.317 -0.838 0 N-CA-C 109.611 -0.514 . . . . 0.0 109.611 171.48 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . 0.423 ' HA ' ' CD2' ' A' ' 138' ' ' PHE . . . -61.59 -49.8 75.16 Favored 'General case' 0 C--O 1.236 0.39 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.659 174.742 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . 0.79 ' HG2' ' HA ' ' A' ' 133' ' ' LYS . 11.9 pt-20 -63.65 -28.32 69.83 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 120.961 0.41 . . . . 0.0 110.111 179.104 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . 0.629 ' O ' ' HG ' ' A' ' 141' ' ' LEU . 0.7 OUTLIER -60.09 -48.27 82.41 Favored 'General case' 0 N--CA 1.446 -0.654 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.406 175.866 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . 0.692 ' CZ ' HG21 ' A' ' 134' ' ' THR . 8.6 m-85 -54.46 -47.12 73.31 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.012 177.566 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 85.3 m-20 -56.63 -47.71 79.12 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.262 177.147 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . 0.535 ' HA ' ' HB2' ' A' ' 145' ' ' GLU . 43.6 tt0 -60.15 -43.01 96.08 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.553 179.103 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . 0.629 ' HG ' ' O ' ' A' ' 137' ' ' LYS . 94.0 mt -57.39 -44.82 84.84 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.409 -178.646 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 10.0 mp -81.64 -14.96 56.03 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.819 0.342 . . . . 0.0 111.032 -179.667 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 89.27 20.05 47.19 Favored Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 120.829 -0.7 . . . . 0.0 111.733 -179.852 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 10.3 tt -82.23 -24.77 34.67 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.43 -0.581 . . . . 0.0 109.43 -179.643 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . 0.535 ' HB2' ' HA ' ' A' ' 140' ' ' GLU . 1.8 mm-40 -56.52 145.18 28.78 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 115.435 -0.802 . . . . 0.0 111.553 176.261 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -159.99 -140.71 2.96 Favored Glycine 0 N--CA 1.445 -0.718 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.092 -178.759 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 54.3 t-80 -80.47 63.68 5.0 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 109.705 -0.48 . . . . 0.0 109.705 179.501 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 2.3 p80 -74.7 -13.88 60.67 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.102 -177.809 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 4.1 t-80 -168.51 -81.68 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.166 -0.47 . . . . 0.0 109.815 172.272 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -155.2 130.78 9.82 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 110.1 -0.333 . . . . 0.0 110.1 179.904 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 20.3 p-80 -95.85 -22.78 17.25 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 172.253 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 60.1 t-80 . . . . . 0 C--O 1.248 0.984 0 CA-C-N 114.5 -1.227 . . . . 0.0 108.319 175.125 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 51.1 ttm . . . . . 0 N--CA 1.484 1.228 0 N-CA-C 109.98 -0.378 . . . . 0.0 109.98 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 20.3 m 59.35 -166.57 0.17 Allowed 'General case' 0 CA--C 1.53 0.173 0 O-C-N 123.736 0.647 . . . . 0.0 110.262 -177.078 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.449 HD21 ' O ' ' A' ' 3' ' ' LEU . 0.0 OUTLIER -137.56 132.96 33.91 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.129 0.49 . . . . 0.0 110.577 176.558 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . 0.431 ' HB2' ' O ' ' A' ' 3' ' ' LEU . 40.7 ttm180 170.01 -45.49 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 -179.159 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 23.1 t -149.01 143.62 26.21 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 114.51 -1.223 . . . . 0.0 108.129 174.899 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 82.12 -111.34 3.33 Favored Glycine 0 N--CA 1.446 -0.691 0 C-N-CA 120.469 -0.872 . . . . 0.0 111.641 -176.083 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 32.0 p30 -168.25 159.69 9.05 Favored Pre-proline 0 C--O 1.238 0.482 0 CA-C-O 120.953 0.406 . . . . 0.0 111.372 -178.961 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 15.4 Cg_exo -69.43 145.28 58.55 Favored 'Trans proline' 0 N--CA 1.462 -0.377 0 C-N-CA 122.54 2.16 . . . . 0.0 110.663 171.083 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 27.6 m -73.08 87.33 1.38 Allowed 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.633 0.254 . . . . 0.0 110.805 -177.169 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.689 ' HA ' ' CE1' ' A' ' 100' ' ' PHE . . . 63.01 10.81 4.67 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 115.562 -0.744 . . . . 0.0 111.839 178.4 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.634 ' HB1' ' HE3' ' A' ' 120' ' ' LYS . . . -89.77 -6.07 56.33 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.582 -175.142 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 50.1 m -158.12 129.83 6.77 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.557 179.908 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . 0.44 ' CE2' HD11 ' A' ' 25' ' ' LEU . 52.4 p90 -157.65 159.46 37.01 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.481 -0.327 . . . . 0.0 110.295 176.451 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' SER . . . . . 0.542 ' HA ' ' HA ' ' A' ' 24' ' ' SER . 19.2 m -142.46 124.97 15.71 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.215 -0.448 . . . . 0.0 109.801 177.785 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 77.7 m-85 -139.25 154.18 71.8 Favored Pre-proline 0 C--N 1.326 -0.425 0 CA-C-O 120.516 0.198 . . . . 0.0 110.869 -178.002 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.467 ' HA ' ' O ' ' A' ' 21' ' ' LYS . 6.8 Cg_endo -85.15 127.93 3.53 Favored 'Trans proline' 0 N--CA 1.452 -0.92 0 C-N-CA 122.478 2.118 . . . . 0.0 112.928 179.437 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . 0.501 ' HA ' ' O ' ' A' ' 91' ' ' GLN . 11.7 t70 -67.18 154.65 40.74 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 169.409 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.47 HD11 ' CG1' ' A' ' 82' ' ' VAL . 5.9 tt -52.06 -33.3 16.26 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.435 0 O-C-N 123.729 0.643 . . . . 0.0 111.431 -176.338 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 40.3 m-80 -69.09 -9.68 53.88 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.027 -179.627 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 92.93 36.83 5.9 Favored Glycine 0 N--CA 1.446 -0.656 0 CA-C-N 115.802 -0.636 . . . . 0.0 111.802 -179.382 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.467 ' O ' ' HA ' ' A' ' 16' ' ' PRO . 62.3 tttm -107.04 121.79 45.18 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 120.573 -0.451 . . . . 0.0 110.617 -178.306 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 12.9 m -67.35 99.76 0.76 Allowed 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 109.651 -0.5 . . . . 0.0 109.651 173.566 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.434 HG22 ' HZ1' ' A' ' 21' ' ' LYS . 96.6 t -107.57 115.43 48.77 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-N 115.888 -0.596 . . . . 0.0 109.905 -178.77 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' SER . . . . . 0.542 ' HA ' ' HA ' ' A' ' 14' ' ' SER . 77.9 p -98.75 171.08 8.32 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 115.878 -0.601 . . . . 0.0 109.712 179.411 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.488 HD21 ' O ' ' A' ' 119' ' ' GLY . 27.0 tp -66.99 -22.27 65.92 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.087 0.47 . . . . 0.0 110.435 177.113 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -79.94 -31.48 40.01 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.092 176.593 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.413 ' OD2' HG11 ' A' ' 23' ' ' VAL . 20.6 t70 -66.69 -21.95 66.09 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 115.511 -0.768 . . . . 0.0 110.005 176.813 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.599 HD11 HG21 ' A' ' 67' ' ' VAL . 96.0 mt -105.96 3.22 28.17 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.456 -0.793 . . . . 0.0 111.779 -179.446 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.457 ' HG2' ' HA ' ' A' ' 118' ' ' ASP . 18.8 mtpt -75.08 162.01 28.91 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 121.377 0.608 . . . . 0.0 112.063 -177.6 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 113.84 -41.82 2.1 Favored Glycine 0 N--CA 1.447 -0.6 0 CA-C-N 115.332 -0.849 . . . . 0.0 111.459 179.809 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.471 ' O ' ' HA ' ' A' ' 117' ' ' ARG . 60.7 mttm -125.79 165.4 18.72 Favored 'General case' 0 N--CA 1.447 -0.623 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 177.48 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -63.68 134.82 56.08 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 177.667 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.443 HD11 ' HA2' ' A' ' 119' ' ' GLY . 5.0 mp -102.49 132.31 48.82 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.914 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 179.289 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 18.6 t80 -113.49 107.61 16.05 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 174.711 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.703 ' HA ' ' O ' ' A' ' 67' ' ' VAL . 62.6 mt -91.56 120.45 40.64 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.746 -176.251 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.476 ' O ' ' HA ' ' A' ' 68' ' ' SER . 3.8 t70 -118.13 125.96 51.28 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 177.176 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.555 ' HA ' ' O ' ' A' ' 69' ' ' LEU . 42.5 t -79.49 112.38 17.46 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.761 0 CA-C-O 121.507 0.67 . . . . 0.0 111.57 -175.572 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' TRP . . . . . 0.579 ' HZ3' ' CG2' ' A' ' 82' ' ' VAL . 0.8 OUTLIER -101.36 134.31 44.64 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.092 -0.958 . . . . 0.0 109.629 178.651 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -146.54 170.46 16.85 Favored 'General case' 0 C--N 1.321 -0.661 0 O-C-N 122.072 -0.393 . . . . 0.0 110.316 -179.592 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' THR . . . . . 0.69 ' HB ' ' CE3' ' A' ' 78' ' ' TRP . 8.8 t -91.05 1.44 57.08 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.508 0.671 . . . . 0.0 110.109 178.369 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 8.4 p-90 -126.6 17.93 7.47 Favored 'General case' 0 N--CA 1.448 -0.568 0 CA-C-N 115.613 -0.721 . . . . 0.0 111.411 -179.237 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 26.4 p -105.83 108.36 19.83 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-O 121.302 0.572 . . . . 0.0 109.973 175.764 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . 0.439 ' N ' ' HD2' ' A' ' 44' ' ' PRO . . . -72.56 -62.83 3.09 Favored Glycine 0 CA--C 1.525 0.71 0 CA-C-N 115.563 -0.744 . . . . 0.0 114.446 -174.502 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.439 ' HD2' ' N ' ' A' ' 43' ' ' GLY . 10.4 Cg_endo -52.1 -32.53 49.64 Favored 'Trans proline' 0 C--N 1.356 0.936 0 C-N-CA 123.523 2.815 . . . . 0.0 113.687 -171.364 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . 0.669 ' HB2' ' CG ' ' A' ' 110' ' ' PRO . 37.1 t -57.37 -31.17 65.51 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.657 -177.544 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.476 ' HA ' ' HG ' ' A' ' 49' ' ' LEU . 1.7 mpt_? -63.96 -43.29 96.26 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 112.478 0.548 . . . . 0.0 112.478 -172.501 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -69.17 -8.32 58.48 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.89 -0.671 . . . . 0.0 113.291 -174.82 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.446 ' CD ' ' HE ' ' A' ' 128' ' ' ARG . 24.4 mt-10 -119.21 3.62 11.36 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.649 0.261 . . . . 0.0 111.14 -177.719 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.546 ' HB2' ' HD3' ' A' ' 50' ' ' PRO . 87.2 mt -53.97 -46.88 98.45 Favored Pre-proline 0 CA--C 1.534 0.354 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.451 176.584 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.546 ' HD3' ' HB2' ' A' ' 49' ' ' LEU . 75.0 Cg_exo -51.34 -44.22 44.62 Favored 'Trans proline' 0 C--N 1.358 1.07 0 C-N-CA 121.93 1.753 . . . . 0.0 111.994 172.518 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -69.92 -32.42 70.69 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.024 0.44 . . . . 0.0 110.942 -176.329 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 7.6 tt -63.94 -50.44 68.67 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.344 -178.34 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.575 ' O ' ' HG3' ' A' ' 57' ' ' GLU . 24.9 pttm -71.56 -30.14 65.53 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 120.38 -0.528 . . . . 0.0 110.586 -177.398 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -68.28 -37.98 81.24 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-O 121.017 0.437 . . . . 0.0 110.795 177.028 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.46 HD21 ' O ' ' A' ' 129' ' ' PRO . 14.7 tp -63.78 -40.11 95.87 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 177.469 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -64.39 -47.65 78.41 Favored 'General case' 0 N--CA 1.443 -0.785 0 CA-C-N 115.987 -0.551 . . . . 0.0 109.934 177.931 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.575 ' HG3' ' O ' ' A' ' 53' ' ' LYS . 42.1 mt-10 -50.2 -40.1 46.09 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-O 121.199 0.523 . . . . 0.0 110.942 178.533 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . 0.795 ' HE3' ' CE2' ' A' ' 59' ' ' TYR . 34.6 ttpt -73.11 -43.03 62.28 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.532 -0.758 . . . . 0.0 112.327 -177.159 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.795 ' CE2' ' HE3' ' A' ' 58' ' ' LYS . 97.6 m-85 -102.66 -2.5 28.18 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 112.561 0.578 . . . . 0.0 112.561 -172.279 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -57.66 122.75 13.53 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.09 0.471 . . . . 0.0 111.61 179.755 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 99.58 -20.71 48.43 Favored Glycine 0 N--CA 1.445 -0.716 0 CA-C-N 115.536 -0.757 . . . . 0.0 113.263 174.036 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.52 ' N ' ' HD2' ' A' ' 62' ' ' LYS . 10.8 mptt -78.69 -97.57 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 117.204 0.502 . . . . 0.0 111.657 -176.25 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.419 ' HB3' HD22 ' A' ' 142' ' ' LEU . 12.3 p-10 -119.68 -3.4 10.32 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.537 -0.301 . . . . 0.0 111.73 -173.029 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.451 HG12 ' N ' ' A' ' 65' ' ' HIS . 16.7 tt -144.64 164.65 13.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-O 120.731 0.3 . . . . 0.0 111.086 -170.893 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' HIS . . . . . 0.451 ' N ' HG12 ' A' ' 64' ' ' ILE . 0.1 OUTLIER -156.83 141.36 16.74 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.111 171.497 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 74.9 m-85 -94.67 132.27 39.58 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.223 0.535 . . . . 0.0 110.983 -174.257 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.703 ' O ' ' HA ' ' A' ' 35' ' ' ILE . 56.9 t -132.52 118.57 35.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.176 -178.401 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' SER . . . . . 0.476 ' HA ' ' O ' ' A' ' 36' ' ' ASP . 49.7 m -88.38 136.51 32.95 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.542 -179.692 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.555 ' O ' ' HA ' ' A' ' 37' ' ' VAL . 64.2 tp -121.84 128.93 52.19 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 110.304 -0.258 . . . . 0.0 110.304 177.279 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' SER . . . . . 0.449 ' HB2' ' CD1' ' A' ' 38' ' ' TRP . 44.2 t -109.7 114.87 28.83 Favored 'General case' 0 C--O 1.216 -0.684 0 N-CA-C 112.102 0.408 . . . . 0.0 112.102 -172.901 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 3.3 m -84.64 21.49 1.51 Allowed 'General case' 0 C--N 1.312 -1.048 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.805 175.672 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -71.76 143.95 49.4 Favored 'General case' 0 CA--C 1.515 -0.396 0 C-N-CA 120.069 -0.652 . . . . 0.0 109.916 178.372 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.95 ' HB3' ' HZ1' ' A' ' 73' ' ' LYS . 0.0 OUTLIER -96.68 -15.23 21.57 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.179 -177.277 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . 0.514 ' HB2' ' HB2' ' A' ' 77' ' ' ALA . 0.0 OUTLIER -104.2 79.84 1.65 Allowed 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 -177.736 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.536 ' HA ' ' CE1' ' A' ' 93' ' ' HIS . 21.1 tttm -51.6 -63.5 1.11 Allowed 'General case' 0 CA--C 1.513 -0.451 0 N-CA-C 112.782 0.66 . . . . 0.0 112.782 -173.544 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 26.3 tptp -46.51 -51.46 15.32 Favored 'General case' 0 C--N 1.323 -0.556 0 O-C-N 123.431 0.457 . . . . 0.0 110.726 -178.359 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.686 ' HA ' ' ND2' ' A' ' 80' ' ' ASN . . . -58.95 -42.81 90.72 Favored 'General case' 0 C--O 1.239 0.551 0 CA-C-O 121.198 0.523 . . . . 0.0 110.826 179.619 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' TRP . . . . . 0.69 ' CE3' ' HB ' ' A' ' 40' ' ' THR . 6.9 t-105 -64.35 -51.98 60.65 Favored 'General case' 0 N--CA 1.435 -1.188 0 CA-C-N 115.51 -0.768 . . . . 0.0 112.489 -179.94 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.481 ' CD ' ' HE2' ' A' ' 75' ' ' LYS . 19.2 mm-40 -48.14 -40.1 22.71 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-O 120.948 0.404 . . . . 0.0 111.39 178.278 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . 0.686 ' ND2' ' HA ' ' A' ' 77' ' ' ALA . 3.6 m-20 -60.66 -50.19 74.52 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-O 120.846 0.355 . . . . 0.0 110.614 177.146 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 16.2 tpt -63.5 -37.7 88.29 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 112.164 0.431 . . . . 0.0 112.164 -175.183 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.579 ' CG2' ' HZ3' ' A' ' 38' ' ' TRP . 0.6 OUTLIER -68.58 -36.9 76.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 C-N-CA 119.965 -0.694 . . . . 0.0 111.13 179.053 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 12.7 t -78.69 -21.39 48.28 Favored 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 120.127 -0.629 . . . . 0.0 110.512 178.051 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 60.9 tttp -80.94 -53.68 6.24 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-O 120.973 0.416 . . . . 0.0 110.379 177.537 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -77.29 -20.04 55.59 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.143 -177.204 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 26.5 mt-30 65.16 78.42 0.28 Allowed 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 115.147 -0.933 . . . . 0.0 112.244 177.304 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.519 HD12 ' HA ' ' A' ' 82' ' ' VAL . 5.5 mp -104.45 118.42 36.57 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.116 -0.947 . . . . 0.0 108.61 174.101 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 72.9 mmtt -103.04 179.17 4.35 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 112.706 0.632 . . . . 0.0 112.706 -177.323 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 105.84 179.17 23.63 Favored Glycine 0 N--CA 1.45 -0.383 0 CA-C-N 115.096 -0.956 . . . . 0.0 111.172 -175.972 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.472 ' O ' ' HA ' ' A' ' 67' ' ' VAL . 63.4 mt -76.82 116.36 19.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 173.242 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . 0.555 ' HB2' ' CZ2' ' A' ' 38' ' ' TRP . 3.0 pt20 -136.81 107.42 6.54 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 121.793 0.806 . . . . 0.0 112.646 -166.075 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.43 ' CD2' ' HB ' ' A' ' 23' ' ' VAL . 21.9 mt -99.15 144.31 28.43 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.012 -0.994 . . . . 0.0 110.117 -178.618 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' HIS . . . . . 0.536 ' CE1' ' HA ' ' A' ' 75' ' ' LYS . 10.3 t-160 -115.83 131.34 56.97 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 121.69 0.757 . . . . 0.0 111.334 178.725 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' MET . . . . . 0.768 ' HG3' ' HB2' ' A' ' 97' ' ' ASP . 34.4 ttp -108.84 90.2 3.22 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 114.059 -1.428 . . . . 0.0 108.491 179.626 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . 0.513 ' O ' ' HA ' ' A' ' 73' ' ' LYS . . . -64.25 -65.53 2.96 Favored Glycine 0 C--N 1.318 -0.45 0 CA-C-N 115.319 -0.855 . . . . 0.0 113.513 -173.387 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 7.4 p -121.02 7.19 10.32 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-O 121.438 0.637 . . . . 0.0 110.393 -178.135 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . 0.768 ' HB2' ' HG3' ' A' ' 94' ' ' MET . 0.6 OUTLIER -90.56 12.73 17.86 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.32 -0.854 . . . . 0.0 110.663 -170.998 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . 0.684 ' HA ' ' SD ' ' A' ' 94' ' ' MET . 0.0 OUTLIER -72.19 14.03 0.26 Allowed 'General case' 0 C--O 1.222 -0.356 0 N-CA-C 113.068 0.766 . . . . 0.0 113.068 -170.704 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 9.8 t -70.52 -21.98 62.68 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 169.234 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . 0.689 ' CE1' ' HA ' ' A' ' 10' ' ' ALA . 88.9 t80 -79.31 -24.42 42.85 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.52 -0.764 . . . . 0.0 109.653 174.255 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' MET . . . . . 0.642 ' HB3' ' O ' ' A' ' 98' ' ' ARG . 14.8 tpt -59.69 -38.14 80.76 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.321 -0.854 . . . . 0.0 110.177 175.102 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 78.6 m-20 -65.21 -21.43 66.75 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.6 -0.727 . . . . 0.0 111.401 179.207 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -66.29 -14.52 62.13 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-O 120.592 0.234 . . . . 0.0 111.502 178.465 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' TYR . . . . . 0.431 ' C ' ' H ' ' A' ' 106' ' ' ILE . 65.5 m-85 -95.69 -13.27 24.38 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 110.195 -0.298 . . . . 0.0 110.195 176.427 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 98.3 mt 71.17 -24.36 0.17 Allowed 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 123.791 0.836 . . . . 0.0 112.864 176.811 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . 0.431 ' H ' ' C ' ' A' ' 104' ' ' TYR . 14.4 mt -98.1 93.72 3.43 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-O 120.875 0.369 . . . . 0.0 110.721 -175.871 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . 0.51 ' HA ' ' HE3' ' A' ' 101' ' ' MET . 67.0 t30 -82.62 -1.33 50.65 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.857 -178.282 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -81.46 98.46 1.89 Allowed Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.802 -0.713 . . . . 0.0 111.742 177.813 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . 0.571 ' HB ' ' HA ' ' A' ' 110' ' ' PRO . 44.8 pt -104.56 161.11 23.83 Favored Pre-proline 0 C--N 1.325 -0.475 0 CA-C-N 116.473 0.137 . . . . 0.0 111.062 -177.156 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . 0.669 ' CG ' ' HB2' ' A' ' 45' ' ' CYS . 23.4 Cg_exo -64.26 134.44 18.44 Favored 'Cis proline' 0 C--N 1.35 0.657 0 C-N-CA 123.928 -1.28 . . . . 0.0 113.178 0.89 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . 0.934 ' HE ' ' HA ' ' A' ' 111' ' ' ARG . 0.0 OUTLIER -102.28 141.78 34.57 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-N 116.246 -0.434 . . . . 0.0 109.964 174.263 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -113.93 113.74 25.25 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.301 -0.863 . . . . 0.0 108.739 -174.949 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.457 ' HB ' ' HB ' ' A' ' 35' ' ' ILE . 81.0 mt -123.97 138.16 54.58 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-O 121.249 0.547 . . . . 0.0 111.488 -173.024 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.466 ' HG ' HD13 ' A' ' 122' ' ' ILE . 58.8 tp -112.96 134.31 54.53 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 115.415 -0.811 . . . . 0.0 109.062 175.916 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.477 ' N ' HD13 ' A' ' 115' ' ' LEU . 2.3 mp -131.58 147.04 52.49 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 -179.831 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 23.6 t0 -65.75 164.8 13.91 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.119 176.409 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . 0.471 ' HA ' ' O ' ' A' ' 31' ' ' LYS . 0.6 OUTLIER -53.84 -21.71 8.18 Favored 'General case' 0 N--CA 1.471 0.586 0 O-C-N 124.2 0.937 . . . . 0.0 112.376 -176.15 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . 0.497 ' HB3' ' HG2' ' A' ' 120' ' ' LYS . 6.0 t70 -88.46 6.21 38.75 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.557 0.694 . . . . 0.0 110.075 -178.974 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . 0.488 ' O ' HD21 ' A' ' 25' ' ' LEU . . . 75.82 24.78 68.76 Favored Glycine 0 N--CA 1.437 -1.26 0 N-CA-C 110.833 -0.907 . . . . 0.0 110.833 -173.859 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . 0.634 ' HE3' ' HB1' ' A' ' 11' ' ' ALA . 43.6 mmtm -99.76 106.35 18.24 Favored 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 120.317 -0.553 . . . . 0.0 111.351 -175.803 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . 0.403 ' HA ' ' HG ' ' A' ' 115' ' ' LEU . 3.0 mp -39.84 115.78 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 114.852 -1.067 . . . . 0.0 112.419 -177.648 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' ILE . . . . . 0.466 HD13 ' HG ' ' A' ' 114' ' ' LEU . 57.4 mt -86.88 -41.14 14.58 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 114.957 -1.02 . . . . 0.0 108.797 173.978 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 19.8 m -153.53 121.55 6.09 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.444 179.019 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -79.19 -17.03 55.66 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-O 121.488 0.661 . . . . 0.0 110.497 177.407 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 45.6 t30 -128.26 98.83 5.21 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 108.477 -0.935 . . . . 0.0 108.477 174.457 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 17.1 tpt -100.77 -97.43 0.26 Allowed 'General case' 0 C--N 1.322 -0.616 0 C-N-CA 120.696 -0.402 . . . . 0.0 111.409 -174.999 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' THR . . . . . 0.557 ' O ' ' HB2' ' A' ' 128' ' ' ARG . 3.4 p -152.01 -73.81 0.14 Allowed 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 111.534 0.198 . . . . 0.0 111.534 -173.42 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . 0.598 ' HD2' ' HD2' ' A' ' 129' ' ' PRO . 20.2 tpt180 157.0 136.27 0.0 OUTLIER Pre-proline 0 N--CA 1.456 -0.151 0 C-N-CA 124.196 0.999 . . . . 0.0 108.514 -172.424 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . 0.598 ' HD2' ' HD2' ' A' ' 128' ' ' ARG . 84.2 Cg_exo -49.45 -44.13 35.91 Favored 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 122.285 1.99 . . . . 0.0 112.6 172.166 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -78.6 3.03 17.34 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 112.263 0.468 . . . . 0.0 112.263 -177.54 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -89.23 123.76 66.34 Favored Pre-proline 0 C--O 1.236 0.363 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 177.291 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -55.43 -37.06 95.14 Favored 'Trans proline' 0 C--N 1.342 0.236 0 C-N-CA 123.345 2.696 . . . . 0.0 113.653 -176.069 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . 0.521 ' HA ' ' HG2' ' A' ' 136' ' ' GLU . 36.4 mtmm -61.11 -33.21 73.01 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 121.357 0.598 . . . . 0.0 110.964 -175.367 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 134' ' ' THR . . . . . 0.576 HG22 ' CZ ' ' A' ' 138' ' ' PHE . 0.2 OUTLIER -67.13 -53.05 34.26 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.885 176.843 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . 0.474 ' HA ' ' CD2' ' A' ' 138' ' ' PHE . . . -60.64 -47.3 86.84 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.41 -0.814 . . . . 0.0 111.555 -178.999 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . 0.521 ' HG2' ' HA ' ' A' ' 133' ' ' LYS . 12.9 pt-20 -63.29 -30.39 71.54 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.395 -178.205 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . 1.049 ' HA ' ' HE3' ' A' ' 137' ' ' LYS . 0.4 OUTLIER -65.43 -44.64 86.71 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-N 116.573 -0.285 . . . . 0.0 110.405 177.709 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . 0.576 ' CZ ' HG22 ' A' ' 134' ' ' THR . 7.2 m-85 -60.51 -57.58 12.14 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-O 121.056 0.455 . . . . 0.0 110.694 -179.708 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . 0.453 ' C ' HD21 ' A' ' 139' ' ' ASN . 0.3 OUTLIER -67.68 -18.28 64.88 Favored 'General case' 0 C--O 1.222 -0.354 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.811 -175.514 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . 0.518 ' CD ' ' HZ3' ' A' ' 137' ' ' LYS . 24.6 tt0 -66.35 -50.36 63.81 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 172.595 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . 0.465 ' HG ' ' O ' ' A' ' 137' ' ' LYS . 60.8 mt -61.17 -33.55 73.61 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.659 -179.783 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . 0.419 HD22 ' HB3' ' A' ' 63' ' ' ASP . 94.6 mt -80.48 -24.13 39.68 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.255 178.896 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 74.51 41.49 36.22 Favored Glycine 0 N--CA 1.45 -0.415 0 N-CA-C 110.41 -1.076 . . . . 0.0 110.41 -173.958 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . 0.428 ' O ' ' HG ' ' A' ' 144' ' ' LEU . 35.2 tp -120.85 20.33 11.64 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 114.916 -0.642 . . . . 0.0 111.226 -169.678 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -80.43 -178.63 6.75 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 120.519 -0.472 . . . . 0.0 110.566 -179.557 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -77.4 21.74 2.83 Favored Glycine 0 CA--C 1.519 0.343 0 C-N-CA 121.101 -0.571 . . . . 0.0 112.791 -179.603 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -64.97 144.34 57.35 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-O 120.804 0.335 . . . . 0.0 111.432 178.806 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 20.5 t-80 60.59 38.14 18.96 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 115.402 -0.817 . . . . 0.0 110.684 177.398 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 33.5 m80 -136.88 163.61 30.25 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.092 178.201 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 47.8 t60 -74.85 116.51 15.65 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 179.13 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 88.8 m-70 -84.37 149.15 26.22 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 121.101 0.477 . . . . 0.0 111.496 -173.518 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 25.1 p-80 . . . . . 0 C--O 1.244 0.779 0 N-CA-C 108.485 -0.931 . . . . 0.0 108.485 175.749 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.0 ptp . . . . . 0 N--CA 1.481 1.116 0 CA-C-O 120.621 0.248 . . . . 0.0 111.103 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 10.5 m -81.28 87.45 6.12 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.948 0.404 . . . . 0.0 110.619 -177.872 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.605 HD22 ' N ' ' A' ' 4' ' ' ARG . 0.0 OUTLIER -70.7 -37.25 73.56 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.498 178.053 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . 0.605 ' N ' HD22 ' A' ' 3' ' ' LEU . 29.3 mtm180 68.75 -24.54 0.14 Allowed 'General case' 0 N--CA 1.474 0.772 0 N-CA-C 113.429 0.9 . . . . 0.0 113.429 172.57 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' SER . . . . . 0.446 ' H ' ' C ' ' A' ' 3' ' ' LEU . 8.0 m -46.1 -67.9 0.24 Allowed 'General case' 0 C--O 1.233 0.228 0 C-N-CA 123.008 0.523 . . . . 0.0 111.44 -178.142 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . 0.419 ' O ' ' HB2' ' A' ' 7' ' ' ASN . . . -93.29 36.74 3.6 Favored Glycine 0 N--CA 1.448 -0.551 0 C-N-CA 120.488 -0.863 . . . . 0.0 112.215 177.843 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . 0.559 ' HB3' ' HD2' ' A' ' 8' ' ' PRO . 52.6 m-80 70.28 169.48 0.12 Allowed Pre-proline 0 N--CA 1.471 0.619 0 C-N-CA 122.863 0.465 . . . . 0.0 110.836 -179.051 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.559 ' HD2' ' HB3' ' A' ' 7' ' ' ASN . 19.3 Cg_endo -62.23 -60.23 0.21 Allowed 'Trans proline' 0 C--N 1.35 0.626 0 C-N-CA 121.811 1.674 . . . . 0.0 111.656 173.04 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 15.1 m -73.06 161.71 30.32 Favored 'General case' 0 N--CA 1.444 -0.745 0 CA-C-N 116.04 -0.527 . . . . 0.0 109.633 176.361 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . 73.7 -50.45 0.69 Allowed 'General case' 0 N--CA 1.471 0.589 0 O-C-N 124.007 0.817 . . . . 0.0 111.161 -177.345 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.41 ' HA ' ' HE3' ' A' ' 120' ' ' LYS . . . -70.55 -29.3 65.72 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.977 0.418 . . . . 0.0 110.683 176.926 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 26.6 t -164.75 83.56 0.4 Allowed 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.244 -0.889 . . . . 0.0 109.906 176.396 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 41.1 p90 -101.43 164.46 11.76 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.416 179.985 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' SER . . . . . 0.519 ' HA ' ' HA ' ' A' ' 24' ' ' SER . 20.2 m -142.24 126.03 17.05 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 109.905 -0.406 . . . . 0.0 109.905 178.258 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . 0.403 ' HA ' ' HD3' ' A' ' 16' ' ' PRO . 59.2 m-85 -141.04 144.96 37.03 Favored Pre-proline 0 C--N 1.325 -0.465 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.834 -178.602 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.447 ' HA ' ' O ' ' A' ' 21' ' ' LYS . 4.2 Cg_exo -77.68 125.65 7.64 Favored 'Trans proline' 0 N--CA 1.461 -0.412 0 C-N-CA 122.87 2.38 . . . . 0.0 113.018 -179.846 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . 0.592 ' HA ' ' HA ' ' A' ' 92' ' ' LEU . 11.2 t70 -65.37 158.42 26.63 Favored 'General case' 0 C--O 1.238 0.457 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 172.228 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.468 HG12 HG13 ' A' ' 82' ' ' VAL . 11.0 tp -55.03 -27.38 19.16 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 O-C-N 123.669 0.606 . . . . 0.0 112.248 -170.281 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . 0.539 HD22 ' HB2' ' A' ' 21' ' ' LYS . 3.3 p-10 -78.78 -13.27 59.9 Favored 'General case' 0 N--CA 1.456 -0.16 0 CA-C-O 121.2 0.524 . . . . 0.0 110.189 -178.177 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 104.36 31.61 4.57 Favored Glycine 0 N--CA 1.445 -0.732 0 CA-C-N 115.712 -0.676 . . . . 0.0 112.154 -177.29 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.539 ' HB2' HD22 ' A' ' 19' ' ' ASN . 62.3 tttt -101.9 115.03 29.64 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 120.439 -0.504 . . . . 0.0 110.805 179.354 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 14.7 m -64.83 99.69 0.35 Allowed 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 120.892 0.377 . . . . 0.0 110.157 174.579 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 92.9 t -103.3 119.16 51.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.46 -178.457 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' SER . . . . . 0.519 ' HA ' ' HA ' ' A' ' 14' ' ' SER . 88.2 p -97.45 171.51 8.34 Favored 'General case' 0 C--N 1.316 -0.878 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 177.082 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.451 ' O ' ' HB2' ' A' ' 29' ' ' LYS . 37.8 tp -63.83 -24.66 67.84 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.72 0.295 . . . . 0.0 111.128 179.709 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -75.61 -24.85 56.57 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.533 -0.303 . . . . 0.0 111.013 -179.312 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -66.33 -25.07 66.65 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-O 121.489 0.661 . . . . 0.0 110.326 179.839 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.645 HD12 HG23 ' A' ' 90' ' ' ILE . 85.7 mt -122.75 15.66 10.18 Favored 'General case' 0 N--CA 1.449 -0.52 0 CA-C-N 115.663 -0.699 . . . . 0.0 111.237 -177.145 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.49 ' HE2' ' O ' ' A' ' 118' ' ' ASP . 61.1 tttm -83.82 157.51 22.01 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.572 -175.38 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 114.72 -34.65 4.78 Favored Glycine 0 N--CA 1.449 -0.433 0 C-N-CA 120.756 -0.735 . . . . 0.0 111.73 179.383 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.743 ' HD3' ' HA ' ' A' ' 63' ' ' ASP . 63.6 mttm -120.52 170.03 9.79 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.733 -0.233 . . . . 0.0 110.683 177.67 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 87.3 m-85 -65.81 155.56 35.87 Favored 'General case' 0 C--N 1.329 -0.296 0 O-C-N 123.298 0.374 . . . . 0.0 110.272 178.52 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.559 ' HB ' ' HB2' ' A' ' 115' ' ' LEU . 70.9 mt -129.38 140.68 48.52 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-O 120.87 0.366 . . . . 0.0 111.163 -175.684 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 93.3 t80 -125.56 110.69 14.15 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 174.001 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.587 ' HA ' ' O ' ' A' ' 67' ' ' VAL . 59.2 mt -98.01 130.03 47.35 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.07 -176.346 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.445 ' O ' ' HA ' ' A' ' 68' ' ' SER . 5.7 p-10 -116.38 150.33 37.92 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.761 -0.654 . . . . 0.0 109.519 174.762 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 38.2 t -102.65 130.55 52.47 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.801 0 C-N-CA 120.487 -0.485 . . . . 0.0 110.148 174.927 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' TRP . . . . . 0.655 ' CZ2' ' HB2' ' A' ' 91' ' ' GLN . 0.6 OUTLIER -132.66 135.81 46.07 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.771 -0.65 . . . . 0.0 109.623 -173.569 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.444 ' HB3' ' SG ' ' A' ' 42' ' ' CYS . . . -147.06 161.7 40.31 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 122.257 -0.277 . . . . 0.0 111.092 178.664 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' THR . . . . . 0.695 ' HB ' ' CE3' ' A' ' 78' ' ' TRP . 3.0 t -85.52 -4.84 59.28 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.012 0.434 . . . . 0.0 110.925 178.025 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 10.2 p-90 -115.86 16.51 16.23 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.442 -176.855 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . 0.444 ' SG ' ' HB3' ' A' ' 39' ' ' ALA . 19.8 p -120.93 95.46 4.71 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.228 0.537 . . . . 0.0 110.755 178.675 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -63.39 -51.12 57.07 Favored Glycine 0 CA--C 1.527 0.805 0 CA-C-O 119.184 -0.787 . . . . 0.0 113.894 -179.778 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -54.45 -38.7 89.71 Favored 'Trans proline' 0 C--N 1.357 0.999 0 C-N-CA 122.483 2.122 . . . . 0.0 112.632 -179.111 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . 0.497 ' SG ' ' HB3' ' A' ' 110' ' ' PRO . 16.8 t -59.01 -40.86 86.25 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.303 0.573 . . . . 0.0 110.634 177.35 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.593 ' HA ' ' CD1' ' A' ' 49' ' ' LEU . 23.2 ttt180 -72.57 -3.74 26.49 Favored 'General case' 0 N--CA 1.447 -0.621 0 CA-C-N 115.309 -0.859 . . . . 0.0 111.409 -175.847 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -66.59 -48.36 63.03 Favored Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 121.055 -0.593 . . . . 0.0 112.693 179.857 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.53 ' OE1' ' HB2' ' A' ' 128' ' ' ARG . 11.9 pt-20 -115.29 17.28 16.64 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 112.179 0.437 . . . . 0.0 112.179 -176.441 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.933 HD11 HD22 ' A' ' 87' ' ' LEU . 37.7 mt -52.41 -50.72 78.32 Favored Pre-proline 0 C--N 1.324 -0.54 0 N-CA-C 112.248 0.462 . . . . 0.0 112.248 175.987 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.518 ' HD2' ' N ' ' A' ' 49' ' ' LEU . 10.3 Cg_endo -55.2 -36.08 92.46 Favored 'Trans proline' 0 C--N 1.356 0.96 0 C-N-CA 122.0 1.8 . . . . 0.0 112.305 176.601 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -71.87 -23.29 61.48 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.021 0.439 . . . . 0.0 111.08 -178.707 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 6.7 tt -70.01 -44.09 70.04 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 177.532 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.558 ' HD2' ' N ' ' A' ' 53' ' ' LYS . 3.2 mptp? -68.82 -40.02 79.71 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.396 177.638 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.603 ' O ' ' HG3' ' A' ' 58' ' ' LYS . 0.2 OUTLIER -48.2 -49.37 33.17 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.395 0.617 . . . . 0.0 110.72 168.568 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.595 HD21 ' HE2' ' A' ' 138' ' ' PHE . 21.7 tp -60.11 -40.03 88.27 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.151 176.97 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.583 ' HG2' ' CG ' ' A' ' 66' ' ' PHE . 44.4 mt-10 -57.67 -48.45 79.46 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.527 -0.76 . . . . 0.0 111.332 178.137 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -61.13 -36.84 80.83 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.846 0.355 . . . . 0.0 110.954 -179.703 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . 0.603 ' HG3' ' O ' ' A' ' 54' ' ' GLU . 53.1 mttm -62.47 -43.8 97.93 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-O 121.41 0.624 . . . . 0.0 110.535 177.387 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 96.1 m-85 -101.93 16.38 26.14 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.434 -175.126 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -64.7 135.57 56.02 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.118 172.749 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 80.75 9.37 86.44 Favored Glycine 0 N--CA 1.449 -0.487 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.762 178.985 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 37.7 mmtm -94.7 -151.59 0.33 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.345 0.593 . . . . 0.0 110.164 177.764 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.743 ' HA ' ' HD3' ' A' ' 31' ' ' LYS . 4.0 t70 -111.82 64.89 0.62 Allowed 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.731 -0.668 . . . . 0.0 109.789 178.517 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 19.9 tt -156.53 156.28 4.68 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.446 0 CA-C-N 115.857 -0.611 . . . . 0.0 110.537 -175.035 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' HIS . . . . . 0.73 ' NE2' ' HB2' ' A' ' 31' ' ' LYS . 81.1 m-70 -134.97 115.05 13.1 Favored 'General case' 0 CA--C 1.515 -0.377 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 175.631 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . 0.583 ' CG ' ' HG2' ' A' ' 56' ' ' GLU . 71.0 m-85 -79.67 118.95 21.96 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 172.05 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.587 ' O ' ' HA ' ' A' ' 35' ' ' ILE . 40.5 t -128.94 111.36 22.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.674 -174.256 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' SER . . . . . 0.525 ' HB3' ' CD1' ' A' ' 38' ' ' TRP . 8.2 m -87.81 146.97 25.36 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.145 179.655 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.476 ' HA ' ' O ' ' A' ' 92' ' ' LEU . 7.2 mp -131.45 122.78 26.81 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-O 120.762 0.315 . . . . 0.0 110.338 171.81 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 14.7 t -110.09 114.62 28.28 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.135 0.493 . . . . 0.0 112.106 -175.782 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 64.0 m -79.19 19.09 0.59 Allowed 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.328 175.798 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -61.58 152.72 29.72 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-O 120.676 0.274 . . . . 0.0 110.79 176.428 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 21.9 pttp -108.06 -21.99 12.58 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.182 -178.351 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -100.88 67.97 1.26 Allowed 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 -179.087 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.53 ' O ' ' HG3' ' A' ' 79' ' ' GLU . 9.7 tttt -48.06 -52.78 18.76 Favored 'General case' 0 C--N 1.331 -0.237 0 O-C-N 123.782 0.676 . . . . 0.0 112.795 -168.606 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.46 ' O ' ' ND2' ' A' ' 80' ' ' ASN . 35.1 tptt -52.67 -50.03 64.06 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 123.397 0.435 . . . . 0.0 110.646 -179.067 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.556 ' HA ' ' ND2' ' A' ' 80' ' ' ASN . . . -58.15 -37.53 74.84 Favored 'General case' 0 C--O 1.245 0.834 0 CA-C-O 121.492 0.663 . . . . 0.0 110.405 -179.152 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' TRP . . . . . 0.695 ' CE3' ' HB ' ' A' ' 40' ' ' THR . 5.8 t-105 -68.41 -35.94 78.39 Favored 'General case' 0 N--CA 1.438 -1.03 0 CA-C-N 115.051 -0.977 . . . . 0.0 110.306 -178.642 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.53 ' HG3' ' O ' ' A' ' 75' ' ' LYS . 55.9 mt-10 -51.07 -48.85 61.5 Favored 'General case' 0 CA--C 1.52 -0.189 0 CA-C-O 121.328 0.585 . . . . 0.0 110.965 173.435 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . 0.556 ' ND2' ' HA ' ' A' ' 77' ' ' ALA . 2.7 m-80 -64.85 -42.76 94.63 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.544 -175.504 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' MET . . . . . 0.429 ' SD ' ' HZ3' ' A' ' 78' ' ' TRP . 34.8 ttm -66.82 -47.25 72.59 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 119.892 -0.723 . . . . 0.0 111.667 -177.844 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.541 ' CG2' ' HZ3' ' A' ' 38' ' ' TRP . 4.4 p -62.18 -32.39 54.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 C-N-CA 120.49 -0.484 . . . . 0.0 110.93 179.947 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 89.3 m -70.72 -40.72 72.63 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.707 178.406 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . 0.53 ' HD3' ' O ' ' A' ' 80' ' ' ASN . 1.3 mptm? -81.78 -32.47 31.36 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.579 -0.282 . . . . 0.0 111.394 -175.866 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . 0.499 ' HB3' HD12 ' A' ' 87' ' ' LEU . 1.2 t0 -81.71 -3.77 54.54 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.438 0.637 . . . . 0.0 110.164 -179.718 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . 0.506 ' HA ' ' OE1' ' A' ' 86' ' ' GLN . 13.6 mm-40 68.88 16.77 8.81 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 115.017 -0.992 . . . . 0.0 113.444 172.757 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.933 HD22 HD11 ' A' ' 49' ' ' LEU . 10.6 mp -66.58 103.81 1.15 Allowed 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 110.326 -0.25 . . . . 0.0 110.326 173.867 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 43.6 mmtm -108.72 -178.8 3.69 Favored 'General case' 0 C--N 1.323 -0.548 0 O-C-N 122.431 -0.168 . . . . 0.0 110.698 176.168 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 122.2 -153.24 16.82 Favored Glycine 0 N--CA 1.452 -0.278 0 N-CA-C 110.762 -0.935 . . . . 0.0 110.762 -177.069 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.645 HG23 HD12 ' A' ' 28' ' ' LEU . 48.5 mm -104.67 116.03 47.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 N-CA-C 108.369 -0.974 . . . . 0.0 108.369 171.356 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . 0.655 ' HB2' ' CZ2' ' A' ' 38' ' ' TRP . 2.2 pt20 -141.41 100.19 3.73 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-O 122.099 0.952 . . . . 0.0 112.57 -165.55 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.592 ' HA ' ' HA ' ' A' ' 17' ' ' ASP . 22.9 mt -89.89 149.29 22.69 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 114.623 -1.171 . . . . 0.0 110.366 -176.93 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' HIS . . . . . 0.407 ' O ' ' HD2' ' A' ' 16' ' ' PRO . 15.0 t-80 -121.11 134.14 55.24 Favored 'General case' 0 C--N 1.31 -1.132 0 CA-C-N 115.585 -0.734 . . . . 0.0 109.402 177.619 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' MET . . . . . 0.579 ' SD ' ' HA ' ' A' ' 98' ' ' ARG . 48.3 ttm -78.98 -83.8 0.09 Allowed 'General case' 0 N--CA 1.435 -1.203 0 CA-C-N 115.302 -0.863 . . . . 0.0 110.349 -175.423 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 125.08 42.11 0.34 Allowed Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.102 -1.047 . . . . 0.0 113.045 178.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' THR . . . . . 0.438 ' C ' ' H ' ' A' ' 98' ' ' ARG . 3.7 m 78.03 0.35 2.72 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 123.021 0.528 . . . . 0.0 111.378 -179.329 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -79.3 34.75 0.26 Allowed 'General case' 0 N--CA 1.467 0.409 0 CA-C-O 121.405 0.622 . . . . 0.0 109.52 178.577 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . 0.579 ' HA ' ' SD ' ' A' ' 94' ' ' MET . 0.1 OUTLIER -76.24 20.24 0.21 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.4 -0.818 . . . . 0.0 112.773 -167.106 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 14.3 m -70.38 -24.3 62.93 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.732 0.777 . . . . 0.0 108.916 169.832 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 17.1 t80 -75.83 -23.95 55.78 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.367 -0.833 . . . . 0.0 109.506 175.354 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' MET . . . . . 0.477 ' HB3' ' O ' ' A' ' 98' ' ' ARG . 16.6 tpt -64.43 -33.77 76.63 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.482 -0.781 . . . . 0.0 109.407 175.035 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 46.1 m-20 -70.55 -22.73 62.57 Favored 'General case' 0 N--CA 1.461 0.104 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.819 177.177 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -71.73 -14.59 62.06 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.892 0.377 . . . . 0.0 111.013 -179.004 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' TYR . . . . . 0.592 ' O ' ' HG ' ' A' ' 105' ' ' LEU . 65.1 m-85 -96.47 -4.06 42.26 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 174.563 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.592 ' HG ' ' O ' ' A' ' 104' ' ' TYR . 2.9 pp 51.52 14.37 0.26 Allowed 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 125.108 1.363 . . . . 0.0 113.605 178.818 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . 0.565 ' HB ' ' CG ' ' A' ' 111' ' ' ARG . 17.2 mm -120.1 95.27 3.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 N-CA-C 109.025 -0.732 . . . . 0.0 109.025 172.665 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . 0.503 ' ND2' HH22 ' A' ' 98' ' ' ARG . 4.6 m-20 -86.32 20.49 2.37 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.903 -173.067 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -113.76 123.42 6.11 Favored Glycine 0 N--CA 1.447 -0.629 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.06 -179.626 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . 0.459 ' CG2' ' HA ' ' A' ' 110' ' ' PRO . 21.8 mt -87.85 137.45 31.69 Favored Pre-proline 0 C--N 1.325 -0.469 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 176.838 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . 0.51 ' HG2' ' CZ ' ' A' ' 112' ' ' PHE . 95.1 Cg_endo -88.96 144.2 19.84 Favored 'Cis proline' 0 N--CA 1.456 -0.681 0 C-N-CA 123.522 -1.449 . . . . 0.0 113.496 1.188 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . 0.565 ' CG ' ' HB ' ' A' ' 106' ' ' ILE . 0.0 OUTLIER -100.2 133.25 44.88 Favored 'General case' 0 N--CA 1.444 -0.761 0 N-CA-C 108.879 -0.786 . . . . 0.0 108.879 172.587 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . 0.577 ' CZ ' ' HB3' ' A' ' 128' ' ' ARG . 13.1 m-85 -102.44 124.84 48.72 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 108.52 -0.919 . . . . 0.0 108.52 179.616 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.582 ' HB ' ' HB ' ' A' ' 35' ' ' ILE . 74.7 mt -133.46 147.07 31.15 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-O 120.981 0.419 . . . . 0.0 111.135 -175.276 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 37.1 tp -127.76 135.99 50.89 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.923 -0.581 . . . . 0.0 109.725 179.108 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.559 ' HB2' ' HB ' ' A' ' 33' ' ' ILE . 2.8 mp -133.81 154.87 50.7 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 179.264 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . 0.405 ' HB3' HD13 ' A' ' 122' ' ' ILE . 2.7 p30 -84.92 178.1 7.72 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.664 -179.956 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . 0.542 ' HG2' ' HA ' ' A' ' 31' ' ' LYS . 79.7 mtt180 -58.82 -20.48 50.89 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 114.538 -1.21 . . . . 0.0 112.927 -174.434 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . 0.49 ' O ' ' HE2' ' A' ' 29' ' ' LYS . 22.4 t70 -85.27 1.77 46.84 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.741 0.781 . . . . 0.0 109.137 179.506 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 77.87 25.08 63.07 Favored Glycine 0 N--CA 1.431 -1.7 0 N-CA-C 110.221 -1.151 . . . . 0.0 110.221 -173.366 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . 0.41 ' HE3' ' HA ' ' A' ' 11' ' ' ALA . 46.1 mmtm -108.45 120.8 43.47 Favored 'General case' 0 C--O 1.22 -0.451 0 C-N-CA 119.246 -0.982 . . . . 0.0 112.326 -172.369 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . 0.545 ' HA ' ' HG ' ' A' ' 115' ' ' LEU . 33.3 mt -42.62 117.83 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-N 115.079 -0.964 . . . . 0.0 113.159 -179.363 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' ILE . . . . . 0.405 HD13 ' HB3' ' A' ' 116' ' ' ASP . 59.4 mt -93.0 -37.13 8.18 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.828 0 CA-C-N 113.863 -1.517 . . . . 0.0 108.862 174.286 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 11.1 m -146.61 115.58 6.92 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.406 -0.815 . . . . 0.0 110.44 179.346 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -69.41 -30.47 68.44 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.52 0.676 . . . . 0.0 109.429 172.647 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . 0.422 ' HA ' ' NH1' ' A' ' 111' ' ' ARG . 11.0 t30 -111.07 95.77 5.74 Favored 'General case' 0 N--CA 1.449 -0.519 0 CA-C-N 115.245 -0.888 . . . . 0.0 109.675 175.985 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' MET . . . . . 0.543 ' HE3' ' HD3' ' A' ' 137' ' ' LYS . 10.5 tpt -105.98 -175.72 2.87 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 107.742 -1.206 . . . . 0.0 107.742 177.592 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' THR . . . . . 0.499 ' H ' ' HG3' ' A' ' 126' ' ' MET . 4.1 p -115.95 139.07 50.61 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-O 121.441 0.638 . . . . 0.0 112.387 -173.025 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . 0.577 ' HB3' ' CZ ' ' A' ' 112' ' ' PHE . 0.0 OUTLIER -41.2 146.84 0.48 Allowed Pre-proline 0 N--CA 1.468 0.452 0 CA-C-N 114.472 -1.24 . . . . 0.0 113.558 171.593 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 26.0 Cg_endo -61.85 -31.35 85.12 Favored 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 123.464 2.776 . . . . 0.0 113.293 -178.593 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' SER . . . . . 0.425 ' HB3' ' CZ ' ' A' ' 128' ' ' ARG . 47.1 t -74.93 -2.38 26.75 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.698 0.285 . . . . 0.0 111.164 -179.125 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . 0.463 ' HB2' ' CD ' ' A' ' 128' ' ' ARG . 14.5 t70 -91.59 129.25 43.39 Favored Pre-proline 0 C--N 1.327 -0.377 0 N-CA-C 110.059 -0.349 . . . . 0.0 110.059 176.289 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -67.85 -26.59 38.11 Favored 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 122.774 2.316 . . . . 0.0 113.414 -176.668 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . 0.552 ' O ' ' HG3' ' A' ' 137' ' ' LYS . 13.7 mmmm -70.44 -28.92 65.41 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.862 0.363 . . . . 0.0 110.238 -178.48 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 134' ' ' THR . . . . . 0.774 HG23 ' CZ ' ' A' ' 138' ' ' PHE . 2.8 m -59.04 -50.91 72.27 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.662 -0.699 . . . . 0.0 109.899 175.004 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . 0.609 ' HA ' ' CD2' ' A' ' 138' ' ' PHE . . . -56.41 -43.78 79.7 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.288 -0.869 . . . . 0.0 111.383 176.567 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 7.6 mt-10 -54.8 -49.16 71.63 Favored 'General case' 0 CA--C 1.516 -0.364 0 CA-C-O 121.316 0.579 . . . . 0.0 110.724 177.793 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . 0.552 ' HG3' ' O ' ' A' ' 133' ' ' LYS . 39.3 mtpt -55.63 -41.65 73.84 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.239 -0.892 . . . . 0.0 111.142 -179.705 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . 0.774 ' CZ ' HG23 ' A' ' 134' ' ' THR . 13.7 m-85 -61.36 -61.2 2.72 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.728 179.35 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . 0.514 HD21 ' N ' ' A' ' 140' ' ' GLU . 0.3 OUTLIER -69.43 -18.91 63.78 Favored 'General case' 0 C--O 1.224 -0.285 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.819 -172.711 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . 0.514 ' N ' HD21 ' A' ' 139' ' ' ASN . 36.1 tt0 -75.39 -51.07 13.98 Favored 'General case' 0 C--N 1.321 -0.64 0 C-N-CA 120.97 -0.292 . . . . 0.0 110.688 175.616 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . 0.4 ' HG ' ' O ' ' A' ' 137' ' ' LYS . 89.3 mt -66.92 -27.11 67.22 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.318 -177.562 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 96.9 mt -85.86 -17.57 35.22 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.653 177.031 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 72.06 30.55 65.27 Favored Glycine 0 N--CA 1.45 -0.368 0 N-CA-C 110.42 -1.072 . . . . 0.0 110.42 -176.202 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . 0.403 ' HG ' ' O ' ' A' ' 144' ' ' LEU . 50.5 tp -95.75 6.29 49.27 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 114.374 -0.913 . . . . 0.0 110.244 -173.912 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -64.14 158.63 22.42 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.742 -0.663 . . . . 0.0 112.305 -179.09 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . 0.473 ' HA2' ' O ' ' A' ' 149' ' ' HIS . . . -104.44 12.12 51.04 Favored Glycine 0 N--CA 1.445 -0.728 0 CA-C-N 115.013 -0.994 . . . . 0.0 111.103 172.5 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 3.5 t-160 -56.64 -57.56 11.86 Favored 'General case' 0 N--CA 1.464 0.232 0 C-N-CA 123.17 0.588 . . . . 0.0 111.039 -177.925 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 16.6 t-80 -90.62 -3.87 57.23 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.751 -176.273 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . 0.473 ' O ' ' HA2' ' A' ' 146' ' ' GLY . 53.6 t-80 178.18 112.5 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 -178.083 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 95.9 m-70 -48.52 113.39 0.75 Allowed 'General case' 0 N--CA 1.467 0.408 0 O-C-N 123.728 0.643 . . . . 0.0 109.671 179.229 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -77.58 123.32 26.47 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.668 -0.696 . . . . 0.0 112.455 -164.129 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 29.9 p-80 . . . . . 0 C--O 1.251 1.181 0 CA-C-O 117.05 -1.452 . . . . 0.0 107.34 172.351 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.403 ' SD ' ' N ' ' A' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.48 1.028 0 CA-C-O 120.792 0.329 . . . . 0.0 110.25 . . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 16.2 p -89.07 -6.38 57.15 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.219 0.533 . . . . 0.0 110.877 179.34 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -84.48 86.69 7.25 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.194 -178.705 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 13.6 ptt180 -132.83 12.43 4.37 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.791 0.805 . . . . 0.0 109.356 172.845 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 51.4 m -156.86 -163.2 1.37 Allowed 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 114.788 -1.097 . . . . 0.0 108.215 -179.251 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -68.54 -74.7 0.58 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.027 -1.082 . . . . 0.0 111.017 176.016 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 93.9 m-20 -110.01 156.4 40.07 Favored Pre-proline 0 C--N 1.321 -0.672 0 N-CA-C 109.203 -0.665 . . . . 0.0 109.203 172.059 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 12.9 Cg_endo -59.25 98.65 0.11 Allowed 'Trans proline' 0 C--O 1.234 0.322 0 C-N-CA 122.4 2.066 . . . . 0.0 112.121 -179.2 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.407 ' C ' ' H ' ' A' ' 11' ' ' ALA . 22.1 m -80.06 140.38 36.53 Favored 'General case' 0 N--CA 1.443 -0.813 0 CA-C-N 115.624 -0.716 . . . . 0.0 109.853 -177.791 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.556 ' HA ' ' CZ ' ' A' ' 100' ' ' PHE . . . 74.78 -39.91 0.43 Allowed 'General case' 0 N--CA 1.47 0.537 0 O-C-N 124.108 0.88 . . . . 0.0 111.312 -177.864 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.42 ' O ' HD21 ' A' ' 25' ' ' LEU . . . -74.89 -11.65 60.18 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.223 178.971 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.696 ' HA ' ' HB3' ' A' ' 25' ' ' LEU . 18.3 p -159.67 93.36 1.09 Allowed 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.857 174.427 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 38.2 p90 -97.76 159.85 14.68 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.437 174.8 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 13.2 p -134.59 115.18 13.56 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.642 0.258 . . . . 0.0 111.117 -178.908 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 65.3 m-85 -138.88 159.62 66.32 Favored Pre-proline 0 N--CA 1.465 0.288 0 CA-C-N 116.451 -0.34 . . . . 0.0 111.3 -177.487 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 79.4 Cg_endo -84.86 134.15 5.23 Favored 'Trans proline' 0 C--N 1.351 0.676 0 C-N-CA 122.683 2.255 . . . . 0.0 113.406 177.895 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . 0.514 ' HB3' ' HB3' ' A' ' 21' ' ' LYS . 7.4 t70 -80.0 160.12 26.0 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 114.826 -1.079 . . . . 0.0 109.428 174.96 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.406 HD12 HG22 ' A' ' 82' ' ' VAL . 2.2 tt -46.94 -38.19 4.0 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 O-C-N 124.151 0.907 . . . . 0.0 112.105 -178.392 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 45.0 m-80 -71.82 -13.2 61.62 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.097 0.475 . . . . 0.0 111.056 -178.389 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 95.28 34.43 6.11 Favored Glycine 0 N--CA 1.446 -0.654 0 N-CA-C 110.949 -0.86 . . . . 0.0 110.949 -175.027 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.596 ' HZ3' HG23 ' A' ' 23' ' ' VAL . 25.7 tptp -106.08 131.05 53.82 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.121 0.486 . . . . 0.0 111.012 -176.241 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 7.6 m -80.76 99.06 8.05 Favored 'General case' 0 C--N 1.314 -0.97 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 179.618 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.596 ' HB ' HD13 ' A' ' 92' ' ' LEU . 25.2 t -109.43 134.52 51.22 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-O 121.321 0.581 . . . . 0.0 109.728 178.848 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 13.7 m -122.52 166.47 14.75 Favored 'General case' 0 C--N 1.306 -1.287 0 CA-C-N 115.59 -0.732 . . . . 0.0 109.184 178.334 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.696 ' HB3' ' HA ' ' A' ' 12' ' ' SER . 19.6 tp -66.35 -22.51 66.26 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.083 0.468 . . . . 0.0 110.298 179.472 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.468 ' HA ' ' HB2' ' A' ' 29' ' ' LYS . . . -91.29 0.69 57.48 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.746 175.583 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -91.73 -33.44 15.02 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 179.415 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.672 HD12 HG21 ' A' ' 90' ' ' ILE . 76.9 mt -105.37 10.3 33.47 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.635 176.166 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.468 ' HB2' ' HA ' ' A' ' 26' ' ' ALA . 64.0 tttt -65.94 148.13 52.28 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 115.443 -0.799 . . . . 0.0 111.12 -176.825 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 121.04 -23.59 7.68 Favored Glycine 0 N--CA 1.447 -0.622 0 N-CA-C 111.185 -0.766 . . . . 0.0 111.185 -177.092 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.514 ' HD3' ' HA ' ' A' ' 63' ' ' ASP . 43.7 mttm -128.49 166.72 18.23 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 109.527 -0.546 . . . . 0.0 109.527 177.574 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.877 ' HB2' HG23 ' A' ' 64' ' ' ILE . 67.9 m-85 -66.55 144.87 56.18 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.83 0.348 . . . . 0.0 110.54 -179.644 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 47.0 mm -117.13 128.67 74.45 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-N 116.301 -0.408 . . . . 0.0 110.838 -176.31 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 84.6 t80 -110.57 121.54 45.57 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 171.774 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.702 ' HB ' ' HB ' ' A' ' 113' ' ' ILE . 54.5 mt -107.78 128.59 62.91 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-O 120.905 0.383 . . . . 0.0 110.569 -178.995 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.431 ' O ' ' HA ' ' A' ' 68' ' ' SER . 4.5 t70 -132.77 141.62 48.6 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 176.693 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.51 ' HA ' ' O ' ' A' ' 69' ' ' LEU . 39.1 t -89.5 112.82 24.94 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 C-N-CA 120.531 -0.468 . . . . 0.0 111.675 -176.289 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' TRP . . . . . 0.678 ' CZ2' ' HB2' ' A' ' 91' ' ' GLN . 0.7 OUTLIER -102.72 132.91 48.54 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.642 -0.708 . . . . 0.0 109.353 178.905 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -147.71 164.57 33.15 Favored 'General case' 0 N--CA 1.464 0.252 0 N-CA-C 111.689 0.255 . . . . 0.0 111.689 -175.03 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' THR . . . . . 0.586 HG22 ' OD2' ' A' ' 72' ' ' ASP . 4.2 t -99.22 -33.08 10.9 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-O 120.856 0.36 . . . . 0.0 110.794 172.037 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 21.2 p-90 -82.94 21.21 1.07 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.158 0.504 . . . . 0.0 110.531 -178.947 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . 0.809 ' SG ' ' HB3' ' A' ' 45' ' ' CYS . 12.7 p -87.51 -69.88 0.66 Allowed 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.35 -176.649 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . 0.439 ' N ' ' SG ' ' A' ' 42' ' ' CYS . . . 110.35 -92.36 0.68 Allowed Glycine 0 N--CA 1.448 -0.565 0 C-N-CA 121.111 -0.566 . . . . 0.0 111.949 -175.511 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.419 ' HD2' ' O ' ' A' ' 42' ' ' CYS . 12.2 Cg_endo -55.97 -29.57 74.11 Favored 'Trans proline' 0 C--N 1.349 0.602 0 C-N-CA 123.464 2.776 . . . . 0.0 112.747 -178.65 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . 0.991 ' HB2' ' HD3' ' A' ' 110' ' ' PRO . 43.6 t -54.33 -33.49 59.04 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.729 -0.669 . . . . 0.0 111.445 178.978 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.522 ' HA ' ' HG ' ' A' ' 49' ' ' LEU . 56.8 mtp180 -68.31 -18.0 64.4 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.712 0.291 . . . . 0.0 110.937 -176.396 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -82.02 -22.47 59.28 Favored Glycine 0 N--CA 1.448 -0.512 0 C-N-CA 120.713 -0.756 . . . . 0.0 111.865 177.135 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -104.63 -5.67 21.19 Favored 'General case' 0 C--N 1.329 -0.313 0 O-C-N 122.783 -0.245 . . . . 0.0 111.043 179.488 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.717 HD12 HD13 ' A' ' 87' ' ' LEU . 65.0 mt -53.64 -48.04 94.54 Favored Pre-proline 0 C--O 1.235 0.295 0 CA-C-N 116.677 -0.238 . . . . 0.0 110.975 174.401 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.681 ' O ' ' HG2' ' A' ' 54' ' ' GLU . 54.2 Cg_exo -54.57 -40.91 81.68 Favored 'Trans proline' 0 C--N 1.356 0.949 0 C-N-CA 121.824 1.682 . . . . 0.0 112.029 171.724 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -69.29 -31.56 70.14 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-O 121.26 0.552 . . . . 0.0 110.571 -176.728 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 6.6 tt -67.04 -48.25 68.89 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.364 -0.834 . . . . 0.0 109.916 -179.395 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.56 ' O ' ' HG3' ' A' ' 57' ' ' GLU . 6.2 ptmm? -67.58 -32.45 73.21 Favored 'General case' 0 C--N 1.333 -0.134 0 C-N-CA 121.009 -0.276 . . . . 0.0 110.48 -179.909 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.681 ' HG2' ' O ' ' A' ' 50' ' ' PRO . 51.6 mm-40 -59.51 -47.38 85.76 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.904 0.383 . . . . 0.0 110.394 176.493 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.417 ' CD1' ' HA ' ' A' ' 129' ' ' PRO . 29.6 mt -61.9 -53.41 56.17 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.683 175.598 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.549 ' HA ' ' CD2' ' A' ' 66' ' ' PHE . 4.5 tm-20 -44.7 -59.87 2.29 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 114.872 -1.058 . . . . 0.0 112.039 179.957 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.56 ' HG3' ' O ' ' A' ' 53' ' ' LYS . 20.1 mt-10 -71.78 -35.6 70.08 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.77 0.319 . . . . 0.0 111.664 -173.082 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . 0.402 ' HD3' ' CE2' ' A' ' 59' ' ' TYR . 83.5 tttt -67.09 -39.48 86.78 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.224 0.535 . . . . 0.0 110.771 -178.875 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.438 ' HB3' HD13 ' A' ' 64' ' ' ILE . 96.9 m-85 -105.32 10.27 33.58 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.241 -176.141 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -68.19 157.41 35.47 Favored 'General case' 0 C--O 1.239 0.516 0 CA-C-O 120.795 0.331 . . . . 0.0 110.427 172.215 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 77.9 8.49 87.3 Favored Glycine 0 N--CA 1.447 -0.633 0 C-N-CA 120.98 -0.629 . . . . 0.0 112.583 178.421 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.497 ' HB2' HG12 ' A' ' 64' ' ' ILE . 43.6 mmtm -98.77 -161.17 0.85 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.129 0.49 . . . . 0.0 110.029 177.99 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.514 ' HA ' ' HD3' ' A' ' 31' ' ' LYS . 21.5 m-20 -91.16 32.69 1.01 Allowed 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 115.352 -0.84 . . . . 0.0 110.556 179.267 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.877 HG23 ' HB2' ' A' ' 32' ' ' TYR . 31.7 pt -141.67 165.59 18.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.129 -176.955 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 87.1 m-70 -136.44 137.72 40.73 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 175.118 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . 0.549 ' CD2' ' HA ' ' A' ' 56' ' ' GLU . 93.4 m-85 -94.69 110.11 21.98 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.624 -0.51 . . . . 0.0 109.624 174.172 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.597 ' O ' ' HA ' ' A' ' 35' ' ' ILE . 57.1 t -116.81 106.17 19.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.713 -175.581 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' SER . . . . . 0.431 ' HA ' ' O ' ' A' ' 36' ' ' ASP . 34.5 m -88.96 133.41 34.33 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.171 177.302 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.51 ' O ' ' HA ' ' A' ' 37' ' ' VAL . 79.2 mt -117.24 135.18 53.99 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.735 0.302 . . . . 0.0 110.42 176.712 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' SER . . . . . 0.426 ' O ' ' HB3' ' A' ' 94' ' ' MET . 1.4 t -113.87 120.73 41.73 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.279 -0.418 . . . . 0.0 111.63 -176.247 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 1.8 p -89.14 16.4 7.27 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.908 177.142 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.586 ' OD2' HG22 ' A' ' 40' ' ' THR . 1.4 m-20 -68.23 132.75 47.69 Favored 'General case' 0 CA--C 1.518 -0.266 0 N-CA-C 109.919 -0.4 . . . . 0.0 109.919 178.923 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 38.7 ttpt -76.85 -35.37 57.55 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-O 121.18 0.514 . . . . 0.0 109.862 177.86 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . 0.517 ' HB2' ' HB1' ' A' ' 77' ' ' ALA . 0.9 OUTLIER -74.29 102.07 4.23 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.538 -0.755 . . . . 0.0 110.216 176.553 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 10.8 tttt -78.19 -55.68 5.07 Favored 'General case' 0 C--N 1.319 -0.732 0 C-N-CA 120.521 -0.472 . . . . 0.0 111.282 -178.343 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 47.4 tptt -60.43 -48.6 81.04 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.254 -174.986 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.517 ' HB1' ' HB2' ' A' ' 74' ' ' ASN . . . -58.31 -36.38 73.27 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.972 178.714 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' TRP . . . . . 0.509 ' O ' HG12 ' A' ' 82' ' ' VAL . 12.2 t-105 -76.9 -48.6 17.8 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.197 -177.714 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.417 ' O ' HG13 ' A' ' 82' ' ' VAL . 4.6 pt-20 -62.15 -32.91 73.57 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-O 120.938 0.399 . . . . 0.0 110.919 -176.326 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . 0.528 HD21 ' N ' ' A' ' 81' ' ' MET . 0.2 OUTLIER -79.99 -27.3 39.64 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 119.717 -0.793 . . . . 0.0 111.149 177.866 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' MET . . . . . 0.528 ' N ' HD21 ' A' ' 80' ' ' ASN . 15.4 ttt -65.91 -48.47 71.32 Favored 'General case' 0 C--O 1.22 -0.495 0 C-N-CA 120.45 -0.5 . . . . 0.0 111.068 173.481 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.603 HG23 ' HB2' ' A' ' 87' ' ' LEU . 0.6 OUTLIER -58.88 -37.59 67.83 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 C-N-CA 120.408 -0.517 . . . . 0.0 110.518 177.832 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 58.7 m -63.33 -41.96 98.94 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.84 175.241 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 1.3 tmtp? -71.81 -45.17 62.4 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.435 -178.873 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -72.36 -10.91 60.4 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.461 -0.79 . . . . 0.0 111.627 -178.026 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 22.5 mt-30 67.67 49.27 0.98 Allowed 'General case' 0 N--CA 1.464 0.267 0 O-C-N 123.517 0.511 . . . . 0.0 111.855 173.731 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.717 HD13 HD12 ' A' ' 49' ' ' LEU . 21.2 mt -104.67 130.66 52.66 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 176.687 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.584 ' C ' ' HD3' ' A' ' 88' ' ' LYS . 0.0 OUTLIER -135.53 165.51 25.35 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.8 0.333 . . . . 0.0 111.847 -179.112 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 140.3 -142.08 12.1 Favored Glycine 0 N--CA 1.449 -0.448 0 N-CA-C 109.998 -1.241 . . . . 0.0 109.998 -176.208 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.672 HG21 HD12 ' A' ' 28' ' ' LEU . 45.9 mm -108.79 113.18 43.39 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 169.792 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . 0.678 ' HB2' ' CZ2' ' A' ' 38' ' ' TRP . 1.7 pt20 -141.48 104.17 4.53 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-O 121.836 0.827 . . . . 0.0 112.207 -169.33 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.596 HD13 ' HB ' ' A' ' 23' ' ' VAL . 3.0 mm? -99.04 163.31 12.63 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 114.905 -1.043 . . . . 0.0 110.766 -177.439 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 25.2 t-80 -131.68 121.73 24.78 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.93 -174.95 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' MET . . . . . 0.426 ' HB3' ' O ' ' A' ' 70' ' ' SER . 25.3 ttm -73.07 -61.11 1.93 Allowed 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 114.901 -1.045 . . . . 0.0 110.697 -179.169 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 95.04 -101.62 2.74 Favored Glycine 0 N--CA 1.446 -0.671 0 C-N-CA 120.661 -0.78 . . . . 0.0 112.712 178.14 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 19.2 p -110.91 16.68 21.12 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 111.884 0.327 . . . . 0.0 111.884 -175.508 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -102.06 48.18 0.88 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.051 0.453 . . . . 0.0 110.452 -179.133 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -68.55 -6.82 27.54 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.516 -174.471 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 28.9 m -64.49 -30.99 72.02 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.113 0.482 . . . . 0.0 110.025 173.082 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . 0.556 ' CZ ' ' HA ' ' A' ' 10' ' ' ALA . 20.5 t80 -74.2 -36.79 64.01 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 176.442 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' MET . . . . . 0.677 ' HG3' HG13 ' A' ' 106' ' ' ILE . 12.9 ttt -59.07 -45.55 90.53 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.063 -0.971 . . . . 0.0 110.311 172.138 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -67.09 -35.14 79.15 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.985 179.733 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -61.26 -38.19 85.8 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-O 120.997 0.427 . . . . 0.0 111.167 -179.504 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 39.7 m-85 -87.44 -7.66 57.41 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.533 179.316 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 80.0 mt 61.05 30.49 19.56 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.956 -179.696 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . 0.677 HG13 ' HG3' ' A' ' 101' ' ' MET . 22.9 pt -77.79 77.79 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 121.685 0.755 . . . . 0.0 110.901 179.008 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 17.6 p-10 -88.28 -54.26 4.29 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.613 -0.721 . . . . 0.0 111.542 -177.878 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -81.53 63.22 4.39 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 121.103 -0.57 . . . . 0.0 112.379 -176.559 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . 0.587 ' HA ' ' C ' ' A' ' 110' ' ' PRO . 44.9 pt -71.43 147.46 92.72 Favored Pre-proline 0 C--N 1.324 -0.509 0 N-CA-C 110.496 -0.187 . . . . 0.0 110.496 -179.363 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . 0.991 ' HD3' ' HB2' ' A' ' 45' ' ' CYS . 24.9 Cg_endo -62.57 136.05 19.57 Favored 'Cis proline' 0 C--N 1.348 0.52 0 C-N-CA 124.013 -1.245 . . . . 0.0 113.168 2.096 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . 0.574 ' HG3' ' HA ' ' A' ' 106' ' ' ILE . 0.0 OUTLIER -113.15 141.5 46.85 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.41 -0.814 . . . . 0.0 109.764 -177.708 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . 0.49 ' O ' ' HA ' ' A' ' 125' ' ' ASN . 0.3 OUTLIER -97.95 124.99 42.65 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 114.935 -1.03 . . . . 0.0 112.116 -173.657 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.702 ' HB ' ' HB ' ' A' ' 35' ' ' ILE . 85.6 mt -136.01 148.2 27.87 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.487 0 CA-C-O 120.737 0.303 . . . . 0.0 110.8 178.442 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 33.5 tp -137.77 137.8 38.61 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 116.62 -0.264 . . . . 0.0 110.335 179.411 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.535 ' N ' HD13 ' A' ' 115' ' ' LEU . 0.3 OUTLIER -135.58 156.26 49.15 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-O 121.504 0.669 . . . . 0.0 111.41 -178.723 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . 0.686 ' HB3' ' HB2' ' A' ' 120' ' ' LYS . 11.2 t70 -75.77 162.67 27.99 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 114.572 -1.194 . . . . 0.0 110.876 179.695 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . 0.471 ' HA ' ' O ' ' A' ' 31' ' ' LYS . 17.0 mtm180 -49.94 -32.67 15.39 Favored 'General case' 0 N--CA 1.47 0.555 0 O-C-N 124.513 1.133 . . . . 0.0 112.703 -177.408 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . 0.72 ' HB3' ' HG3' ' A' ' 120' ' ' LYS . 19.8 t70 -77.97 -5.58 51.67 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-O 121.256 0.55 . . . . 0.0 110.948 -178.512 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 90.55 21.77 36.28 Favored Glycine 0 N--CA 1.438 -1.191 0 N-CA-C 110.459 -1.056 . . . . 0.0 110.459 -171.138 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . 0.72 ' HG3' ' HB3' ' A' ' 118' ' ' ASP . 35.9 mttp -87.22 105.29 17.11 Favored 'General case' 0 CA--C 1.515 -0.375 0 C-N-CA 120.304 -0.558 . . . . 0.0 110.342 -176.074 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . 0.418 HG13 ' CD2' ' A' ' 115' ' ' LEU . 3.6 mp -47.23 108.61 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-O 121.147 0.498 . . . . 0.0 110.669 178.353 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' ILE . . . . . 0.424 ' H ' ' HA ' ' A' ' 115' ' ' LEU . 48.2 mt -83.56 -51.6 14.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 -177.952 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 15.0 m -136.01 126.3 26.51 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.189 -0.914 . . . . 0.0 109.988 -178.665 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -74.02 -18.74 60.81 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.386 0.612 . . . . 0.0 109.803 176.616 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . 0.49 ' HA ' ' O ' ' A' ' 112' ' ' PHE . 3.9 p30 -140.18 118.09 11.78 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.106 -0.952 . . . . 0.0 109.995 174.617 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' MET . . . . . 0.443 ' H ' ' HD1' ' A' ' 112' ' ' PHE . 15.9 tpt -110.94 -115.82 0.31 Allowed 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.686 -0.688 . . . . 0.0 109.859 179.084 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' THR . . . . . 0.422 ' HB ' ' HB3' ' A' ' 131' ' ' ASP . 3.3 p -145.76 139.91 26.79 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 122.379 0.272 . . . . 0.0 110.321 178.571 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 65.7 mtt180 -62.87 161.5 28.96 Favored Pre-proline 0 N--CA 1.468 0.458 0 N-CA-C 112.876 0.695 . . . . 0.0 112.876 179.924 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . 0.417 ' HA ' ' CD1' ' A' ' 55' ' ' LEU . 1.9 Cg_endo -49.47 -31.25 23.26 Favored 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 123.862 3.041 . . . . 0.0 113.165 170.499 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 22.7 t -74.08 -26.34 60.32 Favored 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 111.543 0.201 . . . . 0.0 111.543 -179.264 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . 0.422 ' HB3' ' HB ' ' A' ' 127' ' ' THR . 8.7 t70 -81.9 128.1 69.78 Favored Pre-proline 0 C--N 1.331 -0.22 0 C-N-CA 120.236 -0.585 . . . . 0.0 110.734 179.64 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . 0.422 ' HD3' ' HA ' ' A' ' 131' ' ' ASP . 31.4 Cg_exo -61.86 -25.01 77.85 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 123.233 2.622 . . . . 0.0 113.671 -178.714 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . 0.548 ' O ' ' HB2' ' A' ' 137' ' ' LYS . 45.5 mmtm -61.04 -34.81 75.45 Favored 'General case' 0 CA--C 1.516 -0.357 0 CA-C-O 120.674 0.273 . . . . 0.0 110.926 -178.288 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 134' ' ' THR . . . . . 0.63 HG23 ' CZ ' ' A' ' 138' ' ' PHE . 1.2 m -59.56 -52.58 64.96 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.99 -0.55 . . . . 0.0 109.792 177.018 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . 0.534 ' HA ' ' CD2' ' A' ' 138' ' ' PHE . . . -60.44 -47.08 87.66 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.242 -0.89 . . . . 0.0 111.891 -179.481 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . 0.532 ' HG2' ' HA ' ' A' ' 133' ' ' LYS . 12.5 pt-20 -73.14 -23.19 60.43 Favored 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 120.444 -0.502 . . . . 0.0 110.852 -176.177 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . 0.548 ' HB2' ' O ' ' A' ' 133' ' ' LYS . 4.1 tmtm? -66.24 -43.01 87.76 Favored 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 109.492 -0.558 . . . . 0.0 109.492 175.855 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . 0.63 ' CZ ' HG23 ' A' ' 134' ' ' THR . 9.9 m-85 -56.37 -50.59 71.11 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.817 -0.629 . . . . 0.0 109.484 174.459 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 85.9 m-20 -54.66 -46.42 74.0 Favored 'General case' 0 C--O 1.222 -0.383 0 CA-C-N 115.795 -0.639 . . . . 0.0 109.881 176.984 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -53.88 -48.78 69.73 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.441 179.28 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . 0.525 HD22 ' HE3' ' A' ' 137' ' ' LYS . 91.1 mt -58.48 -45.93 87.68 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.451 -177.594 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -86.27 -3.38 58.97 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.898 0.38 . . . . 0.0 111.053 -178.603 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 75.53 26.33 65.75 Favored Glycine 0 N--CA 1.452 -0.278 0 N-CA-C 111.753 -0.539 . . . . 0.0 111.753 177.81 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 49.7 tp -86.59 3.49 44.18 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 114.879 -0.661 . . . . 0.0 111.083 -174.619 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -70.03 165.37 21.99 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.21 0.529 . . . . 0.0 111.253 178.839 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -144.3 83.76 0.2 Allowed Glycine 0 N--CA 1.445 -0.72 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.626 178.264 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 85.1 m-70 -111.42 112.12 23.64 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 109.641 -0.504 . . . . 0.0 109.641 -179.715 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 8.7 p-80 -99.03 161.67 13.49 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 120.76 0.314 . . . . 0.0 110.379 179.112 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 68.5 m-70 -103.76 178.47 4.55 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.071 -0.513 . . . . 0.0 109.75 -179.245 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 26.3 t-80 -126.06 133.7 51.63 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 179.664 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 45.7 t-80 -62.45 120.69 11.56 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.22 -178.311 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 11.8 t-160 . . . . . 0 C--O 1.245 0.845 0 CA-C-N 115.658 -0.701 . . . . 0.0 109.461 176.195 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 72.0 mtm . . . . . 0 N--CA 1.479 1.009 0 CA-C-O 120.547 0.213 . . . . 0.0 110.651 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 20.2 m -112.31 94.32 4.87 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.745 0.307 . . . . 0.0 111.094 -177.906 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -168.42 98.48 0.42 Allowed 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 109.117 -0.697 . . . . 0.0 109.117 175.637 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.26 2.97 5.12 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 112.338 0.495 . . . . 0.0 112.338 -173.841 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 9.4 m -106.23 4.8 29.24 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 120.987 0.422 . . . . 0.0 110.766 -179.138 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 82.17 -68.8 3.44 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.919 -0.657 . . . . 0.0 112.694 178.986 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 10.2 p30 -88.32 159.03 48.34 Favored Pre-proline 0 C--N 1.324 -0.54 0 N-CA-C 109.392 -0.595 . . . . 0.0 109.392 177.523 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -75.64 89.69 1.19 Allowed 'Trans proline' 0 N--CA 1.453 -0.906 0 C-N-CA 121.748 1.632 . . . . 0.0 111.819 178.597 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 16.2 m -77.03 94.91 4.07 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.159 -0.928 . . . . 0.0 109.978 179.248 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.481 ' HB2' ' HZ ' ' A' ' 100' ' ' PHE . . . 68.49 -75.44 0.07 Allowed 'General case' 0 C--O 1.231 0.11 0 CA-C-N 115.178 -0.919 . . . . 0.0 110.482 -177.473 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . 63.05 -69.36 0.07 Allowed 'General case' 0 N--CA 1.468 0.449 0 O-C-N 124.294 0.996 . . . . 0.0 111.996 -178.875 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 50.5 m -156.23 109.72 2.7 Favored 'General case' 0 C--N 1.311 -1.095 0 CA-C-N 115.223 -0.899 . . . . 0.0 109.615 179.938 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . 0.405 ' H ' ' HB2' ' A' ' 25' ' ' LEU . 12.7 p90 -124.57 176.43 6.53 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.753 -177.514 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' SER . . . . . 0.539 ' HA ' ' HA ' ' A' ' 24' ' ' SER . 3.1 p -142.03 122.75 14.29 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.301 177.63 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 45.5 m-85 -132.09 145.67 58.38 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-O 120.819 0.342 . . . . 0.0 111.609 -177.685 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.555 ' HA ' ' O ' ' A' ' 21' ' ' LYS . 78.3 Cg_endo -81.69 128.19 5.92 Favored 'Trans proline' 0 N--CA 1.46 -0.48 0 C-N-CA 122.817 2.345 . . . . 0.0 113.931 179.692 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . 0.496 ' HB3' ' HB3' ' A' ' 21' ' ' LYS . 1.3 t70 -71.26 161.16 31.54 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 114.89 -1.05 . . . . 0.0 109.321 169.789 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.497 HG22 HG13 ' A' ' 82' ' ' VAL . 29.9 pt -46.76 -38.18 3.79 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.358 0 O-C-N 124.165 0.915 . . . . 0.0 112.849 -174.158 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 42.3 m-80 -75.88 -13.23 60.26 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-O 120.984 0.421 . . . . 0.0 111.357 -176.159 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 103.17 23.64 8.41 Favored Glycine 0 N--CA 1.449 -0.456 0 N-CA-C 111.182 -0.767 . . . . 0.0 111.182 -174.318 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.851 ' HE3' HG22 ' A' ' 23' ' ' VAL . 19.8 tptt -90.23 137.65 32.17 Favored 'General case' 0 C--O 1.219 -0.523 0 CA-C-O 121.081 0.467 . . . . 0.0 110.545 -176.063 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.495 ' N ' ' HD2' ' A' ' 21' ' ' LYS . 52.2 m -91.32 99.98 12.86 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-O 121.023 0.439 . . . . 0.0 110.163 -177.181 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.851 HG22 ' HE3' ' A' ' 21' ' ' LYS . 41.5 t -104.35 113.82 42.32 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 115.707 -0.679 . . . . 0.0 109.475 178.156 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' SER . . . . . 0.539 ' HA ' ' HA ' ' A' ' 14' ' ' SER . 7.1 m -105.98 173.34 6.35 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.249 -177.984 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.523 HD13 ' HA3' ' A' ' 119' ' ' GLY . 3.4 tm? -59.01 -45.23 91.2 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.058 179.035 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -72.08 -17.9 61.96 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.973 0.416 . . . . 0.0 111.076 -177.851 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -73.8 -28.68 61.76 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.92 -0.582 . . . . 0.0 109.815 -178.91 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.483 HD11 HG22 ' A' ' 90' ' ' ILE . 97.6 mt -111.54 -1.18 15.91 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.316 179.25 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 85.2 tttt -67.51 146.29 54.09 Favored 'General case' 0 N--CA 1.448 -0.543 0 CA-C-O 121.104 0.478 . . . . 0.0 111.497 -174.119 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 116.9 -20.5 11.64 Favored Glycine 0 N--CA 1.445 -0.746 0 N-CA-C 111.139 -0.785 . . . . 0.0 111.139 -177.309 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.473 ' HB3' ' N ' ' A' ' 64' ' ' ILE . 64.3 mttm -126.11 149.38 48.98 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.727 -0.237 . . . . 0.0 110.656 178.746 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.538 ' CE1' ' HA ' ' A' ' 116' ' ' ASP . 22.4 m-85 -61.57 119.66 9.05 Favored 'General case' 0 CA--C 1.516 -0.341 0 CA-C-O 120.75 0.31 . . . . 0.0 110.707 -179.978 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 68.6 mt -100.29 115.35 41.39 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.921 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.057 -174.673 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 81.7 t80 -92.03 120.71 32.92 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 108.669 -0.864 . . . . 0.0 108.669 170.953 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.595 ' HA ' ' O ' ' A' ' 67' ' ' VAL . 49.8 mt -107.73 122.64 62.32 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-O 120.985 0.421 . . . . 0.0 110.616 -178.802 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.505 ' O ' ' HA ' ' A' ' 68' ' ' SER . 1.9 t70 -120.06 159.47 24.72 Favored 'General case' 0 C--N 1.315 -0.926 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 174.432 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.517 HG12 HG21 ' A' ' 109' ' ' ILE . 42.9 t -102.32 114.55 42.11 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.98 0 C-N-CA 119.651 -0.819 . . . . 0.0 111.822 178.882 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' TRP . . . . . 0.633 ' CE3' ' HZ2' ' A' ' 78' ' ' TRP . 0.8 OUTLIER -102.62 134.44 45.98 Favored 'General case' 0 C--O 1.225 -0.198 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 -179.994 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.621 ' HB1' ' SG ' ' A' ' 42' ' ' CYS . . . -146.94 164.68 32.15 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 112.285 0.476 . . . . 0.0 112.285 -175.474 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' THR . . . . . 0.418 HG22 ' SD ' ' A' ' 81' ' ' MET . 1.4 m -78.64 -30.82 46.59 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.519 0.676 . . . . 0.0 110.383 178.117 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . 0.58 ' CH2' HD12 ' A' ' 109' ' ' ILE . 9.4 p-90 -106.48 21.83 16.8 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.234 -0.894 . . . . 0.0 112.116 -172.486 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . 0.621 ' SG ' ' HB1' ' A' ' 39' ' ' ALA . 25.7 p -116.99 88.98 3.01 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.477 0.656 . . . . 0.0 109.972 173.434 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -56.79 -53.97 40.05 Favored Glycine 0 CA--C 1.524 0.644 0 CA-C-N 115.486 -0.779 . . . . 0.0 113.912 -178.0 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 78.2 Cg_exo -52.41 -35.91 67.26 Favored 'Trans proline' 0 C--N 1.357 0.992 0 C-N-CA 122.818 2.345 . . . . 0.0 113.144 -178.333 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . 0.719 ' HB2' ' HD3' ' A' ' 110' ' ' PRO . 51.2 t -57.21 -30.82 64.88 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 121.041 0.448 . . . . 0.0 111.308 -177.564 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.495 ' HA ' HD12 ' A' ' 49' ' ' LEU . 41.9 mtp-105 -74.67 0.25 15.74 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.114 -0.493 . . . . 0.0 111.298 -174.162 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -84.45 -40.24 8.53 Favored Glycine 0 N--CA 1.446 -0.65 0 N-CA-C 111.539 -0.625 . . . . 0.0 111.539 174.22 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.435 ' CD ' ' HE ' ' A' ' 128' ' ' ARG . 4.4 pm0 -93.92 -8.28 40.63 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 111.531 0.197 . . . . 0.0 111.531 -179.447 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.601 ' HB2' ' HD3' ' A' ' 50' ' ' PRO . 48.6 mt -54.97 -51.47 79.17 Favored Pre-proline 0 CA--C 1.535 0.374 0 N-CA-C 111.773 0.286 . . . . 0.0 111.773 177.473 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.601 ' HD3' ' HB2' ' A' ' 49' ' ' LEU . 50.8 Cg_exo -57.77 -38.08 94.21 Favored 'Trans proline' 0 C--N 1.357 1.007 0 C-N-CA 122.007 1.805 . . . . 0.0 112.077 175.574 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -70.01 -33.26 71.78 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.009 0.433 . . . . 0.0 110.775 -179.921 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 9.3 tt -66.56 -48.67 68.93 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.59 -177.759 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.57 ' O ' ' HG3' ' A' ' 57' ' ' GLU . 12.4 ptmm? -62.58 -42.59 99.65 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 109.97 -0.381 . . . . 0.0 109.97 177.676 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -62.91 -34.47 77.51 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.323 179.687 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 18.2 mt -60.89 -48.02 83.74 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.931 175.42 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.447 ' HB2' ' HB2' ' A' ' 66' ' ' PHE . 7.8 tp10 -63.19 -41.78 99.23 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.572 -0.74 . . . . 0.0 109.999 178.615 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.57 ' HG3' ' O ' ' A' ' 53' ' ' LYS . 35.9 mt-10 -66.94 -21.38 65.98 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.827 177.627 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 61.7 tttp -86.21 -43.71 12.76 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.582 -179.267 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 80.3 m-85 -95.45 0.52 53.38 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 112.097 0.406 . . . . 0.0 112.097 -174.062 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -58.31 111.78 1.33 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.113 0.483 . . . . 0.0 110.829 176.349 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 150.69 -36.07 0.92 Allowed Glycine 0 N--CA 1.445 -0.718 0 N-CA-C 111.234 -0.746 . . . . 0.0 111.234 -178.597 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.522 ' HB3' HD22 ' A' ' 142' ' ' LEU . 2.2 mmmm -103.12 -160.64 0.79 Allowed 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.104 0.478 . . . . 0.0 110.695 175.93 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.442 ' H ' ' HB3' ' A' ' 62' ' ' LYS . 23.0 m-20 -97.92 79.15 2.61 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 116.024 -0.534 . . . . 0.0 111.884 -174.988 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.571 ' HB ' HD21 ' A' ' 142' ' ' LEU . 14.7 tt -154.03 156.93 4.81 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 115.59 -0.732 . . . . 0.0 109.613 176.725 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' HIS . . . . . 0.447 ' CE1' ' HD2' ' A' ' 31' ' ' LYS . 47.6 m-70 -143.61 142.59 31.11 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 109.893 -0.41 . . . . 0.0 109.893 175.857 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . 0.447 ' HB2' ' HB2' ' A' ' 56' ' ' GLU . 87.5 m-85 -109.88 102.93 11.65 Favored 'General case' 0 C--N 1.314 -0.96 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 172.28 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.61 HG23 ' HB ' ' A' ' 90' ' ' ILE . 51.1 t -119.68 125.98 74.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 115.134 -0.939 . . . . 0.0 110.72 -171.85 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' SER . . . . . 0.53 ' HB2' ' OE1' ' A' ' 91' ' ' GLN . 21.2 m -107.31 140.59 39.98 Favored 'General case' 0 C--N 1.312 -1.061 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.261 176.951 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 57.4 tp -117.76 133.52 55.85 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.089 179.388 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' SER . . . . . 0.429 ' O ' ' HB3' ' A' ' 94' ' ' MET . 1.6 t -109.81 116.9 32.5 Favored 'General case' 0 C--O 1.221 -0.446 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.845 -172.303 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 42.6 m -85.55 19.85 2.27 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 120.827 0.346 . . . . 0.0 111.1 177.937 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.554 ' OD1' ' HA ' ' A' ' 39' ' ' ALA . 3.6 m-20 -73.95 147.83 42.72 Favored 'General case' 0 CA--C 1.517 -0.321 0 CA-C-O 121.261 0.553 . . . . 0.0 111.41 -177.228 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.478 ' HB2' ' HE3' ' A' ' 73' ' ' LYS . 28.1 ttmt -95.38 -32.61 12.85 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 115.415 -0.812 . . . . 0.0 109.912 177.734 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -78.86 73.74 5.4 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.703 -0.681 . . . . 0.0 109.722 -178.319 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.431 ' HZ1' ' CD ' ' A' ' 79' ' ' GLU . 10.5 tttt -58.55 -50.8 72.46 Favored 'General case' 0 C--N 1.323 -0.575 0 C-N-CA 120.71 -0.396 . . . . 0.0 111.437 -175.116 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.441 ' HA ' ' OE1' ' A' ' 79' ' ' GLU . 1.6 tmtt? -57.49 -48.01 80.39 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.695 -177.795 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -67.38 -38.44 84.72 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-O 121.475 0.655 . . . . 0.0 110.126 -177.545 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' TRP . . . . . 0.633 ' HZ2' ' CE3' ' A' ' 38' ' ' TRP . 13.8 t-105 -71.28 -47.65 55.62 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 115.1 -0.955 . . . . 0.0 111.412 -178.348 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.441 ' OE1' ' HA ' ' A' ' 76' ' ' LYS . 3.1 pt-20 -62.23 -37.04 83.87 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-O 120.631 0.253 . . . . 0.0 111.405 -175.547 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 6.0 p30 -77.45 -31.29 53.72 Favored 'General case' 0 C--N 1.332 -0.181 0 C-N-CA 119.413 -0.915 . . . . 0.0 110.301 179.581 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' MET . . . . . 0.418 ' SD ' HG22 ' A' ' 40' ' ' THR . 16.3 ttt -64.67 -46.86 80.64 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.632 -0.258 . . . . 0.0 111.497 176.661 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.584 HG22 ' HB2' ' A' ' 87' ' ' LEU . 1.0 OUTLIER -60.44 -36.74 71.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 C-N-CA 120.373 -0.531 . . . . 0.0 110.389 175.982 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 31.3 m -64.13 -38.11 89.89 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.641 177.046 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . 0.484 ' HA ' ' HD3' ' A' ' 84' ' ' LYS . 35.3 mmtm -74.03 -47.44 36.89 Favored 'General case' 0 CA--C 1.519 -0.222 0 CA-C-O 121.214 0.531 . . . . 0.0 111.385 178.213 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -72.74 -8.12 53.89 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.319 -0.855 . . . . 0.0 111.918 -178.442 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 49.9 mt-30 69.23 26.06 5.52 Favored 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 112.634 0.605 . . . . 0.0 112.634 169.91 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.584 ' HB2' HG22 ' A' ' 82' ' ' VAL . 18.8 mt -67.77 108.54 3.0 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.719 0.295 . . . . 0.0 110.393 -178.091 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.404 ' HB2' ' HE2' ' A' ' 53' ' ' LYS . 39.7 mmtm -95.87 -177.44 4.03 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.388 -178.68 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 96.56 -162.57 22.44 Favored Glycine 0 N--CA 1.448 -0.556 0 N-CA-C 111.017 -0.833 . . . . 0.0 111.017 -174.632 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.61 ' HB ' HG23 ' A' ' 67' ' ' VAL . 49.4 mm -97.31 113.62 32.22 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 117.435 0.618 . . . . 0.0 109.693 176.885 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . 0.582 ' HB3' ' CZ2' ' A' ' 38' ' ' TRP . 60.4 mm-40 -123.98 106.77 10.67 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.45 -173.965 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 41.7 mt -104.67 145.61 30.09 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.095 -175.636 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' HIS . . . . . 0.527 ' O ' ' HD2' ' A' ' 16' ' ' PRO . 26.7 t-80 -113.22 139.76 48.52 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-O 121.502 0.668 . . . . 0.0 111.383 -177.929 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' MET . . . . . 0.608 ' HG3' ' HB2' ' A' ' 97' ' ' ASP . 27.1 ttm -107.72 94.18 4.94 Favored 'General case' 0 N--CA 1.442 -0.849 0 CA-C-N 114.905 -1.043 . . . . 0.0 108.629 179.075 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -68.93 78.12 0.28 Allowed Glycine 0 C--N 1.315 -0.592 0 CA-C-N 115.122 -0.945 . . . . 0.0 113.599 -178.669 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' THR . . . . . 0.44 ' C ' ' H ' ' A' ' 98' ' ' ARG . 5.3 m 71.87 5.13 5.27 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 123.148 0.579 . . . . 0.0 111.674 174.337 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . 0.608 ' HB2' ' HG3' ' A' ' 94' ' ' MET . 13.2 m-20 -79.02 32.06 0.21 Allowed 'General case' 0 N--CA 1.466 0.331 0 CA-C-O 121.036 0.446 . . . . 0.0 110.011 178.743 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . 0.592 ' HA ' ' SD ' ' A' ' 94' ' ' MET . 0.0 OUTLIER -78.59 14.06 1.41 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.129 -0.487 . . . . 0.0 112.225 -169.589 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -66.43 -28.09 68.34 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 168.082 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . 0.481 ' HZ ' ' HB2' ' A' ' 10' ' ' ALA . 55.1 t80 -70.95 -38.92 72.85 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.011 -0.995 . . . . 0.0 109.283 172.928 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' MET . . . . . 0.512 ' HG3' HG13 ' A' ' 106' ' ' ILE . 11.5 ttt -57.25 -44.9 84.29 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.296 -0.866 . . . . 0.0 110.333 172.702 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -67.61 -33.54 75.2 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.43 -0.805 . . . . 0.0 111.189 179.327 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -73.93 -39.91 63.45 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.925 0.393 . . . . 0.0 111.4 -179.589 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' TYR . . . . . 0.585 ' HB3' HG22 ' A' ' 106' ' ' ILE . 2.4 m-85 -83.64 -5.12 59.1 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.745 -178.917 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 93.8 mt 63.51 20.78 12.43 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.292 177.92 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . 0.595 HG21 ' HG3' ' A' ' 111' ' ' ARG . 39.0 pt -77.99 59.38 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 CA-C-O 121.586 0.708 . . . . 0.0 110.871 178.399 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 9.8 p30 -86.82 -38.5 16.77 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.928 179.505 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -85.12 76.72 2.18 Favored Glycine 0 N--CA 1.447 -0.6 0 N-CA-C 111.41 -0.676 . . . . 0.0 111.41 176.416 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . 0.58 HD12 ' CH2' ' A' ' 41' ' ' TRP . 23.0 pt -94.78 156.46 38.18 Favored Pre-proline 0 C--N 1.323 -0.57 0 CA-C-N 115.973 -0.114 . . . . 0.0 110.955 -177.742 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . 0.719 ' HD3' ' HB2' ' A' ' 45' ' ' CYS . 29.2 Cg_endo -61.52 147.57 51.01 Favored 'Cis proline' 0 C--N 1.349 0.583 0 C-N-CA 124.348 -1.105 . . . . 0.0 114.049 2.117 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . 0.595 ' HG3' HG21 ' A' ' 106' ' ' ILE . 0.0 OUTLIER -118.54 137.87 52.92 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 179.125 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . 0.454 ' CD1' ' HA ' ' A' ' 128' ' ' ARG . 0.9 OUTLIER -103.2 120.96 41.7 Favored 'General case' 0 C--N 1.329 -0.285 0 O-C-N 123.908 0.755 . . . . 0.0 110.066 -175.366 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 87.3 mt -136.93 147.62 27.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-O 120.656 0.265 . . . . 0.0 110.307 -179.971 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.477 ' HB2' ' HG2' ' A' ' 126' ' ' MET . 54.7 tp -129.24 137.49 51.12 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.508 0.194 . . . . 0.0 110.546 -179.936 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.747 ' HG ' ' HA ' ' A' ' 121' ' ' ILE . 4.7 mp -129.56 151.12 50.52 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.127 0.489 . . . . 0.0 110.379 179.324 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . 0.538 ' HA ' ' CE1' ' A' ' 32' ' ' TYR . 22.4 t70 -70.88 164.33 25.58 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.243 -0.89 . . . . 0.0 110.205 176.564 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 76.4 mtp180 -49.77 -31.71 12.18 Favored 'General case' 0 N--CA 1.466 0.369 0 O-C-N 124.068 0.855 . . . . 0.0 111.858 179.683 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . 0.466 ' HB3' ' HG2' ' A' ' 120' ' ' LYS . 6.4 t70 -71.77 -4.29 26.86 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.164 -178.906 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . 0.523 ' HA3' HD13 ' A' ' 25' ' ' LEU . . . 79.49 30.54 44.52 Favored Glycine 0 N--CA 1.439 -1.154 0 N-CA-C 110.286 -1.126 . . . . 0.0 110.286 -171.757 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . 0.466 ' HG2' ' HB3' ' A' ' 118' ' ' ASP . 40.6 mmtm -110.65 110.43 21.11 Favored 'General case' 0 CA--C 1.516 -0.333 0 C-N-CA 120.707 -0.397 . . . . 0.0 111.536 -175.418 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . 0.747 ' HA ' ' HG ' ' A' ' 115' ' ' LEU . 3.3 mp -42.15 112.22 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 115.272 -0.876 . . . . 0.0 111.94 -179.145 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' ILE . . . . . 0.498 HD11 ' HB2' ' A' ' 116' ' ' ASP . 27.3 mm -87.68 -46.8 15.94 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-N 115.275 -0.875 . . . . 0.0 109.281 176.096 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 12.4 m -134.7 114.4 12.66 Favored 'General case' 0 N--CA 1.447 -0.622 0 CA-C-N 115.142 -0.935 . . . . 0.0 110.03 179.559 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -76.12 -16.04 59.97 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.77 0.795 . . . . 0.0 109.714 175.735 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 12.2 p-10 -124.17 87.62 2.76 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 114.679 -1.146 . . . . 0.0 109.728 175.264 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' MET . . . . . 0.654 ' HE2' HG22 ' A' ' 134' ' ' THR . 5.0 tpt -94.44 -170.18 2.21 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 108.936 -0.764 . . . . 0.0 108.936 -180.0 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' THR . . . . . 0.542 ' HB ' ' OG1' ' A' ' 134' ' ' THR . 3.7 m -117.7 138.98 51.64 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 110.205 -0.295 . . . . 0.0 110.205 -177.914 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . 0.454 ' HA ' ' CD1' ' A' ' 112' ' ' PHE . 49.1 ttt180 -32.32 136.63 0.25 Allowed Pre-proline 0 C--O 1.237 0.401 0 C-N-CA 124.36 1.064 . . . . 0.0 112.686 173.314 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_exo -50.56 -40.21 54.99 Favored 'Trans proline' 0 C--N 1.347 0.474 0 C-N-CA 123.731 2.954 . . . . 0.0 113.479 -178.016 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 8.8 p -84.27 18.2 2.27 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 112.219 0.452 . . . . 0.0 112.219 -175.716 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . 0.438 ' HA ' ' HD3' ' A' ' 132' ' ' PRO . 15.2 t70 -97.99 131.05 27.32 Favored Pre-proline 0 C--N 1.328 -0.328 0 C-N-CA 120.582 -0.447 . . . . 0.0 110.003 175.893 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . 0.438 ' HD3' ' HA ' ' A' ' 131' ' ' ASP . 56.5 Cg_exo -53.91 -35.43 80.09 Favored 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 123.139 2.56 . . . . 0.0 113.56 -177.988 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 35.5 mtmm -68.13 -36.48 79.77 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.046 0.451 . . . . 0.0 110.16 -178.33 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 134' ' ' THR . . . . . 0.68 HG21 ' CZ ' ' A' ' 138' ' ' PHE . 1.3 m -65.58 -48.54 71.97 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.128 178.26 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . 0.534 ' HA ' ' CD2' ' A' ' 138' ' ' PHE . . . -58.31 -46.77 85.51 Favored 'General case' 0 C--O 1.237 0.418 0 CA-C-N 115.494 -0.776 . . . . 0.0 112.099 -179.713 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -71.0 -24.33 62.36 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.832 0.348 . . . . 0.0 110.701 -178.567 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . 0.533 ' O ' ' HG ' ' A' ' 141' ' ' LEU . 44.6 tptt -65.95 -41.14 91.65 Favored 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 109.611 -0.514 . . . . 0.0 109.611 175.189 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . 0.68 ' CZ ' HG21 ' A' ' 134' ' ' THR . 12.1 m-85 -58.84 -51.87 68.16 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.504 177.726 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 19.3 p30 -69.95 -24.19 63.3 Favored 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 120.392 -0.523 . . . . 0.0 111.351 -175.35 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 51.0 tt0 -67.67 -48.51 66.42 Favored 'General case' 0 N--CA 1.45 -0.453 0 CA-C-O 120.826 0.346 . . . . 0.0 110.573 172.226 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . 0.533 ' HG ' ' O ' ' A' ' 137' ' ' LYS . 86.9 mt -64.4 -35.05 79.63 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.972 -178.163 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . 0.571 HD21 ' HB ' ' A' ' 64' ' ' ILE . 79.1 mt -85.33 -15.96 41.55 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.228 -179.395 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 76.84 35.51 39.52 Favored Glycine 0 N--CA 1.451 -0.344 0 N-CA-C 111.236 -0.746 . . . . 0.0 111.236 179.565 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . 0.436 ' O ' ' HG ' ' A' ' 144' ' ' LEU . 46.1 tp -103.51 15.45 28.95 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.391 0.615 . . . . 0.0 110.192 -174.39 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -63.06 141.53 58.73 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.755 178.208 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -121.16 67.58 0.43 Allowed Glycine 0 N--CA 1.448 -0.56 0 C-N-CA 120.907 -0.663 . . . . 0.0 112.026 179.397 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 30.1 t60 -76.55 -27.41 55.91 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.001 0.429 . . . . 0.0 110.208 -179.087 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 53.4 m80 -99.23 118.38 35.79 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.256 -179.935 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 33.2 m170 -107.99 98.4 7.97 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.084 179.819 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 4.8 t60 -65.88 -31.15 71.92 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.231 0.539 . . . . 0.0 110.124 178.764 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 19.2 t-80 -173.52 -24.47 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 179.853 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 63.8 t60 . . . . . 0 C--O 1.244 0.796 0 CA-C-N 114.846 -1.07 . . . . 0.0 108.937 171.281 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 0.667 0 N-CA-C 112.458 0.54 . . . . 0.0 112.458 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -80.55 78.9 7.24 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 120.9 0.381 . . . . 0.0 110.95 -177.958 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 53.6 m 68.65 95.5 0.07 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.032 -0.985 . . . . 0.0 111.899 176.613 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 33.9 p90 -98.1 165.99 11.63 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.416 178.067 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' SER . . . . . 0.502 ' HA ' ' HA ' ' A' ' 24' ' ' SER . 25.0 m -142.51 120.43 12.02 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.896 -0.409 . . . . 0.0 109.896 175.664 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' TYR . . . . . 0.42 ' CE2' ' HA ' ' A' ' 94' ' ' MET . 57.8 m-85 -128.19 161.72 54.62 Favored Pre-proline 0 C--N 1.324 -0.528 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.45 -177.407 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.459 ' HD2' ' O ' ' A' ' 93' ' ' HIS . 2.7 Cg_endo -86.18 124.95 2.54 Favored 'Trans proline' 0 N--CA 1.454 -0.846 0 C-N-CA 122.476 2.117 . . . . 0.0 112.567 174.008 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' ASP . . . . . 0.505 ' HB3' ' HB3' ' A' ' 21' ' ' LYS . 4.0 t70 -69.56 159.03 34.12 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.529 -0.759 . . . . 0.0 109.122 171.971 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.781 HG13 HG11 ' A' ' 82' ' ' VAL . 18.5 mm -40.94 -49.71 0.67 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.401 0 O-C-N 124.558 1.161 . . . . 0.0 112.898 -176.585 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 4.8 p30 -69.55 -16.49 63.43 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-O 121.126 0.488 . . . . 0.0 110.974 -174.947 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 107.73 33.83 2.98 Favored Glycine 0 N--CA 1.444 -0.781 0 CA-C-N 115.802 -0.636 . . . . 0.0 111.663 -177.969 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.646 ' HZ2' HG22 ' A' ' 23' ' ' VAL . 48.2 tttm -102.32 128.99 48.64 Favored 'General case' 0 CA--C 1.515 -0.381 0 C-N-CA 120.402 -0.519 . . . . 0.0 111.188 -177.617 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 8.3 m -64.75 104.88 0.89 Allowed 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 109.527 -0.546 . . . . 0.0 109.527 170.429 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 1.031 ' HB ' HD11 ' A' ' 92' ' ' LEU . 41.6 t -111.79 118.46 57.65 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 176.067 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' SER . . . . . 0.502 ' HA ' ' HA ' ' A' ' 14' ' ' SER . 89.6 p -100.48 -173.81 2.5 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.563 -175.762 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.587 HD11 ' HA3' ' A' ' 119' ' ' GLY . 1.5 tm? -82.35 -1.02 48.47 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 176.219 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -95.99 -21.69 17.85 Favored 'General case' 0 CA--C 1.51 -0.563 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 -178.482 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -65.7 -22.38 66.61 Favored 'General case' 0 N--CA 1.437 -1.09 0 CA-C-N 113.755 -1.566 . . . . 0.0 110.208 173.354 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.62 HD13 HG21 ' A' ' 67' ' ' VAL . 37.1 mt -112.37 -15.67 13.08 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-N 115.407 -0.815 . . . . 0.0 111.008 -177.009 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.459 ' HB2' ' O ' ' A' ' 25' ' ' LEU . 62.2 tttp -69.75 133.38 47.4 Favored 'General case' 0 N--CA 1.445 -0.693 0 CA-C-N 115.694 -0.684 . . . . 0.0 111.455 -171.174 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 119.19 -18.9 10.2 Favored Glycine 0 N--CA 1.45 -0.387 0 N-CA-C 111.172 -0.771 . . . . 0.0 111.172 -176.896 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.601 ' HB3' ' NE2' ' A' ' 65' ' ' HIS . 24.5 ttmm -140.18 147.47 40.16 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 179.241 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.54 ' HB2' ' O ' ' A' ' 63' ' ' ASP . 81.8 m-85 -54.0 140.76 30.32 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-O 121.119 0.485 . . . . 0.0 111.659 -176.261 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 5.1 mp -112.18 132.25 61.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.634 -177.111 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 85.5 t80 -115.58 116.54 28.33 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 172.595 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.625 ' HB ' ' HB ' ' A' ' 113' ' ' ILE . 67.9 mt -103.33 109.73 27.81 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 CA-C-O 120.999 0.428 . . . . 0.0 110.671 -177.937 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.557 ' HA ' ' O ' ' A' ' 111' ' ' ARG . 5.7 p-10 -105.57 158.31 16.78 Favored 'General case' 0 C--N 1.316 -0.858 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 173.238 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.469 HG21 HG21 ' A' ' 106' ' ' ILE . 52.6 t -103.26 136.68 34.84 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.806 0 C-N-CA 120.485 -0.486 . . . . 0.0 111.447 179.068 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' TRP . . . . . 0.663 ' CZ2' ' HB2' ' A' ' 91' ' ' GLN . 0.2 OUTLIER -128.5 141.77 51.28 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 -179.95 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.505 ' HA ' ' OD1' ' A' ' 72' ' ' ASP . . . -146.15 158.11 43.86 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 112.445 0.535 . . . . 0.0 112.445 -176.67 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -76.35 -46.22 28.49 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.798 -0.637 . . . . 0.0 109.559 175.917 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 5.3 p-90 -80.77 -1.16 41.76 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 114.885 -1.052 . . . . 0.0 111.687 -175.352 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 43.6 t -95.31 110.89 22.84 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.252 0.549 . . . . 0.0 110.127 177.596 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.408 ' N ' ' CD ' ' A' ' 44' ' ' PRO . . . -85.31 -43.97 6.4 Favored Glycine 0 CA--C 1.528 0.859 0 CA-C-O 118.967 -0.907 . . . . 0.0 113.727 176.352 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.408 ' CD ' ' N ' ' A' ' 43' ' ' GLY . 71.2 Cg_exo -53.03 -38.34 80.07 Favored 'Trans proline' 0 C--N 1.362 1.274 0 C-N-CA 122.584 2.189 . . . . 0.0 113.221 -176.835 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 45' ' ' CYS . . . . . 0.691 ' O ' ' HG ' ' A' ' 49' ' ' LEU . 29.8 p -58.95 -32.51 69.67 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.8 0.333 . . . . 0.0 111.021 -179.653 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.593 ' HG2' HD12 ' A' ' 49' ' ' LEU . 52.0 mtt85 -69.38 -8.18 44.17 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.757 -176.412 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -78.26 -27.81 57.09 Favored Glycine 0 N--CA 1.444 -0.774 0 C-N-CA 120.53 -0.843 . . . . 0.0 111.658 175.687 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' GLU . . . . . 0.462 ' OE2' ' HD3' ' A' ' 128' ' ' ARG . 15.7 pt-20 -114.53 -8.03 12.78 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 111.695 0.257 . . . . 0.0 111.695 -177.687 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.691 ' HG ' ' O ' ' A' ' 45' ' ' CYS . 68.8 mt -55.18 -47.13 99.27 Favored Pre-proline 0 CA--C 1.537 0.442 0 N-CA-C 112.248 0.462 . . . . 0.0 112.248 178.22 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.496 ' HD3' ' HB2' ' A' ' 49' ' ' LEU . 53.6 Cg_exo -54.97 -37.46 93.59 Favored 'Trans proline' 0 C--N 1.355 0.905 0 C-N-CA 121.688 1.592 . . . . 0.0 111.944 172.552 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -73.51 -28.64 62.01 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.619 179.544 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 8.2 tt -64.59 -39.62 94.06 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.009 -0.737 . . . . 0.0 109.009 175.096 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.437 ' HE2' ' O ' ' A' ' 88' ' ' LYS . 4.5 mmmp? -63.83 -46.99 82.58 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.486 174.59 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.41 ' O ' ' HB2' ' A' ' 58' ' ' LYS . 0.3 OUTLIER -53.09 -43.56 66.9 Favored 'General case' 0 C--O 1.222 -0.348 0 O-C-N 123.565 0.541 . . . . 0.0 111.082 173.944 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.479 HD21 ' HE2' ' A' ' 138' ' ' PHE . 21.7 tp -59.51 -44.42 93.13 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.951 0.405 . . . . 0.0 110.474 178.572 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.408 ' OE1' ' HD2' ' A' ' 66' ' ' PHE . 10.1 tp10 -65.5 -55.96 15.03 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.022 179.906 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 29.9 mt-10 -72.75 -19.24 61.41 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.561 -172.534 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' LYS . . . . . 0.41 ' HB2' ' O ' ' A' ' 54' ' ' GLU . 18.1 ttmm -82.37 -31.6 29.65 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.139 0.495 . . . . 0.0 110.044 174.326 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.436 ' O ' ' HD2' ' A' ' 62' ' ' LYS . 25.8 m-85 -103.9 12.95 33.74 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.657 -0.702 . . . . 0.0 111.166 -178.552 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -47.16 113.8 0.74 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.077 0.465 . . . . 0.0 111.819 178.673 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 115.01 -12.19 20.11 Favored Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 120.88 -0.676 . . . . 0.0 112.254 -178.192 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.71 ' H ' ' HD2' ' A' ' 62' ' ' LYS . 0.0 OUTLIER -65.9 169.48 6.61 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-O 121.405 0.621 . . . . 0.0 111.599 -178.397 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 63' ' ' ASP . . . . . 0.574 ' CG ' ' HG3' ' A' ' 31' ' ' LYS . 4.6 t70 -94.77 55.77 1.93 Allowed 'General case' 0 C--N 1.318 -0.773 0 CA-C-O 121.367 0.604 . . . . 0.0 109.992 178.786 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.477 ' HB ' ' HG2' ' A' ' 62' ' ' LYS . 4.0 mp -145.99 134.09 15.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.571 -0.74 . . . . 0.0 109.752 -178.698 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 65' ' ' HIS . . . . . 0.601 ' NE2' ' HB3' ' A' ' 31' ' ' LYS . 88.4 m-70 -101.55 120.81 40.88 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.511 -0.552 . . . . 0.0 109.511 173.623 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 66' ' ' PHE . . . . . 0.56 ' O ' ' HB ' ' A' ' 90' ' ' ILE . 63.5 m-85 -83.32 108.93 16.85 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 171.163 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.62 HG21 HD13 ' A' ' 28' ' ' LEU . 44.2 t -120.77 105.16 16.38 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.696 -174.188 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 68' ' ' SER . . . . . 0.542 ' HA ' ' O ' ' A' ' 36' ' ' ASP . 13.3 m -88.09 124.53 33.87 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.531 -179.191 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 55.7 tp -110.0 129.98 55.6 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.777 0.322 . . . . 0.0 110.453 177.655 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' SER . . . . . 0.504 ' O ' ' HB3' ' A' ' 94' ' ' MET . 1.0 OUTLIER -112.09 122.41 47.68 Favored 'General case' 0 C--O 1.221 -0.396 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.721 -175.147 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 12.9 t -85.41 9.31 15.97 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.403 177.674 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.505 ' OD1' ' HA ' ' A' ' 39' ' ' ALA . 3.0 m-20 -64.56 136.47 57.06 Favored 'General case' 0 CA--C 1.516 -0.343 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.592 -178.013 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 18.2 ttmm -82.83 -33.72 27.09 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-O 121.254 0.549 . . . . 0.0 109.846 177.451 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' ASN . . . . . 0.562 ' HB2' ' HB3' ' A' ' 77' ' ' ALA . 0.9 OUTLIER -77.9 85.84 4.14 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.477 -0.783 . . . . 0.0 111.217 -179.641 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.424 ' HB2' ' CE1' ' A' ' 93' ' ' HIS . 18.0 tttm -62.54 -62.95 1.39 Allowed 'General case' 0 C--O 1.218 -0.553 0 C-N-CA 120.024 -0.67 . . . . 0.0 111.782 -179.649 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.435 ' HA ' ' HD2' ' A' ' 76' ' ' LYS . 42.2 tptt -53.23 -37.7 62.29 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 123.279 0.362 . . . . 0.0 111.777 -174.445 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.562 ' HB3' ' HB2' ' A' ' 74' ' ' ASN . . . -66.47 -38.08 86.54 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.565 0.698 . . . . 0.0 110.466 177.217 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 78' ' ' TRP . . . . . 0.451 ' HZ3' HH22 ' A' ' 46' ' ' ARG . 7.5 t-105 -80.58 -41.89 23.25 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.313 -0.858 . . . . 0.0 111.229 -176.271 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.73 ' HB2' HG23 ' A' ' 18' ' ' ILE . 1.4 pt-20 -62.44 -39.11 92.27 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-O 120.711 0.291 . . . . 0.0 110.754 179.927 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 3.8 p30 -75.15 -28.55 60.18 Favored 'General case' 0 CA--C 1.518 -0.259 0 C-N-CA 119.784 -0.766 . . . . 0.0 109.65 177.188 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' MET . . . . . 0.506 ' HG3' ' OD2' ' A' ' 85' ' ' ASP . 9.9 tpt -64.72 -51.97 59.57 Favored 'General case' 0 C--O 1.209 -1.068 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.362 176.822 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.781 HG11 HG13 ' A' ' 18' ' ' ILE . 3.2 p -61.24 -30.6 48.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 C-N-CA 120.744 -0.382 . . . . 0.0 110.746 178.869 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 71.8 m -64.41 -38.09 89.8 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.264 0.554 . . . . 0.0 110.08 173.471 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' LYS . . . . . 0.476 ' HZ2' ' HB2' ' A' ' 84' ' ' LYS . 3.1 ttmp? -77.55 -44.77 27.47 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.421 -0.809 . . . . 0.0 110.381 179.865 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 85' ' ' ASP . . . . . 0.724 ' HB3' ' HG ' ' A' ' 87' ' ' LEU . 1.2 m-20 -69.57 -16.37 63.4 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 114.68 -1.146 . . . . 0.0 111.007 179.949 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 18.8 mm-40 59.53 31.12 20.78 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-N 115.764 -0.653 . . . . 0.0 112.468 178.585 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.724 ' HG ' ' HB3' ' A' ' 85' ' ' ASP . 58.6 mt -85.01 39.84 0.78 Allowed 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.279 -177.739 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.437 ' O ' ' HE2' ' A' ' 53' ' ' LYS . 0.1 OUTLIER -65.56 150.53 48.25 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-O 121.407 0.623 . . . . 0.0 112.491 -178.801 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 166.4 -134.82 3.42 Favored Glycine 0 C--O 1.229 -0.172 0 N-CA-C 109.861 -1.296 . . . . 0.0 109.861 -172.587 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.56 ' HB ' ' O ' ' A' ' 66' ' ' PHE . 48.0 mm -111.22 114.09 46.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 170.073 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 91' ' ' GLN . . . . . 0.663 ' HB2' ' CZ2' ' A' ' 38' ' ' TRP . 5.3 pt20 -141.88 146.78 36.16 Favored 'General case' 0 C--N 1.314 -0.948 0 N-CA-C 113.232 0.827 . . . . 0.0 113.232 -168.643 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 1.031 HD11 ' HB ' ' A' ' 23' ' ' VAL . 2.5 mm? -134.13 153.86 51.57 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 114.853 -1.067 . . . . 0.0 110.581 179.161 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 93' ' ' HIS . . . . . 0.459 ' O ' ' HD2' ' A' ' 16' ' ' PRO . 25.5 t-80 -129.43 125.07 35.66 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.907 -179.724 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 94' ' ' MET . . . . . 0.529 ' SD ' ' HA ' ' A' ' 98' ' ' ARG . 24.5 ttm -76.26 -85.3 0.05 Allowed 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.38 -0.827 . . . . 0.0 110.313 179.393 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 95' ' ' GLY . . . . . 0.502 ' HA2' ' O ' ' A' ' 72' ' ' ASP . . . 117.78 -74.03 0.29 Allowed Glycine 0 N--CA 1.443 -0.869 0 C-N-CA 120.1 -1.048 . . . . 0.0 113.417 177.865 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 14.8 m -135.67 -8.12 2.16 Favored 'General case' 0 C--N 1.316 -0.861 0 C-N-CA 120.557 -0.457 . . . . 0.0 111.618 -174.956 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 97' ' ' ASP . . . . . 0.481 ' CG ' ' HG3' ' A' ' 94' ' ' MET . 8.2 p-10 -89.97 48.21 1.55 Allowed 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.883 0.849 . . . . 0.0 110.083 -176.091 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 98' ' ' ARG . . . . . 0.542 ' O ' ' HB3' ' A' ' 101' ' ' MET . 0.0 OUTLIER -75.91 20.52 0.18 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.133 -0.94 . . . . 0.0 112.614 -172.342 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 9.9 m -70.18 -30.17 67.23 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 171.24 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 100' ' ' PHE . . . . . 0.477 ' CZ ' ' HE2' ' A' ' 104' ' ' TYR . 1.3 t80 -73.59 -25.73 60.48 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.23 -0.895 . . . . 0.0 109.53 177.898 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 101' ' ' MET . . . . . 0.542 ' HB3' ' O ' ' A' ' 98' ' ' ARG . 13.4 tpt -58.81 -52.34 66.15 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 114.769 -1.105 . . . . 0.0 109.745 175.578 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 67.9 m-20 -73.38 -26.7 61.1 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.579 -0.737 . . . . 0.0 111.318 179.486 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -60.72 -26.82 67.45 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-O 121.025 0.44 . . . . 0.0 111.062 -179.224 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 104' ' ' TYR . . . . . 0.52 ' HB2' HG13 ' A' ' 106' ' ' ILE . 49.4 m-85 -108.52 -3.32 18.19 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.478 178.365 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 7.7 mp 60.36 32.19 20.59 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.147 0.499 . . . . 0.0 110.316 -174.547 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 106' ' ' ILE . . . . . 0.583 HG23 ' HB2' ' A' ' 111' ' ' ARG . 79.0 mt -64.2 131.14 29.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.737 176.505 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 16.3 t-20 -157.59 161.02 38.69 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 178.421 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 81.35 -60.88 4.67 Favored Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 121.242 -0.504 . . . . 0.0 112.991 178.092 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.471 HD13 ' HB2' ' A' ' 39' ' ' ALA . 44.3 mt 72.08 131.04 0.04 OUTLIER Pre-proline 0 CA--C 1.535 0.371 0 C-N-CA 122.971 0.508 . . . . 0.0 110.399 -176.22 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 110' ' ' PRO . . . . . 0.414 ' HB3' ' O ' ' A' ' 37' ' ' VAL . 2.2 Cg_endo -84.15 145.89 48.9 Favored 'Cis proline' 0 N--CA 1.461 -0.384 0 C-N-CA 124.153 -1.186 . . . . 0.0 112.963 0.3 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 111' ' ' ARG . . . . . 0.629 ' HD2' ' N ' ' A' ' 112' ' ' PHE . 0.0 OUTLIER -97.34 141.67 30.14 Favored 'General case' 0 N--CA 1.446 -0.626 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 173.093 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 112' ' ' PHE . . . . . 0.629 ' N ' ' HD2' ' A' ' 111' ' ' ARG . 0.7 OUTLIER -104.04 117.86 35.3 Favored 'General case' 0 C--N 1.324 -0.537 0 O-C-N 124.024 0.827 . . . . 0.0 111.714 -177.792 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.625 ' HB ' ' HB ' ' A' ' 35' ' ' ILE . 77.4 mt -129.22 149.41 33.65 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.428 0 C-N-CA 122.359 0.263 . . . . 0.0 110.38 177.106 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 21.4 tp -137.12 139.84 41.5 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.583 0.23 . . . . 0.0 110.621 178.041 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.515 ' HG ' ' HA ' ' A' ' 121' ' ' ILE . 1.0 OUTLIER -135.8 156.64 48.49 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.897 0.379 . . . . 0.0 110.207 -179.105 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 116' ' ' ASP . . . . . 0.58 ' HB3' ' HB2' ' A' ' 120' ' ' LYS . 23.0 t70 -73.04 160.74 31.58 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.571 -0.74 . . . . 0.0 110.786 176.91 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 117' ' ' ARG . . . . . 0.401 HH11 ' HD3' ' A' ' 117' ' ' ARG . 75.0 mtt-85 -44.81 -39.94 5.72 Favored 'General case' 0 N--CA 1.466 0.345 0 O-C-N 124.536 1.147 . . . . 0.0 112.18 179.838 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 118' ' ' ASP . . . . . 0.509 ' HB3' ' HG2' ' A' ' 120' ' ' LYS . 25.1 t70 -63.43 -23.55 67.45 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.335 0.588 . . . . 0.0 111.151 -178.03 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 119' ' ' GLY . . . . . 0.587 ' HA3' HD11 ' A' ' 25' ' ' LEU . . . 105.54 19.84 10.09 Favored Glycine 0 N--CA 1.432 -1.571 0 N-CA-C 110.001 -1.24 . . . . 0.0 110.001 -169.376 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 120' ' ' LYS . . . . . 0.58 ' HB2' ' HB3' ' A' ' 116' ' ' ASP . 32.8 mmtm -91.85 107.97 19.59 Favored 'General case' 0 C--O 1.221 -0.447 0 C-N-CA 120.71 -0.396 . . . . 0.0 111.207 -175.128 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 121' ' ' ILE . . . . . 0.655 ' H ' HD12 ' A' ' 121' ' ' ILE . 3.5 mp -47.18 113.02 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 O-C-N 123.55 0.531 . . . . 0.0 110.651 177.553 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 122' ' ' ILE . . . . . 0.404 ' H ' ' HA ' ' A' ' 115' ' ' LEU . 38.5 mm -94.34 -53.79 7.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 115.678 -0.692 . . . . 0.0 109.773 179.98 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 6.1 m -127.04 114.46 17.81 Favored 'General case' 0 N--CA 1.446 -0.653 0 CA-C-N 115.504 -0.771 . . . . 0.0 109.911 179.832 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 124' ' ' ALA . . . . . 0.533 ' O ' HG12 ' A' ' 113' ' ' ILE . . . -65.0 -32.13 73.71 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 109.446 -0.576 . . . . 0.0 109.446 174.89 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 12.4 p-10 -127.33 106.92 9.54 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.08 -0.964 . . . . 0.0 109.019 173.586 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 126' ' ' MET . . . . . 0.451 ' N ' ' HD1' ' A' ' 112' ' ' PHE . 14.1 tpt -99.55 -101.3 0.23 Allowed 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.077 -175.469 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 127' ' ' THR . . . . . 0.686 ' HB ' ' HB ' ' A' ' 134' ' ' THR . 0.2 OUTLIER -155.17 122.73 5.65 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.916 0.389 . . . . 0.0 110.885 -179.236 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 128' ' ' ARG . . . . . 0.462 ' HD3' ' OE2' ' A' ' 48' ' ' GLU . 30.1 ttm-85 -49.29 140.84 12.4 Favored Pre-proline 0 C--N 1.326 -0.454 0 CA-C-N 115.153 -0.931 . . . . 0.0 111.421 176.632 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -54.74 -38.77 91.58 Favored 'Trans proline' 0 C--N 1.35 0.615 0 C-N-CA 122.797 2.331 . . . . 0.0 113.14 178.996 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 130' ' ' SER . . . . . 0.417 ' HB2' ' CB ' ' A' ' 48' ' ' GLU . 36.4 t -72.51 -2.22 18.88 Favored 'General case' 0 CA--C 1.535 0.395 0 N-CA-C 111.657 0.243 . . . . 0.0 111.657 177.981 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 131' ' ' ASP . . . . . 0.487 ' O ' HG22 ' A' ' 134' ' ' THR . 9.5 t70 -94.45 115.16 64.95 Favored Pre-proline 0 C--N 1.326 -0.417 0 N-CA-C 109.716 -0.476 . . . . 0.0 109.716 179.204 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 132' ' ' PRO . . . . . 0.403 ' HD3' ' HA ' ' A' ' 131' ' ' ASP . 51.3 Cg_exo -56.71 -25.46 60.38 Favored 'Trans proline' 0 N--CA 1.473 0.268 0 C-N-CA 123.041 2.494 . . . . 0.0 113.602 -176.425 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 133' ' ' LYS . . . . . 0.575 ' HZ2' ' HB2' ' A' ' 133' ' ' LYS . 9.7 mtmp? -70.02 -20.36 63.27 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 121.328 -0.149 . . . . 0.0 111.017 -177.984 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 134' ' ' THR . . . . . 0.686 ' HB ' ' HB ' ' A' ' 127' ' ' THR . 1.6 t -72.67 -40.7 66.11 Favored 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 177.348 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 135' ' ' ALA . . . . . 0.625 ' HA ' ' CD2' ' A' ' 138' ' ' PHE . . . -62.85 -41.53 99.4 Favored 'General case' 0 N--CA 1.453 -0.324 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.14 176.885 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -55.74 -42.34 75.24 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.417 -0.81 . . . . 0.0 110.649 175.014 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 137' ' ' LYS . . . . . 0.866 ' HE2' ' HA ' ' A' ' 137' ' ' LYS . 10.0 mmpt? -63.35 -42.8 98.93 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.144 179.559 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 138' ' ' PHE . . . . . 0.625 ' CD2' ' HA ' ' A' ' 135' ' ' ALA . 11.2 m-85 -57.88 -54.27 48.8 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-O 120.838 0.352 . . . . 0.0 110.366 -179.866 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 49.8 m-20 -56.34 -46.16 80.05 Favored 'General case' 0 C--O 1.223 -0.301 0 CA-C-N 115.918 -0.583 . . . . 0.0 109.966 179.743 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 28.7 tt0 -57.65 -55.22 37.62 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.544 -0.753 . . . . 0.0 111.987 -177.897 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 4.6 pp -68.54 -20.12 64.54 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-O 120.722 0.296 . . . . 0.0 111.673 -174.913 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 0.41 HD11 ' HB2' ' A' ' 62' ' ' LYS . 95.7 mt . . . . . 0 C--N 1.327 -0.372 0 CA-C-O 120.789 0.328 . . . . 0.0 110.489 175.424 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.474 ' HB1' HD11 ' A' ' 121' ' ' ILE . . . . . . . . 0 N--CA 1.469 0.522 0 CA-C-O 121.086 0.47 . . . . 0.0 111.654 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -82.91 75.69 9.79 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.764 -179.214 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' SER . . . . . 0.514 ' HA ' ' HB3' ' A' ' 25' ' ' LEU . 15.9 m 68.74 79.0 0.21 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.004 -0.998 . . . . 0.0 111.482 176.433 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 23.6 p90 -101.3 -179.53 4.06 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.744 179.134 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' SER . . . . . 0.43 ' HA ' ' HA ' ' A' ' 24' ' ' SER . 21.0 t -142.37 132.09 24.1 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 109.338 -0.616 . . . . 0.0 109.338 177.537 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' TYR . . . . . 0.533 ' HB3' ' HB3' ' A' ' 92' ' ' LEU . 12.9 m-85 -138.42 154.67 73.77 Favored Pre-proline 0 C--N 1.326 -0.456 0 CA-C-O 120.608 0.242 . . . . 0.0 111.433 -176.873 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' A' ' 15' ' ' TYR . 1.1 Cg_endo -85.09 127.89 3.55 Favored 'Trans proline' 0 N--CA 1.457 -0.652 0 C-N-CA 123.196 2.597 . . . . 0.0 113.165 179.444 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' ASP . . . . . 0.693 ' HB3' ' HB3' ' A' ' 21' ' ' LYS . 0.5 OUTLIER -72.53 161.63 30.54 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.167 -0.924 . . . . 0.0 109.746 170.815 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.532 HD12 ' CG1' ' A' ' 82' ' ' VAL . 1.4 tt -46.59 -40.37 4.45 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 O-C-N 124.032 0.832 . . . . 0.0 112.083 -175.95 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' ASN . . . . . 0.484 ' ND2' HG23 ' A' ' 18' ' ' ILE . 27.9 m-80 -79.53 9.93 4.41 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.228 -175.439 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 77.19 25.81 63.13 Favored Glycine 0 N--CA 1.445 -0.706 0 N-CA-C 110.758 -0.937 . . . . 0.0 110.758 -174.753 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.693 ' HB3' ' HB3' ' A' ' 17' ' ' ASP . 8.0 ttpm? -94.86 106.94 18.96 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.427 -0.386 . . . . 0.0 110.328 -174.694 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 24.7 m -69.29 111.54 5.27 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.154 -178.225 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.645 ' HB ' HD11 ' A' ' 92' ' ' LEU . 47.7 t -115.82 133.86 60.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 116.139 -0.482 . . . . 0.0 109.862 178.352 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' SER . . . . . 0.43 ' HA ' ' HA ' ' A' ' 14' ' ' SER . 97.7 p -101.74 160.49 14.42 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.35 -178.434 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.586 HD12 ' HG ' ' A' ' 28' ' ' LEU . 20.8 tp -75.17 0.52 16.07 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.164 0.507 . . . . 0.0 109.961 175.45 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -75.68 -25.97 57.21 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.827 -179.734 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -74.87 -21.51 59.2 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-O 122.68 1.229 . . . . 0.0 108.87 177.137 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.586 ' HG ' HD12 ' A' ' 25' ' ' LEU . 3.9 mm? -82.7 -7.4 59.65 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 113.581 -1.645 . . . . 0.0 111.542 -170.941 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.762 ' HA ' ' O ' ' A' ' 117' ' ' ARG . 2.6 mptp? -73.65 175.92 6.7 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.239 0.542 . . . . 0.0 111.272 179.423 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 84.19 -44.51 3.34 Favored Glycine 0 N--CA 1.449 -0.49 0 CA-C-N 115.775 -0.648 . . . . 0.0 112.437 177.814 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.722 ' HD3' ' HA ' ' A' ' 63' ' ' ASP . 66.1 mttm -121.33 164.93 16.25 Favored 'General case' 0 C--N 1.323 -0.577 0 C-N-CA 122.226 0.211 . . . . 0.0 110.582 -177.848 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 44.1 m-85 -67.21 151.75 46.97 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.779 0.323 . . . . 0.0 111.24 -177.609 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.769 HD12 ' HA2' ' A' ' 119' ' ' GLY . 53.4 mt -121.5 132.63 70.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-O 120.832 0.349 . . . . 0.0 111.202 -174.623 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 86.0 t80 -121.37 125.35 46.74 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 109.071 -0.715 . . . . 0.0 109.071 172.74 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.557 HG12 ' HB ' ' A' ' 67' ' ' VAL . 64.2 mt -114.44 134.47 57.28 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-O 120.955 0.407 . . . . 0.0 110.718 -177.877 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.536 ' HA ' ' O ' ' A' ' 111' ' ' ARG . 24.3 t0 -126.68 158.55 36.12 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.372 -0.831 . . . . 0.0 109.0 177.121 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.575 ' HA ' ' O ' ' A' ' 69' ' ' LEU . 59.2 t -105.74 111.47 35.09 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.904 0 C-N-CA 120.228 -0.589 . . . . 0.0 110.816 173.164 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' TRP . . . . . 0.662 ' CZ2' ' HB2' ' A' ' 91' ' ' GLN . 0.6 OUTLIER -95.22 133.27 39.28 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.275 178.716 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.555 ' HB3' ' HB3' ' A' ' 42' ' ' CYS . . . -146.85 163.02 37.42 Favored 'General case' 0 N--CA 1.464 0.266 0 N-CA-C 111.7 0.259 . . . . 0.0 111.7 -175.722 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' THR . . . . . 0.715 ' HB ' ' CE3' ' A' ' 78' ' ' TRP . 8.2 t -98.34 -35.72 10.22 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-O 120.885 0.374 . . . . 0.0 110.762 176.693 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' TRP . . . . . 0.419 ' HE1' ' HA ' ' A' ' 72' ' ' ASP . 22.6 p-90 -86.39 16.27 4.66 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.164 0.507 . . . . 0.0 110.547 -178.994 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' CYS . . . . . 0.786 ' SG ' ' HB3' ' A' ' 45' ' ' CYS . 14.8 p -75.37 -56.55 4.6 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.611 -0.722 . . . . 0.0 111.791 -175.775 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 98.15 -99.37 2.19 Favored Glycine 0 CA--C 1.521 0.424 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.101 -176.161 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -55.32 -28.35 62.23 Favored 'Trans proline' 0 C--N 1.352 0.714 0 C-N-CA 123.331 2.688 . . . . 0.0 113.274 -179.635 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' CYS . . . . . 0.832 ' HB2' ' HD3' ' A' ' 110' ' ' PRO . 18.2 t -57.57 -22.85 47.34 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-O 120.979 0.419 . . . . 0.0 111.428 179.425 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.55 ' HA ' ' CD1' ' A' ' 49' ' ' LEU . 33.0 mtp-105 -70.9 -15.67 62.63 Favored 'General case' 0 C--N 1.324 -0.5 0 C-N-CA 120.577 -0.449 . . . . 0.0 111.301 -178.748 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -84.23 -12.97 75.1 Favored Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 120.678 -0.772 . . . . 0.0 111.67 176.08 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' GLU . . . . . 0.68 ' HB3' ' HB2' ' A' ' 129' ' ' PRO . 0.5 OUTLIER -91.51 -26.34 18.83 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.135 0.493 . . . . 0.0 109.884 -179.342 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.809 HD23 HD12 ' A' ' 52' ' ' LEU . 54.9 mt -51.53 -45.27 90.77 Favored Pre-proline 0 CA--C 1.536 0.406 0 CA-C-N 115.315 -0.857 . . . . 0.0 113.147 -176.664 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.536 ' HD2' ' N ' ' A' ' 49' ' ' LEU . 10.3 Cg_endo -54.2 -36.42 85.79 Favored 'Trans proline' 0 C--N 1.354 0.818 0 C-N-CA 121.683 1.589 . . . . 0.0 112.048 174.426 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.53 ' HA ' ' HB2' ' A' ' 54' ' ' GLU . . . -82.21 -22.44 35.93 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.329 0.585 . . . . 0.0 110.106 -178.443 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.809 HD12 HD23 ' A' ' 49' ' ' LEU . 27.3 mt -64.74 -37.26 86.99 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.423 -0.808 . . . . 0.0 110.156 175.423 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.453 ' HE3' ' HB3' ' A' ' 53' ' ' LYS . 10.2 mtpp -75.2 -40.21 59.44 Favored 'General case' 0 CA--C 1.517 -0.322 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.951 173.567 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.53 ' HB2' ' HA ' ' A' ' 51' ' ' ALA . 6.4 mm-40 -47.16 -50.38 20.65 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.538 -0.755 . . . . 0.0 110.678 173.213 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 73.6 mt -59.01 -55.35 36.3 Favored 'General case' 0 N--CA 1.446 -0.631 0 CA-C-N 115.592 -0.731 . . . . 0.0 111.072 176.261 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.62 ' OE2' ' HB3' ' A' ' 88' ' ' LYS . 37.7 tt0 -45.01 -60.64 1.98 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.477 -0.783 . . . . 0.0 112.558 179.776 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 61.5 mt-10 -74.42 -31.99 62.5 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 111.96 0.356 . . . . 0.0 111.96 -169.86 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 49.5 mttp -78.38 -40.67 35.54 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.131 0.491 . . . . 0.0 111.081 -178.169 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.586 ' HB2' ' HE2' ' A' ' 66' ' ' PHE . 73.2 m-85 -102.78 8.43 39.38 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.497 -173.915 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.453 ' HB2' ' O ' ' A' ' 56' ' ' GLU . . . -59.53 131.41 50.85 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.657 172.156 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 77.13 11.01 85.95 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.962 -0.637 . . . . 0.0 113.027 176.147 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.416 ' HA ' ' HD3' ' A' ' 62' ' ' LYS . 33.5 mmtm -89.13 -136.11 0.11 Allowed 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.966 -0.383 . . . . 0.0 109.966 177.624 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 63' ' ' ASP . . . . . 0.722 ' HA ' ' HD3' ' A' ' 31' ' ' LYS . 4.6 t0 -120.02 42.14 3.01 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 121.542 0.687 . . . . 0.0 109.778 179.008 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.438 HG21 ' HB3' ' A' ' 59' ' ' TYR . 7.3 tp -148.81 151.21 13.35 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 115.083 -0.962 . . . . 0.0 109.868 -171.624 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 65' ' ' HIS . . . . . 0.581 ' NE2' ' HB2' ' A' ' 31' ' ' LYS . 80.9 m-70 -126.99 137.8 53.16 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 175.128 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 66' ' ' PHE . . . . . 0.586 ' HE2' ' HB2' ' A' ' 59' ' ' TYR . 91.0 m-85 -110.43 109.98 20.57 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 120.624 0.249 . . . . 0.0 110.415 178.714 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.557 ' HB ' HG12 ' A' ' 35' ' ' ILE . 49.8 t -109.1 109.26 27.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.156 -177.115 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 50.2 m -91.68 114.0 26.41 Favored 'General case' 0 C--N 1.316 -0.884 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 174.144 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.575 ' O ' ' HA ' ' A' ' 37' ' ' VAL . 66.7 tp -109.83 130.02 55.57 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.555 -0.293 . . . . 0.0 110.266 178.649 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 70' ' ' SER . . . . . 0.565 ' O ' ' HB3' ' A' ' 94' ' ' MET . 1.8 t -109.02 119.23 38.94 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 111.93 0.344 . . . . 0.0 111.93 -173.758 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 71' ' ' CYS . . . . . 0.559 ' HB3' ' SD ' ' A' ' 101' ' ' MET . 33.6 m -88.14 19.29 3.76 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.519 177.368 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.562 ' OD2' HG22 ' A' ' 40' ' ' THR . 2.2 m-20 -73.33 113.99 11.04 Favored 'General case' 0 CA--C 1.515 -0.403 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.705 -178.54 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.538 ' HA ' ' O ' ' A' ' 95' ' ' GLY . 47.3 tttm -71.63 -17.53 62.26 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-O 121.155 0.502 . . . . 0.0 110.312 177.812 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 4.6 m-20 -83.83 91.31 7.52 Favored 'General case' 0 CA--C 1.515 -0.392 0 N-CA-C 109.025 -0.731 . . . . 0.0 109.025 175.945 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.614 ' O ' ' HG2' ' A' ' 79' ' ' GLU . 13.0 tmtt? -64.98 -65.09 0.72 Allowed 'General case' 0 C--N 1.322 -0.629 0 C-N-CA 120.066 -0.654 . . . . 0.0 110.984 -176.69 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 11.1 tmtt? -52.24 -45.66 65.41 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.2 -0.909 . . . . 0.0 111.195 -176.357 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.695 ' HA ' ' ND2' ' A' ' 80' ' ' ASN . . . -61.77 -38.69 88.96 Favored 'General case' 0 C--O 1.246 0.881 0 CA-C-O 121.572 0.701 . . . . 0.0 110.644 -177.281 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 78' ' ' TRP . . . . . 0.715 ' CE3' ' HB ' ' A' ' 40' ' ' THR . 4.7 t-105 -70.14 -47.55 61.24 Favored 'General case' 0 N--CA 1.438 -1.042 0 CA-C-N 115.099 -0.955 . . . . 0.0 110.634 -176.798 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.614 ' HG2' ' O ' ' A' ' 75' ' ' LYS . 4.0 mm-40 -47.25 -44.78 23.13 Favored 'General case' 0 C--O 1.236 0.355 0 O-C-N 123.418 0.449 . . . . 0.0 111.774 175.347 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 80' ' ' ASN . . . . . 0.695 ' ND2' ' HA ' ' A' ' 77' ' ' ALA . 1.8 m-80 -59.83 -50.84 72.21 Favored 'General case' 0 CA--C 1.518 -0.288 0 C-N-CA 120.196 -0.601 . . . . 0.0 110.468 179.501 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 23.1 ttm -64.27 -42.32 96.49 Favored 'General case' 0 C--N 1.332 -0.156 0 N-CA-C 112.578 0.585 . . . . 0.0 112.578 -173.016 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.532 ' CG1' HD12 ' A' ' 18' ' ' ILE . 1.3 p -62.45 -37.43 78.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 C-N-CA 120.061 -0.656 . . . . 0.0 110.714 177.884 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 32.8 m -70.74 -35.75 72.82 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.221 0.534 . . . . 0.0 110.532 178.427 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 22.0 tttm -73.4 -52.29 14.31 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.721 -0.672 . . . . 0.0 111.571 -178.554 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -85.81 6.74 26.71 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.444 -0.798 . . . . 0.0 111.899 -173.404 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 89.8 mt-30 57.84 38.34 27.16 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 122.927 0.491 . . . . 0.0 111.605 175.237 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.646 HD22 HD22 ' A' ' 49' ' ' LEU . 44.4 mt -73.72 111.48 8.91 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.515 -177.08 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.62 ' HB3' ' OE2' ' A' ' 56' ' ' GLU . 3.9 mmmp? -105.51 -157.1 0.6 Allowed 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 112.537 0.569 . . . . 0.0 112.537 -177.346 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 97.04 176.76 34.89 Favored Glycine 0 N--CA 1.447 -0.591 0 N-CA-C 110.507 -1.037 . . . . 0.0 110.507 -169.254 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.405 ' HB ' ' O ' ' A' ' 66' ' ' PHE . 63.0 mt -83.22 110.94 18.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 N-CA-C 107.065 -1.457 . . . . 0.0 107.065 169.873 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 91' ' ' GLN . . . . . 0.662 ' HB2' ' CZ2' ' A' ' 38' ' ' TRP . 1.3 pt20 -122.78 123.21 40.52 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-O 121.666 0.746 . . . . 0.0 112.837 -164.114 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.645 HD11 ' HB ' ' A' ' 23' ' ' VAL . 2.5 mm? -121.23 149.93 42.12 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 114.937 -1.029 . . . . 0.0 109.318 178.272 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 93' ' ' HIS . . . . . 0.404 ' CE1' ' HA ' ' A' ' 75' ' ' LYS . 16.1 t-80 -120.33 135.23 55.08 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-O 121.642 0.734 . . . . 0.0 111.589 -176.113 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 94' ' ' MET . . . . . 0.784 ' HG3' ' HB2' ' A' ' 97' ' ' ASP . 25.7 ttm -103.21 91.96 4.31 Favored 'General case' 0 N--CA 1.442 -0.871 0 CA-C-N 114.391 -1.277 . . . . 0.0 108.16 178.933 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 95' ' ' GLY . . . . . 0.538 ' O ' ' HA ' ' A' ' 73' ' ' LYS . . . -57.76 -55.19 31.86 Favored Glycine 0 C--N 1.318 -0.426 0 CA-C-N 115.169 -0.923 . . . . 0.0 113.807 -175.256 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 10.9 m -146.94 13.0 1.12 Allowed 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 122.064 0.935 . . . . 0.0 109.49 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 97' ' ' ASP . . . . . 0.784 ' HB2' ' HG3' ' A' ' 94' ' ' MET . 0.7 OUTLIER -81.56 31.83 0.35 Allowed 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 114.838 -1.074 . . . . 0.0 110.462 -175.471 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 98' ' ' ARG . . . . . 0.549 ' HA ' ' SD ' ' A' ' 94' ' ' MET . 0.0 OUTLIER -67.52 0.03 3.42 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 113.362 0.875 . . . . 0.0 113.362 -170.619 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 99' ' ' THR . . . . . 0.457 ' HA ' ' NH2' ' A' ' 98' ' ' ARG . 10.4 m -66.01 -19.23 65.79 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.66 0.743 . . . . 0.0 109.568 172.806 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 16.4 t80 -79.55 -24.14 42.34 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 115.317 -0.856 . . . . 0.0 110.135 177.773 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 101' ' ' MET . . . . . 0.559 ' SD ' ' HB3' ' A' ' 71' ' ' CYS . 88.6 mtp -60.17 -48.12 83.06 Favored 'General case' 0 CA--C 1.515 -0.395 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 174.357 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 67.5 m-20 -56.04 -40.89 74.17 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.224 -0.898 . . . . 0.0 111.088 176.577 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -63.25 -28.64 70.17 Favored 'General case' 0 N--CA 1.462 0.131 0 CA-C-N 116.198 -0.455 . . . . 0.0 112.075 -176.058 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 104' ' ' TYR . . . . . 0.94 ' HB3' HG23 ' A' ' 106' ' ' ILE . 2.8 m-85 -107.49 -6.36 17.08 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 111.937 0.347 . . . . 0.0 111.937 -178.602 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 3.4 mm? 57.94 33.06 22.77 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-O 121.425 0.631 . . . . 0.0 110.269 -174.049 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 106' ' ' ILE . . . . . 0.94 HG23 ' HB3' ' A' ' 104' ' ' TYR . 32.9 pt -88.93 36.18 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.248 -177.854 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 5.0 p-10 -67.28 -28.34 67.94 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.962 0.41 . . . . 0.0 110.376 179.266 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -92.06 103.5 3.06 Favored Glycine 0 N--CA 1.444 -0.769 0 N-CA-C 111.106 -0.798 . . . . 0.0 111.106 175.608 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.525 HG21 HG11 ' A' ' 37' ' ' VAL . 34.3 pt -110.79 153.46 43.69 Favored Pre-proline 0 C--N 1.324 -0.501 0 O-C-N 123.315 0.068 . . . . 0.0 110.943 -178.131 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 110' ' ' PRO . . . . . 0.832 ' HD3' ' HB2' ' A' ' 45' ' ' CYS . 42.2 Cg_endo -68.98 150.5 88.26 Favored 'Cis proline' 0 C--N 1.35 0.654 0 C-N-CA 123.547 -1.439 . . . . 0.0 112.428 0.982 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 111' ' ' ARG . . . . . 0.599 ' HG3' HG22 ' A' ' 106' ' ' ILE . 0.0 OUTLIER -114.52 127.9 56.05 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.209 -177.215 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 112' ' ' PHE . . . . . 0.556 ' HB2' ' HB3' ' A' ' 126' ' ' MET . 0.2 OUTLIER -102.47 114.35 28.48 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 114.701 -1.136 . . . . 0.0 110.608 -177.504 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 86.8 mt -130.75 143.51 40.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 120.85 0.357 . . . . 0.0 111.119 -178.244 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 48.2 tp -124.05 134.63 53.37 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.032 178.762 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.454 ' N ' HD12 ' A' ' 115' ' ' LEU . 1.6 mp -134.36 160.47 37.84 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.225 0.536 . . . . 0.0 110.615 -177.341 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 116' ' ' ASP . . . . . 0.51 ' HB2' HD11 ' A' ' 122' ' ' ILE . 28.5 t70 -77.17 167.96 20.87 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.193 -0.912 . . . . 0.0 110.351 177.288 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 117' ' ' ARG . . . . . 0.762 ' O ' ' HA ' ' A' ' 29' ' ' LYS . 81.9 mtt-85 -47.97 -37.66 15.06 Favored 'General case' 0 C--N 1.327 -0.382 0 O-C-N 124.402 1.064 . . . . 0.0 112.446 -177.524 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 118' ' ' ASP . . . . . 0.577 ' HA ' ' HG3' ' A' ' 29' ' ' LYS . 25.4 t0 -76.84 -0.1 22.77 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.532 0.682 . . . . 0.0 111.244 -178.922 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 119' ' ' GLY . . . . . 0.769 ' HA2' HD12 ' A' ' 33' ' ' ILE . . . 82.86 24.53 52.64 Favored Glycine 0 N--CA 1.431 -1.678 0 N-CA-C 110.058 -1.217 . . . . 0.0 110.058 -171.523 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 120' ' ' LYS . . . . . 0.485 ' HB2' ' HB3' ' A' ' 116' ' ' ASP . 44.9 mmtm -92.73 106.22 18.23 Favored 'General case' 0 C--O 1.222 -0.371 0 C-N-CA 120.601 -0.439 . . . . 0.0 111.466 -178.047 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 121' ' ' ILE . . . . . 0.702 ' H ' HD12 ' A' ' 121' ' ' ILE . 4.4 mp -41.51 117.58 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.397 0 CA-C-N 115.416 -0.811 . . . . 0.0 112.273 -177.95 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 122' ' ' ILE . . . . . 0.51 HD11 ' HB2' ' A' ' 116' ' ' ASP . 45.6 mm -98.95 -43.62 11.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 115.392 -0.822 . . . . 0.0 109.313 176.288 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 16.2 m -135.6 114.32 11.9 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.305 -0.861 . . . . 0.0 109.917 178.428 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -77.49 -12.38 59.95 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.24 0.543 . . . . 0.0 110.555 179.681 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 6.5 t30 -143.65 98.58 3.27 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.186 -0.915 . . . . 0.0 108.573 175.686 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 126' ' ' MET . . . . . 0.556 ' HB3' ' HB2' ' A' ' 112' ' ' PHE . 17.6 tpt -77.79 -86.6 0.06 Allowed 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.649 -174.546 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 8.4 m -155.87 -73.01 0.11 Allowed 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.945 0.402 . . . . 0.0 110.055 -178.889 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 128' ' ' ARG . . . . . 0.775 ' HB3' ' HB2' ' A' ' 131' ' ' ASP . 44.9 ttt180 -178.35 143.17 0.45 Allowed Pre-proline 0 N--CA 1.44 -0.955 0 CA-C-N 115.508 -0.769 . . . . 0.0 109.159 -179.226 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 129' ' ' PRO . . . . . 0.68 ' HB2' ' HB3' ' A' ' 48' ' ' GLU . 57.3 Cg_exo -52.72 -45.45 40.35 Favored 'Trans proline' 0 C--N 1.346 0.431 0 C-N-CA 122.577 2.185 . . . . 0.0 112.856 178.405 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 130' ' ' SER . . . . . 0.534 ' HB3' ' HA ' ' A' ' 48' ' ' GLU . 31.2 p -96.22 5.7 50.43 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 112.279 0.474 . . . . 0.0 112.279 -176.717 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 131' ' ' ASP . . . . . 0.796 ' OD1' ' HG2' ' A' ' 133' ' ' LYS . 11.3 t70 -89.3 128.43 51.36 Favored Pre-proline 0 C--O 1.235 0.312 0 C-N-CA 120.101 -0.64 . . . . 0.0 110.469 -178.658 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 132' ' ' PRO . . . . . 0.621 ' O ' ' HG3' ' A' ' 136' ' ' GLU . 82.6 Cg_exo -46.92 -41.23 25.71 Favored 'Trans proline' 0 C--N 1.344 0.325 0 C-N-CA 124.048 3.165 . . . . 0.0 114.944 -178.042 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 133' ' ' LYS . . . . . 0.796 ' HG2' ' OD1' ' A' ' 131' ' ' ASP . 27.7 mmtm -53.61 -37.71 63.29 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-O 121.209 0.528 . . . . 0.0 110.194 -172.097 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 134' ' ' THR . . . . . 0.722 HG22 ' CZ ' ' A' ' 138' ' ' PHE . 4.9 m -59.31 -59.62 5.16 Favored 'General case' 0 N--CA 1.446 -0.642 0 CA-C-N 115.23 -0.895 . . . . 0.0 110.657 178.0 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 135' ' ' ALA . . . . . 0.546 ' HA ' ' CD2' ' A' ' 138' ' ' PHE . . . -61.54 -41.21 97.0 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.862 -179.626 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 136' ' ' GLU . . . . . 0.621 ' HG3' ' O ' ' A' ' 132' ' ' PRO . 19.9 mt-10 -66.92 -28.77 68.57 Favored 'General case' 0 CA--C 1.514 -0.423 0 CA-C-O 121.409 0.623 . . . . 0.0 110.511 -177.154 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 137' ' ' LYS . . . . . 0.548 ' O ' ' HG ' ' A' ' 141' ' ' LEU . 60.8 tttp -75.06 -31.23 61.2 Favored 'General case' 0 C--N 1.317 -0.848 0 CA-C-N 115.298 -0.865 . . . . 0.0 111.024 177.119 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 138' ' ' PHE . . . . . 0.722 ' CZ ' HG22 ' A' ' 134' ' ' THR . 12.2 m-30 -62.08 -41.06 97.79 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 173.69 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 139' ' ' ASN . . . . . 0.42 ' HB2' ' O ' ' A' ' 136' ' ' GLU . 5.7 m-20 -57.48 -53.15 61.37 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.02 -0.991 . . . . 0.0 110.157 172.901 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 140' ' ' GLU . . . . . 0.538 ' HB3' ' O ' ' A' ' 137' ' ' LYS . 8.0 tt0 -43.07 -51.55 5.75 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 123.14 0.576 . . . . 0.0 111.958 171.392 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.548 ' HG ' ' O ' ' A' ' 137' ' ' LYS . 94.2 mt -58.34 -37.92 76.14 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.9 -178.112 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 11.2 mp . . . . . 0 C--N 1.329 -0.296 0 CA-C-O 120.89 0.376 . . . . 0.0 111.163 -179.764 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.235 0.322 0 CA-C-O 121.054 0.454 . . . . 0.0 111.121 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -155.24 101.45 2.22 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.98 177.83 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' SER . . . . . 0.477 ' HA ' HD23 ' A' ' 25' ' ' LEU . 36.9 m 65.01 103.85 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.474 0 CA-C-O 121.398 0.618 . . . . 0.0 112.128 178.128 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 36.5 p90 -125.81 171.03 11.02 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.426 178.487 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 30.7 m -140.91 129.21 22.34 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.899 -0.408 . . . . 0.0 109.899 178.227 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 45.8 m-85 -144.46 158.06 54.82 Favored Pre-proline 0 C--N 1.327 -0.372 0 CA-C-O 120.612 0.244 . . . . 0.0 110.841 -177.599 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_endo -87.09 128.5 2.71 Favored 'Trans proline' 0 N--CA 1.455 -0.751 0 C-N-CA 123.028 2.485 . . . . 0.0 113.023 178.882 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' ASP . . . . . 1.135 ' HB3' ' HB3' ' A' ' 21' ' ' LYS . 0.8 OUTLIER -66.32 162.77 19.5 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.409 -0.814 . . . . 0.0 109.735 170.687 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.842 HG13 HG11 ' A' ' 82' ' ' VAL . 24.5 mm -44.23 -45.43 2.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 O-C-N 124.27 0.981 . . . . 0.0 112.392 -177.367 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 33.2 m-80 -79.54 2.98 20.18 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.674 -172.941 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 87.5 35.79 9.17 Favored Glycine 0 N--CA 1.448 -0.557 0 N-CA-C 110.574 -1.011 . . . . 0.0 110.574 -174.526 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 1.135 ' HB3' ' HB3' ' A' ' 17' ' ' ASP . 35.5 ttmt -100.92 107.33 18.8 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.209 -0.495 . . . . 0.0 110.412 -174.835 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 25.2 m -74.34 105.73 5.64 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 120.924 0.392 . . . . 0.0 110.976 -177.137 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.629 ' HB ' HD11 ' A' ' 92' ' ' LEU . 45.8 t -117.99 138.07 49.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 116.064 -0.517 . . . . 0.0 109.668 179.192 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 80.3 p -113.6 156.5 23.55 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 116.316 -0.402 . . . . 0.0 109.93 179.263 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.519 ' O ' ' HB2' ' A' ' 29' ' ' LYS . 34.4 tp -70.42 -9.69 57.09 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.16 177.543 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -80.96 -26.98 36.2 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.494 177.288 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -74.15 -34.72 63.94 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.548 0.69 . . . . 0.0 110.107 175.795 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.496 HD11 HG21 ' A' ' 90' ' ' ILE . 66.6 mt -91.78 0.44 57.49 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.322 -0.854 . . . . 0.0 110.557 179.226 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.519 ' HB2' ' O ' ' A' ' 25' ' ' LEU . 60.2 tttp -74.54 150.63 39.69 Favored 'General case' 0 N--CA 1.443 -0.808 0 CA-C-N 115.134 -0.939 . . . . 0.0 110.633 -176.504 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 94.65 5.41 61.51 Favored Glycine 0 N--CA 1.447 -0.601 0 N-CA-C 110.576 -1.01 . . . . 0.0 110.576 -175.128 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 1.032 ' HD2' ' HA ' ' A' ' 63' ' ' ASP . 11.0 tppt? -146.0 151.44 37.78 Favored 'General case' 0 N--CA 1.446 -0.646 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 -177.982 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.41 ' HB2' HG22 ' A' ' 64' ' ' ILE . 61.3 m-85 -65.92 151.28 47.11 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 120.985 -0.286 . . . . 0.0 110.652 179.793 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.563 ' HB ' ' HB2' ' A' ' 115' ' ' LEU . 46.1 mm -127.08 125.86 67.13 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.975 -176.068 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' TYR . . . . . 0.445 ' CE2' ' HB2' ' A' ' 36' ' ' ASP . 59.0 t80 -105.43 112.01 24.95 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 170.554 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.57 ' HB ' ' HB ' ' A' ' 113' ' ' ILE . 40.3 mt -92.14 120.72 41.82 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-O 121.298 0.57 . . . . 0.0 110.461 179.77 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.561 ' O ' ' HA ' ' A' ' 68' ' ' SER . 15.9 t70 -120.24 125.03 47.11 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 115.133 -0.94 . . . . 0.0 109.231 178.919 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.661 HG11 HG21 ' A' ' 109' ' ' ILE . 21.5 t -82.5 113.92 22.53 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.913 0 C-N-CA 119.817 -0.753 . . . . 0.0 110.717 -178.981 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' TRP . . . . . 0.61 ' CZ2' ' HB2' ' A' ' 91' ' ' GLN . 0.5 OUTLIER -108.95 135.82 49.5 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.268 -0.878 . . . . 0.0 108.926 -177.967 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.624 ' HB3' ' HB3' ' A' ' 42' ' ' CYS . . . -145.04 172.36 13.17 Favored 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 120.433 -0.507 . . . . 0.0 111.96 -176.919 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -89.18 -43.17 11.21 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.661 0.743 . . . . 0.0 109.855 176.95 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' TRP . . . . . 0.551 ' CH2' HD11 ' A' ' 109' ' ' ILE . 11.1 p-90 -88.39 12.35 14.43 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 114.957 -1.02 . . . . 0.0 111.233 -176.056 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' CYS . . . . . 0.755 ' SG ' ' HB3' ' A' ' 45' ' ' CYS . 28.3 p -79.33 -17.86 53.68 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.154 -178.792 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 57.49 -107.06 0.88 Allowed Glycine 0 CA--C 1.522 0.508 0 CA-C-N 116.057 -0.519 . . . . 0.0 113.829 177.258 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_exo -51.6 -25.77 20.73 Favored 'Trans proline' 0 C--N 1.353 0.776 0 C-N-CA 123.746 2.964 . . . . 0.0 113.688 -177.348 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' CYS . . . . . 0.756 ' HB2' ' HD3' ' A' ' 110' ' ' PRO . 7.0 t -52.95 -30.68 36.11 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-O 120.844 0.354 . . . . 0.0 111.3 176.838 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.579 ' HA ' ' HG ' ' A' ' 49' ' ' LEU . 64.9 mtp180 -68.15 -11.42 59.14 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.835 -0.62 . . . . 0.0 111.677 -175.679 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -69.56 -33.23 71.75 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.919 -0.658 . . . . 0.0 112.595 179.802 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' GLU . . . . . 0.551 ' OE2' ' HD3' ' A' ' 128' ' ' ARG . 28.0 mt-10 -93.6 -9.0 39.55 Favored 'General case' 0 C--N 1.328 -0.366 0 O-C-N 122.738 -0.272 . . . . 0.0 111.061 -177.561 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.617 ' HB3' HD22 ' A' ' 87' ' ' LEU . 81.4 mt -55.52 -46.69 99.68 Favored Pre-proline 0 C--N 1.326 -0.426 0 CA-C-N 116.558 -0.292 . . . . 0.0 111.455 179.331 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 1.004 ' HA ' ' HE3' ' A' ' 53' ' ' LYS . 51.5 Cg_exo -55.34 -43.95 53.56 Favored 'Trans proline' 0 C--N 1.356 0.956 0 C-N-CA 121.635 1.556 . . . . 0.0 111.895 170.781 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -69.02 -24.29 64.19 Favored 'General case' 0 N--CA 1.462 0.138 0 CA-C-O 121.13 0.49 . . . . 0.0 110.686 -174.483 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 8.7 tt -68.42 -39.28 81.65 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.486 -0.779 . . . . 0.0 109.252 178.015 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 1.004 ' HE3' ' HA ' ' A' ' 50' ' ' PRO . 8.4 mtmp? -62.84 -51.48 66.88 Favored 'General case' 0 CA--C 1.519 -0.248 0 CA-C-O 121.73 0.776 . . . . 0.0 109.375 177.302 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -57.82 -37.81 74.48 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 114.977 -1.01 . . . . 0.0 111.205 179.347 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.486 HD21 ' HE2' ' A' ' 138' ' ' PHE . 12.9 tp -73.98 -40.7 62.79 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.543 -0.299 . . . . 0.0 110.64 179.583 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.651 ' HG3' ' O ' ' A' ' 53' ' ' LYS . 0.0 OUTLIER -66.24 -39.52 89.6 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.711 -0.222 . . . . 0.0 110.473 -177.496 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 51.5 mt-10 -76.44 -28.27 56.53 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.009 0.433 . . . . 0.0 110.73 -179.255 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 63.7 tttm -70.21 -31.36 68.76 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.862 176.489 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.453 ' HB3' HD11 ' A' ' 64' ' ' ILE . 88.0 m-85 -112.17 5.71 18.65 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 112.0 0.37 . . . . 0.0 112.0 -176.099 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -62.93 142.97 58.11 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.618 175.687 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 95.11 -14.24 65.59 Favored Glycine 0 N--CA 1.446 -0.673 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.054 -179.743 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.764 ' HE2' ' HB3' ' A' ' 142' ' ' LEU . 18.7 mmmt -104.13 -169.86 1.69 Allowed 'General case' 0 N--CA 1.448 -0.532 0 CA-C-O 121.271 0.558 . . . . 0.0 111.463 178.859 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 63' ' ' ASP . . . . . 1.032 ' HA ' ' HD2' ' A' ' 31' ' ' LYS . 28.0 m-20 -87.91 34.12 0.72 Allowed 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 113.401 0.889 . . . . 0.0 113.401 -165.848 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.453 HD11 ' HB3' ' A' ' 59' ' ' TYR . 27.6 pt -140.57 135.8 35.27 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-O 120.786 0.327 . . . . 0.0 110.639 176.213 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 65' ' ' HIS . . . . . 0.515 ' HB2' HD13 ' A' ' 33' ' ' ILE . 29.1 m170 -109.61 144.25 38.2 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.074 175.889 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 66' ' ' PHE . . . . . 0.447 ' HE2' HD23 ' A' ' 55' ' ' LEU . 59.8 m-85 -100.78 114.6 28.53 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 173.468 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.64 ' HA ' ' O ' ' A' ' 90' ' ' ILE . 58.2 t -123.35 115.07 44.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-O 120.974 0.416 . . . . 0.0 111.125 -175.315 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 68' ' ' SER . . . . . 0.561 ' HA ' ' O ' ' A' ' 36' ' ' ASP . 50.9 m -96.48 131.15 43.37 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.688 179.01 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.429 ' O ' ' HA ' ' A' ' 37' ' ' VAL . 84.8 mt -120.9 139.03 53.78 Favored 'General case' 0 N--CA 1.468 0.47 0 N-CA-C 110.51 -0.182 . . . . 0.0 110.51 178.062 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 70' ' ' SER . . . . . 0.589 ' HB2' ' O ' ' A' ' 38' ' ' TRP . 0.8 OUTLIER -123.69 129.94 51.88 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 112.5 0.556 . . . . 0.0 112.5 -174.374 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 4.8 p -93.65 23.03 4.95 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.301 173.995 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.475 ' OD1' ' HA ' ' A' ' 39' ' ' ALA . 3.0 m-20 -79.47 108.02 12.68 Favored 'General case' 0 N--CA 1.467 0.382 0 O-C-N 122.339 -0.226 . . . . 0.0 111.013 -177.389 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 16.2 ptpt -68.12 -20.95 64.96 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 120.979 0.418 . . . . 0.0 110.658 178.09 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' ASN . . . . . 0.578 ' HB2' ' HB3' ' A' ' 77' ' ' ALA . 1.0 OUTLIER -79.42 69.09 5.61 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.394 174.122 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 11.9 tttt -58.73 -51.24 70.8 Favored 'General case' 0 C--O 1.218 -0.564 0 CA-C-N 116.63 -0.259 . . . . 0.0 111.649 -174.97 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.662 ' HA ' ' OE2' ' A' ' 79' ' ' GLU . 0.2 OUTLIER -58.11 -44.37 87.65 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 120.811 0.339 . . . . 0.0 110.442 -177.478 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.578 ' HB3' ' HB2' ' A' ' 74' ' ' ASN . . . -62.37 -43.29 99.18 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.683 0.754 . . . . 0.0 110.567 178.285 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 78' ' ' TRP . . . . . 0.464 ' O ' HG12 ' A' ' 82' ' ' VAL . 3.9 t-105 -73.34 -45.76 53.29 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 115.159 -0.928 . . . . 0.0 111.268 -176.731 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.662 ' OE2' ' HA ' ' A' ' 76' ' ' LYS . 0.6 OUTLIER -62.79 -35.29 79.39 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.001 -175.026 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 4.6 p30 -78.03 -33.51 51.06 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 119.657 -0.817 . . . . 0.0 110.339 178.772 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 45.4 tpp -61.96 -51.92 66.12 Favored 'General case' 0 C--O 1.222 -0.391 0 N-CA-C 111.462 0.171 . . . . 0.0 111.462 176.572 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.842 HG11 HG13 ' A' ' 18' ' ' ILE . 2.4 p -59.17 -37.03 66.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 C-N-CA 120.828 -0.349 . . . . 0.0 110.628 177.817 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 91.8 m -61.53 -39.09 89.8 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-O 120.894 0.378 . . . . 0.0 110.694 175.724 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' LYS . . . . . 0.445 ' HB3' ' HE3' ' A' ' 84' ' ' LYS . 0.2 OUTLIER -75.91 -44.94 37.85 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 179.717 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 85' ' ' ASP . . . . . 0.465 ' CG ' HH21 ' A' ' 46' ' ' ARG . 1.8 m-20 -69.6 -19.92 63.64 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.466 -0.788 . . . . 0.0 111.702 -176.387 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 73.1 mt-30 60.08 58.93 2.53 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-O 121.531 0.681 . . . . 0.0 110.936 176.853 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.617 HD22 ' HB3' ' A' ' 49' ' ' LEU . 81.9 mt -86.31 134.14 33.76 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.458 -0.792 . . . . 0.0 111.132 -177.068 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.582 ' HB3' ' OE2' ' A' ' 56' ' ' GLU . 11.7 mmmm -91.93 -168.99 2.14 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.934 177.249 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 84.49 160.25 31.35 Favored Glycine 0 N--CA 1.447 -0.612 0 C-N-CA 121.098 -0.573 . . . . 0.0 112.336 -177.436 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.64 ' O ' ' HA ' ' A' ' 67' ' ' VAL . 53.8 mt -77.68 113.0 16.29 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 175.405 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 91' ' ' GLN . . . . . 0.61 ' HB2' ' CZ2' ' A' ' 38' ' ' TRP . 9.2 pt20 -124.14 123.12 39.61 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-O 121.439 0.637 . . . . 0.0 112.074 -167.452 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.629 HD11 ' HB ' ' A' ' 23' ' ' VAL . 2.8 mm? -120.6 167.51 12.34 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.391 -0.822 . . . . 0.0 109.621 178.276 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 20.6 t-80 -138.66 126.89 22.82 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-O 121.201 0.524 . . . . 0.0 111.36 -173.084 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 94' ' ' MET . . . . . 0.446 ' HB3' ' HE2' ' A' ' 94' ' ' MET . 37.1 ttp -88.57 -67.05 0.86 Allowed 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 114.989 -1.005 . . . . 0.0 109.4 176.683 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 95' ' ' GLY . . . . . 0.441 ' HA2' ' O ' ' A' ' 72' ' ' ASP . . . 84.07 -77.5 2.11 Favored Glycine 0 N--CA 1.442 -0.901 0 C-N-CA 120.74 -0.743 . . . . 0.0 114.069 172.951 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 5.6 p -84.93 -19.57 32.0 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 113.247 0.832 . . . . 0.0 113.247 -169.75 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -101.54 154.77 18.55 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 119.723 -0.791 . . . . 0.0 111.023 -178.172 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 98' ' ' ARG . . . . . 0.515 ' HA ' ' HB3' ' A' ' 101' ' ' MET . 0.0 OUTLIER -140.66 9.05 2.19 Favored 'General case' 0 N--CA 1.446 -0.643 0 CA-C-N 115.511 -0.768 . . . . 0.0 109.789 173.083 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 4.5 m -78.32 -36.31 46.55 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.246 0.546 . . . . 0.0 109.793 178.426 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 70.5 t80 -74.78 -30.5 61.46 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 174.957 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 101' ' ' MET . . . . . 0.714 ' HG2' HG13 ' A' ' 106' ' ' ILE . 1.6 tmt? -64.2 -38.02 89.55 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 114.453 -1.249 . . . . 0.0 109.977 172.034 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -65.72 -44.44 86.05 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.468 -0.787 . . . . 0.0 110.483 177.61 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -62.88 -21.24 65.85 Favored 'General case' 0 CA--C 1.528 0.132 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.882 -177.604 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 104' ' ' TYR . . . . . 0.414 ' HB3' HG23 ' A' ' 106' ' ' ILE . 6.3 m-30 -100.39 -3.1 31.77 Favored 'General case' 0 C--O 1.237 0.419 0 CA-C-N 116.418 -0.355 . . . . 0.0 111.002 179.645 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 95.4 mt 59.05 25.94 14.49 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.108 -179.168 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 106' ' ' ILE . . . . . 0.714 HG13 ' HG2' ' A' ' 101' ' ' MET . 30.4 pt -86.64 66.14 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-O 121.664 0.745 . . . . 0.0 111.01 -177.693 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 44.2 t-20 -81.51 -59.72 2.52 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.364 -0.834 . . . . 0.0 109.81 179.786 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -82.93 90.2 1.53 Allowed Glycine 0 N--CA 1.446 -0.673 0 C-N-CA 120.634 -0.794 . . . . 0.0 111.482 176.931 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.661 HG21 HG11 ' A' ' 37' ' ' VAL . 46.5 pt -91.33 158.23 41.32 Favored Pre-proline 0 C--N 1.326 -0.448 0 N-CA-C 110.655 -0.128 . . . . 0.0 110.655 179.89 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 110' ' ' PRO . . . . . 0.756 ' HD3' ' HB2' ' A' ' 45' ' ' CYS . 40.9 Cg_endo -65.84 153.98 79.98 Favored 'Cis proline' 0 C--N 1.35 0.605 0 C-N-CA 124.006 -1.248 . . . . 0.0 113.691 1.939 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 111' ' ' ARG . . . . . 0.513 ' HG3' ' HA ' ' A' ' 106' ' ' ILE . 0.0 OUTLIER -125.8 138.14 53.82 Favored 'General case' 0 N--CA 1.446 -0.668 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.017 -179.302 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 112' ' ' PHE . . . . . 0.795 ' HD2' ' HB2' ' A' ' 128' ' ' ARG . 0.1 OUTLIER -102.05 117.53 34.99 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.358 -0.837 . . . . 0.0 110.633 -177.74 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.57 ' HB ' ' HB ' ' A' ' 35' ' ' ILE . 92.7 mt -131.15 145.13 35.87 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.283 0 CA-C-O 120.87 0.367 . . . . 0.0 111.128 -178.065 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.424 ' C ' HD12 ' A' ' 115' ' ' LEU . 42.0 tp -125.61 141.65 51.92 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.332 -0.395 . . . . 0.0 109.943 178.193 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.693 ' HG ' ' HA ' ' A' ' 121' ' ' ILE . 3.0 mp -134.87 153.98 51.84 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.061 0.458 . . . . 0.0 110.587 -178.018 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 27.8 t0 -79.72 166.49 21.74 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.221 -0.9 . . . . 0.0 110.765 178.596 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 117' ' ' ARG . . . . . 0.423 ' HA ' ' O ' ' A' ' 31' ' ' LYS . 5.6 mtm180 -53.57 -26.42 21.42 Favored 'General case' 0 N--CA 1.466 0.348 0 O-C-N 124.437 1.085 . . . . 0.0 111.956 -178.8 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -69.31 -16.72 63.61 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.302 0.573 . . . . 0.0 110.549 178.89 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 93.0 24.44 22.65 Favored Glycine 0 N--CA 1.436 -1.353 0 N-CA-C 109.762 -1.335 . . . . 0.0 109.762 -169.893 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 24.6 mmmt -111.7 114.34 27.29 Favored 'General case' 0 C--O 1.221 -0.403 0 N-CA-C 112.235 0.457 . . . . 0.0 112.235 -172.507 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 121' ' ' ILE . . . . . 0.703 ' H ' HD12 ' A' ' 121' ' ' ILE . 4.1 mp -42.74 116.01 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 O-C-N 123.972 0.795 . . . . 0.0 111.761 178.576 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 122' ' ' ILE . . . . . 0.442 ' H ' ' HA ' ' A' ' 115' ' ' LEU . 69.3 mt -87.84 -47.69 15.52 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-N 115.21 -0.904 . . . . 0.0 108.726 174.94 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 15.1 m -128.52 114.53 16.87 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-N 115.003 -0.999 . . . . 0.0 109.944 179.631 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -70.98 -21.66 62.29 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.103 0.478 . . . . 0.0 110.577 178.509 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 6.9 t30 -139.57 101.53 4.24 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.539 -0.755 . . . . 0.0 109.009 176.399 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 13.1 tpt -105.48 -127.04 0.24 Allowed 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.2 -175.891 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 2.0 p -145.08 136.61 25.28 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 110.134 -0.321 . . . . 0.0 110.134 -178.062 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 128' ' ' ARG . . . . . 0.795 ' HB2' ' HD2' ' A' ' 112' ' ' PHE . 14.8 ttt180 -94.68 152.55 39.92 Favored Pre-proline 0 CA--C 1.535 0.401 0 CA-C-O 119.242 -0.408 . . . . 0.0 110.854 -177.978 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 129' ' ' PRO . . . . . 0.663 ' HD2' ' CG ' ' A' ' 128' ' ' ARG . 47.0 Cg_exo -24.4 -39.72 0.02 OUTLIER 'Trans proline' 0 C--N 1.366 1.469 1 C-N-CA 126.32 4.68 . . . . 0.0 117.275 175.771 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 66.6 m -50.33 -29.85 10.79 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-N 118.526 0.603 . . . . 0.0 111.129 175.302 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -92.2 121.36 66.77 Favored Pre-proline 0 C--N 1.323 -0.571 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.536 175.519 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 132' ' ' PRO . . . . . 0.471 ' O ' ' HG3' ' A' ' 136' ' ' GLU . 59.9 Cg_endo -72.16 -23.73 20.93 Favored 'Trans proline' 0 N--CA 1.462 -0.346 0 C-N-CA 122.492 2.128 . . . . 0.0 112.322 179.664 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 133' ' ' LYS . . . . . 0.476 ' HA ' ' HD3' ' A' ' 133' ' ' LYS . 57.3 mmtt -63.09 -30.25 71.45 Favored 'General case' 0 CA--C 1.518 -0.259 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.878 -177.771 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 134' ' ' THR . . . . . 0.773 HG22 ' CZ ' ' A' ' 138' ' ' PHE . 3.0 m -59.11 -54.81 42.83 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.742 -0.663 . . . . 0.0 109.718 175.234 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 135' ' ' ALA . . . . . 0.598 ' HA ' ' CD2' ' A' ' 138' ' ' PHE . . . -59.99 -43.56 95.09 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-N 115.67 -0.695 . . . . 0.0 112.045 177.817 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 136' ' ' GLU . . . . . 0.471 ' HG3' ' O ' ' A' ' 132' ' ' PRO . 50.8 mt-10 -55.72 -52.01 65.38 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-O 122.025 0.917 . . . . 0.0 110.269 177.47 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 137' ' ' LYS . . . . . 0.685 ' HE3' HD21 ' A' ' 141' ' ' LEU . 52.3 tptt -54.53 -40.63 68.83 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 113.956 -1.475 . . . . 0.0 111.319 179.113 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 138' ' ' PHE . . . . . 0.773 ' CZ ' HG22 ' A' ' 134' ' ' THR . 19.5 m-30 -55.49 -47.69 75.77 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 116.63 -0.259 . . . . 0.0 110.582 177.105 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 39.5 m-20 -54.18 -55.03 31.86 Favored 'General case' 0 CA--C 1.521 -0.162 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 -179.254 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 8.8 tt0 -48.87 -57.71 5.99 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.403 -0.817 . . . . 0.0 111.968 174.95 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.685 HD21 ' HE3' ' A' ' 137' ' ' LYS . 90.2 mt -60.89 -37.3 81.74 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.799 -174.477 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 0.764 ' HB3' ' HE2' ' A' ' 62' ' ' LYS . 89.2 mt . . . . . 0 C--N 1.323 -0.56 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.144 -178.387 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.644 ' HA ' ' CZ ' ' A' ' 100' ' ' PHE . . . . . . . . 0 N--CA 1.47 0.542 0 N-CA-C 112.667 0.618 . . . . 0.0 112.667 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -56.67 -32.54 65.51 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 112.87 0.693 . . . . 0.0 112.87 -172.895 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 31.1 m -147.68 86.56 1.6 Allowed 'General case' 0 C--N 1.316 -0.873 0 CA-C-O 121.128 0.489 . . . . 0.0 111.362 179.188 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' PHE . . . . . 0.477 ' CE2' HD22 ' A' ' 25' ' ' LEU . 47.9 p90 -105.57 163.15 12.89 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 172.712 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' SER . . . . . 0.439 ' HA ' ' HA ' ' A' ' 24' ' ' SER . 14.0 m -139.71 122.03 15.99 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 109.805 -0.442 . . . . 0.0 109.805 178.852 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' TYR . . . . . 0.424 ' HA ' ' HD3' ' A' ' 16' ' ' PRO . 19.6 m-85 -137.11 149.32 65.84 Favored Pre-proline 0 C--N 1.327 -0.393 0 CA-C-O 120.678 0.275 . . . . 0.0 110.744 -177.262 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.471 ' HD2' ' O ' ' A' ' 93' ' ' HIS . 9.2 Cg_exo -72.35 124.37 9.87 Favored 'Trans proline' 0 N--CA 1.456 -0.678 0 C-N-CA 122.473 2.115 . . . . 0.0 112.54 178.02 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' ASP . . . . . 0.874 ' HB3' ' HB3' ' A' ' 21' ' ' LYS . 0.2 OUTLIER -68.97 162.95 25.65 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.132 -0.94 . . . . 0.0 109.765 172.769 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.668 HD12 HG13 ' A' ' 82' ' ' VAL . 0.8 OUTLIER -44.78 -43.42 2.49 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 O-C-N 124.147 0.904 . . . . 0.0 112.171 -177.227 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 19' ' ' ASN . . . . . 0.52 ' ND2' HG23 ' A' ' 18' ' ' ILE . 21.8 m-80 -77.42 1.2 19.82 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.144 -175.349 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 85.84 30.61 23.08 Favored Glycine 0 N--CA 1.446 -0.663 0 N-CA-C 110.682 -0.967 . . . . 0.0 110.682 -173.626 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.874 ' HB3' ' HB3' ' A' ' 17' ' ' ASP . 2.0 ttmp? -98.09 116.04 29.48 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.481 -0.36 . . . . 0.0 110.902 -172.933 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 25.6 m -70.38 104.78 2.81 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 120.867 0.365 . . . . 0.0 110.905 178.799 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.472 ' HB ' HD21 ' A' ' 92' ' ' LEU . 61.0 t -121.32 146.16 26.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 178.741 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' SER . . . . . 0.439 ' HA ' ' HA ' ' A' ' 14' ' ' SER . 86.7 p -121.52 -173.96 2.75 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 109.985 -0.376 . . . . 0.0 109.985 -178.666 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.698 ' O ' ' HB2' ' A' ' 29' ' ' LYS . 15.0 tp -98.84 0.69 44.78 Favored 'General case' 0 C--N 1.32 -0.685 0 C-N-CA 120.16 -0.616 . . . . 0.0 109.951 173.881 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -85.99 -32.71 21.37 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.398 -179.06 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -77.01 -17.98 58.47 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.367 0.603 . . . . 0.0 110.117 176.104 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 85.8 mt -100.12 -5.31 28.06 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.602 -0.727 . . . . 0.0 110.429 176.859 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.698 ' HB2' ' O ' ' A' ' 25' ' ' LEU . 58.4 tttm -81.7 140.98 34.0 Favored 'General case' 0 N--CA 1.443 -0.79 0 CA-C-N 115.582 -0.735 . . . . 0.0 110.705 -172.338 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 115.63 -13.58 17.88 Favored Glycine 0 N--CA 1.452 -0.239 0 N-CA-C 111.326 -0.71 . . . . 0.0 111.326 -175.389 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.502 ' HG3' ' OD1' ' A' ' 63' ' ' ASP . 25.0 ttmm -132.27 153.1 50.99 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 177.129 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.667 ' HB2' HG22 ' A' ' 64' ' ' ILE . 24.7 m-85 -51.92 141.85 16.78 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 118.328 0.513 . . . . 0.0 110.916 -176.491 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.589 HG21 HD11 ' A' ' 25' ' ' LEU . 67.3 mt -119.27 122.29 68.72 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.74 -174.545 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' TYR . . . . . 0.531 ' OH ' ' HG3' ' A' ' 128' ' ' ARG . 30.2 t80 -114.99 134.66 54.99 Favored 'General case' 0 C--N 1.316 -0.863 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 173.94 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.611 ' HA ' ' O ' ' A' ' 67' ' ' VAL . 82.1 mt -130.26 129.88 65.3 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.047 -176.651 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.635 ' O ' ' HA ' ' A' ' 68' ' ' SER . 4.6 p30 -130.6 160.29 34.64 Favored 'General case' 0 C--O 1.217 -0.614 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.418 172.71 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.544 ' HB ' ' HA ' ' A' ' 110' ' ' PRO . 47.8 t -95.56 137.94 22.44 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 CA-C-O 121.087 0.47 . . . . 0.0 111.779 -178.429 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' TRP . . . . . 0.936 ' HZ3' HG21 ' A' ' 82' ' ' VAL . 0.6 OUTLIER -122.34 132.91 54.62 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 174.244 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -148.43 154.14 39.48 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 120.767 -0.373 . . . . 0.0 111.655 -176.727 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' THR . . . . . 0.687 ' HB ' ' CE3' ' A' ' 78' ' ' TRP . 4.1 t -92.93 -28.68 16.31 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 121.203 -0.199 . . . . 0.0 110.785 173.516 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 11.5 p-90 -81.69 -8.32 59.69 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.939 0.4 . . . . 0.0 110.417 179.537 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' CYS . . . . . 0.56 ' O ' ' HD2' ' A' ' 44' ' ' PRO . 47.7 t -86.35 -71.33 0.55 Allowed 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 173.099 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 112.21 -77.53 0.24 Allowed Glycine 0 C--O 1.227 -0.293 0 C-N-CA 120.532 -0.842 . . . . 0.0 113.239 176.87 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.56 ' HD2' ' O ' ' A' ' 42' ' ' CYS . 9.7 Cg_endo -52.38 -31.79 49.08 Favored 'Trans proline' 0 C--N 1.353 0.815 0 C-N-CA 123.182 2.588 . . . . 0.0 112.431 -178.636 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' CYS . . . . . 0.56 ' HB3' ' HD3' ' A' ' 110' ' ' PRO . 26.9 p -61.41 -17.0 52.21 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.688 -179.899 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.514 ' HA ' HD23 ' A' ' 49' ' ' LEU . 61.7 mtp180 -83.27 -19.4 36.41 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.814 0.34 . . . . 0.0 111.075 -177.48 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -83.77 -7.68 85.5 Favored Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.479 -176.705 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -95.58 -10.44 29.55 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.513 0.197 . . . . 0.0 111.152 -177.283 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.991 ' HG ' ' HB3' ' A' ' 87' ' ' LEU . 4.2 mm? -55.25 -44.85 99.85 Favored Pre-proline 0 CA--C 1.538 0.487 0 CA-C-N 116.649 -0.251 . . . . 0.0 111.505 176.709 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.672 ' O ' ' HG2' ' A' ' 54' ' ' GLU . 76.0 Cg_exo -52.68 -37.37 75.1 Favored 'Trans proline' 0 C--N 1.357 0.981 0 C-N-CA 121.816 1.677 . . . . 0.0 112.131 170.606 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -71.51 -19.84 62.14 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.35 0.595 . . . . 0.0 110.704 -178.071 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 8.1 tt -72.88 -45.69 56.85 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.568 -0.742 . . . . 0.0 109.692 -179.83 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.509 ' HG3' ' N ' ' A' ' 54' ' ' GLU . 7.9 ptmm? -63.89 -42.04 97.57 Favored 'General case' 0 C--O 1.226 -0.15 0 N-CA-C 109.878 -0.415 . . . . 0.0 109.878 177.704 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.672 ' HG2' ' O ' ' A' ' 50' ' ' PRO . 55.2 mm-40 -51.22 -49.75 60.44 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-O 121.64 0.733 . . . . 0.0 110.224 177.932 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.769 HD13 ' HD2' ' A' ' 59' ' ' TYR . 0.2 OUTLIER -66.7 -39.21 87.98 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.068 -0.969 . . . . 0.0 110.755 -179.021 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 14.2 tp10 -61.23 -57.66 11.51 Favored 'General case' 0 N--CA 1.447 -0.591 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.045 -177.207 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 -67.97 -25.42 65.42 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 111.744 0.276 . . . . 0.0 111.744 -176.113 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' LYS . . . . . 0.494 ' HD3' ' CE2' ' A' ' 59' ' ' TYR . 63.4 tttt -67.7 -34.12 76.25 Favored 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 120.759 -0.376 . . . . 0.0 110.51 174.064 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.769 ' HD2' HD13 ' A' ' 55' ' ' LEU . 68.3 m-85 -119.81 25.17 10.15 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.426 -176.327 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -49.63 116.51 1.79 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.059 0.457 . . . . 0.0 111.972 178.143 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 105.11 -0.73 40.96 Favored Glycine 0 N--CA 1.453 -0.214 0 C-N-CA 120.945 -0.645 . . . . 0.0 112.451 179.504 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.852 ' HG2' HG12 ' A' ' 64' ' ' ILE . 0.0 OUTLIER -67.32 174.9 2.98 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.523 0.678 . . . . 0.0 112.422 -178.299 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 63' ' ' ASP . . . . . 0.502 ' OD1' ' HG3' ' A' ' 31' ' ' LYS . 32.3 t70 -101.28 51.45 0.85 Allowed 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.905 -177.317 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.852 HG12 ' HG2' ' A' ' 62' ' ' LYS . 19.4 pt -146.8 165.57 7.3 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.401 0 N-CA-C 110.113 -0.329 . . . . 0.0 110.113 177.546 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 65' ' ' HIS . . . . . 0.48 ' NE2' ' HB3' ' A' ' 31' ' ' LYS . 85.2 m-70 -122.9 140.42 52.99 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 175.922 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 66' ' ' PHE . . . . . 0.692 ' O ' ' HB ' ' A' ' 90' ' ' ILE . 79.6 m-85 -102.01 103.18 13.78 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 172.381 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.611 ' O ' ' HA ' ' A' ' 35' ' ' ILE . 39.0 t -119.12 113.6 41.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-O 120.967 0.413 . . . . 0.0 111.11 -175.465 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 68' ' ' SER . . . . . 0.635 ' HA ' ' O ' ' A' ' 36' ' ' ASP . 0.7 OUTLIER -93.95 131.96 38.88 Favored 'General case' 0 C--N 1.317 -0.824 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 177.521 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.546 ' CD2' ' HB2' ' A' ' 92' ' ' LEU . 73.2 mt -118.2 137.7 52.83 Favored 'General case' 0 N--CA 1.468 0.463 0 O-C-N 122.072 -0.392 . . . . 0.0 110.426 176.918 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 70' ' ' SER . . . . . 0.536 ' HB2' ' O ' ' A' ' 38' ' ' TRP . 1.3 t -118.06 123.5 45.81 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.188 0.518 . . . . 0.0 112.029 -176.209 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 49.7 t -89.85 14.14 12.75 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.75 176.417 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.574 ' O ' ' HA2' ' A' ' 95' ' ' GLY . 0.9 OUTLIER -65.53 133.11 50.53 Favored 'General case' 0 CA--C 1.516 -0.362 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 -178.292 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.48 ' HB2' ' NZ ' ' A' ' 73' ' ' LYS . 1.0 OUTLIER -87.45 -24.94 23.99 Favored 'General case' 0 C--N 1.316 -0.872 0 C-N-CA 120.084 -0.646 . . . . 0.0 110.571 -177.646 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 74' ' ' ASN . . . . . 0.571 ' HB2' ' HB3' ' A' ' 77' ' ' ALA . 0.6 OUTLIER -84.12 78.97 9.67 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.343 176.175 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.432 ' HG3' ' CE1' ' A' ' 93' ' ' HIS . 10.2 tttt -61.63 -56.58 18.31 Favored 'General case' 0 C--O 1.221 -0.443 0 C-N-CA 120.826 -0.35 . . . . 0.0 111.741 -173.763 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.557 ' HA ' ' OE1' ' A' ' 79' ' ' GLU . 17.3 tppt? -57.09 -40.62 77.32 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 111.882 0.327 . . . . 0.0 111.882 -177.903 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.571 ' HB3' ' HB2' ' A' ' 74' ' ' ASN . . . -62.79 -41.2 99.16 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.827 0.823 . . . . 0.0 110.188 177.393 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 78' ' ' TRP . . . . . 0.687 ' CE3' ' HB ' ' A' ' 40' ' ' THR . 5.2 t-105 -74.31 -47.57 33.81 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 114.698 -1.137 . . . . 0.0 111.202 -176.802 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.557 ' OE1' ' HA ' ' A' ' 76' ' ' LYS . 3.3 pt-20 -64.57 -35.52 81.24 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.938 -174.782 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 3.6 p30 -74.94 -37.13 62.07 Favored 'General case' 0 CA--C 1.523 -0.081 0 C-N-CA 119.995 -0.682 . . . . 0.0 110.114 179.053 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 34.4 ttm -64.1 -50.52 67.98 Favored 'General case' 0 C--O 1.219 -0.552 0 C-N-CA 120.65 -0.42 . . . . 0.0 110.784 175.914 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.936 HG21 ' HZ3' ' A' ' 38' ' ' TRP . 12.5 p -63.18 -23.23 32.75 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-O 121.086 0.469 . . . . 0.0 111.005 -178.158 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 83' ' ' THR . . . . . 0.573 ' OG1' HD11 ' A' ' 18' ' ' ILE . 88.2 m -76.38 -46.82 25.65 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.566 -0.288 . . . . 0.0 110.453 171.98 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.32 -42.36 88.32 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.337 0.589 . . . . 0.0 110.384 -178.286 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -74.51 -5.61 43.66 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.186 -0.915 . . . . 0.0 111.282 -179.824 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 47.7 mt-30 63.52 17.74 10.57 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 115.867 -0.606 . . . . 0.0 112.368 174.556 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.991 ' HB3' ' HG ' ' A' ' 49' ' ' LEU . 29.2 mt -74.67 93.78 2.6 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.96 -0.385 . . . . 0.0 109.96 -179.986 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 9.0 mmtm -110.07 -178.84 3.62 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 113.006 0.743 . . . . 0.0 113.006 -176.261 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 130.88 -165.02 23.08 Favored Glycine 0 N--CA 1.449 -0.448 0 N-CA-C 109.71 -1.356 . . . . 0.0 109.71 -172.117 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.692 ' HB ' ' O ' ' A' ' 66' ' ' PHE . 60.9 mt -85.02 112.14 21.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 118.054 0.927 . . . . 0.0 108.508 172.808 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 91' ' ' GLN . . . . . 0.587 ' HB2' ' CZ2' ' A' ' 38' ' ' TRP . 2.1 pt20 -142.01 113.26 7.6 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 121.457 0.646 . . . . 0.0 111.69 -170.647 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.546 ' HB2' ' CD2' ' A' ' 69' ' ' LEU . 77.5 mt -110.42 154.23 23.87 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.495 -0.775 . . . . 0.0 109.902 -179.75 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 93' ' ' HIS . . . . . 0.471 ' O ' ' HD2' ' A' ' 16' ' ' PRO . 35.4 t-80 -121.93 126.81 49.47 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-O 121.455 0.645 . . . . 0.0 111.134 -175.254 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 94' ' ' MET . . . . . 0.436 ' HB3' ' HE2' ' A' ' 94' ' ' MET . 28.2 ttp -91.12 -72.62 0.57 Allowed 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 114.801 -1.09 . . . . 0.0 109.923 178.197 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 95' ' ' GLY . . . . . 0.574 ' HA2' ' O ' ' A' ' 72' ' ' ASP . . . 86.48 -75.26 2.26 Favored Glycine 0 N--CA 1.446 -0.648 0 C-N-CA 120.601 -0.809 . . . . 0.0 114.24 173.863 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -90.42 -34.59 15.57 Favored 'General case' 0 C--N 1.315 -0.928 0 N-CA-C 112.126 0.417 . . . . 0.0 112.126 -174.556 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -92.75 54.91 2.32 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.717 -163.833 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.71 4.94 0.94 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.952 -0.567 . . . . 0.0 112.405 -176.812 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 9.4 t -66.74 -19.44 65.75 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.126 0.489 . . . . 0.0 109.76 174.887 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 100' ' ' PHE . . . . . 0.644 ' CZ ' ' HA ' ' A' ' 10' ' ' ALA . 10.5 t80 -77.28 -23.87 51.09 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.174 177.652 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 93.6 mmm -62.41 -48.12 81.11 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 174.761 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -62.25 -22.49 66.03 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 115.405 -0.816 . . . . 0.0 111.649 176.603 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -70.42 -24.06 62.85 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.697 0.284 . . . . 0.0 111.115 179.544 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 104' ' ' TYR . . . . . 0.585 ' HB2' HD12 ' A' ' 106' ' ' ILE . 47.2 m-85 -106.28 -11.31 16.06 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.802 176.561 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 7.2 mp 67.14 14.59 9.83 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 115.61 -0.723 . . . . 0.0 112.071 179.181 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 106' ' ' ILE . . . . . 1.039 ' HB ' ' HG3' ' A' ' 111' ' ' ARG . 0.2 OUTLIER -82.84 149.95 4.45 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.428 0 CA-C-O 120.933 0.397 . . . . 0.0 110.804 -179.926 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 5.1 p30 -127.37 -57.65 1.29 Allowed 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.435 -179.289 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -76.38 116.1 4.62 Favored Glycine 0 N--CA 1.447 -0.601 0 C-N-CA 120.966 -0.635 . . . . 0.0 112.587 -179.389 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.454 ' HB ' ' HA ' ' A' ' 110' ' ' PRO . 40.2 pt -102.65 153.62 38.05 Favored Pre-proline 0 C--N 1.326 -0.441 0 N-CA-C 110.43 -0.211 . . . . 0.0 110.43 176.344 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 110' ' ' PRO . . . . . 0.56 ' HD3' ' HB3' ' A' ' 45' ' ' CYS . 49.5 Cg_endo -71.61 133.94 30.69 Favored 'Cis proline' 0 C--N 1.343 0.288 0 C-N-CA 123.175 -1.594 . . . . 0.0 113.236 1.312 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 111' ' ' ARG . . . . . 1.039 ' HG3' ' HB ' ' A' ' 106' ' ' ILE . 0.0 OUTLIER -95.22 146.41 24.35 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 173.975 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 112' ' ' PHE . . . . . 0.549 ' CE1' ' HB2' ' A' ' 128' ' ' ARG . 9.7 m-85 -119.35 119.44 34.0 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 -177.495 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.407 HD11 HG21 ' A' ' 106' ' ' ILE . 91.7 mt -131.13 138.19 53.96 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-O 121.015 0.436 . . . . 0.0 110.975 -177.283 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.72 HD21 HD11 ' A' ' 141' ' ' LEU . 30.6 tp -119.47 133.09 55.86 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.631 -0.713 . . . . 0.0 109.471 177.738 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.421 ' N ' HD12 ' A' ' 115' ' ' LEU . 0.7 OUTLIER -133.74 155.33 49.96 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.206 0.527 . . . . 0.0 110.61 -178.003 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 116' ' ' ASP . . . . . 0.637 ' HB3' ' HB2' ' A' ' 120' ' ' LYS . 17.6 t70 -71.21 166.82 20.71 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.176 -0.92 . . . . 0.0 110.804 176.76 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 117' ' ' ARG . . . . . 0.406 ' N ' ' CG ' ' A' ' 116' ' ' ASP . 69.4 mtt85 -51.55 -32.15 27.1 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 124.281 1.033 . . . . 0.0 112.974 -178.09 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 118' ' ' ASP . . . . . 0.684 ' HB3' ' HD3' ' A' ' 120' ' ' LYS . 25.4 t70 -81.25 4.48 20.24 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-O 121.474 0.654 . . . . 0.0 110.474 179.45 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 81.31 23.11 59.38 Favored Glycine 0 N--CA 1.438 -1.207 0 N-CA-C 110.466 -1.054 . . . . 0.0 110.466 -173.832 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 120' ' ' LYS . . . . . 0.684 ' HD3' ' HB3' ' A' ' 118' ' ' ASP . 19.8 mmmt -81.27 106.69 13.45 Favored 'General case' 0 CA--C 1.51 -0.566 0 C-N-CA 120.646 -0.422 . . . . 0.0 110.864 -176.028 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 121' ' ' ILE . . . . . 0.637 ' H ' HD12 ' A' ' 121' ' ' ILE . 3.6 mp -47.05 106.58 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.315 -0.916 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.822 178.189 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 39.3 mm -88.34 -47.21 15.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 115.51 -0.768 . . . . 0.0 109.661 -179.75 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 13.6 m -144.95 114.64 7.26 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.721 178.576 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -74.52 -24.13 58.93 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.621 0.724 . . . . 0.0 109.782 174.774 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 125' ' ' ASN . . . . . 0.733 ' HA ' ' NH1' ' A' ' 111' ' ' ARG . 53.6 t30 -110.4 85.04 2.03 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.487 -0.779 . . . . 0.0 109.329 175.485 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 126' ' ' MET . . . . . 0.623 ' HG2' ' HB2' ' A' ' 114' ' ' LEU . 3.3 tpt -113.54 -166.91 1.13 Allowed 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 107.813 -1.18 . . . . 0.0 107.813 179.026 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 127' ' ' THR . . . . . 0.561 ' O ' HG21 ' A' ' 134' ' ' THR . 2.1 p -132.11 161.53 33.07 Favored 'General case' 0 C--N 1.316 -0.882 0 N-CA-C 109.684 -0.487 . . . . 0.0 109.684 179.864 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 128' ' ' ARG . . . . . 0.636 ' CG ' ' HD2' ' A' ' 129' ' ' PRO . 19.2 ttt180 -86.76 158.01 54.23 Favored Pre-proline 0 C--N 1.316 -0.887 0 N-CA-C 109.795 -0.446 . . . . 0.0 109.795 179.387 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 129' ' ' PRO . . . . . 0.636 ' HD2' ' CG ' ' A' ' 128' ' ' ARG . 49.3 Cg_exo -42.81 -23.66 0.35 Allowed 'Trans proline' 0 C--N 1.356 0.945 0 C-N-CA 123.468 2.779 . . . . 0.0 113.908 170.906 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -55.85 -31.91 63.17 Favored 'General case' 0 CA--C 1.529 0.143 0 CA-C-O 121.092 0.472 . . . . 0.0 110.691 175.325 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 11.1 t0 -101.67 127.83 30.4 Favored Pre-proline 0 C--O 1.237 0.439 0 CA-C-N 115.852 -0.613 . . . . 0.0 109.92 179.51 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -58.35 -26.81 78.93 Favored 'Trans proline' 0 C--N 1.347 0.464 0 C-N-CA 123.299 2.666 . . . . 0.0 114.047 -178.385 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 42.3 mttp -56.15 -42.25 76.7 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-O 121.457 0.646 . . . . 0.0 110.842 -177.451 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 134' ' ' THR . . . . . 0.561 HG21 ' O ' ' A' ' 127' ' ' THR . 0.1 OUTLIER -69.14 -43.07 75.08 Favored 'General case' 0 N--CA 1.443 -0.821 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.539 178.883 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 135' ' ' ALA . . . . . 0.539 ' HA ' ' CD2' ' A' ' 138' ' ' PHE . . . -56.78 -46.92 81.22 Favored 'General case' 0 C--O 1.238 0.478 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.618 179.259 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 136' ' ' GLU . . . . . 0.647 ' HA ' ' OD1' ' A' ' 139' ' ' ASN . 14.7 pt-20 -71.15 -23.75 62.13 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.621 -179.559 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 137' ' ' LYS . . . . . 0.634 ' O ' ' HB3' ' A' ' 140' ' ' GLU . 60.9 tttp -79.28 -26.9 42.25 Favored 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 120.422 -0.511 . . . . 0.0 111.023 173.313 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 138' ' ' PHE . . . . . 0.637 ' HD2' HD11 ' A' ' 55' ' ' LEU . 21.5 m-85 -65.15 -43.2 92.57 Favored 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 120.469 -0.492 . . . . 0.0 110.213 177.138 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 139' ' ' ASN . . . . . 0.647 ' OD1' ' HA ' ' A' ' 136' ' ' GLU . 2.0 p-10 -70.01 -32.18 70.22 Favored 'General case' 0 C--O 1.224 -0.264 0 C-N-CA 120.006 -0.678 . . . . 0.0 110.128 175.099 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 140' ' ' GLU . . . . . 0.634 ' HB3' ' O ' ' A' ' 137' ' ' LYS . 4.4 tt0 -51.23 -55.13 19.69 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-O 120.823 0.344 . . . . 0.0 110.657 169.371 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.72 HD11 HD21 ' A' ' 114' ' ' LEU . 90.1 mt -58.42 -36.26 73.34 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.533 -178.918 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 0.506 ' HG ' ' O ' ' A' ' 138' ' ' PHE . 86.9 mt . . . . . 0 C--N 1.327 -0.382 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.2 -179.671 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 0.708 0 CA-C-O 121.125 0.488 . . . . 0.0 111.592 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -80.92 73.75 7.93 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.649 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' SER . . . . . 0.571 ' HA ' ' HB3' ' A' ' 25' ' ' LEU . 18.1 m 71.79 90.47 0.09 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.151 -0.931 . . . . 0.0 111.103 178.644 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 33.6 p90 -105.69 163.51 12.64 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.509 179.031 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' SER . . . . . 0.411 ' HA ' ' HA ' ' A' ' 24' ' ' SER . 11.9 p -137.45 128.27 27.18 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.276 -0.42 . . . . 0.0 109.902 178.053 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' TYR . . . . . 0.431 ' HA ' ' HD3' ' A' ' 16' ' ' PRO . 36.3 m-85 -140.91 149.63 56.78 Favored Pre-proline 0 C--N 1.326 -0.427 0 CA-C-N 116.532 -0.304 . . . . 0.0 110.248 -177.016 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.684 ' HA ' ' O ' ' A' ' 21' ' ' LYS . 3.8 Cg_exo -75.23 124.91 8.82 Favored 'Trans proline' 0 N--CA 1.453 -0.885 0 C-N-CA 122.201 1.934 . . . . 0.0 112.726 179.677 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' ASP . . . . . 0.769 ' HB3' ' HB3' ' A' ' 21' ' ' LYS . 0.0 OUTLIER -64.89 162.01 17.2 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.38 -0.827 . . . . 0.0 109.05 170.732 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.633 HG21 HG11 ' A' ' 82' ' ' VAL . 9.6 tp -62.42 -25.95 39.19 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.242 -171.656 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' ASN . . . . . 0.497 ' HB2' ' OD2' ' A' ' 17' ' ' ASP . 4.4 m-20 -80.85 4.98 17.4 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.127 177.253 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 78.89 49.54 6.4 Favored Glycine 0 N--CA 1.449 -0.451 0 N-CA-C 110.809 -0.917 . . . . 0.0 110.809 -176.258 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.769 ' HB3' ' HB3' ' A' ' 17' ' ' ASP . 0.0 OUTLIER -114.84 140.85 48.61 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.531 -0.335 . . . . 0.0 110.521 -173.63 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 19.6 m -90.62 99.07 12.17 Favored 'General case' 0 C--N 1.318 -0.762 0 C-N-CA 120.512 -0.475 . . . . 0.0 110.078 178.207 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.415 ' HB ' ' CD2' ' A' ' 92' ' ' LEU . 48.7 t -115.34 137.79 47.78 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 116.069 -0.514 . . . . 0.0 109.735 -179.756 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' SER . . . . . 0.411 ' HA ' ' HA ' ' A' ' 14' ' ' SER . 59.7 p -122.55 169.52 10.93 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.964 -175.786 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.8 HD12 HD12 ' A' ' 28' ' ' LEU . 32.5 tp -66.74 -16.1 64.0 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.026 174.87 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.409 ' HA ' ' HD3' ' A' ' 29' ' ' LYS . . . -62.4 -39.74 94.22 Favored 'General case' 0 C--N 1.333 -0.123 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.948 179.75 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -61.16 -33.81 74.02 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-O 121.772 0.796 . . . . 0.0 110.226 174.952 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.8 HD12 HD12 ' A' ' 25' ' ' LEU . 33.4 mt -79.64 -15.02 58.36 Favored 'General case' 0 N--CA 1.445 -0.688 0 CA-C-N 115.0 -1.0 . . . . 0.0 111.684 -173.008 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.67 ' HA ' ' O ' ' A' ' 117' ' ' ARG . 1.7 mptm? -66.46 160.83 24.11 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.392 0.615 . . . . 0.0 111.881 178.198 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 84.32 -14.83 43.25 Favored Glycine 0 N--CA 1.45 -0.374 0 CA-C-N 115.464 -0.789 . . . . 0.0 112.29 178.986 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.578 ' HG3' ' CG ' ' A' ' 63' ' ' ASP . 24.5 ttmm -144.15 143.15 30.96 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 109.311 -0.625 . . . . 0.0 109.311 -176.507 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 63.0 m-85 -56.2 155.04 7.11 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-O 120.681 0.277 . . . . 0.0 111.276 -177.689 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.557 HD12 ' HA2' ' A' ' 119' ' ' GLY . 43.3 mt -128.11 135.39 62.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-O 120.74 0.305 . . . . 0.0 111.565 -171.913 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' TYR . . . . . 0.541 ' HB2' HD11 ' A' ' 64' ' ' ILE . 88.1 t80 -120.04 116.47 25.79 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 173.532 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.538 ' HA ' ' O ' ' A' ' 67' ' ' VAL . 28.9 mm -101.7 132.21 48.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.566 -179.299 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.57 ' HA ' ' O ' ' A' ' 111' ' ' ARG . 1.2 t70 -140.77 162.76 34.65 Favored 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 176.992 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.555 ' HB ' ' HA ' ' A' ' 110' ' ' PRO . 46.8 t -102.06 131.22 50.5 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.919 0 C-N-CA 120.212 -0.595 . . . . 0.0 111.45 176.736 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' TRP . . . . . 0.685 ' CZ2' ' HB3' ' A' ' 91' ' ' GLN . 0.9 OUTLIER -126.14 132.75 51.78 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-O 120.822 0.344 . . . . 0.0 110.128 179.325 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.54 ' HB3' ' SG ' ' A' ' 42' ' ' CYS . . . -148.68 168.74 22.06 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-N 116.688 -0.233 . . . . 0.0 110.85 178.013 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' THR . . . . . 0.599 ' HB ' ' CE3' ' A' ' 78' ' ' TRP . 9.6 t -92.08 -18.68 23.24 Favored 'General case' 0 C--O 1.233 0.235 0 C-N-CA 120.868 -0.333 . . . . 0.0 111.667 179.265 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 1.5 p-90 -90.41 -13.46 34.9 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.788 0.328 . . . . 0.0 111.712 -177.44 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' CYS . . . . . 0.54 ' SG ' ' HB3' ' A' ' 39' ' ' ALA . 5.9 p -88.34 94.99 10.02 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.014 0.435 . . . . 0.0 110.515 177.723 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -54.17 -58.3 13.42 Favored Glycine 0 CA--C 1.524 0.647 0 CA-C-N 115.43 -0.804 . . . . 0.0 113.967 -179.309 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -53.95 -38.41 86.32 Favored 'Trans proline' 0 C--N 1.354 0.83 0 C-N-CA 122.721 2.28 . . . . 0.0 112.68 -178.31 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' CYS . . . . . 0.809 ' HB2' ' HD3' ' A' ' 110' ' ' PRO . 36.7 t -59.07 -38.54 79.69 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.184 0.516 . . . . 0.0 110.689 178.888 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.518 ' HA ' ' HG ' ' A' ' 49' ' ' LEU . 39.3 mtp180 -70.9 -15.83 62.64 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.911 -176.322 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -77.91 -26.48 60.28 Favored Glycine 0 N--CA 1.445 -0.701 0 C-N-CA 120.754 -0.736 . . . . 0.0 111.769 177.119 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' GLU . . . . . 0.652 ' HB3' ' HB3' ' A' ' 130' ' ' SER . 14.2 pt-20 -107.03 0.99 24.01 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.841 0.353 . . . . 0.0 111.5 -179.854 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.538 ' N ' ' HD2' ' A' ' 50' ' ' PRO . 68.4 mt -59.94 -45.8 98.16 Favored Pre-proline 0 CA--C 1.537 0.456 0 CA-C-N 116.531 -0.304 . . . . 0.0 111.288 172.992 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.538 ' HD2' ' N ' ' A' ' 49' ' ' LEU . 11.9 Cg_endo -57.53 -35.16 98.89 Favored 'Trans proline' 0 C--N 1.356 0.965 0 C-N-CA 121.761 1.641 . . . . 0.0 111.913 171.323 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.586 ' HA ' ' HG2' ' A' ' 54' ' ' GLU . . . -67.3 -23.43 65.65 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-O 121.079 0.466 . . . . 0.0 110.806 179.042 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 10.0 tt -69.88 -34.08 73.08 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.944 -0.571 . . . . 0.0 109.554 176.073 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.486 ' HB3' ' O ' ' A' ' 50' ' ' PRO . 11.3 tttm -65.54 -46.71 78.5 Favored 'General case' 0 N--CA 1.425 -1.675 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 172.402 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.586 ' HG2' ' HA ' ' A' ' 51' ' ' ALA . 24.4 mm-40 -52.6 -44.65 66.11 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.05 -0.977 . . . . 0.0 110.001 176.688 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 47.8 mt -57.15 -53.55 56.8 Favored 'General case' 0 N--CA 1.452 -0.375 0 CA-C-N 115.433 -0.803 . . . . 0.0 111.249 175.418 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -48.87 -58.86 4.16 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.204 -0.907 . . . . 0.0 111.848 -179.052 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -71.11 -27.69 63.77 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 111.828 0.306 . . . . 0.0 111.828 -176.49 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 33.5 tttm -66.12 -25.04 66.81 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-O 121.01 0.433 . . . . 0.0 109.911 175.185 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.715 ' HD1' ' HG3' ' A' ' 62' ' ' LYS . 53.1 m-85 -124.26 18.34 9.06 Favored 'General case' 0 N--CA 1.453 -0.284 0 N-CA-C 112.766 0.654 . . . . 0.0 112.766 -176.522 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -62.03 110.23 1.52 Allowed 'General case' 0 C--N 1.323 -0.543 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 169.595 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 113.74 -13.27 22.57 Favored Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 120.802 -0.713 . . . . 0.0 111.758 -175.215 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.777 ' HD2' ' HG ' ' A' ' 142' ' ' LEU . 28.7 mmtp -84.82 -170.38 3.09 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-O 121.416 0.627 . . . . 0.0 110.809 177.418 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 63' ' ' ASP . . . . . 0.578 ' CG ' ' HG3' ' A' ' 31' ' ' LYS . 16.9 t70 -116.95 82.96 1.89 Allowed 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.417 -179.217 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.541 HD11 ' HB2' ' A' ' 34' ' ' TYR . 17.2 tt -157.97 141.94 7.05 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.535 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.342 177.211 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 65' ' ' HIS . . . . . 0.527 ' NE2' ' HB3' ' A' ' 31' ' ' LYS . 84.5 m-70 -103.52 108.58 19.89 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 109.176 -0.676 . . . . 0.0 109.176 171.258 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 89.6 m-85 -78.78 103.54 8.79 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 172.783 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.701 ' HA ' ' O ' ' A' ' 90' ' ' ILE . 41.2 t -127.79 117.87 47.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-O 120.797 0.332 . . . . 0.0 111.068 -174.501 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 68' ' ' SER . . . . . 0.533 ' HA ' ' O ' ' A' ' 36' ' ' ASP . 8.3 m -109.16 147.37 32.61 Favored 'General case' 0 C--N 1.318 -0.768 0 C-N-CA 120.687 -0.405 . . . . 0.0 110.597 178.03 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.56 HD13 ' HB2' ' A' ' 92' ' ' LEU . 3.8 mm? -110.96 132.91 53.81 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.476 178.355 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 27.5 t -112.95 117.33 31.78 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.106 0.479 . . . . 0.0 111.693 -179.118 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 71.7 m -91.81 33.24 1.05 Allowed 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.247 172.791 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.528 ' OD2' HG22 ' A' ' 40' ' ' THR . 0.4 OUTLIER -75.62 126.41 30.95 Favored 'General case' 0 CA--C 1.512 -0.514 0 C-N-CA 120.155 -0.618 . . . . 0.0 110.446 178.07 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.597 ' H ' ' HE3' ' A' ' 73' ' ' LYS . 0.0 OUTLIER -78.13 -14.56 59.43 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.224 -178.887 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 74' ' ' ASN . . . . . 0.603 ' HB2' ' HB3' ' A' ' 77' ' ' ALA . 0.6 OUTLIER -101.19 68.95 1.26 Allowed 'General case' 0 CA--C 1.512 -0.51 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 179.283 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.613 ' O ' ' HG3' ' A' ' 79' ' ' GLU . 11.8 tmtt? -54.66 -53.13 58.8 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.616 -173.779 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.451 ' HA ' ' CD ' ' A' ' 79' ' ' GLU . 18.2 tptp -52.87 -53.74 44.66 Favored 'General case' 0 C--N 1.327 -0.376 0 O-C-N 123.321 0.388 . . . . 0.0 110.847 179.018 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.603 ' HB3' ' HB2' ' A' ' 74' ' ' ASN . . . -56.53 -36.67 69.49 Favored 'General case' 0 C--O 1.24 0.565 0 CA-C-O 121.517 0.675 . . . . 0.0 110.505 179.358 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 78' ' ' TRP . . . . . 0.659 ' HZ2' ' CE3' ' A' ' 38' ' ' TRP . 8.0 t-105 -68.64 -34.21 75.35 Favored 'General case' 0 N--CA 1.435 -1.216 0 CA-C-N 114.807 -1.088 . . . . 0.0 110.606 -178.02 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.613 ' HG3' ' O ' ' A' ' 75' ' ' LYS . 52.7 mt-10 -53.66 -51.35 63.46 Favored 'General case' 0 CA--C 1.515 -0.39 0 CA-C-O 121.482 0.658 . . . . 0.0 110.822 173.766 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 80' ' ' ASN . . . . . 0.446 ' OD1' ' HA ' ' A' ' 77' ' ' ALA . 0.9 OUTLIER -66.23 -33.57 76.06 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.253 -0.885 . . . . 0.0 111.188 -173.282 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 1.4 tmt? -63.87 -59.12 4.92 Favored 'General case' 0 CA--C 1.517 -0.314 0 C-N-CA 120.849 -0.34 . . . . 0.0 111.306 177.731 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.633 HG11 HG21 ' A' ' 18' ' ' ILE . 5.7 p -58.52 -28.65 36.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-O 121.066 0.46 . . . . 0.0 110.873 -176.27 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 27.8 m -76.23 -40.43 52.12 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.927 -0.578 . . . . 0.0 110.954 176.902 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' LYS . . . . . 0.508 ' C ' ' HE2' ' A' ' 84' ' ' LYS . 0.0 OUTLIER -73.69 -49.0 27.92 Favored 'General case' 0 N--CA 1.456 -0.16 0 CA-C-O 121.338 0.589 . . . . 0.0 109.656 -178.096 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -76.27 0.49 19.09 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.129 -0.941 . . . . 0.0 111.211 -173.427 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 77.4 mt-30 61.41 34.21 18.34 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-N 115.79 -0.641 . . . . 0.0 112.575 168.853 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.596 ' HB2' HG23 ' A' ' 82' ' ' VAL . 72.0 mt -67.34 151.44 47.46 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.193 0.521 . . . . 0.0 111.548 -176.662 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 22.0 mmtm -117.75 -168.03 1.43 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.562 176.482 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 82.65 170.58 45.76 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 121.151 -0.547 . . . . 0.0 112.743 -177.719 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.701 ' O ' ' HA ' ' A' ' 67' ' ' VAL . 62.9 mt -85.64 112.11 21.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 N-CA-C 108.509 -0.922 . . . . 0.0 108.509 175.064 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 91' ' ' GLN . . . . . 0.685 ' HB3' ' CZ2' ' A' ' 38' ' ' TRP . 11.6 mm-40 -119.28 109.95 16.43 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-O 121.139 0.495 . . . . 0.0 111.181 -169.452 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.56 ' HB2' HD13 ' A' ' 69' ' ' LEU . 61.2 mt -106.55 149.46 27.12 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.465 0.65 . . . . 0.0 110.725 -177.64 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 93' ' ' HIS . . . . . 0.612 ' CE1' ' HA2' ' A' ' 95' ' ' GLY . 17.2 t-80 -119.95 111.59 18.11 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.662 -177.011 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 1.4 ttp -61.95 -49.64 75.3 Favored 'General case' 0 N--CA 1.448 -0.574 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.442 179.102 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 95' ' ' GLY . . . . . 0.612 ' HA2' ' CE1' ' A' ' 93' ' ' HIS . . . 118.68 -109.59 1.77 Allowed Glycine 0 N--CA 1.44 -1.076 0 CA-C-N 115.335 -0.848 . . . . 0.0 111.212 -177.997 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 1.7 m -126.94 24.17 6.48 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-O 120.731 0.3 . . . . 0.0 110.591 -179.255 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -87.32 142.65 27.73 Favored 'General case' 0 C--O 1.236 0.375 0 C-N-CA 119.656 -0.818 . . . . 0.0 111.276 -176.993 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 98' ' ' ARG . . . . . 0.807 ' HA ' ' HB2' ' A' ' 101' ' ' MET . 8.0 tpt180 -127.34 -3.42 6.19 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.039 -0.982 . . . . 0.0 110.163 178.057 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 1.5 m -66.49 -41.17 89.34 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 176.207 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 100' ' ' PHE . . . . . 0.403 ' CZ ' ' HE2' ' A' ' 104' ' ' TYR . 6.1 t80 -83.11 -24.34 32.66 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.433 -0.803 . . . . 0.0 109.707 176.298 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 101' ' ' MET . . . . . 0.807 ' HB2' ' HA ' ' A' ' 98' ' ' ARG . 0.0 OUTLIER -64.39 -55.49 20.69 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.432 -0.803 . . . . 0.0 109.078 178.125 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 102' ' ' ASP . . . . . 0.493 ' CG ' ' HE ' ' A' ' 98' ' ' ARG . 7.8 m-20 -65.02 -25.3 67.79 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.907 174.826 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -59.97 -32.24 70.64 Favored 'General case' 0 N--CA 1.466 0.33 0 N-CA-C 112.02 0.378 . . . . 0.0 112.02 -176.399 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 104' ' ' TYR . . . . . 0.403 ' HE2' ' CZ ' ' A' ' 100' ' ' PHE . 23.4 m-85 -101.04 8.55 42.89 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.619 0.247 . . . . 0.0 111.386 179.299 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 3.5 mm? 61.18 21.03 11.52 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.211 -179.831 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 106' ' ' ILE . . . . . 0.603 HG12 ' O ' ' A' ' 101' ' ' MET . 15.3 pt -79.98 150.55 4.91 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 176.013 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 107' ' ' ASN . . . . . 0.481 ' ND2' HH22 ' A' ' 98' ' ' ARG . 12.1 t-20 -160.82 -64.34 0.06 Allowed 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 -179.798 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -77.28 78.8 1.4 Allowed Glycine 0 N--CA 1.449 -0.498 0 N-CA-C 111.061 -0.815 . . . . 0.0 111.061 174.359 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.587 ' HB ' ' HA ' ' A' ' 110' ' ' PRO . 2.8 pp -75.68 161.1 77.48 Favored Pre-proline 0 C--N 1.323 -0.572 0 CA-C-N 115.719 -0.241 . . . . 0.0 111.546 -175.366 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 110' ' ' PRO . . . . . 0.809 ' HD3' ' HB2' ' A' ' 45' ' ' CYS . 40.1 Cg_endo -68.72 164.21 76.73 Favored 'Cis proline' 0 C--N 1.35 0.633 0 C-N-CA 124.029 -1.238 . . . . 0.0 113.504 0.983 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 111' ' ' ARG . . . . . 0.578 HH11 HG22 ' A' ' 106' ' ' ILE . 0.0 OUTLIER -129.54 137.59 50.85 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.728 -0.669 . . . . 0.0 109.43 179.314 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 112' ' ' PHE . . . . . 0.434 ' H ' ' HD3' ' A' ' 111' ' ' ARG . 0.2 OUTLIER -105.55 115.47 30.3 Favored 'General case' 0 C--N 1.323 -0.583 0 O-C-N 124.712 1.257 . . . . 0.0 111.413 -172.157 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.511 ' HB ' ' HB ' ' A' ' 35' ' ' ILE . 79.3 mt -131.16 146.15 34.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 120.936 0.398 . . . . 0.0 110.903 -178.956 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 42.0 tp -128.89 135.6 49.28 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.148 178.382 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.489 ' N ' HD12 ' A' ' 115' ' ' LEU . 1.3 mp -135.51 161.13 36.34 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.368 0.604 . . . . 0.0 110.892 -178.216 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 116' ' ' ASP . . . . . 0.867 ' HB3' ' HB2' ' A' ' 120' ' ' LYS . 17.8 t70 -74.22 165.35 25.31 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 114.874 -1.057 . . . . 0.0 110.443 175.728 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 117' ' ' ARG . . . . . 0.67 ' O ' ' HA ' ' A' ' 29' ' ' LYS . 53.8 mtt-85 -46.71 -39.35 11.35 Favored 'General case' 0 C--N 1.33 -0.271 0 O-C-N 124.308 1.005 . . . . 0.0 112.423 -178.562 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 118' ' ' ASP . . . . . 0.621 ' HA ' ' HG3' ' A' ' 29' ' ' LYS . 14.6 t0 -83.92 16.77 2.65 Favored 'General case' 0 C--O 1.237 0.423 0 CA-C-O 121.154 0.502 . . . . 0.0 111.253 -177.623 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 119' ' ' GLY . . . . . 0.557 ' HA2' HD12 ' A' ' 33' ' ' ILE . . . 72.85 25.26 74.32 Favored Glycine 0 N--CA 1.435 -1.416 0 C-N-CA 120.417 -0.897 . . . . 0.0 110.869 -175.712 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 120' ' ' LYS . . . . . 0.867 ' HB2' ' HB3' ' A' ' 116' ' ' ASP . 40.3 mmtm -85.7 104.17 15.17 Favored 'General case' 0 C--O 1.22 -0.462 0 C-N-CA 120.378 -0.529 . . . . 0.0 111.458 -179.196 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 121' ' ' ILE . . . . . 0.647 ' H ' HD12 ' A' ' 121' ' ' ILE . 3.8 mp -44.81 113.22 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.678 -179.053 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 122' ' ' ILE . . . . . 0.42 ' H ' ' HA ' ' A' ' 115' ' ' LEU . 46.0 mm -95.75 -44.25 12.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.664 -0.698 . . . . 0.0 109.597 177.855 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 14.6 m -142.29 114.82 8.48 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.485 -0.78 . . . . 0.0 110.086 177.964 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 124' ' ' ALA . . . . . 0.407 ' HA ' HG23 ' A' ' 113' ' ' ILE . . . -78.06 -6.9 56.05 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.043 0.449 . . . . 0.0 110.832 179.276 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 5.9 t30 -150.81 100.59 2.83 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.83 -0.623 . . . . 0.0 109.416 179.456 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 126' ' ' MET . . . . . 0.633 ' HG2' HG23 ' A' ' 134' ' ' THR . 43.9 tpp -89.67 -91.04 0.14 Allowed 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 111.935 0.346 . . . . 0.0 111.935 -176.76 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 127' ' ' THR . . . . . 0.527 ' O ' ' HG2' ' A' ' 128' ' ' ARG . 0.0 OUTLIER -152.67 -70.21 0.15 Allowed 'General case' 0 CA--C 1.531 0.235 0 N-CA-C 112.322 0.49 . . . . 0.0 112.322 -178.326 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 128' ' ' ARG . . . . . 0.527 ' HG2' ' O ' ' A' ' 127' ' ' THR . 3.5 mmt180 175.99 140.13 0.21 Allowed Pre-proline 0 N--CA 1.467 0.393 0 C-N-CA 124.351 1.06 . . . . 0.0 109.299 -173.474 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 129' ' ' PRO . . . . . 0.422 ' HG3' ' OD2' ' A' ' 36' ' ' ASP . 46.0 Cg_exo -56.44 -37.33 97.38 Favored 'Trans proline' 0 C--N 1.342 0.23 0 C-N-CA 122.339 2.026 . . . . 0.0 111.874 171.522 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 130' ' ' SER . . . . . 0.652 ' HB3' ' HB3' ' A' ' 48' ' ' GLU . 13.3 p -78.06 -25.67 47.83 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.821 179.663 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 131' ' ' ASP . . . . . 0.501 ' OD2' ' HB2' ' A' ' 133' ' ' LYS . 29.7 t70 -78.49 117.6 67.31 Favored Pre-proline 0 C--N 1.327 -0.406 0 CA-C-O 120.832 0.348 . . . . 0.0 110.724 -175.336 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 132' ' ' PRO . . . . . 0.585 ' O ' ' HG2' ' A' ' 136' ' ' GLU . 49.6 Cg_exo -56.6 -29.49 79.47 Favored 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 123.469 2.78 . . . . 0.0 113.73 -175.233 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 133' ' ' LYS . . . . . 0.763 ' H ' ' HD3' ' A' ' 133' ' ' LYS . 0.0 OUTLIER -54.48 -35.36 62.99 Favored 'General case' 0 N--CA 1.456 -0.152 0 CA-C-O 120.578 0.227 . . . . 0.0 110.688 -177.824 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 134' ' ' THR . . . . . 0.633 HG23 ' HG2' ' A' ' 126' ' ' MET . 4.6 m -60.69 -48.81 80.13 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.482 0.658 . . . . 0.0 110.666 178.399 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 135' ' ' ALA . . . . . 0.626 ' HA ' ' CD2' ' A' ' 138' ' ' PHE . . . -61.78 -43.36 99.0 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.315 -0.857 . . . . 0.0 111.106 -178.228 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 136' ' ' GLU . . . . . 0.585 ' HG2' ' O ' ' A' ' 132' ' ' PRO . 10.8 mm-40 -72.05 -23.97 61.45 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.546 -177.279 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 137' ' ' LYS . . . . . 0.718 ' HG2' ' O ' ' A' ' 133' ' ' LYS . 17.8 mmtm -56.07 -49.77 72.85 Favored 'General case' 0 CA--C 1.515 -0.369 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 167.901 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 138' ' ' PHE . . . . . 0.626 ' CD2' ' HA ' ' A' ' 135' ' ' ALA . 7.0 m-30 -55.26 -36.91 66.58 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-N 115.163 -0.926 . . . . 0.0 110.57 -178.746 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 139' ' ' ASN . . . . . 0.558 ' ND2' ' HA ' ' A' ' 136' ' ' GLU . 72.8 m-20 -58.13 -56.41 22.38 Favored 'General case' 0 C--N 1.332 -0.179 0 C-N-CA 120.686 -0.406 . . . . 0.0 110.693 175.839 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -44.73 -59.91 2.28 Favored 'General case' 0 C--N 1.342 0.258 0 O-C-N 123.615 0.572 . . . . 0.0 111.675 178.95 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.434 HD13 ' O ' ' A' ' 137' ' ' LYS . 8.5 mp -50.69 -37.8 43.33 Favored 'General case' 0 CA--C 1.531 0.226 0 N-CA-C 112.595 0.591 . . . . 0.0 112.595 178.86 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 0.777 ' HG ' ' HD2' ' A' ' 62' ' ' LYS . 3.8 mm? . . . . . 0 C--N 1.327 -0.401 0 CA-C-O 120.623 0.249 . . . . 0.0 111.623 179.264 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.455 -0.181 0 CA-C-O 121.136 0.493 . . . . 0.0 110.489 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -156.2 -43.44 0.08 Allowed 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.291 -0.868 . . . . 0.0 110.768 -179.35 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 23.5 p -149.91 33.49 0.68 Allowed 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 115.165 -0.925 . . . . 0.0 110.628 -178.256 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' PHE . . . . . 0.426 ' CE2' HD22 ' A' ' 25' ' ' LEU . 27.5 p90 -63.18 150.11 43.73 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.252 -177.278 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' SER . . . . . 0.42 ' HA ' ' HA ' ' A' ' 24' ' ' SER . 15.9 m -137.06 127.53 26.7 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 178.047 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' TYR . . . . . 0.42 ' CE2' ' HB2' ' A' ' 13' ' ' PHE . 77.6 m-85 -138.34 156.93 73.34 Favored Pre-proline 0 C--N 1.326 -0.436 0 CA-C-O 120.752 0.311 . . . . 0.0 111.356 -175.399 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.481 ' HD2' ' O ' ' A' ' 93' ' ' HIS . 1.6 Cg_endo -83.53 126.77 4.2 Favored 'Trans proline' 0 N--CA 1.459 -0.556 0 C-N-CA 123.183 2.588 . . . . 0.0 113.85 -178.488 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' ASP . . . . . 1.028 ' HB3' ' HB3' ' A' ' 21' ' ' LYS . 0.4 OUTLIER -65.08 166.14 9.99 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 114.88 -1.055 . . . . 0.0 109.584 169.47 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.579 ' HB ' ' HB2' ' A' ' 79' ' ' GLU . 40.0 pt -48.74 -33.36 5.01 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 C-N-CA 123.561 0.744 . . . . 0.0 112.803 -175.169 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 36.8 m-80 -83.7 -3.1 57.5 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.776 0.322 . . . . 0.0 111.599 -177.48 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 89.83 29.25 16.19 Favored Glycine 0 N--CA 1.45 -0.377 0 N-CA-C 110.212 -1.155 . . . . 0.0 110.212 -171.21 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 1.028 ' HB3' ' HB3' ' A' ' 17' ' ' ASP . 19.1 ttmt -92.23 111.74 23.42 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 114.872 -0.664 . . . . 0.0 110.639 -172.921 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 20.3 m -70.58 112.54 6.91 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 120.796 0.331 . . . . 0.0 111.376 -177.755 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.588 ' HB ' HD21 ' A' ' 92' ' ' LEU . 59.9 t -124.3 145.57 31.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 177.107 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' SER . . . . . 0.42 ' HA ' ' HA ' ' A' ' 14' ' ' SER . 94.5 p -122.01 -175.46 3.12 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.084 0.468 . . . . 0.0 110.904 -175.784 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.471 ' O ' ' HB2' ' A' ' 29' ' ' LYS . 30.8 tp -93.68 -0.32 56.11 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.072 175.479 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.436 ' O ' ' HB3' ' A' ' 29' ' ' LYS . . . -88.94 -35.41 16.48 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.004 -179.196 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 3.9 p30 -78.18 -22.87 47.99 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.448 0.642 . . . . 0.0 110.062 176.7 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.426 HD13 HG21 ' A' ' 67' ' ' VAL . 85.7 mt -89.66 -8.79 51.69 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.105 175.311 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.471 ' HB2' ' O ' ' A' ' 25' ' ' LEU . 48.3 tttp -76.45 140.29 41.21 Favored 'General case' 0 N--CA 1.446 -0.654 0 CA-C-N 115.48 -0.782 . . . . 0.0 111.177 -176.254 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 110.54 2.32 29.16 Favored Glycine 0 N--CA 1.449 -0.481 0 N-CA-C 111.382 -0.687 . . . . 0.0 111.382 -177.153 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.597 ' HG3' ' CG ' ' A' ' 63' ' ' ASP . 24.6 ttmm -152.43 149.91 29.08 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 109.076 -0.712 . . . . 0.0 109.076 -179.758 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.449 ' HB2' ' O ' ' A' ' 63' ' ' ASP . 39.3 m-85 -49.11 144.92 4.53 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-O 121.044 0.45 . . . . 0.0 111.889 -177.307 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.511 ' HB ' ' HB2' ' A' ' 115' ' ' LEU . 35.3 mm -121.53 122.69 67.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.985 -177.234 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 78.6 t80 -116.96 112.01 20.4 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 108.782 -0.822 . . . . 0.0 108.782 171.701 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.716 ' HB ' ' CG2' ' A' ' 113' ' ' ILE . 78.8 mt -105.35 129.4 58.24 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 C-N-CA 120.563 -0.455 . . . . 0.0 110.446 -177.023 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.504 ' HA ' ' O ' ' A' ' 111' ' ' ARG . 1.8 t70 -123.34 159.72 28.26 Favored 'General case' 0 C--N 1.314 -0.938 0 N-CA-C 108.798 -0.815 . . . . 0.0 108.798 178.06 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.532 HG11 HG21 ' A' ' 109' ' ' ILE . 58.9 t -104.59 112.79 39.6 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.953 0 C-N-CA 120.258 -0.577 . . . . 0.0 110.49 176.24 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' TRP . . . . . 0.597 ' CZ2' ' HB3' ' A' ' 91' ' ' GLN . 0.6 OUTLIER -101.98 132.64 47.7 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.235 -176.055 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.427 ' HA ' ' OD1' ' A' ' 72' ' ' ASP . . . -147.05 156.25 42.87 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.885 -178.21 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' THR . . . . . 0.717 ' HB ' ' CE3' ' A' ' 78' ' ' TRP . 14.6 t -99.14 -23.46 15.23 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 120.898 -0.321 . . . . 0.0 110.808 175.418 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 8.8 p-90 -84.08 -8.0 59.23 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.076 0.465 . . . . 0.0 110.831 -179.94 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 42.5 t -91.99 105.29 17.57 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 175.713 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.406 ' N ' ' HD2' ' A' ' 44' ' ' PRO . . . -54.74 -61.68 7.05 Favored Glycine 0 CA--C 1.524 0.641 0 CA-C-N 115.712 -0.676 . . . . 0.0 113.837 -178.424 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.406 ' HD2' ' N ' ' A' ' 43' ' ' GLY . 12.3 Cg_endo -55.76 -34.33 90.66 Favored 'Trans proline' 0 C--N 1.352 0.755 0 C-N-CA 122.901 2.401 . . . . 0.0 112.66 -177.415 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 45' ' ' CYS . . . . . 0.706 ' O ' ' HG ' ' A' ' 49' ' ' LEU . 49.6 t -53.08 -39.75 63.57 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.178 179.481 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.678 HH12 ' HH2' ' A' ' 78' ' ' TRP . 20.1 mmm180 -65.92 -20.76 66.33 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.585 -174.409 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -80.56 -40.18 13.26 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.84 -0.695 . . . . 0.0 113.383 -174.126 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -95.72 -6.36 39.98 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 117.077 0.438 . . . . 0.0 111.604 -174.424 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.706 ' HG ' ' O ' ' A' ' 45' ' ' CYS . 39.7 mt -56.96 -47.42 99.12 Favored Pre-proline 0 C--N 1.327 -0.376 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.926 175.868 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.518 ' O ' ' HG2' ' A' ' 54' ' ' GLU . 75.4 Cg_exo -51.6 -40.39 64.14 Favored 'Trans proline' 0 C--N 1.358 1.051 0 C-N-CA 121.972 1.781 . . . . 0.0 112.113 173.906 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -69.86 -27.45 64.85 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.431 0.634 . . . . 0.0 110.695 -178.418 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.592 HD22 ' HE3' ' A' ' 88' ' ' LYS . 3.6 tt -73.36 -33.2 64.94 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.506 -0.77 . . . . 0.0 109.214 176.247 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.87 ' HE2' HD23 ' A' ' 87' ' ' LEU . 85.0 mttt -64.61 -50.37 67.44 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 108.933 -0.765 . . . . 0.0 108.933 174.905 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.518 ' HG2' ' O ' ' A' ' 50' ' ' PRO . 33.1 mm-40 -51.82 -41.75 62.0 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-N 114.822 -1.081 . . . . 0.0 110.836 175.797 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.594 HD21 ' CE2' ' A' ' 138' ' ' PHE . 17.6 tp -61.29 -44.41 97.26 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.05 -0.977 . . . . 0.0 111.057 -178.624 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.569 ' OE1' ' HB2' ' A' ' 88' ' ' LYS . 24.4 tt0 -65.17 -36.53 84.5 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-N 116.61 -0.268 . . . . 0.0 111.306 -178.192 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 17.2 mm-40 -54.07 -54.41 39.83 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.579 0.704 . . . . 0.0 109.832 173.851 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' LYS . . . . . 0.491 ' HE3' ' CZ ' ' A' ' 59' ' ' TYR . 32.6 tttp -53.81 -33.88 57.47 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 114.58 -1.191 . . . . 0.0 112.333 177.334 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.491 ' CZ ' ' HE3' ' A' ' 58' ' ' LYS . 84.9 m-85 -111.16 16.95 20.78 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 112.335 0.494 . . . . 0.0 112.335 -175.88 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -64.1 131.68 48.22 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.868 0.366 . . . . 0.0 110.64 176.552 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 68.68 44.7 69.53 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.922 -0.656 . . . . 0.0 112.176 -179.506 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 40.2 mmtm -128.51 -154.11 0.61 Allowed 'General case' 0 N--CA 1.45 -0.432 0 CA-C-O 120.981 0.419 . . . . 0.0 109.981 177.2 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' ASP . . . . . 0.597 ' CG ' ' HG3' ' A' ' 31' ' ' LYS . 10.4 t70 -111.77 69.46 0.69 Allowed 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 116.182 -0.463 . . . . 0.0 109.799 177.022 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.569 HG13 ' O ' ' A' ' 63' ' ' ASP . 15.1 mt -151.89 139.32 13.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.274 178.437 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 65' ' ' HIS . . . . . 0.509 ' NE2' ' HB3' ' A' ' 31' ' ' LYS . 92.0 m-70 -114.92 111.3 20.96 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.49 -0.777 . . . . 0.0 109.949 173.406 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 66' ' ' PHE . . . . . 0.506 ' HE1' HD23 ' A' ' 55' ' ' LEU . 89.4 m-85 -81.9 103.66 11.71 Favored 'General case' 0 C--N 1.318 -0.782 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 171.179 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.626 ' HA ' ' O ' ' A' ' 90' ' ' ILE . 41.9 t -116.28 122.12 69.03 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.436 -176.242 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 68' ' ' SER . . . . . 0.76 ' HB2' ' HG2' ' A' ' 91' ' ' GLN . 50.7 m -110.54 134.94 51.93 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 116.544 -0.298 . . . . 0.0 110.932 -178.707 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.485 HD13 ' HB2' ' A' ' 92' ' ' LEU . 4.5 mm? -115.75 139.45 50.14 Favored 'General case' 0 N--CA 1.471 0.598 0 N-CA-C 110.081 -0.34 . . . . 0.0 110.081 175.6 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 3.5 t -118.11 124.87 49.08 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 112.926 0.713 . . . . 0.0 112.926 -172.882 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 10.6 m -87.1 13.07 10.03 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.876 174.217 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.59 ' O ' ' HA2' ' A' ' 95' ' ' GLY . 1.0 OUTLIER -71.45 136.31 47.58 Favored 'General case' 0 CA--C 1.516 -0.331 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 -178.476 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.468 ' H ' ' HG2' ' A' ' 73' ' ' LYS . 0.4 OUTLIER -99.98 -18.84 16.85 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-O 121.481 0.657 . . . . 0.0 110.034 178.92 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 74' ' ' ASN . . . . . 0.65 ' HB2' ' HB3' ' A' ' 77' ' ' ALA . 0.8 OUTLIER -80.8 61.05 4.3 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.026 -0.988 . . . . 0.0 109.785 174.369 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 9.5 tttt -50.67 -53.79 28.31 Favored 'General case' 0 C--O 1.222 -0.35 0 N-CA-C 112.647 0.61 . . . . 0.0 112.647 -171.177 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.506 ' HA ' ' OE1' ' A' ' 79' ' ' GLU . 40.3 tptt -61.7 -42.3 98.74 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.842 0.353 . . . . 0.0 110.989 -177.149 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.65 ' HB3' ' HB2' ' A' ' 74' ' ' ASN . . . -63.84 -33.76 76.4 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 121.746 0.784 . . . . 0.0 110.119 176.927 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 78' ' ' TRP . . . . . 0.717 ' CE3' ' HB ' ' A' ' 40' ' ' THR . 9.7 t-105 -76.72 -50.21 14.17 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 114.797 -1.092 . . . . 0.0 111.555 -177.463 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.579 ' HB2' ' HB ' ' A' ' 18' ' ' ILE . 4.1 pt-20 -60.38 -34.44 73.9 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-O 121.198 0.523 . . . . 0.0 110.357 -176.255 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 80' ' ' ASN . . . . . 0.63 ' O ' ' HD3' ' A' ' 84' ' ' LYS . 3.4 p30 -79.42 -29.97 42.15 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 119.67 -0.812 . . . . 0.0 110.668 177.622 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 13.6 tpt -61.4 -47.56 85.26 Favored 'General case' 0 C--O 1.225 -0.235 0 O-C-N 122.437 -0.164 . . . . 0.0 111.175 175.374 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.696 HG23 ' HB2' ' A' ' 87' ' ' LEU . 0.2 OUTLIER -61.1 -36.15 70.55 Favored 'Isoleucine or valine' 0 C--O 1.232 0.164 0 C-N-CA 120.386 -0.526 . . . . 0.0 110.17 175.602 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 76.3 m -61.51 -41.93 98.04 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.289 174.863 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' LYS . . . . . 0.63 ' HD3' ' O ' ' A' ' 80' ' ' ASN . 1.9 mptm? -72.9 -46.92 50.08 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-O 121.092 0.472 . . . . 0.0 110.912 179.684 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -66.03 -25.81 67.23 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.287 -0.869 . . . . 0.0 111.01 -176.477 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 29.2 mm-40 64.59 72.8 0.44 Allowed 'General case' 0 C--O 1.234 0.287 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.561 -175.843 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.87 HD23 ' HE2' ' A' ' 53' ' ' LYS . 89.8 mt -92.99 -179.46 5.11 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.05 177.007 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.592 ' HE3' HD22 ' A' ' 52' ' ' LEU . 0.0 OUTLIER -145.74 173.62 11.93 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 112.534 0.568 . . . . 0.0 112.534 -171.424 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 78.4 -170.71 54.95 Favored Glycine 0 N--CA 1.452 -0.24 0 CA-C-N 115.593 -0.731 . . . . 0.0 112.856 178.883 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.626 ' O ' ' HA ' ' A' ' 67' ' ' VAL . 5.0 mp -89.66 112.1 24.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 177.219 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 91' ' ' GLN . . . . . 0.76 ' HG2' ' HB2' ' A' ' 68' ' ' SER . 21.8 mt-30 -123.11 111.02 16.03 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-O 121.475 0.655 . . . . 0.0 111.061 -174.561 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.588 HD21 ' HB ' ' A' ' 23' ' ' VAL . 55.2 mt -105.98 164.36 12.02 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 114.979 -1.009 . . . . 0.0 109.668 -178.238 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 93' ' ' HIS . . . . . 0.481 ' O ' ' HD2' ' A' ' 16' ' ' PRO . 17.7 t-80 -131.46 124.67 30.67 Favored 'General case' 0 C--N 1.313 -1.015 0 CA-C-O 120.936 0.398 . . . . 0.0 111.357 -171.577 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 24.0 ttp -79.94 -58.02 3.37 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.241 179.39 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' GLY . . . . . 0.59 ' HA2' ' O ' ' A' ' 72' ' ' ASP . . . 101.34 -93.88 1.18 Allowed Glycine 0 N--CA 1.444 -0.789 0 C-N-CA 120.304 -0.951 . . . . 0.0 113.549 174.212 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 4.6 p -109.09 8.63 26.17 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 112.84 0.682 . . . . 0.0 112.84 -172.067 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -102.21 153.11 20.27 Favored 'General case' 0 CA--C 1.517 -0.309 0 C-N-CA 119.811 -0.756 . . . . 0.0 109.962 177.269 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.14 6.93 3.37 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.965 -0.561 . . . . 0.0 109.608 173.462 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 6.9 m -76.54 -32.7 58.39 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.044 -176.038 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 59.5 t80 -74.6 -37.49 62.85 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.546 -0.752 . . . . 0.0 111.014 178.938 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 5.2 ppp? -77.4 -26.17 51.52 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 176.999 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -68.05 -29.92 69.01 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.427 -0.806 . . . . 0.0 109.965 172.876 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -63.25 -18.61 63.74 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-N 115.991 -0.549 . . . . 0.0 111.37 179.181 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 72.3 m-85 -97.36 -5.43 36.43 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-O 120.837 0.351 . . . . 0.0 110.078 178.511 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 87.1 mt 60.19 17.04 6.55 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 115.35 -0.841 . . . . 0.0 111.345 179.349 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 11.1 tp -73.7 -45.15 51.29 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.35 0 N-CA-C 112.566 0.58 . . . . 0.0 112.566 -172.573 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 9.0 t30 67.66 -62.64 0.33 Allowed 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 123.158 0.583 . . . . 0.0 111.613 -176.909 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -91.77 111.05 3.95 Favored Glycine 0 N--CA 1.447 -0.579 0 C-N-CA 121.183 -0.532 . . . . 0.0 112.575 -176.537 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.532 HG21 HG11 ' A' ' 37' ' ' VAL . 43.2 pt -85.1 158.28 58.63 Favored Pre-proline 0 C--N 1.322 -0.595 0 N-CA-C 110.434 -0.21 . . . . 0.0 110.434 176.81 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 110' ' ' PRO . . . . . 0.531 ' HA ' ' HB ' ' A' ' 109' ' ' ILE . 3.0 Cg_exo -74.31 158.69 98.61 Favored 'Cis proline' 0 C--N 1.348 0.53 0 C-N-CA 124.132 -1.195 . . . . 0.0 113.426 1.473 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 111' ' ' ARG . . . . . 0.707 ' HD2' ' N ' ' A' ' 112' ' ' PHE . 0.1 OUTLIER -113.32 140.41 48.04 Favored 'General case' 0 N--CA 1.442 -0.874 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 175.979 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 112' ' ' PHE . . . . . 0.707 ' N ' ' HD2' ' A' ' 111' ' ' ARG . 4.2 m-85 -115.44 132.41 56.63 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 108.609 -0.885 . . . . 0.0 108.609 -177.953 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.716 ' CG2' ' HB ' ' A' ' 35' ' ' ILE . 7.5 tt -147.53 156.77 9.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 118.492 0.587 . . . . 0.0 111.278 -177.846 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 35.3 tp -136.29 132.56 35.89 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.837 0.351 . . . . 0.0 110.495 177.754 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.562 ' HG ' ' HA ' ' A' ' 121' ' ' ILE . 2.5 mp -130.97 151.54 51.26 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 178.979 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 116' ' ' ASP . . . . . 0.432 ' N ' HG13 ' A' ' 122' ' ' ILE . 9.7 t70 -73.1 164.56 26.51 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.965 -0.561 . . . . 0.0 109.792 179.044 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 117' ' ' ARG . . . . . 0.525 ' HG2' ' HA ' ' A' ' 31' ' ' LYS . 3.9 mtm180 -47.32 -33.96 6.27 Favored 'General case' 0 C--N 1.323 -0.554 0 O-C-N 124.519 1.137 . . . . 0.0 112.271 -179.645 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -71.24 -6.03 36.58 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.215 -177.883 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 84.69 22.61 52.95 Favored Glycine 0 N--CA 1.441 -1.027 0 N-CA-C 110.006 -1.238 . . . . 0.0 110.006 -172.542 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 120' ' ' LYS . . . . . 0.401 ' HA ' ' HD3' ' A' ' 120' ' ' LYS . 30.4 mmtp -102.75 111.13 23.31 Favored 'General case' 0 CA--C 1.518 -0.287 0 CA-C-N 115.521 -0.339 . . . . 0.0 111.267 -174.107 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 121' ' ' ILE . . . . . 0.637 ' H ' HD12 ' A' ' 121' ' ' ILE . 3.8 mp -41.4 115.08 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 O-C-N 124.196 0.935 . . . . 0.0 111.817 179.883 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 122' ' ' ILE . . . . . 0.489 ' H ' ' HA ' ' A' ' 115' ' ' LEU . 63.8 mt -83.72 -41.5 16.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 175.92 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 49.4 m -146.55 125.36 12.66 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 114.843 -1.072 . . . . 0.0 109.164 176.091 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -61.34 -31.56 71.43 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-O 121.046 0.45 . . . . 0.0 111.584 -176.189 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 10.9 t30 -138.35 113.83 9.61 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.917 -0.583 . . . . 0.0 109.468 174.554 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 126' ' ' MET . . . . . 0.463 ' HG3' ' H ' ' A' ' 127' ' ' THR . 7.7 tpt -93.91 -148.03 0.26 Allowed 'General case' 0 C--N 1.317 -0.833 0 N-CA-C 108.917 -0.771 . . . . 0.0 108.917 -179.401 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 127' ' ' THR . . . . . 0.463 ' H ' ' HG3' ' A' ' 126' ' ' MET . 1.1 p -135.94 143.09 44.72 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-O 120.707 0.289 . . . . 0.0 110.928 -177.497 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 128' ' ' ARG . . . . . 0.441 ' HA ' ' CD1' ' A' ' 112' ' ' PHE . 9.2 ptp180 -40.65 154.49 0.21 Allowed Pre-proline 0 C--N 1.327 -0.408 0 N-CA-C 113.536 0.939 . . . . 0.0 113.536 176.353 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_exo -54.81 -34.02 83.45 Favored 'Trans proline' 0 C--N 1.348 0.505 0 C-N-CA 123.503 2.802 . . . . 0.0 113.135 178.178 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 16.3 m -76.16 -1.86 28.29 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.655 -178.254 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 131' ' ' ASP . . . . . 0.455 ' HA ' ' HD3' ' A' ' 132' ' ' PRO . 9.8 t70 -90.3 124.82 61.99 Favored Pre-proline 0 C--N 1.324 -0.511 0 N-CA-C 109.974 -0.38 . . . . 0.0 109.974 178.757 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 132' ' ' PRO . . . . . 0.455 ' HD3' ' HA ' ' A' ' 131' ' ' ASP . 43.5 Cg_exo -58.77 -35.71 98.2 Favored 'Trans proline' 0 C--N 1.344 0.325 0 C-N-CA 123.173 2.582 . . . . 0.0 113.414 -177.827 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 133' ' ' LYS . . . . . 0.668 ' HZ2' ' HB2' ' A' ' 133' ' ' LYS . 10.0 mtmp? -62.88 -34.42 77.34 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-O 121.082 0.467 . . . . 0.0 111.031 -177.036 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 134' ' ' THR . . . . . 0.546 HG22 ' CZ ' ' A' ' 138' ' ' PHE . 0.3 OUTLIER -69.64 -51.49 34.39 Favored 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 109.765 -0.457 . . . . 0.0 109.765 177.168 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 135' ' ' ALA . . . . . 0.5 ' HA ' ' CD2' ' A' ' 138' ' ' PHE . . . -54.96 -49.95 70.14 Favored 'General case' 0 C--O 1.24 0.553 0 CA-C-N 115.605 -0.725 . . . . 0.0 112.25 179.653 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 136' ' ' GLU . . . . . 0.538 ' HG3' ' N ' ' A' ' 137' ' ' LYS . 2.0 pt-20 -60.57 -41.44 94.64 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-O 120.978 0.418 . . . . 0.0 110.268 -179.56 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 137' ' ' LYS . . . . . 0.538 ' N ' ' HG3' ' A' ' 136' ' ' GLU . 0.0 OUTLIER -66.53 -33.15 75.03 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.76 -177.217 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 138' ' ' PHE . . . . . 0.594 ' CE2' HD21 ' A' ' 55' ' ' LEU . 20.5 m-85 -58.52 -52.54 65.2 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.336 175.008 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 56.6 m-20 -57.47 -54.55 45.59 Favored 'General case' 0 N--CA 1.464 0.26 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 177.718 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 23.3 tt0 -49.91 -60.5 2.86 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 114.798 -1.092 . . . . 0.0 113.204 179.868 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 84.7 mt -67.43 -28.89 68.27 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-O 120.644 0.259 . . . . 0.0 111.616 -173.994 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 66.8 tp . . . . . 0 C--N 1.325 -0.485 0 CA-C-O 121.335 0.588 . . . . 0.0 109.737 175.202 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.326 0 CA-C-O 121.554 0.692 . . . . 0.0 110.068 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -139.59 91.7 2.51 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.402 -0.817 . . . . 0.0 110.969 -178.355 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' SER . . . . . 1.026 ' HA ' ' HB3' ' A' ' 25' ' ' LEU . 67.2 m 59.06 77.09 0.32 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.702 -0.681 . . . . 0.0 112.105 178.154 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 31.4 p90 -82.3 -178.98 7.25 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.569 177.324 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' SER . . . . . 0.483 ' HA ' ' HA ' ' A' ' 24' ' ' SER . 23.2 t -142.53 134.64 27.36 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 175.469 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' TYR . . . . . 0.412 ' HA ' ' HD3' ' A' ' 16' ' ' PRO . 36.4 m-85 -146.07 150.3 41.55 Favored Pre-proline 0 C--N 1.325 -0.472 0 N-CA-C 109.999 -0.371 . . . . 0.0 109.999 179.835 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' A' ' 15' ' ' TYR . 3.9 Cg_exo -76.64 125.3 8.14 Favored 'Trans proline' 0 N--CA 1.455 -0.778 0 C-N-CA 122.458 2.106 . . . . 0.0 112.14 178.351 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' ASP . . . . . 0.811 ' HB3' ' HB3' ' A' ' 21' ' ' LYS . 0.0 OUTLIER -60.76 163.49 5.57 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.709 -0.678 . . . . 0.0 109.62 172.051 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.548 HG12 HG11 ' A' ' 82' ' ' VAL . 10.5 tp -61.33 -25.52 36.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.817 -170.9 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' ASN . . . . . 0.488 ' HB2' ' OD2' ' A' ' 17' ' ' ASP . 5.6 m-20 -81.88 -5.37 58.19 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 120.932 0.396 . . . . 0.0 110.779 178.064 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 93.42 37.38 5.61 Favored Glycine 0 N--CA 1.447 -0.576 0 N-CA-C 110.888 -0.885 . . . . 0.0 110.888 -175.6 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.811 ' HB3' ' HB3' ' A' ' 17' ' ' ASP . 3.2 ttmp? -108.37 111.48 23.42 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.709 0.29 . . . . 0.0 110.89 -173.449 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 16.7 m -70.49 109.14 4.64 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 120.87 0.366 . . . . 0.0 111.095 -179.257 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.591 ' HB ' HD21 ' A' ' 92' ' ' LEU . 39.4 t -126.48 152.78 34.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 178.355 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' SER . . . . . 0.483 ' HA ' ' HA ' ' A' ' 14' ' ' SER . 93.8 p -122.67 176.35 6.0 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.186 0.517 . . . . 0.0 110.718 -179.973 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 1.026 ' HB3' ' HA ' ' A' ' 12' ' ' SER . 21.0 tp -95.77 15.08 21.17 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 121.761 0.791 . . . . 0.0 108.882 173.435 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.528 ' HA ' ' HE2' ' A' ' 29' ' ' LYS . . . -100.05 -35.0 9.85 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 114.915 -1.038 . . . . 0.0 110.503 177.282 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -81.26 -17.7 48.54 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.458 177.69 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 72.4 mt -91.25 22.79 3.63 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.72 -179.911 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.528 ' HE2' ' HA ' ' A' ' 26' ' ' ALA . 1.1 mptp? -70.43 -169.64 0.32 Allowed 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 121.308 0.575 . . . . 0.0 111.348 176.469 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 89.23 -47.67 3.34 Favored Glycine 0 N--CA 1.45 -0.372 0 CA-C-N 115.83 -0.623 . . . . 0.0 112.616 173.328 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.723 ' HD3' ' HA ' ' A' ' 63' ' ' ASP . 72.6 mttt -127.05 167.72 15.56 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 110.0 -0.37 . . . . 0.0 110.0 -178.311 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.406 ' HD1' ' HA ' ' A' ' 116' ' ' ASP . 97.6 m-85 -64.95 154.12 38.47 Favored 'General case' 0 C--N 1.327 -0.4 0 O-C-N 123.197 0.311 . . . . 0.0 110.798 -176.579 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.468 HD13 ' HA2' ' A' ' 119' ' ' GLY . 4.6 mp -120.26 124.61 72.95 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-O 120.706 0.289 . . . . 0.0 110.475 -179.543 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 84.4 t80 -107.45 116.23 31.58 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 109.006 -0.738 . . . . 0.0 109.006 172.339 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.551 ' HA ' ' O ' ' A' ' 67' ' ' VAL . 67.8 mt -102.81 116.77 47.14 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.697 -178.239 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -109.93 158.82 17.82 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.503 -0.772 . . . . 0.0 109.14 174.112 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.452 HG11 ' CG2' ' A' ' 109' ' ' ILE . 57.5 t -101.25 125.55 55.21 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 C-N-CA 120.34 -0.544 . . . . 0.0 110.852 172.996 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' TRP . . . . . 0.661 ' HZ3' HG21 ' A' ' 82' ' ' VAL . 1.0 OUTLIER -118.95 135.11 54.77 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.04 -0.527 . . . . 0.0 109.778 -178.973 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.455 ' HA ' ' OD1' ' A' ' 72' ' ' ASP . . . -146.63 165.23 30.18 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.683 -0.235 . . . . 0.0 111.307 179.943 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' THR . . . . . 0.819 ' HB ' ' CE3' ' A' ' 78' ' ' TRP . 12.3 t -99.87 -29.55 12.53 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.946 0.403 . . . . 0.0 110.572 173.069 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 19.4 p-90 -80.42 11.15 3.84 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.117 0.484 . . . . 0.0 110.956 -179.138 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' CYS . . . . . 0.745 ' SG ' ' HB3' ' A' ' 45' ' ' CYS . 29.2 p -104.35 172.1 6.98 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.649 -177.044 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -123.03 -70.52 0.24 Allowed Glycine 0 N--CA 1.448 -0.549 0 CA-C-N 115.857 -0.611 . . . . 0.0 112.252 177.218 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -55.28 -35.53 91.56 Favored 'Trans proline' 0 C--N 1.351 0.676 0 C-N-CA 122.991 2.461 . . . . 0.0 112.882 178.974 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' CYS . . . . . 0.745 ' HB3' ' SG ' ' A' ' 42' ' ' CYS . 8.4 t -59.02 -34.41 71.86 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.872 0.368 . . . . 0.0 111.097 177.209 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.716 ' HA ' HD13 ' A' ' 49' ' ' LEU . 32.4 mtp180 -73.5 -4.66 35.17 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.33 -177.218 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -83.95 -19.73 60.71 Favored Glycine 0 N--CA 1.447 -0.62 0 C-N-CA 120.788 -0.72 . . . . 0.0 111.842 176.473 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' GLU . . . . . 0.548 ' OE2' ' HD3' ' A' ' 128' ' ' ARG . 42.1 mm-40 -84.21 -16.87 41.78 Favored 'General case' 0 CA--C 1.515 -0.384 0 N-CA-C 110.401 -0.222 . . . . 0.0 110.401 -177.823 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.716 HD13 ' HA ' ' A' ' 46' ' ' ARG . 5.7 mp -45.44 -53.5 18.3 Favored Pre-proline 0 C--N 1.326 -0.424 0 CA-C-N 115.935 -0.575 . . . . 0.0 112.278 -178.744 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.588 ' HD3' ' HB2' ' A' ' 49' ' ' LEU . 31.7 Cg_exo -64.13 -37.55 41.38 Favored 'Trans proline' 0 C--N 1.353 0.799 0 C-N-CA 121.885 1.723 . . . . 0.0 112.842 175.868 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -77.34 -27.97 52.95 Favored 'General case' 0 CA--C 1.52 -0.193 0 CA-C-O 121.248 0.546 . . . . 0.0 110.6 -172.752 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 6.1 tt -64.13 -41.71 97.1 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 177.802 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 27.0 mmtm -70.64 -40.07 73.29 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.582 -0.735 . . . . 0.0 111.454 -179.731 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.401 ' O ' ' HB2' ' A' ' 58' ' ' LYS . 2.8 mm-40 -51.72 -53.64 37.06 Favored 'General case' 0 N--CA 1.455 -0.189 0 CA-C-O 121.341 0.591 . . . . 0.0 110.947 172.928 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.426 HD13 ' HE2' ' A' ' 138' ' ' PHE . 47.3 mt -61.5 -52.27 65.2 Favored 'General case' 0 N--CA 1.447 -0.611 0 CA-C-N 115.452 -0.795 . . . . 0.0 110.902 177.109 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.46 ' HA ' ' CE2' ' A' ' 66' ' ' PHE . 31.9 tt0 -45.09 -60.16 2.24 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 114.65 -1.159 . . . . 0.0 112.519 -179.308 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -69.7 -36.18 75.71 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-O 120.976 0.417 . . . . 0.0 111.045 -174.664 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' LYS . . . . . 0.555 ' HB2' ' NZ ' ' A' ' 58' ' ' LYS . 0.7 OUTLIER -69.24 -35.2 75.9 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.21 0.528 . . . . 0.0 111.028 -175.482 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 83.3 m-85 -111.03 9.29 22.11 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.058 -178.285 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.416 ' HB2' ' O ' ' A' ' 56' ' ' GLU . . . -56.02 128.61 36.13 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.663 178.355 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 81.86 -4.16 76.26 Favored Glycine 0 N--CA 1.449 -0.44 0 CA-C-N 115.652 -0.704 . . . . 0.0 113.386 174.231 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.585 ' HD3' ' N ' ' A' ' 62' ' ' LYS . 0.0 OUTLIER -76.66 -89.8 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 117.104 0.452 . . . . 0.0 111.142 -174.896 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 63' ' ' ASP . . . . . 0.723 ' HA ' ' HD3' ' A' ' 31' ' ' LYS . 10.9 p-10 -139.07 6.07 2.36 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.635 -175.463 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 16.0 tt -128.8 147.26 33.25 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-O 121.443 0.64 . . . . 0.0 112.623 -168.662 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 87.8 m-70 -112.86 125.8 54.76 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.203 -0.908 . . . . 0.0 108.807 170.697 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' PHE . . . . . 0.612 ' O ' ' HB ' ' A' ' 90' ' ' ILE . 96.4 m-85 -90.94 112.44 24.32 Favored 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 109.176 -0.675 . . . . 0.0 109.176 173.153 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.551 ' O ' ' HA ' ' A' ' 35' ' ' ILE . 45.9 t -123.58 106.32 17.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.662 -175.086 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 68' ' ' SER . . . . . 0.45 ' HB3' ' CD1' ' A' ' 38' ' ' TRP . 15.0 m -88.11 139.55 30.39 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.107 179.069 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 61.4 tp -122.36 124.11 42.93 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-O 120.774 0.321 . . . . 0.0 110.459 176.868 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 1.2 t -104.62 122.05 44.82 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.691 0.758 . . . . 0.0 112.509 -173.219 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 4.2 m -86.81 11.19 13.82 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 114.956 -1.02 . . . . 0.0 111.539 177.05 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.51 ' O ' ' HA2' ' A' ' 95' ' ' GLY . 1.6 m-20 -69.07 125.76 27.67 Favored 'General case' 0 N--CA 1.464 0.266 0 N-CA-C 110.452 -0.203 . . . . 0.0 110.452 -176.521 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 86.0 tttt -76.27 -32.05 58.61 Favored 'General case' 0 C--N 1.321 -0.633 0 C-N-CA 120.344 -0.542 . . . . 0.0 109.708 175.343 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' ASN . . . . . 0.583 ' HB2' ' HB3' ' A' ' 77' ' ' ALA . 0.8 OUTLIER -76.21 71.23 2.92 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.481 -0.781 . . . . 0.0 110.856 177.771 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.532 ' O ' ' HG3' ' A' ' 79' ' ' GLU . 12.0 tmtt? -57.16 -56.61 19.57 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 120.992 -0.283 . . . . 0.0 111.596 -175.423 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.509 ' HA ' ' CD ' ' A' ' 79' ' ' GLU . 2.2 tptp -52.15 -57.44 9.61 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.097 -179.543 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.583 ' HB3' ' HB2' ' A' ' 74' ' ' ASN . . . -52.96 -31.59 41.39 Favored 'General case' 0 C--O 1.237 0.425 0 CA-C-O 121.356 0.598 . . . . 0.0 110.898 -179.766 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 78' ' ' TRP . . . . . 0.819 ' CE3' ' HB ' ' A' ' 40' ' ' THR . 2.1 t-105 -76.91 -34.63 57.69 Favored 'General case' 0 N--CA 1.442 -0.856 0 CA-C-N 115.146 -0.933 . . . . 0.0 110.546 -176.756 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.532 ' HG3' ' O ' ' A' ' 75' ' ' LYS . 29.9 mt-10 -51.19 -52.43 44.41 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-O 121.573 0.702 . . . . 0.0 110.326 172.496 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 1.4 m120 -64.17 -41.19 97.23 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.25 -0.886 . . . . 0.0 110.747 -175.987 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' MET . . . . . 0.49 ' HG2' ' OG1' ' A' ' 40' ' ' THR . 14.4 tpt -67.29 -49.14 65.42 Favored 'General case' 0 N--CA 1.447 -0.601 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.938 -177.766 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.771 HG23 ' HB2' ' A' ' 87' ' ' LEU . 7.5 p -61.35 -30.89 48.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 121.068 0.461 . . . . 0.0 110.788 -179.543 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 45.8 m -74.61 -39.1 62.36 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.534 178.035 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' LYS . . . . . 0.748 ' HB3' ' HZ2' ' A' ' 84' ' ' LYS . 0.0 OUTLIER -74.08 -33.71 63.73 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 121.329 0.585 . . . . 0.0 109.843 179.48 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -82.81 4.29 25.98 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.216 -0.902 . . . . 0.0 111.329 -179.428 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 78.8 mt-30 60.38 28.24 17.86 Favored 'General case' 0 N--CA 1.47 0.545 0 N-CA-C 112.668 0.618 . . . . 0.0 112.668 171.904 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.771 ' HB2' HG23 ' A' ' 82' ' ' VAL . 97.6 mt -89.43 104.09 16.67 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 121.003 0.43 . . . . 0.0 111.523 -176.916 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.553 ' HA ' ' HE3' ' A' ' 88' ' ' LYS . 0.0 OUTLIER -106.95 -167.15 1.24 Allowed 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.031 172.515 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 109.44 -159.58 13.94 Favored Glycine 0 N--CA 1.452 -0.259 0 N-CA-C 111.023 -0.831 . . . . 0.0 111.023 -176.122 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.612 ' HB ' ' O ' ' A' ' 66' ' ' PHE . 62.9 mt -95.15 112.27 27.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 175.007 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 91' ' ' GLN . . . . . 0.644 ' HB2' ' CZ2' ' A' ' 38' ' ' TRP . 1.9 pt20 -139.14 123.04 17.73 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-O 121.348 0.594 . . . . 0.0 111.389 -173.098 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.591 HD21 ' HB ' ' A' ' 23' ' ' VAL . 70.4 mt -113.91 152.23 31.1 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.449 -0.796 . . . . 0.0 109.939 179.788 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 93' ' ' HIS . . . . . 0.454 ' CE1' ' HG3' ' A' ' 75' ' ' LYS . 20.6 t-80 -120.75 126.52 50.37 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.905 -177.416 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 94' ' ' MET . . . . . 0.453 ' SD ' ' HA ' ' A' ' 98' ' ' ARG . 18.6 ttp -84.13 -66.48 0.89 Allowed 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.227 -0.897 . . . . 0.0 110.61 178.567 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 95' ' ' GLY . . . . . 0.51 ' HA2' ' O ' ' A' ' 72' ' ' ASP . . . 108.56 -109.96 2.96 Favored Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 120.528 -0.844 . . . . 0.0 112.083 -178.29 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 8.9 t -112.45 11.18 19.84 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 120.727 0.299 . . . . 0.0 111.111 -177.147 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -97.5 46.46 1.03 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.126 0.489 . . . . 0.0 110.357 -175.371 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 98' ' ' ARG . . . . . 0.453 ' HA ' ' SD ' ' A' ' 94' ' ' MET . 0.0 OUTLIER -77.51 18.45 0.43 Allowed 'General case' 0 CA--C 1.52 -0.174 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.782 -172.812 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 5.2 m -61.0 -24.35 66.09 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 108.358 -0.979 . . . . 0.0 108.358 168.768 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 12.0 t80 -75.56 -29.93 59.52 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-N 114.766 -1.106 . . . . 0.0 110.118 176.172 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 71.2 mtp -63.08 -54.06 43.83 Favored 'General case' 0 CA--C 1.514 -0.42 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 171.307 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -57.16 -33.15 67.14 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.082 -0.963 . . . . 0.0 111.246 179.404 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -60.27 -39.82 88.19 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.793 0.33 . . . . 0.0 111.087 178.019 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 104' ' ' TYR . . . . . 0.478 ' HB2' HG13 ' A' ' 106' ' ' ILE . 42.9 m-85 -93.3 3.34 55.8 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.481 179.661 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 95.4 mt 65.47 22.02 11.85 Favored 'General case' 0 N--CA 1.464 0.242 0 O-C-N 123.755 0.659 . . . . 0.0 110.817 -176.234 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 106' ' ' ILE . . . . . 0.887 HG12 ' HG3' ' A' ' 111' ' ' ARG . 51.2 mt -71.08 112.5 6.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.627 176.036 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 50.9 t-20 -112.61 -68.85 0.9 Allowed 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 172.826 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -82.24 111.28 3.33 Favored Glycine 0 N--CA 1.446 -0.693 0 C-N-CA 120.83 -0.7 . . . . 0.0 111.802 178.5 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.556 ' HB ' ' HA ' ' A' ' 110' ' ' PRO . 34.5 pt -85.82 158.54 56.27 Favored Pre-proline 0 C--N 1.321 -0.633 0 N-CA-C 110.484 -0.191 . . . . 0.0 110.484 178.51 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 110' ' ' PRO . . . . . 0.556 ' HA ' ' HB ' ' A' ' 109' ' ' ILE . 86.8 Cg_endo -81.1 158.86 83.62 Favored 'Cis proline' 0 C--N 1.345 0.37 0 C-N-CA 123.768 -1.346 . . . . 0.0 113.391 1.995 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 111' ' ' ARG . . . . . 0.887 ' HG3' HG12 ' A' ' 106' ' ' ILE . 0.0 OUTLIER -108.58 148.45 30.3 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 108.712 -0.848 . . . . 0.0 108.712 173.215 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 112' ' ' PHE . . . . . 0.551 ' CE1' ' HB3' ' A' ' 128' ' ' ARG . 0.5 OUTLIER -119.11 116.72 26.96 Favored 'General case' 0 C--N 1.324 -0.532 0 O-C-N 123.96 0.788 . . . . 0.0 109.088 -175.008 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 91.6 mt -135.6 143.67 35.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 120.812 0.339 . . . . 0.0 111.261 -177.332 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.576 ' HB2' ' HG3' ' A' ' 126' ' ' MET . 39.3 tp -124.99 138.07 54.23 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.275 178.36 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.619 ' HG ' ' HA ' ' A' ' 121' ' ' ILE . 3.2 mp -131.97 153.45 50.31 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.079 -177.324 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 116' ' ' ASP . . . . . 0.549 ' HB2' HD11 ' A' ' 122' ' ' ILE . 37.4 t0 -68.37 166.81 15.87 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.564 -0.744 . . . . 0.0 110.212 177.308 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 117' ' ' ARG . . . . . 0.577 ' HA ' ' O ' ' A' ' 31' ' ' LYS . 8.3 mtm180 -48.87 -27.77 3.29 Favored 'General case' 0 N--CA 1.465 0.314 0 O-C-N 124.447 1.092 . . . . 0.0 112.615 -177.445 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 118' ' ' ASP . . . . . 0.447 ' HA ' ' HG3' ' A' ' 29' ' ' LYS . 33.0 t70 -83.44 2.31 37.3 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.478 0.656 . . . . 0.0 111.076 -178.835 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 119' ' ' GLY . . . . . 0.468 ' HA2' HD13 ' A' ' 33' ' ' ILE . . . 76.06 29.13 59.25 Favored Glycine 0 N--CA 1.434 -1.438 0 N-CA-C 110.247 -1.141 . . . . 0.0 110.247 -171.968 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 120' ' ' LYS . . . . . 0.405 ' HD3' ' HA ' ' A' ' 120' ' ' LYS . 41.0 mmtm -101.28 112.13 24.55 Favored 'General case' 0 C--O 1.222 -0.356 0 C-N-CA 120.794 -0.363 . . . . 0.0 111.791 -178.856 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 121' ' ' ILE . . . . . 0.69 ' H ' HD12 ' A' ' 121' ' ' ILE . 3.9 mp -41.7 117.54 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 O-C-N 123.888 0.742 . . . . 0.0 112.327 -177.508 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 122' ' ' ILE . . . . . 0.549 HD11 ' HB2' ' A' ' 116' ' ' ASP . 35.6 mm -100.3 -44.54 11.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 115.345 -0.843 . . . . 0.0 109.555 175.983 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 15.9 m -135.2 114.47 12.36 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.503 -0.772 . . . . 0.0 110.343 178.716 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -81.53 -13.22 58.35 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.161 0.505 . . . . 0.0 110.606 179.439 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 3.4 p-10 -128.24 83.69 2.18 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.54 -0.755 . . . . 0.0 110.486 178.14 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 126' ' ' MET . . . . . 0.576 ' HG3' ' HB2' ' A' ' 114' ' ' LEU . 46.4 mmm -94.48 -165.13 1.26 Allowed 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.442 177.784 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 127' ' ' THR . . . . . 0.412 HG21 ' NZ ' ' A' ' 133' ' ' LYS . 6.2 p -120.86 141.75 50.29 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.627 179.268 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 128' ' ' ARG . . . . . 0.551 ' HB3' ' CE1' ' A' ' 112' ' ' PHE . 13.0 ptp180 -48.96 154.28 1.31 Allowed Pre-proline 0 C--N 1.327 -0.385 0 CA-C-N 115.514 -0.766 . . . . 0.0 112.84 177.664 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_exo -51.58 -36.16 59.21 Favored 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 123.447 2.765 . . . . 0.0 113.627 177.275 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 18.8 m -72.79 -7.67 51.78 Favored 'General case' 0 N--CA 1.462 0.153 0 CA-C-O 120.935 0.398 . . . . 0.0 111.643 -178.784 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -90.51 121.39 68.44 Favored Pre-proline 0 C--N 1.327 -0.41 0 N-CA-C 109.751 -0.463 . . . . 0.0 109.751 179.668 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 132' ' ' PRO . . . . . 0.453 ' O ' ' HG2' ' A' ' 136' ' ' GLU . 51.9 Cg_exo -57.45 -31.73 92.15 Favored 'Trans proline' 0 C--N 1.343 0.284 0 C-N-CA 122.976 2.451 . . . . 0.0 113.268 -178.096 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 133' ' ' LYS . . . . . 0.531 ' HZ2' ' HB2' ' A' ' 133' ' ' LYS . 9.7 mtmp? -66.44 -19.24 65.74 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.846 0.355 . . . . 0.0 110.98 -176.908 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 134' ' ' THR . . . . . 0.64 HG22 ' CZ ' ' A' ' 138' ' ' PHE . 3.8 m -68.12 -51.25 48.34 Favored 'General case' 0 N--CA 1.447 -0.584 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 173.786 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 135' ' ' ALA . . . . . 0.649 ' HA ' ' CD2' ' A' ' 138' ' ' PHE . . . -59.96 -38.61 83.01 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.67 -0.696 . . . . 0.0 110.576 175.515 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 136' ' ' GLU . . . . . 0.453 ' HG2' ' O ' ' A' ' 132' ' ' PRO . 5.9 mm-40 -56.15 -41.62 75.71 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.203 177.111 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 137' ' ' LYS . . . . . 0.587 ' O ' ' HG ' ' A' ' 141' ' ' LEU . 21.3 ttmm -72.44 -26.33 61.8 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.56 -0.291 . . . . 0.0 111.043 179.745 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 138' ' ' PHE . . . . . 0.649 ' CD2' ' HA ' ' A' ' 135' ' ' ALA . 10.7 m-30 -66.27 -42.76 88.01 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 173.908 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 76.7 m-20 -58.62 -45.7 88.63 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.583 -0.735 . . . . 0.0 109.341 173.672 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 140' ' ' GLU . . . . . 0.54 ' HB3' ' O ' ' A' ' 137' ' ' LYS . 24.9 tt0 -50.79 -51.72 47.91 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 115.266 -0.879 . . . . 0.0 111.661 174.196 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.587 ' HG ' ' O ' ' A' ' 137' ' ' LYS . 95.2 mt -58.05 -44.46 87.46 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.472 -178.399 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 81.0 mt . . . . . 0 C--N 1.328 -0.347 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.478 179.336 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.405 ' HB2' ' OH ' ' A' ' 104' ' ' TYR . . . . . . . . 0 N--CA 1.471 0.603 0 N-CA-C 112.225 0.454 . . . . 0.0 112.225 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -76.09 82.61 2.93 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.76 -177.491 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' SER . . . . . 0.505 ' HA ' ' HB3' ' A' ' 25' ' ' LEU . 37.8 m 69.5 43.34 1.03 Allowed 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 114.674 -1.148 . . . . 0.0 111.267 174.759 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 55.7 p90 -68.06 161.98 25.6 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.606 177.909 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' SER . . . . . 0.553 ' HA ' ' HA ' ' A' ' 24' ' ' SER . 5.2 p -134.7 129.16 34.33 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.655 179.26 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' TYR . . . . . 0.447 ' OH ' ' HB2' ' A' ' 100' ' ' PHE . 24.6 m-85 -140.44 141.13 24.62 Favored Pre-proline 0 C--N 1.326 -0.414 0 CA-C-O 120.842 0.353 . . . . 0.0 111.119 178.709 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 63.3 Cg_endo -75.25 125.59 9.26 Favored 'Trans proline' 0 N--CA 1.461 -0.388 0 C-N-CA 122.399 2.066 . . . . 0.0 113.481 -177.442 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -69.35 159.13 33.73 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.131 -0.94 . . . . 0.0 109.252 170.379 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.546 HG13 ' OE1' ' A' ' 79' ' ' GLU . 2.6 tt -44.43 -44.56 2.37 Favored 'Isoleucine or valine' 0 C--O 1.24 0.567 0 O-C-N 124.445 1.091 . . . . 0.0 112.221 -176.207 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 43.8 m-80 -65.89 -12.93 58.29 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.375 -176.422 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 97.14 32.15 6.56 Favored Glycine 0 N--CA 1.444 -0.817 0 N-CA-C 111.248 -0.741 . . . . 0.0 111.248 -176.615 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.427 ' NZ ' HG22 ' A' ' 23' ' ' VAL . 23.4 ttpp -106.68 121.11 43.68 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 120.667 -0.413 . . . . 0.0 110.36 -176.815 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 14.1 m -63.0 99.32 0.16 Allowed 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.964 0.412 . . . . 0.0 110.385 176.65 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.427 HG22 ' NZ ' ' A' ' 21' ' ' LYS . 97.0 t -99.82 113.76 36.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 178.098 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' SER . . . . . 0.553 ' HA ' ' HA ' ' A' ' 14' ' ' SER . 14.7 m -105.4 177.0 4.98 Favored 'General case' 0 C--N 1.311 -1.069 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.159 -179.218 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.545 ' O ' ' HB2' ' A' ' 29' ' ' LYS . 2.9 tm? -53.87 -38.0 64.27 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.619 178.718 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -89.66 10.13 24.36 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 112.287 0.477 . . . . 0.0 112.287 -176.596 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -87.43 -27.77 22.52 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-O 121.481 0.658 . . . . 0.0 110.319 -179.187 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.464 HD13 ' CD1' ' A' ' 33' ' ' ILE . 0.9 OUTLIER -132.88 15.91 4.27 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.487 -0.778 . . . . 0.0 110.592 -178.928 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.545 ' HB2' ' O ' ' A' ' 25' ' ' LEU . 17.1 tttt -67.02 150.47 49.18 Favored 'General case' 0 C--N 1.313 -0.979 0 CA-C-N 114.197 -1.365 . . . . 0.0 111.301 -177.063 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 113.49 -18.48 20.32 Favored Glycine 0 N--CA 1.448 -0.565 0 N-CA-C 111.193 -0.763 . . . . 0.0 111.193 -178.85 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.809 ' HD2' ' HA ' ' A' ' 63' ' ' ASP . 72.8 mmtt -117.11 154.72 30.53 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 179.218 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 69.4 m-85 -66.05 121.45 15.16 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 177.365 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.464 ' CD1' HD13 ' A' ' 28' ' ' LEU . 41.8 mm -94.6 115.73 34.14 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.896 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.73 -175.099 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' TYR . . . . . 0.68 ' HE2' ' HA ' ' A' ' 129' ' ' PRO . 59.4 t80 -107.01 111.23 23.62 Favored 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 173.755 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.543 ' HA ' ' O ' ' A' ' 67' ' ' VAL . 59.5 mt -97.01 132.6 41.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-O 121.152 0.501 . . . . 0.0 111.656 -173.392 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.507 ' O ' ' HA ' ' A' ' 68' ' ' SER . 5.3 p-10 -122.99 159.64 27.92 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.262 -0.881 . . . . 0.0 109.034 174.142 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.44 HG21 HG21 ' A' ' 106' ' ' ILE . 85.4 t -103.51 133.32 47.76 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.788 0 C-N-CA 120.5 -0.48 . . . . 0.0 110.805 174.078 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' TRP . . . . . 0.665 ' HZ3' HG21 ' A' ' 82' ' ' VAL . 0.9 OUTLIER -126.51 137.25 53.35 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.136 -0.483 . . . . 0.0 109.889 -178.303 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.556 ' HA ' ' OD1' ' A' ' 72' ' ' ASP . . . -145.55 164.68 30.91 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.64 -0.255 . . . . 0.0 110.666 177.665 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' THR . . . . . 0.714 ' HB ' ' CE3' ' A' ' 78' ' ' TRP . 4.9 t -81.55 -23.71 37.03 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.336 0.588 . . . . 0.0 109.671 172.822 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 12.7 p-90 -97.62 19.25 13.83 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.358 -0.837 . . . . 0.0 110.231 177.824 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' CYS . . . . . 0.644 ' SG ' ' HB3' ' A' ' 45' ' ' CYS . 24.8 p -78.27 -26.46 47.16 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.107 -177.437 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 66.47 -111.73 4.37 Favored Glycine 0 CA--C 1.519 0.337 0 CA-C-N 116.066 -0.515 . . . . 0.0 113.346 178.534 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -54.58 -28.16 54.24 Favored 'Trans proline' 0 C--N 1.351 0.666 0 C-N-CA 123.461 2.774 . . . . 0.0 113.292 -177.726 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' CYS . . . . . 0.644 ' HB3' ' SG ' ' A' ' 42' ' ' CYS . 30.7 t -52.6 -30.88 33.56 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.414 177.147 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.488 HH21 ' CG ' ' A' ' 85' ' ' ASP . 46.0 mtp180 -58.75 -21.42 55.46 Favored 'General case' 0 C--O 1.223 -0.292 0 N-CA-C 111.911 0.337 . . . . 0.0 111.911 -178.782 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -70.96 -23.88 77.64 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.829 -0.7 . . . . 0.0 112.831 -178.118 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' GLU . . . . . 0.457 ' HB3' ' HB2' ' A' ' 130' ' ' SER . 35.7 mt-10 -99.3 -18.43 17.57 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.761 0.28 . . . . 0.0 111.317 -176.978 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.708 ' HB3' HD22 ' A' ' 87' ' ' LEU . 3.6 mm? -57.54 -43.91 99.21 Favored Pre-proline 0 C--N 1.325 -0.486 0 N-CA-C 112.911 0.708 . . . . 0.0 112.911 -179.166 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.516 ' HD2' ' N ' ' A' ' 49' ' ' LEU . 12.3 Cg_endo -58.48 -37.89 92.61 Favored 'Trans proline' 0 C--N 1.351 0.706 0 C-N-CA 121.275 1.317 . . . . 0.0 111.027 170.684 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -73.33 -19.09 61.1 Favored 'General case' 0 CA--C 1.519 -0.212 0 CA-C-O 121.415 0.626 . . . . 0.0 109.796 -176.638 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.442 ' O ' HD23 ' A' ' 52' ' ' LEU . 5.8 tt -65.13 -38.02 89.32 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-N 115.107 -0.951 . . . . 0.0 108.74 174.421 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.66 ' O ' ' HG2' ' A' ' 57' ' ' GLU . 8.9 mtmp? -59.01 -60.95 3.05 Favored 'General case' 0 CA--C 1.505 -0.783 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 171.809 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -45.17 -42.44 9.12 Favored 'General case' 0 C--O 1.224 -0.274 0 O-C-N 124.577 1.173 . . . . 0.0 111.256 -178.698 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.443 ' HB3' ' CE1' ' A' ' 66' ' ' PHE . 39.9 mt -61.41 -57.81 10.75 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.352 175.698 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 18.2 tp10 -65.45 -35.28 80.43 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.42 -174.391 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.66 ' HG2' ' O ' ' A' ' 53' ' ' LYS . 9.4 pt-20 -80.49 -29.05 37.36 Favored 'General case' 0 CA--C 1.532 0.25 0 O-C-N 121.906 -0.496 . . . . 0.0 111.141 179.4 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 75.9 tttt -63.36 -44.53 94.54 Favored 'General case' 0 C--O 1.237 0.426 0 CA-C-O 121.923 0.868 . . . . 0.0 109.11 170.484 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 61.2 m-85 -99.92 14.86 29.01 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.008 -0.997 . . . . 0.0 111.308 -176.414 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.432 ' HB2' ' HA ' ' A' ' 57' ' ' GLU . . . -57.66 126.44 27.38 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.037 170.584 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 85.43 -6.05 81.31 Favored Glycine 0 N--CA 1.445 -0.721 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.126 -179.151 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 30.7 mmtm -88.51 -155.67 0.34 Allowed 'General case' 0 CA--C 1.515 -0.374 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 178.89 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' ASP . . . . . 0.809 ' HA ' ' HD2' ' A' ' 31' ' ' LYS . 36.1 m-20 -111.67 28.45 8.74 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 115.824 -0.626 . . . . 0.0 112.641 -175.793 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 4.7 mp -131.86 146.57 33.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-O 120.527 0.203 . . . . 0.0 110.799 179.925 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 31.8 m170 -124.91 145.65 49.72 Favored 'General case' 0 CA--C 1.514 -0.425 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 170.094 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' PHE . . . . . 0.443 ' CE1' ' HB3' ' A' ' 55' ' ' LEU . 77.0 m-85 -110.37 105.92 15.09 Favored 'General case' 0 C--N 1.315 -0.914 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 172.521 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.546 ' HA ' ' O ' ' A' ' 90' ' ' ILE . 48.0 t -112.63 114.07 45.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 115.374 -0.83 . . . . 0.0 111.232 -170.172 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' SER . . . . . 0.507 ' HA ' ' O ' ' A' ' 36' ' ' ASP . 3.6 m -88.26 150.64 23.15 Favored 'General case' 0 C--N 1.314 -0.935 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.584 -179.379 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.516 HD11 ' HB2' ' A' ' 94' ' ' MET . 61.1 tp -133.92 121.62 21.96 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.984 0.421 . . . . 0.0 110.531 175.092 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 70' ' ' SER . . . . . 0.473 ' O ' ' HB3' ' A' ' 94' ' ' MET . 0.7 OUTLIER -105.28 120.34 41.31 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.395 0.617 . . . . 0.0 112.379 -172.783 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 71' ' ' CYS . . . . . 0.475 ' HA ' ' HE3' ' A' ' 94' ' ' MET . 1.8 p -85.87 13.62 7.16 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.483 -0.78 . . . . 0.0 111.702 175.83 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.578 ' OD2' HG22 ' A' ' 40' ' ' THR . 2.6 m-20 -69.56 115.28 8.63 Favored 'General case' 0 CA--C 1.511 -0.537 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 -179.511 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -67.83 -28.86 67.92 Favored 'General case' 0 C--N 1.318 -0.763 0 C-N-CA 120.093 -0.643 . . . . 0.0 110.209 -179.924 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 74' ' ' ASN . . . . . 0.732 ' ND2' ' HB3' ' A' ' 77' ' ' ALA . 1.0 OUTLIER -77.27 116.28 17.75 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 171.73 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.683 ' HE2' ' CD ' ' A' ' 79' ' ' GLU . 19.9 tttt -81.45 -64.39 1.2 Allowed 'General case' 0 C--N 1.319 -0.745 0 C-N-CA 119.804 -0.759 . . . . 0.0 110.847 171.839 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.833 ' HE2' ' HA ' ' A' ' 76' ' ' LYS . 0.4 OUTLIER -44.25 -56.67 3.96 Favored 'General case' 0 N--CA 1.464 0.246 0 N-CA-C 113.383 0.883 . . . . 0.0 113.383 -172.057 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.841 ' HA ' ' ND2' ' A' ' 80' ' ' ASN . . . -61.28 -27.59 68.58 Favored 'General case' 0 C--O 1.242 0.689 0 CA-C-O 121.51 0.671 . . . . 0.0 111.233 -176.75 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 78' ' ' TRP . . . . . 0.714 ' CE3' ' HB ' ' A' ' 40' ' ' THR . 3.1 t-105 -81.61 -43.0 19.22 Favored 'General case' 0 N--CA 1.435 -1.188 0 CA-C-N 115.373 -0.83 . . . . 0.0 110.192 -173.921 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.683 ' CD ' ' HE2' ' A' ' 75' ' ' LYS . 6.0 mm-40 -49.34 -43.54 43.9 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-O 121.012 0.434 . . . . 0.0 110.747 171.649 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 80' ' ' ASN . . . . . 0.841 ' ND2' ' HA ' ' A' ' 77' ' ' ALA . 7.2 m-20 -56.93 -54.32 47.98 Favored 'General case' 0 CA--C 1.517 -0.315 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.583 179.269 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 37.5 ttm -64.61 -46.17 83.77 Favored 'General case' 0 C--O 1.223 -0.301 0 CA-C-N 116.248 -0.433 . . . . 0.0 112.073 -174.895 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.665 HG21 ' HZ3' ' A' ' 38' ' ' TRP . 5.7 p -63.44 -28.25 44.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 C-N-CA 120.622 -0.431 . . . . 0.0 111.407 -178.162 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 36.7 m -81.72 -34.95 30.27 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 120.87 0.367 . . . . 0.0 110.69 177.642 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 24.9 ttmm -77.48 -44.22 29.61 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.109 0.48 . . . . 0.0 111.059 -177.547 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' ASP . . . . . 0.745 ' HB3' ' HG ' ' A' ' 87' ' ' LEU . 5.4 t0 -77.36 -1.67 31.16 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.185 -0.916 . . . . 0.0 110.943 -176.247 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 48.3 mt-30 65.25 19.83 11.78 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 115.673 -0.694 . . . . 0.0 112.21 175.991 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.745 ' HG ' ' HB3' ' A' ' 85' ' ' ASP . 17.3 mt -74.03 87.81 1.87 Allowed 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.131 -179.119 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 4.2 mmpm? -101.76 -177.85 3.55 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 112.537 0.569 . . . . 0.0 112.537 -175.739 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 122.71 -176.23 16.53 Favored Glycine 0 N--CA 1.448 -0.545 0 N-CA-C 109.554 -1.418 . . . . 0.0 109.554 -171.948 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.546 ' O ' ' HA ' ' A' ' 67' ' ' VAL . 60.6 mt -83.34 112.7 21.3 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 118.063 0.932 . . . . 0.0 108.681 175.481 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 91' ' ' GLN . . . . . 0.481 ' HB2' ' CZ2' ' A' ' 38' ' ' TRP . 2.1 pt20 -137.98 110.71 7.61 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-O 121.834 0.826 . . . . 0.0 112.085 -168.565 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.422 HD22 ' HB ' ' A' ' 23' ' ' VAL . 26.0 mt -97.51 142.11 29.74 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.146 -0.934 . . . . 0.0 110.272 -177.83 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 93' ' ' HIS . . . . . 0.441 ' CE1' ' HG3' ' A' ' 75' ' ' LYS . 29.7 t-80 -110.56 117.04 32.47 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-O 121.35 0.595 . . . . 0.0 110.599 -179.643 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 94' ' ' MET . . . . . 0.636 ' SD ' ' HA ' ' A' ' 98' ' ' ARG . 13.6 ttp -79.81 -63.67 1.36 Allowed 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 114.964 -1.016 . . . . 0.0 110.482 -179.891 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 95' ' ' GLY . . . . . 0.554 ' HA2' ' O ' ' A' ' 72' ' ' ASP . . . 71.36 -79.1 0.55 Allowed Glycine 0 C--O 1.236 0.268 0 C-N-CA 120.967 -0.635 . . . . 0.0 114.466 174.463 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 1.3 p -88.72 -35.52 16.69 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-O 120.819 0.342 . . . . 0.0 111.57 -175.329 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -92.52 57.18 2.88 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.809 -166.793 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 98' ' ' ARG . . . . . 0.636 ' HA ' ' SD ' ' A' ' 94' ' ' MET . 0.0 OUTLIER -70.82 10.28 0.54 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.12 -0.946 . . . . 0.0 112.698 -172.888 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 8.6 m -73.6 -19.14 60.95 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 120.964 0.411 . . . . 0.0 111.079 -179.587 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 100' ' ' PHE . . . . . 0.447 ' HB2' ' OH ' ' A' ' 15' ' ' TYR . 3.2 t80 -79.63 -43.37 22.97 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 120.898 -0.321 . . . . 0.0 110.713 -178.459 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 101' ' ' MET . . . . . 0.556 ' HA ' HD12 ' A' ' 106' ' ' ILE . 5.1 ppp? -69.23 -24.91 64.07 Favored 'General case' 0 C--N 1.332 -0.178 0 N-CA-C 109.176 -0.676 . . . . 0.0 109.176 175.383 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 102' ' ' ASP . . . . . 0.405 ' HB2' ' NH1' ' A' ' 98' ' ' ARG . 11.4 t70 -66.41 -50.98 61.62 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.132 -0.94 . . . . 0.0 110.423 173.904 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -64.6 -18.94 65.36 Favored 'General case' 0 N--CA 1.461 0.095 0 CA-C-N 115.758 -0.655 . . . . 0.0 112.072 -175.29 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 104' ' ' TYR . . . . . 0.405 ' OH ' ' HB2' ' A' ' 10' ' ' ALA . 46.1 m-85 -108.45 2.43 22.33 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 111.844 0.313 . . . . 0.0 111.844 -179.319 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 8.8 tp 59.35 26.41 15.27 Favored 'General case' 0 C--N 1.328 -0.361 0 O-C-N 123.507 0.504 . . . . 0.0 110.423 -179.351 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 106' ' ' ILE . . . . . 0.652 HG12 ' HG3' ' A' ' 111' ' ' ARG . 69.9 mt -60.21 101.46 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.328 0 CA-C-N 115.673 -0.694 . . . . 0.0 111.456 178.769 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 8.7 p30 -134.21 148.88 50.95 Favored 'General case' 0 C--N 1.317 -0.808 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 173.945 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 76.3 84.91 0.41 Allowed Glycine 0 N--CA 1.446 -0.671 0 C-N-CA 120.469 -0.872 . . . . 0.0 111.775 -176.079 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 40.1 mt -69.57 139.16 88.84 Favored Pre-proline 0 C--N 1.325 -0.481 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 177.603 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 110' ' ' PRO . . . . . 0.487 ' HG3' ' SG ' ' A' ' 45' ' ' CYS . 10.0 Cg_endo -93.11 140.39 8.36 Favored 'Cis proline' 0 N--CA 1.459 -0.521 0 C-N-CA 124.455 -1.061 . . . . 0.0 113.974 0.952 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 111' ' ' ARG . . . . . 0.652 ' HG3' HG12 ' A' ' 106' ' ' ILE . 0.0 OUTLIER -83.82 144.18 29.45 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 172.933 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 112' ' ' PHE . . . . . 0.571 ' HD1' ' H ' ' A' ' 126' ' ' MET . 0.9 OUTLIER -118.7 116.83 27.38 Favored 'General case' 0 C--N 1.323 -0.547 0 O-C-N 123.724 0.64 . . . . 0.0 110.792 -176.788 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.497 ' HB ' ' HB ' ' A' ' 35' ' ' ILE . 83.0 mt -130.99 149.56 33.66 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.299 0 CA-C-N 116.703 -0.226 . . . . 0.0 110.908 -177.917 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.423 ' C ' HD12 ' A' ' 115' ' ' LEU . 62.4 tp -128.54 138.07 52.06 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.618 -0.265 . . . . 0.0 110.57 178.941 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.586 ' HG ' ' HA ' ' A' ' 121' ' ' ILE . 2.0 mp -135.19 152.1 51.26 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-O 121.334 0.588 . . . . 0.0 110.623 179.108 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 116' ' ' ASP . . . . . 0.427 ' N ' HG13 ' A' ' 122' ' ' ILE . 7.6 t70 -69.73 160.85 30.91 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 114.872 -1.058 . . . . 0.0 110.645 175.952 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 117' ' ' ARG . . . . . 0.452 ' HA ' ' O ' ' A' ' 31' ' ' LYS . 58.7 mtt-85 -48.51 -37.41 17.5 Favored 'General case' 0 N--CA 1.474 0.728 0 O-C-N 124.267 0.979 . . . . 0.0 111.368 -178.368 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 118' ' ' ASP . . . . . 0.632 ' HB3' ' HG3' ' A' ' 120' ' ' LYS . 29.1 t0 -67.82 -13.01 61.78 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 114.515 -1.221 . . . . 0.0 111.121 -177.069 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 119' ' ' GLY . . . . . 0.534 ' HA3' HD11 ' A' ' 25' ' ' LEU . . . 93.63 23.78 22.71 Favored Glycine 0 N--CA 1.439 -1.112 0 N-CA-C 110.553 -1.019 . . . . 0.0 110.553 -172.132 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 120' ' ' LYS . . . . . 0.632 ' HG3' ' HB3' ' A' ' 118' ' ' ASP . 36.6 mtmm -103.72 106.75 17.35 Favored 'General case' 0 C--O 1.223 -0.333 0 C-N-CA 120.564 -0.454 . . . . 0.0 111.365 -174.619 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 121' ' ' ILE . . . . . 0.681 ' H ' HD12 ' A' ' 121' ' ' ILE . 3.3 mp -42.16 116.57 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 O-C-N 123.909 0.755 . . . . 0.0 111.692 -178.982 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 122' ' ' ILE . . . . . 0.459 ' H ' ' HA ' ' A' ' 115' ' ' LEU . 57.4 mt -89.04 -38.74 11.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 115.346 -0.843 . . . . 0.0 108.902 177.082 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 14.9 m -148.15 126.77 12.49 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.492 -0.776 . . . . 0.0 110.197 -179.812 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 124' ' ' ALA . . . . . 0.403 ' O ' HG12 ' A' ' 113' ' ' ILE . . . -74.24 -14.95 61.0 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-O 121.336 0.589 . . . . 0.0 110.593 178.53 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 125' ' ' ASN . . . . . 0.447 ' HA ' ' O ' ' A' ' 112' ' ' PHE . 5.1 p-10 -149.42 126.83 11.5 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.054 -0.975 . . . . 0.0 108.598 173.613 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 126' ' ' MET . . . . . 0.571 ' H ' ' HD1' ' A' ' 112' ' ' PHE . 15.9 tpt -108.95 -87.34 0.5 Allowed 'General case' 0 C--N 1.321 -0.653 0 C-N-CA 120.804 -0.358 . . . . 0.0 111.567 -176.941 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 7.6 p -141.61 -77.85 0.27 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.269 0.557 . . . . 0.0 110.774 -175.013 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 128' ' ' ARG . . . . . 0.894 ' HB3' ' HB2' ' A' ' 131' ' ' ASP . 43.3 ttm-85 -172.31 141.04 1.09 Allowed Pre-proline 0 N--CA 1.443 -0.807 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 177.5 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 129' ' ' PRO . . . . . 0.68 ' HA ' ' HE2' ' A' ' 34' ' ' TYR . 5.7 Cg_exo -38.48 -52.46 1.98 Allowed 'Trans proline' 0 C--N 1.348 0.551 0 C-N-CA 123.746 2.964 . . . . 0.0 113.455 -179.242 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 130' ' ' SER . . . . . 0.457 ' HB2' ' HB3' ' A' ' 48' ' ' GLU . 36.1 t -109.01 26.16 10.94 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 111.734 0.272 . . . . 0.0 111.734 -177.378 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 131' ' ' ASP . . . . . 0.894 ' HB2' ' HB3' ' A' ' 128' ' ' ARG . 11.1 t0 -73.64 119.69 77.29 Favored Pre-proline 0 C--O 1.237 0.43 0 C-N-CA 120.108 -0.637 . . . . 0.0 109.458 176.598 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 132' ' ' PRO . . . . . 0.425 ' O ' ' HG2' ' A' ' 136' ' ' GLU . 51.5 Cg_exo -55.12 -33.08 82.61 Favored 'Trans proline' 0 C--N 1.349 0.579 0 C-N-CA 123.495 2.797 . . . . 0.0 113.737 -175.034 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 38.3 mttp -57.82 -45.86 85.55 Favored 'General case' 0 CA--C 1.519 -0.227 0 CA-C-O 121.33 0.586 . . . . 0.0 109.912 -177.936 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -63.36 -47.54 81.66 Favored 'General case' 0 N--CA 1.448 -0.538 0 CA-C-N 115.033 -0.985 . . . . 0.0 111.116 -178.881 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 135' ' ' ALA . . . . . 0.68 ' HA ' ' CD2' ' A' ' 138' ' ' PHE . . . -59.61 -50.75 72.67 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.606 -0.725 . . . . 0.0 111.072 -173.895 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 136' ' ' GLU . . . . . 0.686 ' O ' ' HB2' ' A' ' 139' ' ' ASN . 22.7 mm-40 -76.21 -23.16 54.6 Favored 'General case' 0 C--N 1.312 -1.028 0 CA-C-O 121.857 0.837 . . . . 0.0 110.084 -175.175 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 137' ' ' LYS . . . . . 1.05 ' HA ' ' HE3' ' A' ' 137' ' ' LYS . 0.1 OUTLIER -65.45 -39.34 91.9 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 115.522 -0.763 . . . . 0.0 109.655 170.995 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 138' ' ' PHE . . . . . 0.68 ' CD2' ' HA ' ' A' ' 135' ' ' ALA . 15.0 m-85 -55.59 -36.55 67.02 Favored 'General case' 0 N--CA 1.464 0.265 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 172.637 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 139' ' ' ASN . . . . . 0.686 ' HB2' ' O ' ' A' ' 136' ' ' GLU . 94.2 m-20 -51.16 -59.72 3.88 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.148 174.113 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -61.55 -36.12 79.7 Favored 'General case' 0 N--CA 1.463 0.179 0 C-N-CA 120.656 -0.418 . . . . 0.0 111.486 -179.262 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.501 ' HG ' ' O ' ' A' ' 137' ' ' LYS . 96.9 mt -61.48 -27.82 68.85 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.897 0.38 . . . . 0.0 110.841 178.348 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 41.7 tp . . . . . 0 C--N 1.326 -0.438 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.597 178.172 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.227 -0.117 0 CA-C-O 120.913 0.387 . . . . 0.0 111.759 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -89.6 -20.69 23.42 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.306 0.575 . . . . 0.0 110.36 177.817 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' SER . . . . . 0.576 ' HA ' ' HB3' ' A' ' 25' ' ' LEU . 67.6 m -161.24 91.43 0.86 Allowed 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.373 -0.83 . . . . 0.0 109.914 178.482 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' PHE . . . . . 0.504 ' CE2' HD22 ' A' ' 25' ' ' LEU . 25.4 p90 -103.55 178.81 4.45 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.655 -179.79 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 14' ' ' SER . . . . . 0.477 ' HA ' ' HA ' ' A' ' 24' ' ' SER . 25.1 p -142.35 119.72 11.6 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.119 -0.492 . . . . 0.0 109.948 176.578 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' TYR . . . . . 0.584 ' HB2' HD23 ' A' ' 92' ' ' LEU . 28.3 m-85 -134.8 155.3 79.48 Favored Pre-proline 0 C--N 1.324 -0.53 0 CA-C-N 116.652 -0.249 . . . . 0.0 110.675 -179.15 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -83.37 124.84 3.77 Favored 'Trans proline' 0 N--CA 1.453 -0.864 0 C-N-CA 122.016 1.811 . . . . 0.0 112.896 176.19 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' ASP . . . . . 1.001 ' HB3' ' HB3' ' A' ' 21' ' ' LYS . 0.9 OUTLIER -61.47 162.29 8.29 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.077 -0.965 . . . . 0.0 109.173 168.662 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.687 HD12 HG13 ' A' ' 82' ' ' VAL . 0.7 OUTLIER -42.46 -45.08 1.1 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.452 0 O-C-N 123.975 0.797 . . . . 0.0 112.072 -176.644 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 19' ' ' ASN . . . . . 0.511 ' ND2' HG23 ' A' ' 18' ' ' ILE . 28.9 m-80 -77.23 8.54 3.92 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.825 -173.967 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 81.54 25.22 54.58 Favored Glycine 0 N--CA 1.449 -0.442 0 N-CA-C 110.769 -0.932 . . . . 0.0 110.769 -175.022 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 1.001 ' HB3' ' HB3' ' A' ' 17' ' ' ASP . 1.4 ttmp? -89.96 107.39 19.09 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.435 -0.383 . . . . 0.0 110.473 -173.744 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 23.6 m -67.37 108.29 2.72 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.84 -179.648 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 57.5 t -123.89 133.07 70.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 116.021 -0.536 . . . . 0.0 109.683 179.846 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' SER . . . . . 0.477 ' HA ' ' HA ' ' A' ' 14' ' ' SER . 26.5 p -104.46 171.27 7.42 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.128 0.489 . . . . 0.0 110.031 178.6 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.576 ' HB3' ' HA ' ' A' ' 12' ' ' SER . 20.9 tp -91.18 11.86 21.95 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 121.257 0.551 . . . . 0.0 109.608 176.725 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.591 ' HA ' ' HD3' ' A' ' 29' ' ' LYS . . . -103.29 -25.63 13.25 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 -176.09 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 62.5 m-20 -70.29 -11.79 61.14 Favored 'General case' 0 N--CA 1.436 -1.154 0 CA-C-N 114.05 -1.432 . . . . 0.0 110.797 177.538 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 79.4 mt -110.3 3.19 19.67 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.575 -0.739 . . . . 0.0 112.317 -170.582 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.591 ' HD3' ' HA ' ' A' ' 26' ' ' ALA . 1.3 mptm? -61.98 150.07 38.97 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.192 0.52 . . . . 0.0 111.041 178.462 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 98.55 5.92 56.63 Favored Glycine 0 N--CA 1.445 -0.73 0 C-N-CA 120.807 -0.711 . . . . 0.0 111.731 -179.826 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.798 ' HD3' ' HA ' ' A' ' 63' ' ' ASP . 7.5 ttmm -161.79 148.39 13.99 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.958 -0.386 . . . . 0.0 109.958 179.45 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.491 ' HB2' ' O ' ' A' ' 63' ' ' ASP . 40.6 m-85 -56.28 149.57 16.14 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-O 121.266 0.555 . . . . 0.0 112.365 -173.765 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.697 ' HB ' ' HB2' ' A' ' 115' ' ' LEU . 31.4 mm -118.94 135.65 58.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 115.593 -0.731 . . . . 0.0 110.611 -176.139 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 87.8 t80 -123.32 112.08 17.18 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 109.583 -0.525 . . . . 0.0 109.583 172.197 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.702 ' HB ' ' HB ' ' A' ' 113' ' ' ILE . 39.4 mm -100.8 116.99 45.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.26 179.445 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -117.14 158.56 24.04 Favored 'General case' 0 C--N 1.315 -0.925 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 176.612 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.549 HG11 ' CG2' ' A' ' 109' ' ' ILE . 32.6 t -107.86 112.07 38.6 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.009 0 C-N-CA 120.171 -0.612 . . . . 0.0 109.888 175.315 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' TRP . . . . . 0.692 ' CE3' ' HZ2' ' A' ' 78' ' ' TRP . 0.9 OUTLIER -109.92 134.15 52.4 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 115.575 -0.739 . . . . 0.0 109.174 -175.461 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.546 ' HB3' ' HB3' ' A' ' 42' ' ' CYS . . . -147.07 165.62 29.36 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 116.477 -0.329 . . . . 0.0 110.702 -177.123 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' THR . . . . . 0.689 ' HB ' ' CE3' ' A' ' 78' ' ' TRP . 9.8 t -89.02 -24.96 22.22 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.271 0.558 . . . . 0.0 109.698 173.824 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' TRP . . . . . 0.453 ' HZ2' ' HG ' ' A' ' 71' ' ' CYS . 13.4 p-90 -94.86 8.81 41.49 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.108 179.782 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' CYS . . . . . 0.618 ' SG ' ' HB3' ' A' ' 45' ' ' CYS . 17.5 p -88.54 148.28 24.19 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 175.311 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -92.18 -65.69 1.12 Allowed Glycine 0 N--CA 1.448 -0.527 0 C-N-CA 120.277 -0.963 . . . . 0.0 113.087 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -56.12 -51.82 8.64 Favored 'Trans proline' 0 C--N 1.35 0.655 0 C-N-CA 122.743 2.295 . . . . 0.0 112.865 -175.328 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' CYS . . . . . 0.618 ' HB3' ' SG ' ' A' ' 42' ' ' CYS . 35.1 t -63.11 -39.75 95.61 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.874 0.369 . . . . 0.0 110.325 -175.846 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.537 ' HA ' ' HG ' ' A' ' 49' ' ' LEU . 62.3 ttt180 -71.14 -27.89 63.88 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.493 179.252 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -79.73 -37.75 22.13 Favored Glycine 0 N--CA 1.447 -0.609 0 C-N-CA 120.69 -0.767 . . . . 0.0 111.945 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' GLU . . . . . 0.55 ' OE2' ' HD3' ' A' ' 128' ' ' ARG . 35.5 mt-10 -90.16 10.1 25.8 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 122.976 -0.132 . . . . 0.0 111.27 -178.495 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.632 ' O ' ' HG3' ' A' ' 53' ' ' LYS . 41.0 mt -46.23 -52.17 29.57 Favored Pre-proline 0 N--CA 1.468 0.465 0 N-CA-C 112.419 0.526 . . . . 0.0 112.419 -179.725 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.529 ' HD2' ' N ' ' A' ' 49' ' ' LEU . 10.3 Cg_endo -54.26 -41.33 77.1 Favored 'Trans proline' 0 C--N 1.355 0.876 0 C-N-CA 122.035 1.823 . . . . 0.0 112.46 179.077 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -80.46 -26.65 38.18 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.379 0.609 . . . . 0.0 110.172 -177.204 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 7.9 tt -66.71 -43.7 83.62 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.424 -0.807 . . . . 0.0 108.884 175.585 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.632 ' HG3' ' O ' ' A' ' 49' ' ' LEU . 88.5 mttt -57.83 -48.58 79.36 Favored 'General case' 0 CA--C 1.516 -0.335 0 O-C-N 123.589 0.556 . . . . 0.0 110.345 177.424 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -44.86 -59.09 2.72 Favored 'General case' 0 N--CA 1.452 -0.329 0 O-C-N 124.06 0.85 . . . . 0.0 111.018 175.16 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 60.1 mt -59.99 -51.71 68.48 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.27 177.789 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -44.14 -59.58 2.27 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 114.582 -1.19 . . . . 0.0 112.528 -179.056 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.556 ' HG2' ' O ' ' A' ' 53' ' ' LYS . 6.1 pt-20 -82.75 -29.27 29.82 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 112.154 0.427 . . . . 0.0 112.154 -173.868 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' LYS . . . . . 0.533 ' HE3' ' HE1' ' A' ' 59' ' ' TYR . 32.4 ttpt -68.68 -36.65 78.78 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.236 0.541 . . . . 0.0 110.229 178.316 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.742 ' HB3' HD11 ' A' ' 64' ' ' ILE . 41.7 m-85 -99.45 -1.0 39.66 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.371 -178.857 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -63.83 142.09 58.53 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.538 -0.541 . . . . 0.0 109.538 169.19 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 84.86 9.72 80.33 Favored Glycine 0 N--CA 1.448 -0.521 0 C-N-CA 120.494 -0.86 . . . . 0.0 112.555 179.712 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.536 ' HD2' HD21 ' A' ' 142' ' ' LEU . 39.8 mmtm -100.61 -160.72 0.81 Allowed 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 174.532 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 63' ' ' ASP . . . . . 0.798 ' HA ' ' HD3' ' A' ' 31' ' ' LYS . 2.6 t70 -90.66 52.04 2.11 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-O 121.271 0.558 . . . . 0.0 110.019 -179.688 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.742 HD11 ' HB3' ' A' ' 59' ' ' TYR . 9.2 pt -151.73 156.63 5.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 115.525 -0.761 . . . . 0.0 110.396 -178.418 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 65' ' ' HIS . . . . . 0.665 ' NE2' ' HB3' ' A' ' 31' ' ' LYS . 95.0 m-70 -126.28 113.64 17.21 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.165 -0.47 . . . . 0.0 109.779 175.397 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 88.7 m-85 -76.77 103.8 6.93 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 172.783 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.633 ' HB ' HD13 ' A' ' 35' ' ' ILE . 23.1 t -121.26 104.78 15.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 116.162 -0.472 . . . . 0.0 109.789 -178.928 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 68' ' ' SER . . . . . 0.412 ' HB3' ' CD1' ' A' ' 38' ' ' TRP . 6.8 m -99.28 144.7 28.1 Favored 'General case' 0 C--N 1.313 -1.015 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.508 -177.063 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.435 HD23 ' HB2' ' A' ' 92' ' ' LEU . 78.5 mt -122.95 124.1 42.43 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-O 120.696 0.284 . . . . 0.0 111.49 177.564 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 70' ' ' SER . . . . . 0.419 ' HA ' ' O ' ' A' ' 38' ' ' TRP . 40.6 m -96.0 119.71 34.98 Favored 'General case' 0 N--CA 1.464 0.272 0 N-CA-C 112.542 0.571 . . . . 0.0 112.542 -179.49 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 71' ' ' CYS . . . . . 0.453 ' HG ' ' HZ2' ' A' ' 41' ' ' TRP . 7.4 p -92.64 28.53 1.99 Allowed 'General case' 0 C--N 1.313 -1.008 0 CA-C-O 121.198 0.523 . . . . 0.0 110.118 175.03 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.514 ' OD2' HG22 ' A' ' 40' ' ' THR . 2.1 m-20 -81.77 112.79 19.25 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.312 178.255 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.452 ' HB3' ' HB ' ' A' ' 96' ' ' THR . 8.8 ptmm? -67.98 -28.6 67.58 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.078 0.466 . . . . 0.0 111.127 178.994 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -87.32 75.83 9.22 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 109.608 -0.515 . . . . 0.0 109.608 179.556 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.422 ' O ' ' HG2' ' A' ' 79' ' ' GLU . 8.5 tttm -55.06 -64.01 0.97 Allowed 'General case' 0 C--O 1.217 -0.655 0 CA-C-N 115.849 -0.614 . . . . 0.0 112.45 -175.711 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 64.2 tttp -43.94 -50.17 8.24 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 112.258 0.466 . . . . 0.0 112.258 -177.605 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.557 ' HA ' ' OD1' ' A' ' 80' ' ' ASN . . . -58.75 -41.6 86.91 Favored 'General case' 0 C--O 1.246 0.905 0 CA-C-O 122.142 0.972 . . . . 0.0 110.341 179.769 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 78' ' ' TRP . . . . . 0.692 ' HZ2' ' CE3' ' A' ' 38' ' ' TRP . 10.0 t-105 -65.55 -49.98 66.87 Favored 'General case' 0 C--N 1.312 -1.056 0 CA-C-N 114.012 -1.449 . . . . 0.0 110.988 -178.97 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.479 ' OE1' HG13 ' A' ' 18' ' ' ILE . 6.1 mm-40 -47.4 -44.07 24.12 Favored 'General case' 0 C--O 1.234 0.276 0 N-CA-C 112.069 0.396 . . . . 0.0 112.069 175.678 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 80' ' ' ASN . . . . . 0.717 ' O ' ' HG2' ' A' ' 84' ' ' LYS . 2.4 m120 -60.64 -46.85 88.75 Favored 'General case' 0 CA--C 1.514 -0.41 0 C-N-CA 120.326 -0.55 . . . . 0.0 110.288 -179.243 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 81' ' ' MET . . . . . 0.453 ' SD ' ' HZ3' ' A' ' 78' ' ' TRP . 19.0 ttt -63.07 -47.79 81.44 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 120.41 -0.516 . . . . 0.0 111.993 -177.214 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.687 HG13 HD12 ' A' ' 18' ' ' ILE . 7.2 p -64.17 -28.48 44.99 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 C-N-CA 120.308 -0.557 . . . . 0.0 111.41 -177.54 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 83' ' ' THR . . . . . 0.435 HG23 HD11 ' A' ' 18' ' ' ILE . 5.0 p -81.17 -21.89 39.37 Favored 'General case' 0 N--CA 1.444 -0.749 0 O-C-N 121.941 -0.475 . . . . 0.0 111.757 176.406 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 84' ' ' LYS . . . . . 0.717 ' HG2' ' O ' ' A' ' 80' ' ' ASN . 27.1 mmtm -84.73 -38.39 19.75 Favored 'General case' 0 CA--C 1.519 -0.237 0 CA-C-O 121.249 0.547 . . . . 0.0 110.597 178.195 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -80.15 -22.76 41.67 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.241 -0.891 . . . . 0.0 110.305 179.393 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 78.6 mt-30 66.54 76.46 0.3 Allowed 'General case' 0 C--O 1.234 0.268 0 CA-C-N 115.188 -0.914 . . . . 0.0 111.96 177.085 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.543 ' HB2' HG23 ' A' ' 82' ' ' VAL . 89.4 mt -103.85 133.09 49.42 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.426 -0.806 . . . . 0.0 109.065 173.658 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.525 ' HD2' ' H ' ' A' ' 88' ' ' LYS . 0.0 OUTLIER -134.73 157.97 45.34 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.349 0.595 . . . . 0.0 111.96 -175.499 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 124.91 -132.75 8.24 Favored Glycine 0 N--CA 1.447 -0.626 0 N-CA-C 110.224 -1.15 . . . . 0.0 110.224 -173.278 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 57.7 mt -112.03 108.02 24.45 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 173.414 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 91' ' ' GLN . . . . . 0.657 ' HB3' ' CZ2' ' A' ' 38' ' ' TRP . 7.0 mm-40 -129.04 103.75 7.18 Favored 'General case' 0 N--CA 1.445 -0.708 0 N-CA-C 109.926 -0.398 . . . . 0.0 109.926 -175.828 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.584 HD23 ' HB2' ' A' ' 15' ' ' TYR . 5.1 mp -103.29 151.36 22.79 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-O 121.493 0.663 . . . . 0.0 110.87 -175.765 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 16.7 t-80 -120.77 119.59 33.17 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-N 115.613 -0.722 . . . . 0.0 110.425 -176.912 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 33.7 ttm -71.78 -75.78 0.12 Allowed 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.433 -0.803 . . . . 0.0 110.129 176.363 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 134.94 -95.15 0.26 Allowed Glycine 0 N--CA 1.442 -0.95 0 N-CA-C 111.114 -0.794 . . . . 0.0 111.114 -174.181 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.452 ' HB ' ' HB3' ' A' ' 73' ' ' LYS . 9.2 t -150.49 25.61 0.77 Allowed 'General case' 0 C--N 1.313 -0.981 0 CA-C-O 121.834 0.826 . . . . 0.0 109.287 177.831 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -81.55 72.61 8.6 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 114.86 -1.063 . . . . 0.0 109.766 -179.092 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 98' ' ' ARG . . . . . 0.591 ' HA ' ' HG3' ' A' ' 101' ' ' MET . 7.4 mmm180 -69.36 -10.91 60.03 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.724 -173.298 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 7.6 m -58.24 -36.81 73.76 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.165 0.507 . . . . 0.0 109.927 175.262 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 24.8 t80 -81.74 -25.43 35.38 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.184 178.782 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 101' ' ' MET . . . . . 0.591 ' HG3' ' HA ' ' A' ' 98' ' ' ARG . 1.3 mmt -58.92 -51.44 70.04 Favored 'General case' 0 CA--C 1.519 -0.245 0 CA-C-O 121.265 0.555 . . . . 0.0 109.507 175.451 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -77.02 -23.03 52.19 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.406 -0.815 . . . . 0.0 110.538 -177.793 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -64.8 -26.93 68.55 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-O 121.12 0.486 . . . . 0.0 111.043 176.931 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 104' ' ' TYR . . . . . 0.555 ' HB3' HG23 ' A' ' 106' ' ' ILE . 0.3 OUTLIER -96.38 -4.11 42.47 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.296 174.875 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 93.5 mt 58.59 32.21 21.91 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.356 -172.301 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 106' ' ' ILE . . . . . 0.997 HG21 HD11 ' A' ' 113' ' ' ILE . 40.8 pt -114.43 31.96 1.52 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.333 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.356 -178.622 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 15.3 p30 -56.47 -29.74 62.09 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.469 -0.787 . . . . 0.0 111.82 -178.699 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -89.48 108.95 3.54 Favored Glycine 0 N--CA 1.448 -0.525 0 C-N-CA 121.02 -0.61 . . . . 0.0 111.61 174.077 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.549 ' CG2' HG11 ' A' ' 37' ' ' VAL . 2.5 pp -100.43 153.81 37.54 Favored Pre-proline 0 C--N 1.325 -0.466 0 CA-C-O 120.344 0.116 . . . . 0.0 110.767 -177.528 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 110' ' ' PRO . . . . . 0.429 ' HG3' ' HB2' ' A' ' 42' ' ' CYS . 2.7 Cg_exo -76.82 152.51 95.43 Favored 'Cis proline' 0 C--N 1.344 0.326 0 C-N-CA 123.899 -1.292 . . . . 0.0 111.966 -0.068 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 111' ' ' ARG . . . . . 0.779 HH11 HG22 ' A' ' 106' ' ' ILE . 0.0 OUTLIER -125.17 138.45 54.14 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.365 0.603 . . . . 0.0 110.966 -179.0 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 112' ' ' PHE . . . . . 0.611 ' HD1' ' H ' ' A' ' 126' ' ' MET . 0.2 OUTLIER -106.74 114.97 29.39 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 114.341 -1.3 . . . . 0.0 110.354 -176.548 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.997 HD11 HG21 ' A' ' 106' ' ' ILE . 61.6 mt -123.57 142.54 39.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-O 120.858 0.361 . . . . 0.0 110.754 -178.483 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 23.0 tp -129.23 135.14 48.42 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.996 -0.547 . . . . 0.0 109.655 177.662 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.697 ' HB2' ' HB ' ' A' ' 33' ' ' ILE . 2.0 mp -132.57 153.44 51.0 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.878 0.37 . . . . 0.0 110.495 -177.054 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 116' ' ' ASP . . . . . 0.496 ' HB3' ' HB2' ' A' ' 120' ' ' LYS . 27.9 t0 -68.93 166.1 18.58 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.468 -0.787 . . . . 0.0 110.261 177.276 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 117' ' ' ARG . . . . . 0.513 ' HA ' ' C ' ' A' ' 31' ' ' LYS . 9.2 mtm180 -49.39 -27.64 4.28 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 124.335 1.054 . . . . 0.0 112.733 -177.076 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 118' ' ' ASP . . . . . 0.552 ' HB3' ' HG3' ' A' ' 120' ' ' LYS . 30.6 t70 -83.32 -0.97 52.1 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.257 0.551 . . . . 0.0 110.965 -178.784 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 81.26 22.5 60.61 Favored Glycine 0 N--CA 1.439 -1.16 0 N-CA-C 110.203 -1.159 . . . . 0.0 110.203 -170.513 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 120' ' ' LYS . . . . . 0.552 ' HG3' ' HB3' ' A' ' 118' ' ' ASP . 56.5 mttp -88.56 107.4 18.88 Favored 'General case' 0 C--O 1.223 -0.325 0 C-N-CA 120.478 -0.489 . . . . 0.0 111.052 -178.267 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 121' ' ' ILE . . . . . 0.479 ' HA ' ' HG ' ' A' ' 115' ' ' LEU . 19.5 mt -42.74 116.27 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-O 121.725 0.774 . . . . 0.0 112.332 179.251 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 122' ' ' ILE . . . . . 0.461 HD11 ' HB2' ' A' ' 116' ' ' ASP . 39.2 mm -97.87 -50.87 10.94 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.927 0 CA-C-N 114.283 -1.326 . . . . 0.0 109.203 177.163 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 14.6 m -129.44 114.21 15.87 Favored 'General case' 0 N--CA 1.446 -0.664 0 CA-C-N 115.22 -0.9 . . . . 0.0 110.113 179.305 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -68.05 -20.38 64.97 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 121.807 0.813 . . . . 0.0 109.496 174.046 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 7.4 p30 -141.46 122.07 14.23 Favored 'General case' 0 N--CA 1.447 -0.586 0 CA-C-N 114.523 -1.217 . . . . 0.0 108.25 171.291 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 126' ' ' MET . . . . . 0.611 ' H ' ' HD1' ' A' ' 112' ' ' PHE . 17.3 tpt -92.76 -80.66 0.37 Allowed 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.915 -176.664 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 4.2 m -155.44 -61.91 0.11 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.576 -0.284 . . . . 0.0 110.48 179.605 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 128' ' ' ARG . . . . . 1.087 ' HB3' ' HB2' ' A' ' 131' ' ' ASP . 0.0 OUTLIER -179.82 142.1 0.35 Allowed Pre-proline 0 N--CA 1.453 -0.314 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 -176.467 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 129' ' ' PRO . . . . . 0.566 ' HD2' ' HG2' ' A' ' 128' ' ' ARG . 1.5 Cg_endo -43.19 -49.0 7.58 Favored 'Trans proline' 0 C--N 1.351 0.671 0 C-N-CA 123.431 2.754 . . . . 0.0 113.353 -178.626 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 25.3 t -113.24 29.72 7.76 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.821 0.343 . . . . 0.0 111.196 -177.561 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 131' ' ' ASP . . . . . 1.087 ' HB2' ' HB3' ' A' ' 128' ' ' ARG . 11.2 t70 -84.88 135.94 39.39 Favored Pre-proline 0 C--N 1.328 -0.341 0 C-N-CA 120.389 -0.525 . . . . 0.0 110.426 -179.975 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 80.8 Cg_exo -48.24 -37.82 32.34 Favored 'Trans proline' 0 C--N 1.344 0.303 0 C-N-CA 123.231 2.621 . . . . 0.0 113.258 176.66 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 28.9 mmtm -56.98 -36.22 70.1 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-O 120.866 0.365 . . . . 0.0 111.711 -177.336 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 134' ' ' THR . . . . . 0.684 HG22 ' CZ ' ' A' ' 138' ' ' PHE . 2.4 m -64.51 -51.19 64.22 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.284 0.564 . . . . 0.0 109.69 177.244 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 135' ' ' ALA . . . . . 0.672 ' HA ' ' CD2' ' A' ' 138' ' ' PHE . . . -61.56 -41.01 96.75 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.583 -0.735 . . . . 0.0 111.542 177.576 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -53.5 -52.1 60.67 Favored 'General case' 0 CA--C 1.511 -0.531 0 CA-C-O 121.44 0.638 . . . . 0.0 110.458 176.882 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 137' ' ' LYS . . . . . 0.707 ' HE2' ' HA ' ' A' ' 137' ' ' LYS . 0.3 OUTLIER -48.93 -46.56 43.26 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 114.333 -1.303 . . . . 0.0 111.261 175.614 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 138' ' ' PHE . . . . . 0.684 ' CZ ' HG22 ' A' ' 134' ' ' THR . 5.9 m-85 -63.1 -53.77 48.29 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 120.889 0.376 . . . . 0.0 109.991 178.4 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 94.2 m-20 -50.9 -50.12 58.04 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.789 -179.886 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -49.41 -54.47 17.35 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.648 -0.705 . . . . 0.0 112.133 178.17 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.55 ' HG ' ' O ' ' A' ' 138' ' ' PHE . 3.2 pp -69.35 -19.38 63.85 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 120.953 -0.299 . . . . 0.0 111.206 -174.842 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 0.536 HD21 ' HD2' ' A' ' 62' ' ' LYS . 8.2 mp . . . . . 0 C--N 1.331 -0.215 0 CA-C-O 120.907 0.384 . . . . 0.0 110.56 173.418 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.359 0 CA-C-O 121.542 0.687 . . . . 0.0 110.499 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -138.77 99.22 3.74 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 115.131 -0.94 . . . . 0.0 110.216 -179.752 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 49.0 m 64.7 80.02 0.24 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.405 -0.816 . . . . 0.0 111.454 179.463 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 53.5 p90 -96.08 155.32 16.81 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.116 178.014 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 5.4 p -142.1 112.92 7.35 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 120.98 0.419 . . . . 0.0 110.147 177.307 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' TYR . . . . . 0.559 ' HB2' HD13 ' A' ' 92' ' ' LEU . 35.8 m-85 -135.75 149.7 69.69 Favored Pre-proline 0 C--N 1.326 -0.431 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.413 -176.38 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.456 ' HA ' ' O ' ' A' ' 21' ' ' LYS . 97.3 Cg_endo -87.07 131.37 3.11 Favored 'Trans proline' 0 N--CA 1.452 -0.946 0 C-N-CA 122.528 2.152 . . . . 0.0 113.23 179.808 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' ASP . . . . . 0.506 ' HB3' ' HB3' ' A' ' 21' ' ' LYS . 12.1 t70 -67.95 154.49 41.49 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 114.958 -1.019 . . . . 0.0 108.63 170.403 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -53.21 -32.93 19.75 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.6 0 O-C-N 124.018 0.824 . . . . 0.0 110.883 -179.391 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 43.7 m-80 -76.29 -1.77 28.23 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 121.089 0.471 . . . . 0.0 110.82 179.051 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 86.05 42.11 6.83 Favored Glycine 0 N--CA 1.446 -0.647 0 CA-C-N 115.739 -0.664 . . . . 0.0 112.172 -179.619 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.506 ' HB3' ' HB3' ' A' ' 17' ' ' ASP . 56.8 tttm -107.71 124.2 49.66 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 120.173 -0.611 . . . . 0.0 111.252 -179.453 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 19.4 m -66.49 107.38 2.04 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.29 -0.414 . . . . 0.0 109.945 172.652 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.444 ' HB ' HD21 ' A' ' 92' ' ' LEU . 91.6 t -116.35 117.32 55.1 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-O 120.996 0.427 . . . . 0.0 109.909 178.342 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 17.6 m -122.77 179.47 4.62 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.288 -178.15 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.418 HD11 ' HA3' ' A' ' 119' ' ' GLY . 52.7 tp -56.4 -42.28 77.7 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.924 0.393 . . . . 0.0 111.027 -179.287 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -82.27 15.91 2.24 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.86 -177.793 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -102.18 -17.08 16.14 Favored 'General case' 0 CA--C 1.517 -0.294 0 N-CA-C 107.692 -1.225 . . . . 0.0 107.692 178.319 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -117.22 -20.81 9.07 Favored 'General case' 0 N--CA 1.445 -0.723 0 CA-C-N 113.973 -1.467 . . . . 0.0 110.494 -179.323 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 58.3 tttm -61.71 132.07 52.0 Favored 'General case' 0 N--CA 1.446 -0.662 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.273 -173.931 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 120.5 -8.59 11.03 Favored Glycine 0 N--CA 1.451 -0.328 0 N-CA-C 110.61 -0.996 . . . . 0.0 110.61 -174.496 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.687 ' HD3' ' HA ' ' A' ' 63' ' ' ASP . 25.2 ttmm -155.63 154.96 32.44 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 -178.784 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.445 ' HB2' ' O ' ' A' ' 63' ' ' ASP . 61.8 m-85 -59.07 147.1 36.12 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-O 121.094 0.473 . . . . 0.0 111.601 -174.482 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.553 HD12 ' HA2' ' A' ' 119' ' ' GLY . 40.0 mt -124.45 134.77 65.83 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.439 -175.633 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' TYR . . . . . 0.414 ' HE2' ' HB3' ' A' ' 36' ' ' ASP . 80.3 t80 -121.79 130.71 53.61 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 173.177 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.547 ' HA ' ' O ' ' A' ' 67' ' ' VAL . 62.5 mt -115.2 110.76 33.1 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-O 121.093 0.473 . . . . 0.0 110.577 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.582 ' O ' ' HA ' ' A' ' 68' ' ' SER . 7.1 p-10 -110.34 158.97 17.87 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-N 115.5 -0.773 . . . . 0.0 109.063 175.257 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.522 HG11 HG21 ' A' ' 109' ' ' ILE . 85.5 t -102.88 126.68 57.09 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.806 0 C-N-CA 120.144 -0.622 . . . . 0.0 111.119 176.598 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' TRP . . . . . 0.588 ' CE3' ' CZ2' ' A' ' 78' ' ' TRP . 0.7 OUTLIER -113.31 130.49 56.25 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 109.368 -0.605 . . . . 0.0 109.368 177.958 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -150.19 167.47 26.81 Favored 'General case' 0 C--N 1.328 -0.354 0 O-C-N 122.362 -0.211 . . . . 0.0 111.039 -178.497 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' THR . . . . . 0.601 HG22 ' OD2' ' A' ' 72' ' ' ASP . 13.8 t -108.85 -33.63 6.89 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 120.696 -0.401 . . . . 0.0 110.694 174.313 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' TRP . . . . . 0.726 ' HE1' ' HA ' ' A' ' 72' ' ' ASP . 65.6 p-90 -73.94 -9.24 58.44 Favored 'General case' 0 C--N 1.343 0.291 0 C-N-CA 120.319 -0.552 . . . . 0.0 111.002 178.489 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 25.5 t -63.55 -57.57 9.72 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.102 -179.917 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 107.28 -85.18 0.41 Allowed Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.642 -0.789 . . . . 0.0 112.493 -176.712 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_exo -53.42 -28.63 45.04 Favored 'Trans proline' 0 C--N 1.354 0.818 0 C-N-CA 123.134 2.556 . . . . 0.0 112.727 179.277 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 42.4 t -54.13 -29.15 44.06 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.055 176.963 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 54.8 mtp180 -83.65 -26.23 30.08 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-O 120.903 0.382 . . . . 0.0 110.695 -179.701 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -80.52 -36.67 22.65 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.865 -0.683 . . . . 0.0 111.689 -179.335 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' GLU . . . . . 0.422 ' OE2' ' HD2' ' A' ' 128' ' ' ARG . 21.3 mt-10 -90.23 10.36 24.95 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.292 0.568 . . . . 0.0 109.985 177.95 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.546 ' N ' ' HD2' ' A' ' 50' ' ' PRO . 20.2 tp -69.05 -45.99 30.24 Favored Pre-proline 0 N--CA 1.441 -0.89 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.869 -177.936 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.546 ' HD2' ' N ' ' A' ' 49' ' ' LEU . 11.7 Cg_endo -56.83 -22.28 44.59 Favored 'Trans proline' 0 C--N 1.351 0.698 0 C-N-CA 121.565 1.51 . . . . 0.0 111.363 171.379 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -85.05 -31.38 23.44 Favored 'General case' 0 CA--C 1.515 -0.386 0 CA-C-O 121.924 0.869 . . . . 0.0 108.895 -179.233 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 6.0 tt -69.94 -48.07 59.88 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-N 114.443 -1.253 . . . . 0.0 108.573 178.228 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.687 ' HZ3' ' HB3' ' A' ' 53' ' ' LYS . 7.6 mtpm? -58.83 -49.37 77.99 Favored 'General case' 0 C--O 1.225 -0.193 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.751 179.119 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -46.03 -56.37 5.64 Favored 'General case' 0 C--N 1.332 -0.16 0 O-C-N 123.514 0.509 . . . . 0.0 111.586 176.397 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.598 HD21 ' HE2' ' A' ' 138' ' ' PHE . 38.8 tp -66.95 -48.7 67.75 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.255 -178.392 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.437 ' HA ' ' CE2' ' A' ' 66' ' ' PHE . 5.9 tm-20 -59.03 -55.1 39.47 Favored 'General case' 0 N--CA 1.448 -0.553 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.563 -175.998 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.674 ' HG2' ' NZ ' ' A' ' 88' ' ' LYS . 38.2 mt-10 -70.12 -30.43 67.62 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.724 0.297 . . . . 0.0 111.244 -174.73 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 58' ' ' LYS . . . . . 0.482 ' HE3' ' HB2' ' A' ' 58' ' ' LYS . 34.3 ttmt -69.96 -41.77 74.07 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-O 121.198 0.523 . . . . 0.0 110.665 179.237 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 17.2 m-85 -100.3 7.82 44.12 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.473 -177.032 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -65.11 136.19 56.41 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.258 -0.428 . . . . 0.0 109.941 173.245 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 82.61 1.52 90.53 Favored Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.407 179.187 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.452 ' O ' ' HD3' ' A' ' 31' ' ' LYS . 34.8 mmtm -90.59 -154.16 0.33 Allowed 'General case' 0 CA--C 1.515 -0.395 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 176.601 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 63' ' ' ASP . . . . . 0.687 ' HA ' ' HD3' ' A' ' 31' ' ' LYS . 2.6 t70 -95.1 47.26 1.14 Allowed 'General case' 0 C--N 1.318 -0.762 0 CA-C-O 121.35 0.595 . . . . 0.0 110.344 179.153 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 13.3 tt -155.16 135.31 4.18 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.721 0 CA-C-N 115.582 -0.735 . . . . 0.0 109.961 178.038 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' HIS . . . . . 0.659 ' NE2' ' HB3' ' A' ' 31' ' ' LYS . 75.3 m-70 -105.0 114.27 28.38 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 176.911 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 66' ' ' PHE . . . . . 0.453 ' CZ ' ' HG ' ' A' ' 55' ' ' LEU . 73.6 m-85 -78.4 104.81 9.23 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 172.442 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.547 ' O ' ' HA ' ' A' ' 35' ' ' ILE . 48.4 t -117.49 104.46 16.42 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.884 -178.359 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 68' ' ' SER . . . . . 0.582 ' HA ' ' O ' ' A' ' 36' ' ' ASP . 23.3 p -89.26 146.03 25.0 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.169 -179.8 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.471 ' O ' HG13 ' A' ' 37' ' ' VAL . 64.8 tp -124.12 126.84 46.87 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 109.689 -0.486 . . . . 0.0 109.689 176.77 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 70' ' ' SER . . . . . 0.487 ' HB3' ' HA ' ' A' ' 93' ' ' HIS . 19.3 t -103.94 109.03 20.62 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.435 0.636 . . . . 0.0 112.29 -174.301 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 6.8 m -81.02 25.11 0.48 Allowed 'General case' 0 C--N 1.314 -0.974 0 CA-C-N 115.067 -0.969 . . . . 0.0 110.188 169.553 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.726 ' HA ' ' HE1' ' A' ' 41' ' ' TRP . 2.9 t70 -72.79 129.74 38.89 Favored 'General case' 0 CA--C 1.51 -0.578 0 C-N-CA 119.899 -0.72 . . . . 0.0 110.174 -178.646 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.494 ' NZ ' ' HB3' ' A' ' 73' ' ' LYS . 3.0 ttpm? -88.02 -11.95 45.81 Favored 'General case' 0 C--N 1.313 -0.979 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.338 -177.856 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 -104.39 60.04 0.71 Allowed 'General case' 0 CA--C 1.51 -0.595 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 -176.779 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.64 ' O ' ' HG2' ' A' ' 79' ' ' GLU . 64.9 tttt -47.75 -51.33 22.59 Favored 'General case' 0 C--O 1.221 -0.414 0 O-C-N 123.644 0.59 . . . . 0.0 112.447 -170.029 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 23.6 tptm -48.3 -54.24 14.45 Favored 'General case' 0 C--O 1.245 0.855 0 CA-C-N 116.735 -0.211 . . . . 0.0 110.456 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -61.27 -39.86 91.95 Favored 'General case' 0 N--CA 1.452 -0.355 0 O-C-N 123.972 0.795 . . . . 0.0 110.034 -178.844 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' TRP . . . . . 0.588 ' CZ2' ' CE3' ' A' ' 38' ' ' TRP . 9.3 t-105 -61.43 -58.51 7.88 Favored 'General case' 0 N--CA 1.437 -1.088 0 CA-C-N 114.96 -1.018 . . . . 0.0 112.263 -179.458 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.64 ' HG2' ' O ' ' A' ' 75' ' ' LYS . 3.3 mm-40 -52.25 -48.04 65.43 Favored 'General case' 0 C--O 1.236 0.39 0 N-CA-C 112.426 0.528 . . . . 0.0 112.426 -175.669 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 3.9 p-10 -71.16 -28.82 64.53 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 118.859 -1.136 . . . . 0.0 110.852 -178.159 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 15.3 ttt -68.19 -47.81 66.93 Favored 'General case' 0 C--O 1.222 -0.359 0 C-N-CA 120.978 -0.289 . . . . 0.0 111.542 177.518 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.586 HG23 ' HB2' ' A' ' 87' ' ' LEU . 0.2 OUTLIER -58.69 -37.9 68.44 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.313 0 C-N-CA 120.429 -0.509 . . . . 0.0 110.205 178.72 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 25.3 m -67.34 -33.31 74.97 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.81 177.376 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 21.0 tttm -80.25 -49.97 10.86 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.699 -177.958 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 52.8 m-20 -84.37 6.79 21.78 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.633 -0.712 . . . . 0.0 111.406 -173.983 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 89.7 mt-30 64.28 41.72 5.8 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 115.72 -0.673 . . . . 0.0 112.745 171.007 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.586 ' HB2' HG23 ' A' ' 82' ' ' VAL . 7.9 mp -83.95 82.11 8.49 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 120.758 -0.377 . . . . 0.0 110.218 176.036 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.674 ' NZ ' ' HG2' ' A' ' 57' ' ' GLU . 0.0 OUTLIER -95.79 171.53 8.59 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.594 -0.276 . . . . 0.0 111.676 -179.852 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 128.07 -139.74 11.3 Favored Glycine 0 N--CA 1.452 -0.258 0 N-CA-C 110.286 -1.126 . . . . 0.0 110.286 -175.795 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 63.8 mt -111.44 109.05 27.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 N-CA-C 107.935 -1.135 . . . . 0.0 107.935 168.408 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 91' ' ' GLN . . . . . 0.541 ' HB3' ' CZ2' ' A' ' 38' ' ' TRP . 3.5 mm100 -127.73 100.22 5.87 Favored 'General case' 0 N--CA 1.442 -0.85 0 CA-C-O 120.838 0.351 . . . . 0.0 110.953 -167.669 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.559 HD13 ' HB2' ' A' ' 15' ' ' TYR . 27.0 mt -97.22 140.58 31.49 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 120.817 0.342 . . . . 0.0 110.787 -177.133 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 93' ' ' HIS . . . . . 0.547 ' CE1' ' HG3' ' A' ' 75' ' ' LYS . 30.0 t-80 -114.53 120.63 40.88 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 120.864 0.364 . . . . 0.0 110.896 178.301 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 19.7 ttp -79.0 -55.83 4.84 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.74 -0.664 . . . . 0.0 109.999 176.553 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 95' ' ' GLY . . . . . 0.453 ' HA2' ' NE2' ' A' ' 93' ' ' HIS . . . 111.19 -119.33 5.14 Favored Glycine 0 N--CA 1.438 -1.178 0 C-N-CA 120.557 -0.83 . . . . 0.0 111.879 -179.465 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 8.9 t -109.85 21.71 16.55 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-O 120.555 0.217 . . . . 0.0 110.994 -175.28 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -90.84 134.17 34.65 Favored 'General case' 0 CA--C 1.515 -0.383 0 C-N-CA 119.699 -0.8 . . . . 0.0 109.74 179.9 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 98' ' ' ARG . . . . . 0.598 ' HA ' ' HG3' ' A' ' 101' ' ' MET . 0.0 OUTLIER -113.71 6.08 16.69 Favored 'General case' 0 C--N 1.32 -0.676 0 C-N-CA 120.361 -0.536 . . . . 0.0 110.699 176.689 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 4.0 m -71.0 -39.68 72.29 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.373 -178.611 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 27.7 t80 -82.24 -30.61 30.65 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.585 -176.948 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 101' ' ' MET . . . . . 0.598 ' HG3' ' HA ' ' A' ' 98' ' ' ARG . 4.7 ppp? -74.68 -20.92 59.67 Favored 'General case' 0 C--N 1.332 -0.168 0 C-N-CA 120.144 -0.622 . . . . 0.0 109.495 177.554 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -68.0 -42.81 80.18 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.41 -0.814 . . . . 0.0 109.8 172.331 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -64.46 -16.99 63.4 Favored 'General case' 0 CA--C 1.529 0.158 0 CA-C-N 115.674 -0.694 . . . . 0.0 111.815 -177.621 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 9.0 m-85 -108.28 -2.32 19.35 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.402 178.212 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 7.8 mp 55.34 37.64 29.18 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.812 -176.793 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 106' ' ' ILE . . . . . 0.855 HG12 ' HG3' ' A' ' 111' ' ' ARG . 60.8 mt -59.41 106.51 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.006 177.906 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 7.1 m120 -73.79 -66.18 0.74 Allowed 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.626 0.727 . . . . 0.0 109.938 178.483 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -135.14 145.82 17.88 Favored Glycine 0 N--CA 1.438 -1.216 0 CA-C-N 114.971 -1.013 . . . . 0.0 111.12 178.979 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.522 HG21 HG11 ' A' ' 37' ' ' VAL . 40.2 pt -100.53 154.3 37.26 Favored Pre-proline 0 C--N 1.316 -0.85 0 N-CA-C 110.34 -0.244 . . . . 0.0 110.34 179.736 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 110' ' ' PRO . . . . . 0.487 ' HB3' ' O ' ' A' ' 37' ' ' VAL . 15.9 Cg_exo -69.1 131.73 19.34 Favored 'Cis proline' 0 C--N 1.348 0.515 0 C-N-CA 123.973 -1.261 . . . . 0.0 113.54 0.656 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 111' ' ' ARG . . . . . 0.855 ' HG3' HG12 ' A' ' 106' ' ' ILE . 0.0 OUTLIER -82.26 160.3 22.99 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 175.215 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 112' ' ' PHE . . . . . 0.429 ' HD2' ' HB2' ' A' ' 128' ' ' ARG . 0.2 OUTLIER -130.45 114.43 15.52 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.76 -0.654 . . . . 0.0 109.958 -177.445 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.516 ' HB ' ' HB ' ' A' ' 35' ' ' ILE . 81.5 mt -134.44 142.88 39.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-O 120.735 0.303 . . . . 0.0 111.142 -176.306 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.491 ' HB2' ' SD ' ' A' ' 126' ' ' MET . 41.2 tp -127.13 140.41 52.28 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.262 178.689 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.492 ' HB2' ' HB ' ' A' ' 33' ' ' ILE . 1.9 mp -133.29 150.0 51.91 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.302 0.572 . . . . 0.0 110.042 178.152 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 116' ' ' ASP . . . . . 0.624 ' HB3' ' HB2' ' A' ' 120' ' ' LYS . 14.1 t70 -70.29 164.3 24.7 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.029 -0.987 . . . . 0.0 110.604 178.905 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 117' ' ' ARG . . . . . 0.405 ' HA ' ' C ' ' A' ' 31' ' ' LYS . 84.5 mtt180 -48.13 -38.09 17.05 Favored 'General case' 0 N--CA 1.464 0.247 0 O-C-N 124.198 0.936 . . . . 0.0 112.613 -178.63 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -80.54 9.77 5.61 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.638 0.256 . . . . 0.0 111.607 -178.962 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 119' ' ' GLY . . . . . 0.553 ' HA2' HD12 ' A' ' 33' ' ' ILE . . . 79.04 28.81 53.34 Favored Glycine 0 N--CA 1.445 -0.744 0 N-CA-C 111.244 -0.743 . . . . 0.0 111.244 -176.988 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 120' ' ' LYS . . . . . 0.624 ' HB2' ' HB3' ' A' ' 116' ' ' ASP . 32.4 mtmm -99.47 104.29 16.11 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 120.674 -0.411 . . . . 0.0 110.742 -175.147 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 121' ' ' ILE . . . . . 0.676 ' H ' HD12 ' A' ' 121' ' ' ILE . 4.0 mp -43.65 111.57 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-O 121.31 0.576 . . . . 0.0 111.396 -178.286 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 122' ' ' ILE . . . . . 0.451 ' H ' ' HA ' ' A' ' 115' ' ' LEU . 58.7 mt -85.59 -41.3 15.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 115.337 -0.847 . . . . 0.0 109.18 178.921 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 17.3 m -149.72 115.44 5.6 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.416 -0.811 . . . . 0.0 110.299 -179.522 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -69.92 -15.22 63.03 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.348 0.594 . . . . 0.0 110.307 174.937 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 18.1 p-10 -139.95 102.77 4.48 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.313 -0.858 . . . . 0.0 110.066 174.24 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 126' ' ' MET . . . . . 0.491 ' SD ' ' HB2' ' A' ' 114' ' ' LEU . 20.8 ttp -107.97 -133.4 0.33 Allowed 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.036 -0.529 . . . . 0.0 109.676 178.602 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 6.3 p -124.69 138.07 54.32 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 110.149 -0.315 . . . . 0.0 110.149 177.328 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 128' ' ' ARG . . . . . 0.43 ' CG ' ' HD2' ' A' ' 129' ' ' PRO . 37.9 ttm180 -67.78 147.36 98.59 Favored Pre-proline 0 C--N 1.325 -0.475 0 CA-C-N 116.198 -0.455 . . . . 0.0 109.874 177.565 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 129' ' ' PRO . . . . . 0.43 ' HD2' ' CG ' ' A' ' 128' ' ' ARG . 2.9 Cg_endo -42.62 -25.82 0.54 Allowed 'Trans proline' 0 C--N 1.356 0.966 0 C-N-CA 124.119 3.213 . . . . 0.0 114.226 177.095 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 1.4 m -57.76 -26.05 61.32 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 122.723 0.409 . . . . 0.0 111.708 178.432 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 131' ' ' ASP . . . . . 0.479 ' OD1' ' HG3' ' A' ' 133' ' ' LYS . 21.1 t0 -99.05 124.88 43.76 Favored Pre-proline 0 C--N 1.329 -0.32 0 N-CA-C 109.938 -0.393 . . . . 0.0 109.938 179.511 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 28.7 Cg_endo -61.0 -18.11 55.73 Favored 'Trans proline' 0 C--N 1.347 0.489 0 C-N-CA 123.273 2.648 . . . . 0.0 113.788 -178.081 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 133' ' ' LYS . . . . . 0.479 ' HG3' ' OD1' ' A' ' 131' ' ' ASP . 48.6 mttp -58.2 -23.93 57.31 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-O 120.833 0.349 . . . . 0.0 110.605 178.843 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 36.2 p -58.39 -59.32 5.53 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.235 175.494 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -56.75 -47.17 80.66 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.917 -177.907 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -56.63 -39.9 74.47 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.44 -0.8 . . . . 0.0 111.15 -179.633 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 137' ' ' LYS . . . . . 0.514 ' O ' ' HG ' ' A' ' 141' ' ' LEU . 75.5 tttt -74.08 -34.09 63.88 Favored 'General case' 0 N--CA 1.451 -0.396 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.883 -179.271 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 138' ' ' PHE . . . . . 0.598 ' HE2' HD21 ' A' ' 55' ' ' LEU . 11.1 m-30 -64.43 -40.22 95.33 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 109.689 -0.486 . . . . 0.0 109.689 177.747 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 75.6 m-20 -58.17 -45.74 86.96 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.69 -0.686 . . . . 0.0 109.66 174.989 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -60.58 -48.07 83.39 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.067 177.467 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.514 ' HG ' ' O ' ' A' ' 137' ' ' LYS . 95.5 mt -56.38 -45.59 80.46 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.776 -179.402 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 0.543 HD13 ' HB2' ' A' ' 63' ' ' ASP . 60.0 tp . . . . . 0 C--N 1.33 -0.278 0 CA-C-O 121.201 0.524 . . . . 0.0 110.811 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.441 ' HA ' ' CZ ' ' A' ' 100' ' ' PHE . . . . . . . . 0 N--CA 1.455 -0.191 0 CA-C-O 121.308 0.575 . . . . 0.0 109.884 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -128.38 13.24 6.56 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.344 -0.844 . . . . 0.0 110.535 -178.644 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 35.6 p -143.16 18.34 1.92 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.13 0.491 . . . . 0.0 110.852 -179.747 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 49.5 p90 -73.81 149.64 41.54 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.055 -0.521 . . . . 0.0 111.008 -176.958 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' SER . . . . . 0.466 ' HA ' ' HA ' ' A' ' 24' ' ' SER . 39.1 m -142.22 117.23 9.98 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.773 -0.649 . . . . 0.0 109.377 176.811 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 15' ' ' TYR . . . . . 0.538 ' HB2' HD22 ' A' ' 92' ' ' LEU . 57.5 m-85 -128.32 145.68 56.64 Favored Pre-proline 0 C--N 1.323 -0.55 0 CA-C-O 120.851 0.357 . . . . 0.0 111.236 -176.321 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 63.2 Cg_endo -76.07 125.39 8.58 Favored 'Trans proline' 0 N--CA 1.459 -0.553 0 C-N-CA 122.434 2.089 . . . . 0.0 113.449 -179.029 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' ASP . . . . . 0.68 ' HB3' ' HB3' ' A' ' 21' ' ' LYS . 3.3 t70 -64.15 157.36 25.79 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.044 -0.98 . . . . 0.0 108.528 168.007 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.526 HD12 ' CG1' ' A' ' 82' ' ' VAL . 3.4 tt -50.06 -39.04 15.41 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.519 0 O-C-N 123.959 0.787 . . . . 0.0 111.561 -173.867 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 37.8 m-80 -75.61 3.8 8.87 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.474 -175.407 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 82.59 37.77 13.42 Favored Glycine 0 N--CA 1.445 -0.719 0 N-CA-C 111.186 -0.765 . . . . 0.0 111.186 -176.739 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.68 ' HB3' ' HB3' ' A' ' 17' ' ' ASP . 4.2 tmmt? -110.72 120.9 43.92 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.723 0.297 . . . . 0.0 110.333 -177.786 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 26.0 m -70.68 101.66 2.11 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-O 120.956 0.407 . . . . 0.0 110.917 -177.039 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.518 ' HB ' HD23 ' A' ' 92' ' ' LEU . 41.5 t -92.61 109.26 21.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 175.703 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 24' ' ' SER . . . . . 0.466 ' HA ' ' HA ' ' A' ' 14' ' ' SER . 57.4 p -106.16 175.86 5.36 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.204 -177.956 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.49 HD11 ' HA3' ' A' ' 119' ' ' GLY . 2.9 tm? -58.42 -33.7 69.98 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 109.662 -0.496 . . . . 0.0 109.662 176.098 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -74.32 -25.86 59.81 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.735 -178.456 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -69.17 -32.47 71.82 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-O 121.523 0.678 . . . . 0.0 110.472 -179.556 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.661 HD13 HG21 ' A' ' 67' ' ' VAL . 68.9 mt -100.35 -8.6 23.17 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.56 -0.745 . . . . 0.0 110.902 -178.623 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 56.1 tttp -70.75 138.45 50.49 Favored 'General case' 0 N--CA 1.443 -0.813 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.219 -173.874 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 109.22 -3.64 31.4 Favored Glycine 0 N--CA 1.446 -0.656 0 N-CA-C 111.203 -0.759 . . . . 0.0 111.203 -176.96 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.581 ' HD3' ' HA ' ' A' ' 63' ' ' ASP . 21.6 ttmm -154.1 150.25 27.98 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 -179.486 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.484 ' CD1' ' HA ' ' A' ' 116' ' ' ASP . 29.1 m-85 -59.99 148.68 34.53 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 121.145 0.498 . . . . 0.0 111.667 -175.829 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.488 ' HB ' ' HB2' ' A' ' 115' ' ' LEU . 55.3 mt -123.39 128.12 74.59 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.772 -175.602 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 91.7 t80 -118.16 110.19 17.29 Favored 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 108.72 -0.845 . . . . 0.0 108.72 173.395 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.563 ' HB ' ' HB ' ' A' ' 113' ' ' ILE . 68.0 mt -97.48 126.03 50.45 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-O 121.06 0.457 . . . . 0.0 111.135 -175.455 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.444 ' HA ' ' O ' ' A' ' 111' ' ' ARG . 3.2 p30 -113.04 159.33 19.27 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 173.18 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.522 HG21 HG21 ' A' ' 106' ' ' ILE . 61.6 t -105.05 131.19 54.83 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.933 0 C-N-CA 120.36 -0.536 . . . . 0.0 111.055 173.427 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 38' ' ' TRP . . . . . 0.575 ' CZ2' ' HB2' ' A' ' 91' ' ' GLN . 0.4 OUTLIER -125.05 134.17 52.63 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-O 120.748 0.308 . . . . 0.0 110.718 -179.014 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -147.74 162.04 40.01 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 116.646 -0.252 . . . . 0.0 110.588 178.377 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' THR . . . . . 0.727 ' HB ' ' CE3' ' A' ' 78' ' ' TRP . 12.2 t -99.6 -10.12 22.41 Favored 'General case' 0 N--CA 1.462 0.136 0 C-N-CA 120.537 -0.465 . . . . 0.0 111.528 179.845 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 41' ' ' TRP . . . . . 0.502 ' HE1' ' HA ' ' A' ' 72' ' ' ASP . 9.7 p-90 -99.02 15.88 24.37 Favored 'General case' 0 CA--C 1.51 -0.595 0 CA-C-O 122.56 1.171 . . . . 0.0 108.025 -177.381 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 42' ' ' CYS . . . . . 0.592 ' SG ' HD12 ' A' ' 109' ' ' ILE . 99.6 m -123.18 135.95 54.54 Favored 'General case' 0 N--CA 1.429 -1.505 0 CA-C-N 113.267 -1.788 . . . . 0.0 109.398 -178.212 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.716 ' H ' ' HD2' ' A' ' 44' ' ' PRO . . . -101.92 -49.86 1.22 Allowed Glycine 0 CA--C 1.525 0.671 0 CA-C-O 119.203 -0.776 . . . . 0.0 113.879 -177.945 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.716 ' HD2' ' H ' ' A' ' 43' ' ' GLY . 10.5 Cg_endo -53.38 -34.6 71.77 Favored 'Trans proline' 0 C--N 1.357 1.022 0 C-N-CA 122.8 2.333 . . . . 0.0 112.826 -176.661 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 45' ' ' CYS . . . . . 0.652 ' O ' ' HG ' ' A' ' 49' ' ' LEU . 18.4 p -58.42 -34.06 70.37 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.109 179.547 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.534 ' HG2' HD12 ' A' ' 49' ' ' LEU . 33.8 mtt85 -72.01 -8.01 52.04 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.787 -174.811 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -74.79 -33.87 54.49 Favored Glycine 0 N--CA 1.446 -0.677 0 C-N-CA 120.428 -0.892 . . . . 0.0 111.979 177.262 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' GLU . . . . . 0.546 ' OE2' ' HD2' ' A' ' 129' ' ' PRO . 7.4 pt-20 -112.69 -0.49 15.05 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 112.198 0.444 . . . . 0.0 112.198 -177.478 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.652 ' HG ' ' O ' ' A' ' 45' ' ' CYS . 34.7 mt -55.05 -49.6 91.26 Favored Pre-proline 0 N--CA 1.468 0.443 0 N-CA-C 112.29 0.478 . . . . 0.0 112.29 177.069 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.563 ' HD3' ' HB2' ' A' ' 49' ' ' LEU . 77.2 Cg_exo -52.72 -44.33 48.73 Favored 'Trans proline' 0 C--N 1.357 1.016 0 C-N-CA 121.901 1.734 . . . . 0.0 112.161 176.483 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -73.61 -31.09 63.38 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.235 0.54 . . . . 0.0 110.563 -178.037 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.448 ' O ' ' HB2' ' A' ' 55' ' ' LEU . 6.5 tt -64.1 -53.44 49.7 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.264 -0.88 . . . . 0.0 109.885 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.689 ' O ' ' HG3' ' A' ' 57' ' ' GLU . 17.7 pttp -60.97 -39.64 90.36 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.121 179.71 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.472 ' HG3' ' O ' ' A' ' 50' ' ' PRO . 18.3 mt-10 -68.6 -29.06 67.5 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.469 -178.915 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.51 HD12 ' HB3' ' A' ' 129' ' ' PRO . 12.6 mt -59.32 -47.17 86.39 Favored 'General case' 0 N--CA 1.448 -0.55 0 N-CA-C 109.753 -0.462 . . . . 0.0 109.753 172.044 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 1.025 ' HG2' ' HA2' ' A' ' 89' ' ' GLY . 8.2 tp10 -65.18 -43.49 91.48 Favored 'General case' 0 C--O 1.218 -0.591 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.2 177.498 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.689 ' HG3' ' O ' ' A' ' 53' ' ' LYS . 37.1 mt-10 -61.42 -22.57 65.13 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.126 0.489 . . . . 0.0 110.776 179.773 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 63.2 tttp -85.45 -39.46 17.49 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.668 177.197 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.406 ' HB2' ' HE1' ' A' ' 66' ' ' PHE . 83.1 m-85 -110.48 18.29 19.92 Favored 'General case' 0 C--O 1.235 0.339 0 N-CA-C 111.859 0.318 . . . . 0.0 111.859 -173.556 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.409 ' HA ' ' OE2' ' A' ' 56' ' ' GLU . . . -56.48 117.16 3.58 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.914 -177.315 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 75.65 -3.5 49.01 Favored Glycine 0 N--CA 1.45 -0.428 0 CA-C-N 115.768 -0.651 . . . . 0.0 113.237 175.848 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.487 ' HA ' ' HD3' ' A' ' 62' ' ' LYS . 30.4 mmtm -66.56 -80.87 0.04 OUTLIER 'General case' 0 CA--C 1.515 -0.394 0 CA-C-O 120.956 0.408 . . . . 0.0 110.561 -178.082 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 63' ' ' ASP . . . . . 0.581 ' HA ' ' HD3' ' A' ' 31' ' ' LYS . 14.5 t0 -156.87 28.89 0.31 Allowed 'General case' 0 C--N 1.313 -0.983 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.904 170.343 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 5.3 mp -142.53 133.89 24.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 115.888 -0.596 . . . . 0.0 109.528 178.667 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' HIS . . . . . 0.509 ' NE2' ' HB3' ' A' ' 31' ' ' LYS . 99.4 m-70 -107.21 116.43 31.91 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 109.241 -0.652 . . . . 0.0 109.241 172.312 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 66' ' ' PHE . . . . . 0.563 ' HB2' ' HB2' ' A' ' 56' ' ' GLU . 76.4 m-85 -87.85 103.32 15.54 Favored 'General case' 0 C--N 1.316 -0.866 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 174.286 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.722 ' HA ' ' O ' ' A' ' 90' ' ' ILE . 47.3 t -111.39 110.33 31.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 115.505 -0.77 . . . . 0.0 111.348 -169.641 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 68' ' ' SER . . . . . 0.426 ' HB3' ' CG ' ' A' ' 38' ' ' TRP . 14.0 m -88.25 125.26 34.56 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 115.531 -0.758 . . . . 0.0 110.489 -179.642 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.493 HD11 ' HB2' ' A' ' 94' ' ' MET . 55.1 tp -113.57 121.19 43.46 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 122.784 0.433 . . . . 0.0 110.358 178.84 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 70' ' ' SER . . . . . 0.482 ' HB2' ' CD1' ' A' ' 38' ' ' TRP . 10.2 t -109.15 116.9 32.82 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 112.488 0.551 . . . . 0.0 112.488 -174.188 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 42.8 t -86.09 21.93 1.87 Allowed 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.208 173.907 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.614 ' OD2' HG22 ' A' ' 40' ' ' THR . 5.4 t70 -66.51 131.48 46.13 Favored 'General case' 0 CA--C 1.513 -0.465 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 179.63 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.437 ' NZ ' ' HB3' ' A' ' 73' ' ' LYS . 3.7 ttpm? -82.63 -14.19 55.16 Favored 'General case' 0 C--N 1.315 -0.91 0 C-N-CA 120.427 -0.509 . . . . 0.0 110.642 -177.561 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 74' ' ' ASN . . . . . 0.545 ' HB2' ' HB3' ' A' ' 77' ' ' ALA . 0.2 OUTLIER -109.06 83.32 1.73 Allowed 'General case' 0 CA--C 1.51 -0.574 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 -176.766 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.641 ' HE2' ' CD ' ' A' ' 79' ' ' GLU . 18.0 tttt -56.41 -60.7 3.15 Favored 'General case' 0 C--O 1.22 -0.459 0 C-N-CA 120.742 -0.383 . . . . 0.0 111.346 -172.513 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 4.4 ttmp? -46.9 -43.99 19.32 Favored 'General case' 0 C--O 1.239 0.545 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.474 179.59 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.565 ' HA ' HD21 ' A' ' 80' ' ' ASN . . . -64.84 -38.56 91.38 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-O 121.347 0.594 . . . . 0.0 110.019 -177.804 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 78' ' ' TRP . . . . . 0.727 ' CE3' ' HB ' ' A' ' 40' ' ' THR . 5.6 t-105 -69.49 -47.71 63.01 Favored 'General case' 0 N--CA 1.44 -0.938 0 CA-C-N 115.015 -0.993 . . . . 0.0 111.515 -178.759 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.641 ' CD ' ' HE2' ' A' ' 75' ' ' LYS . 4.4 mm-40 -48.43 -54.01 15.69 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-O 121.165 0.507 . . . . 0.0 111.756 177.018 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 80' ' ' ASN . . . . . 0.565 HD21 ' HA ' ' A' ' 77' ' ' ALA . 9.2 p30 -72.88 -23.17 60.69 Favored 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 119.482 -0.887 . . . . 0.0 110.858 -176.518 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 81' ' ' MET . . . . . 0.582 ' HG2' ' OG1' ' A' ' 40' ' ' THR . 10.9 tpt -70.02 -48.45 57.99 Favored 'General case' 0 C--O 1.21 -0.979 0 CA-C-O 119.488 -0.291 . . . . 0.0 111.242 176.152 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.619 HG23 ' HB2' ' A' ' 87' ' ' LEU . 2.3 p -62.92 -25.34 38.23 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 C-N-CA 120.474 -0.491 . . . . 0.0 110.355 177.79 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 29.7 m -64.32 -36.65 84.81 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-O 121.189 0.518 . . . . 0.0 110.294 171.611 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 80.6 mttt -82.88 -45.79 13.79 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.573 179.119 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 85' ' ' ASP . . . . . 0.526 ' OD2' ' HG3' ' A' ' 81' ' ' MET . 1.2 m-20 -64.55 -23.09 67.15 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 114.881 -1.054 . . . . 0.0 110.665 179.2 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 51.4 mt-30 57.59 61.62 2.4 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 115.517 -0.765 . . . . 0.0 111.483 178.298 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.619 ' HB2' HG23 ' A' ' 82' ' ' VAL . 79.3 mt -100.21 113.17 25.64 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.612 -178.709 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.548 ' HB2' ' HB2' ' A' ' 53' ' ' LYS . 11.8 mmmm -86.49 178.98 6.93 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.234 178.36 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 89' ' ' GLY . . . . . 1.025 ' HA2' ' HG2' ' A' ' 56' ' ' GLU . . . 105.19 -177.84 23.29 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.825 -0.702 . . . . 0.0 112.538 178.138 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.722 ' O ' ' HA ' ' A' ' 67' ' ' VAL . 45.6 mm -86.75 113.61 24.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 175.638 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 91' ' ' GLN . . . . . 0.575 ' HB2' ' CZ2' ' A' ' 38' ' ' TRP . 1.8 pt20 -130.72 142.11 50.41 Favored 'General case' 0 C--N 1.309 -1.162 0 C-N-CA 120.321 -0.551 . . . . 0.0 111.713 -170.207 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.538 HD22 ' HB2' ' A' ' 15' ' ' TYR . 1.0 OUTLIER -145.01 156.26 43.84 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.677 178.756 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 93' ' ' HIS . . . . . 0.558 ' CE1' ' HG3' ' A' ' 75' ' ' LYS . 19.0 t-80 -117.53 138.57 51.81 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-O 121.422 0.63 . . . . 0.0 111.471 -175.06 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 94' ' ' MET . . . . . 0.759 ' SD ' ' HA ' ' A' ' 98' ' ' ARG . 27.1 ttm -98.25 -76.68 0.52 Allowed 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 114.973 -1.012 . . . . 0.0 109.902 177.771 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 95' ' ' GLY . . . . . 0.509 ' HA2' ' O ' ' A' ' 72' ' ' ASP . . . 80.64 -85.41 1.36 Allowed Glycine 0 N--CA 1.447 -0.608 0 C-N-CA 121.065 -0.588 . . . . 0.0 113.207 178.474 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 7.6 p -82.47 -25.61 33.39 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 120.942 0.401 . . . . 0.0 112.063 -173.635 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 97' ' ' ASP . . . . . 0.52 ' HB2' ' HG3' ' A' ' 94' ' ' MET . 4.0 m-20 -87.85 38.05 0.82 Allowed 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.55 -173.307 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 98' ' ' ARG . . . . . 0.759 ' HA ' ' SD ' ' A' ' 94' ' ' MET . 0.0 OUTLIER -64.69 -12.42 46.36 Favored 'General case' 0 C--O 1.222 -0.35 0 N-CA-C 112.532 0.568 . . . . 0.0 112.532 -171.327 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 4.8 m -58.75 -20.61 51.02 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.385 0.612 . . . . 0.0 110.742 177.85 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 100' ' ' PHE . . . . . 0.441 ' CZ ' ' HA ' ' A' ' 10' ' ' ALA . 36.0 t80 -81.15 -32.0 33.87 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.096 179.932 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 101' ' ' MET . . . . . 0.689 ' HG3' ' O ' ' A' ' 98' ' ' ARG . 4.2 ppp? -77.08 -31.26 55.89 Favored 'General case' 0 C--O 1.235 0.321 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 177.919 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -59.84 -39.68 85.97 Favored 'General case' 0 CA--C 1.52 -0.177 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.145 170.875 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -62.96 -23.88 67.63 Favored 'General case' 0 N--CA 1.462 0.148 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.451 -178.617 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 104' ' ' TYR . . . . . 0.401 ' HB2' HG13 ' A' ' 106' ' ' ILE . 48.0 m-85 -100.38 -4.81 28.29 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.304 178.817 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 3.4 mm? 59.61 32.4 21.53 Favored 'General case' 0 C--O 1.234 0.271 0 O-C-N 123.417 0.448 . . . . 0.0 110.818 -176.874 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 106' ' ' ILE . . . . . 0.522 HG21 HG21 ' A' ' 37' ' ' VAL . 68.4 mt -65.8 88.95 0.1 OUTLIER 'Isoleucine or valine' 0 C--O 1.225 -0.221 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.179 177.316 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 31.1 m-80 -98.52 -13.8 20.3 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.125 0.488 . . . . 0.0 110.342 176.18 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -122.43 115.06 2.63 Favored Glycine 0 N--CA 1.442 -0.945 0 C-N-CA 120.571 -0.823 . . . . 0.0 112.192 -177.58 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.592 HD12 ' SG ' ' A' ' 42' ' ' CYS . 32.0 mt -97.2 131.39 27.59 Favored Pre-proline 0 C--N 1.32 -0.676 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 174.37 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -82.73 151.23 71.89 Favored 'Cis proline' 0 N--CA 1.459 -0.539 0 C-N-CA 123.769 -1.346 . . . . 0.0 112.935 1.729 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 111' ' ' ARG . . . . . 0.515 ' HG3' HG12 ' A' ' 106' ' ' ILE . 0.0 OUTLIER -102.77 140.18 37.38 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 173.596 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 112' ' ' PHE . . . . . 0.668 ' CE1' ' HB3' ' A' ' 128' ' ' ARG . 0.0 OUTLIER -105.1 118.03 35.51 Favored 'General case' 0 C--N 1.327 -0.371 0 O-C-N 124.102 0.876 . . . . 0.0 110.174 -175.102 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.563 ' HB ' ' HB ' ' A' ' 35' ' ' ILE . 90.8 mt -132.81 148.62 31.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.65 0.262 . . . . 0.0 110.904 -178.737 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.401 ' C ' HD12 ' A' ' 115' ' ' LEU . 42.5 tp -132.1 139.22 48.4 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.504 -0.316 . . . . 0.0 110.674 179.706 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.613 ' HG ' ' HA ' ' A' ' 121' ' ' ILE . 2.3 mp -136.09 153.83 51.2 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 178.768 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 116' ' ' ASP . . . . . 0.542 ' HB2' HD11 ' A' ' 122' ' ' ILE . 24.2 t70 -76.94 163.68 26.5 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.648 178.409 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 63.3 mtt180 -51.49 -30.05 18.71 Favored 'General case' 0 N--CA 1.464 0.256 0 O-C-N 124.354 1.034 . . . . 0.0 111.748 178.692 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -64.82 -17.86 64.61 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.077 0.465 . . . . 0.0 110.759 178.378 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 119' ' ' GLY . . . . . 0.49 ' HA3' HD11 ' A' ' 25' ' ' LEU . . . 93.97 25.16 17.99 Favored Glycine 0 N--CA 1.438 -1.173 0 N-CA-C 110.187 -1.165 . . . . 0.0 110.187 -172.438 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 30.3 mmtp -112.56 116.77 30.74 Favored 'General case' 0 C--O 1.223 -0.297 0 C-N-CA 120.304 -0.558 . . . . 0.0 112.097 -172.991 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 121' ' ' ILE . . . . . 0.665 ' H ' HD12 ' A' ' 121' ' ' ILE . 3.8 mp -44.38 119.5 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.27 0 CA-C-N 115.436 -0.802 . . . . 0.0 111.984 179.698 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 122' ' ' ILE . . . . . 0.542 HD11 ' HB2' ' A' ' 116' ' ' ASP . 45.5 mm -98.62 -41.02 9.82 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-N 115.301 -0.863 . . . . 0.0 109.335 175.727 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 16.4 m -137.2 115.83 12.08 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.393 -0.821 . . . . 0.0 110.41 179.07 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -74.23 -16.01 60.97 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.06 0.457 . . . . 0.0 110.821 178.091 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 6.1 t30 -146.83 100.6 3.34 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.762 -0.654 . . . . 0.0 109.398 177.059 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 12.4 ttt -101.21 -139.0 0.34 Allowed 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.192 -177.978 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -124.96 127.25 46.75 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-O 121.039 0.447 . . . . 0.0 111.003 -175.733 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 128' ' ' ARG . . . . . 0.668 ' HB3' ' CE1' ' A' ' 112' ' ' PHE . 11.6 ptp180 -51.28 153.91 3.23 Favored Pre-proline 0 N--CA 1.468 0.473 0 N-CA-C 113.414 0.894 . . . . 0.0 113.414 178.778 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 129' ' ' PRO . . . . . 0.546 ' HD2' ' OE2' ' A' ' 48' ' ' GLU . 51.9 Cg_exo -55.69 -27.39 60.86 Favored 'Trans proline' 0 C--N 1.35 0.656 0 C-N-CA 123.575 2.85 . . . . 0.0 113.557 177.193 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 130' ' ' SER . . . . . 0.523 ' OG ' ' HB3' ' A' ' 48' ' ' GLU . 67.9 m -62.95 -20.64 65.43 Favored 'General case' 0 N--CA 1.462 0.132 0 CA-C-O 120.919 0.39 . . . . 0.0 111.301 176.912 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 131' ' ' ASP . . . . . 0.43 ' OD2' ' HB2' ' A' ' 133' ' ' LYS . 7.3 t70 -85.32 122.1 73.73 Favored Pre-proline 0 C--N 1.325 -0.484 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.708 178.774 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 132' ' ' PRO . . . . . 0.406 ' O ' ' HG3' ' A' ' 136' ' ' GLU . 30.5 Cg_exo -63.97 -30.01 66.84 Favored 'Trans proline' 0 C--N 1.343 0.252 0 C-N-CA 122.922 2.415 . . . . 0.0 112.675 179.921 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 133' ' ' LYS . . . . . 0.43 ' HB2' ' OD2' ' A' ' 131' ' ' ASP . 26.7 mmmt -61.64 -37.64 84.76 Favored 'General case' 0 CA--C 1.519 -0.219 0 CA-C-O 121.007 0.432 . . . . 0.0 110.391 -176.801 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 134' ' ' THR . . . . . 0.738 HG22 ' CZ ' ' A' ' 138' ' ' PHE . 5.2 m -61.66 -53.25 58.66 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.238 176.255 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 135' ' ' ALA . . . . . 0.561 ' HA ' ' CD2' ' A' ' 138' ' ' PHE . . . -54.93 -46.52 74.94 Favored 'General case' 0 C--O 1.242 0.672 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.183 176.925 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 136' ' ' GLU . . . . . 0.406 ' HG3' ' O ' ' A' ' 132' ' ' PRO . 48.8 mt-10 -54.39 -55.74 25.61 Favored 'General case' 0 CA--C 1.509 -0.625 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.169 176.551 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 137' ' ' LYS . . . . . 0.569 ' HE2' ' HA ' ' A' ' 137' ' ' LYS . 0.1 OUTLIER -43.79 -42.88 5.81 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 114.221 -1.354 . . . . 0.0 111.774 179.825 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 138' ' ' PHE . . . . . 0.738 ' CZ ' HG22 ' A' ' 134' ' ' THR . 13.6 m-85 -63.74 -60.73 2.93 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-O 120.774 0.321 . . . . 0.0 110.921 179.961 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 2.0 p-10 -68.86 -23.7 64.26 Favored 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 120.313 -0.555 . . . . 0.0 110.989 -174.387 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 13.2 tt0 -60.47 -51.81 67.87 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.054 0.454 . . . . 0.0 110.454 173.568 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.53 ' HG ' ' O ' ' A' ' 137' ' ' LYS . 88.6 mt -64.56 -30.01 71.03 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.147 -177.906 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 4.4 mm? . . . . . 0 C--N 1.327 -0.377 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.428 178.048 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.444 -0.735 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -69.43 59.77 0.13 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 114.861 -1.063 . . . . 0.0 113.641 -172.445 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' SER . . . . . 0.535 ' HA ' ' HB3' ' A' ' 25' ' ' LEU . 26.4 m 53.58 33.4 16.3 Favored 'General case' 0 N--CA 1.465 0.28 0 N-CA-C 112.767 0.655 . . . . 0.0 112.767 170.493 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 34.7 p90 -60.77 147.92 40.82 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.893 0.378 . . . . 0.0 110.747 179.084 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' SER . . . . . 0.514 ' HA ' ' HA ' ' A' ' 24' ' ' SER . 28.2 t -139.81 117.96 11.93 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.111 -0.495 . . . . 0.0 109.707 -179.293 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 15' ' ' TYR . . . . . 0.438 ' HB2' ' HB3' ' A' ' 92' ' ' LEU . 92.1 m-85 -138.78 155.14 73.38 Favored Pre-proline 0 C--N 1.323 -0.562 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.322 -176.976 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -81.19 125.89 5.39 Favored 'Trans proline' 0 N--CA 1.454 -0.85 0 C-N-CA 122.015 1.81 . . . . 0.0 112.116 175.469 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' ASP . . . . . 0.503 ' HA ' ' HA ' ' A' ' 92' ' ' LEU . 12.5 t70 -62.32 152.95 32.36 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.196 -0.911 . . . . 0.0 108.894 172.127 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.646 HG22 ' HG3' ' A' ' 91' ' ' GLN . 12.1 tt -58.67 -25.81 29.63 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.435 0 O-C-N 123.781 0.675 . . . . 0.0 111.301 -178.287 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 44.7 m-80 -79.35 -2.17 40.32 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.321 0.582 . . . . 0.0 110.053 176.47 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 86.82 40.64 7.06 Favored Glycine 0 N--CA 1.447 -0.583 0 CA-C-N 115.401 -0.818 . . . . 0.0 112.371 179.244 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.542 ' NZ ' HG22 ' A' ' 23' ' ' VAL . 62.0 tttm -113.84 117.22 30.84 Favored 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 120.372 -0.531 . . . . 0.0 111.027 179.989 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 17.7 m -64.45 108.84 1.75 Allowed 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 109.938 -0.393 . . . . 0.0 109.938 174.384 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.542 HG22 ' NZ ' ' A' ' 21' ' ' LYS . 99.6 t -119.83 125.5 74.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-O 121.011 0.434 . . . . 0.0 110.201 -179.829 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 24' ' ' SER . . . . . 0.514 ' HA ' ' HA ' ' A' ' 14' ' ' SER . 57.3 p -113.19 176.6 4.95 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 115.731 -0.668 . . . . 0.0 109.426 177.57 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.535 ' HB3' ' HA ' ' A' ' 12' ' ' SER . 2.7 tm? -60.98 -30.39 70.24 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 176.908 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -72.11 -24.42 61.47 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.66 -0.246 . . . . 0.0 111.325 -179.896 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -73.18 -21.75 60.61 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-O 121.924 0.868 . . . . 0.0 109.616 177.798 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.469 HD13 HG21 ' A' ' 67' ' ' VAL . 32.9 mt -104.5 -21.02 13.51 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-N 115.073 -0.967 . . . . 0.0 110.742 -179.492 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.41 ' HB2' HD13 ' A' ' 25' ' ' LEU . 52.9 tttp -71.41 149.32 46.06 Favored 'General case' 0 N--CA 1.445 -0.688 0 CA-C-N 115.459 -0.792 . . . . 0.0 110.909 -173.542 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 91.81 10.21 61.76 Favored Glycine 0 N--CA 1.452 -0.295 0 N-CA-C 111.066 -0.814 . . . . 0.0 111.066 -175.198 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.832 ' HD3' ' HA ' ' A' ' 63' ' ' ASP . 13.1 ttmm -162.12 157.48 23.35 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 108.196 -1.038 . . . . 0.0 108.196 179.73 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.532 ' CD2' HD13 ' A' ' 141' ' ' LEU . 82.3 m-85 -66.17 143.51 57.23 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 118.287 0.494 . . . . 0.0 110.808 -178.641 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.873 HD13 HD12 ' A' ' 115' ' ' LEU . 3.6 mp -126.04 146.37 31.95 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.226 0 CA-C-O 120.811 0.339 . . . . 0.0 110.561 -179.55 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 34' ' ' TYR . . . . . 0.737 ' HD1' ' HB3' ' A' ' 114' ' ' LEU . 75.2 t80 -129.7 121.64 27.35 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 173.224 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.697 HD13 ' HB ' ' A' ' 67' ' ' VAL . 25.9 mm -109.96 110.9 33.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 N-CA-C 112.156 0.428 . . . . 0.0 112.156 -173.253 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.589 ' O ' ' HA ' ' A' ' 68' ' ' SER . 33.7 m-20 -99.04 158.21 15.82 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 169.549 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.58 HG11 HG21 ' A' ' 109' ' ' ILE . 40.5 t -103.67 112.18 36.19 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.859 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 171.066 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 38' ' ' TRP . . . . . 0.791 ' CZ3' HG21 ' A' ' 82' ' ' VAL . 0.6 OUTLIER -103.29 132.55 49.46 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 -177.298 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.456 ' HB3' ' SG ' ' A' ' 42' ' ' CYS . . . -148.22 174.7 11.72 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.505 -0.316 . . . . 0.0 110.762 -178.551 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 40' ' ' THR . . . . . 0.553 HG22 ' OD2' ' A' ' 72' ' ' ASP . 5.9 t -104.27 -30.3 10.23 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 120.975 0.417 . . . . 0.0 110.379 171.618 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 21.0 p-90 -85.59 7.36 23.45 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.549 -178.108 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' CYS . . . . . 0.553 ' SG ' ' HB3' ' A' ' 45' ' ' CYS . 5.7 p -87.55 -2.21 58.47 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.677 -0.238 . . . . 0.0 111.41 -179.068 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.58 ' O ' ' HG2' ' A' ' 46' ' ' ARG . . . 64.94 -108.35 2.3 Favored Glycine 0 CA--C 1.523 0.579 0 N-CA-C 114.773 0.669 . . . . 0.0 114.773 171.736 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.41 ' HD2' ' O ' ' A' ' 42' ' ' CYS . 9.6 Cg_endo -50.75 -23.15 10.86 Favored 'Trans proline' 0 C--N 1.356 0.96 0 C-N-CA 124.342 3.361 . . . . 0.0 113.541 -174.647 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 45' ' ' CYS . . . . . 0.724 ' HB2' ' HD3' ' A' ' 110' ' ' PRO . 47.1 t -52.19 -15.97 0.71 Allowed 'General case' 0 C--N 1.323 -0.55 0 O-C-N 124.071 0.857 . . . . 0.0 112.924 178.533 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.58 ' HG2' ' O ' ' A' ' 43' ' ' GLY . 24.7 mmm180 -71.02 -6.64 40.49 Favored 'General case' 0 N--CA 1.448 -0.574 0 O-C-N 121.806 -0.559 . . . . 0.0 110.467 -179.43 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.454 ' O ' ' HD2' ' A' ' 50' ' ' PRO . . . -84.13 -23.44 51.87 Favored Glycine 0 N--CA 1.446 -0.643 0 CA-C-N 115.818 -0.628 . . . . 0.0 112.95 -178.478 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 48' ' ' GLU . . . . . 0.56 ' HG3' ' HB3' ' A' ' 129' ' ' PRO . 2.0 mp0 -83.01 -4.49 58.38 Favored 'General case' 0 CA--C 1.516 -0.333 0 CA-C-N 117.2 0.5 . . . . 0.0 110.524 -179.379 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.797 ' HG ' HD21 ' A' ' 87' ' ' LEU . 7.3 mp -43.96 -55.23 9.61 Favored Pre-proline 0 CA--C 1.536 0.432 0 N-CA-C 112.487 0.551 . . . . 0.0 112.487 177.09 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.497 ' HD3' ' HB2' ' A' ' 49' ' ' LEU . 43.5 Cg_exo -58.45 -42.89 50.64 Favored 'Trans proline' 0 C--N 1.355 0.909 0 C-N-CA 121.874 1.716 . . . . 0.0 112.185 175.047 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -69.49 -21.75 63.66 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-O 121.476 0.655 . . . . 0.0 110.411 -174.226 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.556 HD13 HD22 ' A' ' 87' ' ' LEU . 7.6 tt -70.14 -55.44 9.4 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 114.974 -1.012 . . . . 0.0 108.643 178.673 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.694 ' HB3' ' NZ ' ' A' ' 53' ' ' LYS . 1.8 mtpm? -52.63 -63.01 1.28 Allowed 'General case' 0 C--O 1.219 -0.508 0 CA-C-N 115.503 -0.771 . . . . 0.0 111.365 175.826 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -52.39 -39.45 60.86 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 113.302 0.853 . . . . 0.0 113.302 -173.146 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.434 ' O ' ' HB2' ' A' ' 58' ' ' LYS . 14.4 mt -67.49 -44.77 77.69 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.174 0.512 . . . . 0.0 110.622 174.43 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -57.39 -42.68 82.68 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.145 -0.934 . . . . 0.0 111.582 176.538 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.618 ' HG2' ' O ' ' A' ' 53' ' ' LYS . 16.0 mm-40 -53.47 -52.01 60.88 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-O 121.714 0.768 . . . . 0.0 109.287 175.74 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 58' ' ' LYS . . . . . 0.468 ' HB3' ' HE3' ' A' ' 58' ' ' LYS . 10.4 mmmt -53.01 -58.12 8.07 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-N 114.504 -1.225 . . . . 0.0 112.439 178.804 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.57 ' HB2' ' HE2' ' A' ' 66' ' ' PHE . 96.0 m-85 -106.71 21.6 17.23 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.047 -0.524 . . . . 0.0 112.322 -166.537 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -61.59 120.79 11.26 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.603 173.75 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 72.26 33.81 61.5 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.946 -0.645 . . . . 0.0 112.866 177.141 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.507 ' HB3' HD11 ' A' ' 142' ' ' LEU . 40.1 mmtm -109.03 -164.91 0.97 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.154 0.502 . . . . 0.0 110.128 175.623 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 63' ' ' ASP . . . . . 0.832 ' HA ' ' HD3' ' A' ' 31' ' ' LYS . 3.7 t70 -89.87 54.95 2.99 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-O 121.792 0.806 . . . . 0.0 109.497 179.362 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.46 HG22 ' HB2' ' A' ' 62' ' ' LYS . 6.8 tp -157.0 129.98 1.15 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 CA-C-N 115.061 -0.972 . . . . 0.0 109.774 -178.114 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 65' ' ' HIS . . . . . 0.47 ' NE2' ' HB3' ' A' ' 31' ' ' LYS . 68.0 m-70 -103.3 106.58 17.13 Favored 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 175.773 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 66' ' ' PHE . . . . . 0.57 ' HE2' ' HB2' ' A' ' 59' ' ' TYR . 61.0 m-85 -79.01 103.13 8.74 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 171.082 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.697 ' HB ' HD13 ' A' ' 35' ' ' ILE . 29.6 t -122.26 126.53 74.4 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.476 -175.196 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 68' ' ' SER . . . . . 0.589 ' HA ' ' O ' ' A' ' 36' ' ' ASP . 37.1 m -114.05 134.3 54.96 Favored 'General case' 0 C--N 1.311 -1.066 0 CA-C-N 116.106 -0.497 . . . . 0.0 109.855 177.191 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.516 HD22 ' HB2' ' A' ' 92' ' ' LEU . 26.6 mt -110.53 132.78 53.88 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 110.006 -0.368 . . . . 0.0 110.006 177.116 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 70' ' ' SER . . . . . 0.471 ' O ' ' HB3' ' A' ' 94' ' ' MET . 0.9 OUTLIER -105.15 117.89 35.14 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.008 0.432 . . . . 0.0 111.348 -176.882 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 34.8 m -88.39 15.7 7.43 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.773 179.61 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.553 ' OD2' HG22 ' A' ' 40' ' ' THR . 1.3 m-20 -71.73 135.52 46.81 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.249 -0.648 . . . . 0.0 109.249 -179.867 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.416 ' O ' ' HD3' ' A' ' 73' ' ' LYS . 1.5 tmtp? -89.04 -30.1 18.95 Favored 'General case' 0 C--N 1.318 -0.784 0 C-N-CA 119.918 -0.713 . . . . 0.0 109.464 177.62 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 74' ' ' ASN . . . . . 0.586 ' HB2' ' HB3' ' A' ' 77' ' ' ALA . 0.8 OUTLIER -72.53 68.18 0.79 Allowed 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.135 -0.939 . . . . 0.0 110.434 174.127 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.483 ' O ' ' HG2' ' A' ' 79' ' ' GLU . 9.4 tttm -51.8 -64.5 0.79 Allowed 'General case' 0 C--O 1.22 -0.482 0 N-CA-C 112.489 0.551 . . . . 0.0 112.489 -175.984 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 51.9 tttm -49.77 -49.18 49.39 Favored 'General case' 0 C--N 1.329 -0.297 0 O-C-N 123.162 0.289 . . . . 0.0 111.204 -176.793 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.665 ' HA ' ' ND2' ' A' ' 80' ' ' ASN . . . -52.29 -44.05 64.79 Favored 'General case' 0 C--O 1.244 0.802 0 CA-C-O 121.886 0.85 . . . . 0.0 110.359 178.478 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 78' ' ' TRP . . . . . 0.548 ' CE3' ' HB ' ' A' ' 40' ' ' THR . 6.8 t-105 -66.92 -51.13 59.08 Favored 'General case' 0 N--CA 1.437 -1.114 0 CA-C-N 114.278 -1.328 . . . . 0.0 111.048 -179.438 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.522 ' OE1' HG13 ' A' ' 18' ' ' ILE . 5.3 mm-40 -46.22 -47.08 17.99 Favored 'General case' 0 CA--C 1.537 0.459 0 N-CA-C 111.87 0.322 . . . . 0.0 111.87 176.189 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 80' ' ' ASN . . . . . 0.665 ' ND2' ' HA ' ' A' ' 77' ' ' ALA . 0.6 OUTLIER -60.33 -49.23 78.42 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 120.823 -0.351 . . . . 0.0 110.526 -177.738 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 22.5 ttm -59.47 -48.47 81.53 Favored 'General case' 0 N--CA 1.466 0.341 0 N-CA-C 112.433 0.531 . . . . 0.0 112.433 -175.756 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.791 HG21 ' CZ3' ' A' ' 38' ' ' TRP . 0.9 OUTLIER -67.25 -26.05 35.24 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 C-N-CA 120.158 -0.617 . . . . 0.0 110.918 -178.046 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 90.6 m -72.78 -37.0 67.74 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.294 -0.412 . . . . 0.0 109.986 174.646 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 84' ' ' LYS . . . . . 0.4 ' HB3' ' HE3' ' A' ' 84' ' ' LYS . 1.2 tmmt? -71.26 -41.38 70.16 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.375 0.607 . . . . 0.0 110.018 177.513 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 15.6 m-20 -83.67 -1.72 54.64 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.225 -0.898 . . . . 0.0 111.881 -177.349 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 45.3 mt-30 62.0 23.63 13.95 Favored 'General case' 0 N--CA 1.468 0.466 0 N-CA-C 112.727 0.64 . . . . 0.0 112.727 172.074 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.797 HD21 ' HG ' ' A' ' 49' ' ' LEU . 94.1 mt -73.61 117.46 15.4 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 110.236 -0.283 . . . . 0.0 110.236 178.796 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.564 ' HA ' ' HE3' ' A' ' 88' ' ' LYS . 0.0 OUTLIER -119.61 -168.08 1.53 Allowed 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.693 -0.23 . . . . 0.0 111.581 177.314 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 112.75 -163.23 12.17 Favored Glycine 0 N--CA 1.451 -0.35 0 N-CA-C 110.241 -1.144 . . . . 0.0 110.241 -173.966 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.654 ' O ' ' HA ' ' A' ' 67' ' ' VAL . 52.5 mt -92.72 111.67 24.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 173.679 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 91' ' ' GLN . . . . . 0.693 ' HB2' ' CZ2' ' A' ' 38' ' ' TRP . 1.0 OUTLIER -143.24 103.59 4.15 Favored 'General case' 0 C--N 1.311 -1.086 0 CA-C-O 121.598 0.713 . . . . 0.0 111.789 -168.934 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.518 HD21 ' HB ' ' A' ' 23' ' ' VAL . 20.6 mt -96.79 151.28 19.81 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.275 -0.875 . . . . 0.0 110.622 -175.846 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 37.3 t-80 -113.47 127.87 56.25 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.081 178.847 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 94' ' ' MET . . . . . 0.471 ' HB3' ' O ' ' A' ' 70' ' ' SER . 35.9 ttm -81.06 -83.14 0.11 Allowed 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 115.053 -0.976 . . . . 0.0 110.279 -179.682 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 131.2 -83.72 0.31 Allowed Glycine 0 N--CA 1.444 -0.79 0 C-N-CA 120.396 -0.907 . . . . 0.0 112.245 -178.19 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 1.7 m -137.72 4.63 2.59 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.583 0.706 . . . . 0.0 109.964 179.472 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -87.16 53.03 2.68 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.248 -0.887 . . . . 0.0 110.448 -172.485 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 98' ' ' ARG . . . . . 0.498 ' HB3' ' OD1' ' A' ' 102' ' ' ASP . 4.0 mtm180 -63.35 -8.94 9.96 Favored 'General case' 0 CA--C 1.512 -0.5 0 N-CA-C 112.542 0.571 . . . . 0.0 112.542 -172.924 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 5.4 m -38.4 -33.09 0.09 Allowed 'General case' 0 C--N 1.313 -0.988 0 O-C-N 124.146 0.904 . . . . 0.0 112.376 179.197 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 80.2 t80 -81.27 -39.21 25.63 Favored 'General case' 0 CA--C 1.532 0.281 0 N-CA-C 112.356 0.502 . . . . 0.0 112.356 -179.822 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 101' ' ' MET . . . . . 0.459 ' SD ' ' HD2' ' A' ' 98' ' ' ARG . 24.9 ptm -78.66 -34.02 46.63 Favored 'General case' 0 CA--C 1.52 -0.185 0 C-N-CA 120.107 -0.637 . . . . 0.0 109.592 -177.268 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 102' ' ' ASP . . . . . 0.498 ' OD1' ' HB3' ' A' ' 98' ' ' ARG . 2.5 m-20 -75.57 -21.62 57.71 Favored 'General case' 0 N--CA 1.447 -0.604 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.186 176.581 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -64.95 -29.57 70.51 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-O 121.063 0.459 . . . . 0.0 110.701 174.88 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 59.7 m-85 -96.96 2.35 51.46 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.519 177.796 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 95.6 mt 65.89 5.21 3.33 Favored 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 113.386 0.884 . . . . 0.0 113.386 173.164 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 106' ' ' ILE . . . . . 0.545 ' CG1' ' HG3' ' A' ' 111' ' ' ARG . 1.2 pp -97.34 88.83 1.88 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.575 0 CA-C-O 121.509 0.671 . . . . 0.0 112.194 -179.277 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 4.0 p-10 -77.1 -11.73 59.85 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.609 -0.723 . . . . 0.0 109.812 175.642 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -89.75 98.56 2.46 Favored Glycine 0 N--CA 1.445 -0.716 0 CA-C-N 115.445 -0.798 . . . . 0.0 111.621 177.357 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.631 ' HB ' ' HA ' ' A' ' 110' ' ' PRO . 34.2 pt -104.88 162.79 18.72 Favored Pre-proline 0 C--N 1.321 -0.641 0 N-CA-C 110.088 -0.338 . . . . 0.0 110.088 179.823 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 110' ' ' PRO . . . . . 0.724 ' HD3' ' HB2' ' A' ' 45' ' ' CYS . 39.6 Cg_endo -70.11 143.74 75.39 Favored 'Cis proline' 0 C--N 1.349 0.567 0 C-N-CA 124.158 -1.184 . . . . 0.0 113.559 1.63 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 111' ' ' ARG . . . . . 0.545 ' HG3' ' CG1' ' A' ' 106' ' ' ILE . 0.0 OUTLIER -117.51 136.49 53.21 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.625 -0.716 . . . . 0.0 109.081 177.295 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 112' ' ' PHE . . . . . 0.571 ' CD2' ' HA ' ' A' ' 127' ' ' THR . 1.4 m-85 -105.7 117.23 33.5 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.789 -176.173 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.495 HD12 ' HA ' ' A' ' 124' ' ' ALA . 24.4 mm -128.53 164.0 31.61 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 N-CA-C 108.144 -1.058 . . . . 0.0 108.144 177.137 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.737 ' HB3' ' HD1' ' A' ' 34' ' ' TYR . 1.8 pt? -158.45 154.24 26.5 Favored 'General case' 0 C--N 1.316 -0.882 0 C-N-CA 120.573 -0.451 . . . . 0.0 110.978 173.455 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.873 HD12 HD13 ' A' ' 33' ' ' ILE . 0.0 OUTLIER -138.17 150.98 47.29 Favored 'General case' 0 N--CA 1.448 -0.569 0 CA-C-O 122.329 1.062 . . . . 0.0 113.377 -173.788 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 12.8 t0 -69.19 163.73 24.24 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 113.174 -1.83 . . . . 0.0 109.782 176.328 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 117' ' ' ARG . . . . . 0.482 ' HA ' ' O ' ' A' ' 31' ' ' LYS . 31.1 mtm180 -48.39 -28.05 2.99 Favored 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 124.503 1.121 . . . . 0.0 113.272 -174.877 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 26.6 t0 -82.52 -5.13 58.56 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.104 0.478 . . . . 0.0 111.44 -177.314 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 89.34 16.6 57.0 Favored Glycine 0 N--CA 1.441 -0.986 0 N-CA-C 110.013 -1.235 . . . . 0.0 110.013 -171.241 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 4.9 tttm -90.27 147.21 23.67 Favored 'General case' 0 C--O 1.204 -1.327 0 CA-C-N 115.034 -0.583 . . . . 0.0 110.766 -175.522 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 121' ' ' ILE . . . . . 0.463 ' H ' HD12 ' A' ' 121' ' ' ILE . 3.8 mp -67.76 130.47 33.03 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.668 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.03 -174.775 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 122' ' ' ILE . . . . . 0.575 ' HB ' ' HG ' ' A' ' 114' ' ' LEU . 37.4 mm -100.53 -56.4 5.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 171.122 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 123' ' ' SER . . . . . 0.475 ' HB3' ' CD2' ' A' ' 114' ' ' LEU . 42.9 t -135.14 142.72 46.22 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.481 174.375 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 124' ' ' ALA . . . . . 0.495 ' HA ' HD12 ' A' ' 113' ' ' ILE . . . -112.55 23.48 13.51 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.425 -0.807 . . . . 0.0 109.429 176.018 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 4.1 p-10 -161.67 38.63 0.13 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.349 -0.841 . . . . 0.0 110.108 -179.913 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 126' ' ' MET . . . . . 0.73 ' HG2' HD22 ' A' ' 114' ' ' LEU . 2.2 tpt -71.7 -168.72 0.37 Allowed 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 115.762 -0.654 . . . . 0.0 111.206 -176.949 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 127' ' ' THR . . . . . 0.571 ' HA ' ' CD2' ' A' ' 112' ' ' PHE . 4.1 m -161.0 120.79 2.67 Favored 'General case' 0 C--O 1.223 -0.312 0 N-CA-C 110.108 -0.33 . . . . 0.0 110.108 -174.867 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 128' ' ' ARG . . . . . 0.569 ' HB2' ' OH ' ' A' ' 34' ' ' TYR . 21.8 ttt85 -88.94 -62.94 0.21 Allowed Pre-proline 0 CA--C 1.498 -1.039 0 CA-C-O 117.846 -1.073 . . . . 0.0 113.401 178.491 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 129' ' ' PRO . . . . . 0.56 ' HB3' ' HG3' ' A' ' 48' ' ' GLU . 1.0 OUTLIER -37.96 79.04 0.0 OUTLIER 'Trans proline' 0 C--N 1.372 1.784 0 C-N-CA 124.352 3.368 . . . . 0.0 113.814 -158.648 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 130' ' ' SER . . . . . 0.471 ' N ' ' O ' ' A' ' 128' ' ' ARG . 43.5 p 54.73 26.72 7.86 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 114.299 -1.319 . . . . 0.0 110.67 -179.47 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -70.76 123.56 89.4 Favored Pre-proline 0 C--O 1.236 0.355 0 CA-C-N 115.513 -0.767 . . . . 0.0 111.041 -178.648 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_endo -63.92 -37.51 43.66 Favored 'Trans proline' 0 N--CA 1.46 -0.459 0 C-N-CA 122.505 2.136 . . . . 0.0 112.881 -178.343 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 133' ' ' LYS . . . . . 0.414 ' O ' ' HG2' ' A' ' 137' ' ' LYS . 26.1 mtmm -54.3 -50.11 68.09 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-O 121.599 0.714 . . . . 0.0 110.113 -177.036 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 134' ' ' THR . . . . . 0.652 HG22 ' CZ ' ' A' ' 138' ' ' PHE . 13.8 m -78.76 -35.52 44.47 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 114.977 -1.01 . . . . 0.0 111.221 -174.494 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 135' ' ' ALA . . . . . 0.736 ' HA ' ' CD2' ' A' ' 138' ' ' PHE . . . -62.31 -40.7 97.16 Favored 'General case' 0 C--O 1.242 0.658 0 CA-C-O 121.167 0.508 . . . . 0.0 110.372 178.269 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 136' ' ' GLU . . . . . 0.556 ' HA ' ' ND2' ' A' ' 139' ' ' ASN . 7.1 mm-40 -65.19 -41.4 94.6 Favored 'General case' 0 N--CA 1.447 -0.614 0 CA-C-N 115.254 -0.885 . . . . 0.0 111.062 176.486 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 137' ' ' LYS . . . . . 0.96 ' HE2' ' HA ' ' A' ' 137' ' ' LYS . 9.1 mmpt? -55.79 -41.71 74.51 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.554 175.975 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 138' ' ' PHE . . . . . 0.736 ' CD2' ' HA ' ' A' ' 135' ' ' ALA . 15.3 m-85 -56.81 -60.37 3.66 Favored 'General case' 0 N--CA 1.463 0.2 0 O-C-N 123.181 0.301 . . . . 0.0 110.783 178.556 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 139' ' ' ASN . . . . . 0.556 ' ND2' ' HA ' ' A' ' 136' ' ' GLU . 11.7 p30 -69.49 -27.03 64.85 Favored 'General case' 0 C--O 1.224 -0.249 0 C-N-CA 120.602 -0.439 . . . . 0.0 111.506 -173.326 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 21.7 tt0 -63.18 -60.66 3.13 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.597 0.237 . . . . 0.0 111.464 177.092 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.704 ' HG ' ' O ' ' A' ' 137' ' ' LYS . 3.0 pp -69.85 -19.86 63.43 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-O 120.845 0.355 . . . . 0.0 111.417 -175.69 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 0.507 HD11 ' HB3' ' A' ' 62' ' ' LYS . 0.8 OUTLIER . . . . . 0 C--N 1.325 -0.494 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.065 175.039 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.463 0.187 0 CA-C-O 119.857 -0.116 . . . . 0.0 111.181 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . 11.97 74.54 0.01 OUTLIER 'General case' 0 N--CA 1.479 0.994 0 O-C-N 125.061 1.475 . . . . 0.0 113.807 -178.21 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' SER . . . . . 1.036 ' HA ' ' HB3' ' A' ' 25' ' ' LEU . 68.5 m 62.35 84.14 0.14 Allowed 'General case' 0 CA--C 1.534 0.362 0 CA-C-O 121.593 0.711 . . . . 0.0 111.354 -175.778 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 16.3 p90 -99.84 175.17 5.88 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.403 -0.817 . . . . 0.0 110.419 178.528 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 13.8 p -142.75 123.26 14.02 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.514 0.197 . . . . 0.0 110.57 178.963 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' TYR . . . . . 0.616 ' HB2' HD13 ' A' ' 92' ' ' LEU . 80.5 m-85 -134.65 150.05 72.51 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.655 -0.248 . . . . 0.0 110.483 179.24 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.41 ' HD2' ' O ' ' A' ' 93' ' ' HIS . 3.1 Cg_exo -80.83 124.85 5.21 Favored 'Trans proline' 0 N--CA 1.457 -0.636 0 C-N-CA 122.581 2.187 . . . . 0.0 112.805 178.638 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 17' ' ' ASP . . . . . 0.698 ' HB3' ' HB3' ' A' ' 21' ' ' LYS . 4.8 t70 -70.36 159.93 33.24 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.32 -0.855 . . . . 0.0 109.123 171.136 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.686 HD12 HG13 ' A' ' 82' ' ' VAL . 1.5 tt -50.24 -35.57 12.08 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.512 0 O-C-N 123.68 0.613 . . . . 0.0 111.651 -176.187 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 34.5 m-80 -77.54 11.93 1.83 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.411 -177.384 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 70.56 32.16 67.77 Favored Glycine 0 CA--C 1.505 -0.55 0 N-CA-C 110.335 -1.106 . . . . 0.0 110.335 -175.582 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.698 ' HB3' ' HB3' ' A' ' 17' ' ' ASP . 8.2 ttpm? -103.52 109.25 20.83 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.048 -0.576 . . . . 0.0 110.519 -173.997 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 20.9 m -65.19 106.94 1.42 Allowed 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.756 178.515 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.57 ' HB ' HD21 ' A' ' 92' ' ' LEU . 63.3 t -112.95 127.99 69.92 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 N-CA-C 109.176 -0.676 . . . . 0.0 109.176 179.028 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 24' ' ' SER . . . . . 0.421 ' C ' ' H ' ' A' ' 26' ' ' ALA . 92.9 p -122.62 165.01 17.16 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.535 0.683 . . . . 0.0 111.757 -173.193 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 1.036 ' HB3' ' HA ' ' A' ' 12' ' ' SER . 20.8 tp -85.35 33.15 0.55 Allowed 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.894 0.854 . . . . 0.0 109.311 175.385 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.421 ' H ' ' C ' ' A' ' 24' ' ' SER . . . -118.73 -41.37 2.8 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 114.505 -1.225 . . . . 0.0 109.745 174.155 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -79.1 -31.77 44.37 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.337 0.589 . . . . 0.0 109.937 173.969 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.616 HD13 HG21 ' A' ' 67' ' ' VAL . 75.9 mt -78.97 -18.46 53.67 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.217 174.862 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.519 ' HB2' ' O ' ' A' ' 25' ' ' LEU . 44.7 tttp -71.48 131.66 43.63 Favored 'General case' 0 N--CA 1.444 -0.729 0 CA-C-N 115.317 -0.856 . . . . 0.0 110.817 -175.336 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 117.17 -8.74 15.8 Favored Glycine 0 N--CA 1.448 -0.512 0 N-CA-C 110.79 -0.924 . . . . 0.0 110.79 -174.655 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.424 ' C ' ' HA ' ' A' ' 117' ' ' ARG . 24.9 ttmm -143.47 147.94 35.3 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 179.637 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 54.9 m-85 -54.01 144.66 18.59 Favored 'General case' 0 N--CA 1.47 0.543 0 N-CA-C 112.562 0.578 . . . . 0.0 112.562 -174.223 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.519 HG13 HD11 ' A' ' 25' ' ' LEU . 39.2 mm -120.73 133.93 65.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.562 -0.745 . . . . 0.0 110.99 -175.04 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 34' ' ' TYR . . . . . 0.481 ' OH ' ' HD3' ' A' ' 129' ' ' PRO . 80.1 t80 -120.67 118.98 31.5 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 172.253 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.61 ' HB ' ' HB ' ' A' ' 113' ' ' ILE . 75.1 mt -99.98 126.78 53.39 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 N-CA-C 110.138 -0.319 . . . . 0.0 110.138 179.399 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.552 ' O ' ' HA ' ' A' ' 68' ' ' SER . 11.8 t70 -129.9 124.91 34.3 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.23 -178.924 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 26.5 t -81.78 121.77 35.63 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.913 0 C-N-CA 120.557 -0.457 . . . . 0.0 110.423 -179.598 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' TRP . . . . . 0.656 ' CE3' ' HZ2' ' A' ' 78' ' ' TRP . 0.7 OUTLIER -121.74 133.41 54.93 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.161 -0.472 . . . . 0.0 109.896 -176.618 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.505 ' HA ' ' OD1' ' A' ' 72' ' ' ASP . . . -148.27 158.28 44.0 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.577 -177.482 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 40' ' ' THR . . . . . 0.643 ' HB ' ' CE3' ' A' ' 78' ' ' TRP . 11.1 t -94.89 -25.59 16.52 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.114 0.483 . . . . 0.0 110.611 175.111 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 41' ' ' TRP . . . . . 0.431 ' HE1' ' HA ' ' A' ' 72' ' ' ASP . 14.9 p-90 -87.78 13.32 10.86 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.079 -177.742 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 42' ' ' CYS . . . . . 0.469 ' SG ' ' HB2' ' A' ' 45' ' ' CYS . 14.9 t -86.24 -60.69 1.93 Allowed 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.09 175.92 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 110.92 -91.37 0.61 Allowed Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.641 -179.269 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -53.62 -28.87 48.11 Favored 'Trans proline' 0 C--N 1.35 0.638 0 C-N-CA 123.302 2.668 . . . . 0.0 113.066 -178.59 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' CYS . . . . . 0.504 ' SG ' ' HG3' ' A' ' 110' ' ' PRO . 42.2 t -51.64 -30.05 20.09 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.66 178.594 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.558 ' HA ' ' HG ' ' A' ' 49' ' ' LEU . 55.8 mtp180 -65.44 -30.58 71.39 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.451 -0.341 . . . . 0.0 111.686 -176.592 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -68.9 -26.39 74.66 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.652 -0.785 . . . . 0.0 112.49 -176.65 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' GLU . . . . . 0.456 ' OE2' ' HG2' ' A' ' 128' ' ' ARG . 14.6 mt-10 -94.49 -12.24 28.06 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.594 0.235 . . . . 0.0 111.005 -176.94 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.633 ' O ' ' HG3' ' A' ' 53' ' ' LYS . 73.2 mt -49.75 -49.19 74.74 Favored Pre-proline 0 C--N 1.331 -0.239 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.948 -178.598 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.55 ' HD3' ' HB2' ' A' ' 49' ' ' LEU . 71.3 Cg_exo -50.83 -37.82 56.04 Favored 'Trans proline' 0 C--N 1.357 1.003 0 C-N-CA 122.184 1.923 . . . . 0.0 112.767 176.984 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.513 ' O ' ' HB2' ' A' ' 55' ' ' LEU . . . -75.14 -25.4 58.36 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-O 121.617 0.722 . . . . 0.0 110.504 -176.114 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 6.8 tt -79.02 -48.34 14.6 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.0 -1.0 . . . . 0.0 108.419 -177.155 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.761 ' HB3' ' HG2' ' A' ' 88' ' ' LYS . 81.9 mttt -51.59 -55.71 17.67 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-N 114.655 -1.157 . . . . 0.0 109.909 176.893 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.473 ' HG2' ' O ' ' A' ' 50' ' ' PRO . 9.6 mm-40 -73.58 -23.32 59.93 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 114.074 -1.421 . . . . 0.0 112.55 -171.185 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.513 ' HB2' ' O ' ' A' ' 51' ' ' ALA . 0.4 OUTLIER -73.35 -34.0 65.4 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 120.302 -0.559 . . . . 0.0 109.588 176.408 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.447 ' OE2' ' HB2' ' A' ' 66' ' ' PHE . 5.1 tp10 -68.14 -37.13 80.74 Favored 'General case' 0 C--O 1.217 -0.63 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 175.686 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.463 ' HG2' ' O ' ' A' ' 53' ' ' LYS . 7.1 mm-40 -54.04 -53.96 45.8 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.391 0.615 . . . . 0.0 110.451 175.492 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 34.4 ttpt -55.57 -35.41 65.74 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.369 -0.832 . . . . 0.0 110.903 177.755 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.47 ' CZ ' ' HB2' ' A' ' 138' ' ' PHE . 38.3 m-85 -102.91 12.29 36.32 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 113.109 0.781 . . . . 0.0 113.109 -176.114 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -65.09 123.63 20.0 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 120.878 0.371 . . . . 0.0 110.352 176.516 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 83.52 7.68 85.94 Favored Glycine 0 N--CA 1.448 -0.541 0 C-N-CA 120.826 -0.702 . . . . 0.0 112.782 178.195 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 34.2 mmtm -89.92 -153.47 0.29 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.194 0.521 . . . . 0.0 109.821 177.997 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' ASP . . . . . 0.403 ' H ' HD21 ' A' ' 142' ' ' LEU . 4.2 t70 -106.75 62.39 0.63 Allowed 'General case' 0 C--N 1.316 -0.878 0 CA-C-O 121.571 0.701 . . . . 0.0 110.021 176.853 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 17.8 tt -157.35 163.98 1.21 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.787 0 CA-C-N 115.12 -0.945 . . . . 0.0 109.174 177.503 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 96.8 m-70 -139.25 114.97 10.01 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 174.453 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' PHE . . . . . 0.452 ' HZ ' HD12 ' A' ' 55' ' ' LEU . 12.5 m-85 -80.47 103.0 10.04 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 171.998 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.616 HG21 HD13 ' A' ' 28' ' ' LEU . 46.8 t -115.82 104.54 16.9 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 CA-C-N 115.332 -0.849 . . . . 0.0 109.739 -176.566 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 68' ' ' SER . . . . . 0.552 ' HA ' ' O ' ' A' ' 36' ' ' ASP . 28.9 m -88.1 148.26 24.54 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.531 -178.132 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.413 HD11 ' HB2' ' A' ' 94' ' ' MET . 63.7 tp -126.73 119.9 28.07 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 120.839 0.352 . . . . 0.0 110.664 178.139 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 70' ' ' SER . . . . . 0.505 ' HB3' ' HA ' ' A' ' 93' ' ' HIS . 3.4 t -100.74 119.05 38.05 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.228 0.537 . . . . 0.0 112.095 -174.552 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 18.7 m -90.76 15.34 11.33 Favored 'General case' 0 C--N 1.31 -1.121 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.816 177.864 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.505 ' OD1' ' HA ' ' A' ' 39' ' ' ALA . 2.4 m-20 -68.2 127.26 32.25 Favored 'General case' 0 CA--C 1.516 -0.344 0 CA-C-O 121.049 0.452 . . . . 0.0 110.663 -177.957 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 38.5 ttmt -79.01 -31.65 44.81 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 121.413 0.625 . . . . 0.0 109.323 175.335 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' ASN . . . . . 0.561 ' HB2' ' HB3' ' A' ' 77' ' ' ALA . 0.8 OUTLIER -80.36 68.59 6.59 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.175 -0.92 . . . . 0.0 110.25 177.45 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.547 ' HG3' ' CE1' ' A' ' 93' ' ' HIS . 33.0 tttt -58.91 -49.54 77.43 Favored 'General case' 0 C--O 1.223 -0.338 0 C-N-CA 120.936 -0.306 . . . . 0.0 111.462 -173.862 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 64.7 tttp -52.43 -56.04 17.77 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 110.343 -0.243 . . . . 0.0 110.343 179.273 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.561 ' HB3' ' HB2' ' A' ' 74' ' ' ASN . . . -51.45 -35.66 40.63 Favored 'General case' 0 C--O 1.242 0.678 0 CA-C-O 122.03 0.919 . . . . 0.0 110.933 177.011 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 78' ' ' TRP . . . . . 0.656 ' HZ2' ' CE3' ' A' ' 38' ' ' TRP . 14.8 t-105 -74.25 -51.05 16.5 Favored 'General case' 0 N--CA 1.431 -1.377 0 CA-C-N 114.434 -1.257 . . . . 0.0 111.828 -173.045 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.498 ' HG2' ' O ' ' A' ' 75' ' ' LYS . 4.8 mm-40 -49.61 -41.06 41.17 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-O 121.082 0.468 . . . . 0.0 110.485 176.849 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 80' ' ' ASN . . . . . 0.532 ' OD1' ' HA ' ' A' ' 77' ' ' ALA . 2.9 m120 -56.87 -54.26 48.53 Favored 'General case' 0 CA--C 1.518 -0.261 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.706 177.795 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 81' ' ' MET . . . . . 0.539 ' SD ' ' HZ3' ' A' ' 78' ' ' TRP . 16.6 ttt -61.09 -48.42 81.75 Favored 'General case' 0 C--O 1.223 -0.316 0 N-CA-C 112.358 0.503 . . . . 0.0 112.358 -175.435 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.686 HG13 HD12 ' A' ' 18' ' ' ILE . 0.9 OUTLIER -60.91 -34.79 60.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 C-N-CA 120.386 -0.526 . . . . 0.0 111.069 -178.478 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 25.5 m -73.41 -29.79 62.82 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.106 0.479 . . . . 0.0 110.574 176.992 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 51.3 tttp -81.3 -41.97 21.33 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.179 0.514 . . . . 0.0 111.043 -177.905 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -77.24 -21.04 54.38 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.239 -0.891 . . . . 0.0 110.084 -176.126 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 17.8 mm-40 63.99 79.52 0.26 Allowed 'General case' 0 C--O 1.233 0.192 0 CA-C-N 115.375 -0.83 . . . . 0.0 111.229 -179.885 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.69 HD23 ' HE2' ' A' ' 53' ' ' LYS . 49.4 mt -96.55 140.93 30.45 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.422 -0.808 . . . . 0.0 111.001 179.402 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.761 ' HG2' ' HB3' ' A' ' 53' ' ' LYS . 30.6 mmtp -95.47 174.28 7.09 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.234 -0.439 . . . . 0.0 109.821 179.341 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 89' ' ' GLY . . . . . 0.425 ' CA ' ' HG2' ' A' ' 56' ' ' GLU . . . 86.33 -164.83 36.84 Favored Glycine 0 CA--C 1.517 0.184 0 C-N-CA 120.927 -0.654 . . . . 0.0 113.432 174.418 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.527 HG21 HG11 ' A' ' 23' ' ' VAL . 64.2 mt -103.51 113.45 40.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 178.297 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 91' ' ' GLN . . . . . 0.644 ' HB3' ' CZ2' ' A' ' 38' ' ' TRP . 8.1 mm100 -117.23 104.83 11.57 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 120.892 0.377 . . . . 0.0 111.022 -169.624 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.616 HD13 ' HB2' ' A' ' 15' ' ' TYR . 34.9 mt -100.04 147.94 25.07 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.146 0.498 . . . . 0.0 111.111 -176.51 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 93' ' ' HIS . . . . . 0.547 ' CE1' ' HG3' ' A' ' 75' ' ' LYS . 28.1 t-80 -115.08 127.86 55.87 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.144 0.497 . . . . 0.0 111.086 179.759 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 94' ' ' MET . . . . . 0.496 ' HB3' ' O ' ' A' ' 70' ' ' SER . 24.1 ttm -77.32 -74.95 0.22 Allowed 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.294 -0.866 . . . . 0.0 109.93 176.167 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 78.67 101.96 0.21 Allowed Glycine 0 N--CA 1.445 -0.734 0 C-N-CA 120.755 -0.735 . . . . 0.0 113.135 -179.689 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 64.9 p 61.17 16.29 7.08 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 114.221 1.193 . . . . 0.0 114.221 170.098 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -123.99 54.47 1.33 Allowed 'General case' 0 CA--C 1.518 -0.265 0 CA-C-O 121.502 0.667 . . . . 0.0 110.096 174.989 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 98' ' ' ARG . . . . . 0.491 ' HB2' ' SD ' ' A' ' 101' ' ' MET . 0.1 OUTLIER -77.3 5.62 8.26 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.27 -0.877 . . . . 0.0 111.911 -170.433 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 2.8 m -61.0 -29.95 70.0 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.294 0.569 . . . . 0.0 110.529 177.42 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 27.3 t80 -73.94 -24.83 59.71 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.567 -179.14 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 101' ' ' MET . . . . . 0.491 ' SD ' ' HB2' ' A' ' 98' ' ' ARG . 83.2 mtp -61.7 -51.58 67.8 Favored 'General case' 0 CA--C 1.515 -0.402 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 174.059 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -62.03 -25.36 67.61 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 114.649 -1.16 . . . . 0.0 111.424 -177.696 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -65.84 -28.97 69.37 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-O 121.074 0.464 . . . . 0.0 110.877 178.1 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 61.9 m-85 -109.27 10.81 25.61 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.495 179.766 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 95.4 mt 64.72 15.51 9.81 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.1 -177.24 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 106' ' ' ILE . . . . . 0.885 HG12 ' HG3' ' A' ' 111' ' ' ARG . 61.2 mt -67.03 112.92 2.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.271 175.111 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 16.2 t-20 -124.96 -53.85 1.63 Allowed 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 176.346 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -92.19 115.02 4.7 Favored Glycine 0 N--CA 1.442 -0.915 0 CA-C-N 115.29 -0.868 . . . . 0.0 111.979 178.339 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.507 ' CG2' ' HA ' ' A' ' 110' ' ' PRO . 41.9 mt -77.7 142.97 66.59 Favored Pre-proline 0 C--N 1.321 -0.655 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 175.383 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 110' ' ' PRO . . . . . 0.507 ' HA ' ' CG2' ' A' ' 109' ' ' ILE . 1.0 OUTLIER -86.13 170.67 42.16 Favored 'Cis proline' 0 C--N 1.348 0.553 0 C-N-CA 124.775 -0.927 . . . . 0.0 113.853 1.087 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 111' ' ' ARG . . . . . 0.885 ' HG3' HG12 ' A' ' 106' ' ' ILE . 0.0 OUTLIER -134.79 133.82 40.23 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.477 -0.783 . . . . 0.0 108.897 179.413 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 112' ' ' PHE . . . . . 0.491 ' CE1' ' HB2' ' A' ' 128' ' ' ARG . 0.0 OUTLIER -102.33 117.05 33.91 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 123.365 0.415 . . . . 0.0 110.502 -175.604 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.61 ' HB ' ' HB ' ' A' ' 35' ' ' ILE . 82.1 mt -129.16 141.81 45.64 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.326 0 CA-C-O 120.708 0.29 . . . . 0.0 111.004 179.559 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 40.4 tp -130.31 139.21 50.72 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.5 -179.775 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.468 ' N ' HD12 ' A' ' 115' ' ' LEU . 0.8 OUTLIER -136.03 155.77 49.73 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.04 0.447 . . . . 0.0 110.54 179.673 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 116' ' ' ASP . . . . . 0.692 ' HB3' ' HB2' ' A' ' 120' ' ' LYS . 19.2 t70 -71.94 162.55 29.29 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.221 -0.899 . . . . 0.0 110.568 176.684 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 117' ' ' ARG . . . . . 0.424 ' HA ' ' C ' ' A' ' 31' ' ' LYS . 33.0 mtt180 -46.53 -40.2 12.21 Favored 'General case' 0 N--CA 1.462 0.136 0 O-C-N 124.43 1.081 . . . . 0.0 111.895 -178.611 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 118' ' ' ASP . . . . . 0.85 ' HB3' ' HG3' ' A' ' 120' ' ' LYS . 38.4 t70 -66.09 -18.87 65.62 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.36 0.6 . . . . 0.0 111.173 -177.448 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 104.26 16.96 16.93 Favored Glycine 0 N--CA 1.436 -1.344 0 N-CA-C 110.288 -1.125 . . . . 0.0 110.288 -170.151 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 120' ' ' LYS . . . . . 0.85 ' HG3' ' HB3' ' A' ' 118' ' ' ASP . 60.0 mttm -86.03 107.35 17.75 Favored 'General case' 0 C--O 1.219 -0.528 0 C-N-CA 120.805 -0.358 . . . . 0.0 111.115 -173.929 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 121' ' ' ILE . . . . . 0.65 ' H ' HD12 ' A' ' 121' ' ' ILE . 3.9 mp -48.18 111.67 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-O 121.02 0.438 . . . . 0.0 110.797 177.725 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 122' ' ' ILE . . . . . 0.412 HD11 ' HB2' ' A' ' 116' ' ' ASP . 45.5 mm -95.48 -50.38 11.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 115.659 -0.7 . . . . 0.0 109.9 -179.508 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 19.9 m -125.99 114.59 18.67 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.212 -177.86 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -72.08 -16.98 62.03 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.13 0.491 . . . . 0.0 110.091 176.694 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 125' ' ' ASN . . . . . 0.406 ' HA ' ' O ' ' A' ' 112' ' ' PHE . 7.7 t30 -149.8 101.18 3.03 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.299 -0.864 . . . . 0.0 109.159 173.909 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 12.6 tpt -91.48 -125.2 0.08 Allowed 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 -178.761 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 127' ' ' THR . . . . . 0.463 ' OG1' ' HB ' ' A' ' 134' ' ' THR . 0.0 OUTLIER -140.82 131.72 26.01 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.879 0.371 . . . . 0.0 110.48 178.399 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 128' ' ' ARG . . . . . 0.651 ' HD2' ' HD2' ' A' ' 129' ' ' PRO . 17.7 tpt180 -51.52 138.03 30.83 Favored Pre-proline 0 C--N 1.323 -0.56 0 CA-C-N 115.252 -0.885 . . . . 0.0 111.073 176.04 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 129' ' ' PRO . . . . . 0.651 ' HD2' ' HD2' ' A' ' 128' ' ' ARG . 68.8 Cg_exo -48.49 -21.48 3.34 Favored 'Trans proline' 0 C--N 1.351 0.664 0 C-N-CA 123.496 2.797 . . . . 0.0 113.747 174.074 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 130' ' ' SER . . . . . 0.455 ' H ' ' HG3' ' A' ' 128' ' ' ARG . 4.4 m -61.11 -28.06 68.82 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.762 0.315 . . . . 0.0 111.035 176.774 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 131' ' ' ASP . . . . . 0.65 ' OD1' ' HG2' ' A' ' 133' ' ' LYS . 24.1 t0 -100.64 117.35 62.93 Favored Pre-proline 0 N--CA 1.453 -0.321 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.162 179.736 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 132' ' ' PRO . . . . . 0.598 ' O ' ' HG2' ' A' ' 136' ' ' GLU . 14.1 Cg_endo -56.98 -21.18 40.19 Favored 'Trans proline' 0 CA--C 1.53 0.315 0 C-N-CA 123.196 2.597 . . . . 0.0 114.018 179.736 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 133' ' ' LYS . . . . . 0.65 ' HG2' ' OD1' ' A' ' 131' ' ' ASP . 31.1 mmtm -48.15 -55.31 10.68 Favored 'General case' 0 N--CA 1.474 0.73 0 CA-C-O 121.066 0.46 . . . . 0.0 110.724 -177.528 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 134' ' ' THR . . . . . 0.463 ' HB ' ' OG1' ' A' ' 127' ' ' THR . 15.1 t -65.15 -41.15 95.02 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.233 -0.894 . . . . 0.0 110.755 -175.069 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 135' ' ' ALA . . . . . 0.587 ' HA ' ' CD2' ' A' ' 138' ' ' PHE . . . -64.24 -47.87 78.0 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-O 121.402 0.62 . . . . 0.0 110.758 -176.801 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 136' ' ' GLU . . . . . 0.598 ' HG2' ' O ' ' A' ' 132' ' ' PRO . 8.6 mm-40 -77.12 -22.86 52.02 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-O 121.465 0.65 . . . . 0.0 109.821 -176.2 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 137' ' ' LYS . . . . . 0.583 ' O ' ' HG ' ' A' ' 141' ' ' LEU . 0.1 OUTLIER -57.68 -39.17 76.48 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.15 -0.932 . . . . 0.0 109.441 168.659 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 138' ' ' PHE . . . . . 0.587 ' CD2' ' HA ' ' A' ' 135' ' ' ALA . 9.3 m-85 -66.76 -40.59 88.31 Favored 'General case' 0 N--CA 1.462 0.15 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.373 177.596 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 139' ' ' ASN . . . . . 0.515 ' ND2' ' HA ' ' A' ' 136' ' ' GLU . 92.6 m-20 -47.53 -53.76 13.52 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 175.758 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 21.8 tt0 -53.85 -48.42 70.0 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.287 -0.869 . . . . 0.0 111.472 179.111 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.583 ' HG ' ' O ' ' A' ' 137' ' ' LYS . 83.4 mt -58.32 -29.35 65.84 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.899 -176.688 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 0.403 HD21 ' H ' ' A' ' 63' ' ' ASP . 10.0 mp . . . . . 0 C--N 1.327 -0.412 0 CA-C-N 116.678 -0.237 . . . . 0.0 111.442 -179.756 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.548 ' HB2' HD13 ' A' ' 121' ' ' ILE . . . . . . . . 0 N--CA 1.471 0.584 0 N-CA-C 112.823 0.675 . . . . 0.0 112.823 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -76.2 69.35 2.73 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 112.281 0.474 . . . . 0.0 112.281 -175.598 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 42.5 m 62.6 102.86 0.03 OUTLIER 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 113.188 0.811 . . . . 0.0 113.188 172.042 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' PHE . . . . . 0.502 ' CE1' HD13 ' A' ' 25' ' ' LEU . 38.7 p90 -105.58 129.91 53.74 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.137 -0.483 . . . . 0.0 109.943 173.985 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 3.4 m -121.82 111.76 17.52 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.395 -177.841 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 63.9 m-85 -134.79 151.63 76.07 Favored Pre-proline 0 C--N 1.322 -0.597 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.605 -175.885 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -76.41 125.81 8.63 Favored 'Trans proline' 0 N--CA 1.46 -0.497 0 C-N-CA 122.569 2.18 . . . . 0.0 112.587 178.966 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' ASP . . . . . 0.544 ' HA ' ' HA ' ' A' ' 92' ' ' LEU . 10.5 t70 -70.51 159.16 34.79 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.484 -0.78 . . . . 0.0 108.926 172.114 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.559 HG13 HG11 ' A' ' 82' ' ' VAL . 0.0 OUTLIER -55.8 -25.64 19.01 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.487 0 O-C-N 123.722 0.639 . . . . 0.0 111.55 -176.947 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 42.8 m-80 -72.65 2.42 6.55 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.137 0.494 . . . . 0.0 110.91 176.065 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 73.67 36.35 53.73 Favored Glycine 0 N--CA 1.446 -0.639 0 N-CA-C 110.835 -0.906 . . . . 0.0 110.835 -179.501 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.461 ' HB2' ' NZ ' ' A' ' 21' ' ' LYS . 0.1 OUTLIER -119.56 134.07 55.39 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 110.273 -0.269 . . . . 0.0 110.273 -175.045 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 7.0 m -80.11 107.83 13.22 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-O 120.868 0.366 . . . . 0.0 110.619 -177.326 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.52 ' HB ' HD21 ' A' ' 92' ' ' LEU . 62.0 t -108.4 141.7 22.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 115.871 -0.604 . . . . 0.0 109.69 -179.969 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 82.3 p -120.53 -173.71 2.64 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 120.867 0.365 . . . . 0.0 110.716 -176.895 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.659 ' O ' ' HB2' ' A' ' 29' ' ' LYS . 65.0 tp -78.73 -26.52 44.72 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.465 -179.716 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -84.76 -30.58 24.54 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 112.8 0.667 . . . . 0.0 112.8 -169.709 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 3.4 p30 -81.04 -15.5 55.94 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.171 0.51 . . . . 0.0 110.849 -175.796 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 18.8 tp -118.36 21.87 12.42 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.756 0.788 . . . . 0.0 109.319 178.007 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.659 ' HB2' ' O ' ' A' ' 25' ' ' LEU . 57.6 tttm -94.18 163.27 13.52 Favored 'General case' 0 N--CA 1.44 -0.957 0 CA-C-N 114.813 -1.085 . . . . 0.0 109.961 -178.45 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 114.49 -31.33 6.45 Favored Glycine 0 CA--C 1.509 -0.301 0 C-N-CA 120.591 -0.814 . . . . 0.0 111.669 177.734 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 1.05 ' HD3' ' HA ' ' A' ' 63' ' ' ASP . 65.2 mttm -119.36 165.55 14.16 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 109.662 -0.496 . . . . 0.0 109.662 174.822 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 81.5 m-85 -60.89 149.15 37.18 Favored 'General case' 0 C--N 1.329 -0.311 0 O-C-N 123.323 0.39 . . . . 0.0 110.639 -177.87 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 71.1 mt -124.5 132.18 71.7 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 CA-C-O 120.853 0.359 . . . . 0.0 110.807 -174.737 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 88.3 t80 -117.12 121.05 40.19 Favored 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 173.013 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.533 ' HB ' ' HB ' ' A' ' 113' ' ' ILE . 57.1 mt -105.58 118.83 53.78 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-O 121.171 0.51 . . . . 0.0 110.736 -178.286 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -106.41 156.87 18.08 Favored 'General case' 0 C--N 1.316 -0.849 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 172.3 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.524 ' HB ' ' H ' ' A' ' 111' ' ' ARG . 62.0 t -110.46 112.1 39.08 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.877 0 C-N-CA 120.034 -0.666 . . . . 0.0 110.22 174.161 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 38' ' ' TRP . . . . . 0.655 ' CZ2' ' HB2' ' A' ' 91' ' ' GLN . 0.2 OUTLIER -98.02 132.86 43.2 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.097 -0.956 . . . . 0.0 109.516 -177.257 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.582 ' HA ' ' OD1' ' A' ' 72' ' ' ASP . . . -147.58 155.09 41.49 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.664 -178.714 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 40' ' ' THR . . . . . 0.675 ' HB ' ' CE3' ' A' ' 78' ' ' TRP . 13.3 t -100.34 -28.41 12.97 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.781 0.324 . . . . 0.0 110.704 174.601 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 41' ' ' TRP . . . . . 0.429 ' HE1' ' HA ' ' A' ' 72' ' ' ASP . 18.5 p-90 -81.31 11.03 4.69 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.785 -177.053 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 42' ' ' CYS . . . . . 0.777 ' HB3' ' SG ' ' A' ' 45' ' ' CYS . 44.5 t -91.55 -61.03 1.73 Allowed 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 109.912 -0.403 . . . . 0.0 109.912 174.854 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 111.0 -83.68 0.33 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.597 -179.629 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_exo -54.19 -26.86 44.32 Favored 'Trans proline' 0 C--N 1.351 0.704 0 C-N-CA 123.188 2.592 . . . . 0.0 112.854 179.463 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' CYS . . . . . 0.777 ' SG ' ' HB3' ' A' ' 42' ' ' CYS . 23.1 p -51.47 -35.49 40.1 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.399 176.797 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.589 ' HA ' HD13 ' A' ' 49' ' ' LEU . 33.6 mtp180 -67.9 -12.3 60.41 Favored 'General case' 0 N--CA 1.456 -0.157 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.21 -175.698 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -80.37 -19.93 67.93 Favored Glycine 0 N--CA 1.446 -0.654 0 C-N-CA 120.648 -0.786 . . . . 0.0 111.369 175.437 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 24.6 mt-10 -99.34 -12.81 19.97 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-O 120.606 0.241 . . . . 0.0 110.615 -179.282 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.589 HD13 ' HA ' ' A' ' 46' ' ' ARG . 7.5 mp -51.89 -48.57 87.52 Favored Pre-proline 0 CA--C 1.536 0.436 0 CA-C-N 116.561 -0.29 . . . . 0.0 111.701 172.279 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -57.04 -35.84 99.07 Favored 'Trans proline' 0 C--N 1.355 0.896 0 C-N-CA 121.791 1.661 . . . . 0.0 111.937 171.601 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.445 ' O ' ' HB2' ' A' ' 54' ' ' GLU . . . -72.0 -26.03 62.06 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-O 121.234 0.54 . . . . 0.0 110.574 -179.1 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 87.3 mt -67.6 -33.67 75.47 Favored 'General case' 0 N--CA 1.444 -0.74 0 CA-C-N 115.858 -0.61 . . . . 0.0 109.67 174.225 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 5.5 mtpm? -70.36 -39.19 74.76 Favored 'General case' 0 CA--C 1.519 -0.236 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.166 175.005 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.445 ' HB2' ' O ' ' A' ' 51' ' ' ALA . 28.1 mm-40 -50.7 -50.82 54.18 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.755 -0.657 . . . . 0.0 109.669 172.9 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 62.8 mt -62.23 -53.12 59.74 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.976 175.409 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 26.4 tt0 -43.41 -59.84 1.96 Allowed 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 114.575 -1.193 . . . . 0.0 112.427 179.522 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -78.67 -29.04 45.41 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 120.777 0.322 . . . . 0.0 111.598 -172.666 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 65.5 tttm -70.48 -27.69 64.41 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.884 0.374 . . . . 0.0 110.831 178.62 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.434 ' HB2' ' HE2' ' A' ' 66' ' ' PHE . 68.4 m-85 -122.58 13.7 10.13 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.46 -0.336 . . . . 0.0 111.845 -176.343 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -60.07 132.09 52.85 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.217 172.392 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 69.36 46.37 56.87 Favored Glycine 0 N--CA 1.447 -0.599 0 C-N-CA 120.854 -0.689 . . . . 0.0 112.169 -179.702 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.414 ' HB2' HG22 ' A' ' 64' ' ' ILE . 40.3 mmtm -126.6 -164.42 1.33 Allowed 'General case' 0 N--CA 1.45 -0.451 0 CA-C-O 121.216 0.531 . . . . 0.0 110.313 174.859 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 63' ' ' ASP . . . . . 1.05 ' HA ' ' HD3' ' A' ' 31' ' ' LYS . 0.1 OUTLIER -97.85 44.32 1.04 Allowed 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.639 -0.71 . . . . 0.0 110.805 -179.41 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.414 HG22 ' HB2' ' A' ' 62' ' ' LYS . 18.2 tt -144.45 149.27 17.49 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.761 0 CA-C-N 114.929 -1.032 . . . . 0.0 109.761 -177.036 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 65' ' ' HIS . . . . . 0.55 ' NE2' ' HB2' ' A' ' 31' ' ' LYS . 89.4 m-70 -124.25 121.34 34.78 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 109.918 -0.401 . . . . 0.0 109.918 178.287 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 66' ' ' PHE . . . . . 0.434 ' HE2' ' HB2' ' A' ' 59' ' ' TYR . 91.8 m-85 -88.65 111.31 21.78 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 173.585 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.504 ' O ' ' HA ' ' A' ' 35' ' ' ILE . 27.4 t -118.58 109.37 26.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.459 -175.83 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 68' ' ' SER . . . . . 0.426 ' HB3' ' CD1' ' A' ' 38' ' ' TRP . 10.9 m -88.07 143.73 26.91 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-N 115.918 -0.583 . . . . 0.0 109.856 178.844 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.48 ' O ' HG13 ' A' ' 37' ' ' VAL . 62.7 tp -131.88 124.0 28.63 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 174.652 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 70' ' ' SER . . . . . 0.565 ' O ' ' HB3' ' A' ' 94' ' ' MET . 1.3 t -108.15 119.61 39.98 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.076 0.465 . . . . 0.0 112.046 -173.957 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 2.4 p -87.06 17.6 4.1 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.749 -0.659 . . . . 0.0 110.806 177.214 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.582 ' OD1' ' HA ' ' A' ' 39' ' ' ALA . 1.9 m-20 -69.64 121.3 16.86 Favored 'General case' 0 CA--C 1.515 -0.4 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.011 179.496 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 45.9 tttm -75.91 -25.86 56.42 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-O 121.146 0.498 . . . . 0.0 110.062 -179.874 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' ASN . . . . . 0.522 ' HB2' ' HB3' ' A' ' 77' ' ' ALA . 0.2 OUTLIER -78.7 96.87 5.67 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.747 -0.66 . . . . 0.0 109.788 174.027 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.55 ' O ' ' HG2' ' A' ' 79' ' ' GLU . 11.4 tmtt? -71.41 -66.33 0.64 Allowed 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 120.446 -0.502 . . . . 0.0 112.038 -173.863 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 36.0 ttpt -58.3 -43.28 88.04 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 121.009 -0.277 . . . . 0.0 110.819 -173.044 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.522 ' HB3' ' HB2' ' A' ' 74' ' ' ASN . . . -52.22 -38.82 59.09 Favored 'General case' 0 C--O 1.246 0.879 0 CA-C-O 121.86 0.838 . . . . 0.0 111.277 178.716 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 78' ' ' TRP . . . . . 0.675 ' CE3' ' HB ' ' A' ' 40' ' ' THR . 16.2 t-105 -79.02 -42.53 26.31 Favored 'General case' 0 N--CA 1.44 -0.959 0 CA-C-N 115.151 -0.931 . . . . 0.0 111.045 -173.175 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.55 ' HG2' ' O ' ' A' ' 75' ' ' LYS . 3.8 mm-40 -51.97 -40.72 61.33 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-O 121.473 0.654 . . . . 0.0 110.248 175.748 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 80' ' ' ASN . . . . . 0.455 ' OD1' ' HA ' ' A' ' 77' ' ' ALA . 3.3 m120 -59.25 -54.07 51.02 Favored 'General case' 0 CA--C 1.513 -0.446 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.257 177.858 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 28.6 ttm -61.37 -45.99 92.05 Favored 'General case' 0 C--O 1.219 -0.507 0 CA-C-N 116.02 -0.536 . . . . 0.0 112.235 -174.209 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.567 ' CG2' ' HZ3' ' A' ' 38' ' ' TRP . 3.9 p -61.57 -32.82 54.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 C-N-CA 120.07 -0.652 . . . . 0.0 111.016 179.519 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 58.9 m -63.75 -40.34 96.48 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.979 0.419 . . . . 0.0 110.239 175.886 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 12.8 mptt -81.13 -29.96 34.66 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.495 -179.396 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 85' ' ' ASP . . . . . 0.406 ' CG ' HH21 ' A' ' 46' ' ' ARG . 1.5 m-20 -77.6 -6.8 55.02 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.142 0.496 . . . . 0.0 110.975 178.529 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 84.7 mt-30 66.18 18.26 10.92 Favored 'General case' 0 N--CA 1.468 0.43 0 N-CA-C 113.271 0.841 . . . . 0.0 113.271 170.357 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.554 ' HB2' HG23 ' A' ' 82' ' ' VAL . 71.0 mt -64.14 143.18 58.07 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.558 0.218 . . . . 0.0 110.89 -179.926 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 24.6 mmtm -123.15 -166.91 1.52 Allowed 'General case' 0 N--CA 1.451 -0.382 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.934 176.367 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 92.2 -157.01 23.83 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 121.002 -0.618 . . . . 0.0 111.685 -178.986 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 50.1 mm -107.26 117.48 53.12 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 N-CA-C 108.933 -0.766 . . . . 0.0 108.933 175.631 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 91' ' ' GLN . . . . . 0.655 ' HB2' ' CZ2' ' A' ' 38' ' ' TRP . 0.6 OUTLIER -135.2 102.59 5.23 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-O 121.916 0.865 . . . . 0.0 111.724 -169.4 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.544 ' HA ' ' HA ' ' A' ' 17' ' ' ASP . 38.6 mt -91.73 142.2 27.86 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 114.806 -1.088 . . . . 0.0 110.588 -175.982 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 23.2 t-80 -111.82 116.07 30.07 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-O 121.37 0.605 . . . . 0.0 110.443 179.544 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 94' ' ' MET . . . . . 0.733 ' SD ' ' HA ' ' A' ' 98' ' ' ARG . 10.7 ttm -69.47 -52.28 28.1 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.048 -0.978 . . . . 0.0 111.073 -178.899 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 95' ' ' GLY . . . . . 0.419 ' HA2' ' O ' ' A' ' 72' ' ' ASP . . . 77.86 -86.7 1.07 Allowed Glycine 0 N--CA 1.448 -0.557 0 C-N-CA 120.628 -0.796 . . . . 0.0 113.243 175.781 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 5.1 m -120.7 -5.45 9.7 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 120.843 0.354 . . . . 0.0 111.112 -176.173 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 97' ' ' ASP . . . . . 0.536 ' O ' ' HG3' ' A' ' 94' ' ' MET . 13.0 t70 -98.46 72.65 2.07 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 120.056 -0.657 . . . . 0.0 109.719 -177.907 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 98' ' ' ARG . . . . . 0.733 ' HA ' ' SD ' ' A' ' 94' ' ' MET . 0.0 OUTLIER -82.62 31.31 0.41 Allowed 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.384 -175.462 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 3.0 m -65.67 -43.45 89.31 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.489 179.837 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -71.73 -36.58 70.53 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.247 177.3 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 101' ' ' MET . . . . . 0.537 ' HG3' ' O ' ' A' ' 106' ' ' ILE . 15.1 ttt -56.08 -45.11 79.47 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.568 -0.742 . . . . 0.0 109.982 173.95 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 102' ' ' ASP . . . . . 0.476 ' HB2' ' CZ ' ' A' ' 98' ' ' ARG . 21.9 t70 -69.07 -49.56 56.29 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.242 -0.89 . . . . 0.0 110.919 179.462 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -69.01 -21.71 64.12 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.957 -0.565 . . . . 0.0 112.344 -171.512 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 25.8 m-85 -109.08 2.63 21.28 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 111.752 0.279 . . . . 0.0 111.752 -178.441 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 9.0 mp 59.39 27.27 16.34 Favored 'General case' 0 N--CA 1.466 0.334 0 O-C-N 123.47 0.481 . . . . 0.0 111.09 -177.968 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 106' ' ' ILE . . . . . 0.537 ' O ' ' HG3' ' A' ' 101' ' ' MET . 53.6 mt -66.7 77.85 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.271 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.71 174.084 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 61.2 t30 -109.19 -46.47 3.57 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 175.427 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -77.77 91.95 1.1 Allowed Glycine 0 N--CA 1.446 -0.639 0 CA-C-N 115.455 -0.793 . . . . 0.0 111.222 174.575 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.47 HD13 ' HB2' ' A' ' 42' ' ' CYS . 2.4 pp -103.34 151.57 38.6 Favored Pre-proline 0 C--N 1.322 -0.609 0 CA-C-N 115.963 -0.118 . . . . 0.0 111.094 -178.829 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 110' ' ' PRO . . . . . 0.567 ' HD3' ' HB3' ' A' ' 45' ' ' CYS . 30.0 Cg_endo -68.51 153.49 89.39 Favored 'Cis proline' 0 C--N 1.349 0.573 0 C-N-CA 123.725 -1.365 . . . . 0.0 113.623 1.115 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 111' ' ' ARG . . . . . 0.524 ' H ' ' HB ' ' A' ' 37' ' ' VAL . 0.0 OUTLIER -113.57 144.41 42.93 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.727 -0.669 . . . . 0.0 109.519 -177.526 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 112' ' ' PHE . . . . . 0.651 ' HD2' ' HD3' ' A' ' 129' ' ' PRO . 0.9 OUTLIER -112.66 114.52 27.17 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.835 -177.873 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.533 ' HB ' ' HB ' ' A' ' 35' ' ' ILE . 85.6 mt -128.57 141.97 45.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.854 0.359 . . . . 0.0 110.801 -178.796 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.411 HD22 ' HE3' ' A' ' 126' ' ' MET . 41.2 tp -126.48 136.45 52.64 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.172 179.097 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.516 ' N ' HD12 ' A' ' 115' ' ' LEU . 0.7 OUTLIER -136.27 156.7 48.29 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.397 0.618 . . . . 0.0 110.553 -178.175 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 116' ' ' ASP . . . . . 0.645 ' HB3' ' HB2' ' A' ' 120' ' ' LYS . 9.6 t70 -77.96 168.2 20.28 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 114.88 -1.055 . . . . 0.0 111.351 177.722 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 117' ' ' ARG . . . . . 0.496 ' HA ' ' O ' ' A' ' 31' ' ' LYS . 88.1 mtt-85 -45.88 -40.55 10.15 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 124.569 1.148 . . . . 0.0 113.115 179.911 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 118' ' ' ASP . . . . . 0.788 ' HB2' ' HG3' ' A' ' 120' ' ' LYS . 40.2 m-20 -78.34 5.19 11.03 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.576 0.227 . . . . 0.0 111.502 -178.461 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 119' ' ' GLY . . . . . 0.454 ' HA3' HD11 ' A' ' 25' ' ' LEU . . . 80.63 26.6 53.71 Favored Glycine 0 N--CA 1.44 -1.09 0 N-CA-C 110.521 -1.032 . . . . 0.0 110.521 -173.268 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 120' ' ' LYS . . . . . 0.788 ' HG3' ' HB2' ' A' ' 118' ' ' ASP . 33.9 mtmm -94.17 103.98 16.01 Favored 'General case' 0 C--O 1.223 -0.332 0 C-N-CA 120.574 -0.45 . . . . 0.0 110.468 -173.511 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 121' ' ' ILE . . . . . 0.558 ' H ' HD12 ' A' ' 121' ' ' ILE . 2.7 mp -45.0 112.72 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 115.566 -0.743 . . . . 0.0 111.651 -178.47 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 122' ' ' ILE . . . . . 0.446 HD11 ' HB2' ' A' ' 116' ' ' ASP . 46.3 mm -89.5 -40.1 12.83 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-N 115.216 -0.902 . . . . 0.0 109.126 176.504 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 14.8 m -142.66 117.49 9.9 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.338 -0.847 . . . . 0.0 110.497 178.237 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 124' ' ' ALA . . . . . 0.512 ' O ' HG12 ' A' ' 113' ' ' ILE . . . -68.29 -27.16 66.07 Favored 'General case' 0 C--N 1.334 -0.103 0 CA-C-O 121.409 0.623 . . . . 0.0 109.75 175.453 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 3.9 p-10 -136.82 109.25 7.37 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.044 -0.98 . . . . 0.0 108.646 171.103 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 126' ' ' MET . . . . . 0.422 ' N ' ' HD1' ' A' ' 112' ' ' PHE . 27.9 ttt -83.17 -87.83 0.1 Allowed 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.518 -174.728 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -137.03 -75.76 0.42 Allowed 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.574 -0.285 . . . . 0.0 111.579 -178.266 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 128' ' ' ARG . . . . . 0.936 ' HB3' ' HB2' ' A' ' 131' ' ' ASP . 3.6 tmm_? 177.88 139.06 0.24 Allowed Pre-proline 0 N--CA 1.453 -0.297 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 -178.128 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 129' ' ' PRO . . . . . 0.651 ' HD3' ' HD2' ' A' ' 112' ' ' PHE . 85.1 Cg_exo -48.65 -44.8 29.81 Favored 'Trans proline' 0 C--N 1.349 0.554 0 C-N-CA 122.869 2.379 . . . . 0.0 113.617 -176.649 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 130' ' ' SER . . . . . 0.637 ' HB3' ' NH1' ' A' ' 128' ' ' ARG . 43.8 t -107.1 26.83 9.66 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.063 0.459 . . . . 0.0 110.863 -178.719 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 131' ' ' ASP . . . . . 0.936 ' HB2' ' HB3' ' A' ' 128' ' ' ARG . 13.6 t70 -92.09 134.06 29.25 Favored Pre-proline 0 C--N 1.325 -0.496 0 N-CA-C 109.781 -0.451 . . . . 0.0 109.781 177.686 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 132' ' ' PRO . . . . . 0.621 ' O ' ' HG3' ' A' ' 136' ' ' GLU . 18.8 Cg_endo -58.22 -40.87 72.51 Favored 'Trans proline' 0 C--N 1.343 0.269 0 C-N-CA 122.748 2.299 . . . . 0.0 113.142 -178.867 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 36.0 mtmm -61.17 -27.44 68.41 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 121.048 0.451 . . . . 0.0 110.69 -175.05 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 134' ' ' THR . . . . . 0.713 HG22 ' CZ ' ' A' ' 138' ' ' PHE . 1.3 m -60.94 -57.18 13.74 Favored 'General case' 0 N--CA 1.447 -0.595 0 CA-C-N 115.73 -0.668 . . . . 0.0 109.464 173.772 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 135' ' ' ALA . . . . . 0.643 ' HA ' ' CD2' ' A' ' 138' ' ' PHE . . . -60.09 -42.73 95.26 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.011 -0.995 . . . . 0.0 111.696 178.599 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 136' ' ' GLU . . . . . 0.621 ' HG3' ' O ' ' A' ' 132' ' ' PRO . 38.6 mt-10 -54.18 -52.45 61.15 Favored 'General case' 0 CA--C 1.512 -0.516 0 CA-C-O 121.382 0.61 . . . . 0.0 110.534 179.177 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 137' ' ' LYS . . . . . 0.51 ' O ' ' HB3' ' A' ' 140' ' ' GLU . 5.8 tmtm? -55.24 -43.61 74.73 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-N 114.792 -1.094 . . . . 0.0 111.148 -178.747 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 138' ' ' PHE . . . . . 0.713 ' CZ ' HG22 ' A' ' 134' ' ' THR . 14.8 m-85 -53.68 -60.54 3.18 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.07 -0.513 . . . . 0.0 111.44 177.674 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 139' ' ' ASN . . . . . 0.501 HD22 ' N ' ' A' ' 140' ' ' GLU . 0.3 OUTLIER -72.28 -17.37 61.88 Favored 'General case' 0 C--O 1.224 -0.287 0 C-N-CA 120.423 -0.511 . . . . 0.0 111.2 -175.491 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 140' ' ' GLU . . . . . 0.51 ' HB3' ' O ' ' A' ' 137' ' ' LYS . 3.8 tt0 -59.21 -57.44 13.0 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.736 171.351 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.449 ' HG ' ' O ' ' A' ' 138' ' ' PHE . 4.5 pp -71.53 -19.58 62.15 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.965 -177.31 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 95.7 mt . . . . . 0 C--N 1.328 -0.361 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.424 174.064 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.119 0 CA-C-O 121.107 0.48 . . . . 0.0 110.153 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -159.79 117.31 2.64 Favored 'General case' 0 N--CA 1.447 -0.585 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.66 -175.526 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' SER . . . . . 0.661 ' H ' HD23 ' A' ' 25' ' ' LEU . 47.3 m 67.04 36.01 4.37 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.235 -0.893 . . . . 0.0 112.141 171.954 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 37.5 p90 -66.06 163.87 16.53 Favored 'General case' 0 N--CA 1.463 0.208 0 N-CA-C 110.093 -0.336 . . . . 0.0 110.093 174.672 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' SER . . . . . 0.43 ' HA ' ' HA ' ' A' ' 24' ' ' SER . 16.2 t -142.36 128.0 19.16 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 120.865 0.364 . . . . 0.0 110.802 179.843 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 15' ' ' TYR . . . . . 0.455 ' O ' HD22 ' A' ' 92' ' ' LEU . 75.7 m-85 -141.83 159.65 58.82 Favored Pre-proline 0 C--N 1.327 -0.402 0 CA-C-N 115.874 -0.603 . . . . 0.0 109.81 178.942 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.702 ' HA ' ' O ' ' A' ' 21' ' ' LYS . 85.9 Cg_endo -88.44 134.16 2.85 Favored 'Trans proline' 0 N--CA 1.459 -0.549 0 C-N-CA 122.557 2.172 . . . . 0.0 113.996 -178.896 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 17' ' ' ASP . . . . . 0.478 ' HA ' ' O ' ' A' ' 91' ' ' GLN . 8.3 m-20 -69.1 168.62 13.55 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.054 171.203 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.567 HD12 HG13 ' A' ' 82' ' ' VAL . 1.9 tt -41.69 -40.36 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 O-C-N 124.563 1.164 . . . . 0.0 112.238 175.539 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 40.4 m-80 -68.54 -3.99 13.59 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.484 -177.086 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 79.14 33.63 35.57 Favored Glycine 0 N--CA 1.442 -0.931 0 N-CA-C 110.561 -1.016 . . . . 0.0 110.561 -174.389 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.702 ' O ' ' HA ' ' A' ' 16' ' ' PRO . 15.9 tppt? -110.43 126.73 54.62 Favored 'General case' 0 C--O 1.22 -0.48 0 CA-C-N 115.607 -0.297 . . . . 0.0 110.853 -173.952 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 18.8 m -84.44 106.86 16.35 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.974 -174.392 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.421 ' HB ' HD21 ' A' ' 92' ' ' LEU . 71.7 t -112.81 144.65 20.07 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 115.646 -0.706 . . . . 0.0 109.748 179.837 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 24' ' ' SER . . . . . 0.43 ' HA ' ' HA ' ' A' ' 14' ' ' SER . 95.7 p -113.98 162.01 16.96 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.912 -178.928 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.661 HD23 ' H ' ' A' ' 12' ' ' SER . 53.9 tp -66.98 -16.89 64.64 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.761 178.33 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -74.56 -18.95 60.51 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.825 0.345 . . . . 0.0 110.815 179.408 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -76.86 -39.1 52.33 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.629 0.728 . . . . 0.0 109.749 175.37 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.584 HD13 HG21 ' A' ' 67' ' ' VAL . 24.0 mt -84.69 -7.83 59.08 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 114.853 -1.067 . . . . 0.0 110.152 -179.402 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 32.9 tttp -73.78 130.2 39.48 Favored 'General case' 0 N--CA 1.439 -1.019 0 CA-C-N 114.847 -1.07 . . . . 0.0 110.496 -178.131 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 128.2 -31.14 3.72 Favored Glycine 0 N--CA 1.445 -0.747 0 N-CA-C 110.305 -1.118 . . . . 0.0 110.305 -173.985 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.857 ' HD3' ' HA ' ' A' ' 63' ' ' ASP . 61.4 mttm -122.56 174.31 7.15 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.526 -0.337 . . . . 0.0 110.154 175.518 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.962 ' HB2' HG22 ' A' ' 64' ' ' ILE . 92.4 m-85 -69.16 150.97 46.93 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 110.189 -0.3 . . . . 0.0 110.189 179.767 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.555 HD13 ' HA2' ' A' ' 119' ' ' GLY . 5.3 mp -124.59 134.47 66.69 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-O 120.79 0.328 . . . . 0.0 110.619 178.945 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 60.9 t80 -118.58 114.46 22.83 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 171.677 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.493 ' HA ' ' O ' ' A' ' 67' ' ' VAL . 67.4 mt -103.13 114.32 42.4 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 CA-C-O 121.134 0.493 . . . . 0.0 110.755 -177.791 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.486 ' O ' ' HA ' ' A' ' 68' ' ' SER . 5.5 p-10 -110.98 158.43 18.79 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 115.549 -0.75 . . . . 0.0 109.365 174.394 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.428 HG11 ' CG2' ' A' ' 109' ' ' ILE . 59.7 t -102.33 130.08 52.77 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.822 0 C-N-CA 120.779 -0.368 . . . . 0.0 110.421 178.359 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 38' ' ' TRP . . . . . 0.625 ' CZ2' ' HB2' ' A' ' 91' ' ' GLN . 0.6 OUTLIER -122.31 134.34 54.66 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 -179.223 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.55 ' HB3' ' HB3' ' A' ' 42' ' ' CYS . . . -145.03 162.23 37.47 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.548 -179.689 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 40' ' ' THR . . . . . 0.764 ' HB ' ' CE3' ' A' ' 78' ' ' TRP . 8.8 t -88.05 -22.19 24.34 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.226 0.536 . . . . 0.0 110.02 175.338 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 19.0 p-90 -96.71 18.0 15.3 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.674 -0.694 . . . . 0.0 109.848 176.045 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' CYS . . . . . 0.668 ' SG ' ' HB3' ' A' ' 45' ' ' CYS . 23.9 p -76.15 -19.38 58.53 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.542 -0.754 . . . . 0.0 111.089 -177.572 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 47.65 -98.31 0.01 OUTLIER Glycine 0 C--N 1.338 0.645 0 O-C-N 124.12 0.887 . . . . 0.0 114.261 176.602 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 81.6 Cg_exo -51.19 -26.11 19.02 Favored 'Trans proline' 0 C--N 1.354 0.821 0 C-N-CA 123.623 2.882 . . . . 0.0 113.502 178.217 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' CYS . . . . . 0.668 ' HB3' ' SG ' ' A' ' 42' ' ' CYS . 42.1 t -67.33 -41.14 85.75 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.286 0.565 . . . . 0.0 110.003 174.599 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.631 ' HA ' ' HG ' ' A' ' 49' ' ' LEU . 28.6 ttt-85 -67.49 -23.19 65.45 Favored 'General case' 0 N--CA 1.44 -0.953 0 CA-C-N 115.177 -0.92 . . . . 0.0 111.901 -173.487 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -63.2 -25.93 68.78 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.727 -0.749 . . . . 0.0 111.953 179.831 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' GLU . . . . . 0.482 ' CD ' ' HE ' ' A' ' 128' ' ' ARG . 47.9 mt-10 -109.78 24.56 12.88 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 111.708 0.262 . . . . 0.0 111.708 -179.934 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.631 ' HG ' ' HA ' ' A' ' 46' ' ' ARG . 34.6 mt -59.29 -42.7 94.34 Favored Pre-proline 0 C--N 1.328 -0.369 0 C-N-CA 120.692 -0.403 . . . . 0.0 110.543 170.625 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.447 ' HD3' ' HB2' ' A' ' 49' ' ' LEU . 76.2 Cg_exo -51.94 -38.91 69.7 Favored 'Trans proline' 0 C--N 1.36 1.139 0 C-N-CA 122.02 1.813 . . . . 0.0 112.108 169.386 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -74.72 -26.76 60.03 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.146 0.498 . . . . 0.0 110.675 179.948 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 6.5 tt -67.01 -44.01 81.42 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 173.487 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 3.1 mmmp? -60.98 -42.63 98.74 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.558 176.353 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -47.76 -58.58 4.14 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.786 173.662 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.572 ' HG ' ' CZ ' ' A' ' 66' ' ' PHE . 18.0 tp -62.79 -44.24 96.68 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.538 -0.755 . . . . 0.0 110.479 179.169 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 23.7 tt0 -49.46 -60.41 2.87 Favored 'General case' 0 C--N 1.331 -0.212 0 C-N-CA 123.853 0.861 . . . . 0.0 111.876 -179.597 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 32.1 mt-10 -73.03 -35.51 66.77 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.767 -172.797 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 43.6 mtpt -68.14 -38.31 82.01 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.005 0.431 . . . . 0.0 111.609 179.714 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.641 ' HB3' HD11 ' A' ' 64' ' ' ILE . 51.7 m-85 -107.13 10.41 30.12 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.897 -175.769 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -70.45 150.3 46.35 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 109.773 -0.455 . . . . 0.0 109.773 170.478 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 68.72 38.78 86.12 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.574 178.988 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.691 ' HB2' HG12 ' A' ' 64' ' ' ILE . 47.6 mmtm -119.67 -163.53 1.0 Allowed 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.233 0.539 . . . . 0.0 109.933 176.154 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 63' ' ' ASP . . . . . 0.857 ' HA ' ' HD3' ' A' ' 31' ' ' LYS . 0.6 OUTLIER -92.49 36.62 1.0 Allowed 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 115.265 -0.879 . . . . 0.0 110.127 178.165 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.962 HG22 ' HB2' ' A' ' 32' ' ' TYR . 30.4 pt -141.8 167.38 16.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.543 -174.507 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 65' ' ' HIS . . . . . 0.673 ' NE2' ' HB2' ' A' ' 31' ' ' LYS . 63.2 m-70 -136.45 119.03 15.93 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.172 -0.467 . . . . 0.0 109.919 177.02 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 66' ' ' PHE . . . . . 0.572 ' CZ ' ' HG ' ' A' ' 55' ' ' LEU . 11.8 m-85 -79.5 118.71 21.61 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 170.016 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.584 HG21 HD13 ' A' ' 28' ' ' LEU . 25.4 t -127.59 103.94 11.37 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-O 121.138 0.494 . . . . 0.0 110.707 -175.279 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 68' ' ' SER . . . . . 0.486 ' HA ' ' O ' ' A' ' 36' ' ' ASP . 16.1 m -88.56 129.21 35.53 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-N 115.536 -0.757 . . . . 0.0 110.039 178.613 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.489 ' CD2' ' HB2' ' A' ' 92' ' ' LEU . 54.4 mt -114.33 132.21 56.27 Favored 'General case' 0 N--CA 1.465 0.303 0 O-C-N 122.147 -0.346 . . . . 0.0 110.287 174.988 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 1.4 t -112.34 120.33 41.35 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.17 0.51 . . . . 0.0 112.327 -174.586 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 4.7 p -88.76 18.49 4.69 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.842 177.014 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.531 ' OD2' HG22 ' A' ' 40' ' ' THR . 2.1 m-20 -72.34 136.55 46.2 Favored 'General case' 0 CA--C 1.519 -0.25 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.231 -179.497 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 51.4 tptt -79.16 -37.97 37.11 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 121.228 0.537 . . . . 0.0 110.045 177.936 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' ASN . . . . . 0.547 ' HB2' ' HB3' ' A' ' 77' ' ' ALA . 0.6 OUTLIER -79.42 82.96 5.49 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.759 -179.846 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.498 ' HB2' ' CE1' ' A' ' 93' ' ' HIS . 10.0 tttt -64.38 -51.9 60.96 Favored 'General case' 0 C--N 1.323 -0.545 0 C-N-CA 120.968 -0.293 . . . . 0.0 111.396 -177.129 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.489 ' HD3' ' C ' ' A' ' 76' ' ' LYS . 3.1 tmtm? -58.98 -51.27 70.79 Favored 'General case' 0 N--CA 1.444 -0.757 0 CA-C-N 116.103 -0.499 . . . . 0.0 109.715 -174.922 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.694 ' HA ' ' ND2' ' A' ' 80' ' ' ASN . . . -56.36 -38.48 71.46 Favored 'General case' 0 C--O 1.243 0.72 0 CA-C-O 121.959 0.885 . . . . 0.0 110.926 178.455 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 78' ' ' TRP . . . . . 0.764 ' CE3' ' HB ' ' A' ' 40' ' ' THR . 11.7 t-105 -75.83 -43.86 43.84 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 114.963 -1.017 . . . . 0.0 111.757 -174.169 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.55 ' HB2' HG13 ' A' ' 18' ' ' ILE . 4.0 pt-20 -60.49 -27.92 67.96 Favored 'General case' 0 CA--C 1.542 0.647 0 CA-C-O 121.047 0.451 . . . . 0.0 109.914 179.422 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 80' ' ' ASN . . . . . 0.694 ' ND2' ' HA ' ' A' ' 77' ' ' ALA . 8.9 m-20 -63.12 -52.98 60.42 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-O 120.795 0.331 . . . . 0.0 110.145 171.862 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 81' ' ' MET . . . . . 0.411 ' HG2' ' HZ3' ' A' ' 78' ' ' TRP . 54.8 tpp -56.45 -47.84 78.28 Favored 'General case' 0 CA--C 1.518 -0.288 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.991 -175.83 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.572 HG23 ' HB2' ' A' ' 87' ' ' LEU . 1.6 p -61.16 -34.1 58.98 Favored 'Isoleucine or valine' 0 C--O 1.237 0.401 0 CA-C-O 120.939 0.4 . . . . 0.0 110.847 178.737 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 90.5 m -64.63 -42.53 95.41 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.82 0.343 . . . . 0.0 110.467 174.896 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 84' ' ' LYS . . . . . 0.761 ' HB3' ' HZ2' ' A' ' 84' ' ' LYS . 0.0 OUTLIER -76.79 -37.95 54.88 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.008 -176.535 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 55.8 m-20 -83.02 -0.1 47.31 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.49 -177.95 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 79.5 mt-30 66.08 11.56 7.87 Favored 'General case' 0 N--CA 1.467 0.391 0 N-CA-C 113.69 0.996 . . . . 0.0 113.69 170.724 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.572 ' HB2' HG23 ' A' ' 82' ' ' VAL . 84.9 mt -64.63 126.32 27.51 Favored 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 110.323 -0.251 . . . . 0.0 110.323 178.582 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 21.6 mmtm -123.33 -161.98 1.01 Allowed 'General case' 0 N--CA 1.45 -0.427 0 CA-C-O 120.768 0.318 . . . . 0.0 111.799 -179.217 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 96.13 -156.58 21.34 Favored Glycine 0 N--CA 1.448 -0.535 0 N-CA-C 111.416 -0.674 . . . . 0.0 111.416 -177.579 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.526 ' O ' ' HA ' ' A' ' 67' ' ' VAL . 45.8 mm -93.29 116.46 34.49 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 174.529 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 91' ' ' GLN . . . . . 0.625 ' HB2' ' CZ2' ' A' ' 38' ' ' TRP . 1.9 pt20 -141.64 95.17 2.78 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-O 121.813 0.816 . . . . 0.0 111.83 -168.854 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.489 ' HB2' ' CD2' ' A' ' 69' ' ' LEU . 37.9 mt -94.43 157.11 16.16 Favored 'General case' 0 N--CA 1.442 -0.844 0 CA-C-N 114.779 -1.101 . . . . 0.0 110.421 -176.647 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 93' ' ' HIS . . . . . 0.498 ' CE1' ' HB2' ' A' ' 75' ' ' LYS . 21.9 t-80 -123.98 127.17 47.53 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-N 115.498 -0.774 . . . . 0.0 110.248 -177.684 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 94' ' ' MET . . . . . 0.649 ' HG3' ' HB2' ' A' ' 97' ' ' ASP . 30.2 ttm -81.58 -65.93 0.95 Allowed 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 114.96 -1.018 . . . . 0.0 110.764 -177.289 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 106.53 -94.18 0.92 Allowed Glycine 0 N--CA 1.446 -0.688 0 C-N-CA 120.492 -0.861 . . . . 0.0 112.664 179.772 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -117.75 0.42 11.99 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 120.81 0.338 . . . . 0.0 111.399 -176.279 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 97' ' ' ASP . . . . . 0.649 ' HB2' ' HG3' ' A' ' 94' ' ' MET . 3.9 m-20 -83.89 41.55 0.81 Allowed 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.008 0.433 . . . . 0.0 110.658 -174.294 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.9 -6.74 9.04 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.789 -0.641 . . . . 0.0 112.399 -172.264 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 16.7 m -70.24 -19.27 63.15 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.347 0.594 . . . . 0.0 110.17 176.625 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 52.8 t80 -74.21 -37.94 63.72 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.839 -0.618 . . . . 0.0 109.463 175.069 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 101' ' ' MET . . . . . 0.408 ' HE1' HG21 ' A' ' 106' ' ' ILE . 71.4 mmm -63.37 -42.74 98.88 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 173.353 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -58.7 -47.5 84.33 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 114.422 -1.263 . . . . 0.0 110.701 178.711 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -67.85 -12.76 61.29 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.721 -177.503 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 7.7 m-85 -105.64 6.82 32.36 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.021 179.918 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 3.7 mm? 62.57 25.39 15.11 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.812 -179.097 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 106' ' ' ILE . . . . . 0.735 HG12 ' HG3' ' A' ' 111' ' ' ARG . 58.9 mt -83.61 86.3 2.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.004 174.267 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 13.9 m120 -84.76 -51.41 6.81 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.045 177.274 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -107.73 130.67 10.23 Favored Glycine 0 N--CA 1.441 -1.019 0 CA-C-N 115.448 -0.796 . . . . 0.0 111.676 -179.933 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.428 ' CG2' HG11 ' A' ' 37' ' ' VAL . 2.9 pp -98.98 154.95 37.09 Favored Pre-proline 0 C--N 1.319 -0.751 0 N-CA-C 110.43 -0.211 . . . . 0.0 110.43 177.988 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 110' ' ' PRO . . . . . 0.624 ' HG3' ' SG ' ' A' ' 45' ' ' CYS . 71.8 Cg_endo -82.89 149.5 67.82 Favored 'Cis proline' 0 N--CA 1.46 -0.449 0 C-N-CA 123.523 -1.449 . . . . 0.0 113.036 0.199 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 111' ' ' ARG . . . . . 0.735 ' HG3' HG12 ' A' ' 106' ' ' ILE . 0.0 OUTLIER -103.99 153.17 21.15 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.902 -0.59 . . . . 0.0 109.658 177.657 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 11.9 m-85 -119.72 127.69 53.09 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 108.89 -0.782 . . . . 0.0 108.89 -178.231 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.428 ' HB ' ' HB ' ' A' ' 35' ' ' ILE . 89.6 mt -138.26 144.8 29.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-O 120.685 0.279 . . . . 0.0 110.764 -175.769 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 28.5 tp -128.58 139.78 52.12 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 109.879 -0.415 . . . . 0.0 109.879 178.494 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.691 ' HG ' ' HA ' ' A' ' 121' ' ' ILE . 2.1 mp -133.75 158.83 42.33 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 109.947 -0.39 . . . . 0.0 109.947 -177.796 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 116' ' ' ASP . . . . . 0.54 ' OD2' ' HB2' ' A' ' 120' ' ' LYS . 3.9 p30 -86.12 175.31 8.6 Favored 'General case' 0 CA--C 1.516 -0.349 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.023 177.73 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 117' ' ' ARG . . . . . 0.603 ' HA ' ' O ' ' A' ' 31' ' ' LYS . 21.9 mtp85 -58.17 -26.98 63.42 Favored 'General case' 0 N--CA 1.465 0.298 0 O-C-N 124.36 1.038 . . . . 0.0 112.384 -173.124 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -76.29 -6.91 53.56 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.529 0.68 . . . . 0.0 109.356 -179.239 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 119' ' ' GLY . . . . . 0.555 ' HA2' HD13 ' A' ' 33' ' ' ILE . . . 89.47 23.48 33.85 Favored Glycine 0 N--CA 1.434 -1.463 0 N-CA-C 110.319 -1.113 . . . . 0.0 110.319 -174.857 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 120' ' ' LYS . . . . . 0.54 ' HB2' ' OD2' ' A' ' 116' ' ' ASP . 10.1 mmmm -102.96 118.38 36.7 Favored 'General case' 0 C--O 1.223 -0.295 0 C-N-CA 119.792 -0.763 . . . . 0.0 112.045 -172.96 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 121' ' ' ILE . . . . . 0.691 ' HA ' ' HG ' ' A' ' 115' ' ' LEU . 3.6 mp -46.79 114.69 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.55 -0.75 . . . . 0.0 111.681 178.618 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 122' ' ' ILE . . . . . 0.406 HD11 ' HB3' ' A' ' 116' ' ' ASP . 40.0 mm -92.68 -44.4 13.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 115.229 -0.896 . . . . 0.0 109.659 176.519 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 20.8 m -127.63 114.79 17.83 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.386 -0.824 . . . . 0.0 110.024 177.774 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -72.31 -17.72 61.84 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.074 0.464 . . . . 0.0 110.774 178.971 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 7.2 t30 -142.3 98.84 3.39 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.62 -0.718 . . . . 0.0 109.828 175.969 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 126' ' ' MET . . . . . 0.47 ' HG3' ' H ' ' A' ' 127' ' ' THR . 7.7 tpt -92.73 -150.49 0.27 Allowed 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 178.135 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 127' ' ' THR . . . . . 0.626 ' OG1' ' HB ' ' A' ' 134' ' ' THR . 1.3 p -133.37 131.47 40.09 Favored 'General case' 0 N--CA 1.446 -0.642 0 CA-C-O 121.593 0.711 . . . . 0.0 112.356 -175.053 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 128' ' ' ARG . . . . . 0.482 ' HE ' ' CD ' ' A' ' 48' ' ' GLU . 34.4 ttt85 -31.89 139.2 0.2 Allowed Pre-proline 0 N--CA 1.471 0.588 0 CA-C-N 113.753 -1.567 . . . . 0.0 113.316 170.169 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_exo -40.54 -39.96 3.09 Favored 'Trans proline' 0 C--N 1.352 0.727 0 C-N-CA 124.682 3.588 . . . . 0.0 115.338 179.028 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -72.36 -7.0 47.27 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 112.22 0.452 . . . . 0.0 112.22 -175.589 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 131' ' ' ASP . . . . . 0.554 ' O ' HG22 ' A' ' 134' ' ' THR . 4.5 t70 -85.18 130.09 53.28 Favored Pre-proline 0 C--N 1.324 -0.542 0 CA-C-O 120.829 0.347 . . . . 0.0 110.887 178.468 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -68.6 -22.77 37.56 Favored 'Trans proline' 0 C--N 1.343 0.239 0 C-N-CA 122.648 2.232 . . . . 0.0 113.111 -179.907 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 133' ' ' LYS . . . . . 0.622 ' HA ' ' HG2' ' A' ' 136' ' ' GLU . 0.8 OUTLIER -73.76 -35.38 64.99 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.114 0.483 . . . . 0.0 110.7 -175.87 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 134' ' ' THR . . . . . 0.626 ' HB ' ' OG1' ' A' ' 127' ' ' THR . 4.2 t -71.2 -40.25 71.3 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 176.048 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 135' ' ' ALA . . . . . 0.514 ' HA ' ' CD2' ' A' ' 138' ' ' PHE . . . -62.48 -49.12 76.63 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 115.78 -0.645 . . . . 0.0 111.462 179.162 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 136' ' ' GLU . . . . . 0.622 ' HG2' ' HA ' ' A' ' 133' ' ' LYS . 5.2 pt-20 -58.91 -38.22 78.43 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 121.215 0.531 . . . . 0.0 109.818 179.56 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 137' ' ' LYS . . . . . 0.558 ' O ' ' HG ' ' A' ' 141' ' ' LEU . 0.0 OUTLIER -65.4 -41.52 93.55 Favored 'General case' 0 N--CA 1.448 -0.547 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.014 -177.913 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 138' ' ' PHE . . . . . 0.514 ' CD2' ' HA ' ' A' ' 135' ' ' ALA . 15.3 m-85 -54.5 -52.48 61.81 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-O 121.012 0.434 . . . . 0.0 109.996 176.524 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 66.2 m-20 -59.37 -50.42 74.02 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.01 179.32 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -52.04 -56.25 15.55 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.242 -0.89 . . . . 0.0 112.768 179.547 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.558 ' HG ' ' O ' ' A' ' 137' ' ' LYS . 4.1 pp -68.87 -21.8 64.24 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 120.816 0.341 . . . . 0.0 111.336 -175.962 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 0.407 ' N ' HD12 ' A' ' 141' ' ' LEU . 0.2 OUTLIER . . . . . 0 C--N 1.326 -0.427 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 175.22 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.234 0.257 0 CA-C-O 121.284 0.564 . . . . 0.0 109.672 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -154.47 -34.7 0.1 Allowed 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.49 -0.777 . . . . 0.0 111.193 -178.836 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 22.8 t -169.54 153.42 5.11 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 178.521 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' PHE . . . . . 0.427 ' CD2' ' HZ ' ' A' ' 100' ' ' PHE . 52.3 p90 -154.98 152.82 30.14 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-O 120.81 0.338 . . . . 0.0 110.938 179.405 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 19.3 m -143.75 106.56 4.47 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 169.701 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' TYR . . . . . 0.776 ' HB2' HD12 ' A' ' 92' ' ' LEU . 24.8 m-85 -128.35 154.7 79.13 Favored Pre-proline 0 C--N 1.325 -0.483 0 CA-C-N 116.762 -0.199 . . . . 0.0 110.963 -174.716 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -81.89 125.43 4.79 Favored 'Trans proline' 0 CA--C 1.532 0.386 0 C-N-CA 122.6 2.2 . . . . 0.0 113.87 -178.479 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' ASP . . . . . 0.671 ' HB3' ' HB3' ' A' ' 21' ' ' LYS . 0.4 OUTLIER -69.53 163.62 25.01 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.009 -0.996 . . . . 0.0 109.918 171.212 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.65 HD12 HG13 ' A' ' 82' ' ' VAL . 0.9 OUTLIER -43.85 -44.99 1.94 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.662 0 O-C-N 123.858 0.724 . . . . 0.0 112.252 -177.883 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 19' ' ' ASN . . . . . 0.486 ' ND2' HG23 ' A' ' 18' ' ' ILE . 29.2 m-80 -77.24 3.81 12.0 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.495 -174.792 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 83.62 32.57 24.31 Favored Glycine 0 N--CA 1.446 -0.683 0 N-CA-C 110.662 -0.975 . . . . 0.0 110.662 -174.289 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.671 ' HB3' ' HB3' ' A' ' 17' ' ' ASP . 8.0 ttpm? -104.94 105.97 16.25 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.758 0.313 . . . . 0.0 110.796 -174.549 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 19.3 m -67.68 117.33 9.46 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.147 -179.935 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.452 HG11 HD22 ' A' ' 92' ' ' LEU . 7.1 p -117.77 143.49 28.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 115.939 -0.573 . . . . 0.0 109.475 177.396 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 60.4 p -122.48 -173.19 2.63 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.02 0.438 . . . . 0.0 110.579 -175.621 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 64.8 tp -85.91 -19.89 29.83 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.775 177.973 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.901 ' HA ' ' HD3' ' A' ' 29' ' ' LYS . . . -78.46 -35.23 46.97 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.568 -0.287 . . . . 0.0 111.423 -172.593 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -78.24 -11.79 59.95 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.36 0.6 . . . . 0.0 110.543 179.783 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.528 HD13 HG21 ' A' ' 67' ' ' VAL . 92.8 mt -92.78 -9.18 41.46 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.632 177.324 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.901 ' HD3' ' HA ' ' A' ' 26' ' ' ALA . 13.4 mtpp -75.98 153.59 36.44 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.266 0.555 . . . . 0.0 111.537 -179.07 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 101.7 -3.12 52.96 Favored Glycine 0 N--CA 1.45 -0.385 0 CA-C-N 115.357 -0.838 . . . . 0.0 111.747 -178.227 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.617 ' HB3' ' NE2' ' A' ' 65' ' ' HIS . 24.2 ttmm -157.97 145.89 18.62 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 -179.108 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.44 ' HB2' ' O ' ' A' ' 63' ' ' ASP . 34.6 m-85 -53.63 149.37 8.28 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-O 120.906 0.384 . . . . 0.0 111.424 -177.861 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.468 HD12 ' HA2' ' A' ' 119' ' ' GLY . 55.1 mt -125.28 138.69 53.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.554 -175.581 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 59.4 t80 -127.45 123.74 36.75 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 174.677 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.602 ' HB ' ' HB ' ' A' ' 113' ' ' ILE . 66.4 mt -109.59 123.13 65.23 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-O 121.074 0.464 . . . . 0.0 111.189 -177.028 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.432 ' HA ' ' O ' ' A' ' 111' ' ' ARG . 4.7 p-10 -116.37 159.32 22.13 Favored 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 173.216 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.553 HG11 HG21 ' A' ' 109' ' ' ILE . 60.7 t -105.22 115.47 47.13 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.839 0 C-N-CA 120.203 -0.599 . . . . 0.0 111.235 176.241 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 38' ' ' TRP . . . . . 0.644 ' HZ3' HG21 ' A' ' 82' ' ' VAL . 0.6 OUTLIER -98.12 132.79 43.36 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 179.358 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.568 ' HA ' ' OD1' ' A' ' 72' ' ' ASP . . . -147.05 152.99 39.47 Favored 'General case' 0 C--O 1.236 0.368 0 N-CA-C 112.268 0.47 . . . . 0.0 112.268 -173.837 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 40' ' ' THR . . . . . 0.557 HG23 ' SD ' ' A' ' 81' ' ' MET . 0.5 OUTLIER -83.68 -48.06 10.56 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.703 0.763 . . . . 0.0 110.182 176.561 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 41' ' ' TRP . . . . . 0.428 ' HE1' ' HA ' ' A' ' 72' ' ' ASP . 17.4 p-90 -81.73 20.08 0.99 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 114.654 -1.157 . . . . 0.0 112.283 -171.309 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 42' ' ' CYS . . . . . 0.687 ' HB3' ' SG ' ' A' ' 45' ' ' CYS . 40.5 t -88.39 -64.03 1.21 Allowed 'General case' 0 C--N 1.322 -0.613 0 C-N-CA 120.541 -0.464 . . . . 0.0 110.38 -179.672 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 108.46 -84.1 0.36 Allowed Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.611 -0.804 . . . . 0.0 112.232 -178.736 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_exo -53.91 -22.6 24.69 Favored 'Trans proline' 0 C--N 1.352 0.736 0 C-N-CA 123.244 2.63 . . . . 0.0 112.946 177.57 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' CYS . . . . . 0.687 ' SG ' ' HB3' ' A' ' 42' ' ' CYS . 26.3 p -52.45 -31.87 36.84 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.26 177.843 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.573 ' HA ' ' HG ' ' A' ' 49' ' ' LEU . 64.9 mtp180 -72.91 -14.39 61.46 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.121 -175.617 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -84.26 -25.56 43.43 Favored Glycine 0 N--CA 1.448 -0.535 0 N-CA-C 111.244 -0.742 . . . . 0.0 111.244 174.484 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -87.12 -20.95 26.34 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.952 -0.388 . . . . 0.0 109.952 -179.186 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.687 ' HB2' ' HD3' ' A' ' 50' ' ' PRO . 79.4 mt -52.74 -50.61 80.09 Favored Pre-proline 0 CA--C 1.534 0.365 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.4 -179.225 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.687 ' HD3' ' HB2' ' A' ' 49' ' ' LEU . 52.8 Cg_exo -57.73 -34.91 98.85 Favored 'Trans proline' 0 C--N 1.355 0.875 0 C-N-CA 121.905 1.737 . . . . 0.0 112.552 173.476 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -75.48 -31.82 60.36 Favored 'General case' 0 N--CA 1.454 -0.236 0 CA-C-O 121.274 0.559 . . . . 0.0 109.889 -176.948 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 6.9 tt -68.0 -40.2 83.09 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.326 -0.852 . . . . 0.0 108.934 177.097 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.862 ' HA ' ' HG2' ' A' ' 56' ' ' GLU . 12.3 mtpp -60.13 -43.99 95.27 Favored 'General case' 0 CA--C 1.517 -0.298 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.857 176.198 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.596 ' O ' ' HB2' ' A' ' 58' ' ' LYS . 23.5 mm-40 -50.2 -47.82 54.53 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.814 173.365 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 6.0 mp -66.27 -51.77 54.14 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 111.873 0.324 . . . . 0.0 111.873 179.074 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.862 ' HG2' ' HA ' ' A' ' 53' ' ' LYS . 10.2 pt-20 -58.11 -46.48 85.49 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 120.571 0.224 . . . . 0.0 111.436 -173.964 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.726 ' HG3' ' HG3' ' A' ' 56' ' ' GLU . 62.4 mt-10 -80.88 -25.53 37.55 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.819 0.342 . . . . 0.0 111.024 -174.173 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 58' ' ' LYS . . . . . 0.596 ' HB2' ' O ' ' A' ' 54' ' ' GLU . 16.2 ttmm -75.84 -34.53 60.09 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.343 0.592 . . . . 0.0 110.25 178.099 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.469 ' HD1' ' HG3' ' A' ' 62' ' ' LYS . 97.9 m-85 -108.63 8.54 27.09 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.488 -176.45 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -60.9 112.08 1.91 Allowed 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 170.467 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 111.27 -8.42 28.81 Favored Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 120.641 -0.79 . . . . 0.0 111.822 -177.763 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.469 ' HG3' ' HD1' ' A' ' 59' ' ' TYR . 45.8 mmtm -84.65 -157.72 0.3 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.465 0.65 . . . . 0.0 109.892 176.371 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 63' ' ' ASP . . . . . 0.522 ' CG ' ' HG3' ' A' ' 31' ' ' LYS . 9.1 t70 -108.46 75.1 0.96 Allowed 'General case' 0 C--N 1.314 -0.955 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.026 176.387 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 17.1 tt -157.4 143.54 9.22 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.64 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.01 178.084 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' HIS . . . . . 0.617 ' NE2' ' HB3' ' A' ' 31' ' ' LYS . 93.1 m-70 -111.14 108.94 18.79 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 171.663 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 73.3 m-85 -77.05 107.75 9.63 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 173.211 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.56 HG13 HD21 ' A' ' 92' ' ' LEU . 98.1 t -120.28 104.68 15.83 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-N 115.211 -0.904 . . . . 0.0 110.843 -173.086 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 68' ' ' SER . . . . . 0.693 ' HB2' ' HG2' ' A' ' 91' ' ' GLN . 11.0 m -91.25 130.97 37.06 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.815 178.152 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.717 HD11 ' HB2' ' A' ' 94' ' ' MET . 62.3 tp -121.66 131.95 54.38 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 110.05 -0.352 . . . . 0.0 110.05 177.537 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 1.7 t -112.89 120.78 42.6 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.318 0.58 . . . . 0.0 112.297 -173.013 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 9.9 m -82.71 9.61 9.27 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.58 -0.736 . . . . 0.0 111.398 175.251 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.697 ' O ' ' HA2' ' A' ' 95' ' ' GLY . 2.2 m-20 -66.02 132.81 49.43 Favored 'General case' 0 CA--C 1.517 -0.307 0 CA-C-O 120.917 0.389 . . . . 0.0 111.766 -174.78 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 21.0 ttpp -76.12 -30.63 58.29 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 121.367 0.603 . . . . 0.0 110.051 175.16 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -84.62 105.32 15.34 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 108.933 -0.766 . . . . 0.0 108.933 -179.949 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 14.3 tttt -78.01 -57.25 3.9 Favored 'General case' 0 C--N 1.319 -0.735 0 C-N-CA 118.834 -1.146 . . . . 0.0 111.055 177.996 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.675 ' HA ' ' OE2' ' A' ' 79' ' ' GLU . 12.5 ttmm -55.56 -50.41 70.13 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 112.535 0.568 . . . . 0.0 112.535 -175.298 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -60.58 -33.2 72.36 Favored 'General case' 0 CA--C 1.522 -0.104 0 CA-C-O 121.545 0.688 . . . . 0.0 110.297 -178.09 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 78' ' ' TRP . . . . . 0.564 ' CZ2' ' CE3' ' A' ' 38' ' ' TRP . 10.9 t-105 -80.47 -43.88 20.14 Favored 'General case' 0 N--CA 1.442 -0.827 0 CA-C-N 115.236 -0.893 . . . . 0.0 110.937 -178.285 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.675 ' OE2' ' HA ' ' A' ' 76' ' ' LYS . 1.3 pt-20 -64.09 -36.51 84.25 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.405 -178.953 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 24.9 p30 -78.11 -27.61 48.43 Favored 'General case' 0 C--N 1.332 -0.189 0 C-N-CA 120.111 -0.636 . . . . 0.0 110.636 178.652 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 81' ' ' MET . . . . . 0.557 ' SD ' HG23 ' A' ' 40' ' ' THR . 19.5 ttt -68.17 -50.06 56.86 Favored 'General case' 0 C--O 1.218 -0.605 0 C-N-CA 121.031 -0.268 . . . . 0.0 111.021 173.946 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.65 HG13 HD12 ' A' ' 18' ' ' ILE . 5.6 p -59.91 -31.99 48.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 C-N-CA 120.306 -0.558 . . . . 0.0 110.598 179.491 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 60.5 m -67.25 -41.47 85.53 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-O 120.952 0.406 . . . . 0.0 110.762 173.734 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 51.2 tptt -70.0 -46.19 65.65 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.912 179.738 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 85' ' ' ASP . . . . . 0.419 ' CG ' HH21 ' A' ' 46' ' ' ARG . 0.9 OUTLIER -73.85 -8.62 56.75 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.184 -0.916 . . . . 0.0 111.045 179.511 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 88.0 mt-30 61.56 32.82 18.61 Favored 'General case' 0 C--O 1.238 0.454 0 N-CA-C 113.328 0.862 . . . . 0.0 113.328 169.388 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.569 ' HB2' HG23 ' A' ' 82' ' ' VAL . 75.9 mt -67.86 152.37 45.68 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.632 0.253 . . . . 0.0 110.582 177.85 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.453 ' HB2' ' OE1' ' A' ' 56' ' ' GLU . 28.9 mmtm -125.03 -162.46 1.1 Allowed 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.998 178.352 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 86.53 -155.29 28.01 Favored Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 120.918 -0.658 . . . . 0.0 111.944 -178.797 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 63.0 mt -109.98 110.94 34.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 176.342 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 91' ' ' GLN . . . . . 0.693 ' HG2' ' HB2' ' A' ' 68' ' ' SER . 95.1 mt-30 -128.53 111.57 13.39 Favored 'General case' 0 N--CA 1.441 -0.883 0 CA-C-O 121.33 0.586 . . . . 0.0 111.131 -175.541 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.776 HD12 ' HB2' ' A' ' 15' ' ' TYR . 0.4 OUTLIER -109.1 146.08 34.63 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.238 -179.0 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 18.9 t-80 -110.27 119.14 38.28 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.783 -175.585 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 94' ' ' MET . . . . . 0.717 ' HB2' HD11 ' A' ' 69' ' ' LEU . 26.2 ttp -83.11 -56.88 3.53 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 114.929 -1.032 . . . . 0.0 110.838 -177.343 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 95' ' ' GLY . . . . . 0.697 ' HA2' ' O ' ' A' ' 72' ' ' ASP . . . 86.78 -90.43 1.67 Allowed Glycine 0 N--CA 1.445 -0.703 0 C-N-CA 120.214 -0.993 . . . . 0.0 113.296 176.126 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 1.7 p -103.56 -20.24 14.09 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 112.33 0.493 . . . . 0.0 112.33 -174.125 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -93.09 54.15 2.09 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-O 121.185 0.517 . . . . 0.0 111.033 -165.627 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 98' ' ' ARG . . . . . 0.696 ' HA ' ' SD ' ' A' ' 94' ' ' MET . 0.0 OUTLIER -81.24 40.26 0.55 Allowed 'General case' 0 CA--C 1.516 -0.363 0 N-CA-C 112.845 0.683 . . . . 0.0 112.845 -172.243 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 7.3 t -60.9 -17.71 52.3 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 169.77 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 100' ' ' PHE . . . . . 0.427 ' HZ ' ' CD2' ' A' ' 13' ' ' PHE . 2.8 m-85 -72.91 -37.14 67.34 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-N 115.218 -0.901 . . . . 0.0 111.377 174.392 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 101' ' ' MET . . . . . 0.93 ' HA ' ' HB ' ' A' ' 106' ' ' ILE . 83.8 mtp -63.67 -48.47 77.06 Favored 'General case' 0 CA--C 1.517 -0.313 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 178.717 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -62.77 -37.87 88.37 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.824 -0.625 . . . . 0.0 111.112 177.053 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -71.68 -47.35 54.76 Favored 'General case' 0 N--CA 1.463 0.197 0 N-CA-C 112.367 0.506 . . . . 0.0 112.367 -175.071 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 104' ' ' TYR . . . . . 0.704 ' HB2' HG12 ' A' ' 106' ' ' ILE . 67.3 m-85 -96.95 0.48 49.0 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 112.069 0.396 . . . . 0.0 112.069 -174.491 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 9.6 mp 64.57 26.34 13.28 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.309 0.576 . . . . 0.0 110.006 -173.104 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 106' ' ' ILE . . . . . 0.93 ' HB ' ' HA ' ' A' ' 101' ' ' MET . 33.8 mm -55.67 108.96 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.155 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.188 172.933 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 48.5 t-20 -139.65 -66.61 0.45 Allowed 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 178.328 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -72.03 100.1 0.91 Allowed Glycine 0 N--CA 1.446 -0.699 0 C-N-CA 120.62 -0.8 . . . . 0.0 111.188 174.366 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.553 HG21 HG11 ' A' ' 37' ' ' VAL . 2.7 pp -106.2 154.22 39.81 Favored Pre-proline 0 C--N 1.323 -0.587 0 C-N-CA 121.544 -0.062 . . . . 0.0 110.986 -178.74 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 110' ' ' PRO . . . . . 0.502 ' C ' ' HA ' ' A' ' 109' ' ' ILE . 22.7 Cg_exo -65.52 138.38 36.19 Favored 'Cis proline' 0 C--N 1.349 0.561 0 C-N-CA 124.224 -1.156 . . . . 0.0 113.392 1.016 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 111' ' ' ARG . . . . . 0.505 ' HD3' ' H ' ' A' ' 112' ' ' PHE . 0.0 OUTLIER -96.1 150.49 20.44 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.842 -0.617 . . . . 0.0 109.56 178.46 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 112' ' ' PHE . . . . . 0.579 ' HB2' ' HB2' ' A' ' 126' ' ' MET . 0.1 OUTLIER -116.35 114.36 24.2 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.279 -0.873 . . . . 0.0 110.583 -174.97 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.658 HD11 HD11 ' A' ' 106' ' ' ILE . 67.6 mt -128.86 144.46 38.04 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.354 0 CA-C-O 120.819 0.343 . . . . 0.0 111.064 -179.187 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 45.6 tp -128.71 134.08 48.35 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.064 -0.516 . . . . 0.0 109.987 176.717 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.48 HD23 HG13 ' A' ' 121' ' ' ILE . 0.4 OUTLIER -135.47 152.69 51.6 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.453 0.644 . . . . 0.0 110.601 -178.959 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 116' ' ' ASP . . . . . 0.827 ' HB3' ' HB2' ' A' ' 120' ' ' LYS . 43.0 t0 -70.61 164.5 24.79 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 114.735 -1.12 . . . . 0.0 110.36 179.707 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 117' ' ' ARG . . . . . 0.42 ' HA ' ' O ' ' A' ' 31' ' ' LYS . 40.0 mtm180 -51.56 -20.99 2.19 Favored 'General case' 0 C--N 1.323 -0.578 0 C-N-CA 124.589 1.155 . . . . 0.0 113.515 -173.98 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 118' ' ' ASP . . . . . 0.511 ' HB3' ' HG3' ' A' ' 120' ' ' LYS . 26.6 t70 -96.91 1.9 51.02 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-O 121.471 0.653 . . . . 0.0 110.262 -175.966 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 119' ' ' GLY . . . . . 0.468 ' HA2' HD12 ' A' ' 33' ' ' ILE . . . 88.17 16.93 58.46 Favored Glycine 0 N--CA 1.44 -1.034 0 N-CA-C 110.504 -1.038 . . . . 0.0 110.504 -171.752 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 120' ' ' LYS . . . . . 0.827 ' HB2' ' HB3' ' A' ' 116' ' ' ASP . 6.2 mtpm? -85.02 102.85 13.53 Favored 'General case' 0 C--O 1.221 -0.419 0 C-N-CA 121.047 -0.261 . . . . 0.0 110.953 -175.955 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 121' ' ' ILE . . . . . 0.684 ' H ' HD12 ' A' ' 121' ' ' ILE . 4.1 mp -45.8 115.94 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 O-C-N 123.728 0.643 . . . . 0.0 111.561 -176.546 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 122' ' ' ILE . . . . . 0.469 ' H ' ' HA ' ' A' ' 115' ' ' LEU . 56.3 mt -89.77 -39.27 12.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 178.404 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 17.1 m -154.4 125.11 7.07 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.369 -0.832 . . . . 0.0 109.77 176.932 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 124' ' ' ALA . . . . . 0.447 ' O ' HG12 ' A' ' 113' ' ' ILE . . . -72.5 -18.74 61.64 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.33 0.586 . . . . 0.0 110.21 177.982 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 16.2 p-10 -142.03 121.69 13.41 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.402 -0.817 . . . . 0.0 110.445 176.668 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 126' ' ' MET . . . . . 0.579 ' HB2' ' HB2' ' A' ' 112' ' ' PHE . 92.3 mmm -95.65 -117.86 0.11 Allowed 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.048 174.197 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 127' ' ' THR . . . . . 0.603 ' HB ' ' CG ' ' A' ' 131' ' ' ASP . 4.0 m -132.36 -50.38 0.93 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.877 0.37 . . . . 0.0 110.768 -179.482 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 128' ' ' ARG . . . . . 0.972 ' HB3' ' HB3' ' A' ' 131' ' ' ASP . 46.9 ttt180 -165.76 151.18 8.05 Favored Pre-proline 0 N--CA 1.444 -0.746 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 -178.674 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 20.5 Cg_exo -64.98 7.78 0.25 Allowed 'Trans proline' 0 CA--C 1.532 0.417 0 C-N-CA 122.141 1.894 . . . . 0.0 112.797 175.589 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 130' ' ' SER . . . . . 0.427 ' H ' ' C ' ' A' ' 128' ' ' ARG . 11.4 p -158.77 21.15 0.21 Allowed 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 111.808 0.299 . . . . 0.0 111.808 -178.895 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 131' ' ' ASP . . . . . 0.972 ' HB3' ' HB3' ' A' ' 128' ' ' ARG . 1.2 p30 -75.97 152.76 84.64 Favored Pre-proline 0 N--CA 1.444 -0.77 0 O-C-N 122.151 -0.343 . . . . 0.0 110.412 179.7 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -65.65 -28.01 52.69 Favored 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.842 2.361 . . . . 0.0 114.042 -175.028 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 133' ' ' LYS . . . . . 0.802 ' HA ' ' HG2' ' A' ' 136' ' ' GLU . 36.0 mttm -79.24 -28.92 42.48 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.019 0.437 . . . . 0.0 111.041 -176.289 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 134' ' ' THR . . . . . 0.701 HG22 ' CZ ' ' A' ' 138' ' ' PHE . 96.9 m -71.89 -38.82 69.92 Favored 'General case' 0 C--N 1.317 -0.838 0 N-CA-C 109.611 -0.514 . . . . 0.0 109.611 171.48 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 135' ' ' ALA . . . . . 0.439 ' HA ' ' CD2' ' A' ' 138' ' ' PHE . . . -61.59 -49.8 75.16 Favored 'General case' 0 C--O 1.236 0.39 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.659 174.742 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 136' ' ' GLU . . . . . 0.802 ' HG2' ' HA ' ' A' ' 133' ' ' LYS . 11.9 pt-20 -63.65 -28.32 69.83 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 120.961 0.41 . . . . 0.0 110.111 179.104 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 137' ' ' LYS . . . . . 0.638 ' O ' ' HG ' ' A' ' 141' ' ' LEU . 0.7 OUTLIER -60.09 -48.27 82.41 Favored 'General case' 0 N--CA 1.446 -0.654 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.406 175.866 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 138' ' ' PHE . . . . . 0.701 ' CZ ' HG22 ' A' ' 134' ' ' THR . 8.6 m-85 -54.46 -47.12 73.31 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.012 177.566 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 85.3 m-20 -56.63 -47.71 79.12 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.262 177.147 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -60.15 -43.01 96.08 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.553 179.103 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.638 ' HG ' ' O ' ' A' ' 137' ' ' LYS . 94.0 mt -57.39 -44.82 84.84 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.409 -178.646 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 10.0 mp . . . . . 0 C--N 1.327 -0.408 0 CA-C-O 120.819 0.342 . . . . 0.0 111.032 -179.667 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.692 ' HA ' ' CE1' ' A' ' 100' ' ' PHE . . . . . . . . 0 N--CA 1.466 0.342 0 CA-C-O 121.042 0.449 . . . . 0.0 111.839 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.621 ' HB1' ' HE3' ' A' ' 120' ' ' LYS . . . -89.77 -6.07 56.33 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.582 -175.142 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 50.1 m -158.12 129.83 6.77 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.557 179.908 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' PHE . . . . . 0.442 ' CE2' HD13 ' A' ' 25' ' ' LEU . 52.4 p90 -157.65 159.46 37.01 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.481 -0.327 . . . . 0.0 110.295 176.451 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 14' ' ' SER . . . . . 0.561 ' HA ' ' HA ' ' A' ' 24' ' ' SER . 19.2 m -142.46 124.97 15.71 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.215 -0.448 . . . . 0.0 109.801 177.785 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 77.7 m-85 -139.25 154.18 71.8 Favored Pre-proline 0 C--N 1.326 -0.425 0 CA-C-O 120.516 0.198 . . . . 0.0 110.869 -178.002 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.514 ' HA ' ' O ' ' A' ' 21' ' ' LYS . 6.8 Cg_endo -85.15 127.93 3.53 Favored 'Trans proline' 0 N--CA 1.452 -0.92 0 C-N-CA 122.478 2.118 . . . . 0.0 112.928 179.437 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 17' ' ' ASP . . . . . 0.52 ' HA ' ' O ' ' A' ' 91' ' ' GLN . 11.7 t70 -67.18 154.65 40.74 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 169.409 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.497 HD12 ' CG1' ' A' ' 82' ' ' VAL . 5.9 tt -52.06 -33.3 16.26 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.435 0 O-C-N 123.729 0.643 . . . . 0.0 111.431 -176.338 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 40.3 m-80 -69.09 -9.68 53.88 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.027 -179.627 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 92.93 36.83 5.9 Favored Glycine 0 N--CA 1.446 -0.656 0 CA-C-N 115.802 -0.636 . . . . 0.0 111.802 -179.382 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.514 ' O ' ' HA ' ' A' ' 16' ' ' PRO . 62.3 tttm -107.04 121.79 45.18 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 120.573 -0.451 . . . . 0.0 110.617 -178.306 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 12.9 m -67.35 99.76 0.76 Allowed 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 109.651 -0.5 . . . . 0.0 109.651 173.566 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.431 ' HB ' ' CD2' ' A' ' 92' ' ' LEU . 96.6 t -107.57 115.43 48.77 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-N 115.888 -0.596 . . . . 0.0 109.905 -178.77 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 24' ' ' SER . . . . . 0.561 ' HA ' ' HA ' ' A' ' 14' ' ' SER . 77.9 p -98.75 171.08 8.32 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 115.878 -0.601 . . . . 0.0 109.712 179.411 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.503 HD21 ' O ' ' A' ' 119' ' ' GLY . 27.0 tp -66.99 -22.27 65.92 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.087 0.47 . . . . 0.0 110.435 177.113 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -79.94 -31.48 40.01 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.092 176.593 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.428 ' OD2' HG13 ' A' ' 23' ' ' VAL . 20.6 t70 -66.69 -21.95 66.09 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 115.511 -0.768 . . . . 0.0 110.005 176.813 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.647 HD13 HG21 ' A' ' 67' ' ' VAL . 96.0 mt -105.96 3.22 28.17 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.456 -0.793 . . . . 0.0 111.779 -179.446 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.47 ' HG2' ' HA ' ' A' ' 118' ' ' ASP . 18.8 mtpt -75.08 162.01 28.91 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 121.377 0.608 . . . . 0.0 112.063 -177.6 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 113.84 -41.82 2.1 Favored Glycine 0 N--CA 1.447 -0.6 0 CA-C-N 115.332 -0.849 . . . . 0.0 111.459 179.809 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.478 ' O ' ' HA ' ' A' ' 117' ' ' ARG . 60.7 mttm -125.79 165.4 18.72 Favored 'General case' 0 N--CA 1.447 -0.623 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 177.48 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -63.68 134.82 56.08 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 177.667 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.462 HD13 ' HA2' ' A' ' 119' ' ' GLY . 5.0 mp -102.49 132.31 48.82 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.914 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 179.289 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 18.6 t80 -113.49 107.61 16.05 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 174.711 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.708 ' HA ' ' O ' ' A' ' 67' ' ' VAL . 62.6 mt -91.56 120.45 40.64 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.746 -176.251 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.495 ' O ' ' HA ' ' A' ' 68' ' ' SER . 3.8 t70 -118.13 125.96 51.28 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 177.176 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.661 HG11 HG21 ' A' ' 109' ' ' ILE . 42.5 t -79.49 112.38 17.46 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.761 0 CA-C-O 121.507 0.67 . . . . 0.0 111.57 -175.572 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 38' ' ' TRP . . . . . 0.579 ' HZ3' ' CG2' ' A' ' 82' ' ' VAL . 0.8 OUTLIER -101.36 134.31 44.64 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.092 -0.958 . . . . 0.0 109.629 178.651 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -146.54 170.46 16.85 Favored 'General case' 0 C--N 1.321 -0.661 0 O-C-N 122.072 -0.393 . . . . 0.0 110.316 -179.592 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' THR . . . . . 0.701 ' HB ' ' CE3' ' A' ' 78' ' ' TRP . 8.8 t -91.05 1.44 57.08 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.508 0.671 . . . . 0.0 110.109 178.369 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 8.4 p-90 -126.6 17.93 7.47 Favored 'General case' 0 N--CA 1.448 -0.568 0 CA-C-N 115.613 -0.721 . . . . 0.0 111.411 -179.237 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 26.4 p -105.83 108.36 19.83 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-O 121.302 0.572 . . . . 0.0 109.973 175.764 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.449 ' N ' ' HD2' ' A' ' 44' ' ' PRO . . . -72.56 -62.83 3.09 Favored Glycine 0 CA--C 1.525 0.71 0 CA-C-N 115.563 -0.744 . . . . 0.0 114.446 -174.502 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.449 ' HD2' ' N ' ' A' ' 43' ' ' GLY . 10.4 Cg_endo -52.1 -32.53 49.64 Favored 'Trans proline' 0 C--N 1.356 0.936 0 C-N-CA 123.523 2.815 . . . . 0.0 113.687 -171.364 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 45' ' ' CYS . . . . . 0.68 ' HB2' ' CG ' ' A' ' 110' ' ' PRO . 37.1 t -57.37 -31.17 65.51 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.657 -177.544 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.5 ' HA ' ' HG ' ' A' ' 49' ' ' LEU . 1.7 mpt_? -63.96 -43.29 96.26 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 112.478 0.548 . . . . 0.0 112.478 -172.501 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -69.17 -8.32 58.48 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.89 -0.671 . . . . 0.0 113.291 -174.82 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' GLU . . . . . 0.474 ' CD ' ' HE ' ' A' ' 128' ' ' ARG . 24.4 mt-10 -119.21 3.62 11.36 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.649 0.261 . . . . 0.0 111.14 -177.719 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.57 ' HB2' ' HD3' ' A' ' 50' ' ' PRO . 87.2 mt -53.97 -46.88 98.45 Favored Pre-proline 0 CA--C 1.534 0.354 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.451 176.584 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.57 ' HD3' ' HB2' ' A' ' 49' ' ' LEU . 75.0 Cg_exo -51.34 -44.22 44.62 Favored 'Trans proline' 0 C--N 1.358 1.07 0 C-N-CA 121.93 1.753 . . . . 0.0 111.994 172.518 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -69.92 -32.42 70.69 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.024 0.44 . . . . 0.0 110.942 -176.329 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 7.6 tt -63.94 -50.44 68.67 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.344 -178.34 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.583 ' O ' ' HG3' ' A' ' 57' ' ' GLU . 24.9 pttm -71.56 -30.14 65.53 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 120.38 -0.528 . . . . 0.0 110.586 -177.398 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -68.28 -37.98 81.24 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-O 121.017 0.437 . . . . 0.0 110.795 177.028 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.469 HD22 ' O ' ' A' ' 129' ' ' PRO . 14.7 tp -63.78 -40.11 95.87 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 177.469 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -64.39 -47.65 78.41 Favored 'General case' 0 N--CA 1.443 -0.785 0 CA-C-N 115.987 -0.551 . . . . 0.0 109.934 177.931 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.583 ' HG3' ' O ' ' A' ' 53' ' ' LYS . 42.1 mt-10 -50.2 -40.1 46.09 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-O 121.199 0.523 . . . . 0.0 110.942 178.533 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 58' ' ' LYS . . . . . 0.806 ' HE3' ' CE2' ' A' ' 59' ' ' TYR . 34.6 ttpt -73.11 -43.03 62.28 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.532 -0.758 . . . . 0.0 112.327 -177.159 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.806 ' CE2' ' HE3' ' A' ' 58' ' ' LYS . 97.6 m-85 -102.66 -2.5 28.18 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 112.561 0.578 . . . . 0.0 112.561 -172.279 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -57.66 122.75 13.53 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.09 0.471 . . . . 0.0 111.61 179.755 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 99.58 -20.71 48.43 Favored Glycine 0 N--CA 1.445 -0.716 0 CA-C-N 115.536 -0.757 . . . . 0.0 113.263 174.036 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.53 ' N ' ' HD2' ' A' ' 62' ' ' LYS . 10.8 mptt -78.69 -97.57 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 117.204 0.502 . . . . 0.0 111.657 -176.25 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 63' ' ' ASP . . . . . 0.413 ' HB3' HD21 ' A' ' 142' ' ' LEU . 12.3 p-10 -119.68 -3.4 10.32 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.537 -0.301 . . . . 0.0 111.73 -173.029 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.473 HG12 ' N ' ' A' ' 65' ' ' HIS . 16.7 tt -144.64 164.65 13.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-O 120.731 0.3 . . . . 0.0 111.086 -170.893 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 65' ' ' HIS . . . . . 0.473 ' N ' HG12 ' A' ' 64' ' ' ILE . 0.1 OUTLIER -156.83 141.36 16.74 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.111 171.497 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 66' ' ' PHE . . . . . 0.4 ' CE2' HD23 ' A' ' 55' ' ' LEU . 74.9 m-85 -94.67 132.27 39.58 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.223 0.535 . . . . 0.0 110.983 -174.257 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.708 ' O ' ' HA ' ' A' ' 35' ' ' ILE . 56.9 t -132.52 118.57 35.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.176 -178.401 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 68' ' ' SER . . . . . 0.495 ' HA ' ' O ' ' A' ' 36' ' ' ASP . 49.7 m -88.38 136.51 32.95 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.542 -179.692 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.551 ' O ' ' HA ' ' A' ' 37' ' ' VAL . 64.2 tp -121.84 128.93 52.19 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 110.304 -0.258 . . . . 0.0 110.304 177.279 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 70' ' ' SER . . . . . 0.457 ' HB2' ' CD1' ' A' ' 38' ' ' TRP . 44.2 t -109.7 114.87 28.83 Favored 'General case' 0 C--O 1.216 -0.684 0 N-CA-C 112.102 0.408 . . . . 0.0 112.102 -172.901 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 3.3 m -84.64 21.49 1.51 Allowed 'General case' 0 C--N 1.312 -1.048 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.805 175.672 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -71.76 143.95 49.4 Favored 'General case' 0 CA--C 1.515 -0.396 0 C-N-CA 120.069 -0.652 . . . . 0.0 109.916 178.372 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.655 ' HB3' ' HZ2' ' A' ' 73' ' ' LYS . 0.0 OUTLIER -96.68 -15.23 21.57 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.179 -177.277 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 74' ' ' ASN . . . . . 0.559 ' HB2' ' HB3' ' A' ' 77' ' ' ALA . 0.0 OUTLIER -104.2 79.84 1.65 Allowed 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 -177.736 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.551 ' HA ' ' CE1' ' A' ' 93' ' ' HIS . 21.1 tttm -51.6 -63.5 1.11 Allowed 'General case' 0 CA--C 1.513 -0.451 0 N-CA-C 112.782 0.66 . . . . 0.0 112.782 -173.544 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 26.3 tptp -46.51 -51.46 15.32 Favored 'General case' 0 C--N 1.323 -0.556 0 O-C-N 123.431 0.457 . . . . 0.0 110.726 -178.359 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.702 ' HA ' ' ND2' ' A' ' 80' ' ' ASN . . . -58.95 -42.81 90.72 Favored 'General case' 0 C--O 1.239 0.551 0 CA-C-O 121.198 0.523 . . . . 0.0 110.826 179.619 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 78' ' ' TRP . . . . . 0.701 ' CE3' ' HB ' ' A' ' 40' ' ' THR . 6.9 t-105 -64.35 -51.98 60.65 Favored 'General case' 0 N--CA 1.435 -1.188 0 CA-C-N 115.51 -0.768 . . . . 0.0 112.489 -179.94 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.466 ' CD ' ' HE2' ' A' ' 75' ' ' LYS . 19.2 mm-40 -48.14 -40.1 22.71 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-O 120.948 0.404 . . . . 0.0 111.39 178.278 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 80' ' ' ASN . . . . . 0.702 ' ND2' ' HA ' ' A' ' 77' ' ' ALA . 3.6 m-20 -60.66 -50.19 74.52 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-O 120.846 0.355 . . . . 0.0 110.614 177.146 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 16.2 tpt -63.5 -37.7 88.29 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 112.164 0.431 . . . . 0.0 112.164 -175.183 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.579 ' CG2' ' HZ3' ' A' ' 38' ' ' TRP . 0.6 OUTLIER -68.58 -36.9 76.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 C-N-CA 119.965 -0.694 . . . . 0.0 111.13 179.053 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 12.7 t -78.69 -21.39 48.28 Favored 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 120.127 -0.629 . . . . 0.0 110.512 178.051 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 60.9 tttp -80.94 -53.68 6.24 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-O 120.973 0.416 . . . . 0.0 110.379 177.537 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -77.29 -20.04 55.59 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.143 -177.204 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 77.4 mt-30 65.16 78.42 0.28 Allowed 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 115.147 -0.933 . . . . 0.0 112.244 177.304 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.546 HD13 ' HA ' ' A' ' 82' ' ' VAL . 5.5 mp -104.45 118.42 36.57 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.116 -0.947 . . . . 0.0 108.61 174.101 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 72.9 mmtt -103.04 179.17 4.35 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 112.706 0.632 . . . . 0.0 112.706 -177.323 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 105.84 179.17 23.63 Favored Glycine 0 N--CA 1.45 -0.383 0 CA-C-N 115.096 -0.956 . . . . 0.0 111.172 -175.972 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.465 ' O ' ' HA ' ' A' ' 67' ' ' VAL . 63.4 mt -76.82 116.36 19.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 173.242 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 91' ' ' GLN . . . . . 0.556 ' HB2' ' CZ2' ' A' ' 38' ' ' TRP . 3.0 pt20 -136.81 107.42 6.54 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 121.793 0.806 . . . . 0.0 112.646 -166.075 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.431 ' CD2' ' HB ' ' A' ' 23' ' ' VAL . 21.9 mt -99.15 144.31 28.43 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.012 -0.994 . . . . 0.0 110.117 -178.618 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 93' ' ' HIS . . . . . 0.551 ' CE1' ' HA ' ' A' ' 75' ' ' LYS . 10.3 t-160 -115.83 131.34 56.97 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 121.69 0.757 . . . . 0.0 111.334 178.725 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 94' ' ' MET . . . . . 0.755 ' HG3' ' HB2' ' A' ' 97' ' ' ASP . 34.4 ttp -108.84 90.2 3.22 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 114.059 -1.428 . . . . 0.0 108.491 179.626 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 95' ' ' GLY . . . . . 0.51 ' O ' ' HA ' ' A' ' 73' ' ' LYS . . . -64.25 -65.53 2.96 Favored Glycine 0 C--N 1.318 -0.45 0 CA-C-N 115.319 -0.855 . . . . 0.0 113.513 -173.387 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 7.4 p -121.02 7.19 10.32 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-O 121.438 0.637 . . . . 0.0 110.393 -178.135 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 97' ' ' ASP . . . . . 0.755 ' HB2' ' HG3' ' A' ' 94' ' ' MET . 0.6 OUTLIER -90.56 12.73 17.86 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.32 -0.854 . . . . 0.0 110.663 -170.998 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 98' ' ' ARG . . . . . 0.686 ' HA ' ' SD ' ' A' ' 94' ' ' MET . 0.0 OUTLIER -72.19 14.03 0.26 Allowed 'General case' 0 C--O 1.222 -0.356 0 N-CA-C 113.068 0.766 . . . . 0.0 113.068 -170.704 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 9.8 t -70.52 -21.98 62.68 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 169.234 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 100' ' ' PHE . . . . . 0.692 ' CE1' ' HA ' ' A' ' 10' ' ' ALA . 88.9 t80 -79.31 -24.42 42.85 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.52 -0.764 . . . . 0.0 109.653 174.255 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 101' ' ' MET . . . . . 0.653 ' HB3' ' O ' ' A' ' 98' ' ' ARG . 14.8 tpt -59.69 -38.14 80.76 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.321 -0.854 . . . . 0.0 110.177 175.102 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 78.6 m-20 -65.21 -21.43 66.75 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.6 -0.727 . . . . 0.0 111.401 179.207 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -66.29 -14.52 62.13 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-O 120.592 0.234 . . . . 0.0 111.502 178.465 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 65.5 m-85 -95.69 -13.27 24.38 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 110.195 -0.298 . . . . 0.0 110.195 176.427 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 98.3 mt 71.17 -24.36 0.17 Allowed 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 123.791 0.836 . . . . 0.0 112.864 176.811 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 106' ' ' ILE . . . . . 0.428 HG21 HH11 ' A' ' 111' ' ' ARG . 14.4 mt -98.1 93.72 3.43 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-O 120.875 0.369 . . . . 0.0 110.721 -175.871 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 107' ' ' ASN . . . . . 0.497 ' HA ' ' HE3' ' A' ' 101' ' ' MET . 67.0 t30 -82.62 -1.33 50.65 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.857 -178.282 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -81.46 98.46 1.89 Allowed Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.802 -0.713 . . . . 0.0 111.742 177.813 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.661 HG21 HG11 ' A' ' 37' ' ' VAL . 44.8 pt -104.56 161.11 23.83 Favored Pre-proline 0 C--N 1.325 -0.475 0 CA-C-N 116.473 0.137 . . . . 0.0 111.062 -177.156 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 110' ' ' PRO . . . . . 0.68 ' CG ' ' HB2' ' A' ' 45' ' ' CYS . 23.4 Cg_exo -64.26 134.44 18.44 Favored 'Cis proline' 0 C--N 1.35 0.657 0 C-N-CA 123.928 -1.28 . . . . 0.0 113.178 0.89 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 111' ' ' ARG . . . . . 0.951 ' HE ' ' HA ' ' A' ' 111' ' ' ARG . 0.0 OUTLIER -102.28 141.78 34.57 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-N 116.246 -0.434 . . . . 0.0 109.964 174.263 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 112' ' ' PHE . . . . . 0.42 ' CE1' ' HD3' ' A' ' 128' ' ' ARG . 0.6 OUTLIER -113.93 113.74 25.25 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.301 -0.863 . . . . 0.0 108.739 -174.949 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.478 ' HB ' ' HB ' ' A' ' 35' ' ' ILE . 81.0 mt -123.97 138.16 54.58 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-O 121.249 0.547 . . . . 0.0 111.488 -173.024 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.471 ' HG ' HD12 ' A' ' 122' ' ' ILE . 58.8 tp -112.96 134.31 54.53 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 115.415 -0.811 . . . . 0.0 109.062 175.916 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.462 ' N ' HD12 ' A' ' 115' ' ' LEU . 2.3 mp -131.58 147.04 52.49 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 -179.831 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 23.6 t0 -65.75 164.8 13.91 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.119 176.409 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 117' ' ' ARG . . . . . 0.478 ' HA ' ' O ' ' A' ' 31' ' ' LYS . 0.6 OUTLIER -53.84 -21.71 8.18 Favored 'General case' 0 N--CA 1.471 0.586 0 O-C-N 124.2 0.937 . . . . 0.0 112.376 -176.15 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 118' ' ' ASP . . . . . 0.509 ' HB3' ' HG2' ' A' ' 120' ' ' LYS . 6.0 t70 -88.46 6.21 38.75 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.557 0.694 . . . . 0.0 110.075 -178.974 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 119' ' ' GLY . . . . . 0.503 ' O ' HD21 ' A' ' 25' ' ' LEU . . . 75.82 24.78 68.76 Favored Glycine 0 N--CA 1.437 -1.26 0 N-CA-C 110.833 -0.907 . . . . 0.0 110.833 -173.859 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 120' ' ' LYS . . . . . 0.621 ' HE3' ' HB1' ' A' ' 11' ' ' ALA . 43.6 mmtm -99.76 106.35 18.24 Favored 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 120.317 -0.553 . . . . 0.0 111.351 -175.803 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 121' ' ' ILE . . . . . 0.611 ' H ' HD12 ' A' ' 121' ' ' ILE . 3.0 mp -39.84 115.78 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 114.852 -1.067 . . . . 0.0 112.419 -177.648 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 122' ' ' ILE . . . . . 0.471 HD12 ' HG ' ' A' ' 114' ' ' LEU . 57.4 mt -86.88 -41.14 14.58 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 114.957 -1.02 . . . . 0.0 108.797 173.978 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 19.8 m -153.53 121.55 6.09 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.444 179.019 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -79.19 -17.03 55.66 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-O 121.488 0.661 . . . . 0.0 110.497 177.407 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 45.6 t30 -128.26 98.83 5.21 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 108.477 -0.935 . . . . 0.0 108.477 174.457 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 17.1 tpt -100.77 -97.43 0.26 Allowed 'General case' 0 C--N 1.322 -0.616 0 C-N-CA 120.696 -0.402 . . . . 0.0 111.409 -174.999 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 127' ' ' THR . . . . . 0.568 ' O ' ' HB2' ' A' ' 128' ' ' ARG . 3.4 p -152.01 -73.81 0.14 Allowed 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 111.534 0.198 . . . . 0.0 111.534 -173.42 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 128' ' ' ARG . . . . . 0.626 ' HD2' ' HD2' ' A' ' 129' ' ' PRO . 20.2 tpt180 157.0 136.27 0.0 OUTLIER Pre-proline 0 N--CA 1.456 -0.151 0 C-N-CA 124.196 0.999 . . . . 0.0 108.514 -172.424 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 129' ' ' PRO . . . . . 0.626 ' HD2' ' HD2' ' A' ' 128' ' ' ARG . 84.2 Cg_exo -49.45 -44.13 35.91 Favored 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 122.285 1.99 . . . . 0.0 112.6 172.166 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 130' ' ' SER . . . . . 0.455 ' H ' ' HG3' ' A' ' 128' ' ' ARG . 0.0 OUTLIER -78.6 3.03 17.34 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 112.263 0.468 . . . . 0.0 112.263 -177.54 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 131' ' ' ASP . . . . . 0.429 ' HB2' ' HB3' ' A' ' 128' ' ' ARG . 10.5 t70 -89.23 123.76 66.34 Favored Pre-proline 0 C--O 1.236 0.363 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 177.291 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -55.43 -37.06 95.14 Favored 'Trans proline' 0 C--N 1.342 0.236 0 C-N-CA 123.345 2.696 . . . . 0.0 113.653 -176.069 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 133' ' ' LYS . . . . . 0.528 ' HA ' ' HG2' ' A' ' 136' ' ' GLU . 36.4 mtmm -61.11 -33.21 73.01 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 121.357 0.598 . . . . 0.0 110.964 -175.367 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 134' ' ' THR . . . . . 0.591 HG22 ' CZ ' ' A' ' 138' ' ' PHE . 0.2 OUTLIER -67.13 -53.05 34.26 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.885 176.843 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 135' ' ' ALA . . . . . 0.493 ' HA ' ' CD2' ' A' ' 138' ' ' PHE . . . -60.64 -47.3 86.84 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.41 -0.814 . . . . 0.0 111.555 -178.999 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 136' ' ' GLU . . . . . 0.528 ' HG2' ' HA ' ' A' ' 133' ' ' LYS . 12.9 pt-20 -63.29 -30.39 71.54 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.395 -178.205 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 137' ' ' LYS . . . . . 1.083 ' HA ' ' HE3' ' A' ' 137' ' ' LYS . 0.4 OUTLIER -65.43 -44.64 86.71 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-N 116.573 -0.285 . . . . 0.0 110.405 177.709 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 138' ' ' PHE . . . . . 0.591 ' CZ ' HG22 ' A' ' 134' ' ' THR . 7.2 m-85 -60.51 -57.58 12.14 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-O 121.056 0.455 . . . . 0.0 110.694 -179.708 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 27.9 p30 -67.68 -18.28 64.88 Favored 'General case' 0 C--O 1.222 -0.354 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.811 -175.514 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 24.6 tt0 -66.35 -50.36 63.81 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 172.595 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.475 ' HG ' ' O ' ' A' ' 137' ' ' LYS . 60.8 mt -61.17 -33.55 73.61 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.659 -179.783 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 0.413 HD21 ' HB3' ' A' ' 63' ' ' ASP . 94.6 mt . . . . . 0 C--N 1.328 -0.365 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.255 178.896 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 0.589 0 CA-C-O 120.696 0.284 . . . . 0.0 111.161 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.405 ' HA ' ' HE3' ' A' ' 120' ' ' LYS . . . -70.55 -29.3 65.72 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.977 0.418 . . . . 0.0 110.683 176.926 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 26.6 t -164.75 83.56 0.4 Allowed 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.244 -0.889 . . . . 0.0 109.906 176.396 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 41.1 p90 -101.43 164.46 11.76 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.416 179.985 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' SER . . . . . 0.541 ' HA ' ' HA ' ' A' ' 24' ' ' SER . 20.2 m -142.24 126.03 17.05 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 109.905 -0.406 . . . . 0.0 109.905 178.258 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 15' ' ' TYR . . . . . 0.412 ' HA ' ' HD3' ' A' ' 16' ' ' PRO . 59.2 m-85 -141.04 144.96 37.03 Favored Pre-proline 0 C--N 1.325 -0.465 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.834 -178.602 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.485 ' HA ' ' O ' ' A' ' 21' ' ' LYS . 4.2 Cg_exo -77.68 125.65 7.64 Favored 'Trans proline' 0 N--CA 1.461 -0.412 0 C-N-CA 122.87 2.38 . . . . 0.0 113.018 -179.846 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 17' ' ' ASP . . . . . 0.608 ' HA ' ' HA ' ' A' ' 92' ' ' LEU . 11.2 t70 -65.37 158.42 26.63 Favored 'General case' 0 C--O 1.238 0.457 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 172.228 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.479 HG12 HG11 ' A' ' 82' ' ' VAL . 11.0 tp -55.03 -27.38 19.16 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 O-C-N 123.669 0.606 . . . . 0.0 112.248 -170.281 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 9.5 p30 -78.78 -13.27 59.9 Favored 'General case' 0 N--CA 1.456 -0.16 0 CA-C-O 121.2 0.524 . . . . 0.0 110.189 -178.177 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 104.36 31.61 4.57 Favored Glycine 0 N--CA 1.445 -0.732 0 CA-C-N 115.712 -0.676 . . . . 0.0 112.154 -177.29 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.485 ' O ' ' HA ' ' A' ' 16' ' ' PRO . 62.3 tttt -101.9 115.03 29.64 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 120.439 -0.504 . . . . 0.0 110.805 179.354 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 14.7 m -64.83 99.69 0.35 Allowed 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 120.892 0.377 . . . . 0.0 110.157 174.579 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 92.9 t -103.3 119.16 51.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.46 -178.457 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' SER . . . . . 0.541 ' HA ' ' HA ' ' A' ' 14' ' ' SER . 88.2 p -97.45 171.51 8.34 Favored 'General case' 0 C--N 1.316 -0.878 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 177.082 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.464 ' O ' ' HB2' ' A' ' 29' ' ' LYS . 37.8 tp -63.83 -24.66 67.84 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.72 0.295 . . . . 0.0 111.128 179.709 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -75.61 -24.85 56.57 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.533 -0.303 . . . . 0.0 111.013 -179.312 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -66.33 -25.07 66.65 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-O 121.489 0.661 . . . . 0.0 110.326 179.839 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.659 HD11 HG21 ' A' ' 90' ' ' ILE . 85.7 mt -122.75 15.66 10.18 Favored 'General case' 0 N--CA 1.449 -0.52 0 CA-C-N 115.663 -0.699 . . . . 0.0 111.237 -177.145 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.504 ' HE2' ' O ' ' A' ' 118' ' ' ASP . 61.1 tttm -83.82 157.51 22.01 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.572 -175.38 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 114.72 -34.65 4.78 Favored Glycine 0 N--CA 1.449 -0.433 0 C-N-CA 120.756 -0.735 . . . . 0.0 111.73 179.383 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.732 ' HB2' ' NE2' ' A' ' 65' ' ' HIS . 63.6 mttm -120.52 170.03 9.79 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.733 -0.233 . . . . 0.0 110.683 177.67 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 87.3 m-85 -65.81 155.56 35.87 Favored 'General case' 0 C--N 1.329 -0.296 0 O-C-N 123.298 0.374 . . . . 0.0 110.272 178.52 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.583 ' HB ' ' HB2' ' A' ' 115' ' ' LEU . 70.9 mt -129.38 140.68 48.52 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-O 120.87 0.366 . . . . 0.0 111.163 -175.684 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 93.3 t80 -125.56 110.69 14.15 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 174.001 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.605 ' HB ' ' HB ' ' A' ' 113' ' ' ILE . 59.2 mt -98.01 130.03 47.35 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.07 -176.346 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.47 ' O ' ' HA ' ' A' ' 68' ' ' SER . 5.7 p-10 -116.38 150.33 37.92 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.761 -0.654 . . . . 0.0 109.519 174.762 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.424 ' HB ' ' H ' ' A' ' 111' ' ' ARG . 38.2 t -102.65 130.55 52.47 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.801 0 C-N-CA 120.487 -0.485 . . . . 0.0 110.148 174.927 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 38' ' ' TRP . . . . . 0.661 ' CZ2' ' HB2' ' A' ' 91' ' ' GLN . 0.6 OUTLIER -132.66 135.81 46.07 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.771 -0.65 . . . . 0.0 109.623 -173.569 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.463 ' HB3' ' SG ' ' A' ' 42' ' ' CYS . . . -147.06 161.7 40.31 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 122.257 -0.277 . . . . 0.0 111.092 178.664 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 40' ' ' THR . . . . . 0.712 ' HB ' ' CE3' ' A' ' 78' ' ' TRP . 3.0 t -85.52 -4.84 59.28 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.012 0.434 . . . . 0.0 110.925 178.025 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 41' ' ' TRP . . . . . 0.447 ' HE1' ' HA ' ' A' ' 72' ' ' ASP . 10.2 p-90 -115.86 16.51 16.23 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.442 -176.855 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 42' ' ' CYS . . . . . 0.463 ' SG ' ' HB3' ' A' ' 39' ' ' ALA . 19.8 p -120.93 95.46 4.71 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.228 0.537 . . . . 0.0 110.755 178.675 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -63.39 -51.12 57.07 Favored Glycine 0 CA--C 1.527 0.805 0 CA-C-O 119.184 -0.787 . . . . 0.0 113.894 -179.778 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -54.45 -38.7 89.71 Favored 'Trans proline' 0 C--N 1.357 0.999 0 C-N-CA 122.483 2.122 . . . . 0.0 112.632 -179.111 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' CYS . . . . . 0.504 ' SG ' ' HB3' ' A' ' 110' ' ' PRO . 16.8 t -59.01 -40.86 86.25 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.303 0.573 . . . . 0.0 110.634 177.35 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.598 ' HA ' ' CD1' ' A' ' 49' ' ' LEU . 23.2 ttt180 -72.57 -3.74 26.49 Favored 'General case' 0 N--CA 1.447 -0.621 0 CA-C-N 115.309 -0.859 . . . . 0.0 111.409 -175.847 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -66.59 -48.36 63.03 Favored Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 121.055 -0.593 . . . . 0.0 112.693 179.857 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' GLU . . . . . 0.543 ' OE1' ' HB2' ' A' ' 128' ' ' ARG . 11.9 pt-20 -115.29 17.28 16.64 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 112.179 0.437 . . . . 0.0 112.179 -176.441 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.949 HD13 HD21 ' A' ' 87' ' ' LEU . 37.7 mt -52.41 -50.72 78.32 Favored Pre-proline 0 C--N 1.324 -0.54 0 N-CA-C 112.248 0.462 . . . . 0.0 112.248 175.987 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.519 ' HD2' ' N ' ' A' ' 49' ' ' LEU . 10.3 Cg_endo -55.2 -36.08 92.46 Favored 'Trans proline' 0 C--N 1.356 0.96 0 C-N-CA 122.0 1.8 . . . . 0.0 112.305 176.601 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -71.87 -23.29 61.48 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.021 0.439 . . . . 0.0 111.08 -178.707 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 6.7 tt -70.01 -44.09 70.04 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 177.532 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.573 ' HD2' ' N ' ' A' ' 53' ' ' LYS . 3.2 mptp? -68.82 -40.02 79.71 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.396 177.638 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.614 ' O ' ' HG3' ' A' ' 58' ' ' LYS . 0.2 OUTLIER -48.2 -49.37 33.17 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.395 0.617 . . . . 0.0 110.72 168.568 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.601 HD21 ' HE2' ' A' ' 138' ' ' PHE . 21.7 tp -60.11 -40.03 88.27 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.151 176.97 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.6 ' HG2' ' CG ' ' A' ' 66' ' ' PHE . 44.4 mt-10 -57.67 -48.45 79.46 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.527 -0.76 . . . . 0.0 111.332 178.137 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -61.13 -36.84 80.83 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.846 0.355 . . . . 0.0 110.954 -179.703 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' LYS . . . . . 0.614 ' HG3' ' O ' ' A' ' 54' ' ' GLU . 53.1 mttm -62.47 -43.8 97.93 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-O 121.41 0.624 . . . . 0.0 110.535 177.387 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 96.1 m-85 -101.93 16.38 26.14 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.434 -175.126 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -64.7 135.57 56.02 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.118 172.749 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 80.75 9.37 86.44 Favored Glycine 0 N--CA 1.449 -0.487 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.762 178.985 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 37.7 mmtm -94.7 -151.59 0.33 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.345 0.593 . . . . 0.0 110.164 177.764 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' ASP . . . . . 0.728 ' HA ' ' HD3' ' A' ' 31' ' ' LYS . 4.0 t70 -111.82 64.89 0.62 Allowed 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.731 -0.668 . . . . 0.0 109.789 178.517 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 19.9 tt -156.53 156.28 4.68 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.446 0 CA-C-N 115.857 -0.611 . . . . 0.0 110.537 -175.035 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' HIS . . . . . 0.732 ' NE2' ' HB2' ' A' ' 31' ' ' LYS . 81.1 m-70 -134.97 115.05 13.1 Favored 'General case' 0 CA--C 1.515 -0.377 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 175.631 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 66' ' ' PHE . . . . . 0.6 ' CG ' ' HG2' ' A' ' 56' ' ' GLU . 71.0 m-85 -79.67 118.95 21.96 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 172.05 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.587 ' O ' ' HA ' ' A' ' 35' ' ' ILE . 40.5 t -128.94 111.36 22.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.674 -174.256 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 68' ' ' SER . . . . . 0.548 ' HB3' ' CD1' ' A' ' 38' ' ' TRP . 8.2 m -87.81 146.97 25.36 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.145 179.655 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.468 ' HA ' ' O ' ' A' ' 92' ' ' LEU . 7.2 mp -131.45 122.78 26.81 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-O 120.762 0.315 . . . . 0.0 110.338 171.81 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 14.7 t -110.09 114.62 28.28 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.135 0.493 . . . . 0.0 112.106 -175.782 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 64.0 m -79.19 19.09 0.59 Allowed 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.328 175.798 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.447 ' HA ' ' HE1' ' A' ' 41' ' ' TRP . 0.1 OUTLIER -61.58 152.72 29.72 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-O 120.676 0.274 . . . . 0.0 110.79 176.428 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 21.9 pttp -108.06 -21.99 12.58 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.182 -178.351 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 74' ' ' ASN . . . . . 0.433 ' HB2' ' HB3' ' A' ' 77' ' ' ALA . 0.0 OUTLIER -100.88 67.97 1.26 Allowed 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 -179.087 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.547 ' O ' ' HG3' ' A' ' 79' ' ' GLU . 9.7 tttt -48.06 -52.78 18.76 Favored 'General case' 0 C--N 1.331 -0.237 0 O-C-N 123.782 0.676 . . . . 0.0 112.795 -168.606 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.464 ' HA ' ' HD2' ' A' ' 76' ' ' LYS . 35.1 tptt -52.67 -50.03 64.06 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 123.397 0.435 . . . . 0.0 110.646 -179.067 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.433 ' HB3' ' HB2' ' A' ' 74' ' ' ASN . . . -58.15 -37.53 74.84 Favored 'General case' 0 C--O 1.245 0.834 0 CA-C-O 121.492 0.663 . . . . 0.0 110.405 -179.152 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 78' ' ' TRP . . . . . 0.712 ' CE3' ' HB ' ' A' ' 40' ' ' THR . 5.8 t-105 -68.41 -35.94 78.39 Favored 'General case' 0 N--CA 1.438 -1.03 0 CA-C-N 115.051 -0.977 . . . . 0.0 110.306 -178.642 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.547 ' HG3' ' O ' ' A' ' 75' ' ' LYS . 55.9 mt-10 -51.07 -48.85 61.5 Favored 'General case' 0 CA--C 1.52 -0.189 0 CA-C-O 121.328 0.585 . . . . 0.0 110.965 173.435 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 80' ' ' ASN . . . . . 0.542 ' O ' ' HD3' ' A' ' 84' ' ' LYS . 2.9 m120 -64.85 -42.76 94.63 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.544 -175.504 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 81' ' ' MET . . . . . 0.43 ' SD ' ' HZ3' ' A' ' 78' ' ' TRP . 34.8 ttm -66.82 -47.25 72.59 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 119.892 -0.723 . . . . 0.0 111.667 -177.844 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.545 ' CG2' ' HZ3' ' A' ' 38' ' ' TRP . 4.4 p -62.18 -32.39 54.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 C-N-CA 120.49 -0.484 . . . . 0.0 110.93 179.947 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 89.3 m -70.72 -40.72 72.63 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.707 178.406 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 84' ' ' LYS . . . . . 0.542 ' HD3' ' O ' ' A' ' 80' ' ' ASN . 1.3 mptm? -81.78 -32.47 31.36 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.579 -0.282 . . . . 0.0 111.394 -175.866 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 85' ' ' ASP . . . . . 0.515 ' HB3' HD13 ' A' ' 87' ' ' LEU . 1.2 t0 -81.71 -3.77 54.54 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.438 0.637 . . . . 0.0 110.164 -179.718 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 86' ' ' GLN . . . . . 0.49 ' HA ' ' OE1' ' A' ' 86' ' ' GLN . 13.6 mm-40 68.88 16.77 8.81 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 115.017 -0.992 . . . . 0.0 113.444 172.757 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.949 HD21 HD13 ' A' ' 49' ' ' LEU . 10.6 mp -66.58 103.81 1.15 Allowed 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 110.326 -0.25 . . . . 0.0 110.326 173.867 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 43.6 mmtm -108.72 -178.8 3.69 Favored 'General case' 0 C--N 1.323 -0.548 0 O-C-N 122.431 -0.168 . . . . 0.0 110.698 176.168 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 122.2 -153.24 16.82 Favored Glycine 0 N--CA 1.452 -0.278 0 N-CA-C 110.762 -0.935 . . . . 0.0 110.762 -177.069 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.659 HG21 HD11 ' A' ' 28' ' ' LEU . 48.5 mm -104.67 116.03 47.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 N-CA-C 108.369 -0.974 . . . . 0.0 108.369 171.356 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 91' ' ' GLN . . . . . 0.661 ' HB2' ' CZ2' ' A' ' 38' ' ' TRP . 2.2 pt20 -141.41 100.19 3.73 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-O 122.099 0.952 . . . . 0.0 112.57 -165.55 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.608 ' HA ' ' HA ' ' A' ' 17' ' ' ASP . 22.9 mt -89.89 149.29 22.69 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 114.623 -1.171 . . . . 0.0 110.366 -176.93 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 93' ' ' HIS . . . . . 0.414 ' O ' ' HD2' ' A' ' 16' ' ' PRO . 15.0 t-80 -121.11 134.14 55.24 Favored 'General case' 0 C--N 1.31 -1.132 0 CA-C-N 115.585 -0.734 . . . . 0.0 109.402 177.619 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 94' ' ' MET . . . . . 0.566 ' SD ' ' HA ' ' A' ' 98' ' ' ARG . 48.3 ttm -78.98 -83.8 0.09 Allowed 'General case' 0 N--CA 1.435 -1.203 0 CA-C-N 115.302 -0.863 . . . . 0.0 110.349 -175.423 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 125.08 42.11 0.34 Allowed Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.102 -1.047 . . . . 0.0 113.045 178.99 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.411 ' C ' ' H ' ' A' ' 98' ' ' ARG . 3.7 m 78.03 0.35 2.72 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 123.021 0.528 . . . . 0.0 111.378 -179.329 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -79.3 34.75 0.26 Allowed 'General case' 0 N--CA 1.467 0.409 0 CA-C-O 121.405 0.622 . . . . 0.0 109.52 178.577 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 98' ' ' ARG . . . . . 0.566 ' HA ' ' SD ' ' A' ' 94' ' ' MET . 0.1 OUTLIER -76.24 20.24 0.21 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.4 -0.818 . . . . 0.0 112.773 -167.106 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 14.3 m -70.38 -24.3 62.93 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.732 0.777 . . . . 0.0 108.916 169.832 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 17.1 t80 -75.83 -23.95 55.78 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.367 -0.833 . . . . 0.0 109.506 175.354 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 101' ' ' MET . . . . . 0.493 ' HB3' ' O ' ' A' ' 98' ' ' ARG . 16.6 tpt -64.43 -33.77 76.63 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.482 -0.781 . . . . 0.0 109.407 175.035 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 46.1 m-20 -70.55 -22.73 62.57 Favored 'General case' 0 N--CA 1.461 0.104 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.819 177.177 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -71.73 -14.59 62.06 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.892 0.377 . . . . 0.0 111.013 -179.004 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 104' ' ' TYR . . . . . 0.607 ' O ' ' HG ' ' A' ' 105' ' ' LEU . 65.1 m-85 -96.47 -4.06 42.26 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 174.563 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.607 ' HG ' ' O ' ' A' ' 104' ' ' TYR . 2.9 pp 51.52 14.37 0.26 Allowed 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 125.108 1.363 . . . . 0.0 113.605 178.818 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 106' ' ' ILE . . . . . 0.558 ' HB ' ' CG ' ' A' ' 111' ' ' ARG . 17.2 mm -120.1 95.27 3.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 N-CA-C 109.025 -0.732 . . . . 0.0 109.025 172.665 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 107' ' ' ASN . . . . . 0.518 ' ND2' HH22 ' A' ' 98' ' ' ARG . 4.6 m-20 -86.32 20.49 2.37 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.903 -173.067 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -113.76 123.42 6.11 Favored Glycine 0 N--CA 1.447 -0.629 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.06 -179.626 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.432 ' CG2' ' HA ' ' A' ' 110' ' ' PRO . 21.8 mt -87.85 137.45 31.69 Favored Pre-proline 0 C--N 1.325 -0.469 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 176.838 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 110' ' ' PRO . . . . . 0.519 ' HG2' ' CZ ' ' A' ' 112' ' ' PHE . 95.1 Cg_endo -88.96 144.2 19.84 Favored 'Cis proline' 0 N--CA 1.456 -0.681 0 C-N-CA 123.522 -1.449 . . . . 0.0 113.496 1.188 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 111' ' ' ARG . . . . . 0.558 ' CG ' ' HB ' ' A' ' 106' ' ' ILE . 0.0 OUTLIER -100.2 133.25 44.88 Favored 'General case' 0 N--CA 1.444 -0.761 0 N-CA-C 108.879 -0.786 . . . . 0.0 108.879 172.587 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 112' ' ' PHE . . . . . 0.59 ' CZ ' ' HB3' ' A' ' 128' ' ' ARG . 13.1 m-85 -102.44 124.84 48.72 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 108.52 -0.919 . . . . 0.0 108.52 179.616 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.605 ' HB ' ' HB ' ' A' ' 35' ' ' ILE . 74.7 mt -133.46 147.07 31.15 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-O 120.981 0.419 . . . . 0.0 111.135 -175.276 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 37.1 tp -127.76 135.99 50.89 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.923 -0.581 . . . . 0.0 109.725 179.108 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.583 ' HB2' ' HB ' ' A' ' 33' ' ' ILE . 2.8 mp -133.81 154.87 50.7 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 179.264 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 116' ' ' ASP . . . . . 0.42 ' OD2' ' HB2' ' A' ' 120' ' ' LYS . 2.7 p30 -84.92 178.1 7.72 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.664 -179.956 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 117' ' ' ARG . . . . . 0.557 ' HG2' ' HA ' ' A' ' 31' ' ' LYS . 79.7 mtt180 -58.82 -20.48 50.89 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 114.538 -1.21 . . . . 0.0 112.927 -174.434 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 118' ' ' ASP . . . . . 0.504 ' O ' ' HE2' ' A' ' 29' ' ' LYS . 22.4 t70 -85.27 1.77 46.84 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.741 0.781 . . . . 0.0 109.137 179.506 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 77.87 25.08 63.07 Favored Glycine 0 N--CA 1.431 -1.7 0 N-CA-C 110.221 -1.151 . . . . 0.0 110.221 -173.366 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 120' ' ' LYS . . . . . 0.42 ' HB2' ' OD2' ' A' ' 116' ' ' ASP . 46.1 mmtm -108.45 120.8 43.47 Favored 'General case' 0 C--O 1.22 -0.451 0 C-N-CA 119.246 -0.982 . . . . 0.0 112.326 -172.369 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 121' ' ' ILE . . . . . 0.558 ' HA ' ' HG ' ' A' ' 115' ' ' LEU . 33.3 mt -42.62 117.83 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-N 115.079 -0.964 . . . . 0.0 113.159 -179.363 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 122' ' ' ILE . . . . . 0.413 HD11 ' HB3' ' A' ' 116' ' ' ASP . 59.4 mt -93.0 -37.13 8.18 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.828 0 CA-C-N 113.863 -1.517 . . . . 0.0 108.862 174.286 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 11.1 m -146.61 115.58 6.92 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.406 -0.815 . . . . 0.0 110.44 179.346 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -69.41 -30.47 68.44 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.52 0.676 . . . . 0.0 109.429 172.647 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 125' ' ' ASN . . . . . 0.428 ' HA ' ' NH1' ' A' ' 111' ' ' ARG . 11.0 t30 -111.07 95.77 5.74 Favored 'General case' 0 N--CA 1.449 -0.519 0 CA-C-N 115.245 -0.888 . . . . 0.0 109.675 175.985 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 126' ' ' MET . . . . . 0.496 ' HG3' ' H ' ' A' ' 127' ' ' THR . 10.5 tpt -105.98 -175.72 2.87 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 107.742 -1.206 . . . . 0.0 107.742 177.592 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 127' ' ' THR . . . . . 0.496 ' H ' ' HG3' ' A' ' 126' ' ' MET . 4.1 p -115.95 139.07 50.61 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-O 121.441 0.638 . . . . 0.0 112.387 -173.025 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 128' ' ' ARG . . . . . 0.59 ' HB3' ' CZ ' ' A' ' 112' ' ' PHE . 0.0 OUTLIER -41.2 146.84 0.48 Allowed Pre-proline 0 N--CA 1.468 0.452 0 CA-C-N 114.472 -1.24 . . . . 0.0 113.558 171.593 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 26.0 Cg_endo -61.85 -31.35 85.12 Favored 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 123.464 2.776 . . . . 0.0 113.293 -178.593 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 130' ' ' SER . . . . . 0.423 ' HB3' ' CZ ' ' A' ' 128' ' ' ARG . 47.1 t -74.93 -2.38 26.75 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.698 0.285 . . . . 0.0 111.164 -179.125 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 131' ' ' ASP . . . . . 0.481 ' HB2' ' CD ' ' A' ' 128' ' ' ARG . 14.5 t70 -91.59 129.25 43.39 Favored Pre-proline 0 C--N 1.327 -0.377 0 N-CA-C 110.059 -0.349 . . . . 0.0 110.059 176.289 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -67.85 -26.59 38.11 Favored 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 122.774 2.316 . . . . 0.0 113.414 -176.668 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 133' ' ' LYS . . . . . 0.561 ' O ' ' HG3' ' A' ' 137' ' ' LYS . 13.7 mmmm -70.44 -28.92 65.41 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.862 0.363 . . . . 0.0 110.238 -178.48 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 134' ' ' THR . . . . . 0.784 HG22 ' CZ ' ' A' ' 138' ' ' PHE . 2.8 m -59.04 -50.91 72.27 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.662 -0.699 . . . . 0.0 109.899 175.004 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 135' ' ' ALA . . . . . 0.625 ' HA ' ' CD2' ' A' ' 138' ' ' PHE . . . -56.41 -43.78 79.7 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.288 -0.869 . . . . 0.0 111.383 176.567 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 7.6 mt-10 -54.8 -49.16 71.63 Favored 'General case' 0 CA--C 1.516 -0.364 0 CA-C-O 121.316 0.579 . . . . 0.0 110.724 177.793 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 137' ' ' LYS . . . . . 0.561 ' HG3' ' O ' ' A' ' 133' ' ' LYS . 39.3 mtpt -55.63 -41.65 73.84 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.239 -0.892 . . . . 0.0 111.142 -179.705 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 138' ' ' PHE . . . . . 0.784 ' CZ ' HG22 ' A' ' 134' ' ' THR . 13.7 m-85 -61.36 -61.2 2.72 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.728 179.35 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 29.3 p30 -69.43 -18.91 63.78 Favored 'General case' 0 C--O 1.224 -0.285 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.819 -172.711 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -75.39 -51.07 13.98 Favored 'General case' 0 C--N 1.321 -0.64 0 C-N-CA 120.97 -0.292 . . . . 0.0 110.688 175.616 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.41 ' HG ' ' O ' ' A' ' 137' ' ' LYS . 89.3 mt -66.92 -27.11 67.22 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.318 -177.562 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 96.9 mt . . . . . 0 C--N 1.325 -0.485 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.653 177.031 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.564 ' HA ' ' CZ ' ' A' ' 100' ' ' PHE . . . . . . . . 0 N--CA 1.47 0.537 0 CA-C-O 120.812 0.339 . . . . 0.0 111.312 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.429 ' O ' HD23 ' A' ' 25' ' ' LEU . . . -74.89 -11.65 60.18 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.223 178.971 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 12' ' ' SER . . . . . 0.722 ' HA ' ' HB3' ' A' ' 25' ' ' LEU . 18.3 p -159.67 93.36 1.09 Allowed 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.857 174.427 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 38.2 p90 -97.76 159.85 14.68 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.437 174.8 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 13.2 p -134.59 115.18 13.56 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.642 0.258 . . . . 0.0 111.117 -178.908 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 65.3 m-85 -138.88 159.62 66.32 Favored Pre-proline 0 N--CA 1.465 0.288 0 CA-C-N 116.451 -0.34 . . . . 0.0 111.3 -177.487 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 79.4 Cg_endo -84.86 134.15 5.23 Favored 'Trans proline' 0 C--N 1.351 0.676 0 C-N-CA 122.683 2.255 . . . . 0.0 113.406 177.895 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' ASP . . . . . 0.524 ' HB3' ' HB3' ' A' ' 21' ' ' LYS . 7.4 t70 -80.0 160.12 26.0 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 114.826 -1.079 . . . . 0.0 109.428 174.96 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 2.2 tt -46.94 -38.19 4.0 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 O-C-N 124.151 0.907 . . . . 0.0 112.105 -178.392 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 45.0 m-80 -71.82 -13.2 61.62 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.097 0.475 . . . . 0.0 111.056 -178.389 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 95.28 34.43 6.11 Favored Glycine 0 N--CA 1.446 -0.654 0 N-CA-C 110.949 -0.86 . . . . 0.0 110.949 -175.027 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.524 ' HB3' ' HB3' ' A' ' 17' ' ' ASP . 25.7 tptp -106.08 131.05 53.82 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.121 0.486 . . . . 0.0 111.012 -176.241 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 7.6 m -80.76 99.06 8.05 Favored 'General case' 0 C--N 1.314 -0.97 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 179.618 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.756 ' HB ' HD11 ' A' ' 92' ' ' LEU . 25.2 t -109.43 134.52 51.22 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-O 121.321 0.581 . . . . 0.0 109.728 178.848 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 24' ' ' SER . . . . . 0.461 ' H ' ' CB ' ' A' ' 27' ' ' ASP . 13.7 m -122.52 166.47 14.75 Favored 'General case' 0 C--N 1.306 -1.287 0 CA-C-N 115.59 -0.732 . . . . 0.0 109.184 178.334 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.722 ' HB3' ' HA ' ' A' ' 12' ' ' SER . 19.6 tp -66.35 -22.51 66.26 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.083 0.468 . . . . 0.0 110.298 179.472 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.498 ' HA ' ' HB2' ' A' ' 29' ' ' LYS . . . -91.29 0.69 57.48 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.746 175.583 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.461 ' CB ' ' H ' ' A' ' 24' ' ' SER . 35.7 t70 -91.73 -33.44 15.02 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 179.415 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.702 HD11 HG21 ' A' ' 90' ' ' ILE . 76.9 mt -105.37 10.3 33.47 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.635 176.166 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.498 ' HB2' ' HA ' ' A' ' 26' ' ' ALA . 64.0 tttt -65.94 148.13 52.28 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 115.443 -0.799 . . . . 0.0 111.12 -176.825 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 121.04 -23.59 7.68 Favored Glycine 0 N--CA 1.447 -0.622 0 N-CA-C 111.185 -0.766 . . . . 0.0 111.185 -177.092 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.529 ' HD3' ' HA ' ' A' ' 63' ' ' ASP . 43.7 mttm -128.49 166.72 18.23 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 109.527 -0.546 . . . . 0.0 109.527 177.574 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.912 ' HB2' HG22 ' A' ' 64' ' ' ILE . 67.9 m-85 -66.55 144.87 56.18 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.83 0.348 . . . . 0.0 110.54 -179.644 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 47.0 mm -117.13 128.67 74.45 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-N 116.301 -0.408 . . . . 0.0 110.838 -176.31 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 84.6 t80 -110.57 121.54 45.57 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 171.774 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.714 ' HB ' ' HB ' ' A' ' 113' ' ' ILE . 54.5 mt -107.78 128.59 62.91 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-O 120.905 0.383 . . . . 0.0 110.569 -178.995 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.455 ' O ' ' HA ' ' A' ' 68' ' ' SER . 4.5 t70 -132.77 141.62 48.6 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 176.693 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.502 ' HA ' ' O ' ' A' ' 69' ' ' LEU . 39.1 t -89.5 112.82 24.94 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 C-N-CA 120.531 -0.468 . . . . 0.0 111.675 -176.289 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 38' ' ' TRP . . . . . 0.682 ' CZ2' ' HB2' ' A' ' 91' ' ' GLN . 0.7 OUTLIER -102.72 132.91 48.54 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.642 -0.708 . . . . 0.0 109.353 178.905 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -147.71 164.57 33.15 Favored 'General case' 0 N--CA 1.464 0.252 0 N-CA-C 111.689 0.255 . . . . 0.0 111.689 -175.03 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' THR . . . . . 0.597 HG22 ' OD2' ' A' ' 72' ' ' ASP . 4.2 t -99.22 -33.08 10.9 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-O 120.856 0.36 . . . . 0.0 110.794 172.037 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 21.2 p-90 -82.94 21.21 1.07 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.158 0.504 . . . . 0.0 110.531 -178.947 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' CYS . . . . . 0.816 ' SG ' ' HB3' ' A' ' 45' ' ' CYS . 12.7 p -87.51 -69.88 0.66 Allowed 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.35 -176.649 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.439 ' N ' ' SG ' ' A' ' 42' ' ' CYS . . . 110.35 -92.36 0.68 Allowed Glycine 0 N--CA 1.448 -0.565 0 C-N-CA 121.111 -0.566 . . . . 0.0 111.949 -175.511 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.439 ' HD2' ' O ' ' A' ' 42' ' ' CYS . 12.2 Cg_endo -55.97 -29.57 74.11 Favored 'Trans proline' 0 C--N 1.349 0.602 0 C-N-CA 123.464 2.776 . . . . 0.0 112.747 -178.65 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 45' ' ' CYS . . . . . 0.993 ' HB2' ' HD3' ' A' ' 110' ' ' PRO . 43.6 t -54.33 -33.49 59.04 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.729 -0.669 . . . . 0.0 111.445 178.978 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.526 ' HA ' ' HG ' ' A' ' 49' ' ' LEU . 56.8 mtp180 -68.31 -18.0 64.4 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.712 0.291 . . . . 0.0 110.937 -176.396 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -82.02 -22.47 59.28 Favored Glycine 0 N--CA 1.448 -0.512 0 C-N-CA 120.713 -0.756 . . . . 0.0 111.865 177.135 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -104.63 -5.67 21.19 Favored 'General case' 0 C--N 1.329 -0.313 0 O-C-N 122.783 -0.245 . . . . 0.0 111.043 179.488 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.717 HD13 HD11 ' A' ' 87' ' ' LEU . 65.0 mt -53.64 -48.04 94.54 Favored Pre-proline 0 C--O 1.235 0.295 0 CA-C-N 116.677 -0.238 . . . . 0.0 110.975 174.401 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.687 ' O ' ' HG2' ' A' ' 54' ' ' GLU . 54.2 Cg_exo -54.57 -40.91 81.68 Favored 'Trans proline' 0 C--N 1.356 0.949 0 C-N-CA 121.824 1.682 . . . . 0.0 112.029 171.724 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -69.29 -31.56 70.14 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-O 121.26 0.552 . . . . 0.0 110.571 -176.728 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 6.6 tt -67.04 -48.25 68.89 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.364 -0.834 . . . . 0.0 109.916 -179.395 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.566 ' O ' ' HG3' ' A' ' 57' ' ' GLU . 6.2 ptmm? -67.58 -32.45 73.21 Favored 'General case' 0 C--N 1.333 -0.134 0 C-N-CA 121.009 -0.276 . . . . 0.0 110.48 -179.909 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.687 ' HG2' ' O ' ' A' ' 50' ' ' PRO . 51.6 mm-40 -59.51 -47.38 85.76 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.904 0.383 . . . . 0.0 110.394 176.493 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 29.6 mt -61.9 -53.41 56.17 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.683 175.598 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.566 ' HA ' ' CD2' ' A' ' 66' ' ' PHE . 4.5 tm-20 -44.7 -59.87 2.29 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 114.872 -1.058 . . . . 0.0 112.039 179.957 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.566 ' HG3' ' O ' ' A' ' 53' ' ' LYS . 20.1 mt-10 -71.78 -35.6 70.08 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.77 0.319 . . . . 0.0 111.664 -173.082 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 58' ' ' LYS . . . . . 0.402 ' HD3' ' CE2' ' A' ' 59' ' ' TYR . 83.5 tttt -67.09 -39.48 86.78 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.224 0.535 . . . . 0.0 110.771 -178.875 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.475 ' HB3' HD11 ' A' ' 64' ' ' ILE . 96.9 m-85 -105.32 10.27 33.58 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.241 -176.141 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -68.19 157.41 35.47 Favored 'General case' 0 C--O 1.239 0.516 0 CA-C-O 120.795 0.331 . . . . 0.0 110.427 172.215 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 77.9 8.49 87.3 Favored Glycine 0 N--CA 1.447 -0.633 0 C-N-CA 120.98 -0.629 . . . . 0.0 112.583 178.421 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.524 ' HB2' HG12 ' A' ' 64' ' ' ILE . 43.6 mmtm -98.77 -161.17 0.85 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.129 0.49 . . . . 0.0 110.029 177.99 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 63' ' ' ASP . . . . . 0.529 ' HA ' ' HD3' ' A' ' 31' ' ' LYS . 21.5 m-20 -91.16 32.69 1.01 Allowed 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 115.352 -0.84 . . . . 0.0 110.556 179.267 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.912 HG22 ' HB2' ' A' ' 32' ' ' TYR . 31.7 pt -141.67 165.59 18.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.129 -176.955 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 87.1 m-70 -136.44 137.72 40.73 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 175.118 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' PHE . . . . . 0.566 ' CD2' ' HA ' ' A' ' 56' ' ' GLU . 93.4 m-85 -94.69 110.11 21.98 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.624 -0.51 . . . . 0.0 109.624 174.172 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.601 ' O ' ' HA ' ' A' ' 35' ' ' ILE . 57.1 t -116.81 106.17 19.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.713 -175.581 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 68' ' ' SER . . . . . 0.455 ' HA ' ' O ' ' A' ' 36' ' ' ASP . 34.5 m -88.96 133.41 34.33 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.171 177.302 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.502 ' O ' ' HA ' ' A' ' 37' ' ' VAL . 79.2 mt -117.24 135.18 53.99 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.735 0.302 . . . . 0.0 110.42 176.712 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 70' ' ' SER . . . . . 0.436 ' O ' ' HB3' ' A' ' 94' ' ' MET . 1.4 t -113.87 120.73 41.73 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.279 -0.418 . . . . 0.0 111.63 -176.247 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 1.8 p -89.14 16.4 7.27 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.908 177.142 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.597 ' OD2' HG22 ' A' ' 40' ' ' THR . 1.4 m-20 -68.23 132.75 47.69 Favored 'General case' 0 CA--C 1.518 -0.266 0 N-CA-C 109.919 -0.4 . . . . 0.0 109.919 178.923 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 38.7 ttpt -76.85 -35.37 57.55 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-O 121.18 0.514 . . . . 0.0 109.862 177.86 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 74' ' ' ASN . . . . . 0.548 ' HB2' ' HB3' ' A' ' 77' ' ' ALA . 0.7 OUTLIER -74.29 102.07 4.23 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.538 -0.755 . . . . 0.0 110.216 176.553 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 10.8 tttt -78.19 -55.68 5.07 Favored 'General case' 0 C--N 1.319 -0.732 0 C-N-CA 120.521 -0.472 . . . . 0.0 111.282 -178.343 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 47.4 tptt -60.43 -48.6 81.04 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.254 -174.986 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.548 ' HB3' ' HB2' ' A' ' 74' ' ' ASN . . . -58.31 -36.38 73.27 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.972 178.714 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 78' ' ' TRP . . . . . 0.524 ' O ' HG12 ' A' ' 82' ' ' VAL . 12.2 t-105 -76.9 -48.6 17.8 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.197 -177.714 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.405 ' O ' HG13 ' A' ' 82' ' ' VAL . 4.6 pt-20 -62.15 -32.91 73.57 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-O 120.938 0.399 . . . . 0.0 110.919 -176.326 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 26.5 p30 -79.99 -27.3 39.64 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 119.717 -0.793 . . . . 0.0 111.149 177.866 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 81' ' ' MET . . . . . 0.467 ' SD ' ' HZ3' ' A' ' 78' ' ' TRP . 15.4 ttt -65.91 -48.47 71.32 Favored 'General case' 0 C--O 1.22 -0.495 0 C-N-CA 120.45 -0.5 . . . . 0.0 111.068 173.481 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.645 HG23 ' HB2' ' A' ' 87' ' ' LEU . 0.6 OUTLIER -58.88 -37.59 67.83 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 C-N-CA 120.408 -0.517 . . . . 0.0 110.518 177.832 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 58.7 m -63.33 -41.96 98.94 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.84 175.241 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 1.3 tmtp? -71.81 -45.17 62.4 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.435 -178.873 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -72.36 -10.91 60.4 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.461 -0.79 . . . . 0.0 111.627 -178.026 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 96.5 mt-30 67.67 49.27 0.98 Allowed 'General case' 0 N--CA 1.464 0.267 0 O-C-N 123.517 0.511 . . . . 0.0 111.855 173.731 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.717 HD11 HD13 ' A' ' 49' ' ' LEU . 21.2 mt -104.67 130.66 52.66 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 176.687 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.545 ' C ' ' HD3' ' A' ' 88' ' ' LYS . 0.0 OUTLIER -135.53 165.51 25.35 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.8 0.333 . . . . 0.0 111.847 -179.112 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 140.3 -142.08 12.1 Favored Glycine 0 N--CA 1.449 -0.448 0 N-CA-C 109.998 -1.241 . . . . 0.0 109.998 -176.208 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.702 HG21 HD11 ' A' ' 28' ' ' LEU . 45.9 mm -108.79 113.18 43.39 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 169.792 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 91' ' ' GLN . . . . . 0.682 ' HB2' ' CZ2' ' A' ' 38' ' ' TRP . 1.7 pt20 -141.48 104.17 4.53 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-O 121.836 0.827 . . . . 0.0 112.207 -169.33 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.756 HD11 ' HB ' ' A' ' 23' ' ' VAL . 3.0 mm? -99.04 163.31 12.63 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 114.905 -1.043 . . . . 0.0 110.766 -177.439 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 25.2 t-80 -131.68 121.73 24.78 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.93 -174.95 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 94' ' ' MET . . . . . 0.436 ' HB3' ' O ' ' A' ' 70' ' ' SER . 25.3 ttm -73.07 -61.11 1.93 Allowed 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 114.901 -1.045 . . . . 0.0 110.697 -179.169 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 95.04 -101.62 2.74 Favored Glycine 0 N--CA 1.446 -0.671 0 C-N-CA 120.661 -0.78 . . . . 0.0 112.712 178.14 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 19.2 p -110.91 16.68 21.12 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 111.884 0.327 . . . . 0.0 111.884 -175.508 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -102.06 48.18 0.88 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.051 0.453 . . . . 0.0 110.452 -179.133 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -68.55 -6.82 27.54 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.516 -174.471 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 28.9 m -64.49 -30.99 72.02 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.113 0.482 . . . . 0.0 110.025 173.082 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 100' ' ' PHE . . . . . 0.564 ' CZ ' ' HA ' ' A' ' 10' ' ' ALA . 20.5 t80 -74.2 -36.79 64.01 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 176.442 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 101' ' ' MET . . . . . 0.699 ' HG3' HG13 ' A' ' 106' ' ' ILE . 12.9 ttt -59.07 -45.55 90.53 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.063 -0.971 . . . . 0.0 110.311 172.138 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -67.09 -35.14 79.15 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.985 179.733 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -61.26 -38.19 85.8 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-O 120.997 0.427 . . . . 0.0 111.167 -179.504 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 39.7 m-85 -87.44 -7.66 57.41 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.533 179.316 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 80.0 mt 61.05 30.49 19.56 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.956 -179.696 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 106' ' ' ILE . . . . . 0.699 HG13 ' HG3' ' A' ' 101' ' ' MET . 22.9 pt -77.79 77.79 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 121.685 0.755 . . . . 0.0 110.901 179.008 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 17.6 p-10 -88.28 -54.26 4.29 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.613 -0.721 . . . . 0.0 111.542 -177.878 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -81.53 63.22 4.39 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 121.103 -0.57 . . . . 0.0 112.379 -176.559 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.593 ' HA ' ' C ' ' A' ' 110' ' ' PRO . 44.9 pt -71.43 147.46 92.72 Favored Pre-proline 0 C--N 1.324 -0.509 0 N-CA-C 110.496 -0.187 . . . . 0.0 110.496 -179.363 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 110' ' ' PRO . . . . . 0.993 ' HD3' ' HB2' ' A' ' 45' ' ' CYS . 24.9 Cg_endo -62.57 136.05 19.57 Favored 'Cis proline' 0 C--N 1.348 0.52 0 C-N-CA 124.013 -1.245 . . . . 0.0 113.168 2.096 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 111' ' ' ARG . . . . . 0.593 ' HG3' ' HA ' ' A' ' 106' ' ' ILE . 0.0 OUTLIER -113.15 141.5 46.85 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.41 -0.814 . . . . 0.0 109.764 -177.708 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 112' ' ' PHE . . . . . 0.487 ' O ' ' HA ' ' A' ' 125' ' ' ASN . 0.3 OUTLIER -97.95 124.99 42.65 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 114.935 -1.03 . . . . 0.0 112.116 -173.657 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.714 ' HB ' ' HB ' ' A' ' 35' ' ' ILE . 85.6 mt -136.01 148.2 27.87 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.487 0 CA-C-O 120.737 0.303 . . . . 0.0 110.8 178.442 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 33.5 tp -137.77 137.8 38.61 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 116.62 -0.264 . . . . 0.0 110.335 179.411 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.519 ' N ' HD12 ' A' ' 115' ' ' LEU . 0.3 OUTLIER -135.58 156.26 49.15 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-O 121.504 0.669 . . . . 0.0 111.41 -178.723 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 116' ' ' ASP . . . . . 0.703 ' HB3' ' HB2' ' A' ' 120' ' ' LYS . 11.2 t70 -75.77 162.67 27.99 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 114.572 -1.194 . . . . 0.0 110.876 179.695 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 117' ' ' ARG . . . . . 0.484 ' HA ' ' O ' ' A' ' 31' ' ' LYS . 17.0 mtm180 -49.94 -32.67 15.39 Favored 'General case' 0 N--CA 1.47 0.555 0 O-C-N 124.513 1.133 . . . . 0.0 112.703 -177.408 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 118' ' ' ASP . . . . . 0.769 ' HB3' ' HG3' ' A' ' 120' ' ' LYS . 19.8 t70 -77.97 -5.58 51.67 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-O 121.256 0.55 . . . . 0.0 110.948 -178.512 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 90.55 21.77 36.28 Favored Glycine 0 N--CA 1.438 -1.191 0 N-CA-C 110.459 -1.056 . . . . 0.0 110.459 -171.138 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 120' ' ' LYS . . . . . 0.769 ' HG3' ' HB3' ' A' ' 118' ' ' ASP . 35.9 mttp -87.22 105.29 17.11 Favored 'General case' 0 CA--C 1.515 -0.375 0 C-N-CA 120.304 -0.558 . . . . 0.0 110.342 -176.074 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 121' ' ' ILE . . . . . 0.636 ' H ' HD12 ' A' ' 121' ' ' ILE . 3.6 mp -47.23 108.61 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-O 121.147 0.498 . . . . 0.0 110.669 178.353 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 122' ' ' ILE . . . . . 0.493 ' H ' ' HA ' ' A' ' 115' ' ' LEU . 48.2 mt -83.56 -51.6 14.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 -177.952 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 15.0 m -136.01 126.3 26.51 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.189 -0.914 . . . . 0.0 109.988 -178.665 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -74.02 -18.74 60.81 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.386 0.612 . . . . 0.0 109.803 176.616 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 125' ' ' ASN . . . . . 0.487 ' HA ' ' O ' ' A' ' 112' ' ' PHE . 3.9 p30 -140.18 118.09 11.78 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.106 -0.952 . . . . 0.0 109.995 174.617 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 126' ' ' MET . . . . . 0.435 ' N ' ' HD1' ' A' ' 112' ' ' PHE . 15.9 tpt -110.94 -115.82 0.31 Allowed 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.686 -0.688 . . . . 0.0 109.859 179.084 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 127' ' ' THR . . . . . 0.445 ' HB ' ' HB3' ' A' ' 131' ' ' ASP . 3.3 p -145.76 139.91 26.79 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 122.379 0.272 . . . . 0.0 110.321 178.571 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 65.7 mtt180 -62.87 161.5 28.96 Favored Pre-proline 0 N--CA 1.468 0.458 0 N-CA-C 112.876 0.695 . . . . 0.0 112.876 179.924 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -49.47 -31.25 23.26 Favored 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 123.862 3.041 . . . . 0.0 113.165 170.499 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 22.7 t -74.08 -26.34 60.32 Favored 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 111.543 0.201 . . . . 0.0 111.543 -179.264 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 131' ' ' ASP . . . . . 0.445 ' HB3' ' HB ' ' A' ' 127' ' ' THR . 8.7 t70 -81.9 128.1 69.78 Favored Pre-proline 0 C--N 1.331 -0.22 0 C-N-CA 120.236 -0.585 . . . . 0.0 110.734 179.64 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 132' ' ' PRO . . . . . 0.434 ' HD3' ' HA ' ' A' ' 131' ' ' ASP . 31.4 Cg_exo -61.86 -25.01 77.85 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 123.233 2.622 . . . . 0.0 113.671 -178.714 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 133' ' ' LYS . . . . . 0.561 ' O ' ' HB2' ' A' ' 137' ' ' LYS . 45.5 mmtm -61.04 -34.81 75.45 Favored 'General case' 0 CA--C 1.516 -0.357 0 CA-C-O 120.674 0.273 . . . . 0.0 110.926 -178.288 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 134' ' ' THR . . . . . 0.643 HG22 ' CZ ' ' A' ' 138' ' ' PHE . 1.2 m -59.56 -52.58 64.96 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.99 -0.55 . . . . 0.0 109.792 177.018 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 135' ' ' ALA . . . . . 0.558 ' HA ' ' CD2' ' A' ' 138' ' ' PHE . . . -60.44 -47.08 87.66 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.242 -0.89 . . . . 0.0 111.891 -179.481 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 136' ' ' GLU . . . . . 0.549 ' HG2' ' HA ' ' A' ' 133' ' ' LYS . 12.5 pt-20 -73.14 -23.19 60.43 Favored 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 120.444 -0.502 . . . . 0.0 110.852 -176.177 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 137' ' ' LYS . . . . . 0.561 ' HB2' ' O ' ' A' ' 133' ' ' LYS . 4.1 tmtm? -66.24 -43.01 87.76 Favored 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 109.492 -0.558 . . . . 0.0 109.492 175.855 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 138' ' ' PHE . . . . . 0.643 ' CZ ' HG22 ' A' ' 134' ' ' THR . 9.9 m-85 -56.37 -50.59 71.11 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.817 -0.629 . . . . 0.0 109.484 174.459 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 85.9 m-20 -54.66 -46.42 74.0 Favored 'General case' 0 C--O 1.222 -0.383 0 CA-C-N 115.795 -0.639 . . . . 0.0 109.881 176.984 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -53.88 -48.78 69.73 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.441 179.28 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.532 HD21 ' HE3' ' A' ' 137' ' ' LYS . 91.1 mt -58.48 -45.93 87.68 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.451 -177.594 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 2.9 mm? . . . . . 0 C--N 1.327 -0.399 0 CA-C-O 120.898 0.38 . . . . 0.0 111.053 -178.603 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.512 ' HB2' ' HZ ' ' A' ' 100' ' ' PHE . . . . . . . . 0 C--O 1.231 0.11 0 N-CA-C 110.482 -0.192 . . . . 0.0 110.482 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . 63.05 -69.36 0.07 Allowed 'General case' 0 N--CA 1.468 0.449 0 O-C-N 124.294 0.996 . . . . 0.0 111.996 -178.875 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 50.5 m -156.23 109.72 2.7 Favored 'General case' 0 C--N 1.311 -1.095 0 CA-C-N 115.223 -0.899 . . . . 0.0 109.615 179.938 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' PHE . . . . . 0.447 ' H ' ' HB2' ' A' ' 25' ' ' LEU . 12.7 p90 -124.57 176.43 6.53 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.753 -177.514 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 14' ' ' SER . . . . . 0.561 ' HA ' ' HA ' ' A' ' 24' ' ' SER . 3.1 p -142.03 122.75 14.29 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.301 177.63 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 45.5 m-85 -132.09 145.67 58.38 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-O 120.819 0.342 . . . . 0.0 111.609 -177.685 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.607 ' HA ' ' O ' ' A' ' 21' ' ' LYS . 78.3 Cg_endo -81.69 128.19 5.92 Favored 'Trans proline' 0 N--CA 1.46 -0.48 0 C-N-CA 122.817 2.345 . . . . 0.0 113.931 179.692 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 17' ' ' ASP . . . . . 0.488 ' HB3' ' HB3' ' A' ' 21' ' ' LYS . 1.3 t70 -71.26 161.16 31.54 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 114.89 -1.05 . . . . 0.0 109.321 169.789 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.553 HG21 HG11 ' A' ' 82' ' ' VAL . 29.9 pt -46.76 -38.18 3.79 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.358 0 O-C-N 124.165 0.915 . . . . 0.0 112.849 -174.158 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 42.3 m-80 -75.88 -13.23 60.26 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-O 120.984 0.421 . . . . 0.0 111.357 -176.159 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 103.17 23.64 8.41 Favored Glycine 0 N--CA 1.449 -0.456 0 N-CA-C 111.182 -0.767 . . . . 0.0 111.182 -174.318 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.865 ' HE3' HG22 ' A' ' 23' ' ' VAL . 19.8 tptt -90.23 137.65 32.17 Favored 'General case' 0 C--O 1.219 -0.523 0 CA-C-O 121.081 0.467 . . . . 0.0 110.545 -176.063 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.493 ' N ' ' HD2' ' A' ' 21' ' ' LYS . 52.2 m -91.32 99.98 12.86 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-O 121.023 0.439 . . . . 0.0 110.163 -177.181 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.865 HG22 ' HE3' ' A' ' 21' ' ' LYS . 41.5 t -104.35 113.82 42.32 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 115.707 -0.679 . . . . 0.0 109.475 178.156 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 24' ' ' SER . . . . . 0.561 ' HA ' ' HA ' ' A' ' 14' ' ' SER . 7.1 m -105.98 173.34 6.35 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.249 -177.984 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.552 HD11 ' HA3' ' A' ' 119' ' ' GLY . 3.4 tm? -59.01 -45.23 91.2 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.058 179.035 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -72.08 -17.9 61.96 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.973 0.416 . . . . 0.0 111.076 -177.851 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -73.8 -28.68 61.76 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.92 -0.582 . . . . 0.0 109.815 -178.91 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.501 HD11 HG21 ' A' ' 90' ' ' ILE . 97.6 mt -111.54 -1.18 15.91 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.316 179.25 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 85.2 tttt -67.51 146.29 54.09 Favored 'General case' 0 N--CA 1.448 -0.543 0 CA-C-O 121.104 0.478 . . . . 0.0 111.497 -174.119 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 116.9 -20.5 11.64 Favored Glycine 0 N--CA 1.445 -0.746 0 N-CA-C 111.139 -0.785 . . . . 0.0 111.139 -177.309 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.48 ' HB3' ' N ' ' A' ' 64' ' ' ILE . 64.3 mttm -126.11 149.38 48.98 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.727 -0.237 . . . . 0.0 110.656 178.746 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.547 ' CE1' ' HA ' ' A' ' 116' ' ' ASP . 22.4 m-85 -61.57 119.66 9.05 Favored 'General case' 0 CA--C 1.516 -0.341 0 CA-C-O 120.75 0.31 . . . . 0.0 110.707 -179.978 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 68.6 mt -100.29 115.35 41.39 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.921 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.057 -174.673 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 81.7 t80 -92.03 120.71 32.92 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 108.669 -0.864 . . . . 0.0 108.669 170.953 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.596 ' HA ' ' O ' ' A' ' 67' ' ' VAL . 49.8 mt -107.73 122.64 62.32 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-O 120.985 0.421 . . . . 0.0 110.616 -178.802 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.53 ' O ' ' HA ' ' A' ' 68' ' ' SER . 1.9 t70 -120.06 159.47 24.72 Favored 'General case' 0 C--N 1.315 -0.926 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 174.432 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.591 HG11 HG21 ' A' ' 109' ' ' ILE . 42.9 t -102.32 114.55 42.11 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.98 0 C-N-CA 119.651 -0.819 . . . . 0.0 111.822 178.882 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 38' ' ' TRP . . . . . 0.621 ' CE3' ' HZ2' ' A' ' 78' ' ' TRP . 0.8 OUTLIER -102.62 134.44 45.98 Favored 'General case' 0 C--O 1.225 -0.198 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 -179.994 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.646 ' HB3' ' SG ' ' A' ' 42' ' ' CYS . . . -146.94 164.68 32.15 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 112.285 0.476 . . . . 0.0 112.285 -175.474 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 40' ' ' THR . . . . . 0.425 HG23 ' SD ' ' A' ' 81' ' ' MET . 1.4 m -78.64 -30.82 46.59 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.519 0.676 . . . . 0.0 110.383 178.117 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 41' ' ' TRP . . . . . 0.58 ' CH2' HD11 ' A' ' 109' ' ' ILE . 9.4 p-90 -106.48 21.83 16.8 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.234 -0.894 . . . . 0.0 112.116 -172.486 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 42' ' ' CYS . . . . . 0.646 ' SG ' ' HB3' ' A' ' 39' ' ' ALA . 25.7 p -116.99 88.98 3.01 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.477 0.656 . . . . 0.0 109.972 173.434 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -56.79 -53.97 40.05 Favored Glycine 0 CA--C 1.524 0.644 0 CA-C-N 115.486 -0.779 . . . . 0.0 113.912 -178.0 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 78.2 Cg_exo -52.41 -35.91 67.26 Favored 'Trans proline' 0 C--N 1.357 0.992 0 C-N-CA 122.818 2.345 . . . . 0.0 113.144 -178.333 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' CYS . . . . . 0.723 ' HB2' ' HD3' ' A' ' 110' ' ' PRO . 51.2 t -57.21 -30.82 64.88 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 121.041 0.448 . . . . 0.0 111.308 -177.564 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.577 ' HA ' HD12 ' A' ' 49' ' ' LEU . 41.9 mtp-105 -74.67 0.25 15.74 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.114 -0.493 . . . . 0.0 111.298 -174.162 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -84.45 -40.24 8.53 Favored Glycine 0 N--CA 1.446 -0.65 0 N-CA-C 111.539 -0.625 . . . . 0.0 111.539 174.22 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' GLU . . . . . 0.461 ' CD ' ' HE ' ' A' ' 128' ' ' ARG . 4.4 pm0 -93.92 -8.28 40.63 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 111.531 0.197 . . . . 0.0 111.531 -179.447 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.614 ' HG ' ' O ' ' A' ' 45' ' ' CYS . 48.6 mt -54.97 -51.47 79.17 Favored Pre-proline 0 CA--C 1.535 0.374 0 N-CA-C 111.773 0.286 . . . . 0.0 111.773 177.473 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.613 ' HD3' ' HB2' ' A' ' 49' ' ' LEU . 50.8 Cg_exo -57.77 -38.08 94.21 Favored 'Trans proline' 0 C--N 1.357 1.007 0 C-N-CA 122.007 1.805 . . . . 0.0 112.077 175.574 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -70.01 -33.26 71.78 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.009 0.433 . . . . 0.0 110.775 -179.921 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 9.3 tt -66.56 -48.67 68.93 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.59 -177.759 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.564 ' O ' ' HG3' ' A' ' 57' ' ' GLU . 12.4 ptmm? -62.58 -42.59 99.65 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 109.97 -0.381 . . . . 0.0 109.97 177.676 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -62.91 -34.47 77.51 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.323 179.687 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 18.2 mt -60.89 -48.02 83.74 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.931 175.42 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.453 ' HB2' ' HB2' ' A' ' 66' ' ' PHE . 7.8 tp10 -63.19 -41.78 99.23 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.572 -0.74 . . . . 0.0 109.999 178.615 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.564 ' HG3' ' O ' ' A' ' 53' ' ' LYS . 35.9 mt-10 -66.94 -21.38 65.98 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.827 177.627 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 61.7 tttp -86.21 -43.71 12.76 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.582 -179.267 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 80.3 m-85 -95.45 0.52 53.38 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 112.097 0.406 . . . . 0.0 112.097 -174.062 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -58.31 111.78 1.33 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.113 0.483 . . . . 0.0 110.829 176.349 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 150.69 -36.07 0.92 Allowed Glycine 0 N--CA 1.445 -0.718 0 N-CA-C 111.234 -0.746 . . . . 0.0 111.234 -178.597 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.551 ' HB3' HD22 ' A' ' 142' ' ' LEU . 2.2 mmmm -103.12 -160.64 0.79 Allowed 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.104 0.478 . . . . 0.0 110.695 175.93 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 63' ' ' ASP . . . . . 0.446 ' H ' ' HE2' ' A' ' 62' ' ' LYS . 23.0 m-20 -97.92 79.15 2.61 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 116.024 -0.534 . . . . 0.0 111.884 -174.988 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.588 ' HB ' HD21 ' A' ' 142' ' ' LEU . 14.7 tt -154.03 156.93 4.81 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 115.59 -0.732 . . . . 0.0 109.613 176.725 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 65' ' ' HIS . . . . . 0.464 ' CE1' ' HD2' ' A' ' 31' ' ' LYS . 47.6 m-70 -143.61 142.59 31.11 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 109.893 -0.41 . . . . 0.0 109.893 175.857 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 66' ' ' PHE . . . . . 0.453 ' HB2' ' HB2' ' A' ' 56' ' ' GLU . 87.5 m-85 -109.88 102.93 11.65 Favored 'General case' 0 C--N 1.314 -0.96 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 172.28 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.615 HG22 ' HB ' ' A' ' 90' ' ' ILE . 51.1 t -119.68 125.98 74.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 115.134 -0.939 . . . . 0.0 110.72 -171.85 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 68' ' ' SER . . . . . 0.535 ' HB2' ' OE1' ' A' ' 91' ' ' GLN . 21.2 m -107.31 140.59 39.98 Favored 'General case' 0 C--N 1.312 -1.061 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.261 176.951 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 57.4 tp -117.76 133.52 55.85 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.089 179.388 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' SER . . . . . 0.437 ' O ' ' HB3' ' A' ' 94' ' ' MET . 1.6 t -109.81 116.9 32.5 Favored 'General case' 0 C--O 1.221 -0.446 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.845 -172.303 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 42.6 m -85.55 19.85 2.27 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 120.827 0.346 . . . . 0.0 111.1 177.937 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.548 ' OD1' ' HA ' ' A' ' 39' ' ' ALA . 3.6 m-20 -73.95 147.83 42.72 Favored 'General case' 0 CA--C 1.517 -0.321 0 CA-C-O 121.261 0.553 . . . . 0.0 111.41 -177.228 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.48 ' HB2' ' HE3' ' A' ' 73' ' ' LYS . 28.1 ttmt -95.38 -32.61 12.85 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 115.415 -0.812 . . . . 0.0 109.912 177.734 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -78.86 73.74 5.4 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.703 -0.681 . . . . 0.0 109.722 -178.319 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 10.5 tttt -58.55 -50.8 72.46 Favored 'General case' 0 C--N 1.323 -0.575 0 C-N-CA 120.71 -0.396 . . . . 0.0 111.437 -175.116 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.446 ' HA ' ' OE1' ' A' ' 79' ' ' GLU . 1.6 tmtt? -57.49 -48.01 80.39 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.695 -177.795 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -67.38 -38.44 84.72 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-O 121.475 0.655 . . . . 0.0 110.126 -177.545 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 78' ' ' TRP . . . . . 0.621 ' HZ2' ' CE3' ' A' ' 38' ' ' TRP . 13.8 t-105 -71.28 -47.65 55.62 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 115.1 -0.955 . . . . 0.0 111.412 -178.348 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.446 ' OE1' ' HA ' ' A' ' 76' ' ' LYS . 3.1 pt-20 -62.23 -37.04 83.87 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-O 120.631 0.253 . . . . 0.0 111.405 -175.547 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 6.0 p30 -77.45 -31.29 53.72 Favored 'General case' 0 C--N 1.332 -0.181 0 C-N-CA 119.413 -0.915 . . . . 0.0 110.301 179.581 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 81' ' ' MET . . . . . 0.425 ' SD ' HG23 ' A' ' 40' ' ' THR . 16.3 ttt -64.67 -46.86 80.64 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.632 -0.258 . . . . 0.0 111.497 176.661 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.686 HG23 ' HB2' ' A' ' 87' ' ' LEU . 1.0 OUTLIER -60.44 -36.74 71.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 C-N-CA 120.373 -0.531 . . . . 0.0 110.389 175.982 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 31.3 m -64.13 -38.11 89.89 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.641 177.046 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 84' ' ' LYS . . . . . 0.47 ' HA ' ' HD3' ' A' ' 84' ' ' LYS . 35.3 mmtm -74.03 -47.44 36.89 Favored 'General case' 0 CA--C 1.519 -0.222 0 CA-C-O 121.214 0.531 . . . . 0.0 111.385 178.213 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -72.74 -8.12 53.89 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.319 -0.855 . . . . 0.0 111.918 -178.442 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 49.9 mt-30 69.23 26.06 5.52 Favored 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 112.634 0.605 . . . . 0.0 112.634 169.91 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.686 ' HB2' HG23 ' A' ' 82' ' ' VAL . 18.8 mt -67.77 108.54 3.0 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.719 0.295 . . . . 0.0 110.393 -178.091 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.417 ' HB2' ' HE2' ' A' ' 53' ' ' LYS . 39.7 mmtm -95.87 -177.44 4.03 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.388 -178.68 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 96.56 -162.57 22.44 Favored Glycine 0 N--CA 1.448 -0.556 0 N-CA-C 111.017 -0.833 . . . . 0.0 111.017 -174.632 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.615 ' HB ' HG22 ' A' ' 67' ' ' VAL . 49.4 mm -97.31 113.62 32.22 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 117.435 0.618 . . . . 0.0 109.693 176.885 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 91' ' ' GLN . . . . . 0.61 ' HB3' ' CZ2' ' A' ' 38' ' ' TRP . 60.4 mm-40 -123.98 106.77 10.67 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.45 -173.965 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 41.7 mt -104.67 145.61 30.09 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.095 -175.636 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 93' ' ' HIS . . . . . 0.518 ' O ' ' HD2' ' A' ' 16' ' ' PRO . 26.7 t-80 -113.22 139.76 48.52 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-O 121.502 0.668 . . . . 0.0 111.383 -177.929 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 94' ' ' MET . . . . . 0.634 ' HG3' ' HB2' ' A' ' 97' ' ' ASP . 27.1 ttm -107.72 94.18 4.94 Favored 'General case' 0 N--CA 1.442 -0.849 0 CA-C-N 114.905 -1.043 . . . . 0.0 108.629 179.075 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -68.93 78.12 0.28 Allowed Glycine 0 C--N 1.315 -0.592 0 CA-C-N 115.122 -0.945 . . . . 0.0 113.599 -178.669 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 5.3 m 71.87 5.13 5.27 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 123.148 0.579 . . . . 0.0 111.674 174.337 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 97' ' ' ASP . . . . . 0.634 ' HB2' ' HG3' ' A' ' 94' ' ' MET . 13.2 m-20 -79.02 32.06 0.21 Allowed 'General case' 0 N--CA 1.466 0.331 0 CA-C-O 121.036 0.446 . . . . 0.0 110.011 178.743 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 98' ' ' ARG . . . . . 0.586 ' HA ' ' SD ' ' A' ' 94' ' ' MET . 0.0 OUTLIER -78.59 14.06 1.41 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.129 -0.487 . . . . 0.0 112.225 -169.589 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -66.43 -28.09 68.34 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 168.082 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 100' ' ' PHE . . . . . 0.512 ' HZ ' ' HB2' ' A' ' 10' ' ' ALA . 55.1 t80 -70.95 -38.92 72.85 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.011 -0.995 . . . . 0.0 109.283 172.928 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 101' ' ' MET . . . . . 0.538 ' HG3' HG13 ' A' ' 106' ' ' ILE . 11.5 ttt -57.25 -44.9 84.29 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.296 -0.866 . . . . 0.0 110.333 172.702 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -67.61 -33.54 75.2 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.43 -0.805 . . . . 0.0 111.189 179.327 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -73.93 -39.91 63.45 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.925 0.393 . . . . 0.0 111.4 -179.589 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 104' ' ' TYR . . . . . 0.568 ' HB3' HG23 ' A' ' 106' ' ' ILE . 2.4 m-85 -83.64 -5.12 59.1 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.745 -178.917 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 93.8 mt 63.51 20.78 12.43 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.292 177.92 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 106' ' ' ILE . . . . . 0.614 HG22 ' HG3' ' A' ' 111' ' ' ARG . 39.0 pt -77.99 59.38 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 CA-C-O 121.586 0.708 . . . . 0.0 110.871 178.399 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 9.8 p30 -86.82 -38.5 16.77 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.928 179.505 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -85.12 76.72 2.18 Favored Glycine 0 N--CA 1.447 -0.6 0 N-CA-C 111.41 -0.676 . . . . 0.0 111.41 176.416 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.591 HG21 HG11 ' A' ' 37' ' ' VAL . 23.0 pt -94.78 156.46 38.18 Favored Pre-proline 0 C--N 1.323 -0.57 0 CA-C-N 115.973 -0.114 . . . . 0.0 110.955 -177.742 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 110' ' ' PRO . . . . . 0.723 ' HD3' ' HB2' ' A' ' 45' ' ' CYS . 29.2 Cg_endo -61.52 147.57 51.01 Favored 'Cis proline' 0 C--N 1.349 0.583 0 C-N-CA 124.348 -1.105 . . . . 0.0 114.049 2.117 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 111' ' ' ARG . . . . . 0.614 ' HG3' HG22 ' A' ' 106' ' ' ILE . 0.0 OUTLIER -118.54 137.87 52.92 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 179.125 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 112' ' ' PHE . . . . . 0.448 ' CD1' ' HA ' ' A' ' 128' ' ' ARG . 0.9 OUTLIER -103.2 120.96 41.7 Favored 'General case' 0 C--N 1.329 -0.285 0 O-C-N 123.908 0.755 . . . . 0.0 110.066 -175.366 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 87.3 mt -136.93 147.62 27.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-O 120.656 0.265 . . . . 0.0 110.307 -179.971 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.476 ' HB2' ' HG2' ' A' ' 126' ' ' MET . 54.7 tp -129.24 137.49 51.12 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.508 0.194 . . . . 0.0 110.546 -179.936 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.781 ' HG ' ' HA ' ' A' ' 121' ' ' ILE . 4.7 mp -129.56 151.12 50.52 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.127 0.489 . . . . 0.0 110.379 179.324 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 116' ' ' ASP . . . . . 0.547 ' HA ' ' CE1' ' A' ' 32' ' ' TYR . 22.4 t70 -70.88 164.33 25.58 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.243 -0.89 . . . . 0.0 110.205 176.564 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 117' ' ' ARG . . . . . 0.412 ' HG3' ' CD2' ' A' ' 32' ' ' TYR . 76.4 mtp180 -49.77 -31.71 12.18 Favored 'General case' 0 N--CA 1.466 0.369 0 O-C-N 124.068 0.855 . . . . 0.0 111.858 179.683 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 118' ' ' ASP . . . . . 0.475 ' HB3' ' HG2' ' A' ' 120' ' ' LYS . 6.4 t70 -71.77 -4.29 26.86 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.164 -178.906 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 119' ' ' GLY . . . . . 0.552 ' HA3' HD11 ' A' ' 25' ' ' LEU . . . 79.49 30.54 44.52 Favored Glycine 0 N--CA 1.439 -1.154 0 N-CA-C 110.286 -1.126 . . . . 0.0 110.286 -171.757 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 120' ' ' LYS . . . . . 0.475 ' HG2' ' HB3' ' A' ' 118' ' ' ASP . 40.6 mmtm -110.65 110.43 21.11 Favored 'General case' 0 CA--C 1.516 -0.333 0 C-N-CA 120.707 -0.397 . . . . 0.0 111.536 -175.418 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 121' ' ' ILE . . . . . 0.781 ' HA ' ' HG ' ' A' ' 115' ' ' LEU . 3.3 mp -42.15 112.22 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 115.272 -0.876 . . . . 0.0 111.94 -179.145 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 122' ' ' ILE . . . . . 0.503 HD11 ' HB2' ' A' ' 116' ' ' ASP . 27.3 mm -87.68 -46.8 15.94 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-N 115.275 -0.875 . . . . 0.0 109.281 176.096 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 12.4 m -134.7 114.4 12.66 Favored 'General case' 0 N--CA 1.447 -0.622 0 CA-C-N 115.142 -0.935 . . . . 0.0 110.03 179.559 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -76.12 -16.04 59.97 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.77 0.795 . . . . 0.0 109.714 175.735 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 12.2 p-10 -124.17 87.62 2.76 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 114.679 -1.146 . . . . 0.0 109.728 175.264 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 126' ' ' MET . . . . . 0.497 ' HG3' ' H ' ' A' ' 127' ' ' THR . 5.0 tpt -94.44 -170.18 2.21 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 108.936 -0.764 . . . . 0.0 108.936 -180.0 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 127' ' ' THR . . . . . 0.551 ' HB ' ' OG1' ' A' ' 134' ' ' THR . 3.7 m -117.7 138.98 51.64 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 110.205 -0.295 . . . . 0.0 110.205 -177.914 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 128' ' ' ARG . . . . . 0.461 ' HE ' ' CD ' ' A' ' 48' ' ' GLU . 49.1 ttt180 -32.32 136.63 0.25 Allowed Pre-proline 0 C--O 1.237 0.401 0 C-N-CA 124.36 1.064 . . . . 0.0 112.686 173.314 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 129' ' ' PRO . . . . . 0.417 ' HD3' ' HA ' ' A' ' 128' ' ' ARG . 86.5 Cg_exo -50.56 -40.21 54.99 Favored 'Trans proline' 0 C--N 1.347 0.474 0 C-N-CA 123.731 2.954 . . . . 0.0 113.479 -178.016 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 8.8 p -84.27 18.2 2.27 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 112.219 0.452 . . . . 0.0 112.219 -175.716 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 131' ' ' ASP . . . . . 0.446 ' HA ' ' HD3' ' A' ' 132' ' ' PRO . 15.2 t70 -97.99 131.05 27.32 Favored Pre-proline 0 C--N 1.328 -0.328 0 C-N-CA 120.582 -0.447 . . . . 0.0 110.003 175.893 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 132' ' ' PRO . . . . . 0.446 ' HD3' ' HA ' ' A' ' 131' ' ' ASP . 56.5 Cg_exo -53.91 -35.43 80.09 Favored 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 123.139 2.56 . . . . 0.0 113.56 -177.988 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 35.5 mtmm -68.13 -36.48 79.77 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.046 0.451 . . . . 0.0 110.16 -178.33 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 134' ' ' THR . . . . . 0.7 HG22 ' CZ ' ' A' ' 138' ' ' PHE . 1.3 m -65.58 -48.54 71.97 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.128 178.26 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 135' ' ' ALA . . . . . 0.554 ' HA ' ' CD2' ' A' ' 138' ' ' PHE . . . -58.31 -46.77 85.51 Favored 'General case' 0 C--O 1.237 0.418 0 CA-C-N 115.494 -0.776 . . . . 0.0 112.099 -179.713 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -71.0 -24.33 62.36 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.832 0.348 . . . . 0.0 110.701 -178.567 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 137' ' ' LYS . . . . . 0.545 ' O ' ' HG ' ' A' ' 141' ' ' LEU . 44.6 tptt -65.95 -41.14 91.65 Favored 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 109.611 -0.514 . . . . 0.0 109.611 175.189 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 138' ' ' PHE . . . . . 0.7 ' CZ ' HG22 ' A' ' 134' ' ' THR . 12.1 m-85 -58.84 -51.87 68.16 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.504 177.726 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 19.3 p30 -69.95 -24.19 63.3 Favored 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 120.392 -0.523 . . . . 0.0 111.351 -175.35 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 51.0 tt0 -67.67 -48.51 66.42 Favored 'General case' 0 N--CA 1.45 -0.453 0 CA-C-O 120.826 0.346 . . . . 0.0 110.573 172.226 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.545 ' HG ' ' O ' ' A' ' 137' ' ' LYS . 86.9 mt -64.4 -35.05 79.63 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.972 -178.163 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 0.588 HD21 ' HB ' ' A' ' 64' ' ' ILE . 79.1 mt . . . . . 0 C--N 1.326 -0.444 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.228 -179.395 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.689 ' HB2' ' HA2' ' A' ' 6' ' ' GLY . 2.0 mpt? . . . . . 0 N--CA 1.482 1.165 0 N-CA-C 110.24 -0.281 . . . . 0.0 110.24 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 10.6 m -50.23 144.66 6.94 Favored 'General case' 0 C--O 1.24 0.569 0 N-CA-C 112.488 0.551 . . . . 0.0 112.488 -176.144 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER 73.46 -67.46 0.26 Allowed 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 115.134 -0.939 . . . . 0.0 109.43 -176.553 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 12.3 ptm180 -175.73 -38.0 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.81 -0.632 . . . . 0.0 109.375 174.407 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 3.3 m -89.97 -78.35 0.37 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.969 -0.56 . . . . 0.0 109.64 176.826 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' GLY . . . . . 0.689 ' HA2' ' HB2' ' A' ' 1' ' ' MET . . . 174.6 47.12 0.05 OUTLIER Glycine 0 N--CA 1.447 -0.599 0 N-CA-C 111.536 -0.626 . . . . 0.0 111.536 179.378 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 67.8 m-20 -104.09 137.26 19.18 Favored Pre-proline 0 C--N 1.325 -0.499 0 CA-C-O 120.61 0.243 . . . . 0.0 110.532 -175.832 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 69.8 Cg_endo -79.76 113.61 3.07 Favored 'Trans proline' 0 N--CA 1.458 -0.613 0 C-N-CA 122.698 2.266 . . . . 0.0 111.589 176.975 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.508 ' HB3' ' HE1' ' A' ' 100' ' ' PHE . 43.6 m -151.85 156.62 40.52 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.365 -177.477 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . 73.76 -34.97 0.3 Allowed 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 123.863 0.865 . . . . 0.0 112.458 175.847 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -80.55 78.9 7.24 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 120.9 0.381 . . . . 0.0 110.95 -177.958 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 53.6 m 68.65 95.5 0.07 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.032 -0.985 . . . . 0.0 111.899 176.613 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 33.9 p90 -98.1 165.99 11.63 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.416 178.067 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.502 ' HA ' ' HA ' ' A' ' 24' ' ' SER . 25.0 m -142.51 120.43 12.02 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.896 -0.409 . . . . 0.0 109.896 175.664 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' TYR . . . . . 0.42 ' CE2' ' HA ' ' A' ' 94' ' ' MET . 57.8 m-85 -128.19 161.72 54.62 Favored Pre-proline 0 C--N 1.324 -0.528 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.45 -177.407 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.459 ' HD2' ' O ' ' A' ' 93' ' ' HIS . 2.7 Cg_endo -86.18 124.95 2.54 Favored 'Trans proline' 0 N--CA 1.454 -0.846 0 C-N-CA 122.476 2.117 . . . . 0.0 112.567 174.008 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' ASP . . . . . 0.505 ' HB3' ' HB3' ' A' ' 21' ' ' LYS . 4.0 t70 -69.56 159.03 34.12 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.529 -0.759 . . . . 0.0 109.122 171.971 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.781 HG13 HG11 ' A' ' 82' ' ' VAL . 18.5 mm -40.94 -49.71 0.67 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.401 0 O-C-N 124.558 1.161 . . . . 0.0 112.898 -176.585 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 4.8 p30 -69.55 -16.49 63.43 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-O 121.126 0.488 . . . . 0.0 110.974 -174.947 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 107.73 33.83 2.98 Favored Glycine 0 N--CA 1.444 -0.781 0 CA-C-N 115.802 -0.636 . . . . 0.0 111.663 -177.969 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.646 ' HZ2' HG22 ' A' ' 23' ' ' VAL . 48.2 tttm -102.32 128.99 48.64 Favored 'General case' 0 CA--C 1.515 -0.381 0 C-N-CA 120.402 -0.519 . . . . 0.0 111.188 -177.617 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 8.3 m -64.75 104.88 0.89 Allowed 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 109.527 -0.546 . . . . 0.0 109.527 170.429 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 1.031 ' HB ' HD11 ' A' ' 92' ' ' LEU . 41.6 t -111.79 118.46 57.65 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 176.067 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' SER . . . . . 0.502 ' HA ' ' HA ' ' A' ' 14' ' ' SER . 89.6 p -100.48 -173.81 2.5 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.563 -175.762 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.587 HD11 ' HA3' ' A' ' 119' ' ' GLY . 1.5 tm? -82.35 -1.02 48.47 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 176.219 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -95.99 -21.69 17.85 Favored 'General case' 0 CA--C 1.51 -0.563 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 -178.482 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -65.7 -22.38 66.61 Favored 'General case' 0 N--CA 1.437 -1.09 0 CA-C-N 113.755 -1.566 . . . . 0.0 110.208 173.354 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.62 HD13 HG21 ' A' ' 67' ' ' VAL . 37.1 mt -112.37 -15.67 13.08 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-N 115.407 -0.815 . . . . 0.0 111.008 -177.009 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.459 ' HB2' ' O ' ' A' ' 25' ' ' LEU . 62.2 tttp -69.75 133.38 47.4 Favored 'General case' 0 N--CA 1.445 -0.693 0 CA-C-N 115.694 -0.684 . . . . 0.0 111.455 -171.174 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 119.19 -18.9 10.2 Favored Glycine 0 N--CA 1.45 -0.387 0 N-CA-C 111.172 -0.771 . . . . 0.0 111.172 -176.896 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.601 ' HB3' ' NE2' ' A' ' 65' ' ' HIS . 24.5 ttmm -140.18 147.47 40.16 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 179.241 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.54 ' HB2' ' O ' ' A' ' 63' ' ' ASP . 81.8 m-85 -54.0 140.76 30.32 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-O 121.119 0.485 . . . . 0.0 111.659 -176.261 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 5.1 mp -112.18 132.25 61.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.634 -177.111 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 85.5 t80 -115.58 116.54 28.33 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 172.595 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.625 ' HB ' ' HB ' ' A' ' 113' ' ' ILE . 67.9 mt -103.33 109.73 27.81 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 CA-C-O 120.999 0.428 . . . . 0.0 110.671 -177.937 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.557 ' HA ' ' O ' ' A' ' 111' ' ' ARG . 5.7 p-10 -105.57 158.31 16.78 Favored 'General case' 0 C--N 1.316 -0.858 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 173.238 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.469 HG21 HG21 ' A' ' 106' ' ' ILE . 52.6 t -103.26 136.68 34.84 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.806 0 C-N-CA 120.485 -0.486 . . . . 0.0 111.447 179.068 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' TRP . . . . . 0.663 ' CZ2' ' HB2' ' A' ' 91' ' ' GLN . 0.2 OUTLIER -128.5 141.77 51.28 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 -179.95 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.505 ' HA ' ' OD1' ' A' ' 72' ' ' ASP . . . -146.15 158.11 43.86 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 112.445 0.535 . . . . 0.0 112.445 -176.67 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -76.35 -46.22 28.49 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.798 -0.637 . . . . 0.0 109.559 175.917 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 5.3 p-90 -80.77 -1.16 41.76 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 114.885 -1.052 . . . . 0.0 111.687 -175.352 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 43.6 t -95.31 110.89 22.84 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.252 0.549 . . . . 0.0 110.127 177.596 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.408 ' N ' ' CD ' ' A' ' 44' ' ' PRO . . . -85.31 -43.97 6.4 Favored Glycine 0 CA--C 1.528 0.859 0 CA-C-O 118.967 -0.907 . . . . 0.0 113.727 176.352 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.408 ' CD ' ' N ' ' A' ' 43' ' ' GLY . 71.2 Cg_exo -53.03 -38.34 80.07 Favored 'Trans proline' 0 C--N 1.362 1.274 0 C-N-CA 122.584 2.189 . . . . 0.0 113.221 -176.835 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' CYS . . . . . 0.691 ' O ' ' HG ' ' A' ' 49' ' ' LEU . 29.8 p -58.95 -32.51 69.67 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.8 0.333 . . . . 0.0 111.021 -179.653 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.593 ' HG2' HD12 ' A' ' 49' ' ' LEU . 52.0 mtt85 -69.38 -8.18 44.17 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.757 -176.412 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -78.26 -27.81 57.09 Favored Glycine 0 N--CA 1.444 -0.774 0 C-N-CA 120.53 -0.843 . . . . 0.0 111.658 175.687 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.462 ' OE2' ' HD3' ' A' ' 128' ' ' ARG . 15.7 pt-20 -114.53 -8.03 12.78 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 111.695 0.257 . . . . 0.0 111.695 -177.687 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.691 ' HG ' ' O ' ' A' ' 45' ' ' CYS . 68.8 mt -55.18 -47.13 99.27 Favored Pre-proline 0 CA--C 1.537 0.442 0 N-CA-C 112.248 0.462 . . . . 0.0 112.248 178.22 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.496 ' HD3' ' HB2' ' A' ' 49' ' ' LEU . 53.6 Cg_exo -54.97 -37.46 93.59 Favored 'Trans proline' 0 C--N 1.355 0.905 0 C-N-CA 121.688 1.592 . . . . 0.0 111.944 172.552 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -73.51 -28.64 62.01 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.619 179.544 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 8.2 tt -64.59 -39.62 94.06 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.009 -0.737 . . . . 0.0 109.009 175.096 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.437 ' HE2' ' O ' ' A' ' 88' ' ' LYS . 4.5 mmmp? -63.83 -46.99 82.58 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.486 174.59 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.41 ' O ' ' HB2' ' A' ' 58' ' ' LYS . 0.3 OUTLIER -53.09 -43.56 66.9 Favored 'General case' 0 C--O 1.222 -0.348 0 O-C-N 123.565 0.541 . . . . 0.0 111.082 173.944 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.479 HD21 ' HE2' ' A' ' 138' ' ' PHE . 21.7 tp -59.51 -44.42 93.13 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.951 0.405 . . . . 0.0 110.474 178.572 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.408 ' OE1' ' HD2' ' A' ' 66' ' ' PHE . 10.1 tp10 -65.5 -55.96 15.03 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.022 179.906 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 29.9 mt-10 -72.75 -19.24 61.41 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.561 -172.534 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.41 ' HB2' ' O ' ' A' ' 54' ' ' GLU . 18.1 ttmm -82.37 -31.6 29.65 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.139 0.495 . . . . 0.0 110.044 174.326 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.436 ' O ' ' HD2' ' A' ' 62' ' ' LYS . 25.8 m-85 -103.9 12.95 33.74 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.657 -0.702 . . . . 0.0 111.166 -178.552 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -47.16 113.8 0.74 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.077 0.465 . . . . 0.0 111.819 178.673 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 115.01 -12.19 20.11 Favored Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 120.88 -0.676 . . . . 0.0 112.254 -178.192 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.71 ' H ' ' HD2' ' A' ' 62' ' ' LYS . 0.0 OUTLIER -65.9 169.48 6.61 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-O 121.405 0.621 . . . . 0.0 111.599 -178.397 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.574 ' CG ' ' HG3' ' A' ' 31' ' ' LYS . 4.6 t70 -94.77 55.77 1.93 Allowed 'General case' 0 C--N 1.318 -0.773 0 CA-C-O 121.367 0.604 . . . . 0.0 109.992 178.786 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.477 ' HB ' ' HG2' ' A' ' 62' ' ' LYS . 4.0 mp -145.99 134.09 15.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.571 -0.74 . . . . 0.0 109.752 -178.698 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' HIS . . . . . 0.601 ' NE2' ' HB3' ' A' ' 31' ' ' LYS . 88.4 m-70 -101.55 120.81 40.88 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.511 -0.552 . . . . 0.0 109.511 173.623 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' PHE . . . . . 0.56 ' O ' ' HB ' ' A' ' 90' ' ' ILE . 63.5 m-85 -83.32 108.93 16.85 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 171.163 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.62 HG21 HD13 ' A' ' 28' ' ' LEU . 44.2 t -120.77 105.16 16.38 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.696 -174.188 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' SER . . . . . 0.542 ' HA ' ' O ' ' A' ' 36' ' ' ASP . 13.3 m -88.09 124.53 33.87 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.531 -179.191 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 55.7 tp -110.0 129.98 55.6 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.777 0.322 . . . . 0.0 110.453 177.655 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' SER . . . . . 0.504 ' O ' ' HB3' ' A' ' 94' ' ' MET . 1.0 OUTLIER -112.09 122.41 47.68 Favored 'General case' 0 C--O 1.221 -0.396 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.721 -175.147 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 12.9 t -85.41 9.31 15.97 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.403 177.674 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.505 ' OD1' ' HA ' ' A' ' 39' ' ' ALA . 3.0 m-20 -64.56 136.47 57.06 Favored 'General case' 0 CA--C 1.516 -0.343 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.592 -178.013 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 18.2 ttmm -82.83 -33.72 27.09 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-O 121.254 0.549 . . . . 0.0 109.846 177.451 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' ASN . . . . . 0.562 ' HB2' ' HB3' ' A' ' 77' ' ' ALA . 0.9 OUTLIER -77.9 85.84 4.14 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.477 -0.783 . . . . 0.0 111.217 -179.641 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.424 ' HB2' ' CE1' ' A' ' 93' ' ' HIS . 18.0 tttm -62.54 -62.95 1.39 Allowed 'General case' 0 C--O 1.218 -0.553 0 C-N-CA 120.024 -0.67 . . . . 0.0 111.782 -179.649 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.435 ' HA ' ' HD2' ' A' ' 76' ' ' LYS . 42.2 tptt -53.23 -37.7 62.29 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 123.279 0.362 . . . . 0.0 111.777 -174.445 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.562 ' HB3' ' HB2' ' A' ' 74' ' ' ASN . . . -66.47 -38.08 86.54 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.565 0.698 . . . . 0.0 110.466 177.217 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' TRP . . . . . 0.451 ' HZ3' HH22 ' A' ' 46' ' ' ARG . 7.5 t-105 -80.58 -41.89 23.25 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.313 -0.858 . . . . 0.0 111.229 -176.271 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.73 ' HB2' HG23 ' A' ' 18' ' ' ILE . 1.4 pt-20 -62.44 -39.11 92.27 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-O 120.711 0.291 . . . . 0.0 110.754 179.927 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 3.8 p30 -75.15 -28.55 60.18 Favored 'General case' 0 CA--C 1.518 -0.259 0 C-N-CA 119.784 -0.766 . . . . 0.0 109.65 177.188 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' MET . . . . . 0.506 ' HG3' ' OD2' ' A' ' 85' ' ' ASP . 9.9 tpt -64.72 -51.97 59.57 Favored 'General case' 0 C--O 1.209 -1.068 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.362 176.822 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.781 HG11 HG13 ' A' ' 18' ' ' ILE . 3.2 p -61.24 -30.6 48.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 C-N-CA 120.744 -0.382 . . . . 0.0 110.746 178.869 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 71.8 m -64.41 -38.09 89.8 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.264 0.554 . . . . 0.0 110.08 173.471 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' LYS . . . . . 0.476 ' HZ2' ' HB2' ' A' ' 84' ' ' LYS . 3.1 ttmp? -77.55 -44.77 27.47 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.421 -0.809 . . . . 0.0 110.381 179.865 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 85' ' ' ASP . . . . . 0.724 ' HB3' ' HG ' ' A' ' 87' ' ' LEU . 1.2 m-20 -69.57 -16.37 63.4 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 114.68 -1.146 . . . . 0.0 111.007 179.949 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 18.8 mm-40 59.53 31.12 20.78 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-N 115.764 -0.653 . . . . 0.0 112.468 178.585 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.724 ' HG ' ' HB3' ' A' ' 85' ' ' ASP . 58.6 mt -85.01 39.84 0.78 Allowed 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.279 -177.739 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.437 ' O ' ' HE2' ' A' ' 53' ' ' LYS . 0.1 OUTLIER -65.56 150.53 48.25 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-O 121.407 0.623 . . . . 0.0 112.491 -178.801 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 166.4 -134.82 3.42 Favored Glycine 0 C--O 1.229 -0.172 0 N-CA-C 109.861 -1.296 . . . . 0.0 109.861 -172.587 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.56 ' HB ' ' O ' ' A' ' 66' ' ' PHE . 48.0 mm -111.22 114.09 46.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 170.073 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 91' ' ' GLN . . . . . 0.663 ' HB2' ' CZ2' ' A' ' 38' ' ' TRP . 5.3 pt20 -141.88 146.78 36.16 Favored 'General case' 0 C--N 1.314 -0.948 0 N-CA-C 113.232 0.827 . . . . 0.0 113.232 -168.643 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 1.031 HD11 ' HB ' ' A' ' 23' ' ' VAL . 2.5 mm? -134.13 153.86 51.57 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 114.853 -1.067 . . . . 0.0 110.581 179.161 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 93' ' ' HIS . . . . . 0.459 ' O ' ' HD2' ' A' ' 16' ' ' PRO . 25.5 t-80 -129.43 125.07 35.66 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.907 -179.724 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 94' ' ' MET . . . . . 0.529 ' SD ' ' HA ' ' A' ' 98' ' ' ARG . 24.5 ttm -76.26 -85.3 0.05 Allowed 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.38 -0.827 . . . . 0.0 110.313 179.393 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 95' ' ' GLY . . . . . 0.502 ' HA2' ' O ' ' A' ' 72' ' ' ASP . . . 117.78 -74.03 0.29 Allowed Glycine 0 N--CA 1.443 -0.869 0 C-N-CA 120.1 -1.048 . . . . 0.0 113.417 177.865 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 14.8 m -135.67 -8.12 2.16 Favored 'General case' 0 C--N 1.316 -0.861 0 C-N-CA 120.557 -0.457 . . . . 0.0 111.618 -174.956 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' ASP . . . . . 0.481 ' CG ' ' HG3' ' A' ' 94' ' ' MET . 8.2 p-10 -89.97 48.21 1.55 Allowed 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.883 0.849 . . . . 0.0 110.083 -176.091 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 98' ' ' ARG . . . . . 0.542 ' O ' ' HB3' ' A' ' 101' ' ' MET . 0.0 OUTLIER -75.91 20.52 0.18 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.133 -0.94 . . . . 0.0 112.614 -172.342 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 9.9 m -70.18 -30.17 67.23 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 171.24 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' PHE . . . . . 0.508 ' HE1' ' HB3' ' A' ' 9' ' ' SER . 1.3 t80 -73.59 -25.73 60.48 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.23 -0.895 . . . . 0.0 109.53 177.898 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 101' ' ' MET . . . . . 0.542 ' HB3' ' O ' ' A' ' 98' ' ' ARG . 13.4 tpt -58.81 -52.34 66.15 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 114.769 -1.105 . . . . 0.0 109.745 175.578 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 67.9 m-20 -73.38 -26.7 61.1 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.579 -0.737 . . . . 0.0 111.318 179.486 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -60.72 -26.82 67.45 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-O 121.025 0.44 . . . . 0.0 111.062 -179.224 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' TYR . . . . . 0.52 ' HB2' HG13 ' A' ' 106' ' ' ILE . 49.4 m-85 -108.52 -3.32 18.19 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.478 178.365 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 7.7 mp 60.36 32.19 20.59 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.147 0.499 . . . . 0.0 110.316 -174.547 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' ILE . . . . . 0.583 HG23 ' HB2' ' A' ' 111' ' ' ARG . 79.0 mt -64.2 131.14 29.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.737 176.505 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 16.3 t-20 -157.59 161.02 38.69 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 178.421 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 81.35 -60.88 4.67 Favored Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 121.242 -0.504 . . . . 0.0 112.991 178.092 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.471 HD13 ' HB2' ' A' ' 39' ' ' ALA . 44.3 mt 72.08 131.04 0.04 OUTLIER Pre-proline 0 CA--C 1.535 0.371 0 C-N-CA 122.971 0.508 . . . . 0.0 110.399 -176.22 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 110' ' ' PRO . . . . . 0.414 ' HB3' ' O ' ' A' ' 37' ' ' VAL . 2.2 Cg_endo -84.15 145.89 48.9 Favored 'Cis proline' 0 N--CA 1.461 -0.384 0 C-N-CA 124.153 -1.186 . . . . 0.0 112.963 0.3 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 111' ' ' ARG . . . . . 0.629 ' HD2' ' N ' ' A' ' 112' ' ' PHE . 0.0 OUTLIER -97.34 141.67 30.14 Favored 'General case' 0 N--CA 1.446 -0.626 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 173.093 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 112' ' ' PHE . . . . . 0.629 ' N ' ' HD2' ' A' ' 111' ' ' ARG . 0.7 OUTLIER -104.04 117.86 35.3 Favored 'General case' 0 C--N 1.324 -0.537 0 O-C-N 124.024 0.827 . . . . 0.0 111.714 -177.792 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.625 ' HB ' ' HB ' ' A' ' 35' ' ' ILE . 77.4 mt -129.22 149.41 33.65 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.428 0 C-N-CA 122.359 0.263 . . . . 0.0 110.38 177.106 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 21.4 tp -137.12 139.84 41.5 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.583 0.23 . . . . 0.0 110.621 178.041 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.515 ' HG ' ' HA ' ' A' ' 121' ' ' ILE . 1.0 OUTLIER -135.8 156.64 48.49 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.897 0.379 . . . . 0.0 110.207 -179.105 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 116' ' ' ASP . . . . . 0.58 ' HB3' ' HB2' ' A' ' 120' ' ' LYS . 23.0 t70 -73.04 160.74 31.58 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.571 -0.74 . . . . 0.0 110.786 176.91 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 117' ' ' ARG . . . . . 0.401 HH11 ' HD3' ' A' ' 117' ' ' ARG . 75.0 mtt-85 -44.81 -39.94 5.72 Favored 'General case' 0 N--CA 1.466 0.345 0 O-C-N 124.536 1.147 . . . . 0.0 112.18 179.838 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 118' ' ' ASP . . . . . 0.509 ' HB3' ' HG2' ' A' ' 120' ' ' LYS . 25.1 t70 -63.43 -23.55 67.45 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.335 0.588 . . . . 0.0 111.151 -178.03 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 119' ' ' GLY . . . . . 0.587 ' HA3' HD11 ' A' ' 25' ' ' LEU . . . 105.54 19.84 10.09 Favored Glycine 0 N--CA 1.432 -1.571 0 N-CA-C 110.001 -1.24 . . . . 0.0 110.001 -169.376 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 120' ' ' LYS . . . . . 0.58 ' HB2' ' HB3' ' A' ' 116' ' ' ASP . 32.8 mmtm -91.85 107.97 19.59 Favored 'General case' 0 C--O 1.221 -0.447 0 C-N-CA 120.71 -0.396 . . . . 0.0 111.207 -175.128 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 0.655 ' H ' HD12 ' A' ' 121' ' ' ILE . 3.5 mp -47.18 113.02 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 O-C-N 123.55 0.531 . . . . 0.0 110.651 177.553 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 122' ' ' ILE . . . . . 0.404 ' H ' ' HA ' ' A' ' 115' ' ' LEU . 38.5 mm -94.34 -53.79 7.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 115.678 -0.692 . . . . 0.0 109.773 179.98 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 6.1 m -127.04 114.46 17.81 Favored 'General case' 0 N--CA 1.446 -0.653 0 CA-C-N 115.504 -0.771 . . . . 0.0 109.911 179.832 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 124' ' ' ALA . . . . . 0.533 ' O ' HG12 ' A' ' 113' ' ' ILE . . . -65.0 -32.13 73.71 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 109.446 -0.576 . . . . 0.0 109.446 174.89 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 12.4 p-10 -127.33 106.92 9.54 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.08 -0.964 . . . . 0.0 109.019 173.586 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 126' ' ' MET . . . . . 0.451 ' N ' ' HD1' ' A' ' 112' ' ' PHE . 14.1 tpt -99.55 -101.3 0.23 Allowed 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.077 -175.469 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 127' ' ' THR . . . . . 0.686 ' HB ' ' HB ' ' A' ' 134' ' ' THR . 0.2 OUTLIER -155.17 122.73 5.65 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.916 0.389 . . . . 0.0 110.885 -179.236 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 128' ' ' ARG . . . . . 0.462 ' HD3' ' OE2' ' A' ' 48' ' ' GLU . 30.1 ttm-85 -49.29 140.84 12.4 Favored Pre-proline 0 C--N 1.326 -0.454 0 CA-C-N 115.153 -0.931 . . . . 0.0 111.421 176.632 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -54.74 -38.77 91.58 Favored 'Trans proline' 0 C--N 1.35 0.615 0 C-N-CA 122.797 2.331 . . . . 0.0 113.14 178.996 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 130' ' ' SER . . . . . 0.417 ' HB2' ' CB ' ' A' ' 48' ' ' GLU . 36.4 t -72.51 -2.22 18.88 Favored 'General case' 0 CA--C 1.535 0.395 0 N-CA-C 111.657 0.243 . . . . 0.0 111.657 177.981 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 131' ' ' ASP . . . . . 0.487 ' O ' HG22 ' A' ' 134' ' ' THR . 9.5 t70 -94.45 115.16 64.95 Favored Pre-proline 0 C--N 1.326 -0.417 0 N-CA-C 109.716 -0.476 . . . . 0.0 109.716 179.204 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 132' ' ' PRO . . . . . 0.403 ' HD3' ' HA ' ' A' ' 131' ' ' ASP . 51.3 Cg_exo -56.71 -25.46 60.38 Favored 'Trans proline' 0 N--CA 1.473 0.268 0 C-N-CA 123.041 2.494 . . . . 0.0 113.602 -176.425 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 133' ' ' LYS . . . . . 0.575 ' HZ2' ' HB2' ' A' ' 133' ' ' LYS . 9.7 mtmp? -70.02 -20.36 63.27 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 121.328 -0.149 . . . . 0.0 111.017 -177.984 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 134' ' ' THR . . . . . 0.686 ' HB ' ' HB ' ' A' ' 127' ' ' THR . 1.6 t -72.67 -40.7 66.11 Favored 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 177.348 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 135' ' ' ALA . . . . . 0.625 ' HA ' ' CD2' ' A' ' 138' ' ' PHE . . . -62.85 -41.53 99.4 Favored 'General case' 0 N--CA 1.453 -0.324 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.14 176.885 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -55.74 -42.34 75.24 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.417 -0.81 . . . . 0.0 110.649 175.014 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 137' ' ' LYS . . . . . 0.866 ' HE2' ' HA ' ' A' ' 137' ' ' LYS . 10.0 mmpt? -63.35 -42.8 98.93 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.144 179.559 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 138' ' ' PHE . . . . . 0.625 ' CD2' ' HA ' ' A' ' 135' ' ' ALA . 11.2 m-85 -57.88 -54.27 48.8 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-O 120.838 0.352 . . . . 0.0 110.366 -179.866 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 49.8 m-20 -56.34 -46.16 80.05 Favored 'General case' 0 C--O 1.223 -0.301 0 CA-C-N 115.918 -0.583 . . . . 0.0 109.966 179.743 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 140' ' ' GLU . . . . . 0.472 ' HB2' ' NE2' ' A' ' 149' ' ' HIS . 28.7 tt0 -57.65 -55.22 37.62 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.544 -0.753 . . . . 0.0 111.987 -177.897 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 4.6 pp -68.54 -20.12 64.54 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-O 120.722 0.296 . . . . 0.0 111.673 -174.913 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.41 HD11 ' HB2' ' A' ' 62' ' ' LYS . 95.7 mt -89.37 -11.87 42.02 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.789 0.328 . . . . 0.0 110.489 175.424 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 71.79 30.11 66.47 Favored Glycine 0 N--CA 1.449 -0.495 0 N-CA-C 110.72 -0.952 . . . . 0.0 110.72 -176.046 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.466 ' O ' ' HG ' ' A' ' 144' ' ' LEU . 58.1 tp -88.81 16.76 6.35 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 114.559 -0.821 . . . . 0.0 110.617 -174.741 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 145' ' ' GLU . . . . . 0.699 ' HB3' ' HA ' ' A' ' 148' ' ' HIS . 47.4 mt-10 -79.99 131.31 35.78 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.322 -178.786 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -76.49 73.7 1.81 Allowed Glycine 0 N--CA 1.454 -0.125 0 N-CA-C 110.661 -0.976 . . . . 0.0 110.661 174.035 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 7.1 t-160 77.2 -40.38 0.35 Allowed 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 124.197 0.999 . . . . 0.0 108.637 -167.21 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 148' ' ' HIS . . . . . 0.699 ' HA ' ' HB3' ' A' ' 145' ' ' GLU . 0.1 OUTLIER -171.84 166.41 6.43 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.399 -0.819 . . . . 0.0 109.188 167.934 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 149' ' ' HIS . . . . . 0.472 ' NE2' ' HB2' ' A' ' 140' ' ' GLU . 37.2 m80 -34.23 -63.54 0.28 Allowed 'General case' 0 N--CA 1.477 0.878 0 O-C-N 124.275 0.984 . . . . 0.0 112.5 -176.896 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 68.9 m-70 -102.49 112.43 25.15 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 177.02 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 59.4 t-80 -45.34 103.59 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.269 0 O-C-N 124.453 1.096 . . . . 0.0 113.214 -167.052 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 53.3 t60 . . . . . 0 C--O 1.245 0.862 0 CA-C-N 115.087 -0.96 . . . . 0.0 108.693 172.864 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.571 ' HG3' ' HG ' ' A' ' 3' ' ' LEU . 11.2 tpt . . . . . 0 N--CA 1.483 1.221 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 25.9 t -59.85 -34.06 72.62 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-O 120.998 0.428 . . . . 0.0 110.336 177.03 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.571 ' HG ' ' HG3' ' A' ' 1' ' ' MET . 2.8 pp -87.06 26.82 1.1 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.358 0.599 . . . . 0.0 110.448 176.188 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 17.7 tpp180 68.0 -87.82 0.03 OUTLIER 'General case' 0 C--O 1.233 0.19 0 CA-C-N 115.12 -0.945 . . . . 0.0 111.318 -176.866 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 69.9 p 40.75 -93.16 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.576 0 O-C-N 124.271 0.982 . . . . 0.0 111.731 -170.988 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -162.61 -78.6 0.03 OUTLIER Glycine 0 N--CA 1.442 -0.934 0 N-CA-C 111.159 -0.776 . . . . 0.0 111.159 176.554 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 27.9 p-10 -73.85 153.86 89.08 Favored Pre-proline 0 C--N 1.323 -0.578 0 CA-C-O 120.892 0.377 . . . . 0.0 110.686 -179.802 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 7.2 Cg_endo -86.53 107.37 0.79 Allowed 'Trans proline' 0 N--CA 1.453 -0.895 0 C-N-CA 122.901 2.401 . . . . 0.0 111.346 172.434 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.471 ' HA ' ' HE1' ' A' ' 100' ' ' PHE . 16.6 m -96.25 111.36 23.45 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.272 -178.8 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.474 ' HB1' HD11 ' A' ' 121' ' ' ILE . . . 73.94 -40.22 0.45 Allowed 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 123.595 0.758 . . . . 0.0 111.654 179.402 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -82.91 75.69 9.79 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.764 -179.214 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.514 ' HA ' ' HB3' ' A' ' 25' ' ' LEU . 15.9 m 68.74 79.0 0.21 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.004 -0.998 . . . . 0.0 111.482 176.433 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 23.6 p90 -101.3 -179.53 4.06 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.744 179.134 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.43 ' HA ' ' HA ' ' A' ' 24' ' ' SER . 21.0 t -142.37 132.09 24.1 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 109.338 -0.616 . . . . 0.0 109.338 177.537 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' TYR . . . . . 0.533 ' HB3' ' HB3' ' A' ' 92' ' ' LEU . 12.9 m-85 -138.42 154.67 73.77 Favored Pre-proline 0 C--N 1.326 -0.456 0 CA-C-O 120.608 0.242 . . . . 0.0 111.433 -176.873 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' A' ' 15' ' ' TYR . 1.1 Cg_endo -85.09 127.89 3.55 Favored 'Trans proline' 0 N--CA 1.457 -0.652 0 C-N-CA 123.196 2.597 . . . . 0.0 113.165 179.444 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' ASP . . . . . 0.693 ' HB3' ' HB3' ' A' ' 21' ' ' LYS . 0.5 OUTLIER -72.53 161.63 30.54 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.167 -0.924 . . . . 0.0 109.746 170.815 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.532 HD12 ' CG1' ' A' ' 82' ' ' VAL . 1.4 tt -46.59 -40.37 4.45 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 O-C-N 124.032 0.832 . . . . 0.0 112.083 -175.95 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.484 ' ND2' HG23 ' A' ' 18' ' ' ILE . 27.9 m-80 -79.53 9.93 4.41 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.228 -175.439 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 77.19 25.81 63.13 Favored Glycine 0 N--CA 1.445 -0.706 0 N-CA-C 110.758 -0.937 . . . . 0.0 110.758 -174.753 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.693 ' HB3' ' HB3' ' A' ' 17' ' ' ASP . 8.0 ttpm? -94.86 106.94 18.96 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.427 -0.386 . . . . 0.0 110.328 -174.694 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 24.7 m -69.29 111.54 5.27 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.154 -178.225 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.645 ' HB ' HD11 ' A' ' 92' ' ' LEU . 47.7 t -115.82 133.86 60.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 116.139 -0.482 . . . . 0.0 109.862 178.352 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' SER . . . . . 0.43 ' HA ' ' HA ' ' A' ' 14' ' ' SER . 97.7 p -101.74 160.49 14.42 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.35 -178.434 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.586 HD12 ' HG ' ' A' ' 28' ' ' LEU . 20.8 tp -75.17 0.52 16.07 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.164 0.507 . . . . 0.0 109.961 175.45 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -75.68 -25.97 57.21 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.827 -179.734 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -74.87 -21.51 59.2 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-O 122.68 1.229 . . . . 0.0 108.87 177.137 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.586 ' HG ' HD12 ' A' ' 25' ' ' LEU . 3.9 mm? -82.7 -7.4 59.65 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 113.581 -1.645 . . . . 0.0 111.542 -170.941 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.762 ' HA ' ' O ' ' A' ' 117' ' ' ARG . 2.6 mptp? -73.65 175.92 6.7 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.239 0.542 . . . . 0.0 111.272 179.423 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 84.19 -44.51 3.34 Favored Glycine 0 N--CA 1.449 -0.49 0 CA-C-N 115.775 -0.648 . . . . 0.0 112.437 177.814 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.722 ' HD3' ' HA ' ' A' ' 63' ' ' ASP . 66.1 mttm -121.33 164.93 16.25 Favored 'General case' 0 C--N 1.323 -0.577 0 C-N-CA 122.226 0.211 . . . . 0.0 110.582 -177.848 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 44.1 m-85 -67.21 151.75 46.97 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.779 0.323 . . . . 0.0 111.24 -177.609 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.769 HD12 ' HA2' ' A' ' 119' ' ' GLY . 53.4 mt -121.5 132.63 70.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-O 120.832 0.349 . . . . 0.0 111.202 -174.623 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 86.0 t80 -121.37 125.35 46.74 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 109.071 -0.715 . . . . 0.0 109.071 172.74 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.557 HG12 ' HB ' ' A' ' 67' ' ' VAL . 64.2 mt -114.44 134.47 57.28 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-O 120.955 0.407 . . . . 0.0 110.718 -177.877 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.536 ' HA ' ' O ' ' A' ' 111' ' ' ARG . 24.3 t0 -126.68 158.55 36.12 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.372 -0.831 . . . . 0.0 109.0 177.121 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.575 ' HA ' ' O ' ' A' ' 69' ' ' LEU . 59.2 t -105.74 111.47 35.09 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.904 0 C-N-CA 120.228 -0.589 . . . . 0.0 110.816 173.164 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' TRP . . . . . 0.662 ' CZ2' ' HB2' ' A' ' 91' ' ' GLN . 0.6 OUTLIER -95.22 133.27 39.28 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.275 178.716 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.555 ' HB3' ' HB3' ' A' ' 42' ' ' CYS . . . -146.85 163.02 37.42 Favored 'General case' 0 N--CA 1.464 0.266 0 N-CA-C 111.7 0.259 . . . . 0.0 111.7 -175.722 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.715 ' HB ' ' CE3' ' A' ' 78' ' ' TRP . 8.2 t -98.34 -35.72 10.22 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-O 120.885 0.374 . . . . 0.0 110.762 176.693 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' TRP . . . . . 0.419 ' HE1' ' HA ' ' A' ' 72' ' ' ASP . 22.6 p-90 -86.39 16.27 4.66 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.164 0.507 . . . . 0.0 110.547 -178.994 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' CYS . . . . . 0.786 ' SG ' ' HB3' ' A' ' 45' ' ' CYS . 14.8 p -75.37 -56.55 4.6 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.611 -0.722 . . . . 0.0 111.791 -175.775 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 98.15 -99.37 2.19 Favored Glycine 0 CA--C 1.521 0.424 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.101 -176.161 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -55.32 -28.35 62.23 Favored 'Trans proline' 0 C--N 1.352 0.714 0 C-N-CA 123.331 2.688 . . . . 0.0 113.274 -179.635 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' CYS . . . . . 0.832 ' HB2' ' HD3' ' A' ' 110' ' ' PRO . 18.2 t -57.57 -22.85 47.34 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-O 120.979 0.419 . . . . 0.0 111.428 179.425 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.55 ' HA ' ' CD1' ' A' ' 49' ' ' LEU . 33.0 mtp-105 -70.9 -15.67 62.63 Favored 'General case' 0 C--N 1.324 -0.5 0 C-N-CA 120.577 -0.449 . . . . 0.0 111.301 -178.748 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -84.23 -12.97 75.1 Favored Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 120.678 -0.772 . . . . 0.0 111.67 176.08 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.68 ' HB3' ' HB2' ' A' ' 129' ' ' PRO . 0.5 OUTLIER -91.51 -26.34 18.83 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.135 0.493 . . . . 0.0 109.884 -179.342 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.809 HD23 HD12 ' A' ' 52' ' ' LEU . 54.9 mt -51.53 -45.27 90.77 Favored Pre-proline 0 CA--C 1.536 0.406 0 CA-C-N 115.315 -0.857 . . . . 0.0 113.147 -176.664 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.536 ' HD2' ' N ' ' A' ' 49' ' ' LEU . 10.3 Cg_endo -54.2 -36.42 85.79 Favored 'Trans proline' 0 C--N 1.354 0.818 0 C-N-CA 121.683 1.589 . . . . 0.0 112.048 174.426 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.53 ' HA ' ' HB2' ' A' ' 54' ' ' GLU . . . -82.21 -22.44 35.93 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.329 0.585 . . . . 0.0 110.106 -178.443 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.809 HD12 HD23 ' A' ' 49' ' ' LEU . 27.3 mt -64.74 -37.26 86.99 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.423 -0.808 . . . . 0.0 110.156 175.423 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.453 ' HE3' ' HB3' ' A' ' 53' ' ' LYS . 10.2 mtpp -75.2 -40.21 59.44 Favored 'General case' 0 CA--C 1.517 -0.322 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.951 173.567 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.53 ' HB2' ' HA ' ' A' ' 51' ' ' ALA . 6.4 mm-40 -47.16 -50.38 20.65 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.538 -0.755 . . . . 0.0 110.678 173.213 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 73.6 mt -59.01 -55.35 36.3 Favored 'General case' 0 N--CA 1.446 -0.631 0 CA-C-N 115.592 -0.731 . . . . 0.0 111.072 176.261 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.62 ' OE2' ' HB3' ' A' ' 88' ' ' LYS . 37.7 tt0 -45.01 -60.64 1.98 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.477 -0.783 . . . . 0.0 112.558 179.776 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 61.5 mt-10 -74.42 -31.99 62.5 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 111.96 0.356 . . . . 0.0 111.96 -169.86 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 49.5 mttp -78.38 -40.67 35.54 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.131 0.491 . . . . 0.0 111.081 -178.169 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.586 ' HB2' ' HE2' ' A' ' 66' ' ' PHE . 73.2 m-85 -102.78 8.43 39.38 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.497 -173.915 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.453 ' HB2' ' O ' ' A' ' 56' ' ' GLU . . . -59.53 131.41 50.85 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.657 172.156 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 77.13 11.01 85.95 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.962 -0.637 . . . . 0.0 113.027 176.147 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.416 ' HA ' ' HD3' ' A' ' 62' ' ' LYS . 33.5 mmtm -89.13 -136.11 0.11 Allowed 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.966 -0.383 . . . . 0.0 109.966 177.624 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.722 ' HA ' ' HD3' ' A' ' 31' ' ' LYS . 4.6 t0 -120.02 42.14 3.01 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 121.542 0.687 . . . . 0.0 109.778 179.008 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.438 HG21 ' HB3' ' A' ' 59' ' ' TYR . 7.3 tp -148.81 151.21 13.35 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 115.083 -0.962 . . . . 0.0 109.868 -171.624 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' HIS . . . . . 0.581 ' NE2' ' HB2' ' A' ' 31' ' ' LYS . 80.9 m-70 -126.99 137.8 53.16 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 175.128 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' PHE . . . . . 0.586 ' HE2' ' HB2' ' A' ' 59' ' ' TYR . 91.0 m-85 -110.43 109.98 20.57 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 120.624 0.249 . . . . 0.0 110.415 178.714 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.557 ' HB ' HG12 ' A' ' 35' ' ' ILE . 49.8 t -109.1 109.26 27.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.156 -177.115 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 50.2 m -91.68 114.0 26.41 Favored 'General case' 0 C--N 1.316 -0.884 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 174.144 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.575 ' O ' ' HA ' ' A' ' 37' ' ' VAL . 66.7 tp -109.83 130.02 55.57 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.555 -0.293 . . . . 0.0 110.266 178.649 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' SER . . . . . 0.565 ' O ' ' HB3' ' A' ' 94' ' ' MET . 1.8 t -109.02 119.23 38.94 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 111.93 0.344 . . . . 0.0 111.93 -173.758 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' CYS . . . . . 0.559 ' HB3' ' SD ' ' A' ' 101' ' ' MET . 33.6 m -88.14 19.29 3.76 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.519 177.368 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.562 ' OD2' HG22 ' A' ' 40' ' ' THR . 2.2 m-20 -73.33 113.99 11.04 Favored 'General case' 0 CA--C 1.515 -0.403 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.705 -178.54 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.538 ' HA ' ' O ' ' A' ' 95' ' ' GLY . 47.3 tttm -71.63 -17.53 62.26 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-O 121.155 0.502 . . . . 0.0 110.312 177.812 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 4.6 m-20 -83.83 91.31 7.52 Favored 'General case' 0 CA--C 1.515 -0.392 0 N-CA-C 109.025 -0.731 . . . . 0.0 109.025 175.945 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.614 ' O ' ' HG2' ' A' ' 79' ' ' GLU . 13.0 tmtt? -64.98 -65.09 0.72 Allowed 'General case' 0 C--N 1.322 -0.629 0 C-N-CA 120.066 -0.654 . . . . 0.0 110.984 -176.69 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 11.1 tmtt? -52.24 -45.66 65.41 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.2 -0.909 . . . . 0.0 111.195 -176.357 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.695 ' HA ' ' ND2' ' A' ' 80' ' ' ASN . . . -61.77 -38.69 88.96 Favored 'General case' 0 C--O 1.246 0.881 0 CA-C-O 121.572 0.701 . . . . 0.0 110.644 -177.281 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 78' ' ' TRP . . . . . 0.715 ' CE3' ' HB ' ' A' ' 40' ' ' THR . 4.7 t-105 -70.14 -47.55 61.24 Favored 'General case' 0 N--CA 1.438 -1.042 0 CA-C-N 115.099 -0.955 . . . . 0.0 110.634 -176.798 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.614 ' HG2' ' O ' ' A' ' 75' ' ' LYS . 4.0 mm-40 -47.25 -44.78 23.13 Favored 'General case' 0 C--O 1.236 0.355 0 O-C-N 123.418 0.449 . . . . 0.0 111.774 175.347 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' ASN . . . . . 0.695 ' ND2' ' HA ' ' A' ' 77' ' ' ALA . 1.8 m-80 -59.83 -50.84 72.21 Favored 'General case' 0 CA--C 1.518 -0.288 0 C-N-CA 120.196 -0.601 . . . . 0.0 110.468 179.501 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 23.1 ttm -64.27 -42.32 96.49 Favored 'General case' 0 C--N 1.332 -0.156 0 N-CA-C 112.578 0.585 . . . . 0.0 112.578 -173.016 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.532 ' CG1' HD12 ' A' ' 18' ' ' ILE . 1.3 p -62.45 -37.43 78.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 C-N-CA 120.061 -0.656 . . . . 0.0 110.714 177.884 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 32.8 m -70.74 -35.75 72.82 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.221 0.534 . . . . 0.0 110.532 178.427 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 22.0 tttm -73.4 -52.29 14.31 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.721 -0.672 . . . . 0.0 111.571 -178.554 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -85.81 6.74 26.71 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.444 -0.798 . . . . 0.0 111.899 -173.404 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 89.8 mt-30 57.84 38.34 27.16 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 122.927 0.491 . . . . 0.0 111.605 175.237 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.646 HD22 HD22 ' A' ' 49' ' ' LEU . 44.4 mt -73.72 111.48 8.91 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.515 -177.08 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.62 ' HB3' ' OE2' ' A' ' 56' ' ' GLU . 3.9 mmmp? -105.51 -157.1 0.6 Allowed 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 112.537 0.569 . . . . 0.0 112.537 -177.346 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 97.04 176.76 34.89 Favored Glycine 0 N--CA 1.447 -0.591 0 N-CA-C 110.507 -1.037 . . . . 0.0 110.507 -169.254 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.405 ' HB ' ' O ' ' A' ' 66' ' ' PHE . 63.0 mt -83.22 110.94 18.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 N-CA-C 107.065 -1.457 . . . . 0.0 107.065 169.873 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 91' ' ' GLN . . . . . 0.662 ' HB2' ' CZ2' ' A' ' 38' ' ' TRP . 1.3 pt20 -122.78 123.21 40.52 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-O 121.666 0.746 . . . . 0.0 112.837 -164.114 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.645 HD11 ' HB ' ' A' ' 23' ' ' VAL . 2.5 mm? -121.23 149.93 42.12 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 114.937 -1.029 . . . . 0.0 109.318 178.272 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 93' ' ' HIS . . . . . 0.404 ' CE1' ' HA ' ' A' ' 75' ' ' LYS . 16.1 t-80 -120.33 135.23 55.08 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-O 121.642 0.734 . . . . 0.0 111.589 -176.113 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 94' ' ' MET . . . . . 0.784 ' HG3' ' HB2' ' A' ' 97' ' ' ASP . 25.7 ttm -103.21 91.96 4.31 Favored 'General case' 0 N--CA 1.442 -0.871 0 CA-C-N 114.391 -1.277 . . . . 0.0 108.16 178.933 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 95' ' ' GLY . . . . . 0.538 ' O ' ' HA ' ' A' ' 73' ' ' LYS . . . -57.76 -55.19 31.86 Favored Glycine 0 C--N 1.318 -0.426 0 CA-C-N 115.169 -0.923 . . . . 0.0 113.807 -175.256 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 10.9 m -146.94 13.0 1.12 Allowed 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 122.064 0.935 . . . . 0.0 109.49 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' ASP . . . . . 0.784 ' HB2' ' HG3' ' A' ' 94' ' ' MET . 0.7 OUTLIER -81.56 31.83 0.35 Allowed 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 114.838 -1.074 . . . . 0.0 110.462 -175.471 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 98' ' ' ARG . . . . . 0.549 ' HA ' ' SD ' ' A' ' 94' ' ' MET . 0.0 OUTLIER -67.52 0.03 3.42 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 113.362 0.875 . . . . 0.0 113.362 -170.619 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 99' ' ' THR . . . . . 0.457 ' HA ' ' NH2' ' A' ' 98' ' ' ARG . 10.4 m -66.01 -19.23 65.79 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.66 0.743 . . . . 0.0 109.568 172.806 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 100' ' ' PHE . . . . . 0.471 ' HE1' ' HA ' ' A' ' 9' ' ' SER . 16.4 t80 -79.55 -24.14 42.34 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 115.317 -0.856 . . . . 0.0 110.135 177.773 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 101' ' ' MET . . . . . 0.559 ' SD ' ' HB3' ' A' ' 71' ' ' CYS . 88.6 mtp -60.17 -48.12 83.06 Favored 'General case' 0 CA--C 1.515 -0.395 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 174.357 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 67.5 m-20 -56.04 -40.89 74.17 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.224 -0.898 . . . . 0.0 111.088 176.577 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -63.25 -28.64 70.17 Favored 'General case' 0 N--CA 1.462 0.131 0 CA-C-N 116.198 -0.455 . . . . 0.0 112.075 -176.058 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' TYR . . . . . 0.94 ' HB3' HG23 ' A' ' 106' ' ' ILE . 2.8 m-85 -107.49 -6.36 17.08 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 111.937 0.347 . . . . 0.0 111.937 -178.602 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 3.4 mm? 57.94 33.06 22.77 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-O 121.425 0.631 . . . . 0.0 110.269 -174.049 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' ILE . . . . . 0.94 HG23 ' HB3' ' A' ' 104' ' ' TYR . 32.9 pt -88.93 36.18 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.248 -177.854 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 5.0 p-10 -67.28 -28.34 67.94 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.962 0.41 . . . . 0.0 110.376 179.266 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -92.06 103.5 3.06 Favored Glycine 0 N--CA 1.444 -0.769 0 N-CA-C 111.106 -0.798 . . . . 0.0 111.106 175.608 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.525 HG21 HG11 ' A' ' 37' ' ' VAL . 34.3 pt -110.79 153.46 43.69 Favored Pre-proline 0 C--N 1.324 -0.501 0 O-C-N 123.315 0.068 . . . . 0.0 110.943 -178.131 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 110' ' ' PRO . . . . . 0.832 ' HD3' ' HB2' ' A' ' 45' ' ' CYS . 42.2 Cg_endo -68.98 150.5 88.26 Favored 'Cis proline' 0 C--N 1.35 0.654 0 C-N-CA 123.547 -1.439 . . . . 0.0 112.428 0.982 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 111' ' ' ARG . . . . . 0.599 ' HG3' HG22 ' A' ' 106' ' ' ILE . 0.0 OUTLIER -114.52 127.9 56.05 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.209 -177.215 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 112' ' ' PHE . . . . . 0.556 ' HB2' ' HB3' ' A' ' 126' ' ' MET . 0.2 OUTLIER -102.47 114.35 28.48 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 114.701 -1.136 . . . . 0.0 110.608 -177.504 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 86.8 mt -130.75 143.51 40.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 120.85 0.357 . . . . 0.0 111.119 -178.244 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 48.2 tp -124.05 134.63 53.37 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.032 178.762 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.454 ' N ' HD12 ' A' ' 115' ' ' LEU . 1.6 mp -134.36 160.47 37.84 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.225 0.536 . . . . 0.0 110.615 -177.341 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 116' ' ' ASP . . . . . 0.51 ' HB2' HD11 ' A' ' 122' ' ' ILE . 28.5 t70 -77.17 167.96 20.87 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.193 -0.912 . . . . 0.0 110.351 177.288 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 117' ' ' ARG . . . . . 0.762 ' O ' ' HA ' ' A' ' 29' ' ' LYS . 81.9 mtt-85 -47.97 -37.66 15.06 Favored 'General case' 0 C--N 1.327 -0.382 0 O-C-N 124.402 1.064 . . . . 0.0 112.446 -177.524 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 118' ' ' ASP . . . . . 0.577 ' HA ' ' HG3' ' A' ' 29' ' ' LYS . 25.4 t0 -76.84 -0.1 22.77 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.532 0.682 . . . . 0.0 111.244 -178.922 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 119' ' ' GLY . . . . . 0.769 ' HA2' HD12 ' A' ' 33' ' ' ILE . . . 82.86 24.53 52.64 Favored Glycine 0 N--CA 1.431 -1.678 0 N-CA-C 110.058 -1.217 . . . . 0.0 110.058 -171.523 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 120' ' ' LYS . . . . . 0.485 ' HB2' ' HB3' ' A' ' 116' ' ' ASP . 44.9 mmtm -92.73 106.22 18.23 Favored 'General case' 0 C--O 1.222 -0.371 0 C-N-CA 120.601 -0.439 . . . . 0.0 111.466 -178.047 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 0.702 ' H ' HD12 ' A' ' 121' ' ' ILE . 4.4 mp -41.51 117.58 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.397 0 CA-C-N 115.416 -0.811 . . . . 0.0 112.273 -177.95 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 122' ' ' ILE . . . . . 0.51 HD11 ' HB2' ' A' ' 116' ' ' ASP . 45.6 mm -98.95 -43.62 11.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 115.392 -0.822 . . . . 0.0 109.313 176.288 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 16.2 m -135.6 114.32 11.9 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.305 -0.861 . . . . 0.0 109.917 178.428 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -77.49 -12.38 59.95 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.24 0.543 . . . . 0.0 110.555 179.681 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 6.5 t30 -143.65 98.58 3.27 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.186 -0.915 . . . . 0.0 108.573 175.686 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 126' ' ' MET . . . . . 0.556 ' HB3' ' HB2' ' A' ' 112' ' ' PHE . 17.6 tpt -77.79 -86.6 0.06 Allowed 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.649 -174.546 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 8.4 m -155.87 -73.01 0.11 Allowed 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.945 0.402 . . . . 0.0 110.055 -178.889 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 128' ' ' ARG . . . . . 0.775 ' HB3' ' HB2' ' A' ' 131' ' ' ASP . 44.9 ttt180 -178.35 143.17 0.45 Allowed Pre-proline 0 N--CA 1.44 -0.955 0 CA-C-N 115.508 -0.769 . . . . 0.0 109.159 -179.226 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 129' ' ' PRO . . . . . 0.68 ' HB2' ' HB3' ' A' ' 48' ' ' GLU . 57.3 Cg_exo -52.72 -45.45 40.35 Favored 'Trans proline' 0 C--N 1.346 0.431 0 C-N-CA 122.577 2.185 . . . . 0.0 112.856 178.405 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 130' ' ' SER . . . . . 0.534 ' HB3' ' HA ' ' A' ' 48' ' ' GLU . 31.2 p -96.22 5.7 50.43 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 112.279 0.474 . . . . 0.0 112.279 -176.717 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 131' ' ' ASP . . . . . 0.796 ' OD1' ' HG2' ' A' ' 133' ' ' LYS . 11.3 t70 -89.3 128.43 51.36 Favored Pre-proline 0 C--O 1.235 0.312 0 C-N-CA 120.101 -0.64 . . . . 0.0 110.469 -178.658 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 132' ' ' PRO . . . . . 0.621 ' O ' ' HG3' ' A' ' 136' ' ' GLU . 82.6 Cg_exo -46.92 -41.23 25.71 Favored 'Trans proline' 0 C--N 1.344 0.325 0 C-N-CA 124.048 3.165 . . . . 0.0 114.944 -178.042 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 133' ' ' LYS . . . . . 0.796 ' HG2' ' OD1' ' A' ' 131' ' ' ASP . 27.7 mmtm -53.61 -37.71 63.29 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-O 121.209 0.528 . . . . 0.0 110.194 -172.097 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 134' ' ' THR . . . . . 0.722 HG22 ' CZ ' ' A' ' 138' ' ' PHE . 4.9 m -59.31 -59.62 5.16 Favored 'General case' 0 N--CA 1.446 -0.642 0 CA-C-N 115.23 -0.895 . . . . 0.0 110.657 178.0 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 135' ' ' ALA . . . . . 0.546 ' HA ' ' CD2' ' A' ' 138' ' ' PHE . . . -61.54 -41.21 97.0 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.862 -179.626 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 136' ' ' GLU . . . . . 0.891 ' HB3' ' HA3' ' A' ' 146' ' ' GLY . 19.9 mt-10 -66.92 -28.77 68.57 Favored 'General case' 0 CA--C 1.514 -0.423 0 CA-C-O 121.409 0.623 . . . . 0.0 110.511 -177.154 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 137' ' ' LYS . . . . . 0.548 ' O ' ' HG ' ' A' ' 141' ' ' LEU . 60.8 tttp -75.06 -31.23 61.2 Favored 'General case' 0 C--N 1.317 -0.848 0 CA-C-N 115.298 -0.865 . . . . 0.0 111.024 177.119 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 138' ' ' PHE . . . . . 0.722 ' CZ ' HG22 ' A' ' 134' ' ' THR . 12.2 m-30 -62.08 -41.06 97.79 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 173.69 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 139' ' ' ASN . . . . . 0.42 ' HB2' ' O ' ' A' ' 136' ' ' GLU . 5.7 m-20 -57.48 -53.15 61.37 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.02 -0.991 . . . . 0.0 110.157 172.901 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 140' ' ' GLU . . . . . 0.538 ' HB3' ' O ' ' A' ' 137' ' ' LYS . 8.0 tt0 -43.07 -51.55 5.75 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 123.14 0.576 . . . . 0.0 111.958 171.392 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.548 ' HG ' ' O ' ' A' ' 137' ' ' LYS . 94.2 mt -58.34 -37.92 76.14 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.9 -178.112 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 11.2 mp -84.95 -7.16 59.27 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.89 0.376 . . . . 0.0 111.163 -179.764 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 89.44 6.16 71.2 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 121.132 -0.556 . . . . 0.0 111.799 179.284 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 65.5 tp -86.71 -25.75 24.6 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.483 -0.359 . . . . 0.0 110.405 -179.458 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 145' ' ' GLU . . . . . 0.579 ' HB3' ' CE1' ' A' ' 147' ' ' HIS . 3.2 tt0 58.5 154.29 0.02 OUTLIER 'General case' 0 N--CA 1.452 -0.333 0 N-CA-C 114.524 1.305 . . . . 0.0 114.524 -177.8 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 146' ' ' GLY . . . . . 0.891 ' HA3' ' HB3' ' A' ' 136' ' ' GLU . . . -86.35 98.74 2.35 Favored Glycine 0 N--CA 1.444 -0.823 0 N-CA-C 110.252 -1.139 . . . . 0.0 110.252 169.682 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 147' ' ' HIS . . . . . 0.579 ' CE1' ' HB3' ' A' ' 145' ' ' GLU . 4.5 m-70 -82.22 28.31 0.45 Allowed 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 112.319 0.489 . . . . 0.0 112.319 -171.616 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 148' ' ' HIS . . . . . 0.58 ' HB2' ' OE1' ' A' ' 136' ' ' GLU . 0.0 OUTLIER -57.43 -30.32 64.88 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.288 0.566 . . . . 0.0 110.673 176.809 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 37.8 p-80 -126.76 21.53 6.98 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.343 -0.844 . . . . 0.0 109.687 -179.42 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 2.9 t-80 -126.23 103.99 7.98 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 -176.305 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 29.5 m170 -75.48 -0.47 20.28 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 111.848 0.314 . . . . 0.0 111.848 -174.554 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 25.3 t60 . . . . . 0 C--O 1.245 0.839 0 CA-C-O 118.149 -0.929 . . . . 0.0 109.136 173.795 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 85.8 mmm . . . . . 0 N--CA 1.481 1.109 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 14.6 m -66.73 117.41 8.83 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 123.281 0.363 . . . . 0.0 110.408 178.738 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 80.1 mt -149.86 102.33 3.12 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-N 116.328 -0.397 . . . . 0.0 110.651 179.107 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -166.25 28.71 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.31 0.576 . . . . 0.0 109.87 175.233 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' SER . . . . . 0.62 ' HB2' ' O ' ' A' ' 7' ' ' ASN . 2.0 m -146.54 -179.11 6.54 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 -179.06 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -67.2 -20.18 70.93 Favored Glycine 0 C--N 1.331 0.271 0 N-CA-C 110.898 -0.881 . . . . 0.0 110.898 171.034 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' ASN . . . . . 0.62 ' O ' ' HB2' ' A' ' 5' ' ' SER . 41.7 m-80 -125.64 158.53 64.61 Favored Pre-proline 0 C--N 1.326 -0.432 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 173.332 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_exo -54.24 -35.88 84.46 Favored 'Trans proline' 0 CA--C 1.533 0.472 0 C-N-CA 122.5 2.134 . . . . 0.0 113.035 178.351 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 9.2 m -73.66 -172.79 1.32 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.083 0.468 . . . . 0.0 111.456 -178.389 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . 64.81 24.15 12.77 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-N 115.651 -0.704 . . . . 0.0 111.121 -179.104 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -155.24 101.45 2.22 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.98 177.83 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.477 ' HA ' HD23 ' A' ' 25' ' ' LEU . 36.9 m 65.01 103.85 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.474 0 CA-C-O 121.398 0.618 . . . . 0.0 112.128 178.128 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 36.5 p90 -125.81 171.03 11.02 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.426 178.487 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 30.7 m -140.91 129.21 22.34 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.899 -0.408 . . . . 0.0 109.899 178.227 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 45.8 m-85 -144.46 158.06 54.82 Favored Pre-proline 0 C--N 1.327 -0.372 0 CA-C-O 120.612 0.244 . . . . 0.0 110.841 -177.599 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_endo -87.09 128.5 2.71 Favored 'Trans proline' 0 N--CA 1.455 -0.751 0 C-N-CA 123.028 2.485 . . . . 0.0 113.023 178.882 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' ASP . . . . . 1.135 ' HB3' ' HB3' ' A' ' 21' ' ' LYS . 0.8 OUTLIER -66.32 162.77 19.5 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.409 -0.814 . . . . 0.0 109.735 170.687 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.842 HG13 HG11 ' A' ' 82' ' ' VAL . 24.5 mm -44.23 -45.43 2.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 O-C-N 124.27 0.981 . . . . 0.0 112.392 -177.367 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 33.2 m-80 -79.54 2.98 20.18 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.674 -172.941 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 87.5 35.79 9.17 Favored Glycine 0 N--CA 1.448 -0.557 0 N-CA-C 110.574 -1.011 . . . . 0.0 110.574 -174.526 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 1.135 ' HB3' ' HB3' ' A' ' 17' ' ' ASP . 35.5 ttmt -100.92 107.33 18.8 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.209 -0.495 . . . . 0.0 110.412 -174.835 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 25.2 m -74.34 105.73 5.64 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 120.924 0.392 . . . . 0.0 110.976 -177.137 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.629 ' HB ' HD11 ' A' ' 92' ' ' LEU . 45.8 t -117.99 138.07 49.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 116.064 -0.517 . . . . 0.0 109.668 179.192 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 80.3 p -113.6 156.5 23.55 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 116.316 -0.402 . . . . 0.0 109.93 179.263 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.519 ' O ' ' HB2' ' A' ' 29' ' ' LYS . 34.4 tp -70.42 -9.69 57.09 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.16 177.543 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -80.96 -26.98 36.2 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.494 177.288 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -74.15 -34.72 63.94 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.548 0.69 . . . . 0.0 110.107 175.795 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.496 HD11 HG21 ' A' ' 90' ' ' ILE . 66.6 mt -91.78 0.44 57.49 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.322 -0.854 . . . . 0.0 110.557 179.226 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.519 ' HB2' ' O ' ' A' ' 25' ' ' LEU . 60.2 tttp -74.54 150.63 39.69 Favored 'General case' 0 N--CA 1.443 -0.808 0 CA-C-N 115.134 -0.939 . . . . 0.0 110.633 -176.504 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 94.65 5.41 61.51 Favored Glycine 0 N--CA 1.447 -0.601 0 N-CA-C 110.576 -1.01 . . . . 0.0 110.576 -175.128 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 1.032 ' HD2' ' HA ' ' A' ' 63' ' ' ASP . 11.0 tppt? -146.0 151.44 37.78 Favored 'General case' 0 N--CA 1.446 -0.646 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 -177.982 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.41 ' HB2' HG22 ' A' ' 64' ' ' ILE . 61.3 m-85 -65.92 151.28 47.11 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 120.985 -0.286 . . . . 0.0 110.652 179.793 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.563 ' HB ' ' HB2' ' A' ' 115' ' ' LEU . 46.1 mm -127.08 125.86 67.13 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.975 -176.068 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' TYR . . . . . 0.445 ' CE2' ' HB2' ' A' ' 36' ' ' ASP . 59.0 t80 -105.43 112.01 24.95 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 170.554 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.57 ' HB ' ' HB ' ' A' ' 113' ' ' ILE . 40.3 mt -92.14 120.72 41.82 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-O 121.298 0.57 . . . . 0.0 110.461 179.77 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.561 ' O ' ' HA ' ' A' ' 68' ' ' SER . 15.9 t70 -120.24 125.03 47.11 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 115.133 -0.94 . . . . 0.0 109.231 178.919 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.661 HG11 HG21 ' A' ' 109' ' ' ILE . 21.5 t -82.5 113.92 22.53 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.913 0 C-N-CA 119.817 -0.753 . . . . 0.0 110.717 -178.981 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' TRP . . . . . 0.61 ' CZ2' ' HB2' ' A' ' 91' ' ' GLN . 0.5 OUTLIER -108.95 135.82 49.5 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.268 -0.878 . . . . 0.0 108.926 -177.967 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.624 ' HB3' ' HB3' ' A' ' 42' ' ' CYS . . . -145.04 172.36 13.17 Favored 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 120.433 -0.507 . . . . 0.0 111.96 -176.919 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -89.18 -43.17 11.21 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.661 0.743 . . . . 0.0 109.855 176.95 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' TRP . . . . . 0.551 ' CH2' HD11 ' A' ' 109' ' ' ILE . 11.1 p-90 -88.39 12.35 14.43 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 114.957 -1.02 . . . . 0.0 111.233 -176.056 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' CYS . . . . . 0.755 ' SG ' ' HB3' ' A' ' 45' ' ' CYS . 28.3 p -79.33 -17.86 53.68 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.154 -178.792 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 57.49 -107.06 0.88 Allowed Glycine 0 CA--C 1.522 0.508 0 CA-C-N 116.057 -0.519 . . . . 0.0 113.829 177.258 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_exo -51.6 -25.77 20.73 Favored 'Trans proline' 0 C--N 1.353 0.776 0 C-N-CA 123.746 2.964 . . . . 0.0 113.688 -177.348 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' CYS . . . . . 0.756 ' HB2' ' HD3' ' A' ' 110' ' ' PRO . 7.0 t -52.95 -30.68 36.11 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-O 120.844 0.354 . . . . 0.0 111.3 176.838 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.579 ' HA ' ' HG ' ' A' ' 49' ' ' LEU . 64.9 mtp180 -68.15 -11.42 59.14 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.835 -0.62 . . . . 0.0 111.677 -175.679 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -69.56 -33.23 71.75 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.919 -0.658 . . . . 0.0 112.595 179.802 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.551 ' OE2' ' HD3' ' A' ' 128' ' ' ARG . 28.0 mt-10 -93.6 -9.0 39.55 Favored 'General case' 0 C--N 1.328 -0.366 0 O-C-N 122.738 -0.272 . . . . 0.0 111.061 -177.561 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.617 ' HB3' HD22 ' A' ' 87' ' ' LEU . 81.4 mt -55.52 -46.69 99.68 Favored Pre-proline 0 C--N 1.326 -0.426 0 CA-C-N 116.558 -0.292 . . . . 0.0 111.455 179.331 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 1.004 ' HA ' ' HE3' ' A' ' 53' ' ' LYS . 51.5 Cg_exo -55.34 -43.95 53.56 Favored 'Trans proline' 0 C--N 1.356 0.956 0 C-N-CA 121.635 1.556 . . . . 0.0 111.895 170.781 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -69.02 -24.29 64.19 Favored 'General case' 0 N--CA 1.462 0.138 0 CA-C-O 121.13 0.49 . . . . 0.0 110.686 -174.483 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 8.7 tt -68.42 -39.28 81.65 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.486 -0.779 . . . . 0.0 109.252 178.015 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 1.004 ' HE3' ' HA ' ' A' ' 50' ' ' PRO . 8.4 mtmp? -62.84 -51.48 66.88 Favored 'General case' 0 CA--C 1.519 -0.248 0 CA-C-O 121.73 0.776 . . . . 0.0 109.375 177.302 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -57.82 -37.81 74.48 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 114.977 -1.01 . . . . 0.0 111.205 179.347 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.486 HD21 ' HE2' ' A' ' 138' ' ' PHE . 12.9 tp -73.98 -40.7 62.79 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.543 -0.299 . . . . 0.0 110.64 179.583 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.651 ' HG3' ' O ' ' A' ' 53' ' ' LYS . 0.0 OUTLIER -66.24 -39.52 89.6 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.711 -0.222 . . . . 0.0 110.473 -177.496 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 51.5 mt-10 -76.44 -28.27 56.53 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.009 0.433 . . . . 0.0 110.73 -179.255 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 63.7 tttm -70.21 -31.36 68.76 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.862 176.489 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.453 ' HB3' HD11 ' A' ' 64' ' ' ILE . 88.0 m-85 -112.17 5.71 18.65 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 112.0 0.37 . . . . 0.0 112.0 -176.099 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -62.93 142.97 58.11 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.618 175.687 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 95.11 -14.24 65.59 Favored Glycine 0 N--CA 1.446 -0.673 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.054 -179.743 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.764 ' HE2' ' HB3' ' A' ' 142' ' ' LEU . 18.7 mmmt -104.13 -169.86 1.69 Allowed 'General case' 0 N--CA 1.448 -0.532 0 CA-C-O 121.271 0.558 . . . . 0.0 111.463 178.859 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 1.032 ' HA ' ' HD2' ' A' ' 31' ' ' LYS . 28.0 m-20 -87.91 34.12 0.72 Allowed 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 113.401 0.889 . . . . 0.0 113.401 -165.848 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.453 HD11 ' HB3' ' A' ' 59' ' ' TYR . 27.6 pt -140.57 135.8 35.27 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-O 120.786 0.327 . . . . 0.0 110.639 176.213 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' HIS . . . . . 0.515 ' HB2' HD13 ' A' ' 33' ' ' ILE . 29.1 m170 -109.61 144.25 38.2 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.074 175.889 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' PHE . . . . . 0.447 ' HE2' HD23 ' A' ' 55' ' ' LEU . 59.8 m-85 -100.78 114.6 28.53 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 173.468 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.64 ' HA ' ' O ' ' A' ' 90' ' ' ILE . 58.2 t -123.35 115.07 44.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-O 120.974 0.416 . . . . 0.0 111.125 -175.315 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' SER . . . . . 0.561 ' HA ' ' O ' ' A' ' 36' ' ' ASP . 50.9 m -96.48 131.15 43.37 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.688 179.01 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.429 ' O ' ' HA ' ' A' ' 37' ' ' VAL . 84.8 mt -120.9 139.03 53.78 Favored 'General case' 0 N--CA 1.468 0.47 0 N-CA-C 110.51 -0.182 . . . . 0.0 110.51 178.062 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' SER . . . . . 0.589 ' HB2' ' O ' ' A' ' 38' ' ' TRP . 0.8 OUTLIER -123.69 129.94 51.88 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 112.5 0.556 . . . . 0.0 112.5 -174.374 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 4.8 p -93.65 23.03 4.95 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.301 173.995 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.475 ' OD1' ' HA ' ' A' ' 39' ' ' ALA . 3.0 m-20 -79.47 108.02 12.68 Favored 'General case' 0 N--CA 1.467 0.382 0 O-C-N 122.339 -0.226 . . . . 0.0 111.013 -177.389 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 16.2 ptpt -68.12 -20.95 64.96 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 120.979 0.418 . . . . 0.0 110.658 178.09 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' ASN . . . . . 0.578 ' HB2' ' HB3' ' A' ' 77' ' ' ALA . 1.0 OUTLIER -79.42 69.09 5.61 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.394 174.122 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 11.9 tttt -58.73 -51.24 70.8 Favored 'General case' 0 C--O 1.218 -0.564 0 CA-C-N 116.63 -0.259 . . . . 0.0 111.649 -174.97 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.662 ' HA ' ' OE2' ' A' ' 79' ' ' GLU . 0.2 OUTLIER -58.11 -44.37 87.65 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 120.811 0.339 . . . . 0.0 110.442 -177.478 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.578 ' HB3' ' HB2' ' A' ' 74' ' ' ASN . . . -62.37 -43.29 99.18 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.683 0.754 . . . . 0.0 110.567 178.285 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' TRP . . . . . 0.464 ' O ' HG12 ' A' ' 82' ' ' VAL . 3.9 t-105 -73.34 -45.76 53.29 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 115.159 -0.928 . . . . 0.0 111.268 -176.731 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.662 ' OE2' ' HA ' ' A' ' 76' ' ' LYS . 0.6 OUTLIER -62.79 -35.29 79.39 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.001 -175.026 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 4.6 p30 -78.03 -33.51 51.06 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 119.657 -0.817 . . . . 0.0 110.339 178.772 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 45.4 tpp -61.96 -51.92 66.12 Favored 'General case' 0 C--O 1.222 -0.391 0 N-CA-C 111.462 0.171 . . . . 0.0 111.462 176.572 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.842 HG11 HG13 ' A' ' 18' ' ' ILE . 2.4 p -59.17 -37.03 66.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 C-N-CA 120.828 -0.349 . . . . 0.0 110.628 177.817 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 91.8 m -61.53 -39.09 89.8 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-O 120.894 0.378 . . . . 0.0 110.694 175.724 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' LYS . . . . . 0.445 ' HB3' ' HE3' ' A' ' 84' ' ' LYS . 0.2 OUTLIER -75.91 -44.94 37.85 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 179.717 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 85' ' ' ASP . . . . . 0.465 ' CG ' HH21 ' A' ' 46' ' ' ARG . 1.8 m-20 -69.6 -19.92 63.64 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.466 -0.788 . . . . 0.0 111.702 -176.387 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 73.1 mt-30 60.08 58.93 2.53 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-O 121.531 0.681 . . . . 0.0 110.936 176.853 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.617 HD22 ' HB3' ' A' ' 49' ' ' LEU . 81.9 mt -86.31 134.14 33.76 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.458 -0.792 . . . . 0.0 111.132 -177.068 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.582 ' HB3' ' OE2' ' A' ' 56' ' ' GLU . 11.7 mmmm -91.93 -168.99 2.14 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.934 177.249 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 84.49 160.25 31.35 Favored Glycine 0 N--CA 1.447 -0.612 0 C-N-CA 121.098 -0.573 . . . . 0.0 112.336 -177.436 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.64 ' O ' ' HA ' ' A' ' 67' ' ' VAL . 53.8 mt -77.68 113.0 16.29 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 175.405 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 91' ' ' GLN . . . . . 0.61 ' HB2' ' CZ2' ' A' ' 38' ' ' TRP . 9.2 pt20 -124.14 123.12 39.61 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-O 121.439 0.637 . . . . 0.0 112.074 -167.452 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.629 HD11 ' HB ' ' A' ' 23' ' ' VAL . 2.8 mm? -120.6 167.51 12.34 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.391 -0.822 . . . . 0.0 109.621 178.276 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 20.6 t-80 -138.66 126.89 22.82 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-O 121.201 0.524 . . . . 0.0 111.36 -173.084 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' MET . . . . . 0.446 ' HB3' ' HE2' ' A' ' 94' ' ' MET . 37.1 ttp -88.57 -67.05 0.86 Allowed 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 114.989 -1.005 . . . . 0.0 109.4 176.683 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 95' ' ' GLY . . . . . 0.441 ' HA2' ' O ' ' A' ' 72' ' ' ASP . . . 84.07 -77.5 2.11 Favored Glycine 0 N--CA 1.442 -0.901 0 C-N-CA 120.74 -0.743 . . . . 0.0 114.069 172.951 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 5.6 p -84.93 -19.57 32.0 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 113.247 0.832 . . . . 0.0 113.247 -169.75 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -101.54 154.77 18.55 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 119.723 -0.791 . . . . 0.0 111.023 -178.172 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' ARG . . . . . 0.515 ' HA ' ' HB3' ' A' ' 101' ' ' MET . 0.0 OUTLIER -140.66 9.05 2.19 Favored 'General case' 0 N--CA 1.446 -0.643 0 CA-C-N 115.511 -0.768 . . . . 0.0 109.789 173.083 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 4.5 m -78.32 -36.31 46.55 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.246 0.546 . . . . 0.0 109.793 178.426 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 70.5 t80 -74.78 -30.5 61.46 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 174.957 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' MET . . . . . 0.714 ' HG2' HG13 ' A' ' 106' ' ' ILE . 1.6 tmt? -64.2 -38.02 89.55 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 114.453 -1.249 . . . . 0.0 109.977 172.034 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -65.72 -44.44 86.05 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.468 -0.787 . . . . 0.0 110.483 177.61 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -62.88 -21.24 65.85 Favored 'General case' 0 CA--C 1.528 0.132 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.882 -177.604 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' TYR . . . . . 0.414 ' HB3' HG23 ' A' ' 106' ' ' ILE . 6.3 m-30 -100.39 -3.1 31.77 Favored 'General case' 0 C--O 1.237 0.419 0 CA-C-N 116.418 -0.355 . . . . 0.0 111.002 179.645 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 95.4 mt 59.05 25.94 14.49 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.108 -179.168 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' ILE . . . . . 0.714 HG13 ' HG2' ' A' ' 101' ' ' MET . 30.4 pt -86.64 66.14 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-O 121.664 0.745 . . . . 0.0 111.01 -177.693 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 44.2 t-20 -81.51 -59.72 2.52 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.364 -0.834 . . . . 0.0 109.81 179.786 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -82.93 90.2 1.53 Allowed Glycine 0 N--CA 1.446 -0.673 0 C-N-CA 120.634 -0.794 . . . . 0.0 111.482 176.931 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.661 HG21 HG11 ' A' ' 37' ' ' VAL . 46.5 pt -91.33 158.23 41.32 Favored Pre-proline 0 C--N 1.326 -0.448 0 N-CA-C 110.655 -0.128 . . . . 0.0 110.655 179.89 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 110' ' ' PRO . . . . . 0.756 ' HD3' ' HB2' ' A' ' 45' ' ' CYS . 40.9 Cg_endo -65.84 153.98 79.98 Favored 'Cis proline' 0 C--N 1.35 0.605 0 C-N-CA 124.006 -1.248 . . . . 0.0 113.691 1.939 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 111' ' ' ARG . . . . . 0.513 ' HG3' ' HA ' ' A' ' 106' ' ' ILE . 0.0 OUTLIER -125.8 138.14 53.82 Favored 'General case' 0 N--CA 1.446 -0.668 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.017 -179.302 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 112' ' ' PHE . . . . . 0.795 ' HD2' ' HB2' ' A' ' 128' ' ' ARG . 0.1 OUTLIER -102.05 117.53 34.99 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.358 -0.837 . . . . 0.0 110.633 -177.74 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.57 ' HB ' ' HB ' ' A' ' 35' ' ' ILE . 92.7 mt -131.15 145.13 35.87 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.283 0 CA-C-O 120.87 0.367 . . . . 0.0 111.128 -178.065 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.424 ' C ' HD12 ' A' ' 115' ' ' LEU . 42.0 tp -125.61 141.65 51.92 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.332 -0.395 . . . . 0.0 109.943 178.193 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.693 ' HG ' ' HA ' ' A' ' 121' ' ' ILE . 3.0 mp -134.87 153.98 51.84 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.061 0.458 . . . . 0.0 110.587 -178.018 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 27.8 t0 -79.72 166.49 21.74 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.221 -0.9 . . . . 0.0 110.765 178.596 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 117' ' ' ARG . . . . . 0.423 ' HA ' ' O ' ' A' ' 31' ' ' LYS . 5.6 mtm180 -53.57 -26.42 21.42 Favored 'General case' 0 N--CA 1.466 0.348 0 O-C-N 124.437 1.085 . . . . 0.0 111.956 -178.8 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -69.31 -16.72 63.61 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.302 0.573 . . . . 0.0 110.549 178.89 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 93.0 24.44 22.65 Favored Glycine 0 N--CA 1.436 -1.353 0 N-CA-C 109.762 -1.335 . . . . 0.0 109.762 -169.893 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 24.6 mmmt -111.7 114.34 27.29 Favored 'General case' 0 C--O 1.221 -0.403 0 N-CA-C 112.235 0.457 . . . . 0.0 112.235 -172.507 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 0.703 ' H ' HD12 ' A' ' 121' ' ' ILE . 4.1 mp -42.74 116.01 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 O-C-N 123.972 0.795 . . . . 0.0 111.761 178.576 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 122' ' ' ILE . . . . . 0.442 ' H ' ' HA ' ' A' ' 115' ' ' LEU . 69.3 mt -87.84 -47.69 15.52 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-N 115.21 -0.904 . . . . 0.0 108.726 174.94 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 15.1 m -128.52 114.53 16.87 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-N 115.003 -0.999 . . . . 0.0 109.944 179.631 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -70.98 -21.66 62.29 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.103 0.478 . . . . 0.0 110.577 178.509 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 6.9 t30 -139.57 101.53 4.24 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.539 -0.755 . . . . 0.0 109.009 176.399 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 13.1 tpt -105.48 -127.04 0.24 Allowed 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.2 -175.891 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 2.0 p -145.08 136.61 25.28 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 110.134 -0.321 . . . . 0.0 110.134 -178.062 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 128' ' ' ARG . . . . . 0.795 ' HB2' ' HD2' ' A' ' 112' ' ' PHE . 14.8 ttt180 -94.68 152.55 39.92 Favored Pre-proline 0 CA--C 1.535 0.401 0 CA-C-O 119.242 -0.408 . . . . 0.0 110.854 -177.978 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 129' ' ' PRO . . . . . 0.663 ' HD2' ' CG ' ' A' ' 128' ' ' ARG . 47.0 Cg_exo -24.4 -39.72 0.02 OUTLIER 'Trans proline' 0 C--N 1.366 1.469 1 C-N-CA 126.32 4.68 . . . . 0.0 117.275 175.771 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 66.6 m -50.33 -29.85 10.79 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-N 118.526 0.603 . . . . 0.0 111.129 175.302 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -92.2 121.36 66.77 Favored Pre-proline 0 C--N 1.323 -0.571 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.536 175.519 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 132' ' ' PRO . . . . . 0.471 ' O ' ' HG3' ' A' ' 136' ' ' GLU . 59.9 Cg_endo -72.16 -23.73 20.93 Favored 'Trans proline' 0 N--CA 1.462 -0.346 0 C-N-CA 122.492 2.128 . . . . 0.0 112.322 179.664 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 133' ' ' LYS . . . . . 0.476 ' HA ' ' HD3' ' A' ' 133' ' ' LYS . 57.3 mmtt -63.09 -30.25 71.45 Favored 'General case' 0 CA--C 1.518 -0.259 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.878 -177.771 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 134' ' ' THR . . . . . 0.773 HG22 ' CZ ' ' A' ' 138' ' ' PHE . 3.0 m -59.11 -54.81 42.83 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.742 -0.663 . . . . 0.0 109.718 175.234 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 135' ' ' ALA . . . . . 0.598 ' HA ' ' CD2' ' A' ' 138' ' ' PHE . . . -59.99 -43.56 95.09 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-N 115.67 -0.695 . . . . 0.0 112.045 177.817 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 136' ' ' GLU . . . . . 0.471 ' HG3' ' O ' ' A' ' 132' ' ' PRO . 50.8 mt-10 -55.72 -52.01 65.38 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-O 122.025 0.917 . . . . 0.0 110.269 177.47 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 137' ' ' LYS . . . . . 0.685 ' HE3' HD21 ' A' ' 141' ' ' LEU . 52.3 tptt -54.53 -40.63 68.83 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 113.956 -1.475 . . . . 0.0 111.319 179.113 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 138' ' ' PHE . . . . . 0.773 ' CZ ' HG22 ' A' ' 134' ' ' THR . 19.5 m-30 -55.49 -47.69 75.77 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 116.63 -0.259 . . . . 0.0 110.582 177.105 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 139' ' ' ASN . . . . . 0.623 ' HB3' ' HG3' ' A' ' 145' ' ' GLU . 39.5 m-20 -54.18 -55.03 31.86 Favored 'General case' 0 CA--C 1.521 -0.162 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 -179.254 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 8.8 tt0 -48.87 -57.71 5.99 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.403 -0.817 . . . . 0.0 111.968 174.95 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.685 HD21 ' HE3' ' A' ' 137' ' ' LYS . 90.2 mt -60.89 -37.3 81.74 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.799 -174.477 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.764 ' HB3' ' HE2' ' A' ' 62' ' ' LYS . 89.2 mt -79.14 -11.35 59.97 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.144 -178.387 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 86.9 19.67 55.47 Favored Glycine 0 N--CA 1.449 -0.454 0 N-CA-C 111.528 -0.629 . . . . 0.0 111.528 178.713 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 9.5 tt -80.15 -40.15 27.96 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 -179.594 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 145' ' ' GLU . . . . . 0.623 ' HG3' ' HB3' ' A' ' 139' ' ' ASN . 34.6 mt-10 -107.9 -171.56 1.89 Allowed 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.812 177.077 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 78.56 -119.59 5.16 Favored Glycine 0 N--CA 1.447 -0.614 0 C-N-CA 121.002 -0.618 . . . . 0.0 112.258 178.751 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 70.0 m80 -87.45 54.99 3.33 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.306 0.574 . . . . 0.0 110.594 -177.073 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 12.3 t60 -93.65 -5.4 48.73 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.006 -179.312 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -101.84 140.59 35.91 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.344 179.313 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 17.4 p80 -163.4 127.56 2.86 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.209 178.845 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 84.6 t60 -127.41 140.74 51.97 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 120.859 0.361 . . . . 0.0 110.799 -176.303 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 15.5 m170 . . . . . 0 C--O 1.242 0.661 0 CA-C-O 118.46 -0.781 . . . . 0.0 109.937 175.531 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.8 mtt . . . . . 0 N--CA 1.48 1.052 0 N-CA-C 110.164 -0.31 . . . . 0.0 110.164 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.731 ' HA ' ' HA ' ' A' ' 8' ' ' PRO . 27.9 m -78.83 131.54 36.51 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 109.738 -0.467 . . . . 0.0 109.738 175.876 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.616 HD22 ' H ' ' A' ' 3' ' ' LEU . 2.8 mm? -55.36 -58.36 8.05 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.988 0.423 . . . . 0.0 110.326 179.915 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 57.0 mtt180 -138.76 -68.75 0.44 Allowed 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 109.287 -0.635 . . . . 0.0 109.287 174.34 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 50.5 m -149.31 144.37 26.42 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.55 -0.75 . . . . 0.0 109.423 176.169 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 128.32 -94.16 0.37 Allowed Glycine 0 N--CA 1.447 -0.619 0 C-N-CA 120.811 -0.709 . . . . 0.0 111.84 -179.43 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' ASN . . . . . 0.892 ' HB2' ' HB2' ' A' ' 11' ' ' ALA . 78.7 m-20 -130.1 151.13 77.83 Favored Pre-proline 0 C--N 1.326 -0.451 0 N-CA-C 109.823 -0.436 . . . . 0.0 109.823 177.465 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.731 ' HA ' ' HA ' ' A' ' 2' ' ' SER . 9.7 Cg_exo -72.21 -62.61 0.04 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.368 0 C-N-CA 122.559 2.173 . . . . 0.0 111.484 174.084 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 16.2 m -102.08 165.39 11.19 Favored 'General case' 0 N--CA 1.447 -0.611 0 CA-C-N 115.952 -0.567 . . . . 0.0 109.897 179.296 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.644 ' HA ' ' CZ ' ' A' ' 100' ' ' PHE . . . 75.76 -44.65 0.52 Allowed 'General case' 0 N--CA 1.47 0.542 0 O-C-N 124.065 0.853 . . . . 0.0 112.667 174.896 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.892 ' HB2' ' HB2' ' A' ' 7' ' ' ASN . . . -56.67 -32.54 65.51 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 112.87 0.693 . . . . 0.0 112.87 -172.895 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 31.1 m -147.68 86.56 1.6 Allowed 'General case' 0 C--N 1.316 -0.873 0 CA-C-O 121.128 0.489 . . . . 0.0 111.362 179.188 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' PHE . . . . . 0.477 ' CE2' HD22 ' A' ' 25' ' ' LEU . 47.9 p90 -105.57 163.15 12.89 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 172.712 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.439 ' HA ' ' HA ' ' A' ' 24' ' ' SER . 14.0 m -139.71 122.03 15.99 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 109.805 -0.442 . . . . 0.0 109.805 178.852 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' TYR . . . . . 0.424 ' HA ' ' HD3' ' A' ' 16' ' ' PRO . 19.6 m-85 -137.11 149.32 65.84 Favored Pre-proline 0 C--N 1.327 -0.393 0 CA-C-O 120.678 0.275 . . . . 0.0 110.744 -177.262 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.471 ' HD2' ' O ' ' A' ' 93' ' ' HIS . 9.2 Cg_exo -72.35 124.37 9.87 Favored 'Trans proline' 0 N--CA 1.456 -0.678 0 C-N-CA 122.473 2.115 . . . . 0.0 112.54 178.02 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' ASP . . . . . 0.874 ' HB3' ' HB3' ' A' ' 21' ' ' LYS . 0.2 OUTLIER -68.97 162.95 25.65 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.132 -0.94 . . . . 0.0 109.765 172.769 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.668 HD12 HG13 ' A' ' 82' ' ' VAL . 0.8 OUTLIER -44.78 -43.42 2.49 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 O-C-N 124.147 0.904 . . . . 0.0 112.171 -177.227 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.52 ' ND2' HG23 ' A' ' 18' ' ' ILE . 21.8 m-80 -77.42 1.2 19.82 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.144 -175.349 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 85.84 30.61 23.08 Favored Glycine 0 N--CA 1.446 -0.663 0 N-CA-C 110.682 -0.967 . . . . 0.0 110.682 -173.626 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.874 ' HB3' ' HB3' ' A' ' 17' ' ' ASP . 2.0 ttmp? -98.09 116.04 29.48 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.481 -0.36 . . . . 0.0 110.902 -172.933 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 25.6 m -70.38 104.78 2.81 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 120.867 0.365 . . . . 0.0 110.905 178.799 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.472 ' HB ' HD21 ' A' ' 92' ' ' LEU . 61.0 t -121.32 146.16 26.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 178.741 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' SER . . . . . 0.439 ' HA ' ' HA ' ' A' ' 14' ' ' SER . 86.7 p -121.52 -173.96 2.75 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 109.985 -0.376 . . . . 0.0 109.985 -178.666 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.698 ' O ' ' HB2' ' A' ' 29' ' ' LYS . 15.0 tp -98.84 0.69 44.78 Favored 'General case' 0 C--N 1.32 -0.685 0 C-N-CA 120.16 -0.616 . . . . 0.0 109.951 173.881 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -85.99 -32.71 21.37 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.398 -179.06 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -77.01 -17.98 58.47 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.367 0.603 . . . . 0.0 110.117 176.104 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 85.8 mt -100.12 -5.31 28.06 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.602 -0.727 . . . . 0.0 110.429 176.859 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.698 ' HB2' ' O ' ' A' ' 25' ' ' LEU . 58.4 tttm -81.7 140.98 34.0 Favored 'General case' 0 N--CA 1.443 -0.79 0 CA-C-N 115.582 -0.735 . . . . 0.0 110.705 -172.338 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 115.63 -13.58 17.88 Favored Glycine 0 N--CA 1.452 -0.239 0 N-CA-C 111.326 -0.71 . . . . 0.0 111.326 -175.389 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.502 ' HG3' ' OD1' ' A' ' 63' ' ' ASP . 25.0 ttmm -132.27 153.1 50.99 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 177.129 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.667 ' HB2' HG22 ' A' ' 64' ' ' ILE . 24.7 m-85 -51.92 141.85 16.78 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 118.328 0.513 . . . . 0.0 110.916 -176.491 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.589 HG21 HD11 ' A' ' 25' ' ' LEU . 67.3 mt -119.27 122.29 68.72 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.74 -174.545 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' TYR . . . . . 0.531 ' OH ' ' HG3' ' A' ' 128' ' ' ARG . 30.2 t80 -114.99 134.66 54.99 Favored 'General case' 0 C--N 1.316 -0.863 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 173.94 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.611 ' HA ' ' O ' ' A' ' 67' ' ' VAL . 82.1 mt -130.26 129.88 65.3 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.047 -176.651 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.635 ' O ' ' HA ' ' A' ' 68' ' ' SER . 4.6 p30 -130.6 160.29 34.64 Favored 'General case' 0 C--O 1.217 -0.614 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.418 172.71 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.544 ' HB ' ' HA ' ' A' ' 110' ' ' PRO . 47.8 t -95.56 137.94 22.44 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 CA-C-O 121.087 0.47 . . . . 0.0 111.779 -178.429 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' TRP . . . . . 0.936 ' HZ3' HG21 ' A' ' 82' ' ' VAL . 0.6 OUTLIER -122.34 132.91 54.62 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 174.244 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -148.43 154.14 39.48 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 120.767 -0.373 . . . . 0.0 111.655 -176.727 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.687 ' HB ' ' CE3' ' A' ' 78' ' ' TRP . 4.1 t -92.93 -28.68 16.31 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 121.203 -0.199 . . . . 0.0 110.785 173.516 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 11.5 p-90 -81.69 -8.32 59.69 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.939 0.4 . . . . 0.0 110.417 179.537 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' CYS . . . . . 0.56 ' O ' ' HD2' ' A' ' 44' ' ' PRO . 47.7 t -86.35 -71.33 0.55 Allowed 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 173.099 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 112.21 -77.53 0.24 Allowed Glycine 0 C--O 1.227 -0.293 0 C-N-CA 120.532 -0.842 . . . . 0.0 113.239 176.87 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.56 ' HD2' ' O ' ' A' ' 42' ' ' CYS . 9.7 Cg_endo -52.38 -31.79 49.08 Favored 'Trans proline' 0 C--N 1.353 0.815 0 C-N-CA 123.182 2.588 . . . . 0.0 112.431 -178.636 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' CYS . . . . . 0.56 ' HB3' ' HD3' ' A' ' 110' ' ' PRO . 26.9 p -61.41 -17.0 52.21 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.688 -179.899 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.514 ' HA ' HD23 ' A' ' 49' ' ' LEU . 61.7 mtp180 -83.27 -19.4 36.41 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.814 0.34 . . . . 0.0 111.075 -177.48 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -83.77 -7.68 85.5 Favored Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.479 -176.705 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -95.58 -10.44 29.55 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.513 0.197 . . . . 0.0 111.152 -177.283 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.991 ' HG ' ' HB3' ' A' ' 87' ' ' LEU . 4.2 mm? -55.25 -44.85 99.85 Favored Pre-proline 0 CA--C 1.538 0.487 0 CA-C-N 116.649 -0.251 . . . . 0.0 111.505 176.709 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.672 ' O ' ' HG2' ' A' ' 54' ' ' GLU . 76.0 Cg_exo -52.68 -37.37 75.1 Favored 'Trans proline' 0 C--N 1.357 0.981 0 C-N-CA 121.816 1.677 . . . . 0.0 112.131 170.606 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -71.51 -19.84 62.14 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.35 0.595 . . . . 0.0 110.704 -178.071 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 8.1 tt -72.88 -45.69 56.85 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.568 -0.742 . . . . 0.0 109.692 -179.83 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.509 ' HG3' ' N ' ' A' ' 54' ' ' GLU . 7.9 ptmm? -63.89 -42.04 97.57 Favored 'General case' 0 C--O 1.226 -0.15 0 N-CA-C 109.878 -0.415 . . . . 0.0 109.878 177.704 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.672 ' HG2' ' O ' ' A' ' 50' ' ' PRO . 55.2 mm-40 -51.22 -49.75 60.44 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-O 121.64 0.733 . . . . 0.0 110.224 177.932 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.769 HD13 ' HD2' ' A' ' 59' ' ' TYR . 0.2 OUTLIER -66.7 -39.21 87.98 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.068 -0.969 . . . . 0.0 110.755 -179.021 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 14.2 tp10 -61.23 -57.66 11.51 Favored 'General case' 0 N--CA 1.447 -0.591 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.045 -177.207 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 -67.97 -25.42 65.42 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 111.744 0.276 . . . . 0.0 111.744 -176.113 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.494 ' HD3' ' CE2' ' A' ' 59' ' ' TYR . 63.4 tttt -67.7 -34.12 76.25 Favored 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 120.759 -0.376 . . . . 0.0 110.51 174.064 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.769 ' HD2' HD13 ' A' ' 55' ' ' LEU . 68.3 m-85 -119.81 25.17 10.15 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.426 -176.327 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -49.63 116.51 1.79 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.059 0.457 . . . . 0.0 111.972 178.143 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 105.11 -0.73 40.96 Favored Glycine 0 N--CA 1.453 -0.214 0 C-N-CA 120.945 -0.645 . . . . 0.0 112.451 179.504 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.852 ' HG2' HG12 ' A' ' 64' ' ' ILE . 0.0 OUTLIER -67.32 174.9 2.98 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.523 0.678 . . . . 0.0 112.422 -178.299 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.502 ' OD1' ' HG3' ' A' ' 31' ' ' LYS . 32.3 t70 -101.28 51.45 0.85 Allowed 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.905 -177.317 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.852 HG12 ' HG2' ' A' ' 62' ' ' LYS . 19.4 pt -146.8 165.57 7.3 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.401 0 N-CA-C 110.113 -0.329 . . . . 0.0 110.113 177.546 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' HIS . . . . . 0.48 ' NE2' ' HB3' ' A' ' 31' ' ' LYS . 85.2 m-70 -122.9 140.42 52.99 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 175.922 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' PHE . . . . . 0.692 ' O ' ' HB ' ' A' ' 90' ' ' ILE . 79.6 m-85 -102.01 103.18 13.78 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 172.381 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.611 ' O ' ' HA ' ' A' ' 35' ' ' ILE . 39.0 t -119.12 113.6 41.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-O 120.967 0.413 . . . . 0.0 111.11 -175.465 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' SER . . . . . 0.635 ' HA ' ' O ' ' A' ' 36' ' ' ASP . 0.7 OUTLIER -93.95 131.96 38.88 Favored 'General case' 0 C--N 1.317 -0.824 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 177.521 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.546 ' CD2' ' HB2' ' A' ' 92' ' ' LEU . 73.2 mt -118.2 137.7 52.83 Favored 'General case' 0 N--CA 1.468 0.463 0 O-C-N 122.072 -0.392 . . . . 0.0 110.426 176.918 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' SER . . . . . 0.536 ' HB2' ' O ' ' A' ' 38' ' ' TRP . 1.3 t -118.06 123.5 45.81 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.188 0.518 . . . . 0.0 112.029 -176.209 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 49.7 t -89.85 14.14 12.75 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.75 176.417 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.574 ' O ' ' HA2' ' A' ' 95' ' ' GLY . 0.9 OUTLIER -65.53 133.11 50.53 Favored 'General case' 0 CA--C 1.516 -0.362 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 -178.292 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.48 ' HB2' ' NZ ' ' A' ' 73' ' ' LYS . 1.0 OUTLIER -87.45 -24.94 23.99 Favored 'General case' 0 C--N 1.316 -0.872 0 C-N-CA 120.084 -0.646 . . . . 0.0 110.571 -177.646 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 74' ' ' ASN . . . . . 0.571 ' HB2' ' HB3' ' A' ' 77' ' ' ALA . 0.6 OUTLIER -84.12 78.97 9.67 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.343 176.175 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.432 ' HG3' ' CE1' ' A' ' 93' ' ' HIS . 10.2 tttt -61.63 -56.58 18.31 Favored 'General case' 0 C--O 1.221 -0.443 0 C-N-CA 120.826 -0.35 . . . . 0.0 111.741 -173.763 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.557 ' HA ' ' OE1' ' A' ' 79' ' ' GLU . 17.3 tppt? -57.09 -40.62 77.32 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 111.882 0.327 . . . . 0.0 111.882 -177.903 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.571 ' HB3' ' HB2' ' A' ' 74' ' ' ASN . . . -62.79 -41.2 99.16 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.827 0.823 . . . . 0.0 110.188 177.393 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 78' ' ' TRP . . . . . 0.687 ' CE3' ' HB ' ' A' ' 40' ' ' THR . 5.2 t-105 -74.31 -47.57 33.81 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 114.698 -1.137 . . . . 0.0 111.202 -176.802 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.557 ' OE1' ' HA ' ' A' ' 76' ' ' LYS . 3.3 pt-20 -64.57 -35.52 81.24 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.938 -174.782 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 3.6 p30 -74.94 -37.13 62.07 Favored 'General case' 0 CA--C 1.523 -0.081 0 C-N-CA 119.995 -0.682 . . . . 0.0 110.114 179.053 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 34.4 ttm -64.1 -50.52 67.98 Favored 'General case' 0 C--O 1.219 -0.552 0 C-N-CA 120.65 -0.42 . . . . 0.0 110.784 175.914 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.936 HG21 ' HZ3' ' A' ' 38' ' ' TRP . 12.5 p -63.18 -23.23 32.75 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-O 121.086 0.469 . . . . 0.0 111.005 -178.158 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 83' ' ' THR . . . . . 0.573 ' OG1' HD11 ' A' ' 18' ' ' ILE . 88.2 m -76.38 -46.82 25.65 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.566 -0.288 . . . . 0.0 110.453 171.98 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.32 -42.36 88.32 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.337 0.589 . . . . 0.0 110.384 -178.286 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -74.51 -5.61 43.66 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.186 -0.915 . . . . 0.0 111.282 -179.824 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 47.7 mt-30 63.52 17.74 10.57 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 115.867 -0.606 . . . . 0.0 112.368 174.556 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.991 ' HB3' ' HG ' ' A' ' 49' ' ' LEU . 29.2 mt -74.67 93.78 2.6 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.96 -0.385 . . . . 0.0 109.96 -179.986 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 9.0 mmtm -110.07 -178.84 3.62 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 113.006 0.743 . . . . 0.0 113.006 -176.261 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 130.88 -165.02 23.08 Favored Glycine 0 N--CA 1.449 -0.448 0 N-CA-C 109.71 -1.356 . . . . 0.0 109.71 -172.117 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.692 ' HB ' ' O ' ' A' ' 66' ' ' PHE . 60.9 mt -85.02 112.14 21.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 118.054 0.927 . . . . 0.0 108.508 172.808 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 91' ' ' GLN . . . . . 0.587 ' HB2' ' CZ2' ' A' ' 38' ' ' TRP . 2.1 pt20 -142.01 113.26 7.6 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 121.457 0.646 . . . . 0.0 111.69 -170.647 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.546 ' HB2' ' CD2' ' A' ' 69' ' ' LEU . 77.5 mt -110.42 154.23 23.87 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.495 -0.775 . . . . 0.0 109.902 -179.75 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 93' ' ' HIS . . . . . 0.471 ' O ' ' HD2' ' A' ' 16' ' ' PRO . 35.4 t-80 -121.93 126.81 49.47 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-O 121.455 0.645 . . . . 0.0 111.134 -175.254 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 94' ' ' MET . . . . . 0.436 ' HB3' ' HE2' ' A' ' 94' ' ' MET . 28.2 ttp -91.12 -72.62 0.57 Allowed 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 114.801 -1.09 . . . . 0.0 109.923 178.197 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 95' ' ' GLY . . . . . 0.574 ' HA2' ' O ' ' A' ' 72' ' ' ASP . . . 86.48 -75.26 2.26 Favored Glycine 0 N--CA 1.446 -0.648 0 C-N-CA 120.601 -0.809 . . . . 0.0 114.24 173.863 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -90.42 -34.59 15.57 Favored 'General case' 0 C--N 1.315 -0.928 0 N-CA-C 112.126 0.417 . . . . 0.0 112.126 -174.556 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -92.75 54.91 2.32 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.717 -163.833 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.71 4.94 0.94 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.952 -0.567 . . . . 0.0 112.405 -176.812 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 9.4 t -66.74 -19.44 65.75 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.126 0.489 . . . . 0.0 109.76 174.887 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' PHE . . . . . 0.644 ' CZ ' ' HA ' ' A' ' 10' ' ' ALA . 10.5 t80 -77.28 -23.87 51.09 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.174 177.652 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 93.6 mmm -62.41 -48.12 81.11 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 174.761 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -62.25 -22.49 66.03 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 115.405 -0.816 . . . . 0.0 111.649 176.603 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -70.42 -24.06 62.85 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.697 0.284 . . . . 0.0 111.115 179.544 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' TYR . . . . . 0.585 ' HB2' HD12 ' A' ' 106' ' ' ILE . 47.2 m-85 -106.28 -11.31 16.06 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.802 176.561 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 7.2 mp 67.14 14.59 9.83 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 115.61 -0.723 . . . . 0.0 112.071 179.181 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' ILE . . . . . 1.039 ' HB ' ' HG3' ' A' ' 111' ' ' ARG . 0.2 OUTLIER -82.84 149.95 4.45 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.428 0 CA-C-O 120.933 0.397 . . . . 0.0 110.804 -179.926 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 5.1 p30 -127.37 -57.65 1.29 Allowed 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.435 -179.289 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -76.38 116.1 4.62 Favored Glycine 0 N--CA 1.447 -0.601 0 C-N-CA 120.966 -0.635 . . . . 0.0 112.587 -179.389 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.454 ' HB ' ' HA ' ' A' ' 110' ' ' PRO . 40.2 pt -102.65 153.62 38.05 Favored Pre-proline 0 C--N 1.326 -0.441 0 N-CA-C 110.43 -0.211 . . . . 0.0 110.43 176.344 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 110' ' ' PRO . . . . . 0.56 ' HD3' ' HB3' ' A' ' 45' ' ' CYS . 49.5 Cg_endo -71.61 133.94 30.69 Favored 'Cis proline' 0 C--N 1.343 0.288 0 C-N-CA 123.175 -1.594 . . . . 0.0 113.236 1.312 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 111' ' ' ARG . . . . . 1.039 ' HG3' ' HB ' ' A' ' 106' ' ' ILE . 0.0 OUTLIER -95.22 146.41 24.35 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 173.975 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 112' ' ' PHE . . . . . 0.549 ' CE1' ' HB2' ' A' ' 128' ' ' ARG . 9.7 m-85 -119.35 119.44 34.0 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 -177.495 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.407 HD11 HG21 ' A' ' 106' ' ' ILE . 91.7 mt -131.13 138.19 53.96 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-O 121.015 0.436 . . . . 0.0 110.975 -177.283 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.72 HD21 HD11 ' A' ' 141' ' ' LEU . 30.6 tp -119.47 133.09 55.86 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.631 -0.713 . . . . 0.0 109.471 177.738 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.421 ' N ' HD12 ' A' ' 115' ' ' LEU . 0.7 OUTLIER -133.74 155.33 49.96 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.206 0.527 . . . . 0.0 110.61 -178.003 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 116' ' ' ASP . . . . . 0.637 ' HB3' ' HB2' ' A' ' 120' ' ' LYS . 17.6 t70 -71.21 166.82 20.71 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.176 -0.92 . . . . 0.0 110.804 176.76 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 117' ' ' ARG . . . . . 0.406 ' N ' ' CG ' ' A' ' 116' ' ' ASP . 69.4 mtt85 -51.55 -32.15 27.1 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 124.281 1.033 . . . . 0.0 112.974 -178.09 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 118' ' ' ASP . . . . . 0.684 ' HB3' ' HD3' ' A' ' 120' ' ' LYS . 25.4 t70 -81.25 4.48 20.24 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-O 121.474 0.654 . . . . 0.0 110.474 179.45 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 81.31 23.11 59.38 Favored Glycine 0 N--CA 1.438 -1.207 0 N-CA-C 110.466 -1.054 . . . . 0.0 110.466 -173.832 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 120' ' ' LYS . . . . . 0.684 ' HD3' ' HB3' ' A' ' 118' ' ' ASP . 19.8 mmmt -81.27 106.69 13.45 Favored 'General case' 0 CA--C 1.51 -0.566 0 C-N-CA 120.646 -0.422 . . . . 0.0 110.864 -176.028 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 0.637 ' H ' HD12 ' A' ' 121' ' ' ILE . 3.6 mp -47.05 106.58 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.315 -0.916 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.822 178.189 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 39.3 mm -88.34 -47.21 15.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 115.51 -0.768 . . . . 0.0 109.661 -179.75 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 13.6 m -144.95 114.64 7.26 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.721 178.576 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -74.52 -24.13 58.93 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.621 0.724 . . . . 0.0 109.782 174.774 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 125' ' ' ASN . . . . . 0.733 ' HA ' ' NH1' ' A' ' 111' ' ' ARG . 53.6 t30 -110.4 85.04 2.03 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.487 -0.779 . . . . 0.0 109.329 175.485 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 126' ' ' MET . . . . . 0.623 ' HG2' ' HB2' ' A' ' 114' ' ' LEU . 3.3 tpt -113.54 -166.91 1.13 Allowed 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 107.813 -1.18 . . . . 0.0 107.813 179.026 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 127' ' ' THR . . . . . 0.561 ' O ' HG21 ' A' ' 134' ' ' THR . 2.1 p -132.11 161.53 33.07 Favored 'General case' 0 C--N 1.316 -0.882 0 N-CA-C 109.684 -0.487 . . . . 0.0 109.684 179.864 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 128' ' ' ARG . . . . . 0.636 ' CG ' ' HD2' ' A' ' 129' ' ' PRO . 19.2 ttt180 -86.76 158.01 54.23 Favored Pre-proline 0 C--N 1.316 -0.887 0 N-CA-C 109.795 -0.446 . . . . 0.0 109.795 179.387 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 129' ' ' PRO . . . . . 0.636 ' HD2' ' CG ' ' A' ' 128' ' ' ARG . 49.3 Cg_exo -42.81 -23.66 0.35 Allowed 'Trans proline' 0 C--N 1.356 0.945 0 C-N-CA 123.468 2.779 . . . . 0.0 113.908 170.906 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -55.85 -31.91 63.17 Favored 'General case' 0 CA--C 1.529 0.143 0 CA-C-O 121.092 0.472 . . . . 0.0 110.691 175.325 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 11.1 t0 -101.67 127.83 30.4 Favored Pre-proline 0 C--O 1.237 0.439 0 CA-C-N 115.852 -0.613 . . . . 0.0 109.92 179.51 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -58.35 -26.81 78.93 Favored 'Trans proline' 0 C--N 1.347 0.464 0 C-N-CA 123.299 2.666 . . . . 0.0 114.047 -178.385 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 42.3 mttp -56.15 -42.25 76.7 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-O 121.457 0.646 . . . . 0.0 110.842 -177.451 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 134' ' ' THR . . . . . 0.561 HG21 ' O ' ' A' ' 127' ' ' THR . 0.1 OUTLIER -69.14 -43.07 75.08 Favored 'General case' 0 N--CA 1.443 -0.821 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.539 178.883 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 135' ' ' ALA . . . . . 0.539 ' HA ' ' CD2' ' A' ' 138' ' ' PHE . . . -56.78 -46.92 81.22 Favored 'General case' 0 C--O 1.238 0.478 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.618 179.259 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 136' ' ' GLU . . . . . 0.647 ' HA ' ' OD1' ' A' ' 139' ' ' ASN . 14.7 pt-20 -71.15 -23.75 62.13 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.621 -179.559 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 137' ' ' LYS . . . . . 0.634 ' O ' ' HB3' ' A' ' 140' ' ' GLU . 60.9 tttp -79.28 -26.9 42.25 Favored 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 120.422 -0.511 . . . . 0.0 111.023 173.313 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 138' ' ' PHE . . . . . 0.637 ' HD2' HD11 ' A' ' 55' ' ' LEU . 21.5 m-85 -65.15 -43.2 92.57 Favored 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 120.469 -0.492 . . . . 0.0 110.213 177.138 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 139' ' ' ASN . . . . . 0.647 ' OD1' ' HA ' ' A' ' 136' ' ' GLU . 2.0 p-10 -70.01 -32.18 70.22 Favored 'General case' 0 C--O 1.224 -0.264 0 C-N-CA 120.006 -0.678 . . . . 0.0 110.128 175.099 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 140' ' ' GLU . . . . . 0.634 ' HB3' ' O ' ' A' ' 137' ' ' LYS . 4.4 tt0 -51.23 -55.13 19.69 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-O 120.823 0.344 . . . . 0.0 110.657 169.371 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.72 HD11 HD21 ' A' ' 114' ' ' LEU . 90.1 mt -58.42 -36.26 73.34 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.533 -178.918 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.506 ' HG ' ' O ' ' A' ' 138' ' ' PHE . 86.9 mt -77.32 -18.51 57.41 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.2 -179.671 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 86.05 13.83 68.19 Favored Glycine 0 N--CA 1.45 -0.417 0 N-CA-C 110.749 -0.94 . . . . 0.0 110.749 -175.625 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 37.4 tp -97.86 37.45 1.4 Allowed 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 -178.128 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 145' ' ' GLU . . . . . 0.471 ' HG2' ' HA ' ' A' ' 140' ' ' GLU . 0.0 OUTLIER -54.57 138.25 41.38 Favored 'General case' 0 N--CA 1.445 -0.71 0 CA-C-N 114.663 -1.153 . . . . 0.0 113.69 -176.325 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -115.2 -2.4 21.76 Favored Glycine 0 N--CA 1.446 -0.697 0 CA-C-N 114.797 -1.092 . . . . 0.0 112.283 -177.546 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 147' ' ' HIS . . . . . 0.403 ' HD1' ' CD ' ' A' ' 145' ' ' GLU . 36.2 m80 -83.23 -2.29 55.2 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.25 0.547 . . . . 0.0 109.597 177.194 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 44.5 t-80 -78.01 110.33 12.85 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.551 -0.749 . . . . 0.0 111.478 -176.364 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 1.6 t60 -113.99 162.41 16.46 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 175.915 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 49.0 t-80 -101.3 108.87 20.62 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.783 0.325 . . . . 0.0 111.348 -178.162 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 78.4 t60 -124.36 -1.37 8.13 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.522 0.677 . . . . 0.0 109.223 172.026 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 26.8 t-80 . . . . . 0 C--O 1.244 0.786 0 CA-C-N 115.185 -0.916 . . . . 0.0 109.109 178.829 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 54.3 ttm . . . . . 0 N--CA 1.482 1.173 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 13.2 m -141.1 -175.41 4.31 Favored 'General case' 0 C--N 1.324 -0.523 0 O-C-N 123.21 0.319 . . . . 0.0 110.208 -175.518 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.923 HD13 ' H ' ' A' ' 3' ' ' LEU . 0.0 OUTLIER -79.53 13.16 2.12 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.293 0.568 . . . . 0.0 111.088 178.799 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 4' ' ' ARG . . . . . 0.511 ' HG3' ' O ' ' A' ' 7' ' ' ASN . 19.1 tpt180 -145.93 105.35 3.94 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.648 -0.705 . . . . 0.0 109.898 -173.848 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 15.6 m -75.4 140.31 42.87 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.013 176.856 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 87.23 54.15 2.64 Favored Glycine 0 N--CA 1.449 -0.44 0 N-CA-C 110.821 -0.912 . . . . 0.0 110.821 -174.783 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' ASN . . . . . 0.511 ' O ' ' HG3' ' A' ' 4' ' ' ARG . 10.1 m-20 68.26 141.18 0.07 OUTLIER Pre-proline 0 N--CA 1.467 0.394 0 C-N-CA 123.307 0.643 . . . . 0.0 111.162 -174.382 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.433 ' HD3' ' HA ' ' A' ' 7' ' ' ASN . 25.2 Cg_exo -62.66 -15.81 48.79 Favored 'Trans proline' 0 CA--C 1.527 0.149 0 C-N-CA 123.001 2.467 . . . . 0.0 112.651 -176.82 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 19.7 m 67.98 99.62 0.05 Allowed 'General case' 0 N--CA 1.464 0.233 0 O-C-N 123.784 0.677 . . . . 0.0 111.58 175.861 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . 73.72 -42.08 0.51 Allowed 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 123.991 0.917 . . . . 0.0 111.592 179.125 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -80.92 73.75 7.93 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.649 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.571 ' HA ' ' HB3' ' A' ' 25' ' ' LEU . 18.1 m 71.79 90.47 0.09 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.151 -0.931 . . . . 0.0 111.103 178.644 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 33.6 p90 -105.69 163.51 12.64 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.509 179.031 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.411 ' HA ' ' HA ' ' A' ' 24' ' ' SER . 11.9 p -137.45 128.27 27.18 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.276 -0.42 . . . . 0.0 109.902 178.053 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' TYR . . . . . 0.431 ' HA ' ' HD3' ' A' ' 16' ' ' PRO . 36.3 m-85 -140.91 149.63 56.78 Favored Pre-proline 0 C--N 1.326 -0.427 0 CA-C-N 116.532 -0.304 . . . . 0.0 110.248 -177.016 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.684 ' HA ' ' O ' ' A' ' 21' ' ' LYS . 3.8 Cg_exo -75.23 124.91 8.82 Favored 'Trans proline' 0 N--CA 1.453 -0.885 0 C-N-CA 122.201 1.934 . . . . 0.0 112.726 179.677 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' ASP . . . . . 0.769 ' HB3' ' HB3' ' A' ' 21' ' ' LYS . 0.0 OUTLIER -64.89 162.01 17.2 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.38 -0.827 . . . . 0.0 109.05 170.732 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.633 HG21 HG11 ' A' ' 82' ' ' VAL . 9.6 tp -62.42 -25.95 39.19 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.242 -171.656 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.497 ' HB2' ' OD2' ' A' ' 17' ' ' ASP . 4.4 m-20 -80.85 4.98 17.4 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.127 177.253 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 78.89 49.54 6.4 Favored Glycine 0 N--CA 1.449 -0.451 0 N-CA-C 110.809 -0.917 . . . . 0.0 110.809 -176.258 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.769 ' HB3' ' HB3' ' A' ' 17' ' ' ASP . 0.0 OUTLIER -114.84 140.85 48.61 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.531 -0.335 . . . . 0.0 110.521 -173.63 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 19.6 m -90.62 99.07 12.17 Favored 'General case' 0 C--N 1.318 -0.762 0 C-N-CA 120.512 -0.475 . . . . 0.0 110.078 178.207 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.415 ' HB ' ' CD2' ' A' ' 92' ' ' LEU . 48.7 t -115.34 137.79 47.78 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 116.069 -0.514 . . . . 0.0 109.735 -179.756 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' SER . . . . . 0.411 ' HA ' ' HA ' ' A' ' 14' ' ' SER . 59.7 p -122.55 169.52 10.93 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.964 -175.786 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.8 HD12 HD12 ' A' ' 28' ' ' LEU . 32.5 tp -66.74 -16.1 64.0 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.026 174.87 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.409 ' HA ' ' HD3' ' A' ' 29' ' ' LYS . . . -62.4 -39.74 94.22 Favored 'General case' 0 C--N 1.333 -0.123 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.948 179.75 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -61.16 -33.81 74.02 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-O 121.772 0.796 . . . . 0.0 110.226 174.952 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.8 HD12 HD12 ' A' ' 25' ' ' LEU . 33.4 mt -79.64 -15.02 58.36 Favored 'General case' 0 N--CA 1.445 -0.688 0 CA-C-N 115.0 -1.0 . . . . 0.0 111.684 -173.008 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.67 ' HA ' ' O ' ' A' ' 117' ' ' ARG . 1.7 mptm? -66.46 160.83 24.11 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.392 0.615 . . . . 0.0 111.881 178.198 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 84.32 -14.83 43.25 Favored Glycine 0 N--CA 1.45 -0.374 0 CA-C-N 115.464 -0.789 . . . . 0.0 112.29 178.986 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.578 ' HG3' ' CG ' ' A' ' 63' ' ' ASP . 24.5 ttmm -144.15 143.15 30.96 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 109.311 -0.625 . . . . 0.0 109.311 -176.507 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 63.0 m-85 -56.2 155.04 7.11 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-O 120.681 0.277 . . . . 0.0 111.276 -177.689 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.557 HD12 ' HA2' ' A' ' 119' ' ' GLY . 43.3 mt -128.11 135.39 62.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-O 120.74 0.305 . . . . 0.0 111.565 -171.913 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' TYR . . . . . 0.541 ' HB2' HD11 ' A' ' 64' ' ' ILE . 88.1 t80 -120.04 116.47 25.79 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 173.532 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.538 ' HA ' ' O ' ' A' ' 67' ' ' VAL . 28.9 mm -101.7 132.21 48.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.566 -179.299 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.57 ' HA ' ' O ' ' A' ' 111' ' ' ARG . 1.2 t70 -140.77 162.76 34.65 Favored 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 176.992 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.555 ' HB ' ' HA ' ' A' ' 110' ' ' PRO . 46.8 t -102.06 131.22 50.5 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.919 0 C-N-CA 120.212 -0.595 . . . . 0.0 111.45 176.736 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' TRP . . . . . 0.685 ' CZ2' ' HB3' ' A' ' 91' ' ' GLN . 0.9 OUTLIER -126.14 132.75 51.78 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-O 120.822 0.344 . . . . 0.0 110.128 179.325 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.54 ' HB3' ' SG ' ' A' ' 42' ' ' CYS . . . -148.68 168.74 22.06 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-N 116.688 -0.233 . . . . 0.0 110.85 178.013 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.599 ' HB ' ' CE3' ' A' ' 78' ' ' TRP . 9.6 t -92.08 -18.68 23.24 Favored 'General case' 0 C--O 1.233 0.235 0 C-N-CA 120.868 -0.333 . . . . 0.0 111.667 179.265 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 1.5 p-90 -90.41 -13.46 34.9 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.788 0.328 . . . . 0.0 111.712 -177.44 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' CYS . . . . . 0.54 ' SG ' ' HB3' ' A' ' 39' ' ' ALA . 5.9 p -88.34 94.99 10.02 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.014 0.435 . . . . 0.0 110.515 177.723 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -54.17 -58.3 13.42 Favored Glycine 0 CA--C 1.524 0.647 0 CA-C-N 115.43 -0.804 . . . . 0.0 113.967 -179.309 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -53.95 -38.41 86.32 Favored 'Trans proline' 0 C--N 1.354 0.83 0 C-N-CA 122.721 2.28 . . . . 0.0 112.68 -178.31 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' CYS . . . . . 0.809 ' HB2' ' HD3' ' A' ' 110' ' ' PRO . 36.7 t -59.07 -38.54 79.69 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.184 0.516 . . . . 0.0 110.689 178.888 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.518 ' HA ' ' HG ' ' A' ' 49' ' ' LEU . 39.3 mtp180 -70.9 -15.83 62.64 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.911 -176.322 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -77.91 -26.48 60.28 Favored Glycine 0 N--CA 1.445 -0.701 0 C-N-CA 120.754 -0.736 . . . . 0.0 111.769 177.119 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.652 ' HB3' ' HB3' ' A' ' 130' ' ' SER . 14.2 pt-20 -107.03 0.99 24.01 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.841 0.353 . . . . 0.0 111.5 -179.854 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.538 ' N ' ' HD2' ' A' ' 50' ' ' PRO . 68.4 mt -59.94 -45.8 98.16 Favored Pre-proline 0 CA--C 1.537 0.456 0 CA-C-N 116.531 -0.304 . . . . 0.0 111.288 172.992 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.538 ' HD2' ' N ' ' A' ' 49' ' ' LEU . 11.9 Cg_endo -57.53 -35.16 98.89 Favored 'Trans proline' 0 C--N 1.356 0.965 0 C-N-CA 121.761 1.641 . . . . 0.0 111.913 171.323 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.586 ' HA ' ' HG2' ' A' ' 54' ' ' GLU . . . -67.3 -23.43 65.65 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-O 121.079 0.466 . . . . 0.0 110.806 179.042 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 10.0 tt -69.88 -34.08 73.08 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.944 -0.571 . . . . 0.0 109.554 176.073 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.486 ' HB3' ' O ' ' A' ' 50' ' ' PRO . 11.3 tttm -65.54 -46.71 78.5 Favored 'General case' 0 N--CA 1.425 -1.675 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 172.402 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.586 ' HG2' ' HA ' ' A' ' 51' ' ' ALA . 24.4 mm-40 -52.6 -44.65 66.11 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.05 -0.977 . . . . 0.0 110.001 176.688 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 47.8 mt -57.15 -53.55 56.8 Favored 'General case' 0 N--CA 1.452 -0.375 0 CA-C-N 115.433 -0.803 . . . . 0.0 111.249 175.418 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -48.87 -58.86 4.16 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.204 -0.907 . . . . 0.0 111.848 -179.052 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -71.11 -27.69 63.77 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 111.828 0.306 . . . . 0.0 111.828 -176.49 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 33.5 tttm -66.12 -25.04 66.81 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-O 121.01 0.433 . . . . 0.0 109.911 175.185 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.715 ' HD1' ' HG3' ' A' ' 62' ' ' LYS . 53.1 m-85 -124.26 18.34 9.06 Favored 'General case' 0 N--CA 1.453 -0.284 0 N-CA-C 112.766 0.654 . . . . 0.0 112.766 -176.522 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -62.03 110.23 1.52 Allowed 'General case' 0 C--N 1.323 -0.543 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 169.595 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 113.74 -13.27 22.57 Favored Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 120.802 -0.713 . . . . 0.0 111.758 -175.215 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.777 ' HD2' ' HG ' ' A' ' 142' ' ' LEU . 28.7 mmtp -84.82 -170.38 3.09 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-O 121.416 0.627 . . . . 0.0 110.809 177.418 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.578 ' CG ' ' HG3' ' A' ' 31' ' ' LYS . 16.9 t70 -116.95 82.96 1.89 Allowed 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.417 -179.217 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.541 HD11 ' HB2' ' A' ' 34' ' ' TYR . 17.2 tt -157.97 141.94 7.05 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.535 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.342 177.211 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' HIS . . . . . 0.527 ' NE2' ' HB3' ' A' ' 31' ' ' LYS . 84.5 m-70 -103.52 108.58 19.89 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 109.176 -0.676 . . . . 0.0 109.176 171.258 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 89.6 m-85 -78.78 103.54 8.79 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 172.783 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.701 ' HA ' ' O ' ' A' ' 90' ' ' ILE . 41.2 t -127.79 117.87 47.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-O 120.797 0.332 . . . . 0.0 111.068 -174.501 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' SER . . . . . 0.533 ' HA ' ' O ' ' A' ' 36' ' ' ASP . 8.3 m -109.16 147.37 32.61 Favored 'General case' 0 C--N 1.318 -0.768 0 C-N-CA 120.687 -0.405 . . . . 0.0 110.597 178.03 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.56 HD13 ' HB2' ' A' ' 92' ' ' LEU . 3.8 mm? -110.96 132.91 53.81 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.476 178.355 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 27.5 t -112.95 117.33 31.78 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.106 0.479 . . . . 0.0 111.693 -179.118 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 71.7 m -91.81 33.24 1.05 Allowed 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.247 172.791 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.528 ' OD2' HG22 ' A' ' 40' ' ' THR . 0.4 OUTLIER -75.62 126.41 30.95 Favored 'General case' 0 CA--C 1.512 -0.514 0 C-N-CA 120.155 -0.618 . . . . 0.0 110.446 178.07 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.597 ' H ' ' HE3' ' A' ' 73' ' ' LYS . 0.0 OUTLIER -78.13 -14.56 59.43 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.224 -178.887 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 74' ' ' ASN . . . . . 0.603 ' HB2' ' HB3' ' A' ' 77' ' ' ALA . 0.6 OUTLIER -101.19 68.95 1.26 Allowed 'General case' 0 CA--C 1.512 -0.51 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 179.283 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.613 ' O ' ' HG3' ' A' ' 79' ' ' GLU . 11.8 tmtt? -54.66 -53.13 58.8 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.616 -173.779 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.451 ' HA ' ' CD ' ' A' ' 79' ' ' GLU . 18.2 tptp -52.87 -53.74 44.66 Favored 'General case' 0 C--N 1.327 -0.376 0 O-C-N 123.321 0.388 . . . . 0.0 110.847 179.018 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.603 ' HB3' ' HB2' ' A' ' 74' ' ' ASN . . . -56.53 -36.67 69.49 Favored 'General case' 0 C--O 1.24 0.565 0 CA-C-O 121.517 0.675 . . . . 0.0 110.505 179.358 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' TRP . . . . . 0.659 ' HZ2' ' CE3' ' A' ' 38' ' ' TRP . 8.0 t-105 -68.64 -34.21 75.35 Favored 'General case' 0 N--CA 1.435 -1.216 0 CA-C-N 114.807 -1.088 . . . . 0.0 110.606 -178.02 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.613 ' HG3' ' O ' ' A' ' 75' ' ' LYS . 52.7 mt-10 -53.66 -51.35 63.46 Favored 'General case' 0 CA--C 1.515 -0.39 0 CA-C-O 121.482 0.658 . . . . 0.0 110.822 173.766 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' ASN . . . . . 0.446 ' OD1' ' HA ' ' A' ' 77' ' ' ALA . 0.9 OUTLIER -66.23 -33.57 76.06 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.253 -0.885 . . . . 0.0 111.188 -173.282 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 1.4 tmt? -63.87 -59.12 4.92 Favored 'General case' 0 CA--C 1.517 -0.314 0 C-N-CA 120.849 -0.34 . . . . 0.0 111.306 177.731 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.633 HG11 HG21 ' A' ' 18' ' ' ILE . 5.7 p -58.52 -28.65 36.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-O 121.066 0.46 . . . . 0.0 110.873 -176.27 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 27.8 m -76.23 -40.43 52.12 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.927 -0.578 . . . . 0.0 110.954 176.902 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' LYS . . . . . 0.508 ' C ' ' HE2' ' A' ' 84' ' ' LYS . 0.0 OUTLIER -73.69 -49.0 27.92 Favored 'General case' 0 N--CA 1.456 -0.16 0 CA-C-O 121.338 0.589 . . . . 0.0 109.656 -178.096 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -76.27 0.49 19.09 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.129 -0.941 . . . . 0.0 111.211 -173.427 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 77.4 mt-30 61.41 34.21 18.34 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-N 115.79 -0.641 . . . . 0.0 112.575 168.853 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.596 ' HB2' HG23 ' A' ' 82' ' ' VAL . 72.0 mt -67.34 151.44 47.46 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.193 0.521 . . . . 0.0 111.548 -176.662 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 22.0 mmtm -117.75 -168.03 1.43 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.562 176.482 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 82.65 170.58 45.76 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 121.151 -0.547 . . . . 0.0 112.743 -177.719 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.701 ' O ' ' HA ' ' A' ' 67' ' ' VAL . 62.9 mt -85.64 112.11 21.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 N-CA-C 108.509 -0.922 . . . . 0.0 108.509 175.064 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 91' ' ' GLN . . . . . 0.685 ' HB3' ' CZ2' ' A' ' 38' ' ' TRP . 11.6 mm-40 -119.28 109.95 16.43 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-O 121.139 0.495 . . . . 0.0 111.181 -169.452 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.56 ' HB2' HD13 ' A' ' 69' ' ' LEU . 61.2 mt -106.55 149.46 27.12 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.465 0.65 . . . . 0.0 110.725 -177.64 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 93' ' ' HIS . . . . . 0.612 ' CE1' ' HA2' ' A' ' 95' ' ' GLY . 17.2 t-80 -119.95 111.59 18.11 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.662 -177.011 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 1.4 ttp -61.95 -49.64 75.3 Favored 'General case' 0 N--CA 1.448 -0.574 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.442 179.102 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' GLY . . . . . 0.612 ' HA2' ' CE1' ' A' ' 93' ' ' HIS . . . 118.68 -109.59 1.77 Allowed Glycine 0 N--CA 1.44 -1.076 0 CA-C-N 115.335 -0.848 . . . . 0.0 111.212 -177.997 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 1.7 m -126.94 24.17 6.48 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-O 120.731 0.3 . . . . 0.0 110.591 -179.255 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -87.32 142.65 27.73 Favored 'General case' 0 C--O 1.236 0.375 0 C-N-CA 119.656 -0.818 . . . . 0.0 111.276 -176.993 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' ARG . . . . . 0.807 ' HA ' ' HB2' ' A' ' 101' ' ' MET . 8.0 tpt180 -127.34 -3.42 6.19 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.039 -0.982 . . . . 0.0 110.163 178.057 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 1.5 m -66.49 -41.17 89.34 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 176.207 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' PHE . . . . . 0.403 ' CZ ' ' HE2' ' A' ' 104' ' ' TYR . 6.1 t80 -83.11 -24.34 32.66 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.433 -0.803 . . . . 0.0 109.707 176.298 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 101' ' ' MET . . . . . 0.807 ' HB2' ' HA ' ' A' ' 98' ' ' ARG . 0.0 OUTLIER -64.39 -55.49 20.69 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.432 -0.803 . . . . 0.0 109.078 178.125 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 102' ' ' ASP . . . . . 0.493 ' CG ' ' HE ' ' A' ' 98' ' ' ARG . 7.8 m-20 -65.02 -25.3 67.79 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.907 174.826 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -59.97 -32.24 70.64 Favored 'General case' 0 N--CA 1.466 0.33 0 N-CA-C 112.02 0.378 . . . . 0.0 112.02 -176.399 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' TYR . . . . . 0.403 ' HE2' ' CZ ' ' A' ' 100' ' ' PHE . 23.4 m-85 -101.04 8.55 42.89 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.619 0.247 . . . . 0.0 111.386 179.299 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 3.5 mm? 61.18 21.03 11.52 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.211 -179.831 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' ILE . . . . . 0.603 HG12 ' O ' ' A' ' 101' ' ' MET . 15.3 pt -79.98 150.55 4.91 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 176.013 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 107' ' ' ASN . . . . . 0.481 ' ND2' HH22 ' A' ' 98' ' ' ARG . 12.1 t-20 -160.82 -64.34 0.06 Allowed 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 -179.798 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -77.28 78.8 1.4 Allowed Glycine 0 N--CA 1.449 -0.498 0 N-CA-C 111.061 -0.815 . . . . 0.0 111.061 174.359 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.587 ' HB ' ' HA ' ' A' ' 110' ' ' PRO . 2.8 pp -75.68 161.1 77.48 Favored Pre-proline 0 C--N 1.323 -0.572 0 CA-C-N 115.719 -0.241 . . . . 0.0 111.546 -175.366 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 110' ' ' PRO . . . . . 0.809 ' HD3' ' HB2' ' A' ' 45' ' ' CYS . 40.1 Cg_endo -68.72 164.21 76.73 Favored 'Cis proline' 0 C--N 1.35 0.633 0 C-N-CA 124.029 -1.238 . . . . 0.0 113.504 0.983 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 111' ' ' ARG . . . . . 0.578 HH11 HG22 ' A' ' 106' ' ' ILE . 0.0 OUTLIER -129.54 137.59 50.85 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.728 -0.669 . . . . 0.0 109.43 179.314 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 112' ' ' PHE . . . . . 0.434 ' H ' ' HD3' ' A' ' 111' ' ' ARG . 0.2 OUTLIER -105.55 115.47 30.3 Favored 'General case' 0 C--N 1.323 -0.583 0 O-C-N 124.712 1.257 . . . . 0.0 111.413 -172.157 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.511 ' HB ' ' HB ' ' A' ' 35' ' ' ILE . 79.3 mt -131.16 146.15 34.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 120.936 0.398 . . . . 0.0 110.903 -178.956 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 42.0 tp -128.89 135.6 49.28 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.148 178.382 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.489 ' N ' HD12 ' A' ' 115' ' ' LEU . 1.3 mp -135.51 161.13 36.34 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.368 0.604 . . . . 0.0 110.892 -178.216 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 116' ' ' ASP . . . . . 0.867 ' HB3' ' HB2' ' A' ' 120' ' ' LYS . 17.8 t70 -74.22 165.35 25.31 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 114.874 -1.057 . . . . 0.0 110.443 175.728 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 117' ' ' ARG . . . . . 0.67 ' O ' ' HA ' ' A' ' 29' ' ' LYS . 53.8 mtt-85 -46.71 -39.35 11.35 Favored 'General case' 0 C--N 1.33 -0.271 0 O-C-N 124.308 1.005 . . . . 0.0 112.423 -178.562 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 118' ' ' ASP . . . . . 0.621 ' HA ' ' HG3' ' A' ' 29' ' ' LYS . 14.6 t0 -83.92 16.77 2.65 Favored 'General case' 0 C--O 1.237 0.423 0 CA-C-O 121.154 0.502 . . . . 0.0 111.253 -177.623 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 119' ' ' GLY . . . . . 0.557 ' HA2' HD12 ' A' ' 33' ' ' ILE . . . 72.85 25.26 74.32 Favored Glycine 0 N--CA 1.435 -1.416 0 C-N-CA 120.417 -0.897 . . . . 0.0 110.869 -175.712 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 120' ' ' LYS . . . . . 0.867 ' HB2' ' HB3' ' A' ' 116' ' ' ASP . 40.3 mmtm -85.7 104.17 15.17 Favored 'General case' 0 C--O 1.22 -0.462 0 C-N-CA 120.378 -0.529 . . . . 0.0 111.458 -179.196 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 0.647 ' H ' HD12 ' A' ' 121' ' ' ILE . 3.8 mp -44.81 113.22 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.678 -179.053 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 122' ' ' ILE . . . . . 0.42 ' H ' ' HA ' ' A' ' 115' ' ' LEU . 46.0 mm -95.75 -44.25 12.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.664 -0.698 . . . . 0.0 109.597 177.855 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 14.6 m -142.29 114.82 8.48 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.485 -0.78 . . . . 0.0 110.086 177.964 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 124' ' ' ALA . . . . . 0.407 ' HA ' HG23 ' A' ' 113' ' ' ILE . . . -78.06 -6.9 56.05 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.043 0.449 . . . . 0.0 110.832 179.276 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 5.9 t30 -150.81 100.59 2.83 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.83 -0.623 . . . . 0.0 109.416 179.456 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 126' ' ' MET . . . . . 0.633 ' HG2' HG23 ' A' ' 134' ' ' THR . 43.9 tpp -89.67 -91.04 0.14 Allowed 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 111.935 0.346 . . . . 0.0 111.935 -176.76 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 127' ' ' THR . . . . . 0.527 ' O ' ' HG2' ' A' ' 128' ' ' ARG . 0.0 OUTLIER -152.67 -70.21 0.15 Allowed 'General case' 0 CA--C 1.531 0.235 0 N-CA-C 112.322 0.49 . . . . 0.0 112.322 -178.326 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 128' ' ' ARG . . . . . 0.527 ' HG2' ' O ' ' A' ' 127' ' ' THR . 3.5 mmt180 175.99 140.13 0.21 Allowed Pre-proline 0 N--CA 1.467 0.393 0 C-N-CA 124.351 1.06 . . . . 0.0 109.299 -173.474 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 129' ' ' PRO . . . . . 0.422 ' HG3' ' OD2' ' A' ' 36' ' ' ASP . 46.0 Cg_exo -56.44 -37.33 97.38 Favored 'Trans proline' 0 C--N 1.342 0.23 0 C-N-CA 122.339 2.026 . . . . 0.0 111.874 171.522 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 130' ' ' SER . . . . . 0.652 ' HB3' ' HB3' ' A' ' 48' ' ' GLU . 13.3 p -78.06 -25.67 47.83 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.821 179.663 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 131' ' ' ASP . . . . . 0.501 ' OD2' ' HB2' ' A' ' 133' ' ' LYS . 29.7 t70 -78.49 117.6 67.31 Favored Pre-proline 0 C--N 1.327 -0.406 0 CA-C-O 120.832 0.348 . . . . 0.0 110.724 -175.336 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 132' ' ' PRO . . . . . 0.585 ' O ' ' HG2' ' A' ' 136' ' ' GLU . 49.6 Cg_exo -56.6 -29.49 79.47 Favored 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 123.469 2.78 . . . . 0.0 113.73 -175.233 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 133' ' ' LYS . . . . . 0.763 ' H ' ' HD3' ' A' ' 133' ' ' LYS . 0.0 OUTLIER -54.48 -35.36 62.99 Favored 'General case' 0 N--CA 1.456 -0.152 0 CA-C-O 120.578 0.227 . . . . 0.0 110.688 -177.824 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 134' ' ' THR . . . . . 0.633 HG23 ' HG2' ' A' ' 126' ' ' MET . 4.6 m -60.69 -48.81 80.13 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.482 0.658 . . . . 0.0 110.666 178.399 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 135' ' ' ALA . . . . . 0.626 ' HA ' ' CD2' ' A' ' 138' ' ' PHE . . . -61.78 -43.36 99.0 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.315 -0.857 . . . . 0.0 111.106 -178.228 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 136' ' ' GLU . . . . . 0.585 ' HG2' ' O ' ' A' ' 132' ' ' PRO . 10.8 mm-40 -72.05 -23.97 61.45 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.546 -177.279 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 137' ' ' LYS . . . . . 0.718 ' HG2' ' O ' ' A' ' 133' ' ' LYS . 17.8 mmtm -56.07 -49.77 72.85 Favored 'General case' 0 CA--C 1.515 -0.369 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 167.901 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 138' ' ' PHE . . . . . 0.626 ' CD2' ' HA ' ' A' ' 135' ' ' ALA . 7.0 m-30 -55.26 -36.91 66.58 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-N 115.163 -0.926 . . . . 0.0 110.57 -178.746 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 139' ' ' ASN . . . . . 0.558 ' ND2' ' HA ' ' A' ' 136' ' ' GLU . 72.8 m-20 -58.13 -56.41 22.38 Favored 'General case' 0 C--N 1.332 -0.179 0 C-N-CA 120.686 -0.406 . . . . 0.0 110.693 175.839 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -44.73 -59.91 2.28 Favored 'General case' 0 C--N 1.342 0.258 0 O-C-N 123.615 0.572 . . . . 0.0 111.675 178.95 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.434 HD13 ' O ' ' A' ' 137' ' ' LYS . 8.5 mp -50.69 -37.8 43.33 Favored 'General case' 0 CA--C 1.531 0.226 0 N-CA-C 112.595 0.591 . . . . 0.0 112.595 178.86 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.777 ' HG ' ' HD2' ' A' ' 62' ' ' LYS . 3.8 mm? -79.3 -29.2 42.34 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.623 0.249 . . . . 0.0 111.623 179.264 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 98.13 27.27 8.89 Favored Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 120.949 -0.643 . . . . 0.0 112.297 178.789 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.544 ' HB3' ' HB3' ' A' ' 139' ' ' ASN . 50.4 tp -75.25 -32.28 61.04 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.037 0.446 . . . . 0.0 110.46 -177.621 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 4.4 mp0 -54.76 -34.92 63.21 Favored 'General case' 0 C--O 1.238 0.449 0 CA-C-N 115.287 -0.869 . . . . 0.0 110.88 178.477 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 64.45 8.4 31.67 Favored Glycine 0 C--N 1.32 -0.335 0 CA-C-N 114.097 -1.41 . . . . 0.0 112.525 -178.791 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 74.4 m80 -151.5 -57.18 0.15 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.216 0.531 . . . . 0.0 109.587 -175.766 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 148' ' ' HIS . . . . . 0.535 ' O ' ' HB2' ' A' ' 149' ' ' HIS . 67.5 t60 -76.62 92.32 3.49 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.602 -0.727 . . . . 0.0 111.272 -178.514 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 149' ' ' HIS . . . . . 0.535 ' HB2' ' O ' ' A' ' 148' ' ' HIS . 4.5 t-160 172.41 -80.53 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 115.408 -0.815 . . . . 0.0 108.911 170.235 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 150' ' ' HIS . . . . . 0.408 ' H ' ' HB3' ' A' ' 149' ' ' HIS . 17.0 t60 65.33 -65.95 0.15 Allowed 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 123.651 0.78 . . . . 0.0 111.427 -179.837 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 54.1 t-80 -153.8 99.5 2.29 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 109.934 -0.395 . . . . 0.0 109.934 177.222 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 152' ' ' HIS . . . . . 0.415 ' HB3' ' CD2' ' A' ' 149' ' ' HIS . 11.0 t-80 . . . . . 0 C--N 1.318 -0.77 0 CA-C-O 118.175 -0.917 . . . . 0.0 109.268 179.545 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 58.1 tpp . . . . . 0 N--CA 1.479 0.99 0 CA-C-O 120.792 0.329 . . . . 0.0 110.219 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 14.8 m -96.2 86.23 4.19 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.006 0.431 . . . . 0.0 109.93 179.385 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 88.5 mt -67.47 112.68 4.79 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.646 -0.706 . . . . 0.0 111.063 -178.492 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 5.9 ptp180 -117.52 6.86 12.57 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.539 -0.755 . . . . 0.0 109.547 178.494 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 8.0 m -141.03 129.56 22.62 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-N 115.039 -0.982 . . . . 0.0 109.243 -178.838 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 109.1 -133.23 11.53 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.756 -0.735 . . . . 0.0 111.381 -178.164 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' ASN . . . . . 0.411 ' HA ' ' HD3' ' A' ' 8' ' ' PRO . 25.1 p-10 -114.93 149.79 43.06 Favored Pre-proline 0 C--N 1.325 -0.482 0 CA-C-N 116.994 0.397 . . . . 0.0 110.429 176.769 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.421 ' HB3' ' HA ' ' A' ' 13' ' ' PHE . 14.1 Cg_exo -68.16 146.72 71.12 Favored 'Trans proline' 0 N--CA 1.464 -0.219 0 C-N-CA 122.801 2.334 . . . . 0.0 112.279 179.521 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 51.0 m -103.12 174.01 6.05 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.18 -0.463 . . . . 0.0 109.968 176.524 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -76.45 71.08 3.09 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.136 0.493 . . . . 0.0 110.489 178.784 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -156.2 -43.44 0.08 Allowed 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.291 -0.868 . . . . 0.0 110.768 -179.35 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 23.5 p -149.91 33.49 0.68 Allowed 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 115.165 -0.925 . . . . 0.0 110.628 -178.256 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' PHE . . . . . 0.426 ' CE2' HD22 ' A' ' 25' ' ' LEU . 27.5 p90 -63.18 150.11 43.73 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.252 -177.278 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.42 ' HA ' ' HA ' ' A' ' 24' ' ' SER . 15.9 m -137.06 127.53 26.7 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 178.047 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' TYR . . . . . 0.42 ' CE2' ' HB2' ' A' ' 13' ' ' PHE . 77.6 m-85 -138.34 156.93 73.34 Favored Pre-proline 0 C--N 1.326 -0.436 0 CA-C-O 120.752 0.311 . . . . 0.0 111.356 -175.399 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.481 ' HD2' ' O ' ' A' ' 93' ' ' HIS . 1.6 Cg_endo -83.53 126.77 4.2 Favored 'Trans proline' 0 N--CA 1.459 -0.556 0 C-N-CA 123.183 2.588 . . . . 0.0 113.85 -178.488 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' ASP . . . . . 1.028 ' HB3' ' HB3' ' A' ' 21' ' ' LYS . 0.4 OUTLIER -65.08 166.14 9.99 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 114.88 -1.055 . . . . 0.0 109.584 169.47 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.579 ' HB ' ' HB2' ' A' ' 79' ' ' GLU . 40.0 pt -48.74 -33.36 5.01 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 C-N-CA 123.561 0.744 . . . . 0.0 112.803 -175.169 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 36.8 m-80 -83.7 -3.1 57.5 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.776 0.322 . . . . 0.0 111.599 -177.48 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 89.83 29.25 16.19 Favored Glycine 0 N--CA 1.45 -0.377 0 N-CA-C 110.212 -1.155 . . . . 0.0 110.212 -171.21 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 1.028 ' HB3' ' HB3' ' A' ' 17' ' ' ASP . 19.1 ttmt -92.23 111.74 23.42 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 114.872 -0.664 . . . . 0.0 110.639 -172.921 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 20.3 m -70.58 112.54 6.91 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 120.796 0.331 . . . . 0.0 111.376 -177.755 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.588 ' HB ' HD21 ' A' ' 92' ' ' LEU . 59.9 t -124.3 145.57 31.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 177.107 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' SER . . . . . 0.42 ' HA ' ' HA ' ' A' ' 14' ' ' SER . 94.5 p -122.01 -175.46 3.12 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.084 0.468 . . . . 0.0 110.904 -175.784 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.471 ' O ' ' HB2' ' A' ' 29' ' ' LYS . 30.8 tp -93.68 -0.32 56.11 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.072 175.479 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.436 ' O ' ' HB3' ' A' ' 29' ' ' LYS . . . -88.94 -35.41 16.48 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.004 -179.196 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 3.9 p30 -78.18 -22.87 47.99 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.448 0.642 . . . . 0.0 110.062 176.7 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.426 HD13 HG21 ' A' ' 67' ' ' VAL . 85.7 mt -89.66 -8.79 51.69 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.105 175.311 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.471 ' HB2' ' O ' ' A' ' 25' ' ' LEU . 48.3 tttp -76.45 140.29 41.21 Favored 'General case' 0 N--CA 1.446 -0.654 0 CA-C-N 115.48 -0.782 . . . . 0.0 111.177 -176.254 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 110.54 2.32 29.16 Favored Glycine 0 N--CA 1.449 -0.481 0 N-CA-C 111.382 -0.687 . . . . 0.0 111.382 -177.153 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.597 ' HG3' ' CG ' ' A' ' 63' ' ' ASP . 24.6 ttmm -152.43 149.91 29.08 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 109.076 -0.712 . . . . 0.0 109.076 -179.758 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.449 ' HB2' ' O ' ' A' ' 63' ' ' ASP . 39.3 m-85 -49.11 144.92 4.53 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-O 121.044 0.45 . . . . 0.0 111.889 -177.307 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.511 ' HB ' ' HB2' ' A' ' 115' ' ' LEU . 35.3 mm -121.53 122.69 67.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.985 -177.234 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 78.6 t80 -116.96 112.01 20.4 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 108.782 -0.822 . . . . 0.0 108.782 171.701 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.716 ' HB ' ' CG2' ' A' ' 113' ' ' ILE . 78.8 mt -105.35 129.4 58.24 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 C-N-CA 120.563 -0.455 . . . . 0.0 110.446 -177.023 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.504 ' HA ' ' O ' ' A' ' 111' ' ' ARG . 1.8 t70 -123.34 159.72 28.26 Favored 'General case' 0 C--N 1.314 -0.938 0 N-CA-C 108.798 -0.815 . . . . 0.0 108.798 178.06 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.532 HG11 HG21 ' A' ' 109' ' ' ILE . 58.9 t -104.59 112.79 39.6 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.953 0 C-N-CA 120.258 -0.577 . . . . 0.0 110.49 176.24 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' TRP . . . . . 0.597 ' CZ2' ' HB3' ' A' ' 91' ' ' GLN . 0.6 OUTLIER -101.98 132.64 47.7 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.235 -176.055 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.427 ' HA ' ' OD1' ' A' ' 72' ' ' ASP . . . -147.05 156.25 42.87 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.885 -178.21 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.717 ' HB ' ' CE3' ' A' ' 78' ' ' TRP . 14.6 t -99.14 -23.46 15.23 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 120.898 -0.321 . . . . 0.0 110.808 175.418 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 8.8 p-90 -84.08 -8.0 59.23 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.076 0.465 . . . . 0.0 110.831 -179.94 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 42.5 t -91.99 105.29 17.57 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 175.713 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.406 ' N ' ' HD2' ' A' ' 44' ' ' PRO . . . -54.74 -61.68 7.05 Favored Glycine 0 CA--C 1.524 0.641 0 CA-C-N 115.712 -0.676 . . . . 0.0 113.837 -178.424 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.406 ' HD2' ' N ' ' A' ' 43' ' ' GLY . 12.3 Cg_endo -55.76 -34.33 90.66 Favored 'Trans proline' 0 C--N 1.352 0.755 0 C-N-CA 122.901 2.401 . . . . 0.0 112.66 -177.415 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' CYS . . . . . 0.706 ' O ' ' HG ' ' A' ' 49' ' ' LEU . 49.6 t -53.08 -39.75 63.57 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.178 179.481 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.678 HH12 ' HH2' ' A' ' 78' ' ' TRP . 20.1 mmm180 -65.92 -20.76 66.33 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.585 -174.409 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -80.56 -40.18 13.26 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.84 -0.695 . . . . 0.0 113.383 -174.126 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -95.72 -6.36 39.98 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 117.077 0.438 . . . . 0.0 111.604 -174.424 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.706 ' HG ' ' O ' ' A' ' 45' ' ' CYS . 39.7 mt -56.96 -47.42 99.12 Favored Pre-proline 0 C--N 1.327 -0.376 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.926 175.868 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.518 ' O ' ' HG2' ' A' ' 54' ' ' GLU . 75.4 Cg_exo -51.6 -40.39 64.14 Favored 'Trans proline' 0 C--N 1.358 1.051 0 C-N-CA 121.972 1.781 . . . . 0.0 112.113 173.906 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -69.86 -27.45 64.85 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.431 0.634 . . . . 0.0 110.695 -178.418 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.592 HD22 ' HE3' ' A' ' 88' ' ' LYS . 3.6 tt -73.36 -33.2 64.94 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.506 -0.77 . . . . 0.0 109.214 176.247 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.87 ' HE2' HD23 ' A' ' 87' ' ' LEU . 85.0 mttt -64.61 -50.37 67.44 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 108.933 -0.765 . . . . 0.0 108.933 174.905 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.518 ' HG2' ' O ' ' A' ' 50' ' ' PRO . 33.1 mm-40 -51.82 -41.75 62.0 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-N 114.822 -1.081 . . . . 0.0 110.836 175.797 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.594 HD21 ' CE2' ' A' ' 138' ' ' PHE . 17.6 tp -61.29 -44.41 97.26 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.05 -0.977 . . . . 0.0 111.057 -178.624 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.569 ' OE1' ' HB2' ' A' ' 88' ' ' LYS . 24.4 tt0 -65.17 -36.53 84.5 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-N 116.61 -0.268 . . . . 0.0 111.306 -178.192 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 17.2 mm-40 -54.07 -54.41 39.83 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.579 0.704 . . . . 0.0 109.832 173.851 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.491 ' HE3' ' CZ ' ' A' ' 59' ' ' TYR . 32.6 tttp -53.81 -33.88 57.47 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 114.58 -1.191 . . . . 0.0 112.333 177.334 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.491 ' CZ ' ' HE3' ' A' ' 58' ' ' LYS . 84.9 m-85 -111.16 16.95 20.78 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 112.335 0.494 . . . . 0.0 112.335 -175.88 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -64.1 131.68 48.22 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.868 0.366 . . . . 0.0 110.64 176.552 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 68.68 44.7 69.53 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.922 -0.656 . . . . 0.0 112.176 -179.506 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 40.2 mmtm -128.51 -154.11 0.61 Allowed 'General case' 0 N--CA 1.45 -0.432 0 CA-C-O 120.981 0.419 . . . . 0.0 109.981 177.2 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.597 ' CG ' ' HG3' ' A' ' 31' ' ' LYS . 10.4 t70 -111.77 69.46 0.69 Allowed 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 116.182 -0.463 . . . . 0.0 109.799 177.022 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.569 HG13 ' O ' ' A' ' 63' ' ' ASP . 15.1 mt -151.89 139.32 13.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.274 178.437 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' HIS . . . . . 0.509 ' NE2' ' HB3' ' A' ' 31' ' ' LYS . 92.0 m-70 -114.92 111.3 20.96 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.49 -0.777 . . . . 0.0 109.949 173.406 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' PHE . . . . . 0.506 ' HE1' HD23 ' A' ' 55' ' ' LEU . 89.4 m-85 -81.9 103.66 11.71 Favored 'General case' 0 C--N 1.318 -0.782 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 171.179 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.626 ' HA ' ' O ' ' A' ' 90' ' ' ILE . 41.9 t -116.28 122.12 69.03 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.436 -176.242 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' SER . . . . . 0.76 ' HB2' ' HG2' ' A' ' 91' ' ' GLN . 50.7 m -110.54 134.94 51.93 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 116.544 -0.298 . . . . 0.0 110.932 -178.707 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.485 HD13 ' HB2' ' A' ' 92' ' ' LEU . 4.5 mm? -115.75 139.45 50.14 Favored 'General case' 0 N--CA 1.471 0.598 0 N-CA-C 110.081 -0.34 . . . . 0.0 110.081 175.6 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 3.5 t -118.11 124.87 49.08 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 112.926 0.713 . . . . 0.0 112.926 -172.882 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 10.6 m -87.1 13.07 10.03 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.876 174.217 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.59 ' O ' ' HA2' ' A' ' 95' ' ' GLY . 1.0 OUTLIER -71.45 136.31 47.58 Favored 'General case' 0 CA--C 1.516 -0.331 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 -178.476 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.468 ' H ' ' HG2' ' A' ' 73' ' ' LYS . 0.4 OUTLIER -99.98 -18.84 16.85 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-O 121.481 0.657 . . . . 0.0 110.034 178.92 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 74' ' ' ASN . . . . . 0.65 ' HB2' ' HB3' ' A' ' 77' ' ' ALA . 0.8 OUTLIER -80.8 61.05 4.3 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.026 -0.988 . . . . 0.0 109.785 174.369 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 9.5 tttt -50.67 -53.79 28.31 Favored 'General case' 0 C--O 1.222 -0.35 0 N-CA-C 112.647 0.61 . . . . 0.0 112.647 -171.177 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.506 ' HA ' ' OE1' ' A' ' 79' ' ' GLU . 40.3 tptt -61.7 -42.3 98.74 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.842 0.353 . . . . 0.0 110.989 -177.149 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.65 ' HB3' ' HB2' ' A' ' 74' ' ' ASN . . . -63.84 -33.76 76.4 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 121.746 0.784 . . . . 0.0 110.119 176.927 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' TRP . . . . . 0.717 ' CE3' ' HB ' ' A' ' 40' ' ' THR . 9.7 t-105 -76.72 -50.21 14.17 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 114.797 -1.092 . . . . 0.0 111.555 -177.463 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.579 ' HB2' ' HB ' ' A' ' 18' ' ' ILE . 4.1 pt-20 -60.38 -34.44 73.9 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-O 121.198 0.523 . . . . 0.0 110.357 -176.255 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 80' ' ' ASN . . . . . 0.63 ' O ' ' HD3' ' A' ' 84' ' ' LYS . 3.4 p30 -79.42 -29.97 42.15 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 119.67 -0.812 . . . . 0.0 110.668 177.622 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 13.6 tpt -61.4 -47.56 85.26 Favored 'General case' 0 C--O 1.225 -0.235 0 O-C-N 122.437 -0.164 . . . . 0.0 111.175 175.374 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.696 HG23 ' HB2' ' A' ' 87' ' ' LEU . 0.2 OUTLIER -61.1 -36.15 70.55 Favored 'Isoleucine or valine' 0 C--O 1.232 0.164 0 C-N-CA 120.386 -0.526 . . . . 0.0 110.17 175.602 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 76.3 m -61.51 -41.93 98.04 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.289 174.863 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' LYS . . . . . 0.63 ' HD3' ' O ' ' A' ' 80' ' ' ASN . 1.9 mptm? -72.9 -46.92 50.08 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-O 121.092 0.472 . . . . 0.0 110.912 179.684 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -66.03 -25.81 67.23 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.287 -0.869 . . . . 0.0 111.01 -176.477 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 29.2 mm-40 64.59 72.8 0.44 Allowed 'General case' 0 C--O 1.234 0.287 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.561 -175.843 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.87 HD23 ' HE2' ' A' ' 53' ' ' LYS . 89.8 mt -92.99 -179.46 5.11 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.05 177.007 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.592 ' HE3' HD22 ' A' ' 52' ' ' LEU . 0.0 OUTLIER -145.74 173.62 11.93 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 112.534 0.568 . . . . 0.0 112.534 -171.424 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 78.4 -170.71 54.95 Favored Glycine 0 N--CA 1.452 -0.24 0 CA-C-N 115.593 -0.731 . . . . 0.0 112.856 178.883 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.626 ' O ' ' HA ' ' A' ' 67' ' ' VAL . 5.0 mp -89.66 112.1 24.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 177.219 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 91' ' ' GLN . . . . . 0.76 ' HG2' ' HB2' ' A' ' 68' ' ' SER . 21.8 mt-30 -123.11 111.02 16.03 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-O 121.475 0.655 . . . . 0.0 111.061 -174.561 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.588 HD21 ' HB ' ' A' ' 23' ' ' VAL . 55.2 mt -105.98 164.36 12.02 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 114.979 -1.009 . . . . 0.0 109.668 -178.238 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 93' ' ' HIS . . . . . 0.481 ' O ' ' HD2' ' A' ' 16' ' ' PRO . 17.7 t-80 -131.46 124.67 30.67 Favored 'General case' 0 C--N 1.313 -1.015 0 CA-C-O 120.936 0.398 . . . . 0.0 111.357 -171.577 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 24.0 ttp -79.94 -58.02 3.37 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.241 179.39 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' GLY . . . . . 0.59 ' HA2' ' O ' ' A' ' 72' ' ' ASP . . . 101.34 -93.88 1.18 Allowed Glycine 0 N--CA 1.444 -0.789 0 C-N-CA 120.304 -0.951 . . . . 0.0 113.549 174.212 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 4.6 p -109.09 8.63 26.17 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 112.84 0.682 . . . . 0.0 112.84 -172.067 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -102.21 153.11 20.27 Favored 'General case' 0 CA--C 1.517 -0.309 0 C-N-CA 119.811 -0.756 . . . . 0.0 109.962 177.269 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.14 6.93 3.37 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.965 -0.561 . . . . 0.0 109.608 173.462 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 6.9 m -76.54 -32.7 58.39 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.044 -176.038 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 59.5 t80 -74.6 -37.49 62.85 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.546 -0.752 . . . . 0.0 111.014 178.938 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 5.2 ppp? -77.4 -26.17 51.52 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 176.999 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -68.05 -29.92 69.01 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.427 -0.806 . . . . 0.0 109.965 172.876 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -63.25 -18.61 63.74 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-N 115.991 -0.549 . . . . 0.0 111.37 179.181 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 72.3 m-85 -97.36 -5.43 36.43 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-O 120.837 0.351 . . . . 0.0 110.078 178.511 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 87.1 mt 60.19 17.04 6.55 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 115.35 -0.841 . . . . 0.0 111.345 179.349 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 11.1 tp -73.7 -45.15 51.29 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.35 0 N-CA-C 112.566 0.58 . . . . 0.0 112.566 -172.573 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 9.0 t30 67.66 -62.64 0.33 Allowed 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 123.158 0.583 . . . . 0.0 111.613 -176.909 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -91.77 111.05 3.95 Favored Glycine 0 N--CA 1.447 -0.579 0 C-N-CA 121.183 -0.532 . . . . 0.0 112.575 -176.537 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.532 HG21 HG11 ' A' ' 37' ' ' VAL . 43.2 pt -85.1 158.28 58.63 Favored Pre-proline 0 C--N 1.322 -0.595 0 N-CA-C 110.434 -0.21 . . . . 0.0 110.434 176.81 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 110' ' ' PRO . . . . . 0.531 ' HA ' ' HB ' ' A' ' 109' ' ' ILE . 3.0 Cg_exo -74.31 158.69 98.61 Favored 'Cis proline' 0 C--N 1.348 0.53 0 C-N-CA 124.132 -1.195 . . . . 0.0 113.426 1.473 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 111' ' ' ARG . . . . . 0.707 ' HD2' ' N ' ' A' ' 112' ' ' PHE . 0.1 OUTLIER -113.32 140.41 48.04 Favored 'General case' 0 N--CA 1.442 -0.874 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 175.979 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 112' ' ' PHE . . . . . 0.707 ' N ' ' HD2' ' A' ' 111' ' ' ARG . 4.2 m-85 -115.44 132.41 56.63 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 108.609 -0.885 . . . . 0.0 108.609 -177.953 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.716 ' CG2' ' HB ' ' A' ' 35' ' ' ILE . 7.5 tt -147.53 156.77 9.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 118.492 0.587 . . . . 0.0 111.278 -177.846 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 35.3 tp -136.29 132.56 35.89 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.837 0.351 . . . . 0.0 110.495 177.754 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.562 ' HG ' ' HA ' ' A' ' 121' ' ' ILE . 2.5 mp -130.97 151.54 51.26 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 178.979 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 116' ' ' ASP . . . . . 0.432 ' N ' HG13 ' A' ' 122' ' ' ILE . 9.7 t70 -73.1 164.56 26.51 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.965 -0.561 . . . . 0.0 109.792 179.044 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 117' ' ' ARG . . . . . 0.525 ' HG2' ' HA ' ' A' ' 31' ' ' LYS . 3.9 mtm180 -47.32 -33.96 6.27 Favored 'General case' 0 C--N 1.323 -0.554 0 O-C-N 124.519 1.137 . . . . 0.0 112.271 -179.645 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -71.24 -6.03 36.58 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.215 -177.883 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 84.69 22.61 52.95 Favored Glycine 0 N--CA 1.441 -1.027 0 N-CA-C 110.006 -1.238 . . . . 0.0 110.006 -172.542 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 120' ' ' LYS . . . . . 0.401 ' HA ' ' HD3' ' A' ' 120' ' ' LYS . 30.4 mmtp -102.75 111.13 23.31 Favored 'General case' 0 CA--C 1.518 -0.287 0 CA-C-N 115.521 -0.339 . . . . 0.0 111.267 -174.107 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 0.637 ' H ' HD12 ' A' ' 121' ' ' ILE . 3.8 mp -41.4 115.08 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 O-C-N 124.196 0.935 . . . . 0.0 111.817 179.883 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 122' ' ' ILE . . . . . 0.489 ' H ' ' HA ' ' A' ' 115' ' ' LEU . 63.8 mt -83.72 -41.5 16.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 175.92 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 49.4 m -146.55 125.36 12.66 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 114.843 -1.072 . . . . 0.0 109.164 176.091 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -61.34 -31.56 71.43 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-O 121.046 0.45 . . . . 0.0 111.584 -176.189 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 10.9 t30 -138.35 113.83 9.61 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.917 -0.583 . . . . 0.0 109.468 174.554 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 126' ' ' MET . . . . . 0.463 ' HG3' ' H ' ' A' ' 127' ' ' THR . 7.7 tpt -93.91 -148.03 0.26 Allowed 'General case' 0 C--N 1.317 -0.833 0 N-CA-C 108.917 -0.771 . . . . 0.0 108.917 -179.401 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 127' ' ' THR . . . . . 0.463 ' H ' ' HG3' ' A' ' 126' ' ' MET . 1.1 p -135.94 143.09 44.72 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-O 120.707 0.289 . . . . 0.0 110.928 -177.497 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 128' ' ' ARG . . . . . 0.441 ' HA ' ' CD1' ' A' ' 112' ' ' PHE . 9.2 ptp180 -40.65 154.49 0.21 Allowed Pre-proline 0 C--N 1.327 -0.408 0 N-CA-C 113.536 0.939 . . . . 0.0 113.536 176.353 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_exo -54.81 -34.02 83.45 Favored 'Trans proline' 0 C--N 1.348 0.505 0 C-N-CA 123.503 2.802 . . . . 0.0 113.135 178.178 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 16.3 m -76.16 -1.86 28.29 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.655 -178.254 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 131' ' ' ASP . . . . . 0.455 ' HA ' ' HD3' ' A' ' 132' ' ' PRO . 9.8 t70 -90.3 124.82 61.99 Favored Pre-proline 0 C--N 1.324 -0.511 0 N-CA-C 109.974 -0.38 . . . . 0.0 109.974 178.757 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 132' ' ' PRO . . . . . 0.455 ' HD3' ' HA ' ' A' ' 131' ' ' ASP . 43.5 Cg_exo -58.77 -35.71 98.2 Favored 'Trans proline' 0 C--N 1.344 0.325 0 C-N-CA 123.173 2.582 . . . . 0.0 113.414 -177.827 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 133' ' ' LYS . . . . . 0.668 ' HZ2' ' HB2' ' A' ' 133' ' ' LYS . 10.0 mtmp? -62.88 -34.42 77.34 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-O 121.082 0.467 . . . . 0.0 111.031 -177.036 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 134' ' ' THR . . . . . 0.546 HG22 ' CZ ' ' A' ' 138' ' ' PHE . 0.3 OUTLIER -69.64 -51.49 34.39 Favored 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 109.765 -0.457 . . . . 0.0 109.765 177.168 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 135' ' ' ALA . . . . . 0.5 ' HA ' ' CD2' ' A' ' 138' ' ' PHE . . . -54.96 -49.95 70.14 Favored 'General case' 0 C--O 1.24 0.553 0 CA-C-N 115.605 -0.725 . . . . 0.0 112.25 179.653 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 136' ' ' GLU . . . . . 0.538 ' HG3' ' N ' ' A' ' 137' ' ' LYS . 2.0 pt-20 -60.57 -41.44 94.64 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-O 120.978 0.418 . . . . 0.0 110.268 -179.56 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 137' ' ' LYS . . . . . 0.538 ' N ' ' HG3' ' A' ' 136' ' ' GLU . 0.0 OUTLIER -66.53 -33.15 75.03 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.76 -177.217 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 138' ' ' PHE . . . . . 0.594 ' CE2' HD21 ' A' ' 55' ' ' LEU . 20.5 m-85 -58.52 -52.54 65.2 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.336 175.008 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 139' ' ' ASN . . . . . 0.862 ' HB3' ' HG3' ' A' ' 145' ' ' GLU . 56.6 m-20 -57.47 -54.55 45.59 Favored 'General case' 0 N--CA 1.464 0.26 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 177.718 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 23.3 tt0 -49.91 -60.5 2.86 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 114.798 -1.092 . . . . 0.0 113.204 179.868 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 84.7 mt -67.43 -28.89 68.27 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-O 120.644 0.259 . . . . 0.0 111.616 -173.994 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.424 HD23 ' HB2' ' A' ' 144' ' ' LEU . 66.8 tp -76.19 -21.77 56.1 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.335 0.588 . . . . 0.0 109.737 175.202 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 78.22 25.14 62.17 Favored Glycine 0 N--CA 1.445 -0.749 0 N-CA-C 110.588 -1.005 . . . . 0.0 110.588 -176.562 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.424 ' HB2' HD23 ' A' ' 142' ' ' LEU . 9.7 tt -73.47 -35.05 65.64 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-N 114.782 -0.709 . . . . 0.0 109.727 -176.461 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 145' ' ' GLU . . . . . 0.862 ' HG3' ' HB3' ' A' ' 139' ' ' ASN . 50.6 mt-10 -81.64 96.97 7.67 Favored 'General case' 0 N--CA 1.444 -0.732 0 CA-C-O 121.605 0.717 . . . . 0.0 110.709 178.683 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -74.9 64.66 2.29 Favored Glycine 0 C--N 1.311 -0.808 0 CA-C-N 114.693 -1.139 . . . . 0.0 110.848 175.175 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 11.9 t-80 -78.67 34.96 0.23 Allowed 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 122.83 0.452 . . . . 0.0 111.93 -170.756 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 22.5 p-80 -143.88 137.61 28.01 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.849 -0.426 . . . . 0.0 109.849 178.493 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 13.9 p-80 -58.92 115.73 3.31 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-O 121.121 0.486 . . . . 0.0 110.078 177.591 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 60.3 t60 -81.6 85.23 6.58 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.739 -0.664 . . . . 0.0 112.45 -170.042 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 34.6 t-80 -99.0 -8.55 25.21 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 106.713 -1.588 . . . . 0.0 106.713 161.374 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 32.0 p80 . . . . . 0 C--O 1.243 0.716 0 CA-C-N 113.536 -1.666 . . . . 0.0 108.057 173.217 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.443 ' SD ' ' N ' ' A' ' 1' ' ' MET . 1.4 mpt? . . . . . 0 N--CA 1.48 1.057 0 N-CA-C 109.901 -0.407 . . . . 0.0 109.901 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 22.3 t -174.11 101.03 0.1 Allowed 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 178.197 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 6.4 mp -96.28 84.38 3.74 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 120.954 0.407 . . . . 0.0 110.553 -176.76 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 35.2 mtp180 -73.69 -3.94 31.34 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.032 0.444 . . . . 0.0 110.698 178.834 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 10.3 p -91.83 -4.51 54.78 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.487 175.855 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -145.36 -85.54 0.07 OUTLIER Glycine 0 N--CA 1.447 -0.582 0 C-N-CA 120.883 -0.675 . . . . 0.0 112.041 -179.207 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' ASN . . . . . 0.421 ' HA ' ' HD3' ' A' ' 8' ' ' PRO . 45.8 m-80 -134.64 145.59 55.58 Favored Pre-proline 0 C--N 1.327 -0.388 0 N-CA-C 110.409 -0.219 . . . . 0.0 110.409 -179.157 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.421 ' HD3' ' HA ' ' A' ' 7' ' ' ASN . 21.3 Cg_exo -65.55 158.22 54.23 Favored 'Trans proline' 0 N--CA 1.464 -0.223 0 C-N-CA 122.924 2.416 . . . . 0.0 111.975 178.182 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 16.6 m -114.28 166.74 11.34 Favored 'General case' 0 N--CA 1.445 -0.707 0 CA-C-N 116.073 -0.512 . . . . 0.0 109.793 -179.254 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -77.81 72.99 4.38 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.554 0.692 . . . . 0.0 110.068 178.169 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -139.59 91.7 2.51 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.402 -0.817 . . . . 0.0 110.969 -178.355 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' SER . . . . . 1.026 ' HA ' ' HB3' ' A' ' 25' ' ' LEU . 67.2 m 59.06 77.09 0.32 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.702 -0.681 . . . . 0.0 112.105 178.154 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 31.4 p90 -82.3 -178.98 7.25 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.569 177.324 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.483 ' HA ' ' HA ' ' A' ' 24' ' ' SER . 23.2 t -142.53 134.64 27.36 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 175.469 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' TYR . . . . . 0.412 ' HA ' ' HD3' ' A' ' 16' ' ' PRO . 36.4 m-85 -146.07 150.3 41.55 Favored Pre-proline 0 C--N 1.325 -0.472 0 N-CA-C 109.999 -0.371 . . . . 0.0 109.999 179.835 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' A' ' 15' ' ' TYR . 3.9 Cg_exo -76.64 125.3 8.14 Favored 'Trans proline' 0 N--CA 1.455 -0.778 0 C-N-CA 122.458 2.106 . . . . 0.0 112.14 178.351 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' ASP . . . . . 0.811 ' HB3' ' HB3' ' A' ' 21' ' ' LYS . 0.0 OUTLIER -60.76 163.49 5.57 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.709 -0.678 . . . . 0.0 109.62 172.051 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.548 HG12 HG11 ' A' ' 82' ' ' VAL . 10.5 tp -61.33 -25.52 36.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.817 -170.9 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.488 ' HB2' ' OD2' ' A' ' 17' ' ' ASP . 5.6 m-20 -81.88 -5.37 58.19 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 120.932 0.396 . . . . 0.0 110.779 178.064 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 93.42 37.38 5.61 Favored Glycine 0 N--CA 1.447 -0.576 0 N-CA-C 110.888 -0.885 . . . . 0.0 110.888 -175.6 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.811 ' HB3' ' HB3' ' A' ' 17' ' ' ASP . 3.2 ttmp? -108.37 111.48 23.42 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.709 0.29 . . . . 0.0 110.89 -173.449 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 16.7 m -70.49 109.14 4.64 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 120.87 0.366 . . . . 0.0 111.095 -179.257 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.591 ' HB ' HD21 ' A' ' 92' ' ' LEU . 39.4 t -126.48 152.78 34.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 178.355 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' SER . . . . . 0.483 ' HA ' ' HA ' ' A' ' 14' ' ' SER . 93.8 p -122.67 176.35 6.0 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.186 0.517 . . . . 0.0 110.718 -179.973 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 1.026 ' HB3' ' HA ' ' A' ' 12' ' ' SER . 21.0 tp -95.77 15.08 21.17 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 121.761 0.791 . . . . 0.0 108.882 173.435 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.528 ' HA ' ' HE2' ' A' ' 29' ' ' LYS . . . -100.05 -35.0 9.85 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 114.915 -1.038 . . . . 0.0 110.503 177.282 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -81.26 -17.7 48.54 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.458 177.69 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 72.4 mt -91.25 22.79 3.63 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.72 -179.911 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.528 ' HE2' ' HA ' ' A' ' 26' ' ' ALA . 1.1 mptp? -70.43 -169.64 0.32 Allowed 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 121.308 0.575 . . . . 0.0 111.348 176.469 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 89.23 -47.67 3.34 Favored Glycine 0 N--CA 1.45 -0.372 0 CA-C-N 115.83 -0.623 . . . . 0.0 112.616 173.328 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.723 ' HD3' ' HA ' ' A' ' 63' ' ' ASP . 72.6 mttt -127.05 167.72 15.56 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 110.0 -0.37 . . . . 0.0 110.0 -178.311 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.406 ' HD1' ' HA ' ' A' ' 116' ' ' ASP . 97.6 m-85 -64.95 154.12 38.47 Favored 'General case' 0 C--N 1.327 -0.4 0 O-C-N 123.197 0.311 . . . . 0.0 110.798 -176.579 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.468 HD13 ' HA2' ' A' ' 119' ' ' GLY . 4.6 mp -120.26 124.61 72.95 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-O 120.706 0.289 . . . . 0.0 110.475 -179.543 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 84.4 t80 -107.45 116.23 31.58 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 109.006 -0.738 . . . . 0.0 109.006 172.339 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.551 ' HA ' ' O ' ' A' ' 67' ' ' VAL . 67.8 mt -102.81 116.77 47.14 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.697 -178.239 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -109.93 158.82 17.82 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.503 -0.772 . . . . 0.0 109.14 174.112 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.452 HG11 ' CG2' ' A' ' 109' ' ' ILE . 57.5 t -101.25 125.55 55.21 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 C-N-CA 120.34 -0.544 . . . . 0.0 110.852 172.996 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' TRP . . . . . 0.661 ' HZ3' HG21 ' A' ' 82' ' ' VAL . 1.0 OUTLIER -118.95 135.11 54.77 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.04 -0.527 . . . . 0.0 109.778 -178.973 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.455 ' HA ' ' OD1' ' A' ' 72' ' ' ASP . . . -146.63 165.23 30.18 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.683 -0.235 . . . . 0.0 111.307 179.943 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.819 ' HB ' ' CE3' ' A' ' 78' ' ' TRP . 12.3 t -99.87 -29.55 12.53 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.946 0.403 . . . . 0.0 110.572 173.069 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 19.4 p-90 -80.42 11.15 3.84 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.117 0.484 . . . . 0.0 110.956 -179.138 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' CYS . . . . . 0.745 ' SG ' ' HB3' ' A' ' 45' ' ' CYS . 29.2 p -104.35 172.1 6.98 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.649 -177.044 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -123.03 -70.52 0.24 Allowed Glycine 0 N--CA 1.448 -0.549 0 CA-C-N 115.857 -0.611 . . . . 0.0 112.252 177.218 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -55.28 -35.53 91.56 Favored 'Trans proline' 0 C--N 1.351 0.676 0 C-N-CA 122.991 2.461 . . . . 0.0 112.882 178.974 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' CYS . . . . . 0.745 ' HB3' ' SG ' ' A' ' 42' ' ' CYS . 8.4 t -59.02 -34.41 71.86 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.872 0.368 . . . . 0.0 111.097 177.209 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.716 ' HA ' HD13 ' A' ' 49' ' ' LEU . 32.4 mtp180 -73.5 -4.66 35.17 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.33 -177.218 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -83.95 -19.73 60.71 Favored Glycine 0 N--CA 1.447 -0.62 0 C-N-CA 120.788 -0.72 . . . . 0.0 111.842 176.473 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.548 ' OE2' ' HD3' ' A' ' 128' ' ' ARG . 42.1 mm-40 -84.21 -16.87 41.78 Favored 'General case' 0 CA--C 1.515 -0.384 0 N-CA-C 110.401 -0.222 . . . . 0.0 110.401 -177.823 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.716 HD13 ' HA ' ' A' ' 46' ' ' ARG . 5.7 mp -45.44 -53.5 18.3 Favored Pre-proline 0 C--N 1.326 -0.424 0 CA-C-N 115.935 -0.575 . . . . 0.0 112.278 -178.744 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.588 ' HD3' ' HB2' ' A' ' 49' ' ' LEU . 31.7 Cg_exo -64.13 -37.55 41.38 Favored 'Trans proline' 0 C--N 1.353 0.799 0 C-N-CA 121.885 1.723 . . . . 0.0 112.842 175.868 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -77.34 -27.97 52.95 Favored 'General case' 0 CA--C 1.52 -0.193 0 CA-C-O 121.248 0.546 . . . . 0.0 110.6 -172.752 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 6.1 tt -64.13 -41.71 97.1 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 177.802 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 27.0 mmtm -70.64 -40.07 73.29 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.582 -0.735 . . . . 0.0 111.454 -179.731 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.401 ' O ' ' HB2' ' A' ' 58' ' ' LYS . 2.8 mm-40 -51.72 -53.64 37.06 Favored 'General case' 0 N--CA 1.455 -0.189 0 CA-C-O 121.341 0.591 . . . . 0.0 110.947 172.928 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.426 HD13 ' HE2' ' A' ' 138' ' ' PHE . 47.3 mt -61.5 -52.27 65.2 Favored 'General case' 0 N--CA 1.447 -0.611 0 CA-C-N 115.452 -0.795 . . . . 0.0 110.902 177.109 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.46 ' HA ' ' CE2' ' A' ' 66' ' ' PHE . 31.9 tt0 -45.09 -60.16 2.24 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 114.65 -1.159 . . . . 0.0 112.519 -179.308 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -69.7 -36.18 75.71 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-O 120.976 0.417 . . . . 0.0 111.045 -174.664 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.555 ' HB2' ' NZ ' ' A' ' 58' ' ' LYS . 0.7 OUTLIER -69.24 -35.2 75.9 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.21 0.528 . . . . 0.0 111.028 -175.482 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 83.3 m-85 -111.03 9.29 22.11 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.058 -178.285 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.416 ' HB2' ' O ' ' A' ' 56' ' ' GLU . . . -56.02 128.61 36.13 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.663 178.355 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 81.86 -4.16 76.26 Favored Glycine 0 N--CA 1.449 -0.44 0 CA-C-N 115.652 -0.704 . . . . 0.0 113.386 174.231 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.585 ' HD3' ' N ' ' A' ' 62' ' ' LYS . 0.0 OUTLIER -76.66 -89.8 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 117.104 0.452 . . . . 0.0 111.142 -174.896 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.723 ' HA ' ' HD3' ' A' ' 31' ' ' LYS . 10.9 p-10 -139.07 6.07 2.36 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.635 -175.463 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 16.0 tt -128.8 147.26 33.25 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-O 121.443 0.64 . . . . 0.0 112.623 -168.662 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 87.8 m-70 -112.86 125.8 54.76 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.203 -0.908 . . . . 0.0 108.807 170.697 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' PHE . . . . . 0.612 ' O ' ' HB ' ' A' ' 90' ' ' ILE . 96.4 m-85 -90.94 112.44 24.32 Favored 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 109.176 -0.675 . . . . 0.0 109.176 173.153 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.551 ' O ' ' HA ' ' A' ' 35' ' ' ILE . 45.9 t -123.58 106.32 17.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.662 -175.086 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' SER . . . . . 0.45 ' HB3' ' CD1' ' A' ' 38' ' ' TRP . 15.0 m -88.11 139.55 30.39 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.107 179.069 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 61.4 tp -122.36 124.11 42.93 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-O 120.774 0.321 . . . . 0.0 110.459 176.868 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 1.2 t -104.62 122.05 44.82 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.691 0.758 . . . . 0.0 112.509 -173.219 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 4.2 m -86.81 11.19 13.82 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 114.956 -1.02 . . . . 0.0 111.539 177.05 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.51 ' O ' ' HA2' ' A' ' 95' ' ' GLY . 1.6 m-20 -69.07 125.76 27.67 Favored 'General case' 0 N--CA 1.464 0.266 0 N-CA-C 110.452 -0.203 . . . . 0.0 110.452 -176.521 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 86.0 tttt -76.27 -32.05 58.61 Favored 'General case' 0 C--N 1.321 -0.633 0 C-N-CA 120.344 -0.542 . . . . 0.0 109.708 175.343 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' ASN . . . . . 0.583 ' HB2' ' HB3' ' A' ' 77' ' ' ALA . 0.8 OUTLIER -76.21 71.23 2.92 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.481 -0.781 . . . . 0.0 110.856 177.771 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.532 ' O ' ' HG3' ' A' ' 79' ' ' GLU . 12.0 tmtt? -57.16 -56.61 19.57 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 120.992 -0.283 . . . . 0.0 111.596 -175.423 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.509 ' HA ' ' CD ' ' A' ' 79' ' ' GLU . 2.2 tptp -52.15 -57.44 9.61 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.097 -179.543 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.583 ' HB3' ' HB2' ' A' ' 74' ' ' ASN . . . -52.96 -31.59 41.39 Favored 'General case' 0 C--O 1.237 0.425 0 CA-C-O 121.356 0.598 . . . . 0.0 110.898 -179.766 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' TRP . . . . . 0.819 ' CE3' ' HB ' ' A' ' 40' ' ' THR . 2.1 t-105 -76.91 -34.63 57.69 Favored 'General case' 0 N--CA 1.442 -0.856 0 CA-C-N 115.146 -0.933 . . . . 0.0 110.546 -176.756 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.532 ' HG3' ' O ' ' A' ' 75' ' ' LYS . 29.9 mt-10 -51.19 -52.43 44.41 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-O 121.573 0.702 . . . . 0.0 110.326 172.496 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 1.4 m120 -64.17 -41.19 97.23 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.25 -0.886 . . . . 0.0 110.747 -175.987 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' MET . . . . . 0.49 ' HG2' ' OG1' ' A' ' 40' ' ' THR . 14.4 tpt -67.29 -49.14 65.42 Favored 'General case' 0 N--CA 1.447 -0.601 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.938 -177.766 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.771 HG23 ' HB2' ' A' ' 87' ' ' LEU . 7.5 p -61.35 -30.89 48.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 121.068 0.461 . . . . 0.0 110.788 -179.543 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 45.8 m -74.61 -39.1 62.36 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.534 178.035 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' LYS . . . . . 0.748 ' HB3' ' HZ2' ' A' ' 84' ' ' LYS . 0.0 OUTLIER -74.08 -33.71 63.73 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 121.329 0.585 . . . . 0.0 109.843 179.48 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -82.81 4.29 25.98 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.216 -0.902 . . . . 0.0 111.329 -179.428 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 78.8 mt-30 60.38 28.24 17.86 Favored 'General case' 0 N--CA 1.47 0.545 0 N-CA-C 112.668 0.618 . . . . 0.0 112.668 171.904 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.771 ' HB2' HG23 ' A' ' 82' ' ' VAL . 97.6 mt -89.43 104.09 16.67 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 121.003 0.43 . . . . 0.0 111.523 -176.916 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.553 ' HA ' ' HE3' ' A' ' 88' ' ' LYS . 0.0 OUTLIER -106.95 -167.15 1.24 Allowed 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.031 172.515 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 109.44 -159.58 13.94 Favored Glycine 0 N--CA 1.452 -0.259 0 N-CA-C 111.023 -0.831 . . . . 0.0 111.023 -176.122 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.612 ' HB ' ' O ' ' A' ' 66' ' ' PHE . 62.9 mt -95.15 112.27 27.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 175.007 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 91' ' ' GLN . . . . . 0.644 ' HB2' ' CZ2' ' A' ' 38' ' ' TRP . 1.9 pt20 -139.14 123.04 17.73 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-O 121.348 0.594 . . . . 0.0 111.389 -173.098 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.591 HD21 ' HB ' ' A' ' 23' ' ' VAL . 70.4 mt -113.91 152.23 31.1 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.449 -0.796 . . . . 0.0 109.939 179.788 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 93' ' ' HIS . . . . . 0.454 ' CE1' ' HG3' ' A' ' 75' ' ' LYS . 20.6 t-80 -120.75 126.52 50.37 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.905 -177.416 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 94' ' ' MET . . . . . 0.453 ' SD ' ' HA ' ' A' ' 98' ' ' ARG . 18.6 ttp -84.13 -66.48 0.89 Allowed 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.227 -0.897 . . . . 0.0 110.61 178.567 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 95' ' ' GLY . . . . . 0.51 ' HA2' ' O ' ' A' ' 72' ' ' ASP . . . 108.56 -109.96 2.96 Favored Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 120.528 -0.844 . . . . 0.0 112.083 -178.29 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 8.9 t -112.45 11.18 19.84 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 120.727 0.299 . . . . 0.0 111.111 -177.147 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -97.5 46.46 1.03 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.126 0.489 . . . . 0.0 110.357 -175.371 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' ARG . . . . . 0.453 ' HA ' ' SD ' ' A' ' 94' ' ' MET . 0.0 OUTLIER -77.51 18.45 0.43 Allowed 'General case' 0 CA--C 1.52 -0.174 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.782 -172.812 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 5.2 m -61.0 -24.35 66.09 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 108.358 -0.979 . . . . 0.0 108.358 168.768 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 12.0 t80 -75.56 -29.93 59.52 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-N 114.766 -1.106 . . . . 0.0 110.118 176.172 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 71.2 mtp -63.08 -54.06 43.83 Favored 'General case' 0 CA--C 1.514 -0.42 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 171.307 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -57.16 -33.15 67.14 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.082 -0.963 . . . . 0.0 111.246 179.404 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -60.27 -39.82 88.19 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.793 0.33 . . . . 0.0 111.087 178.019 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' TYR . . . . . 0.478 ' HB2' HG13 ' A' ' 106' ' ' ILE . 42.9 m-85 -93.3 3.34 55.8 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.481 179.661 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 95.4 mt 65.47 22.02 11.85 Favored 'General case' 0 N--CA 1.464 0.242 0 O-C-N 123.755 0.659 . . . . 0.0 110.817 -176.234 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' ILE . . . . . 0.887 HG12 ' HG3' ' A' ' 111' ' ' ARG . 51.2 mt -71.08 112.5 6.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.627 176.036 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 50.9 t-20 -112.61 -68.85 0.9 Allowed 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 172.826 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -82.24 111.28 3.33 Favored Glycine 0 N--CA 1.446 -0.693 0 C-N-CA 120.83 -0.7 . . . . 0.0 111.802 178.5 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.556 ' HB ' ' HA ' ' A' ' 110' ' ' PRO . 34.5 pt -85.82 158.54 56.27 Favored Pre-proline 0 C--N 1.321 -0.633 0 N-CA-C 110.484 -0.191 . . . . 0.0 110.484 178.51 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 110' ' ' PRO . . . . . 0.556 ' HA ' ' HB ' ' A' ' 109' ' ' ILE . 86.8 Cg_endo -81.1 158.86 83.62 Favored 'Cis proline' 0 C--N 1.345 0.37 0 C-N-CA 123.768 -1.346 . . . . 0.0 113.391 1.995 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 111' ' ' ARG . . . . . 0.887 ' HG3' HG12 ' A' ' 106' ' ' ILE . 0.0 OUTLIER -108.58 148.45 30.3 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 108.712 -0.848 . . . . 0.0 108.712 173.215 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 112' ' ' PHE . . . . . 0.551 ' CE1' ' HB3' ' A' ' 128' ' ' ARG . 0.5 OUTLIER -119.11 116.72 26.96 Favored 'General case' 0 C--N 1.324 -0.532 0 O-C-N 123.96 0.788 . . . . 0.0 109.088 -175.008 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 91.6 mt -135.6 143.67 35.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 120.812 0.339 . . . . 0.0 111.261 -177.332 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.576 ' HB2' ' HG3' ' A' ' 126' ' ' MET . 39.3 tp -124.99 138.07 54.23 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.275 178.36 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.619 ' HG ' ' HA ' ' A' ' 121' ' ' ILE . 3.2 mp -131.97 153.45 50.31 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.079 -177.324 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 116' ' ' ASP . . . . . 0.549 ' HB2' HD11 ' A' ' 122' ' ' ILE . 37.4 t0 -68.37 166.81 15.87 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.564 -0.744 . . . . 0.0 110.212 177.308 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 117' ' ' ARG . . . . . 0.577 ' HA ' ' O ' ' A' ' 31' ' ' LYS . 8.3 mtm180 -48.87 -27.77 3.29 Favored 'General case' 0 N--CA 1.465 0.314 0 O-C-N 124.447 1.092 . . . . 0.0 112.615 -177.445 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 118' ' ' ASP . . . . . 0.447 ' HA ' ' HG3' ' A' ' 29' ' ' LYS . 33.0 t70 -83.44 2.31 37.3 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.478 0.656 . . . . 0.0 111.076 -178.835 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 119' ' ' GLY . . . . . 0.468 ' HA2' HD13 ' A' ' 33' ' ' ILE . . . 76.06 29.13 59.25 Favored Glycine 0 N--CA 1.434 -1.438 0 N-CA-C 110.247 -1.141 . . . . 0.0 110.247 -171.968 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 120' ' ' LYS . . . . . 0.405 ' HD3' ' HA ' ' A' ' 120' ' ' LYS . 41.0 mmtm -101.28 112.13 24.55 Favored 'General case' 0 C--O 1.222 -0.356 0 C-N-CA 120.794 -0.363 . . . . 0.0 111.791 -178.856 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 0.69 ' H ' HD12 ' A' ' 121' ' ' ILE . 3.9 mp -41.7 117.54 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 O-C-N 123.888 0.742 . . . . 0.0 112.327 -177.508 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 122' ' ' ILE . . . . . 0.549 HD11 ' HB2' ' A' ' 116' ' ' ASP . 35.6 mm -100.3 -44.54 11.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 115.345 -0.843 . . . . 0.0 109.555 175.983 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 15.9 m -135.2 114.47 12.36 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.503 -0.772 . . . . 0.0 110.343 178.716 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -81.53 -13.22 58.35 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.161 0.505 . . . . 0.0 110.606 179.439 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 3.4 p-10 -128.24 83.69 2.18 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.54 -0.755 . . . . 0.0 110.486 178.14 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 126' ' ' MET . . . . . 0.576 ' HG3' ' HB2' ' A' ' 114' ' ' LEU . 46.4 mmm -94.48 -165.13 1.26 Allowed 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.442 177.784 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 127' ' ' THR . . . . . 0.412 HG21 ' NZ ' ' A' ' 133' ' ' LYS . 6.2 p -120.86 141.75 50.29 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.627 179.268 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 128' ' ' ARG . . . . . 0.551 ' HB3' ' CE1' ' A' ' 112' ' ' PHE . 13.0 ptp180 -48.96 154.28 1.31 Allowed Pre-proline 0 C--N 1.327 -0.385 0 CA-C-N 115.514 -0.766 . . . . 0.0 112.84 177.664 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_exo -51.58 -36.16 59.21 Favored 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 123.447 2.765 . . . . 0.0 113.627 177.275 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 18.8 m -72.79 -7.67 51.78 Favored 'General case' 0 N--CA 1.462 0.153 0 CA-C-O 120.935 0.398 . . . . 0.0 111.643 -178.784 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -90.51 121.39 68.44 Favored Pre-proline 0 C--N 1.327 -0.41 0 N-CA-C 109.751 -0.463 . . . . 0.0 109.751 179.668 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 132' ' ' PRO . . . . . 0.453 ' O ' ' HG2' ' A' ' 136' ' ' GLU . 51.9 Cg_exo -57.45 -31.73 92.15 Favored 'Trans proline' 0 C--N 1.343 0.284 0 C-N-CA 122.976 2.451 . . . . 0.0 113.268 -178.096 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 133' ' ' LYS . . . . . 0.531 ' HZ2' ' HB2' ' A' ' 133' ' ' LYS . 9.7 mtmp? -66.44 -19.24 65.74 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.846 0.355 . . . . 0.0 110.98 -176.908 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 134' ' ' THR . . . . . 0.64 HG22 ' CZ ' ' A' ' 138' ' ' PHE . 3.8 m -68.12 -51.25 48.34 Favored 'General case' 0 N--CA 1.447 -0.584 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 173.786 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 135' ' ' ALA . . . . . 0.649 ' HA ' ' CD2' ' A' ' 138' ' ' PHE . . . -59.96 -38.61 83.01 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.67 -0.696 . . . . 0.0 110.576 175.515 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 136' ' ' GLU . . . . . 0.453 ' HG2' ' O ' ' A' ' 132' ' ' PRO . 5.9 mm-40 -56.15 -41.62 75.71 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.203 177.111 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 137' ' ' LYS . . . . . 0.587 ' O ' ' HG ' ' A' ' 141' ' ' LEU . 21.3 ttmm -72.44 -26.33 61.8 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.56 -0.291 . . . . 0.0 111.043 179.745 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 138' ' ' PHE . . . . . 0.649 ' CD2' ' HA ' ' A' ' 135' ' ' ALA . 10.7 m-30 -66.27 -42.76 88.01 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 173.908 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 76.7 m-20 -58.62 -45.7 88.63 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.583 -0.735 . . . . 0.0 109.341 173.672 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 140' ' ' GLU . . . . . 0.54 ' HB3' ' O ' ' A' ' 137' ' ' LYS . 24.9 tt0 -50.79 -51.72 47.91 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 115.266 -0.879 . . . . 0.0 111.661 174.196 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.587 ' HG ' ' O ' ' A' ' 137' ' ' LYS . 95.2 mt -58.05 -44.46 87.46 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.472 -178.399 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 81.0 mt -73.12 -10.82 60.19 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.478 179.336 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 82.4 19.39 64.41 Favored Glycine 0 N--CA 1.447 -0.594 0 N-CA-C 111.196 -0.762 . . . . 0.0 111.196 -179.271 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.494 ' O ' ' HG ' ' A' ' 144' ' ' LEU . 52.4 tp -89.63 22.79 2.88 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.563 0.697 . . . . 0.0 109.907 -178.55 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -59.11 146.23 39.43 Favored 'General case' 0 N--CA 1.44 -0.932 0 CA-C-O 121.569 0.7 . . . . 0.0 111.67 177.323 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 96.84 -17.74 58.74 Favored Glycine 0 N--CA 1.443 -0.885 0 N-CA-C 110.115 -1.194 . . . . 0.0 110.115 -167.563 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 147' ' ' HIS . . . . . 0.402 ' NE2' ' OE2' ' A' ' 136' ' ' GLU . 0.4 OUTLIER 75.5 -70.22 0.15 Allowed 'General case' 0 N--CA 1.465 0.31 0 C-N-CA 123.966 0.907 . . . . 0.0 111.173 172.59 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 78.0 m-70 -146.17 14.86 1.31 Allowed 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.299 176.633 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 8.1 p80 -170.62 -73.15 0.02 OUTLIER 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.823 175.456 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER 176.01 139.65 0.06 Allowed 'General case' 0 N--CA 1.464 0.259 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 -178.494 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 4.6 p80 -99.24 -2.12 37.42 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-O 121.325 0.583 . . . . 0.0 109.652 174.098 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.242 0.668 0 CA-C-N 114.726 -1.125 . . . . 0.0 108.288 176.769 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.41 ' SD ' ' N ' ' A' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.481 1.103 0 N-CA-C 110.103 -0.332 . . . . 0.0 110.103 . . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 12.9 m -104.87 -66.82 0.94 Allowed 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.274 -179.393 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.707 ' H ' HD23 ' A' ' 3' ' ' LEU . 2.3 pt? -73.36 145.11 46.16 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.023 -0.535 . . . . 0.0 109.914 177.584 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 17.7 ptt180 -171.83 -44.26 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.39 -176.44 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 17.1 m -81.4 100.85 9.48 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.456 179.473 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 133.65 -104.09 0.52 Allowed Glycine 0 N--CA 1.447 -0.608 0 C-N-CA 120.882 -0.675 . . . . 0.0 112.087 178.889 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 7.7 m-20 -128.01 146.02 57.58 Favored Pre-proline 0 C--N 1.324 -0.529 0 N-CA-C 110.246 -0.279 . . . . 0.0 110.246 179.246 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_endo -82.75 93.11 0.89 Allowed 'Trans proline' 0 N--CA 1.456 -0.682 0 C-N-CA 122.885 2.39 . . . . 0.0 112.148 177.269 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 16.3 m -84.5 95.63 8.87 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.632 -178.514 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.405 ' HB2' ' OH ' ' A' ' 104' ' ' TYR . . . 74.75 -37.89 0.37 Allowed 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 123.751 0.82 . . . . 0.0 112.225 176.355 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -76.09 82.61 2.93 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.76 -177.491 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.505 ' HA ' ' HB3' ' A' ' 25' ' ' LEU . 37.8 m 69.5 43.34 1.03 Allowed 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 114.674 -1.148 . . . . 0.0 111.267 174.759 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 55.7 p90 -68.06 161.98 25.6 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.606 177.909 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.553 ' HA ' ' HA ' ' A' ' 24' ' ' SER . 5.2 p -134.7 129.16 34.33 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.655 179.26 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' TYR . . . . . 0.447 ' OH ' ' HB2' ' A' ' 100' ' ' PHE . 24.6 m-85 -140.44 141.13 24.62 Favored Pre-proline 0 C--N 1.326 -0.414 0 CA-C-O 120.842 0.353 . . . . 0.0 111.119 178.709 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 63.3 Cg_endo -75.25 125.59 9.26 Favored 'Trans proline' 0 N--CA 1.461 -0.388 0 C-N-CA 122.399 2.066 . . . . 0.0 113.481 -177.442 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -69.35 159.13 33.73 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.131 -0.94 . . . . 0.0 109.252 170.379 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.546 HG13 ' OE1' ' A' ' 79' ' ' GLU . 2.6 tt -44.43 -44.56 2.37 Favored 'Isoleucine or valine' 0 C--O 1.24 0.567 0 O-C-N 124.445 1.091 . . . . 0.0 112.221 -176.207 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 43.8 m-80 -65.89 -12.93 58.29 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.375 -176.422 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 97.14 32.15 6.56 Favored Glycine 0 N--CA 1.444 -0.817 0 N-CA-C 111.248 -0.741 . . . . 0.0 111.248 -176.615 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.427 ' NZ ' HG22 ' A' ' 23' ' ' VAL . 23.4 ttpp -106.68 121.11 43.68 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 120.667 -0.413 . . . . 0.0 110.36 -176.815 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 14.1 m -63.0 99.32 0.16 Allowed 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.964 0.412 . . . . 0.0 110.385 176.65 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.427 HG22 ' NZ ' ' A' ' 21' ' ' LYS . 97.0 t -99.82 113.76 36.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 178.098 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' SER . . . . . 0.553 ' HA ' ' HA ' ' A' ' 14' ' ' SER . 14.7 m -105.4 177.0 4.98 Favored 'General case' 0 C--N 1.311 -1.069 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.159 -179.218 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.545 ' O ' ' HB2' ' A' ' 29' ' ' LYS . 2.9 tm? -53.87 -38.0 64.27 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.619 178.718 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -89.66 10.13 24.36 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 112.287 0.477 . . . . 0.0 112.287 -176.596 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -87.43 -27.77 22.52 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-O 121.481 0.658 . . . . 0.0 110.319 -179.187 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.464 HD13 ' CD1' ' A' ' 33' ' ' ILE . 0.9 OUTLIER -132.88 15.91 4.27 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.487 -0.778 . . . . 0.0 110.592 -178.928 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.545 ' HB2' ' O ' ' A' ' 25' ' ' LEU . 17.1 tttt -67.02 150.47 49.18 Favored 'General case' 0 C--N 1.313 -0.979 0 CA-C-N 114.197 -1.365 . . . . 0.0 111.301 -177.063 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 113.49 -18.48 20.32 Favored Glycine 0 N--CA 1.448 -0.565 0 N-CA-C 111.193 -0.763 . . . . 0.0 111.193 -178.85 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.809 ' HD2' ' HA ' ' A' ' 63' ' ' ASP . 72.8 mmtt -117.11 154.72 30.53 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 179.218 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 69.4 m-85 -66.05 121.45 15.16 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 177.365 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.464 ' CD1' HD13 ' A' ' 28' ' ' LEU . 41.8 mm -94.6 115.73 34.14 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.896 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.73 -175.099 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' TYR . . . . . 0.68 ' HE2' ' HA ' ' A' ' 129' ' ' PRO . 59.4 t80 -107.01 111.23 23.62 Favored 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 173.755 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.543 ' HA ' ' O ' ' A' ' 67' ' ' VAL . 59.5 mt -97.01 132.6 41.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-O 121.152 0.501 . . . . 0.0 111.656 -173.392 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.507 ' O ' ' HA ' ' A' ' 68' ' ' SER . 5.3 p-10 -122.99 159.64 27.92 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.262 -0.881 . . . . 0.0 109.034 174.142 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.44 HG21 HG21 ' A' ' 106' ' ' ILE . 85.4 t -103.51 133.32 47.76 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.788 0 C-N-CA 120.5 -0.48 . . . . 0.0 110.805 174.078 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' TRP . . . . . 0.665 ' HZ3' HG21 ' A' ' 82' ' ' VAL . 0.9 OUTLIER -126.51 137.25 53.35 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.136 -0.483 . . . . 0.0 109.889 -178.303 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.556 ' HA ' ' OD1' ' A' ' 72' ' ' ASP . . . -145.55 164.68 30.91 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.64 -0.255 . . . . 0.0 110.666 177.665 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.714 ' HB ' ' CE3' ' A' ' 78' ' ' TRP . 4.9 t -81.55 -23.71 37.03 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.336 0.588 . . . . 0.0 109.671 172.822 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 12.7 p-90 -97.62 19.25 13.83 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.358 -0.837 . . . . 0.0 110.231 177.824 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' CYS . . . . . 0.644 ' SG ' ' HB3' ' A' ' 45' ' ' CYS . 24.8 p -78.27 -26.46 47.16 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.107 -177.437 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 66.47 -111.73 4.37 Favored Glycine 0 CA--C 1.519 0.337 0 CA-C-N 116.066 -0.515 . . . . 0.0 113.346 178.534 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -54.58 -28.16 54.24 Favored 'Trans proline' 0 C--N 1.351 0.666 0 C-N-CA 123.461 2.774 . . . . 0.0 113.292 -177.726 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' CYS . . . . . 0.644 ' HB3' ' SG ' ' A' ' 42' ' ' CYS . 30.7 t -52.6 -30.88 33.56 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.414 177.147 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.488 HH21 ' CG ' ' A' ' 85' ' ' ASP . 46.0 mtp180 -58.75 -21.42 55.46 Favored 'General case' 0 C--O 1.223 -0.292 0 N-CA-C 111.911 0.337 . . . . 0.0 111.911 -178.782 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -70.96 -23.88 77.64 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.829 -0.7 . . . . 0.0 112.831 -178.118 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.457 ' HB3' ' HB2' ' A' ' 130' ' ' SER . 35.7 mt-10 -99.3 -18.43 17.57 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.761 0.28 . . . . 0.0 111.317 -176.978 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.708 ' HB3' HD22 ' A' ' 87' ' ' LEU . 3.6 mm? -57.54 -43.91 99.21 Favored Pre-proline 0 C--N 1.325 -0.486 0 N-CA-C 112.911 0.708 . . . . 0.0 112.911 -179.166 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.516 ' HD2' ' N ' ' A' ' 49' ' ' LEU . 12.3 Cg_endo -58.48 -37.89 92.61 Favored 'Trans proline' 0 C--N 1.351 0.706 0 C-N-CA 121.275 1.317 . . . . 0.0 111.027 170.684 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -73.33 -19.09 61.1 Favored 'General case' 0 CA--C 1.519 -0.212 0 CA-C-O 121.415 0.626 . . . . 0.0 109.796 -176.638 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.442 ' O ' HD23 ' A' ' 52' ' ' LEU . 5.8 tt -65.13 -38.02 89.32 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-N 115.107 -0.951 . . . . 0.0 108.74 174.421 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.66 ' O ' ' HG2' ' A' ' 57' ' ' GLU . 8.9 mtmp? -59.01 -60.95 3.05 Favored 'General case' 0 CA--C 1.505 -0.783 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 171.809 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -45.17 -42.44 9.12 Favored 'General case' 0 C--O 1.224 -0.274 0 O-C-N 124.577 1.173 . . . . 0.0 111.256 -178.698 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.443 ' HB3' ' CE1' ' A' ' 66' ' ' PHE . 39.9 mt -61.41 -57.81 10.75 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.352 175.698 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 18.2 tp10 -65.45 -35.28 80.43 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.42 -174.391 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.66 ' HG2' ' O ' ' A' ' 53' ' ' LYS . 9.4 pt-20 -80.49 -29.05 37.36 Favored 'General case' 0 CA--C 1.532 0.25 0 O-C-N 121.906 -0.496 . . . . 0.0 111.141 179.4 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 75.9 tttt -63.36 -44.53 94.54 Favored 'General case' 0 C--O 1.237 0.426 0 CA-C-O 121.923 0.868 . . . . 0.0 109.11 170.484 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 61.2 m-85 -99.92 14.86 29.01 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.008 -0.997 . . . . 0.0 111.308 -176.414 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.432 ' HB2' ' HA ' ' A' ' 57' ' ' GLU . . . -57.66 126.44 27.38 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.037 170.584 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 85.43 -6.05 81.31 Favored Glycine 0 N--CA 1.445 -0.721 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.126 -179.151 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 30.7 mmtm -88.51 -155.67 0.34 Allowed 'General case' 0 CA--C 1.515 -0.374 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 178.89 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.809 ' HA ' ' HD2' ' A' ' 31' ' ' LYS . 36.1 m-20 -111.67 28.45 8.74 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 115.824 -0.626 . . . . 0.0 112.641 -175.793 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 4.7 mp -131.86 146.57 33.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-O 120.527 0.203 . . . . 0.0 110.799 179.925 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 31.8 m170 -124.91 145.65 49.72 Favored 'General case' 0 CA--C 1.514 -0.425 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 170.094 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' PHE . . . . . 0.443 ' CE1' ' HB3' ' A' ' 55' ' ' LEU . 77.0 m-85 -110.37 105.92 15.09 Favored 'General case' 0 C--N 1.315 -0.914 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 172.521 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.546 ' HA ' ' O ' ' A' ' 90' ' ' ILE . 48.0 t -112.63 114.07 45.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 115.374 -0.83 . . . . 0.0 111.232 -170.172 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' SER . . . . . 0.507 ' HA ' ' O ' ' A' ' 36' ' ' ASP . 3.6 m -88.26 150.64 23.15 Favored 'General case' 0 C--N 1.314 -0.935 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.584 -179.379 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.516 HD11 ' HB2' ' A' ' 94' ' ' MET . 61.1 tp -133.92 121.62 21.96 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.984 0.421 . . . . 0.0 110.531 175.092 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' SER . . . . . 0.473 ' O ' ' HB3' ' A' ' 94' ' ' MET . 0.7 OUTLIER -105.28 120.34 41.31 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.395 0.617 . . . . 0.0 112.379 -172.783 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 71' ' ' CYS . . . . . 0.475 ' HA ' ' HE3' ' A' ' 94' ' ' MET . 1.8 p -85.87 13.62 7.16 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.483 -0.78 . . . . 0.0 111.702 175.83 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.578 ' OD2' HG22 ' A' ' 40' ' ' THR . 2.6 m-20 -69.56 115.28 8.63 Favored 'General case' 0 CA--C 1.511 -0.537 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 -179.511 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -67.83 -28.86 67.92 Favored 'General case' 0 C--N 1.318 -0.763 0 C-N-CA 120.093 -0.643 . . . . 0.0 110.209 -179.924 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' ASN . . . . . 0.732 ' ND2' ' HB3' ' A' ' 77' ' ' ALA . 1.0 OUTLIER -77.27 116.28 17.75 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 171.73 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.683 ' HE2' ' CD ' ' A' ' 79' ' ' GLU . 19.9 tttt -81.45 -64.39 1.2 Allowed 'General case' 0 C--N 1.319 -0.745 0 C-N-CA 119.804 -0.759 . . . . 0.0 110.847 171.839 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.833 ' HE2' ' HA ' ' A' ' 76' ' ' LYS . 0.4 OUTLIER -44.25 -56.67 3.96 Favored 'General case' 0 N--CA 1.464 0.246 0 N-CA-C 113.383 0.883 . . . . 0.0 113.383 -172.057 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.841 ' HA ' ' ND2' ' A' ' 80' ' ' ASN . . . -61.28 -27.59 68.58 Favored 'General case' 0 C--O 1.242 0.689 0 CA-C-O 121.51 0.671 . . . . 0.0 111.233 -176.75 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' TRP . . . . . 0.714 ' CE3' ' HB ' ' A' ' 40' ' ' THR . 3.1 t-105 -81.61 -43.0 19.22 Favored 'General case' 0 N--CA 1.435 -1.188 0 CA-C-N 115.373 -0.83 . . . . 0.0 110.192 -173.921 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.683 ' CD ' ' HE2' ' A' ' 75' ' ' LYS . 6.0 mm-40 -49.34 -43.54 43.9 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-O 121.012 0.434 . . . . 0.0 110.747 171.649 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 80' ' ' ASN . . . . . 0.841 ' ND2' ' HA ' ' A' ' 77' ' ' ALA . 7.2 m-20 -56.93 -54.32 47.98 Favored 'General case' 0 CA--C 1.517 -0.315 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.583 179.269 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 37.5 ttm -64.61 -46.17 83.77 Favored 'General case' 0 C--O 1.223 -0.301 0 CA-C-N 116.248 -0.433 . . . . 0.0 112.073 -174.895 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.665 HG21 ' HZ3' ' A' ' 38' ' ' TRP . 5.7 p -63.44 -28.25 44.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 C-N-CA 120.622 -0.431 . . . . 0.0 111.407 -178.162 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 36.7 m -81.72 -34.95 30.27 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 120.87 0.367 . . . . 0.0 110.69 177.642 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 24.9 ttmm -77.48 -44.22 29.61 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.109 0.48 . . . . 0.0 111.059 -177.547 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' ASP . . . . . 0.745 ' HB3' ' HG ' ' A' ' 87' ' ' LEU . 5.4 t0 -77.36 -1.67 31.16 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.185 -0.916 . . . . 0.0 110.943 -176.247 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 48.3 mt-30 65.25 19.83 11.78 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 115.673 -0.694 . . . . 0.0 112.21 175.991 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.745 ' HG ' ' HB3' ' A' ' 85' ' ' ASP . 17.3 mt -74.03 87.81 1.87 Allowed 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.131 -179.119 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 4.2 mmpm? -101.76 -177.85 3.55 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 112.537 0.569 . . . . 0.0 112.537 -175.739 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 122.71 -176.23 16.53 Favored Glycine 0 N--CA 1.448 -0.545 0 N-CA-C 109.554 -1.418 . . . . 0.0 109.554 -171.948 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.546 ' O ' ' HA ' ' A' ' 67' ' ' VAL . 60.6 mt -83.34 112.7 21.3 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 118.063 0.932 . . . . 0.0 108.681 175.481 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 91' ' ' GLN . . . . . 0.481 ' HB2' ' CZ2' ' A' ' 38' ' ' TRP . 2.1 pt20 -137.98 110.71 7.61 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-O 121.834 0.826 . . . . 0.0 112.085 -168.565 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.422 HD22 ' HB ' ' A' ' 23' ' ' VAL . 26.0 mt -97.51 142.11 29.74 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.146 -0.934 . . . . 0.0 110.272 -177.83 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 93' ' ' HIS . . . . . 0.441 ' CE1' ' HG3' ' A' ' 75' ' ' LYS . 29.7 t-80 -110.56 117.04 32.47 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-O 121.35 0.595 . . . . 0.0 110.599 -179.643 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 94' ' ' MET . . . . . 0.636 ' SD ' ' HA ' ' A' ' 98' ' ' ARG . 13.6 ttp -79.81 -63.67 1.36 Allowed 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 114.964 -1.016 . . . . 0.0 110.482 -179.891 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 95' ' ' GLY . . . . . 0.554 ' HA2' ' O ' ' A' ' 72' ' ' ASP . . . 71.36 -79.1 0.55 Allowed Glycine 0 C--O 1.236 0.268 0 C-N-CA 120.967 -0.635 . . . . 0.0 114.466 174.463 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 1.3 p -88.72 -35.52 16.69 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-O 120.819 0.342 . . . . 0.0 111.57 -175.329 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -92.52 57.18 2.88 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.809 -166.793 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' ARG . . . . . 0.636 ' HA ' ' SD ' ' A' ' 94' ' ' MET . 0.0 OUTLIER -70.82 10.28 0.54 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.12 -0.946 . . . . 0.0 112.698 -172.888 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 8.6 m -73.6 -19.14 60.95 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 120.964 0.411 . . . . 0.0 111.079 -179.587 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' PHE . . . . . 0.447 ' HB2' ' OH ' ' A' ' 15' ' ' TYR . 3.2 t80 -79.63 -43.37 22.97 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 120.898 -0.321 . . . . 0.0 110.713 -178.459 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 101' ' ' MET . . . . . 0.556 ' HA ' HD12 ' A' ' 106' ' ' ILE . 5.1 ppp? -69.23 -24.91 64.07 Favored 'General case' 0 C--N 1.332 -0.178 0 N-CA-C 109.176 -0.676 . . . . 0.0 109.176 175.383 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 102' ' ' ASP . . . . . 0.405 ' HB2' ' NH1' ' A' ' 98' ' ' ARG . 11.4 t70 -66.41 -50.98 61.62 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.132 -0.94 . . . . 0.0 110.423 173.904 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -64.6 -18.94 65.36 Favored 'General case' 0 N--CA 1.461 0.095 0 CA-C-N 115.758 -0.655 . . . . 0.0 112.072 -175.29 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' TYR . . . . . 0.405 ' OH ' ' HB2' ' A' ' 10' ' ' ALA . 46.1 m-85 -108.45 2.43 22.33 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 111.844 0.313 . . . . 0.0 111.844 -179.319 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 8.8 tp 59.35 26.41 15.27 Favored 'General case' 0 C--N 1.328 -0.361 0 O-C-N 123.507 0.504 . . . . 0.0 110.423 -179.351 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' ILE . . . . . 0.652 HG12 ' HG3' ' A' ' 111' ' ' ARG . 69.9 mt -60.21 101.46 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.328 0 CA-C-N 115.673 -0.694 . . . . 0.0 111.456 178.769 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 8.7 p30 -134.21 148.88 50.95 Favored 'General case' 0 C--N 1.317 -0.808 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 173.945 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 76.3 84.91 0.41 Allowed Glycine 0 N--CA 1.446 -0.671 0 C-N-CA 120.469 -0.872 . . . . 0.0 111.775 -176.079 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 40.1 mt -69.57 139.16 88.84 Favored Pre-proline 0 C--N 1.325 -0.481 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 177.603 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' PRO . . . . . 0.487 ' HG3' ' SG ' ' A' ' 45' ' ' CYS . 10.0 Cg_endo -93.11 140.39 8.36 Favored 'Cis proline' 0 N--CA 1.459 -0.521 0 C-N-CA 124.455 -1.061 . . . . 0.0 113.974 0.952 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 111' ' ' ARG . . . . . 0.652 ' HG3' HG12 ' A' ' 106' ' ' ILE . 0.0 OUTLIER -83.82 144.18 29.45 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 172.933 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 112' ' ' PHE . . . . . 0.571 ' HD1' ' H ' ' A' ' 126' ' ' MET . 0.9 OUTLIER -118.7 116.83 27.38 Favored 'General case' 0 C--N 1.323 -0.547 0 O-C-N 123.724 0.64 . . . . 0.0 110.792 -176.788 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.497 ' HB ' ' HB ' ' A' ' 35' ' ' ILE . 83.0 mt -130.99 149.56 33.66 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.299 0 CA-C-N 116.703 -0.226 . . . . 0.0 110.908 -177.917 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.423 ' C ' HD12 ' A' ' 115' ' ' LEU . 62.4 tp -128.54 138.07 52.06 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.618 -0.265 . . . . 0.0 110.57 178.941 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.586 ' HG ' ' HA ' ' A' ' 121' ' ' ILE . 2.0 mp -135.19 152.1 51.26 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-O 121.334 0.588 . . . . 0.0 110.623 179.108 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 116' ' ' ASP . . . . . 0.427 ' N ' HG13 ' A' ' 122' ' ' ILE . 7.6 t70 -69.73 160.85 30.91 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 114.872 -1.058 . . . . 0.0 110.645 175.952 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 117' ' ' ARG . . . . . 0.452 ' HA ' ' O ' ' A' ' 31' ' ' LYS . 58.7 mtt-85 -48.51 -37.41 17.5 Favored 'General case' 0 N--CA 1.474 0.728 0 O-C-N 124.267 0.979 . . . . 0.0 111.368 -178.368 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 118' ' ' ASP . . . . . 0.632 ' HB3' ' HG3' ' A' ' 120' ' ' LYS . 29.1 t0 -67.82 -13.01 61.78 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 114.515 -1.221 . . . . 0.0 111.121 -177.069 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 119' ' ' GLY . . . . . 0.534 ' HA3' HD11 ' A' ' 25' ' ' LEU . . . 93.63 23.78 22.71 Favored Glycine 0 N--CA 1.439 -1.112 0 N-CA-C 110.553 -1.019 . . . . 0.0 110.553 -172.132 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 120' ' ' LYS . . . . . 0.632 ' HG3' ' HB3' ' A' ' 118' ' ' ASP . 36.6 mtmm -103.72 106.75 17.35 Favored 'General case' 0 C--O 1.223 -0.333 0 C-N-CA 120.564 -0.454 . . . . 0.0 111.365 -174.619 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 0.681 ' H ' HD12 ' A' ' 121' ' ' ILE . 3.3 mp -42.16 116.57 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 O-C-N 123.909 0.755 . . . . 0.0 111.692 -178.982 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 122' ' ' ILE . . . . . 0.459 ' H ' ' HA ' ' A' ' 115' ' ' LEU . 57.4 mt -89.04 -38.74 11.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 115.346 -0.843 . . . . 0.0 108.902 177.082 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 14.9 m -148.15 126.77 12.49 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.492 -0.776 . . . . 0.0 110.197 -179.812 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 124' ' ' ALA . . . . . 0.403 ' O ' HG12 ' A' ' 113' ' ' ILE . . . -74.24 -14.95 61.0 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-O 121.336 0.589 . . . . 0.0 110.593 178.53 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 125' ' ' ASN . . . . . 0.447 ' HA ' ' O ' ' A' ' 112' ' ' PHE . 5.1 p-10 -149.42 126.83 11.5 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.054 -0.975 . . . . 0.0 108.598 173.613 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 126' ' ' MET . . . . . 0.571 ' H ' ' HD1' ' A' ' 112' ' ' PHE . 15.9 tpt -108.95 -87.34 0.5 Allowed 'General case' 0 C--N 1.321 -0.653 0 C-N-CA 120.804 -0.358 . . . . 0.0 111.567 -176.941 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 7.6 p -141.61 -77.85 0.27 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.269 0.557 . . . . 0.0 110.774 -175.013 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 128' ' ' ARG . . . . . 0.894 ' HB3' ' HB2' ' A' ' 131' ' ' ASP . 43.3 ttm-85 -172.31 141.04 1.09 Allowed Pre-proline 0 N--CA 1.443 -0.807 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 177.5 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 129' ' ' PRO . . . . . 0.68 ' HA ' ' HE2' ' A' ' 34' ' ' TYR . 5.7 Cg_exo -38.48 -52.46 1.98 Allowed 'Trans proline' 0 C--N 1.348 0.551 0 C-N-CA 123.746 2.964 . . . . 0.0 113.455 -179.242 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 130' ' ' SER . . . . . 0.457 ' HB2' ' HB3' ' A' ' 48' ' ' GLU . 36.1 t -109.01 26.16 10.94 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 111.734 0.272 . . . . 0.0 111.734 -177.378 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 131' ' ' ASP . . . . . 0.894 ' HB2' ' HB3' ' A' ' 128' ' ' ARG . 11.1 t0 -73.64 119.69 77.29 Favored Pre-proline 0 C--O 1.237 0.43 0 C-N-CA 120.108 -0.637 . . . . 0.0 109.458 176.598 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 132' ' ' PRO . . . . . 0.425 ' O ' ' HG2' ' A' ' 136' ' ' GLU . 51.5 Cg_exo -55.12 -33.08 82.61 Favored 'Trans proline' 0 C--N 1.349 0.579 0 C-N-CA 123.495 2.797 . . . . 0.0 113.737 -175.034 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 38.3 mttp -57.82 -45.86 85.55 Favored 'General case' 0 CA--C 1.519 -0.227 0 CA-C-O 121.33 0.586 . . . . 0.0 109.912 -177.936 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -63.36 -47.54 81.66 Favored 'General case' 0 N--CA 1.448 -0.538 0 CA-C-N 115.033 -0.985 . . . . 0.0 111.116 -178.881 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 135' ' ' ALA . . . . . 0.68 ' HA ' ' CD2' ' A' ' 138' ' ' PHE . . . -59.61 -50.75 72.67 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.606 -0.725 . . . . 0.0 111.072 -173.895 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 136' ' ' GLU . . . . . 0.686 ' O ' ' HB2' ' A' ' 139' ' ' ASN . 22.7 mm-40 -76.21 -23.16 54.6 Favored 'General case' 0 C--N 1.312 -1.028 0 CA-C-O 121.857 0.837 . . . . 0.0 110.084 -175.175 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 137' ' ' LYS . . . . . 1.05 ' HA ' ' HE3' ' A' ' 137' ' ' LYS . 0.1 OUTLIER -65.45 -39.34 91.9 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 115.522 -0.763 . . . . 0.0 109.655 170.995 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 138' ' ' PHE . . . . . 0.68 ' CD2' ' HA ' ' A' ' 135' ' ' ALA . 15.0 m-85 -55.59 -36.55 67.02 Favored 'General case' 0 N--CA 1.464 0.265 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 172.637 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 139' ' ' ASN . . . . . 0.686 ' HB2' ' O ' ' A' ' 136' ' ' GLU . 94.2 m-20 -51.16 -59.72 3.88 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.148 174.113 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 140' ' ' GLU . . . . . 0.469 ' HB2' ' OE2' ' A' ' 145' ' ' GLU . 33.8 tt0 -61.55 -36.12 79.7 Favored 'General case' 0 N--CA 1.463 0.179 0 C-N-CA 120.656 -0.418 . . . . 0.0 111.486 -179.262 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.501 ' HG ' ' O ' ' A' ' 137' ' ' LYS . 96.9 mt -61.48 -27.82 68.85 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.897 0.38 . . . . 0.0 110.841 178.348 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 41.7 tp -93.06 -18.08 23.07 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.597 178.172 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 97.78 22.05 17.07 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 121.179 -0.534 . . . . 0.0 111.88 -177.913 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 8.6 tt -89.56 -34.39 16.37 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.775 -0.213 . . . . 0.0 111.321 -175.7 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 145' ' ' GLU . . . . . 0.469 ' OE2' ' HB2' ' A' ' 140' ' ' GLU . 23.5 mt-10 -64.96 108.61 1.84 Allowed 'General case' 0 CA--C 1.516 -0.331 0 CA-C-O 121.784 0.802 . . . . 0.0 111.061 -179.694 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -84.23 66.13 3.95 Favored Glycine 0 C--N 1.312 -0.792 0 CA-C-N 114.682 -1.145 . . . . 0.0 112.053 -179.172 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 38.3 m170 -68.25 105.02 1.98 Allowed 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.849 0.357 . . . . 0.0 110.159 179.241 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 36.7 m80 -126.57 116.44 21.06 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.414 -179.087 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 31.0 t-80 -156.48 90.78 1.19 Allowed 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.088 177.826 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 45.4 t60 -146.05 6.07 1.01 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.938 0.399 . . . . 0.0 110.793 178.456 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 6.5 t60 -83.21 -33.73 26.06 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 109.333 -0.618 . . . . 0.0 109.333 177.484 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 61.7 t-80 . . . . . 0 C--O 1.24 0.583 0 CA-C-N 115.083 -0.962 . . . . 0.0 109.058 177.013 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.3 mpp? . . . . . 0 N--CA 1.483 1.183 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 25.0 m -92.8 134.44 35.06 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.931 0.396 . . . . 0.0 110.417 179.844 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.429 ' H ' HD23 ' A' ' 3' ' ' LEU . 2.1 pt? -134.19 171.54 14.1 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.064 -179.726 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 4' ' ' ARG . . . . . 0.468 ' HD2' ' N ' ' A' ' 4' ' ' ARG . 8.6 mpt_? -88.34 19.89 3.56 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.206 0.526 . . . . 0.0 110.548 -176.097 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 17.7 m -148.44 26.42 0.95 Allowed 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.643 -0.708 . . . . 0.0 109.737 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -159.44 -150.71 5.91 Favored Glycine 0 N--CA 1.446 -0.672 0 C-N-CA 120.633 -0.794 . . . . 0.0 112.514 -176.833 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 3.9 m-20 -82.96 150.42 61.64 Favored Pre-proline 0 C--N 1.323 -0.559 0 CA-C-O 120.943 0.401 . . . . 0.0 111.591 -175.331 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -80.38 -155.34 0.06 OUTLIER 'Trans proline' 0 C--N 1.346 0.441 0 C-N-CA 123.222 2.615 . . . . 0.0 111.879 175.102 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 19.2 p -149.58 -171.04 3.79 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.722 0.296 . . . . 0.0 110.726 -179.909 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -75.0 4.45 6.61 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.759 -178.403 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -89.6 -20.69 23.42 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.306 0.575 . . . . 0.0 110.36 177.817 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.576 ' HA ' ' HB3' ' A' ' 25' ' ' LEU . 67.6 m -161.24 91.43 0.86 Allowed 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.373 -0.83 . . . . 0.0 109.914 178.482 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' PHE . . . . . 0.504 ' CE2' HD22 ' A' ' 25' ' ' LEU . 25.4 p90 -103.55 178.81 4.45 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.655 -179.79 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.477 ' HA ' ' HA ' ' A' ' 24' ' ' SER . 25.1 p -142.35 119.72 11.6 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.119 -0.492 . . . . 0.0 109.948 176.578 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' TYR . . . . . 0.584 ' HB2' HD23 ' A' ' 92' ' ' LEU . 28.3 m-85 -134.8 155.3 79.48 Favored Pre-proline 0 C--N 1.324 -0.53 0 CA-C-N 116.652 -0.249 . . . . 0.0 110.675 -179.15 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -83.37 124.84 3.77 Favored 'Trans proline' 0 N--CA 1.453 -0.864 0 C-N-CA 122.016 1.811 . . . . 0.0 112.896 176.19 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' ASP . . . . . 1.001 ' HB3' ' HB3' ' A' ' 21' ' ' LYS . 0.9 OUTLIER -61.47 162.29 8.29 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.077 -0.965 . . . . 0.0 109.173 168.662 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.687 HD12 HG13 ' A' ' 82' ' ' VAL . 0.7 OUTLIER -42.46 -45.08 1.1 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.452 0 O-C-N 123.975 0.797 . . . . 0.0 112.072 -176.644 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.511 ' ND2' HG23 ' A' ' 18' ' ' ILE . 28.9 m-80 -77.23 8.54 3.92 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.825 -173.967 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 81.54 25.22 54.58 Favored Glycine 0 N--CA 1.449 -0.442 0 N-CA-C 110.769 -0.932 . . . . 0.0 110.769 -175.022 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 1.001 ' HB3' ' HB3' ' A' ' 17' ' ' ASP . 1.4 ttmp? -89.96 107.39 19.09 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.435 -0.383 . . . . 0.0 110.473 -173.744 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 23.6 m -67.37 108.29 2.72 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.84 -179.648 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 57.5 t -123.89 133.07 70.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 116.021 -0.536 . . . . 0.0 109.683 179.846 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' SER . . . . . 0.477 ' HA ' ' HA ' ' A' ' 14' ' ' SER . 26.5 p -104.46 171.27 7.42 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.128 0.489 . . . . 0.0 110.031 178.6 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.576 ' HB3' ' HA ' ' A' ' 12' ' ' SER . 20.9 tp -91.18 11.86 21.95 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 121.257 0.551 . . . . 0.0 109.608 176.725 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.591 ' HA ' ' HD3' ' A' ' 29' ' ' LYS . . . -103.29 -25.63 13.25 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 -176.09 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 62.5 m-20 -70.29 -11.79 61.14 Favored 'General case' 0 N--CA 1.436 -1.154 0 CA-C-N 114.05 -1.432 . . . . 0.0 110.797 177.538 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 79.4 mt -110.3 3.19 19.67 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.575 -0.739 . . . . 0.0 112.317 -170.582 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.591 ' HD3' ' HA ' ' A' ' 26' ' ' ALA . 1.3 mptm? -61.98 150.07 38.97 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.192 0.52 . . . . 0.0 111.041 178.462 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 98.55 5.92 56.63 Favored Glycine 0 N--CA 1.445 -0.73 0 C-N-CA 120.807 -0.711 . . . . 0.0 111.731 -179.826 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.798 ' HD3' ' HA ' ' A' ' 63' ' ' ASP . 7.5 ttmm -161.79 148.39 13.99 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.958 -0.386 . . . . 0.0 109.958 179.45 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.491 ' HB2' ' O ' ' A' ' 63' ' ' ASP . 40.6 m-85 -56.28 149.57 16.14 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-O 121.266 0.555 . . . . 0.0 112.365 -173.765 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.697 ' HB ' ' HB2' ' A' ' 115' ' ' LEU . 31.4 mm -118.94 135.65 58.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 115.593 -0.731 . . . . 0.0 110.611 -176.139 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 87.8 t80 -123.32 112.08 17.18 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 109.583 -0.525 . . . . 0.0 109.583 172.197 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.702 ' HB ' ' HB ' ' A' ' 113' ' ' ILE . 39.4 mm -100.8 116.99 45.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.26 179.445 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -117.14 158.56 24.04 Favored 'General case' 0 C--N 1.315 -0.925 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 176.612 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.549 HG11 ' CG2' ' A' ' 109' ' ' ILE . 32.6 t -107.86 112.07 38.6 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.009 0 C-N-CA 120.171 -0.612 . . . . 0.0 109.888 175.315 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' TRP . . . . . 0.692 ' CE3' ' HZ2' ' A' ' 78' ' ' TRP . 0.9 OUTLIER -109.92 134.15 52.4 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 115.575 -0.739 . . . . 0.0 109.174 -175.461 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.546 ' HB3' ' HB3' ' A' ' 42' ' ' CYS . . . -147.07 165.62 29.36 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 116.477 -0.329 . . . . 0.0 110.702 -177.123 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.689 ' HB ' ' CE3' ' A' ' 78' ' ' TRP . 9.8 t -89.02 -24.96 22.22 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.271 0.558 . . . . 0.0 109.698 173.824 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' TRP . . . . . 0.453 ' HZ2' ' HG ' ' A' ' 71' ' ' CYS . 13.4 p-90 -94.86 8.81 41.49 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.108 179.782 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' CYS . . . . . 0.618 ' SG ' ' HB3' ' A' ' 45' ' ' CYS . 17.5 p -88.54 148.28 24.19 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 175.311 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -92.18 -65.69 1.12 Allowed Glycine 0 N--CA 1.448 -0.527 0 C-N-CA 120.277 -0.963 . . . . 0.0 113.087 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -56.12 -51.82 8.64 Favored 'Trans proline' 0 C--N 1.35 0.655 0 C-N-CA 122.743 2.295 . . . . 0.0 112.865 -175.328 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' CYS . . . . . 0.618 ' HB3' ' SG ' ' A' ' 42' ' ' CYS . 35.1 t -63.11 -39.75 95.61 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.874 0.369 . . . . 0.0 110.325 -175.846 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.537 ' HA ' ' HG ' ' A' ' 49' ' ' LEU . 62.3 ttt180 -71.14 -27.89 63.88 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.493 179.252 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -79.73 -37.75 22.13 Favored Glycine 0 N--CA 1.447 -0.609 0 C-N-CA 120.69 -0.767 . . . . 0.0 111.945 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.55 ' OE2' ' HD3' ' A' ' 128' ' ' ARG . 35.5 mt-10 -90.16 10.1 25.8 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 122.976 -0.132 . . . . 0.0 111.27 -178.495 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.632 ' O ' ' HG3' ' A' ' 53' ' ' LYS . 41.0 mt -46.23 -52.17 29.57 Favored Pre-proline 0 N--CA 1.468 0.465 0 N-CA-C 112.419 0.526 . . . . 0.0 112.419 -179.725 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.529 ' HD2' ' N ' ' A' ' 49' ' ' LEU . 10.3 Cg_endo -54.26 -41.33 77.1 Favored 'Trans proline' 0 C--N 1.355 0.876 0 C-N-CA 122.035 1.823 . . . . 0.0 112.46 179.077 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -80.46 -26.65 38.18 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.379 0.609 . . . . 0.0 110.172 -177.204 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 7.9 tt -66.71 -43.7 83.62 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.424 -0.807 . . . . 0.0 108.884 175.585 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.632 ' HG3' ' O ' ' A' ' 49' ' ' LEU . 88.5 mttt -57.83 -48.58 79.36 Favored 'General case' 0 CA--C 1.516 -0.335 0 O-C-N 123.589 0.556 . . . . 0.0 110.345 177.424 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -44.86 -59.09 2.72 Favored 'General case' 0 N--CA 1.452 -0.329 0 O-C-N 124.06 0.85 . . . . 0.0 111.018 175.16 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 60.1 mt -59.99 -51.71 68.48 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.27 177.789 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -44.14 -59.58 2.27 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 114.582 -1.19 . . . . 0.0 112.528 -179.056 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.556 ' HG2' ' O ' ' A' ' 53' ' ' LYS . 6.1 pt-20 -82.75 -29.27 29.82 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 112.154 0.427 . . . . 0.0 112.154 -173.868 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.533 ' HE3' ' HE1' ' A' ' 59' ' ' TYR . 32.4 ttpt -68.68 -36.65 78.78 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.236 0.541 . . . . 0.0 110.229 178.316 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.742 ' HB3' HD11 ' A' ' 64' ' ' ILE . 41.7 m-85 -99.45 -1.0 39.66 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.371 -178.857 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -63.83 142.09 58.53 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.538 -0.541 . . . . 0.0 109.538 169.19 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 84.86 9.72 80.33 Favored Glycine 0 N--CA 1.448 -0.521 0 C-N-CA 120.494 -0.86 . . . . 0.0 112.555 179.712 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.536 ' HD2' HD21 ' A' ' 142' ' ' LEU . 39.8 mmtm -100.61 -160.72 0.81 Allowed 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 174.532 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.798 ' HA ' ' HD3' ' A' ' 31' ' ' LYS . 2.6 t70 -90.66 52.04 2.11 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-O 121.271 0.558 . . . . 0.0 110.019 -179.688 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.742 HD11 ' HB3' ' A' ' 59' ' ' TYR . 9.2 pt -151.73 156.63 5.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 115.525 -0.761 . . . . 0.0 110.396 -178.418 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' HIS . . . . . 0.665 ' NE2' ' HB3' ' A' ' 31' ' ' LYS . 95.0 m-70 -126.28 113.64 17.21 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.165 -0.47 . . . . 0.0 109.779 175.397 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 88.7 m-85 -76.77 103.8 6.93 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 172.783 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.633 ' HB ' HD13 ' A' ' 35' ' ' ILE . 23.1 t -121.26 104.78 15.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 116.162 -0.472 . . . . 0.0 109.789 -178.928 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' SER . . . . . 0.412 ' HB3' ' CD1' ' A' ' 38' ' ' TRP . 6.8 m -99.28 144.7 28.1 Favored 'General case' 0 C--N 1.313 -1.015 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.508 -177.063 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.435 HD23 ' HB2' ' A' ' 92' ' ' LEU . 78.5 mt -122.95 124.1 42.43 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-O 120.696 0.284 . . . . 0.0 111.49 177.564 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 70' ' ' SER . . . . . 0.419 ' HA ' ' O ' ' A' ' 38' ' ' TRP . 40.6 m -96.0 119.71 34.98 Favored 'General case' 0 N--CA 1.464 0.272 0 N-CA-C 112.542 0.571 . . . . 0.0 112.542 -179.49 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' CYS . . . . . 0.453 ' HG ' ' HZ2' ' A' ' 41' ' ' TRP . 7.4 p -92.64 28.53 1.99 Allowed 'General case' 0 C--N 1.313 -1.008 0 CA-C-O 121.198 0.523 . . . . 0.0 110.118 175.03 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.514 ' OD2' HG22 ' A' ' 40' ' ' THR . 2.1 m-20 -81.77 112.79 19.25 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.312 178.255 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.452 ' HB3' ' HB ' ' A' ' 96' ' ' THR . 8.8 ptmm? -67.98 -28.6 67.58 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.078 0.466 . . . . 0.0 111.127 178.994 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -87.32 75.83 9.22 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 109.608 -0.515 . . . . 0.0 109.608 179.556 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.422 ' O ' ' HG2' ' A' ' 79' ' ' GLU . 8.5 tttm -55.06 -64.01 0.97 Allowed 'General case' 0 C--O 1.217 -0.655 0 CA-C-N 115.849 -0.614 . . . . 0.0 112.45 -175.711 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 64.2 tttp -43.94 -50.17 8.24 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 112.258 0.466 . . . . 0.0 112.258 -177.605 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.557 ' HA ' ' OD1' ' A' ' 80' ' ' ASN . . . -58.75 -41.6 86.91 Favored 'General case' 0 C--O 1.246 0.905 0 CA-C-O 122.142 0.972 . . . . 0.0 110.341 179.769 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' TRP . . . . . 0.692 ' HZ2' ' CE3' ' A' ' 38' ' ' TRP . 10.0 t-105 -65.55 -49.98 66.87 Favored 'General case' 0 C--N 1.312 -1.056 0 CA-C-N 114.012 -1.449 . . . . 0.0 110.988 -178.97 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.479 ' OE1' HG13 ' A' ' 18' ' ' ILE . 6.1 mm-40 -47.4 -44.07 24.12 Favored 'General case' 0 C--O 1.234 0.276 0 N-CA-C 112.069 0.396 . . . . 0.0 112.069 175.678 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 80' ' ' ASN . . . . . 0.717 ' O ' ' HG2' ' A' ' 84' ' ' LYS . 2.4 m120 -60.64 -46.85 88.75 Favored 'General case' 0 CA--C 1.514 -0.41 0 C-N-CA 120.326 -0.55 . . . . 0.0 110.288 -179.243 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 81' ' ' MET . . . . . 0.453 ' SD ' ' HZ3' ' A' ' 78' ' ' TRP . 19.0 ttt -63.07 -47.79 81.44 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 120.41 -0.516 . . . . 0.0 111.993 -177.214 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.687 HG13 HD12 ' A' ' 18' ' ' ILE . 7.2 p -64.17 -28.48 44.99 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 C-N-CA 120.308 -0.557 . . . . 0.0 111.41 -177.54 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 83' ' ' THR . . . . . 0.435 HG23 HD11 ' A' ' 18' ' ' ILE . 5.0 p -81.17 -21.89 39.37 Favored 'General case' 0 N--CA 1.444 -0.749 0 O-C-N 121.941 -0.475 . . . . 0.0 111.757 176.406 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 84' ' ' LYS . . . . . 0.717 ' HG2' ' O ' ' A' ' 80' ' ' ASN . 27.1 mmtm -84.73 -38.39 19.75 Favored 'General case' 0 CA--C 1.519 -0.237 0 CA-C-O 121.249 0.547 . . . . 0.0 110.597 178.195 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -80.15 -22.76 41.67 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.241 -0.891 . . . . 0.0 110.305 179.393 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 78.6 mt-30 66.54 76.46 0.3 Allowed 'General case' 0 C--O 1.234 0.268 0 CA-C-N 115.188 -0.914 . . . . 0.0 111.96 177.085 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.543 ' HB2' HG23 ' A' ' 82' ' ' VAL . 89.4 mt -103.85 133.09 49.42 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.426 -0.806 . . . . 0.0 109.065 173.658 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.525 ' HD2' ' H ' ' A' ' 88' ' ' LYS . 0.0 OUTLIER -134.73 157.97 45.34 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.349 0.595 . . . . 0.0 111.96 -175.499 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 124.91 -132.75 8.24 Favored Glycine 0 N--CA 1.447 -0.626 0 N-CA-C 110.224 -1.15 . . . . 0.0 110.224 -173.278 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 57.7 mt -112.03 108.02 24.45 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 173.414 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' GLN . . . . . 0.657 ' HB3' ' CZ2' ' A' ' 38' ' ' TRP . 7.0 mm-40 -129.04 103.75 7.18 Favored 'General case' 0 N--CA 1.445 -0.708 0 N-CA-C 109.926 -0.398 . . . . 0.0 109.926 -175.828 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.584 HD23 ' HB2' ' A' ' 15' ' ' TYR . 5.1 mp -103.29 151.36 22.79 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-O 121.493 0.663 . . . . 0.0 110.87 -175.765 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 16.7 t-80 -120.77 119.59 33.17 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-N 115.613 -0.722 . . . . 0.0 110.425 -176.912 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 33.7 ttm -71.78 -75.78 0.12 Allowed 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.433 -0.803 . . . . 0.0 110.129 176.363 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 134.94 -95.15 0.26 Allowed Glycine 0 N--CA 1.442 -0.95 0 N-CA-C 111.114 -0.794 . . . . 0.0 111.114 -174.181 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.452 ' HB ' ' HB3' ' A' ' 73' ' ' LYS . 9.2 t -150.49 25.61 0.77 Allowed 'General case' 0 C--N 1.313 -0.981 0 CA-C-O 121.834 0.826 . . . . 0.0 109.287 177.831 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -81.55 72.61 8.6 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 114.86 -1.063 . . . . 0.0 109.766 -179.092 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' ARG . . . . . 0.591 ' HA ' ' HG3' ' A' ' 101' ' ' MET . 7.4 mmm180 -69.36 -10.91 60.03 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.724 -173.298 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 7.6 m -58.24 -36.81 73.76 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.165 0.507 . . . . 0.0 109.927 175.262 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 24.8 t80 -81.74 -25.43 35.38 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.184 178.782 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' MET . . . . . 0.591 ' HG3' ' HA ' ' A' ' 98' ' ' ARG . 1.3 mmt -58.92 -51.44 70.04 Favored 'General case' 0 CA--C 1.519 -0.245 0 CA-C-O 121.265 0.555 . . . . 0.0 109.507 175.451 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -77.02 -23.03 52.19 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.406 -0.815 . . . . 0.0 110.538 -177.793 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -64.8 -26.93 68.55 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-O 121.12 0.486 . . . . 0.0 111.043 176.931 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' TYR . . . . . 0.555 ' HB3' HG23 ' A' ' 106' ' ' ILE . 0.3 OUTLIER -96.38 -4.11 42.47 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.296 174.875 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 93.5 mt 58.59 32.21 21.91 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.356 -172.301 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' ILE . . . . . 0.997 HG21 HD11 ' A' ' 113' ' ' ILE . 40.8 pt -114.43 31.96 1.52 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.333 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.356 -178.622 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 15.3 p30 -56.47 -29.74 62.09 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.469 -0.787 . . . . 0.0 111.82 -178.699 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -89.48 108.95 3.54 Favored Glycine 0 N--CA 1.448 -0.525 0 C-N-CA 121.02 -0.61 . . . . 0.0 111.61 174.077 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.549 ' CG2' HG11 ' A' ' 37' ' ' VAL . 2.5 pp -100.43 153.81 37.54 Favored Pre-proline 0 C--N 1.325 -0.466 0 CA-C-O 120.344 0.116 . . . . 0.0 110.767 -177.528 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 110' ' ' PRO . . . . . 0.429 ' HG3' ' HB2' ' A' ' 42' ' ' CYS . 2.7 Cg_exo -76.82 152.51 95.43 Favored 'Cis proline' 0 C--N 1.344 0.326 0 C-N-CA 123.899 -1.292 . . . . 0.0 111.966 -0.068 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 111' ' ' ARG . . . . . 0.779 HH11 HG22 ' A' ' 106' ' ' ILE . 0.0 OUTLIER -125.17 138.45 54.14 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.365 0.603 . . . . 0.0 110.966 -179.0 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 112' ' ' PHE . . . . . 0.611 ' HD1' ' H ' ' A' ' 126' ' ' MET . 0.2 OUTLIER -106.74 114.97 29.39 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 114.341 -1.3 . . . . 0.0 110.354 -176.548 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.997 HD11 HG21 ' A' ' 106' ' ' ILE . 61.6 mt -123.57 142.54 39.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-O 120.858 0.361 . . . . 0.0 110.754 -178.483 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 23.0 tp -129.23 135.14 48.42 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.996 -0.547 . . . . 0.0 109.655 177.662 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.697 ' HB2' ' HB ' ' A' ' 33' ' ' ILE . 2.0 mp -132.57 153.44 51.0 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.878 0.37 . . . . 0.0 110.495 -177.054 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 116' ' ' ASP . . . . . 0.496 ' HB3' ' HB2' ' A' ' 120' ' ' LYS . 27.9 t0 -68.93 166.1 18.58 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.468 -0.787 . . . . 0.0 110.261 177.276 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 117' ' ' ARG . . . . . 0.513 ' HA ' ' C ' ' A' ' 31' ' ' LYS . 9.2 mtm180 -49.39 -27.64 4.28 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 124.335 1.054 . . . . 0.0 112.733 -177.076 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 118' ' ' ASP . . . . . 0.552 ' HB3' ' HG3' ' A' ' 120' ' ' LYS . 30.6 t70 -83.32 -0.97 52.1 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.257 0.551 . . . . 0.0 110.965 -178.784 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 81.26 22.5 60.61 Favored Glycine 0 N--CA 1.439 -1.16 0 N-CA-C 110.203 -1.159 . . . . 0.0 110.203 -170.513 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 120' ' ' LYS . . . . . 0.552 ' HG3' ' HB3' ' A' ' 118' ' ' ASP . 56.5 mttp -88.56 107.4 18.88 Favored 'General case' 0 C--O 1.223 -0.325 0 C-N-CA 120.478 -0.489 . . . . 0.0 111.052 -178.267 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 0.479 ' HA ' ' HG ' ' A' ' 115' ' ' LEU . 19.5 mt -42.74 116.27 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-O 121.725 0.774 . . . . 0.0 112.332 179.251 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 122' ' ' ILE . . . . . 0.461 HD11 ' HB2' ' A' ' 116' ' ' ASP . 39.2 mm -97.87 -50.87 10.94 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.927 0 CA-C-N 114.283 -1.326 . . . . 0.0 109.203 177.163 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 14.6 m -129.44 114.21 15.87 Favored 'General case' 0 N--CA 1.446 -0.664 0 CA-C-N 115.22 -0.9 . . . . 0.0 110.113 179.305 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -68.05 -20.38 64.97 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 121.807 0.813 . . . . 0.0 109.496 174.046 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 7.4 p30 -141.46 122.07 14.23 Favored 'General case' 0 N--CA 1.447 -0.586 0 CA-C-N 114.523 -1.217 . . . . 0.0 108.25 171.291 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 126' ' ' MET . . . . . 0.611 ' H ' ' HD1' ' A' ' 112' ' ' PHE . 17.3 tpt -92.76 -80.66 0.37 Allowed 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.915 -176.664 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 4.2 m -155.44 -61.91 0.11 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.576 -0.284 . . . . 0.0 110.48 179.605 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 128' ' ' ARG . . . . . 1.087 ' HB3' ' HB2' ' A' ' 131' ' ' ASP . 0.0 OUTLIER -179.82 142.1 0.35 Allowed Pre-proline 0 N--CA 1.453 -0.314 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 -176.467 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 129' ' ' PRO . . . . . 0.566 ' HD2' ' HG2' ' A' ' 128' ' ' ARG . 1.5 Cg_endo -43.19 -49.0 7.58 Favored 'Trans proline' 0 C--N 1.351 0.671 0 C-N-CA 123.431 2.754 . . . . 0.0 113.353 -178.626 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 25.3 t -113.24 29.72 7.76 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.821 0.343 . . . . 0.0 111.196 -177.561 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 131' ' ' ASP . . . . . 1.087 ' HB2' ' HB3' ' A' ' 128' ' ' ARG . 11.2 t70 -84.88 135.94 39.39 Favored Pre-proline 0 C--N 1.328 -0.341 0 C-N-CA 120.389 -0.525 . . . . 0.0 110.426 -179.975 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 80.8 Cg_exo -48.24 -37.82 32.34 Favored 'Trans proline' 0 C--N 1.344 0.303 0 C-N-CA 123.231 2.621 . . . . 0.0 113.258 176.66 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 28.9 mmtm -56.98 -36.22 70.1 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-O 120.866 0.365 . . . . 0.0 111.711 -177.336 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 134' ' ' THR . . . . . 0.684 HG22 ' CZ ' ' A' ' 138' ' ' PHE . 2.4 m -64.51 -51.19 64.22 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.284 0.564 . . . . 0.0 109.69 177.244 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 135' ' ' ALA . . . . . 0.672 ' HA ' ' CD2' ' A' ' 138' ' ' PHE . . . -61.56 -41.01 96.75 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.583 -0.735 . . . . 0.0 111.542 177.576 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -53.5 -52.1 60.67 Favored 'General case' 0 CA--C 1.511 -0.531 0 CA-C-O 121.44 0.638 . . . . 0.0 110.458 176.882 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 137' ' ' LYS . . . . . 0.707 ' HE2' ' HA ' ' A' ' 137' ' ' LYS . 0.3 OUTLIER -48.93 -46.56 43.26 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 114.333 -1.303 . . . . 0.0 111.261 175.614 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 138' ' ' PHE . . . . . 0.684 ' CZ ' HG22 ' A' ' 134' ' ' THR . 5.9 m-85 -63.1 -53.77 48.29 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 120.889 0.376 . . . . 0.0 109.991 178.4 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 139' ' ' ASN . . . . . 0.497 ' C ' ' H ' ' A' ' 145' ' ' GLU . 94.2 m-20 -50.9 -50.12 58.04 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.789 -179.886 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -49.41 -54.47 17.35 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.648 -0.705 . . . . 0.0 112.133 178.17 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.55 ' HG ' ' O ' ' A' ' 138' ' ' PHE . 3.2 pp -69.35 -19.38 63.85 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 120.953 -0.299 . . . . 0.0 111.206 -174.842 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.536 HD21 ' HD2' ' A' ' 62' ' ' LYS . 8.2 mp -82.64 -16.9 46.58 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.907 0.384 . . . . 0.0 110.56 173.418 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 94.14 8.47 60.17 Favored Glycine 0 N--CA 1.45 -0.387 0 N-CA-C 111.603 -0.599 . . . . 0.0 111.603 -178.135 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 60.7 tp -90.33 -52.11 5.09 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.476 -0.362 . . . . 0.0 110.258 -178.886 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 145' ' ' GLU . . . . . 0.497 ' H ' ' C ' ' A' ' 139' ' ' ASN . 2.6 mt-10 60.14 -76.36 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.446 0 O-C-N 124.348 1.03 . . . . 0.0 112.346 179.33 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 145.03 24.42 0.12 Allowed Glycine 0 C--N 1.306 -1.109 0 CA-C-N 113.771 -1.559 . . . . 0.0 109.696 -171.708 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 6.4 p-80 -58.04 118.13 5.09 Favored 'General case' 0 N--CA 1.458 -0.032 0 CA-C-O 121.388 0.613 . . . . 0.0 111.338 -177.062 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 14.8 t60 -102.29 2.48 37.0 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.589 -0.732 . . . . 0.0 109.554 -179.14 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 2.9 m-70 -133.52 141.29 47.68 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.648 -178.561 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 39.4 t-80 65.43 -98.97 0.06 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.109 -0.95 . . . . 0.0 111.902 172.383 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 70.1 t60 171.66 145.13 0.03 OUTLIER 'General case' 0 C--O 1.232 0.174 0 N-CA-C 109.754 -0.461 . . . . 0.0 109.754 -171.911 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 4.9 t60 . . . . . 0 C--O 1.241 0.642 0 N-CA-C 107.88 -1.156 . . . . 0.0 107.88 169.674 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.413 ' HG2' ' HB3' ' A' ' 8' ' ' PRO . 26.8 ptm . . . . . 0 N--CA 1.48 1.031 0 N-CA-C 110.262 -0.273 . . . . 0.0 110.262 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 23.0 m 68.71 -76.2 0.06 Allowed 'General case' 0 CA--C 1.532 0.275 0 O-C-N 124.111 0.882 . . . . 0.0 112.311 173.79 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.756 ' H ' HD23 ' A' ' 3' ' ' LEU . 1.8 pt? -82.65 110.25 17.55 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.902 0.382 . . . . 0.0 110.33 -178.949 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 27.1 mtm180 69.26 -170.68 0.18 Allowed 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 115.254 -0.885 . . . . 0.0 110.247 -179.037 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 34.4 m -111.2 93.29 4.4 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 174.44 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 167.74 -136.25 4.02 Favored Glycine 0 N--CA 1.446 -0.635 0 C-N-CA 120.531 -0.843 . . . . 0.0 112.689 -178.369 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' ASN . . . . . 0.472 ' HA ' ' HD3' ' A' ' 8' ' ' PRO . 4.7 p-10 -70.86 148.35 94.65 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-O 120.975 0.416 . . . . 0.0 111.874 -174.459 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.472 ' HD3' ' HA ' ' A' ' 7' ' ' ASN . 4.4 Cg_exo -74.32 165.93 30.69 Favored 'Trans proline' 0 C--O 1.234 0.279 0 C-N-CA 123.198 2.598 . . . . 0.0 111.708 175.089 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.528 ' HB2' HD11 ' A' ' 3' ' ' LEU . 66.2 m -156.15 176.09 13.12 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.559 -0.291 . . . . 0.0 110.481 179.0 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -77.61 76.29 4.14 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.542 0.687 . . . . 0.0 110.499 178.983 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -138.77 99.22 3.74 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 115.131 -0.94 . . . . 0.0 110.216 -179.752 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 49.0 m 64.7 80.02 0.24 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.405 -0.816 . . . . 0.0 111.454 179.463 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 53.5 p90 -96.08 155.32 16.81 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.116 178.014 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 5.4 p -142.1 112.92 7.35 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 120.98 0.419 . . . . 0.0 110.147 177.307 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' TYR . . . . . 0.559 ' HB2' HD13 ' A' ' 92' ' ' LEU . 35.8 m-85 -135.75 149.7 69.69 Favored Pre-proline 0 C--N 1.326 -0.431 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.413 -176.38 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.456 ' HA ' ' O ' ' A' ' 21' ' ' LYS . 97.3 Cg_endo -87.07 131.37 3.11 Favored 'Trans proline' 0 N--CA 1.452 -0.946 0 C-N-CA 122.528 2.152 . . . . 0.0 113.23 179.808 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' ASP . . . . . 0.506 ' HB3' ' HB3' ' A' ' 21' ' ' LYS . 12.1 t70 -67.95 154.49 41.49 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 114.958 -1.019 . . . . 0.0 108.63 170.403 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -53.21 -32.93 19.75 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.6 0 O-C-N 124.018 0.824 . . . . 0.0 110.883 -179.391 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 43.7 m-80 -76.29 -1.77 28.23 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 121.089 0.471 . . . . 0.0 110.82 179.051 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 86.05 42.11 6.83 Favored Glycine 0 N--CA 1.446 -0.647 0 CA-C-N 115.739 -0.664 . . . . 0.0 112.172 -179.619 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.506 ' HB3' ' HB3' ' A' ' 17' ' ' ASP . 56.8 tttm -107.71 124.2 49.66 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 120.173 -0.611 . . . . 0.0 111.252 -179.453 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 19.4 m -66.49 107.38 2.04 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.29 -0.414 . . . . 0.0 109.945 172.652 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.444 ' HB ' HD21 ' A' ' 92' ' ' LEU . 91.6 t -116.35 117.32 55.1 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-O 120.996 0.427 . . . . 0.0 109.909 178.342 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 17.6 m -122.77 179.47 4.62 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.288 -178.15 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.418 HD11 ' HA3' ' A' ' 119' ' ' GLY . 52.7 tp -56.4 -42.28 77.7 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.924 0.393 . . . . 0.0 111.027 -179.287 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -82.27 15.91 2.24 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.86 -177.793 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -102.18 -17.08 16.14 Favored 'General case' 0 CA--C 1.517 -0.294 0 N-CA-C 107.692 -1.225 . . . . 0.0 107.692 178.319 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -117.22 -20.81 9.07 Favored 'General case' 0 N--CA 1.445 -0.723 0 CA-C-N 113.973 -1.467 . . . . 0.0 110.494 -179.323 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 58.3 tttm -61.71 132.07 52.0 Favored 'General case' 0 N--CA 1.446 -0.662 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.273 -173.931 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 120.5 -8.59 11.03 Favored Glycine 0 N--CA 1.451 -0.328 0 N-CA-C 110.61 -0.996 . . . . 0.0 110.61 -174.496 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.687 ' HD3' ' HA ' ' A' ' 63' ' ' ASP . 25.2 ttmm -155.63 154.96 32.44 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 -178.784 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.445 ' HB2' ' O ' ' A' ' 63' ' ' ASP . 61.8 m-85 -59.07 147.1 36.12 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-O 121.094 0.473 . . . . 0.0 111.601 -174.482 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.553 HD12 ' HA2' ' A' ' 119' ' ' GLY . 40.0 mt -124.45 134.77 65.83 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.439 -175.633 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' TYR . . . . . 0.414 ' HE2' ' HB3' ' A' ' 36' ' ' ASP . 80.3 t80 -121.79 130.71 53.61 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 173.177 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.547 ' HA ' ' O ' ' A' ' 67' ' ' VAL . 62.5 mt -115.2 110.76 33.1 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-O 121.093 0.473 . . . . 0.0 110.577 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.582 ' O ' ' HA ' ' A' ' 68' ' ' SER . 7.1 p-10 -110.34 158.97 17.87 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-N 115.5 -0.773 . . . . 0.0 109.063 175.257 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.522 HG11 HG21 ' A' ' 109' ' ' ILE . 85.5 t -102.88 126.68 57.09 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.806 0 C-N-CA 120.144 -0.622 . . . . 0.0 111.119 176.598 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' TRP . . . . . 0.588 ' CE3' ' CZ2' ' A' ' 78' ' ' TRP . 0.7 OUTLIER -113.31 130.49 56.25 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 109.368 -0.605 . . . . 0.0 109.368 177.958 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -150.19 167.47 26.81 Favored 'General case' 0 C--N 1.328 -0.354 0 O-C-N 122.362 -0.211 . . . . 0.0 111.039 -178.497 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.601 HG22 ' OD2' ' A' ' 72' ' ' ASP . 13.8 t -108.85 -33.63 6.89 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 120.696 -0.401 . . . . 0.0 110.694 174.313 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' TRP . . . . . 0.726 ' HE1' ' HA ' ' A' ' 72' ' ' ASP . 65.6 p-90 -73.94 -9.24 58.44 Favored 'General case' 0 C--N 1.343 0.291 0 C-N-CA 120.319 -0.552 . . . . 0.0 111.002 178.489 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 25.5 t -63.55 -57.57 9.72 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.102 -179.917 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 107.28 -85.18 0.41 Allowed Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.642 -0.789 . . . . 0.0 112.493 -176.712 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_exo -53.42 -28.63 45.04 Favored 'Trans proline' 0 C--N 1.354 0.818 0 C-N-CA 123.134 2.556 . . . . 0.0 112.727 179.277 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 42.4 t -54.13 -29.15 44.06 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.055 176.963 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 54.8 mtp180 -83.65 -26.23 30.08 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-O 120.903 0.382 . . . . 0.0 110.695 -179.701 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -80.52 -36.67 22.65 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.865 -0.683 . . . . 0.0 111.689 -179.335 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.422 ' OE2' ' HD2' ' A' ' 128' ' ' ARG . 21.3 mt-10 -90.23 10.36 24.95 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.292 0.568 . . . . 0.0 109.985 177.95 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.546 ' N ' ' HD2' ' A' ' 50' ' ' PRO . 20.2 tp -69.05 -45.99 30.24 Favored Pre-proline 0 N--CA 1.441 -0.89 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.869 -177.936 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.546 ' HD2' ' N ' ' A' ' 49' ' ' LEU . 11.7 Cg_endo -56.83 -22.28 44.59 Favored 'Trans proline' 0 C--N 1.351 0.698 0 C-N-CA 121.565 1.51 . . . . 0.0 111.363 171.379 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -85.05 -31.38 23.44 Favored 'General case' 0 CA--C 1.515 -0.386 0 CA-C-O 121.924 0.869 . . . . 0.0 108.895 -179.233 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 6.0 tt -69.94 -48.07 59.88 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-N 114.443 -1.253 . . . . 0.0 108.573 178.228 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.687 ' HZ3' ' HB3' ' A' ' 53' ' ' LYS . 7.6 mtpm? -58.83 -49.37 77.99 Favored 'General case' 0 C--O 1.225 -0.193 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.751 179.119 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -46.03 -56.37 5.64 Favored 'General case' 0 C--N 1.332 -0.16 0 O-C-N 123.514 0.509 . . . . 0.0 111.586 176.397 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.598 HD21 ' HE2' ' A' ' 138' ' ' PHE . 38.8 tp -66.95 -48.7 67.75 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.255 -178.392 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.437 ' HA ' ' CE2' ' A' ' 66' ' ' PHE . 5.9 tm-20 -59.03 -55.1 39.47 Favored 'General case' 0 N--CA 1.448 -0.553 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.563 -175.998 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.674 ' HG2' ' NZ ' ' A' ' 88' ' ' LYS . 38.2 mt-10 -70.12 -30.43 67.62 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.724 0.297 . . . . 0.0 111.244 -174.73 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.482 ' HE3' ' HB2' ' A' ' 58' ' ' LYS . 34.3 ttmt -69.96 -41.77 74.07 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-O 121.198 0.523 . . . . 0.0 110.665 179.237 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 17.2 m-85 -100.3 7.82 44.12 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.473 -177.032 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -65.11 136.19 56.41 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.258 -0.428 . . . . 0.0 109.941 173.245 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 82.61 1.52 90.53 Favored Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.407 179.187 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.452 ' O ' ' HD3' ' A' ' 31' ' ' LYS . 34.8 mmtm -90.59 -154.16 0.33 Allowed 'General case' 0 CA--C 1.515 -0.395 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 176.601 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.687 ' HA ' ' HD3' ' A' ' 31' ' ' LYS . 2.6 t70 -95.1 47.26 1.14 Allowed 'General case' 0 C--N 1.318 -0.762 0 CA-C-O 121.35 0.595 . . . . 0.0 110.344 179.153 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 13.3 tt -155.16 135.31 4.18 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.721 0 CA-C-N 115.582 -0.735 . . . . 0.0 109.961 178.038 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' HIS . . . . . 0.659 ' NE2' ' HB3' ' A' ' 31' ' ' LYS . 75.3 m-70 -105.0 114.27 28.38 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 176.911 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' PHE . . . . . 0.453 ' CZ ' ' HG ' ' A' ' 55' ' ' LEU . 73.6 m-85 -78.4 104.81 9.23 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 172.442 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.547 ' O ' ' HA ' ' A' ' 35' ' ' ILE . 48.4 t -117.49 104.46 16.42 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.884 -178.359 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' SER . . . . . 0.582 ' HA ' ' O ' ' A' ' 36' ' ' ASP . 23.3 p -89.26 146.03 25.0 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.169 -179.8 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.471 ' O ' HG13 ' A' ' 37' ' ' VAL . 64.8 tp -124.12 126.84 46.87 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 109.689 -0.486 . . . . 0.0 109.689 176.77 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' SER . . . . . 0.487 ' HB3' ' HA ' ' A' ' 93' ' ' HIS . 19.3 t -103.94 109.03 20.62 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.435 0.636 . . . . 0.0 112.29 -174.301 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 6.8 m -81.02 25.11 0.48 Allowed 'General case' 0 C--N 1.314 -0.974 0 CA-C-N 115.067 -0.969 . . . . 0.0 110.188 169.553 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.726 ' HA ' ' HE1' ' A' ' 41' ' ' TRP . 2.9 t70 -72.79 129.74 38.89 Favored 'General case' 0 CA--C 1.51 -0.578 0 C-N-CA 119.899 -0.72 . . . . 0.0 110.174 -178.646 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.494 ' NZ ' ' HB3' ' A' ' 73' ' ' LYS . 3.0 ttpm? -88.02 -11.95 45.81 Favored 'General case' 0 C--N 1.313 -0.979 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.338 -177.856 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 -104.39 60.04 0.71 Allowed 'General case' 0 CA--C 1.51 -0.595 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 -176.779 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.64 ' O ' ' HG2' ' A' ' 79' ' ' GLU . 64.9 tttt -47.75 -51.33 22.59 Favored 'General case' 0 C--O 1.221 -0.414 0 O-C-N 123.644 0.59 . . . . 0.0 112.447 -170.029 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 23.6 tptm -48.3 -54.24 14.45 Favored 'General case' 0 C--O 1.245 0.855 0 CA-C-N 116.735 -0.211 . . . . 0.0 110.456 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -61.27 -39.86 91.95 Favored 'General case' 0 N--CA 1.452 -0.355 0 O-C-N 123.972 0.795 . . . . 0.0 110.034 -178.844 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' TRP . . . . . 0.588 ' CZ2' ' CE3' ' A' ' 38' ' ' TRP . 9.3 t-105 -61.43 -58.51 7.88 Favored 'General case' 0 N--CA 1.437 -1.088 0 CA-C-N 114.96 -1.018 . . . . 0.0 112.263 -179.458 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.64 ' HG2' ' O ' ' A' ' 75' ' ' LYS . 3.3 mm-40 -52.25 -48.04 65.43 Favored 'General case' 0 C--O 1.236 0.39 0 N-CA-C 112.426 0.528 . . . . 0.0 112.426 -175.669 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 3.9 p-10 -71.16 -28.82 64.53 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 118.859 -1.136 . . . . 0.0 110.852 -178.159 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 15.3 ttt -68.19 -47.81 66.93 Favored 'General case' 0 C--O 1.222 -0.359 0 C-N-CA 120.978 -0.289 . . . . 0.0 111.542 177.518 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.586 HG23 ' HB2' ' A' ' 87' ' ' LEU . 0.2 OUTLIER -58.69 -37.9 68.44 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.313 0 C-N-CA 120.429 -0.509 . . . . 0.0 110.205 178.72 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 25.3 m -67.34 -33.31 74.97 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.81 177.376 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 21.0 tttm -80.25 -49.97 10.86 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.699 -177.958 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 52.8 m-20 -84.37 6.79 21.78 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.633 -0.712 . . . . 0.0 111.406 -173.983 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 89.7 mt-30 64.28 41.72 5.8 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 115.72 -0.673 . . . . 0.0 112.745 171.007 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.586 ' HB2' HG23 ' A' ' 82' ' ' VAL . 7.9 mp -83.95 82.11 8.49 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 120.758 -0.377 . . . . 0.0 110.218 176.036 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.674 ' NZ ' ' HG2' ' A' ' 57' ' ' GLU . 0.0 OUTLIER -95.79 171.53 8.59 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.594 -0.276 . . . . 0.0 111.676 -179.852 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 128.07 -139.74 11.3 Favored Glycine 0 N--CA 1.452 -0.258 0 N-CA-C 110.286 -1.126 . . . . 0.0 110.286 -175.795 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 63.8 mt -111.44 109.05 27.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 N-CA-C 107.935 -1.135 . . . . 0.0 107.935 168.408 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' GLN . . . . . 0.541 ' HB3' ' CZ2' ' A' ' 38' ' ' TRP . 3.5 mm100 -127.73 100.22 5.87 Favored 'General case' 0 N--CA 1.442 -0.85 0 CA-C-O 120.838 0.351 . . . . 0.0 110.953 -167.669 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.559 HD13 ' HB2' ' A' ' 15' ' ' TYR . 27.0 mt -97.22 140.58 31.49 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 120.817 0.342 . . . . 0.0 110.787 -177.133 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 93' ' ' HIS . . . . . 0.547 ' CE1' ' HG3' ' A' ' 75' ' ' LYS . 30.0 t-80 -114.53 120.63 40.88 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 120.864 0.364 . . . . 0.0 110.896 178.301 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 19.7 ttp -79.0 -55.83 4.84 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.74 -0.664 . . . . 0.0 109.999 176.553 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' GLY . . . . . 0.453 ' HA2' ' NE2' ' A' ' 93' ' ' HIS . . . 111.19 -119.33 5.14 Favored Glycine 0 N--CA 1.438 -1.178 0 C-N-CA 120.557 -0.83 . . . . 0.0 111.879 -179.465 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 8.9 t -109.85 21.71 16.55 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-O 120.555 0.217 . . . . 0.0 110.994 -175.28 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -90.84 134.17 34.65 Favored 'General case' 0 CA--C 1.515 -0.383 0 C-N-CA 119.699 -0.8 . . . . 0.0 109.74 179.9 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' ARG . . . . . 0.598 ' HA ' ' HG3' ' A' ' 101' ' ' MET . 0.0 OUTLIER -113.71 6.08 16.69 Favored 'General case' 0 C--N 1.32 -0.676 0 C-N-CA 120.361 -0.536 . . . . 0.0 110.699 176.689 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 4.0 m -71.0 -39.68 72.29 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.373 -178.611 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 27.7 t80 -82.24 -30.61 30.65 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.585 -176.948 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' MET . . . . . 0.598 ' HG3' ' HA ' ' A' ' 98' ' ' ARG . 4.7 ppp? -74.68 -20.92 59.67 Favored 'General case' 0 C--N 1.332 -0.168 0 C-N-CA 120.144 -0.622 . . . . 0.0 109.495 177.554 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -68.0 -42.81 80.18 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.41 -0.814 . . . . 0.0 109.8 172.331 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -64.46 -16.99 63.4 Favored 'General case' 0 CA--C 1.529 0.158 0 CA-C-N 115.674 -0.694 . . . . 0.0 111.815 -177.621 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 9.0 m-85 -108.28 -2.32 19.35 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.402 178.212 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 7.8 mp 55.34 37.64 29.18 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.812 -176.793 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' ILE . . . . . 0.855 HG12 ' HG3' ' A' ' 111' ' ' ARG . 60.8 mt -59.41 106.51 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.006 177.906 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 7.1 m120 -73.79 -66.18 0.74 Allowed 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.626 0.727 . . . . 0.0 109.938 178.483 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -135.14 145.82 17.88 Favored Glycine 0 N--CA 1.438 -1.216 0 CA-C-N 114.971 -1.013 . . . . 0.0 111.12 178.979 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.522 HG21 HG11 ' A' ' 37' ' ' VAL . 40.2 pt -100.53 154.3 37.26 Favored Pre-proline 0 C--N 1.316 -0.85 0 N-CA-C 110.34 -0.244 . . . . 0.0 110.34 179.736 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 110' ' ' PRO . . . . . 0.487 ' HB3' ' O ' ' A' ' 37' ' ' VAL . 15.9 Cg_exo -69.1 131.73 19.34 Favored 'Cis proline' 0 C--N 1.348 0.515 0 C-N-CA 123.973 -1.261 . . . . 0.0 113.54 0.656 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 111' ' ' ARG . . . . . 0.855 ' HG3' HG12 ' A' ' 106' ' ' ILE . 0.0 OUTLIER -82.26 160.3 22.99 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 175.215 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 112' ' ' PHE . . . . . 0.429 ' HD2' ' HB2' ' A' ' 128' ' ' ARG . 0.2 OUTLIER -130.45 114.43 15.52 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.76 -0.654 . . . . 0.0 109.958 -177.445 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.516 ' HB ' ' HB ' ' A' ' 35' ' ' ILE . 81.5 mt -134.44 142.88 39.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-O 120.735 0.303 . . . . 0.0 111.142 -176.306 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.491 ' HB2' ' SD ' ' A' ' 126' ' ' MET . 41.2 tp -127.13 140.41 52.28 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.262 178.689 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.492 ' HB2' ' HB ' ' A' ' 33' ' ' ILE . 1.9 mp -133.29 150.0 51.91 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.302 0.572 . . . . 0.0 110.042 178.152 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 116' ' ' ASP . . . . . 0.624 ' HB3' ' HB2' ' A' ' 120' ' ' LYS . 14.1 t70 -70.29 164.3 24.7 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.029 -0.987 . . . . 0.0 110.604 178.905 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 117' ' ' ARG . . . . . 0.405 ' HA ' ' C ' ' A' ' 31' ' ' LYS . 84.5 mtt180 -48.13 -38.09 17.05 Favored 'General case' 0 N--CA 1.464 0.247 0 O-C-N 124.198 0.936 . . . . 0.0 112.613 -178.63 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -80.54 9.77 5.61 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.638 0.256 . . . . 0.0 111.607 -178.962 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 119' ' ' GLY . . . . . 0.553 ' HA2' HD12 ' A' ' 33' ' ' ILE . . . 79.04 28.81 53.34 Favored Glycine 0 N--CA 1.445 -0.744 0 N-CA-C 111.244 -0.743 . . . . 0.0 111.244 -176.988 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 120' ' ' LYS . . . . . 0.624 ' HB2' ' HB3' ' A' ' 116' ' ' ASP . 32.4 mtmm -99.47 104.29 16.11 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 120.674 -0.411 . . . . 0.0 110.742 -175.147 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 0.676 ' H ' HD12 ' A' ' 121' ' ' ILE . 4.0 mp -43.65 111.57 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-O 121.31 0.576 . . . . 0.0 111.396 -178.286 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 122' ' ' ILE . . . . . 0.451 ' H ' ' HA ' ' A' ' 115' ' ' LEU . 58.7 mt -85.59 -41.3 15.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 115.337 -0.847 . . . . 0.0 109.18 178.921 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 17.3 m -149.72 115.44 5.6 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.416 -0.811 . . . . 0.0 110.299 -179.522 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -69.92 -15.22 63.03 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.348 0.594 . . . . 0.0 110.307 174.937 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 18.1 p-10 -139.95 102.77 4.48 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.313 -0.858 . . . . 0.0 110.066 174.24 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 126' ' ' MET . . . . . 0.491 ' SD ' ' HB2' ' A' ' 114' ' ' LEU . 20.8 ttp -107.97 -133.4 0.33 Allowed 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.036 -0.529 . . . . 0.0 109.676 178.602 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 6.3 p -124.69 138.07 54.32 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 110.149 -0.315 . . . . 0.0 110.149 177.328 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 128' ' ' ARG . . . . . 0.43 ' CG ' ' HD2' ' A' ' 129' ' ' PRO . 37.9 ttm180 -67.78 147.36 98.59 Favored Pre-proline 0 C--N 1.325 -0.475 0 CA-C-N 116.198 -0.455 . . . . 0.0 109.874 177.565 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 129' ' ' PRO . . . . . 0.43 ' HD2' ' CG ' ' A' ' 128' ' ' ARG . 2.9 Cg_endo -42.62 -25.82 0.54 Allowed 'Trans proline' 0 C--N 1.356 0.966 0 C-N-CA 124.119 3.213 . . . . 0.0 114.226 177.095 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 1.4 m -57.76 -26.05 61.32 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 122.723 0.409 . . . . 0.0 111.708 178.432 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 131' ' ' ASP . . . . . 0.479 ' OD1' ' HG3' ' A' ' 133' ' ' LYS . 21.1 t0 -99.05 124.88 43.76 Favored Pre-proline 0 C--N 1.329 -0.32 0 N-CA-C 109.938 -0.393 . . . . 0.0 109.938 179.511 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 28.7 Cg_endo -61.0 -18.11 55.73 Favored 'Trans proline' 0 C--N 1.347 0.489 0 C-N-CA 123.273 2.648 . . . . 0.0 113.788 -178.081 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 133' ' ' LYS . . . . . 0.479 ' HG3' ' OD1' ' A' ' 131' ' ' ASP . 48.6 mttp -58.2 -23.93 57.31 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-O 120.833 0.349 . . . . 0.0 110.605 178.843 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 36.2 p -58.39 -59.32 5.53 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.235 175.494 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -56.75 -47.17 80.66 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.917 -177.907 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -56.63 -39.9 74.47 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.44 -0.8 . . . . 0.0 111.15 -179.633 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 137' ' ' LYS . . . . . 0.514 ' O ' ' HG ' ' A' ' 141' ' ' LEU . 75.5 tttt -74.08 -34.09 63.88 Favored 'General case' 0 N--CA 1.451 -0.396 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.883 -179.271 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 138' ' ' PHE . . . . . 0.598 ' HE2' HD21 ' A' ' 55' ' ' LEU . 11.1 m-30 -64.43 -40.22 95.33 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 109.689 -0.486 . . . . 0.0 109.689 177.747 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 75.6 m-20 -58.17 -45.74 86.96 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.69 -0.686 . . . . 0.0 109.66 174.989 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -60.58 -48.07 83.39 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.067 177.467 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.514 ' HG ' ' O ' ' A' ' 137' ' ' LYS . 95.5 mt -56.38 -45.59 80.46 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.776 -179.402 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.543 HD13 ' HB2' ' A' ' 63' ' ' ASP . 60.0 tp -67.71 -23.28 65.26 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.201 0.524 . . . . 0.0 110.811 -179.973 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 95.27 23.81 18.45 Favored Glycine 0 N--CA 1.442 -0.924 0 C-N-CA 120.719 -0.753 . . . . 0.0 111.383 -176.904 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 55.6 tp -82.26 -68.66 0.68 Allowed 'General case' 0 N--CA 1.446 -0.632 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 175.822 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 8.2 mm-40 -70.4 -22.44 62.74 Favored 'General case' 0 CA--C 1.505 -0.756 0 CA-C-O 122.086 0.946 . . . . 0.0 110.704 172.95 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -71.77 64.9 1.16 Allowed Glycine 0 C--N 1.305 -1.145 0 CA-C-N 113.974 -1.466 . . . . 0.0 110.078 166.272 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 88.9 m-70 -74.8 44.44 0.22 Allowed 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 122.754 0.421 . . . . 0.0 111.014 -174.544 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 27.3 p80 -78.97 48.43 0.84 Allowed 'General case' 0 N--CA 1.466 0.348 0 N-CA-C 112.366 0.506 . . . . 0.0 112.366 -173.486 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -166.7 174.36 8.78 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-N 116.46 -0.336 . . . . 0.0 110.718 175.594 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 15.2 t-80 66.97 22.39 10.08 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 123.509 0.723 . . . . 0.0 111.444 176.543 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 34.3 p-80 -166.94 -173.58 2.41 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 110.14 -0.318 . . . . 0.0 110.14 176.982 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 84.5 t60 . . . . . 0 C--O 1.246 0.914 0 CA-C-O 118.555 -0.736 . . . . 0.0 110.133 178.922 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.1 ptt? . . . . . 0 N--CA 1.481 1.125 0 CA-C-O 120.794 0.331 . . . . 0.0 111.035 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 18.7 p -154.88 178.29 10.33 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 110.153 -0.314 . . . . 0.0 110.153 -178.565 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 6.9 mp -71.96 98.28 2.02 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 176.204 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 38.9 ttm180 -62.46 -37.78 87.24 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.119 -175.704 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 37.1 m -110.89 101.49 10.08 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.33 -179.476 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 113.4 -39.37 2.86 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.552 177.693 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 53.5 m-80 68.41 162.91 0.14 Allowed Pre-proline 0 N--CA 1.469 0.493 0 C-N-CA 122.919 0.488 . . . . 0.0 110.789 -175.978 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -57.01 110.97 0.67 Allowed 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.008 1.806 . . . . 0.0 111.149 175.792 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.431 ' HA ' ' OG ' ' A' ' 12' ' ' SER . 5.5 m -70.23 -5.9 30.79 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.285 0.564 . . . . 0.0 111.775 -172.546 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.441 ' HA ' ' CZ ' ' A' ' 100' ' ' PHE . . . -79.0 -11.06 60.0 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 115.417 -0.81 . . . . 0.0 109.884 178.391 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -128.38 13.24 6.56 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.344 -0.844 . . . . 0.0 110.535 -178.644 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.431 ' OG ' ' HA ' ' A' ' 9' ' ' SER . 35.6 p -143.16 18.34 1.92 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.13 0.491 . . . . 0.0 110.852 -179.747 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 49.5 p90 -73.81 149.64 41.54 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.055 -0.521 . . . . 0.0 111.008 -176.958 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.466 ' HA ' ' HA ' ' A' ' 24' ' ' SER . 39.1 m -142.22 117.23 9.98 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.773 -0.649 . . . . 0.0 109.377 176.811 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' TYR . . . . . 0.538 ' HB2' HD22 ' A' ' 92' ' ' LEU . 57.5 m-85 -128.32 145.68 56.64 Favored Pre-proline 0 C--N 1.323 -0.55 0 CA-C-O 120.851 0.357 . . . . 0.0 111.236 -176.321 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 63.2 Cg_endo -76.07 125.39 8.58 Favored 'Trans proline' 0 N--CA 1.459 -0.553 0 C-N-CA 122.434 2.089 . . . . 0.0 113.449 -179.029 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' ASP . . . . . 0.68 ' HB3' ' HB3' ' A' ' 21' ' ' LYS . 3.3 t70 -64.15 157.36 25.79 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.044 -0.98 . . . . 0.0 108.528 168.007 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.526 HD12 ' CG1' ' A' ' 82' ' ' VAL . 3.4 tt -50.06 -39.04 15.41 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.519 0 O-C-N 123.959 0.787 . . . . 0.0 111.561 -173.867 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 37.8 m-80 -75.61 3.8 8.87 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.474 -175.407 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 82.59 37.77 13.42 Favored Glycine 0 N--CA 1.445 -0.719 0 N-CA-C 111.186 -0.765 . . . . 0.0 111.186 -176.739 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.68 ' HB3' ' HB3' ' A' ' 17' ' ' ASP . 4.2 tmmt? -110.72 120.9 43.92 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.723 0.297 . . . . 0.0 110.333 -177.786 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 26.0 m -70.68 101.66 2.11 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-O 120.956 0.407 . . . . 0.0 110.917 -177.039 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.518 ' HB ' HD23 ' A' ' 92' ' ' LEU . 41.5 t -92.61 109.26 21.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 175.703 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' SER . . . . . 0.466 ' HA ' ' HA ' ' A' ' 14' ' ' SER . 57.4 p -106.16 175.86 5.36 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.204 -177.956 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.49 HD11 ' HA3' ' A' ' 119' ' ' GLY . 2.9 tm? -58.42 -33.7 69.98 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 109.662 -0.496 . . . . 0.0 109.662 176.098 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -74.32 -25.86 59.81 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.735 -178.456 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -69.17 -32.47 71.82 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-O 121.523 0.678 . . . . 0.0 110.472 -179.556 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.661 HD13 HG21 ' A' ' 67' ' ' VAL . 68.9 mt -100.35 -8.6 23.17 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.56 -0.745 . . . . 0.0 110.902 -178.623 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 56.1 tttp -70.75 138.45 50.49 Favored 'General case' 0 N--CA 1.443 -0.813 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.219 -173.874 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 109.22 -3.64 31.4 Favored Glycine 0 N--CA 1.446 -0.656 0 N-CA-C 111.203 -0.759 . . . . 0.0 111.203 -176.96 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.581 ' HD3' ' HA ' ' A' ' 63' ' ' ASP . 21.6 ttmm -154.1 150.25 27.98 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 -179.486 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.484 ' CD1' ' HA ' ' A' ' 116' ' ' ASP . 29.1 m-85 -59.99 148.68 34.53 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 121.145 0.498 . . . . 0.0 111.667 -175.829 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.488 ' HB ' ' HB2' ' A' ' 115' ' ' LEU . 55.3 mt -123.39 128.12 74.59 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.772 -175.602 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 91.7 t80 -118.16 110.19 17.29 Favored 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 108.72 -0.845 . . . . 0.0 108.72 173.395 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.563 ' HB ' ' HB ' ' A' ' 113' ' ' ILE . 68.0 mt -97.48 126.03 50.45 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-O 121.06 0.457 . . . . 0.0 111.135 -175.455 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.444 ' HA ' ' O ' ' A' ' 111' ' ' ARG . 3.2 p30 -113.04 159.33 19.27 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 173.18 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.522 HG21 HG21 ' A' ' 106' ' ' ILE . 61.6 t -105.05 131.19 54.83 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.933 0 C-N-CA 120.36 -0.536 . . . . 0.0 111.055 173.427 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' TRP . . . . . 0.575 ' CZ2' ' HB2' ' A' ' 91' ' ' GLN . 0.4 OUTLIER -125.05 134.17 52.63 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-O 120.748 0.308 . . . . 0.0 110.718 -179.014 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -147.74 162.04 40.01 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 116.646 -0.252 . . . . 0.0 110.588 178.377 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.727 ' HB ' ' CE3' ' A' ' 78' ' ' TRP . 12.2 t -99.6 -10.12 22.41 Favored 'General case' 0 N--CA 1.462 0.136 0 C-N-CA 120.537 -0.465 . . . . 0.0 111.528 179.845 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' TRP . . . . . 0.502 ' HE1' ' HA ' ' A' ' 72' ' ' ASP . 9.7 p-90 -99.02 15.88 24.37 Favored 'General case' 0 CA--C 1.51 -0.595 0 CA-C-O 122.56 1.171 . . . . 0.0 108.025 -177.381 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' CYS . . . . . 0.592 ' SG ' HD12 ' A' ' 109' ' ' ILE . 99.6 m -123.18 135.95 54.54 Favored 'General case' 0 N--CA 1.429 -1.505 0 CA-C-N 113.267 -1.788 . . . . 0.0 109.398 -178.212 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.716 ' H ' ' HD2' ' A' ' 44' ' ' PRO . . . -101.92 -49.86 1.22 Allowed Glycine 0 CA--C 1.525 0.671 0 CA-C-O 119.203 -0.776 . . . . 0.0 113.879 -177.945 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.716 ' HD2' ' H ' ' A' ' 43' ' ' GLY . 10.5 Cg_endo -53.38 -34.6 71.77 Favored 'Trans proline' 0 C--N 1.357 1.022 0 C-N-CA 122.8 2.333 . . . . 0.0 112.826 -176.661 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 45' ' ' CYS . . . . . 0.652 ' O ' ' HG ' ' A' ' 49' ' ' LEU . 18.4 p -58.42 -34.06 70.37 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.109 179.547 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.534 ' HG2' HD12 ' A' ' 49' ' ' LEU . 33.8 mtt85 -72.01 -8.01 52.04 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.787 -174.811 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -74.79 -33.87 54.49 Favored Glycine 0 N--CA 1.446 -0.677 0 C-N-CA 120.428 -0.892 . . . . 0.0 111.979 177.262 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.546 ' OE2' ' HD2' ' A' ' 129' ' ' PRO . 7.4 pt-20 -112.69 -0.49 15.05 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 112.198 0.444 . . . . 0.0 112.198 -177.478 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.652 ' HG ' ' O ' ' A' ' 45' ' ' CYS . 34.7 mt -55.05 -49.6 91.26 Favored Pre-proline 0 N--CA 1.468 0.443 0 N-CA-C 112.29 0.478 . . . . 0.0 112.29 177.069 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.563 ' HD3' ' HB2' ' A' ' 49' ' ' LEU . 77.2 Cg_exo -52.72 -44.33 48.73 Favored 'Trans proline' 0 C--N 1.357 1.016 0 C-N-CA 121.901 1.734 . . . . 0.0 112.161 176.483 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -73.61 -31.09 63.38 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.235 0.54 . . . . 0.0 110.563 -178.037 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.448 ' O ' ' HB2' ' A' ' 55' ' ' LEU . 6.5 tt -64.1 -53.44 49.7 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.264 -0.88 . . . . 0.0 109.885 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.689 ' O ' ' HG3' ' A' ' 57' ' ' GLU . 17.7 pttp -60.97 -39.64 90.36 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.121 179.71 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.472 ' HG3' ' O ' ' A' ' 50' ' ' PRO . 18.3 mt-10 -68.6 -29.06 67.5 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.469 -178.915 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.51 HD12 ' HB3' ' A' ' 129' ' ' PRO . 12.6 mt -59.32 -47.17 86.39 Favored 'General case' 0 N--CA 1.448 -0.55 0 N-CA-C 109.753 -0.462 . . . . 0.0 109.753 172.044 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 1.025 ' HG2' ' HA2' ' A' ' 89' ' ' GLY . 8.2 tp10 -65.18 -43.49 91.48 Favored 'General case' 0 C--O 1.218 -0.591 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.2 177.498 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.689 ' HG3' ' O ' ' A' ' 53' ' ' LYS . 37.1 mt-10 -61.42 -22.57 65.13 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.126 0.489 . . . . 0.0 110.776 179.773 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 63.2 tttp -85.45 -39.46 17.49 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.668 177.197 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.406 ' HB2' ' HE1' ' A' ' 66' ' ' PHE . 83.1 m-85 -110.48 18.29 19.92 Favored 'General case' 0 C--O 1.235 0.339 0 N-CA-C 111.859 0.318 . . . . 0.0 111.859 -173.556 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.409 ' HA ' ' OE2' ' A' ' 56' ' ' GLU . . . -56.48 117.16 3.58 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.914 -177.315 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 75.65 -3.5 49.01 Favored Glycine 0 N--CA 1.45 -0.428 0 CA-C-N 115.768 -0.651 . . . . 0.0 113.237 175.848 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.487 ' HA ' ' HD3' ' A' ' 62' ' ' LYS . 30.4 mmtm -66.56 -80.87 0.04 OUTLIER 'General case' 0 CA--C 1.515 -0.394 0 CA-C-O 120.956 0.408 . . . . 0.0 110.561 -178.082 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.581 ' HA ' ' HD3' ' A' ' 31' ' ' LYS . 14.5 t0 -156.87 28.89 0.31 Allowed 'General case' 0 C--N 1.313 -0.983 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.904 170.343 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 5.3 mp -142.53 133.89 24.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 115.888 -0.596 . . . . 0.0 109.528 178.667 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' HIS . . . . . 0.509 ' NE2' ' HB3' ' A' ' 31' ' ' LYS . 99.4 m-70 -107.21 116.43 31.91 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 109.241 -0.652 . . . . 0.0 109.241 172.312 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 66' ' ' PHE . . . . . 0.563 ' HB2' ' HB2' ' A' ' 56' ' ' GLU . 76.4 m-85 -87.85 103.32 15.54 Favored 'General case' 0 C--N 1.316 -0.866 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 174.286 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.722 ' HA ' ' O ' ' A' ' 90' ' ' ILE . 47.3 t -111.39 110.33 31.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 115.505 -0.77 . . . . 0.0 111.348 -169.641 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 68' ' ' SER . . . . . 0.426 ' HB3' ' CG ' ' A' ' 38' ' ' TRP . 14.0 m -88.25 125.26 34.56 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 115.531 -0.758 . . . . 0.0 110.489 -179.642 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.493 HD11 ' HB2' ' A' ' 94' ' ' MET . 55.1 tp -113.57 121.19 43.46 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 122.784 0.433 . . . . 0.0 110.358 178.84 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 70' ' ' SER . . . . . 0.482 ' HB2' ' CD1' ' A' ' 38' ' ' TRP . 10.2 t -109.15 116.9 32.82 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 112.488 0.551 . . . . 0.0 112.488 -174.188 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 42.8 t -86.09 21.93 1.87 Allowed 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.208 173.907 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.614 ' OD2' HG22 ' A' ' 40' ' ' THR . 5.4 t70 -66.51 131.48 46.13 Favored 'General case' 0 CA--C 1.513 -0.465 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 179.63 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.437 ' NZ ' ' HB3' ' A' ' 73' ' ' LYS . 3.7 ttpm? -82.63 -14.19 55.16 Favored 'General case' 0 C--N 1.315 -0.91 0 C-N-CA 120.427 -0.509 . . . . 0.0 110.642 -177.561 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 74' ' ' ASN . . . . . 0.545 ' HB2' ' HB3' ' A' ' 77' ' ' ALA . 0.2 OUTLIER -109.06 83.32 1.73 Allowed 'General case' 0 CA--C 1.51 -0.574 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 -176.766 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.641 ' HE2' ' CD ' ' A' ' 79' ' ' GLU . 18.0 tttt -56.41 -60.7 3.15 Favored 'General case' 0 C--O 1.22 -0.459 0 C-N-CA 120.742 -0.383 . . . . 0.0 111.346 -172.513 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 4.4 ttmp? -46.9 -43.99 19.32 Favored 'General case' 0 C--O 1.239 0.545 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.474 179.59 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.565 ' HA ' HD21 ' A' ' 80' ' ' ASN . . . -64.84 -38.56 91.38 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-O 121.347 0.594 . . . . 0.0 110.019 -177.804 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 78' ' ' TRP . . . . . 0.727 ' CE3' ' HB ' ' A' ' 40' ' ' THR . 5.6 t-105 -69.49 -47.71 63.01 Favored 'General case' 0 N--CA 1.44 -0.938 0 CA-C-N 115.015 -0.993 . . . . 0.0 111.515 -178.759 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.641 ' CD ' ' HE2' ' A' ' 75' ' ' LYS . 4.4 mm-40 -48.43 -54.01 15.69 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-O 121.165 0.507 . . . . 0.0 111.756 177.018 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 80' ' ' ASN . . . . . 0.565 HD21 ' HA ' ' A' ' 77' ' ' ALA . 9.2 p30 -72.88 -23.17 60.69 Favored 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 119.482 -0.887 . . . . 0.0 110.858 -176.518 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 81' ' ' MET . . . . . 0.582 ' HG2' ' OG1' ' A' ' 40' ' ' THR . 10.9 tpt -70.02 -48.45 57.99 Favored 'General case' 0 C--O 1.21 -0.979 0 CA-C-O 119.488 -0.291 . . . . 0.0 111.242 176.152 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.619 HG23 ' HB2' ' A' ' 87' ' ' LEU . 2.3 p -62.92 -25.34 38.23 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 C-N-CA 120.474 -0.491 . . . . 0.0 110.355 177.79 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 29.7 m -64.32 -36.65 84.81 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-O 121.189 0.518 . . . . 0.0 110.294 171.611 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 80.6 mttt -82.88 -45.79 13.79 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.573 179.119 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' ASP . . . . . 0.526 ' OD2' ' HG3' ' A' ' 81' ' ' MET . 1.2 m-20 -64.55 -23.09 67.15 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 114.881 -1.054 . . . . 0.0 110.665 179.2 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 51.4 mt-30 57.59 61.62 2.4 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 115.517 -0.765 . . . . 0.0 111.483 178.298 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.619 ' HB2' HG23 ' A' ' 82' ' ' VAL . 79.3 mt -100.21 113.17 25.64 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.612 -178.709 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.548 ' HB2' ' HB2' ' A' ' 53' ' ' LYS . 11.8 mmmm -86.49 178.98 6.93 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.234 178.36 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 89' ' ' GLY . . . . . 1.025 ' HA2' ' HG2' ' A' ' 56' ' ' GLU . . . 105.19 -177.84 23.29 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.825 -0.702 . . . . 0.0 112.538 178.138 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.722 ' O ' ' HA ' ' A' ' 67' ' ' VAL . 45.6 mm -86.75 113.61 24.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 175.638 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 91' ' ' GLN . . . . . 0.575 ' HB2' ' CZ2' ' A' ' 38' ' ' TRP . 1.8 pt20 -130.72 142.11 50.41 Favored 'General case' 0 C--N 1.309 -1.162 0 C-N-CA 120.321 -0.551 . . . . 0.0 111.713 -170.207 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.538 HD22 ' HB2' ' A' ' 15' ' ' TYR . 1.0 OUTLIER -145.01 156.26 43.84 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.677 178.756 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 93' ' ' HIS . . . . . 0.558 ' CE1' ' HG3' ' A' ' 75' ' ' LYS . 19.0 t-80 -117.53 138.57 51.81 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-O 121.422 0.63 . . . . 0.0 111.471 -175.06 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 94' ' ' MET . . . . . 0.759 ' SD ' ' HA ' ' A' ' 98' ' ' ARG . 27.1 ttm -98.25 -76.68 0.52 Allowed 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 114.973 -1.012 . . . . 0.0 109.902 177.771 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 95' ' ' GLY . . . . . 0.509 ' HA2' ' O ' ' A' ' 72' ' ' ASP . . . 80.64 -85.41 1.36 Allowed Glycine 0 N--CA 1.447 -0.608 0 C-N-CA 121.065 -0.588 . . . . 0.0 113.207 178.474 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 7.6 p -82.47 -25.61 33.39 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 120.942 0.401 . . . . 0.0 112.063 -173.635 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 97' ' ' ASP . . . . . 0.52 ' HB2' ' HG3' ' A' ' 94' ' ' MET . 4.0 m-20 -87.85 38.05 0.82 Allowed 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.55 -173.307 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 98' ' ' ARG . . . . . 0.759 ' HA ' ' SD ' ' A' ' 94' ' ' MET . 0.0 OUTLIER -64.69 -12.42 46.36 Favored 'General case' 0 C--O 1.222 -0.35 0 N-CA-C 112.532 0.568 . . . . 0.0 112.532 -171.327 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 4.8 m -58.75 -20.61 51.02 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.385 0.612 . . . . 0.0 110.742 177.85 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 100' ' ' PHE . . . . . 0.441 ' CZ ' ' HA ' ' A' ' 10' ' ' ALA . 36.0 t80 -81.15 -32.0 33.87 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.096 179.932 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 101' ' ' MET . . . . . 0.689 ' HG3' ' O ' ' A' ' 98' ' ' ARG . 4.2 ppp? -77.08 -31.26 55.89 Favored 'General case' 0 C--O 1.235 0.321 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 177.919 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -59.84 -39.68 85.97 Favored 'General case' 0 CA--C 1.52 -0.177 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.145 170.875 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -62.96 -23.88 67.63 Favored 'General case' 0 N--CA 1.462 0.148 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.451 -178.617 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 104' ' ' TYR . . . . . 0.401 ' HB2' HG13 ' A' ' 106' ' ' ILE . 48.0 m-85 -100.38 -4.81 28.29 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.304 178.817 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 3.4 mm? 59.61 32.4 21.53 Favored 'General case' 0 C--O 1.234 0.271 0 O-C-N 123.417 0.448 . . . . 0.0 110.818 -176.874 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 106' ' ' ILE . . . . . 0.522 HG21 HG21 ' A' ' 37' ' ' VAL . 68.4 mt -65.8 88.95 0.1 OUTLIER 'Isoleucine or valine' 0 C--O 1.225 -0.221 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.179 177.316 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 31.1 m-80 -98.52 -13.8 20.3 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.125 0.488 . . . . 0.0 110.342 176.18 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -122.43 115.06 2.63 Favored Glycine 0 N--CA 1.442 -0.945 0 C-N-CA 120.571 -0.823 . . . . 0.0 112.192 -177.58 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.592 HD12 ' SG ' ' A' ' 42' ' ' CYS . 32.0 mt -97.2 131.39 27.59 Favored Pre-proline 0 C--N 1.32 -0.676 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 174.37 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -82.73 151.23 71.89 Favored 'Cis proline' 0 N--CA 1.459 -0.539 0 C-N-CA 123.769 -1.346 . . . . 0.0 112.935 1.729 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 111' ' ' ARG . . . . . 0.515 ' HG3' HG12 ' A' ' 106' ' ' ILE . 0.0 OUTLIER -102.77 140.18 37.38 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 173.596 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 112' ' ' PHE . . . . . 0.668 ' CE1' ' HB3' ' A' ' 128' ' ' ARG . 0.0 OUTLIER -105.1 118.03 35.51 Favored 'General case' 0 C--N 1.327 -0.371 0 O-C-N 124.102 0.876 . . . . 0.0 110.174 -175.102 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.563 ' HB ' ' HB ' ' A' ' 35' ' ' ILE . 90.8 mt -132.81 148.62 31.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.65 0.262 . . . . 0.0 110.904 -178.737 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.401 ' C ' HD12 ' A' ' 115' ' ' LEU . 42.5 tp -132.1 139.22 48.4 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.504 -0.316 . . . . 0.0 110.674 179.706 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.613 ' HG ' ' HA ' ' A' ' 121' ' ' ILE . 2.3 mp -136.09 153.83 51.2 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 178.768 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 116' ' ' ASP . . . . . 0.542 ' HB2' HD11 ' A' ' 122' ' ' ILE . 24.2 t70 -76.94 163.68 26.5 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.648 178.409 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 63.3 mtt180 -51.49 -30.05 18.71 Favored 'General case' 0 N--CA 1.464 0.256 0 O-C-N 124.354 1.034 . . . . 0.0 111.748 178.692 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -64.82 -17.86 64.61 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.077 0.465 . . . . 0.0 110.759 178.378 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 119' ' ' GLY . . . . . 0.49 ' HA3' HD11 ' A' ' 25' ' ' LEU . . . 93.97 25.16 17.99 Favored Glycine 0 N--CA 1.438 -1.173 0 N-CA-C 110.187 -1.165 . . . . 0.0 110.187 -172.438 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 30.3 mmtp -112.56 116.77 30.74 Favored 'General case' 0 C--O 1.223 -0.297 0 C-N-CA 120.304 -0.558 . . . . 0.0 112.097 -172.991 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 0.665 ' H ' HD12 ' A' ' 121' ' ' ILE . 3.8 mp -44.38 119.5 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.27 0 CA-C-N 115.436 -0.802 . . . . 0.0 111.984 179.698 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 122' ' ' ILE . . . . . 0.542 HD11 ' HB2' ' A' ' 116' ' ' ASP . 45.5 mm -98.62 -41.02 9.82 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-N 115.301 -0.863 . . . . 0.0 109.335 175.727 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 16.4 m -137.2 115.83 12.08 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.393 -0.821 . . . . 0.0 110.41 179.07 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -74.23 -16.01 60.97 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.06 0.457 . . . . 0.0 110.821 178.091 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 6.1 t30 -146.83 100.6 3.34 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.762 -0.654 . . . . 0.0 109.398 177.059 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 12.4 ttt -101.21 -139.0 0.34 Allowed 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.192 -177.978 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -124.96 127.25 46.75 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-O 121.039 0.447 . . . . 0.0 111.003 -175.733 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 128' ' ' ARG . . . . . 0.668 ' HB3' ' CE1' ' A' ' 112' ' ' PHE . 11.6 ptp180 -51.28 153.91 3.23 Favored Pre-proline 0 N--CA 1.468 0.473 0 N-CA-C 113.414 0.894 . . . . 0.0 113.414 178.778 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 129' ' ' PRO . . . . . 0.546 ' HD2' ' OE2' ' A' ' 48' ' ' GLU . 51.9 Cg_exo -55.69 -27.39 60.86 Favored 'Trans proline' 0 C--N 1.35 0.656 0 C-N-CA 123.575 2.85 . . . . 0.0 113.557 177.193 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 130' ' ' SER . . . . . 0.523 ' OG ' ' HB3' ' A' ' 48' ' ' GLU . 67.9 m -62.95 -20.64 65.43 Favored 'General case' 0 N--CA 1.462 0.132 0 CA-C-O 120.919 0.39 . . . . 0.0 111.301 176.912 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 131' ' ' ASP . . . . . 0.43 ' OD2' ' HB2' ' A' ' 133' ' ' LYS . 7.3 t70 -85.32 122.1 73.73 Favored Pre-proline 0 C--N 1.325 -0.484 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.708 178.774 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 132' ' ' PRO . . . . . 0.406 ' O ' ' HG3' ' A' ' 136' ' ' GLU . 30.5 Cg_exo -63.97 -30.01 66.84 Favored 'Trans proline' 0 C--N 1.343 0.252 0 C-N-CA 122.922 2.415 . . . . 0.0 112.675 179.921 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 133' ' ' LYS . . . . . 0.43 ' HB2' ' OD2' ' A' ' 131' ' ' ASP . 26.7 mmmt -61.64 -37.64 84.76 Favored 'General case' 0 CA--C 1.519 -0.219 0 CA-C-O 121.007 0.432 . . . . 0.0 110.391 -176.801 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 134' ' ' THR . . . . . 0.738 HG22 ' CZ ' ' A' ' 138' ' ' PHE . 5.2 m -61.66 -53.25 58.66 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.238 176.255 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 135' ' ' ALA . . . . . 0.561 ' HA ' ' CD2' ' A' ' 138' ' ' PHE . . . -54.93 -46.52 74.94 Favored 'General case' 0 C--O 1.242 0.672 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.183 176.925 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 136' ' ' GLU . . . . . 0.406 ' HG3' ' O ' ' A' ' 132' ' ' PRO . 48.8 mt-10 -54.39 -55.74 25.61 Favored 'General case' 0 CA--C 1.509 -0.625 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.169 176.551 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 137' ' ' LYS . . . . . 0.569 ' HE2' ' HA ' ' A' ' 137' ' ' LYS . 0.1 OUTLIER -43.79 -42.88 5.81 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 114.221 -1.354 . . . . 0.0 111.774 179.825 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 138' ' ' PHE . . . . . 0.738 ' CZ ' HG22 ' A' ' 134' ' ' THR . 13.6 m-85 -63.74 -60.73 2.93 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-O 120.774 0.321 . . . . 0.0 110.921 179.961 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 139' ' ' ASN . . . . . 0.48 ' HB2' ' HB3' ' A' ' 144' ' ' LEU . 11.0 p30 -68.86 -23.7 64.26 Favored 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 120.313 -0.555 . . . . 0.0 110.989 -174.387 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 13.2 tt0 -60.47 -51.81 67.87 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.054 0.454 . . . . 0.0 110.454 173.568 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.53 ' HG ' ' O ' ' A' ' 137' ' ' LYS . 88.6 mt -64.56 -30.01 71.03 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.147 -177.906 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -82.16 -16.09 51.02 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.428 178.048 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 74.74 36.34 48.3 Favored Glycine 0 N--CA 1.45 -0.401 0 N-CA-C 110.705 -0.958 . . . . 0.0 110.705 -178.039 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.48 ' HB3' ' HB2' ' A' ' 139' ' ' ASN . 49.8 tp -106.63 12.46 29.32 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 114.862 -0.669 . . . . 0.0 110.32 -173.527 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 145' ' ' GLU . . . . . 0.419 ' HB2' ' CD2' ' A' ' 147' ' ' HIS . 0.0 OUTLIER -104.33 -32.77 8.91 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.516 0.674 . . . . 0.0 111.315 -179.492 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 99.67 7.0 54.23 Favored Glycine 0 C--N 1.315 -0.622 0 CA-C-N 114.827 -1.079 . . . . 0.0 113.262 175.773 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 147' ' ' HIS . . . . . 0.419 ' CD2' ' HB2' ' A' ' 145' ' ' GLU . 13.6 m-70 -95.55 56.48 1.81 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 117.428 0.614 . . . . 0.0 109.72 -176.99 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 19.6 p80 -73.25 63.72 0.75 Allowed 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 115.693 -0.685 . . . . 0.0 112.449 -174.714 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 23.8 t60 51.56 86.95 0.03 OUTLIER 'General case' 0 C--O 1.234 0.286 0 C-N-CA 124.034 0.934 . . . . 0.0 112.623 174.13 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 42.9 t-80 -62.74 108.97 1.28 Allowed 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.232 176.205 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 25.7 p80 -121.0 13.69 11.38 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.964 0.412 . . . . 0.0 110.367 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 41.6 t-80 . . . . . 0 C--O 1.242 0.691 0 CA-C-N 115.49 -0.777 . . . . 0.0 109.083 179.034 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 10.9 tpt . . . . . 0 N--CA 1.48 1.043 0 N-CA-C 110.023 -0.362 . . . . 0.0 110.023 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.485 ' HB2' HD22 ' A' ' 3' ' ' LEU . 1.2 m -57.9 -49.01 78.19 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.749 -174.77 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.494 ' O ' ' HG3' ' A' ' 4' ' ' ARG . 3.1 mm? -81.8 -4.03 55.38 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.353 -176.674 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 4' ' ' ARG . . . . . 0.494 ' HG3' ' O ' ' A' ' 3' ' ' LEU . 0.3 OUTLIER 37.08 -102.66 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 123.647 0.779 . . . . 0.0 112.365 -172.311 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 12.2 p -134.37 19.37 3.66 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.133 0.492 . . . . 0.0 110.387 179.328 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 142.53 73.78 0.03 OUTLIER Glycine 0 N--CA 1.448 -0.51 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.346 -178.022 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' ASN . . . . . 0.453 ' HA ' ' HD3' ' A' ' 8' ' ' PRO . 8.5 t30 -156.17 144.11 14.22 Favored Pre-proline 0 C--N 1.325 -0.479 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 178.207 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.453 ' HD3' ' HA ' ' A' ' 7' ' ' ASN . 39.6 Cg_exo -60.81 -67.17 0.05 OUTLIER 'Trans proline' 0 C--N 1.343 0.257 0 C-N-CA 123.047 2.498 . . . . 0.0 112.103 -176.39 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.81 ' HA ' HD11 ' A' ' 121' ' ' ILE . 18.3 m 57.88 -162.41 0.21 Allowed 'General case' 0 N--CA 1.453 -0.299 0 CA-C-O 121.803 0.811 . . . . 0.0 111.592 175.124 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -86.9 78.13 9.1 Favored 'General case' 0 C--N 1.314 -0.948 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 169.845 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -69.43 59.77 0.13 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 114.861 -1.063 . . . . 0.0 113.641 -172.445 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.535 ' HA ' ' HB3' ' A' ' 25' ' ' LEU . 26.4 m 53.58 33.4 16.3 Favored 'General case' 0 N--CA 1.465 0.28 0 N-CA-C 112.767 0.655 . . . . 0.0 112.767 170.493 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 34.7 p90 -60.77 147.92 40.82 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.893 0.378 . . . . 0.0 110.747 179.084 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.514 ' HA ' ' HA ' ' A' ' 24' ' ' SER . 28.2 t -139.81 117.96 11.93 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.111 -0.495 . . . . 0.0 109.707 -179.293 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' TYR . . . . . 0.438 ' HB2' ' HB3' ' A' ' 92' ' ' LEU . 92.1 m-85 -138.78 155.14 73.38 Favored Pre-proline 0 C--N 1.323 -0.562 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.322 -176.976 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -81.19 125.89 5.39 Favored 'Trans proline' 0 N--CA 1.454 -0.85 0 C-N-CA 122.015 1.81 . . . . 0.0 112.116 175.469 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' ASP . . . . . 0.503 ' HA ' ' HA ' ' A' ' 92' ' ' LEU . 12.5 t70 -62.32 152.95 32.36 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.196 -0.911 . . . . 0.0 108.894 172.127 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.646 HG22 ' HG3' ' A' ' 91' ' ' GLN . 12.1 tt -58.67 -25.81 29.63 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.435 0 O-C-N 123.781 0.675 . . . . 0.0 111.301 -178.287 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 44.7 m-80 -79.35 -2.17 40.32 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.321 0.582 . . . . 0.0 110.053 176.47 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 86.82 40.64 7.06 Favored Glycine 0 N--CA 1.447 -0.583 0 CA-C-N 115.401 -0.818 . . . . 0.0 112.371 179.244 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.542 ' NZ ' HG22 ' A' ' 23' ' ' VAL . 62.0 tttm -113.84 117.22 30.84 Favored 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 120.372 -0.531 . . . . 0.0 111.027 179.989 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 17.7 m -64.45 108.84 1.75 Allowed 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 109.938 -0.393 . . . . 0.0 109.938 174.384 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.542 HG22 ' NZ ' ' A' ' 21' ' ' LYS . 99.6 t -119.83 125.5 74.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-O 121.011 0.434 . . . . 0.0 110.201 -179.829 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' SER . . . . . 0.514 ' HA ' ' HA ' ' A' ' 14' ' ' SER . 57.3 p -113.19 176.6 4.95 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 115.731 -0.668 . . . . 0.0 109.426 177.57 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.535 ' HB3' ' HA ' ' A' ' 12' ' ' SER . 2.7 tm? -60.98 -30.39 70.24 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 176.908 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -72.11 -24.42 61.47 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.66 -0.246 . . . . 0.0 111.325 -179.896 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -73.18 -21.75 60.61 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-O 121.924 0.868 . . . . 0.0 109.616 177.798 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.469 HD13 HG21 ' A' ' 67' ' ' VAL . 32.9 mt -104.5 -21.02 13.51 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-N 115.073 -0.967 . . . . 0.0 110.742 -179.492 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.41 ' HB2' HD13 ' A' ' 25' ' ' LEU . 52.9 tttp -71.41 149.32 46.06 Favored 'General case' 0 N--CA 1.445 -0.688 0 CA-C-N 115.459 -0.792 . . . . 0.0 110.909 -173.542 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 91.81 10.21 61.76 Favored Glycine 0 N--CA 1.452 -0.295 0 N-CA-C 111.066 -0.814 . . . . 0.0 111.066 -175.198 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.832 ' HD3' ' HA ' ' A' ' 63' ' ' ASP . 13.1 ttmm -162.12 157.48 23.35 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 108.196 -1.038 . . . . 0.0 108.196 179.73 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.532 ' CD2' HD13 ' A' ' 141' ' ' LEU . 82.3 m-85 -66.17 143.51 57.23 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 118.287 0.494 . . . . 0.0 110.808 -178.641 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.873 HD13 HD12 ' A' ' 115' ' ' LEU . 3.6 mp -126.04 146.37 31.95 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.226 0 CA-C-O 120.811 0.339 . . . . 0.0 110.561 -179.55 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' TYR . . . . . 0.737 ' HD1' ' HB3' ' A' ' 114' ' ' LEU . 75.2 t80 -129.7 121.64 27.35 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 173.224 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.697 HD13 ' HB ' ' A' ' 67' ' ' VAL . 25.9 mm -109.96 110.9 33.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 N-CA-C 112.156 0.428 . . . . 0.0 112.156 -173.253 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.589 ' O ' ' HA ' ' A' ' 68' ' ' SER . 33.7 m-20 -99.04 158.21 15.82 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 169.549 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.58 HG11 HG21 ' A' ' 109' ' ' ILE . 40.5 t -103.67 112.18 36.19 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.859 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 171.066 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' TRP . . . . . 0.791 ' CZ3' HG21 ' A' ' 82' ' ' VAL . 0.6 OUTLIER -103.29 132.55 49.46 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 -177.298 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.456 ' HB3' ' SG ' ' A' ' 42' ' ' CYS . . . -148.22 174.7 11.72 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.505 -0.316 . . . . 0.0 110.762 -178.551 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.553 HG22 ' OD2' ' A' ' 72' ' ' ASP . 5.9 t -104.27 -30.3 10.23 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 120.975 0.417 . . . . 0.0 110.379 171.618 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 21.0 p-90 -85.59 7.36 23.45 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.549 -178.108 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' CYS . . . . . 0.553 ' SG ' ' HB3' ' A' ' 45' ' ' CYS . 5.7 p -87.55 -2.21 58.47 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.677 -0.238 . . . . 0.0 111.41 -179.068 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.58 ' O ' ' HG2' ' A' ' 46' ' ' ARG . . . 64.94 -108.35 2.3 Favored Glycine 0 CA--C 1.523 0.579 0 N-CA-C 114.773 0.669 . . . . 0.0 114.773 171.736 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.41 ' HD2' ' O ' ' A' ' 42' ' ' CYS . 9.6 Cg_endo -50.75 -23.15 10.86 Favored 'Trans proline' 0 C--N 1.356 0.96 0 C-N-CA 124.342 3.361 . . . . 0.0 113.541 -174.647 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 45' ' ' CYS . . . . . 0.724 ' HB2' ' HD3' ' A' ' 110' ' ' PRO . 47.1 t -52.19 -15.97 0.71 Allowed 'General case' 0 C--N 1.323 -0.55 0 O-C-N 124.071 0.857 . . . . 0.0 112.924 178.533 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.58 ' HG2' ' O ' ' A' ' 43' ' ' GLY . 24.7 mmm180 -71.02 -6.64 40.49 Favored 'General case' 0 N--CA 1.448 -0.574 0 O-C-N 121.806 -0.559 . . . . 0.0 110.467 -179.43 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.454 ' O ' ' HD2' ' A' ' 50' ' ' PRO . . . -84.13 -23.44 51.87 Favored Glycine 0 N--CA 1.446 -0.643 0 CA-C-N 115.818 -0.628 . . . . 0.0 112.95 -178.478 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.56 ' HG3' ' HB3' ' A' ' 129' ' ' PRO . 2.0 mp0 -83.01 -4.49 58.38 Favored 'General case' 0 CA--C 1.516 -0.333 0 CA-C-N 117.2 0.5 . . . . 0.0 110.524 -179.379 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.797 ' HG ' HD21 ' A' ' 87' ' ' LEU . 7.3 mp -43.96 -55.23 9.61 Favored Pre-proline 0 CA--C 1.536 0.432 0 N-CA-C 112.487 0.551 . . . . 0.0 112.487 177.09 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.497 ' HD3' ' HB2' ' A' ' 49' ' ' LEU . 43.5 Cg_exo -58.45 -42.89 50.64 Favored 'Trans proline' 0 C--N 1.355 0.909 0 C-N-CA 121.874 1.716 . . . . 0.0 112.185 175.047 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -69.49 -21.75 63.66 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-O 121.476 0.655 . . . . 0.0 110.411 -174.226 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.556 HD13 HD22 ' A' ' 87' ' ' LEU . 7.6 tt -70.14 -55.44 9.4 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 114.974 -1.012 . . . . 0.0 108.643 178.673 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.694 ' HB3' ' NZ ' ' A' ' 53' ' ' LYS . 1.8 mtpm? -52.63 -63.01 1.28 Allowed 'General case' 0 C--O 1.219 -0.508 0 CA-C-N 115.503 -0.771 . . . . 0.0 111.365 175.826 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -52.39 -39.45 60.86 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 113.302 0.853 . . . . 0.0 113.302 -173.146 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.434 ' O ' ' HB2' ' A' ' 58' ' ' LYS . 14.4 mt -67.49 -44.77 77.69 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.174 0.512 . . . . 0.0 110.622 174.43 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -57.39 -42.68 82.68 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.145 -0.934 . . . . 0.0 111.582 176.538 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.618 ' HG2' ' O ' ' A' ' 53' ' ' LYS . 16.0 mm-40 -53.47 -52.01 60.88 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-O 121.714 0.768 . . . . 0.0 109.287 175.74 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.468 ' HB3' ' HE3' ' A' ' 58' ' ' LYS . 10.4 mmmt -53.01 -58.12 8.07 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-N 114.504 -1.225 . . . . 0.0 112.439 178.804 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.57 ' HB2' ' HE2' ' A' ' 66' ' ' PHE . 96.0 m-85 -106.71 21.6 17.23 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.047 -0.524 . . . . 0.0 112.322 -166.537 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -61.59 120.79 11.26 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.603 173.75 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 72.26 33.81 61.5 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.946 -0.645 . . . . 0.0 112.866 177.141 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.507 ' HB3' HD11 ' A' ' 142' ' ' LEU . 40.1 mmtm -109.03 -164.91 0.97 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.154 0.502 . . . . 0.0 110.128 175.623 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.832 ' HA ' ' HD3' ' A' ' 31' ' ' LYS . 3.7 t70 -89.87 54.95 2.99 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-O 121.792 0.806 . . . . 0.0 109.497 179.362 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.46 HG22 ' HB2' ' A' ' 62' ' ' LYS . 6.8 tp -157.0 129.98 1.15 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 CA-C-N 115.061 -0.972 . . . . 0.0 109.774 -178.114 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 65' ' ' HIS . . . . . 0.47 ' NE2' ' HB3' ' A' ' 31' ' ' LYS . 68.0 m-70 -103.3 106.58 17.13 Favored 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 175.773 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 66' ' ' PHE . . . . . 0.57 ' HE2' ' HB2' ' A' ' 59' ' ' TYR . 61.0 m-85 -79.01 103.13 8.74 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 171.082 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.697 ' HB ' HD13 ' A' ' 35' ' ' ILE . 29.6 t -122.26 126.53 74.4 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.476 -175.196 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 68' ' ' SER . . . . . 0.589 ' HA ' ' O ' ' A' ' 36' ' ' ASP . 37.1 m -114.05 134.3 54.96 Favored 'General case' 0 C--N 1.311 -1.066 0 CA-C-N 116.106 -0.497 . . . . 0.0 109.855 177.191 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.516 HD22 ' HB2' ' A' ' 92' ' ' LEU . 26.6 mt -110.53 132.78 53.88 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 110.006 -0.368 . . . . 0.0 110.006 177.116 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 70' ' ' SER . . . . . 0.471 ' O ' ' HB3' ' A' ' 94' ' ' MET . 0.9 OUTLIER -105.15 117.89 35.14 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.008 0.432 . . . . 0.0 111.348 -176.882 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 34.8 m -88.39 15.7 7.43 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.773 179.61 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.553 ' OD2' HG22 ' A' ' 40' ' ' THR . 1.3 m-20 -71.73 135.52 46.81 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.249 -0.648 . . . . 0.0 109.249 -179.867 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.416 ' O ' ' HD3' ' A' ' 73' ' ' LYS . 1.5 tmtp? -89.04 -30.1 18.95 Favored 'General case' 0 C--N 1.318 -0.784 0 C-N-CA 119.918 -0.713 . . . . 0.0 109.464 177.62 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 74' ' ' ASN . . . . . 0.586 ' HB2' ' HB3' ' A' ' 77' ' ' ALA . 0.8 OUTLIER -72.53 68.18 0.79 Allowed 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.135 -0.939 . . . . 0.0 110.434 174.127 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.483 ' O ' ' HG2' ' A' ' 79' ' ' GLU . 9.4 tttm -51.8 -64.5 0.79 Allowed 'General case' 0 C--O 1.22 -0.482 0 N-CA-C 112.489 0.551 . . . . 0.0 112.489 -175.984 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 51.9 tttm -49.77 -49.18 49.39 Favored 'General case' 0 C--N 1.329 -0.297 0 O-C-N 123.162 0.289 . . . . 0.0 111.204 -176.793 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.665 ' HA ' ' ND2' ' A' ' 80' ' ' ASN . . . -52.29 -44.05 64.79 Favored 'General case' 0 C--O 1.244 0.802 0 CA-C-O 121.886 0.85 . . . . 0.0 110.359 178.478 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 78' ' ' TRP . . . . . 0.548 ' CE3' ' HB ' ' A' ' 40' ' ' THR . 6.8 t-105 -66.92 -51.13 59.08 Favored 'General case' 0 N--CA 1.437 -1.114 0 CA-C-N 114.278 -1.328 . . . . 0.0 111.048 -179.438 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.522 ' OE1' HG13 ' A' ' 18' ' ' ILE . 5.3 mm-40 -46.22 -47.08 17.99 Favored 'General case' 0 CA--C 1.537 0.459 0 N-CA-C 111.87 0.322 . . . . 0.0 111.87 176.189 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 80' ' ' ASN . . . . . 0.665 ' ND2' ' HA ' ' A' ' 77' ' ' ALA . 0.6 OUTLIER -60.33 -49.23 78.42 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 120.823 -0.351 . . . . 0.0 110.526 -177.738 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 22.5 ttm -59.47 -48.47 81.53 Favored 'General case' 0 N--CA 1.466 0.341 0 N-CA-C 112.433 0.531 . . . . 0.0 112.433 -175.756 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.791 HG21 ' CZ3' ' A' ' 38' ' ' TRP . 0.9 OUTLIER -67.25 -26.05 35.24 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 C-N-CA 120.158 -0.617 . . . . 0.0 110.918 -178.046 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 90.6 m -72.78 -37.0 67.74 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.294 -0.412 . . . . 0.0 109.986 174.646 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' LYS . . . . . 0.4 ' HB3' ' HE3' ' A' ' 84' ' ' LYS . 1.2 tmmt? -71.26 -41.38 70.16 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.375 0.607 . . . . 0.0 110.018 177.513 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 15.6 m-20 -83.67 -1.72 54.64 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.225 -0.898 . . . . 0.0 111.881 -177.349 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 45.3 mt-30 62.0 23.63 13.95 Favored 'General case' 0 N--CA 1.468 0.466 0 N-CA-C 112.727 0.64 . . . . 0.0 112.727 172.074 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.797 HD21 ' HG ' ' A' ' 49' ' ' LEU . 94.1 mt -73.61 117.46 15.4 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 110.236 -0.283 . . . . 0.0 110.236 178.796 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.564 ' HA ' ' HE3' ' A' ' 88' ' ' LYS . 0.0 OUTLIER -119.61 -168.08 1.53 Allowed 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.693 -0.23 . . . . 0.0 111.581 177.314 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 112.75 -163.23 12.17 Favored Glycine 0 N--CA 1.451 -0.35 0 N-CA-C 110.241 -1.144 . . . . 0.0 110.241 -173.966 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.654 ' O ' ' HA ' ' A' ' 67' ' ' VAL . 52.5 mt -92.72 111.67 24.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 173.679 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 91' ' ' GLN . . . . . 0.693 ' HB2' ' CZ2' ' A' ' 38' ' ' TRP . 1.0 OUTLIER -143.24 103.59 4.15 Favored 'General case' 0 C--N 1.311 -1.086 0 CA-C-O 121.598 0.713 . . . . 0.0 111.789 -168.934 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.518 HD21 ' HB ' ' A' ' 23' ' ' VAL . 20.6 mt -96.79 151.28 19.81 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.275 -0.875 . . . . 0.0 110.622 -175.846 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 37.3 t-80 -113.47 127.87 56.25 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.081 178.847 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 94' ' ' MET . . . . . 0.471 ' HB3' ' O ' ' A' ' 70' ' ' SER . 35.9 ttm -81.06 -83.14 0.11 Allowed 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 115.053 -0.976 . . . . 0.0 110.279 -179.682 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 131.2 -83.72 0.31 Allowed Glycine 0 N--CA 1.444 -0.79 0 C-N-CA 120.396 -0.907 . . . . 0.0 112.245 -178.19 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 1.7 m -137.72 4.63 2.59 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.583 0.706 . . . . 0.0 109.964 179.472 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -87.16 53.03 2.68 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.248 -0.887 . . . . 0.0 110.448 -172.485 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 98' ' ' ARG . . . . . 0.498 ' HB3' ' OD1' ' A' ' 102' ' ' ASP . 4.0 mtm180 -63.35 -8.94 9.96 Favored 'General case' 0 CA--C 1.512 -0.5 0 N-CA-C 112.542 0.571 . . . . 0.0 112.542 -172.924 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 5.4 m -38.4 -33.09 0.09 Allowed 'General case' 0 C--N 1.313 -0.988 0 O-C-N 124.146 0.904 . . . . 0.0 112.376 179.197 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 80.2 t80 -81.27 -39.21 25.63 Favored 'General case' 0 CA--C 1.532 0.281 0 N-CA-C 112.356 0.502 . . . . 0.0 112.356 -179.822 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 101' ' ' MET . . . . . 0.459 ' SD ' ' HD2' ' A' ' 98' ' ' ARG . 24.9 ptm -78.66 -34.02 46.63 Favored 'General case' 0 CA--C 1.52 -0.185 0 C-N-CA 120.107 -0.637 . . . . 0.0 109.592 -177.268 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 102' ' ' ASP . . . . . 0.498 ' OD1' ' HB3' ' A' ' 98' ' ' ARG . 2.5 m-20 -75.57 -21.62 57.71 Favored 'General case' 0 N--CA 1.447 -0.604 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.186 176.581 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -64.95 -29.57 70.51 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-O 121.063 0.459 . . . . 0.0 110.701 174.88 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 59.7 m-85 -96.96 2.35 51.46 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.519 177.796 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 95.6 mt 65.89 5.21 3.33 Favored 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 113.386 0.884 . . . . 0.0 113.386 173.164 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 106' ' ' ILE . . . . . 0.545 ' CG1' ' HG3' ' A' ' 111' ' ' ARG . 1.2 pp -97.34 88.83 1.88 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.575 0 CA-C-O 121.509 0.671 . . . . 0.0 112.194 -179.277 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 4.0 p-10 -77.1 -11.73 59.85 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.609 -0.723 . . . . 0.0 109.812 175.642 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -89.75 98.56 2.46 Favored Glycine 0 N--CA 1.445 -0.716 0 CA-C-N 115.445 -0.798 . . . . 0.0 111.621 177.357 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.631 ' HB ' ' HA ' ' A' ' 110' ' ' PRO . 34.2 pt -104.88 162.79 18.72 Favored Pre-proline 0 C--N 1.321 -0.641 0 N-CA-C 110.088 -0.338 . . . . 0.0 110.088 179.823 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 110' ' ' PRO . . . . . 0.724 ' HD3' ' HB2' ' A' ' 45' ' ' CYS . 39.6 Cg_endo -70.11 143.74 75.39 Favored 'Cis proline' 0 C--N 1.349 0.567 0 C-N-CA 124.158 -1.184 . . . . 0.0 113.559 1.63 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 111' ' ' ARG . . . . . 0.545 ' HG3' ' CG1' ' A' ' 106' ' ' ILE . 0.0 OUTLIER -117.51 136.49 53.21 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.625 -0.716 . . . . 0.0 109.081 177.295 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 112' ' ' PHE . . . . . 0.571 ' CD2' ' HA ' ' A' ' 127' ' ' THR . 1.4 m-85 -105.7 117.23 33.5 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.789 -176.173 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.495 HD12 ' HA ' ' A' ' 124' ' ' ALA . 24.4 mm -128.53 164.0 31.61 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 N-CA-C 108.144 -1.058 . . . . 0.0 108.144 177.137 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.737 ' HB3' ' HD1' ' A' ' 34' ' ' TYR . 1.8 pt? -158.45 154.24 26.5 Favored 'General case' 0 C--N 1.316 -0.882 0 C-N-CA 120.573 -0.451 . . . . 0.0 110.978 173.455 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.873 HD12 HD13 ' A' ' 33' ' ' ILE . 0.0 OUTLIER -138.17 150.98 47.29 Favored 'General case' 0 N--CA 1.448 -0.569 0 CA-C-O 122.329 1.062 . . . . 0.0 113.377 -173.788 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 12.8 t0 -69.19 163.73 24.24 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 113.174 -1.83 . . . . 0.0 109.782 176.328 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 117' ' ' ARG . . . . . 0.482 ' HA ' ' O ' ' A' ' 31' ' ' LYS . 31.1 mtm180 -48.39 -28.05 2.99 Favored 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 124.503 1.121 . . . . 0.0 113.272 -174.877 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 26.6 t0 -82.52 -5.13 58.56 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.104 0.478 . . . . 0.0 111.44 -177.314 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 89.34 16.6 57.0 Favored Glycine 0 N--CA 1.441 -0.986 0 N-CA-C 110.013 -1.235 . . . . 0.0 110.013 -171.241 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 4.9 tttm -90.27 147.21 23.67 Favored 'General case' 0 C--O 1.204 -1.327 0 CA-C-N 115.034 -0.583 . . . . 0.0 110.766 -175.522 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 0.81 HD11 ' HA ' ' A' ' 9' ' ' SER . 3.8 mp -67.76 130.47 33.03 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.668 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.03 -174.775 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 122' ' ' ILE . . . . . 0.575 ' HB ' ' HG ' ' A' ' 114' ' ' LEU . 37.4 mm -100.53 -56.4 5.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 171.122 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 123' ' ' SER . . . . . 0.475 ' HB3' ' CD2' ' A' ' 114' ' ' LEU . 42.9 t -135.14 142.72 46.22 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.481 174.375 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 124' ' ' ALA . . . . . 0.495 ' HA ' HD12 ' A' ' 113' ' ' ILE . . . -112.55 23.48 13.51 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.425 -0.807 . . . . 0.0 109.429 176.018 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 4.1 p-10 -161.67 38.63 0.13 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.349 -0.841 . . . . 0.0 110.108 -179.913 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 126' ' ' MET . . . . . 0.73 ' HG2' HD22 ' A' ' 114' ' ' LEU . 2.2 tpt -71.7 -168.72 0.37 Allowed 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 115.762 -0.654 . . . . 0.0 111.206 -176.949 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 127' ' ' THR . . . . . 0.571 ' HA ' ' CD2' ' A' ' 112' ' ' PHE . 4.1 m -161.0 120.79 2.67 Favored 'General case' 0 C--O 1.223 -0.312 0 N-CA-C 110.108 -0.33 . . . . 0.0 110.108 -174.867 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 128' ' ' ARG . . . . . 0.569 ' HB2' ' OH ' ' A' ' 34' ' ' TYR . 21.8 ttt85 -88.94 -62.94 0.21 Allowed Pre-proline 0 CA--C 1.498 -1.039 0 CA-C-O 117.846 -1.073 . . . . 0.0 113.401 178.491 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 129' ' ' PRO . . . . . 0.56 ' HB3' ' HG3' ' A' ' 48' ' ' GLU . 1.0 OUTLIER -37.96 79.04 0.0 OUTLIER 'Trans proline' 0 C--N 1.372 1.784 0 C-N-CA 124.352 3.368 . . . . 0.0 113.814 -158.648 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 130' ' ' SER . . . . . 0.471 ' N ' ' O ' ' A' ' 128' ' ' ARG . 43.5 p 54.73 26.72 7.86 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 114.299 -1.319 . . . . 0.0 110.67 -179.47 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -70.76 123.56 89.4 Favored Pre-proline 0 C--O 1.236 0.355 0 CA-C-N 115.513 -0.767 . . . . 0.0 111.041 -178.648 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_endo -63.92 -37.51 43.66 Favored 'Trans proline' 0 N--CA 1.46 -0.459 0 C-N-CA 122.505 2.136 . . . . 0.0 112.881 -178.343 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 133' ' ' LYS . . . . . 0.414 ' O ' ' HG2' ' A' ' 137' ' ' LYS . 26.1 mtmm -54.3 -50.11 68.09 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-O 121.599 0.714 . . . . 0.0 110.113 -177.036 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 134' ' ' THR . . . . . 0.652 HG22 ' CZ ' ' A' ' 138' ' ' PHE . 13.8 m -78.76 -35.52 44.47 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 114.977 -1.01 . . . . 0.0 111.221 -174.494 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 135' ' ' ALA . . . . . 0.736 ' HA ' ' CD2' ' A' ' 138' ' ' PHE . . . -62.31 -40.7 97.16 Favored 'General case' 0 C--O 1.242 0.658 0 CA-C-O 121.167 0.508 . . . . 0.0 110.372 178.269 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 136' ' ' GLU . . . . . 0.556 ' HA ' ' ND2' ' A' ' 139' ' ' ASN . 7.1 mm-40 -65.19 -41.4 94.6 Favored 'General case' 0 N--CA 1.447 -0.614 0 CA-C-N 115.254 -0.885 . . . . 0.0 111.062 176.486 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 137' ' ' LYS . . . . . 0.96 ' HE2' ' HA ' ' A' ' 137' ' ' LYS . 9.1 mmpt? -55.79 -41.71 74.51 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.554 175.975 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 138' ' ' PHE . . . . . 0.736 ' CD2' ' HA ' ' A' ' 135' ' ' ALA . 15.3 m-85 -56.81 -60.37 3.66 Favored 'General case' 0 N--CA 1.463 0.2 0 O-C-N 123.181 0.301 . . . . 0.0 110.783 178.556 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 139' ' ' ASN . . . . . 0.571 ' OD1' ' HA ' ' A' ' 145' ' ' GLU . 11.7 p30 -69.49 -27.03 64.85 Favored 'General case' 0 C--O 1.224 -0.249 0 C-N-CA 120.602 -0.439 . . . . 0.0 111.506 -173.326 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 21.7 tt0 -63.18 -60.66 3.13 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.597 0.237 . . . . 0.0 111.464 177.092 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.704 ' HG ' ' O ' ' A' ' 137' ' ' LYS . 3.0 pp -69.85 -19.86 63.43 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-O 120.845 0.355 . . . . 0.0 111.417 -175.69 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.507 HD11 ' HB3' ' A' ' 62' ' ' LYS . 0.8 OUTLIER -81.46 -21.38 38.82 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.065 175.039 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 73.57 27.51 67.33 Favored Glycine 0 N--CA 1.448 -0.548 0 N-CA-C 110.304 -1.118 . . . . 0.0 110.304 -176.231 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.415 ' HG ' ' O ' ' A' ' 144' ' ' LEU . 42.5 tp -109.66 27.15 9.85 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 114.308 -0.946 . . . . 0.0 108.987 -174.265 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 145' ' ' GLU . . . . . 0.571 ' HA ' ' OD1' ' A' ' 139' ' ' ASN . 51.3 mt-10 -54.31 -71.3 0.08 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 114.505 -1.225 . . . . 0.0 113.748 -173.659 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 78.73 -80.77 1.43 Allowed Glycine 0 C--N 1.31 -0.893 0 N-CA-C 109.424 -1.471 . . . . 0.0 109.424 -165.295 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 9.3 m170 63.92 -60.14 0.19 Allowed 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 115.061 1.504 . . . . 0.0 115.061 167.721 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 47.9 t-80 -70.96 75.94 0.64 Allowed 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 112.391 0.515 . . . . 0.0 112.391 -169.287 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 21.3 t-80 54.08 76.11 0.25 Allowed 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 115.561 -0.745 . . . . 0.0 111.994 173.663 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 150' ' ' HIS . . . . . 0.439 ' O ' ' HB3' ' A' ' 151' ' ' HIS . 52.4 m-70 -137.94 90.78 2.52 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.389 -0.368 . . . . 0.0 110.994 175.954 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 151' ' ' HIS . . . . . 0.439 ' HB3' ' O ' ' A' ' 150' ' ' HIS . 16.9 p80 172.19 -38.69 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.488 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 175.429 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 66.0 t-80 . . . . . 0 C--O 1.242 0.682 0 N-CA-C 107.598 -1.26 . . . . 0.0 107.598 178.458 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.738 ' HA ' ' O ' ' A' ' 11' ' ' ALA . 67.7 mtm . . . . . 0 N--CA 1.48 1.074 0 N-CA-C 109.999 -0.371 . . . . 0.0 109.999 . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 16.8 t -140.99 156.77 45.99 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 179.888 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.683 HD22 ' HG3' ' A' ' 8' ' ' PRO . 2.6 pt? -137.73 161.47 36.43 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 120.712 0.291 . . . . 0.0 110.353 -177.837 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 63.4 mmt-85 -117.06 -19.37 9.77 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 172.396 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 19.0 t -173.03 153.75 2.63 Favored 'General case' 0 N--CA 1.451 -0.397 0 CA-C-N 115.399 -0.819 . . . . 0.0 108.979 178.324 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 76.89 -92.4 1.02 Allowed Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 120.917 -0.658 . . . . 0.0 112.722 178.721 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' ASN . . . . . 0.423 ' HA ' ' HD3' ' A' ' 8' ' ' PRO . 9.1 p30 -154.74 151.43 23.46 Favored Pre-proline 0 C--N 1.325 -0.473 0 N-CA-C 110.419 -0.215 . . . . 0.0 110.419 -176.766 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.683 ' HG3' HD22 ' A' ' 3' ' ' LEU . 3.1 Cg_exo -74.31 106.87 2.32 Favored 'Trans proline' 0 N--CA 1.462 -0.363 0 C-N-CA 122.649 2.233 . . . . 0.0 111.753 177.24 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 1.6 p -104.9 104.0 13.68 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.142 -177.586 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.627 ' O ' ' HG2' ' A' ' 1' ' ' MET . . . 70.53 -75.66 0.07 Allowed 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 115.134 -0.939 . . . . 0.0 111.181 178.762 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.738 ' O ' ' HA ' ' A' ' 1' ' ' MET . . . 11.97 74.54 0.01 OUTLIER 'General case' 0 N--CA 1.479 0.994 0 O-C-N 125.061 1.475 . . . . 0.0 113.807 -178.21 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 12' ' ' SER . . . . . 1.036 ' HA ' ' HB3' ' A' ' 25' ' ' LEU . 68.5 m 62.35 84.14 0.14 Allowed 'General case' 0 CA--C 1.534 0.362 0 CA-C-O 121.593 0.711 . . . . 0.0 111.354 -175.778 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 16.3 p90 -99.84 175.17 5.88 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.403 -0.817 . . . . 0.0 110.419 178.528 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 13.8 p -142.75 123.26 14.02 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.514 0.197 . . . . 0.0 110.57 178.963 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' TYR . . . . . 0.616 ' HB2' HD13 ' A' ' 92' ' ' LEU . 80.5 m-85 -134.65 150.05 72.51 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.655 -0.248 . . . . 0.0 110.483 179.24 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.41 ' HD2' ' O ' ' A' ' 93' ' ' HIS . 3.1 Cg_exo -80.83 124.85 5.21 Favored 'Trans proline' 0 N--CA 1.457 -0.636 0 C-N-CA 122.581 2.187 . . . . 0.0 112.805 178.638 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' ASP . . . . . 0.698 ' HB3' ' HB3' ' A' ' 21' ' ' LYS . 4.8 t70 -70.36 159.93 33.24 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.32 -0.855 . . . . 0.0 109.123 171.136 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.686 HD12 HG13 ' A' ' 82' ' ' VAL . 1.5 tt -50.24 -35.57 12.08 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.512 0 O-C-N 123.68 0.613 . . . . 0.0 111.651 -176.187 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 34.5 m-80 -77.54 11.93 1.83 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.411 -177.384 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 70.56 32.16 67.77 Favored Glycine 0 CA--C 1.505 -0.55 0 N-CA-C 110.335 -1.106 . . . . 0.0 110.335 -175.582 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.698 ' HB3' ' HB3' ' A' ' 17' ' ' ASP . 8.2 ttpm? -103.52 109.25 20.83 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.048 -0.576 . . . . 0.0 110.519 -173.997 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 20.9 m -65.19 106.94 1.42 Allowed 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.756 178.515 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.57 ' HB ' HD21 ' A' ' 92' ' ' LEU . 63.3 t -112.95 127.99 69.92 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 N-CA-C 109.176 -0.676 . . . . 0.0 109.176 179.028 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' SER . . . . . 0.421 ' C ' ' H ' ' A' ' 26' ' ' ALA . 92.9 p -122.62 165.01 17.16 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.535 0.683 . . . . 0.0 111.757 -173.193 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 1.036 ' HB3' ' HA ' ' A' ' 12' ' ' SER . 20.8 tp -85.35 33.15 0.55 Allowed 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.894 0.854 . . . . 0.0 109.311 175.385 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.421 ' H ' ' C ' ' A' ' 24' ' ' SER . . . -118.73 -41.37 2.8 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 114.505 -1.225 . . . . 0.0 109.745 174.155 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -79.1 -31.77 44.37 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.337 0.589 . . . . 0.0 109.937 173.969 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.616 HD13 HG21 ' A' ' 67' ' ' VAL . 75.9 mt -78.97 -18.46 53.67 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.217 174.862 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.519 ' HB2' ' O ' ' A' ' 25' ' ' LEU . 44.7 tttp -71.48 131.66 43.63 Favored 'General case' 0 N--CA 1.444 -0.729 0 CA-C-N 115.317 -0.856 . . . . 0.0 110.817 -175.336 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 117.17 -8.74 15.8 Favored Glycine 0 N--CA 1.448 -0.512 0 N-CA-C 110.79 -0.924 . . . . 0.0 110.79 -174.655 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.424 ' C ' ' HA ' ' A' ' 117' ' ' ARG . 24.9 ttmm -143.47 147.94 35.3 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 179.637 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 54.9 m-85 -54.01 144.66 18.59 Favored 'General case' 0 N--CA 1.47 0.543 0 N-CA-C 112.562 0.578 . . . . 0.0 112.562 -174.223 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.519 HG13 HD11 ' A' ' 25' ' ' LEU . 39.2 mm -120.73 133.93 65.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.562 -0.745 . . . . 0.0 110.99 -175.04 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' TYR . . . . . 0.481 ' OH ' ' HD3' ' A' ' 129' ' ' PRO . 80.1 t80 -120.67 118.98 31.5 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 172.253 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.61 ' HB ' ' HB ' ' A' ' 113' ' ' ILE . 75.1 mt -99.98 126.78 53.39 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 N-CA-C 110.138 -0.319 . . . . 0.0 110.138 179.399 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.552 ' O ' ' HA ' ' A' ' 68' ' ' SER . 11.8 t70 -129.9 124.91 34.3 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.23 -178.924 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 26.5 t -81.78 121.77 35.63 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.913 0 C-N-CA 120.557 -0.457 . . . . 0.0 110.423 -179.598 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' TRP . . . . . 0.656 ' CE3' ' HZ2' ' A' ' 78' ' ' TRP . 0.7 OUTLIER -121.74 133.41 54.93 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.161 -0.472 . . . . 0.0 109.896 -176.618 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.505 ' HA ' ' OD1' ' A' ' 72' ' ' ASP . . . -148.27 158.28 44.0 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.577 -177.482 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.643 ' HB ' ' CE3' ' A' ' 78' ' ' TRP . 11.1 t -94.89 -25.59 16.52 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.114 0.483 . . . . 0.0 110.611 175.111 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 41' ' ' TRP . . . . . 0.431 ' HE1' ' HA ' ' A' ' 72' ' ' ASP . 14.9 p-90 -87.78 13.32 10.86 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.079 -177.742 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 42' ' ' CYS . . . . . 0.469 ' SG ' ' HB2' ' A' ' 45' ' ' CYS . 14.9 t -86.24 -60.69 1.93 Allowed 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.09 175.92 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 110.92 -91.37 0.61 Allowed Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.641 -179.269 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -53.62 -28.87 48.11 Favored 'Trans proline' 0 C--N 1.35 0.638 0 C-N-CA 123.302 2.668 . . . . 0.0 113.066 -178.59 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' CYS . . . . . 0.504 ' SG ' ' HG3' ' A' ' 110' ' ' PRO . 42.2 t -51.64 -30.05 20.09 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.66 178.594 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.558 ' HA ' ' HG ' ' A' ' 49' ' ' LEU . 55.8 mtp180 -65.44 -30.58 71.39 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.451 -0.341 . . . . 0.0 111.686 -176.592 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -68.9 -26.39 74.66 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.652 -0.785 . . . . 0.0 112.49 -176.65 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.456 ' OE2' ' HG2' ' A' ' 128' ' ' ARG . 14.6 mt-10 -94.49 -12.24 28.06 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.594 0.235 . . . . 0.0 111.005 -176.94 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.633 ' O ' ' HG3' ' A' ' 53' ' ' LYS . 73.2 mt -49.75 -49.19 74.74 Favored Pre-proline 0 C--N 1.331 -0.239 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.948 -178.598 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.55 ' HD3' ' HB2' ' A' ' 49' ' ' LEU . 71.3 Cg_exo -50.83 -37.82 56.04 Favored 'Trans proline' 0 C--N 1.357 1.003 0 C-N-CA 122.184 1.923 . . . . 0.0 112.767 176.984 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.513 ' O ' ' HB2' ' A' ' 55' ' ' LEU . . . -75.14 -25.4 58.36 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-O 121.617 0.722 . . . . 0.0 110.504 -176.114 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 6.8 tt -79.02 -48.34 14.6 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.0 -1.0 . . . . 0.0 108.419 -177.155 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.761 ' HB3' ' HG2' ' A' ' 88' ' ' LYS . 81.9 mttt -51.59 -55.71 17.67 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-N 114.655 -1.157 . . . . 0.0 109.909 176.893 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.473 ' HG2' ' O ' ' A' ' 50' ' ' PRO . 9.6 mm-40 -73.58 -23.32 59.93 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 114.074 -1.421 . . . . 0.0 112.55 -171.185 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.513 ' HB2' ' O ' ' A' ' 51' ' ' ALA . 0.4 OUTLIER -73.35 -34.0 65.4 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 120.302 -0.559 . . . . 0.0 109.588 176.408 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.447 ' OE2' ' HB2' ' A' ' 66' ' ' PHE . 5.1 tp10 -68.14 -37.13 80.74 Favored 'General case' 0 C--O 1.217 -0.63 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 175.686 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.463 ' HG2' ' O ' ' A' ' 53' ' ' LYS . 7.1 mm-40 -54.04 -53.96 45.8 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.391 0.615 . . . . 0.0 110.451 175.492 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 34.4 ttpt -55.57 -35.41 65.74 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.369 -0.832 . . . . 0.0 110.903 177.755 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.47 ' CZ ' ' HB2' ' A' ' 138' ' ' PHE . 38.3 m-85 -102.91 12.29 36.32 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 113.109 0.781 . . . . 0.0 113.109 -176.114 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -65.09 123.63 20.0 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 120.878 0.371 . . . . 0.0 110.352 176.516 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 83.52 7.68 85.94 Favored Glycine 0 N--CA 1.448 -0.541 0 C-N-CA 120.826 -0.702 . . . . 0.0 112.782 178.195 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 34.2 mmtm -89.92 -153.47 0.29 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.194 0.521 . . . . 0.0 109.821 177.997 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.403 ' H ' HD21 ' A' ' 142' ' ' LEU . 4.2 t70 -106.75 62.39 0.63 Allowed 'General case' 0 C--N 1.316 -0.878 0 CA-C-O 121.571 0.701 . . . . 0.0 110.021 176.853 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 17.8 tt -157.35 163.98 1.21 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.787 0 CA-C-N 115.12 -0.945 . . . . 0.0 109.174 177.503 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 96.8 m-70 -139.25 114.97 10.01 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 174.453 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' PHE . . . . . 0.452 ' HZ ' HD12 ' A' ' 55' ' ' LEU . 12.5 m-85 -80.47 103.0 10.04 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 171.998 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.616 HG21 HD13 ' A' ' 28' ' ' LEU . 46.8 t -115.82 104.54 16.9 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 CA-C-N 115.332 -0.849 . . . . 0.0 109.739 -176.566 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 68' ' ' SER . . . . . 0.552 ' HA ' ' O ' ' A' ' 36' ' ' ASP . 28.9 m -88.1 148.26 24.54 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.531 -178.132 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.413 HD11 ' HB2' ' A' ' 94' ' ' MET . 63.7 tp -126.73 119.9 28.07 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 120.839 0.352 . . . . 0.0 110.664 178.139 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 70' ' ' SER . . . . . 0.505 ' HB3' ' HA ' ' A' ' 93' ' ' HIS . 3.4 t -100.74 119.05 38.05 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.228 0.537 . . . . 0.0 112.095 -174.552 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 18.7 m -90.76 15.34 11.33 Favored 'General case' 0 C--N 1.31 -1.121 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.816 177.864 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.505 ' OD1' ' HA ' ' A' ' 39' ' ' ALA . 2.4 m-20 -68.2 127.26 32.25 Favored 'General case' 0 CA--C 1.516 -0.344 0 CA-C-O 121.049 0.452 . . . . 0.0 110.663 -177.957 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 38.5 ttmt -79.01 -31.65 44.81 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 121.413 0.625 . . . . 0.0 109.323 175.335 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' ASN . . . . . 0.561 ' HB2' ' HB3' ' A' ' 77' ' ' ALA . 0.8 OUTLIER -80.36 68.59 6.59 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.175 -0.92 . . . . 0.0 110.25 177.45 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.547 ' HG3' ' CE1' ' A' ' 93' ' ' HIS . 33.0 tttt -58.91 -49.54 77.43 Favored 'General case' 0 C--O 1.223 -0.338 0 C-N-CA 120.936 -0.306 . . . . 0.0 111.462 -173.862 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 64.7 tttp -52.43 -56.04 17.77 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 110.343 -0.243 . . . . 0.0 110.343 179.273 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.561 ' HB3' ' HB2' ' A' ' 74' ' ' ASN . . . -51.45 -35.66 40.63 Favored 'General case' 0 C--O 1.242 0.678 0 CA-C-O 122.03 0.919 . . . . 0.0 110.933 177.011 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 78' ' ' TRP . . . . . 0.656 ' HZ2' ' CE3' ' A' ' 38' ' ' TRP . 14.8 t-105 -74.25 -51.05 16.5 Favored 'General case' 0 N--CA 1.431 -1.377 0 CA-C-N 114.434 -1.257 . . . . 0.0 111.828 -173.045 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.498 ' HG2' ' O ' ' A' ' 75' ' ' LYS . 4.8 mm-40 -49.61 -41.06 41.17 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-O 121.082 0.468 . . . . 0.0 110.485 176.849 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 80' ' ' ASN . . . . . 0.532 ' OD1' ' HA ' ' A' ' 77' ' ' ALA . 2.9 m120 -56.87 -54.26 48.53 Favored 'General case' 0 CA--C 1.518 -0.261 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.706 177.795 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 81' ' ' MET . . . . . 0.539 ' SD ' ' HZ3' ' A' ' 78' ' ' TRP . 16.6 ttt -61.09 -48.42 81.75 Favored 'General case' 0 C--O 1.223 -0.316 0 N-CA-C 112.358 0.503 . . . . 0.0 112.358 -175.435 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.686 HG13 HD12 ' A' ' 18' ' ' ILE . 0.9 OUTLIER -60.91 -34.79 60.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 C-N-CA 120.386 -0.526 . . . . 0.0 111.069 -178.478 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 25.5 m -73.41 -29.79 62.82 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.106 0.479 . . . . 0.0 110.574 176.992 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 51.3 tttp -81.3 -41.97 21.33 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.179 0.514 . . . . 0.0 111.043 -177.905 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -77.24 -21.04 54.38 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.239 -0.891 . . . . 0.0 110.084 -176.126 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 17.8 mm-40 63.99 79.52 0.26 Allowed 'General case' 0 C--O 1.233 0.192 0 CA-C-N 115.375 -0.83 . . . . 0.0 111.229 -179.885 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.69 HD23 ' HE2' ' A' ' 53' ' ' LYS . 49.4 mt -96.55 140.93 30.45 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.422 -0.808 . . . . 0.0 111.001 179.402 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.761 ' HG2' ' HB3' ' A' ' 53' ' ' LYS . 30.6 mmtp -95.47 174.28 7.09 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.234 -0.439 . . . . 0.0 109.821 179.341 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 89' ' ' GLY . . . . . 0.425 ' CA ' ' HG2' ' A' ' 56' ' ' GLU . . . 86.33 -164.83 36.84 Favored Glycine 0 CA--C 1.517 0.184 0 C-N-CA 120.927 -0.654 . . . . 0.0 113.432 174.418 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.527 HG21 HG11 ' A' ' 23' ' ' VAL . 64.2 mt -103.51 113.45 40.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 178.297 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 91' ' ' GLN . . . . . 0.644 ' HB3' ' CZ2' ' A' ' 38' ' ' TRP . 8.1 mm100 -117.23 104.83 11.57 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 120.892 0.377 . . . . 0.0 111.022 -169.624 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.616 HD13 ' HB2' ' A' ' 15' ' ' TYR . 34.9 mt -100.04 147.94 25.07 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.146 0.498 . . . . 0.0 111.111 -176.51 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 93' ' ' HIS . . . . . 0.547 ' CE1' ' HG3' ' A' ' 75' ' ' LYS . 28.1 t-80 -115.08 127.86 55.87 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.144 0.497 . . . . 0.0 111.086 179.759 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 94' ' ' MET . . . . . 0.496 ' HB3' ' O ' ' A' ' 70' ' ' SER . 24.1 ttm -77.32 -74.95 0.22 Allowed 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.294 -0.866 . . . . 0.0 109.93 176.167 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 78.67 101.96 0.21 Allowed Glycine 0 N--CA 1.445 -0.734 0 C-N-CA 120.755 -0.735 . . . . 0.0 113.135 -179.689 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 64.9 p 61.17 16.29 7.08 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 114.221 1.193 . . . . 0.0 114.221 170.098 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -123.99 54.47 1.33 Allowed 'General case' 0 CA--C 1.518 -0.265 0 CA-C-O 121.502 0.667 . . . . 0.0 110.096 174.989 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 98' ' ' ARG . . . . . 0.491 ' HB2' ' SD ' ' A' ' 101' ' ' MET . 0.1 OUTLIER -77.3 5.62 8.26 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.27 -0.877 . . . . 0.0 111.911 -170.433 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 2.8 m -61.0 -29.95 70.0 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.294 0.569 . . . . 0.0 110.529 177.42 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 27.3 t80 -73.94 -24.83 59.71 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.567 -179.14 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 101' ' ' MET . . . . . 0.491 ' SD ' ' HB2' ' A' ' 98' ' ' ARG . 83.2 mtp -61.7 -51.58 67.8 Favored 'General case' 0 CA--C 1.515 -0.402 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 174.059 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -62.03 -25.36 67.61 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 114.649 -1.16 . . . . 0.0 111.424 -177.696 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -65.84 -28.97 69.37 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-O 121.074 0.464 . . . . 0.0 110.877 178.1 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 61.9 m-85 -109.27 10.81 25.61 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.495 179.766 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 95.4 mt 64.72 15.51 9.81 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.1 -177.24 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 106' ' ' ILE . . . . . 0.885 HG12 ' HG3' ' A' ' 111' ' ' ARG . 61.2 mt -67.03 112.92 2.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.271 175.111 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 16.2 t-20 -124.96 -53.85 1.63 Allowed 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 176.346 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -92.19 115.02 4.7 Favored Glycine 0 N--CA 1.442 -0.915 0 CA-C-N 115.29 -0.868 . . . . 0.0 111.979 178.339 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.507 ' CG2' ' HA ' ' A' ' 110' ' ' PRO . 41.9 mt -77.7 142.97 66.59 Favored Pre-proline 0 C--N 1.321 -0.655 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 175.383 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 110' ' ' PRO . . . . . 0.507 ' HA ' ' CG2' ' A' ' 109' ' ' ILE . 1.0 OUTLIER -86.13 170.67 42.16 Favored 'Cis proline' 0 C--N 1.348 0.553 0 C-N-CA 124.775 -0.927 . . . . 0.0 113.853 1.087 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 111' ' ' ARG . . . . . 0.885 ' HG3' HG12 ' A' ' 106' ' ' ILE . 0.0 OUTLIER -134.79 133.82 40.23 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.477 -0.783 . . . . 0.0 108.897 179.413 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 112' ' ' PHE . . . . . 0.491 ' CE1' ' HB2' ' A' ' 128' ' ' ARG . 0.0 OUTLIER -102.33 117.05 33.91 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 123.365 0.415 . . . . 0.0 110.502 -175.604 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.61 ' HB ' ' HB ' ' A' ' 35' ' ' ILE . 82.1 mt -129.16 141.81 45.64 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.326 0 CA-C-O 120.708 0.29 . . . . 0.0 111.004 179.559 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 40.4 tp -130.31 139.21 50.72 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.5 -179.775 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.468 ' N ' HD12 ' A' ' 115' ' ' LEU . 0.8 OUTLIER -136.03 155.77 49.73 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.04 0.447 . . . . 0.0 110.54 179.673 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 116' ' ' ASP . . . . . 0.692 ' HB3' ' HB2' ' A' ' 120' ' ' LYS . 19.2 t70 -71.94 162.55 29.29 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.221 -0.899 . . . . 0.0 110.568 176.684 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 117' ' ' ARG . . . . . 0.424 ' HA ' ' C ' ' A' ' 31' ' ' LYS . 33.0 mtt180 -46.53 -40.2 12.21 Favored 'General case' 0 N--CA 1.462 0.136 0 O-C-N 124.43 1.081 . . . . 0.0 111.895 -178.611 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 118' ' ' ASP . . . . . 0.85 ' HB3' ' HG3' ' A' ' 120' ' ' LYS . 38.4 t70 -66.09 -18.87 65.62 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.36 0.6 . . . . 0.0 111.173 -177.448 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 104.26 16.96 16.93 Favored Glycine 0 N--CA 1.436 -1.344 0 N-CA-C 110.288 -1.125 . . . . 0.0 110.288 -170.151 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 120' ' ' LYS . . . . . 0.85 ' HG3' ' HB3' ' A' ' 118' ' ' ASP . 60.0 mttm -86.03 107.35 17.75 Favored 'General case' 0 C--O 1.219 -0.528 0 C-N-CA 120.805 -0.358 . . . . 0.0 111.115 -173.929 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 0.65 ' H ' HD12 ' A' ' 121' ' ' ILE . 3.9 mp -48.18 111.67 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-O 121.02 0.438 . . . . 0.0 110.797 177.725 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 122' ' ' ILE . . . . . 0.412 HD11 ' HB2' ' A' ' 116' ' ' ASP . 45.5 mm -95.48 -50.38 11.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 115.659 -0.7 . . . . 0.0 109.9 -179.508 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 19.9 m -125.99 114.59 18.67 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.212 -177.86 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -72.08 -16.98 62.03 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.13 0.491 . . . . 0.0 110.091 176.694 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 125' ' ' ASN . . . . . 0.406 ' HA ' ' O ' ' A' ' 112' ' ' PHE . 7.7 t30 -149.8 101.18 3.03 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.299 -0.864 . . . . 0.0 109.159 173.909 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 12.6 tpt -91.48 -125.2 0.08 Allowed 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 -178.761 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 127' ' ' THR . . . . . 0.463 ' OG1' ' HB ' ' A' ' 134' ' ' THR . 0.0 OUTLIER -140.82 131.72 26.01 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.879 0.371 . . . . 0.0 110.48 178.399 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 128' ' ' ARG . . . . . 0.651 ' HD2' ' HD2' ' A' ' 129' ' ' PRO . 17.7 tpt180 -51.52 138.03 30.83 Favored Pre-proline 0 C--N 1.323 -0.56 0 CA-C-N 115.252 -0.885 . . . . 0.0 111.073 176.04 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 129' ' ' PRO . . . . . 0.651 ' HD2' ' HD2' ' A' ' 128' ' ' ARG . 68.8 Cg_exo -48.49 -21.48 3.34 Favored 'Trans proline' 0 C--N 1.351 0.664 0 C-N-CA 123.496 2.797 . . . . 0.0 113.747 174.074 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 130' ' ' SER . . . . . 0.455 ' H ' ' HG3' ' A' ' 128' ' ' ARG . 4.4 m -61.11 -28.06 68.82 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.762 0.315 . . . . 0.0 111.035 176.774 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 131' ' ' ASP . . . . . 0.65 ' OD1' ' HG2' ' A' ' 133' ' ' LYS . 24.1 t0 -100.64 117.35 62.93 Favored Pre-proline 0 N--CA 1.453 -0.321 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.162 179.736 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 132' ' ' PRO . . . . . 0.598 ' O ' ' HG2' ' A' ' 136' ' ' GLU . 14.1 Cg_endo -56.98 -21.18 40.19 Favored 'Trans proline' 0 CA--C 1.53 0.315 0 C-N-CA 123.196 2.597 . . . . 0.0 114.018 179.736 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 133' ' ' LYS . . . . . 0.65 ' HG2' ' OD1' ' A' ' 131' ' ' ASP . 31.1 mmtm -48.15 -55.31 10.68 Favored 'General case' 0 N--CA 1.474 0.73 0 CA-C-O 121.066 0.46 . . . . 0.0 110.724 -177.528 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 134' ' ' THR . . . . . 0.463 ' HB ' ' OG1' ' A' ' 127' ' ' THR . 15.1 t -65.15 -41.15 95.02 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.233 -0.894 . . . . 0.0 110.755 -175.069 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 135' ' ' ALA . . . . . 0.587 ' HA ' ' CD2' ' A' ' 138' ' ' PHE . . . -64.24 -47.87 78.0 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-O 121.402 0.62 . . . . 0.0 110.758 -176.801 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 136' ' ' GLU . . . . . 0.598 ' HG2' ' O ' ' A' ' 132' ' ' PRO . 8.6 mm-40 -77.12 -22.86 52.02 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-O 121.465 0.65 . . . . 0.0 109.821 -176.2 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 137' ' ' LYS . . . . . 0.583 ' O ' ' HG ' ' A' ' 141' ' ' LEU . 0.1 OUTLIER -57.68 -39.17 76.48 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.15 -0.932 . . . . 0.0 109.441 168.659 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 138' ' ' PHE . . . . . 0.587 ' CD2' ' HA ' ' A' ' 135' ' ' ALA . 9.3 m-85 -66.76 -40.59 88.31 Favored 'General case' 0 N--CA 1.462 0.15 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.373 177.596 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 139' ' ' ASN . . . . . 0.615 ' HB3' ' HG3' ' A' ' 145' ' ' GLU . 92.6 m-20 -47.53 -53.76 13.52 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 175.758 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 21.8 tt0 -53.85 -48.42 70.0 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.287 -0.869 . . . . 0.0 111.472 179.111 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.583 ' HG ' ' O ' ' A' ' 137' ' ' LYS . 83.4 mt -58.32 -29.35 65.84 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.899 -176.688 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.403 HD21 ' H ' ' A' ' 63' ' ' ASP . 10.0 mp -102.16 -5.66 24.16 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.678 -0.237 . . . . 0.0 111.442 -179.756 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 72.63 28.56 67.13 Favored Glycine 0 C--N 1.329 0.152 0 N-CA-C 110.827 -0.909 . . . . 0.0 110.827 -176.749 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.513 HD23 ' OD1' ' A' ' 139' ' ' ASN . 26.9 tp -76.14 -31.58 58.67 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 114.77 -0.715 . . . . 0.0 110.837 -173.139 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 145' ' ' GLU . . . . . 0.615 ' HG3' ' HB3' ' A' ' 139' ' ' ASN . 0.0 OUTLIER -86.4 -29.9 22.54 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.793 0.806 . . . . 0.0 110.372 178.477 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -76.93 28.79 1.6 Allowed Glycine 0 C--N 1.317 -0.484 0 CA-C-N 114.061 -1.427 . . . . 0.0 113.992 -174.93 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 18.9 p-80 -76.03 61.53 1.54 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.709 0.766 . . . . 0.0 110.232 176.263 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 12.3 m170 -92.0 100.0 12.73 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.69 -0.687 . . . . 0.0 109.573 -176.523 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 7.3 p80 -61.85 142.15 57.53 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.054 0.454 . . . . 0.0 111.367 -176.483 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 46.7 m80 -129.01 116.12 18.84 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.052 -0.522 . . . . 0.0 109.592 177.134 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 23.0 m170 69.39 103.6 0.06 Allowed 'General case' 0 N--CA 1.468 0.472 0 O-C-N 123.947 0.779 . . . . 0.0 111.503 -177.115 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 56.0 t-80 . . . . . 0 C--O 1.245 0.823 0 CA-C-O 118.318 -0.849 . . . . 0.0 109.515 177.98 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.5 mmt . . . . . 0 N--CA 1.479 0.986 0 N-CA-C 109.535 -0.543 . . . . 0.0 109.535 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 6.4 m -77.92 69.91 4.21 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.573 -0.528 . . . . 0.0 109.573 176.702 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 43.7 tp 69.52 -58.24 0.52 Allowed 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 115.268 -0.878 . . . . 0.0 110.367 -172.131 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 90.7 mtm180 -117.75 -179.72 3.82 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.115 -0.493 . . . . 0.0 109.706 176.913 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 16.3 m -78.4 -9.35 59.25 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.375 0.607 . . . . 0.0 110.577 178.183 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -165.85 143.85 8.74 Favored Glycine 0 N--CA 1.444 -0.788 0 N-CA-C 110.137 -1.185 . . . . 0.0 110.137 177.752 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' ASN . . . . . 0.612 ' HB3' ' HB2' ' A' ' 103' ' ' ALA . 8.9 m120 64.81 108.84 0.03 OUTLIER Pre-proline 0 N--CA 1.469 0.515 0 CA-C-O 121.171 0.51 . . . . 0.0 110.349 -177.094 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_exo -68.59 -75.34 0.01 OUTLIER 'Trans proline' 0 C--N 1.331 -0.362 0 C-N-CA 122.882 2.388 . . . . 0.0 112.367 -176.886 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 48.7 m 68.04 111.77 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.309 0 O-C-N 123.631 0.582 . . . . 0.0 111.271 -177.538 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.548 ' HB2' HD13 ' A' ' 121' ' ' ILE . . . 71.89 -40.95 0.49 Allowed 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 123.465 0.706 . . . . 0.0 112.823 178.077 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -76.2 69.35 2.73 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 112.281 0.474 . . . . 0.0 112.281 -175.598 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 42.5 m 62.6 102.86 0.03 OUTLIER 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 113.188 0.811 . . . . 0.0 113.188 172.042 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' PHE . . . . . 0.502 ' CE1' HD13 ' A' ' 25' ' ' LEU . 38.7 p90 -105.58 129.91 53.74 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.137 -0.483 . . . . 0.0 109.943 173.985 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 3.4 m -121.82 111.76 17.52 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.395 -177.841 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 63.9 m-85 -134.79 151.63 76.07 Favored Pre-proline 0 C--N 1.322 -0.597 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.605 -175.885 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -76.41 125.81 8.63 Favored 'Trans proline' 0 N--CA 1.46 -0.497 0 C-N-CA 122.569 2.18 . . . . 0.0 112.587 178.966 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' ASP . . . . . 0.544 ' HA ' ' HA ' ' A' ' 92' ' ' LEU . 10.5 t70 -70.51 159.16 34.79 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.484 -0.78 . . . . 0.0 108.926 172.114 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.559 HG13 HG11 ' A' ' 82' ' ' VAL . 0.0 OUTLIER -55.8 -25.64 19.01 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.487 0 O-C-N 123.722 0.639 . . . . 0.0 111.55 -176.947 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 42.8 m-80 -72.65 2.42 6.55 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.137 0.494 . . . . 0.0 110.91 176.065 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 73.67 36.35 53.73 Favored Glycine 0 N--CA 1.446 -0.639 0 N-CA-C 110.835 -0.906 . . . . 0.0 110.835 -179.501 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.461 ' HB2' ' NZ ' ' A' ' 21' ' ' LYS . 0.1 OUTLIER -119.56 134.07 55.39 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 110.273 -0.269 . . . . 0.0 110.273 -175.045 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 7.0 m -80.11 107.83 13.22 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-O 120.868 0.366 . . . . 0.0 110.619 -177.326 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.52 ' HB ' HD21 ' A' ' 92' ' ' LEU . 62.0 t -108.4 141.7 22.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 115.871 -0.604 . . . . 0.0 109.69 -179.969 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 82.3 p -120.53 -173.71 2.64 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 120.867 0.365 . . . . 0.0 110.716 -176.895 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.659 ' O ' ' HB2' ' A' ' 29' ' ' LYS . 65.0 tp -78.73 -26.52 44.72 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.465 -179.716 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -84.76 -30.58 24.54 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 112.8 0.667 . . . . 0.0 112.8 -169.709 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 3.4 p30 -81.04 -15.5 55.94 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.171 0.51 . . . . 0.0 110.849 -175.796 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 18.8 tp -118.36 21.87 12.42 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.756 0.788 . . . . 0.0 109.319 178.007 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.659 ' HB2' ' O ' ' A' ' 25' ' ' LEU . 57.6 tttm -94.18 163.27 13.52 Favored 'General case' 0 N--CA 1.44 -0.957 0 CA-C-N 114.813 -1.085 . . . . 0.0 109.961 -178.45 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 114.49 -31.33 6.45 Favored Glycine 0 CA--C 1.509 -0.301 0 C-N-CA 120.591 -0.814 . . . . 0.0 111.669 177.734 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 1.05 ' HD3' ' HA ' ' A' ' 63' ' ' ASP . 65.2 mttm -119.36 165.55 14.16 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 109.662 -0.496 . . . . 0.0 109.662 174.822 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 81.5 m-85 -60.89 149.15 37.18 Favored 'General case' 0 C--N 1.329 -0.311 0 O-C-N 123.323 0.39 . . . . 0.0 110.639 -177.87 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 71.1 mt -124.5 132.18 71.7 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 CA-C-O 120.853 0.359 . . . . 0.0 110.807 -174.737 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 88.3 t80 -117.12 121.05 40.19 Favored 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 173.013 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.533 ' HB ' ' HB ' ' A' ' 113' ' ' ILE . 57.1 mt -105.58 118.83 53.78 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-O 121.171 0.51 . . . . 0.0 110.736 -178.286 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -106.41 156.87 18.08 Favored 'General case' 0 C--N 1.316 -0.849 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 172.3 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.524 ' HB ' ' H ' ' A' ' 111' ' ' ARG . 62.0 t -110.46 112.1 39.08 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.877 0 C-N-CA 120.034 -0.666 . . . . 0.0 110.22 174.161 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' TRP . . . . . 0.655 ' CZ2' ' HB2' ' A' ' 91' ' ' GLN . 0.2 OUTLIER -98.02 132.86 43.2 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.097 -0.956 . . . . 0.0 109.516 -177.257 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.582 ' HA ' ' OD1' ' A' ' 72' ' ' ASP . . . -147.58 155.09 41.49 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.664 -178.714 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.675 ' HB ' ' CE3' ' A' ' 78' ' ' TRP . 13.3 t -100.34 -28.41 12.97 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.781 0.324 . . . . 0.0 110.704 174.601 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' TRP . . . . . 0.429 ' HE1' ' HA ' ' A' ' 72' ' ' ASP . 18.5 p-90 -81.31 11.03 4.69 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.785 -177.053 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 42' ' ' CYS . . . . . 0.777 ' HB3' ' SG ' ' A' ' 45' ' ' CYS . 44.5 t -91.55 -61.03 1.73 Allowed 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 109.912 -0.403 . . . . 0.0 109.912 174.854 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 111.0 -83.68 0.33 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.597 -179.629 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_exo -54.19 -26.86 44.32 Favored 'Trans proline' 0 C--N 1.351 0.704 0 C-N-CA 123.188 2.592 . . . . 0.0 112.854 179.463 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' CYS . . . . . 0.777 ' SG ' ' HB3' ' A' ' 42' ' ' CYS . 23.1 p -51.47 -35.49 40.1 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.399 176.797 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.589 ' HA ' HD13 ' A' ' 49' ' ' LEU . 33.6 mtp180 -67.9 -12.3 60.41 Favored 'General case' 0 N--CA 1.456 -0.157 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.21 -175.698 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -80.37 -19.93 67.93 Favored Glycine 0 N--CA 1.446 -0.654 0 C-N-CA 120.648 -0.786 . . . . 0.0 111.369 175.437 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 24.6 mt-10 -99.34 -12.81 19.97 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-O 120.606 0.241 . . . . 0.0 110.615 -179.282 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.589 HD13 ' HA ' ' A' ' 46' ' ' ARG . 7.5 mp -51.89 -48.57 87.52 Favored Pre-proline 0 CA--C 1.536 0.436 0 CA-C-N 116.561 -0.29 . . . . 0.0 111.701 172.279 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -57.04 -35.84 99.07 Favored 'Trans proline' 0 C--N 1.355 0.896 0 C-N-CA 121.791 1.661 . . . . 0.0 111.937 171.601 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.445 ' O ' ' HB2' ' A' ' 54' ' ' GLU . . . -72.0 -26.03 62.06 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-O 121.234 0.54 . . . . 0.0 110.574 -179.1 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 87.3 mt -67.6 -33.67 75.47 Favored 'General case' 0 N--CA 1.444 -0.74 0 CA-C-N 115.858 -0.61 . . . . 0.0 109.67 174.225 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 5.5 mtpm? -70.36 -39.19 74.76 Favored 'General case' 0 CA--C 1.519 -0.236 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.166 175.005 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.445 ' HB2' ' O ' ' A' ' 51' ' ' ALA . 28.1 mm-40 -50.7 -50.82 54.18 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.755 -0.657 . . . . 0.0 109.669 172.9 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 62.8 mt -62.23 -53.12 59.74 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.976 175.409 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 26.4 tt0 -43.41 -59.84 1.96 Allowed 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 114.575 -1.193 . . . . 0.0 112.427 179.522 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -78.67 -29.04 45.41 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 120.777 0.322 . . . . 0.0 111.598 -172.666 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 65.5 tttm -70.48 -27.69 64.41 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.884 0.374 . . . . 0.0 110.831 178.62 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.434 ' HB2' ' HE2' ' A' ' 66' ' ' PHE . 68.4 m-85 -122.58 13.7 10.13 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.46 -0.336 . . . . 0.0 111.845 -176.343 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -60.07 132.09 52.85 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.217 172.392 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 69.36 46.37 56.87 Favored Glycine 0 N--CA 1.447 -0.599 0 C-N-CA 120.854 -0.689 . . . . 0.0 112.169 -179.702 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.414 ' HB2' HG22 ' A' ' 64' ' ' ILE . 40.3 mmtm -126.6 -164.42 1.33 Allowed 'General case' 0 N--CA 1.45 -0.451 0 CA-C-O 121.216 0.531 . . . . 0.0 110.313 174.859 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 1.05 ' HA ' ' HD3' ' A' ' 31' ' ' LYS . 0.1 OUTLIER -97.85 44.32 1.04 Allowed 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.639 -0.71 . . . . 0.0 110.805 -179.41 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.414 HG22 ' HB2' ' A' ' 62' ' ' LYS . 18.2 tt -144.45 149.27 17.49 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.761 0 CA-C-N 114.929 -1.032 . . . . 0.0 109.761 -177.036 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 65' ' ' HIS . . . . . 0.55 ' NE2' ' HB2' ' A' ' 31' ' ' LYS . 89.4 m-70 -124.25 121.34 34.78 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 109.918 -0.401 . . . . 0.0 109.918 178.287 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 66' ' ' PHE . . . . . 0.434 ' HE2' ' HB2' ' A' ' 59' ' ' TYR . 91.8 m-85 -88.65 111.31 21.78 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 173.585 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.504 ' O ' ' HA ' ' A' ' 35' ' ' ILE . 27.4 t -118.58 109.37 26.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.459 -175.83 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 68' ' ' SER . . . . . 0.426 ' HB3' ' CD1' ' A' ' 38' ' ' TRP . 10.9 m -88.07 143.73 26.91 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-N 115.918 -0.583 . . . . 0.0 109.856 178.844 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.48 ' O ' HG13 ' A' ' 37' ' ' VAL . 62.7 tp -131.88 124.0 28.63 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 174.652 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 70' ' ' SER . . . . . 0.565 ' O ' ' HB3' ' A' ' 94' ' ' MET . 1.3 t -108.15 119.61 39.98 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.076 0.465 . . . . 0.0 112.046 -173.957 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 2.4 p -87.06 17.6 4.1 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.749 -0.659 . . . . 0.0 110.806 177.214 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.582 ' OD1' ' HA ' ' A' ' 39' ' ' ALA . 1.9 m-20 -69.64 121.3 16.86 Favored 'General case' 0 CA--C 1.515 -0.4 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.011 179.496 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 45.9 tttm -75.91 -25.86 56.42 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-O 121.146 0.498 . . . . 0.0 110.062 -179.874 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' ASN . . . . . 0.522 ' HB2' ' HB3' ' A' ' 77' ' ' ALA . 0.2 OUTLIER -78.7 96.87 5.67 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.747 -0.66 . . . . 0.0 109.788 174.027 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.55 ' O ' ' HG2' ' A' ' 79' ' ' GLU . 11.4 tmtt? -71.41 -66.33 0.64 Allowed 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 120.446 -0.502 . . . . 0.0 112.038 -173.863 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 36.0 ttpt -58.3 -43.28 88.04 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 121.009 -0.277 . . . . 0.0 110.819 -173.044 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.522 ' HB3' ' HB2' ' A' ' 74' ' ' ASN . . . -52.22 -38.82 59.09 Favored 'General case' 0 C--O 1.246 0.879 0 CA-C-O 121.86 0.838 . . . . 0.0 111.277 178.716 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 78' ' ' TRP . . . . . 0.675 ' CE3' ' HB ' ' A' ' 40' ' ' THR . 16.2 t-105 -79.02 -42.53 26.31 Favored 'General case' 0 N--CA 1.44 -0.959 0 CA-C-N 115.151 -0.931 . . . . 0.0 111.045 -173.175 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.55 ' HG2' ' O ' ' A' ' 75' ' ' LYS . 3.8 mm-40 -51.97 -40.72 61.33 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-O 121.473 0.654 . . . . 0.0 110.248 175.748 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 80' ' ' ASN . . . . . 0.455 ' OD1' ' HA ' ' A' ' 77' ' ' ALA . 3.3 m120 -59.25 -54.07 51.02 Favored 'General case' 0 CA--C 1.513 -0.446 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.257 177.858 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 28.6 ttm -61.37 -45.99 92.05 Favored 'General case' 0 C--O 1.219 -0.507 0 CA-C-N 116.02 -0.536 . . . . 0.0 112.235 -174.209 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.567 ' CG2' ' HZ3' ' A' ' 38' ' ' TRP . 3.9 p -61.57 -32.82 54.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 C-N-CA 120.07 -0.652 . . . . 0.0 111.016 179.519 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 58.9 m -63.75 -40.34 96.48 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.979 0.419 . . . . 0.0 110.239 175.886 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 12.8 mptt -81.13 -29.96 34.66 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.495 -179.396 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' ASP . . . . . 0.406 ' CG ' HH21 ' A' ' 46' ' ' ARG . 1.5 m-20 -77.6 -6.8 55.02 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.142 0.496 . . . . 0.0 110.975 178.529 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 84.7 mt-30 66.18 18.26 10.92 Favored 'General case' 0 N--CA 1.468 0.43 0 N-CA-C 113.271 0.841 . . . . 0.0 113.271 170.357 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.554 ' HB2' HG23 ' A' ' 82' ' ' VAL . 71.0 mt -64.14 143.18 58.07 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.558 0.218 . . . . 0.0 110.89 -179.926 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 24.6 mmtm -123.15 -166.91 1.52 Allowed 'General case' 0 N--CA 1.451 -0.382 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.934 176.367 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 92.2 -157.01 23.83 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 121.002 -0.618 . . . . 0.0 111.685 -178.986 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 50.1 mm -107.26 117.48 53.12 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 N-CA-C 108.933 -0.766 . . . . 0.0 108.933 175.631 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' GLN . . . . . 0.655 ' HB2' ' CZ2' ' A' ' 38' ' ' TRP . 0.6 OUTLIER -135.2 102.59 5.23 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-O 121.916 0.865 . . . . 0.0 111.724 -169.4 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.544 ' HA ' ' HA ' ' A' ' 17' ' ' ASP . 38.6 mt -91.73 142.2 27.86 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 114.806 -1.088 . . . . 0.0 110.588 -175.982 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 23.2 t-80 -111.82 116.07 30.07 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-O 121.37 0.605 . . . . 0.0 110.443 179.544 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' MET . . . . . 0.733 ' SD ' ' HA ' ' A' ' 98' ' ' ARG . 10.7 ttm -69.47 -52.28 28.1 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.048 -0.978 . . . . 0.0 111.073 -178.899 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 95' ' ' GLY . . . . . 0.419 ' HA2' ' O ' ' A' ' 72' ' ' ASP . . . 77.86 -86.7 1.07 Allowed Glycine 0 N--CA 1.448 -0.557 0 C-N-CA 120.628 -0.796 . . . . 0.0 113.243 175.781 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 5.1 m -120.7 -5.45 9.7 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 120.843 0.354 . . . . 0.0 111.112 -176.173 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 97' ' ' ASP . . . . . 0.536 ' O ' ' HG3' ' A' ' 94' ' ' MET . 13.0 t70 -98.46 72.65 2.07 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 120.056 -0.657 . . . . 0.0 109.719 -177.907 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 98' ' ' ARG . . . . . 0.733 ' HA ' ' SD ' ' A' ' 94' ' ' MET . 0.0 OUTLIER -82.62 31.31 0.41 Allowed 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.384 -175.462 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 3.0 m -65.67 -43.45 89.31 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.489 179.837 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -71.73 -36.58 70.53 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.247 177.3 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 101' ' ' MET . . . . . 0.537 ' HG3' ' O ' ' A' ' 106' ' ' ILE . 15.1 ttt -56.08 -45.11 79.47 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.568 -0.742 . . . . 0.0 109.982 173.95 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 102' ' ' ASP . . . . . 0.476 ' HB2' ' CZ ' ' A' ' 98' ' ' ARG . 21.9 t70 -69.07 -49.56 56.29 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.242 -0.89 . . . . 0.0 110.919 179.462 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 103' ' ' ALA . . . . . 0.612 ' HB2' ' HB3' ' A' ' 7' ' ' ASN . . . -69.01 -21.71 64.12 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.957 -0.565 . . . . 0.0 112.344 -171.512 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 25.8 m-85 -109.08 2.63 21.28 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 111.752 0.279 . . . . 0.0 111.752 -178.441 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 9.0 mp 59.39 27.27 16.34 Favored 'General case' 0 N--CA 1.466 0.334 0 O-C-N 123.47 0.481 . . . . 0.0 111.09 -177.968 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 106' ' ' ILE . . . . . 0.537 ' O ' ' HG3' ' A' ' 101' ' ' MET . 53.6 mt -66.7 77.85 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.271 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.71 174.084 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 61.2 t30 -109.19 -46.47 3.57 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 175.427 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -77.77 91.95 1.1 Allowed Glycine 0 N--CA 1.446 -0.639 0 CA-C-N 115.455 -0.793 . . . . 0.0 111.222 174.575 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.47 HD13 ' HB2' ' A' ' 42' ' ' CYS . 2.4 pp -103.34 151.57 38.6 Favored Pre-proline 0 C--N 1.322 -0.609 0 CA-C-N 115.963 -0.118 . . . . 0.0 111.094 -178.829 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 110' ' ' PRO . . . . . 0.567 ' HD3' ' HB3' ' A' ' 45' ' ' CYS . 30.0 Cg_endo -68.51 153.49 89.39 Favored 'Cis proline' 0 C--N 1.349 0.573 0 C-N-CA 123.725 -1.365 . . . . 0.0 113.623 1.115 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 111' ' ' ARG . . . . . 0.524 ' H ' ' HB ' ' A' ' 37' ' ' VAL . 0.0 OUTLIER -113.57 144.41 42.93 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.727 -0.669 . . . . 0.0 109.519 -177.526 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 112' ' ' PHE . . . . . 0.651 ' HD2' ' HD3' ' A' ' 129' ' ' PRO . 0.9 OUTLIER -112.66 114.52 27.17 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.835 -177.873 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.533 ' HB ' ' HB ' ' A' ' 35' ' ' ILE . 85.6 mt -128.57 141.97 45.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.854 0.359 . . . . 0.0 110.801 -178.796 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.411 HD22 ' HE3' ' A' ' 126' ' ' MET . 41.2 tp -126.48 136.45 52.64 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.172 179.097 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.516 ' N ' HD12 ' A' ' 115' ' ' LEU . 0.7 OUTLIER -136.27 156.7 48.29 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.397 0.618 . . . . 0.0 110.553 -178.175 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 116' ' ' ASP . . . . . 0.645 ' HB3' ' HB2' ' A' ' 120' ' ' LYS . 9.6 t70 -77.96 168.2 20.28 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 114.88 -1.055 . . . . 0.0 111.351 177.722 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 117' ' ' ARG . . . . . 0.496 ' HA ' ' O ' ' A' ' 31' ' ' LYS . 88.1 mtt-85 -45.88 -40.55 10.15 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 124.569 1.148 . . . . 0.0 113.115 179.911 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 118' ' ' ASP . . . . . 0.788 ' HB2' ' HG3' ' A' ' 120' ' ' LYS . 40.2 m-20 -78.34 5.19 11.03 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.576 0.227 . . . . 0.0 111.502 -178.461 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 119' ' ' GLY . . . . . 0.454 ' HA3' HD11 ' A' ' 25' ' ' LEU . . . 80.63 26.6 53.71 Favored Glycine 0 N--CA 1.44 -1.09 0 N-CA-C 110.521 -1.032 . . . . 0.0 110.521 -173.268 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 120' ' ' LYS . . . . . 0.788 ' HG3' ' HB2' ' A' ' 118' ' ' ASP . 33.9 mtmm -94.17 103.98 16.01 Favored 'General case' 0 C--O 1.223 -0.332 0 C-N-CA 120.574 -0.45 . . . . 0.0 110.468 -173.511 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 0.558 ' H ' HD12 ' A' ' 121' ' ' ILE . 2.7 mp -45.0 112.72 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 115.566 -0.743 . . . . 0.0 111.651 -178.47 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 122' ' ' ILE . . . . . 0.446 HD11 ' HB2' ' A' ' 116' ' ' ASP . 46.3 mm -89.5 -40.1 12.83 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-N 115.216 -0.902 . . . . 0.0 109.126 176.504 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 14.8 m -142.66 117.49 9.9 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.338 -0.847 . . . . 0.0 110.497 178.237 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 124' ' ' ALA . . . . . 0.512 ' O ' HG12 ' A' ' 113' ' ' ILE . . . -68.29 -27.16 66.07 Favored 'General case' 0 C--N 1.334 -0.103 0 CA-C-O 121.409 0.623 . . . . 0.0 109.75 175.453 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 3.9 p-10 -136.82 109.25 7.37 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.044 -0.98 . . . . 0.0 108.646 171.103 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 126' ' ' MET . . . . . 0.422 ' N ' ' HD1' ' A' ' 112' ' ' PHE . 27.9 ttt -83.17 -87.83 0.1 Allowed 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.518 -174.728 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -137.03 -75.76 0.42 Allowed 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.574 -0.285 . . . . 0.0 111.579 -178.266 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 128' ' ' ARG . . . . . 0.936 ' HB3' ' HB2' ' A' ' 131' ' ' ASP . 3.6 tmm_? 177.88 139.06 0.24 Allowed Pre-proline 0 N--CA 1.453 -0.297 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 -178.128 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 129' ' ' PRO . . . . . 0.651 ' HD3' ' HD2' ' A' ' 112' ' ' PHE . 85.1 Cg_exo -48.65 -44.8 29.81 Favored 'Trans proline' 0 C--N 1.349 0.554 0 C-N-CA 122.869 2.379 . . . . 0.0 113.617 -176.649 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 130' ' ' SER . . . . . 0.637 ' HB3' ' NH1' ' A' ' 128' ' ' ARG . 43.8 t -107.1 26.83 9.66 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.063 0.459 . . . . 0.0 110.863 -178.719 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 131' ' ' ASP . . . . . 0.936 ' HB2' ' HB3' ' A' ' 128' ' ' ARG . 13.6 t70 -92.09 134.06 29.25 Favored Pre-proline 0 C--N 1.325 -0.496 0 N-CA-C 109.781 -0.451 . . . . 0.0 109.781 177.686 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 132' ' ' PRO . . . . . 0.621 ' O ' ' HG3' ' A' ' 136' ' ' GLU . 18.8 Cg_endo -58.22 -40.87 72.51 Favored 'Trans proline' 0 C--N 1.343 0.269 0 C-N-CA 122.748 2.299 . . . . 0.0 113.142 -178.867 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 36.0 mtmm -61.17 -27.44 68.41 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 121.048 0.451 . . . . 0.0 110.69 -175.05 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 134' ' ' THR . . . . . 0.713 HG22 ' CZ ' ' A' ' 138' ' ' PHE . 1.3 m -60.94 -57.18 13.74 Favored 'General case' 0 N--CA 1.447 -0.595 0 CA-C-N 115.73 -0.668 . . . . 0.0 109.464 173.772 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 135' ' ' ALA . . . . . 0.643 ' HA ' ' CD2' ' A' ' 138' ' ' PHE . . . -60.09 -42.73 95.26 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.011 -0.995 . . . . 0.0 111.696 178.599 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 136' ' ' GLU . . . . . 0.621 ' HG3' ' O ' ' A' ' 132' ' ' PRO . 38.6 mt-10 -54.18 -52.45 61.15 Favored 'General case' 0 CA--C 1.512 -0.516 0 CA-C-O 121.382 0.61 . . . . 0.0 110.534 179.177 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 137' ' ' LYS . . . . . 0.51 ' O ' ' HB3' ' A' ' 140' ' ' GLU . 5.8 tmtm? -55.24 -43.61 74.73 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-N 114.792 -1.094 . . . . 0.0 111.148 -178.747 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 138' ' ' PHE . . . . . 0.713 ' CZ ' HG22 ' A' ' 134' ' ' THR . 14.8 m-85 -53.68 -60.54 3.18 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.07 -0.513 . . . . 0.0 111.44 177.674 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 139' ' ' ASN . . . . . 0.606 ' HB2' ' HB3' ' A' ' 144' ' ' LEU . 0.3 OUTLIER -72.28 -17.37 61.88 Favored 'General case' 0 C--O 1.224 -0.287 0 C-N-CA 120.423 -0.511 . . . . 0.0 111.2 -175.491 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 140' ' ' GLU . . . . . 0.51 ' HB3' ' O ' ' A' ' 137' ' ' LYS . 3.8 tt0 -59.21 -57.44 13.0 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.736 171.351 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.449 ' HG ' ' O ' ' A' ' 138' ' ' PHE . 4.5 pp -71.53 -19.58 62.15 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.965 -177.31 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 95.7 mt -81.05 -18.5 46.48 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.424 174.064 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 73.91 40.03 45.2 Favored Glycine 0 N--CA 1.45 -0.389 0 N-CA-C 110.848 -0.901 . . . . 0.0 110.848 -178.63 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.606 ' HB3' ' HB2' ' A' ' 139' ' ' ASN . 46.9 tp -117.38 20.39 13.63 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 114.882 -0.659 . . . . 0.0 110.398 -173.361 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -88.9 -32.37 17.76 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.332 0.587 . . . . 0.0 110.174 179.712 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -64.23 100.4 0.4 Allowed Glycine 0 C--N 1.317 -0.503 0 CA-C-N 114.659 -1.155 . . . . 0.0 112.46 179.613 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 28.0 m170 -110.85 145.23 38.6 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 110.489 -0.189 . . . . 0.0 110.489 -178.23 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER 65.36 129.94 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.701 0 O-C-N 124.455 1.097 . . . . 0.0 110.779 -173.841 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 9.6 p80 -68.43 153.94 42.79 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.873 -175.026 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 43.7 p-80 -148.02 121.14 8.87 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.095 -179.849 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 7.8 t-160 -103.62 79.26 1.66 Allowed 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 120.988 0.423 . . . . 0.0 110.028 179.763 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 55.6 t-80 . . . . . 0 C--O 1.243 0.728 0 CA-C-N 115.224 -0.898 . . . . 0.0 109.053 -178.726 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 93.6 mtp . . . . . 0 N--CA 1.482 1.14 0 CA-C-O 120.296 0.093 . . . . 0.0 110.76 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 50.8 m 61.93 -164.28 0.25 Allowed 'General case' 0 N--CA 1.463 0.176 0 O-C-N 123.587 0.554 . . . . 0.0 109.9 -174.916 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.46 ' HB3' ' HA ' ' A' ' 8' ' ' PRO . 92.6 mt 56.43 93.85 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.516 0 CA-C-O 121.357 0.599 . . . . 0.0 112.374 173.133 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 4.4 ptp180 -151.48 -171.46 3.94 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.959 -177.083 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 29.5 m 60.15 31.78 20.67 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-O 121.606 0.717 . . . . 0.0 110.113 -175.7 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 173.73 -97.35 0.11 Allowed Glycine 0 N--CA 1.444 -0.821 0 CA-C-N 115.131 -0.941 . . . . 0.0 111.316 -178.734 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' ASN . . . . . 0.499 ' HA ' ' HD3' ' A' ' 8' ' ' PRO . 15.0 t-20 -155.2 142.76 13.98 Favored Pre-proline 0 C--N 1.325 -0.481 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 178.904 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.499 ' HD3' ' HA ' ' A' ' 7' ' ' ASN . 12.2 Cg_exo -70.95 -25.23 23.34 Favored 'Trans proline' 0 N--CA 1.466 -0.135 0 C-N-CA 123.194 2.596 . . . . 0.0 112.688 -178.675 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 28.8 m -90.12 15.32 10.44 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.315 0.578 . . . . 0.0 110.863 -178.269 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -89.14 28.72 1.16 Allowed 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.153 178.879 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -159.79 117.31 2.64 Favored 'General case' 0 N--CA 1.447 -0.585 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.66 -175.526 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.661 ' H ' HD23 ' A' ' 25' ' ' LEU . 47.3 m 67.04 36.01 4.37 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.235 -0.893 . . . . 0.0 112.141 171.954 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 37.5 p90 -66.06 163.87 16.53 Favored 'General case' 0 N--CA 1.463 0.208 0 N-CA-C 110.093 -0.336 . . . . 0.0 110.093 174.672 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.43 ' HA ' ' HA ' ' A' ' 24' ' ' SER . 16.2 t -142.36 128.0 19.16 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 120.865 0.364 . . . . 0.0 110.802 179.843 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' TYR . . . . . 0.455 ' O ' HD22 ' A' ' 92' ' ' LEU . 75.7 m-85 -141.83 159.65 58.82 Favored Pre-proline 0 C--N 1.327 -0.402 0 CA-C-N 115.874 -0.603 . . . . 0.0 109.81 178.942 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.702 ' HA ' ' O ' ' A' ' 21' ' ' LYS . 85.9 Cg_endo -88.44 134.16 2.85 Favored 'Trans proline' 0 N--CA 1.459 -0.549 0 C-N-CA 122.557 2.172 . . . . 0.0 113.996 -178.896 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 17' ' ' ASP . . . . . 0.478 ' HA ' ' O ' ' A' ' 91' ' ' GLN . 8.3 m-20 -69.1 168.62 13.55 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.054 171.203 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.567 HD12 HG13 ' A' ' 82' ' ' VAL . 1.9 tt -41.69 -40.36 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 O-C-N 124.563 1.164 . . . . 0.0 112.238 175.539 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 40.4 m-80 -68.54 -3.99 13.59 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.484 -177.086 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 79.14 33.63 35.57 Favored Glycine 0 N--CA 1.442 -0.931 0 N-CA-C 110.561 -1.016 . . . . 0.0 110.561 -174.389 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.702 ' O ' ' HA ' ' A' ' 16' ' ' PRO . 15.9 tppt? -110.43 126.73 54.62 Favored 'General case' 0 C--O 1.22 -0.48 0 CA-C-N 115.607 -0.297 . . . . 0.0 110.853 -173.952 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 18.8 m -84.44 106.86 16.35 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.974 -174.392 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.421 ' HB ' HD21 ' A' ' 92' ' ' LEU . 71.7 t -112.81 144.65 20.07 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 115.646 -0.706 . . . . 0.0 109.748 179.837 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' SER . . . . . 0.43 ' HA ' ' HA ' ' A' ' 14' ' ' SER . 95.7 p -113.98 162.01 16.96 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.912 -178.928 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.661 HD23 ' H ' ' A' ' 12' ' ' SER . 53.9 tp -66.98 -16.89 64.64 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.761 178.33 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -74.56 -18.95 60.51 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.825 0.345 . . . . 0.0 110.815 179.408 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -76.86 -39.1 52.33 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.629 0.728 . . . . 0.0 109.749 175.37 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.584 HD13 HG21 ' A' ' 67' ' ' VAL . 24.0 mt -84.69 -7.83 59.08 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 114.853 -1.067 . . . . 0.0 110.152 -179.402 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 32.9 tttp -73.78 130.2 39.48 Favored 'General case' 0 N--CA 1.439 -1.019 0 CA-C-N 114.847 -1.07 . . . . 0.0 110.496 -178.131 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 128.2 -31.14 3.72 Favored Glycine 0 N--CA 1.445 -0.747 0 N-CA-C 110.305 -1.118 . . . . 0.0 110.305 -173.985 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.857 ' HD3' ' HA ' ' A' ' 63' ' ' ASP . 61.4 mttm -122.56 174.31 7.15 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.526 -0.337 . . . . 0.0 110.154 175.518 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.962 ' HB2' HG22 ' A' ' 64' ' ' ILE . 92.4 m-85 -69.16 150.97 46.93 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 110.189 -0.3 . . . . 0.0 110.189 179.767 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.555 HD13 ' HA2' ' A' ' 119' ' ' GLY . 5.3 mp -124.59 134.47 66.69 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-O 120.79 0.328 . . . . 0.0 110.619 178.945 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 60.9 t80 -118.58 114.46 22.83 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 171.677 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.493 ' HA ' ' O ' ' A' ' 67' ' ' VAL . 67.4 mt -103.13 114.32 42.4 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 CA-C-O 121.134 0.493 . . . . 0.0 110.755 -177.791 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.486 ' O ' ' HA ' ' A' ' 68' ' ' SER . 5.5 p-10 -110.98 158.43 18.79 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 115.549 -0.75 . . . . 0.0 109.365 174.394 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.428 HG11 ' CG2' ' A' ' 109' ' ' ILE . 59.7 t -102.33 130.08 52.77 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.822 0 C-N-CA 120.779 -0.368 . . . . 0.0 110.421 178.359 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' TRP . . . . . 0.625 ' CZ2' ' HB2' ' A' ' 91' ' ' GLN . 0.6 OUTLIER -122.31 134.34 54.66 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 -179.223 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.55 ' HB3' ' HB3' ' A' ' 42' ' ' CYS . . . -145.03 162.23 37.47 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.548 -179.689 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.764 ' HB ' ' CE3' ' A' ' 78' ' ' TRP . 8.8 t -88.05 -22.19 24.34 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.226 0.536 . . . . 0.0 110.02 175.338 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 19.0 p-90 -96.71 18.0 15.3 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.674 -0.694 . . . . 0.0 109.848 176.045 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' CYS . . . . . 0.668 ' SG ' ' HB3' ' A' ' 45' ' ' CYS . 23.9 p -76.15 -19.38 58.53 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.542 -0.754 . . . . 0.0 111.089 -177.572 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 47.65 -98.31 0.01 OUTLIER Glycine 0 C--N 1.338 0.645 0 O-C-N 124.12 0.887 . . . . 0.0 114.261 176.602 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 81.6 Cg_exo -51.19 -26.11 19.02 Favored 'Trans proline' 0 C--N 1.354 0.821 0 C-N-CA 123.623 2.882 . . . . 0.0 113.502 178.217 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' CYS . . . . . 0.668 ' HB3' ' SG ' ' A' ' 42' ' ' CYS . 42.1 t -67.33 -41.14 85.75 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.286 0.565 . . . . 0.0 110.003 174.599 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.631 ' HA ' ' HG ' ' A' ' 49' ' ' LEU . 28.6 ttt-85 -67.49 -23.19 65.45 Favored 'General case' 0 N--CA 1.44 -0.953 0 CA-C-N 115.177 -0.92 . . . . 0.0 111.901 -173.487 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -63.2 -25.93 68.78 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.727 -0.749 . . . . 0.0 111.953 179.831 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.482 ' CD ' ' HE ' ' A' ' 128' ' ' ARG . 47.9 mt-10 -109.78 24.56 12.88 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 111.708 0.262 . . . . 0.0 111.708 -179.934 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.631 ' HG ' ' HA ' ' A' ' 46' ' ' ARG . 34.6 mt -59.29 -42.7 94.34 Favored Pre-proline 0 C--N 1.328 -0.369 0 C-N-CA 120.692 -0.403 . . . . 0.0 110.543 170.625 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.447 ' HD3' ' HB2' ' A' ' 49' ' ' LEU . 76.2 Cg_exo -51.94 -38.91 69.7 Favored 'Trans proline' 0 C--N 1.36 1.139 0 C-N-CA 122.02 1.813 . . . . 0.0 112.108 169.386 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -74.72 -26.76 60.03 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.146 0.498 . . . . 0.0 110.675 179.948 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 6.5 tt -67.01 -44.01 81.42 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 173.487 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 3.1 mmmp? -60.98 -42.63 98.74 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.558 176.353 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -47.76 -58.58 4.14 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.786 173.662 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.572 ' HG ' ' CZ ' ' A' ' 66' ' ' PHE . 18.0 tp -62.79 -44.24 96.68 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.538 -0.755 . . . . 0.0 110.479 179.169 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 23.7 tt0 -49.46 -60.41 2.87 Favored 'General case' 0 C--N 1.331 -0.212 0 C-N-CA 123.853 0.861 . . . . 0.0 111.876 -179.597 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 32.1 mt-10 -73.03 -35.51 66.77 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.767 -172.797 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 43.6 mtpt -68.14 -38.31 82.01 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.005 0.431 . . . . 0.0 111.609 179.714 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.641 ' HB3' HD11 ' A' ' 64' ' ' ILE . 51.7 m-85 -107.13 10.41 30.12 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.897 -175.769 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -70.45 150.3 46.35 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 109.773 -0.455 . . . . 0.0 109.773 170.478 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 68.72 38.78 86.12 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.574 178.988 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.691 ' HB2' HG12 ' A' ' 64' ' ' ILE . 47.6 mmtm -119.67 -163.53 1.0 Allowed 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.233 0.539 . . . . 0.0 109.933 176.154 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.857 ' HA ' ' HD3' ' A' ' 31' ' ' LYS . 0.6 OUTLIER -92.49 36.62 1.0 Allowed 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 115.265 -0.879 . . . . 0.0 110.127 178.165 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.962 HG22 ' HB2' ' A' ' 32' ' ' TYR . 30.4 pt -141.8 167.38 16.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.543 -174.507 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 65' ' ' HIS . . . . . 0.673 ' NE2' ' HB2' ' A' ' 31' ' ' LYS . 63.2 m-70 -136.45 119.03 15.93 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.172 -0.467 . . . . 0.0 109.919 177.02 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 66' ' ' PHE . . . . . 0.572 ' CZ ' ' HG ' ' A' ' 55' ' ' LEU . 11.8 m-85 -79.5 118.71 21.61 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 170.016 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.584 HG21 HD13 ' A' ' 28' ' ' LEU . 25.4 t -127.59 103.94 11.37 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-O 121.138 0.494 . . . . 0.0 110.707 -175.279 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 68' ' ' SER . . . . . 0.486 ' HA ' ' O ' ' A' ' 36' ' ' ASP . 16.1 m -88.56 129.21 35.53 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-N 115.536 -0.757 . . . . 0.0 110.039 178.613 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.489 ' CD2' ' HB2' ' A' ' 92' ' ' LEU . 54.4 mt -114.33 132.21 56.27 Favored 'General case' 0 N--CA 1.465 0.303 0 O-C-N 122.147 -0.346 . . . . 0.0 110.287 174.988 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 1.4 t -112.34 120.33 41.35 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.17 0.51 . . . . 0.0 112.327 -174.586 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 4.7 p -88.76 18.49 4.69 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.842 177.014 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.531 ' OD2' HG22 ' A' ' 40' ' ' THR . 2.1 m-20 -72.34 136.55 46.2 Favored 'General case' 0 CA--C 1.519 -0.25 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.231 -179.497 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 51.4 tptt -79.16 -37.97 37.11 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 121.228 0.537 . . . . 0.0 110.045 177.936 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' ASN . . . . . 0.547 ' HB2' ' HB3' ' A' ' 77' ' ' ALA . 0.6 OUTLIER -79.42 82.96 5.49 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.759 -179.846 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.498 ' HB2' ' CE1' ' A' ' 93' ' ' HIS . 10.0 tttt -64.38 -51.9 60.96 Favored 'General case' 0 C--N 1.323 -0.545 0 C-N-CA 120.968 -0.293 . . . . 0.0 111.396 -177.129 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.489 ' HD3' ' C ' ' A' ' 76' ' ' LYS . 3.1 tmtm? -58.98 -51.27 70.79 Favored 'General case' 0 N--CA 1.444 -0.757 0 CA-C-N 116.103 -0.499 . . . . 0.0 109.715 -174.922 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.694 ' HA ' ' ND2' ' A' ' 80' ' ' ASN . . . -56.36 -38.48 71.46 Favored 'General case' 0 C--O 1.243 0.72 0 CA-C-O 121.959 0.885 . . . . 0.0 110.926 178.455 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 78' ' ' TRP . . . . . 0.764 ' CE3' ' HB ' ' A' ' 40' ' ' THR . 11.7 t-105 -75.83 -43.86 43.84 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 114.963 -1.017 . . . . 0.0 111.757 -174.169 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.55 ' HB2' HG13 ' A' ' 18' ' ' ILE . 4.0 pt-20 -60.49 -27.92 67.96 Favored 'General case' 0 CA--C 1.542 0.647 0 CA-C-O 121.047 0.451 . . . . 0.0 109.914 179.422 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 80' ' ' ASN . . . . . 0.694 ' ND2' ' HA ' ' A' ' 77' ' ' ALA . 8.9 m-20 -63.12 -52.98 60.42 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-O 120.795 0.331 . . . . 0.0 110.145 171.862 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 81' ' ' MET . . . . . 0.411 ' HG2' ' HZ3' ' A' ' 78' ' ' TRP . 54.8 tpp -56.45 -47.84 78.28 Favored 'General case' 0 CA--C 1.518 -0.288 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.991 -175.83 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.572 HG23 ' HB2' ' A' ' 87' ' ' LEU . 1.6 p -61.16 -34.1 58.98 Favored 'Isoleucine or valine' 0 C--O 1.237 0.401 0 CA-C-O 120.939 0.4 . . . . 0.0 110.847 178.737 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 90.5 m -64.63 -42.53 95.41 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.82 0.343 . . . . 0.0 110.467 174.896 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' LYS . . . . . 0.761 ' HB3' ' HZ2' ' A' ' 84' ' ' LYS . 0.0 OUTLIER -76.79 -37.95 54.88 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.008 -176.535 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 55.8 m-20 -83.02 -0.1 47.31 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.49 -177.95 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 79.5 mt-30 66.08 11.56 7.87 Favored 'General case' 0 N--CA 1.467 0.391 0 N-CA-C 113.69 0.996 . . . . 0.0 113.69 170.724 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.572 ' HB2' HG23 ' A' ' 82' ' ' VAL . 84.9 mt -64.63 126.32 27.51 Favored 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 110.323 -0.251 . . . . 0.0 110.323 178.582 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 21.6 mmtm -123.33 -161.98 1.01 Allowed 'General case' 0 N--CA 1.45 -0.427 0 CA-C-O 120.768 0.318 . . . . 0.0 111.799 -179.217 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 96.13 -156.58 21.34 Favored Glycine 0 N--CA 1.448 -0.535 0 N-CA-C 111.416 -0.674 . . . . 0.0 111.416 -177.579 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.526 ' O ' ' HA ' ' A' ' 67' ' ' VAL . 45.8 mm -93.29 116.46 34.49 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 174.529 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 91' ' ' GLN . . . . . 0.625 ' HB2' ' CZ2' ' A' ' 38' ' ' TRP . 1.9 pt20 -141.64 95.17 2.78 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-O 121.813 0.816 . . . . 0.0 111.83 -168.854 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.489 ' HB2' ' CD2' ' A' ' 69' ' ' LEU . 37.9 mt -94.43 157.11 16.16 Favored 'General case' 0 N--CA 1.442 -0.844 0 CA-C-N 114.779 -1.101 . . . . 0.0 110.421 -176.647 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 93' ' ' HIS . . . . . 0.498 ' CE1' ' HB2' ' A' ' 75' ' ' LYS . 21.9 t-80 -123.98 127.17 47.53 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-N 115.498 -0.774 . . . . 0.0 110.248 -177.684 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 94' ' ' MET . . . . . 0.649 ' HG3' ' HB2' ' A' ' 97' ' ' ASP . 30.2 ttm -81.58 -65.93 0.95 Allowed 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 114.96 -1.018 . . . . 0.0 110.764 -177.289 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 106.53 -94.18 0.92 Allowed Glycine 0 N--CA 1.446 -0.688 0 C-N-CA 120.492 -0.861 . . . . 0.0 112.664 179.772 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -117.75 0.42 11.99 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 120.81 0.338 . . . . 0.0 111.399 -176.279 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 97' ' ' ASP . . . . . 0.649 ' HB2' ' HG3' ' A' ' 94' ' ' MET . 3.9 m-20 -83.89 41.55 0.81 Allowed 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.008 0.433 . . . . 0.0 110.658 -174.294 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.9 -6.74 9.04 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.789 -0.641 . . . . 0.0 112.399 -172.264 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 16.7 m -70.24 -19.27 63.15 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.347 0.594 . . . . 0.0 110.17 176.625 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 52.8 t80 -74.21 -37.94 63.72 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.839 -0.618 . . . . 0.0 109.463 175.069 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 101' ' ' MET . . . . . 0.408 ' HE1' HG21 ' A' ' 106' ' ' ILE . 71.4 mmm -63.37 -42.74 98.88 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 173.353 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -58.7 -47.5 84.33 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 114.422 -1.263 . . . . 0.0 110.701 178.711 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -67.85 -12.76 61.29 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.721 -177.503 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 7.7 m-85 -105.64 6.82 32.36 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.021 179.918 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 3.7 mm? 62.57 25.39 15.11 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.812 -179.097 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 106' ' ' ILE . . . . . 0.735 HG12 ' HG3' ' A' ' 111' ' ' ARG . 58.9 mt -83.61 86.3 2.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.004 174.267 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 13.9 m120 -84.76 -51.41 6.81 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.045 177.274 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -107.73 130.67 10.23 Favored Glycine 0 N--CA 1.441 -1.019 0 CA-C-N 115.448 -0.796 . . . . 0.0 111.676 -179.933 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.428 ' CG2' HG11 ' A' ' 37' ' ' VAL . 2.9 pp -98.98 154.95 37.09 Favored Pre-proline 0 C--N 1.319 -0.751 0 N-CA-C 110.43 -0.211 . . . . 0.0 110.43 177.988 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 110' ' ' PRO . . . . . 0.624 ' HG3' ' SG ' ' A' ' 45' ' ' CYS . 71.8 Cg_endo -82.89 149.5 67.82 Favored 'Cis proline' 0 N--CA 1.46 -0.449 0 C-N-CA 123.523 -1.449 . . . . 0.0 113.036 0.199 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 111' ' ' ARG . . . . . 0.735 ' HG3' HG12 ' A' ' 106' ' ' ILE . 0.0 OUTLIER -103.99 153.17 21.15 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.902 -0.59 . . . . 0.0 109.658 177.657 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 11.9 m-85 -119.72 127.69 53.09 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 108.89 -0.782 . . . . 0.0 108.89 -178.231 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.428 ' HB ' ' HB ' ' A' ' 35' ' ' ILE . 89.6 mt -138.26 144.8 29.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-O 120.685 0.279 . . . . 0.0 110.764 -175.769 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 28.5 tp -128.58 139.78 52.12 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 109.879 -0.415 . . . . 0.0 109.879 178.494 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.691 ' HG ' ' HA ' ' A' ' 121' ' ' ILE . 2.1 mp -133.75 158.83 42.33 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 109.947 -0.39 . . . . 0.0 109.947 -177.796 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 116' ' ' ASP . . . . . 0.54 ' OD2' ' HB2' ' A' ' 120' ' ' LYS . 3.9 p30 -86.12 175.31 8.6 Favored 'General case' 0 CA--C 1.516 -0.349 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.023 177.73 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 117' ' ' ARG . . . . . 0.603 ' HA ' ' O ' ' A' ' 31' ' ' LYS . 21.9 mtp85 -58.17 -26.98 63.42 Favored 'General case' 0 N--CA 1.465 0.298 0 O-C-N 124.36 1.038 . . . . 0.0 112.384 -173.124 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -76.29 -6.91 53.56 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.529 0.68 . . . . 0.0 109.356 -179.239 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 119' ' ' GLY . . . . . 0.555 ' HA2' HD13 ' A' ' 33' ' ' ILE . . . 89.47 23.48 33.85 Favored Glycine 0 N--CA 1.434 -1.463 0 N-CA-C 110.319 -1.113 . . . . 0.0 110.319 -174.857 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 120' ' ' LYS . . . . . 0.54 ' HB2' ' OD2' ' A' ' 116' ' ' ASP . 10.1 mmmm -102.96 118.38 36.7 Favored 'General case' 0 C--O 1.223 -0.295 0 C-N-CA 119.792 -0.763 . . . . 0.0 112.045 -172.96 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 0.691 ' HA ' ' HG ' ' A' ' 115' ' ' LEU . 3.6 mp -46.79 114.69 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.55 -0.75 . . . . 0.0 111.681 178.618 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 122' ' ' ILE . . . . . 0.406 HD11 ' HB3' ' A' ' 116' ' ' ASP . 40.0 mm -92.68 -44.4 13.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 115.229 -0.896 . . . . 0.0 109.659 176.519 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 20.8 m -127.63 114.79 17.83 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.386 -0.824 . . . . 0.0 110.024 177.774 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -72.31 -17.72 61.84 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.074 0.464 . . . . 0.0 110.774 178.971 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 7.2 t30 -142.3 98.84 3.39 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.62 -0.718 . . . . 0.0 109.828 175.969 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 126' ' ' MET . . . . . 0.47 ' HG3' ' H ' ' A' ' 127' ' ' THR . 7.7 tpt -92.73 -150.49 0.27 Allowed 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 178.135 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 127' ' ' THR . . . . . 0.626 ' OG1' ' HB ' ' A' ' 134' ' ' THR . 1.3 p -133.37 131.47 40.09 Favored 'General case' 0 N--CA 1.446 -0.642 0 CA-C-O 121.593 0.711 . . . . 0.0 112.356 -175.053 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 128' ' ' ARG . . . . . 0.482 ' HE ' ' CD ' ' A' ' 48' ' ' GLU . 34.4 ttt85 -31.89 139.2 0.2 Allowed Pre-proline 0 N--CA 1.471 0.588 0 CA-C-N 113.753 -1.567 . . . . 0.0 113.316 170.169 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_exo -40.54 -39.96 3.09 Favored 'Trans proline' 0 C--N 1.352 0.727 0 C-N-CA 124.682 3.588 . . . . 0.0 115.338 179.028 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -72.36 -7.0 47.27 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 112.22 0.452 . . . . 0.0 112.22 -175.589 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 131' ' ' ASP . . . . . 0.554 ' O ' HG22 ' A' ' 134' ' ' THR . 4.5 t70 -85.18 130.09 53.28 Favored Pre-proline 0 C--N 1.324 -0.542 0 CA-C-O 120.829 0.347 . . . . 0.0 110.887 178.468 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -68.6 -22.77 37.56 Favored 'Trans proline' 0 C--N 1.343 0.239 0 C-N-CA 122.648 2.232 . . . . 0.0 113.111 -179.907 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 133' ' ' LYS . . . . . 0.622 ' HA ' ' HG2' ' A' ' 136' ' ' GLU . 0.8 OUTLIER -73.76 -35.38 64.99 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.114 0.483 . . . . 0.0 110.7 -175.87 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 134' ' ' THR . . . . . 0.626 ' HB ' ' OG1' ' A' ' 127' ' ' THR . 4.2 t -71.2 -40.25 71.3 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 176.048 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 135' ' ' ALA . . . . . 0.514 ' HA ' ' CD2' ' A' ' 138' ' ' PHE . . . -62.48 -49.12 76.63 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 115.78 -0.645 . . . . 0.0 111.462 179.162 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 136' ' ' GLU . . . . . 0.622 ' HG2' ' HA ' ' A' ' 133' ' ' LYS . 5.2 pt-20 -58.91 -38.22 78.43 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 121.215 0.531 . . . . 0.0 109.818 179.56 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 137' ' ' LYS . . . . . 0.558 ' O ' ' HG ' ' A' ' 141' ' ' LEU . 0.0 OUTLIER -65.4 -41.52 93.55 Favored 'General case' 0 N--CA 1.448 -0.547 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.014 -177.913 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 138' ' ' PHE . . . . . 0.514 ' CD2' ' HA ' ' A' ' 135' ' ' ALA . 15.3 m-85 -54.5 -52.48 61.81 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-O 121.012 0.434 . . . . 0.0 109.996 176.524 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 139' ' ' ASN . . . . . 0.569 ' HB3' ' HG3' ' A' ' 145' ' ' GLU . 66.2 m-20 -59.37 -50.42 74.02 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.01 179.32 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -52.04 -56.25 15.55 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.242 -0.89 . . . . 0.0 112.768 179.547 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.558 ' HG ' ' O ' ' A' ' 137' ' ' LYS . 4.1 pp -68.87 -21.8 64.24 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 120.816 0.341 . . . . 0.0 111.336 -175.962 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.407 ' N ' HD12 ' A' ' 141' ' ' LEU . 0.2 OUTLIER -78.22 -18.82 54.92 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 175.22 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 87.17 17.72 58.7 Favored Glycine 0 N--CA 1.446 -0.644 0 N-CA-C 111.005 -0.838 . . . . 0.0 111.005 -178.066 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 9.8 tt -80.97 -39.17 26.41 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-N 115.201 -0.499 . . . . 0.0 109.664 -179.355 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 145' ' ' GLU . . . . . 0.569 ' HG3' ' HB3' ' A' ' 139' ' ' ASN . 30.7 mt-10 -101.67 -172.03 2.08 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.248 179.544 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 127.66 63.76 0.13 Allowed Glycine 0 N--CA 1.444 -0.769 0 N-CA-C 111.119 -0.792 . . . . 0.0 111.119 -177.403 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 46.2 t-80 -76.46 64.88 2.23 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-O 121.29 0.567 . . . . 0.0 111.32 -174.682 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 41.6 t60 -135.57 7.31 3.28 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 108.558 -0.904 . . . . 0.0 108.558 172.875 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 149' ' ' HIS . . . . . 0.403 ' HD1' ' C ' ' A' ' 152' ' ' HIS . 16.5 m170 -104.55 -179.87 4.07 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 114.928 -1.033 . . . . 0.0 109.146 179.038 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 50.9 m-70 -110.22 2.6 19.39 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.803 0.335 . . . . 0.0 111.414 -179.407 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 58.2 m-70 -152.67 -63.67 0.16 Allowed 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 173.954 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 152' ' ' HIS . . . . . 0.403 ' C ' ' HD1' ' A' ' 149' ' ' HIS . 53.0 t-80 . . . . . 0 C--O 1.25 1.091 0 CA-C-O 117.454 -1.26 . . . . 0.0 107.689 173.272 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.448 ' HG3' ' HB3' ' A' ' 10' ' ' ALA . 93.1 mtp . . . . . 0 N--CA 1.481 1.112 0 N-CA-C 110.007 -0.368 . . . . 0.0 110.007 . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 9.9 m -83.9 120.55 26.22 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.808 -0.441 . . . . 0.0 109.808 177.041 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -76.44 73.93 3.19 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.117 0.484 . . . . 0.0 110.762 -178.822 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 35.1 tpt85 -109.21 -22.66 11.99 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.256 177.287 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 13.2 p -79.48 -25.17 41.92 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.997 -178.459 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 88.38 -6.14 83.91 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.797 -0.716 . . . . 0.0 111.652 -178.008 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 4.3 m-20 -97.03 156.1 36.74 Favored Pre-proline 0 C--N 1.325 -0.48 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 178.865 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.564 ' HG2' HG21 ' A' ' 99' ' ' THR . 2.3 Cg_endo -48.31 -56.01 3.53 Favored 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 123.39 2.727 . . . . 0.0 112.892 -177.34 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 13.7 m 61.28 -171.25 0.15 Allowed 'General case' 0 C--O 1.233 0.184 0 CA-C-O 121.475 0.655 . . . . 0.0 111.158 176.96 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.448 ' HB3' ' HG3' ' A' ' 1' ' ' MET . . . -79.28 68.64 5.33 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.937 -0.574 . . . . 0.0 109.672 174.18 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -154.47 -34.7 0.1 Allowed 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.49 -0.777 . . . . 0.0 111.193 -178.836 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 22.8 t -169.54 153.42 5.11 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 178.521 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' PHE . . . . . 0.427 ' CD2' ' HZ ' ' A' ' 100' ' ' PHE . 52.3 p90 -154.98 152.82 30.14 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-O 120.81 0.338 . . . . 0.0 110.938 179.405 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 19.3 m -143.75 106.56 4.47 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 169.701 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' TYR . . . . . 0.776 ' HB2' HD12 ' A' ' 92' ' ' LEU . 24.8 m-85 -128.35 154.7 79.13 Favored Pre-proline 0 C--N 1.325 -0.483 0 CA-C-N 116.762 -0.199 . . . . 0.0 110.963 -174.716 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -81.89 125.43 4.79 Favored 'Trans proline' 0 CA--C 1.532 0.386 0 C-N-CA 122.6 2.2 . . . . 0.0 113.87 -178.479 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' ASP . . . . . 0.671 ' HB3' ' HB3' ' A' ' 21' ' ' LYS . 0.4 OUTLIER -69.53 163.62 25.01 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.009 -0.996 . . . . 0.0 109.918 171.212 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.65 HD12 HG13 ' A' ' 82' ' ' VAL . 0.9 OUTLIER -43.85 -44.99 1.94 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.662 0 O-C-N 123.858 0.724 . . . . 0.0 112.252 -177.883 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.486 ' ND2' HG23 ' A' ' 18' ' ' ILE . 29.2 m-80 -77.24 3.81 12.0 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.495 -174.792 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 83.62 32.57 24.31 Favored Glycine 0 N--CA 1.446 -0.683 0 N-CA-C 110.662 -0.975 . . . . 0.0 110.662 -174.289 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.671 ' HB3' ' HB3' ' A' ' 17' ' ' ASP . 8.0 ttpm? -104.94 105.97 16.25 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.758 0.313 . . . . 0.0 110.796 -174.549 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 19.3 m -67.68 117.33 9.46 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.147 -179.935 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.452 HG11 HD22 ' A' ' 92' ' ' LEU . 7.1 p -117.77 143.49 28.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 115.939 -0.573 . . . . 0.0 109.475 177.396 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 60.4 p -122.48 -173.19 2.63 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.02 0.438 . . . . 0.0 110.579 -175.621 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 64.8 tp -85.91 -19.89 29.83 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.775 177.973 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.901 ' HA ' ' HD3' ' A' ' 29' ' ' LYS . . . -78.46 -35.23 46.97 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.568 -0.287 . . . . 0.0 111.423 -172.593 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -78.24 -11.79 59.95 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.36 0.6 . . . . 0.0 110.543 179.783 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.528 HD13 HG21 ' A' ' 67' ' ' VAL . 92.8 mt -92.78 -9.18 41.46 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.632 177.324 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.901 ' HD3' ' HA ' ' A' ' 26' ' ' ALA . 13.4 mtpp -75.98 153.59 36.44 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.266 0.555 . . . . 0.0 111.537 -179.07 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 101.7 -3.12 52.96 Favored Glycine 0 N--CA 1.45 -0.385 0 CA-C-N 115.357 -0.838 . . . . 0.0 111.747 -178.227 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.617 ' HB3' ' NE2' ' A' ' 65' ' ' HIS . 24.2 ttmm -157.97 145.89 18.62 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 -179.108 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.44 ' HB2' ' O ' ' A' ' 63' ' ' ASP . 34.6 m-85 -53.63 149.37 8.28 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-O 120.906 0.384 . . . . 0.0 111.424 -177.861 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.468 HD12 ' HA2' ' A' ' 119' ' ' GLY . 55.1 mt -125.28 138.69 53.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.554 -175.581 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 59.4 t80 -127.45 123.74 36.75 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 174.677 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.602 ' HB ' ' HB ' ' A' ' 113' ' ' ILE . 66.4 mt -109.59 123.13 65.23 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-O 121.074 0.464 . . . . 0.0 111.189 -177.028 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.432 ' HA ' ' O ' ' A' ' 111' ' ' ARG . 4.7 p-10 -116.37 159.32 22.13 Favored 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 173.216 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.553 HG11 HG21 ' A' ' 109' ' ' ILE . 60.7 t -105.22 115.47 47.13 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.839 0 C-N-CA 120.203 -0.599 . . . . 0.0 111.235 176.241 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 38' ' ' TRP . . . . . 0.644 ' HZ3' HG21 ' A' ' 82' ' ' VAL . 0.6 OUTLIER -98.12 132.79 43.36 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 179.358 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.568 ' HA ' ' OD1' ' A' ' 72' ' ' ASP . . . -147.05 152.99 39.47 Favored 'General case' 0 C--O 1.236 0.368 0 N-CA-C 112.268 0.47 . . . . 0.0 112.268 -173.837 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.557 HG23 ' SD ' ' A' ' 81' ' ' MET . 0.5 OUTLIER -83.68 -48.06 10.56 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.703 0.763 . . . . 0.0 110.182 176.561 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 41' ' ' TRP . . . . . 0.428 ' HE1' ' HA ' ' A' ' 72' ' ' ASP . 17.4 p-90 -81.73 20.08 0.99 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 114.654 -1.157 . . . . 0.0 112.283 -171.309 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 42' ' ' CYS . . . . . 0.687 ' HB3' ' SG ' ' A' ' 45' ' ' CYS . 40.5 t -88.39 -64.03 1.21 Allowed 'General case' 0 C--N 1.322 -0.613 0 C-N-CA 120.541 -0.464 . . . . 0.0 110.38 -179.672 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 108.46 -84.1 0.36 Allowed Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.611 -0.804 . . . . 0.0 112.232 -178.736 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_exo -53.91 -22.6 24.69 Favored 'Trans proline' 0 C--N 1.352 0.736 0 C-N-CA 123.244 2.63 . . . . 0.0 112.946 177.57 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' CYS . . . . . 0.687 ' SG ' ' HB3' ' A' ' 42' ' ' CYS . 26.3 p -52.45 -31.87 36.84 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.26 177.843 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.573 ' HA ' ' HG ' ' A' ' 49' ' ' LEU . 64.9 mtp180 -72.91 -14.39 61.46 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.121 -175.617 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -84.26 -25.56 43.43 Favored Glycine 0 N--CA 1.448 -0.535 0 N-CA-C 111.244 -0.742 . . . . 0.0 111.244 174.484 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -87.12 -20.95 26.34 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.952 -0.388 . . . . 0.0 109.952 -179.186 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.687 ' HB2' ' HD3' ' A' ' 50' ' ' PRO . 79.4 mt -52.74 -50.61 80.09 Favored Pre-proline 0 CA--C 1.534 0.365 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.4 -179.225 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.687 ' HD3' ' HB2' ' A' ' 49' ' ' LEU . 52.8 Cg_exo -57.73 -34.91 98.85 Favored 'Trans proline' 0 C--N 1.355 0.875 0 C-N-CA 121.905 1.737 . . . . 0.0 112.552 173.476 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -75.48 -31.82 60.36 Favored 'General case' 0 N--CA 1.454 -0.236 0 CA-C-O 121.274 0.559 . . . . 0.0 109.889 -176.948 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 6.9 tt -68.0 -40.2 83.09 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.326 -0.852 . . . . 0.0 108.934 177.097 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.862 ' HA ' ' HG2' ' A' ' 56' ' ' GLU . 12.3 mtpp -60.13 -43.99 95.27 Favored 'General case' 0 CA--C 1.517 -0.298 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.857 176.198 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.596 ' O ' ' HB2' ' A' ' 58' ' ' LYS . 23.5 mm-40 -50.2 -47.82 54.53 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.814 173.365 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 6.0 mp -66.27 -51.77 54.14 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 111.873 0.324 . . . . 0.0 111.873 179.074 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.862 ' HG2' ' HA ' ' A' ' 53' ' ' LYS . 10.2 pt-20 -58.11 -46.48 85.49 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 120.571 0.224 . . . . 0.0 111.436 -173.964 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.726 ' HG3' ' HG3' ' A' ' 56' ' ' GLU . 62.4 mt-10 -80.88 -25.53 37.55 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.819 0.342 . . . . 0.0 111.024 -174.173 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.596 ' HB2' ' O ' ' A' ' 54' ' ' GLU . 16.2 ttmm -75.84 -34.53 60.09 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.343 0.592 . . . . 0.0 110.25 178.099 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.469 ' HD1' ' HG3' ' A' ' 62' ' ' LYS . 97.9 m-85 -108.63 8.54 27.09 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.488 -176.45 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -60.9 112.08 1.91 Allowed 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 170.467 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 111.27 -8.42 28.81 Favored Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 120.641 -0.79 . . . . 0.0 111.822 -177.763 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.469 ' HG3' ' HD1' ' A' ' 59' ' ' TYR . 45.8 mmtm -84.65 -157.72 0.3 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.465 0.65 . . . . 0.0 109.892 176.371 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.522 ' CG ' ' HG3' ' A' ' 31' ' ' LYS . 9.1 t70 -108.46 75.1 0.96 Allowed 'General case' 0 C--N 1.314 -0.955 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.026 176.387 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 17.1 tt -157.4 143.54 9.22 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.64 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.01 178.084 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' HIS . . . . . 0.617 ' NE2' ' HB3' ' A' ' 31' ' ' LYS . 93.1 m-70 -111.14 108.94 18.79 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 171.663 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 73.3 m-85 -77.05 107.75 9.63 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 173.211 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.56 HG13 HD21 ' A' ' 92' ' ' LEU . 98.1 t -120.28 104.68 15.83 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-N 115.211 -0.904 . . . . 0.0 110.843 -173.086 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 68' ' ' SER . . . . . 0.693 ' HB2' ' HG2' ' A' ' 91' ' ' GLN . 11.0 m -91.25 130.97 37.06 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.815 178.152 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.717 HD11 ' HB2' ' A' ' 94' ' ' MET . 62.3 tp -121.66 131.95 54.38 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 110.05 -0.352 . . . . 0.0 110.05 177.537 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 1.7 t -112.89 120.78 42.6 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.318 0.58 . . . . 0.0 112.297 -173.013 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 9.9 m -82.71 9.61 9.27 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.58 -0.736 . . . . 0.0 111.398 175.251 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.697 ' O ' ' HA2' ' A' ' 95' ' ' GLY . 2.2 m-20 -66.02 132.81 49.43 Favored 'General case' 0 CA--C 1.517 -0.307 0 CA-C-O 120.917 0.389 . . . . 0.0 111.766 -174.78 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 21.0 ttpp -76.12 -30.63 58.29 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 121.367 0.603 . . . . 0.0 110.051 175.16 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -84.62 105.32 15.34 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 108.933 -0.766 . . . . 0.0 108.933 -179.949 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 14.3 tttt -78.01 -57.25 3.9 Favored 'General case' 0 C--N 1.319 -0.735 0 C-N-CA 118.834 -1.146 . . . . 0.0 111.055 177.996 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.675 ' HA ' ' OE2' ' A' ' 79' ' ' GLU . 12.5 ttmm -55.56 -50.41 70.13 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 112.535 0.568 . . . . 0.0 112.535 -175.298 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -60.58 -33.2 72.36 Favored 'General case' 0 CA--C 1.522 -0.104 0 CA-C-O 121.545 0.688 . . . . 0.0 110.297 -178.09 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' TRP . . . . . 0.564 ' CZ2' ' CE3' ' A' ' 38' ' ' TRP . 10.9 t-105 -80.47 -43.88 20.14 Favored 'General case' 0 N--CA 1.442 -0.827 0 CA-C-N 115.236 -0.893 . . . . 0.0 110.937 -178.285 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.675 ' OE2' ' HA ' ' A' ' 76' ' ' LYS . 1.3 pt-20 -64.09 -36.51 84.25 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.405 -178.953 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 24.9 p30 -78.11 -27.61 48.43 Favored 'General case' 0 C--N 1.332 -0.189 0 C-N-CA 120.111 -0.636 . . . . 0.0 110.636 178.652 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' MET . . . . . 0.557 ' SD ' HG23 ' A' ' 40' ' ' THR . 19.5 ttt -68.17 -50.06 56.86 Favored 'General case' 0 C--O 1.218 -0.605 0 C-N-CA 121.031 -0.268 . . . . 0.0 111.021 173.946 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.65 HG13 HD12 ' A' ' 18' ' ' ILE . 5.6 p -59.91 -31.99 48.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 C-N-CA 120.306 -0.558 . . . . 0.0 110.598 179.491 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 60.5 m -67.25 -41.47 85.53 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-O 120.952 0.406 . . . . 0.0 110.762 173.734 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 51.2 tptt -70.0 -46.19 65.65 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.912 179.738 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' ASP . . . . . 0.419 ' CG ' HH21 ' A' ' 46' ' ' ARG . 0.9 OUTLIER -73.85 -8.62 56.75 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.184 -0.916 . . . . 0.0 111.045 179.511 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 88.0 mt-30 61.56 32.82 18.61 Favored 'General case' 0 C--O 1.238 0.454 0 N-CA-C 113.328 0.862 . . . . 0.0 113.328 169.388 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.569 ' HB2' HG23 ' A' ' 82' ' ' VAL . 75.9 mt -67.86 152.37 45.68 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.632 0.253 . . . . 0.0 110.582 177.85 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.453 ' HB2' ' OE1' ' A' ' 56' ' ' GLU . 28.9 mmtm -125.03 -162.46 1.1 Allowed 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.998 178.352 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 86.53 -155.29 28.01 Favored Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 120.918 -0.658 . . . . 0.0 111.944 -178.797 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 63.0 mt -109.98 110.94 34.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 176.342 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 91' ' ' GLN . . . . . 0.693 ' HG2' ' HB2' ' A' ' 68' ' ' SER . 95.1 mt-30 -128.53 111.57 13.39 Favored 'General case' 0 N--CA 1.441 -0.883 0 CA-C-O 121.33 0.586 . . . . 0.0 111.131 -175.541 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.776 HD12 ' HB2' ' A' ' 15' ' ' TYR . 0.4 OUTLIER -109.1 146.08 34.63 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.238 -179.0 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 18.9 t-80 -110.27 119.14 38.28 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.783 -175.585 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 94' ' ' MET . . . . . 0.717 ' HB2' HD11 ' A' ' 69' ' ' LEU . 26.2 ttp -83.11 -56.88 3.53 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 114.929 -1.032 . . . . 0.0 110.838 -177.343 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 95' ' ' GLY . . . . . 0.697 ' HA2' ' O ' ' A' ' 72' ' ' ASP . . . 86.78 -90.43 1.67 Allowed Glycine 0 N--CA 1.445 -0.703 0 C-N-CA 120.214 -0.993 . . . . 0.0 113.296 176.126 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 1.7 p -103.56 -20.24 14.09 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 112.33 0.493 . . . . 0.0 112.33 -174.125 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -93.09 54.15 2.09 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-O 121.185 0.517 . . . . 0.0 111.033 -165.627 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 98' ' ' ARG . . . . . 0.696 ' HA ' ' SD ' ' A' ' 94' ' ' MET . 0.0 OUTLIER -81.24 40.26 0.55 Allowed 'General case' 0 CA--C 1.516 -0.363 0 N-CA-C 112.845 0.683 . . . . 0.0 112.845 -172.243 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 99' ' ' THR . . . . . 0.564 HG21 ' HG2' ' A' ' 8' ' ' PRO . 7.3 t -60.9 -17.71 52.3 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 169.77 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 100' ' ' PHE . . . . . 0.427 ' HZ ' ' CD2' ' A' ' 13' ' ' PHE . 2.8 m-85 -72.91 -37.14 67.34 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-N 115.218 -0.901 . . . . 0.0 111.377 174.392 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 101' ' ' MET . . . . . 0.93 ' HA ' ' HB ' ' A' ' 106' ' ' ILE . 83.8 mtp -63.67 -48.47 77.06 Favored 'General case' 0 CA--C 1.517 -0.313 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 178.717 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -62.77 -37.87 88.37 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.824 -0.625 . . . . 0.0 111.112 177.053 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -71.68 -47.35 54.76 Favored 'General case' 0 N--CA 1.463 0.197 0 N-CA-C 112.367 0.506 . . . . 0.0 112.367 -175.071 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 104' ' ' TYR . . . . . 0.704 ' HB2' HG12 ' A' ' 106' ' ' ILE . 67.3 m-85 -96.95 0.48 49.0 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 112.069 0.396 . . . . 0.0 112.069 -174.491 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 9.6 mp 64.57 26.34 13.28 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.309 0.576 . . . . 0.0 110.006 -173.104 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 106' ' ' ILE . . . . . 0.93 ' HB ' ' HA ' ' A' ' 101' ' ' MET . 33.8 mm -55.67 108.96 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.155 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.188 172.933 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 48.5 t-20 -139.65 -66.61 0.45 Allowed 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 178.328 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -72.03 100.1 0.91 Allowed Glycine 0 N--CA 1.446 -0.699 0 C-N-CA 120.62 -0.8 . . . . 0.0 111.188 174.366 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.553 HG21 HG11 ' A' ' 37' ' ' VAL . 2.7 pp -106.2 154.22 39.81 Favored Pre-proline 0 C--N 1.323 -0.587 0 C-N-CA 121.544 -0.062 . . . . 0.0 110.986 -178.74 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 110' ' ' PRO . . . . . 0.502 ' C ' ' HA ' ' A' ' 109' ' ' ILE . 22.7 Cg_exo -65.52 138.38 36.19 Favored 'Cis proline' 0 C--N 1.349 0.561 0 C-N-CA 124.224 -1.156 . . . . 0.0 113.392 1.016 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 111' ' ' ARG . . . . . 0.505 ' HD3' ' H ' ' A' ' 112' ' ' PHE . 0.0 OUTLIER -96.1 150.49 20.44 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.842 -0.617 . . . . 0.0 109.56 178.46 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 112' ' ' PHE . . . . . 0.579 ' HB2' ' HB2' ' A' ' 126' ' ' MET . 0.1 OUTLIER -116.35 114.36 24.2 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.279 -0.873 . . . . 0.0 110.583 -174.97 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.658 HD11 HD11 ' A' ' 106' ' ' ILE . 67.6 mt -128.86 144.46 38.04 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.354 0 CA-C-O 120.819 0.343 . . . . 0.0 111.064 -179.187 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 45.6 tp -128.71 134.08 48.35 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.064 -0.516 . . . . 0.0 109.987 176.717 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.48 HD23 HG13 ' A' ' 121' ' ' ILE . 0.4 OUTLIER -135.47 152.69 51.6 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.453 0.644 . . . . 0.0 110.601 -178.959 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 116' ' ' ASP . . . . . 0.827 ' HB3' ' HB2' ' A' ' 120' ' ' LYS . 43.0 t0 -70.61 164.5 24.79 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 114.735 -1.12 . . . . 0.0 110.36 179.707 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 117' ' ' ARG . . . . . 0.42 ' HA ' ' O ' ' A' ' 31' ' ' LYS . 40.0 mtm180 -51.56 -20.99 2.19 Favored 'General case' 0 C--N 1.323 -0.578 0 C-N-CA 124.589 1.155 . . . . 0.0 113.515 -173.98 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 118' ' ' ASP . . . . . 0.511 ' HB3' ' HG3' ' A' ' 120' ' ' LYS . 26.6 t70 -96.91 1.9 51.02 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-O 121.471 0.653 . . . . 0.0 110.262 -175.966 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 119' ' ' GLY . . . . . 0.468 ' HA2' HD12 ' A' ' 33' ' ' ILE . . . 88.17 16.93 58.46 Favored Glycine 0 N--CA 1.44 -1.034 0 N-CA-C 110.504 -1.038 . . . . 0.0 110.504 -171.752 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 120' ' ' LYS . . . . . 0.827 ' HB2' ' HB3' ' A' ' 116' ' ' ASP . 6.2 mtpm? -85.02 102.85 13.53 Favored 'General case' 0 C--O 1.221 -0.419 0 C-N-CA 121.047 -0.261 . . . . 0.0 110.953 -175.955 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 0.684 ' H ' HD12 ' A' ' 121' ' ' ILE . 4.1 mp -45.8 115.94 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 O-C-N 123.728 0.643 . . . . 0.0 111.561 -176.546 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 122' ' ' ILE . . . . . 0.469 ' H ' ' HA ' ' A' ' 115' ' ' LEU . 56.3 mt -89.77 -39.27 12.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 178.404 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 17.1 m -154.4 125.11 7.07 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.369 -0.832 . . . . 0.0 109.77 176.932 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 124' ' ' ALA . . . . . 0.447 ' O ' HG12 ' A' ' 113' ' ' ILE . . . -72.5 -18.74 61.64 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.33 0.586 . . . . 0.0 110.21 177.982 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 16.2 p-10 -142.03 121.69 13.41 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.402 -0.817 . . . . 0.0 110.445 176.668 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 126' ' ' MET . . . . . 0.579 ' HB2' ' HB2' ' A' ' 112' ' ' PHE . 92.3 mmm -95.65 -117.86 0.11 Allowed 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.048 174.197 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 127' ' ' THR . . . . . 0.603 ' HB ' ' CG ' ' A' ' 131' ' ' ASP . 4.0 m -132.36 -50.38 0.93 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.877 0.37 . . . . 0.0 110.768 -179.482 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 128' ' ' ARG . . . . . 0.972 ' HB3' ' HB3' ' A' ' 131' ' ' ASP . 46.9 ttt180 -165.76 151.18 8.05 Favored Pre-proline 0 N--CA 1.444 -0.746 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 -178.674 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 20.5 Cg_exo -64.98 7.78 0.25 Allowed 'Trans proline' 0 CA--C 1.532 0.417 0 C-N-CA 122.141 1.894 . . . . 0.0 112.797 175.589 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 130' ' ' SER . . . . . 0.427 ' H ' ' C ' ' A' ' 128' ' ' ARG . 11.4 p -158.77 21.15 0.21 Allowed 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 111.808 0.299 . . . . 0.0 111.808 -178.895 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 131' ' ' ASP . . . . . 0.972 ' HB3' ' HB3' ' A' ' 128' ' ' ARG . 1.2 p30 -75.97 152.76 84.64 Favored Pre-proline 0 N--CA 1.444 -0.77 0 O-C-N 122.151 -0.343 . . . . 0.0 110.412 179.7 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -65.65 -28.01 52.69 Favored 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.842 2.361 . . . . 0.0 114.042 -175.028 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 133' ' ' LYS . . . . . 0.802 ' HA ' ' HG2' ' A' ' 136' ' ' GLU . 36.0 mttm -79.24 -28.92 42.48 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.019 0.437 . . . . 0.0 111.041 -176.289 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 134' ' ' THR . . . . . 0.701 HG22 ' CZ ' ' A' ' 138' ' ' PHE . 96.9 m -71.89 -38.82 69.92 Favored 'General case' 0 C--N 1.317 -0.838 0 N-CA-C 109.611 -0.514 . . . . 0.0 109.611 171.48 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 135' ' ' ALA . . . . . 0.439 ' HA ' ' CD2' ' A' ' 138' ' ' PHE . . . -61.59 -49.8 75.16 Favored 'General case' 0 C--O 1.236 0.39 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.659 174.742 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 136' ' ' GLU . . . . . 0.802 ' HG2' ' HA ' ' A' ' 133' ' ' LYS . 11.9 pt-20 -63.65 -28.32 69.83 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 120.961 0.41 . . . . 0.0 110.111 179.104 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 137' ' ' LYS . . . . . 0.638 ' O ' ' HG ' ' A' ' 141' ' ' LEU . 0.7 OUTLIER -60.09 -48.27 82.41 Favored 'General case' 0 N--CA 1.446 -0.654 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.406 175.866 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 138' ' ' PHE . . . . . 0.701 ' CZ ' HG22 ' A' ' 134' ' ' THR . 8.6 m-85 -54.46 -47.12 73.31 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.012 177.566 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 85.3 m-20 -56.63 -47.71 79.12 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.262 177.147 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 140' ' ' GLU . . . . . 0.538 ' HA ' ' HB2' ' A' ' 145' ' ' GLU . 43.6 tt0 -60.15 -43.01 96.08 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.553 179.103 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.638 ' HG ' ' O ' ' A' ' 137' ' ' LYS . 94.0 mt -57.39 -44.82 84.84 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.409 -178.646 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 10.0 mp -81.64 -14.96 56.03 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.819 0.342 . . . . 0.0 111.032 -179.667 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 89.27 20.05 47.19 Favored Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 120.829 -0.7 . . . . 0.0 111.733 -179.852 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 10.3 tt -82.23 -24.77 34.67 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.43 -0.581 . . . . 0.0 109.43 -179.643 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 145' ' ' GLU . . . . . 0.538 ' HB2' ' HA ' ' A' ' 140' ' ' GLU . 1.8 mm-40 -56.52 145.18 28.78 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 115.435 -0.802 . . . . 0.0 111.553 176.261 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -159.99 -140.71 2.96 Favored Glycine 0 N--CA 1.445 -0.718 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.092 -178.759 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 54.3 t-80 -80.47 63.68 5.0 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 109.705 -0.48 . . . . 0.0 109.705 179.501 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 13.5 p-80 -74.7 -13.88 60.67 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.102 -177.809 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 4.1 t-80 -168.51 -81.68 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.166 -0.47 . . . . 0.0 109.815 172.272 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -155.2 130.78 9.82 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 110.1 -0.333 . . . . 0.0 110.1 179.904 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 20.3 p-80 -95.85 -22.78 17.25 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 172.253 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 60.1 t-80 . . . . . 0 C--O 1.248 0.984 0 CA-C-N 114.5 -1.227 . . . . 0.0 108.319 175.125 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 51.1 ttm . . . . . 0 N--CA 1.484 1.228 0 N-CA-C 109.98 -0.378 . . . . 0.0 109.98 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 20.3 m 59.35 -166.57 0.17 Allowed 'General case' 0 CA--C 1.53 0.173 0 O-C-N 123.736 0.647 . . . . 0.0 110.262 -177.078 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.461 ' O ' HD22 ' A' ' 3' ' ' LEU . 0.0 OUTLIER -137.56 132.96 33.91 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.129 0.49 . . . . 0.0 110.577 176.558 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 4' ' ' ARG . . . . . 0.443 ' HB2' ' O ' ' A' ' 3' ' ' LEU . 40.7 ttm180 170.01 -45.49 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 -179.159 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 23.1 t -149.01 143.62 26.21 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 114.51 -1.223 . . . . 0.0 108.129 174.899 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 82.12 -111.34 3.33 Favored Glycine 0 N--CA 1.446 -0.691 0 C-N-CA 120.469 -0.872 . . . . 0.0 111.641 -176.083 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 32.0 p30 -168.25 159.69 9.05 Favored Pre-proline 0 C--O 1.238 0.482 0 CA-C-O 120.953 0.406 . . . . 0.0 111.372 -178.961 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 15.4 Cg_exo -69.43 145.28 58.55 Favored 'Trans proline' 0 N--CA 1.462 -0.377 0 C-N-CA 122.54 2.16 . . . . 0.0 110.663 171.083 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 27.6 m -73.08 87.33 1.38 Allowed 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.633 0.254 . . . . 0.0 110.805 -177.169 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.692 ' HA ' ' CE1' ' A' ' 100' ' ' PHE . . . 63.01 10.81 4.67 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 115.562 -0.744 . . . . 0.0 111.839 178.4 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.621 ' HB1' ' HE3' ' A' ' 120' ' ' LYS . . . -89.77 -6.07 56.33 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.582 -175.142 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 50.1 m -158.12 129.83 6.77 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.557 179.908 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' PHE . . . . . 0.442 ' CE2' HD13 ' A' ' 25' ' ' LEU . 52.4 p90 -157.65 159.46 37.01 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.481 -0.327 . . . . 0.0 110.295 176.451 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.561 ' HA ' ' HA ' ' A' ' 24' ' ' SER . 19.2 m -142.46 124.97 15.71 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.215 -0.448 . . . . 0.0 109.801 177.785 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 77.7 m-85 -139.25 154.18 71.8 Favored Pre-proline 0 C--N 1.326 -0.425 0 CA-C-O 120.516 0.198 . . . . 0.0 110.869 -178.002 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.514 ' HA ' ' O ' ' A' ' 21' ' ' LYS . 6.8 Cg_endo -85.15 127.93 3.53 Favored 'Trans proline' 0 N--CA 1.452 -0.92 0 C-N-CA 122.478 2.118 . . . . 0.0 112.928 179.437 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 17' ' ' ASP . . . . . 0.52 ' HA ' ' O ' ' A' ' 91' ' ' GLN . 11.7 t70 -67.18 154.65 40.74 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 169.409 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.497 HD12 ' CG1' ' A' ' 82' ' ' VAL . 5.9 tt -52.06 -33.3 16.26 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.435 0 O-C-N 123.729 0.643 . . . . 0.0 111.431 -176.338 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 40.3 m-80 -69.09 -9.68 53.88 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.027 -179.627 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 92.93 36.83 5.9 Favored Glycine 0 N--CA 1.446 -0.656 0 CA-C-N 115.802 -0.636 . . . . 0.0 111.802 -179.382 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.514 ' O ' ' HA ' ' A' ' 16' ' ' PRO . 62.3 tttm -107.04 121.79 45.18 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 120.573 -0.451 . . . . 0.0 110.617 -178.306 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 12.9 m -67.35 99.76 0.76 Allowed 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 109.651 -0.5 . . . . 0.0 109.651 173.566 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.431 ' HB ' ' CD2' ' A' ' 92' ' ' LEU . 96.6 t -107.57 115.43 48.77 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-N 115.888 -0.596 . . . . 0.0 109.905 -178.77 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' SER . . . . . 0.561 ' HA ' ' HA ' ' A' ' 14' ' ' SER . 77.9 p -98.75 171.08 8.32 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 115.878 -0.601 . . . . 0.0 109.712 179.411 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.503 HD21 ' O ' ' A' ' 119' ' ' GLY . 27.0 tp -66.99 -22.27 65.92 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.087 0.47 . . . . 0.0 110.435 177.113 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -79.94 -31.48 40.01 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.092 176.593 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.428 ' OD2' HG13 ' A' ' 23' ' ' VAL . 20.6 t70 -66.69 -21.95 66.09 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 115.511 -0.768 . . . . 0.0 110.005 176.813 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.647 HD13 HG21 ' A' ' 67' ' ' VAL . 96.0 mt -105.96 3.22 28.17 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.456 -0.793 . . . . 0.0 111.779 -179.446 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.47 ' HG2' ' HA ' ' A' ' 118' ' ' ASP . 18.8 mtpt -75.08 162.01 28.91 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 121.377 0.608 . . . . 0.0 112.063 -177.6 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 113.84 -41.82 2.1 Favored Glycine 0 N--CA 1.447 -0.6 0 CA-C-N 115.332 -0.849 . . . . 0.0 111.459 179.809 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.478 ' O ' ' HA ' ' A' ' 117' ' ' ARG . 60.7 mttm -125.79 165.4 18.72 Favored 'General case' 0 N--CA 1.447 -0.623 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 177.48 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -63.68 134.82 56.08 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 177.667 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.462 HD13 ' HA2' ' A' ' 119' ' ' GLY . 5.0 mp -102.49 132.31 48.82 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.914 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 179.289 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 18.6 t80 -113.49 107.61 16.05 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 174.711 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.708 ' HA ' ' O ' ' A' ' 67' ' ' VAL . 62.6 mt -91.56 120.45 40.64 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.746 -176.251 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.495 ' O ' ' HA ' ' A' ' 68' ' ' SER . 3.8 t70 -118.13 125.96 51.28 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 177.176 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.661 HG11 HG21 ' A' ' 109' ' ' ILE . 42.5 t -79.49 112.38 17.46 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.761 0 CA-C-O 121.507 0.67 . . . . 0.0 111.57 -175.572 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 38' ' ' TRP . . . . . 0.579 ' HZ3' ' CG2' ' A' ' 82' ' ' VAL . 0.8 OUTLIER -101.36 134.31 44.64 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.092 -0.958 . . . . 0.0 109.629 178.651 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -146.54 170.46 16.85 Favored 'General case' 0 C--N 1.321 -0.661 0 O-C-N 122.072 -0.393 . . . . 0.0 110.316 -179.592 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.701 ' HB ' ' CE3' ' A' ' 78' ' ' TRP . 8.8 t -91.05 1.44 57.08 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.508 0.671 . . . . 0.0 110.109 178.369 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 8.4 p-90 -126.6 17.93 7.47 Favored 'General case' 0 N--CA 1.448 -0.568 0 CA-C-N 115.613 -0.721 . . . . 0.0 111.411 -179.237 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 26.4 p -105.83 108.36 19.83 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-O 121.302 0.572 . . . . 0.0 109.973 175.764 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.449 ' N ' ' HD2' ' A' ' 44' ' ' PRO . . . -72.56 -62.83 3.09 Favored Glycine 0 CA--C 1.525 0.71 0 CA-C-N 115.563 -0.744 . . . . 0.0 114.446 -174.502 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.449 ' HD2' ' N ' ' A' ' 43' ' ' GLY . 10.4 Cg_endo -52.1 -32.53 49.64 Favored 'Trans proline' 0 C--N 1.356 0.936 0 C-N-CA 123.523 2.815 . . . . 0.0 113.687 -171.364 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 45' ' ' CYS . . . . . 0.68 ' HB2' ' CG ' ' A' ' 110' ' ' PRO . 37.1 t -57.37 -31.17 65.51 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.657 -177.544 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.5 ' HA ' ' HG ' ' A' ' 49' ' ' LEU . 1.7 mpt_? -63.96 -43.29 96.26 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 112.478 0.548 . . . . 0.0 112.478 -172.501 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -69.17 -8.32 58.48 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.89 -0.671 . . . . 0.0 113.291 -174.82 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.474 ' CD ' ' HE ' ' A' ' 128' ' ' ARG . 24.4 mt-10 -119.21 3.62 11.36 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.649 0.261 . . . . 0.0 111.14 -177.719 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.57 ' HB2' ' HD3' ' A' ' 50' ' ' PRO . 87.2 mt -53.97 -46.88 98.45 Favored Pre-proline 0 CA--C 1.534 0.354 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.451 176.584 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.57 ' HD3' ' HB2' ' A' ' 49' ' ' LEU . 75.0 Cg_exo -51.34 -44.22 44.62 Favored 'Trans proline' 0 C--N 1.358 1.07 0 C-N-CA 121.93 1.753 . . . . 0.0 111.994 172.518 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -69.92 -32.42 70.69 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.024 0.44 . . . . 0.0 110.942 -176.329 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 7.6 tt -63.94 -50.44 68.67 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.344 -178.34 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.583 ' O ' ' HG3' ' A' ' 57' ' ' GLU . 24.9 pttm -71.56 -30.14 65.53 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 120.38 -0.528 . . . . 0.0 110.586 -177.398 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -68.28 -37.98 81.24 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-O 121.017 0.437 . . . . 0.0 110.795 177.028 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.469 HD22 ' O ' ' A' ' 129' ' ' PRO . 14.7 tp -63.78 -40.11 95.87 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 177.469 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -64.39 -47.65 78.41 Favored 'General case' 0 N--CA 1.443 -0.785 0 CA-C-N 115.987 -0.551 . . . . 0.0 109.934 177.931 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.583 ' HG3' ' O ' ' A' ' 53' ' ' LYS . 42.1 mt-10 -50.2 -40.1 46.09 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-O 121.199 0.523 . . . . 0.0 110.942 178.533 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.806 ' HE3' ' CE2' ' A' ' 59' ' ' TYR . 34.6 ttpt -73.11 -43.03 62.28 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.532 -0.758 . . . . 0.0 112.327 -177.159 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.806 ' CE2' ' HE3' ' A' ' 58' ' ' LYS . 97.6 m-85 -102.66 -2.5 28.18 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 112.561 0.578 . . . . 0.0 112.561 -172.279 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -57.66 122.75 13.53 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.09 0.471 . . . . 0.0 111.61 179.755 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 99.58 -20.71 48.43 Favored Glycine 0 N--CA 1.445 -0.716 0 CA-C-N 115.536 -0.757 . . . . 0.0 113.263 174.036 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.53 ' N ' ' HD2' ' A' ' 62' ' ' LYS . 10.8 mptt -78.69 -97.57 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 117.204 0.502 . . . . 0.0 111.657 -176.25 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.413 ' HB3' HD21 ' A' ' 142' ' ' LEU . 12.3 p-10 -119.68 -3.4 10.32 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.537 -0.301 . . . . 0.0 111.73 -173.029 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.473 HG12 ' N ' ' A' ' 65' ' ' HIS . 16.7 tt -144.64 164.65 13.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-O 120.731 0.3 . . . . 0.0 111.086 -170.893 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 65' ' ' HIS . . . . . 0.473 ' N ' HG12 ' A' ' 64' ' ' ILE . 0.1 OUTLIER -156.83 141.36 16.74 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.111 171.497 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 66' ' ' PHE . . . . . 0.4 ' CE2' HD23 ' A' ' 55' ' ' LEU . 74.9 m-85 -94.67 132.27 39.58 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.223 0.535 . . . . 0.0 110.983 -174.257 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.708 ' O ' ' HA ' ' A' ' 35' ' ' ILE . 56.9 t -132.52 118.57 35.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.176 -178.401 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 68' ' ' SER . . . . . 0.495 ' HA ' ' O ' ' A' ' 36' ' ' ASP . 49.7 m -88.38 136.51 32.95 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.542 -179.692 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.551 ' O ' ' HA ' ' A' ' 37' ' ' VAL . 64.2 tp -121.84 128.93 52.19 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 110.304 -0.258 . . . . 0.0 110.304 177.279 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 70' ' ' SER . . . . . 0.457 ' HB2' ' CD1' ' A' ' 38' ' ' TRP . 44.2 t -109.7 114.87 28.83 Favored 'General case' 0 C--O 1.216 -0.684 0 N-CA-C 112.102 0.408 . . . . 0.0 112.102 -172.901 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 3.3 m -84.64 21.49 1.51 Allowed 'General case' 0 C--N 1.312 -1.048 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.805 175.672 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -71.76 143.95 49.4 Favored 'General case' 0 CA--C 1.515 -0.396 0 C-N-CA 120.069 -0.652 . . . . 0.0 109.916 178.372 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.655 ' HB3' ' HZ2' ' A' ' 73' ' ' LYS . 0.0 OUTLIER -96.68 -15.23 21.57 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.179 -177.277 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 74' ' ' ASN . . . . . 0.559 ' HB2' ' HB3' ' A' ' 77' ' ' ALA . 0.0 OUTLIER -104.2 79.84 1.65 Allowed 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 -177.736 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.551 ' HA ' ' CE1' ' A' ' 93' ' ' HIS . 21.1 tttm -51.6 -63.5 1.11 Allowed 'General case' 0 CA--C 1.513 -0.451 0 N-CA-C 112.782 0.66 . . . . 0.0 112.782 -173.544 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 26.3 tptp -46.51 -51.46 15.32 Favored 'General case' 0 C--N 1.323 -0.556 0 O-C-N 123.431 0.457 . . . . 0.0 110.726 -178.359 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.702 ' HA ' ' ND2' ' A' ' 80' ' ' ASN . . . -58.95 -42.81 90.72 Favored 'General case' 0 C--O 1.239 0.551 0 CA-C-O 121.198 0.523 . . . . 0.0 110.826 179.619 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 78' ' ' TRP . . . . . 0.701 ' CE3' ' HB ' ' A' ' 40' ' ' THR . 6.9 t-105 -64.35 -51.98 60.65 Favored 'General case' 0 N--CA 1.435 -1.188 0 CA-C-N 115.51 -0.768 . . . . 0.0 112.489 -179.94 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.466 ' CD ' ' HE2' ' A' ' 75' ' ' LYS . 19.2 mm-40 -48.14 -40.1 22.71 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-O 120.948 0.404 . . . . 0.0 111.39 178.278 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 80' ' ' ASN . . . . . 0.702 ' ND2' ' HA ' ' A' ' 77' ' ' ALA . 3.6 m-20 -60.66 -50.19 74.52 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-O 120.846 0.355 . . . . 0.0 110.614 177.146 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 16.2 tpt -63.5 -37.7 88.29 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 112.164 0.431 . . . . 0.0 112.164 -175.183 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.579 ' CG2' ' HZ3' ' A' ' 38' ' ' TRP . 0.6 OUTLIER -68.58 -36.9 76.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 C-N-CA 119.965 -0.694 . . . . 0.0 111.13 179.053 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 12.7 t -78.69 -21.39 48.28 Favored 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 120.127 -0.629 . . . . 0.0 110.512 178.051 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 60.9 tttp -80.94 -53.68 6.24 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-O 120.973 0.416 . . . . 0.0 110.379 177.537 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -77.29 -20.04 55.59 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.143 -177.204 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 77.4 mt-30 65.16 78.42 0.28 Allowed 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 115.147 -0.933 . . . . 0.0 112.244 177.304 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.546 HD13 ' HA ' ' A' ' 82' ' ' VAL . 5.5 mp -104.45 118.42 36.57 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.116 -0.947 . . . . 0.0 108.61 174.101 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 72.9 mmtt -103.04 179.17 4.35 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 112.706 0.632 . . . . 0.0 112.706 -177.323 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 105.84 179.17 23.63 Favored Glycine 0 N--CA 1.45 -0.383 0 CA-C-N 115.096 -0.956 . . . . 0.0 111.172 -175.972 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.465 ' O ' ' HA ' ' A' ' 67' ' ' VAL . 63.4 mt -76.82 116.36 19.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 173.242 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 91' ' ' GLN . . . . . 0.556 ' HB2' ' CZ2' ' A' ' 38' ' ' TRP . 3.0 pt20 -136.81 107.42 6.54 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 121.793 0.806 . . . . 0.0 112.646 -166.075 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.431 ' CD2' ' HB ' ' A' ' 23' ' ' VAL . 21.9 mt -99.15 144.31 28.43 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.012 -0.994 . . . . 0.0 110.117 -178.618 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 93' ' ' HIS . . . . . 0.551 ' CE1' ' HA ' ' A' ' 75' ' ' LYS . 10.3 t-160 -115.83 131.34 56.97 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 121.69 0.757 . . . . 0.0 111.334 178.725 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 94' ' ' MET . . . . . 0.755 ' HG3' ' HB2' ' A' ' 97' ' ' ASP . 34.4 ttp -108.84 90.2 3.22 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 114.059 -1.428 . . . . 0.0 108.491 179.626 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 95' ' ' GLY . . . . . 0.51 ' O ' ' HA ' ' A' ' 73' ' ' LYS . . . -64.25 -65.53 2.96 Favored Glycine 0 C--N 1.318 -0.45 0 CA-C-N 115.319 -0.855 . . . . 0.0 113.513 -173.387 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 7.4 p -121.02 7.19 10.32 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-O 121.438 0.637 . . . . 0.0 110.393 -178.135 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 97' ' ' ASP . . . . . 0.755 ' HB2' ' HG3' ' A' ' 94' ' ' MET . 0.6 OUTLIER -90.56 12.73 17.86 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.32 -0.854 . . . . 0.0 110.663 -170.998 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 98' ' ' ARG . . . . . 0.686 ' HA ' ' SD ' ' A' ' 94' ' ' MET . 0.0 OUTLIER -72.19 14.03 0.26 Allowed 'General case' 0 C--O 1.222 -0.356 0 N-CA-C 113.068 0.766 . . . . 0.0 113.068 -170.704 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 9.8 t -70.52 -21.98 62.68 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 169.234 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 100' ' ' PHE . . . . . 0.692 ' CE1' ' HA ' ' A' ' 10' ' ' ALA . 88.9 t80 -79.31 -24.42 42.85 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.52 -0.764 . . . . 0.0 109.653 174.255 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 101' ' ' MET . . . . . 0.653 ' HB3' ' O ' ' A' ' 98' ' ' ARG . 14.8 tpt -59.69 -38.14 80.76 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.321 -0.854 . . . . 0.0 110.177 175.102 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 78.6 m-20 -65.21 -21.43 66.75 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.6 -0.727 . . . . 0.0 111.401 179.207 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -66.29 -14.52 62.13 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-O 120.592 0.234 . . . . 0.0 111.502 178.465 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 65.5 m-85 -95.69 -13.27 24.38 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 110.195 -0.298 . . . . 0.0 110.195 176.427 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 98.3 mt 71.17 -24.36 0.17 Allowed 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 123.791 0.836 . . . . 0.0 112.864 176.811 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 106' ' ' ILE . . . . . 0.428 HG21 HH11 ' A' ' 111' ' ' ARG . 14.4 mt -98.1 93.72 3.43 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-O 120.875 0.369 . . . . 0.0 110.721 -175.871 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 107' ' ' ASN . . . . . 0.497 ' HA ' ' HE3' ' A' ' 101' ' ' MET . 67.0 t30 -82.62 -1.33 50.65 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.857 -178.282 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -81.46 98.46 1.89 Allowed Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.802 -0.713 . . . . 0.0 111.742 177.813 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.661 HG21 HG11 ' A' ' 37' ' ' VAL . 44.8 pt -104.56 161.11 23.83 Favored Pre-proline 0 C--N 1.325 -0.475 0 CA-C-N 116.473 0.137 . . . . 0.0 111.062 -177.156 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 110' ' ' PRO . . . . . 0.68 ' CG ' ' HB2' ' A' ' 45' ' ' CYS . 23.4 Cg_exo -64.26 134.44 18.44 Favored 'Cis proline' 0 C--N 1.35 0.657 0 C-N-CA 123.928 -1.28 . . . . 0.0 113.178 0.89 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 111' ' ' ARG . . . . . 0.951 ' HE ' ' HA ' ' A' ' 111' ' ' ARG . 0.0 OUTLIER -102.28 141.78 34.57 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-N 116.246 -0.434 . . . . 0.0 109.964 174.263 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 112' ' ' PHE . . . . . 0.42 ' CE1' ' HD3' ' A' ' 128' ' ' ARG . 0.6 OUTLIER -113.93 113.74 25.25 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.301 -0.863 . . . . 0.0 108.739 -174.949 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.478 ' HB ' ' HB ' ' A' ' 35' ' ' ILE . 81.0 mt -123.97 138.16 54.58 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-O 121.249 0.547 . . . . 0.0 111.488 -173.024 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.471 ' HG ' HD12 ' A' ' 122' ' ' ILE . 58.8 tp -112.96 134.31 54.53 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 115.415 -0.811 . . . . 0.0 109.062 175.916 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.462 ' N ' HD12 ' A' ' 115' ' ' LEU . 2.3 mp -131.58 147.04 52.49 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 -179.831 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 23.6 t0 -65.75 164.8 13.91 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.119 176.409 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 117' ' ' ARG . . . . . 0.478 ' HA ' ' O ' ' A' ' 31' ' ' LYS . 0.6 OUTLIER -53.84 -21.71 8.18 Favored 'General case' 0 N--CA 1.471 0.586 0 O-C-N 124.2 0.937 . . . . 0.0 112.376 -176.15 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 118' ' ' ASP . . . . . 0.509 ' HB3' ' HG2' ' A' ' 120' ' ' LYS . 6.0 t70 -88.46 6.21 38.75 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.557 0.694 . . . . 0.0 110.075 -178.974 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 119' ' ' GLY . . . . . 0.503 ' O ' HD21 ' A' ' 25' ' ' LEU . . . 75.82 24.78 68.76 Favored Glycine 0 N--CA 1.437 -1.26 0 N-CA-C 110.833 -0.907 . . . . 0.0 110.833 -173.859 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 120' ' ' LYS . . . . . 0.621 ' HE3' ' HB1' ' A' ' 11' ' ' ALA . 43.6 mmtm -99.76 106.35 18.24 Favored 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 120.317 -0.553 . . . . 0.0 111.351 -175.803 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 0.611 ' H ' HD12 ' A' ' 121' ' ' ILE . 3.0 mp -39.84 115.78 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 114.852 -1.067 . . . . 0.0 112.419 -177.648 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 122' ' ' ILE . . . . . 0.471 HD12 ' HG ' ' A' ' 114' ' ' LEU . 57.4 mt -86.88 -41.14 14.58 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 114.957 -1.02 . . . . 0.0 108.797 173.978 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 19.8 m -153.53 121.55 6.09 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.444 179.019 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -79.19 -17.03 55.66 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-O 121.488 0.661 . . . . 0.0 110.497 177.407 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 45.6 t30 -128.26 98.83 5.21 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 108.477 -0.935 . . . . 0.0 108.477 174.457 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 17.1 tpt -100.77 -97.43 0.26 Allowed 'General case' 0 C--N 1.322 -0.616 0 C-N-CA 120.696 -0.402 . . . . 0.0 111.409 -174.999 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 127' ' ' THR . . . . . 0.568 ' O ' ' HB2' ' A' ' 128' ' ' ARG . 3.4 p -152.01 -73.81 0.14 Allowed 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 111.534 0.198 . . . . 0.0 111.534 -173.42 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 128' ' ' ARG . . . . . 0.626 ' HD2' ' HD2' ' A' ' 129' ' ' PRO . 20.2 tpt180 157.0 136.27 0.0 OUTLIER Pre-proline 0 N--CA 1.456 -0.151 0 C-N-CA 124.196 0.999 . . . . 0.0 108.514 -172.424 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 129' ' ' PRO . . . . . 0.626 ' HD2' ' HD2' ' A' ' 128' ' ' ARG . 84.2 Cg_exo -49.45 -44.13 35.91 Favored 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 122.285 1.99 . . . . 0.0 112.6 172.166 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 130' ' ' SER . . . . . 0.455 ' H ' ' HG3' ' A' ' 128' ' ' ARG . 0.0 OUTLIER -78.6 3.03 17.34 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 112.263 0.468 . . . . 0.0 112.263 -177.54 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 131' ' ' ASP . . . . . 0.429 ' HB2' ' HB3' ' A' ' 128' ' ' ARG . 10.5 t70 -89.23 123.76 66.34 Favored Pre-proline 0 C--O 1.236 0.363 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 177.291 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -55.43 -37.06 95.14 Favored 'Trans proline' 0 C--N 1.342 0.236 0 C-N-CA 123.345 2.696 . . . . 0.0 113.653 -176.069 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 133' ' ' LYS . . . . . 0.528 ' HA ' ' HG2' ' A' ' 136' ' ' GLU . 36.4 mtmm -61.11 -33.21 73.01 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 121.357 0.598 . . . . 0.0 110.964 -175.367 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 134' ' ' THR . . . . . 0.591 HG22 ' CZ ' ' A' ' 138' ' ' PHE . 0.2 OUTLIER -67.13 -53.05 34.26 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.885 176.843 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 135' ' ' ALA . . . . . 0.493 ' HA ' ' CD2' ' A' ' 138' ' ' PHE . . . -60.64 -47.3 86.84 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.41 -0.814 . . . . 0.0 111.555 -178.999 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 136' ' ' GLU . . . . . 0.528 ' HG2' ' HA ' ' A' ' 133' ' ' LYS . 12.9 pt-20 -63.29 -30.39 71.54 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.395 -178.205 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 137' ' ' LYS . . . . . 1.083 ' HA ' ' HE3' ' A' ' 137' ' ' LYS . 0.4 OUTLIER -65.43 -44.64 86.71 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-N 116.573 -0.285 . . . . 0.0 110.405 177.709 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 138' ' ' PHE . . . . . 0.591 ' CZ ' HG22 ' A' ' 134' ' ' THR . 7.2 m-85 -60.51 -57.58 12.14 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-O 121.056 0.455 . . . . 0.0 110.694 -179.708 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 27.9 p30 -67.68 -18.28 64.88 Favored 'General case' 0 C--O 1.222 -0.354 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.811 -175.514 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 24.6 tt0 -66.35 -50.36 63.81 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 172.595 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.475 ' HG ' ' O ' ' A' ' 137' ' ' LYS . 60.8 mt -61.17 -33.55 73.61 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.659 -179.783 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.413 HD21 ' HB3' ' A' ' 63' ' ' ASP . 94.6 mt -80.48 -24.13 39.68 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.255 178.896 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 74.51 41.49 36.22 Favored Glycine 0 N--CA 1.45 -0.415 0 N-CA-C 110.41 -1.076 . . . . 0.0 110.41 -173.958 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.445 ' O ' ' HG ' ' A' ' 144' ' ' LEU . 35.2 tp -120.85 20.33 11.64 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 114.916 -0.642 . . . . 0.0 111.226 -169.678 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -80.43 -178.63 6.75 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 120.519 -0.472 . . . . 0.0 110.566 -179.557 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -77.4 21.74 2.83 Favored Glycine 0 CA--C 1.519 0.343 0 C-N-CA 121.101 -0.571 . . . . 0.0 112.791 -179.603 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -64.97 144.34 57.35 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-O 120.804 0.335 . . . . 0.0 111.432 178.806 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 20.5 t-80 60.59 38.14 18.96 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 115.402 -0.817 . . . . 0.0 110.684 177.398 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 33.5 m80 -136.88 163.61 30.25 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.092 178.201 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 47.8 t60 -74.85 116.51 15.65 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 179.13 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 88.8 m-70 -84.37 149.15 26.22 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 121.101 0.477 . . . . 0.0 111.496 -173.518 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 25.1 p-80 . . . . . 0 C--O 1.244 0.779 0 N-CA-C 108.485 -0.931 . . . . 0.0 108.485 175.749 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.0 ptp . . . . . 0 N--CA 1.481 1.116 0 CA-C-O 120.621 0.248 . . . . 0.0 111.103 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 10.5 m -81.28 87.45 6.12 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.948 0.404 . . . . 0.0 110.619 -177.872 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.612 HD22 ' N ' ' A' ' 4' ' ' ARG . 0.0 OUTLIER -70.7 -37.25 73.56 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.498 178.053 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 4' ' ' ARG . . . . . 0.612 ' N ' HD22 ' A' ' 3' ' ' LEU . 29.3 mtm180 68.75 -24.54 0.14 Allowed 'General case' 0 N--CA 1.474 0.772 0 N-CA-C 113.429 0.9 . . . . 0.0 113.429 172.57 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 5' ' ' SER . . . . . 0.408 ' H ' ' C ' ' A' ' 3' ' ' LEU . 8.0 m -46.1 -67.9 0.24 Allowed 'General case' 0 C--O 1.233 0.228 0 C-N-CA 123.008 0.523 . . . . 0.0 111.44 -178.142 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 6' ' ' GLY . . . . . 0.415 ' O ' ' HB2' ' A' ' 7' ' ' ASN . . . -93.29 36.74 3.6 Favored Glycine 0 N--CA 1.448 -0.551 0 C-N-CA 120.488 -0.863 . . . . 0.0 112.215 177.843 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 7' ' ' ASN . . . . . 0.554 ' HB3' ' HD2' ' A' ' 8' ' ' PRO . 52.6 m-80 70.28 169.48 0.12 Allowed Pre-proline 0 N--CA 1.471 0.619 0 C-N-CA 122.863 0.465 . . . . 0.0 110.836 -179.051 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.554 ' HD2' ' HB3' ' A' ' 7' ' ' ASN . 19.3 Cg_endo -62.23 -60.23 0.21 Allowed 'Trans proline' 0 C--N 1.35 0.626 0 C-N-CA 121.811 1.674 . . . . 0.0 111.656 173.04 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 15.1 m -73.06 161.71 30.32 Favored 'General case' 0 N--CA 1.444 -0.745 0 CA-C-N 116.04 -0.527 . . . . 0.0 109.633 176.361 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . 73.7 -50.45 0.69 Allowed 'General case' 0 N--CA 1.471 0.589 0 O-C-N 124.007 0.817 . . . . 0.0 111.161 -177.345 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.405 ' HA ' ' HE3' ' A' ' 120' ' ' LYS . . . -70.55 -29.3 65.72 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.977 0.418 . . . . 0.0 110.683 176.926 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 26.6 t -164.75 83.56 0.4 Allowed 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.244 -0.889 . . . . 0.0 109.906 176.396 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 41.1 p90 -101.43 164.46 11.76 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.416 179.985 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.541 ' HA ' ' HA ' ' A' ' 24' ' ' SER . 20.2 m -142.24 126.03 17.05 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 109.905 -0.406 . . . . 0.0 109.905 178.258 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 15' ' ' TYR . . . . . 0.412 ' HA ' ' HD3' ' A' ' 16' ' ' PRO . 59.2 m-85 -141.04 144.96 37.03 Favored Pre-proline 0 C--N 1.325 -0.465 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.834 -178.602 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.485 ' HA ' ' O ' ' A' ' 21' ' ' LYS . 4.2 Cg_exo -77.68 125.65 7.64 Favored 'Trans proline' 0 N--CA 1.461 -0.412 0 C-N-CA 122.87 2.38 . . . . 0.0 113.018 -179.846 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 17' ' ' ASP . . . . . 0.608 ' HA ' ' HA ' ' A' ' 92' ' ' LEU . 11.2 t70 -65.37 158.42 26.63 Favored 'General case' 0 C--O 1.238 0.457 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 172.228 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.479 HG12 HG11 ' A' ' 82' ' ' VAL . 11.0 tp -55.03 -27.38 19.16 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 O-C-N 123.669 0.606 . . . . 0.0 112.248 -170.281 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 9.5 p30 -78.78 -13.27 59.9 Favored 'General case' 0 N--CA 1.456 -0.16 0 CA-C-O 121.2 0.524 . . . . 0.0 110.189 -178.177 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 104.36 31.61 4.57 Favored Glycine 0 N--CA 1.445 -0.732 0 CA-C-N 115.712 -0.676 . . . . 0.0 112.154 -177.29 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.485 ' O ' ' HA ' ' A' ' 16' ' ' PRO . 62.3 tttt -101.9 115.03 29.64 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 120.439 -0.504 . . . . 0.0 110.805 179.354 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 14.7 m -64.83 99.69 0.35 Allowed 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 120.892 0.377 . . . . 0.0 110.157 174.579 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 92.9 t -103.3 119.16 51.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.46 -178.457 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' SER . . . . . 0.541 ' HA ' ' HA ' ' A' ' 14' ' ' SER . 88.2 p -97.45 171.51 8.34 Favored 'General case' 0 C--N 1.316 -0.878 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 177.082 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.464 ' O ' ' HB2' ' A' ' 29' ' ' LYS . 37.8 tp -63.83 -24.66 67.84 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.72 0.295 . . . . 0.0 111.128 179.709 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -75.61 -24.85 56.57 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.533 -0.303 . . . . 0.0 111.013 -179.312 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -66.33 -25.07 66.65 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-O 121.489 0.661 . . . . 0.0 110.326 179.839 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.659 HD11 HG21 ' A' ' 90' ' ' ILE . 85.7 mt -122.75 15.66 10.18 Favored 'General case' 0 N--CA 1.449 -0.52 0 CA-C-N 115.663 -0.699 . . . . 0.0 111.237 -177.145 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.504 ' HE2' ' O ' ' A' ' 118' ' ' ASP . 61.1 tttm -83.82 157.51 22.01 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.572 -175.38 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 114.72 -34.65 4.78 Favored Glycine 0 N--CA 1.449 -0.433 0 C-N-CA 120.756 -0.735 . . . . 0.0 111.73 179.383 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.732 ' HB2' ' NE2' ' A' ' 65' ' ' HIS . 63.6 mttm -120.52 170.03 9.79 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.733 -0.233 . . . . 0.0 110.683 177.67 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 87.3 m-85 -65.81 155.56 35.87 Favored 'General case' 0 C--N 1.329 -0.296 0 O-C-N 123.298 0.374 . . . . 0.0 110.272 178.52 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.583 ' HB ' ' HB2' ' A' ' 115' ' ' LEU . 70.9 mt -129.38 140.68 48.52 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-O 120.87 0.366 . . . . 0.0 111.163 -175.684 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 93.3 t80 -125.56 110.69 14.15 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 174.001 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.605 ' HB ' ' HB ' ' A' ' 113' ' ' ILE . 59.2 mt -98.01 130.03 47.35 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.07 -176.346 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.47 ' O ' ' HA ' ' A' ' 68' ' ' SER . 5.7 p-10 -116.38 150.33 37.92 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.761 -0.654 . . . . 0.0 109.519 174.762 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.424 ' HB ' ' H ' ' A' ' 111' ' ' ARG . 38.2 t -102.65 130.55 52.47 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.801 0 C-N-CA 120.487 -0.485 . . . . 0.0 110.148 174.927 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 38' ' ' TRP . . . . . 0.661 ' CZ2' ' HB2' ' A' ' 91' ' ' GLN . 0.6 OUTLIER -132.66 135.81 46.07 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.771 -0.65 . . . . 0.0 109.623 -173.569 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.463 ' HB3' ' SG ' ' A' ' 42' ' ' CYS . . . -147.06 161.7 40.31 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 122.257 -0.277 . . . . 0.0 111.092 178.664 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.712 ' HB ' ' CE3' ' A' ' 78' ' ' TRP . 3.0 t -85.52 -4.84 59.28 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.012 0.434 . . . . 0.0 110.925 178.025 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 41' ' ' TRP . . . . . 0.447 ' HE1' ' HA ' ' A' ' 72' ' ' ASP . 10.2 p-90 -115.86 16.51 16.23 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.442 -176.855 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 42' ' ' CYS . . . . . 0.463 ' SG ' ' HB3' ' A' ' 39' ' ' ALA . 19.8 p -120.93 95.46 4.71 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.228 0.537 . . . . 0.0 110.755 178.675 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -63.39 -51.12 57.07 Favored Glycine 0 CA--C 1.527 0.805 0 CA-C-O 119.184 -0.787 . . . . 0.0 113.894 -179.778 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -54.45 -38.7 89.71 Favored 'Trans proline' 0 C--N 1.357 0.999 0 C-N-CA 122.483 2.122 . . . . 0.0 112.632 -179.111 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' CYS . . . . . 0.504 ' SG ' ' HB3' ' A' ' 110' ' ' PRO . 16.8 t -59.01 -40.86 86.25 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.303 0.573 . . . . 0.0 110.634 177.35 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.598 ' HA ' ' CD1' ' A' ' 49' ' ' LEU . 23.2 ttt180 -72.57 -3.74 26.49 Favored 'General case' 0 N--CA 1.447 -0.621 0 CA-C-N 115.309 -0.859 . . . . 0.0 111.409 -175.847 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -66.59 -48.36 63.03 Favored Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 121.055 -0.593 . . . . 0.0 112.693 179.857 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.543 ' OE1' ' HB2' ' A' ' 128' ' ' ARG . 11.9 pt-20 -115.29 17.28 16.64 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 112.179 0.437 . . . . 0.0 112.179 -176.441 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.949 HD13 HD21 ' A' ' 87' ' ' LEU . 37.7 mt -52.41 -50.72 78.32 Favored Pre-proline 0 C--N 1.324 -0.54 0 N-CA-C 112.248 0.462 . . . . 0.0 112.248 175.987 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.519 ' HD2' ' N ' ' A' ' 49' ' ' LEU . 10.3 Cg_endo -55.2 -36.08 92.46 Favored 'Trans proline' 0 C--N 1.356 0.96 0 C-N-CA 122.0 1.8 . . . . 0.0 112.305 176.601 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -71.87 -23.29 61.48 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.021 0.439 . . . . 0.0 111.08 -178.707 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 6.7 tt -70.01 -44.09 70.04 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 177.532 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.573 ' HD2' ' N ' ' A' ' 53' ' ' LYS . 3.2 mptp? -68.82 -40.02 79.71 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.396 177.638 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.614 ' O ' ' HG3' ' A' ' 58' ' ' LYS . 0.2 OUTLIER -48.2 -49.37 33.17 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.395 0.617 . . . . 0.0 110.72 168.568 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.601 HD21 ' HE2' ' A' ' 138' ' ' PHE . 21.7 tp -60.11 -40.03 88.27 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.151 176.97 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.6 ' HG2' ' CG ' ' A' ' 66' ' ' PHE . 44.4 mt-10 -57.67 -48.45 79.46 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.527 -0.76 . . . . 0.0 111.332 178.137 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -61.13 -36.84 80.83 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.846 0.355 . . . . 0.0 110.954 -179.703 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.614 ' HG3' ' O ' ' A' ' 54' ' ' GLU . 53.1 mttm -62.47 -43.8 97.93 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-O 121.41 0.624 . . . . 0.0 110.535 177.387 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 96.1 m-85 -101.93 16.38 26.14 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.434 -175.126 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -64.7 135.57 56.02 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.118 172.749 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 80.75 9.37 86.44 Favored Glycine 0 N--CA 1.449 -0.487 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.762 178.985 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 37.7 mmtm -94.7 -151.59 0.33 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.345 0.593 . . . . 0.0 110.164 177.764 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.728 ' HA ' ' HD3' ' A' ' 31' ' ' LYS . 4.0 t70 -111.82 64.89 0.62 Allowed 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.731 -0.668 . . . . 0.0 109.789 178.517 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 19.9 tt -156.53 156.28 4.68 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.446 0 CA-C-N 115.857 -0.611 . . . . 0.0 110.537 -175.035 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' HIS . . . . . 0.732 ' NE2' ' HB2' ' A' ' 31' ' ' LYS . 81.1 m-70 -134.97 115.05 13.1 Favored 'General case' 0 CA--C 1.515 -0.377 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 175.631 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 66' ' ' PHE . . . . . 0.6 ' CG ' ' HG2' ' A' ' 56' ' ' GLU . 71.0 m-85 -79.67 118.95 21.96 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 172.05 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.587 ' O ' ' HA ' ' A' ' 35' ' ' ILE . 40.5 t -128.94 111.36 22.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.674 -174.256 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 68' ' ' SER . . . . . 0.548 ' HB3' ' CD1' ' A' ' 38' ' ' TRP . 8.2 m -87.81 146.97 25.36 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.145 179.655 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.468 ' HA ' ' O ' ' A' ' 92' ' ' LEU . 7.2 mp -131.45 122.78 26.81 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-O 120.762 0.315 . . . . 0.0 110.338 171.81 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 14.7 t -110.09 114.62 28.28 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.135 0.493 . . . . 0.0 112.106 -175.782 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 64.0 m -79.19 19.09 0.59 Allowed 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.328 175.798 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.447 ' HA ' ' HE1' ' A' ' 41' ' ' TRP . 0.1 OUTLIER -61.58 152.72 29.72 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-O 120.676 0.274 . . . . 0.0 110.79 176.428 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 21.9 pttp -108.06 -21.99 12.58 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.182 -178.351 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' ASN . . . . . 0.433 ' HB2' ' HB3' ' A' ' 77' ' ' ALA . 0.0 OUTLIER -100.88 67.97 1.26 Allowed 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 -179.087 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.547 ' O ' ' HG3' ' A' ' 79' ' ' GLU . 9.7 tttt -48.06 -52.78 18.76 Favored 'General case' 0 C--N 1.331 -0.237 0 O-C-N 123.782 0.676 . . . . 0.0 112.795 -168.606 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.464 ' HA ' ' HD2' ' A' ' 76' ' ' LYS . 35.1 tptt -52.67 -50.03 64.06 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 123.397 0.435 . . . . 0.0 110.646 -179.067 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.433 ' HB3' ' HB2' ' A' ' 74' ' ' ASN . . . -58.15 -37.53 74.84 Favored 'General case' 0 C--O 1.245 0.834 0 CA-C-O 121.492 0.663 . . . . 0.0 110.405 -179.152 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 78' ' ' TRP . . . . . 0.712 ' CE3' ' HB ' ' A' ' 40' ' ' THR . 5.8 t-105 -68.41 -35.94 78.39 Favored 'General case' 0 N--CA 1.438 -1.03 0 CA-C-N 115.051 -0.977 . . . . 0.0 110.306 -178.642 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.547 ' HG3' ' O ' ' A' ' 75' ' ' LYS . 55.9 mt-10 -51.07 -48.85 61.5 Favored 'General case' 0 CA--C 1.52 -0.189 0 CA-C-O 121.328 0.585 . . . . 0.0 110.965 173.435 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 80' ' ' ASN . . . . . 0.542 ' O ' ' HD3' ' A' ' 84' ' ' LYS . 2.9 m120 -64.85 -42.76 94.63 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.544 -175.504 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 81' ' ' MET . . . . . 0.43 ' SD ' ' HZ3' ' A' ' 78' ' ' TRP . 34.8 ttm -66.82 -47.25 72.59 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 119.892 -0.723 . . . . 0.0 111.667 -177.844 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.545 ' CG2' ' HZ3' ' A' ' 38' ' ' TRP . 4.4 p -62.18 -32.39 54.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 C-N-CA 120.49 -0.484 . . . . 0.0 110.93 179.947 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 89.3 m -70.72 -40.72 72.63 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.707 178.406 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' LYS . . . . . 0.542 ' HD3' ' O ' ' A' ' 80' ' ' ASN . 1.3 mptm? -81.78 -32.47 31.36 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.579 -0.282 . . . . 0.0 111.394 -175.866 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 85' ' ' ASP . . . . . 0.515 ' HB3' HD13 ' A' ' 87' ' ' LEU . 1.2 t0 -81.71 -3.77 54.54 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.438 0.637 . . . . 0.0 110.164 -179.718 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 86' ' ' GLN . . . . . 0.49 ' HA ' ' OE1' ' A' ' 86' ' ' GLN . 13.6 mm-40 68.88 16.77 8.81 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 115.017 -0.992 . . . . 0.0 113.444 172.757 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.949 HD21 HD13 ' A' ' 49' ' ' LEU . 10.6 mp -66.58 103.81 1.15 Allowed 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 110.326 -0.25 . . . . 0.0 110.326 173.867 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 43.6 mmtm -108.72 -178.8 3.69 Favored 'General case' 0 C--N 1.323 -0.548 0 O-C-N 122.431 -0.168 . . . . 0.0 110.698 176.168 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 122.2 -153.24 16.82 Favored Glycine 0 N--CA 1.452 -0.278 0 N-CA-C 110.762 -0.935 . . . . 0.0 110.762 -177.069 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.659 HG21 HD11 ' A' ' 28' ' ' LEU . 48.5 mm -104.67 116.03 47.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 N-CA-C 108.369 -0.974 . . . . 0.0 108.369 171.356 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 91' ' ' GLN . . . . . 0.661 ' HB2' ' CZ2' ' A' ' 38' ' ' TRP . 2.2 pt20 -141.41 100.19 3.73 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-O 122.099 0.952 . . . . 0.0 112.57 -165.55 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.608 ' HA ' ' HA ' ' A' ' 17' ' ' ASP . 22.9 mt -89.89 149.29 22.69 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 114.623 -1.171 . . . . 0.0 110.366 -176.93 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 93' ' ' HIS . . . . . 0.414 ' O ' ' HD2' ' A' ' 16' ' ' PRO . 15.0 t-80 -121.11 134.14 55.24 Favored 'General case' 0 C--N 1.31 -1.132 0 CA-C-N 115.585 -0.734 . . . . 0.0 109.402 177.619 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 94' ' ' MET . . . . . 0.566 ' SD ' ' HA ' ' A' ' 98' ' ' ARG . 48.3 ttm -78.98 -83.8 0.09 Allowed 'General case' 0 N--CA 1.435 -1.203 0 CA-C-N 115.302 -0.863 . . . . 0.0 110.349 -175.423 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 125.08 42.11 0.34 Allowed Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.102 -1.047 . . . . 0.0 113.045 178.99 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.411 ' C ' ' H ' ' A' ' 98' ' ' ARG . 3.7 m 78.03 0.35 2.72 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 123.021 0.528 . . . . 0.0 111.378 -179.329 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -79.3 34.75 0.26 Allowed 'General case' 0 N--CA 1.467 0.409 0 CA-C-O 121.405 0.622 . . . . 0.0 109.52 178.577 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 98' ' ' ARG . . . . . 0.566 ' HA ' ' SD ' ' A' ' 94' ' ' MET . 0.1 OUTLIER -76.24 20.24 0.21 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.4 -0.818 . . . . 0.0 112.773 -167.106 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 14.3 m -70.38 -24.3 62.93 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.732 0.777 . . . . 0.0 108.916 169.832 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 17.1 t80 -75.83 -23.95 55.78 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.367 -0.833 . . . . 0.0 109.506 175.354 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 101' ' ' MET . . . . . 0.493 ' HB3' ' O ' ' A' ' 98' ' ' ARG . 16.6 tpt -64.43 -33.77 76.63 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.482 -0.781 . . . . 0.0 109.407 175.035 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 46.1 m-20 -70.55 -22.73 62.57 Favored 'General case' 0 N--CA 1.461 0.104 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.819 177.177 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -71.73 -14.59 62.06 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.892 0.377 . . . . 0.0 111.013 -179.004 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 104' ' ' TYR . . . . . 0.607 ' O ' ' HG ' ' A' ' 105' ' ' LEU . 65.1 m-85 -96.47 -4.06 42.26 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 174.563 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.607 ' HG ' ' O ' ' A' ' 104' ' ' TYR . 2.9 pp 51.52 14.37 0.26 Allowed 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 125.108 1.363 . . . . 0.0 113.605 178.818 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 106' ' ' ILE . . . . . 0.558 ' HB ' ' CG ' ' A' ' 111' ' ' ARG . 17.2 mm -120.1 95.27 3.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 N-CA-C 109.025 -0.732 . . . . 0.0 109.025 172.665 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 107' ' ' ASN . . . . . 0.518 ' ND2' HH22 ' A' ' 98' ' ' ARG . 4.6 m-20 -86.32 20.49 2.37 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.903 -173.067 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -113.76 123.42 6.11 Favored Glycine 0 N--CA 1.447 -0.629 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.06 -179.626 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.432 ' CG2' ' HA ' ' A' ' 110' ' ' PRO . 21.8 mt -87.85 137.45 31.69 Favored Pre-proline 0 C--N 1.325 -0.469 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 176.838 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 110' ' ' PRO . . . . . 0.519 ' HG2' ' CZ ' ' A' ' 112' ' ' PHE . 95.1 Cg_endo -88.96 144.2 19.84 Favored 'Cis proline' 0 N--CA 1.456 -0.681 0 C-N-CA 123.522 -1.449 . . . . 0.0 113.496 1.188 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 111' ' ' ARG . . . . . 0.558 ' CG ' ' HB ' ' A' ' 106' ' ' ILE . 0.0 OUTLIER -100.2 133.25 44.88 Favored 'General case' 0 N--CA 1.444 -0.761 0 N-CA-C 108.879 -0.786 . . . . 0.0 108.879 172.587 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 112' ' ' PHE . . . . . 0.59 ' CZ ' ' HB3' ' A' ' 128' ' ' ARG . 13.1 m-85 -102.44 124.84 48.72 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 108.52 -0.919 . . . . 0.0 108.52 179.616 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.605 ' HB ' ' HB ' ' A' ' 35' ' ' ILE . 74.7 mt -133.46 147.07 31.15 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-O 120.981 0.419 . . . . 0.0 111.135 -175.276 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 37.1 tp -127.76 135.99 50.89 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.923 -0.581 . . . . 0.0 109.725 179.108 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.583 ' HB2' ' HB ' ' A' ' 33' ' ' ILE . 2.8 mp -133.81 154.87 50.7 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 179.264 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 116' ' ' ASP . . . . . 0.42 ' OD2' ' HB2' ' A' ' 120' ' ' LYS . 2.7 p30 -84.92 178.1 7.72 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.664 -179.956 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 117' ' ' ARG . . . . . 0.557 ' HG2' ' HA ' ' A' ' 31' ' ' LYS . 79.7 mtt180 -58.82 -20.48 50.89 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 114.538 -1.21 . . . . 0.0 112.927 -174.434 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 118' ' ' ASP . . . . . 0.504 ' O ' ' HE2' ' A' ' 29' ' ' LYS . 22.4 t70 -85.27 1.77 46.84 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.741 0.781 . . . . 0.0 109.137 179.506 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 77.87 25.08 63.07 Favored Glycine 0 N--CA 1.431 -1.7 0 N-CA-C 110.221 -1.151 . . . . 0.0 110.221 -173.366 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 120' ' ' LYS . . . . . 0.42 ' HB2' ' OD2' ' A' ' 116' ' ' ASP . 46.1 mmtm -108.45 120.8 43.47 Favored 'General case' 0 C--O 1.22 -0.451 0 C-N-CA 119.246 -0.982 . . . . 0.0 112.326 -172.369 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 0.558 ' HA ' ' HG ' ' A' ' 115' ' ' LEU . 33.3 mt -42.62 117.83 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-N 115.079 -0.964 . . . . 0.0 113.159 -179.363 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 122' ' ' ILE . . . . . 0.413 HD11 ' HB3' ' A' ' 116' ' ' ASP . 59.4 mt -93.0 -37.13 8.18 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.828 0 CA-C-N 113.863 -1.517 . . . . 0.0 108.862 174.286 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 11.1 m -146.61 115.58 6.92 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.406 -0.815 . . . . 0.0 110.44 179.346 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -69.41 -30.47 68.44 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.52 0.676 . . . . 0.0 109.429 172.647 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 125' ' ' ASN . . . . . 0.428 ' HA ' ' NH1' ' A' ' 111' ' ' ARG . 11.0 t30 -111.07 95.77 5.74 Favored 'General case' 0 N--CA 1.449 -0.519 0 CA-C-N 115.245 -0.888 . . . . 0.0 109.675 175.985 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 126' ' ' MET . . . . . 0.496 ' HG3' ' H ' ' A' ' 127' ' ' THR . 10.5 tpt -105.98 -175.72 2.87 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 107.742 -1.206 . . . . 0.0 107.742 177.592 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 127' ' ' THR . . . . . 0.496 ' H ' ' HG3' ' A' ' 126' ' ' MET . 4.1 p -115.95 139.07 50.61 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-O 121.441 0.638 . . . . 0.0 112.387 -173.025 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 128' ' ' ARG . . . . . 0.59 ' HB3' ' CZ ' ' A' ' 112' ' ' PHE . 0.0 OUTLIER -41.2 146.84 0.48 Allowed Pre-proline 0 N--CA 1.468 0.452 0 CA-C-N 114.472 -1.24 . . . . 0.0 113.558 171.593 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 26.0 Cg_endo -61.85 -31.35 85.12 Favored 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 123.464 2.776 . . . . 0.0 113.293 -178.593 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 130' ' ' SER . . . . . 0.423 ' HB3' ' CZ ' ' A' ' 128' ' ' ARG . 47.1 t -74.93 -2.38 26.75 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.698 0.285 . . . . 0.0 111.164 -179.125 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 131' ' ' ASP . . . . . 0.481 ' HB2' ' CD ' ' A' ' 128' ' ' ARG . 14.5 t70 -91.59 129.25 43.39 Favored Pre-proline 0 C--N 1.327 -0.377 0 N-CA-C 110.059 -0.349 . . . . 0.0 110.059 176.289 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -67.85 -26.59 38.11 Favored 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 122.774 2.316 . . . . 0.0 113.414 -176.668 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 133' ' ' LYS . . . . . 0.561 ' O ' ' HG3' ' A' ' 137' ' ' LYS . 13.7 mmmm -70.44 -28.92 65.41 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.862 0.363 . . . . 0.0 110.238 -178.48 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 134' ' ' THR . . . . . 0.784 HG22 ' CZ ' ' A' ' 138' ' ' PHE . 2.8 m -59.04 -50.91 72.27 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.662 -0.699 . . . . 0.0 109.899 175.004 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 135' ' ' ALA . . . . . 0.625 ' HA ' ' CD2' ' A' ' 138' ' ' PHE . . . -56.41 -43.78 79.7 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.288 -0.869 . . . . 0.0 111.383 176.567 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 7.6 mt-10 -54.8 -49.16 71.63 Favored 'General case' 0 CA--C 1.516 -0.364 0 CA-C-O 121.316 0.579 . . . . 0.0 110.724 177.793 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 137' ' ' LYS . . . . . 0.561 ' HG3' ' O ' ' A' ' 133' ' ' LYS . 39.3 mtpt -55.63 -41.65 73.84 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.239 -0.892 . . . . 0.0 111.142 -179.705 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 138' ' ' PHE . . . . . 0.784 ' CZ ' HG22 ' A' ' 134' ' ' THR . 13.7 m-85 -61.36 -61.2 2.72 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.728 179.35 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 29.3 p30 -69.43 -18.91 63.78 Favored 'General case' 0 C--O 1.224 -0.285 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.819 -172.711 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -75.39 -51.07 13.98 Favored 'General case' 0 C--N 1.321 -0.64 0 C-N-CA 120.97 -0.292 . . . . 0.0 110.688 175.616 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.41 ' HG ' ' O ' ' A' ' 137' ' ' LYS . 89.3 mt -66.92 -27.11 67.22 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.318 -177.562 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 96.9 mt -85.86 -17.57 35.22 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.653 177.031 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 72.06 30.55 65.27 Favored Glycine 0 N--CA 1.45 -0.368 0 N-CA-C 110.42 -1.072 . . . . 0.0 110.42 -176.202 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.419 ' O ' ' HG ' ' A' ' 144' ' ' LEU . 50.5 tp -95.75 6.29 49.27 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 114.374 -0.913 . . . . 0.0 110.244 -173.912 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -64.14 158.63 22.42 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.742 -0.663 . . . . 0.0 112.305 -179.09 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 146' ' ' GLY . . . . . 0.48 ' HA2' ' O ' ' A' ' 149' ' ' HIS . . . -104.44 12.12 51.04 Favored Glycine 0 N--CA 1.445 -0.728 0 CA-C-N 115.013 -0.994 . . . . 0.0 111.103 172.5 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 3.5 t-160 -56.64 -57.56 11.86 Favored 'General case' 0 N--CA 1.464 0.232 0 C-N-CA 123.17 0.588 . . . . 0.0 111.039 -177.925 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 16.6 t-80 -90.62 -3.87 57.23 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.751 -176.273 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 149' ' ' HIS . . . . . 0.48 ' O ' ' HA2' ' A' ' 146' ' ' GLY . 53.6 t-80 178.18 112.5 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 -178.083 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 95.9 m-70 -48.52 113.39 0.75 Allowed 'General case' 0 N--CA 1.467 0.408 0 O-C-N 123.728 0.643 . . . . 0.0 109.671 179.229 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -77.58 123.32 26.47 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.668 -0.696 . . . . 0.0 112.455 -164.129 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 29.9 p-80 . . . . . 0 C--O 1.251 1.181 0 CA-C-O 117.05 -1.452 . . . . 0.0 107.34 172.351 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.48 1.028 0 CA-C-O 120.792 0.329 . . . . 0.0 110.25 . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 16.2 p -89.07 -6.38 57.15 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.219 0.533 . . . . 0.0 110.877 179.34 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -84.48 86.69 7.25 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.194 -178.705 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 13.6 ptt180 -132.83 12.43 4.37 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.791 0.805 . . . . 0.0 109.356 172.845 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 51.4 m -156.86 -163.2 1.37 Allowed 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 114.788 -1.097 . . . . 0.0 108.215 -179.251 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -68.54 -74.7 0.58 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.027 -1.082 . . . . 0.0 111.017 176.016 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 93.9 m-20 -110.01 156.4 40.07 Favored Pre-proline 0 C--N 1.321 -0.672 0 N-CA-C 109.203 -0.665 . . . . 0.0 109.203 172.059 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 12.9 Cg_endo -59.25 98.65 0.11 Allowed 'Trans proline' 0 C--O 1.234 0.322 0 C-N-CA 122.4 2.066 . . . . 0.0 112.121 -179.2 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 22.1 m -80.06 140.38 36.53 Favored 'General case' 0 N--CA 1.443 -0.813 0 CA-C-N 115.624 -0.716 . . . . 0.0 109.853 -177.791 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.564 ' HA ' ' CZ ' ' A' ' 100' ' ' PHE . . . 74.78 -39.91 0.43 Allowed 'General case' 0 N--CA 1.47 0.537 0 O-C-N 124.108 0.88 . . . . 0.0 111.312 -177.864 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.429 ' O ' HD23 ' A' ' 25' ' ' LEU . . . -74.89 -11.65 60.18 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.223 178.971 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.722 ' HA ' ' HB3' ' A' ' 25' ' ' LEU . 18.3 p -159.67 93.36 1.09 Allowed 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.857 174.427 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 38.2 p90 -97.76 159.85 14.68 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.437 174.8 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 13.2 p -134.59 115.18 13.56 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.642 0.258 . . . . 0.0 111.117 -178.908 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 65.3 m-85 -138.88 159.62 66.32 Favored Pre-proline 0 N--CA 1.465 0.288 0 CA-C-N 116.451 -0.34 . . . . 0.0 111.3 -177.487 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 79.4 Cg_endo -84.86 134.15 5.23 Favored 'Trans proline' 0 C--N 1.351 0.676 0 C-N-CA 122.683 2.255 . . . . 0.0 113.406 177.895 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' ASP . . . . . 0.524 ' HB3' ' HB3' ' A' ' 21' ' ' LYS . 7.4 t70 -80.0 160.12 26.0 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 114.826 -1.079 . . . . 0.0 109.428 174.96 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 2.2 tt -46.94 -38.19 4.0 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 O-C-N 124.151 0.907 . . . . 0.0 112.105 -178.392 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 45.0 m-80 -71.82 -13.2 61.62 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.097 0.475 . . . . 0.0 111.056 -178.389 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 95.28 34.43 6.11 Favored Glycine 0 N--CA 1.446 -0.654 0 N-CA-C 110.949 -0.86 . . . . 0.0 110.949 -175.027 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.524 ' HB3' ' HB3' ' A' ' 17' ' ' ASP . 25.7 tptp -106.08 131.05 53.82 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.121 0.486 . . . . 0.0 111.012 -176.241 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 7.6 m -80.76 99.06 8.05 Favored 'General case' 0 C--N 1.314 -0.97 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 179.618 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.756 ' HB ' HD11 ' A' ' 92' ' ' LEU . 25.2 t -109.43 134.52 51.22 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-O 121.321 0.581 . . . . 0.0 109.728 178.848 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 24' ' ' SER . . . . . 0.461 ' H ' ' CB ' ' A' ' 27' ' ' ASP . 13.7 m -122.52 166.47 14.75 Favored 'General case' 0 C--N 1.306 -1.287 0 CA-C-N 115.59 -0.732 . . . . 0.0 109.184 178.334 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.722 ' HB3' ' HA ' ' A' ' 12' ' ' SER . 19.6 tp -66.35 -22.51 66.26 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.083 0.468 . . . . 0.0 110.298 179.472 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.498 ' HA ' ' HB2' ' A' ' 29' ' ' LYS . . . -91.29 0.69 57.48 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.746 175.583 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.461 ' CB ' ' H ' ' A' ' 24' ' ' SER . 35.7 t70 -91.73 -33.44 15.02 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 179.415 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.702 HD11 HG21 ' A' ' 90' ' ' ILE . 76.9 mt -105.37 10.3 33.47 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.635 176.166 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.498 ' HB2' ' HA ' ' A' ' 26' ' ' ALA . 64.0 tttt -65.94 148.13 52.28 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 115.443 -0.799 . . . . 0.0 111.12 -176.825 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 121.04 -23.59 7.68 Favored Glycine 0 N--CA 1.447 -0.622 0 N-CA-C 111.185 -0.766 . . . . 0.0 111.185 -177.092 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.529 ' HD3' ' HA ' ' A' ' 63' ' ' ASP . 43.7 mttm -128.49 166.72 18.23 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 109.527 -0.546 . . . . 0.0 109.527 177.574 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.912 ' HB2' HG22 ' A' ' 64' ' ' ILE . 67.9 m-85 -66.55 144.87 56.18 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.83 0.348 . . . . 0.0 110.54 -179.644 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 47.0 mm -117.13 128.67 74.45 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-N 116.301 -0.408 . . . . 0.0 110.838 -176.31 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 84.6 t80 -110.57 121.54 45.57 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 171.774 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.714 ' HB ' ' HB ' ' A' ' 113' ' ' ILE . 54.5 mt -107.78 128.59 62.91 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-O 120.905 0.383 . . . . 0.0 110.569 -178.995 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.455 ' O ' ' HA ' ' A' ' 68' ' ' SER . 4.5 t70 -132.77 141.62 48.6 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 176.693 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.502 ' HA ' ' O ' ' A' ' 69' ' ' LEU . 39.1 t -89.5 112.82 24.94 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 C-N-CA 120.531 -0.468 . . . . 0.0 111.675 -176.289 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 38' ' ' TRP . . . . . 0.682 ' CZ2' ' HB2' ' A' ' 91' ' ' GLN . 0.7 OUTLIER -102.72 132.91 48.54 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.642 -0.708 . . . . 0.0 109.353 178.905 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -147.71 164.57 33.15 Favored 'General case' 0 N--CA 1.464 0.252 0 N-CA-C 111.689 0.255 . . . . 0.0 111.689 -175.03 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.597 HG22 ' OD2' ' A' ' 72' ' ' ASP . 4.2 t -99.22 -33.08 10.9 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-O 120.856 0.36 . . . . 0.0 110.794 172.037 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 21.2 p-90 -82.94 21.21 1.07 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.158 0.504 . . . . 0.0 110.531 -178.947 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' CYS . . . . . 0.816 ' SG ' ' HB3' ' A' ' 45' ' ' CYS . 12.7 p -87.51 -69.88 0.66 Allowed 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.35 -176.649 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.439 ' N ' ' SG ' ' A' ' 42' ' ' CYS . . . 110.35 -92.36 0.68 Allowed Glycine 0 N--CA 1.448 -0.565 0 C-N-CA 121.111 -0.566 . . . . 0.0 111.949 -175.511 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.439 ' HD2' ' O ' ' A' ' 42' ' ' CYS . 12.2 Cg_endo -55.97 -29.57 74.11 Favored 'Trans proline' 0 C--N 1.349 0.602 0 C-N-CA 123.464 2.776 . . . . 0.0 112.747 -178.65 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 45' ' ' CYS . . . . . 0.993 ' HB2' ' HD3' ' A' ' 110' ' ' PRO . 43.6 t -54.33 -33.49 59.04 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.729 -0.669 . . . . 0.0 111.445 178.978 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.526 ' HA ' ' HG ' ' A' ' 49' ' ' LEU . 56.8 mtp180 -68.31 -18.0 64.4 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.712 0.291 . . . . 0.0 110.937 -176.396 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -82.02 -22.47 59.28 Favored Glycine 0 N--CA 1.448 -0.512 0 C-N-CA 120.713 -0.756 . . . . 0.0 111.865 177.135 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -104.63 -5.67 21.19 Favored 'General case' 0 C--N 1.329 -0.313 0 O-C-N 122.783 -0.245 . . . . 0.0 111.043 179.488 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.717 HD13 HD11 ' A' ' 87' ' ' LEU . 65.0 mt -53.64 -48.04 94.54 Favored Pre-proline 0 C--O 1.235 0.295 0 CA-C-N 116.677 -0.238 . . . . 0.0 110.975 174.401 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.687 ' O ' ' HG2' ' A' ' 54' ' ' GLU . 54.2 Cg_exo -54.57 -40.91 81.68 Favored 'Trans proline' 0 C--N 1.356 0.949 0 C-N-CA 121.824 1.682 . . . . 0.0 112.029 171.724 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -69.29 -31.56 70.14 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-O 121.26 0.552 . . . . 0.0 110.571 -176.728 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 6.6 tt -67.04 -48.25 68.89 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.364 -0.834 . . . . 0.0 109.916 -179.395 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.566 ' O ' ' HG3' ' A' ' 57' ' ' GLU . 6.2 ptmm? -67.58 -32.45 73.21 Favored 'General case' 0 C--N 1.333 -0.134 0 C-N-CA 121.009 -0.276 . . . . 0.0 110.48 -179.909 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.687 ' HG2' ' O ' ' A' ' 50' ' ' PRO . 51.6 mm-40 -59.51 -47.38 85.76 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.904 0.383 . . . . 0.0 110.394 176.493 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 29.6 mt -61.9 -53.41 56.17 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.683 175.598 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.566 ' HA ' ' CD2' ' A' ' 66' ' ' PHE . 4.5 tm-20 -44.7 -59.87 2.29 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 114.872 -1.058 . . . . 0.0 112.039 179.957 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.566 ' HG3' ' O ' ' A' ' 53' ' ' LYS . 20.1 mt-10 -71.78 -35.6 70.08 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.77 0.319 . . . . 0.0 111.664 -173.082 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.402 ' HD3' ' CE2' ' A' ' 59' ' ' TYR . 83.5 tttt -67.09 -39.48 86.78 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.224 0.535 . . . . 0.0 110.771 -178.875 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.475 ' HB3' HD11 ' A' ' 64' ' ' ILE . 96.9 m-85 -105.32 10.27 33.58 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.241 -176.141 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -68.19 157.41 35.47 Favored 'General case' 0 C--O 1.239 0.516 0 CA-C-O 120.795 0.331 . . . . 0.0 110.427 172.215 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 77.9 8.49 87.3 Favored Glycine 0 N--CA 1.447 -0.633 0 C-N-CA 120.98 -0.629 . . . . 0.0 112.583 178.421 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.524 ' HB2' HG12 ' A' ' 64' ' ' ILE . 43.6 mmtm -98.77 -161.17 0.85 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.129 0.49 . . . . 0.0 110.029 177.99 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.529 ' HA ' ' HD3' ' A' ' 31' ' ' LYS . 21.5 m-20 -91.16 32.69 1.01 Allowed 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 115.352 -0.84 . . . . 0.0 110.556 179.267 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.912 HG22 ' HB2' ' A' ' 32' ' ' TYR . 31.7 pt -141.67 165.59 18.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.129 -176.955 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 87.1 m-70 -136.44 137.72 40.73 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 175.118 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' PHE . . . . . 0.566 ' CD2' ' HA ' ' A' ' 56' ' ' GLU . 93.4 m-85 -94.69 110.11 21.98 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.624 -0.51 . . . . 0.0 109.624 174.172 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.601 ' O ' ' HA ' ' A' ' 35' ' ' ILE . 57.1 t -116.81 106.17 19.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.713 -175.581 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 68' ' ' SER . . . . . 0.455 ' HA ' ' O ' ' A' ' 36' ' ' ASP . 34.5 m -88.96 133.41 34.33 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.171 177.302 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.502 ' O ' ' HA ' ' A' ' 37' ' ' VAL . 79.2 mt -117.24 135.18 53.99 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.735 0.302 . . . . 0.0 110.42 176.712 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 70' ' ' SER . . . . . 0.436 ' O ' ' HB3' ' A' ' 94' ' ' MET . 1.4 t -113.87 120.73 41.73 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.279 -0.418 . . . . 0.0 111.63 -176.247 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 1.8 p -89.14 16.4 7.27 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.908 177.142 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.597 ' OD2' HG22 ' A' ' 40' ' ' THR . 1.4 m-20 -68.23 132.75 47.69 Favored 'General case' 0 CA--C 1.518 -0.266 0 N-CA-C 109.919 -0.4 . . . . 0.0 109.919 178.923 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 38.7 ttpt -76.85 -35.37 57.55 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-O 121.18 0.514 . . . . 0.0 109.862 177.86 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' ASN . . . . . 0.548 ' HB2' ' HB3' ' A' ' 77' ' ' ALA . 0.7 OUTLIER -74.29 102.07 4.23 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.538 -0.755 . . . . 0.0 110.216 176.553 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 10.8 tttt -78.19 -55.68 5.07 Favored 'General case' 0 C--N 1.319 -0.732 0 C-N-CA 120.521 -0.472 . . . . 0.0 111.282 -178.343 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 47.4 tptt -60.43 -48.6 81.04 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.254 -174.986 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.548 ' HB3' ' HB2' ' A' ' 74' ' ' ASN . . . -58.31 -36.38 73.27 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.972 178.714 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 78' ' ' TRP . . . . . 0.524 ' O ' HG12 ' A' ' 82' ' ' VAL . 12.2 t-105 -76.9 -48.6 17.8 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.197 -177.714 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.405 ' O ' HG13 ' A' ' 82' ' ' VAL . 4.6 pt-20 -62.15 -32.91 73.57 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-O 120.938 0.399 . . . . 0.0 110.919 -176.326 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 26.5 p30 -79.99 -27.3 39.64 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 119.717 -0.793 . . . . 0.0 111.149 177.866 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' MET . . . . . 0.467 ' SD ' ' HZ3' ' A' ' 78' ' ' TRP . 15.4 ttt -65.91 -48.47 71.32 Favored 'General case' 0 C--O 1.22 -0.495 0 C-N-CA 120.45 -0.5 . . . . 0.0 111.068 173.481 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.645 HG23 ' HB2' ' A' ' 87' ' ' LEU . 0.6 OUTLIER -58.88 -37.59 67.83 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 C-N-CA 120.408 -0.517 . . . . 0.0 110.518 177.832 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 58.7 m -63.33 -41.96 98.94 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.84 175.241 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 1.3 tmtp? -71.81 -45.17 62.4 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.435 -178.873 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -72.36 -10.91 60.4 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.461 -0.79 . . . . 0.0 111.627 -178.026 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 96.5 mt-30 67.67 49.27 0.98 Allowed 'General case' 0 N--CA 1.464 0.267 0 O-C-N 123.517 0.511 . . . . 0.0 111.855 173.731 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.717 HD11 HD13 ' A' ' 49' ' ' LEU . 21.2 mt -104.67 130.66 52.66 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 176.687 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.545 ' C ' ' HD3' ' A' ' 88' ' ' LYS . 0.0 OUTLIER -135.53 165.51 25.35 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.8 0.333 . . . . 0.0 111.847 -179.112 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 140.3 -142.08 12.1 Favored Glycine 0 N--CA 1.449 -0.448 0 N-CA-C 109.998 -1.241 . . . . 0.0 109.998 -176.208 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.702 HG21 HD11 ' A' ' 28' ' ' LEU . 45.9 mm -108.79 113.18 43.39 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 169.792 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 91' ' ' GLN . . . . . 0.682 ' HB2' ' CZ2' ' A' ' 38' ' ' TRP . 1.7 pt20 -141.48 104.17 4.53 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-O 121.836 0.827 . . . . 0.0 112.207 -169.33 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.756 HD11 ' HB ' ' A' ' 23' ' ' VAL . 3.0 mm? -99.04 163.31 12.63 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 114.905 -1.043 . . . . 0.0 110.766 -177.439 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 25.2 t-80 -131.68 121.73 24.78 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.93 -174.95 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 94' ' ' MET . . . . . 0.436 ' HB3' ' O ' ' A' ' 70' ' ' SER . 25.3 ttm -73.07 -61.11 1.93 Allowed 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 114.901 -1.045 . . . . 0.0 110.697 -179.169 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 95.04 -101.62 2.74 Favored Glycine 0 N--CA 1.446 -0.671 0 C-N-CA 120.661 -0.78 . . . . 0.0 112.712 178.14 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 19.2 p -110.91 16.68 21.12 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 111.884 0.327 . . . . 0.0 111.884 -175.508 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -102.06 48.18 0.88 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.051 0.453 . . . . 0.0 110.452 -179.133 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -68.55 -6.82 27.54 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.516 -174.471 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 28.9 m -64.49 -30.99 72.02 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.113 0.482 . . . . 0.0 110.025 173.082 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 100' ' ' PHE . . . . . 0.564 ' CZ ' ' HA ' ' A' ' 10' ' ' ALA . 20.5 t80 -74.2 -36.79 64.01 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 176.442 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 101' ' ' MET . . . . . 0.699 ' HG3' HG13 ' A' ' 106' ' ' ILE . 12.9 ttt -59.07 -45.55 90.53 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.063 -0.971 . . . . 0.0 110.311 172.138 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -67.09 -35.14 79.15 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.985 179.733 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -61.26 -38.19 85.8 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-O 120.997 0.427 . . . . 0.0 111.167 -179.504 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 39.7 m-85 -87.44 -7.66 57.41 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.533 179.316 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 80.0 mt 61.05 30.49 19.56 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.956 -179.696 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 106' ' ' ILE . . . . . 0.699 HG13 ' HG3' ' A' ' 101' ' ' MET . 22.9 pt -77.79 77.79 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 121.685 0.755 . . . . 0.0 110.901 179.008 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 17.6 p-10 -88.28 -54.26 4.29 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.613 -0.721 . . . . 0.0 111.542 -177.878 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -81.53 63.22 4.39 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 121.103 -0.57 . . . . 0.0 112.379 -176.559 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.593 ' HA ' ' C ' ' A' ' 110' ' ' PRO . 44.9 pt -71.43 147.46 92.72 Favored Pre-proline 0 C--N 1.324 -0.509 0 N-CA-C 110.496 -0.187 . . . . 0.0 110.496 -179.363 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 110' ' ' PRO . . . . . 0.993 ' HD3' ' HB2' ' A' ' 45' ' ' CYS . 24.9 Cg_endo -62.57 136.05 19.57 Favored 'Cis proline' 0 C--N 1.348 0.52 0 C-N-CA 124.013 -1.245 . . . . 0.0 113.168 2.096 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 111' ' ' ARG . . . . . 0.593 ' HG3' ' HA ' ' A' ' 106' ' ' ILE . 0.0 OUTLIER -113.15 141.5 46.85 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.41 -0.814 . . . . 0.0 109.764 -177.708 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 112' ' ' PHE . . . . . 0.487 ' O ' ' HA ' ' A' ' 125' ' ' ASN . 0.3 OUTLIER -97.95 124.99 42.65 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 114.935 -1.03 . . . . 0.0 112.116 -173.657 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.714 ' HB ' ' HB ' ' A' ' 35' ' ' ILE . 85.6 mt -136.01 148.2 27.87 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.487 0 CA-C-O 120.737 0.303 . . . . 0.0 110.8 178.442 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 33.5 tp -137.77 137.8 38.61 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 116.62 -0.264 . . . . 0.0 110.335 179.411 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.519 ' N ' HD12 ' A' ' 115' ' ' LEU . 0.3 OUTLIER -135.58 156.26 49.15 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-O 121.504 0.669 . . . . 0.0 111.41 -178.723 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 116' ' ' ASP . . . . . 0.703 ' HB3' ' HB2' ' A' ' 120' ' ' LYS . 11.2 t70 -75.77 162.67 27.99 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 114.572 -1.194 . . . . 0.0 110.876 179.695 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 117' ' ' ARG . . . . . 0.484 ' HA ' ' O ' ' A' ' 31' ' ' LYS . 17.0 mtm180 -49.94 -32.67 15.39 Favored 'General case' 0 N--CA 1.47 0.555 0 O-C-N 124.513 1.133 . . . . 0.0 112.703 -177.408 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 118' ' ' ASP . . . . . 0.769 ' HB3' ' HG3' ' A' ' 120' ' ' LYS . 19.8 t70 -77.97 -5.58 51.67 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-O 121.256 0.55 . . . . 0.0 110.948 -178.512 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 90.55 21.77 36.28 Favored Glycine 0 N--CA 1.438 -1.191 0 N-CA-C 110.459 -1.056 . . . . 0.0 110.459 -171.138 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 120' ' ' LYS . . . . . 0.769 ' HG3' ' HB3' ' A' ' 118' ' ' ASP . 35.9 mttp -87.22 105.29 17.11 Favored 'General case' 0 CA--C 1.515 -0.375 0 C-N-CA 120.304 -0.558 . . . . 0.0 110.342 -176.074 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 0.636 ' H ' HD12 ' A' ' 121' ' ' ILE . 3.6 mp -47.23 108.61 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-O 121.147 0.498 . . . . 0.0 110.669 178.353 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 122' ' ' ILE . . . . . 0.493 ' H ' ' HA ' ' A' ' 115' ' ' LEU . 48.2 mt -83.56 -51.6 14.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 -177.952 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 15.0 m -136.01 126.3 26.51 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.189 -0.914 . . . . 0.0 109.988 -178.665 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -74.02 -18.74 60.81 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.386 0.612 . . . . 0.0 109.803 176.616 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 125' ' ' ASN . . . . . 0.487 ' HA ' ' O ' ' A' ' 112' ' ' PHE . 3.9 p30 -140.18 118.09 11.78 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.106 -0.952 . . . . 0.0 109.995 174.617 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 126' ' ' MET . . . . . 0.435 ' N ' ' HD1' ' A' ' 112' ' ' PHE . 15.9 tpt -110.94 -115.82 0.31 Allowed 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.686 -0.688 . . . . 0.0 109.859 179.084 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 127' ' ' THR . . . . . 0.445 ' HB ' ' HB3' ' A' ' 131' ' ' ASP . 3.3 p -145.76 139.91 26.79 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 122.379 0.272 . . . . 0.0 110.321 178.571 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 65.7 mtt180 -62.87 161.5 28.96 Favored Pre-proline 0 N--CA 1.468 0.458 0 N-CA-C 112.876 0.695 . . . . 0.0 112.876 179.924 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -49.47 -31.25 23.26 Favored 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 123.862 3.041 . . . . 0.0 113.165 170.499 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 22.7 t -74.08 -26.34 60.32 Favored 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 111.543 0.201 . . . . 0.0 111.543 -179.264 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 131' ' ' ASP . . . . . 0.445 ' HB3' ' HB ' ' A' ' 127' ' ' THR . 8.7 t70 -81.9 128.1 69.78 Favored Pre-proline 0 C--N 1.331 -0.22 0 C-N-CA 120.236 -0.585 . . . . 0.0 110.734 179.64 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 132' ' ' PRO . . . . . 0.434 ' HD3' ' HA ' ' A' ' 131' ' ' ASP . 31.4 Cg_exo -61.86 -25.01 77.85 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 123.233 2.622 . . . . 0.0 113.671 -178.714 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 133' ' ' LYS . . . . . 0.561 ' O ' ' HB2' ' A' ' 137' ' ' LYS . 45.5 mmtm -61.04 -34.81 75.45 Favored 'General case' 0 CA--C 1.516 -0.357 0 CA-C-O 120.674 0.273 . . . . 0.0 110.926 -178.288 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 134' ' ' THR . . . . . 0.643 HG22 ' CZ ' ' A' ' 138' ' ' PHE . 1.2 m -59.56 -52.58 64.96 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.99 -0.55 . . . . 0.0 109.792 177.018 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 135' ' ' ALA . . . . . 0.558 ' HA ' ' CD2' ' A' ' 138' ' ' PHE . . . -60.44 -47.08 87.66 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.242 -0.89 . . . . 0.0 111.891 -179.481 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 136' ' ' GLU . . . . . 0.549 ' HG2' ' HA ' ' A' ' 133' ' ' LYS . 12.5 pt-20 -73.14 -23.19 60.43 Favored 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 120.444 -0.502 . . . . 0.0 110.852 -176.177 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 137' ' ' LYS . . . . . 0.561 ' HB2' ' O ' ' A' ' 133' ' ' LYS . 4.1 tmtm? -66.24 -43.01 87.76 Favored 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 109.492 -0.558 . . . . 0.0 109.492 175.855 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 138' ' ' PHE . . . . . 0.643 ' CZ ' HG22 ' A' ' 134' ' ' THR . 9.9 m-85 -56.37 -50.59 71.11 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.817 -0.629 . . . . 0.0 109.484 174.459 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 85.9 m-20 -54.66 -46.42 74.0 Favored 'General case' 0 C--O 1.222 -0.383 0 CA-C-N 115.795 -0.639 . . . . 0.0 109.881 176.984 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -53.88 -48.78 69.73 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.441 179.28 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.532 HD21 ' HE3' ' A' ' 137' ' ' LYS . 91.1 mt -58.48 -45.93 87.68 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.451 -177.594 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -86.27 -3.38 58.97 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.898 0.38 . . . . 0.0 111.053 -178.603 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 75.53 26.33 65.75 Favored Glycine 0 N--CA 1.452 -0.278 0 N-CA-C 111.753 -0.539 . . . . 0.0 111.753 177.81 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 49.7 tp -86.59 3.49 44.18 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 114.879 -0.661 . . . . 0.0 111.083 -174.619 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -70.03 165.37 21.99 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.21 0.529 . . . . 0.0 111.253 178.839 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -144.3 83.76 0.2 Allowed Glycine 0 N--CA 1.445 -0.72 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.626 178.264 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 85.1 m-70 -111.42 112.12 23.64 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 109.641 -0.504 . . . . 0.0 109.641 -179.715 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 8.7 p-80 -99.03 161.67 13.49 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 120.76 0.314 . . . . 0.0 110.379 179.112 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 68.5 m-70 -103.76 178.47 4.55 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.071 -0.513 . . . . 0.0 109.75 -179.245 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 26.3 t-80 -126.06 133.7 51.63 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 179.664 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 45.7 t-80 -62.45 120.69 11.56 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.22 -178.311 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 11.8 t-160 . . . . . 0 C--O 1.245 0.845 0 CA-C-N 115.658 -0.701 . . . . 0.0 109.461 176.195 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 72.0 mtm . . . . . 0 N--CA 1.479 1.009 0 CA-C-O 120.547 0.213 . . . . 0.0 110.651 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 20.2 m -112.31 94.32 4.87 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.745 0.307 . . . . 0.0 111.094 -177.906 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -168.42 98.48 0.42 Allowed 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 109.117 -0.697 . . . . 0.0 109.117 175.637 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 4' ' ' ARG . . . . . 0.438 ' H ' ' HD2' ' A' ' 4' ' ' ARG . 0.0 OUTLIER -72.26 2.97 5.12 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 112.338 0.495 . . . . 0.0 112.338 -173.841 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 9.4 m -106.23 4.8 29.24 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 120.987 0.422 . . . . 0.0 110.766 -179.138 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 82.17 -68.8 3.44 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.919 -0.657 . . . . 0.0 112.694 178.986 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 10.2 p30 -88.32 159.03 48.34 Favored Pre-proline 0 C--N 1.324 -0.54 0 N-CA-C 109.392 -0.595 . . . . 0.0 109.392 177.523 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -75.64 89.69 1.19 Allowed 'Trans proline' 0 N--CA 1.453 -0.906 0 C-N-CA 121.748 1.632 . . . . 0.0 111.819 178.597 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 16.2 m -77.03 94.91 4.07 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.159 -0.928 . . . . 0.0 109.978 179.248 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.512 ' HB2' ' HZ ' ' A' ' 100' ' ' PHE . . . 68.49 -75.44 0.07 Allowed 'General case' 0 C--O 1.231 0.11 0 CA-C-N 115.178 -0.919 . . . . 0.0 110.482 -177.473 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . 63.05 -69.36 0.07 Allowed 'General case' 0 N--CA 1.468 0.449 0 O-C-N 124.294 0.996 . . . . 0.0 111.996 -178.875 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 50.5 m -156.23 109.72 2.7 Favored 'General case' 0 C--N 1.311 -1.095 0 CA-C-N 115.223 -0.899 . . . . 0.0 109.615 179.938 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' PHE . . . . . 0.447 ' H ' ' HB2' ' A' ' 25' ' ' LEU . 12.7 p90 -124.57 176.43 6.53 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.753 -177.514 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.561 ' HA ' ' HA ' ' A' ' 24' ' ' SER . 3.1 p -142.03 122.75 14.29 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.301 177.63 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 45.5 m-85 -132.09 145.67 58.38 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-O 120.819 0.342 . . . . 0.0 111.609 -177.685 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.607 ' HA ' ' O ' ' A' ' 21' ' ' LYS . 78.3 Cg_endo -81.69 128.19 5.92 Favored 'Trans proline' 0 N--CA 1.46 -0.48 0 C-N-CA 122.817 2.345 . . . . 0.0 113.931 179.692 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 17' ' ' ASP . . . . . 0.488 ' HB3' ' HB3' ' A' ' 21' ' ' LYS . 1.3 t70 -71.26 161.16 31.54 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 114.89 -1.05 . . . . 0.0 109.321 169.789 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.553 HG21 HG11 ' A' ' 82' ' ' VAL . 29.9 pt -46.76 -38.18 3.79 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.358 0 O-C-N 124.165 0.915 . . . . 0.0 112.849 -174.158 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 42.3 m-80 -75.88 -13.23 60.26 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-O 120.984 0.421 . . . . 0.0 111.357 -176.159 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 103.17 23.64 8.41 Favored Glycine 0 N--CA 1.449 -0.456 0 N-CA-C 111.182 -0.767 . . . . 0.0 111.182 -174.318 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.865 ' HE3' HG22 ' A' ' 23' ' ' VAL . 19.8 tptt -90.23 137.65 32.17 Favored 'General case' 0 C--O 1.219 -0.523 0 CA-C-O 121.081 0.467 . . . . 0.0 110.545 -176.063 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.493 ' N ' ' HD2' ' A' ' 21' ' ' LYS . 52.2 m -91.32 99.98 12.86 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-O 121.023 0.439 . . . . 0.0 110.163 -177.181 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.865 HG22 ' HE3' ' A' ' 21' ' ' LYS . 41.5 t -104.35 113.82 42.32 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 115.707 -0.679 . . . . 0.0 109.475 178.156 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 24' ' ' SER . . . . . 0.561 ' HA ' ' HA ' ' A' ' 14' ' ' SER . 7.1 m -105.98 173.34 6.35 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.249 -177.984 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.552 HD11 ' HA3' ' A' ' 119' ' ' GLY . 3.4 tm? -59.01 -45.23 91.2 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.058 179.035 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -72.08 -17.9 61.96 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.973 0.416 . . . . 0.0 111.076 -177.851 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -73.8 -28.68 61.76 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.92 -0.582 . . . . 0.0 109.815 -178.91 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.501 HD11 HG21 ' A' ' 90' ' ' ILE . 97.6 mt -111.54 -1.18 15.91 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.316 179.25 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 85.2 tttt -67.51 146.29 54.09 Favored 'General case' 0 N--CA 1.448 -0.543 0 CA-C-O 121.104 0.478 . . . . 0.0 111.497 -174.119 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 116.9 -20.5 11.64 Favored Glycine 0 N--CA 1.445 -0.746 0 N-CA-C 111.139 -0.785 . . . . 0.0 111.139 -177.309 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.48 ' HB3' ' N ' ' A' ' 64' ' ' ILE . 64.3 mttm -126.11 149.38 48.98 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.727 -0.237 . . . . 0.0 110.656 178.746 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.547 ' CE1' ' HA ' ' A' ' 116' ' ' ASP . 22.4 m-85 -61.57 119.66 9.05 Favored 'General case' 0 CA--C 1.516 -0.341 0 CA-C-O 120.75 0.31 . . . . 0.0 110.707 -179.978 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 68.6 mt -100.29 115.35 41.39 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.921 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.057 -174.673 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 81.7 t80 -92.03 120.71 32.92 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 108.669 -0.864 . . . . 0.0 108.669 170.953 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.596 ' HA ' ' O ' ' A' ' 67' ' ' VAL . 49.8 mt -107.73 122.64 62.32 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-O 120.985 0.421 . . . . 0.0 110.616 -178.802 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.53 ' O ' ' HA ' ' A' ' 68' ' ' SER . 1.9 t70 -120.06 159.47 24.72 Favored 'General case' 0 C--N 1.315 -0.926 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 174.432 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.591 HG11 HG21 ' A' ' 109' ' ' ILE . 42.9 t -102.32 114.55 42.11 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.98 0 C-N-CA 119.651 -0.819 . . . . 0.0 111.822 178.882 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 38' ' ' TRP . . . . . 0.621 ' CE3' ' HZ2' ' A' ' 78' ' ' TRP . 0.8 OUTLIER -102.62 134.44 45.98 Favored 'General case' 0 C--O 1.225 -0.198 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 -179.994 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.646 ' HB3' ' SG ' ' A' ' 42' ' ' CYS . . . -146.94 164.68 32.15 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 112.285 0.476 . . . . 0.0 112.285 -175.474 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.425 HG23 ' SD ' ' A' ' 81' ' ' MET . 1.4 m -78.64 -30.82 46.59 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.519 0.676 . . . . 0.0 110.383 178.117 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 41' ' ' TRP . . . . . 0.58 ' CH2' HD11 ' A' ' 109' ' ' ILE . 9.4 p-90 -106.48 21.83 16.8 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.234 -0.894 . . . . 0.0 112.116 -172.486 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 42' ' ' CYS . . . . . 0.646 ' SG ' ' HB3' ' A' ' 39' ' ' ALA . 25.7 p -116.99 88.98 3.01 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.477 0.656 . . . . 0.0 109.972 173.434 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -56.79 -53.97 40.05 Favored Glycine 0 CA--C 1.524 0.644 0 CA-C-N 115.486 -0.779 . . . . 0.0 113.912 -178.0 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 78.2 Cg_exo -52.41 -35.91 67.26 Favored 'Trans proline' 0 C--N 1.357 0.992 0 C-N-CA 122.818 2.345 . . . . 0.0 113.144 -178.333 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' CYS . . . . . 0.723 ' HB2' ' HD3' ' A' ' 110' ' ' PRO . 51.2 t -57.21 -30.82 64.88 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 121.041 0.448 . . . . 0.0 111.308 -177.564 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.577 ' HA ' HD12 ' A' ' 49' ' ' LEU . 41.9 mtp-105 -74.67 0.25 15.74 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.114 -0.493 . . . . 0.0 111.298 -174.162 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -84.45 -40.24 8.53 Favored Glycine 0 N--CA 1.446 -0.65 0 N-CA-C 111.539 -0.625 . . . . 0.0 111.539 174.22 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.461 ' CD ' ' HE ' ' A' ' 128' ' ' ARG . 4.4 pm0 -93.92 -8.28 40.63 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 111.531 0.197 . . . . 0.0 111.531 -179.447 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.614 ' HG ' ' O ' ' A' ' 45' ' ' CYS . 48.6 mt -54.97 -51.47 79.17 Favored Pre-proline 0 CA--C 1.535 0.374 0 N-CA-C 111.773 0.286 . . . . 0.0 111.773 177.473 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.613 ' HD3' ' HB2' ' A' ' 49' ' ' LEU . 50.8 Cg_exo -57.77 -38.08 94.21 Favored 'Trans proline' 0 C--N 1.357 1.007 0 C-N-CA 122.007 1.805 . . . . 0.0 112.077 175.574 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -70.01 -33.26 71.78 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.009 0.433 . . . . 0.0 110.775 -179.921 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 9.3 tt -66.56 -48.67 68.93 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.59 -177.759 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.564 ' O ' ' HG3' ' A' ' 57' ' ' GLU . 12.4 ptmm? -62.58 -42.59 99.65 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 109.97 -0.381 . . . . 0.0 109.97 177.676 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -62.91 -34.47 77.51 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.323 179.687 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 18.2 mt -60.89 -48.02 83.74 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.931 175.42 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.453 ' HB2' ' HB2' ' A' ' 66' ' ' PHE . 7.8 tp10 -63.19 -41.78 99.23 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.572 -0.74 . . . . 0.0 109.999 178.615 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.564 ' HG3' ' O ' ' A' ' 53' ' ' LYS . 35.9 mt-10 -66.94 -21.38 65.98 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.827 177.627 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 61.7 tttp -86.21 -43.71 12.76 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.582 -179.267 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 80.3 m-85 -95.45 0.52 53.38 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 112.097 0.406 . . . . 0.0 112.097 -174.062 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -58.31 111.78 1.33 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.113 0.483 . . . . 0.0 110.829 176.349 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 150.69 -36.07 0.92 Allowed Glycine 0 N--CA 1.445 -0.718 0 N-CA-C 111.234 -0.746 . . . . 0.0 111.234 -178.597 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.551 ' HB3' HD22 ' A' ' 142' ' ' LEU . 2.2 mmmm -103.12 -160.64 0.79 Allowed 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.104 0.478 . . . . 0.0 110.695 175.93 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.446 ' H ' ' HE2' ' A' ' 62' ' ' LYS . 23.0 m-20 -97.92 79.15 2.61 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 116.024 -0.534 . . . . 0.0 111.884 -174.988 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.588 ' HB ' HD21 ' A' ' 142' ' ' LEU . 14.7 tt -154.03 156.93 4.81 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 115.59 -0.732 . . . . 0.0 109.613 176.725 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 65' ' ' HIS . . . . . 0.464 ' CE1' ' HD2' ' A' ' 31' ' ' LYS . 47.6 m-70 -143.61 142.59 31.11 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 109.893 -0.41 . . . . 0.0 109.893 175.857 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 66' ' ' PHE . . . . . 0.453 ' HB2' ' HB2' ' A' ' 56' ' ' GLU . 87.5 m-85 -109.88 102.93 11.65 Favored 'General case' 0 C--N 1.314 -0.96 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 172.28 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.615 HG22 ' HB ' ' A' ' 90' ' ' ILE . 51.1 t -119.68 125.98 74.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 115.134 -0.939 . . . . 0.0 110.72 -171.85 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 68' ' ' SER . . . . . 0.535 ' HB2' ' OE1' ' A' ' 91' ' ' GLN . 21.2 m -107.31 140.59 39.98 Favored 'General case' 0 C--N 1.312 -1.061 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.261 176.951 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 57.4 tp -117.76 133.52 55.85 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.089 179.388 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' SER . . . . . 0.437 ' O ' ' HB3' ' A' ' 94' ' ' MET . 1.6 t -109.81 116.9 32.5 Favored 'General case' 0 C--O 1.221 -0.446 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.845 -172.303 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 42.6 m -85.55 19.85 2.27 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 120.827 0.346 . . . . 0.0 111.1 177.937 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.548 ' OD1' ' HA ' ' A' ' 39' ' ' ALA . 3.6 m-20 -73.95 147.83 42.72 Favored 'General case' 0 CA--C 1.517 -0.321 0 CA-C-O 121.261 0.553 . . . . 0.0 111.41 -177.228 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.48 ' HB2' ' HE3' ' A' ' 73' ' ' LYS . 28.1 ttmt -95.38 -32.61 12.85 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 115.415 -0.812 . . . . 0.0 109.912 177.734 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -78.86 73.74 5.4 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.703 -0.681 . . . . 0.0 109.722 -178.319 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 10.5 tttt -58.55 -50.8 72.46 Favored 'General case' 0 C--N 1.323 -0.575 0 C-N-CA 120.71 -0.396 . . . . 0.0 111.437 -175.116 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.446 ' HA ' ' OE1' ' A' ' 79' ' ' GLU . 1.6 tmtt? -57.49 -48.01 80.39 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.695 -177.795 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -67.38 -38.44 84.72 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-O 121.475 0.655 . . . . 0.0 110.126 -177.545 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' TRP . . . . . 0.621 ' HZ2' ' CE3' ' A' ' 38' ' ' TRP . 13.8 t-105 -71.28 -47.65 55.62 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 115.1 -0.955 . . . . 0.0 111.412 -178.348 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.446 ' OE1' ' HA ' ' A' ' 76' ' ' LYS . 3.1 pt-20 -62.23 -37.04 83.87 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-O 120.631 0.253 . . . . 0.0 111.405 -175.547 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 6.0 p30 -77.45 -31.29 53.72 Favored 'General case' 0 C--N 1.332 -0.181 0 C-N-CA 119.413 -0.915 . . . . 0.0 110.301 179.581 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' MET . . . . . 0.425 ' SD ' HG23 ' A' ' 40' ' ' THR . 16.3 ttt -64.67 -46.86 80.64 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.632 -0.258 . . . . 0.0 111.497 176.661 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.686 HG23 ' HB2' ' A' ' 87' ' ' LEU . 1.0 OUTLIER -60.44 -36.74 71.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 C-N-CA 120.373 -0.531 . . . . 0.0 110.389 175.982 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 31.3 m -64.13 -38.11 89.89 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.641 177.046 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' LYS . . . . . 0.47 ' HA ' ' HD3' ' A' ' 84' ' ' LYS . 35.3 mmtm -74.03 -47.44 36.89 Favored 'General case' 0 CA--C 1.519 -0.222 0 CA-C-O 121.214 0.531 . . . . 0.0 111.385 178.213 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -72.74 -8.12 53.89 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.319 -0.855 . . . . 0.0 111.918 -178.442 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 49.9 mt-30 69.23 26.06 5.52 Favored 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 112.634 0.605 . . . . 0.0 112.634 169.91 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.686 ' HB2' HG23 ' A' ' 82' ' ' VAL . 18.8 mt -67.77 108.54 3.0 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.719 0.295 . . . . 0.0 110.393 -178.091 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.417 ' HB2' ' HE2' ' A' ' 53' ' ' LYS . 39.7 mmtm -95.87 -177.44 4.03 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.388 -178.68 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 96.56 -162.57 22.44 Favored Glycine 0 N--CA 1.448 -0.556 0 N-CA-C 111.017 -0.833 . . . . 0.0 111.017 -174.632 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.615 ' HB ' HG22 ' A' ' 67' ' ' VAL . 49.4 mm -97.31 113.62 32.22 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 117.435 0.618 . . . . 0.0 109.693 176.885 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 91' ' ' GLN . . . . . 0.61 ' HB3' ' CZ2' ' A' ' 38' ' ' TRP . 60.4 mm-40 -123.98 106.77 10.67 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.45 -173.965 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 41.7 mt -104.67 145.61 30.09 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.095 -175.636 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 93' ' ' HIS . . . . . 0.518 ' O ' ' HD2' ' A' ' 16' ' ' PRO . 26.7 t-80 -113.22 139.76 48.52 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-O 121.502 0.668 . . . . 0.0 111.383 -177.929 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 94' ' ' MET . . . . . 0.634 ' HG3' ' HB2' ' A' ' 97' ' ' ASP . 27.1 ttm -107.72 94.18 4.94 Favored 'General case' 0 N--CA 1.442 -0.849 0 CA-C-N 114.905 -1.043 . . . . 0.0 108.629 179.075 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -68.93 78.12 0.28 Allowed Glycine 0 C--N 1.315 -0.592 0 CA-C-N 115.122 -0.945 . . . . 0.0 113.599 -178.669 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 5.3 m 71.87 5.13 5.27 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 123.148 0.579 . . . . 0.0 111.674 174.337 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 97' ' ' ASP . . . . . 0.634 ' HB2' ' HG3' ' A' ' 94' ' ' MET . 13.2 m-20 -79.02 32.06 0.21 Allowed 'General case' 0 N--CA 1.466 0.331 0 CA-C-O 121.036 0.446 . . . . 0.0 110.011 178.743 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 98' ' ' ARG . . . . . 0.586 ' HA ' ' SD ' ' A' ' 94' ' ' MET . 0.0 OUTLIER -78.59 14.06 1.41 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.129 -0.487 . . . . 0.0 112.225 -169.589 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -66.43 -28.09 68.34 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 168.082 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 100' ' ' PHE . . . . . 0.512 ' HZ ' ' HB2' ' A' ' 10' ' ' ALA . 55.1 t80 -70.95 -38.92 72.85 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.011 -0.995 . . . . 0.0 109.283 172.928 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 101' ' ' MET . . . . . 0.538 ' HG3' HG13 ' A' ' 106' ' ' ILE . 11.5 ttt -57.25 -44.9 84.29 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.296 -0.866 . . . . 0.0 110.333 172.702 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -67.61 -33.54 75.2 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.43 -0.805 . . . . 0.0 111.189 179.327 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -73.93 -39.91 63.45 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.925 0.393 . . . . 0.0 111.4 -179.589 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 104' ' ' TYR . . . . . 0.568 ' HB3' HG23 ' A' ' 106' ' ' ILE . 2.4 m-85 -83.64 -5.12 59.1 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.745 -178.917 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 93.8 mt 63.51 20.78 12.43 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.292 177.92 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 106' ' ' ILE . . . . . 0.614 HG22 ' HG3' ' A' ' 111' ' ' ARG . 39.0 pt -77.99 59.38 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 CA-C-O 121.586 0.708 . . . . 0.0 110.871 178.399 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 9.8 p30 -86.82 -38.5 16.77 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.928 179.505 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -85.12 76.72 2.18 Favored Glycine 0 N--CA 1.447 -0.6 0 N-CA-C 111.41 -0.676 . . . . 0.0 111.41 176.416 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.591 HG21 HG11 ' A' ' 37' ' ' VAL . 23.0 pt -94.78 156.46 38.18 Favored Pre-proline 0 C--N 1.323 -0.57 0 CA-C-N 115.973 -0.114 . . . . 0.0 110.955 -177.742 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 110' ' ' PRO . . . . . 0.723 ' HD3' ' HB2' ' A' ' 45' ' ' CYS . 29.2 Cg_endo -61.52 147.57 51.01 Favored 'Cis proline' 0 C--N 1.349 0.583 0 C-N-CA 124.348 -1.105 . . . . 0.0 114.049 2.117 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 111' ' ' ARG . . . . . 0.614 ' HG3' HG22 ' A' ' 106' ' ' ILE . 0.0 OUTLIER -118.54 137.87 52.92 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 179.125 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 112' ' ' PHE . . . . . 0.448 ' CD1' ' HA ' ' A' ' 128' ' ' ARG . 0.9 OUTLIER -103.2 120.96 41.7 Favored 'General case' 0 C--N 1.329 -0.285 0 O-C-N 123.908 0.755 . . . . 0.0 110.066 -175.366 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 87.3 mt -136.93 147.62 27.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-O 120.656 0.265 . . . . 0.0 110.307 -179.971 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.476 ' HB2' ' HG2' ' A' ' 126' ' ' MET . 54.7 tp -129.24 137.49 51.12 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.508 0.194 . . . . 0.0 110.546 -179.936 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.781 ' HG ' ' HA ' ' A' ' 121' ' ' ILE . 4.7 mp -129.56 151.12 50.52 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.127 0.489 . . . . 0.0 110.379 179.324 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 116' ' ' ASP . . . . . 0.547 ' HA ' ' CE1' ' A' ' 32' ' ' TYR . 22.4 t70 -70.88 164.33 25.58 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.243 -0.89 . . . . 0.0 110.205 176.564 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 117' ' ' ARG . . . . . 0.412 ' HG3' ' CD2' ' A' ' 32' ' ' TYR . 76.4 mtp180 -49.77 -31.71 12.18 Favored 'General case' 0 N--CA 1.466 0.369 0 O-C-N 124.068 0.855 . . . . 0.0 111.858 179.683 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 118' ' ' ASP . . . . . 0.475 ' HB3' ' HG2' ' A' ' 120' ' ' LYS . 6.4 t70 -71.77 -4.29 26.86 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.164 -178.906 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 119' ' ' GLY . . . . . 0.552 ' HA3' HD11 ' A' ' 25' ' ' LEU . . . 79.49 30.54 44.52 Favored Glycine 0 N--CA 1.439 -1.154 0 N-CA-C 110.286 -1.126 . . . . 0.0 110.286 -171.757 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 120' ' ' LYS . . . . . 0.475 ' HG2' ' HB3' ' A' ' 118' ' ' ASP . 40.6 mmtm -110.65 110.43 21.11 Favored 'General case' 0 CA--C 1.516 -0.333 0 C-N-CA 120.707 -0.397 . . . . 0.0 111.536 -175.418 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 0.781 ' HA ' ' HG ' ' A' ' 115' ' ' LEU . 3.3 mp -42.15 112.22 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 115.272 -0.876 . . . . 0.0 111.94 -179.145 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 122' ' ' ILE . . . . . 0.503 HD11 ' HB2' ' A' ' 116' ' ' ASP . 27.3 mm -87.68 -46.8 15.94 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-N 115.275 -0.875 . . . . 0.0 109.281 176.096 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 12.4 m -134.7 114.4 12.66 Favored 'General case' 0 N--CA 1.447 -0.622 0 CA-C-N 115.142 -0.935 . . . . 0.0 110.03 179.559 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -76.12 -16.04 59.97 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.77 0.795 . . . . 0.0 109.714 175.735 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 12.2 p-10 -124.17 87.62 2.76 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 114.679 -1.146 . . . . 0.0 109.728 175.264 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 126' ' ' MET . . . . . 0.497 ' HG3' ' H ' ' A' ' 127' ' ' THR . 5.0 tpt -94.44 -170.18 2.21 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 108.936 -0.764 . . . . 0.0 108.936 -180.0 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 127' ' ' THR . . . . . 0.551 ' HB ' ' OG1' ' A' ' 134' ' ' THR . 3.7 m -117.7 138.98 51.64 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 110.205 -0.295 . . . . 0.0 110.205 -177.914 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 128' ' ' ARG . . . . . 0.461 ' HE ' ' CD ' ' A' ' 48' ' ' GLU . 49.1 ttt180 -32.32 136.63 0.25 Allowed Pre-proline 0 C--O 1.237 0.401 0 C-N-CA 124.36 1.064 . . . . 0.0 112.686 173.314 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 129' ' ' PRO . . . . . 0.417 ' HD3' ' HA ' ' A' ' 128' ' ' ARG . 86.5 Cg_exo -50.56 -40.21 54.99 Favored 'Trans proline' 0 C--N 1.347 0.474 0 C-N-CA 123.731 2.954 . . . . 0.0 113.479 -178.016 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 8.8 p -84.27 18.2 2.27 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 112.219 0.452 . . . . 0.0 112.219 -175.716 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 131' ' ' ASP . . . . . 0.446 ' HA ' ' HD3' ' A' ' 132' ' ' PRO . 15.2 t70 -97.99 131.05 27.32 Favored Pre-proline 0 C--N 1.328 -0.328 0 C-N-CA 120.582 -0.447 . . . . 0.0 110.003 175.893 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 132' ' ' PRO . . . . . 0.446 ' HD3' ' HA ' ' A' ' 131' ' ' ASP . 56.5 Cg_exo -53.91 -35.43 80.09 Favored 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 123.139 2.56 . . . . 0.0 113.56 -177.988 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 35.5 mtmm -68.13 -36.48 79.77 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.046 0.451 . . . . 0.0 110.16 -178.33 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 134' ' ' THR . . . . . 0.7 HG22 ' CZ ' ' A' ' 138' ' ' PHE . 1.3 m -65.58 -48.54 71.97 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.128 178.26 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 135' ' ' ALA . . . . . 0.554 ' HA ' ' CD2' ' A' ' 138' ' ' PHE . . . -58.31 -46.77 85.51 Favored 'General case' 0 C--O 1.237 0.418 0 CA-C-N 115.494 -0.776 . . . . 0.0 112.099 -179.713 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -71.0 -24.33 62.36 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.832 0.348 . . . . 0.0 110.701 -178.567 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 137' ' ' LYS . . . . . 0.545 ' O ' ' HG ' ' A' ' 141' ' ' LEU . 44.6 tptt -65.95 -41.14 91.65 Favored 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 109.611 -0.514 . . . . 0.0 109.611 175.189 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 138' ' ' PHE . . . . . 0.7 ' CZ ' HG22 ' A' ' 134' ' ' THR . 12.1 m-85 -58.84 -51.87 68.16 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.504 177.726 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 19.3 p30 -69.95 -24.19 63.3 Favored 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 120.392 -0.523 . . . . 0.0 111.351 -175.35 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 51.0 tt0 -67.67 -48.51 66.42 Favored 'General case' 0 N--CA 1.45 -0.453 0 CA-C-O 120.826 0.346 . . . . 0.0 110.573 172.226 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.545 ' HG ' ' O ' ' A' ' 137' ' ' LYS . 86.9 mt -64.4 -35.05 79.63 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.972 -178.163 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.588 HD21 ' HB ' ' A' ' 64' ' ' ILE . 79.1 mt -85.33 -15.96 41.55 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.228 -179.395 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 76.84 35.51 39.52 Favored Glycine 0 N--CA 1.451 -0.344 0 N-CA-C 111.236 -0.746 . . . . 0.0 111.236 179.565 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.449 ' O ' ' HG ' ' A' ' 144' ' ' LEU . 46.1 tp -103.51 15.45 28.95 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.391 0.615 . . . . 0.0 110.192 -174.39 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -63.06 141.53 58.73 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.755 178.208 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -121.16 67.58 0.43 Allowed Glycine 0 N--CA 1.448 -0.56 0 C-N-CA 120.907 -0.663 . . . . 0.0 112.026 179.397 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 30.1 t60 -76.55 -27.41 55.91 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.001 0.429 . . . . 0.0 110.208 -179.087 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 53.4 m80 -99.23 118.38 35.79 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.256 -179.935 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 33.2 m170 -107.99 98.4 7.97 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.084 179.819 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 4.8 t60 -65.88 -31.15 71.92 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.231 0.539 . . . . 0.0 110.124 178.764 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 19.2 t-80 -173.52 -24.47 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 179.853 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 63.8 t60 . . . . . 0 C--O 1.244 0.796 0 CA-C-N 114.846 -1.07 . . . . 0.0 108.937 171.281 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 0.667 0 N-CA-C 112.458 0.54 . . . . 0.0 112.458 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -80.55 78.9 7.24 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 120.9 0.381 . . . . 0.0 110.95 -177.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 53.6 m 68.65 95.5 0.07 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.032 -0.985 . . . . 0.0 111.899 176.613 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 33.9 p90 -98.1 165.99 11.63 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.416 178.067 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . 0.502 ' HA ' ' HA ' ' A' ' 24' ' ' SER . 25.0 m -142.51 120.43 12.02 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.896 -0.409 . . . . 0.0 109.896 175.664 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . 0.42 ' CE2' ' HA ' ' A' ' 94' ' ' MET . 57.8 m-85 -128.19 161.72 54.62 Favored Pre-proline 0 C--N 1.324 -0.528 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.45 -177.407 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.459 ' HD2' ' O ' ' A' ' 93' ' ' HIS . 2.7 Cg_endo -86.18 124.95 2.54 Favored 'Trans proline' 0 N--CA 1.454 -0.846 0 C-N-CA 122.476 2.117 . . . . 0.0 112.567 174.008 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . 0.505 ' HB3' ' HB3' ' A' ' 21' ' ' LYS . 4.0 t70 -69.56 159.03 34.12 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.529 -0.759 . . . . 0.0 109.122 171.971 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.781 HG13 HG11 ' A' ' 82' ' ' VAL . 18.5 mm -40.94 -49.71 0.67 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.401 0 O-C-N 124.558 1.161 . . . . 0.0 112.898 -176.585 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 4.8 p30 -69.55 -16.49 63.43 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-O 121.126 0.488 . . . . 0.0 110.974 -174.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 107.73 33.83 2.98 Favored Glycine 0 N--CA 1.444 -0.781 0 CA-C-N 115.802 -0.636 . . . . 0.0 111.663 -177.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.646 ' HZ2' HG22 ' A' ' 23' ' ' VAL . 48.2 tttm -102.32 128.99 48.64 Favored 'General case' 0 CA--C 1.515 -0.381 0 C-N-CA 120.402 -0.519 . . . . 0.0 111.188 -177.617 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 8.3 m -64.75 104.88 0.89 Allowed 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 109.527 -0.546 . . . . 0.0 109.527 170.429 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 1.031 ' HB ' HD11 ' A' ' 92' ' ' LEU . 41.6 t -111.79 118.46 57.65 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 176.067 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . 0.502 ' HA ' ' HA ' ' A' ' 14' ' ' SER . 89.6 p -100.48 -173.81 2.5 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.563 -175.762 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.587 HD11 ' HA3' ' A' ' 119' ' ' GLY . 1.5 tm? -82.35 -1.02 48.47 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 176.219 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -95.99 -21.69 17.85 Favored 'General case' 0 CA--C 1.51 -0.563 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 -178.482 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -65.7 -22.38 66.61 Favored 'General case' 0 N--CA 1.437 -1.09 0 CA-C-N 113.755 -1.566 . . . . 0.0 110.208 173.354 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.62 HD13 HG21 ' A' ' 67' ' ' VAL . 37.1 mt -112.37 -15.67 13.08 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-N 115.407 -0.815 . . . . 0.0 111.008 -177.009 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.459 ' HB2' ' O ' ' A' ' 25' ' ' LEU . 62.2 tttp -69.75 133.38 47.4 Favored 'General case' 0 N--CA 1.445 -0.693 0 CA-C-N 115.694 -0.684 . . . . 0.0 111.455 -171.174 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 119.19 -18.9 10.2 Favored Glycine 0 N--CA 1.45 -0.387 0 N-CA-C 111.172 -0.771 . . . . 0.0 111.172 -176.896 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.601 ' HB3' ' NE2' ' A' ' 65' ' ' HIS . 24.5 ttmm -140.18 147.47 40.16 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 179.241 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.54 ' HB2' ' O ' ' A' ' 63' ' ' ASP . 81.8 m-85 -54.0 140.76 30.32 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-O 121.119 0.485 . . . . 0.0 111.659 -176.261 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 5.1 mp -112.18 132.25 61.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.634 -177.111 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 85.5 t80 -115.58 116.54 28.33 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 172.595 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.625 ' HB ' ' HB ' ' A' ' 113' ' ' ILE . 67.9 mt -103.33 109.73 27.81 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 CA-C-O 120.999 0.428 . . . . 0.0 110.671 -177.937 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.557 ' HA ' ' O ' ' A' ' 111' ' ' ARG . 5.7 p-10 -105.57 158.31 16.78 Favored 'General case' 0 C--N 1.316 -0.858 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 173.238 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.469 HG21 HG21 ' A' ' 106' ' ' ILE . 52.6 t -103.26 136.68 34.84 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.806 0 C-N-CA 120.485 -0.486 . . . . 0.0 111.447 179.068 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' TRP . . . . . 0.663 ' CZ2' ' HB2' ' A' ' 91' ' ' GLN . 0.2 OUTLIER -128.5 141.77 51.28 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 -179.95 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.505 ' HA ' ' OD1' ' A' ' 72' ' ' ASP . . . -146.15 158.11 43.86 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 112.445 0.535 . . . . 0.0 112.445 -176.67 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -76.35 -46.22 28.49 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.798 -0.637 . . . . 0.0 109.559 175.917 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 5.3 p-90 -80.77 -1.16 41.76 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 114.885 -1.052 . . . . 0.0 111.687 -175.352 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 43.6 t -95.31 110.89 22.84 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.252 0.549 . . . . 0.0 110.127 177.596 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.408 ' N ' ' CD ' ' A' ' 44' ' ' PRO . . . -85.31 -43.97 6.4 Favored Glycine 0 CA--C 1.528 0.859 0 CA-C-O 118.967 -0.907 . . . . 0.0 113.727 176.352 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.408 ' CD ' ' N ' ' A' ' 43' ' ' GLY . 71.2 Cg_exo -53.03 -38.34 80.07 Favored 'Trans proline' 0 C--N 1.362 1.274 0 C-N-CA 122.584 2.189 . . . . 0.0 113.221 -176.835 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . 0.691 ' O ' ' HG ' ' A' ' 49' ' ' LEU . 29.8 p -58.95 -32.51 69.67 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.8 0.333 . . . . 0.0 111.021 -179.653 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.593 ' HG2' HD12 ' A' ' 49' ' ' LEU . 52.0 mtt85 -69.38 -8.18 44.17 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.757 -176.412 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -78.26 -27.81 57.09 Favored Glycine 0 N--CA 1.444 -0.774 0 C-N-CA 120.53 -0.843 . . . . 0.0 111.658 175.687 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . 0.462 ' OE2' ' HD3' ' A' ' 128' ' ' ARG . 15.7 pt-20 -114.53 -8.03 12.78 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 111.695 0.257 . . . . 0.0 111.695 -177.687 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.691 ' HG ' ' O ' ' A' ' 45' ' ' CYS . 68.8 mt -55.18 -47.13 99.27 Favored Pre-proline 0 CA--C 1.537 0.442 0 N-CA-C 112.248 0.462 . . . . 0.0 112.248 178.22 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.496 ' HD3' ' HB2' ' A' ' 49' ' ' LEU . 53.6 Cg_exo -54.97 -37.46 93.59 Favored 'Trans proline' 0 C--N 1.355 0.905 0 C-N-CA 121.688 1.592 . . . . 0.0 111.944 172.552 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -73.51 -28.64 62.01 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.619 179.544 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 8.2 tt -64.59 -39.62 94.06 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.009 -0.737 . . . . 0.0 109.009 175.096 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.437 ' HE2' ' O ' ' A' ' 88' ' ' LYS . 4.5 mmmp? -63.83 -46.99 82.58 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.486 174.59 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.41 ' O ' ' HB2' ' A' ' 58' ' ' LYS . 0.3 OUTLIER -53.09 -43.56 66.9 Favored 'General case' 0 C--O 1.222 -0.348 0 O-C-N 123.565 0.541 . . . . 0.0 111.082 173.944 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.479 HD21 ' HE2' ' A' ' 138' ' ' PHE . 21.7 tp -59.51 -44.42 93.13 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.951 0.405 . . . . 0.0 110.474 178.572 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.408 ' OE1' ' HD2' ' A' ' 66' ' ' PHE . 10.1 tp10 -65.5 -55.96 15.03 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.022 179.906 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 29.9 mt-10 -72.75 -19.24 61.41 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.561 -172.534 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . 0.41 ' HB2' ' O ' ' A' ' 54' ' ' GLU . 18.1 ttmm -82.37 -31.6 29.65 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.139 0.495 . . . . 0.0 110.044 174.326 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.436 ' O ' ' HD2' ' A' ' 62' ' ' LYS . 25.8 m-85 -103.9 12.95 33.74 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.657 -0.702 . . . . 0.0 111.166 -178.552 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -47.16 113.8 0.74 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.077 0.465 . . . . 0.0 111.819 178.673 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 115.01 -12.19 20.11 Favored Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 120.88 -0.676 . . . . 0.0 112.254 -178.192 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.71 ' H ' ' HD2' ' A' ' 62' ' ' LYS . 0.0 OUTLIER -65.9 169.48 6.61 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-O 121.405 0.621 . . . . 0.0 111.599 -178.397 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . 0.574 ' CG ' ' HG3' ' A' ' 31' ' ' LYS . 4.6 t70 -94.77 55.77 1.93 Allowed 'General case' 0 C--N 1.318 -0.773 0 CA-C-O 121.367 0.604 . . . . 0.0 109.992 178.786 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.477 ' HB ' ' HG2' ' A' ' 62' ' ' LYS . 4.0 mp -145.99 134.09 15.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.571 -0.74 . . . . 0.0 109.752 -178.698 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' HIS . . . . . 0.601 ' NE2' ' HB3' ' A' ' 31' ' ' LYS . 88.4 m-70 -101.55 120.81 40.88 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.511 -0.552 . . . . 0.0 109.511 173.623 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . 0.56 ' O ' ' HB ' ' A' ' 90' ' ' ILE . 63.5 m-85 -83.32 108.93 16.85 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 171.163 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.62 HG21 HD13 ' A' ' 28' ' ' LEU . 44.2 t -120.77 105.16 16.38 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.696 -174.188 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . 0.542 ' HA ' ' O ' ' A' ' 36' ' ' ASP . 13.3 m -88.09 124.53 33.87 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.531 -179.191 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 55.7 tp -110.0 129.98 55.6 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.777 0.322 . . . . 0.0 110.453 177.655 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . 0.504 ' O ' ' HB3' ' A' ' 94' ' ' MET . 1.0 OUTLIER -112.09 122.41 47.68 Favored 'General case' 0 C--O 1.221 -0.396 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.721 -175.147 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 12.9 t -85.41 9.31 15.97 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.403 177.674 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.505 ' OD1' ' HA ' ' A' ' 39' ' ' ALA . 3.0 m-20 -64.56 136.47 57.06 Favored 'General case' 0 CA--C 1.516 -0.343 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.592 -178.013 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 18.2 ttmm -82.83 -33.72 27.09 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-O 121.254 0.549 . . . . 0.0 109.846 177.451 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . 0.562 ' HB2' ' HB3' ' A' ' 77' ' ' ALA . 0.9 OUTLIER -77.9 85.84 4.14 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.477 -0.783 . . . . 0.0 111.217 -179.641 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.424 ' HB2' ' CE1' ' A' ' 93' ' ' HIS . 18.0 tttm -62.54 -62.95 1.39 Allowed 'General case' 0 C--O 1.218 -0.553 0 C-N-CA 120.024 -0.67 . . . . 0.0 111.782 -179.649 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.435 ' HA ' ' HD2' ' A' ' 76' ' ' LYS . 42.2 tptt -53.23 -37.7 62.29 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 123.279 0.362 . . . . 0.0 111.777 -174.445 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.562 ' HB3' ' HB2' ' A' ' 74' ' ' ASN . . . -66.47 -38.08 86.54 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.565 0.698 . . . . 0.0 110.466 177.217 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' TRP . . . . . 0.451 ' HZ3' HH22 ' A' ' 46' ' ' ARG . 7.5 t-105 -80.58 -41.89 23.25 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.313 -0.858 . . . . 0.0 111.229 -176.271 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.73 ' HB2' HG23 ' A' ' 18' ' ' ILE . 1.4 pt-20 -62.44 -39.11 92.27 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-O 120.711 0.291 . . . . 0.0 110.754 179.927 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 3.8 p30 -75.15 -28.55 60.18 Favored 'General case' 0 CA--C 1.518 -0.259 0 C-N-CA 119.784 -0.766 . . . . 0.0 109.65 177.188 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' MET . . . . . 0.506 ' HG3' ' OD2' ' A' ' 85' ' ' ASP . 9.9 tpt -64.72 -51.97 59.57 Favored 'General case' 0 C--O 1.209 -1.068 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.362 176.822 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.781 HG11 HG13 ' A' ' 18' ' ' ILE . 3.2 p -61.24 -30.6 48.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 C-N-CA 120.744 -0.382 . . . . 0.0 110.746 178.869 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 71.8 m -64.41 -38.09 89.8 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.264 0.554 . . . . 0.0 110.08 173.471 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . 0.476 ' HZ2' ' HB2' ' A' ' 84' ' ' LYS . 3.1 ttmp? -77.55 -44.77 27.47 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.421 -0.809 . . . . 0.0 110.381 179.865 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . 0.724 ' HB3' ' HG ' ' A' ' 87' ' ' LEU . 1.2 m-20 -69.57 -16.37 63.4 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 114.68 -1.146 . . . . 0.0 111.007 179.949 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 18.8 mm-40 59.53 31.12 20.78 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-N 115.764 -0.653 . . . . 0.0 112.468 178.585 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.724 ' HG ' ' HB3' ' A' ' 85' ' ' ASP . 58.6 mt -85.01 39.84 0.78 Allowed 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.279 -177.739 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.437 ' O ' ' HE2' ' A' ' 53' ' ' LYS . 0.1 OUTLIER -65.56 150.53 48.25 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-O 121.407 0.623 . . . . 0.0 112.491 -178.801 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 166.4 -134.82 3.42 Favored Glycine 0 C--O 1.229 -0.172 0 N-CA-C 109.861 -1.296 . . . . 0.0 109.861 -172.587 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.56 ' HB ' ' O ' ' A' ' 66' ' ' PHE . 48.0 mm -111.22 114.09 46.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 170.073 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . 0.663 ' HB2' ' CZ2' ' A' ' 38' ' ' TRP . 0.4 OUTLIER -141.88 146.78 36.16 Favored 'General case' 0 C--N 1.314 -0.948 0 N-CA-C 113.232 0.827 . . . . 0.0 113.232 -168.643 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 1.031 HD11 ' HB ' ' A' ' 23' ' ' VAL . 2.5 mm? -134.13 153.86 51.57 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 114.853 -1.067 . . . . 0.0 110.581 179.161 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' HIS . . . . . 0.459 ' O ' ' HD2' ' A' ' 16' ' ' PRO . 25.5 t-80 -129.43 125.07 35.66 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.907 -179.724 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' MET . . . . . 0.529 ' SD ' ' HA ' ' A' ' 98' ' ' ARG . 24.5 ttm -76.26 -85.3 0.05 Allowed 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.38 -0.827 . . . . 0.0 110.313 179.393 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . 0.502 ' HA2' ' O ' ' A' ' 72' ' ' ASP . . . 117.78 -74.03 0.29 Allowed Glycine 0 N--CA 1.443 -0.869 0 C-N-CA 120.1 -1.048 . . . . 0.0 113.417 177.865 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 14.8 m -135.67 -8.12 2.16 Favored 'General case' 0 C--N 1.316 -0.861 0 C-N-CA 120.557 -0.457 . . . . 0.0 111.618 -174.956 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . 0.481 ' CG ' ' HG3' ' A' ' 94' ' ' MET . 8.2 p-10 -89.97 48.21 1.55 Allowed 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.883 0.849 . . . . 0.0 110.083 -176.091 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . 0.542 ' O ' ' HB3' ' A' ' 101' ' ' MET . 0.0 OUTLIER -75.91 20.52 0.18 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.133 -0.94 . . . . 0.0 112.614 -172.342 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 9.9 m -70.18 -30.17 67.23 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 171.24 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' PHE . . . . . 0.477 ' CZ ' ' HE2' ' A' ' 104' ' ' TYR . 1.3 t80 -73.59 -25.73 60.48 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.23 -0.895 . . . . 0.0 109.53 177.898 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' MET . . . . . 0.542 ' HB3' ' O ' ' A' ' 98' ' ' ARG . 13.4 tpt -58.81 -52.34 66.15 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 114.769 -1.105 . . . . 0.0 109.745 175.578 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 67.9 m-20 -73.38 -26.7 61.1 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.579 -0.737 . . . . 0.0 111.318 179.486 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -60.72 -26.82 67.45 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-O 121.025 0.44 . . . . 0.0 111.062 -179.224 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' TYR . . . . . 0.52 ' HB2' HG13 ' A' ' 106' ' ' ILE . 49.4 m-85 -108.52 -3.32 18.19 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.478 178.365 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 7.7 mp 60.36 32.19 20.59 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.147 0.499 . . . . 0.0 110.316 -174.547 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . 0.583 HG23 ' HB2' ' A' ' 111' ' ' ARG . 79.0 mt -64.2 131.14 29.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.737 176.505 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 16.3 t-20 -157.59 161.02 38.69 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 178.421 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 81.35 -60.88 4.67 Favored Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 121.242 -0.504 . . . . 0.0 112.991 178.092 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.471 HD13 ' HB2' ' A' ' 39' ' ' ALA . 44.3 mt 72.08 131.04 0.04 OUTLIER Pre-proline 0 CA--C 1.535 0.371 0 C-N-CA 122.971 0.508 . . . . 0.0 110.399 -176.22 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . 0.414 ' HB3' ' O ' ' A' ' 37' ' ' VAL . 2.2 Cg_endo -84.15 145.89 48.9 Favored 'Cis proline' 0 N--CA 1.461 -0.384 0 C-N-CA 124.153 -1.186 . . . . 0.0 112.963 0.3 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . 0.629 ' HD2' ' N ' ' A' ' 112' ' ' PHE . 0.0 OUTLIER -97.34 141.67 30.14 Favored 'General case' 0 N--CA 1.446 -0.626 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 173.093 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . 0.629 ' N ' ' HD2' ' A' ' 111' ' ' ARG . 0.7 OUTLIER -104.04 117.86 35.3 Favored 'General case' 0 C--N 1.324 -0.537 0 O-C-N 124.024 0.827 . . . . 0.0 111.714 -177.792 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.625 ' HB ' ' HB ' ' A' ' 35' ' ' ILE . 77.4 mt -129.22 149.41 33.65 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.428 0 C-N-CA 122.359 0.263 . . . . 0.0 110.38 177.106 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 21.4 tp -137.12 139.84 41.5 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.583 0.23 . . . . 0.0 110.621 178.041 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.515 ' HG ' ' HA ' ' A' ' 121' ' ' ILE . 1.0 OUTLIER -135.8 156.64 48.49 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.897 0.379 . . . . 0.0 110.207 -179.105 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . 0.58 ' HB3' ' HB2' ' A' ' 120' ' ' LYS . 23.0 t70 -73.04 160.74 31.58 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.571 -0.74 . . . . 0.0 110.786 176.91 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . 0.401 HH11 ' HD3' ' A' ' 117' ' ' ARG . 75.0 mtt-85 -44.81 -39.94 5.72 Favored 'General case' 0 N--CA 1.466 0.345 0 O-C-N 124.536 1.147 . . . . 0.0 112.18 179.838 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . 0.509 ' HB3' ' HG2' ' A' ' 120' ' ' LYS . 25.1 t70 -63.43 -23.55 67.45 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.335 0.588 . . . . 0.0 111.151 -178.03 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . 0.587 ' HA3' HD11 ' A' ' 25' ' ' LEU . . . 105.54 19.84 10.09 Favored Glycine 0 N--CA 1.432 -1.571 0 N-CA-C 110.001 -1.24 . . . . 0.0 110.001 -169.376 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . 0.58 ' HB2' ' HB3' ' A' ' 116' ' ' ASP . 32.8 mmtm -91.85 107.97 19.59 Favored 'General case' 0 C--O 1.221 -0.447 0 C-N-CA 120.71 -0.396 . . . . 0.0 111.207 -175.128 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . 0.655 ' H ' HD12 ' A' ' 121' ' ' ILE . 3.5 mp -47.18 113.02 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 O-C-N 123.55 0.531 . . . . 0.0 110.651 177.553 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' ILE . . . . . 0.404 ' H ' ' HA ' ' A' ' 115' ' ' LEU . 38.5 mm -94.34 -53.79 7.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 115.678 -0.692 . . . . 0.0 109.773 179.98 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 6.1 m -127.04 114.46 17.81 Favored 'General case' 0 N--CA 1.446 -0.653 0 CA-C-N 115.504 -0.771 . . . . 0.0 109.911 179.832 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . 0.533 ' O ' HG12 ' A' ' 113' ' ' ILE . . . -65.0 -32.13 73.71 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 109.446 -0.576 . . . . 0.0 109.446 174.89 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 12.4 p-10 -127.33 106.92 9.54 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.08 -0.964 . . . . 0.0 109.019 173.586 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' MET . . . . . 0.451 ' N ' ' HD1' ' A' ' 112' ' ' PHE . 14.1 tpt -99.55 -101.3 0.23 Allowed 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.077 -175.469 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . 0.686 ' HB ' ' HB ' ' A' ' 134' ' ' THR . 0.2 OUTLIER -155.17 122.73 5.65 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.916 0.389 . . . . 0.0 110.885 -179.236 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . 0.462 ' HD3' ' OE2' ' A' ' 48' ' ' GLU . 30.1 ttm-85 -49.29 140.84 12.4 Favored Pre-proline 0 C--N 1.326 -0.454 0 CA-C-N 115.153 -0.931 . . . . 0.0 111.421 176.632 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -54.74 -38.77 91.58 Favored 'Trans proline' 0 C--N 1.35 0.615 0 C-N-CA 122.797 2.331 . . . . 0.0 113.14 178.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . 0.417 ' HB2' ' CB ' ' A' ' 48' ' ' GLU . 36.4 t -72.51 -2.22 18.88 Favored 'General case' 0 CA--C 1.535 0.395 0 N-CA-C 111.657 0.243 . . . . 0.0 111.657 177.981 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . 0.487 ' O ' HG22 ' A' ' 134' ' ' THR . 9.5 t70 -94.45 115.16 64.95 Favored Pre-proline 0 C--N 1.326 -0.417 0 N-CA-C 109.716 -0.476 . . . . 0.0 109.716 179.204 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . 0.403 ' HD3' ' HA ' ' A' ' 131' ' ' ASP . 51.3 Cg_exo -56.71 -25.46 60.38 Favored 'Trans proline' 0 N--CA 1.473 0.268 0 C-N-CA 123.041 2.494 . . . . 0.0 113.602 -176.425 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . 0.575 ' HZ2' ' HB2' ' A' ' 133' ' ' LYS . 9.7 mtmp? -70.02 -20.36 63.27 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 121.328 -0.149 . . . . 0.0 111.017 -177.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' THR . . . . . 0.686 ' HB ' ' HB ' ' A' ' 127' ' ' THR . 1.6 t -72.67 -40.7 66.11 Favored 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 177.348 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . 0.625 ' HA ' ' CD2' ' A' ' 138' ' ' PHE . . . -62.85 -41.53 99.4 Favored 'General case' 0 N--CA 1.453 -0.324 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.14 176.885 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -55.74 -42.34 75.24 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.417 -0.81 . . . . 0.0 110.649 175.014 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . 0.866 ' HE2' ' HA ' ' A' ' 137' ' ' LYS . 10.0 mmpt? -63.35 -42.8 98.93 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.144 179.559 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . 0.625 ' CD2' ' HA ' ' A' ' 135' ' ' ALA . 11.2 m-85 -57.88 -54.27 48.8 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-O 120.838 0.352 . . . . 0.0 110.366 -179.866 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 49.8 m-20 -56.34 -46.16 80.05 Favored 'General case' 0 C--O 1.223 -0.301 0 CA-C-N 115.918 -0.583 . . . . 0.0 109.966 179.743 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 28.7 tt0 -57.65 -55.22 37.62 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.544 -0.753 . . . . 0.0 111.987 -177.897 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 4.6 pp -68.54 -20.12 64.54 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-O 120.722 0.296 . . . . 0.0 111.673 -174.913 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 0.41 HD11 ' HB2' ' A' ' 62' ' ' LYS . 95.7 mt . . . . . 0 C--N 1.327 -0.372 0 CA-C-O 120.789 0.328 . . . . 0.0 110.489 175.424 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.474 ' HB1' HD11 ' A' ' 121' ' ' ILE . . . . . . . . 0 N--CA 1.469 0.522 0 CA-C-O 121.086 0.47 . . . . 0.0 111.654 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -82.91 75.69 9.79 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.764 -179.214 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . 0.514 ' HA ' ' HB3' ' A' ' 25' ' ' LEU . 15.9 m 68.74 79.0 0.21 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.004 -0.998 . . . . 0.0 111.482 176.433 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 23.6 p90 -101.3 -179.53 4.06 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.744 179.134 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . 0.43 ' HA ' ' HA ' ' A' ' 24' ' ' SER . 21.0 t -142.37 132.09 24.1 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 109.338 -0.616 . . . . 0.0 109.338 177.537 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . 0.533 ' HB3' ' HB3' ' A' ' 92' ' ' LEU . 12.9 m-85 -138.42 154.67 73.77 Favored Pre-proline 0 C--N 1.326 -0.456 0 CA-C-O 120.608 0.242 . . . . 0.0 111.433 -176.873 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' A' ' 15' ' ' TYR . 1.1 Cg_endo -85.09 127.89 3.55 Favored 'Trans proline' 0 N--CA 1.457 -0.652 0 C-N-CA 123.196 2.597 . . . . 0.0 113.165 179.444 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . 0.693 ' HB3' ' HB3' ' A' ' 21' ' ' LYS . 0.5 OUTLIER -72.53 161.63 30.54 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.167 -0.924 . . . . 0.0 109.746 170.815 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.532 HD12 ' CG1' ' A' ' 82' ' ' VAL . 1.4 tt -46.59 -40.37 4.45 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 O-C-N 124.032 0.832 . . . . 0.0 112.083 -175.95 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.484 ' ND2' HG23 ' A' ' 18' ' ' ILE . 27.9 m-80 -79.53 9.93 4.41 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.228 -175.439 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 77.19 25.81 63.13 Favored Glycine 0 N--CA 1.445 -0.706 0 N-CA-C 110.758 -0.937 . . . . 0.0 110.758 -174.753 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.693 ' HB3' ' HB3' ' A' ' 17' ' ' ASP . 8.0 ttpm? -94.86 106.94 18.96 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.427 -0.386 . . . . 0.0 110.328 -174.694 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 24.7 m -69.29 111.54 5.27 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.154 -178.225 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.645 ' HB ' HD11 ' A' ' 92' ' ' LEU . 47.7 t -115.82 133.86 60.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 116.139 -0.482 . . . . 0.0 109.862 178.352 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . 0.43 ' HA ' ' HA ' ' A' ' 14' ' ' SER . 97.7 p -101.74 160.49 14.42 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.35 -178.434 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.586 HD12 ' HG ' ' A' ' 28' ' ' LEU . 20.8 tp -75.17 0.52 16.07 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.164 0.507 . . . . 0.0 109.961 175.45 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -75.68 -25.97 57.21 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.827 -179.734 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -74.87 -21.51 59.2 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-O 122.68 1.229 . . . . 0.0 108.87 177.137 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.586 ' HG ' HD12 ' A' ' 25' ' ' LEU . 3.9 mm? -82.7 -7.4 59.65 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 113.581 -1.645 . . . . 0.0 111.542 -170.941 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.762 ' HA ' ' O ' ' A' ' 117' ' ' ARG . 2.6 mptp? -73.65 175.92 6.7 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.239 0.542 . . . . 0.0 111.272 179.423 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 84.19 -44.51 3.34 Favored Glycine 0 N--CA 1.449 -0.49 0 CA-C-N 115.775 -0.648 . . . . 0.0 112.437 177.814 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.722 ' HD3' ' HA ' ' A' ' 63' ' ' ASP . 66.1 mttm -121.33 164.93 16.25 Favored 'General case' 0 C--N 1.323 -0.577 0 C-N-CA 122.226 0.211 . . . . 0.0 110.582 -177.848 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 44.1 m-85 -67.21 151.75 46.97 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.779 0.323 . . . . 0.0 111.24 -177.609 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.769 HD12 ' HA2' ' A' ' 119' ' ' GLY . 53.4 mt -121.5 132.63 70.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-O 120.832 0.349 . . . . 0.0 111.202 -174.623 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 86.0 t80 -121.37 125.35 46.74 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 109.071 -0.715 . . . . 0.0 109.071 172.74 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.557 HG12 ' HB ' ' A' ' 67' ' ' VAL . 64.2 mt -114.44 134.47 57.28 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-O 120.955 0.407 . . . . 0.0 110.718 -177.877 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.536 ' HA ' ' O ' ' A' ' 111' ' ' ARG . 24.3 t0 -126.68 158.55 36.12 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.372 -0.831 . . . . 0.0 109.0 177.121 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.575 ' HA ' ' O ' ' A' ' 69' ' ' LEU . 59.2 t -105.74 111.47 35.09 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.904 0 C-N-CA 120.228 -0.589 . . . . 0.0 110.816 173.164 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' TRP . . . . . 0.662 ' CZ2' ' HB2' ' A' ' 91' ' ' GLN . 0.6 OUTLIER -95.22 133.27 39.28 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.275 178.716 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.555 ' HB3' ' HB3' ' A' ' 42' ' ' CYS . . . -146.85 163.02 37.42 Favored 'General case' 0 N--CA 1.464 0.266 0 N-CA-C 111.7 0.259 . . . . 0.0 111.7 -175.722 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . 0.715 ' HB ' ' CE3' ' A' ' 78' ' ' TRP . 8.2 t -98.34 -35.72 10.22 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-O 120.885 0.374 . . . . 0.0 110.762 176.693 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' TRP . . . . . 0.419 ' HE1' ' HA ' ' A' ' 72' ' ' ASP . 22.6 p-90 -86.39 16.27 4.66 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.164 0.507 . . . . 0.0 110.547 -178.994 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' CYS . . . . . 0.786 ' SG ' ' HB3' ' A' ' 45' ' ' CYS . 14.8 p -75.37 -56.55 4.6 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.611 -0.722 . . . . 0.0 111.791 -175.775 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 98.15 -99.37 2.19 Favored Glycine 0 CA--C 1.521 0.424 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.101 -176.161 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -55.32 -28.35 62.23 Favored 'Trans proline' 0 C--N 1.352 0.714 0 C-N-CA 123.331 2.688 . . . . 0.0 113.274 -179.635 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . 0.832 ' HB2' ' HD3' ' A' ' 110' ' ' PRO . 18.2 t -57.57 -22.85 47.34 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-O 120.979 0.419 . . . . 0.0 111.428 179.425 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.55 ' HA ' ' CD1' ' A' ' 49' ' ' LEU . 33.0 mtp-105 -70.9 -15.67 62.63 Favored 'General case' 0 C--N 1.324 -0.5 0 C-N-CA 120.577 -0.449 . . . . 0.0 111.301 -178.748 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -84.23 -12.97 75.1 Favored Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 120.678 -0.772 . . . . 0.0 111.67 176.08 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . 0.68 ' HB3' ' HB2' ' A' ' 129' ' ' PRO . 0.5 OUTLIER -91.51 -26.34 18.83 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.135 0.493 . . . . 0.0 109.884 -179.342 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.809 HD23 HD12 ' A' ' 52' ' ' LEU . 54.9 mt -51.53 -45.27 90.77 Favored Pre-proline 0 CA--C 1.536 0.406 0 CA-C-N 115.315 -0.857 . . . . 0.0 113.147 -176.664 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.536 ' HD2' ' N ' ' A' ' 49' ' ' LEU . 10.3 Cg_endo -54.2 -36.42 85.79 Favored 'Trans proline' 0 C--N 1.354 0.818 0 C-N-CA 121.683 1.589 . . . . 0.0 112.048 174.426 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.53 ' HA ' ' HB2' ' A' ' 54' ' ' GLU . . . -82.21 -22.44 35.93 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.329 0.585 . . . . 0.0 110.106 -178.443 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.809 HD12 HD23 ' A' ' 49' ' ' LEU . 27.3 mt -64.74 -37.26 86.99 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.423 -0.808 . . . . 0.0 110.156 175.423 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.453 ' HE3' ' HB3' ' A' ' 53' ' ' LYS . 10.2 mtpp -75.2 -40.21 59.44 Favored 'General case' 0 CA--C 1.517 -0.322 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.951 173.567 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.53 ' HB2' ' HA ' ' A' ' 51' ' ' ALA . 6.4 mm-40 -47.16 -50.38 20.65 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.538 -0.755 . . . . 0.0 110.678 173.213 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 73.6 mt -59.01 -55.35 36.3 Favored 'General case' 0 N--CA 1.446 -0.631 0 CA-C-N 115.592 -0.731 . . . . 0.0 111.072 176.261 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.62 ' OE2' ' HB3' ' A' ' 88' ' ' LYS . 37.7 tt0 -45.01 -60.64 1.98 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.477 -0.783 . . . . 0.0 112.558 179.776 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 61.5 mt-10 -74.42 -31.99 62.5 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 111.96 0.356 . . . . 0.0 111.96 -169.86 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 49.5 mttp -78.38 -40.67 35.54 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.131 0.491 . . . . 0.0 111.081 -178.169 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.586 ' HB2' ' HE2' ' A' ' 66' ' ' PHE . 73.2 m-85 -102.78 8.43 39.38 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.497 -173.915 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.453 ' HB2' ' O ' ' A' ' 56' ' ' GLU . . . -59.53 131.41 50.85 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.657 172.156 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 77.13 11.01 85.95 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.962 -0.637 . . . . 0.0 113.027 176.147 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.416 ' HA ' ' HD3' ' A' ' 62' ' ' LYS . 33.5 mmtm -89.13 -136.11 0.11 Allowed 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.966 -0.383 . . . . 0.0 109.966 177.624 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . 0.722 ' HA ' ' HD3' ' A' ' 31' ' ' LYS . 4.6 t0 -120.02 42.14 3.01 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 121.542 0.687 . . . . 0.0 109.778 179.008 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.438 HG21 ' HB3' ' A' ' 59' ' ' TYR . 7.3 tp -148.81 151.21 13.35 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 115.083 -0.962 . . . . 0.0 109.868 -171.624 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' HIS . . . . . 0.581 ' NE2' ' HB2' ' A' ' 31' ' ' LYS . 80.9 m-70 -126.99 137.8 53.16 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 175.128 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . 0.586 ' HE2' ' HB2' ' A' ' 59' ' ' TYR . 91.0 m-85 -110.43 109.98 20.57 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 120.624 0.249 . . . . 0.0 110.415 178.714 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.557 ' HB ' HG12 ' A' ' 35' ' ' ILE . 49.8 t -109.1 109.26 27.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.156 -177.115 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 50.2 m -91.68 114.0 26.41 Favored 'General case' 0 C--N 1.316 -0.884 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 174.144 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.575 ' O ' ' HA ' ' A' ' 37' ' ' VAL . 66.7 tp -109.83 130.02 55.57 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.555 -0.293 . . . . 0.0 110.266 178.649 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . 0.565 ' O ' ' HB3' ' A' ' 94' ' ' MET . 1.8 t -109.02 119.23 38.94 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 111.93 0.344 . . . . 0.0 111.93 -173.758 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' CYS . . . . . 0.559 ' HB3' ' SD ' ' A' ' 101' ' ' MET . 33.6 m -88.14 19.29 3.76 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.519 177.368 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.562 ' OD2' HG22 ' A' ' 40' ' ' THR . 2.2 m-20 -73.33 113.99 11.04 Favored 'General case' 0 CA--C 1.515 -0.403 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.705 -178.54 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.538 ' HA ' ' O ' ' A' ' 95' ' ' GLY . 47.3 tttm -71.63 -17.53 62.26 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-O 121.155 0.502 . . . . 0.0 110.312 177.812 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 4.6 m-20 -83.83 91.31 7.52 Favored 'General case' 0 CA--C 1.515 -0.392 0 N-CA-C 109.025 -0.731 . . . . 0.0 109.025 175.945 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.614 ' O ' ' HG2' ' A' ' 79' ' ' GLU . 13.0 tmtt? -64.98 -65.09 0.72 Allowed 'General case' 0 C--N 1.322 -0.629 0 C-N-CA 120.066 -0.654 . . . . 0.0 110.984 -176.69 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 11.1 tmtt? -52.24 -45.66 65.41 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.2 -0.909 . . . . 0.0 111.195 -176.357 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.695 ' HA ' ' ND2' ' A' ' 80' ' ' ASN . . . -61.77 -38.69 88.96 Favored 'General case' 0 C--O 1.246 0.881 0 CA-C-O 121.572 0.701 . . . . 0.0 110.644 -177.281 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' TRP . . . . . 0.715 ' CE3' ' HB ' ' A' ' 40' ' ' THR . 4.7 t-105 -70.14 -47.55 61.24 Favored 'General case' 0 N--CA 1.438 -1.042 0 CA-C-N 115.099 -0.955 . . . . 0.0 110.634 -176.798 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.614 ' HG2' ' O ' ' A' ' 75' ' ' LYS . 4.0 mm-40 -47.25 -44.78 23.13 Favored 'General case' 0 C--O 1.236 0.355 0 O-C-N 123.418 0.449 . . . . 0.0 111.774 175.347 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . 0.695 ' ND2' ' HA ' ' A' ' 77' ' ' ALA . 1.8 m-80 -59.83 -50.84 72.21 Favored 'General case' 0 CA--C 1.518 -0.288 0 C-N-CA 120.196 -0.601 . . . . 0.0 110.468 179.501 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 23.1 ttm -64.27 -42.32 96.49 Favored 'General case' 0 C--N 1.332 -0.156 0 N-CA-C 112.578 0.585 . . . . 0.0 112.578 -173.016 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.532 ' CG1' HD12 ' A' ' 18' ' ' ILE . 1.3 p -62.45 -37.43 78.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 C-N-CA 120.061 -0.656 . . . . 0.0 110.714 177.884 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 32.8 m -70.74 -35.75 72.82 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.221 0.534 . . . . 0.0 110.532 178.427 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 22.0 tttm -73.4 -52.29 14.31 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.721 -0.672 . . . . 0.0 111.571 -178.554 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -85.81 6.74 26.71 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.444 -0.798 . . . . 0.0 111.899 -173.404 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 89.8 mt-30 57.84 38.34 27.16 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 122.927 0.491 . . . . 0.0 111.605 175.237 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.646 HD22 HD22 ' A' ' 49' ' ' LEU . 44.4 mt -73.72 111.48 8.91 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.515 -177.08 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.62 ' HB3' ' OE2' ' A' ' 56' ' ' GLU . 3.9 mmmp? -105.51 -157.1 0.6 Allowed 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 112.537 0.569 . . . . 0.0 112.537 -177.346 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 97.04 176.76 34.89 Favored Glycine 0 N--CA 1.447 -0.591 0 N-CA-C 110.507 -1.037 . . . . 0.0 110.507 -169.254 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.405 ' HB ' ' O ' ' A' ' 66' ' ' PHE . 63.0 mt -83.22 110.94 18.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 N-CA-C 107.065 -1.457 . . . . 0.0 107.065 169.873 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . 0.662 ' HB2' ' CZ2' ' A' ' 38' ' ' TRP . 1.3 pt20 -122.78 123.21 40.52 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-O 121.666 0.746 . . . . 0.0 112.837 -164.114 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.645 HD11 ' HB ' ' A' ' 23' ' ' VAL . 2.5 mm? -121.23 149.93 42.12 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 114.937 -1.029 . . . . 0.0 109.318 178.272 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' HIS . . . . . 0.404 ' CE1' ' HA ' ' A' ' 75' ' ' LYS . 16.1 t-80 -120.33 135.23 55.08 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-O 121.642 0.734 . . . . 0.0 111.589 -176.113 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' MET . . . . . 0.784 ' HG3' ' HB2' ' A' ' 97' ' ' ASP . 25.7 ttm -103.21 91.96 4.31 Favored 'General case' 0 N--CA 1.442 -0.871 0 CA-C-N 114.391 -1.277 . . . . 0.0 108.16 178.933 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . 0.538 ' O ' ' HA ' ' A' ' 73' ' ' LYS . . . -57.76 -55.19 31.86 Favored Glycine 0 C--N 1.318 -0.426 0 CA-C-N 115.169 -0.923 . . . . 0.0 113.807 -175.256 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 10.9 m -146.94 13.0 1.12 Allowed 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 122.064 0.935 . . . . 0.0 109.49 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . 0.784 ' HB2' ' HG3' ' A' ' 94' ' ' MET . 0.7 OUTLIER -81.56 31.83 0.35 Allowed 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 114.838 -1.074 . . . . 0.0 110.462 -175.471 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . 0.549 ' HA ' ' SD ' ' A' ' 94' ' ' MET . 0.0 OUTLIER -67.52 0.03 3.42 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 113.362 0.875 . . . . 0.0 113.362 -170.619 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . 0.457 ' HA ' ' NH2' ' A' ' 98' ' ' ARG . 10.4 m -66.01 -19.23 65.79 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.66 0.743 . . . . 0.0 109.568 172.806 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 16.4 t80 -79.55 -24.14 42.34 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 115.317 -0.856 . . . . 0.0 110.135 177.773 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' MET . . . . . 0.559 ' SD ' ' HB3' ' A' ' 71' ' ' CYS . 88.6 mtp -60.17 -48.12 83.06 Favored 'General case' 0 CA--C 1.515 -0.395 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 174.357 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 67.5 m-20 -56.04 -40.89 74.17 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.224 -0.898 . . . . 0.0 111.088 176.577 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -63.25 -28.64 70.17 Favored 'General case' 0 N--CA 1.462 0.131 0 CA-C-N 116.198 -0.455 . . . . 0.0 112.075 -176.058 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' TYR . . . . . 0.94 ' HB3' HG23 ' A' ' 106' ' ' ILE . 2.8 m-85 -107.49 -6.36 17.08 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 111.937 0.347 . . . . 0.0 111.937 -178.602 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 3.4 mm? 57.94 33.06 22.77 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-O 121.425 0.631 . . . . 0.0 110.269 -174.049 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . 0.94 HG23 ' HB3' ' A' ' 104' ' ' TYR . 32.9 pt -88.93 36.18 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.248 -177.854 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 5.0 p-10 -67.28 -28.34 67.94 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.962 0.41 . . . . 0.0 110.376 179.266 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -92.06 103.5 3.06 Favored Glycine 0 N--CA 1.444 -0.769 0 N-CA-C 111.106 -0.798 . . . . 0.0 111.106 175.608 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.525 HG21 HG11 ' A' ' 37' ' ' VAL . 34.3 pt -110.79 153.46 43.69 Favored Pre-proline 0 C--N 1.324 -0.501 0 O-C-N 123.315 0.068 . . . . 0.0 110.943 -178.131 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . 0.832 ' HD3' ' HB2' ' A' ' 45' ' ' CYS . 42.2 Cg_endo -68.98 150.5 88.26 Favored 'Cis proline' 0 C--N 1.35 0.654 0 C-N-CA 123.547 -1.439 . . . . 0.0 112.428 0.982 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . 0.599 ' HG3' HG22 ' A' ' 106' ' ' ILE . 0.0 OUTLIER -114.52 127.9 56.05 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.209 -177.215 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . 0.556 ' HB2' ' HB3' ' A' ' 126' ' ' MET . 0.2 OUTLIER -102.47 114.35 28.48 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 114.701 -1.136 . . . . 0.0 110.608 -177.504 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 86.8 mt -130.75 143.51 40.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 120.85 0.357 . . . . 0.0 111.119 -178.244 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 48.2 tp -124.05 134.63 53.37 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.032 178.762 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.454 ' N ' HD12 ' A' ' 115' ' ' LEU . 1.6 mp -134.36 160.47 37.84 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.225 0.536 . . . . 0.0 110.615 -177.341 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . 0.51 ' HB2' HD11 ' A' ' 122' ' ' ILE . 28.5 t70 -77.17 167.96 20.87 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.193 -0.912 . . . . 0.0 110.351 177.288 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . 0.762 ' O ' ' HA ' ' A' ' 29' ' ' LYS . 81.9 mtt-85 -47.97 -37.66 15.06 Favored 'General case' 0 C--N 1.327 -0.382 0 O-C-N 124.402 1.064 . . . . 0.0 112.446 -177.524 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . 0.577 ' HA ' ' HG3' ' A' ' 29' ' ' LYS . 25.4 t0 -76.84 -0.1 22.77 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.532 0.682 . . . . 0.0 111.244 -178.922 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . 0.769 ' HA2' HD12 ' A' ' 33' ' ' ILE . . . 82.86 24.53 52.64 Favored Glycine 0 N--CA 1.431 -1.678 0 N-CA-C 110.058 -1.217 . . . . 0.0 110.058 -171.523 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . 0.485 ' HB2' ' HB3' ' A' ' 116' ' ' ASP . 44.9 mmtm -92.73 106.22 18.23 Favored 'General case' 0 C--O 1.222 -0.371 0 C-N-CA 120.601 -0.439 . . . . 0.0 111.466 -178.047 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . 0.702 ' H ' HD12 ' A' ' 121' ' ' ILE . 4.4 mp -41.51 117.58 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.397 0 CA-C-N 115.416 -0.811 . . . . 0.0 112.273 -177.95 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' ILE . . . . . 0.51 HD11 ' HB2' ' A' ' 116' ' ' ASP . 45.6 mm -98.95 -43.62 11.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 115.392 -0.822 . . . . 0.0 109.313 176.288 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 16.2 m -135.6 114.32 11.9 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.305 -0.861 . . . . 0.0 109.917 178.428 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -77.49 -12.38 59.95 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.24 0.543 . . . . 0.0 110.555 179.681 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 6.5 t30 -143.65 98.58 3.27 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.186 -0.915 . . . . 0.0 108.573 175.686 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' MET . . . . . 0.556 ' HB3' ' HB2' ' A' ' 112' ' ' PHE . 17.6 tpt -77.79 -86.6 0.06 Allowed 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.649 -174.546 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 8.4 m -155.87 -73.01 0.11 Allowed 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.945 0.402 . . . . 0.0 110.055 -178.889 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . 0.775 ' HB3' ' HB2' ' A' ' 131' ' ' ASP . 44.9 ttt180 -178.35 143.17 0.45 Allowed Pre-proline 0 N--CA 1.44 -0.955 0 CA-C-N 115.508 -0.769 . . . . 0.0 109.159 -179.226 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . 0.68 ' HB2' ' HB3' ' A' ' 48' ' ' GLU . 57.3 Cg_exo -52.72 -45.45 40.35 Favored 'Trans proline' 0 C--N 1.346 0.431 0 C-N-CA 122.577 2.185 . . . . 0.0 112.856 178.405 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . 0.534 ' HB3' ' HA ' ' A' ' 48' ' ' GLU . 31.2 p -96.22 5.7 50.43 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 112.279 0.474 . . . . 0.0 112.279 -176.717 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . 0.796 ' OD1' ' HG2' ' A' ' 133' ' ' LYS . 11.3 t70 -89.3 128.43 51.36 Favored Pre-proline 0 C--O 1.235 0.312 0 C-N-CA 120.101 -0.64 . . . . 0.0 110.469 -178.658 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . 0.621 ' O ' ' HG3' ' A' ' 136' ' ' GLU . 82.6 Cg_exo -46.92 -41.23 25.71 Favored 'Trans proline' 0 C--N 1.344 0.325 0 C-N-CA 124.048 3.165 . . . . 0.0 114.944 -178.042 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . 0.796 ' HG2' ' OD1' ' A' ' 131' ' ' ASP . 27.7 mmtm -53.61 -37.71 63.29 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-O 121.209 0.528 . . . . 0.0 110.194 -172.097 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' THR . . . . . 0.722 HG22 ' CZ ' ' A' ' 138' ' ' PHE . 4.9 m -59.31 -59.62 5.16 Favored 'General case' 0 N--CA 1.446 -0.642 0 CA-C-N 115.23 -0.895 . . . . 0.0 110.657 178.0 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . 0.546 ' HA ' ' CD2' ' A' ' 138' ' ' PHE . . . -61.54 -41.21 97.0 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.862 -179.626 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . 0.621 ' HG3' ' O ' ' A' ' 132' ' ' PRO . 19.9 mt-10 -66.92 -28.77 68.57 Favored 'General case' 0 CA--C 1.514 -0.423 0 CA-C-O 121.409 0.623 . . . . 0.0 110.511 -177.154 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . 0.548 ' O ' ' HG ' ' A' ' 141' ' ' LEU . 60.8 tttp -75.06 -31.23 61.2 Favored 'General case' 0 C--N 1.317 -0.848 0 CA-C-N 115.298 -0.865 . . . . 0.0 111.024 177.119 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . 0.722 ' CZ ' HG22 ' A' ' 134' ' ' THR . 12.2 m-30 -62.08 -41.06 97.79 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 173.69 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' ASN . . . . . 0.42 ' HB2' ' O ' ' A' ' 136' ' ' GLU . 5.7 m-20 -57.48 -53.15 61.37 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.02 -0.991 . . . . 0.0 110.157 172.901 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . 0.538 ' HB3' ' O ' ' A' ' 137' ' ' LYS . 8.0 tt0 -43.07 -51.55 5.75 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 123.14 0.576 . . . . 0.0 111.958 171.392 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.548 ' HG ' ' O ' ' A' ' 137' ' ' LYS . 94.2 mt -58.34 -37.92 76.14 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.9 -178.112 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 11.2 mp . . . . . 0 C--N 1.329 -0.296 0 CA-C-O 120.89 0.376 . . . . 0.0 111.163 -179.764 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.235 0.322 0 CA-C-O 121.054 0.454 . . . . 0.0 111.121 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -155.24 101.45 2.22 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.98 177.83 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . 0.477 ' HA ' HD23 ' A' ' 25' ' ' LEU . 36.9 m 65.01 103.85 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.474 0 CA-C-O 121.398 0.618 . . . . 0.0 112.128 178.128 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 36.5 p90 -125.81 171.03 11.02 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.426 178.487 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 30.7 m -140.91 129.21 22.34 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.899 -0.408 . . . . 0.0 109.899 178.227 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 45.8 m-85 -144.46 158.06 54.82 Favored Pre-proline 0 C--N 1.327 -0.372 0 CA-C-O 120.612 0.244 . . . . 0.0 110.841 -177.599 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_endo -87.09 128.5 2.71 Favored 'Trans proline' 0 N--CA 1.455 -0.751 0 C-N-CA 123.028 2.485 . . . . 0.0 113.023 178.882 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . 1.135 ' HB3' ' HB3' ' A' ' 21' ' ' LYS . 0.8 OUTLIER -66.32 162.77 19.5 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.409 -0.814 . . . . 0.0 109.735 170.687 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.842 HG13 HG11 ' A' ' 82' ' ' VAL . 24.5 mm -44.23 -45.43 2.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 O-C-N 124.27 0.981 . . . . 0.0 112.392 -177.367 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 33.2 m-80 -79.54 2.98 20.18 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.674 -172.941 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 87.5 35.79 9.17 Favored Glycine 0 N--CA 1.448 -0.557 0 N-CA-C 110.574 -1.011 . . . . 0.0 110.574 -174.526 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 1.135 ' HB3' ' HB3' ' A' ' 17' ' ' ASP . 35.5 ttmt -100.92 107.33 18.8 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.209 -0.495 . . . . 0.0 110.412 -174.835 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 25.2 m -74.34 105.73 5.64 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 120.924 0.392 . . . . 0.0 110.976 -177.137 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.629 ' HB ' HD11 ' A' ' 92' ' ' LEU . 45.8 t -117.99 138.07 49.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 116.064 -0.517 . . . . 0.0 109.668 179.192 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 80.3 p -113.6 156.5 23.55 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 116.316 -0.402 . . . . 0.0 109.93 179.263 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.519 ' O ' ' HB2' ' A' ' 29' ' ' LYS . 34.4 tp -70.42 -9.69 57.09 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.16 177.543 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -80.96 -26.98 36.2 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.494 177.288 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -74.15 -34.72 63.94 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.548 0.69 . . . . 0.0 110.107 175.795 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.496 HD11 HG21 ' A' ' 90' ' ' ILE . 66.6 mt -91.78 0.44 57.49 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.322 -0.854 . . . . 0.0 110.557 179.226 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.519 ' HB2' ' O ' ' A' ' 25' ' ' LEU . 60.2 tttp -74.54 150.63 39.69 Favored 'General case' 0 N--CA 1.443 -0.808 0 CA-C-N 115.134 -0.939 . . . . 0.0 110.633 -176.504 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 94.65 5.41 61.51 Favored Glycine 0 N--CA 1.447 -0.601 0 N-CA-C 110.576 -1.01 . . . . 0.0 110.576 -175.128 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 1.032 ' HD2' ' HA ' ' A' ' 63' ' ' ASP . 11.0 tppt? -146.0 151.44 37.78 Favored 'General case' 0 N--CA 1.446 -0.646 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 -177.982 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.41 ' HB2' HG22 ' A' ' 64' ' ' ILE . 61.3 m-85 -65.92 151.28 47.11 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 120.985 -0.286 . . . . 0.0 110.652 179.793 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.563 ' HB ' ' HB2' ' A' ' 115' ' ' LEU . 46.1 mm -127.08 125.86 67.13 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.975 -176.068 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . 0.445 ' CE2' ' HB2' ' A' ' 36' ' ' ASP . 59.0 t80 -105.43 112.01 24.95 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 170.554 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.57 ' HB ' ' HB ' ' A' ' 113' ' ' ILE . 40.3 mt -92.14 120.72 41.82 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-O 121.298 0.57 . . . . 0.0 110.461 179.77 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.561 ' O ' ' HA ' ' A' ' 68' ' ' SER . 15.9 t70 -120.24 125.03 47.11 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 115.133 -0.94 . . . . 0.0 109.231 178.919 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.661 HG11 HG21 ' A' ' 109' ' ' ILE . 21.5 t -82.5 113.92 22.53 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.913 0 C-N-CA 119.817 -0.753 . . . . 0.0 110.717 -178.981 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' TRP . . . . . 0.61 ' CZ2' ' HB2' ' A' ' 91' ' ' GLN . 0.5 OUTLIER -108.95 135.82 49.5 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.268 -0.878 . . . . 0.0 108.926 -177.967 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.624 ' HB3' ' HB3' ' A' ' 42' ' ' CYS . . . -145.04 172.36 13.17 Favored 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 120.433 -0.507 . . . . 0.0 111.96 -176.919 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -89.18 -43.17 11.21 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.661 0.743 . . . . 0.0 109.855 176.95 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' TRP . . . . . 0.551 ' CH2' HD11 ' A' ' 109' ' ' ILE . 11.1 p-90 -88.39 12.35 14.43 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 114.957 -1.02 . . . . 0.0 111.233 -176.056 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' CYS . . . . . 0.755 ' SG ' ' HB3' ' A' ' 45' ' ' CYS . 28.3 p -79.33 -17.86 53.68 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.154 -178.792 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 57.49 -107.06 0.88 Allowed Glycine 0 CA--C 1.522 0.508 0 CA-C-N 116.057 -0.519 . . . . 0.0 113.829 177.258 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_exo -51.6 -25.77 20.73 Favored 'Trans proline' 0 C--N 1.353 0.776 0 C-N-CA 123.746 2.964 . . . . 0.0 113.688 -177.348 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . 0.756 ' HB2' ' HD3' ' A' ' 110' ' ' PRO . 7.0 t -52.95 -30.68 36.11 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-O 120.844 0.354 . . . . 0.0 111.3 176.838 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.579 ' HA ' ' HG ' ' A' ' 49' ' ' LEU . 64.9 mtp180 -68.15 -11.42 59.14 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.835 -0.62 . . . . 0.0 111.677 -175.679 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -69.56 -33.23 71.75 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.919 -0.658 . . . . 0.0 112.595 179.802 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . 0.551 ' OE2' ' HD3' ' A' ' 128' ' ' ARG . 28.0 mt-10 -93.6 -9.0 39.55 Favored 'General case' 0 C--N 1.328 -0.366 0 O-C-N 122.738 -0.272 . . . . 0.0 111.061 -177.561 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.617 ' HB3' HD22 ' A' ' 87' ' ' LEU . 81.4 mt -55.52 -46.69 99.68 Favored Pre-proline 0 C--N 1.326 -0.426 0 CA-C-N 116.558 -0.292 . . . . 0.0 111.455 179.331 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 1.004 ' HA ' ' HE3' ' A' ' 53' ' ' LYS . 51.5 Cg_exo -55.34 -43.95 53.56 Favored 'Trans proline' 0 C--N 1.356 0.956 0 C-N-CA 121.635 1.556 . . . . 0.0 111.895 170.781 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -69.02 -24.29 64.19 Favored 'General case' 0 N--CA 1.462 0.138 0 CA-C-O 121.13 0.49 . . . . 0.0 110.686 -174.483 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 8.7 tt -68.42 -39.28 81.65 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.486 -0.779 . . . . 0.0 109.252 178.015 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 1.004 ' HE3' ' HA ' ' A' ' 50' ' ' PRO . 8.4 mtmp? -62.84 -51.48 66.88 Favored 'General case' 0 CA--C 1.519 -0.248 0 CA-C-O 121.73 0.776 . . . . 0.0 109.375 177.302 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -57.82 -37.81 74.48 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 114.977 -1.01 . . . . 0.0 111.205 179.347 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.486 HD21 ' HE2' ' A' ' 138' ' ' PHE . 12.9 tp -73.98 -40.7 62.79 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.543 -0.299 . . . . 0.0 110.64 179.583 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.651 ' HG3' ' O ' ' A' ' 53' ' ' LYS . 0.0 OUTLIER -66.24 -39.52 89.6 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.711 -0.222 . . . . 0.0 110.473 -177.496 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 51.5 mt-10 -76.44 -28.27 56.53 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.009 0.433 . . . . 0.0 110.73 -179.255 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 63.7 tttm -70.21 -31.36 68.76 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.862 176.489 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.453 ' HB3' HD11 ' A' ' 64' ' ' ILE . 88.0 m-85 -112.17 5.71 18.65 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 112.0 0.37 . . . . 0.0 112.0 -176.099 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -62.93 142.97 58.11 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.618 175.687 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 95.11 -14.24 65.59 Favored Glycine 0 N--CA 1.446 -0.673 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.054 -179.743 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.764 ' HE2' ' HB3' ' A' ' 142' ' ' LEU . 18.7 mmmt -104.13 -169.86 1.69 Allowed 'General case' 0 N--CA 1.448 -0.532 0 CA-C-O 121.271 0.558 . . . . 0.0 111.463 178.859 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . 1.032 ' HA ' ' HD2' ' A' ' 31' ' ' LYS . 28.0 m-20 -87.91 34.12 0.72 Allowed 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 113.401 0.889 . . . . 0.0 113.401 -165.848 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.453 HD11 ' HB3' ' A' ' 59' ' ' TYR . 27.6 pt -140.57 135.8 35.27 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-O 120.786 0.327 . . . . 0.0 110.639 176.213 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' HIS . . . . . 0.515 ' HB2' HD13 ' A' ' 33' ' ' ILE . 39.2 m-70 -109.61 144.25 38.2 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.074 175.889 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . 0.447 ' HE2' HD23 ' A' ' 55' ' ' LEU . 59.8 m-85 -100.78 114.6 28.53 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 173.468 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.64 ' HA ' ' O ' ' A' ' 90' ' ' ILE . 58.2 t -123.35 115.07 44.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-O 120.974 0.416 . . . . 0.0 111.125 -175.315 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . 0.561 ' HA ' ' O ' ' A' ' 36' ' ' ASP . 50.9 m -96.48 131.15 43.37 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.688 179.01 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.429 ' O ' ' HA ' ' A' ' 37' ' ' VAL . 84.8 mt -120.9 139.03 53.78 Favored 'General case' 0 N--CA 1.468 0.47 0 N-CA-C 110.51 -0.182 . . . . 0.0 110.51 178.062 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . 0.589 ' HB2' ' O ' ' A' ' 38' ' ' TRP . 0.8 OUTLIER -123.69 129.94 51.88 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 112.5 0.556 . . . . 0.0 112.5 -174.374 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 4.8 p -93.65 23.03 4.95 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.301 173.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.475 ' OD1' ' HA ' ' A' ' 39' ' ' ALA . 3.0 m-20 -79.47 108.02 12.68 Favored 'General case' 0 N--CA 1.467 0.382 0 O-C-N 122.339 -0.226 . . . . 0.0 111.013 -177.389 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 16.2 ptpt -68.12 -20.95 64.96 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 120.979 0.418 . . . . 0.0 110.658 178.09 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . 0.578 ' HB2' ' HB3' ' A' ' 77' ' ' ALA . 1.0 OUTLIER -79.42 69.09 5.61 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.394 174.122 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 11.9 tttt -58.73 -51.24 70.8 Favored 'General case' 0 C--O 1.218 -0.564 0 CA-C-N 116.63 -0.259 . . . . 0.0 111.649 -174.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.662 ' HA ' ' OE2' ' A' ' 79' ' ' GLU . 0.2 OUTLIER -58.11 -44.37 87.65 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 120.811 0.339 . . . . 0.0 110.442 -177.478 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.578 ' HB3' ' HB2' ' A' ' 74' ' ' ASN . . . -62.37 -43.29 99.18 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.683 0.754 . . . . 0.0 110.567 178.285 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' TRP . . . . . 0.464 ' O ' HG12 ' A' ' 82' ' ' VAL . 3.9 t-105 -73.34 -45.76 53.29 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 115.159 -0.928 . . . . 0.0 111.268 -176.731 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.662 ' OE2' ' HA ' ' A' ' 76' ' ' LYS . 0.6 OUTLIER -62.79 -35.29 79.39 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.001 -175.026 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 4.6 p30 -78.03 -33.51 51.06 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 119.657 -0.817 . . . . 0.0 110.339 178.772 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 45.4 tpp -61.96 -51.92 66.12 Favored 'General case' 0 C--O 1.222 -0.391 0 N-CA-C 111.462 0.171 . . . . 0.0 111.462 176.572 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.842 HG11 HG13 ' A' ' 18' ' ' ILE . 2.4 p -59.17 -37.03 66.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 C-N-CA 120.828 -0.349 . . . . 0.0 110.628 177.817 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 91.8 m -61.53 -39.09 89.8 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-O 120.894 0.378 . . . . 0.0 110.694 175.724 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . 0.445 ' HB3' ' HE3' ' A' ' 84' ' ' LYS . 0.2 OUTLIER -75.91 -44.94 37.85 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 179.717 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . 0.465 ' CG ' HH21 ' A' ' 46' ' ' ARG . 1.8 m-20 -69.6 -19.92 63.64 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.466 -0.788 . . . . 0.0 111.702 -176.387 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 73.1 mt-30 60.08 58.93 2.53 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-O 121.531 0.681 . . . . 0.0 110.936 176.853 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.617 HD22 ' HB3' ' A' ' 49' ' ' LEU . 81.9 mt -86.31 134.14 33.76 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.458 -0.792 . . . . 0.0 111.132 -177.068 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.582 ' HB3' ' OE2' ' A' ' 56' ' ' GLU . 11.7 mmmm -91.93 -168.99 2.14 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.934 177.249 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 84.49 160.25 31.35 Favored Glycine 0 N--CA 1.447 -0.612 0 C-N-CA 121.098 -0.573 . . . . 0.0 112.336 -177.436 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.64 ' O ' ' HA ' ' A' ' 67' ' ' VAL . 53.8 mt -77.68 113.0 16.29 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 175.405 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . 0.61 ' HB2' ' CZ2' ' A' ' 38' ' ' TRP . 1.6 pt20 -124.14 123.12 39.61 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-O 121.439 0.637 . . . . 0.0 112.074 -167.452 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.629 HD11 ' HB ' ' A' ' 23' ' ' VAL . 2.8 mm? -120.6 167.51 12.34 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.391 -0.822 . . . . 0.0 109.621 178.276 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 20.6 t-80 -138.66 126.89 22.82 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-O 121.201 0.524 . . . . 0.0 111.36 -173.084 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' MET . . . . . 0.446 ' HB3' ' HE2' ' A' ' 94' ' ' MET . 37.1 ttp -88.57 -67.05 0.86 Allowed 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 114.989 -1.005 . . . . 0.0 109.4 176.683 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . 0.441 ' HA2' ' O ' ' A' ' 72' ' ' ASP . . . 84.07 -77.5 2.11 Favored Glycine 0 N--CA 1.442 -0.901 0 C-N-CA 120.74 -0.743 . . . . 0.0 114.069 172.951 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 5.6 p -84.93 -19.57 32.0 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 113.247 0.832 . . . . 0.0 113.247 -169.75 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -101.54 154.77 18.55 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 119.723 -0.791 . . . . 0.0 111.023 -178.172 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . 0.515 ' HA ' ' HB3' ' A' ' 101' ' ' MET . 0.0 OUTLIER -140.66 9.05 2.19 Favored 'General case' 0 N--CA 1.446 -0.643 0 CA-C-N 115.511 -0.768 . . . . 0.0 109.789 173.083 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 4.5 m -78.32 -36.31 46.55 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.246 0.546 . . . . 0.0 109.793 178.426 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 70.5 t80 -74.78 -30.5 61.46 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 174.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' MET . . . . . 0.714 ' HG2' HG13 ' A' ' 106' ' ' ILE . 1.6 tmt? -64.2 -38.02 89.55 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 114.453 -1.249 . . . . 0.0 109.977 172.034 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -65.72 -44.44 86.05 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.468 -0.787 . . . . 0.0 110.483 177.61 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -62.88 -21.24 65.85 Favored 'General case' 0 CA--C 1.528 0.132 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.882 -177.604 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' TYR . . . . . 0.414 ' HB3' HG23 ' A' ' 106' ' ' ILE . 6.3 m-30 -100.39 -3.1 31.77 Favored 'General case' 0 C--O 1.237 0.419 0 CA-C-N 116.418 -0.355 . . . . 0.0 111.002 179.645 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 95.4 mt 59.05 25.94 14.49 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.108 -179.168 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . 0.714 HG13 ' HG2' ' A' ' 101' ' ' MET . 30.4 pt -86.64 66.14 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-O 121.664 0.745 . . . . 0.0 111.01 -177.693 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 44.2 t-20 -81.51 -59.72 2.52 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.364 -0.834 . . . . 0.0 109.81 179.786 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -82.93 90.2 1.53 Allowed Glycine 0 N--CA 1.446 -0.673 0 C-N-CA 120.634 -0.794 . . . . 0.0 111.482 176.931 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.661 HG21 HG11 ' A' ' 37' ' ' VAL . 46.5 pt -91.33 158.23 41.32 Favored Pre-proline 0 C--N 1.326 -0.448 0 N-CA-C 110.655 -0.128 . . . . 0.0 110.655 179.89 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . 0.756 ' HD3' ' HB2' ' A' ' 45' ' ' CYS . 40.9 Cg_endo -65.84 153.98 79.98 Favored 'Cis proline' 0 C--N 1.35 0.605 0 C-N-CA 124.006 -1.248 . . . . 0.0 113.691 1.939 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . 0.513 ' HG3' ' HA ' ' A' ' 106' ' ' ILE . 0.0 OUTLIER -125.8 138.14 53.82 Favored 'General case' 0 N--CA 1.446 -0.668 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.017 -179.302 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . 0.795 ' HD2' ' HB2' ' A' ' 128' ' ' ARG . 0.1 OUTLIER -102.05 117.53 34.99 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.358 -0.837 . . . . 0.0 110.633 -177.74 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.57 ' HB ' ' HB ' ' A' ' 35' ' ' ILE . 92.7 mt -131.15 145.13 35.87 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.283 0 CA-C-O 120.87 0.367 . . . . 0.0 111.128 -178.065 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.424 ' C ' HD12 ' A' ' 115' ' ' LEU . 42.0 tp -125.61 141.65 51.92 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.332 -0.395 . . . . 0.0 109.943 178.193 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.693 ' HG ' ' HA ' ' A' ' 121' ' ' ILE . 3.0 mp -134.87 153.98 51.84 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.061 0.458 . . . . 0.0 110.587 -178.018 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 27.8 t0 -79.72 166.49 21.74 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.221 -0.9 . . . . 0.0 110.765 178.596 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . 0.423 ' HA ' ' O ' ' A' ' 31' ' ' LYS . 5.6 mtm180 -53.57 -26.42 21.42 Favored 'General case' 0 N--CA 1.466 0.348 0 O-C-N 124.437 1.085 . . . . 0.0 111.956 -178.8 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -69.31 -16.72 63.61 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.302 0.573 . . . . 0.0 110.549 178.89 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 93.0 24.44 22.65 Favored Glycine 0 N--CA 1.436 -1.353 0 N-CA-C 109.762 -1.335 . . . . 0.0 109.762 -169.893 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 24.6 mmmt -111.7 114.34 27.29 Favored 'General case' 0 C--O 1.221 -0.403 0 N-CA-C 112.235 0.457 . . . . 0.0 112.235 -172.507 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . 0.703 ' H ' HD12 ' A' ' 121' ' ' ILE . 4.1 mp -42.74 116.01 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 O-C-N 123.972 0.795 . . . . 0.0 111.761 178.576 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' ILE . . . . . 0.442 ' H ' ' HA ' ' A' ' 115' ' ' LEU . 69.3 mt -87.84 -47.69 15.52 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-N 115.21 -0.904 . . . . 0.0 108.726 174.94 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 15.1 m -128.52 114.53 16.87 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-N 115.003 -0.999 . . . . 0.0 109.944 179.631 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -70.98 -21.66 62.29 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.103 0.478 . . . . 0.0 110.577 178.509 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 6.9 t30 -139.57 101.53 4.24 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.539 -0.755 . . . . 0.0 109.009 176.399 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 13.1 tpt -105.48 -127.04 0.24 Allowed 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.2 -175.891 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 2.0 p -145.08 136.61 25.28 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 110.134 -0.321 . . . . 0.0 110.134 -178.062 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . 0.795 ' HB2' ' HD2' ' A' ' 112' ' ' PHE . 14.8 ttt180 -94.68 152.55 39.92 Favored Pre-proline 0 CA--C 1.535 0.401 0 CA-C-O 119.242 -0.408 . . . . 0.0 110.854 -177.978 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . 0.663 ' HD2' ' CG ' ' A' ' 128' ' ' ARG . 47.0 Cg_exo -24.4 -39.72 0.02 OUTLIER 'Trans proline' 0 C--N 1.366 1.469 1 C-N-CA 126.32 4.68 . . . . 0.0 117.275 175.771 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 66.6 m -50.33 -29.85 10.79 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-N 118.526 0.603 . . . . 0.0 111.129 175.302 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -92.2 121.36 66.77 Favored Pre-proline 0 C--N 1.323 -0.571 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.536 175.519 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . 0.471 ' O ' ' HG3' ' A' ' 136' ' ' GLU . 59.9 Cg_endo -72.16 -23.73 20.93 Favored 'Trans proline' 0 N--CA 1.462 -0.346 0 C-N-CA 122.492 2.128 . . . . 0.0 112.322 179.664 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . 0.476 ' HA ' ' HD3' ' A' ' 133' ' ' LYS . 57.3 mmtt -63.09 -30.25 71.45 Favored 'General case' 0 CA--C 1.518 -0.259 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.878 -177.771 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' THR . . . . . 0.773 HG22 ' CZ ' ' A' ' 138' ' ' PHE . 3.0 m -59.11 -54.81 42.83 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.742 -0.663 . . . . 0.0 109.718 175.234 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . 0.598 ' HA ' ' CD2' ' A' ' 138' ' ' PHE . . . -59.99 -43.56 95.09 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-N 115.67 -0.695 . . . . 0.0 112.045 177.817 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . 0.471 ' HG3' ' O ' ' A' ' 132' ' ' PRO . 50.8 mt-10 -55.72 -52.01 65.38 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-O 122.025 0.917 . . . . 0.0 110.269 177.47 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . 0.685 ' HE3' HD21 ' A' ' 141' ' ' LEU . 52.3 tptt -54.53 -40.63 68.83 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 113.956 -1.475 . . . . 0.0 111.319 179.113 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . 0.773 ' CZ ' HG22 ' A' ' 134' ' ' THR . 19.5 m-30 -55.49 -47.69 75.77 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 116.63 -0.259 . . . . 0.0 110.582 177.105 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 39.5 m-20 -54.18 -55.03 31.86 Favored 'General case' 0 CA--C 1.521 -0.162 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 -179.254 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 8.8 tt0 -48.87 -57.71 5.99 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.403 -0.817 . . . . 0.0 111.968 174.95 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.685 HD21 ' HE3' ' A' ' 137' ' ' LYS . 90.2 mt -60.89 -37.3 81.74 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.799 -174.477 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 0.764 ' HB3' ' HE2' ' A' ' 62' ' ' LYS . 89.2 mt . . . . . 0 C--N 1.323 -0.56 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.144 -178.387 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.644 ' HA ' ' CZ ' ' A' ' 100' ' ' PHE . . . . . . . . 0 N--CA 1.47 0.542 0 N-CA-C 112.667 0.618 . . . . 0.0 112.667 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -56.67 -32.54 65.51 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 112.87 0.693 . . . . 0.0 112.87 -172.895 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 31.1 m -147.68 86.56 1.6 Allowed 'General case' 0 C--N 1.316 -0.873 0 CA-C-O 121.128 0.489 . . . . 0.0 111.362 179.188 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . 0.477 ' CE2' HD22 ' A' ' 25' ' ' LEU . 47.9 p90 -105.57 163.15 12.89 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 172.712 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . 0.439 ' HA ' ' HA ' ' A' ' 24' ' ' SER . 14.0 m -139.71 122.03 15.99 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 109.805 -0.442 . . . . 0.0 109.805 178.852 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . 0.424 ' HA ' ' HD3' ' A' ' 16' ' ' PRO . 19.6 m-85 -137.11 149.32 65.84 Favored Pre-proline 0 C--N 1.327 -0.393 0 CA-C-O 120.678 0.275 . . . . 0.0 110.744 -177.262 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.471 ' HD2' ' O ' ' A' ' 93' ' ' HIS . 9.2 Cg_exo -72.35 124.37 9.87 Favored 'Trans proline' 0 N--CA 1.456 -0.678 0 C-N-CA 122.473 2.115 . . . . 0.0 112.54 178.02 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . 0.874 ' HB3' ' HB3' ' A' ' 21' ' ' LYS . 0.2 OUTLIER -68.97 162.95 25.65 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.132 -0.94 . . . . 0.0 109.765 172.769 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.668 HD12 HG13 ' A' ' 82' ' ' VAL . 0.8 OUTLIER -44.78 -43.42 2.49 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 O-C-N 124.147 0.904 . . . . 0.0 112.171 -177.227 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.52 ' ND2' HG23 ' A' ' 18' ' ' ILE . 21.8 m-80 -77.42 1.2 19.82 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.144 -175.349 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 85.84 30.61 23.08 Favored Glycine 0 N--CA 1.446 -0.663 0 N-CA-C 110.682 -0.967 . . . . 0.0 110.682 -173.626 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.874 ' HB3' ' HB3' ' A' ' 17' ' ' ASP . 2.0 ttmp? -98.09 116.04 29.48 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.481 -0.36 . . . . 0.0 110.902 -172.933 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 25.6 m -70.38 104.78 2.81 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 120.867 0.365 . . . . 0.0 110.905 178.799 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.472 ' HB ' HD21 ' A' ' 92' ' ' LEU . 61.0 t -121.32 146.16 26.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 178.741 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . 0.439 ' HA ' ' HA ' ' A' ' 14' ' ' SER . 86.7 p -121.52 -173.96 2.75 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 109.985 -0.376 . . . . 0.0 109.985 -178.666 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.698 ' O ' ' HB2' ' A' ' 29' ' ' LYS . 15.0 tp -98.84 0.69 44.78 Favored 'General case' 0 C--N 1.32 -0.685 0 C-N-CA 120.16 -0.616 . . . . 0.0 109.951 173.881 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -85.99 -32.71 21.37 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.398 -179.06 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -77.01 -17.98 58.47 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.367 0.603 . . . . 0.0 110.117 176.104 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 85.8 mt -100.12 -5.31 28.06 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.602 -0.727 . . . . 0.0 110.429 176.859 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.698 ' HB2' ' O ' ' A' ' 25' ' ' LEU . 58.4 tttm -81.7 140.98 34.0 Favored 'General case' 0 N--CA 1.443 -0.79 0 CA-C-N 115.582 -0.735 . . . . 0.0 110.705 -172.338 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 115.63 -13.58 17.88 Favored Glycine 0 N--CA 1.452 -0.239 0 N-CA-C 111.326 -0.71 . . . . 0.0 111.326 -175.389 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.502 ' HG3' ' OD1' ' A' ' 63' ' ' ASP . 25.0 ttmm -132.27 153.1 50.99 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 177.129 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.667 ' HB2' HG22 ' A' ' 64' ' ' ILE . 24.7 m-85 -51.92 141.85 16.78 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 118.328 0.513 . . . . 0.0 110.916 -176.491 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.589 HG21 HD11 ' A' ' 25' ' ' LEU . 67.3 mt -119.27 122.29 68.72 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.74 -174.545 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . 0.531 ' OH ' ' HG3' ' A' ' 128' ' ' ARG . 30.2 t80 -114.99 134.66 54.99 Favored 'General case' 0 C--N 1.316 -0.863 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 173.94 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.611 ' HA ' ' O ' ' A' ' 67' ' ' VAL . 82.1 mt -130.26 129.88 65.3 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.047 -176.651 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.635 ' O ' ' HA ' ' A' ' 68' ' ' SER . 4.6 p30 -130.6 160.29 34.64 Favored 'General case' 0 C--O 1.217 -0.614 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.418 172.71 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.544 ' HB ' ' HA ' ' A' ' 110' ' ' PRO . 47.8 t -95.56 137.94 22.44 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 CA-C-O 121.087 0.47 . . . . 0.0 111.779 -178.429 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' TRP . . . . . 0.936 ' HZ3' HG21 ' A' ' 82' ' ' VAL . 0.6 OUTLIER -122.34 132.91 54.62 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 174.244 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -148.43 154.14 39.48 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 120.767 -0.373 . . . . 0.0 111.655 -176.727 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . 0.687 ' HB ' ' CE3' ' A' ' 78' ' ' TRP . 4.1 t -92.93 -28.68 16.31 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 121.203 -0.199 . . . . 0.0 110.785 173.516 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 11.5 p-90 -81.69 -8.32 59.69 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.939 0.4 . . . . 0.0 110.417 179.537 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' CYS . . . . . 0.56 ' O ' ' HD2' ' A' ' 44' ' ' PRO . 47.7 t -86.35 -71.33 0.55 Allowed 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 173.099 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 112.21 -77.53 0.24 Allowed Glycine 0 C--O 1.227 -0.293 0 C-N-CA 120.532 -0.842 . . . . 0.0 113.239 176.87 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.56 ' HD2' ' O ' ' A' ' 42' ' ' CYS . 9.7 Cg_endo -52.38 -31.79 49.08 Favored 'Trans proline' 0 C--N 1.353 0.815 0 C-N-CA 123.182 2.588 . . . . 0.0 112.431 -178.636 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . 0.56 ' HB3' ' HD3' ' A' ' 110' ' ' PRO . 26.9 p -61.41 -17.0 52.21 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.688 -179.899 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.514 ' HA ' HD23 ' A' ' 49' ' ' LEU . 61.7 mtp180 -83.27 -19.4 36.41 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.814 0.34 . . . . 0.0 111.075 -177.48 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -83.77 -7.68 85.5 Favored Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.479 -176.705 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -95.58 -10.44 29.55 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.513 0.197 . . . . 0.0 111.152 -177.283 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.991 ' HG ' ' HB3' ' A' ' 87' ' ' LEU . 4.2 mm? -55.25 -44.85 99.85 Favored Pre-proline 0 CA--C 1.538 0.487 0 CA-C-N 116.649 -0.251 . . . . 0.0 111.505 176.709 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.672 ' O ' ' HG2' ' A' ' 54' ' ' GLU . 76.0 Cg_exo -52.68 -37.37 75.1 Favored 'Trans proline' 0 C--N 1.357 0.981 0 C-N-CA 121.816 1.677 . . . . 0.0 112.131 170.606 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -71.51 -19.84 62.14 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.35 0.595 . . . . 0.0 110.704 -178.071 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 8.1 tt -72.88 -45.69 56.85 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.568 -0.742 . . . . 0.0 109.692 -179.83 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.509 ' HG3' ' N ' ' A' ' 54' ' ' GLU . 7.9 ptmm? -63.89 -42.04 97.57 Favored 'General case' 0 C--O 1.226 -0.15 0 N-CA-C 109.878 -0.415 . . . . 0.0 109.878 177.704 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.672 ' HG2' ' O ' ' A' ' 50' ' ' PRO . 55.2 mm-40 -51.22 -49.75 60.44 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-O 121.64 0.733 . . . . 0.0 110.224 177.932 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.769 HD13 ' HD2' ' A' ' 59' ' ' TYR . 0.2 OUTLIER -66.7 -39.21 87.98 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.068 -0.969 . . . . 0.0 110.755 -179.021 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 14.2 tp10 -61.23 -57.66 11.51 Favored 'General case' 0 N--CA 1.447 -0.591 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.045 -177.207 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 -67.97 -25.42 65.42 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 111.744 0.276 . . . . 0.0 111.744 -176.113 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . 0.494 ' HD3' ' CE2' ' A' ' 59' ' ' TYR . 63.4 tttt -67.7 -34.12 76.25 Favored 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 120.759 -0.376 . . . . 0.0 110.51 174.064 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.769 ' HD2' HD13 ' A' ' 55' ' ' LEU . 68.3 m-85 -119.81 25.17 10.15 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.426 -176.327 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -49.63 116.51 1.79 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.059 0.457 . . . . 0.0 111.972 178.143 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 105.11 -0.73 40.96 Favored Glycine 0 N--CA 1.453 -0.214 0 C-N-CA 120.945 -0.645 . . . . 0.0 112.451 179.504 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.852 ' HG2' HG12 ' A' ' 64' ' ' ILE . 0.0 OUTLIER -67.32 174.9 2.98 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.523 0.678 . . . . 0.0 112.422 -178.299 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . 0.502 ' OD1' ' HG3' ' A' ' 31' ' ' LYS . 32.3 t70 -101.28 51.45 0.85 Allowed 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.905 -177.317 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.852 HG12 ' HG2' ' A' ' 62' ' ' LYS . 19.4 pt -146.8 165.57 7.3 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.401 0 N-CA-C 110.113 -0.329 . . . . 0.0 110.113 177.546 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' HIS . . . . . 0.48 ' NE2' ' HB3' ' A' ' 31' ' ' LYS . 85.2 m-70 -122.9 140.42 52.99 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 175.922 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . 0.692 ' O ' ' HB ' ' A' ' 90' ' ' ILE . 79.6 m-85 -102.01 103.18 13.78 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 172.381 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.611 ' O ' ' HA ' ' A' ' 35' ' ' ILE . 39.0 t -119.12 113.6 41.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-O 120.967 0.413 . . . . 0.0 111.11 -175.465 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . 0.635 ' HA ' ' O ' ' A' ' 36' ' ' ASP . 0.7 OUTLIER -93.95 131.96 38.88 Favored 'General case' 0 C--N 1.317 -0.824 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 177.521 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.546 ' CD2' ' HB2' ' A' ' 92' ' ' LEU . 73.2 mt -118.2 137.7 52.83 Favored 'General case' 0 N--CA 1.468 0.463 0 O-C-N 122.072 -0.392 . . . . 0.0 110.426 176.918 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . 0.536 ' HB2' ' O ' ' A' ' 38' ' ' TRP . 1.3 t -118.06 123.5 45.81 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.188 0.518 . . . . 0.0 112.029 -176.209 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 49.7 t -89.85 14.14 12.75 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.75 176.417 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.574 ' O ' ' HA2' ' A' ' 95' ' ' GLY . 0.9 OUTLIER -65.53 133.11 50.53 Favored 'General case' 0 CA--C 1.516 -0.362 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 -178.292 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.48 ' HB2' ' NZ ' ' A' ' 73' ' ' LYS . 1.0 OUTLIER -87.45 -24.94 23.99 Favored 'General case' 0 C--N 1.316 -0.872 0 C-N-CA 120.084 -0.646 . . . . 0.0 110.571 -177.646 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . 0.571 ' HB2' ' HB3' ' A' ' 77' ' ' ALA . 0.7 OUTLIER -84.12 78.97 9.67 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.343 176.175 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.432 ' HG3' ' CE1' ' A' ' 93' ' ' HIS . 10.2 tttt -61.63 -56.58 18.31 Favored 'General case' 0 C--O 1.221 -0.443 0 C-N-CA 120.826 -0.35 . . . . 0.0 111.741 -173.763 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.557 ' HA ' ' OE1' ' A' ' 79' ' ' GLU . 17.3 tppt? -57.09 -40.62 77.32 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 111.882 0.327 . . . . 0.0 111.882 -177.903 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.571 ' HB3' ' HB2' ' A' ' 74' ' ' ASN . . . -62.79 -41.2 99.16 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.827 0.823 . . . . 0.0 110.188 177.393 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' TRP . . . . . 0.687 ' CE3' ' HB ' ' A' ' 40' ' ' THR . 5.2 t-105 -74.31 -47.57 33.81 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 114.698 -1.137 . . . . 0.0 111.202 -176.802 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.557 ' OE1' ' HA ' ' A' ' 76' ' ' LYS . 3.3 pt-20 -64.57 -35.52 81.24 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.938 -174.782 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 3.6 p30 -74.94 -37.13 62.07 Favored 'General case' 0 CA--C 1.523 -0.081 0 C-N-CA 119.995 -0.682 . . . . 0.0 110.114 179.053 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 34.4 ttm -64.1 -50.52 67.98 Favored 'General case' 0 C--O 1.219 -0.552 0 C-N-CA 120.65 -0.42 . . . . 0.0 110.784 175.914 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.936 HG21 ' HZ3' ' A' ' 38' ' ' TRP . 12.5 p -63.18 -23.23 32.75 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-O 121.086 0.469 . . . . 0.0 111.005 -178.158 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . 0.573 ' OG1' HD11 ' A' ' 18' ' ' ILE . 88.2 m -76.38 -46.82 25.65 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.566 -0.288 . . . . 0.0 110.453 171.98 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.32 -42.36 88.32 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.337 0.589 . . . . 0.0 110.384 -178.286 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -74.51 -5.61 43.66 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.186 -0.915 . . . . 0.0 111.282 -179.824 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 47.7 mt-30 63.52 17.74 10.57 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 115.867 -0.606 . . . . 0.0 112.368 174.556 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.991 ' HB3' ' HG ' ' A' ' 49' ' ' LEU . 29.2 mt -74.67 93.78 2.6 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.96 -0.385 . . . . 0.0 109.96 -179.986 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 9.0 mmtm -110.07 -178.84 3.62 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 113.006 0.743 . . . . 0.0 113.006 -176.261 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 130.88 -165.02 23.08 Favored Glycine 0 N--CA 1.449 -0.448 0 N-CA-C 109.71 -1.356 . . . . 0.0 109.71 -172.117 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.692 ' HB ' ' O ' ' A' ' 66' ' ' PHE . 60.9 mt -85.02 112.14 21.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 118.054 0.927 . . . . 0.0 108.508 172.808 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . 0.587 ' HB2' ' CZ2' ' A' ' 38' ' ' TRP . 2.1 pt20 -142.01 113.26 7.6 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 121.457 0.646 . . . . 0.0 111.69 -170.647 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.546 ' HB2' ' CD2' ' A' ' 69' ' ' LEU . 77.5 mt -110.42 154.23 23.87 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.495 -0.775 . . . . 0.0 109.902 -179.75 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' HIS . . . . . 0.471 ' O ' ' HD2' ' A' ' 16' ' ' PRO . 35.4 t-80 -121.93 126.81 49.47 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-O 121.455 0.645 . . . . 0.0 111.134 -175.254 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' MET . . . . . 0.436 ' HB3' ' HE2' ' A' ' 94' ' ' MET . 28.2 ttp -91.12 -72.62 0.57 Allowed 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 114.801 -1.09 . . . . 0.0 109.923 178.197 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . 0.574 ' HA2' ' O ' ' A' ' 72' ' ' ASP . . . 86.48 -75.26 2.26 Favored Glycine 0 N--CA 1.446 -0.648 0 C-N-CA 120.601 -0.809 . . . . 0.0 114.24 173.863 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -90.42 -34.59 15.57 Favored 'General case' 0 C--N 1.315 -0.928 0 N-CA-C 112.126 0.417 . . . . 0.0 112.126 -174.556 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -92.75 54.91 2.32 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.717 -163.833 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.71 4.94 0.94 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.952 -0.567 . . . . 0.0 112.405 -176.812 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 9.4 t -66.74 -19.44 65.75 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.126 0.489 . . . . 0.0 109.76 174.887 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' PHE . . . . . 0.644 ' CZ ' ' HA ' ' A' ' 10' ' ' ALA . 10.5 t80 -77.28 -23.87 51.09 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.174 177.652 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 93.6 mmm -62.41 -48.12 81.11 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 174.761 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -62.25 -22.49 66.03 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 115.405 -0.816 . . . . 0.0 111.649 176.603 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -70.42 -24.06 62.85 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.697 0.284 . . . . 0.0 111.115 179.544 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' TYR . . . . . 0.585 ' HB2' HD12 ' A' ' 106' ' ' ILE . 47.2 m-85 -106.28 -11.31 16.06 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.802 176.561 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 7.2 mp 67.14 14.59 9.83 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 115.61 -0.723 . . . . 0.0 112.071 179.181 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . 1.039 ' HB ' ' HG3' ' A' ' 111' ' ' ARG . 0.2 OUTLIER -82.84 149.95 4.45 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.428 0 CA-C-O 120.933 0.397 . . . . 0.0 110.804 -179.926 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 5.1 p30 -127.37 -57.65 1.29 Allowed 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.435 -179.289 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -76.38 116.1 4.62 Favored Glycine 0 N--CA 1.447 -0.601 0 C-N-CA 120.966 -0.635 . . . . 0.0 112.587 -179.389 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.454 ' HB ' ' HA ' ' A' ' 110' ' ' PRO . 40.2 pt -102.65 153.62 38.05 Favored Pre-proline 0 C--N 1.326 -0.441 0 N-CA-C 110.43 -0.211 . . . . 0.0 110.43 176.344 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . 0.56 ' HD3' ' HB3' ' A' ' 45' ' ' CYS . 49.5 Cg_endo -71.61 133.94 30.69 Favored 'Cis proline' 0 C--N 1.343 0.288 0 C-N-CA 123.175 -1.594 . . . . 0.0 113.236 1.312 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . 1.039 ' HG3' ' HB ' ' A' ' 106' ' ' ILE . 0.0 OUTLIER -95.22 146.41 24.35 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 173.975 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . 0.549 ' CE1' ' HB2' ' A' ' 128' ' ' ARG . 9.7 m-85 -119.35 119.44 34.0 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 -177.495 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.407 HD11 HG21 ' A' ' 106' ' ' ILE . 91.7 mt -131.13 138.19 53.96 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-O 121.015 0.436 . . . . 0.0 110.975 -177.283 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.72 HD21 HD11 ' A' ' 141' ' ' LEU . 30.6 tp -119.47 133.09 55.86 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.631 -0.713 . . . . 0.0 109.471 177.738 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.421 ' N ' HD12 ' A' ' 115' ' ' LEU . 0.7 OUTLIER -133.74 155.33 49.96 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.206 0.527 . . . . 0.0 110.61 -178.003 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . 0.637 ' HB3' ' HB2' ' A' ' 120' ' ' LYS . 17.6 t70 -71.21 166.82 20.71 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.176 -0.92 . . . . 0.0 110.804 176.76 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . 0.406 ' N ' ' CG ' ' A' ' 116' ' ' ASP . 69.4 mtt85 -51.55 -32.15 27.1 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 124.281 1.033 . . . . 0.0 112.974 -178.09 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . 0.684 ' HB3' ' HD3' ' A' ' 120' ' ' LYS . 25.4 t70 -81.25 4.48 20.24 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-O 121.474 0.654 . . . . 0.0 110.474 179.45 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 81.31 23.11 59.38 Favored Glycine 0 N--CA 1.438 -1.207 0 N-CA-C 110.466 -1.054 . . . . 0.0 110.466 -173.832 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . 0.684 ' HD3' ' HB3' ' A' ' 118' ' ' ASP . 19.8 mmmt -81.27 106.69 13.45 Favored 'General case' 0 CA--C 1.51 -0.566 0 C-N-CA 120.646 -0.422 . . . . 0.0 110.864 -176.028 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . 0.637 ' H ' HD12 ' A' ' 121' ' ' ILE . 3.6 mp -47.05 106.58 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.315 -0.916 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.822 178.189 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 39.3 mm -88.34 -47.21 15.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 115.51 -0.768 . . . . 0.0 109.661 -179.75 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 13.6 m -144.95 114.64 7.26 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.721 178.576 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -74.52 -24.13 58.93 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.621 0.724 . . . . 0.0 109.782 174.774 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . 0.733 ' HA ' ' NH1' ' A' ' 111' ' ' ARG . 53.6 t30 -110.4 85.04 2.03 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.487 -0.779 . . . . 0.0 109.329 175.485 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' MET . . . . . 0.623 ' HG2' ' HB2' ' A' ' 114' ' ' LEU . 3.3 tpt -113.54 -166.91 1.13 Allowed 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 107.813 -1.18 . . . . 0.0 107.813 179.026 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . 0.561 ' O ' HG21 ' A' ' 134' ' ' THR . 2.1 p -132.11 161.53 33.07 Favored 'General case' 0 C--N 1.316 -0.882 0 N-CA-C 109.684 -0.487 . . . . 0.0 109.684 179.864 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . 0.636 ' CG ' ' HD2' ' A' ' 129' ' ' PRO . 19.2 ttt180 -86.76 158.01 54.23 Favored Pre-proline 0 C--N 1.316 -0.887 0 N-CA-C 109.795 -0.446 . . . . 0.0 109.795 179.387 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . 0.636 ' HD2' ' CG ' ' A' ' 128' ' ' ARG . 49.3 Cg_exo -42.81 -23.66 0.35 Allowed 'Trans proline' 0 C--N 1.356 0.945 0 C-N-CA 123.468 2.779 . . . . 0.0 113.908 170.906 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -55.85 -31.91 63.17 Favored 'General case' 0 CA--C 1.529 0.143 0 CA-C-O 121.092 0.472 . . . . 0.0 110.691 175.325 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 11.1 t0 -101.67 127.83 30.4 Favored Pre-proline 0 C--O 1.237 0.439 0 CA-C-N 115.852 -0.613 . . . . 0.0 109.92 179.51 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -58.35 -26.81 78.93 Favored 'Trans proline' 0 C--N 1.347 0.464 0 C-N-CA 123.299 2.666 . . . . 0.0 114.047 -178.385 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 42.3 mttp -56.15 -42.25 76.7 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-O 121.457 0.646 . . . . 0.0 110.842 -177.451 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' THR . . . . . 0.561 HG21 ' O ' ' A' ' 127' ' ' THR . 0.1 OUTLIER -69.14 -43.07 75.08 Favored 'General case' 0 N--CA 1.443 -0.821 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.539 178.883 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . 0.539 ' HA ' ' CD2' ' A' ' 138' ' ' PHE . . . -56.78 -46.92 81.22 Favored 'General case' 0 C--O 1.238 0.478 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.618 179.259 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . 0.647 ' HA ' ' OD1' ' A' ' 139' ' ' ASN . 14.7 pt-20 -71.15 -23.75 62.13 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.621 -179.559 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . 0.634 ' O ' ' HB3' ' A' ' 140' ' ' GLU . 60.9 tttp -79.28 -26.9 42.25 Favored 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 120.422 -0.511 . . . . 0.0 111.023 173.313 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . 0.637 ' HD2' HD11 ' A' ' 55' ' ' LEU . 21.5 m-85 -65.15 -43.2 92.57 Favored 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 120.469 -0.492 . . . . 0.0 110.213 177.138 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' ASN . . . . . 0.647 ' OD1' ' HA ' ' A' ' 136' ' ' GLU . 2.0 p-10 -70.01 -32.18 70.22 Favored 'General case' 0 C--O 1.224 -0.264 0 C-N-CA 120.006 -0.678 . . . . 0.0 110.128 175.099 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . 0.634 ' HB3' ' O ' ' A' ' 137' ' ' LYS . 4.4 tt0 -51.23 -55.13 19.69 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-O 120.823 0.344 . . . . 0.0 110.657 169.371 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.72 HD11 HD21 ' A' ' 114' ' ' LEU . 90.1 mt -58.42 -36.26 73.34 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.533 -178.918 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 0.506 ' HG ' ' O ' ' A' ' 138' ' ' PHE . 86.9 mt . . . . . 0 C--N 1.327 -0.382 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.2 -179.671 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 0.708 0 CA-C-O 121.125 0.488 . . . . 0.0 111.592 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -80.92 73.75 7.93 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.649 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . 0.571 ' HA ' ' HB3' ' A' ' 25' ' ' LEU . 18.1 m 71.79 90.47 0.09 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.151 -0.931 . . . . 0.0 111.103 178.644 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 33.6 p90 -105.69 163.51 12.64 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.509 179.031 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . 0.411 ' HA ' ' HA ' ' A' ' 24' ' ' SER . 11.9 p -137.45 128.27 27.18 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.276 -0.42 . . . . 0.0 109.902 178.053 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . 0.431 ' HA ' ' HD3' ' A' ' 16' ' ' PRO . 36.3 m-85 -140.91 149.63 56.78 Favored Pre-proline 0 C--N 1.326 -0.427 0 CA-C-N 116.532 -0.304 . . . . 0.0 110.248 -177.016 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.684 ' HA ' ' O ' ' A' ' 21' ' ' LYS . 3.8 Cg_exo -75.23 124.91 8.82 Favored 'Trans proline' 0 N--CA 1.453 -0.885 0 C-N-CA 122.201 1.934 . . . . 0.0 112.726 179.677 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . 0.769 ' HB3' ' HB3' ' A' ' 21' ' ' LYS . 0.0 OUTLIER -64.89 162.01 17.2 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.38 -0.827 . . . . 0.0 109.05 170.732 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.633 HG21 HG11 ' A' ' 82' ' ' VAL . 9.6 tp -62.42 -25.95 39.19 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.242 -171.656 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.502 HD22 HG23 ' A' ' 18' ' ' ILE . 0.9 OUTLIER -80.85 4.98 17.4 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.127 177.253 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 78.89 49.54 6.4 Favored Glycine 0 N--CA 1.449 -0.451 0 N-CA-C 110.809 -0.917 . . . . 0.0 110.809 -176.258 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.769 ' HB3' ' HB3' ' A' ' 17' ' ' ASP . 0.0 OUTLIER -114.84 140.85 48.61 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.531 -0.335 . . . . 0.0 110.521 -173.63 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 19.6 m -90.62 99.07 12.17 Favored 'General case' 0 C--N 1.318 -0.762 0 C-N-CA 120.512 -0.475 . . . . 0.0 110.078 178.207 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.415 ' HB ' ' CD2' ' A' ' 92' ' ' LEU . 48.7 t -115.34 137.79 47.78 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 116.069 -0.514 . . . . 0.0 109.735 -179.756 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . 0.411 ' HA ' ' HA ' ' A' ' 14' ' ' SER . 59.7 p -122.55 169.52 10.93 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.964 -175.786 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.8 HD12 HD12 ' A' ' 28' ' ' LEU . 32.5 tp -66.74 -16.1 64.0 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.026 174.87 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.409 ' HA ' ' HD3' ' A' ' 29' ' ' LYS . . . -62.4 -39.74 94.22 Favored 'General case' 0 C--N 1.333 -0.123 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.948 179.75 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -61.16 -33.81 74.02 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-O 121.772 0.796 . . . . 0.0 110.226 174.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.8 HD12 HD12 ' A' ' 25' ' ' LEU . 33.4 mt -79.64 -15.02 58.36 Favored 'General case' 0 N--CA 1.445 -0.688 0 CA-C-N 115.0 -1.0 . . . . 0.0 111.684 -173.008 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.67 ' HA ' ' O ' ' A' ' 117' ' ' ARG . 1.7 mptm? -66.46 160.83 24.11 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.392 0.615 . . . . 0.0 111.881 178.198 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 84.32 -14.83 43.25 Favored Glycine 0 N--CA 1.45 -0.374 0 CA-C-N 115.464 -0.789 . . . . 0.0 112.29 178.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.578 ' HG3' ' CG ' ' A' ' 63' ' ' ASP . 24.5 ttmm -144.15 143.15 30.96 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 109.311 -0.625 . . . . 0.0 109.311 -176.507 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 63.0 m-85 -56.2 155.04 7.11 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-O 120.681 0.277 . . . . 0.0 111.276 -177.689 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.557 HD12 ' HA2' ' A' ' 119' ' ' GLY . 43.3 mt -128.11 135.39 62.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-O 120.74 0.305 . . . . 0.0 111.565 -171.913 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . 0.541 ' HB2' HD11 ' A' ' 64' ' ' ILE . 88.1 t80 -120.04 116.47 25.79 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 173.532 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.538 ' HA ' ' O ' ' A' ' 67' ' ' VAL . 28.9 mm -101.7 132.21 48.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.566 -179.299 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.57 ' HA ' ' O ' ' A' ' 111' ' ' ARG . 1.2 t70 -140.77 162.76 34.65 Favored 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 176.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.555 ' HB ' ' HA ' ' A' ' 110' ' ' PRO . 46.8 t -102.06 131.22 50.5 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.919 0 C-N-CA 120.212 -0.595 . . . . 0.0 111.45 176.736 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' TRP . . . . . 0.685 ' CZ2' ' HB3' ' A' ' 91' ' ' GLN . 0.9 OUTLIER -126.14 132.75 51.78 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-O 120.822 0.344 . . . . 0.0 110.128 179.325 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.54 ' HB3' ' SG ' ' A' ' 42' ' ' CYS . . . -148.68 168.74 22.06 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-N 116.688 -0.233 . . . . 0.0 110.85 178.013 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . 0.599 ' HB ' ' CE3' ' A' ' 78' ' ' TRP . 9.6 t -92.08 -18.68 23.24 Favored 'General case' 0 C--O 1.233 0.235 0 C-N-CA 120.868 -0.333 . . . . 0.0 111.667 179.265 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 1.5 p-90 -90.41 -13.46 34.9 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.788 0.328 . . . . 0.0 111.712 -177.44 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' CYS . . . . . 0.54 ' SG ' ' HB3' ' A' ' 39' ' ' ALA . 5.9 p -88.34 94.99 10.02 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.014 0.435 . . . . 0.0 110.515 177.723 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -54.17 -58.3 13.42 Favored Glycine 0 CA--C 1.524 0.647 0 CA-C-N 115.43 -0.804 . . . . 0.0 113.967 -179.309 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -53.95 -38.41 86.32 Favored 'Trans proline' 0 C--N 1.354 0.83 0 C-N-CA 122.721 2.28 . . . . 0.0 112.68 -178.31 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . 0.809 ' HB2' ' HD3' ' A' ' 110' ' ' PRO . 36.7 t -59.07 -38.54 79.69 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.184 0.516 . . . . 0.0 110.689 178.888 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.518 ' HA ' ' HG ' ' A' ' 49' ' ' LEU . 39.3 mtp180 -70.9 -15.83 62.64 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.911 -176.322 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -77.91 -26.48 60.28 Favored Glycine 0 N--CA 1.445 -0.701 0 C-N-CA 120.754 -0.736 . . . . 0.0 111.769 177.119 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . 0.652 ' HB3' ' HB3' ' A' ' 130' ' ' SER . 14.2 pt-20 -107.03 0.99 24.01 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.841 0.353 . . . . 0.0 111.5 -179.854 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.538 ' N ' ' HD2' ' A' ' 50' ' ' PRO . 68.4 mt -59.94 -45.8 98.16 Favored Pre-proline 0 CA--C 1.537 0.456 0 CA-C-N 116.531 -0.304 . . . . 0.0 111.288 172.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.538 ' HD2' ' N ' ' A' ' 49' ' ' LEU . 11.9 Cg_endo -57.53 -35.16 98.89 Favored 'Trans proline' 0 C--N 1.356 0.965 0 C-N-CA 121.761 1.641 . . . . 0.0 111.913 171.323 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.586 ' HA ' ' HG2' ' A' ' 54' ' ' GLU . . . -67.3 -23.43 65.65 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-O 121.079 0.466 . . . . 0.0 110.806 179.042 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 10.0 tt -69.88 -34.08 73.08 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.944 -0.571 . . . . 0.0 109.554 176.073 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.486 ' HB3' ' O ' ' A' ' 50' ' ' PRO . 11.3 tttm -65.54 -46.71 78.5 Favored 'General case' 0 N--CA 1.425 -1.675 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 172.402 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.586 ' HG2' ' HA ' ' A' ' 51' ' ' ALA . 24.4 mm-40 -52.6 -44.65 66.11 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.05 -0.977 . . . . 0.0 110.001 176.688 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 47.8 mt -57.15 -53.55 56.8 Favored 'General case' 0 N--CA 1.452 -0.375 0 CA-C-N 115.433 -0.803 . . . . 0.0 111.249 175.418 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -48.87 -58.86 4.16 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.204 -0.907 . . . . 0.0 111.848 -179.052 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -71.11 -27.69 63.77 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 111.828 0.306 . . . . 0.0 111.828 -176.49 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 33.5 tttm -66.12 -25.04 66.81 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-O 121.01 0.433 . . . . 0.0 109.911 175.185 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.715 ' HD1' ' HG3' ' A' ' 62' ' ' LYS . 53.1 m-85 -124.26 18.34 9.06 Favored 'General case' 0 N--CA 1.453 -0.284 0 N-CA-C 112.766 0.654 . . . . 0.0 112.766 -176.522 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -62.03 110.23 1.52 Allowed 'General case' 0 C--N 1.323 -0.543 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 169.595 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 113.74 -13.27 22.57 Favored Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 120.802 -0.713 . . . . 0.0 111.758 -175.215 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.777 ' HD2' ' HG ' ' A' ' 142' ' ' LEU . 28.7 mmtp -84.82 -170.38 3.09 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-O 121.416 0.627 . . . . 0.0 110.809 177.418 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . 0.578 ' CG ' ' HG3' ' A' ' 31' ' ' LYS . 16.9 t70 -116.95 82.96 1.89 Allowed 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.417 -179.217 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.541 HD11 ' HB2' ' A' ' 34' ' ' TYR . 17.2 tt -157.97 141.94 7.05 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.535 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.342 177.211 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' HIS . . . . . 0.527 ' NE2' ' HB3' ' A' ' 31' ' ' LYS . 84.5 m-70 -103.52 108.58 19.89 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 109.176 -0.676 . . . . 0.0 109.176 171.258 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 89.6 m-85 -78.78 103.54 8.79 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 172.783 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.701 ' HA ' ' O ' ' A' ' 90' ' ' ILE . 41.2 t -127.79 117.87 47.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-O 120.797 0.332 . . . . 0.0 111.068 -174.501 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . 0.533 ' HA ' ' O ' ' A' ' 36' ' ' ASP . 8.3 m -109.16 147.37 32.61 Favored 'General case' 0 C--N 1.318 -0.768 0 C-N-CA 120.687 -0.405 . . . . 0.0 110.597 178.03 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.56 HD13 ' HB2' ' A' ' 92' ' ' LEU . 3.8 mm? -110.96 132.91 53.81 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.476 178.355 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 27.5 t -112.95 117.33 31.78 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.106 0.479 . . . . 0.0 111.693 -179.118 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 71.7 m -91.81 33.24 1.05 Allowed 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.247 172.791 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.528 ' OD2' HG22 ' A' ' 40' ' ' THR . 0.4 OUTLIER -75.62 126.41 30.95 Favored 'General case' 0 CA--C 1.512 -0.514 0 C-N-CA 120.155 -0.618 . . . . 0.0 110.446 178.07 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.597 ' H ' ' HE3' ' A' ' 73' ' ' LYS . 0.0 OUTLIER -78.13 -14.56 59.43 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.224 -178.887 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . 0.603 ' HB2' ' HB3' ' A' ' 77' ' ' ALA . 0.6 OUTLIER -101.19 68.95 1.26 Allowed 'General case' 0 CA--C 1.512 -0.51 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 179.283 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.613 ' O ' ' HG3' ' A' ' 79' ' ' GLU . 11.8 tmtt? -54.66 -53.13 58.8 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.616 -173.779 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.451 ' HA ' ' CD ' ' A' ' 79' ' ' GLU . 18.2 tptp -52.87 -53.74 44.66 Favored 'General case' 0 C--N 1.327 -0.376 0 O-C-N 123.321 0.388 . . . . 0.0 110.847 179.018 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.603 ' HB3' ' HB2' ' A' ' 74' ' ' ASN . . . -56.53 -36.67 69.49 Favored 'General case' 0 C--O 1.24 0.565 0 CA-C-O 121.517 0.675 . . . . 0.0 110.505 179.358 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' TRP . . . . . 0.659 ' HZ2' ' CE3' ' A' ' 38' ' ' TRP . 8.0 t-105 -68.64 -34.21 75.35 Favored 'General case' 0 N--CA 1.435 -1.216 0 CA-C-N 114.807 -1.088 . . . . 0.0 110.606 -178.02 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.613 ' HG3' ' O ' ' A' ' 75' ' ' LYS . 52.7 mt-10 -53.66 -51.35 63.46 Favored 'General case' 0 CA--C 1.515 -0.39 0 CA-C-O 121.482 0.658 . . . . 0.0 110.822 173.766 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . 0.596 ' ND2' ' HA ' ' A' ' 77' ' ' ALA . 0.7 OUTLIER -66.23 -33.57 76.06 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.253 -0.885 . . . . 0.0 111.188 -173.282 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 1.4 tmt? -63.87 -59.12 4.92 Favored 'General case' 0 CA--C 1.517 -0.314 0 C-N-CA 120.849 -0.34 . . . . 0.0 111.306 177.731 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.633 HG11 HG21 ' A' ' 18' ' ' ILE . 5.7 p -58.52 -28.65 36.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-O 121.066 0.46 . . . . 0.0 110.873 -176.27 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 27.8 m -76.23 -40.43 52.12 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.927 -0.578 . . . . 0.0 110.954 176.902 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . 0.508 ' C ' ' HE2' ' A' ' 84' ' ' LYS . 0.0 OUTLIER -73.69 -49.0 27.92 Favored 'General case' 0 N--CA 1.456 -0.16 0 CA-C-O 121.338 0.589 . . . . 0.0 109.656 -178.096 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -76.27 0.49 19.09 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.129 -0.941 . . . . 0.0 111.211 -173.427 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 27.5 mt-30 61.41 34.21 18.34 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-N 115.79 -0.641 . . . . 0.0 112.575 168.853 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.596 ' HB2' HG23 ' A' ' 82' ' ' VAL . 72.0 mt -67.34 151.44 47.46 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.193 0.521 . . . . 0.0 111.548 -176.662 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 22.0 mmtm -117.75 -168.03 1.43 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.562 176.482 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 82.65 170.58 45.76 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 121.151 -0.547 . . . . 0.0 112.743 -177.719 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.701 ' O ' ' HA ' ' A' ' 67' ' ' VAL . 62.9 mt -85.64 112.11 21.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 N-CA-C 108.509 -0.922 . . . . 0.0 108.509 175.064 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . 0.685 ' HB3' ' CZ2' ' A' ' 38' ' ' TRP . 11.6 mm-40 -119.28 109.95 16.43 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-O 121.139 0.495 . . . . 0.0 111.181 -169.452 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.56 ' HB2' HD13 ' A' ' 69' ' ' LEU . 61.2 mt -106.55 149.46 27.12 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.465 0.65 . . . . 0.0 110.725 -177.64 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' HIS . . . . . 0.612 ' CE1' ' HA2' ' A' ' 95' ' ' GLY . 17.2 t-80 -119.95 111.59 18.11 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.662 -177.011 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 1.4 ttp -61.95 -49.64 75.3 Favored 'General case' 0 N--CA 1.448 -0.574 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.442 179.102 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . 0.612 ' HA2' ' CE1' ' A' ' 93' ' ' HIS . . . 118.68 -109.59 1.77 Allowed Glycine 0 N--CA 1.44 -1.076 0 CA-C-N 115.335 -0.848 . . . . 0.0 111.212 -177.997 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 1.7 m -126.94 24.17 6.48 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-O 120.731 0.3 . . . . 0.0 110.591 -179.255 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -87.32 142.65 27.73 Favored 'General case' 0 C--O 1.236 0.375 0 C-N-CA 119.656 -0.818 . . . . 0.0 111.276 -176.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . 0.807 ' HA ' ' HB2' ' A' ' 101' ' ' MET . 8.0 tpt180 -127.34 -3.42 6.19 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.039 -0.982 . . . . 0.0 110.163 178.057 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 1.5 m -66.49 -41.17 89.34 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 176.207 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' PHE . . . . . 0.403 ' CZ ' ' HE2' ' A' ' 104' ' ' TYR . 6.1 t80 -83.11 -24.34 32.66 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.433 -0.803 . . . . 0.0 109.707 176.298 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' MET . . . . . 0.807 ' HB2' ' HA ' ' A' ' 98' ' ' ARG . 0.0 OUTLIER -64.39 -55.49 20.69 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.432 -0.803 . . . . 0.0 109.078 178.125 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . 0.493 ' CG ' ' HE ' ' A' ' 98' ' ' ARG . 7.8 m-20 -65.02 -25.3 67.79 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.907 174.826 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -59.97 -32.24 70.64 Favored 'General case' 0 N--CA 1.466 0.33 0 N-CA-C 112.02 0.378 . . . . 0.0 112.02 -176.399 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' TYR . . . . . 0.403 ' HE2' ' CZ ' ' A' ' 100' ' ' PHE . 23.4 m-85 -101.04 8.55 42.89 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.619 0.247 . . . . 0.0 111.386 179.299 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 3.5 mm? 61.18 21.03 11.52 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.211 -179.831 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . 0.603 HG12 ' O ' ' A' ' 101' ' ' MET . 15.3 pt -79.98 150.55 4.91 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 176.013 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . 0.481 ' ND2' HH22 ' A' ' 98' ' ' ARG . 12.1 t-20 -160.82 -64.34 0.06 Allowed 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 -179.798 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -77.28 78.8 1.4 Allowed Glycine 0 N--CA 1.449 -0.498 0 N-CA-C 111.061 -0.815 . . . . 0.0 111.061 174.359 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.587 ' HB ' ' HA ' ' A' ' 110' ' ' PRO . 2.8 pp -75.68 161.1 77.48 Favored Pre-proline 0 C--N 1.323 -0.572 0 CA-C-N 115.719 -0.241 . . . . 0.0 111.546 -175.366 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . 0.809 ' HD3' ' HB2' ' A' ' 45' ' ' CYS . 40.1 Cg_endo -68.72 164.21 76.73 Favored 'Cis proline' 0 C--N 1.35 0.633 0 C-N-CA 124.029 -1.238 . . . . 0.0 113.504 0.983 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . 0.578 HH11 HG22 ' A' ' 106' ' ' ILE . 0.0 OUTLIER -129.54 137.59 50.85 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.728 -0.669 . . . . 0.0 109.43 179.314 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . 0.434 ' H ' ' HD3' ' A' ' 111' ' ' ARG . 0.2 OUTLIER -105.55 115.47 30.3 Favored 'General case' 0 C--N 1.323 -0.583 0 O-C-N 124.712 1.257 . . . . 0.0 111.413 -172.157 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.511 ' HB ' ' HB ' ' A' ' 35' ' ' ILE . 79.3 mt -131.16 146.15 34.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 120.936 0.398 . . . . 0.0 110.903 -178.956 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 42.0 tp -128.89 135.6 49.28 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.148 178.382 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.489 ' N ' HD12 ' A' ' 115' ' ' LEU . 1.3 mp -135.51 161.13 36.34 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.368 0.604 . . . . 0.0 110.892 -178.216 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . 0.867 ' HB3' ' HB2' ' A' ' 120' ' ' LYS . 17.8 t70 -74.22 165.35 25.31 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 114.874 -1.057 . . . . 0.0 110.443 175.728 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . 0.67 ' O ' ' HA ' ' A' ' 29' ' ' LYS . 53.8 mtt-85 -46.71 -39.35 11.35 Favored 'General case' 0 C--N 1.33 -0.271 0 O-C-N 124.308 1.005 . . . . 0.0 112.423 -178.562 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . 0.621 ' HA ' ' HG3' ' A' ' 29' ' ' LYS . 14.6 t0 -83.92 16.77 2.65 Favored 'General case' 0 C--O 1.237 0.423 0 CA-C-O 121.154 0.502 . . . . 0.0 111.253 -177.623 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . 0.557 ' HA2' HD12 ' A' ' 33' ' ' ILE . . . 72.85 25.26 74.32 Favored Glycine 0 N--CA 1.435 -1.416 0 C-N-CA 120.417 -0.897 . . . . 0.0 110.869 -175.712 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . 0.867 ' HB2' ' HB3' ' A' ' 116' ' ' ASP . 40.3 mmtm -85.7 104.17 15.17 Favored 'General case' 0 C--O 1.22 -0.462 0 C-N-CA 120.378 -0.529 . . . . 0.0 111.458 -179.196 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . 0.647 ' H ' HD12 ' A' ' 121' ' ' ILE . 3.8 mp -44.81 113.22 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.678 -179.053 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' ILE . . . . . 0.42 ' H ' ' HA ' ' A' ' 115' ' ' LEU . 46.0 mm -95.75 -44.25 12.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.664 -0.698 . . . . 0.0 109.597 177.855 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 14.6 m -142.29 114.82 8.48 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.485 -0.78 . . . . 0.0 110.086 177.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . 0.407 ' HA ' HG23 ' A' ' 113' ' ' ILE . . . -78.06 -6.9 56.05 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.043 0.449 . . . . 0.0 110.832 179.276 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 5.9 t30 -150.81 100.59 2.83 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.83 -0.623 . . . . 0.0 109.416 179.456 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' MET . . . . . 0.633 ' HG2' HG23 ' A' ' 134' ' ' THR . 43.9 tpp -89.67 -91.04 0.14 Allowed 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 111.935 0.346 . . . . 0.0 111.935 -176.76 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . 0.527 ' O ' ' HG2' ' A' ' 128' ' ' ARG . 0.0 OUTLIER -152.67 -70.21 0.15 Allowed 'General case' 0 CA--C 1.531 0.235 0 N-CA-C 112.322 0.49 . . . . 0.0 112.322 -178.326 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . 0.527 ' HG2' ' O ' ' A' ' 127' ' ' THR . 3.5 mmt180 175.99 140.13 0.21 Allowed Pre-proline 0 N--CA 1.467 0.393 0 C-N-CA 124.351 1.06 . . . . 0.0 109.299 -173.474 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . 0.422 ' HG3' ' OD2' ' A' ' 36' ' ' ASP . 46.0 Cg_exo -56.44 -37.33 97.38 Favored 'Trans proline' 0 C--N 1.342 0.23 0 C-N-CA 122.339 2.026 . . . . 0.0 111.874 171.522 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . 0.652 ' HB3' ' HB3' ' A' ' 48' ' ' GLU . 13.3 p -78.06 -25.67 47.83 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.821 179.663 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . 0.501 ' OD2' ' HB2' ' A' ' 133' ' ' LYS . 29.7 t70 -78.49 117.6 67.31 Favored Pre-proline 0 C--N 1.327 -0.406 0 CA-C-O 120.832 0.348 . . . . 0.0 110.724 -175.336 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . 0.585 ' O ' ' HG2' ' A' ' 136' ' ' GLU . 49.6 Cg_exo -56.6 -29.49 79.47 Favored 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 123.469 2.78 . . . . 0.0 113.73 -175.233 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . 0.763 ' H ' ' HD3' ' A' ' 133' ' ' LYS . 0.0 OUTLIER -54.48 -35.36 62.99 Favored 'General case' 0 N--CA 1.456 -0.152 0 CA-C-O 120.578 0.227 . . . . 0.0 110.688 -177.824 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' THR . . . . . 0.633 HG23 ' HG2' ' A' ' 126' ' ' MET . 4.6 m -60.69 -48.81 80.13 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.482 0.658 . . . . 0.0 110.666 178.399 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . 0.626 ' HA ' ' CD2' ' A' ' 138' ' ' PHE . . . -61.78 -43.36 99.0 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.315 -0.857 . . . . 0.0 111.106 -178.228 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . 0.585 ' HG2' ' O ' ' A' ' 132' ' ' PRO . 10.8 mm-40 -72.05 -23.97 61.45 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.546 -177.279 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . 0.718 ' HG2' ' O ' ' A' ' 133' ' ' LYS . 17.8 mmtm -56.07 -49.77 72.85 Favored 'General case' 0 CA--C 1.515 -0.369 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 167.901 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . 0.626 ' CD2' ' HA ' ' A' ' 135' ' ' ALA . 7.0 m-30 -55.26 -36.91 66.58 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-N 115.163 -0.926 . . . . 0.0 110.57 -178.746 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' ASN . . . . . 0.558 ' ND2' ' HA ' ' A' ' 136' ' ' GLU . 72.8 m-20 -58.13 -56.41 22.38 Favored 'General case' 0 C--N 1.332 -0.179 0 C-N-CA 120.686 -0.406 . . . . 0.0 110.693 175.839 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -44.73 -59.91 2.28 Favored 'General case' 0 C--N 1.342 0.258 0 O-C-N 123.615 0.572 . . . . 0.0 111.675 178.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.434 HD13 ' O ' ' A' ' 137' ' ' LYS . 8.5 mp -50.69 -37.8 43.33 Favored 'General case' 0 CA--C 1.531 0.226 0 N-CA-C 112.595 0.591 . . . . 0.0 112.595 178.86 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 0.777 ' HG ' ' HD2' ' A' ' 62' ' ' LYS . 3.8 mm? . . . . . 0 C--N 1.327 -0.401 0 CA-C-O 120.623 0.249 . . . . 0.0 111.623 179.264 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.455 -0.181 0 CA-C-O 121.136 0.493 . . . . 0.0 110.489 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -156.2 -43.44 0.08 Allowed 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.291 -0.868 . . . . 0.0 110.768 -179.35 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 23.5 p -149.91 33.49 0.68 Allowed 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 115.165 -0.925 . . . . 0.0 110.628 -178.256 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . 0.426 ' CE2' HD22 ' A' ' 25' ' ' LEU . 27.5 p90 -63.18 150.11 43.73 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.252 -177.278 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . 0.42 ' HA ' ' HA ' ' A' ' 24' ' ' SER . 15.9 m -137.06 127.53 26.7 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 178.047 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . 0.42 ' CE2' ' HB2' ' A' ' 13' ' ' PHE . 77.6 m-85 -138.34 156.93 73.34 Favored Pre-proline 0 C--N 1.326 -0.436 0 CA-C-O 120.752 0.311 . . . . 0.0 111.356 -175.399 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.481 ' HD2' ' O ' ' A' ' 93' ' ' HIS . 1.6 Cg_endo -83.53 126.77 4.2 Favored 'Trans proline' 0 N--CA 1.459 -0.556 0 C-N-CA 123.183 2.588 . . . . 0.0 113.85 -178.488 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . 1.028 ' HB3' ' HB3' ' A' ' 21' ' ' LYS . 0.4 OUTLIER -65.08 166.14 9.99 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 114.88 -1.055 . . . . 0.0 109.584 169.47 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.579 ' HB ' ' HB2' ' A' ' 79' ' ' GLU . 40.0 pt -48.74 -33.36 5.01 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 C-N-CA 123.561 0.744 . . . . 0.0 112.803 -175.169 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 36.8 m-80 -83.7 -3.1 57.5 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.776 0.322 . . . . 0.0 111.599 -177.48 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 89.83 29.25 16.19 Favored Glycine 0 N--CA 1.45 -0.377 0 N-CA-C 110.212 -1.155 . . . . 0.0 110.212 -171.21 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 1.028 ' HB3' ' HB3' ' A' ' 17' ' ' ASP . 19.1 ttmt -92.23 111.74 23.42 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 114.872 -0.664 . . . . 0.0 110.639 -172.921 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 20.3 m -70.58 112.54 6.91 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 120.796 0.331 . . . . 0.0 111.376 -177.755 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.588 ' HB ' HD21 ' A' ' 92' ' ' LEU . 59.9 t -124.3 145.57 31.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 177.107 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . 0.42 ' HA ' ' HA ' ' A' ' 14' ' ' SER . 94.5 p -122.01 -175.46 3.12 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.084 0.468 . . . . 0.0 110.904 -175.784 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.471 ' O ' ' HB2' ' A' ' 29' ' ' LYS . 30.8 tp -93.68 -0.32 56.11 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.072 175.479 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.436 ' O ' ' HB3' ' A' ' 29' ' ' LYS . . . -88.94 -35.41 16.48 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.004 -179.196 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 3.9 p30 -78.18 -22.87 47.99 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.448 0.642 . . . . 0.0 110.062 176.7 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.426 HD13 HG21 ' A' ' 67' ' ' VAL . 85.7 mt -89.66 -8.79 51.69 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.105 175.311 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.471 ' HB2' ' O ' ' A' ' 25' ' ' LEU . 48.3 tttp -76.45 140.29 41.21 Favored 'General case' 0 N--CA 1.446 -0.654 0 CA-C-N 115.48 -0.782 . . . . 0.0 111.177 -176.254 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 110.54 2.32 29.16 Favored Glycine 0 N--CA 1.449 -0.481 0 N-CA-C 111.382 -0.687 . . . . 0.0 111.382 -177.153 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.597 ' HG3' ' CG ' ' A' ' 63' ' ' ASP . 24.6 ttmm -152.43 149.91 29.08 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 109.076 -0.712 . . . . 0.0 109.076 -179.758 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.449 ' HB2' ' O ' ' A' ' 63' ' ' ASP . 39.3 m-85 -49.11 144.92 4.53 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-O 121.044 0.45 . . . . 0.0 111.889 -177.307 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.511 ' HB ' ' HB2' ' A' ' 115' ' ' LEU . 35.3 mm -121.53 122.69 67.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.985 -177.234 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 78.6 t80 -116.96 112.01 20.4 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 108.782 -0.822 . . . . 0.0 108.782 171.701 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.716 ' HB ' ' CG2' ' A' ' 113' ' ' ILE . 78.8 mt -105.35 129.4 58.24 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 C-N-CA 120.563 -0.455 . . . . 0.0 110.446 -177.023 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.504 ' HA ' ' O ' ' A' ' 111' ' ' ARG . 1.8 t70 -123.34 159.72 28.26 Favored 'General case' 0 C--N 1.314 -0.938 0 N-CA-C 108.798 -0.815 . . . . 0.0 108.798 178.06 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.532 HG11 HG21 ' A' ' 109' ' ' ILE . 58.9 t -104.59 112.79 39.6 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.953 0 C-N-CA 120.258 -0.577 . . . . 0.0 110.49 176.24 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' TRP . . . . . 0.597 ' CZ2' ' HB3' ' A' ' 91' ' ' GLN . 0.6 OUTLIER -101.98 132.64 47.7 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.235 -176.055 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.427 ' HA ' ' OD1' ' A' ' 72' ' ' ASP . . . -147.05 156.25 42.87 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.885 -178.21 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . 0.717 ' HB ' ' CE3' ' A' ' 78' ' ' TRP . 14.6 t -99.14 -23.46 15.23 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 120.898 -0.321 . . . . 0.0 110.808 175.418 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 8.8 p-90 -84.08 -8.0 59.23 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.076 0.465 . . . . 0.0 110.831 -179.94 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 42.5 t -91.99 105.29 17.57 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 175.713 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.406 ' N ' ' HD2' ' A' ' 44' ' ' PRO . . . -54.74 -61.68 7.05 Favored Glycine 0 CA--C 1.524 0.641 0 CA-C-N 115.712 -0.676 . . . . 0.0 113.837 -178.424 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.406 ' HD2' ' N ' ' A' ' 43' ' ' GLY . 12.3 Cg_endo -55.76 -34.33 90.66 Favored 'Trans proline' 0 C--N 1.352 0.755 0 C-N-CA 122.901 2.401 . . . . 0.0 112.66 -177.415 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . 0.706 ' O ' ' HG ' ' A' ' 49' ' ' LEU . 49.6 t -53.08 -39.75 63.57 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.178 179.481 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.678 HH12 ' HH2' ' A' ' 78' ' ' TRP . 20.1 mmm180 -65.92 -20.76 66.33 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.585 -174.409 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -80.56 -40.18 13.26 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.84 -0.695 . . . . 0.0 113.383 -174.126 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -95.72 -6.36 39.98 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 117.077 0.438 . . . . 0.0 111.604 -174.424 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.706 ' HG ' ' O ' ' A' ' 45' ' ' CYS . 39.7 mt -56.96 -47.42 99.12 Favored Pre-proline 0 C--N 1.327 -0.376 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.926 175.868 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.518 ' O ' ' HG2' ' A' ' 54' ' ' GLU . 75.4 Cg_exo -51.6 -40.39 64.14 Favored 'Trans proline' 0 C--N 1.358 1.051 0 C-N-CA 121.972 1.781 . . . . 0.0 112.113 173.906 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -69.86 -27.45 64.85 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.431 0.634 . . . . 0.0 110.695 -178.418 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.592 HD22 ' HE3' ' A' ' 88' ' ' LYS . 3.6 tt -73.36 -33.2 64.94 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.506 -0.77 . . . . 0.0 109.214 176.247 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.87 ' HE2' HD23 ' A' ' 87' ' ' LEU . 85.0 mttt -64.61 -50.37 67.44 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 108.933 -0.765 . . . . 0.0 108.933 174.905 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.518 ' HG2' ' O ' ' A' ' 50' ' ' PRO . 33.1 mm-40 -51.82 -41.75 62.0 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-N 114.822 -1.081 . . . . 0.0 110.836 175.797 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.594 HD21 ' CE2' ' A' ' 138' ' ' PHE . 17.6 tp -61.29 -44.41 97.26 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.05 -0.977 . . . . 0.0 111.057 -178.624 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.569 ' OE1' ' HB2' ' A' ' 88' ' ' LYS . 24.4 tt0 -65.17 -36.53 84.5 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-N 116.61 -0.268 . . . . 0.0 111.306 -178.192 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 17.2 mm-40 -54.07 -54.41 39.83 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.579 0.704 . . . . 0.0 109.832 173.851 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . 0.491 ' HE3' ' CZ ' ' A' ' 59' ' ' TYR . 32.6 tttp -53.81 -33.88 57.47 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 114.58 -1.191 . . . . 0.0 112.333 177.334 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.491 ' CZ ' ' HE3' ' A' ' 58' ' ' LYS . 84.9 m-85 -111.16 16.95 20.78 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 112.335 0.494 . . . . 0.0 112.335 -175.88 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -64.1 131.68 48.22 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.868 0.366 . . . . 0.0 110.64 176.552 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 68.68 44.7 69.53 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.922 -0.656 . . . . 0.0 112.176 -179.506 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 40.2 mmtm -128.51 -154.11 0.61 Allowed 'General case' 0 N--CA 1.45 -0.432 0 CA-C-O 120.981 0.419 . . . . 0.0 109.981 177.2 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . 0.597 ' CG ' ' HG3' ' A' ' 31' ' ' LYS . 10.4 t70 -111.77 69.46 0.69 Allowed 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 116.182 -0.463 . . . . 0.0 109.799 177.022 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.569 HG13 ' O ' ' A' ' 63' ' ' ASP . 15.1 mt -151.89 139.32 13.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.274 178.437 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' HIS . . . . . 0.509 ' NE2' ' HB3' ' A' ' 31' ' ' LYS . 92.0 m-70 -114.92 111.3 20.96 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.49 -0.777 . . . . 0.0 109.949 173.406 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . 0.506 ' HE1' HD23 ' A' ' 55' ' ' LEU . 89.4 m-85 -81.9 103.66 11.71 Favored 'General case' 0 C--N 1.318 -0.782 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 171.179 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.626 ' HA ' ' O ' ' A' ' 90' ' ' ILE . 41.9 t -116.28 122.12 69.03 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.436 -176.242 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . 0.76 ' HB2' ' HG2' ' A' ' 91' ' ' GLN . 50.7 m -110.54 134.94 51.93 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 116.544 -0.298 . . . . 0.0 110.932 -178.707 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.485 HD13 ' HB2' ' A' ' 92' ' ' LEU . 4.5 mm? -115.75 139.45 50.14 Favored 'General case' 0 N--CA 1.471 0.598 0 N-CA-C 110.081 -0.34 . . . . 0.0 110.081 175.6 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 3.5 t -118.11 124.87 49.08 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 112.926 0.713 . . . . 0.0 112.926 -172.882 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 10.6 m -87.1 13.07 10.03 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.876 174.217 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.59 ' O ' ' HA2' ' A' ' 95' ' ' GLY . 1.0 OUTLIER -71.45 136.31 47.58 Favored 'General case' 0 CA--C 1.516 -0.331 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 -178.476 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.468 ' H ' ' HG2' ' A' ' 73' ' ' LYS . 0.4 OUTLIER -99.98 -18.84 16.85 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-O 121.481 0.657 . . . . 0.0 110.034 178.92 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . 0.65 ' HB2' ' HB3' ' A' ' 77' ' ' ALA . 0.8 OUTLIER -80.8 61.05 4.3 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.026 -0.988 . . . . 0.0 109.785 174.369 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 9.5 tttt -50.67 -53.79 28.31 Favored 'General case' 0 C--O 1.222 -0.35 0 N-CA-C 112.647 0.61 . . . . 0.0 112.647 -171.177 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.506 ' HA ' ' OE1' ' A' ' 79' ' ' GLU . 40.3 tptt -61.7 -42.3 98.74 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.842 0.353 . . . . 0.0 110.989 -177.149 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.65 ' HB3' ' HB2' ' A' ' 74' ' ' ASN . . . -63.84 -33.76 76.4 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 121.746 0.784 . . . . 0.0 110.119 176.927 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' TRP . . . . . 0.717 ' CE3' ' HB ' ' A' ' 40' ' ' THR . 9.7 t-105 -76.72 -50.21 14.17 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 114.797 -1.092 . . . . 0.0 111.555 -177.463 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.579 ' HB2' ' HB ' ' A' ' 18' ' ' ILE . 4.1 pt-20 -60.38 -34.44 73.9 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-O 121.198 0.523 . . . . 0.0 110.357 -176.255 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . 0.63 ' O ' ' HD3' ' A' ' 84' ' ' LYS . 3.4 p30 -79.42 -29.97 42.15 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 119.67 -0.812 . . . . 0.0 110.668 177.622 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 13.6 tpt -61.4 -47.56 85.26 Favored 'General case' 0 C--O 1.225 -0.235 0 O-C-N 122.437 -0.164 . . . . 0.0 111.175 175.374 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.696 HG23 ' HB2' ' A' ' 87' ' ' LEU . 0.2 OUTLIER -61.1 -36.15 70.55 Favored 'Isoleucine or valine' 0 C--O 1.232 0.164 0 C-N-CA 120.386 -0.526 . . . . 0.0 110.17 175.602 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 76.3 m -61.51 -41.93 98.04 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.289 174.863 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . 0.63 ' HD3' ' O ' ' A' ' 80' ' ' ASN . 1.9 mptm? -72.9 -46.92 50.08 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-O 121.092 0.472 . . . . 0.0 110.912 179.684 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -66.03 -25.81 67.23 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.287 -0.869 . . . . 0.0 111.01 -176.477 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 29.2 mm-40 64.59 72.8 0.44 Allowed 'General case' 0 C--O 1.234 0.287 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.561 -175.843 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.87 HD23 ' HE2' ' A' ' 53' ' ' LYS . 89.8 mt -92.99 -179.46 5.11 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.05 177.007 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.592 ' HE3' HD22 ' A' ' 52' ' ' LEU . 0.0 OUTLIER -145.74 173.62 11.93 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 112.534 0.568 . . . . 0.0 112.534 -171.424 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 78.4 -170.71 54.95 Favored Glycine 0 N--CA 1.452 -0.24 0 CA-C-N 115.593 -0.731 . . . . 0.0 112.856 178.883 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.626 ' O ' ' HA ' ' A' ' 67' ' ' VAL . 5.0 mp -89.66 112.1 24.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 177.219 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . 0.76 ' HG2' ' HB2' ' A' ' 68' ' ' SER . 21.8 mt-30 -123.11 111.02 16.03 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-O 121.475 0.655 . . . . 0.0 111.061 -174.561 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.588 HD21 ' HB ' ' A' ' 23' ' ' VAL . 55.2 mt -105.98 164.36 12.02 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 114.979 -1.009 . . . . 0.0 109.668 -178.238 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' HIS . . . . . 0.481 ' O ' ' HD2' ' A' ' 16' ' ' PRO . 17.7 t-80 -131.46 124.67 30.67 Favored 'General case' 0 C--N 1.313 -1.015 0 CA-C-O 120.936 0.398 . . . . 0.0 111.357 -171.577 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 24.0 ttp -79.94 -58.02 3.37 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.241 179.39 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . 0.59 ' HA2' ' O ' ' A' ' 72' ' ' ASP . . . 101.34 -93.88 1.18 Allowed Glycine 0 N--CA 1.444 -0.789 0 C-N-CA 120.304 -0.951 . . . . 0.0 113.549 174.212 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 4.6 p -109.09 8.63 26.17 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 112.84 0.682 . . . . 0.0 112.84 -172.067 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -102.21 153.11 20.27 Favored 'General case' 0 CA--C 1.517 -0.309 0 C-N-CA 119.811 -0.756 . . . . 0.0 109.962 177.269 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.14 6.93 3.37 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.965 -0.561 . . . . 0.0 109.608 173.462 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 6.9 m -76.54 -32.7 58.39 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.044 -176.038 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 59.5 t80 -74.6 -37.49 62.85 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.546 -0.752 . . . . 0.0 111.014 178.938 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 5.2 ppp? -77.4 -26.17 51.52 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 176.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -68.05 -29.92 69.01 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.427 -0.806 . . . . 0.0 109.965 172.876 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -63.25 -18.61 63.74 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-N 115.991 -0.549 . . . . 0.0 111.37 179.181 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 72.3 m-85 -97.36 -5.43 36.43 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-O 120.837 0.351 . . . . 0.0 110.078 178.511 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 87.1 mt 60.19 17.04 6.55 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 115.35 -0.841 . . . . 0.0 111.345 179.349 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 11.1 tp -73.7 -45.15 51.29 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.35 0 N-CA-C 112.566 0.58 . . . . 0.0 112.566 -172.573 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 9.0 t30 67.66 -62.64 0.33 Allowed 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 123.158 0.583 . . . . 0.0 111.613 -176.909 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -91.77 111.05 3.95 Favored Glycine 0 N--CA 1.447 -0.579 0 C-N-CA 121.183 -0.532 . . . . 0.0 112.575 -176.537 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.532 HG21 HG11 ' A' ' 37' ' ' VAL . 43.2 pt -85.1 158.28 58.63 Favored Pre-proline 0 C--N 1.322 -0.595 0 N-CA-C 110.434 -0.21 . . . . 0.0 110.434 176.81 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . 0.531 ' HA ' ' HB ' ' A' ' 109' ' ' ILE . 3.0 Cg_exo -74.31 158.69 98.61 Favored 'Cis proline' 0 C--N 1.348 0.53 0 C-N-CA 124.132 -1.195 . . . . 0.0 113.426 1.473 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . 0.707 ' HD2' ' N ' ' A' ' 112' ' ' PHE . 0.1 OUTLIER -113.32 140.41 48.04 Favored 'General case' 0 N--CA 1.442 -0.874 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 175.979 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . 0.707 ' N ' ' HD2' ' A' ' 111' ' ' ARG . 4.2 m-85 -115.44 132.41 56.63 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 108.609 -0.885 . . . . 0.0 108.609 -177.953 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.716 ' CG2' ' HB ' ' A' ' 35' ' ' ILE . 7.5 tt -147.53 156.77 9.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 118.492 0.587 . . . . 0.0 111.278 -177.846 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 35.3 tp -136.29 132.56 35.89 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.837 0.351 . . . . 0.0 110.495 177.754 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.562 ' HG ' ' HA ' ' A' ' 121' ' ' ILE . 2.5 mp -130.97 151.54 51.26 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 178.979 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . 0.432 ' N ' HG13 ' A' ' 122' ' ' ILE . 9.7 t70 -73.1 164.56 26.51 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.965 -0.561 . . . . 0.0 109.792 179.044 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . 0.525 ' HG2' ' HA ' ' A' ' 31' ' ' LYS . 3.9 mtm180 -47.32 -33.96 6.27 Favored 'General case' 0 C--N 1.323 -0.554 0 O-C-N 124.519 1.137 . . . . 0.0 112.271 -179.645 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -71.24 -6.03 36.58 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.215 -177.883 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 84.69 22.61 52.95 Favored Glycine 0 N--CA 1.441 -1.027 0 N-CA-C 110.006 -1.238 . . . . 0.0 110.006 -172.542 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . 0.401 ' HA ' ' HD3' ' A' ' 120' ' ' LYS . 30.4 mmtp -102.75 111.13 23.31 Favored 'General case' 0 CA--C 1.518 -0.287 0 CA-C-N 115.521 -0.339 . . . . 0.0 111.267 -174.107 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . 0.637 ' H ' HD12 ' A' ' 121' ' ' ILE . 3.8 mp -41.4 115.08 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 O-C-N 124.196 0.935 . . . . 0.0 111.817 179.883 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' ILE . . . . . 0.489 ' H ' ' HA ' ' A' ' 115' ' ' LEU . 63.8 mt -83.72 -41.5 16.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 175.92 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 49.4 m -146.55 125.36 12.66 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 114.843 -1.072 . . . . 0.0 109.164 176.091 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -61.34 -31.56 71.43 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-O 121.046 0.45 . . . . 0.0 111.584 -176.189 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 10.9 t30 -138.35 113.83 9.61 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.917 -0.583 . . . . 0.0 109.468 174.554 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' MET . . . . . 0.463 ' HG3' ' H ' ' A' ' 127' ' ' THR . 7.7 tpt -93.91 -148.03 0.26 Allowed 'General case' 0 C--N 1.317 -0.833 0 N-CA-C 108.917 -0.771 . . . . 0.0 108.917 -179.401 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . 0.463 ' H ' ' HG3' ' A' ' 126' ' ' MET . 1.1 p -135.94 143.09 44.72 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-O 120.707 0.289 . . . . 0.0 110.928 -177.497 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . 0.441 ' HA ' ' CD1' ' A' ' 112' ' ' PHE . 9.2 ptp180 -40.65 154.49 0.21 Allowed Pre-proline 0 C--N 1.327 -0.408 0 N-CA-C 113.536 0.939 . . . . 0.0 113.536 176.353 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_exo -54.81 -34.02 83.45 Favored 'Trans proline' 0 C--N 1.348 0.505 0 C-N-CA 123.503 2.802 . . . . 0.0 113.135 178.178 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 16.3 m -76.16 -1.86 28.29 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.655 -178.254 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . 0.455 ' HA ' ' HD3' ' A' ' 132' ' ' PRO . 9.8 t70 -90.3 124.82 61.99 Favored Pre-proline 0 C--N 1.324 -0.511 0 N-CA-C 109.974 -0.38 . . . . 0.0 109.974 178.757 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . 0.455 ' HD3' ' HA ' ' A' ' 131' ' ' ASP . 43.5 Cg_exo -58.77 -35.71 98.2 Favored 'Trans proline' 0 C--N 1.344 0.325 0 C-N-CA 123.173 2.582 . . . . 0.0 113.414 -177.827 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . 0.668 ' HZ2' ' HB2' ' A' ' 133' ' ' LYS . 10.0 mtmp? -62.88 -34.42 77.34 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-O 121.082 0.467 . . . . 0.0 111.031 -177.036 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' THR . . . . . 0.546 HG22 ' CZ ' ' A' ' 138' ' ' PHE . 0.3 OUTLIER -69.64 -51.49 34.39 Favored 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 109.765 -0.457 . . . . 0.0 109.765 177.168 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . 0.5 ' HA ' ' CD2' ' A' ' 138' ' ' PHE . . . -54.96 -49.95 70.14 Favored 'General case' 0 C--O 1.24 0.553 0 CA-C-N 115.605 -0.725 . . . . 0.0 112.25 179.653 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . 0.538 ' HG3' ' N ' ' A' ' 137' ' ' LYS . 2.0 pt-20 -60.57 -41.44 94.64 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-O 120.978 0.418 . . . . 0.0 110.268 -179.56 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . 0.538 ' N ' ' HG3' ' A' ' 136' ' ' GLU . 0.0 OUTLIER -66.53 -33.15 75.03 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.76 -177.217 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . 0.594 ' CE2' HD21 ' A' ' 55' ' ' LEU . 20.5 m-85 -58.52 -52.54 65.2 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.336 175.008 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 56.6 m-20 -57.47 -54.55 45.59 Favored 'General case' 0 N--CA 1.464 0.26 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 177.718 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 23.3 tt0 -49.91 -60.5 2.86 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 114.798 -1.092 . . . . 0.0 113.204 179.868 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 84.7 mt -67.43 -28.89 68.27 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-O 120.644 0.259 . . . . 0.0 111.616 -173.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 66.8 tp . . . . . 0 C--N 1.325 -0.485 0 CA-C-O 121.335 0.588 . . . . 0.0 109.737 175.202 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.326 0 CA-C-O 121.554 0.692 . . . . 0.0 110.068 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -139.59 91.7 2.51 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.402 -0.817 . . . . 0.0 110.969 -178.355 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . 1.026 ' HA ' ' HB3' ' A' ' 25' ' ' LEU . 67.2 m 59.06 77.09 0.32 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.702 -0.681 . . . . 0.0 112.105 178.154 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 31.4 p90 -82.3 -178.98 7.25 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.569 177.324 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . 0.483 ' HA ' ' HA ' ' A' ' 24' ' ' SER . 23.2 t -142.53 134.64 27.36 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 175.469 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . 0.412 ' HA ' ' HD3' ' A' ' 16' ' ' PRO . 36.4 m-85 -146.07 150.3 41.55 Favored Pre-proline 0 C--N 1.325 -0.472 0 N-CA-C 109.999 -0.371 . . . . 0.0 109.999 179.835 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' A' ' 15' ' ' TYR . 3.9 Cg_exo -76.64 125.3 8.14 Favored 'Trans proline' 0 N--CA 1.455 -0.778 0 C-N-CA 122.458 2.106 . . . . 0.0 112.14 178.351 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . 0.811 ' HB3' ' HB3' ' A' ' 21' ' ' LYS . 0.0 OUTLIER -60.76 163.49 5.57 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.709 -0.678 . . . . 0.0 109.62 172.051 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.548 HG12 HG11 ' A' ' 82' ' ' VAL . 10.5 tp -61.33 -25.52 36.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.817 -170.9 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.488 ' HB2' ' OD2' ' A' ' 17' ' ' ASP . 0.9 OUTLIER -81.88 -5.37 58.19 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 120.932 0.396 . . . . 0.0 110.779 178.064 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 93.42 37.38 5.61 Favored Glycine 0 N--CA 1.447 -0.576 0 N-CA-C 110.888 -0.885 . . . . 0.0 110.888 -175.6 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.811 ' HB3' ' HB3' ' A' ' 17' ' ' ASP . 3.2 ttmp? -108.37 111.48 23.42 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.709 0.29 . . . . 0.0 110.89 -173.449 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 16.7 m -70.49 109.14 4.64 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 120.87 0.366 . . . . 0.0 111.095 -179.257 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.591 ' HB ' HD21 ' A' ' 92' ' ' LEU . 39.4 t -126.48 152.78 34.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 178.355 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . 0.483 ' HA ' ' HA ' ' A' ' 14' ' ' SER . 93.8 p -122.67 176.35 6.0 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.186 0.517 . . . . 0.0 110.718 -179.973 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 1.026 ' HB3' ' HA ' ' A' ' 12' ' ' SER . 21.0 tp -95.77 15.08 21.17 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 121.761 0.791 . . . . 0.0 108.882 173.435 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.528 ' HA ' ' HE2' ' A' ' 29' ' ' LYS . . . -100.05 -35.0 9.85 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 114.915 -1.038 . . . . 0.0 110.503 177.282 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -81.26 -17.7 48.54 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.458 177.69 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 72.4 mt -91.25 22.79 3.63 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.72 -179.911 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.528 ' HE2' ' HA ' ' A' ' 26' ' ' ALA . 1.1 mptp? -70.43 -169.64 0.32 Allowed 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 121.308 0.575 . . . . 0.0 111.348 176.469 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 89.23 -47.67 3.34 Favored Glycine 0 N--CA 1.45 -0.372 0 CA-C-N 115.83 -0.623 . . . . 0.0 112.616 173.328 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.723 ' HD3' ' HA ' ' A' ' 63' ' ' ASP . 72.6 mttt -127.05 167.72 15.56 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 110.0 -0.37 . . . . 0.0 110.0 -178.311 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.406 ' HD1' ' HA ' ' A' ' 116' ' ' ASP . 97.6 m-85 -64.95 154.12 38.47 Favored 'General case' 0 C--N 1.327 -0.4 0 O-C-N 123.197 0.311 . . . . 0.0 110.798 -176.579 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.468 HD13 ' HA2' ' A' ' 119' ' ' GLY . 4.6 mp -120.26 124.61 72.95 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-O 120.706 0.289 . . . . 0.0 110.475 -179.543 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 84.4 t80 -107.45 116.23 31.58 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 109.006 -0.738 . . . . 0.0 109.006 172.339 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.551 ' HA ' ' O ' ' A' ' 67' ' ' VAL . 67.8 mt -102.81 116.77 47.14 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.697 -178.239 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -109.93 158.82 17.82 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.503 -0.772 . . . . 0.0 109.14 174.112 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.452 HG11 ' CG2' ' A' ' 109' ' ' ILE . 57.5 t -101.25 125.55 55.21 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 C-N-CA 120.34 -0.544 . . . . 0.0 110.852 172.996 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' TRP . . . . . 0.661 ' HZ3' HG21 ' A' ' 82' ' ' VAL . 1.0 OUTLIER -118.95 135.11 54.77 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.04 -0.527 . . . . 0.0 109.778 -178.973 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.455 ' HA ' ' OD1' ' A' ' 72' ' ' ASP . . . -146.63 165.23 30.18 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.683 -0.235 . . . . 0.0 111.307 179.943 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . 0.819 ' HB ' ' CE3' ' A' ' 78' ' ' TRP . 12.3 t -99.87 -29.55 12.53 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.946 0.403 . . . . 0.0 110.572 173.069 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 19.4 p-90 -80.42 11.15 3.84 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.117 0.484 . . . . 0.0 110.956 -179.138 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' CYS . . . . . 0.745 ' SG ' ' HB3' ' A' ' 45' ' ' CYS . 29.2 p -104.35 172.1 6.98 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.649 -177.044 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -123.03 -70.52 0.24 Allowed Glycine 0 N--CA 1.448 -0.549 0 CA-C-N 115.857 -0.611 . . . . 0.0 112.252 177.218 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -55.28 -35.53 91.56 Favored 'Trans proline' 0 C--N 1.351 0.676 0 C-N-CA 122.991 2.461 . . . . 0.0 112.882 178.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . 0.745 ' HB3' ' SG ' ' A' ' 42' ' ' CYS . 8.4 t -59.02 -34.41 71.86 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.872 0.368 . . . . 0.0 111.097 177.209 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.716 ' HA ' HD13 ' A' ' 49' ' ' LEU . 32.4 mtp180 -73.5 -4.66 35.17 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.33 -177.218 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -83.95 -19.73 60.71 Favored Glycine 0 N--CA 1.447 -0.62 0 C-N-CA 120.788 -0.72 . . . . 0.0 111.842 176.473 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . 0.548 ' OE2' ' HD3' ' A' ' 128' ' ' ARG . 42.1 mm-40 -84.21 -16.87 41.78 Favored 'General case' 0 CA--C 1.515 -0.384 0 N-CA-C 110.401 -0.222 . . . . 0.0 110.401 -177.823 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.716 HD13 ' HA ' ' A' ' 46' ' ' ARG . 5.7 mp -45.44 -53.5 18.3 Favored Pre-proline 0 C--N 1.326 -0.424 0 CA-C-N 115.935 -0.575 . . . . 0.0 112.278 -178.744 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.588 ' HD3' ' HB2' ' A' ' 49' ' ' LEU . 31.7 Cg_exo -64.13 -37.55 41.38 Favored 'Trans proline' 0 C--N 1.353 0.799 0 C-N-CA 121.885 1.723 . . . . 0.0 112.842 175.868 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -77.34 -27.97 52.95 Favored 'General case' 0 CA--C 1.52 -0.193 0 CA-C-O 121.248 0.546 . . . . 0.0 110.6 -172.752 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 6.1 tt -64.13 -41.71 97.1 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 177.802 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 27.0 mmtm -70.64 -40.07 73.29 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.582 -0.735 . . . . 0.0 111.454 -179.731 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.401 ' O ' ' HB2' ' A' ' 58' ' ' LYS . 2.8 mm-40 -51.72 -53.64 37.06 Favored 'General case' 0 N--CA 1.455 -0.189 0 CA-C-O 121.341 0.591 . . . . 0.0 110.947 172.928 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.426 HD13 ' HE2' ' A' ' 138' ' ' PHE . 47.3 mt -61.5 -52.27 65.2 Favored 'General case' 0 N--CA 1.447 -0.611 0 CA-C-N 115.452 -0.795 . . . . 0.0 110.902 177.109 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.46 ' HA ' ' CE2' ' A' ' 66' ' ' PHE . 31.9 tt0 -45.09 -60.16 2.24 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 114.65 -1.159 . . . . 0.0 112.519 -179.308 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -69.7 -36.18 75.71 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-O 120.976 0.417 . . . . 0.0 111.045 -174.664 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . 0.555 ' HB2' ' NZ ' ' A' ' 58' ' ' LYS . 0.7 OUTLIER -69.24 -35.2 75.9 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.21 0.528 . . . . 0.0 111.028 -175.482 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 83.3 m-85 -111.03 9.29 22.11 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.058 -178.285 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.416 ' HB2' ' O ' ' A' ' 56' ' ' GLU . . . -56.02 128.61 36.13 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.663 178.355 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 81.86 -4.16 76.26 Favored Glycine 0 N--CA 1.449 -0.44 0 CA-C-N 115.652 -0.704 . . . . 0.0 113.386 174.231 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.585 ' HD3' ' N ' ' A' ' 62' ' ' LYS . 0.0 OUTLIER -76.66 -89.8 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 117.104 0.452 . . . . 0.0 111.142 -174.896 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . 0.723 ' HA ' ' HD3' ' A' ' 31' ' ' LYS . 10.9 p-10 -139.07 6.07 2.36 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.635 -175.463 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 16.0 tt -128.8 147.26 33.25 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-O 121.443 0.64 . . . . 0.0 112.623 -168.662 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 87.8 m-70 -112.86 125.8 54.76 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.203 -0.908 . . . . 0.0 108.807 170.697 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . 0.612 ' O ' ' HB ' ' A' ' 90' ' ' ILE . 96.4 m-85 -90.94 112.44 24.32 Favored 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 109.176 -0.675 . . . . 0.0 109.176 173.153 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.551 ' O ' ' HA ' ' A' ' 35' ' ' ILE . 45.9 t -123.58 106.32 17.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.662 -175.086 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . 0.45 ' HB3' ' CD1' ' A' ' 38' ' ' TRP . 15.0 m -88.11 139.55 30.39 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.107 179.069 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 61.4 tp -122.36 124.11 42.93 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-O 120.774 0.321 . . . . 0.0 110.459 176.868 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 1.2 t -104.62 122.05 44.82 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.691 0.758 . . . . 0.0 112.509 -173.219 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 4.2 m -86.81 11.19 13.82 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 114.956 -1.02 . . . . 0.0 111.539 177.05 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.51 ' O ' ' HA2' ' A' ' 95' ' ' GLY . 1.6 m-20 -69.07 125.76 27.67 Favored 'General case' 0 N--CA 1.464 0.266 0 N-CA-C 110.452 -0.203 . . . . 0.0 110.452 -176.521 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 86.0 tttt -76.27 -32.05 58.61 Favored 'General case' 0 C--N 1.321 -0.633 0 C-N-CA 120.344 -0.542 . . . . 0.0 109.708 175.343 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . 0.583 ' HB2' ' HB3' ' A' ' 77' ' ' ALA . 0.8 OUTLIER -76.21 71.23 2.92 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.481 -0.781 . . . . 0.0 110.856 177.771 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.532 ' O ' ' HG3' ' A' ' 79' ' ' GLU . 12.0 tmtt? -57.16 -56.61 19.57 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 120.992 -0.283 . . . . 0.0 111.596 -175.423 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.509 ' HA ' ' CD ' ' A' ' 79' ' ' GLU . 2.2 tptp -52.15 -57.44 9.61 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.097 -179.543 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.583 ' HB3' ' HB2' ' A' ' 74' ' ' ASN . . . -52.96 -31.59 41.39 Favored 'General case' 0 C--O 1.237 0.425 0 CA-C-O 121.356 0.598 . . . . 0.0 110.898 -179.766 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' TRP . . . . . 0.819 ' CE3' ' HB ' ' A' ' 40' ' ' THR . 2.1 t-105 -76.91 -34.63 57.69 Favored 'General case' 0 N--CA 1.442 -0.856 0 CA-C-N 115.146 -0.933 . . . . 0.0 110.546 -176.756 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.532 ' HG3' ' O ' ' A' ' 75' ' ' LYS . 29.9 mt-10 -51.19 -52.43 44.41 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-O 121.573 0.702 . . . . 0.0 110.326 172.496 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . 0.446 ' ND2' ' HA ' ' A' ' 77' ' ' ALA . 1.2 m-80 -64.17 -41.19 97.23 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.25 -0.886 . . . . 0.0 110.747 -175.987 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' MET . . . . . 0.49 ' HG2' ' OG1' ' A' ' 40' ' ' THR . 14.4 tpt -67.29 -49.14 65.42 Favored 'General case' 0 N--CA 1.447 -0.601 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.938 -177.766 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.771 HG23 ' HB2' ' A' ' 87' ' ' LEU . 7.5 p -61.35 -30.89 48.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 121.068 0.461 . . . . 0.0 110.788 -179.543 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 45.8 m -74.61 -39.1 62.36 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.534 178.035 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . 0.748 ' HB3' ' HZ2' ' A' ' 84' ' ' LYS . 0.0 OUTLIER -74.08 -33.71 63.73 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 121.329 0.585 . . . . 0.0 109.843 179.48 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -82.81 4.29 25.98 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.216 -0.902 . . . . 0.0 111.329 -179.428 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 26.6 mt-30 60.38 28.24 17.86 Favored 'General case' 0 N--CA 1.47 0.545 0 N-CA-C 112.668 0.618 . . . . 0.0 112.668 171.904 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.771 ' HB2' HG23 ' A' ' 82' ' ' VAL . 97.6 mt -89.43 104.09 16.67 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 121.003 0.43 . . . . 0.0 111.523 -176.916 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.553 ' HA ' ' HE3' ' A' ' 88' ' ' LYS . 0.0 OUTLIER -106.95 -167.15 1.24 Allowed 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.031 172.515 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 109.44 -159.58 13.94 Favored Glycine 0 N--CA 1.452 -0.259 0 N-CA-C 111.023 -0.831 . . . . 0.0 111.023 -176.122 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.612 ' HB ' ' O ' ' A' ' 66' ' ' PHE . 62.9 mt -95.15 112.27 27.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 175.007 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . 0.644 ' HB2' ' CZ2' ' A' ' 38' ' ' TRP . 1.9 pt20 -139.14 123.04 17.73 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-O 121.348 0.594 . . . . 0.0 111.389 -173.098 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.591 HD21 ' HB ' ' A' ' 23' ' ' VAL . 70.4 mt -113.91 152.23 31.1 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.449 -0.796 . . . . 0.0 109.939 179.788 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' HIS . . . . . 0.454 ' CE1' ' HG3' ' A' ' 75' ' ' LYS . 20.6 t-80 -120.75 126.52 50.37 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.905 -177.416 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' MET . . . . . 0.453 ' SD ' ' HA ' ' A' ' 98' ' ' ARG . 18.6 ttp -84.13 -66.48 0.89 Allowed 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.227 -0.897 . . . . 0.0 110.61 178.567 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . 0.51 ' HA2' ' O ' ' A' ' 72' ' ' ASP . . . 108.56 -109.96 2.96 Favored Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 120.528 -0.844 . . . . 0.0 112.083 -178.29 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 8.9 t -112.45 11.18 19.84 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 120.727 0.299 . . . . 0.0 111.111 -177.147 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -97.5 46.46 1.03 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.126 0.489 . . . . 0.0 110.357 -175.371 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . 0.453 ' HA ' ' SD ' ' A' ' 94' ' ' MET . 0.0 OUTLIER -77.51 18.45 0.43 Allowed 'General case' 0 CA--C 1.52 -0.174 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.782 -172.812 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 5.2 m -61.0 -24.35 66.09 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 108.358 -0.979 . . . . 0.0 108.358 168.768 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 12.0 t80 -75.56 -29.93 59.52 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-N 114.766 -1.106 . . . . 0.0 110.118 176.172 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 71.2 mtp -63.08 -54.06 43.83 Favored 'General case' 0 CA--C 1.514 -0.42 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 171.307 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -57.16 -33.15 67.14 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.082 -0.963 . . . . 0.0 111.246 179.404 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -60.27 -39.82 88.19 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.793 0.33 . . . . 0.0 111.087 178.019 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' TYR . . . . . 0.478 ' HB2' HG13 ' A' ' 106' ' ' ILE . 42.9 m-85 -93.3 3.34 55.8 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.481 179.661 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 95.4 mt 65.47 22.02 11.85 Favored 'General case' 0 N--CA 1.464 0.242 0 O-C-N 123.755 0.659 . . . . 0.0 110.817 -176.234 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . 0.887 HG12 ' HG3' ' A' ' 111' ' ' ARG . 51.2 mt -71.08 112.5 6.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.627 176.036 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 50.9 t-20 -112.61 -68.85 0.9 Allowed 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 172.826 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -82.24 111.28 3.33 Favored Glycine 0 N--CA 1.446 -0.693 0 C-N-CA 120.83 -0.7 . . . . 0.0 111.802 178.5 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.556 ' HB ' ' HA ' ' A' ' 110' ' ' PRO . 34.5 pt -85.82 158.54 56.27 Favored Pre-proline 0 C--N 1.321 -0.633 0 N-CA-C 110.484 -0.191 . . . . 0.0 110.484 178.51 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . 0.556 ' HA ' ' HB ' ' A' ' 109' ' ' ILE . 86.8 Cg_endo -81.1 158.86 83.62 Favored 'Cis proline' 0 C--N 1.345 0.37 0 C-N-CA 123.768 -1.346 . . . . 0.0 113.391 1.995 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . 0.887 ' HG3' HG12 ' A' ' 106' ' ' ILE . 0.0 OUTLIER -108.58 148.45 30.3 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 108.712 -0.848 . . . . 0.0 108.712 173.215 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . 0.551 ' CE1' ' HB3' ' A' ' 128' ' ' ARG . 0.5 OUTLIER -119.11 116.72 26.96 Favored 'General case' 0 C--N 1.324 -0.532 0 O-C-N 123.96 0.788 . . . . 0.0 109.088 -175.008 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 91.6 mt -135.6 143.67 35.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 120.812 0.339 . . . . 0.0 111.261 -177.332 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.576 ' HB2' ' HG3' ' A' ' 126' ' ' MET . 39.3 tp -124.99 138.07 54.23 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.275 178.36 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.619 ' HG ' ' HA ' ' A' ' 121' ' ' ILE . 3.2 mp -131.97 153.45 50.31 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.079 -177.324 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . 0.549 ' HB2' HD11 ' A' ' 122' ' ' ILE . 37.4 t0 -68.37 166.81 15.87 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.564 -0.744 . . . . 0.0 110.212 177.308 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . 0.577 ' HA ' ' O ' ' A' ' 31' ' ' LYS . 8.3 mtm180 -48.87 -27.77 3.29 Favored 'General case' 0 N--CA 1.465 0.314 0 O-C-N 124.447 1.092 . . . . 0.0 112.615 -177.445 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . 0.447 ' HA ' ' HG3' ' A' ' 29' ' ' LYS . 33.0 t70 -83.44 2.31 37.3 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.478 0.656 . . . . 0.0 111.076 -178.835 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . 0.468 ' HA2' HD13 ' A' ' 33' ' ' ILE . . . 76.06 29.13 59.25 Favored Glycine 0 N--CA 1.434 -1.438 0 N-CA-C 110.247 -1.141 . . . . 0.0 110.247 -171.968 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . 0.405 ' HD3' ' HA ' ' A' ' 120' ' ' LYS . 41.0 mmtm -101.28 112.13 24.55 Favored 'General case' 0 C--O 1.222 -0.356 0 C-N-CA 120.794 -0.363 . . . . 0.0 111.791 -178.856 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . 0.69 ' H ' HD12 ' A' ' 121' ' ' ILE . 3.9 mp -41.7 117.54 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 O-C-N 123.888 0.742 . . . . 0.0 112.327 -177.508 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' ILE . . . . . 0.549 HD11 ' HB2' ' A' ' 116' ' ' ASP . 35.6 mm -100.3 -44.54 11.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 115.345 -0.843 . . . . 0.0 109.555 175.983 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 15.9 m -135.2 114.47 12.36 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.503 -0.772 . . . . 0.0 110.343 178.716 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -81.53 -13.22 58.35 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.161 0.505 . . . . 0.0 110.606 179.439 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 3.4 p-10 -128.24 83.69 2.18 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.54 -0.755 . . . . 0.0 110.486 178.14 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' MET . . . . . 0.576 ' HG3' ' HB2' ' A' ' 114' ' ' LEU . 46.4 mmm -94.48 -165.13 1.26 Allowed 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.442 177.784 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . 0.412 HG21 ' NZ ' ' A' ' 133' ' ' LYS . 6.2 p -120.86 141.75 50.29 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.627 179.268 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . 0.551 ' HB3' ' CE1' ' A' ' 112' ' ' PHE . 13.0 ptp180 -48.96 154.28 1.31 Allowed Pre-proline 0 C--N 1.327 -0.385 0 CA-C-N 115.514 -0.766 . . . . 0.0 112.84 177.664 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_exo -51.58 -36.16 59.21 Favored 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 123.447 2.765 . . . . 0.0 113.627 177.275 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 18.8 m -72.79 -7.67 51.78 Favored 'General case' 0 N--CA 1.462 0.153 0 CA-C-O 120.935 0.398 . . . . 0.0 111.643 -178.784 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -90.51 121.39 68.44 Favored Pre-proline 0 C--N 1.327 -0.41 0 N-CA-C 109.751 -0.463 . . . . 0.0 109.751 179.668 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . 0.453 ' O ' ' HG2' ' A' ' 136' ' ' GLU . 51.9 Cg_exo -57.45 -31.73 92.15 Favored 'Trans proline' 0 C--N 1.343 0.284 0 C-N-CA 122.976 2.451 . . . . 0.0 113.268 -178.096 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . 0.531 ' HZ2' ' HB2' ' A' ' 133' ' ' LYS . 9.7 mtmp? -66.44 -19.24 65.74 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.846 0.355 . . . . 0.0 110.98 -176.908 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' THR . . . . . 0.64 HG22 ' CZ ' ' A' ' 138' ' ' PHE . 3.8 m -68.12 -51.25 48.34 Favored 'General case' 0 N--CA 1.447 -0.584 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 173.786 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . 0.649 ' HA ' ' CD2' ' A' ' 138' ' ' PHE . . . -59.96 -38.61 83.01 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.67 -0.696 . . . . 0.0 110.576 175.515 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . 0.453 ' HG2' ' O ' ' A' ' 132' ' ' PRO . 5.9 mm-40 -56.15 -41.62 75.71 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.203 177.111 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . 0.587 ' O ' ' HG ' ' A' ' 141' ' ' LEU . 21.3 ttmm -72.44 -26.33 61.8 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.56 -0.291 . . . . 0.0 111.043 179.745 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . 0.649 ' CD2' ' HA ' ' A' ' 135' ' ' ALA . 10.7 m-30 -66.27 -42.76 88.01 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 173.908 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 76.7 m-20 -58.62 -45.7 88.63 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.583 -0.735 . . . . 0.0 109.341 173.672 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . 0.54 ' HB3' ' O ' ' A' ' 137' ' ' LYS . 24.9 tt0 -50.79 -51.72 47.91 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 115.266 -0.879 . . . . 0.0 111.661 174.196 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.587 ' HG ' ' O ' ' A' ' 137' ' ' LYS . 95.2 mt -58.05 -44.46 87.46 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.472 -178.399 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 81.0 mt . . . . . 0 C--N 1.328 -0.347 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.478 179.336 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.405 ' HB2' ' OH ' ' A' ' 104' ' ' TYR . . . . . . . . 0 N--CA 1.471 0.603 0 N-CA-C 112.225 0.454 . . . . 0.0 112.225 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -76.09 82.61 2.93 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.76 -177.491 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . 0.505 ' HA ' ' HB3' ' A' ' 25' ' ' LEU . 37.8 m 69.5 43.34 1.03 Allowed 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 114.674 -1.148 . . . . 0.0 111.267 174.759 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 55.7 p90 -68.06 161.98 25.6 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.606 177.909 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . 0.553 ' HA ' ' HA ' ' A' ' 24' ' ' SER . 5.2 p -134.7 129.16 34.33 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.655 179.26 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . 0.447 ' OH ' ' HB2' ' A' ' 100' ' ' PHE . 24.6 m-85 -140.44 141.13 24.62 Favored Pre-proline 0 C--N 1.326 -0.414 0 CA-C-O 120.842 0.353 . . . . 0.0 111.119 178.709 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 63.3 Cg_endo -75.25 125.59 9.26 Favored 'Trans proline' 0 N--CA 1.461 -0.388 0 C-N-CA 122.399 2.066 . . . . 0.0 113.481 -177.442 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -69.35 159.13 33.73 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.131 -0.94 . . . . 0.0 109.252 170.379 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.546 HG13 ' OE1' ' A' ' 79' ' ' GLU . 2.6 tt -44.43 -44.56 2.37 Favored 'Isoleucine or valine' 0 C--O 1.24 0.567 0 O-C-N 124.445 1.091 . . . . 0.0 112.221 -176.207 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 43.8 m-80 -65.89 -12.93 58.29 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.375 -176.422 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 97.14 32.15 6.56 Favored Glycine 0 N--CA 1.444 -0.817 0 N-CA-C 111.248 -0.741 . . . . 0.0 111.248 -176.615 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.427 ' NZ ' HG22 ' A' ' 23' ' ' VAL . 23.4 ttpp -106.68 121.11 43.68 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 120.667 -0.413 . . . . 0.0 110.36 -176.815 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 14.1 m -63.0 99.32 0.16 Allowed 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.964 0.412 . . . . 0.0 110.385 176.65 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.427 HG22 ' NZ ' ' A' ' 21' ' ' LYS . 97.0 t -99.82 113.76 36.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 178.098 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . 0.553 ' HA ' ' HA ' ' A' ' 14' ' ' SER . 14.7 m -105.4 177.0 4.98 Favored 'General case' 0 C--N 1.311 -1.069 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.159 -179.218 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.545 ' O ' ' HB2' ' A' ' 29' ' ' LYS . 2.9 tm? -53.87 -38.0 64.27 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.619 178.718 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -89.66 10.13 24.36 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 112.287 0.477 . . . . 0.0 112.287 -176.596 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -87.43 -27.77 22.52 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-O 121.481 0.658 . . . . 0.0 110.319 -179.187 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.464 HD13 ' CD1' ' A' ' 33' ' ' ILE . 0.9 OUTLIER -132.88 15.91 4.27 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.487 -0.778 . . . . 0.0 110.592 -178.928 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.545 ' HB2' ' O ' ' A' ' 25' ' ' LEU . 17.1 tttt -67.02 150.47 49.18 Favored 'General case' 0 C--N 1.313 -0.979 0 CA-C-N 114.197 -1.365 . . . . 0.0 111.301 -177.063 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 113.49 -18.48 20.32 Favored Glycine 0 N--CA 1.448 -0.565 0 N-CA-C 111.193 -0.763 . . . . 0.0 111.193 -178.85 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.809 ' HD2' ' HA ' ' A' ' 63' ' ' ASP . 72.8 mmtt -117.11 154.72 30.53 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 179.218 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 69.4 m-85 -66.05 121.45 15.16 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 177.365 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.464 ' CD1' HD13 ' A' ' 28' ' ' LEU . 41.8 mm -94.6 115.73 34.14 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.896 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.73 -175.099 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . 0.68 ' HE2' ' HA ' ' A' ' 129' ' ' PRO . 59.4 t80 -107.01 111.23 23.62 Favored 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 173.755 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.543 ' HA ' ' O ' ' A' ' 67' ' ' VAL . 59.5 mt -97.01 132.6 41.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-O 121.152 0.501 . . . . 0.0 111.656 -173.392 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.507 ' O ' ' HA ' ' A' ' 68' ' ' SER . 5.3 p-10 -122.99 159.64 27.92 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.262 -0.881 . . . . 0.0 109.034 174.142 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.44 HG21 HG21 ' A' ' 106' ' ' ILE . 85.4 t -103.51 133.32 47.76 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.788 0 C-N-CA 120.5 -0.48 . . . . 0.0 110.805 174.078 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' TRP . . . . . 0.665 ' HZ3' HG21 ' A' ' 82' ' ' VAL . 0.9 OUTLIER -126.51 137.25 53.35 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.136 -0.483 . . . . 0.0 109.889 -178.303 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.556 ' HA ' ' OD1' ' A' ' 72' ' ' ASP . . . -145.55 164.68 30.91 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.64 -0.255 . . . . 0.0 110.666 177.665 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . 0.714 ' HB ' ' CE3' ' A' ' 78' ' ' TRP . 4.9 t -81.55 -23.71 37.03 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.336 0.588 . . . . 0.0 109.671 172.822 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 12.7 p-90 -97.62 19.25 13.83 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.358 -0.837 . . . . 0.0 110.231 177.824 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' CYS . . . . . 0.644 ' SG ' ' HB3' ' A' ' 45' ' ' CYS . 24.8 p -78.27 -26.46 47.16 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.107 -177.437 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 66.47 -111.73 4.37 Favored Glycine 0 CA--C 1.519 0.337 0 CA-C-N 116.066 -0.515 . . . . 0.0 113.346 178.534 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -54.58 -28.16 54.24 Favored 'Trans proline' 0 C--N 1.351 0.666 0 C-N-CA 123.461 2.774 . . . . 0.0 113.292 -177.726 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . 0.644 ' HB3' ' SG ' ' A' ' 42' ' ' CYS . 30.7 t -52.6 -30.88 33.56 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.414 177.147 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.488 HH21 ' CG ' ' A' ' 85' ' ' ASP . 46.0 mtp180 -58.75 -21.42 55.46 Favored 'General case' 0 C--O 1.223 -0.292 0 N-CA-C 111.911 0.337 . . . . 0.0 111.911 -178.782 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -70.96 -23.88 77.64 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.829 -0.7 . . . . 0.0 112.831 -178.118 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . 0.457 ' HB3' ' HB2' ' A' ' 130' ' ' SER . 35.7 mt-10 -99.3 -18.43 17.57 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.761 0.28 . . . . 0.0 111.317 -176.978 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.708 ' HB3' HD22 ' A' ' 87' ' ' LEU . 3.6 mm? -57.54 -43.91 99.21 Favored Pre-proline 0 C--N 1.325 -0.486 0 N-CA-C 112.911 0.708 . . . . 0.0 112.911 -179.166 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.516 ' HD2' ' N ' ' A' ' 49' ' ' LEU . 12.3 Cg_endo -58.48 -37.89 92.61 Favored 'Trans proline' 0 C--N 1.351 0.706 0 C-N-CA 121.275 1.317 . . . . 0.0 111.027 170.684 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -73.33 -19.09 61.1 Favored 'General case' 0 CA--C 1.519 -0.212 0 CA-C-O 121.415 0.626 . . . . 0.0 109.796 -176.638 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.442 ' O ' HD23 ' A' ' 52' ' ' LEU . 5.8 tt -65.13 -38.02 89.32 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-N 115.107 -0.951 . . . . 0.0 108.74 174.421 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.66 ' O ' ' HG2' ' A' ' 57' ' ' GLU . 8.9 mtmp? -59.01 -60.95 3.05 Favored 'General case' 0 CA--C 1.505 -0.783 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 171.809 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -45.17 -42.44 9.12 Favored 'General case' 0 C--O 1.224 -0.274 0 O-C-N 124.577 1.173 . . . . 0.0 111.256 -178.698 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.443 ' HB3' ' CE1' ' A' ' 66' ' ' PHE . 39.9 mt -61.41 -57.81 10.75 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.352 175.698 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 18.2 tp10 -65.45 -35.28 80.43 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.42 -174.391 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.66 ' HG2' ' O ' ' A' ' 53' ' ' LYS . 9.4 pt-20 -80.49 -29.05 37.36 Favored 'General case' 0 CA--C 1.532 0.25 0 O-C-N 121.906 -0.496 . . . . 0.0 111.141 179.4 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 75.9 tttt -63.36 -44.53 94.54 Favored 'General case' 0 C--O 1.237 0.426 0 CA-C-O 121.923 0.868 . . . . 0.0 109.11 170.484 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 61.2 m-85 -99.92 14.86 29.01 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.008 -0.997 . . . . 0.0 111.308 -176.414 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.432 ' HB2' ' HA ' ' A' ' 57' ' ' GLU . . . -57.66 126.44 27.38 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.037 170.584 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 85.43 -6.05 81.31 Favored Glycine 0 N--CA 1.445 -0.721 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.126 -179.151 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 30.7 mmtm -88.51 -155.67 0.34 Allowed 'General case' 0 CA--C 1.515 -0.374 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 178.89 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . 0.809 ' HA ' ' HD2' ' A' ' 31' ' ' LYS . 36.1 m-20 -111.67 28.45 8.74 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 115.824 -0.626 . . . . 0.0 112.641 -175.793 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 4.7 mp -131.86 146.57 33.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-O 120.527 0.203 . . . . 0.0 110.799 179.925 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' HIS . . . . . 0.513 ' CD2' ' HB2' ' A' ' 31' ' ' LYS . 56.8 m-70 -124.91 145.65 49.72 Favored 'General case' 0 CA--C 1.514 -0.425 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 170.094 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . 0.443 ' CE1' ' HB3' ' A' ' 55' ' ' LEU . 77.0 m-85 -110.37 105.92 15.09 Favored 'General case' 0 C--N 1.315 -0.914 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 172.521 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.546 ' HA ' ' O ' ' A' ' 90' ' ' ILE . 48.0 t -112.63 114.07 45.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 115.374 -0.83 . . . . 0.0 111.232 -170.172 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . 0.507 ' HA ' ' O ' ' A' ' 36' ' ' ASP . 3.6 m -88.26 150.64 23.15 Favored 'General case' 0 C--N 1.314 -0.935 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.584 -179.379 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.516 HD11 ' HB2' ' A' ' 94' ' ' MET . 61.1 tp -133.92 121.62 21.96 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.984 0.421 . . . . 0.0 110.531 175.092 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . 0.473 ' O ' ' HB3' ' A' ' 94' ' ' MET . 0.7 OUTLIER -105.28 120.34 41.31 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.395 0.617 . . . . 0.0 112.379 -172.783 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' CYS . . . . . 0.475 ' HA ' ' HE3' ' A' ' 94' ' ' MET . 1.8 p -85.87 13.62 7.16 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.483 -0.78 . . . . 0.0 111.702 175.83 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.578 ' OD2' HG22 ' A' ' 40' ' ' THR . 2.6 m-20 -69.56 115.28 8.63 Favored 'General case' 0 CA--C 1.511 -0.537 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 -179.511 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -67.83 -28.86 67.92 Favored 'General case' 0 C--N 1.318 -0.763 0 C-N-CA 120.093 -0.643 . . . . 0.0 110.209 -179.924 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . 0.732 ' ND2' ' HB3' ' A' ' 77' ' ' ALA . 1.0 OUTLIER -77.27 116.28 17.75 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 171.73 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.683 ' HE2' ' CD ' ' A' ' 79' ' ' GLU . 19.9 tttt -81.45 -64.39 1.2 Allowed 'General case' 0 C--N 1.319 -0.745 0 C-N-CA 119.804 -0.759 . . . . 0.0 110.847 171.839 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.833 ' HE2' ' HA ' ' A' ' 76' ' ' LYS . 0.4 OUTLIER -44.25 -56.67 3.96 Favored 'General case' 0 N--CA 1.464 0.246 0 N-CA-C 113.383 0.883 . . . . 0.0 113.383 -172.057 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.841 ' HA ' ' ND2' ' A' ' 80' ' ' ASN . . . -61.28 -27.59 68.58 Favored 'General case' 0 C--O 1.242 0.689 0 CA-C-O 121.51 0.671 . . . . 0.0 111.233 -176.75 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' TRP . . . . . 0.714 ' CE3' ' HB ' ' A' ' 40' ' ' THR . 3.1 t-105 -81.61 -43.0 19.22 Favored 'General case' 0 N--CA 1.435 -1.188 0 CA-C-N 115.373 -0.83 . . . . 0.0 110.192 -173.921 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.683 ' CD ' ' HE2' ' A' ' 75' ' ' LYS . 6.0 mm-40 -49.34 -43.54 43.9 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-O 121.012 0.434 . . . . 0.0 110.747 171.649 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . 0.841 ' ND2' ' HA ' ' A' ' 77' ' ' ALA . 7.2 m-20 -56.93 -54.32 47.98 Favored 'General case' 0 CA--C 1.517 -0.315 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.583 179.269 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 37.5 ttm -64.61 -46.17 83.77 Favored 'General case' 0 C--O 1.223 -0.301 0 CA-C-N 116.248 -0.433 . . . . 0.0 112.073 -174.895 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.665 HG21 ' HZ3' ' A' ' 38' ' ' TRP . 5.7 p -63.44 -28.25 44.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 C-N-CA 120.622 -0.431 . . . . 0.0 111.407 -178.162 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 36.7 m -81.72 -34.95 30.27 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 120.87 0.367 . . . . 0.0 110.69 177.642 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 24.9 ttmm -77.48 -44.22 29.61 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.109 0.48 . . . . 0.0 111.059 -177.547 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . 0.745 ' HB3' ' HG ' ' A' ' 87' ' ' LEU . 5.4 t0 -77.36 -1.67 31.16 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.185 -0.916 . . . . 0.0 110.943 -176.247 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 48.3 mt-30 65.25 19.83 11.78 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 115.673 -0.694 . . . . 0.0 112.21 175.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.745 ' HG ' ' HB3' ' A' ' 85' ' ' ASP . 17.3 mt -74.03 87.81 1.87 Allowed 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.131 -179.119 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 4.2 mmpm? -101.76 -177.85 3.55 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 112.537 0.569 . . . . 0.0 112.537 -175.739 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 122.71 -176.23 16.53 Favored Glycine 0 N--CA 1.448 -0.545 0 N-CA-C 109.554 -1.418 . . . . 0.0 109.554 -171.948 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.546 ' O ' ' HA ' ' A' ' 67' ' ' VAL . 60.6 mt -83.34 112.7 21.3 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 118.063 0.932 . . . . 0.0 108.681 175.481 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . 0.481 ' HB2' ' CZ2' ' A' ' 38' ' ' TRP . 2.1 pt20 -137.98 110.71 7.61 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-O 121.834 0.826 . . . . 0.0 112.085 -168.565 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.422 HD22 ' HB ' ' A' ' 23' ' ' VAL . 26.0 mt -97.51 142.11 29.74 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.146 -0.934 . . . . 0.0 110.272 -177.83 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' HIS . . . . . 0.441 ' CE1' ' HG3' ' A' ' 75' ' ' LYS . 29.7 t-80 -110.56 117.04 32.47 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-O 121.35 0.595 . . . . 0.0 110.599 -179.643 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' MET . . . . . 0.636 ' SD ' ' HA ' ' A' ' 98' ' ' ARG . 13.6 ttp -79.81 -63.67 1.36 Allowed 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 114.964 -1.016 . . . . 0.0 110.482 -179.891 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . 0.554 ' HA2' ' O ' ' A' ' 72' ' ' ASP . . . 71.36 -79.1 0.55 Allowed Glycine 0 C--O 1.236 0.268 0 C-N-CA 120.967 -0.635 . . . . 0.0 114.466 174.463 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 1.3 p -88.72 -35.52 16.69 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-O 120.819 0.342 . . . . 0.0 111.57 -175.329 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -92.52 57.18 2.88 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.809 -166.793 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . 0.636 ' HA ' ' SD ' ' A' ' 94' ' ' MET . 0.0 OUTLIER -70.82 10.28 0.54 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.12 -0.946 . . . . 0.0 112.698 -172.888 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 8.6 m -73.6 -19.14 60.95 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 120.964 0.411 . . . . 0.0 111.079 -179.587 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' PHE . . . . . 0.447 ' HB2' ' OH ' ' A' ' 15' ' ' TYR . 3.2 t80 -79.63 -43.37 22.97 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 120.898 -0.321 . . . . 0.0 110.713 -178.459 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' MET . . . . . 0.556 ' HA ' HD12 ' A' ' 106' ' ' ILE . 5.1 ppp? -69.23 -24.91 64.07 Favored 'General case' 0 C--N 1.332 -0.178 0 N-CA-C 109.176 -0.676 . . . . 0.0 109.176 175.383 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . 0.405 ' HB2' ' NH1' ' A' ' 98' ' ' ARG . 11.4 t70 -66.41 -50.98 61.62 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.132 -0.94 . . . . 0.0 110.423 173.904 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -64.6 -18.94 65.36 Favored 'General case' 0 N--CA 1.461 0.095 0 CA-C-N 115.758 -0.655 . . . . 0.0 112.072 -175.29 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' TYR . . . . . 0.405 ' OH ' ' HB2' ' A' ' 10' ' ' ALA . 46.1 m-85 -108.45 2.43 22.33 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 111.844 0.313 . . . . 0.0 111.844 -179.319 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 8.8 tp 59.35 26.41 15.27 Favored 'General case' 0 C--N 1.328 -0.361 0 O-C-N 123.507 0.504 . . . . 0.0 110.423 -179.351 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . 0.652 HG12 ' HG3' ' A' ' 111' ' ' ARG . 69.9 mt -60.21 101.46 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.328 0 CA-C-N 115.673 -0.694 . . . . 0.0 111.456 178.769 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 8.7 p30 -134.21 148.88 50.95 Favored 'General case' 0 C--N 1.317 -0.808 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 173.945 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 76.3 84.91 0.41 Allowed Glycine 0 N--CA 1.446 -0.671 0 C-N-CA 120.469 -0.872 . . . . 0.0 111.775 -176.079 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 40.1 mt -69.57 139.16 88.84 Favored Pre-proline 0 C--N 1.325 -0.481 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 177.603 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . 0.487 ' HG3' ' SG ' ' A' ' 45' ' ' CYS . 10.0 Cg_endo -93.11 140.39 8.36 Favored 'Cis proline' 0 N--CA 1.459 -0.521 0 C-N-CA 124.455 -1.061 . . . . 0.0 113.974 0.952 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . 0.652 ' HG3' HG12 ' A' ' 106' ' ' ILE . 0.0 OUTLIER -83.82 144.18 29.45 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 172.933 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . 0.571 ' HD1' ' H ' ' A' ' 126' ' ' MET . 0.9 OUTLIER -118.7 116.83 27.38 Favored 'General case' 0 C--N 1.323 -0.547 0 O-C-N 123.724 0.64 . . . . 0.0 110.792 -176.788 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.497 ' HB ' ' HB ' ' A' ' 35' ' ' ILE . 83.0 mt -130.99 149.56 33.66 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.299 0 CA-C-N 116.703 -0.226 . . . . 0.0 110.908 -177.917 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.423 ' C ' HD12 ' A' ' 115' ' ' LEU . 62.4 tp -128.54 138.07 52.06 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.618 -0.265 . . . . 0.0 110.57 178.941 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.586 ' HG ' ' HA ' ' A' ' 121' ' ' ILE . 2.0 mp -135.19 152.1 51.26 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-O 121.334 0.588 . . . . 0.0 110.623 179.108 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . 0.427 ' N ' HG13 ' A' ' 122' ' ' ILE . 7.6 t70 -69.73 160.85 30.91 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 114.872 -1.058 . . . . 0.0 110.645 175.952 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . 0.452 ' HA ' ' O ' ' A' ' 31' ' ' LYS . 58.7 mtt-85 -48.51 -37.41 17.5 Favored 'General case' 0 N--CA 1.474 0.728 0 O-C-N 124.267 0.979 . . . . 0.0 111.368 -178.368 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . 0.632 ' HB3' ' HG3' ' A' ' 120' ' ' LYS . 29.1 t0 -67.82 -13.01 61.78 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 114.515 -1.221 . . . . 0.0 111.121 -177.069 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . 0.534 ' HA3' HD11 ' A' ' 25' ' ' LEU . . . 93.63 23.78 22.71 Favored Glycine 0 N--CA 1.439 -1.112 0 N-CA-C 110.553 -1.019 . . . . 0.0 110.553 -172.132 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . 0.632 ' HG3' ' HB3' ' A' ' 118' ' ' ASP . 36.6 mtmm -103.72 106.75 17.35 Favored 'General case' 0 C--O 1.223 -0.333 0 C-N-CA 120.564 -0.454 . . . . 0.0 111.365 -174.619 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . 0.681 ' H ' HD12 ' A' ' 121' ' ' ILE . 3.3 mp -42.16 116.57 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 O-C-N 123.909 0.755 . . . . 0.0 111.692 -178.982 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' ILE . . . . . 0.459 ' H ' ' HA ' ' A' ' 115' ' ' LEU . 57.4 mt -89.04 -38.74 11.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 115.346 -0.843 . . . . 0.0 108.902 177.082 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 14.9 m -148.15 126.77 12.49 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.492 -0.776 . . . . 0.0 110.197 -179.812 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . 0.403 ' O ' HG12 ' A' ' 113' ' ' ILE . . . -74.24 -14.95 61.0 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-O 121.336 0.589 . . . . 0.0 110.593 178.53 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . 0.447 ' HA ' ' O ' ' A' ' 112' ' ' PHE . 5.1 p-10 -149.42 126.83 11.5 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.054 -0.975 . . . . 0.0 108.598 173.613 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' MET . . . . . 0.571 ' H ' ' HD1' ' A' ' 112' ' ' PHE . 15.9 tpt -108.95 -87.34 0.5 Allowed 'General case' 0 C--N 1.321 -0.653 0 C-N-CA 120.804 -0.358 . . . . 0.0 111.567 -176.941 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 7.6 p -141.61 -77.85 0.27 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.269 0.557 . . . . 0.0 110.774 -175.013 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . 0.894 ' HB3' ' HB2' ' A' ' 131' ' ' ASP . 43.3 ttm-85 -172.31 141.04 1.09 Allowed Pre-proline 0 N--CA 1.443 -0.807 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 177.5 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . 0.68 ' HA ' ' HE2' ' A' ' 34' ' ' TYR . 5.7 Cg_exo -38.48 -52.46 1.98 Allowed 'Trans proline' 0 C--N 1.348 0.551 0 C-N-CA 123.746 2.964 . . . . 0.0 113.455 -179.242 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . 0.457 ' HB2' ' HB3' ' A' ' 48' ' ' GLU . 36.1 t -109.01 26.16 10.94 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 111.734 0.272 . . . . 0.0 111.734 -177.378 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . 0.894 ' HB2' ' HB3' ' A' ' 128' ' ' ARG . 11.1 t0 -73.64 119.69 77.29 Favored Pre-proline 0 C--O 1.237 0.43 0 C-N-CA 120.108 -0.637 . . . . 0.0 109.458 176.598 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . 0.425 ' O ' ' HG2' ' A' ' 136' ' ' GLU . 51.5 Cg_exo -55.12 -33.08 82.61 Favored 'Trans proline' 0 C--N 1.349 0.579 0 C-N-CA 123.495 2.797 . . . . 0.0 113.737 -175.034 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 38.3 mttp -57.82 -45.86 85.55 Favored 'General case' 0 CA--C 1.519 -0.227 0 CA-C-O 121.33 0.586 . . . . 0.0 109.912 -177.936 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -63.36 -47.54 81.66 Favored 'General case' 0 N--CA 1.448 -0.538 0 CA-C-N 115.033 -0.985 . . . . 0.0 111.116 -178.881 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . 0.68 ' HA ' ' CD2' ' A' ' 138' ' ' PHE . . . -59.61 -50.75 72.67 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.606 -0.725 . . . . 0.0 111.072 -173.895 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . 0.686 ' O ' ' HB2' ' A' ' 139' ' ' ASN . 22.7 mm-40 -76.21 -23.16 54.6 Favored 'General case' 0 C--N 1.312 -1.028 0 CA-C-O 121.857 0.837 . . . . 0.0 110.084 -175.175 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . 1.05 ' HA ' ' HE3' ' A' ' 137' ' ' LYS . 0.1 OUTLIER -65.45 -39.34 91.9 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 115.522 -0.763 . . . . 0.0 109.655 170.995 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . 0.68 ' CD2' ' HA ' ' A' ' 135' ' ' ALA . 15.0 m-85 -55.59 -36.55 67.02 Favored 'General case' 0 N--CA 1.464 0.265 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 172.637 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' ASN . . . . . 0.686 ' HB2' ' O ' ' A' ' 136' ' ' GLU . 94.2 m-20 -51.16 -59.72 3.88 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.148 174.113 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -61.55 -36.12 79.7 Favored 'General case' 0 N--CA 1.463 0.179 0 C-N-CA 120.656 -0.418 . . . . 0.0 111.486 -179.262 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.501 ' HG ' ' O ' ' A' ' 137' ' ' LYS . 96.9 mt -61.48 -27.82 68.85 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.897 0.38 . . . . 0.0 110.841 178.348 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 41.7 tp . . . . . 0 C--N 1.326 -0.438 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.597 178.172 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.227 -0.117 0 CA-C-O 120.913 0.387 . . . . 0.0 111.759 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -89.6 -20.69 23.42 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.306 0.575 . . . . 0.0 110.36 177.817 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . 0.576 ' HA ' ' HB3' ' A' ' 25' ' ' LEU . 67.6 m -161.24 91.43 0.86 Allowed 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.373 -0.83 . . . . 0.0 109.914 178.482 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . 0.504 ' CE2' HD22 ' A' ' 25' ' ' LEU . 25.4 p90 -103.55 178.81 4.45 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.655 -179.79 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . 0.477 ' HA ' ' HA ' ' A' ' 24' ' ' SER . 25.1 p -142.35 119.72 11.6 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.119 -0.492 . . . . 0.0 109.948 176.578 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . 0.584 ' HB2' HD23 ' A' ' 92' ' ' LEU . 28.3 m-85 -134.8 155.3 79.48 Favored Pre-proline 0 C--N 1.324 -0.53 0 CA-C-N 116.652 -0.249 . . . . 0.0 110.675 -179.15 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -83.37 124.84 3.77 Favored 'Trans proline' 0 N--CA 1.453 -0.864 0 C-N-CA 122.016 1.811 . . . . 0.0 112.896 176.19 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . 1.001 ' HB3' ' HB3' ' A' ' 21' ' ' LYS . 0.9 OUTLIER -61.47 162.29 8.29 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.077 -0.965 . . . . 0.0 109.173 168.662 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.687 HD12 HG13 ' A' ' 82' ' ' VAL . 0.7 OUTLIER -42.46 -45.08 1.1 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.452 0 O-C-N 123.975 0.797 . . . . 0.0 112.072 -176.644 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.511 ' ND2' HG23 ' A' ' 18' ' ' ILE . 28.9 m-80 -77.23 8.54 3.92 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.825 -173.967 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 81.54 25.22 54.58 Favored Glycine 0 N--CA 1.449 -0.442 0 N-CA-C 110.769 -0.932 . . . . 0.0 110.769 -175.022 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 1.001 ' HB3' ' HB3' ' A' ' 17' ' ' ASP . 1.4 ttmp? -89.96 107.39 19.09 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.435 -0.383 . . . . 0.0 110.473 -173.744 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 23.6 m -67.37 108.29 2.72 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.84 -179.648 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 57.5 t -123.89 133.07 70.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 116.021 -0.536 . . . . 0.0 109.683 179.846 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . 0.477 ' HA ' ' HA ' ' A' ' 14' ' ' SER . 26.5 p -104.46 171.27 7.42 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.128 0.489 . . . . 0.0 110.031 178.6 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.576 ' HB3' ' HA ' ' A' ' 12' ' ' SER . 20.9 tp -91.18 11.86 21.95 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 121.257 0.551 . . . . 0.0 109.608 176.725 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.591 ' HA ' ' HD3' ' A' ' 29' ' ' LYS . . . -103.29 -25.63 13.25 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 -176.09 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 62.5 m-20 -70.29 -11.79 61.14 Favored 'General case' 0 N--CA 1.436 -1.154 0 CA-C-N 114.05 -1.432 . . . . 0.0 110.797 177.538 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 79.4 mt -110.3 3.19 19.67 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.575 -0.739 . . . . 0.0 112.317 -170.582 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.591 ' HD3' ' HA ' ' A' ' 26' ' ' ALA . 1.3 mptm? -61.98 150.07 38.97 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.192 0.52 . . . . 0.0 111.041 178.462 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 98.55 5.92 56.63 Favored Glycine 0 N--CA 1.445 -0.73 0 C-N-CA 120.807 -0.711 . . . . 0.0 111.731 -179.826 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.798 ' HD3' ' HA ' ' A' ' 63' ' ' ASP . 7.5 ttmm -161.79 148.39 13.99 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.958 -0.386 . . . . 0.0 109.958 179.45 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.491 ' HB2' ' O ' ' A' ' 63' ' ' ASP . 40.6 m-85 -56.28 149.57 16.14 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-O 121.266 0.555 . . . . 0.0 112.365 -173.765 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.697 ' HB ' ' HB2' ' A' ' 115' ' ' LEU . 31.4 mm -118.94 135.65 58.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 115.593 -0.731 . . . . 0.0 110.611 -176.139 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 87.8 t80 -123.32 112.08 17.18 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 109.583 -0.525 . . . . 0.0 109.583 172.197 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.702 ' HB ' ' HB ' ' A' ' 113' ' ' ILE . 39.4 mm -100.8 116.99 45.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.26 179.445 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -117.14 158.56 24.04 Favored 'General case' 0 C--N 1.315 -0.925 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 176.612 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.549 HG11 ' CG2' ' A' ' 109' ' ' ILE . 32.6 t -107.86 112.07 38.6 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.009 0 C-N-CA 120.171 -0.612 . . . . 0.0 109.888 175.315 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' TRP . . . . . 0.692 ' CE3' ' HZ2' ' A' ' 78' ' ' TRP . 0.9 OUTLIER -109.92 134.15 52.4 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 115.575 -0.739 . . . . 0.0 109.174 -175.461 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.546 ' HB3' ' HB3' ' A' ' 42' ' ' CYS . . . -147.07 165.62 29.36 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 116.477 -0.329 . . . . 0.0 110.702 -177.123 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . 0.689 ' HB ' ' CE3' ' A' ' 78' ' ' TRP . 9.8 t -89.02 -24.96 22.22 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.271 0.558 . . . . 0.0 109.698 173.824 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' TRP . . . . . 0.453 ' HZ2' ' HG ' ' A' ' 71' ' ' CYS . 13.4 p-90 -94.86 8.81 41.49 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.108 179.782 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' CYS . . . . . 0.618 ' SG ' ' HB3' ' A' ' 45' ' ' CYS . 17.5 p -88.54 148.28 24.19 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 175.311 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -92.18 -65.69 1.12 Allowed Glycine 0 N--CA 1.448 -0.527 0 C-N-CA 120.277 -0.963 . . . . 0.0 113.087 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -56.12 -51.82 8.64 Favored 'Trans proline' 0 C--N 1.35 0.655 0 C-N-CA 122.743 2.295 . . . . 0.0 112.865 -175.328 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . 0.618 ' HB3' ' SG ' ' A' ' 42' ' ' CYS . 35.1 t -63.11 -39.75 95.61 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.874 0.369 . . . . 0.0 110.325 -175.846 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.537 ' HA ' ' HG ' ' A' ' 49' ' ' LEU . 62.3 ttt180 -71.14 -27.89 63.88 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.493 179.252 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -79.73 -37.75 22.13 Favored Glycine 0 N--CA 1.447 -0.609 0 C-N-CA 120.69 -0.767 . . . . 0.0 111.945 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . 0.55 ' OE2' ' HD3' ' A' ' 128' ' ' ARG . 35.5 mt-10 -90.16 10.1 25.8 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 122.976 -0.132 . . . . 0.0 111.27 -178.495 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.632 ' O ' ' HG3' ' A' ' 53' ' ' LYS . 41.0 mt -46.23 -52.17 29.57 Favored Pre-proline 0 N--CA 1.468 0.465 0 N-CA-C 112.419 0.526 . . . . 0.0 112.419 -179.725 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.529 ' HD2' ' N ' ' A' ' 49' ' ' LEU . 10.3 Cg_endo -54.26 -41.33 77.1 Favored 'Trans proline' 0 C--N 1.355 0.876 0 C-N-CA 122.035 1.823 . . . . 0.0 112.46 179.077 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -80.46 -26.65 38.18 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.379 0.609 . . . . 0.0 110.172 -177.204 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 7.9 tt -66.71 -43.7 83.62 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.424 -0.807 . . . . 0.0 108.884 175.585 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.632 ' HG3' ' O ' ' A' ' 49' ' ' LEU . 88.5 mttt -57.83 -48.58 79.36 Favored 'General case' 0 CA--C 1.516 -0.335 0 O-C-N 123.589 0.556 . . . . 0.0 110.345 177.424 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -44.86 -59.09 2.72 Favored 'General case' 0 N--CA 1.452 -0.329 0 O-C-N 124.06 0.85 . . . . 0.0 111.018 175.16 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 60.1 mt -59.99 -51.71 68.48 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.27 177.789 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -44.14 -59.58 2.27 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 114.582 -1.19 . . . . 0.0 112.528 -179.056 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.556 ' HG2' ' O ' ' A' ' 53' ' ' LYS . 6.1 pt-20 -82.75 -29.27 29.82 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 112.154 0.427 . . . . 0.0 112.154 -173.868 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . 0.533 ' HE3' ' HE1' ' A' ' 59' ' ' TYR . 32.4 ttpt -68.68 -36.65 78.78 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.236 0.541 . . . . 0.0 110.229 178.316 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.742 ' HB3' HD11 ' A' ' 64' ' ' ILE . 41.7 m-85 -99.45 -1.0 39.66 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.371 -178.857 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -63.83 142.09 58.53 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.538 -0.541 . . . . 0.0 109.538 169.19 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 84.86 9.72 80.33 Favored Glycine 0 N--CA 1.448 -0.521 0 C-N-CA 120.494 -0.86 . . . . 0.0 112.555 179.712 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.536 ' HD2' HD21 ' A' ' 142' ' ' LEU . 39.8 mmtm -100.61 -160.72 0.81 Allowed 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 174.532 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . 0.798 ' HA ' ' HD3' ' A' ' 31' ' ' LYS . 2.6 t70 -90.66 52.04 2.11 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-O 121.271 0.558 . . . . 0.0 110.019 -179.688 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.742 HD11 ' HB3' ' A' ' 59' ' ' TYR . 9.2 pt -151.73 156.63 5.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 115.525 -0.761 . . . . 0.0 110.396 -178.418 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' HIS . . . . . 0.665 ' NE2' ' HB3' ' A' ' 31' ' ' LYS . 95.0 m-70 -126.28 113.64 17.21 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.165 -0.47 . . . . 0.0 109.779 175.397 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 88.7 m-85 -76.77 103.8 6.93 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 172.783 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.633 ' HB ' HD13 ' A' ' 35' ' ' ILE . 23.1 t -121.26 104.78 15.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 116.162 -0.472 . . . . 0.0 109.789 -178.928 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . 0.412 ' HB3' ' CD1' ' A' ' 38' ' ' TRP . 6.8 m -99.28 144.7 28.1 Favored 'General case' 0 C--N 1.313 -1.015 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.508 -177.063 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.435 HD23 ' HB2' ' A' ' 92' ' ' LEU . 78.5 mt -122.95 124.1 42.43 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-O 120.696 0.284 . . . . 0.0 111.49 177.564 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . 0.419 ' HA ' ' O ' ' A' ' 38' ' ' TRP . 40.6 m -96.0 119.71 34.98 Favored 'General case' 0 N--CA 1.464 0.272 0 N-CA-C 112.542 0.571 . . . . 0.0 112.542 -179.49 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' CYS . . . . . 0.453 ' HG ' ' HZ2' ' A' ' 41' ' ' TRP . 7.4 p -92.64 28.53 1.99 Allowed 'General case' 0 C--N 1.313 -1.008 0 CA-C-O 121.198 0.523 . . . . 0.0 110.118 175.03 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.514 ' OD2' HG22 ' A' ' 40' ' ' THR . 2.1 m-20 -81.77 112.79 19.25 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.312 178.255 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.452 ' HB3' ' HB ' ' A' ' 96' ' ' THR . 8.8 ptmm? -67.98 -28.6 67.58 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.078 0.466 . . . . 0.0 111.127 178.994 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -87.32 75.83 9.22 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 109.608 -0.515 . . . . 0.0 109.608 179.556 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.422 ' O ' ' HG2' ' A' ' 79' ' ' GLU . 8.5 tttm -55.06 -64.01 0.97 Allowed 'General case' 0 C--O 1.217 -0.655 0 CA-C-N 115.849 -0.614 . . . . 0.0 112.45 -175.711 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 64.2 tttp -43.94 -50.17 8.24 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 112.258 0.466 . . . . 0.0 112.258 -177.605 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.707 ' HA ' ' ND2' ' A' ' 80' ' ' ASN . . . -58.75 -41.6 86.91 Favored 'General case' 0 C--O 1.246 0.905 0 CA-C-O 122.142 0.972 . . . . 0.0 110.341 179.769 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' TRP . . . . . 0.692 ' HZ2' ' CE3' ' A' ' 38' ' ' TRP . 10.0 t-105 -65.55 -49.98 66.87 Favored 'General case' 0 C--N 1.312 -1.056 0 CA-C-N 114.012 -1.449 . . . . 0.0 110.988 -178.97 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.479 ' OE1' HG13 ' A' ' 18' ' ' ILE . 6.1 mm-40 -47.4 -44.07 24.12 Favored 'General case' 0 C--O 1.234 0.276 0 N-CA-C 112.069 0.396 . . . . 0.0 112.069 175.678 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . 0.717 ' O ' ' HG2' ' A' ' 84' ' ' LYS . 1.9 m-80 -60.64 -46.85 88.75 Favored 'General case' 0 CA--C 1.514 -0.41 0 C-N-CA 120.326 -0.55 . . . . 0.0 110.288 -179.243 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' MET . . . . . 0.453 ' SD ' ' HZ3' ' A' ' 78' ' ' TRP . 19.0 ttt -63.07 -47.79 81.44 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 120.41 -0.516 . . . . 0.0 111.993 -177.214 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.687 HG13 HD12 ' A' ' 18' ' ' ILE . 7.2 p -64.17 -28.48 44.99 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 C-N-CA 120.308 -0.557 . . . . 0.0 111.41 -177.54 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . 0.435 HG23 HD11 ' A' ' 18' ' ' ILE . 5.0 p -81.17 -21.89 39.37 Favored 'General case' 0 N--CA 1.444 -0.749 0 O-C-N 121.941 -0.475 . . . . 0.0 111.757 176.406 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . 0.717 ' HG2' ' O ' ' A' ' 80' ' ' ASN . 27.1 mmtm -84.73 -38.39 19.75 Favored 'General case' 0 CA--C 1.519 -0.237 0 CA-C-O 121.249 0.547 . . . . 0.0 110.597 178.195 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -80.15 -22.76 41.67 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.241 -0.891 . . . . 0.0 110.305 179.393 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 26.4 mt-30 66.54 76.46 0.3 Allowed 'General case' 0 C--O 1.234 0.268 0 CA-C-N 115.188 -0.914 . . . . 0.0 111.96 177.085 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.543 ' HB2' HG23 ' A' ' 82' ' ' VAL . 89.4 mt -103.85 133.09 49.42 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.426 -0.806 . . . . 0.0 109.065 173.658 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.525 ' HD2' ' H ' ' A' ' 88' ' ' LYS . 0.0 OUTLIER -134.73 157.97 45.34 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.349 0.595 . . . . 0.0 111.96 -175.499 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 124.91 -132.75 8.24 Favored Glycine 0 N--CA 1.447 -0.626 0 N-CA-C 110.224 -1.15 . . . . 0.0 110.224 -173.278 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 57.7 mt -112.03 108.02 24.45 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 173.414 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . 0.657 ' HB3' ' CZ2' ' A' ' 38' ' ' TRP . 7.0 mm-40 -129.04 103.75 7.18 Favored 'General case' 0 N--CA 1.445 -0.708 0 N-CA-C 109.926 -0.398 . . . . 0.0 109.926 -175.828 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.584 HD23 ' HB2' ' A' ' 15' ' ' TYR . 5.1 mp -103.29 151.36 22.79 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-O 121.493 0.663 . . . . 0.0 110.87 -175.765 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 16.7 t-80 -120.77 119.59 33.17 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-N 115.613 -0.722 . . . . 0.0 110.425 -176.912 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 33.7 ttm -71.78 -75.78 0.12 Allowed 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.433 -0.803 . . . . 0.0 110.129 176.363 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 134.94 -95.15 0.26 Allowed Glycine 0 N--CA 1.442 -0.95 0 N-CA-C 111.114 -0.794 . . . . 0.0 111.114 -174.181 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.452 ' HB ' ' HB3' ' A' ' 73' ' ' LYS . 9.2 t -150.49 25.61 0.77 Allowed 'General case' 0 C--N 1.313 -0.981 0 CA-C-O 121.834 0.826 . . . . 0.0 109.287 177.831 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -81.55 72.61 8.6 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 114.86 -1.063 . . . . 0.0 109.766 -179.092 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . 0.591 ' HA ' ' HG3' ' A' ' 101' ' ' MET . 7.4 mmm180 -69.36 -10.91 60.03 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.724 -173.298 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 7.6 m -58.24 -36.81 73.76 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.165 0.507 . . . . 0.0 109.927 175.262 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 24.8 t80 -81.74 -25.43 35.38 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.184 178.782 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' MET . . . . . 0.591 ' HG3' ' HA ' ' A' ' 98' ' ' ARG . 1.3 mmt -58.92 -51.44 70.04 Favored 'General case' 0 CA--C 1.519 -0.245 0 CA-C-O 121.265 0.555 . . . . 0.0 109.507 175.451 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -77.02 -23.03 52.19 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.406 -0.815 . . . . 0.0 110.538 -177.793 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -64.8 -26.93 68.55 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-O 121.12 0.486 . . . . 0.0 111.043 176.931 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' TYR . . . . . 0.555 ' HB3' HG23 ' A' ' 106' ' ' ILE . 0.3 OUTLIER -96.38 -4.11 42.47 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.296 174.875 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 93.5 mt 58.59 32.21 21.91 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.356 -172.301 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . 0.997 HG21 HD11 ' A' ' 113' ' ' ILE . 40.8 pt -114.43 31.96 1.52 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.333 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.356 -178.622 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 15.3 p30 -56.47 -29.74 62.09 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.469 -0.787 . . . . 0.0 111.82 -178.699 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -89.48 108.95 3.54 Favored Glycine 0 N--CA 1.448 -0.525 0 C-N-CA 121.02 -0.61 . . . . 0.0 111.61 174.077 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.549 ' CG2' HG11 ' A' ' 37' ' ' VAL . 2.5 pp -100.43 153.81 37.54 Favored Pre-proline 0 C--N 1.325 -0.466 0 CA-C-O 120.344 0.116 . . . . 0.0 110.767 -177.528 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . 0.429 ' HG3' ' HB2' ' A' ' 42' ' ' CYS . 2.7 Cg_exo -76.82 152.51 95.43 Favored 'Cis proline' 0 C--N 1.344 0.326 0 C-N-CA 123.899 -1.292 . . . . 0.0 111.966 -0.068 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . 0.779 HH11 HG22 ' A' ' 106' ' ' ILE . 0.0 OUTLIER -125.17 138.45 54.14 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.365 0.603 . . . . 0.0 110.966 -179.0 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . 0.611 ' HD1' ' H ' ' A' ' 126' ' ' MET . 0.2 OUTLIER -106.74 114.97 29.39 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 114.341 -1.3 . . . . 0.0 110.354 -176.548 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.997 HD11 HG21 ' A' ' 106' ' ' ILE . 61.6 mt -123.57 142.54 39.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-O 120.858 0.361 . . . . 0.0 110.754 -178.483 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 23.0 tp -129.23 135.14 48.42 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.996 -0.547 . . . . 0.0 109.655 177.662 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.697 ' HB2' ' HB ' ' A' ' 33' ' ' ILE . 2.0 mp -132.57 153.44 51.0 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.878 0.37 . . . . 0.0 110.495 -177.054 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . 0.496 ' HB3' ' HB2' ' A' ' 120' ' ' LYS . 27.9 t0 -68.93 166.1 18.58 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.468 -0.787 . . . . 0.0 110.261 177.276 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . 0.513 ' HA ' ' C ' ' A' ' 31' ' ' LYS . 9.2 mtm180 -49.39 -27.64 4.28 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 124.335 1.054 . . . . 0.0 112.733 -177.076 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . 0.552 ' HB3' ' HG3' ' A' ' 120' ' ' LYS . 30.6 t70 -83.32 -0.97 52.1 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.257 0.551 . . . . 0.0 110.965 -178.784 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 81.26 22.5 60.61 Favored Glycine 0 N--CA 1.439 -1.16 0 N-CA-C 110.203 -1.159 . . . . 0.0 110.203 -170.513 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . 0.552 ' HG3' ' HB3' ' A' ' 118' ' ' ASP . 56.5 mttp -88.56 107.4 18.88 Favored 'General case' 0 C--O 1.223 -0.325 0 C-N-CA 120.478 -0.489 . . . . 0.0 111.052 -178.267 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . 0.479 ' HA ' ' HG ' ' A' ' 115' ' ' LEU . 19.5 mt -42.74 116.27 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-O 121.725 0.774 . . . . 0.0 112.332 179.251 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' ILE . . . . . 0.461 HD11 ' HB2' ' A' ' 116' ' ' ASP . 39.2 mm -97.87 -50.87 10.94 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.927 0 CA-C-N 114.283 -1.326 . . . . 0.0 109.203 177.163 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 14.6 m -129.44 114.21 15.87 Favored 'General case' 0 N--CA 1.446 -0.664 0 CA-C-N 115.22 -0.9 . . . . 0.0 110.113 179.305 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -68.05 -20.38 64.97 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 121.807 0.813 . . . . 0.0 109.496 174.046 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 7.4 p30 -141.46 122.07 14.23 Favored 'General case' 0 N--CA 1.447 -0.586 0 CA-C-N 114.523 -1.217 . . . . 0.0 108.25 171.291 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' MET . . . . . 0.611 ' H ' ' HD1' ' A' ' 112' ' ' PHE . 17.3 tpt -92.76 -80.66 0.37 Allowed 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.915 -176.664 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 4.2 m -155.44 -61.91 0.11 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.576 -0.284 . . . . 0.0 110.48 179.605 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . 1.087 ' HB3' ' HB2' ' A' ' 131' ' ' ASP . 0.0 OUTLIER -179.82 142.1 0.35 Allowed Pre-proline 0 N--CA 1.453 -0.314 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 -176.467 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . 0.566 ' HD2' ' HG2' ' A' ' 128' ' ' ARG . 1.5 Cg_endo -43.19 -49.0 7.58 Favored 'Trans proline' 0 C--N 1.351 0.671 0 C-N-CA 123.431 2.754 . . . . 0.0 113.353 -178.626 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 25.3 t -113.24 29.72 7.76 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.821 0.343 . . . . 0.0 111.196 -177.561 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . 1.087 ' HB2' ' HB3' ' A' ' 128' ' ' ARG . 11.2 t70 -84.88 135.94 39.39 Favored Pre-proline 0 C--N 1.328 -0.341 0 C-N-CA 120.389 -0.525 . . . . 0.0 110.426 -179.975 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 80.8 Cg_exo -48.24 -37.82 32.34 Favored 'Trans proline' 0 C--N 1.344 0.303 0 C-N-CA 123.231 2.621 . . . . 0.0 113.258 176.66 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 28.9 mmtm -56.98 -36.22 70.1 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-O 120.866 0.365 . . . . 0.0 111.711 -177.336 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' THR . . . . . 0.684 HG22 ' CZ ' ' A' ' 138' ' ' PHE . 2.4 m -64.51 -51.19 64.22 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.284 0.564 . . . . 0.0 109.69 177.244 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . 0.672 ' HA ' ' CD2' ' A' ' 138' ' ' PHE . . . -61.56 -41.01 96.75 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.583 -0.735 . . . . 0.0 111.542 177.576 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -53.5 -52.1 60.67 Favored 'General case' 0 CA--C 1.511 -0.531 0 CA-C-O 121.44 0.638 . . . . 0.0 110.458 176.882 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . 0.707 ' HE2' ' HA ' ' A' ' 137' ' ' LYS . 0.3 OUTLIER -48.93 -46.56 43.26 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 114.333 -1.303 . . . . 0.0 111.261 175.614 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . 0.684 ' CZ ' HG22 ' A' ' 134' ' ' THR . 5.9 m-85 -63.1 -53.77 48.29 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 120.889 0.376 . . . . 0.0 109.991 178.4 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 94.2 m-20 -50.9 -50.12 58.04 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.789 -179.886 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -49.41 -54.47 17.35 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.648 -0.705 . . . . 0.0 112.133 178.17 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.55 ' HG ' ' O ' ' A' ' 138' ' ' PHE . 3.2 pp -69.35 -19.38 63.85 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 120.953 -0.299 . . . . 0.0 111.206 -174.842 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 0.536 HD21 ' HD2' ' A' ' 62' ' ' LYS . 8.2 mp . . . . . 0 C--N 1.331 -0.215 0 CA-C-O 120.907 0.384 . . . . 0.0 110.56 173.418 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.359 0 CA-C-O 121.542 0.687 . . . . 0.0 110.499 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -138.77 99.22 3.74 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 115.131 -0.94 . . . . 0.0 110.216 -179.752 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 49.0 m 64.7 80.02 0.24 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.405 -0.816 . . . . 0.0 111.454 179.463 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 53.5 p90 -96.08 155.32 16.81 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.116 178.014 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 5.4 p -142.1 112.92 7.35 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 120.98 0.419 . . . . 0.0 110.147 177.307 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . 0.559 ' HB2' HD13 ' A' ' 92' ' ' LEU . 35.8 m-85 -135.75 149.7 69.69 Favored Pre-proline 0 C--N 1.326 -0.431 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.413 -176.38 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.456 ' HA ' ' O ' ' A' ' 21' ' ' LYS . 97.3 Cg_endo -87.07 131.37 3.11 Favored 'Trans proline' 0 N--CA 1.452 -0.946 0 C-N-CA 122.528 2.152 . . . . 0.0 113.23 179.808 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . 0.506 ' HB3' ' HB3' ' A' ' 21' ' ' LYS . 12.1 t70 -67.95 154.49 41.49 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 114.958 -1.019 . . . . 0.0 108.63 170.403 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -53.21 -32.93 19.75 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.6 0 O-C-N 124.018 0.824 . . . . 0.0 110.883 -179.391 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 43.7 m-80 -76.29 -1.77 28.23 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 121.089 0.471 . . . . 0.0 110.82 179.051 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 86.05 42.11 6.83 Favored Glycine 0 N--CA 1.446 -0.647 0 CA-C-N 115.739 -0.664 . . . . 0.0 112.172 -179.619 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.506 ' HB3' ' HB3' ' A' ' 17' ' ' ASP . 56.8 tttm -107.71 124.2 49.66 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 120.173 -0.611 . . . . 0.0 111.252 -179.453 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 19.4 m -66.49 107.38 2.04 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.29 -0.414 . . . . 0.0 109.945 172.652 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.444 ' HB ' HD21 ' A' ' 92' ' ' LEU . 91.6 t -116.35 117.32 55.1 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-O 120.996 0.427 . . . . 0.0 109.909 178.342 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 17.6 m -122.77 179.47 4.62 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.288 -178.15 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.418 HD11 ' HA3' ' A' ' 119' ' ' GLY . 52.7 tp -56.4 -42.28 77.7 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.924 0.393 . . . . 0.0 111.027 -179.287 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -82.27 15.91 2.24 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.86 -177.793 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -102.18 -17.08 16.14 Favored 'General case' 0 CA--C 1.517 -0.294 0 N-CA-C 107.692 -1.225 . . . . 0.0 107.692 178.319 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -117.22 -20.81 9.07 Favored 'General case' 0 N--CA 1.445 -0.723 0 CA-C-N 113.973 -1.467 . . . . 0.0 110.494 -179.323 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 58.3 tttm -61.71 132.07 52.0 Favored 'General case' 0 N--CA 1.446 -0.662 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.273 -173.931 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 120.5 -8.59 11.03 Favored Glycine 0 N--CA 1.451 -0.328 0 N-CA-C 110.61 -0.996 . . . . 0.0 110.61 -174.496 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.687 ' HD3' ' HA ' ' A' ' 63' ' ' ASP . 25.2 ttmm -155.63 154.96 32.44 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 -178.784 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.445 ' HB2' ' O ' ' A' ' 63' ' ' ASP . 61.8 m-85 -59.07 147.1 36.12 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-O 121.094 0.473 . . . . 0.0 111.601 -174.482 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.553 HD12 ' HA2' ' A' ' 119' ' ' GLY . 40.0 mt -124.45 134.77 65.83 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.439 -175.633 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . 0.414 ' HE2' ' HB3' ' A' ' 36' ' ' ASP . 80.3 t80 -121.79 130.71 53.61 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 173.177 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.547 ' HA ' ' O ' ' A' ' 67' ' ' VAL . 62.5 mt -115.2 110.76 33.1 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-O 121.093 0.473 . . . . 0.0 110.577 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.582 ' O ' ' HA ' ' A' ' 68' ' ' SER . 7.1 p-10 -110.34 158.97 17.87 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-N 115.5 -0.773 . . . . 0.0 109.063 175.257 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.522 HG11 HG21 ' A' ' 109' ' ' ILE . 85.5 t -102.88 126.68 57.09 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.806 0 C-N-CA 120.144 -0.622 . . . . 0.0 111.119 176.598 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' TRP . . . . . 0.588 ' CE3' ' CZ2' ' A' ' 78' ' ' TRP . 0.7 OUTLIER -113.31 130.49 56.25 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 109.368 -0.605 . . . . 0.0 109.368 177.958 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -150.19 167.47 26.81 Favored 'General case' 0 C--N 1.328 -0.354 0 O-C-N 122.362 -0.211 . . . . 0.0 111.039 -178.497 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . 0.601 HG22 ' OD2' ' A' ' 72' ' ' ASP . 13.8 t -108.85 -33.63 6.89 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 120.696 -0.401 . . . . 0.0 110.694 174.313 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' TRP . . . . . 0.726 ' HE1' ' HA ' ' A' ' 72' ' ' ASP . 65.6 p-90 -73.94 -9.24 58.44 Favored 'General case' 0 C--N 1.343 0.291 0 C-N-CA 120.319 -0.552 . . . . 0.0 111.002 178.489 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 25.5 t -63.55 -57.57 9.72 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.102 -179.917 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 107.28 -85.18 0.41 Allowed Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.642 -0.789 . . . . 0.0 112.493 -176.712 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_exo -53.42 -28.63 45.04 Favored 'Trans proline' 0 C--N 1.354 0.818 0 C-N-CA 123.134 2.556 . . . . 0.0 112.727 179.277 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 42.4 t -54.13 -29.15 44.06 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.055 176.963 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 54.8 mtp180 -83.65 -26.23 30.08 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-O 120.903 0.382 . . . . 0.0 110.695 -179.701 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -80.52 -36.67 22.65 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.865 -0.683 . . . . 0.0 111.689 -179.335 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . 0.422 ' OE2' ' HD2' ' A' ' 128' ' ' ARG . 21.3 mt-10 -90.23 10.36 24.95 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.292 0.568 . . . . 0.0 109.985 177.95 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.546 ' N ' ' HD2' ' A' ' 50' ' ' PRO . 20.2 tp -69.05 -45.99 30.24 Favored Pre-proline 0 N--CA 1.441 -0.89 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.869 -177.936 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.546 ' HD2' ' N ' ' A' ' 49' ' ' LEU . 11.7 Cg_endo -56.83 -22.28 44.59 Favored 'Trans proline' 0 C--N 1.351 0.698 0 C-N-CA 121.565 1.51 . . . . 0.0 111.363 171.379 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -85.05 -31.38 23.44 Favored 'General case' 0 CA--C 1.515 -0.386 0 CA-C-O 121.924 0.869 . . . . 0.0 108.895 -179.233 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 6.0 tt -69.94 -48.07 59.88 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-N 114.443 -1.253 . . . . 0.0 108.573 178.228 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.687 ' HZ3' ' HB3' ' A' ' 53' ' ' LYS . 7.6 mtpm? -58.83 -49.37 77.99 Favored 'General case' 0 C--O 1.225 -0.193 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.751 179.119 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -46.03 -56.37 5.64 Favored 'General case' 0 C--N 1.332 -0.16 0 O-C-N 123.514 0.509 . . . . 0.0 111.586 176.397 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.598 HD21 ' HE2' ' A' ' 138' ' ' PHE . 38.8 tp -66.95 -48.7 67.75 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.255 -178.392 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.437 ' HA ' ' CE2' ' A' ' 66' ' ' PHE . 5.9 tm-20 -59.03 -55.1 39.47 Favored 'General case' 0 N--CA 1.448 -0.553 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.563 -175.998 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.674 ' HG2' ' NZ ' ' A' ' 88' ' ' LYS . 38.2 mt-10 -70.12 -30.43 67.62 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.724 0.297 . . . . 0.0 111.244 -174.73 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . 0.482 ' HE3' ' HB2' ' A' ' 58' ' ' LYS . 34.3 ttmt -69.96 -41.77 74.07 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-O 121.198 0.523 . . . . 0.0 110.665 179.237 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 17.2 m-85 -100.3 7.82 44.12 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.473 -177.032 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -65.11 136.19 56.41 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.258 -0.428 . . . . 0.0 109.941 173.245 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 82.61 1.52 90.53 Favored Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.407 179.187 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.452 ' O ' ' HD3' ' A' ' 31' ' ' LYS . 34.8 mmtm -90.59 -154.16 0.33 Allowed 'General case' 0 CA--C 1.515 -0.395 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 176.601 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . 0.687 ' HA ' ' HD3' ' A' ' 31' ' ' LYS . 2.6 t70 -95.1 47.26 1.14 Allowed 'General case' 0 C--N 1.318 -0.762 0 CA-C-O 121.35 0.595 . . . . 0.0 110.344 179.153 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 13.3 tt -155.16 135.31 4.18 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.721 0 CA-C-N 115.582 -0.735 . . . . 0.0 109.961 178.038 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' HIS . . . . . 0.659 ' NE2' ' HB3' ' A' ' 31' ' ' LYS . 75.3 m-70 -105.0 114.27 28.38 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 176.911 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . 0.453 ' CZ ' ' HG ' ' A' ' 55' ' ' LEU . 73.6 m-85 -78.4 104.81 9.23 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 172.442 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.547 ' O ' ' HA ' ' A' ' 35' ' ' ILE . 48.4 t -117.49 104.46 16.42 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.884 -178.359 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . 0.582 ' HA ' ' O ' ' A' ' 36' ' ' ASP . 23.3 p -89.26 146.03 25.0 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.169 -179.8 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.471 ' O ' HG13 ' A' ' 37' ' ' VAL . 64.8 tp -124.12 126.84 46.87 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 109.689 -0.486 . . . . 0.0 109.689 176.77 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . 0.487 ' HB3' ' HA ' ' A' ' 93' ' ' HIS . 19.3 t -103.94 109.03 20.62 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.435 0.636 . . . . 0.0 112.29 -174.301 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 6.8 m -81.02 25.11 0.48 Allowed 'General case' 0 C--N 1.314 -0.974 0 CA-C-N 115.067 -0.969 . . . . 0.0 110.188 169.553 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.726 ' HA ' ' HE1' ' A' ' 41' ' ' TRP . 2.9 t70 -72.79 129.74 38.89 Favored 'General case' 0 CA--C 1.51 -0.578 0 C-N-CA 119.899 -0.72 . . . . 0.0 110.174 -178.646 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.494 ' NZ ' ' HB3' ' A' ' 73' ' ' LYS . 3.0 ttpm? -88.02 -11.95 45.81 Favored 'General case' 0 C--N 1.313 -0.979 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.338 -177.856 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 -104.39 60.04 0.71 Allowed 'General case' 0 CA--C 1.51 -0.595 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 -176.779 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.64 ' O ' ' HG2' ' A' ' 79' ' ' GLU . 64.9 tttt -47.75 -51.33 22.59 Favored 'General case' 0 C--O 1.221 -0.414 0 O-C-N 123.644 0.59 . . . . 0.0 112.447 -170.029 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 23.6 tptm -48.3 -54.24 14.45 Favored 'General case' 0 C--O 1.245 0.855 0 CA-C-N 116.735 -0.211 . . . . 0.0 110.456 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.587 ' HA ' HD21 ' A' ' 80' ' ' ASN . . . -61.27 -39.86 91.95 Favored 'General case' 0 N--CA 1.452 -0.355 0 O-C-N 123.972 0.795 . . . . 0.0 110.034 -178.844 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' TRP . . . . . 0.588 ' CZ2' ' CE3' ' A' ' 38' ' ' TRP . 9.3 t-105 -61.43 -58.51 7.88 Favored 'General case' 0 N--CA 1.437 -1.088 0 CA-C-N 114.96 -1.018 . . . . 0.0 112.263 -179.458 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.64 ' HG2' ' O ' ' A' ' 75' ' ' LYS . 3.3 mm-40 -52.25 -48.04 65.43 Favored 'General case' 0 C--O 1.236 0.39 0 N-CA-C 112.426 0.528 . . . . 0.0 112.426 -175.669 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . 0.587 HD21 ' HA ' ' A' ' 77' ' ' ALA . 8.4 p30 -71.16 -28.82 64.53 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 118.859 -1.136 . . . . 0.0 110.852 -178.159 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 15.3 ttt -68.19 -47.81 66.93 Favored 'General case' 0 C--O 1.222 -0.359 0 C-N-CA 120.978 -0.289 . . . . 0.0 111.542 177.518 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.586 HG23 ' HB2' ' A' ' 87' ' ' LEU . 0.2 OUTLIER -58.69 -37.9 68.44 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.313 0 C-N-CA 120.429 -0.509 . . . . 0.0 110.205 178.72 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 25.3 m -67.34 -33.31 74.97 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.81 177.376 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 21.0 tttm -80.25 -49.97 10.86 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.699 -177.958 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 52.8 m-20 -84.37 6.79 21.78 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.633 -0.712 . . . . 0.0 111.406 -173.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 89.7 mt-30 64.28 41.72 5.8 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 115.72 -0.673 . . . . 0.0 112.745 171.007 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.586 ' HB2' HG23 ' A' ' 82' ' ' VAL . 7.9 mp -83.95 82.11 8.49 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 120.758 -0.377 . . . . 0.0 110.218 176.036 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.674 ' NZ ' ' HG2' ' A' ' 57' ' ' GLU . 0.0 OUTLIER -95.79 171.53 8.59 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.594 -0.276 . . . . 0.0 111.676 -179.852 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 128.07 -139.74 11.3 Favored Glycine 0 N--CA 1.452 -0.258 0 N-CA-C 110.286 -1.126 . . . . 0.0 110.286 -175.795 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 63.8 mt -111.44 109.05 27.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 N-CA-C 107.935 -1.135 . . . . 0.0 107.935 168.408 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . 0.541 ' HB3' ' CZ2' ' A' ' 38' ' ' TRP . 3.5 mm100 -127.73 100.22 5.87 Favored 'General case' 0 N--CA 1.442 -0.85 0 CA-C-O 120.838 0.351 . . . . 0.0 110.953 -167.669 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.559 HD13 ' HB2' ' A' ' 15' ' ' TYR . 27.0 mt -97.22 140.58 31.49 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 120.817 0.342 . . . . 0.0 110.787 -177.133 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' HIS . . . . . 0.547 ' CE1' ' HG3' ' A' ' 75' ' ' LYS . 30.0 t-80 -114.53 120.63 40.88 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 120.864 0.364 . . . . 0.0 110.896 178.301 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 19.7 ttp -79.0 -55.83 4.84 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.74 -0.664 . . . . 0.0 109.999 176.553 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . 0.453 ' HA2' ' NE2' ' A' ' 93' ' ' HIS . . . 111.19 -119.33 5.14 Favored Glycine 0 N--CA 1.438 -1.178 0 C-N-CA 120.557 -0.83 . . . . 0.0 111.879 -179.465 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 8.9 t -109.85 21.71 16.55 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-O 120.555 0.217 . . . . 0.0 110.994 -175.28 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -90.84 134.17 34.65 Favored 'General case' 0 CA--C 1.515 -0.383 0 C-N-CA 119.699 -0.8 . . . . 0.0 109.74 179.9 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . 0.598 ' HA ' ' HG3' ' A' ' 101' ' ' MET . 0.0 OUTLIER -113.71 6.08 16.69 Favored 'General case' 0 C--N 1.32 -0.676 0 C-N-CA 120.361 -0.536 . . . . 0.0 110.699 176.689 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 4.0 m -71.0 -39.68 72.29 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.373 -178.611 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 27.7 t80 -82.24 -30.61 30.65 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.585 -176.948 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' MET . . . . . 0.598 ' HG3' ' HA ' ' A' ' 98' ' ' ARG . 4.7 ppp? -74.68 -20.92 59.67 Favored 'General case' 0 C--N 1.332 -0.168 0 C-N-CA 120.144 -0.622 . . . . 0.0 109.495 177.554 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -68.0 -42.81 80.18 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.41 -0.814 . . . . 0.0 109.8 172.331 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -64.46 -16.99 63.4 Favored 'General case' 0 CA--C 1.529 0.158 0 CA-C-N 115.674 -0.694 . . . . 0.0 111.815 -177.621 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 9.0 m-85 -108.28 -2.32 19.35 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.402 178.212 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 7.8 mp 55.34 37.64 29.18 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.812 -176.793 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . 0.855 HG12 ' HG3' ' A' ' 111' ' ' ARG . 60.8 mt -59.41 106.51 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.006 177.906 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 7.1 m120 -73.79 -66.18 0.74 Allowed 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.626 0.727 . . . . 0.0 109.938 178.483 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -135.14 145.82 17.88 Favored Glycine 0 N--CA 1.438 -1.216 0 CA-C-N 114.971 -1.013 . . . . 0.0 111.12 178.979 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.522 HG21 HG11 ' A' ' 37' ' ' VAL . 40.2 pt -100.53 154.3 37.26 Favored Pre-proline 0 C--N 1.316 -0.85 0 N-CA-C 110.34 -0.244 . . . . 0.0 110.34 179.736 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . 0.487 ' HB3' ' O ' ' A' ' 37' ' ' VAL . 15.9 Cg_exo -69.1 131.73 19.34 Favored 'Cis proline' 0 C--N 1.348 0.515 0 C-N-CA 123.973 -1.261 . . . . 0.0 113.54 0.656 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . 0.855 ' HG3' HG12 ' A' ' 106' ' ' ILE . 0.0 OUTLIER -82.26 160.3 22.99 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 175.215 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . 0.429 ' HD2' ' HB2' ' A' ' 128' ' ' ARG . 0.2 OUTLIER -130.45 114.43 15.52 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.76 -0.654 . . . . 0.0 109.958 -177.445 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.516 ' HB ' ' HB ' ' A' ' 35' ' ' ILE . 81.5 mt -134.44 142.88 39.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-O 120.735 0.303 . . . . 0.0 111.142 -176.306 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.491 ' HB2' ' SD ' ' A' ' 126' ' ' MET . 41.2 tp -127.13 140.41 52.28 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.262 178.689 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.492 ' HB2' ' HB ' ' A' ' 33' ' ' ILE . 1.9 mp -133.29 150.0 51.91 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.302 0.572 . . . . 0.0 110.042 178.152 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . 0.624 ' HB3' ' HB2' ' A' ' 120' ' ' LYS . 14.1 t70 -70.29 164.3 24.7 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.029 -0.987 . . . . 0.0 110.604 178.905 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . 0.405 ' HA ' ' C ' ' A' ' 31' ' ' LYS . 84.5 mtt180 -48.13 -38.09 17.05 Favored 'General case' 0 N--CA 1.464 0.247 0 O-C-N 124.198 0.936 . . . . 0.0 112.613 -178.63 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -80.54 9.77 5.61 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.638 0.256 . . . . 0.0 111.607 -178.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . 0.553 ' HA2' HD12 ' A' ' 33' ' ' ILE . . . 79.04 28.81 53.34 Favored Glycine 0 N--CA 1.445 -0.744 0 N-CA-C 111.244 -0.743 . . . . 0.0 111.244 -176.988 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . 0.624 ' HB2' ' HB3' ' A' ' 116' ' ' ASP . 32.4 mtmm -99.47 104.29 16.11 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 120.674 -0.411 . . . . 0.0 110.742 -175.147 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . 0.676 ' H ' HD12 ' A' ' 121' ' ' ILE . 4.0 mp -43.65 111.57 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-O 121.31 0.576 . . . . 0.0 111.396 -178.286 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' ILE . . . . . 0.451 ' H ' ' HA ' ' A' ' 115' ' ' LEU . 58.7 mt -85.59 -41.3 15.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 115.337 -0.847 . . . . 0.0 109.18 178.921 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 17.3 m -149.72 115.44 5.6 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.416 -0.811 . . . . 0.0 110.299 -179.522 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -69.92 -15.22 63.03 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.348 0.594 . . . . 0.0 110.307 174.937 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 18.1 p-10 -139.95 102.77 4.48 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.313 -0.858 . . . . 0.0 110.066 174.24 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' MET . . . . . 0.491 ' SD ' ' HB2' ' A' ' 114' ' ' LEU . 20.8 ttp -107.97 -133.4 0.33 Allowed 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.036 -0.529 . . . . 0.0 109.676 178.602 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 6.3 p -124.69 138.07 54.32 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 110.149 -0.315 . . . . 0.0 110.149 177.328 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . 0.43 ' CG ' ' HD2' ' A' ' 129' ' ' PRO . 37.9 ttm180 -67.78 147.36 98.59 Favored Pre-proline 0 C--N 1.325 -0.475 0 CA-C-N 116.198 -0.455 . . . . 0.0 109.874 177.565 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . 0.43 ' HD2' ' CG ' ' A' ' 128' ' ' ARG . 2.9 Cg_endo -42.62 -25.82 0.54 Allowed 'Trans proline' 0 C--N 1.356 0.966 0 C-N-CA 124.119 3.213 . . . . 0.0 114.226 177.095 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 1.4 m -57.76 -26.05 61.32 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 122.723 0.409 . . . . 0.0 111.708 178.432 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . 0.479 ' OD1' ' HG3' ' A' ' 133' ' ' LYS . 21.1 t0 -99.05 124.88 43.76 Favored Pre-proline 0 C--N 1.329 -0.32 0 N-CA-C 109.938 -0.393 . . . . 0.0 109.938 179.511 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 28.7 Cg_endo -61.0 -18.11 55.73 Favored 'Trans proline' 0 C--N 1.347 0.489 0 C-N-CA 123.273 2.648 . . . . 0.0 113.788 -178.081 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . 0.479 ' HG3' ' OD1' ' A' ' 131' ' ' ASP . 48.6 mttp -58.2 -23.93 57.31 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-O 120.833 0.349 . . . . 0.0 110.605 178.843 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 36.2 p -58.39 -59.32 5.53 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.235 175.494 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -56.75 -47.17 80.66 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.917 -177.907 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -56.63 -39.9 74.47 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.44 -0.8 . . . . 0.0 111.15 -179.633 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . 0.514 ' O ' ' HG ' ' A' ' 141' ' ' LEU . 75.5 tttt -74.08 -34.09 63.88 Favored 'General case' 0 N--CA 1.451 -0.396 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.883 -179.271 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . 0.598 ' HE2' HD21 ' A' ' 55' ' ' LEU . 11.1 m-30 -64.43 -40.22 95.33 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 109.689 -0.486 . . . . 0.0 109.689 177.747 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 75.6 m-20 -58.17 -45.74 86.96 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.69 -0.686 . . . . 0.0 109.66 174.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -60.58 -48.07 83.39 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.067 177.467 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.514 ' HG ' ' O ' ' A' ' 137' ' ' LYS . 95.5 mt -56.38 -45.59 80.46 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.776 -179.402 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 0.543 HD13 ' HB2' ' A' ' 63' ' ' ASP . 60.0 tp . . . . . 0 C--N 1.33 -0.278 0 CA-C-O 121.201 0.524 . . . . 0.0 110.811 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.441 ' HA ' ' CZ ' ' A' ' 100' ' ' PHE . . . . . . . . 0 N--CA 1.455 -0.191 0 CA-C-O 121.308 0.575 . . . . 0.0 109.884 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -128.38 13.24 6.56 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.344 -0.844 . . . . 0.0 110.535 -178.644 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 35.6 p -143.16 18.34 1.92 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.13 0.491 . . . . 0.0 110.852 -179.747 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 49.5 p90 -73.81 149.64 41.54 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.055 -0.521 . . . . 0.0 111.008 -176.958 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . 0.466 ' HA ' ' HA ' ' A' ' 24' ' ' SER . 39.1 m -142.22 117.23 9.98 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.773 -0.649 . . . . 0.0 109.377 176.811 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . 0.538 ' HB2' HD22 ' A' ' 92' ' ' LEU . 57.5 m-85 -128.32 145.68 56.64 Favored Pre-proline 0 C--N 1.323 -0.55 0 CA-C-O 120.851 0.357 . . . . 0.0 111.236 -176.321 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 63.2 Cg_endo -76.07 125.39 8.58 Favored 'Trans proline' 0 N--CA 1.459 -0.553 0 C-N-CA 122.434 2.089 . . . . 0.0 113.449 -179.029 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . 0.68 ' HB3' ' HB3' ' A' ' 21' ' ' LYS . 3.3 t70 -64.15 157.36 25.79 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.044 -0.98 . . . . 0.0 108.528 168.007 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.526 HD12 ' CG1' ' A' ' 82' ' ' VAL . 3.4 tt -50.06 -39.04 15.41 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.519 0 O-C-N 123.959 0.787 . . . . 0.0 111.561 -173.867 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 37.8 m-80 -75.61 3.8 8.87 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.474 -175.407 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 82.59 37.77 13.42 Favored Glycine 0 N--CA 1.445 -0.719 0 N-CA-C 111.186 -0.765 . . . . 0.0 111.186 -176.739 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.68 ' HB3' ' HB3' ' A' ' 17' ' ' ASP . 4.2 tmmt? -110.72 120.9 43.92 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.723 0.297 . . . . 0.0 110.333 -177.786 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 26.0 m -70.68 101.66 2.11 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-O 120.956 0.407 . . . . 0.0 110.917 -177.039 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.518 ' HB ' HD23 ' A' ' 92' ' ' LEU . 41.5 t -92.61 109.26 21.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 175.703 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . 0.466 ' HA ' ' HA ' ' A' ' 14' ' ' SER . 57.4 p -106.16 175.86 5.36 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.204 -177.956 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.49 HD11 ' HA3' ' A' ' 119' ' ' GLY . 2.9 tm? -58.42 -33.7 69.98 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 109.662 -0.496 . . . . 0.0 109.662 176.098 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -74.32 -25.86 59.81 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.735 -178.456 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -69.17 -32.47 71.82 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-O 121.523 0.678 . . . . 0.0 110.472 -179.556 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.661 HD13 HG21 ' A' ' 67' ' ' VAL . 68.9 mt -100.35 -8.6 23.17 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.56 -0.745 . . . . 0.0 110.902 -178.623 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 56.1 tttp -70.75 138.45 50.49 Favored 'General case' 0 N--CA 1.443 -0.813 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.219 -173.874 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 109.22 -3.64 31.4 Favored Glycine 0 N--CA 1.446 -0.656 0 N-CA-C 111.203 -0.759 . . . . 0.0 111.203 -176.96 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.581 ' HD3' ' HA ' ' A' ' 63' ' ' ASP . 21.6 ttmm -154.1 150.25 27.98 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 -179.486 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.484 ' CD1' ' HA ' ' A' ' 116' ' ' ASP . 29.1 m-85 -59.99 148.68 34.53 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 121.145 0.498 . . . . 0.0 111.667 -175.829 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.488 ' HB ' ' HB2' ' A' ' 115' ' ' LEU . 55.3 mt -123.39 128.12 74.59 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.772 -175.602 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 91.7 t80 -118.16 110.19 17.29 Favored 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 108.72 -0.845 . . . . 0.0 108.72 173.395 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.563 ' HB ' ' HB ' ' A' ' 113' ' ' ILE . 68.0 mt -97.48 126.03 50.45 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-O 121.06 0.457 . . . . 0.0 111.135 -175.455 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.444 ' HA ' ' O ' ' A' ' 111' ' ' ARG . 3.2 p30 -113.04 159.33 19.27 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 173.18 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.522 HG21 HG21 ' A' ' 106' ' ' ILE . 61.6 t -105.05 131.19 54.83 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.933 0 C-N-CA 120.36 -0.536 . . . . 0.0 111.055 173.427 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' TRP . . . . . 0.575 ' CZ2' ' HB2' ' A' ' 91' ' ' GLN . 0.4 OUTLIER -125.05 134.17 52.63 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-O 120.748 0.308 . . . . 0.0 110.718 -179.014 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -147.74 162.04 40.01 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 116.646 -0.252 . . . . 0.0 110.588 178.377 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . 0.727 ' HB ' ' CE3' ' A' ' 78' ' ' TRP . 12.2 t -99.6 -10.12 22.41 Favored 'General case' 0 N--CA 1.462 0.136 0 C-N-CA 120.537 -0.465 . . . . 0.0 111.528 179.845 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' TRP . . . . . 0.502 ' HE1' ' HA ' ' A' ' 72' ' ' ASP . 9.7 p-90 -99.02 15.88 24.37 Favored 'General case' 0 CA--C 1.51 -0.595 0 CA-C-O 122.56 1.171 . . . . 0.0 108.025 -177.381 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' CYS . . . . . 0.592 ' SG ' HD12 ' A' ' 109' ' ' ILE . 99.6 m -123.18 135.95 54.54 Favored 'General case' 0 N--CA 1.429 -1.505 0 CA-C-N 113.267 -1.788 . . . . 0.0 109.398 -178.212 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.716 ' H ' ' HD2' ' A' ' 44' ' ' PRO . . . -101.92 -49.86 1.22 Allowed Glycine 0 CA--C 1.525 0.671 0 CA-C-O 119.203 -0.776 . . . . 0.0 113.879 -177.945 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.716 ' HD2' ' H ' ' A' ' 43' ' ' GLY . 10.5 Cg_endo -53.38 -34.6 71.77 Favored 'Trans proline' 0 C--N 1.357 1.022 0 C-N-CA 122.8 2.333 . . . . 0.0 112.826 -176.661 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . 0.652 ' O ' ' HG ' ' A' ' 49' ' ' LEU . 18.4 p -58.42 -34.06 70.37 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.109 179.547 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.534 ' HG2' HD12 ' A' ' 49' ' ' LEU . 33.8 mtt85 -72.01 -8.01 52.04 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.787 -174.811 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -74.79 -33.87 54.49 Favored Glycine 0 N--CA 1.446 -0.677 0 C-N-CA 120.428 -0.892 . . . . 0.0 111.979 177.262 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . 0.546 ' OE2' ' HD2' ' A' ' 129' ' ' PRO . 7.4 pt-20 -112.69 -0.49 15.05 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 112.198 0.444 . . . . 0.0 112.198 -177.478 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.652 ' HG ' ' O ' ' A' ' 45' ' ' CYS . 34.7 mt -55.05 -49.6 91.26 Favored Pre-proline 0 N--CA 1.468 0.443 0 N-CA-C 112.29 0.478 . . . . 0.0 112.29 177.069 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.563 ' HD3' ' HB2' ' A' ' 49' ' ' LEU . 77.2 Cg_exo -52.72 -44.33 48.73 Favored 'Trans proline' 0 C--N 1.357 1.016 0 C-N-CA 121.901 1.734 . . . . 0.0 112.161 176.483 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -73.61 -31.09 63.38 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.235 0.54 . . . . 0.0 110.563 -178.037 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.448 ' O ' ' HB2' ' A' ' 55' ' ' LEU . 6.5 tt -64.1 -53.44 49.7 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.264 -0.88 . . . . 0.0 109.885 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.689 ' O ' ' HG3' ' A' ' 57' ' ' GLU . 17.7 pttp -60.97 -39.64 90.36 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.121 179.71 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.472 ' HG3' ' O ' ' A' ' 50' ' ' PRO . 18.3 mt-10 -68.6 -29.06 67.5 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.469 -178.915 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.51 HD12 ' HB3' ' A' ' 129' ' ' PRO . 12.6 mt -59.32 -47.17 86.39 Favored 'General case' 0 N--CA 1.448 -0.55 0 N-CA-C 109.753 -0.462 . . . . 0.0 109.753 172.044 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 1.025 ' HG2' ' HA2' ' A' ' 89' ' ' GLY . 8.2 tp10 -65.18 -43.49 91.48 Favored 'General case' 0 C--O 1.218 -0.591 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.2 177.498 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.689 ' HG3' ' O ' ' A' ' 53' ' ' LYS . 37.1 mt-10 -61.42 -22.57 65.13 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.126 0.489 . . . . 0.0 110.776 179.773 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 63.2 tttp -85.45 -39.46 17.49 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.668 177.197 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.406 ' HB2' ' HE1' ' A' ' 66' ' ' PHE . 83.1 m-85 -110.48 18.29 19.92 Favored 'General case' 0 C--O 1.235 0.339 0 N-CA-C 111.859 0.318 . . . . 0.0 111.859 -173.556 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.409 ' HA ' ' OE2' ' A' ' 56' ' ' GLU . . . -56.48 117.16 3.58 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.914 -177.315 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 75.65 -3.5 49.01 Favored Glycine 0 N--CA 1.45 -0.428 0 CA-C-N 115.768 -0.651 . . . . 0.0 113.237 175.848 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.487 ' HA ' ' HD3' ' A' ' 62' ' ' LYS . 30.4 mmtm -66.56 -80.87 0.04 OUTLIER 'General case' 0 CA--C 1.515 -0.394 0 CA-C-O 120.956 0.408 . . . . 0.0 110.561 -178.082 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . 0.581 ' HA ' ' HD3' ' A' ' 31' ' ' LYS . 14.5 t0 -156.87 28.89 0.31 Allowed 'General case' 0 C--N 1.313 -0.983 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.904 170.343 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 5.3 mp -142.53 133.89 24.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 115.888 -0.596 . . . . 0.0 109.528 178.667 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' HIS . . . . . 0.509 ' NE2' ' HB3' ' A' ' 31' ' ' LYS . 99.4 m-70 -107.21 116.43 31.91 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 109.241 -0.652 . . . . 0.0 109.241 172.312 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . 0.563 ' HB2' ' HB2' ' A' ' 56' ' ' GLU . 76.4 m-85 -87.85 103.32 15.54 Favored 'General case' 0 C--N 1.316 -0.866 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 174.286 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.722 ' HA ' ' O ' ' A' ' 90' ' ' ILE . 47.3 t -111.39 110.33 31.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 115.505 -0.77 . . . . 0.0 111.348 -169.641 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . 0.426 ' HB3' ' CG ' ' A' ' 38' ' ' TRP . 14.0 m -88.25 125.26 34.56 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 115.531 -0.758 . . . . 0.0 110.489 -179.642 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.493 HD11 ' HB2' ' A' ' 94' ' ' MET . 55.1 tp -113.57 121.19 43.46 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 122.784 0.433 . . . . 0.0 110.358 178.84 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . 0.482 ' HB2' ' CD1' ' A' ' 38' ' ' TRP . 10.2 t -109.15 116.9 32.82 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 112.488 0.551 . . . . 0.0 112.488 -174.188 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 42.8 t -86.09 21.93 1.87 Allowed 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.208 173.907 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.614 ' OD2' HG22 ' A' ' 40' ' ' THR . 5.4 t70 -66.51 131.48 46.13 Favored 'General case' 0 CA--C 1.513 -0.465 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 179.63 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.437 ' NZ ' ' HB3' ' A' ' 73' ' ' LYS . 3.7 ttpm? -82.63 -14.19 55.16 Favored 'General case' 0 C--N 1.315 -0.91 0 C-N-CA 120.427 -0.509 . . . . 0.0 110.642 -177.561 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . 0.545 ' HB2' ' HB3' ' A' ' 77' ' ' ALA . 0.2 OUTLIER -109.06 83.32 1.73 Allowed 'General case' 0 CA--C 1.51 -0.574 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 -176.766 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.641 ' HE2' ' CD ' ' A' ' 79' ' ' GLU . 18.0 tttt -56.41 -60.7 3.15 Favored 'General case' 0 C--O 1.22 -0.459 0 C-N-CA 120.742 -0.383 . . . . 0.0 111.346 -172.513 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 4.4 ttmp? -46.9 -43.99 19.32 Favored 'General case' 0 C--O 1.239 0.545 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.474 179.59 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.565 ' HA ' HD21 ' A' ' 80' ' ' ASN . . . -64.84 -38.56 91.38 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-O 121.347 0.594 . . . . 0.0 110.019 -177.804 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' TRP . . . . . 0.727 ' CE3' ' HB ' ' A' ' 40' ' ' THR . 5.6 t-105 -69.49 -47.71 63.01 Favored 'General case' 0 N--CA 1.44 -0.938 0 CA-C-N 115.015 -0.993 . . . . 0.0 111.515 -178.759 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.641 ' CD ' ' HE2' ' A' ' 75' ' ' LYS . 4.4 mm-40 -48.43 -54.01 15.69 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-O 121.165 0.507 . . . . 0.0 111.756 177.018 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . 0.565 HD21 ' HA ' ' A' ' 77' ' ' ALA . 9.2 p30 -72.88 -23.17 60.69 Favored 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 119.482 -0.887 . . . . 0.0 110.858 -176.518 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' MET . . . . . 0.582 ' HG2' ' OG1' ' A' ' 40' ' ' THR . 10.9 tpt -70.02 -48.45 57.99 Favored 'General case' 0 C--O 1.21 -0.979 0 CA-C-O 119.488 -0.291 . . . . 0.0 111.242 176.152 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.619 HG23 ' HB2' ' A' ' 87' ' ' LEU . 2.3 p -62.92 -25.34 38.23 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 C-N-CA 120.474 -0.491 . . . . 0.0 110.355 177.79 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 29.7 m -64.32 -36.65 84.81 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-O 121.189 0.518 . . . . 0.0 110.294 171.611 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 80.6 mttt -82.88 -45.79 13.79 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.573 179.119 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . 0.526 ' OD2' ' HG3' ' A' ' 81' ' ' MET . 1.2 m-20 -64.55 -23.09 67.15 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 114.881 -1.054 . . . . 0.0 110.665 179.2 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 51.4 mt-30 57.59 61.62 2.4 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 115.517 -0.765 . . . . 0.0 111.483 178.298 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.619 ' HB2' HG23 ' A' ' 82' ' ' VAL . 79.3 mt -100.21 113.17 25.64 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.612 -178.709 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.548 ' HB2' ' HB2' ' A' ' 53' ' ' LYS . 11.8 mmmm -86.49 178.98 6.93 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.234 178.36 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . 1.025 ' HA2' ' HG2' ' A' ' 56' ' ' GLU . . . 105.19 -177.84 23.29 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.825 -0.702 . . . . 0.0 112.538 178.138 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.722 ' O ' ' HA ' ' A' ' 67' ' ' VAL . 45.6 mm -86.75 113.61 24.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 175.638 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . 0.575 ' HB2' ' CZ2' ' A' ' 38' ' ' TRP . 1.8 pt20 -130.72 142.11 50.41 Favored 'General case' 0 C--N 1.309 -1.162 0 C-N-CA 120.321 -0.551 . . . . 0.0 111.713 -170.207 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.538 HD22 ' HB2' ' A' ' 15' ' ' TYR . 1.0 OUTLIER -145.01 156.26 43.84 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.677 178.756 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' HIS . . . . . 0.558 ' CE1' ' HG3' ' A' ' 75' ' ' LYS . 19.0 t-80 -117.53 138.57 51.81 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-O 121.422 0.63 . . . . 0.0 111.471 -175.06 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' MET . . . . . 0.759 ' SD ' ' HA ' ' A' ' 98' ' ' ARG . 27.1 ttm -98.25 -76.68 0.52 Allowed 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 114.973 -1.012 . . . . 0.0 109.902 177.771 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . 0.509 ' HA2' ' O ' ' A' ' 72' ' ' ASP . . . 80.64 -85.41 1.36 Allowed Glycine 0 N--CA 1.447 -0.608 0 C-N-CA 121.065 -0.588 . . . . 0.0 113.207 178.474 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 7.6 p -82.47 -25.61 33.39 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 120.942 0.401 . . . . 0.0 112.063 -173.635 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . 0.52 ' HB2' ' HG3' ' A' ' 94' ' ' MET . 4.0 m-20 -87.85 38.05 0.82 Allowed 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.55 -173.307 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . 0.759 ' HA ' ' SD ' ' A' ' 94' ' ' MET . 0.0 OUTLIER -64.69 -12.42 46.36 Favored 'General case' 0 C--O 1.222 -0.35 0 N-CA-C 112.532 0.568 . . . . 0.0 112.532 -171.327 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 4.8 m -58.75 -20.61 51.02 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.385 0.612 . . . . 0.0 110.742 177.85 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' PHE . . . . . 0.441 ' CZ ' ' HA ' ' A' ' 10' ' ' ALA . 36.0 t80 -81.15 -32.0 33.87 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.096 179.932 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' MET . . . . . 0.689 ' HG3' ' O ' ' A' ' 98' ' ' ARG . 4.2 ppp? -77.08 -31.26 55.89 Favored 'General case' 0 C--O 1.235 0.321 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 177.919 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -59.84 -39.68 85.97 Favored 'General case' 0 CA--C 1.52 -0.177 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.145 170.875 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -62.96 -23.88 67.63 Favored 'General case' 0 N--CA 1.462 0.148 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.451 -178.617 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' TYR . . . . . 0.401 ' HB2' HG13 ' A' ' 106' ' ' ILE . 48.0 m-85 -100.38 -4.81 28.29 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.304 178.817 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 3.4 mm? 59.61 32.4 21.53 Favored 'General case' 0 C--O 1.234 0.271 0 O-C-N 123.417 0.448 . . . . 0.0 110.818 -176.874 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . 0.522 HG21 HG21 ' A' ' 37' ' ' VAL . 68.4 mt -65.8 88.95 0.1 OUTLIER 'Isoleucine or valine' 0 C--O 1.225 -0.221 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.179 177.316 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 31.1 m-80 -98.52 -13.8 20.3 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.125 0.488 . . . . 0.0 110.342 176.18 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -122.43 115.06 2.63 Favored Glycine 0 N--CA 1.442 -0.945 0 C-N-CA 120.571 -0.823 . . . . 0.0 112.192 -177.58 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.592 HD12 ' SG ' ' A' ' 42' ' ' CYS . 32.0 mt -97.2 131.39 27.59 Favored Pre-proline 0 C--N 1.32 -0.676 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 174.37 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -82.73 151.23 71.89 Favored 'Cis proline' 0 N--CA 1.459 -0.539 0 C-N-CA 123.769 -1.346 . . . . 0.0 112.935 1.729 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . 0.515 ' HG3' HG12 ' A' ' 106' ' ' ILE . 0.0 OUTLIER -102.77 140.18 37.38 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 173.596 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . 0.668 ' CE1' ' HB3' ' A' ' 128' ' ' ARG . 0.0 OUTLIER -105.1 118.03 35.51 Favored 'General case' 0 C--N 1.327 -0.371 0 O-C-N 124.102 0.876 . . . . 0.0 110.174 -175.102 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.563 ' HB ' ' HB ' ' A' ' 35' ' ' ILE . 90.8 mt -132.81 148.62 31.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.65 0.262 . . . . 0.0 110.904 -178.737 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.401 ' C ' HD12 ' A' ' 115' ' ' LEU . 42.5 tp -132.1 139.22 48.4 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.504 -0.316 . . . . 0.0 110.674 179.706 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.613 ' HG ' ' HA ' ' A' ' 121' ' ' ILE . 2.3 mp -136.09 153.83 51.2 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 178.768 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . 0.542 ' HB2' HD11 ' A' ' 122' ' ' ILE . 24.2 t70 -76.94 163.68 26.5 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.648 178.409 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 63.3 mtt180 -51.49 -30.05 18.71 Favored 'General case' 0 N--CA 1.464 0.256 0 O-C-N 124.354 1.034 . . . . 0.0 111.748 178.692 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -64.82 -17.86 64.61 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.077 0.465 . . . . 0.0 110.759 178.378 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . 0.49 ' HA3' HD11 ' A' ' 25' ' ' LEU . . . 93.97 25.16 17.99 Favored Glycine 0 N--CA 1.438 -1.173 0 N-CA-C 110.187 -1.165 . . . . 0.0 110.187 -172.438 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 30.3 mmtp -112.56 116.77 30.74 Favored 'General case' 0 C--O 1.223 -0.297 0 C-N-CA 120.304 -0.558 . . . . 0.0 112.097 -172.991 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . 0.665 ' H ' HD12 ' A' ' 121' ' ' ILE . 3.8 mp -44.38 119.5 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.27 0 CA-C-N 115.436 -0.802 . . . . 0.0 111.984 179.698 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' ILE . . . . . 0.542 HD11 ' HB2' ' A' ' 116' ' ' ASP . 45.5 mm -98.62 -41.02 9.82 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-N 115.301 -0.863 . . . . 0.0 109.335 175.727 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 16.4 m -137.2 115.83 12.08 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.393 -0.821 . . . . 0.0 110.41 179.07 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -74.23 -16.01 60.97 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.06 0.457 . . . . 0.0 110.821 178.091 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 6.1 t30 -146.83 100.6 3.34 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.762 -0.654 . . . . 0.0 109.398 177.059 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 12.4 ttt -101.21 -139.0 0.34 Allowed 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.192 -177.978 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -124.96 127.25 46.75 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-O 121.039 0.447 . . . . 0.0 111.003 -175.733 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . 0.668 ' HB3' ' CE1' ' A' ' 112' ' ' PHE . 11.6 ptp180 -51.28 153.91 3.23 Favored Pre-proline 0 N--CA 1.468 0.473 0 N-CA-C 113.414 0.894 . . . . 0.0 113.414 178.778 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . 0.546 ' HD2' ' OE2' ' A' ' 48' ' ' GLU . 51.9 Cg_exo -55.69 -27.39 60.86 Favored 'Trans proline' 0 C--N 1.35 0.656 0 C-N-CA 123.575 2.85 . . . . 0.0 113.557 177.193 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . 0.523 ' OG ' ' HB3' ' A' ' 48' ' ' GLU . 67.9 m -62.95 -20.64 65.43 Favored 'General case' 0 N--CA 1.462 0.132 0 CA-C-O 120.919 0.39 . . . . 0.0 111.301 176.912 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . 0.43 ' OD2' ' HB2' ' A' ' 133' ' ' LYS . 7.3 t70 -85.32 122.1 73.73 Favored Pre-proline 0 C--N 1.325 -0.484 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.708 178.774 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . 0.406 ' O ' ' HG3' ' A' ' 136' ' ' GLU . 30.5 Cg_exo -63.97 -30.01 66.84 Favored 'Trans proline' 0 C--N 1.343 0.252 0 C-N-CA 122.922 2.415 . . . . 0.0 112.675 179.921 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . 0.43 ' HB2' ' OD2' ' A' ' 131' ' ' ASP . 26.7 mmmt -61.64 -37.64 84.76 Favored 'General case' 0 CA--C 1.519 -0.219 0 CA-C-O 121.007 0.432 . . . . 0.0 110.391 -176.801 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 134' ' ' THR . . . . . 0.738 HG22 ' CZ ' ' A' ' 138' ' ' PHE . 5.2 m -61.66 -53.25 58.66 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.238 176.255 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . 0.561 ' HA ' ' CD2' ' A' ' 138' ' ' PHE . . . -54.93 -46.52 74.94 Favored 'General case' 0 C--O 1.242 0.672 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.183 176.925 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . 0.406 ' HG3' ' O ' ' A' ' 132' ' ' PRO . 48.8 mt-10 -54.39 -55.74 25.61 Favored 'General case' 0 CA--C 1.509 -0.625 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.169 176.551 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . 0.569 ' HE2' ' HA ' ' A' ' 137' ' ' LYS . 0.1 OUTLIER -43.79 -42.88 5.81 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 114.221 -1.354 . . . . 0.0 111.774 179.825 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . 0.738 ' CZ ' HG22 ' A' ' 134' ' ' THR . 13.6 m-85 -63.74 -60.73 2.93 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-O 120.774 0.321 . . . . 0.0 110.921 179.961 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 11.0 p30 -68.86 -23.7 64.26 Favored 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 120.313 -0.555 . . . . 0.0 110.989 -174.387 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 13.2 tt0 -60.47 -51.81 67.87 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.054 0.454 . . . . 0.0 110.454 173.568 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.53 ' HG ' ' O ' ' A' ' 137' ' ' LYS . 88.6 mt -64.56 -30.01 71.03 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.147 -177.906 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 4.4 mm? . . . . . 0 C--N 1.327 -0.377 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.428 178.048 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.444 -0.735 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -69.43 59.77 0.13 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 114.861 -1.063 . . . . 0.0 113.641 -172.445 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . 0.535 ' HA ' ' HB3' ' A' ' 25' ' ' LEU . 26.4 m 53.58 33.4 16.3 Favored 'General case' 0 N--CA 1.465 0.28 0 N-CA-C 112.767 0.655 . . . . 0.0 112.767 170.493 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 34.7 p90 -60.77 147.92 40.82 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.893 0.378 . . . . 0.0 110.747 179.084 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . 0.514 ' HA ' ' HA ' ' A' ' 24' ' ' SER . 28.2 t -139.81 117.96 11.93 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.111 -0.495 . . . . 0.0 109.707 -179.293 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . 0.438 ' HB2' ' HB3' ' A' ' 92' ' ' LEU . 92.1 m-85 -138.78 155.14 73.38 Favored Pre-proline 0 C--N 1.323 -0.562 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.322 -176.976 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -81.19 125.89 5.39 Favored 'Trans proline' 0 N--CA 1.454 -0.85 0 C-N-CA 122.015 1.81 . . . . 0.0 112.116 175.469 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . 0.503 ' HA ' ' HA ' ' A' ' 92' ' ' LEU . 12.5 t70 -62.32 152.95 32.36 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.196 -0.911 . . . . 0.0 108.894 172.127 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.646 HG22 ' HG3' ' A' ' 91' ' ' GLN . 12.1 tt -58.67 -25.81 29.63 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.435 0 O-C-N 123.781 0.675 . . . . 0.0 111.301 -178.287 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 44.7 m-80 -79.35 -2.17 40.32 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.321 0.582 . . . . 0.0 110.053 176.47 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 86.82 40.64 7.06 Favored Glycine 0 N--CA 1.447 -0.583 0 CA-C-N 115.401 -0.818 . . . . 0.0 112.371 179.244 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.542 ' NZ ' HG22 ' A' ' 23' ' ' VAL . 62.0 tttm -113.84 117.22 30.84 Favored 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 120.372 -0.531 . . . . 0.0 111.027 179.989 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 17.7 m -64.45 108.84 1.75 Allowed 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 109.938 -0.393 . . . . 0.0 109.938 174.384 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.542 HG22 ' NZ ' ' A' ' 21' ' ' LYS . 99.6 t -119.83 125.5 74.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-O 121.011 0.434 . . . . 0.0 110.201 -179.829 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . 0.514 ' HA ' ' HA ' ' A' ' 14' ' ' SER . 57.3 p -113.19 176.6 4.95 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 115.731 -0.668 . . . . 0.0 109.426 177.57 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.535 ' HB3' ' HA ' ' A' ' 12' ' ' SER . 2.7 tm? -60.98 -30.39 70.24 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 176.908 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -72.11 -24.42 61.47 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.66 -0.246 . . . . 0.0 111.325 -179.896 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -73.18 -21.75 60.61 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-O 121.924 0.868 . . . . 0.0 109.616 177.798 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.469 HD13 HG21 ' A' ' 67' ' ' VAL . 32.9 mt -104.5 -21.02 13.51 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-N 115.073 -0.967 . . . . 0.0 110.742 -179.492 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.41 ' HB2' HD13 ' A' ' 25' ' ' LEU . 52.9 tttp -71.41 149.32 46.06 Favored 'General case' 0 N--CA 1.445 -0.688 0 CA-C-N 115.459 -0.792 . . . . 0.0 110.909 -173.542 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 91.81 10.21 61.76 Favored Glycine 0 N--CA 1.452 -0.295 0 N-CA-C 111.066 -0.814 . . . . 0.0 111.066 -175.198 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.832 ' HD3' ' HA ' ' A' ' 63' ' ' ASP . 13.1 ttmm -162.12 157.48 23.35 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 108.196 -1.038 . . . . 0.0 108.196 179.73 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.532 ' CD2' HD13 ' A' ' 141' ' ' LEU . 82.3 m-85 -66.17 143.51 57.23 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 118.287 0.494 . . . . 0.0 110.808 -178.641 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.873 HD13 HD12 ' A' ' 115' ' ' LEU . 3.6 mp -126.04 146.37 31.95 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.226 0 CA-C-O 120.811 0.339 . . . . 0.0 110.561 -179.55 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . 0.737 ' HD1' ' HB3' ' A' ' 114' ' ' LEU . 75.2 t80 -129.7 121.64 27.35 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 173.224 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.697 HD13 ' HB ' ' A' ' 67' ' ' VAL . 25.9 mm -109.96 110.9 33.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 N-CA-C 112.156 0.428 . . . . 0.0 112.156 -173.253 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.589 ' O ' ' HA ' ' A' ' 68' ' ' SER . 33.7 m-20 -99.04 158.21 15.82 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 169.549 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.58 HG11 HG21 ' A' ' 109' ' ' ILE . 40.5 t -103.67 112.18 36.19 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.859 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 171.066 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' TRP . . . . . 0.791 ' CZ3' HG21 ' A' ' 82' ' ' VAL . 0.6 OUTLIER -103.29 132.55 49.46 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 -177.298 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.456 ' HB3' ' SG ' ' A' ' 42' ' ' CYS . . . -148.22 174.7 11.72 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.505 -0.316 . . . . 0.0 110.762 -178.551 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . 0.553 HG22 ' OD2' ' A' ' 72' ' ' ASP . 5.9 t -104.27 -30.3 10.23 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 120.975 0.417 . . . . 0.0 110.379 171.618 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 21.0 p-90 -85.59 7.36 23.45 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.549 -178.108 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' CYS . . . . . 0.553 ' SG ' ' HB3' ' A' ' 45' ' ' CYS . 5.7 p -87.55 -2.21 58.47 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.677 -0.238 . . . . 0.0 111.41 -179.068 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.58 ' O ' ' HG2' ' A' ' 46' ' ' ARG . . . 64.94 -108.35 2.3 Favored Glycine 0 CA--C 1.523 0.579 0 N-CA-C 114.773 0.669 . . . . 0.0 114.773 171.736 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.41 ' HD2' ' O ' ' A' ' 42' ' ' CYS . 9.6 Cg_endo -50.75 -23.15 10.86 Favored 'Trans proline' 0 C--N 1.356 0.96 0 C-N-CA 124.342 3.361 . . . . 0.0 113.541 -174.647 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . 0.724 ' HB2' ' HD3' ' A' ' 110' ' ' PRO . 47.1 t -52.19 -15.97 0.71 Allowed 'General case' 0 C--N 1.323 -0.55 0 O-C-N 124.071 0.857 . . . . 0.0 112.924 178.533 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.58 ' HG2' ' O ' ' A' ' 43' ' ' GLY . 24.7 mmm180 -71.02 -6.64 40.49 Favored 'General case' 0 N--CA 1.448 -0.574 0 O-C-N 121.806 -0.559 . . . . 0.0 110.467 -179.43 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.454 ' O ' ' HD2' ' A' ' 50' ' ' PRO . . . -84.13 -23.44 51.87 Favored Glycine 0 N--CA 1.446 -0.643 0 CA-C-N 115.818 -0.628 . . . . 0.0 112.95 -178.478 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . 0.56 ' HG3' ' HB3' ' A' ' 129' ' ' PRO . 2.0 mp0 -83.01 -4.49 58.38 Favored 'General case' 0 CA--C 1.516 -0.333 0 CA-C-N 117.2 0.5 . . . . 0.0 110.524 -179.379 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.797 ' HG ' HD21 ' A' ' 87' ' ' LEU . 7.3 mp -43.96 -55.23 9.61 Favored Pre-proline 0 CA--C 1.536 0.432 0 N-CA-C 112.487 0.551 . . . . 0.0 112.487 177.09 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.497 ' HD3' ' HB2' ' A' ' 49' ' ' LEU . 43.5 Cg_exo -58.45 -42.89 50.64 Favored 'Trans proline' 0 C--N 1.355 0.909 0 C-N-CA 121.874 1.716 . . . . 0.0 112.185 175.047 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -69.49 -21.75 63.66 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-O 121.476 0.655 . . . . 0.0 110.411 -174.226 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.556 HD13 HD22 ' A' ' 87' ' ' LEU . 7.6 tt -70.14 -55.44 9.4 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 114.974 -1.012 . . . . 0.0 108.643 178.673 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.694 ' HB3' ' NZ ' ' A' ' 53' ' ' LYS . 1.8 mtpm? -52.63 -63.01 1.28 Allowed 'General case' 0 C--O 1.219 -0.508 0 CA-C-N 115.503 -0.771 . . . . 0.0 111.365 175.826 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -52.39 -39.45 60.86 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 113.302 0.853 . . . . 0.0 113.302 -173.146 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.434 ' O ' ' HB2' ' A' ' 58' ' ' LYS . 14.4 mt -67.49 -44.77 77.69 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.174 0.512 . . . . 0.0 110.622 174.43 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -57.39 -42.68 82.68 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.145 -0.934 . . . . 0.0 111.582 176.538 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.618 ' HG2' ' O ' ' A' ' 53' ' ' LYS . 16.0 mm-40 -53.47 -52.01 60.88 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-O 121.714 0.768 . . . . 0.0 109.287 175.74 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . 0.468 ' HB3' ' HE3' ' A' ' 58' ' ' LYS . 10.4 mmmt -53.01 -58.12 8.07 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-N 114.504 -1.225 . . . . 0.0 112.439 178.804 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.57 ' HB2' ' HE2' ' A' ' 66' ' ' PHE . 96.0 m-85 -106.71 21.6 17.23 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.047 -0.524 . . . . 0.0 112.322 -166.537 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -61.59 120.79 11.26 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.603 173.75 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 72.26 33.81 61.5 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.946 -0.645 . . . . 0.0 112.866 177.141 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.507 ' HB3' HD11 ' A' ' 142' ' ' LEU . 40.1 mmtm -109.03 -164.91 0.97 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.154 0.502 . . . . 0.0 110.128 175.623 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . 0.832 ' HA ' ' HD3' ' A' ' 31' ' ' LYS . 3.7 t70 -89.87 54.95 2.99 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-O 121.792 0.806 . . . . 0.0 109.497 179.362 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.46 HG22 ' HB2' ' A' ' 62' ' ' LYS . 6.8 tp -157.0 129.98 1.15 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 CA-C-N 115.061 -0.972 . . . . 0.0 109.774 -178.114 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' HIS . . . . . 0.47 ' NE2' ' HB3' ' A' ' 31' ' ' LYS . 68.0 m-70 -103.3 106.58 17.13 Favored 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 175.773 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . 0.57 ' HE2' ' HB2' ' A' ' 59' ' ' TYR . 61.0 m-85 -79.01 103.13 8.74 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 171.082 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.697 ' HB ' HD13 ' A' ' 35' ' ' ILE . 29.6 t -122.26 126.53 74.4 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.476 -175.196 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . 0.589 ' HA ' ' O ' ' A' ' 36' ' ' ASP . 37.1 m -114.05 134.3 54.96 Favored 'General case' 0 C--N 1.311 -1.066 0 CA-C-N 116.106 -0.497 . . . . 0.0 109.855 177.191 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.516 HD22 ' HB2' ' A' ' 92' ' ' LEU . 26.6 mt -110.53 132.78 53.88 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 110.006 -0.368 . . . . 0.0 110.006 177.116 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . 0.471 ' O ' ' HB3' ' A' ' 94' ' ' MET . 0.9 OUTLIER -105.15 117.89 35.14 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.008 0.432 . . . . 0.0 111.348 -176.882 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 34.8 m -88.39 15.7 7.43 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.773 179.61 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.553 ' OD2' HG22 ' A' ' 40' ' ' THR . 1.3 m-20 -71.73 135.52 46.81 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.249 -0.648 . . . . 0.0 109.249 -179.867 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.416 ' O ' ' HD3' ' A' ' 73' ' ' LYS . 1.5 tmtp? -89.04 -30.1 18.95 Favored 'General case' 0 C--N 1.318 -0.784 0 C-N-CA 119.918 -0.713 . . . . 0.0 109.464 177.62 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . 0.586 ' HB2' ' HB3' ' A' ' 77' ' ' ALA . 0.8 OUTLIER -72.53 68.18 0.79 Allowed 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.135 -0.939 . . . . 0.0 110.434 174.127 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.483 ' O ' ' HG2' ' A' ' 79' ' ' GLU . 9.4 tttm -51.8 -64.5 0.79 Allowed 'General case' 0 C--O 1.22 -0.482 0 N-CA-C 112.489 0.551 . . . . 0.0 112.489 -175.984 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 51.9 tttm -49.77 -49.18 49.39 Favored 'General case' 0 C--N 1.329 -0.297 0 O-C-N 123.162 0.289 . . . . 0.0 111.204 -176.793 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.665 ' HA ' ' ND2' ' A' ' 80' ' ' ASN . . . -52.29 -44.05 64.79 Favored 'General case' 0 C--O 1.244 0.802 0 CA-C-O 121.886 0.85 . . . . 0.0 110.359 178.478 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' TRP . . . . . 0.548 ' CE3' ' HB ' ' A' ' 40' ' ' THR . 6.8 t-105 -66.92 -51.13 59.08 Favored 'General case' 0 N--CA 1.437 -1.114 0 CA-C-N 114.278 -1.328 . . . . 0.0 111.048 -179.438 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.522 ' OE1' HG13 ' A' ' 18' ' ' ILE . 5.3 mm-40 -46.22 -47.08 17.99 Favored 'General case' 0 CA--C 1.537 0.459 0 N-CA-C 111.87 0.322 . . . . 0.0 111.87 176.189 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . 0.665 ' ND2' ' HA ' ' A' ' 77' ' ' ALA . 0.6 OUTLIER -60.33 -49.23 78.42 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 120.823 -0.351 . . . . 0.0 110.526 -177.738 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 22.5 ttm -59.47 -48.47 81.53 Favored 'General case' 0 N--CA 1.466 0.341 0 N-CA-C 112.433 0.531 . . . . 0.0 112.433 -175.756 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.791 HG21 ' CZ3' ' A' ' 38' ' ' TRP . 0.9 OUTLIER -67.25 -26.05 35.24 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 C-N-CA 120.158 -0.617 . . . . 0.0 110.918 -178.046 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 90.6 m -72.78 -37.0 67.74 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.294 -0.412 . . . . 0.0 109.986 174.646 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . 0.4 ' HB3' ' HE3' ' A' ' 84' ' ' LYS . 1.2 tmmt? -71.26 -41.38 70.16 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.375 0.607 . . . . 0.0 110.018 177.513 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 15.6 m-20 -83.67 -1.72 54.64 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.225 -0.898 . . . . 0.0 111.881 -177.349 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 45.3 mt-30 62.0 23.63 13.95 Favored 'General case' 0 N--CA 1.468 0.466 0 N-CA-C 112.727 0.64 . . . . 0.0 112.727 172.074 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.797 HD21 ' HG ' ' A' ' 49' ' ' LEU . 94.1 mt -73.61 117.46 15.4 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 110.236 -0.283 . . . . 0.0 110.236 178.796 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.564 ' HA ' ' HE3' ' A' ' 88' ' ' LYS . 0.0 OUTLIER -119.61 -168.08 1.53 Allowed 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.693 -0.23 . . . . 0.0 111.581 177.314 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 112.75 -163.23 12.17 Favored Glycine 0 N--CA 1.451 -0.35 0 N-CA-C 110.241 -1.144 . . . . 0.0 110.241 -173.966 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.654 ' O ' ' HA ' ' A' ' 67' ' ' VAL . 52.5 mt -92.72 111.67 24.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 173.679 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . 0.693 ' HB2' ' CZ2' ' A' ' 38' ' ' TRP . 1.0 OUTLIER -143.24 103.59 4.15 Favored 'General case' 0 C--N 1.311 -1.086 0 CA-C-O 121.598 0.713 . . . . 0.0 111.789 -168.934 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.518 HD21 ' HB ' ' A' ' 23' ' ' VAL . 20.6 mt -96.79 151.28 19.81 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.275 -0.875 . . . . 0.0 110.622 -175.846 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 37.3 t-80 -113.47 127.87 56.25 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.081 178.847 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' MET . . . . . 0.471 ' HB3' ' O ' ' A' ' 70' ' ' SER . 35.9 ttm -81.06 -83.14 0.11 Allowed 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 115.053 -0.976 . . . . 0.0 110.279 -179.682 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 131.2 -83.72 0.31 Allowed Glycine 0 N--CA 1.444 -0.79 0 C-N-CA 120.396 -0.907 . . . . 0.0 112.245 -178.19 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 1.7 m -137.72 4.63 2.59 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.583 0.706 . . . . 0.0 109.964 179.472 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -87.16 53.03 2.68 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.248 -0.887 . . . . 0.0 110.448 -172.485 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . 0.498 ' HB3' ' OD1' ' A' ' 102' ' ' ASP . 4.0 mtm180 -63.35 -8.94 9.96 Favored 'General case' 0 CA--C 1.512 -0.5 0 N-CA-C 112.542 0.571 . . . . 0.0 112.542 -172.924 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 5.4 m -38.4 -33.09 0.09 Allowed 'General case' 0 C--N 1.313 -0.988 0 O-C-N 124.146 0.904 . . . . 0.0 112.376 179.197 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 80.2 t80 -81.27 -39.21 25.63 Favored 'General case' 0 CA--C 1.532 0.281 0 N-CA-C 112.356 0.502 . . . . 0.0 112.356 -179.822 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' MET . . . . . 0.459 ' SD ' ' HD2' ' A' ' 98' ' ' ARG . 24.9 ptm -78.66 -34.02 46.63 Favored 'General case' 0 CA--C 1.52 -0.185 0 C-N-CA 120.107 -0.637 . . . . 0.0 109.592 -177.268 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . 0.498 ' OD1' ' HB3' ' A' ' 98' ' ' ARG . 2.5 m-20 -75.57 -21.62 57.71 Favored 'General case' 0 N--CA 1.447 -0.604 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.186 176.581 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -64.95 -29.57 70.51 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-O 121.063 0.459 . . . . 0.0 110.701 174.88 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 59.7 m-85 -96.96 2.35 51.46 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.519 177.796 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 95.6 mt 65.89 5.21 3.33 Favored 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 113.386 0.884 . . . . 0.0 113.386 173.164 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . 0.545 ' CG1' ' HG3' ' A' ' 111' ' ' ARG . 1.2 pp -97.34 88.83 1.88 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.575 0 CA-C-O 121.509 0.671 . . . . 0.0 112.194 -179.277 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 4.0 p-10 -77.1 -11.73 59.85 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.609 -0.723 . . . . 0.0 109.812 175.642 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -89.75 98.56 2.46 Favored Glycine 0 N--CA 1.445 -0.716 0 CA-C-N 115.445 -0.798 . . . . 0.0 111.621 177.357 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.631 ' HB ' ' HA ' ' A' ' 110' ' ' PRO . 34.2 pt -104.88 162.79 18.72 Favored Pre-proline 0 C--N 1.321 -0.641 0 N-CA-C 110.088 -0.338 . . . . 0.0 110.088 179.823 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . 0.724 ' HD3' ' HB2' ' A' ' 45' ' ' CYS . 39.6 Cg_endo -70.11 143.74 75.39 Favored 'Cis proline' 0 C--N 1.349 0.567 0 C-N-CA 124.158 -1.184 . . . . 0.0 113.559 1.63 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . 0.545 ' HG3' ' CG1' ' A' ' 106' ' ' ILE . 0.0 OUTLIER -117.51 136.49 53.21 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.625 -0.716 . . . . 0.0 109.081 177.295 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . 0.571 ' CD2' ' HA ' ' A' ' 127' ' ' THR . 1.4 m-85 -105.7 117.23 33.5 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.789 -176.173 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.495 HD12 ' HA ' ' A' ' 124' ' ' ALA . 24.4 mm -128.53 164.0 31.61 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 N-CA-C 108.144 -1.058 . . . . 0.0 108.144 177.137 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.737 ' HB3' ' HD1' ' A' ' 34' ' ' TYR . 1.8 pt? -158.45 154.24 26.5 Favored 'General case' 0 C--N 1.316 -0.882 0 C-N-CA 120.573 -0.451 . . . . 0.0 110.978 173.455 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.873 HD12 HD13 ' A' ' 33' ' ' ILE . 0.0 OUTLIER -138.17 150.98 47.29 Favored 'General case' 0 N--CA 1.448 -0.569 0 CA-C-O 122.329 1.062 . . . . 0.0 113.377 -173.788 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 12.8 t0 -69.19 163.73 24.24 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 113.174 -1.83 . . . . 0.0 109.782 176.328 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . 0.482 ' HA ' ' O ' ' A' ' 31' ' ' LYS . 31.1 mtm180 -48.39 -28.05 2.99 Favored 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 124.503 1.121 . . . . 0.0 113.272 -174.877 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 26.6 t0 -82.52 -5.13 58.56 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.104 0.478 . . . . 0.0 111.44 -177.314 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 89.34 16.6 57.0 Favored Glycine 0 N--CA 1.441 -0.986 0 N-CA-C 110.013 -1.235 . . . . 0.0 110.013 -171.241 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 4.9 tttm -90.27 147.21 23.67 Favored 'General case' 0 C--O 1.204 -1.327 0 CA-C-N 115.034 -0.583 . . . . 0.0 110.766 -175.522 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . 0.463 ' H ' HD12 ' A' ' 121' ' ' ILE . 3.8 mp -67.76 130.47 33.03 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.668 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.03 -174.775 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' ILE . . . . . 0.575 ' HB ' ' HG ' ' A' ' 114' ' ' LEU . 37.4 mm -100.53 -56.4 5.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 171.122 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' SER . . . . . 0.475 ' HB3' ' CD2' ' A' ' 114' ' ' LEU . 42.9 t -135.14 142.72 46.22 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.481 174.375 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . 0.495 ' HA ' HD12 ' A' ' 113' ' ' ILE . . . -112.55 23.48 13.51 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.425 -0.807 . . . . 0.0 109.429 176.018 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 4.1 p-10 -161.67 38.63 0.13 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.349 -0.841 . . . . 0.0 110.108 -179.913 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' MET . . . . . 0.73 ' HG2' HD22 ' A' ' 114' ' ' LEU . 2.2 tpt -71.7 -168.72 0.37 Allowed 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 115.762 -0.654 . . . . 0.0 111.206 -176.949 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . 0.571 ' HA ' ' CD2' ' A' ' 112' ' ' PHE . 4.1 m -161.0 120.79 2.67 Favored 'General case' 0 C--O 1.223 -0.312 0 N-CA-C 110.108 -0.33 . . . . 0.0 110.108 -174.867 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . 0.569 ' HB2' ' OH ' ' A' ' 34' ' ' TYR . 21.8 ttt85 -88.94 -62.94 0.21 Allowed Pre-proline 0 CA--C 1.498 -1.039 0 CA-C-O 117.846 -1.073 . . . . 0.0 113.401 178.491 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . 0.56 ' HB3' ' HG3' ' A' ' 48' ' ' GLU . 1.0 OUTLIER -37.96 79.04 0.0 OUTLIER 'Trans proline' 0 C--N 1.372 1.784 0 C-N-CA 124.352 3.368 . . . . 0.0 113.814 -158.648 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . 0.471 ' N ' ' O ' ' A' ' 128' ' ' ARG . 43.5 p 54.73 26.72 7.86 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 114.299 -1.319 . . . . 0.0 110.67 -179.47 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -70.76 123.56 89.4 Favored Pre-proline 0 C--O 1.236 0.355 0 CA-C-N 115.513 -0.767 . . . . 0.0 111.041 -178.648 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_endo -63.92 -37.51 43.66 Favored 'Trans proline' 0 N--CA 1.46 -0.459 0 C-N-CA 122.505 2.136 . . . . 0.0 112.881 -178.343 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . 0.414 ' O ' ' HG2' ' A' ' 137' ' ' LYS . 26.1 mtmm -54.3 -50.11 68.09 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-O 121.599 0.714 . . . . 0.0 110.113 -177.036 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 134' ' ' THR . . . . . 0.652 HG22 ' CZ ' ' A' ' 138' ' ' PHE . 13.8 m -78.76 -35.52 44.47 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 114.977 -1.01 . . . . 0.0 111.221 -174.494 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . 0.736 ' HA ' ' CD2' ' A' ' 138' ' ' PHE . . . -62.31 -40.7 97.16 Favored 'General case' 0 C--O 1.242 0.658 0 CA-C-O 121.167 0.508 . . . . 0.0 110.372 178.269 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . 0.556 ' HA ' ' ND2' ' A' ' 139' ' ' ASN . 7.1 mm-40 -65.19 -41.4 94.6 Favored 'General case' 0 N--CA 1.447 -0.614 0 CA-C-N 115.254 -0.885 . . . . 0.0 111.062 176.486 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . 0.96 ' HE2' ' HA ' ' A' ' 137' ' ' LYS . 9.1 mmpt? -55.79 -41.71 74.51 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.554 175.975 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . 0.736 ' CD2' ' HA ' ' A' ' 135' ' ' ALA . 15.3 m-85 -56.81 -60.37 3.66 Favored 'General case' 0 N--CA 1.463 0.2 0 O-C-N 123.181 0.301 . . . . 0.0 110.783 178.556 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 139' ' ' ASN . . . . . 0.556 ' ND2' ' HA ' ' A' ' 136' ' ' GLU . 11.7 p30 -69.49 -27.03 64.85 Favored 'General case' 0 C--O 1.224 -0.249 0 C-N-CA 120.602 -0.439 . . . . 0.0 111.506 -173.326 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 21.7 tt0 -63.18 -60.66 3.13 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.597 0.237 . . . . 0.0 111.464 177.092 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.704 ' HG ' ' O ' ' A' ' 137' ' ' LYS . 3.0 pp -69.85 -19.86 63.43 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-O 120.845 0.355 . . . . 0.0 111.417 -175.69 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 0.507 HD11 ' HB3' ' A' ' 62' ' ' LYS . 0.8 OUTLIER . . . . . 0 C--N 1.325 -0.494 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.065 175.039 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.463 0.187 0 CA-C-O 119.857 -0.116 . . . . 0.0 111.181 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . 11.97 74.54 0.01 OUTLIER 'General case' 0 N--CA 1.479 0.994 0 O-C-N 125.061 1.475 . . . . 0.0 113.807 -178.21 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . 1.036 ' HA ' ' HB3' ' A' ' 25' ' ' LEU . 68.5 m 62.35 84.14 0.14 Allowed 'General case' 0 CA--C 1.534 0.362 0 CA-C-O 121.593 0.711 . . . . 0.0 111.354 -175.778 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 16.3 p90 -99.84 175.17 5.88 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.403 -0.817 . . . . 0.0 110.419 178.528 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 13.8 p -142.75 123.26 14.02 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.514 0.197 . . . . 0.0 110.57 178.963 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . 0.616 ' HB2' HD13 ' A' ' 92' ' ' LEU . 80.5 m-85 -134.65 150.05 72.51 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.655 -0.248 . . . . 0.0 110.483 179.24 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.41 ' HD2' ' O ' ' A' ' 93' ' ' HIS . 3.1 Cg_exo -80.83 124.85 5.21 Favored 'Trans proline' 0 N--CA 1.457 -0.636 0 C-N-CA 122.581 2.187 . . . . 0.0 112.805 178.638 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . 0.698 ' HB3' ' HB3' ' A' ' 21' ' ' LYS . 4.8 t70 -70.36 159.93 33.24 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.32 -0.855 . . . . 0.0 109.123 171.136 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.686 HD12 HG13 ' A' ' 82' ' ' VAL . 1.5 tt -50.24 -35.57 12.08 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.512 0 O-C-N 123.68 0.613 . . . . 0.0 111.651 -176.187 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 34.5 m-80 -77.54 11.93 1.83 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.411 -177.384 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 70.56 32.16 67.77 Favored Glycine 0 CA--C 1.505 -0.55 0 N-CA-C 110.335 -1.106 . . . . 0.0 110.335 -175.582 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.698 ' HB3' ' HB3' ' A' ' 17' ' ' ASP . 8.2 ttpm? -103.52 109.25 20.83 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.048 -0.576 . . . . 0.0 110.519 -173.997 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 20.9 m -65.19 106.94 1.42 Allowed 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.756 178.515 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.57 ' HB ' HD21 ' A' ' 92' ' ' LEU . 63.3 t -112.95 127.99 69.92 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 N-CA-C 109.176 -0.676 . . . . 0.0 109.176 179.028 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . 0.421 ' C ' ' H ' ' A' ' 26' ' ' ALA . 92.9 p -122.62 165.01 17.16 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.535 0.683 . . . . 0.0 111.757 -173.193 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 1.036 ' HB3' ' HA ' ' A' ' 12' ' ' SER . 20.8 tp -85.35 33.15 0.55 Allowed 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.894 0.854 . . . . 0.0 109.311 175.385 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.421 ' H ' ' C ' ' A' ' 24' ' ' SER . . . -118.73 -41.37 2.8 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 114.505 -1.225 . . . . 0.0 109.745 174.155 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -79.1 -31.77 44.37 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.337 0.589 . . . . 0.0 109.937 173.969 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.616 HD13 HG21 ' A' ' 67' ' ' VAL . 75.9 mt -78.97 -18.46 53.67 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.217 174.862 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.519 ' HB2' ' O ' ' A' ' 25' ' ' LEU . 44.7 tttp -71.48 131.66 43.63 Favored 'General case' 0 N--CA 1.444 -0.729 0 CA-C-N 115.317 -0.856 . . . . 0.0 110.817 -175.336 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 117.17 -8.74 15.8 Favored Glycine 0 N--CA 1.448 -0.512 0 N-CA-C 110.79 -0.924 . . . . 0.0 110.79 -174.655 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.424 ' C ' ' HA ' ' A' ' 117' ' ' ARG . 24.9 ttmm -143.47 147.94 35.3 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 179.637 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 54.9 m-85 -54.01 144.66 18.59 Favored 'General case' 0 N--CA 1.47 0.543 0 N-CA-C 112.562 0.578 . . . . 0.0 112.562 -174.223 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.519 HG13 HD11 ' A' ' 25' ' ' LEU . 39.2 mm -120.73 133.93 65.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.562 -0.745 . . . . 0.0 110.99 -175.04 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . 0.481 ' OH ' ' HD3' ' A' ' 129' ' ' PRO . 80.1 t80 -120.67 118.98 31.5 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 172.253 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.61 ' HB ' ' HB ' ' A' ' 113' ' ' ILE . 75.1 mt -99.98 126.78 53.39 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 N-CA-C 110.138 -0.319 . . . . 0.0 110.138 179.399 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.552 ' O ' ' HA ' ' A' ' 68' ' ' SER . 11.8 t70 -129.9 124.91 34.3 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.23 -178.924 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 26.5 t -81.78 121.77 35.63 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.913 0 C-N-CA 120.557 -0.457 . . . . 0.0 110.423 -179.598 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' TRP . . . . . 0.656 ' CE3' ' HZ2' ' A' ' 78' ' ' TRP . 0.7 OUTLIER -121.74 133.41 54.93 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.161 -0.472 . . . . 0.0 109.896 -176.618 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.505 ' HA ' ' OD1' ' A' ' 72' ' ' ASP . . . -148.27 158.28 44.0 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.577 -177.482 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . 0.643 ' HB ' ' CE3' ' A' ' 78' ' ' TRP . 11.1 t -94.89 -25.59 16.52 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.114 0.483 . . . . 0.0 110.611 175.111 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' TRP . . . . . 0.431 ' HE1' ' HA ' ' A' ' 72' ' ' ASP . 14.9 p-90 -87.78 13.32 10.86 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.079 -177.742 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' CYS . . . . . 0.469 ' SG ' ' HB2' ' A' ' 45' ' ' CYS . 14.9 t -86.24 -60.69 1.93 Allowed 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.09 175.92 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 110.92 -91.37 0.61 Allowed Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.641 -179.269 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -53.62 -28.87 48.11 Favored 'Trans proline' 0 C--N 1.35 0.638 0 C-N-CA 123.302 2.668 . . . . 0.0 113.066 -178.59 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . 0.504 ' SG ' ' HG3' ' A' ' 110' ' ' PRO . 42.2 t -51.64 -30.05 20.09 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.66 178.594 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.558 ' HA ' ' HG ' ' A' ' 49' ' ' LEU . 55.8 mtp180 -65.44 -30.58 71.39 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.451 -0.341 . . . . 0.0 111.686 -176.592 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -68.9 -26.39 74.66 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.652 -0.785 . . . . 0.0 112.49 -176.65 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . 0.456 ' OE2' ' HG2' ' A' ' 128' ' ' ARG . 14.6 mt-10 -94.49 -12.24 28.06 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.594 0.235 . . . . 0.0 111.005 -176.94 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.633 ' O ' ' HG3' ' A' ' 53' ' ' LYS . 73.2 mt -49.75 -49.19 74.74 Favored Pre-proline 0 C--N 1.331 -0.239 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.948 -178.598 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.55 ' HD3' ' HB2' ' A' ' 49' ' ' LEU . 71.3 Cg_exo -50.83 -37.82 56.04 Favored 'Trans proline' 0 C--N 1.357 1.003 0 C-N-CA 122.184 1.923 . . . . 0.0 112.767 176.984 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.513 ' O ' ' HB2' ' A' ' 55' ' ' LEU . . . -75.14 -25.4 58.36 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-O 121.617 0.722 . . . . 0.0 110.504 -176.114 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 6.8 tt -79.02 -48.34 14.6 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.0 -1.0 . . . . 0.0 108.419 -177.155 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.761 ' HB3' ' HG2' ' A' ' 88' ' ' LYS . 81.9 mttt -51.59 -55.71 17.67 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-N 114.655 -1.157 . . . . 0.0 109.909 176.893 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.473 ' HG2' ' O ' ' A' ' 50' ' ' PRO . 9.6 mm-40 -73.58 -23.32 59.93 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 114.074 -1.421 . . . . 0.0 112.55 -171.185 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.513 ' HB2' ' O ' ' A' ' 51' ' ' ALA . 0.4 OUTLIER -73.35 -34.0 65.4 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 120.302 -0.559 . . . . 0.0 109.588 176.408 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.447 ' OE2' ' HB2' ' A' ' 66' ' ' PHE . 5.1 tp10 -68.14 -37.13 80.74 Favored 'General case' 0 C--O 1.217 -0.63 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 175.686 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.463 ' HG2' ' O ' ' A' ' 53' ' ' LYS . 7.1 mm-40 -54.04 -53.96 45.8 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.391 0.615 . . . . 0.0 110.451 175.492 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 34.4 ttpt -55.57 -35.41 65.74 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.369 -0.832 . . . . 0.0 110.903 177.755 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.47 ' CZ ' ' HB2' ' A' ' 138' ' ' PHE . 38.3 m-85 -102.91 12.29 36.32 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 113.109 0.781 . . . . 0.0 113.109 -176.114 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -65.09 123.63 20.0 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 120.878 0.371 . . . . 0.0 110.352 176.516 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 83.52 7.68 85.94 Favored Glycine 0 N--CA 1.448 -0.541 0 C-N-CA 120.826 -0.702 . . . . 0.0 112.782 178.195 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 34.2 mmtm -89.92 -153.47 0.29 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.194 0.521 . . . . 0.0 109.821 177.997 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . 0.403 ' H ' HD21 ' A' ' 142' ' ' LEU . 4.2 t70 -106.75 62.39 0.63 Allowed 'General case' 0 C--N 1.316 -0.878 0 CA-C-O 121.571 0.701 . . . . 0.0 110.021 176.853 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 17.8 tt -157.35 163.98 1.21 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.787 0 CA-C-N 115.12 -0.945 . . . . 0.0 109.174 177.503 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 96.8 m-70 -139.25 114.97 10.01 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 174.453 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . 0.452 ' HZ ' HD12 ' A' ' 55' ' ' LEU . 12.5 m-85 -80.47 103.0 10.04 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 171.998 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.616 HG21 HD13 ' A' ' 28' ' ' LEU . 46.8 t -115.82 104.54 16.9 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 CA-C-N 115.332 -0.849 . . . . 0.0 109.739 -176.566 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . 0.552 ' HA ' ' O ' ' A' ' 36' ' ' ASP . 28.9 m -88.1 148.26 24.54 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.531 -178.132 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.413 HD11 ' HB2' ' A' ' 94' ' ' MET . 63.7 tp -126.73 119.9 28.07 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 120.839 0.352 . . . . 0.0 110.664 178.139 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . 0.505 ' HB3' ' HA ' ' A' ' 93' ' ' HIS . 3.4 t -100.74 119.05 38.05 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.228 0.537 . . . . 0.0 112.095 -174.552 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 18.7 m -90.76 15.34 11.33 Favored 'General case' 0 C--N 1.31 -1.121 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.816 177.864 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.505 ' OD1' ' HA ' ' A' ' 39' ' ' ALA . 2.4 m-20 -68.2 127.26 32.25 Favored 'General case' 0 CA--C 1.516 -0.344 0 CA-C-O 121.049 0.452 . . . . 0.0 110.663 -177.957 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 38.5 ttmt -79.01 -31.65 44.81 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 121.413 0.625 . . . . 0.0 109.323 175.335 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . 0.561 ' HB2' ' HB3' ' A' ' 77' ' ' ALA . 0.8 OUTLIER -80.36 68.59 6.59 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.175 -0.92 . . . . 0.0 110.25 177.45 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.547 ' HG3' ' CE1' ' A' ' 93' ' ' HIS . 33.0 tttt -58.91 -49.54 77.43 Favored 'General case' 0 C--O 1.223 -0.338 0 C-N-CA 120.936 -0.306 . . . . 0.0 111.462 -173.862 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 64.7 tttp -52.43 -56.04 17.77 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 110.343 -0.243 . . . . 0.0 110.343 179.273 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.676 ' HA ' ' ND2' ' A' ' 80' ' ' ASN . . . -51.45 -35.66 40.63 Favored 'General case' 0 C--O 1.242 0.678 0 CA-C-O 122.03 0.919 . . . . 0.0 110.933 177.011 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' TRP . . . . . 0.656 ' HZ2' ' CE3' ' A' ' 38' ' ' TRP . 14.8 t-105 -74.25 -51.05 16.5 Favored 'General case' 0 N--CA 1.431 -1.377 0 CA-C-N 114.434 -1.257 . . . . 0.0 111.828 -173.045 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.498 ' HG2' ' O ' ' A' ' 75' ' ' LYS . 4.8 mm-40 -49.61 -41.06 41.17 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-O 121.082 0.468 . . . . 0.0 110.485 176.849 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . 0.676 ' ND2' ' HA ' ' A' ' 77' ' ' ALA . 6.0 m-20 -56.87 -54.26 48.53 Favored 'General case' 0 CA--C 1.518 -0.261 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.706 177.795 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' MET . . . . . 0.539 ' SD ' ' HZ3' ' A' ' 78' ' ' TRP . 16.6 ttt -61.09 -48.42 81.75 Favored 'General case' 0 C--O 1.223 -0.316 0 N-CA-C 112.358 0.503 . . . . 0.0 112.358 -175.435 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.686 HG13 HD12 ' A' ' 18' ' ' ILE . 0.9 OUTLIER -60.91 -34.79 60.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 C-N-CA 120.386 -0.526 . . . . 0.0 111.069 -178.478 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 25.5 m -73.41 -29.79 62.82 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.106 0.479 . . . . 0.0 110.574 176.992 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 51.3 tttp -81.3 -41.97 21.33 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.179 0.514 . . . . 0.0 111.043 -177.905 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -77.24 -21.04 54.38 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.239 -0.891 . . . . 0.0 110.084 -176.126 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 17.8 mm-40 63.99 79.52 0.26 Allowed 'General case' 0 C--O 1.233 0.192 0 CA-C-N 115.375 -0.83 . . . . 0.0 111.229 -179.885 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.69 HD23 ' HE2' ' A' ' 53' ' ' LYS . 49.4 mt -96.55 140.93 30.45 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.422 -0.808 . . . . 0.0 111.001 179.402 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.761 ' HG2' ' HB3' ' A' ' 53' ' ' LYS . 30.6 mmtp -95.47 174.28 7.09 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.234 -0.439 . . . . 0.0 109.821 179.341 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . 0.425 ' CA ' ' HG2' ' A' ' 56' ' ' GLU . . . 86.33 -164.83 36.84 Favored Glycine 0 CA--C 1.517 0.184 0 C-N-CA 120.927 -0.654 . . . . 0.0 113.432 174.418 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.527 HG21 HG11 ' A' ' 23' ' ' VAL . 64.2 mt -103.51 113.45 40.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 178.297 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . 0.644 ' HB3' ' CZ2' ' A' ' 38' ' ' TRP . 8.1 mm100 -117.23 104.83 11.57 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 120.892 0.377 . . . . 0.0 111.022 -169.624 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.616 HD13 ' HB2' ' A' ' 15' ' ' TYR . 34.9 mt -100.04 147.94 25.07 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.146 0.498 . . . . 0.0 111.111 -176.51 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' HIS . . . . . 0.547 ' CE1' ' HG3' ' A' ' 75' ' ' LYS . 28.1 t-80 -115.08 127.86 55.87 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.144 0.497 . . . . 0.0 111.086 179.759 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' MET . . . . . 0.496 ' HB3' ' O ' ' A' ' 70' ' ' SER . 24.1 ttm -77.32 -74.95 0.22 Allowed 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.294 -0.866 . . . . 0.0 109.93 176.167 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 78.67 101.96 0.21 Allowed Glycine 0 N--CA 1.445 -0.734 0 C-N-CA 120.755 -0.735 . . . . 0.0 113.135 -179.689 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 64.9 p 61.17 16.29 7.08 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 114.221 1.193 . . . . 0.0 114.221 170.098 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -123.99 54.47 1.33 Allowed 'General case' 0 CA--C 1.518 -0.265 0 CA-C-O 121.502 0.667 . . . . 0.0 110.096 174.989 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . 0.491 ' HB2' ' SD ' ' A' ' 101' ' ' MET . 0.1 OUTLIER -77.3 5.62 8.26 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.27 -0.877 . . . . 0.0 111.911 -170.433 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 2.8 m -61.0 -29.95 70.0 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.294 0.569 . . . . 0.0 110.529 177.42 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 27.3 t80 -73.94 -24.83 59.71 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.567 -179.14 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' MET . . . . . 0.491 ' SD ' ' HB2' ' A' ' 98' ' ' ARG . 83.2 mtp -61.7 -51.58 67.8 Favored 'General case' 0 CA--C 1.515 -0.402 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 174.059 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -62.03 -25.36 67.61 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 114.649 -1.16 . . . . 0.0 111.424 -177.696 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -65.84 -28.97 69.37 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-O 121.074 0.464 . . . . 0.0 110.877 178.1 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 61.9 m-85 -109.27 10.81 25.61 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.495 179.766 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 95.4 mt 64.72 15.51 9.81 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.1 -177.24 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . 0.885 HG12 ' HG3' ' A' ' 111' ' ' ARG . 61.2 mt -67.03 112.92 2.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.271 175.111 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 16.2 t-20 -124.96 -53.85 1.63 Allowed 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 176.346 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -92.19 115.02 4.7 Favored Glycine 0 N--CA 1.442 -0.915 0 CA-C-N 115.29 -0.868 . . . . 0.0 111.979 178.339 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.507 ' CG2' ' HA ' ' A' ' 110' ' ' PRO . 41.9 mt -77.7 142.97 66.59 Favored Pre-proline 0 C--N 1.321 -0.655 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 175.383 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . 0.507 ' HA ' ' CG2' ' A' ' 109' ' ' ILE . 1.0 OUTLIER -86.13 170.67 42.16 Favored 'Cis proline' 0 C--N 1.348 0.553 0 C-N-CA 124.775 -0.927 . . . . 0.0 113.853 1.087 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . 0.885 ' HG3' HG12 ' A' ' 106' ' ' ILE . 0.0 OUTLIER -134.79 133.82 40.23 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.477 -0.783 . . . . 0.0 108.897 179.413 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . 0.491 ' CE1' ' HB2' ' A' ' 128' ' ' ARG . 0.0 OUTLIER -102.33 117.05 33.91 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 123.365 0.415 . . . . 0.0 110.502 -175.604 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.61 ' HB ' ' HB ' ' A' ' 35' ' ' ILE . 82.1 mt -129.16 141.81 45.64 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.326 0 CA-C-O 120.708 0.29 . . . . 0.0 111.004 179.559 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 40.4 tp -130.31 139.21 50.72 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.5 -179.775 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.468 ' N ' HD12 ' A' ' 115' ' ' LEU . 0.8 OUTLIER -136.03 155.77 49.73 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.04 0.447 . . . . 0.0 110.54 179.673 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . 0.692 ' HB3' ' HB2' ' A' ' 120' ' ' LYS . 19.2 t70 -71.94 162.55 29.29 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.221 -0.899 . . . . 0.0 110.568 176.684 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . 0.424 ' HA ' ' C ' ' A' ' 31' ' ' LYS . 33.0 mtt180 -46.53 -40.2 12.21 Favored 'General case' 0 N--CA 1.462 0.136 0 O-C-N 124.43 1.081 . . . . 0.0 111.895 -178.611 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . 0.85 ' HB3' ' HG3' ' A' ' 120' ' ' LYS . 38.4 t70 -66.09 -18.87 65.62 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.36 0.6 . . . . 0.0 111.173 -177.448 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 104.26 16.96 16.93 Favored Glycine 0 N--CA 1.436 -1.344 0 N-CA-C 110.288 -1.125 . . . . 0.0 110.288 -170.151 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . 0.85 ' HG3' ' HB3' ' A' ' 118' ' ' ASP . 60.0 mttm -86.03 107.35 17.75 Favored 'General case' 0 C--O 1.219 -0.528 0 C-N-CA 120.805 -0.358 . . . . 0.0 111.115 -173.929 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . 0.65 ' H ' HD12 ' A' ' 121' ' ' ILE . 3.9 mp -48.18 111.67 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-O 121.02 0.438 . . . . 0.0 110.797 177.725 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' ILE . . . . . 0.412 HD11 ' HB2' ' A' ' 116' ' ' ASP . 45.5 mm -95.48 -50.38 11.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 115.659 -0.7 . . . . 0.0 109.9 -179.508 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 19.9 m -125.99 114.59 18.67 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.212 -177.86 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -72.08 -16.98 62.03 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.13 0.491 . . . . 0.0 110.091 176.694 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . 0.406 ' HA ' ' O ' ' A' ' 112' ' ' PHE . 7.7 t30 -149.8 101.18 3.03 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.299 -0.864 . . . . 0.0 109.159 173.909 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 12.6 tpt -91.48 -125.2 0.08 Allowed 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 -178.761 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . 0.463 ' OG1' ' HB ' ' A' ' 134' ' ' THR . 0.0 OUTLIER -140.82 131.72 26.01 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.879 0.371 . . . . 0.0 110.48 178.399 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . 0.651 ' HD2' ' HD2' ' A' ' 129' ' ' PRO . 17.7 tpt180 -51.52 138.03 30.83 Favored Pre-proline 0 C--N 1.323 -0.56 0 CA-C-N 115.252 -0.885 . . . . 0.0 111.073 176.04 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . 0.651 ' HD2' ' HD2' ' A' ' 128' ' ' ARG . 68.8 Cg_exo -48.49 -21.48 3.34 Favored 'Trans proline' 0 C--N 1.351 0.664 0 C-N-CA 123.496 2.797 . . . . 0.0 113.747 174.074 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . 0.455 ' H ' ' HG3' ' A' ' 128' ' ' ARG . 4.4 m -61.11 -28.06 68.82 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.762 0.315 . . . . 0.0 111.035 176.774 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . 0.65 ' OD1' ' HG2' ' A' ' 133' ' ' LYS . 24.1 t0 -100.64 117.35 62.93 Favored Pre-proline 0 N--CA 1.453 -0.321 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.162 179.736 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . 0.598 ' O ' ' HG2' ' A' ' 136' ' ' GLU . 14.1 Cg_endo -56.98 -21.18 40.19 Favored 'Trans proline' 0 CA--C 1.53 0.315 0 C-N-CA 123.196 2.597 . . . . 0.0 114.018 179.736 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . 0.65 ' HG2' ' OD1' ' A' ' 131' ' ' ASP . 31.1 mmtm -48.15 -55.31 10.68 Favored 'General case' 0 N--CA 1.474 0.73 0 CA-C-O 121.066 0.46 . . . . 0.0 110.724 -177.528 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 134' ' ' THR . . . . . 0.463 ' HB ' ' OG1' ' A' ' 127' ' ' THR . 15.1 t -65.15 -41.15 95.02 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.233 -0.894 . . . . 0.0 110.755 -175.069 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . 0.587 ' HA ' ' CD2' ' A' ' 138' ' ' PHE . . . -64.24 -47.87 78.0 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-O 121.402 0.62 . . . . 0.0 110.758 -176.801 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . 0.598 ' HG2' ' O ' ' A' ' 132' ' ' PRO . 8.6 mm-40 -77.12 -22.86 52.02 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-O 121.465 0.65 . . . . 0.0 109.821 -176.2 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . 0.583 ' O ' ' HG ' ' A' ' 141' ' ' LEU . 0.1 OUTLIER -57.68 -39.17 76.48 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.15 -0.932 . . . . 0.0 109.441 168.659 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . 0.587 ' CD2' ' HA ' ' A' ' 135' ' ' ALA . 9.3 m-85 -66.76 -40.59 88.31 Favored 'General case' 0 N--CA 1.462 0.15 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.373 177.596 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 139' ' ' ASN . . . . . 0.515 ' ND2' ' HA ' ' A' ' 136' ' ' GLU . 92.6 m-20 -47.53 -53.76 13.52 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 175.758 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 21.8 tt0 -53.85 -48.42 70.0 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.287 -0.869 . . . . 0.0 111.472 179.111 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.583 ' HG ' ' O ' ' A' ' 137' ' ' LYS . 83.4 mt -58.32 -29.35 65.84 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.899 -176.688 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 0.403 HD21 ' H ' ' A' ' 63' ' ' ASP . 10.0 mp . . . . . 0 C--N 1.327 -0.412 0 CA-C-N 116.678 -0.237 . . . . 0.0 111.442 -179.756 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.548 ' HB2' HD13 ' A' ' 121' ' ' ILE . . . . . . . . 0 N--CA 1.471 0.584 0 N-CA-C 112.823 0.675 . . . . 0.0 112.823 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -76.2 69.35 2.73 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 112.281 0.474 . . . . 0.0 112.281 -175.598 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 42.5 m 62.6 102.86 0.03 OUTLIER 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 113.188 0.811 . . . . 0.0 113.188 172.042 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . 0.502 ' CE1' HD13 ' A' ' 25' ' ' LEU . 38.7 p90 -105.58 129.91 53.74 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.137 -0.483 . . . . 0.0 109.943 173.985 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 3.4 m -121.82 111.76 17.52 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.395 -177.841 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 63.9 m-85 -134.79 151.63 76.07 Favored Pre-proline 0 C--N 1.322 -0.597 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.605 -175.885 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -76.41 125.81 8.63 Favored 'Trans proline' 0 N--CA 1.46 -0.497 0 C-N-CA 122.569 2.18 . . . . 0.0 112.587 178.966 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . 0.544 ' HA ' ' HA ' ' A' ' 92' ' ' LEU . 10.5 t70 -70.51 159.16 34.79 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.484 -0.78 . . . . 0.0 108.926 172.114 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.559 HG13 HG11 ' A' ' 82' ' ' VAL . 0.0 OUTLIER -55.8 -25.64 19.01 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.487 0 O-C-N 123.722 0.639 . . . . 0.0 111.55 -176.947 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 42.8 m-80 -72.65 2.42 6.55 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.137 0.494 . . . . 0.0 110.91 176.065 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 73.67 36.35 53.73 Favored Glycine 0 N--CA 1.446 -0.639 0 N-CA-C 110.835 -0.906 . . . . 0.0 110.835 -179.501 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.461 ' HB2' ' NZ ' ' A' ' 21' ' ' LYS . 0.1 OUTLIER -119.56 134.07 55.39 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 110.273 -0.269 . . . . 0.0 110.273 -175.045 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 7.0 m -80.11 107.83 13.22 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-O 120.868 0.366 . . . . 0.0 110.619 -177.326 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.52 ' HB ' HD21 ' A' ' 92' ' ' LEU . 62.0 t -108.4 141.7 22.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 115.871 -0.604 . . . . 0.0 109.69 -179.969 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 82.3 p -120.53 -173.71 2.64 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 120.867 0.365 . . . . 0.0 110.716 -176.895 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.659 ' O ' ' HB2' ' A' ' 29' ' ' LYS . 65.0 tp -78.73 -26.52 44.72 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.465 -179.716 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -84.76 -30.58 24.54 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 112.8 0.667 . . . . 0.0 112.8 -169.709 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 3.4 p30 -81.04 -15.5 55.94 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.171 0.51 . . . . 0.0 110.849 -175.796 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 18.8 tp -118.36 21.87 12.42 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.756 0.788 . . . . 0.0 109.319 178.007 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.659 ' HB2' ' O ' ' A' ' 25' ' ' LEU . 57.6 tttm -94.18 163.27 13.52 Favored 'General case' 0 N--CA 1.44 -0.957 0 CA-C-N 114.813 -1.085 . . . . 0.0 109.961 -178.45 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 114.49 -31.33 6.45 Favored Glycine 0 CA--C 1.509 -0.301 0 C-N-CA 120.591 -0.814 . . . . 0.0 111.669 177.734 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 1.05 ' HD3' ' HA ' ' A' ' 63' ' ' ASP . 65.2 mttm -119.36 165.55 14.16 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 109.662 -0.496 . . . . 0.0 109.662 174.822 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 81.5 m-85 -60.89 149.15 37.18 Favored 'General case' 0 C--N 1.329 -0.311 0 O-C-N 123.323 0.39 . . . . 0.0 110.639 -177.87 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 71.1 mt -124.5 132.18 71.7 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 CA-C-O 120.853 0.359 . . . . 0.0 110.807 -174.737 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 88.3 t80 -117.12 121.05 40.19 Favored 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 173.013 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.533 ' HB ' ' HB ' ' A' ' 113' ' ' ILE . 57.1 mt -105.58 118.83 53.78 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-O 121.171 0.51 . . . . 0.0 110.736 -178.286 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -106.41 156.87 18.08 Favored 'General case' 0 C--N 1.316 -0.849 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 172.3 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.524 ' HB ' ' H ' ' A' ' 111' ' ' ARG . 62.0 t -110.46 112.1 39.08 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.877 0 C-N-CA 120.034 -0.666 . . . . 0.0 110.22 174.161 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' TRP . . . . . 0.655 ' CZ2' ' HB2' ' A' ' 91' ' ' GLN . 0.2 OUTLIER -98.02 132.86 43.2 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.097 -0.956 . . . . 0.0 109.516 -177.257 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.582 ' HA ' ' OD1' ' A' ' 72' ' ' ASP . . . -147.58 155.09 41.49 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.664 -178.714 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . 0.675 ' HB ' ' CE3' ' A' ' 78' ' ' TRP . 13.3 t -100.34 -28.41 12.97 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.781 0.324 . . . . 0.0 110.704 174.601 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' TRP . . . . . 0.429 ' HE1' ' HA ' ' A' ' 72' ' ' ASP . 18.5 p-90 -81.31 11.03 4.69 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.785 -177.053 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' CYS . . . . . 0.777 ' HB3' ' SG ' ' A' ' 45' ' ' CYS . 44.5 t -91.55 -61.03 1.73 Allowed 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 109.912 -0.403 . . . . 0.0 109.912 174.854 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 111.0 -83.68 0.33 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.597 -179.629 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_exo -54.19 -26.86 44.32 Favored 'Trans proline' 0 C--N 1.351 0.704 0 C-N-CA 123.188 2.592 . . . . 0.0 112.854 179.463 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . 0.777 ' SG ' ' HB3' ' A' ' 42' ' ' CYS . 23.1 p -51.47 -35.49 40.1 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.399 176.797 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.589 ' HA ' HD13 ' A' ' 49' ' ' LEU . 33.6 mtp180 -67.9 -12.3 60.41 Favored 'General case' 0 N--CA 1.456 -0.157 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.21 -175.698 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -80.37 -19.93 67.93 Favored Glycine 0 N--CA 1.446 -0.654 0 C-N-CA 120.648 -0.786 . . . . 0.0 111.369 175.437 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 24.6 mt-10 -99.34 -12.81 19.97 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-O 120.606 0.241 . . . . 0.0 110.615 -179.282 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.589 HD13 ' HA ' ' A' ' 46' ' ' ARG . 7.5 mp -51.89 -48.57 87.52 Favored Pre-proline 0 CA--C 1.536 0.436 0 CA-C-N 116.561 -0.29 . . . . 0.0 111.701 172.279 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -57.04 -35.84 99.07 Favored 'Trans proline' 0 C--N 1.355 0.896 0 C-N-CA 121.791 1.661 . . . . 0.0 111.937 171.601 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.445 ' O ' ' HB2' ' A' ' 54' ' ' GLU . . . -72.0 -26.03 62.06 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-O 121.234 0.54 . . . . 0.0 110.574 -179.1 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 87.3 mt -67.6 -33.67 75.47 Favored 'General case' 0 N--CA 1.444 -0.74 0 CA-C-N 115.858 -0.61 . . . . 0.0 109.67 174.225 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 5.5 mtpm? -70.36 -39.19 74.76 Favored 'General case' 0 CA--C 1.519 -0.236 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.166 175.005 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.445 ' HB2' ' O ' ' A' ' 51' ' ' ALA . 28.1 mm-40 -50.7 -50.82 54.18 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.755 -0.657 . . . . 0.0 109.669 172.9 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 62.8 mt -62.23 -53.12 59.74 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.976 175.409 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 26.4 tt0 -43.41 -59.84 1.96 Allowed 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 114.575 -1.193 . . . . 0.0 112.427 179.522 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -78.67 -29.04 45.41 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 120.777 0.322 . . . . 0.0 111.598 -172.666 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 65.5 tttm -70.48 -27.69 64.41 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.884 0.374 . . . . 0.0 110.831 178.62 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.434 ' HB2' ' HE2' ' A' ' 66' ' ' PHE . 68.4 m-85 -122.58 13.7 10.13 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.46 -0.336 . . . . 0.0 111.845 -176.343 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -60.07 132.09 52.85 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.217 172.392 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 69.36 46.37 56.87 Favored Glycine 0 N--CA 1.447 -0.599 0 C-N-CA 120.854 -0.689 . . . . 0.0 112.169 -179.702 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.414 ' HB2' HG22 ' A' ' 64' ' ' ILE . 40.3 mmtm -126.6 -164.42 1.33 Allowed 'General case' 0 N--CA 1.45 -0.451 0 CA-C-O 121.216 0.531 . . . . 0.0 110.313 174.859 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . 1.05 ' HA ' ' HD3' ' A' ' 31' ' ' LYS . 0.1 OUTLIER -97.85 44.32 1.04 Allowed 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.639 -0.71 . . . . 0.0 110.805 -179.41 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.414 HG22 ' HB2' ' A' ' 62' ' ' LYS . 18.2 tt -144.45 149.27 17.49 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.761 0 CA-C-N 114.929 -1.032 . . . . 0.0 109.761 -177.036 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' HIS . . . . . 0.55 ' NE2' ' HB2' ' A' ' 31' ' ' LYS . 89.4 m-70 -124.25 121.34 34.78 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 109.918 -0.401 . . . . 0.0 109.918 178.287 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . 0.434 ' HE2' ' HB2' ' A' ' 59' ' ' TYR . 91.8 m-85 -88.65 111.31 21.78 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 173.585 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.504 ' O ' ' HA ' ' A' ' 35' ' ' ILE . 27.4 t -118.58 109.37 26.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.459 -175.83 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . 0.426 ' HB3' ' CD1' ' A' ' 38' ' ' TRP . 10.9 m -88.07 143.73 26.91 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-N 115.918 -0.583 . . . . 0.0 109.856 178.844 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.48 ' O ' HG13 ' A' ' 37' ' ' VAL . 62.7 tp -131.88 124.0 28.63 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 174.652 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . 0.565 ' O ' ' HB3' ' A' ' 94' ' ' MET . 1.3 t -108.15 119.61 39.98 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.076 0.465 . . . . 0.0 112.046 -173.957 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 2.4 p -87.06 17.6 4.1 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.749 -0.659 . . . . 0.0 110.806 177.214 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.582 ' OD1' ' HA ' ' A' ' 39' ' ' ALA . 1.9 m-20 -69.64 121.3 16.86 Favored 'General case' 0 CA--C 1.515 -0.4 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.011 179.496 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 45.9 tttm -75.91 -25.86 56.42 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-O 121.146 0.498 . . . . 0.0 110.062 -179.874 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . 0.522 ' HB2' ' HB3' ' A' ' 77' ' ' ALA . 0.2 OUTLIER -78.7 96.87 5.67 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.747 -0.66 . . . . 0.0 109.788 174.027 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.55 ' O ' ' HG2' ' A' ' 79' ' ' GLU . 11.4 tmtt? -71.41 -66.33 0.64 Allowed 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 120.446 -0.502 . . . . 0.0 112.038 -173.863 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 36.0 ttpt -58.3 -43.28 88.04 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 121.009 -0.277 . . . . 0.0 110.819 -173.044 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.603 ' HA ' ' ND2' ' A' ' 80' ' ' ASN . . . -52.22 -38.82 59.09 Favored 'General case' 0 C--O 1.246 0.879 0 CA-C-O 121.86 0.838 . . . . 0.0 111.277 178.716 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' TRP . . . . . 0.675 ' CE3' ' HB ' ' A' ' 40' ' ' THR . 16.2 t-105 -79.02 -42.53 26.31 Favored 'General case' 0 N--CA 1.44 -0.959 0 CA-C-N 115.151 -0.931 . . . . 0.0 111.045 -173.175 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.55 ' HG2' ' O ' ' A' ' 75' ' ' LYS . 3.8 mm-40 -51.97 -40.72 61.33 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-O 121.473 0.654 . . . . 0.0 110.248 175.748 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . 0.603 ' ND2' ' HA ' ' A' ' 77' ' ' ALA . 7.2 m-20 -59.25 -54.07 51.02 Favored 'General case' 0 CA--C 1.513 -0.446 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.257 177.858 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 28.6 ttm -61.37 -45.99 92.05 Favored 'General case' 0 C--O 1.219 -0.507 0 CA-C-N 116.02 -0.536 . . . . 0.0 112.235 -174.209 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.567 ' CG2' ' HZ3' ' A' ' 38' ' ' TRP . 3.9 p -61.57 -32.82 54.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 C-N-CA 120.07 -0.652 . . . . 0.0 111.016 179.519 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 58.9 m -63.75 -40.34 96.48 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.979 0.419 . . . . 0.0 110.239 175.886 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 12.8 mptt -81.13 -29.96 34.66 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.495 -179.396 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . 0.406 ' CG ' HH21 ' A' ' 46' ' ' ARG . 1.5 m-20 -77.6 -6.8 55.02 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.142 0.496 . . . . 0.0 110.975 178.529 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 84.7 mt-30 66.18 18.26 10.92 Favored 'General case' 0 N--CA 1.468 0.43 0 N-CA-C 113.271 0.841 . . . . 0.0 113.271 170.357 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.554 ' HB2' HG23 ' A' ' 82' ' ' VAL . 71.0 mt -64.14 143.18 58.07 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.558 0.218 . . . . 0.0 110.89 -179.926 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 24.6 mmtm -123.15 -166.91 1.52 Allowed 'General case' 0 N--CA 1.451 -0.382 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.934 176.367 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 92.2 -157.01 23.83 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 121.002 -0.618 . . . . 0.0 111.685 -178.986 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 50.1 mm -107.26 117.48 53.12 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 N-CA-C 108.933 -0.766 . . . . 0.0 108.933 175.631 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . 0.655 ' HB2' ' CZ2' ' A' ' 38' ' ' TRP . 0.6 OUTLIER -135.2 102.59 5.23 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-O 121.916 0.865 . . . . 0.0 111.724 -169.4 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.544 ' HA ' ' HA ' ' A' ' 17' ' ' ASP . 38.6 mt -91.73 142.2 27.86 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 114.806 -1.088 . . . . 0.0 110.588 -175.982 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 23.2 t-80 -111.82 116.07 30.07 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-O 121.37 0.605 . . . . 0.0 110.443 179.544 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' MET . . . . . 0.733 ' SD ' ' HA ' ' A' ' 98' ' ' ARG . 10.7 ttm -69.47 -52.28 28.1 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.048 -0.978 . . . . 0.0 111.073 -178.899 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . 0.419 ' HA2' ' O ' ' A' ' 72' ' ' ASP . . . 77.86 -86.7 1.07 Allowed Glycine 0 N--CA 1.448 -0.557 0 C-N-CA 120.628 -0.796 . . . . 0.0 113.243 175.781 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 5.1 m -120.7 -5.45 9.7 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 120.843 0.354 . . . . 0.0 111.112 -176.173 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . 0.536 ' O ' ' HG3' ' A' ' 94' ' ' MET . 13.0 t70 -98.46 72.65 2.07 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 120.056 -0.657 . . . . 0.0 109.719 -177.907 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . 0.733 ' HA ' ' SD ' ' A' ' 94' ' ' MET . 0.0 OUTLIER -82.62 31.31 0.41 Allowed 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.384 -175.462 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 3.0 m -65.67 -43.45 89.31 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.489 179.837 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -71.73 -36.58 70.53 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.247 177.3 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' MET . . . . . 0.537 ' HG3' ' O ' ' A' ' 106' ' ' ILE . 15.1 ttt -56.08 -45.11 79.47 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.568 -0.742 . . . . 0.0 109.982 173.95 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . 0.476 ' HB2' ' CZ ' ' A' ' 98' ' ' ARG . 21.9 t70 -69.07 -49.56 56.29 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.242 -0.89 . . . . 0.0 110.919 179.462 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -69.01 -21.71 64.12 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.957 -0.565 . . . . 0.0 112.344 -171.512 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 25.8 m-85 -109.08 2.63 21.28 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 111.752 0.279 . . . . 0.0 111.752 -178.441 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 9.0 mp 59.39 27.27 16.34 Favored 'General case' 0 N--CA 1.466 0.334 0 O-C-N 123.47 0.481 . . . . 0.0 111.09 -177.968 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . 0.537 ' O ' ' HG3' ' A' ' 101' ' ' MET . 53.6 mt -66.7 77.85 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.271 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.71 174.084 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 61.2 t30 -109.19 -46.47 3.57 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 175.427 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -77.77 91.95 1.1 Allowed Glycine 0 N--CA 1.446 -0.639 0 CA-C-N 115.455 -0.793 . . . . 0.0 111.222 174.575 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.47 HD13 ' HB2' ' A' ' 42' ' ' CYS . 2.4 pp -103.34 151.57 38.6 Favored Pre-proline 0 C--N 1.322 -0.609 0 CA-C-N 115.963 -0.118 . . . . 0.0 111.094 -178.829 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . 0.567 ' HD3' ' HB3' ' A' ' 45' ' ' CYS . 30.0 Cg_endo -68.51 153.49 89.39 Favored 'Cis proline' 0 C--N 1.349 0.573 0 C-N-CA 123.725 -1.365 . . . . 0.0 113.623 1.115 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . 0.524 ' H ' ' HB ' ' A' ' 37' ' ' VAL . 0.0 OUTLIER -113.57 144.41 42.93 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.727 -0.669 . . . . 0.0 109.519 -177.526 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . 0.651 ' HD2' ' HD3' ' A' ' 129' ' ' PRO . 0.9 OUTLIER -112.66 114.52 27.17 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.835 -177.873 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.533 ' HB ' ' HB ' ' A' ' 35' ' ' ILE . 85.6 mt -128.57 141.97 45.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.854 0.359 . . . . 0.0 110.801 -178.796 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.411 HD22 ' HE3' ' A' ' 126' ' ' MET . 41.2 tp -126.48 136.45 52.64 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.172 179.097 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.516 ' N ' HD12 ' A' ' 115' ' ' LEU . 0.7 OUTLIER -136.27 156.7 48.29 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.397 0.618 . . . . 0.0 110.553 -178.175 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . 0.645 ' HB3' ' HB2' ' A' ' 120' ' ' LYS . 9.6 t70 -77.96 168.2 20.28 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 114.88 -1.055 . . . . 0.0 111.351 177.722 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . 0.496 ' HA ' ' O ' ' A' ' 31' ' ' LYS . 88.1 mtt-85 -45.88 -40.55 10.15 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 124.569 1.148 . . . . 0.0 113.115 179.911 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . 0.788 ' HB2' ' HG3' ' A' ' 120' ' ' LYS . 40.2 m-20 -78.34 5.19 11.03 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.576 0.227 . . . . 0.0 111.502 -178.461 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . 0.454 ' HA3' HD11 ' A' ' 25' ' ' LEU . . . 80.63 26.6 53.71 Favored Glycine 0 N--CA 1.44 -1.09 0 N-CA-C 110.521 -1.032 . . . . 0.0 110.521 -173.268 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . 0.788 ' HG3' ' HB2' ' A' ' 118' ' ' ASP . 33.9 mtmm -94.17 103.98 16.01 Favored 'General case' 0 C--O 1.223 -0.332 0 C-N-CA 120.574 -0.45 . . . . 0.0 110.468 -173.511 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . 0.558 ' H ' HD12 ' A' ' 121' ' ' ILE . 2.7 mp -45.0 112.72 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 115.566 -0.743 . . . . 0.0 111.651 -178.47 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' ILE . . . . . 0.446 HD11 ' HB2' ' A' ' 116' ' ' ASP . 46.3 mm -89.5 -40.1 12.83 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-N 115.216 -0.902 . . . . 0.0 109.126 176.504 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 14.8 m -142.66 117.49 9.9 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.338 -0.847 . . . . 0.0 110.497 178.237 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . 0.512 ' O ' HG12 ' A' ' 113' ' ' ILE . . . -68.29 -27.16 66.07 Favored 'General case' 0 C--N 1.334 -0.103 0 CA-C-O 121.409 0.623 . . . . 0.0 109.75 175.453 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 3.9 p-10 -136.82 109.25 7.37 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.044 -0.98 . . . . 0.0 108.646 171.103 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 126' ' ' MET . . . . . 0.422 ' N ' ' HD1' ' A' ' 112' ' ' PHE . 27.9 ttt -83.17 -87.83 0.1 Allowed 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.518 -174.728 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -137.03 -75.76 0.42 Allowed 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.574 -0.285 . . . . 0.0 111.579 -178.266 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . 0.936 ' HB3' ' HB2' ' A' ' 131' ' ' ASP . 3.6 tmm_? 177.88 139.06 0.24 Allowed Pre-proline 0 N--CA 1.453 -0.297 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 -178.128 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . 0.651 ' HD3' ' HD2' ' A' ' 112' ' ' PHE . 85.1 Cg_exo -48.65 -44.8 29.81 Favored 'Trans proline' 0 C--N 1.349 0.554 0 C-N-CA 122.869 2.379 . . . . 0.0 113.617 -176.649 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . 0.637 ' HB3' ' NH1' ' A' ' 128' ' ' ARG . 43.8 t -107.1 26.83 9.66 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.063 0.459 . . . . 0.0 110.863 -178.719 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . 0.936 ' HB2' ' HB3' ' A' ' 128' ' ' ARG . 13.6 t70 -92.09 134.06 29.25 Favored Pre-proline 0 C--N 1.325 -0.496 0 N-CA-C 109.781 -0.451 . . . . 0.0 109.781 177.686 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . 0.621 ' O ' ' HG3' ' A' ' 136' ' ' GLU . 18.8 Cg_endo -58.22 -40.87 72.51 Favored 'Trans proline' 0 C--N 1.343 0.269 0 C-N-CA 122.748 2.299 . . . . 0.0 113.142 -178.867 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 36.0 mtmm -61.17 -27.44 68.41 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 121.048 0.451 . . . . 0.0 110.69 -175.05 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 134' ' ' THR . . . . . 0.713 HG22 ' CZ ' ' A' ' 138' ' ' PHE . 1.3 m -60.94 -57.18 13.74 Favored 'General case' 0 N--CA 1.447 -0.595 0 CA-C-N 115.73 -0.668 . . . . 0.0 109.464 173.772 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . 0.643 ' HA ' ' CD2' ' A' ' 138' ' ' PHE . . . -60.09 -42.73 95.26 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.011 -0.995 . . . . 0.0 111.696 178.599 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . 0.621 ' HG3' ' O ' ' A' ' 132' ' ' PRO . 38.6 mt-10 -54.18 -52.45 61.15 Favored 'General case' 0 CA--C 1.512 -0.516 0 CA-C-O 121.382 0.61 . . . . 0.0 110.534 179.177 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . 0.51 ' O ' ' HB3' ' A' ' 140' ' ' GLU . 5.8 tmtm? -55.24 -43.61 74.73 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-N 114.792 -1.094 . . . . 0.0 111.148 -178.747 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . 0.713 ' CZ ' HG22 ' A' ' 134' ' ' THR . 14.8 m-85 -53.68 -60.54 3.18 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.07 -0.513 . . . . 0.0 111.44 177.674 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 139' ' ' ASN . . . . . 0.501 HD22 ' N ' ' A' ' 140' ' ' GLU . 0.3 OUTLIER -72.28 -17.37 61.88 Favored 'General case' 0 C--O 1.224 -0.287 0 C-N-CA 120.423 -0.511 . . . . 0.0 111.2 -175.491 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . 0.51 ' HB3' ' O ' ' A' ' 137' ' ' LYS . 3.8 tt0 -59.21 -57.44 13.0 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.736 171.351 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.449 ' HG ' ' O ' ' A' ' 138' ' ' PHE . 4.5 pp -71.53 -19.58 62.15 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.965 -177.31 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 95.7 mt . . . . . 0 C--N 1.328 -0.361 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.424 174.064 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.119 0 CA-C-O 121.107 0.48 . . . . 0.0 110.153 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -159.79 117.31 2.64 Favored 'General case' 0 N--CA 1.447 -0.585 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.66 -175.526 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . 0.661 ' H ' HD23 ' A' ' 25' ' ' LEU . 47.3 m 67.04 36.01 4.37 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.235 -0.893 . . . . 0.0 112.141 171.954 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 37.5 p90 -66.06 163.87 16.53 Favored 'General case' 0 N--CA 1.463 0.208 0 N-CA-C 110.093 -0.336 . . . . 0.0 110.093 174.672 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . 0.43 ' HA ' ' HA ' ' A' ' 24' ' ' SER . 16.2 t -142.36 128.0 19.16 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 120.865 0.364 . . . . 0.0 110.802 179.843 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . 0.455 ' O ' HD22 ' A' ' 92' ' ' LEU . 75.7 m-85 -141.83 159.65 58.82 Favored Pre-proline 0 C--N 1.327 -0.402 0 CA-C-N 115.874 -0.603 . . . . 0.0 109.81 178.942 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.702 ' HA ' ' O ' ' A' ' 21' ' ' LYS . 85.9 Cg_endo -88.44 134.16 2.85 Favored 'Trans proline' 0 N--CA 1.459 -0.549 0 C-N-CA 122.557 2.172 . . . . 0.0 113.996 -178.896 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . 0.478 ' HA ' ' O ' ' A' ' 91' ' ' GLN . 8.3 m-20 -69.1 168.62 13.55 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.054 171.203 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.567 HD12 HG13 ' A' ' 82' ' ' VAL . 1.9 tt -41.69 -40.36 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 O-C-N 124.563 1.164 . . . . 0.0 112.238 175.539 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 40.4 m-80 -68.54 -3.99 13.59 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.484 -177.086 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 79.14 33.63 35.57 Favored Glycine 0 N--CA 1.442 -0.931 0 N-CA-C 110.561 -1.016 . . . . 0.0 110.561 -174.389 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.702 ' O ' ' HA ' ' A' ' 16' ' ' PRO . 15.9 tppt? -110.43 126.73 54.62 Favored 'General case' 0 C--O 1.22 -0.48 0 CA-C-N 115.607 -0.297 . . . . 0.0 110.853 -173.952 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 18.8 m -84.44 106.86 16.35 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.974 -174.392 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.421 ' HB ' HD21 ' A' ' 92' ' ' LEU . 71.7 t -112.81 144.65 20.07 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 115.646 -0.706 . . . . 0.0 109.748 179.837 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . 0.43 ' HA ' ' HA ' ' A' ' 14' ' ' SER . 95.7 p -113.98 162.01 16.96 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.912 -178.928 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.661 HD23 ' H ' ' A' ' 12' ' ' SER . 53.9 tp -66.98 -16.89 64.64 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.761 178.33 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -74.56 -18.95 60.51 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.825 0.345 . . . . 0.0 110.815 179.408 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -76.86 -39.1 52.33 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.629 0.728 . . . . 0.0 109.749 175.37 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.584 HD13 HG21 ' A' ' 67' ' ' VAL . 24.0 mt -84.69 -7.83 59.08 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 114.853 -1.067 . . . . 0.0 110.152 -179.402 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 32.9 tttp -73.78 130.2 39.48 Favored 'General case' 0 N--CA 1.439 -1.019 0 CA-C-N 114.847 -1.07 . . . . 0.0 110.496 -178.131 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 128.2 -31.14 3.72 Favored Glycine 0 N--CA 1.445 -0.747 0 N-CA-C 110.305 -1.118 . . . . 0.0 110.305 -173.985 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.857 ' HD3' ' HA ' ' A' ' 63' ' ' ASP . 61.4 mttm -122.56 174.31 7.15 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.526 -0.337 . . . . 0.0 110.154 175.518 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.962 ' HB2' HG22 ' A' ' 64' ' ' ILE . 92.4 m-85 -69.16 150.97 46.93 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 110.189 -0.3 . . . . 0.0 110.189 179.767 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.555 HD13 ' HA2' ' A' ' 119' ' ' GLY . 5.3 mp -124.59 134.47 66.69 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-O 120.79 0.328 . . . . 0.0 110.619 178.945 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 60.9 t80 -118.58 114.46 22.83 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 171.677 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.493 ' HA ' ' O ' ' A' ' 67' ' ' VAL . 67.4 mt -103.13 114.32 42.4 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 CA-C-O 121.134 0.493 . . . . 0.0 110.755 -177.791 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.486 ' O ' ' HA ' ' A' ' 68' ' ' SER . 5.5 p-10 -110.98 158.43 18.79 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 115.549 -0.75 . . . . 0.0 109.365 174.394 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.428 HG11 ' CG2' ' A' ' 109' ' ' ILE . 59.7 t -102.33 130.08 52.77 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.822 0 C-N-CA 120.779 -0.368 . . . . 0.0 110.421 178.359 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' TRP . . . . . 0.625 ' CZ2' ' HB2' ' A' ' 91' ' ' GLN . 0.6 OUTLIER -122.31 134.34 54.66 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 -179.223 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.55 ' HB3' ' HB3' ' A' ' 42' ' ' CYS . . . -145.03 162.23 37.47 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.548 -179.689 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . 0.764 ' HB ' ' CE3' ' A' ' 78' ' ' TRP . 8.8 t -88.05 -22.19 24.34 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.226 0.536 . . . . 0.0 110.02 175.338 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 19.0 p-90 -96.71 18.0 15.3 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.674 -0.694 . . . . 0.0 109.848 176.045 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' CYS . . . . . 0.668 ' SG ' ' HB3' ' A' ' 45' ' ' CYS . 23.9 p -76.15 -19.38 58.53 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.542 -0.754 . . . . 0.0 111.089 -177.572 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 47.65 -98.31 0.01 OUTLIER Glycine 0 C--N 1.338 0.645 0 O-C-N 124.12 0.887 . . . . 0.0 114.261 176.602 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 81.6 Cg_exo -51.19 -26.11 19.02 Favored 'Trans proline' 0 C--N 1.354 0.821 0 C-N-CA 123.623 2.882 . . . . 0.0 113.502 178.217 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . 0.668 ' HB3' ' SG ' ' A' ' 42' ' ' CYS . 42.1 t -67.33 -41.14 85.75 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.286 0.565 . . . . 0.0 110.003 174.599 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.631 ' HA ' ' HG ' ' A' ' 49' ' ' LEU . 28.6 ttt-85 -67.49 -23.19 65.45 Favored 'General case' 0 N--CA 1.44 -0.953 0 CA-C-N 115.177 -0.92 . . . . 0.0 111.901 -173.487 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -63.2 -25.93 68.78 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.727 -0.749 . . . . 0.0 111.953 179.831 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . 0.482 ' CD ' ' HE ' ' A' ' 128' ' ' ARG . 47.9 mt-10 -109.78 24.56 12.88 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 111.708 0.262 . . . . 0.0 111.708 -179.934 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.631 ' HG ' ' HA ' ' A' ' 46' ' ' ARG . 34.6 mt -59.29 -42.7 94.34 Favored Pre-proline 0 C--N 1.328 -0.369 0 C-N-CA 120.692 -0.403 . . . . 0.0 110.543 170.625 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.447 ' HD3' ' HB2' ' A' ' 49' ' ' LEU . 76.2 Cg_exo -51.94 -38.91 69.7 Favored 'Trans proline' 0 C--N 1.36 1.139 0 C-N-CA 122.02 1.813 . . . . 0.0 112.108 169.386 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -74.72 -26.76 60.03 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.146 0.498 . . . . 0.0 110.675 179.948 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 6.5 tt -67.01 -44.01 81.42 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 173.487 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 3.1 mmmp? -60.98 -42.63 98.74 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.558 176.353 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -47.76 -58.58 4.14 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.786 173.662 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.572 ' HG ' ' CZ ' ' A' ' 66' ' ' PHE . 18.0 tp -62.79 -44.24 96.68 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.538 -0.755 . . . . 0.0 110.479 179.169 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 23.7 tt0 -49.46 -60.41 2.87 Favored 'General case' 0 C--N 1.331 -0.212 0 C-N-CA 123.853 0.861 . . . . 0.0 111.876 -179.597 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 32.1 mt-10 -73.03 -35.51 66.77 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.767 -172.797 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 43.6 mtpt -68.14 -38.31 82.01 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.005 0.431 . . . . 0.0 111.609 179.714 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.641 ' HB3' HD11 ' A' ' 64' ' ' ILE . 51.7 m-85 -107.13 10.41 30.12 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.897 -175.769 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -70.45 150.3 46.35 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 109.773 -0.455 . . . . 0.0 109.773 170.478 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 68.72 38.78 86.12 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.574 178.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.691 ' HB2' HG12 ' A' ' 64' ' ' ILE . 47.6 mmtm -119.67 -163.53 1.0 Allowed 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.233 0.539 . . . . 0.0 109.933 176.154 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . 0.857 ' HA ' ' HD3' ' A' ' 31' ' ' LYS . 0.6 OUTLIER -92.49 36.62 1.0 Allowed 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 115.265 -0.879 . . . . 0.0 110.127 178.165 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.962 HG22 ' HB2' ' A' ' 32' ' ' TYR . 30.4 pt -141.8 167.38 16.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.543 -174.507 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' HIS . . . . . 0.673 ' NE2' ' HB2' ' A' ' 31' ' ' LYS . 63.2 m-70 -136.45 119.03 15.93 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.172 -0.467 . . . . 0.0 109.919 177.02 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . 0.572 ' CZ ' ' HG ' ' A' ' 55' ' ' LEU . 11.8 m-85 -79.5 118.71 21.61 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 170.016 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.584 HG21 HD13 ' A' ' 28' ' ' LEU . 25.4 t -127.59 103.94 11.37 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-O 121.138 0.494 . . . . 0.0 110.707 -175.279 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . 0.486 ' HA ' ' O ' ' A' ' 36' ' ' ASP . 16.1 m -88.56 129.21 35.53 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-N 115.536 -0.757 . . . . 0.0 110.039 178.613 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.489 ' CD2' ' HB2' ' A' ' 92' ' ' LEU . 54.4 mt -114.33 132.21 56.27 Favored 'General case' 0 N--CA 1.465 0.303 0 O-C-N 122.147 -0.346 . . . . 0.0 110.287 174.988 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 1.4 t -112.34 120.33 41.35 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.17 0.51 . . . . 0.0 112.327 -174.586 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 4.7 p -88.76 18.49 4.69 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.842 177.014 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.531 ' OD2' HG22 ' A' ' 40' ' ' THR . 2.1 m-20 -72.34 136.55 46.2 Favored 'General case' 0 CA--C 1.519 -0.25 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.231 -179.497 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 51.4 tptt -79.16 -37.97 37.11 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 121.228 0.537 . . . . 0.0 110.045 177.936 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . 0.547 ' HB2' ' HB3' ' A' ' 77' ' ' ALA . 0.6 OUTLIER -79.42 82.96 5.49 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.759 -179.846 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.498 ' HB2' ' CE1' ' A' ' 93' ' ' HIS . 10.0 tttt -64.38 -51.9 60.96 Favored 'General case' 0 C--N 1.323 -0.545 0 C-N-CA 120.968 -0.293 . . . . 0.0 111.396 -177.129 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.489 ' HD3' ' C ' ' A' ' 76' ' ' LYS . 3.1 tmtm? -58.98 -51.27 70.79 Favored 'General case' 0 N--CA 1.444 -0.757 0 CA-C-N 116.103 -0.499 . . . . 0.0 109.715 -174.922 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.694 ' HA ' ' ND2' ' A' ' 80' ' ' ASN . . . -56.36 -38.48 71.46 Favored 'General case' 0 C--O 1.243 0.72 0 CA-C-O 121.959 0.885 . . . . 0.0 110.926 178.455 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' TRP . . . . . 0.764 ' CE3' ' HB ' ' A' ' 40' ' ' THR . 11.7 t-105 -75.83 -43.86 43.84 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 114.963 -1.017 . . . . 0.0 111.757 -174.169 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.55 ' HB2' HG13 ' A' ' 18' ' ' ILE . 4.0 pt-20 -60.49 -27.92 67.96 Favored 'General case' 0 CA--C 1.542 0.647 0 CA-C-O 121.047 0.451 . . . . 0.0 109.914 179.422 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . 0.694 ' ND2' ' HA ' ' A' ' 77' ' ' ALA . 8.9 m-20 -63.12 -52.98 60.42 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-O 120.795 0.331 . . . . 0.0 110.145 171.862 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' MET . . . . . 0.411 ' HG2' ' HZ3' ' A' ' 78' ' ' TRP . 54.8 tpp -56.45 -47.84 78.28 Favored 'General case' 0 CA--C 1.518 -0.288 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.991 -175.83 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.572 HG23 ' HB2' ' A' ' 87' ' ' LEU . 1.6 p -61.16 -34.1 58.98 Favored 'Isoleucine or valine' 0 C--O 1.237 0.401 0 CA-C-O 120.939 0.4 . . . . 0.0 110.847 178.737 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 90.5 m -64.63 -42.53 95.41 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.82 0.343 . . . . 0.0 110.467 174.896 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . 0.761 ' HB3' ' HZ2' ' A' ' 84' ' ' LYS . 0.0 OUTLIER -76.79 -37.95 54.88 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.008 -176.535 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 55.8 m-20 -83.02 -0.1 47.31 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.49 -177.95 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 27.4 mt-30 66.08 11.56 7.87 Favored 'General case' 0 N--CA 1.467 0.391 0 N-CA-C 113.69 0.996 . . . . 0.0 113.69 170.724 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.572 ' HB2' HG23 ' A' ' 82' ' ' VAL . 84.9 mt -64.63 126.32 27.51 Favored 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 110.323 -0.251 . . . . 0.0 110.323 178.582 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 21.6 mmtm -123.33 -161.98 1.01 Allowed 'General case' 0 N--CA 1.45 -0.427 0 CA-C-O 120.768 0.318 . . . . 0.0 111.799 -179.217 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 96.13 -156.58 21.34 Favored Glycine 0 N--CA 1.448 -0.535 0 N-CA-C 111.416 -0.674 . . . . 0.0 111.416 -177.579 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.526 ' O ' ' HA ' ' A' ' 67' ' ' VAL . 45.8 mm -93.29 116.46 34.49 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 174.529 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . 0.625 ' HB2' ' CZ2' ' A' ' 38' ' ' TRP . 1.9 pt20 -141.64 95.17 2.78 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-O 121.813 0.816 . . . . 0.0 111.83 -168.854 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.489 ' HB2' ' CD2' ' A' ' 69' ' ' LEU . 37.9 mt -94.43 157.11 16.16 Favored 'General case' 0 N--CA 1.442 -0.844 0 CA-C-N 114.779 -1.101 . . . . 0.0 110.421 -176.647 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' HIS . . . . . 0.498 ' CE1' ' HB2' ' A' ' 75' ' ' LYS . 21.9 t-80 -123.98 127.17 47.53 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-N 115.498 -0.774 . . . . 0.0 110.248 -177.684 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' MET . . . . . 0.649 ' HG3' ' HB2' ' A' ' 97' ' ' ASP . 30.2 ttm -81.58 -65.93 0.95 Allowed 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 114.96 -1.018 . . . . 0.0 110.764 -177.289 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 106.53 -94.18 0.92 Allowed Glycine 0 N--CA 1.446 -0.688 0 C-N-CA 120.492 -0.861 . . . . 0.0 112.664 179.772 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -117.75 0.42 11.99 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 120.81 0.338 . . . . 0.0 111.399 -176.279 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . 0.649 ' HB2' ' HG3' ' A' ' 94' ' ' MET . 3.9 m-20 -83.89 41.55 0.81 Allowed 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.008 0.433 . . . . 0.0 110.658 -174.294 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.9 -6.74 9.04 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.789 -0.641 . . . . 0.0 112.399 -172.264 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 16.7 m -70.24 -19.27 63.15 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.347 0.594 . . . . 0.0 110.17 176.625 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 52.8 t80 -74.21 -37.94 63.72 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.839 -0.618 . . . . 0.0 109.463 175.069 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' MET . . . . . 0.408 ' HE1' HG21 ' A' ' 106' ' ' ILE . 71.4 mmm -63.37 -42.74 98.88 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 173.353 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -58.7 -47.5 84.33 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 114.422 -1.263 . . . . 0.0 110.701 178.711 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -67.85 -12.76 61.29 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.721 -177.503 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 7.7 m-85 -105.64 6.82 32.36 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.021 179.918 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 3.7 mm? 62.57 25.39 15.11 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.812 -179.097 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . 0.735 HG12 ' HG3' ' A' ' 111' ' ' ARG . 58.9 mt -83.61 86.3 2.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.004 174.267 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 13.9 m120 -84.76 -51.41 6.81 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.045 177.274 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -107.73 130.67 10.23 Favored Glycine 0 N--CA 1.441 -1.019 0 CA-C-N 115.448 -0.796 . . . . 0.0 111.676 -179.933 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.428 ' CG2' HG11 ' A' ' 37' ' ' VAL . 2.9 pp -98.98 154.95 37.09 Favored Pre-proline 0 C--N 1.319 -0.751 0 N-CA-C 110.43 -0.211 . . . . 0.0 110.43 177.988 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . 0.624 ' HG3' ' SG ' ' A' ' 45' ' ' CYS . 71.8 Cg_endo -82.89 149.5 67.82 Favored 'Cis proline' 0 N--CA 1.46 -0.449 0 C-N-CA 123.523 -1.449 . . . . 0.0 113.036 0.199 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . 0.735 ' HG3' HG12 ' A' ' 106' ' ' ILE . 0.0 OUTLIER -103.99 153.17 21.15 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.902 -0.59 . . . . 0.0 109.658 177.657 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 11.9 m-85 -119.72 127.69 53.09 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 108.89 -0.782 . . . . 0.0 108.89 -178.231 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.428 ' HB ' ' HB ' ' A' ' 35' ' ' ILE . 89.6 mt -138.26 144.8 29.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-O 120.685 0.279 . . . . 0.0 110.764 -175.769 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 28.5 tp -128.58 139.78 52.12 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 109.879 -0.415 . . . . 0.0 109.879 178.494 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.691 ' HG ' ' HA ' ' A' ' 121' ' ' ILE . 2.1 mp -133.75 158.83 42.33 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 109.947 -0.39 . . . . 0.0 109.947 -177.796 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . 0.54 ' OD2' ' HB2' ' A' ' 120' ' ' LYS . 3.9 p30 -86.12 175.31 8.6 Favored 'General case' 0 CA--C 1.516 -0.349 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.023 177.73 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . 0.603 ' HA ' ' O ' ' A' ' 31' ' ' LYS . 21.9 mtp85 -58.17 -26.98 63.42 Favored 'General case' 0 N--CA 1.465 0.298 0 O-C-N 124.36 1.038 . . . . 0.0 112.384 -173.124 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -76.29 -6.91 53.56 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.529 0.68 . . . . 0.0 109.356 -179.239 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . 0.555 ' HA2' HD13 ' A' ' 33' ' ' ILE . . . 89.47 23.48 33.85 Favored Glycine 0 N--CA 1.434 -1.463 0 N-CA-C 110.319 -1.113 . . . . 0.0 110.319 -174.857 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . 0.54 ' HB2' ' OD2' ' A' ' 116' ' ' ASP . 10.1 mmmm -102.96 118.38 36.7 Favored 'General case' 0 C--O 1.223 -0.295 0 C-N-CA 119.792 -0.763 . . . . 0.0 112.045 -172.96 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . 0.691 ' HA ' ' HG ' ' A' ' 115' ' ' LEU . 3.6 mp -46.79 114.69 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.55 -0.75 . . . . 0.0 111.681 178.618 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' ILE . . . . . 0.406 HD11 ' HB3' ' A' ' 116' ' ' ASP . 40.0 mm -92.68 -44.4 13.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 115.229 -0.896 . . . . 0.0 109.659 176.519 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 20.8 m -127.63 114.79 17.83 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.386 -0.824 . . . . 0.0 110.024 177.774 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -72.31 -17.72 61.84 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.074 0.464 . . . . 0.0 110.774 178.971 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 7.2 t30 -142.3 98.84 3.39 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.62 -0.718 . . . . 0.0 109.828 175.969 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 126' ' ' MET . . . . . 0.47 ' HG3' ' H ' ' A' ' 127' ' ' THR . 7.7 tpt -92.73 -150.49 0.27 Allowed 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 178.135 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . 0.626 ' OG1' ' HB ' ' A' ' 134' ' ' THR . 1.3 p -133.37 131.47 40.09 Favored 'General case' 0 N--CA 1.446 -0.642 0 CA-C-O 121.593 0.711 . . . . 0.0 112.356 -175.053 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . 0.482 ' HE ' ' CD ' ' A' ' 48' ' ' GLU . 34.4 ttt85 -31.89 139.2 0.2 Allowed Pre-proline 0 N--CA 1.471 0.588 0 CA-C-N 113.753 -1.567 . . . . 0.0 113.316 170.169 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_exo -40.54 -39.96 3.09 Favored 'Trans proline' 0 C--N 1.352 0.727 0 C-N-CA 124.682 3.588 . . . . 0.0 115.338 179.028 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -72.36 -7.0 47.27 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 112.22 0.452 . . . . 0.0 112.22 -175.589 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . 0.554 ' O ' HG22 ' A' ' 134' ' ' THR . 4.5 t70 -85.18 130.09 53.28 Favored Pre-proline 0 C--N 1.324 -0.542 0 CA-C-O 120.829 0.347 . . . . 0.0 110.887 178.468 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -68.6 -22.77 37.56 Favored 'Trans proline' 0 C--N 1.343 0.239 0 C-N-CA 122.648 2.232 . . . . 0.0 113.111 -179.907 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . 0.622 ' HA ' ' HG2' ' A' ' 136' ' ' GLU . 0.8 OUTLIER -73.76 -35.38 64.99 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.114 0.483 . . . . 0.0 110.7 -175.87 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 134' ' ' THR . . . . . 0.626 ' HB ' ' OG1' ' A' ' 127' ' ' THR . 4.2 t -71.2 -40.25 71.3 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 176.048 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . 0.514 ' HA ' ' CD2' ' A' ' 138' ' ' PHE . . . -62.48 -49.12 76.63 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 115.78 -0.645 . . . . 0.0 111.462 179.162 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . 0.622 ' HG2' ' HA ' ' A' ' 133' ' ' LYS . 5.2 pt-20 -58.91 -38.22 78.43 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 121.215 0.531 . . . . 0.0 109.818 179.56 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . 0.558 ' O ' ' HG ' ' A' ' 141' ' ' LEU . 0.0 OUTLIER -65.4 -41.52 93.55 Favored 'General case' 0 N--CA 1.448 -0.547 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.014 -177.913 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . 0.514 ' CD2' ' HA ' ' A' ' 135' ' ' ALA . 15.3 m-85 -54.5 -52.48 61.81 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-O 121.012 0.434 . . . . 0.0 109.996 176.524 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 66.2 m-20 -59.37 -50.42 74.02 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.01 179.32 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -52.04 -56.25 15.55 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.242 -0.89 . . . . 0.0 112.768 179.547 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.558 ' HG ' ' O ' ' A' ' 137' ' ' LYS . 4.1 pp -68.87 -21.8 64.24 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 120.816 0.341 . . . . 0.0 111.336 -175.962 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 0.407 ' N ' HD12 ' A' ' 141' ' ' LEU . 0.2 OUTLIER . . . . . 0 C--N 1.326 -0.427 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 175.22 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.234 0.257 0 CA-C-O 121.284 0.564 . . . . 0.0 109.672 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -154.47 -34.7 0.1 Allowed 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.49 -0.777 . . . . 0.0 111.193 -178.836 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 22.8 t -169.54 153.42 5.11 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 178.521 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . 0.427 ' CD2' ' HZ ' ' A' ' 100' ' ' PHE . 52.3 p90 -154.98 152.82 30.14 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-O 120.81 0.338 . . . . 0.0 110.938 179.405 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 19.3 m -143.75 106.56 4.47 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 169.701 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . 0.776 ' HB2' HD12 ' A' ' 92' ' ' LEU . 24.8 m-85 -128.35 154.7 79.13 Favored Pre-proline 0 C--N 1.325 -0.483 0 CA-C-N 116.762 -0.199 . . . . 0.0 110.963 -174.716 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -81.89 125.43 4.79 Favored 'Trans proline' 0 CA--C 1.532 0.386 0 C-N-CA 122.6 2.2 . . . . 0.0 113.87 -178.479 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . 0.671 ' HB3' ' HB3' ' A' ' 21' ' ' LYS . 0.4 OUTLIER -69.53 163.62 25.01 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.009 -0.996 . . . . 0.0 109.918 171.212 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.65 HD12 HG13 ' A' ' 82' ' ' VAL . 0.9 OUTLIER -43.85 -44.99 1.94 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.662 0 O-C-N 123.858 0.724 . . . . 0.0 112.252 -177.883 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.486 ' ND2' HG23 ' A' ' 18' ' ' ILE . 29.2 m-80 -77.24 3.81 12.0 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.495 -174.792 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 83.62 32.57 24.31 Favored Glycine 0 N--CA 1.446 -0.683 0 N-CA-C 110.662 -0.975 . . . . 0.0 110.662 -174.289 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.671 ' HB3' ' HB3' ' A' ' 17' ' ' ASP . 8.0 ttpm? -104.94 105.97 16.25 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.758 0.313 . . . . 0.0 110.796 -174.549 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 19.3 m -67.68 117.33 9.46 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.147 -179.935 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.452 HG11 HD22 ' A' ' 92' ' ' LEU . 7.1 p -117.77 143.49 28.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 115.939 -0.573 . . . . 0.0 109.475 177.396 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 60.4 p -122.48 -173.19 2.63 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.02 0.438 . . . . 0.0 110.579 -175.621 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 64.8 tp -85.91 -19.89 29.83 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.775 177.973 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.901 ' HA ' ' HD3' ' A' ' 29' ' ' LYS . . . -78.46 -35.23 46.97 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.568 -0.287 . . . . 0.0 111.423 -172.593 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -78.24 -11.79 59.95 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.36 0.6 . . . . 0.0 110.543 179.783 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.528 HD13 HG21 ' A' ' 67' ' ' VAL . 92.8 mt -92.78 -9.18 41.46 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.632 177.324 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.901 ' HD3' ' HA ' ' A' ' 26' ' ' ALA . 13.4 mtpp -75.98 153.59 36.44 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.266 0.555 . . . . 0.0 111.537 -179.07 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 101.7 -3.12 52.96 Favored Glycine 0 N--CA 1.45 -0.385 0 CA-C-N 115.357 -0.838 . . . . 0.0 111.747 -178.227 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.617 ' HB3' ' NE2' ' A' ' 65' ' ' HIS . 24.2 ttmm -157.97 145.89 18.62 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 -179.108 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.44 ' HB2' ' O ' ' A' ' 63' ' ' ASP . 34.6 m-85 -53.63 149.37 8.28 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-O 120.906 0.384 . . . . 0.0 111.424 -177.861 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.468 HD12 ' HA2' ' A' ' 119' ' ' GLY . 55.1 mt -125.28 138.69 53.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.554 -175.581 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 59.4 t80 -127.45 123.74 36.75 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 174.677 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.602 ' HB ' ' HB ' ' A' ' 113' ' ' ILE . 66.4 mt -109.59 123.13 65.23 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-O 121.074 0.464 . . . . 0.0 111.189 -177.028 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.432 ' HA ' ' O ' ' A' ' 111' ' ' ARG . 4.7 p-10 -116.37 159.32 22.13 Favored 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 173.216 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.553 HG11 HG21 ' A' ' 109' ' ' ILE . 60.7 t -105.22 115.47 47.13 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.839 0 C-N-CA 120.203 -0.599 . . . . 0.0 111.235 176.241 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' TRP . . . . . 0.644 ' HZ3' HG21 ' A' ' 82' ' ' VAL . 0.6 OUTLIER -98.12 132.79 43.36 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 179.358 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.568 ' HA ' ' OD1' ' A' ' 72' ' ' ASP . . . -147.05 152.99 39.47 Favored 'General case' 0 C--O 1.236 0.368 0 N-CA-C 112.268 0.47 . . . . 0.0 112.268 -173.837 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . 0.557 HG23 ' SD ' ' A' ' 81' ' ' MET . 0.5 OUTLIER -83.68 -48.06 10.56 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.703 0.763 . . . . 0.0 110.182 176.561 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' TRP . . . . . 0.428 ' HE1' ' HA ' ' A' ' 72' ' ' ASP . 17.4 p-90 -81.73 20.08 0.99 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 114.654 -1.157 . . . . 0.0 112.283 -171.309 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' CYS . . . . . 0.687 ' HB3' ' SG ' ' A' ' 45' ' ' CYS . 40.5 t -88.39 -64.03 1.21 Allowed 'General case' 0 C--N 1.322 -0.613 0 C-N-CA 120.541 -0.464 . . . . 0.0 110.38 -179.672 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 108.46 -84.1 0.36 Allowed Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.611 -0.804 . . . . 0.0 112.232 -178.736 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_exo -53.91 -22.6 24.69 Favored 'Trans proline' 0 C--N 1.352 0.736 0 C-N-CA 123.244 2.63 . . . . 0.0 112.946 177.57 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . 0.687 ' SG ' ' HB3' ' A' ' 42' ' ' CYS . 26.3 p -52.45 -31.87 36.84 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.26 177.843 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.573 ' HA ' ' HG ' ' A' ' 49' ' ' LEU . 64.9 mtp180 -72.91 -14.39 61.46 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.121 -175.617 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -84.26 -25.56 43.43 Favored Glycine 0 N--CA 1.448 -0.535 0 N-CA-C 111.244 -0.742 . . . . 0.0 111.244 174.484 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -87.12 -20.95 26.34 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.952 -0.388 . . . . 0.0 109.952 -179.186 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.687 ' HB2' ' HD3' ' A' ' 50' ' ' PRO . 79.4 mt -52.74 -50.61 80.09 Favored Pre-proline 0 CA--C 1.534 0.365 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.4 -179.225 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.687 ' HD3' ' HB2' ' A' ' 49' ' ' LEU . 52.8 Cg_exo -57.73 -34.91 98.85 Favored 'Trans proline' 0 C--N 1.355 0.875 0 C-N-CA 121.905 1.737 . . . . 0.0 112.552 173.476 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -75.48 -31.82 60.36 Favored 'General case' 0 N--CA 1.454 -0.236 0 CA-C-O 121.274 0.559 . . . . 0.0 109.889 -176.948 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 6.9 tt -68.0 -40.2 83.09 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.326 -0.852 . . . . 0.0 108.934 177.097 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.862 ' HA ' ' HG2' ' A' ' 56' ' ' GLU . 12.3 mtpp -60.13 -43.99 95.27 Favored 'General case' 0 CA--C 1.517 -0.298 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.857 176.198 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.596 ' O ' ' HB2' ' A' ' 58' ' ' LYS . 23.5 mm-40 -50.2 -47.82 54.53 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.814 173.365 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 6.0 mp -66.27 -51.77 54.14 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 111.873 0.324 . . . . 0.0 111.873 179.074 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.862 ' HG2' ' HA ' ' A' ' 53' ' ' LYS . 10.2 pt-20 -58.11 -46.48 85.49 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 120.571 0.224 . . . . 0.0 111.436 -173.964 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.726 ' HG3' ' HG3' ' A' ' 56' ' ' GLU . 62.4 mt-10 -80.88 -25.53 37.55 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.819 0.342 . . . . 0.0 111.024 -174.173 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . 0.596 ' HB2' ' O ' ' A' ' 54' ' ' GLU . 16.2 ttmm -75.84 -34.53 60.09 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.343 0.592 . . . . 0.0 110.25 178.099 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.469 ' HD1' ' HG3' ' A' ' 62' ' ' LYS . 97.9 m-85 -108.63 8.54 27.09 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.488 -176.45 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -60.9 112.08 1.91 Allowed 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 170.467 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 111.27 -8.42 28.81 Favored Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 120.641 -0.79 . . . . 0.0 111.822 -177.763 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.469 ' HG3' ' HD1' ' A' ' 59' ' ' TYR . 45.8 mmtm -84.65 -157.72 0.3 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.465 0.65 . . . . 0.0 109.892 176.371 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . 0.522 ' CG ' ' HG3' ' A' ' 31' ' ' LYS . 9.1 t70 -108.46 75.1 0.96 Allowed 'General case' 0 C--N 1.314 -0.955 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.026 176.387 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 17.1 tt -157.4 143.54 9.22 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.64 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.01 178.084 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' HIS . . . . . 0.617 ' NE2' ' HB3' ' A' ' 31' ' ' LYS . 93.1 m-70 -111.14 108.94 18.79 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 171.663 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 73.3 m-85 -77.05 107.75 9.63 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 173.211 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.56 HG13 HD21 ' A' ' 92' ' ' LEU . 98.1 t -120.28 104.68 15.83 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-N 115.211 -0.904 . . . . 0.0 110.843 -173.086 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . 0.693 ' HB2' ' HG2' ' A' ' 91' ' ' GLN . 11.0 m -91.25 130.97 37.06 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.815 178.152 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.717 HD11 ' HB2' ' A' ' 94' ' ' MET . 62.3 tp -121.66 131.95 54.38 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 110.05 -0.352 . . . . 0.0 110.05 177.537 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 1.7 t -112.89 120.78 42.6 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.318 0.58 . . . . 0.0 112.297 -173.013 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 9.9 m -82.71 9.61 9.27 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.58 -0.736 . . . . 0.0 111.398 175.251 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.697 ' O ' ' HA2' ' A' ' 95' ' ' GLY . 2.2 m-20 -66.02 132.81 49.43 Favored 'General case' 0 CA--C 1.517 -0.307 0 CA-C-O 120.917 0.389 . . . . 0.0 111.766 -174.78 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 21.0 ttpp -76.12 -30.63 58.29 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 121.367 0.603 . . . . 0.0 110.051 175.16 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -84.62 105.32 15.34 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 108.933 -0.766 . . . . 0.0 108.933 -179.949 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 14.3 tttt -78.01 -57.25 3.9 Favored 'General case' 0 C--N 1.319 -0.735 0 C-N-CA 118.834 -1.146 . . . . 0.0 111.055 177.996 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.675 ' HA ' ' OE2' ' A' ' 79' ' ' GLU . 12.5 ttmm -55.56 -50.41 70.13 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 112.535 0.568 . . . . 0.0 112.535 -175.298 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -60.58 -33.2 72.36 Favored 'General case' 0 CA--C 1.522 -0.104 0 CA-C-O 121.545 0.688 . . . . 0.0 110.297 -178.09 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' TRP . . . . . 0.564 ' CZ2' ' CE3' ' A' ' 38' ' ' TRP . 10.9 t-105 -80.47 -43.88 20.14 Favored 'General case' 0 N--CA 1.442 -0.827 0 CA-C-N 115.236 -0.893 . . . . 0.0 110.937 -178.285 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.675 ' OE2' ' HA ' ' A' ' 76' ' ' LYS . 1.3 pt-20 -64.09 -36.51 84.25 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.405 -178.953 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . 0.541 HD22 ' N ' ' A' ' 81' ' ' MET . 0.2 OUTLIER -78.11 -27.61 48.43 Favored 'General case' 0 C--N 1.332 -0.189 0 C-N-CA 120.111 -0.636 . . . . 0.0 110.636 178.652 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' MET . . . . . 0.557 ' SD ' HG23 ' A' ' 40' ' ' THR . 19.5 ttt -68.17 -50.06 56.86 Favored 'General case' 0 C--O 1.218 -0.605 0 C-N-CA 121.031 -0.268 . . . . 0.0 111.021 173.946 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.65 HG13 HD12 ' A' ' 18' ' ' ILE . 5.6 p -59.91 -31.99 48.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 C-N-CA 120.306 -0.558 . . . . 0.0 110.598 179.491 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 60.5 m -67.25 -41.47 85.53 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-O 120.952 0.406 . . . . 0.0 110.762 173.734 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 51.2 tptt -70.0 -46.19 65.65 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.912 179.738 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . 0.419 ' CG ' HH21 ' A' ' 46' ' ' ARG . 0.9 OUTLIER -73.85 -8.62 56.75 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.184 -0.916 . . . . 0.0 111.045 179.511 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 88.0 mt-30 61.56 32.82 18.61 Favored 'General case' 0 C--O 1.238 0.454 0 N-CA-C 113.328 0.862 . . . . 0.0 113.328 169.388 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.569 ' HB2' HG23 ' A' ' 82' ' ' VAL . 75.9 mt -67.86 152.37 45.68 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.632 0.253 . . . . 0.0 110.582 177.85 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.453 ' HB2' ' OE1' ' A' ' 56' ' ' GLU . 28.9 mmtm -125.03 -162.46 1.1 Allowed 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.998 178.352 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 86.53 -155.29 28.01 Favored Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 120.918 -0.658 . . . . 0.0 111.944 -178.797 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 63.0 mt -109.98 110.94 34.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 176.342 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . 0.693 ' HG2' ' HB2' ' A' ' 68' ' ' SER . 21.9 mt-30 -128.53 111.57 13.39 Favored 'General case' 0 N--CA 1.441 -0.883 0 CA-C-O 121.33 0.586 . . . . 0.0 111.131 -175.541 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.776 HD12 ' HB2' ' A' ' 15' ' ' TYR . 0.4 OUTLIER -109.1 146.08 34.63 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.238 -179.0 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 18.9 t-80 -110.27 119.14 38.28 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.783 -175.585 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' MET . . . . . 0.717 ' HB2' HD11 ' A' ' 69' ' ' LEU . 26.2 ttp -83.11 -56.88 3.53 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 114.929 -1.032 . . . . 0.0 110.838 -177.343 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . 0.697 ' HA2' ' O ' ' A' ' 72' ' ' ASP . . . 86.78 -90.43 1.67 Allowed Glycine 0 N--CA 1.445 -0.703 0 C-N-CA 120.214 -0.993 . . . . 0.0 113.296 176.126 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 1.7 p -103.56 -20.24 14.09 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 112.33 0.493 . . . . 0.0 112.33 -174.125 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -93.09 54.15 2.09 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-O 121.185 0.517 . . . . 0.0 111.033 -165.627 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . 0.696 ' HA ' ' SD ' ' A' ' 94' ' ' MET . 0.0 OUTLIER -81.24 40.26 0.55 Allowed 'General case' 0 CA--C 1.516 -0.363 0 N-CA-C 112.845 0.683 . . . . 0.0 112.845 -172.243 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 7.3 t -60.9 -17.71 52.3 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 169.77 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' PHE . . . . . 0.427 ' HZ ' ' CD2' ' A' ' 13' ' ' PHE . 2.8 m-85 -72.91 -37.14 67.34 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-N 115.218 -0.901 . . . . 0.0 111.377 174.392 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' MET . . . . . 0.93 ' HA ' ' HB ' ' A' ' 106' ' ' ILE . 83.8 mtp -63.67 -48.47 77.06 Favored 'General case' 0 CA--C 1.517 -0.313 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 178.717 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -62.77 -37.87 88.37 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.824 -0.625 . . . . 0.0 111.112 177.053 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -71.68 -47.35 54.76 Favored 'General case' 0 N--CA 1.463 0.197 0 N-CA-C 112.367 0.506 . . . . 0.0 112.367 -175.071 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' TYR . . . . . 0.704 ' HB2' HG12 ' A' ' 106' ' ' ILE . 67.3 m-85 -96.95 0.48 49.0 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 112.069 0.396 . . . . 0.0 112.069 -174.491 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 9.6 mp 64.57 26.34 13.28 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.309 0.576 . . . . 0.0 110.006 -173.104 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . 0.93 ' HB ' ' HA ' ' A' ' 101' ' ' MET . 33.8 mm -55.67 108.96 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.155 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.188 172.933 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 48.5 t-20 -139.65 -66.61 0.45 Allowed 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 178.328 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -72.03 100.1 0.91 Allowed Glycine 0 N--CA 1.446 -0.699 0 C-N-CA 120.62 -0.8 . . . . 0.0 111.188 174.366 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.553 HG21 HG11 ' A' ' 37' ' ' VAL . 2.7 pp -106.2 154.22 39.81 Favored Pre-proline 0 C--N 1.323 -0.587 0 C-N-CA 121.544 -0.062 . . . . 0.0 110.986 -178.74 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . 0.502 ' C ' ' HA ' ' A' ' 109' ' ' ILE . 22.7 Cg_exo -65.52 138.38 36.19 Favored 'Cis proline' 0 C--N 1.349 0.561 0 C-N-CA 124.224 -1.156 . . . . 0.0 113.392 1.016 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . 0.505 ' HD3' ' H ' ' A' ' 112' ' ' PHE . 0.0 OUTLIER -96.1 150.49 20.44 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.842 -0.617 . . . . 0.0 109.56 178.46 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . 0.579 ' HB2' ' HB2' ' A' ' 126' ' ' MET . 0.1 OUTLIER -116.35 114.36 24.2 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.279 -0.873 . . . . 0.0 110.583 -174.97 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.658 HD11 HD11 ' A' ' 106' ' ' ILE . 67.6 mt -128.86 144.46 38.04 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.354 0 CA-C-O 120.819 0.343 . . . . 0.0 111.064 -179.187 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 45.6 tp -128.71 134.08 48.35 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.064 -0.516 . . . . 0.0 109.987 176.717 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.48 HD23 HG13 ' A' ' 121' ' ' ILE . 0.4 OUTLIER -135.47 152.69 51.6 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.453 0.644 . . . . 0.0 110.601 -178.959 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . 0.827 ' HB3' ' HB2' ' A' ' 120' ' ' LYS . 43.0 t0 -70.61 164.5 24.79 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 114.735 -1.12 . . . . 0.0 110.36 179.707 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . 0.42 ' HA ' ' O ' ' A' ' 31' ' ' LYS . 40.0 mtm180 -51.56 -20.99 2.19 Favored 'General case' 0 C--N 1.323 -0.578 0 C-N-CA 124.589 1.155 . . . . 0.0 113.515 -173.98 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . 0.511 ' HB3' ' HG3' ' A' ' 120' ' ' LYS . 26.6 t70 -96.91 1.9 51.02 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-O 121.471 0.653 . . . . 0.0 110.262 -175.966 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . 0.468 ' HA2' HD12 ' A' ' 33' ' ' ILE . . . 88.17 16.93 58.46 Favored Glycine 0 N--CA 1.44 -1.034 0 N-CA-C 110.504 -1.038 . . . . 0.0 110.504 -171.752 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . 0.827 ' HB2' ' HB3' ' A' ' 116' ' ' ASP . 6.2 mtpm? -85.02 102.85 13.53 Favored 'General case' 0 C--O 1.221 -0.419 0 C-N-CA 121.047 -0.261 . . . . 0.0 110.953 -175.955 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . 0.684 ' H ' HD12 ' A' ' 121' ' ' ILE . 4.1 mp -45.8 115.94 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 O-C-N 123.728 0.643 . . . . 0.0 111.561 -176.546 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 122' ' ' ILE . . . . . 0.469 ' H ' ' HA ' ' A' ' 115' ' ' LEU . 56.3 mt -89.77 -39.27 12.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 178.404 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 17.1 m -154.4 125.11 7.07 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.369 -0.832 . . . . 0.0 109.77 176.932 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . 0.447 ' O ' HG12 ' A' ' 113' ' ' ILE . . . -72.5 -18.74 61.64 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.33 0.586 . . . . 0.0 110.21 177.982 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 16.2 p-10 -142.03 121.69 13.41 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.402 -0.817 . . . . 0.0 110.445 176.668 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 126' ' ' MET . . . . . 0.579 ' HB2' ' HB2' ' A' ' 112' ' ' PHE . 92.3 mmm -95.65 -117.86 0.11 Allowed 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.048 174.197 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . 0.603 ' HB ' ' CG ' ' A' ' 131' ' ' ASP . 4.0 m -132.36 -50.38 0.93 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.877 0.37 . . . . 0.0 110.768 -179.482 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . 0.972 ' HB3' ' HB3' ' A' ' 131' ' ' ASP . 46.9 ttt180 -165.76 151.18 8.05 Favored Pre-proline 0 N--CA 1.444 -0.746 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 -178.674 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 20.5 Cg_exo -64.98 7.78 0.25 Allowed 'Trans proline' 0 CA--C 1.532 0.417 0 C-N-CA 122.141 1.894 . . . . 0.0 112.797 175.589 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . 0.427 ' H ' ' C ' ' A' ' 128' ' ' ARG . 11.4 p -158.77 21.15 0.21 Allowed 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 111.808 0.299 . . . . 0.0 111.808 -178.895 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . 0.972 ' HB3' ' HB3' ' A' ' 128' ' ' ARG . 1.2 p30 -75.97 152.76 84.64 Favored Pre-proline 0 N--CA 1.444 -0.77 0 O-C-N 122.151 -0.343 . . . . 0.0 110.412 179.7 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -65.65 -28.01 52.69 Favored 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.842 2.361 . . . . 0.0 114.042 -175.028 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . 0.802 ' HA ' ' HG2' ' A' ' 136' ' ' GLU . 36.0 mttm -79.24 -28.92 42.48 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.019 0.437 . . . . 0.0 111.041 -176.289 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 134' ' ' THR . . . . . 0.701 HG22 ' CZ ' ' A' ' 138' ' ' PHE . 96.9 m -71.89 -38.82 69.92 Favored 'General case' 0 C--N 1.317 -0.838 0 N-CA-C 109.611 -0.514 . . . . 0.0 109.611 171.48 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . 0.439 ' HA ' ' CD2' ' A' ' 138' ' ' PHE . . . -61.59 -49.8 75.16 Favored 'General case' 0 C--O 1.236 0.39 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.659 174.742 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . 0.802 ' HG2' ' HA ' ' A' ' 133' ' ' LYS . 11.9 pt-20 -63.65 -28.32 69.83 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 120.961 0.41 . . . . 0.0 110.111 179.104 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . 0.638 ' O ' ' HG ' ' A' ' 141' ' ' LEU . 0.7 OUTLIER -60.09 -48.27 82.41 Favored 'General case' 0 N--CA 1.446 -0.654 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.406 175.866 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . 0.701 ' CZ ' HG22 ' A' ' 134' ' ' THR . 8.6 m-85 -54.46 -47.12 73.31 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.012 177.566 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 85.3 m-20 -56.63 -47.71 79.12 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.262 177.147 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -60.15 -43.01 96.08 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.553 179.103 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.638 ' HG ' ' O ' ' A' ' 137' ' ' LYS . 94.0 mt -57.39 -44.82 84.84 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.409 -178.646 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 10.0 mp . . . . . 0 C--N 1.327 -0.408 0 CA-C-O 120.819 0.342 . . . . 0.0 111.032 -179.667 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.692 ' HA ' ' CE1' ' A' ' 100' ' ' PHE . . . . . . . . 0 N--CA 1.466 0.342 0 CA-C-O 121.042 0.449 . . . . 0.0 111.839 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.621 ' HB1' ' HE3' ' A' ' 120' ' ' LYS . . . -89.77 -6.07 56.33 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.582 -175.142 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 50.1 m -158.12 129.83 6.77 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.557 179.908 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . 0.442 ' CE2' HD13 ' A' ' 25' ' ' LEU . 52.4 p90 -157.65 159.46 37.01 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.481 -0.327 . . . . 0.0 110.295 176.451 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . 0.561 ' HA ' ' HA ' ' A' ' 24' ' ' SER . 19.2 m -142.46 124.97 15.71 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.215 -0.448 . . . . 0.0 109.801 177.785 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 77.7 m-85 -139.25 154.18 71.8 Favored Pre-proline 0 C--N 1.326 -0.425 0 CA-C-O 120.516 0.198 . . . . 0.0 110.869 -178.002 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.514 ' HA ' ' O ' ' A' ' 21' ' ' LYS . 6.8 Cg_endo -85.15 127.93 3.53 Favored 'Trans proline' 0 N--CA 1.452 -0.92 0 C-N-CA 122.478 2.118 . . . . 0.0 112.928 179.437 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . 0.52 ' HA ' ' O ' ' A' ' 91' ' ' GLN . 11.7 t70 -67.18 154.65 40.74 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 169.409 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.497 HD12 ' CG1' ' A' ' 82' ' ' VAL . 5.9 tt -52.06 -33.3 16.26 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.435 0 O-C-N 123.729 0.643 . . . . 0.0 111.431 -176.338 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 40.3 m-80 -69.09 -9.68 53.88 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.027 -179.627 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 92.93 36.83 5.9 Favored Glycine 0 N--CA 1.446 -0.656 0 CA-C-N 115.802 -0.636 . . . . 0.0 111.802 -179.382 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.514 ' O ' ' HA ' ' A' ' 16' ' ' PRO . 62.3 tttm -107.04 121.79 45.18 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 120.573 -0.451 . . . . 0.0 110.617 -178.306 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 12.9 m -67.35 99.76 0.76 Allowed 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 109.651 -0.5 . . . . 0.0 109.651 173.566 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.431 ' HB ' ' CD2' ' A' ' 92' ' ' LEU . 96.6 t -107.57 115.43 48.77 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-N 115.888 -0.596 . . . . 0.0 109.905 -178.77 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . 0.561 ' HA ' ' HA ' ' A' ' 14' ' ' SER . 77.9 p -98.75 171.08 8.32 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 115.878 -0.601 . . . . 0.0 109.712 179.411 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.503 HD21 ' O ' ' A' ' 119' ' ' GLY . 27.0 tp -66.99 -22.27 65.92 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.087 0.47 . . . . 0.0 110.435 177.113 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -79.94 -31.48 40.01 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.092 176.593 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.428 ' OD2' HG13 ' A' ' 23' ' ' VAL . 20.6 t70 -66.69 -21.95 66.09 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 115.511 -0.768 . . . . 0.0 110.005 176.813 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.647 HD13 HG21 ' A' ' 67' ' ' VAL . 96.0 mt -105.96 3.22 28.17 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.456 -0.793 . . . . 0.0 111.779 -179.446 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.47 ' HG2' ' HA ' ' A' ' 118' ' ' ASP . 18.8 mtpt -75.08 162.01 28.91 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 121.377 0.608 . . . . 0.0 112.063 -177.6 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 113.84 -41.82 2.1 Favored Glycine 0 N--CA 1.447 -0.6 0 CA-C-N 115.332 -0.849 . . . . 0.0 111.459 179.809 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.478 ' O ' ' HA ' ' A' ' 117' ' ' ARG . 60.7 mttm -125.79 165.4 18.72 Favored 'General case' 0 N--CA 1.447 -0.623 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 177.48 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -63.68 134.82 56.08 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 177.667 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.462 HD13 ' HA2' ' A' ' 119' ' ' GLY . 5.0 mp -102.49 132.31 48.82 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.914 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 179.289 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 18.6 t80 -113.49 107.61 16.05 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 174.711 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.708 ' HA ' ' O ' ' A' ' 67' ' ' VAL . 62.6 mt -91.56 120.45 40.64 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.746 -176.251 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.495 ' O ' ' HA ' ' A' ' 68' ' ' SER . 3.8 t70 -118.13 125.96 51.28 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 177.176 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.661 HG11 HG21 ' A' ' 109' ' ' ILE . 42.5 t -79.49 112.38 17.46 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.761 0 CA-C-O 121.507 0.67 . . . . 0.0 111.57 -175.572 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' TRP . . . . . 0.579 ' HZ3' ' CG2' ' A' ' 82' ' ' VAL . 0.8 OUTLIER -101.36 134.31 44.64 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.092 -0.958 . . . . 0.0 109.629 178.651 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -146.54 170.46 16.85 Favored 'General case' 0 C--N 1.321 -0.661 0 O-C-N 122.072 -0.393 . . . . 0.0 110.316 -179.592 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . 0.701 ' HB ' ' CE3' ' A' ' 78' ' ' TRP . 8.8 t -91.05 1.44 57.08 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.508 0.671 . . . . 0.0 110.109 178.369 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 8.4 p-90 -126.6 17.93 7.47 Favored 'General case' 0 N--CA 1.448 -0.568 0 CA-C-N 115.613 -0.721 . . . . 0.0 111.411 -179.237 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 26.4 p -105.83 108.36 19.83 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-O 121.302 0.572 . . . . 0.0 109.973 175.764 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.449 ' N ' ' HD2' ' A' ' 44' ' ' PRO . . . -72.56 -62.83 3.09 Favored Glycine 0 CA--C 1.525 0.71 0 CA-C-N 115.563 -0.744 . . . . 0.0 114.446 -174.502 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.449 ' HD2' ' N ' ' A' ' 43' ' ' GLY . 10.4 Cg_endo -52.1 -32.53 49.64 Favored 'Trans proline' 0 C--N 1.356 0.936 0 C-N-CA 123.523 2.815 . . . . 0.0 113.687 -171.364 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . 0.68 ' HB2' ' CG ' ' A' ' 110' ' ' PRO . 37.1 t -57.37 -31.17 65.51 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.657 -177.544 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.5 ' HA ' ' HG ' ' A' ' 49' ' ' LEU . 1.7 mpt_? -63.96 -43.29 96.26 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 112.478 0.548 . . . . 0.0 112.478 -172.501 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -69.17 -8.32 58.48 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.89 -0.671 . . . . 0.0 113.291 -174.82 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . 0.474 ' CD ' ' HE ' ' A' ' 128' ' ' ARG . 24.4 mt-10 -119.21 3.62 11.36 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.649 0.261 . . . . 0.0 111.14 -177.719 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.57 ' HB2' ' HD3' ' A' ' 50' ' ' PRO . 87.2 mt -53.97 -46.88 98.45 Favored Pre-proline 0 CA--C 1.534 0.354 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.451 176.584 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.57 ' HD3' ' HB2' ' A' ' 49' ' ' LEU . 75.0 Cg_exo -51.34 -44.22 44.62 Favored 'Trans proline' 0 C--N 1.358 1.07 0 C-N-CA 121.93 1.753 . . . . 0.0 111.994 172.518 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -69.92 -32.42 70.69 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.024 0.44 . . . . 0.0 110.942 -176.329 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 7.6 tt -63.94 -50.44 68.67 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.344 -178.34 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.583 ' O ' ' HG3' ' A' ' 57' ' ' GLU . 24.9 pttm -71.56 -30.14 65.53 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 120.38 -0.528 . . . . 0.0 110.586 -177.398 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -68.28 -37.98 81.24 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-O 121.017 0.437 . . . . 0.0 110.795 177.028 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.469 HD22 ' O ' ' A' ' 129' ' ' PRO . 14.7 tp -63.78 -40.11 95.87 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 177.469 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -64.39 -47.65 78.41 Favored 'General case' 0 N--CA 1.443 -0.785 0 CA-C-N 115.987 -0.551 . . . . 0.0 109.934 177.931 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.583 ' HG3' ' O ' ' A' ' 53' ' ' LYS . 42.1 mt-10 -50.2 -40.1 46.09 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-O 121.199 0.523 . . . . 0.0 110.942 178.533 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . 0.806 ' HE3' ' CE2' ' A' ' 59' ' ' TYR . 34.6 ttpt -73.11 -43.03 62.28 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.532 -0.758 . . . . 0.0 112.327 -177.159 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.806 ' CE2' ' HE3' ' A' ' 58' ' ' LYS . 97.6 m-85 -102.66 -2.5 28.18 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 112.561 0.578 . . . . 0.0 112.561 -172.279 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -57.66 122.75 13.53 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.09 0.471 . . . . 0.0 111.61 179.755 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 99.58 -20.71 48.43 Favored Glycine 0 N--CA 1.445 -0.716 0 CA-C-N 115.536 -0.757 . . . . 0.0 113.263 174.036 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.53 ' N ' ' HD2' ' A' ' 62' ' ' LYS . 10.8 mptt -78.69 -97.57 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 117.204 0.502 . . . . 0.0 111.657 -176.25 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . 0.413 ' HB3' HD21 ' A' ' 142' ' ' LEU . 12.3 p-10 -119.68 -3.4 10.32 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.537 -0.301 . . . . 0.0 111.73 -173.029 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.473 HG12 ' N ' ' A' ' 65' ' ' HIS . 16.7 tt -144.64 164.65 13.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-O 120.731 0.3 . . . . 0.0 111.086 -170.893 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' HIS . . . . . 0.473 ' N ' HG12 ' A' ' 64' ' ' ILE . 0.1 OUTLIER -156.83 141.36 16.74 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.111 171.497 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . 0.4 ' CE2' HD23 ' A' ' 55' ' ' LEU . 74.9 m-85 -94.67 132.27 39.58 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.223 0.535 . . . . 0.0 110.983 -174.257 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.708 ' O ' ' HA ' ' A' ' 35' ' ' ILE . 56.9 t -132.52 118.57 35.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.176 -178.401 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . 0.495 ' HA ' ' O ' ' A' ' 36' ' ' ASP . 49.7 m -88.38 136.51 32.95 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.542 -179.692 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.551 ' O ' ' HA ' ' A' ' 37' ' ' VAL . 64.2 tp -121.84 128.93 52.19 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 110.304 -0.258 . . . . 0.0 110.304 177.279 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . 0.457 ' HB2' ' CD1' ' A' ' 38' ' ' TRP . 44.2 t -109.7 114.87 28.83 Favored 'General case' 0 C--O 1.216 -0.684 0 N-CA-C 112.102 0.408 . . . . 0.0 112.102 -172.901 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 3.3 m -84.64 21.49 1.51 Allowed 'General case' 0 C--N 1.312 -1.048 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.805 175.672 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -71.76 143.95 49.4 Favored 'General case' 0 CA--C 1.515 -0.396 0 C-N-CA 120.069 -0.652 . . . . 0.0 109.916 178.372 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.655 ' HB3' ' HZ2' ' A' ' 73' ' ' LYS . 0.0 OUTLIER -96.68 -15.23 21.57 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.179 -177.277 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . 0.559 ' HB2' ' HB3' ' A' ' 77' ' ' ALA . 0.0 OUTLIER -104.2 79.84 1.65 Allowed 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 -177.736 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.551 ' HA ' ' CE1' ' A' ' 93' ' ' HIS . 21.1 tttm -51.6 -63.5 1.11 Allowed 'General case' 0 CA--C 1.513 -0.451 0 N-CA-C 112.782 0.66 . . . . 0.0 112.782 -173.544 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 26.3 tptp -46.51 -51.46 15.32 Favored 'General case' 0 C--N 1.323 -0.556 0 O-C-N 123.431 0.457 . . . . 0.0 110.726 -178.359 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.702 ' HA ' ' ND2' ' A' ' 80' ' ' ASN . . . -58.95 -42.81 90.72 Favored 'General case' 0 C--O 1.239 0.551 0 CA-C-O 121.198 0.523 . . . . 0.0 110.826 179.619 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' TRP . . . . . 0.701 ' CE3' ' HB ' ' A' ' 40' ' ' THR . 6.9 t-105 -64.35 -51.98 60.65 Favored 'General case' 0 N--CA 1.435 -1.188 0 CA-C-N 115.51 -0.768 . . . . 0.0 112.489 -179.94 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.466 ' CD ' ' HE2' ' A' ' 75' ' ' LYS . 19.2 mm-40 -48.14 -40.1 22.71 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-O 120.948 0.404 . . . . 0.0 111.39 178.278 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . 0.702 ' ND2' ' HA ' ' A' ' 77' ' ' ALA . 3.6 m-20 -60.66 -50.19 74.52 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-O 120.846 0.355 . . . . 0.0 110.614 177.146 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 16.2 tpt -63.5 -37.7 88.29 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 112.164 0.431 . . . . 0.0 112.164 -175.183 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.579 ' CG2' ' HZ3' ' A' ' 38' ' ' TRP . 0.6 OUTLIER -68.58 -36.9 76.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 C-N-CA 119.965 -0.694 . . . . 0.0 111.13 179.053 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 12.7 t -78.69 -21.39 48.28 Favored 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 120.127 -0.629 . . . . 0.0 110.512 178.051 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 60.9 tttp -80.94 -53.68 6.24 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-O 120.973 0.416 . . . . 0.0 110.379 177.537 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -77.29 -20.04 55.59 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.143 -177.204 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 26.5 mt-30 65.16 78.42 0.28 Allowed 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 115.147 -0.933 . . . . 0.0 112.244 177.304 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.546 HD13 ' HA ' ' A' ' 82' ' ' VAL . 5.5 mp -104.45 118.42 36.57 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.116 -0.947 . . . . 0.0 108.61 174.101 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 72.9 mmtt -103.04 179.17 4.35 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 112.706 0.632 . . . . 0.0 112.706 -177.323 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 105.84 179.17 23.63 Favored Glycine 0 N--CA 1.45 -0.383 0 CA-C-N 115.096 -0.956 . . . . 0.0 111.172 -175.972 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.465 ' O ' ' HA ' ' A' ' 67' ' ' VAL . 63.4 mt -76.82 116.36 19.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 173.242 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . 0.556 ' HB2' ' CZ2' ' A' ' 38' ' ' TRP . 3.0 pt20 -136.81 107.42 6.54 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 121.793 0.806 . . . . 0.0 112.646 -166.075 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.431 ' CD2' ' HB ' ' A' ' 23' ' ' VAL . 21.9 mt -99.15 144.31 28.43 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.012 -0.994 . . . . 0.0 110.117 -178.618 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' HIS . . . . . 0.551 ' CE1' ' HA ' ' A' ' 75' ' ' LYS . 10.3 t-160 -115.83 131.34 56.97 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 121.69 0.757 . . . . 0.0 111.334 178.725 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' MET . . . . . 0.755 ' HG3' ' HB2' ' A' ' 97' ' ' ASP . 34.4 ttp -108.84 90.2 3.22 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 114.059 -1.428 . . . . 0.0 108.491 179.626 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . 0.51 ' O ' ' HA ' ' A' ' 73' ' ' LYS . . . -64.25 -65.53 2.96 Favored Glycine 0 C--N 1.318 -0.45 0 CA-C-N 115.319 -0.855 . . . . 0.0 113.513 -173.387 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 7.4 p -121.02 7.19 10.32 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-O 121.438 0.637 . . . . 0.0 110.393 -178.135 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . 0.755 ' HB2' ' HG3' ' A' ' 94' ' ' MET . 0.6 OUTLIER -90.56 12.73 17.86 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.32 -0.854 . . . . 0.0 110.663 -170.998 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . 0.686 ' HA ' ' SD ' ' A' ' 94' ' ' MET . 0.0 OUTLIER -72.19 14.03 0.26 Allowed 'General case' 0 C--O 1.222 -0.356 0 N-CA-C 113.068 0.766 . . . . 0.0 113.068 -170.704 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 9.8 t -70.52 -21.98 62.68 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 169.234 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' PHE . . . . . 0.692 ' CE1' ' HA ' ' A' ' 10' ' ' ALA . 88.9 t80 -79.31 -24.42 42.85 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.52 -0.764 . . . . 0.0 109.653 174.255 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' MET . . . . . 0.653 ' HB3' ' O ' ' A' ' 98' ' ' ARG . 14.8 tpt -59.69 -38.14 80.76 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.321 -0.854 . . . . 0.0 110.177 175.102 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 78.6 m-20 -65.21 -21.43 66.75 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.6 -0.727 . . . . 0.0 111.401 179.207 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -66.29 -14.52 62.13 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-O 120.592 0.234 . . . . 0.0 111.502 178.465 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 65.5 m-85 -95.69 -13.27 24.38 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 110.195 -0.298 . . . . 0.0 110.195 176.427 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 98.3 mt 71.17 -24.36 0.17 Allowed 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 123.791 0.836 . . . . 0.0 112.864 176.811 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . 0.428 HG21 HH11 ' A' ' 111' ' ' ARG . 14.4 mt -98.1 93.72 3.43 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-O 120.875 0.369 . . . . 0.0 110.721 -175.871 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . 0.497 ' HA ' ' HE3' ' A' ' 101' ' ' MET . 67.0 t30 -82.62 -1.33 50.65 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.857 -178.282 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -81.46 98.46 1.89 Allowed Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.802 -0.713 . . . . 0.0 111.742 177.813 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.661 HG21 HG11 ' A' ' 37' ' ' VAL . 44.8 pt -104.56 161.11 23.83 Favored Pre-proline 0 C--N 1.325 -0.475 0 CA-C-N 116.473 0.137 . . . . 0.0 111.062 -177.156 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . 0.68 ' CG ' ' HB2' ' A' ' 45' ' ' CYS . 23.4 Cg_exo -64.26 134.44 18.44 Favored 'Cis proline' 0 C--N 1.35 0.657 0 C-N-CA 123.928 -1.28 . . . . 0.0 113.178 0.89 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . 0.951 ' HE ' ' HA ' ' A' ' 111' ' ' ARG . 0.0 OUTLIER -102.28 141.78 34.57 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-N 116.246 -0.434 . . . . 0.0 109.964 174.263 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . 0.42 ' CE1' ' HD3' ' A' ' 128' ' ' ARG . 0.6 OUTLIER -113.93 113.74 25.25 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.301 -0.863 . . . . 0.0 108.739 -174.949 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.478 ' HB ' ' HB ' ' A' ' 35' ' ' ILE . 81.0 mt -123.97 138.16 54.58 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-O 121.249 0.547 . . . . 0.0 111.488 -173.024 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.471 ' HG ' HD12 ' A' ' 122' ' ' ILE . 58.8 tp -112.96 134.31 54.53 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 115.415 -0.811 . . . . 0.0 109.062 175.916 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.462 ' N ' HD12 ' A' ' 115' ' ' LEU . 2.3 mp -131.58 147.04 52.49 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 -179.831 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 23.6 t0 -65.75 164.8 13.91 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.119 176.409 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . 0.478 ' HA ' ' O ' ' A' ' 31' ' ' LYS . 0.6 OUTLIER -53.84 -21.71 8.18 Favored 'General case' 0 N--CA 1.471 0.586 0 O-C-N 124.2 0.937 . . . . 0.0 112.376 -176.15 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . 0.509 ' HB3' ' HG2' ' A' ' 120' ' ' LYS . 6.0 t70 -88.46 6.21 38.75 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.557 0.694 . . . . 0.0 110.075 -178.974 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . 0.503 ' O ' HD21 ' A' ' 25' ' ' LEU . . . 75.82 24.78 68.76 Favored Glycine 0 N--CA 1.437 -1.26 0 N-CA-C 110.833 -0.907 . . . . 0.0 110.833 -173.859 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . 0.621 ' HE3' ' HB1' ' A' ' 11' ' ' ALA . 43.6 mmtm -99.76 106.35 18.24 Favored 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 120.317 -0.553 . . . . 0.0 111.351 -175.803 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . 0.611 ' H ' HD12 ' A' ' 121' ' ' ILE . 3.0 mp -39.84 115.78 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 114.852 -1.067 . . . . 0.0 112.419 -177.648 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 122' ' ' ILE . . . . . 0.471 HD12 ' HG ' ' A' ' 114' ' ' LEU . 57.4 mt -86.88 -41.14 14.58 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 114.957 -1.02 . . . . 0.0 108.797 173.978 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 19.8 m -153.53 121.55 6.09 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.444 179.019 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -79.19 -17.03 55.66 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-O 121.488 0.661 . . . . 0.0 110.497 177.407 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 45.6 t30 -128.26 98.83 5.21 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 108.477 -0.935 . . . . 0.0 108.477 174.457 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 17.1 tpt -100.77 -97.43 0.26 Allowed 'General case' 0 C--N 1.322 -0.616 0 C-N-CA 120.696 -0.402 . . . . 0.0 111.409 -174.999 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . 0.568 ' O ' ' HB2' ' A' ' 128' ' ' ARG . 3.4 p -152.01 -73.81 0.14 Allowed 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 111.534 0.198 . . . . 0.0 111.534 -173.42 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . 0.626 ' HD2' ' HD2' ' A' ' 129' ' ' PRO . 20.2 tpt180 157.0 136.27 0.0 OUTLIER Pre-proline 0 N--CA 1.456 -0.151 0 C-N-CA 124.196 0.999 . . . . 0.0 108.514 -172.424 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . 0.626 ' HD2' ' HD2' ' A' ' 128' ' ' ARG . 84.2 Cg_exo -49.45 -44.13 35.91 Favored 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 122.285 1.99 . . . . 0.0 112.6 172.166 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . 0.455 ' H ' ' HG3' ' A' ' 128' ' ' ARG . 0.0 OUTLIER -78.6 3.03 17.34 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 112.263 0.468 . . . . 0.0 112.263 -177.54 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . 0.429 ' HB2' ' HB3' ' A' ' 128' ' ' ARG . 10.5 t70 -89.23 123.76 66.34 Favored Pre-proline 0 C--O 1.236 0.363 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 177.291 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -55.43 -37.06 95.14 Favored 'Trans proline' 0 C--N 1.342 0.236 0 C-N-CA 123.345 2.696 . . . . 0.0 113.653 -176.069 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . 0.528 ' HA ' ' HG2' ' A' ' 136' ' ' GLU . 36.4 mtmm -61.11 -33.21 73.01 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 121.357 0.598 . . . . 0.0 110.964 -175.367 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 134' ' ' THR . . . . . 0.591 HG22 ' CZ ' ' A' ' 138' ' ' PHE . 0.2 OUTLIER -67.13 -53.05 34.26 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.885 176.843 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . 0.493 ' HA ' ' CD2' ' A' ' 138' ' ' PHE . . . -60.64 -47.3 86.84 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.41 -0.814 . . . . 0.0 111.555 -178.999 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . 0.528 ' HG2' ' HA ' ' A' ' 133' ' ' LYS . 12.9 pt-20 -63.29 -30.39 71.54 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.395 -178.205 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . 1.083 ' HA ' ' HE3' ' A' ' 137' ' ' LYS . 0.4 OUTLIER -65.43 -44.64 86.71 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-N 116.573 -0.285 . . . . 0.0 110.405 177.709 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . 0.591 ' CZ ' HG22 ' A' ' 134' ' ' THR . 7.2 m-85 -60.51 -57.58 12.14 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-O 121.056 0.455 . . . . 0.0 110.694 -179.708 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 139' ' ' ASN . . . . . 0.496 HD22 ' N ' ' A' ' 140' ' ' GLU . 0.3 OUTLIER -67.68 -18.28 64.88 Favored 'General case' 0 C--O 1.222 -0.354 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.811 -175.514 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . 0.496 ' N ' HD22 ' A' ' 139' ' ' ASN . 24.6 tt0 -66.35 -50.36 63.81 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 172.595 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.475 ' HG ' ' O ' ' A' ' 137' ' ' LYS . 60.8 mt -61.17 -33.55 73.61 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.659 -179.783 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 0.413 HD21 ' HB3' ' A' ' 63' ' ' ASP . 94.6 mt . . . . . 0 C--N 1.328 -0.365 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.255 178.896 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 0.589 0 CA-C-O 120.696 0.284 . . . . 0.0 111.161 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.405 ' HA ' ' HE3' ' A' ' 120' ' ' LYS . . . -70.55 -29.3 65.72 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.977 0.418 . . . . 0.0 110.683 176.926 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 26.6 t -164.75 83.56 0.4 Allowed 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.244 -0.889 . . . . 0.0 109.906 176.396 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 41.1 p90 -101.43 164.46 11.76 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.416 179.985 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . 0.541 ' HA ' ' HA ' ' A' ' 24' ' ' SER . 20.2 m -142.24 126.03 17.05 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 109.905 -0.406 . . . . 0.0 109.905 178.258 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . 0.412 ' HA ' ' HD3' ' A' ' 16' ' ' PRO . 59.2 m-85 -141.04 144.96 37.03 Favored Pre-proline 0 C--N 1.325 -0.465 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.834 -178.602 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.485 ' HA ' ' O ' ' A' ' 21' ' ' LYS . 4.2 Cg_exo -77.68 125.65 7.64 Favored 'Trans proline' 0 N--CA 1.461 -0.412 0 C-N-CA 122.87 2.38 . . . . 0.0 113.018 -179.846 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . 0.608 ' HA ' ' HA ' ' A' ' 92' ' ' LEU . 11.2 t70 -65.37 158.42 26.63 Favored 'General case' 0 C--O 1.238 0.457 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 172.228 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.479 HG12 HG11 ' A' ' 82' ' ' VAL . 11.0 tp -55.03 -27.38 19.16 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 O-C-N 123.669 0.606 . . . . 0.0 112.248 -170.281 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.584 HD21 ' HB2' ' A' ' 21' ' ' LYS . 3.3 p-10 -78.78 -13.27 59.9 Favored 'General case' 0 N--CA 1.456 -0.16 0 CA-C-O 121.2 0.524 . . . . 0.0 110.189 -178.177 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 104.36 31.61 4.57 Favored Glycine 0 N--CA 1.445 -0.732 0 CA-C-N 115.712 -0.676 . . . . 0.0 112.154 -177.29 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.584 ' HB2' HD21 ' A' ' 19' ' ' ASN . 62.3 tttt -101.9 115.03 29.64 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 120.439 -0.504 . . . . 0.0 110.805 179.354 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 14.7 m -64.83 99.69 0.35 Allowed 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 120.892 0.377 . . . . 0.0 110.157 174.579 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 92.9 t -103.3 119.16 51.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.46 -178.457 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . 0.541 ' HA ' ' HA ' ' A' ' 14' ' ' SER . 88.2 p -97.45 171.51 8.34 Favored 'General case' 0 C--N 1.316 -0.878 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 177.082 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.464 ' O ' ' HB2' ' A' ' 29' ' ' LYS . 37.8 tp -63.83 -24.66 67.84 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.72 0.295 . . . . 0.0 111.128 179.709 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -75.61 -24.85 56.57 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.533 -0.303 . . . . 0.0 111.013 -179.312 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -66.33 -25.07 66.65 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-O 121.489 0.661 . . . . 0.0 110.326 179.839 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.659 HD11 HG21 ' A' ' 90' ' ' ILE . 85.7 mt -122.75 15.66 10.18 Favored 'General case' 0 N--CA 1.449 -0.52 0 CA-C-N 115.663 -0.699 . . . . 0.0 111.237 -177.145 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.504 ' HE2' ' O ' ' A' ' 118' ' ' ASP . 61.1 tttm -83.82 157.51 22.01 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.572 -175.38 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 114.72 -34.65 4.78 Favored Glycine 0 N--CA 1.449 -0.433 0 C-N-CA 120.756 -0.735 . . . . 0.0 111.73 179.383 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.732 ' HB2' ' NE2' ' A' ' 65' ' ' HIS . 63.6 mttm -120.52 170.03 9.79 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.733 -0.233 . . . . 0.0 110.683 177.67 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 87.3 m-85 -65.81 155.56 35.87 Favored 'General case' 0 C--N 1.329 -0.296 0 O-C-N 123.298 0.374 . . . . 0.0 110.272 178.52 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.583 ' HB ' ' HB2' ' A' ' 115' ' ' LEU . 70.9 mt -129.38 140.68 48.52 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-O 120.87 0.366 . . . . 0.0 111.163 -175.684 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 93.3 t80 -125.56 110.69 14.15 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 174.001 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.605 ' HB ' ' HB ' ' A' ' 113' ' ' ILE . 59.2 mt -98.01 130.03 47.35 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.07 -176.346 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.47 ' O ' ' HA ' ' A' ' 68' ' ' SER . 5.7 p-10 -116.38 150.33 37.92 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.761 -0.654 . . . . 0.0 109.519 174.762 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.424 ' HB ' ' H ' ' A' ' 111' ' ' ARG . 38.2 t -102.65 130.55 52.47 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.801 0 C-N-CA 120.487 -0.485 . . . . 0.0 110.148 174.927 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' TRP . . . . . 0.661 ' CZ2' ' HB2' ' A' ' 91' ' ' GLN . 0.6 OUTLIER -132.66 135.81 46.07 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.771 -0.65 . . . . 0.0 109.623 -173.569 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.463 ' HB3' ' SG ' ' A' ' 42' ' ' CYS . . . -147.06 161.7 40.31 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 122.257 -0.277 . . . . 0.0 111.092 178.664 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . 0.712 ' HB ' ' CE3' ' A' ' 78' ' ' TRP . 3.0 t -85.52 -4.84 59.28 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.012 0.434 . . . . 0.0 110.925 178.025 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' TRP . . . . . 0.447 ' HE1' ' HA ' ' A' ' 72' ' ' ASP . 10.2 p-90 -115.86 16.51 16.23 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.442 -176.855 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' CYS . . . . . 0.463 ' SG ' ' HB3' ' A' ' 39' ' ' ALA . 19.8 p -120.93 95.46 4.71 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.228 0.537 . . . . 0.0 110.755 178.675 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -63.39 -51.12 57.07 Favored Glycine 0 CA--C 1.527 0.805 0 CA-C-O 119.184 -0.787 . . . . 0.0 113.894 -179.778 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -54.45 -38.7 89.71 Favored 'Trans proline' 0 C--N 1.357 0.999 0 C-N-CA 122.483 2.122 . . . . 0.0 112.632 -179.111 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . 0.504 ' SG ' ' HB3' ' A' ' 110' ' ' PRO . 16.8 t -59.01 -40.86 86.25 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.303 0.573 . . . . 0.0 110.634 177.35 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.598 ' HA ' ' CD1' ' A' ' 49' ' ' LEU . 23.2 ttt180 -72.57 -3.74 26.49 Favored 'General case' 0 N--CA 1.447 -0.621 0 CA-C-N 115.309 -0.859 . . . . 0.0 111.409 -175.847 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -66.59 -48.36 63.03 Favored Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 121.055 -0.593 . . . . 0.0 112.693 179.857 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . 0.543 ' OE1' ' HB2' ' A' ' 128' ' ' ARG . 11.9 pt-20 -115.29 17.28 16.64 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 112.179 0.437 . . . . 0.0 112.179 -176.441 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.949 HD13 HD21 ' A' ' 87' ' ' LEU . 37.7 mt -52.41 -50.72 78.32 Favored Pre-proline 0 C--N 1.324 -0.54 0 N-CA-C 112.248 0.462 . . . . 0.0 112.248 175.987 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.519 ' HD2' ' N ' ' A' ' 49' ' ' LEU . 10.3 Cg_endo -55.2 -36.08 92.46 Favored 'Trans proline' 0 C--N 1.356 0.96 0 C-N-CA 122.0 1.8 . . . . 0.0 112.305 176.601 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -71.87 -23.29 61.48 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.021 0.439 . . . . 0.0 111.08 -178.707 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 6.7 tt -70.01 -44.09 70.04 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 177.532 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.573 ' HD2' ' N ' ' A' ' 53' ' ' LYS . 3.2 mptp? -68.82 -40.02 79.71 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.396 177.638 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.614 ' O ' ' HG3' ' A' ' 58' ' ' LYS . 0.2 OUTLIER -48.2 -49.37 33.17 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.395 0.617 . . . . 0.0 110.72 168.568 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.601 HD21 ' HE2' ' A' ' 138' ' ' PHE . 21.7 tp -60.11 -40.03 88.27 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.151 176.97 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.6 ' HG2' ' CG ' ' A' ' 66' ' ' PHE . 44.4 mt-10 -57.67 -48.45 79.46 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.527 -0.76 . . . . 0.0 111.332 178.137 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -61.13 -36.84 80.83 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.846 0.355 . . . . 0.0 110.954 -179.703 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . 0.614 ' HG3' ' O ' ' A' ' 54' ' ' GLU . 53.1 mttm -62.47 -43.8 97.93 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-O 121.41 0.624 . . . . 0.0 110.535 177.387 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 96.1 m-85 -101.93 16.38 26.14 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.434 -175.126 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -64.7 135.57 56.02 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.118 172.749 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 80.75 9.37 86.44 Favored Glycine 0 N--CA 1.449 -0.487 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.762 178.985 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 37.7 mmtm -94.7 -151.59 0.33 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.345 0.593 . . . . 0.0 110.164 177.764 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . 0.728 ' HA ' ' HD3' ' A' ' 31' ' ' LYS . 4.0 t70 -111.82 64.89 0.62 Allowed 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.731 -0.668 . . . . 0.0 109.789 178.517 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 19.9 tt -156.53 156.28 4.68 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.446 0 CA-C-N 115.857 -0.611 . . . . 0.0 110.537 -175.035 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' HIS . . . . . 0.732 ' NE2' ' HB2' ' A' ' 31' ' ' LYS . 81.1 m-70 -134.97 115.05 13.1 Favored 'General case' 0 CA--C 1.515 -0.377 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 175.631 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . 0.6 ' CG ' ' HG2' ' A' ' 56' ' ' GLU . 71.0 m-85 -79.67 118.95 21.96 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 172.05 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.587 ' O ' ' HA ' ' A' ' 35' ' ' ILE . 40.5 t -128.94 111.36 22.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.674 -174.256 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . 0.548 ' HB3' ' CD1' ' A' ' 38' ' ' TRP . 8.2 m -87.81 146.97 25.36 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.145 179.655 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.468 ' HA ' ' O ' ' A' ' 92' ' ' LEU . 7.2 mp -131.45 122.78 26.81 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-O 120.762 0.315 . . . . 0.0 110.338 171.81 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 14.7 t -110.09 114.62 28.28 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.135 0.493 . . . . 0.0 112.106 -175.782 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 64.0 m -79.19 19.09 0.59 Allowed 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.328 175.798 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.447 ' HA ' ' HE1' ' A' ' 41' ' ' TRP . 0.1 OUTLIER -61.58 152.72 29.72 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-O 120.676 0.274 . . . . 0.0 110.79 176.428 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 21.9 pttp -108.06 -21.99 12.58 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.182 -178.351 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . 0.433 ' HB2' ' HB3' ' A' ' 77' ' ' ALA . 0.0 OUTLIER -100.88 67.97 1.26 Allowed 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 -179.087 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.547 ' O ' ' HG3' ' A' ' 79' ' ' GLU . 9.7 tttt -48.06 -52.78 18.76 Favored 'General case' 0 C--N 1.331 -0.237 0 O-C-N 123.782 0.676 . . . . 0.0 112.795 -168.606 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.464 ' HA ' ' HD2' ' A' ' 76' ' ' LYS . 35.1 tptt -52.67 -50.03 64.06 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 123.397 0.435 . . . . 0.0 110.646 -179.067 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.568 ' HA ' ' ND2' ' A' ' 80' ' ' ASN . . . -58.15 -37.53 74.84 Favored 'General case' 0 C--O 1.245 0.834 0 CA-C-O 121.492 0.663 . . . . 0.0 110.405 -179.152 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' TRP . . . . . 0.712 ' CE3' ' HB ' ' A' ' 40' ' ' THR . 5.8 t-105 -68.41 -35.94 78.39 Favored 'General case' 0 N--CA 1.438 -1.03 0 CA-C-N 115.051 -0.977 . . . . 0.0 110.306 -178.642 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.547 ' HG3' ' O ' ' A' ' 75' ' ' LYS . 55.9 mt-10 -51.07 -48.85 61.5 Favored 'General case' 0 CA--C 1.52 -0.189 0 CA-C-O 121.328 0.585 . . . . 0.0 110.965 173.435 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . 0.568 ' ND2' ' HA ' ' A' ' 77' ' ' ALA . 2.7 m-80 -64.85 -42.76 94.63 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.544 -175.504 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' MET . . . . . 0.43 ' SD ' ' HZ3' ' A' ' 78' ' ' TRP . 34.8 ttm -66.82 -47.25 72.59 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 119.892 -0.723 . . . . 0.0 111.667 -177.844 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.545 ' CG2' ' HZ3' ' A' ' 38' ' ' TRP . 4.4 p -62.18 -32.39 54.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 C-N-CA 120.49 -0.484 . . . . 0.0 110.93 179.947 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 89.3 m -70.72 -40.72 72.63 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.707 178.406 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . 0.542 ' HD3' ' O ' ' A' ' 80' ' ' ASN . 1.3 mptm? -81.78 -32.47 31.36 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.579 -0.282 . . . . 0.0 111.394 -175.866 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . 0.515 ' HB3' HD13 ' A' ' 87' ' ' LEU . 1.2 t0 -81.71 -3.77 54.54 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.438 0.637 . . . . 0.0 110.164 -179.718 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . 0.49 ' HA ' ' OE1' ' A' ' 86' ' ' GLN . 13.6 mm-40 68.88 16.77 8.81 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 115.017 -0.992 . . . . 0.0 113.444 172.757 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.949 HD21 HD13 ' A' ' 49' ' ' LEU . 10.6 mp -66.58 103.81 1.15 Allowed 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 110.326 -0.25 . . . . 0.0 110.326 173.867 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 43.6 mmtm -108.72 -178.8 3.69 Favored 'General case' 0 C--N 1.323 -0.548 0 O-C-N 122.431 -0.168 . . . . 0.0 110.698 176.168 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 122.2 -153.24 16.82 Favored Glycine 0 N--CA 1.452 -0.278 0 N-CA-C 110.762 -0.935 . . . . 0.0 110.762 -177.069 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.659 HG21 HD11 ' A' ' 28' ' ' LEU . 48.5 mm -104.67 116.03 47.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 N-CA-C 108.369 -0.974 . . . . 0.0 108.369 171.356 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . 0.661 ' HB2' ' CZ2' ' A' ' 38' ' ' TRP . 2.2 pt20 -141.41 100.19 3.73 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-O 122.099 0.952 . . . . 0.0 112.57 -165.55 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.608 ' HA ' ' HA ' ' A' ' 17' ' ' ASP . 22.9 mt -89.89 149.29 22.69 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 114.623 -1.171 . . . . 0.0 110.366 -176.93 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' HIS . . . . . 0.414 ' O ' ' HD2' ' A' ' 16' ' ' PRO . 15.0 t-80 -121.11 134.14 55.24 Favored 'General case' 0 C--N 1.31 -1.132 0 CA-C-N 115.585 -0.734 . . . . 0.0 109.402 177.619 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' MET . . . . . 0.566 ' SD ' ' HA ' ' A' ' 98' ' ' ARG . 48.3 ttm -78.98 -83.8 0.09 Allowed 'General case' 0 N--CA 1.435 -1.203 0 CA-C-N 115.302 -0.863 . . . . 0.0 110.349 -175.423 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 125.08 42.11 0.34 Allowed Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.102 -1.047 . . . . 0.0 113.045 178.99 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.411 ' C ' ' H ' ' A' ' 98' ' ' ARG . 3.7 m 78.03 0.35 2.72 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 123.021 0.528 . . . . 0.0 111.378 -179.329 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -79.3 34.75 0.26 Allowed 'General case' 0 N--CA 1.467 0.409 0 CA-C-O 121.405 0.622 . . . . 0.0 109.52 178.577 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . 0.566 ' HA ' ' SD ' ' A' ' 94' ' ' MET . 0.1 OUTLIER -76.24 20.24 0.21 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.4 -0.818 . . . . 0.0 112.773 -167.106 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 14.3 m -70.38 -24.3 62.93 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.732 0.777 . . . . 0.0 108.916 169.832 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 17.1 t80 -75.83 -23.95 55.78 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.367 -0.833 . . . . 0.0 109.506 175.354 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' MET . . . . . 0.493 ' HB3' ' O ' ' A' ' 98' ' ' ARG . 16.6 tpt -64.43 -33.77 76.63 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.482 -0.781 . . . . 0.0 109.407 175.035 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 46.1 m-20 -70.55 -22.73 62.57 Favored 'General case' 0 N--CA 1.461 0.104 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.819 177.177 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -71.73 -14.59 62.06 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.892 0.377 . . . . 0.0 111.013 -179.004 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' TYR . . . . . 0.607 ' O ' ' HG ' ' A' ' 105' ' ' LEU . 65.1 m-85 -96.47 -4.06 42.26 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 174.563 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.607 ' HG ' ' O ' ' A' ' 104' ' ' TYR . 2.9 pp 51.52 14.37 0.26 Allowed 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 125.108 1.363 . . . . 0.0 113.605 178.818 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . 0.558 ' HB ' ' CG ' ' A' ' 111' ' ' ARG . 17.2 mm -120.1 95.27 3.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 N-CA-C 109.025 -0.732 . . . . 0.0 109.025 172.665 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . 0.518 ' ND2' HH22 ' A' ' 98' ' ' ARG . 4.6 m-20 -86.32 20.49 2.37 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.903 -173.067 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -113.76 123.42 6.11 Favored Glycine 0 N--CA 1.447 -0.629 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.06 -179.626 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.432 ' CG2' ' HA ' ' A' ' 110' ' ' PRO . 21.8 mt -87.85 137.45 31.69 Favored Pre-proline 0 C--N 1.325 -0.469 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 176.838 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . 0.519 ' HG2' ' CZ ' ' A' ' 112' ' ' PHE . 95.1 Cg_endo -88.96 144.2 19.84 Favored 'Cis proline' 0 N--CA 1.456 -0.681 0 C-N-CA 123.522 -1.449 . . . . 0.0 113.496 1.188 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . 0.558 ' CG ' ' HB ' ' A' ' 106' ' ' ILE . 0.0 OUTLIER -100.2 133.25 44.88 Favored 'General case' 0 N--CA 1.444 -0.761 0 N-CA-C 108.879 -0.786 . . . . 0.0 108.879 172.587 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . 0.59 ' CZ ' ' HB3' ' A' ' 128' ' ' ARG . 13.1 m-85 -102.44 124.84 48.72 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 108.52 -0.919 . . . . 0.0 108.52 179.616 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.605 ' HB ' ' HB ' ' A' ' 35' ' ' ILE . 74.7 mt -133.46 147.07 31.15 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-O 120.981 0.419 . . . . 0.0 111.135 -175.276 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 37.1 tp -127.76 135.99 50.89 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.923 -0.581 . . . . 0.0 109.725 179.108 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.583 ' HB2' ' HB ' ' A' ' 33' ' ' ILE . 2.8 mp -133.81 154.87 50.7 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 179.264 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . 0.42 ' OD2' ' HB2' ' A' ' 120' ' ' LYS . 2.7 p30 -84.92 178.1 7.72 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.664 -179.956 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . 0.557 ' HG2' ' HA ' ' A' ' 31' ' ' LYS . 79.7 mtt180 -58.82 -20.48 50.89 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 114.538 -1.21 . . . . 0.0 112.927 -174.434 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . 0.504 ' O ' ' HE2' ' A' ' 29' ' ' LYS . 22.4 t70 -85.27 1.77 46.84 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.741 0.781 . . . . 0.0 109.137 179.506 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 77.87 25.08 63.07 Favored Glycine 0 N--CA 1.431 -1.7 0 N-CA-C 110.221 -1.151 . . . . 0.0 110.221 -173.366 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . 0.42 ' HB2' ' OD2' ' A' ' 116' ' ' ASP . 46.1 mmtm -108.45 120.8 43.47 Favored 'General case' 0 C--O 1.22 -0.451 0 C-N-CA 119.246 -0.982 . . . . 0.0 112.326 -172.369 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . 0.558 ' HA ' ' HG ' ' A' ' 115' ' ' LEU . 33.3 mt -42.62 117.83 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-N 115.079 -0.964 . . . . 0.0 113.159 -179.363 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 122' ' ' ILE . . . . . 0.413 HD11 ' HB3' ' A' ' 116' ' ' ASP . 59.4 mt -93.0 -37.13 8.18 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.828 0 CA-C-N 113.863 -1.517 . . . . 0.0 108.862 174.286 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 11.1 m -146.61 115.58 6.92 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.406 -0.815 . . . . 0.0 110.44 179.346 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -69.41 -30.47 68.44 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.52 0.676 . . . . 0.0 109.429 172.647 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . 0.428 ' HA ' ' NH1' ' A' ' 111' ' ' ARG . 11.0 t30 -111.07 95.77 5.74 Favored 'General case' 0 N--CA 1.449 -0.519 0 CA-C-N 115.245 -0.888 . . . . 0.0 109.675 175.985 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 126' ' ' MET . . . . . 0.496 ' HG3' ' H ' ' A' ' 127' ' ' THR . 10.5 tpt -105.98 -175.72 2.87 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 107.742 -1.206 . . . . 0.0 107.742 177.592 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . 0.496 ' H ' ' HG3' ' A' ' 126' ' ' MET . 4.1 p -115.95 139.07 50.61 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-O 121.441 0.638 . . . . 0.0 112.387 -173.025 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . 0.59 ' HB3' ' CZ ' ' A' ' 112' ' ' PHE . 0.0 OUTLIER -41.2 146.84 0.48 Allowed Pre-proline 0 N--CA 1.468 0.452 0 CA-C-N 114.472 -1.24 . . . . 0.0 113.558 171.593 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 26.0 Cg_endo -61.85 -31.35 85.12 Favored 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 123.464 2.776 . . . . 0.0 113.293 -178.593 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . 0.423 ' HB3' ' CZ ' ' A' ' 128' ' ' ARG . 47.1 t -74.93 -2.38 26.75 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.698 0.285 . . . . 0.0 111.164 -179.125 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . 0.481 ' HB2' ' CD ' ' A' ' 128' ' ' ARG . 14.5 t70 -91.59 129.25 43.39 Favored Pre-proline 0 C--N 1.327 -0.377 0 N-CA-C 110.059 -0.349 . . . . 0.0 110.059 176.289 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -67.85 -26.59 38.11 Favored 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 122.774 2.316 . . . . 0.0 113.414 -176.668 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . 0.561 ' O ' ' HG3' ' A' ' 137' ' ' LYS . 13.7 mmmm -70.44 -28.92 65.41 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.862 0.363 . . . . 0.0 110.238 -178.48 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 134' ' ' THR . . . . . 0.784 HG22 ' CZ ' ' A' ' 138' ' ' PHE . 2.8 m -59.04 -50.91 72.27 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.662 -0.699 . . . . 0.0 109.899 175.004 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . 0.625 ' HA ' ' CD2' ' A' ' 138' ' ' PHE . . . -56.41 -43.78 79.7 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.288 -0.869 . . . . 0.0 111.383 176.567 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 7.6 mt-10 -54.8 -49.16 71.63 Favored 'General case' 0 CA--C 1.516 -0.364 0 CA-C-O 121.316 0.579 . . . . 0.0 110.724 177.793 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . 0.561 ' HG3' ' O ' ' A' ' 133' ' ' LYS . 39.3 mtpt -55.63 -41.65 73.84 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.239 -0.892 . . . . 0.0 111.142 -179.705 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . 0.784 ' CZ ' HG22 ' A' ' 134' ' ' THR . 13.7 m-85 -61.36 -61.2 2.72 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.728 179.35 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 139' ' ' ASN . . . . . 0.563 HD22 ' N ' ' A' ' 140' ' ' GLU . 0.3 OUTLIER -69.43 -18.91 63.78 Favored 'General case' 0 C--O 1.224 -0.285 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.819 -172.711 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . 0.563 ' N ' HD22 ' A' ' 139' ' ' ASN . 36.1 tt0 -75.39 -51.07 13.98 Favored 'General case' 0 C--N 1.321 -0.64 0 C-N-CA 120.97 -0.292 . . . . 0.0 110.688 175.616 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.41 ' HG ' ' O ' ' A' ' 137' ' ' LYS . 89.3 mt -66.92 -27.11 67.22 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.318 -177.562 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 96.9 mt . . . . . 0 C--N 1.325 -0.485 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.653 177.031 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.564 ' HA ' ' CZ ' ' A' ' 100' ' ' PHE . . . . . . . . 0 N--CA 1.47 0.537 0 CA-C-O 120.812 0.339 . . . . 0.0 111.312 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.429 ' O ' HD23 ' A' ' 25' ' ' LEU . . . -74.89 -11.65 60.18 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.223 178.971 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . 0.722 ' HA ' ' HB3' ' A' ' 25' ' ' LEU . 18.3 p -159.67 93.36 1.09 Allowed 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.857 174.427 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 38.2 p90 -97.76 159.85 14.68 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.437 174.8 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 13.2 p -134.59 115.18 13.56 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.642 0.258 . . . . 0.0 111.117 -178.908 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 65.3 m-85 -138.88 159.62 66.32 Favored Pre-proline 0 N--CA 1.465 0.288 0 CA-C-N 116.451 -0.34 . . . . 0.0 111.3 -177.487 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 79.4 Cg_endo -84.86 134.15 5.23 Favored 'Trans proline' 0 C--N 1.351 0.676 0 C-N-CA 122.683 2.255 . . . . 0.0 113.406 177.895 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . 0.524 ' HB3' ' HB3' ' A' ' 21' ' ' LYS . 7.4 t70 -80.0 160.12 26.0 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 114.826 -1.079 . . . . 0.0 109.428 174.96 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 2.2 tt -46.94 -38.19 4.0 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 O-C-N 124.151 0.907 . . . . 0.0 112.105 -178.392 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 45.0 m-80 -71.82 -13.2 61.62 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.097 0.475 . . . . 0.0 111.056 -178.389 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 95.28 34.43 6.11 Favored Glycine 0 N--CA 1.446 -0.654 0 N-CA-C 110.949 -0.86 . . . . 0.0 110.949 -175.027 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.524 ' HB3' ' HB3' ' A' ' 17' ' ' ASP . 25.7 tptp -106.08 131.05 53.82 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.121 0.486 . . . . 0.0 111.012 -176.241 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 7.6 m -80.76 99.06 8.05 Favored 'General case' 0 C--N 1.314 -0.97 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 179.618 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.756 ' HB ' HD11 ' A' ' 92' ' ' LEU . 25.2 t -109.43 134.52 51.22 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-O 121.321 0.581 . . . . 0.0 109.728 178.848 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . 0.461 ' H ' ' CB ' ' A' ' 27' ' ' ASP . 13.7 m -122.52 166.47 14.75 Favored 'General case' 0 C--N 1.306 -1.287 0 CA-C-N 115.59 -0.732 . . . . 0.0 109.184 178.334 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.722 ' HB3' ' HA ' ' A' ' 12' ' ' SER . 19.6 tp -66.35 -22.51 66.26 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.083 0.468 . . . . 0.0 110.298 179.472 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.498 ' HA ' ' HB2' ' A' ' 29' ' ' LYS . . . -91.29 0.69 57.48 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.746 175.583 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.461 ' CB ' ' H ' ' A' ' 24' ' ' SER . 35.7 t70 -91.73 -33.44 15.02 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 179.415 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.702 HD11 HG21 ' A' ' 90' ' ' ILE . 76.9 mt -105.37 10.3 33.47 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.635 176.166 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.498 ' HB2' ' HA ' ' A' ' 26' ' ' ALA . 64.0 tttt -65.94 148.13 52.28 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 115.443 -0.799 . . . . 0.0 111.12 -176.825 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 121.04 -23.59 7.68 Favored Glycine 0 N--CA 1.447 -0.622 0 N-CA-C 111.185 -0.766 . . . . 0.0 111.185 -177.092 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.529 ' HD3' ' HA ' ' A' ' 63' ' ' ASP . 43.7 mttm -128.49 166.72 18.23 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 109.527 -0.546 . . . . 0.0 109.527 177.574 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.912 ' HB2' HG22 ' A' ' 64' ' ' ILE . 67.9 m-85 -66.55 144.87 56.18 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.83 0.348 . . . . 0.0 110.54 -179.644 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 47.0 mm -117.13 128.67 74.45 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-N 116.301 -0.408 . . . . 0.0 110.838 -176.31 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 84.6 t80 -110.57 121.54 45.57 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 171.774 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.714 ' HB ' ' HB ' ' A' ' 113' ' ' ILE . 54.5 mt -107.78 128.59 62.91 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-O 120.905 0.383 . . . . 0.0 110.569 -178.995 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.455 ' O ' ' HA ' ' A' ' 68' ' ' SER . 4.5 t70 -132.77 141.62 48.6 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 176.693 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.502 ' HA ' ' O ' ' A' ' 69' ' ' LEU . 39.1 t -89.5 112.82 24.94 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 C-N-CA 120.531 -0.468 . . . . 0.0 111.675 -176.289 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' TRP . . . . . 0.682 ' CZ2' ' HB2' ' A' ' 91' ' ' GLN . 0.7 OUTLIER -102.72 132.91 48.54 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.642 -0.708 . . . . 0.0 109.353 178.905 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -147.71 164.57 33.15 Favored 'General case' 0 N--CA 1.464 0.252 0 N-CA-C 111.689 0.255 . . . . 0.0 111.689 -175.03 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . 0.597 HG22 ' OD2' ' A' ' 72' ' ' ASP . 4.2 t -99.22 -33.08 10.9 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-O 120.856 0.36 . . . . 0.0 110.794 172.037 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 21.2 p-90 -82.94 21.21 1.07 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.158 0.504 . . . . 0.0 110.531 -178.947 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' CYS . . . . . 0.816 ' SG ' ' HB3' ' A' ' 45' ' ' CYS . 12.7 p -87.51 -69.88 0.66 Allowed 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.35 -176.649 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.439 ' N ' ' SG ' ' A' ' 42' ' ' CYS . . . 110.35 -92.36 0.68 Allowed Glycine 0 N--CA 1.448 -0.565 0 C-N-CA 121.111 -0.566 . . . . 0.0 111.949 -175.511 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.439 ' HD2' ' O ' ' A' ' 42' ' ' CYS . 12.2 Cg_endo -55.97 -29.57 74.11 Favored 'Trans proline' 0 C--N 1.349 0.602 0 C-N-CA 123.464 2.776 . . . . 0.0 112.747 -178.65 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . 0.993 ' HB2' ' HD3' ' A' ' 110' ' ' PRO . 43.6 t -54.33 -33.49 59.04 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.729 -0.669 . . . . 0.0 111.445 178.978 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.526 ' HA ' ' HG ' ' A' ' 49' ' ' LEU . 56.8 mtp180 -68.31 -18.0 64.4 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.712 0.291 . . . . 0.0 110.937 -176.396 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -82.02 -22.47 59.28 Favored Glycine 0 N--CA 1.448 -0.512 0 C-N-CA 120.713 -0.756 . . . . 0.0 111.865 177.135 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -104.63 -5.67 21.19 Favored 'General case' 0 C--N 1.329 -0.313 0 O-C-N 122.783 -0.245 . . . . 0.0 111.043 179.488 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.717 HD13 HD11 ' A' ' 87' ' ' LEU . 65.0 mt -53.64 -48.04 94.54 Favored Pre-proline 0 C--O 1.235 0.295 0 CA-C-N 116.677 -0.238 . . . . 0.0 110.975 174.401 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.687 ' O ' ' HG2' ' A' ' 54' ' ' GLU . 54.2 Cg_exo -54.57 -40.91 81.68 Favored 'Trans proline' 0 C--N 1.356 0.949 0 C-N-CA 121.824 1.682 . . . . 0.0 112.029 171.724 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -69.29 -31.56 70.14 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-O 121.26 0.552 . . . . 0.0 110.571 -176.728 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 6.6 tt -67.04 -48.25 68.89 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.364 -0.834 . . . . 0.0 109.916 -179.395 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.566 ' O ' ' HG3' ' A' ' 57' ' ' GLU . 6.2 ptmm? -67.58 -32.45 73.21 Favored 'General case' 0 C--N 1.333 -0.134 0 C-N-CA 121.009 -0.276 . . . . 0.0 110.48 -179.909 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.687 ' HG2' ' O ' ' A' ' 50' ' ' PRO . 51.6 mm-40 -59.51 -47.38 85.76 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.904 0.383 . . . . 0.0 110.394 176.493 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 29.6 mt -61.9 -53.41 56.17 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.683 175.598 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.566 ' HA ' ' CD2' ' A' ' 66' ' ' PHE . 4.5 tm-20 -44.7 -59.87 2.29 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 114.872 -1.058 . . . . 0.0 112.039 179.957 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.566 ' HG3' ' O ' ' A' ' 53' ' ' LYS . 20.1 mt-10 -71.78 -35.6 70.08 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.77 0.319 . . . . 0.0 111.664 -173.082 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . 0.402 ' HD3' ' CE2' ' A' ' 59' ' ' TYR . 83.5 tttt -67.09 -39.48 86.78 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.224 0.535 . . . . 0.0 110.771 -178.875 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.475 ' HB3' HD11 ' A' ' 64' ' ' ILE . 96.9 m-85 -105.32 10.27 33.58 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.241 -176.141 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -68.19 157.41 35.47 Favored 'General case' 0 C--O 1.239 0.516 0 CA-C-O 120.795 0.331 . . . . 0.0 110.427 172.215 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 77.9 8.49 87.3 Favored Glycine 0 N--CA 1.447 -0.633 0 C-N-CA 120.98 -0.629 . . . . 0.0 112.583 178.421 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.524 ' HB2' HG12 ' A' ' 64' ' ' ILE . 43.6 mmtm -98.77 -161.17 0.85 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.129 0.49 . . . . 0.0 110.029 177.99 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . 0.529 ' HA ' ' HD3' ' A' ' 31' ' ' LYS . 21.5 m-20 -91.16 32.69 1.01 Allowed 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 115.352 -0.84 . . . . 0.0 110.556 179.267 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.912 HG22 ' HB2' ' A' ' 32' ' ' TYR . 31.7 pt -141.67 165.59 18.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.129 -176.955 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 87.1 m-70 -136.44 137.72 40.73 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 175.118 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . 0.566 ' CD2' ' HA ' ' A' ' 56' ' ' GLU . 93.4 m-85 -94.69 110.11 21.98 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.624 -0.51 . . . . 0.0 109.624 174.172 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.601 ' O ' ' HA ' ' A' ' 35' ' ' ILE . 57.1 t -116.81 106.17 19.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.713 -175.581 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . 0.455 ' HA ' ' O ' ' A' ' 36' ' ' ASP . 34.5 m -88.96 133.41 34.33 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.171 177.302 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.502 ' O ' ' HA ' ' A' ' 37' ' ' VAL . 79.2 mt -117.24 135.18 53.99 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.735 0.302 . . . . 0.0 110.42 176.712 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . 0.436 ' O ' ' HB3' ' A' ' 94' ' ' MET . 1.4 t -113.87 120.73 41.73 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.279 -0.418 . . . . 0.0 111.63 -176.247 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 1.8 p -89.14 16.4 7.27 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.908 177.142 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.597 ' OD2' HG22 ' A' ' 40' ' ' THR . 1.4 m-20 -68.23 132.75 47.69 Favored 'General case' 0 CA--C 1.518 -0.266 0 N-CA-C 109.919 -0.4 . . . . 0.0 109.919 178.923 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 38.7 ttpt -76.85 -35.37 57.55 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-O 121.18 0.514 . . . . 0.0 109.862 177.86 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . 0.548 ' HB2' ' HB3' ' A' ' 77' ' ' ALA . 0.9 OUTLIER -74.29 102.07 4.23 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.538 -0.755 . . . . 0.0 110.216 176.553 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 10.8 tttt -78.19 -55.68 5.07 Favored 'General case' 0 C--N 1.319 -0.732 0 C-N-CA 120.521 -0.472 . . . . 0.0 111.282 -178.343 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 47.4 tptt -60.43 -48.6 81.04 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.254 -174.986 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.548 ' HB3' ' HB2' ' A' ' 74' ' ' ASN . . . -58.31 -36.38 73.27 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.972 178.714 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' TRP . . . . . 0.524 ' O ' HG12 ' A' ' 82' ' ' VAL . 12.2 t-105 -76.9 -48.6 17.8 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.197 -177.714 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.405 ' O ' HG13 ' A' ' 82' ' ' VAL . 4.6 pt-20 -62.15 -32.91 73.57 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-O 120.938 0.399 . . . . 0.0 110.919 -176.326 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . 0.597 HD22 ' N ' ' A' ' 81' ' ' MET . 0.2 OUTLIER -79.99 -27.3 39.64 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 119.717 -0.793 . . . . 0.0 111.149 177.866 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' MET . . . . . 0.597 ' N ' HD22 ' A' ' 80' ' ' ASN . 15.4 ttt -65.91 -48.47 71.32 Favored 'General case' 0 C--O 1.22 -0.495 0 C-N-CA 120.45 -0.5 . . . . 0.0 111.068 173.481 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.645 HG23 ' HB2' ' A' ' 87' ' ' LEU . 0.6 OUTLIER -58.88 -37.59 67.83 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 C-N-CA 120.408 -0.517 . . . . 0.0 110.518 177.832 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 58.7 m -63.33 -41.96 98.94 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.84 175.241 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 1.3 tmtp? -71.81 -45.17 62.4 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.435 -178.873 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -72.36 -10.91 60.4 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.461 -0.79 . . . . 0.0 111.627 -178.026 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 22.5 mt-30 67.67 49.27 0.98 Allowed 'General case' 0 N--CA 1.464 0.267 0 O-C-N 123.517 0.511 . . . . 0.0 111.855 173.731 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.717 HD11 HD13 ' A' ' 49' ' ' LEU . 21.2 mt -104.67 130.66 52.66 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 176.687 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.545 ' C ' ' HD3' ' A' ' 88' ' ' LYS . 0.0 OUTLIER -135.53 165.51 25.35 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.8 0.333 . . . . 0.0 111.847 -179.112 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 140.3 -142.08 12.1 Favored Glycine 0 N--CA 1.449 -0.448 0 N-CA-C 109.998 -1.241 . . . . 0.0 109.998 -176.208 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.702 HG21 HD11 ' A' ' 28' ' ' LEU . 45.9 mm -108.79 113.18 43.39 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 169.792 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . 0.682 ' HB2' ' CZ2' ' A' ' 38' ' ' TRP . 1.7 pt20 -141.48 104.17 4.53 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-O 121.836 0.827 . . . . 0.0 112.207 -169.33 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.756 HD11 ' HB ' ' A' ' 23' ' ' VAL . 3.0 mm? -99.04 163.31 12.63 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 114.905 -1.043 . . . . 0.0 110.766 -177.439 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 25.2 t-80 -131.68 121.73 24.78 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.93 -174.95 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' MET . . . . . 0.436 ' HB3' ' O ' ' A' ' 70' ' ' SER . 25.3 ttm -73.07 -61.11 1.93 Allowed 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 114.901 -1.045 . . . . 0.0 110.697 -179.169 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 95.04 -101.62 2.74 Favored Glycine 0 N--CA 1.446 -0.671 0 C-N-CA 120.661 -0.78 . . . . 0.0 112.712 178.14 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 19.2 p -110.91 16.68 21.12 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 111.884 0.327 . . . . 0.0 111.884 -175.508 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -102.06 48.18 0.88 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.051 0.453 . . . . 0.0 110.452 -179.133 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -68.55 -6.82 27.54 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.516 -174.471 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 28.9 m -64.49 -30.99 72.02 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.113 0.482 . . . . 0.0 110.025 173.082 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' PHE . . . . . 0.564 ' CZ ' ' HA ' ' A' ' 10' ' ' ALA . 20.5 t80 -74.2 -36.79 64.01 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 176.442 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' MET . . . . . 0.699 ' HG3' HG13 ' A' ' 106' ' ' ILE . 12.9 ttt -59.07 -45.55 90.53 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.063 -0.971 . . . . 0.0 110.311 172.138 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -67.09 -35.14 79.15 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.985 179.733 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -61.26 -38.19 85.8 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-O 120.997 0.427 . . . . 0.0 111.167 -179.504 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 39.7 m-85 -87.44 -7.66 57.41 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.533 179.316 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 80.0 mt 61.05 30.49 19.56 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.956 -179.696 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . 0.699 HG13 ' HG3' ' A' ' 101' ' ' MET . 22.9 pt -77.79 77.79 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 121.685 0.755 . . . . 0.0 110.901 179.008 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 17.6 p-10 -88.28 -54.26 4.29 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.613 -0.721 . . . . 0.0 111.542 -177.878 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -81.53 63.22 4.39 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 121.103 -0.57 . . . . 0.0 112.379 -176.559 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.593 ' HA ' ' C ' ' A' ' 110' ' ' PRO . 44.9 pt -71.43 147.46 92.72 Favored Pre-proline 0 C--N 1.324 -0.509 0 N-CA-C 110.496 -0.187 . . . . 0.0 110.496 -179.363 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . 0.993 ' HD3' ' HB2' ' A' ' 45' ' ' CYS . 24.9 Cg_endo -62.57 136.05 19.57 Favored 'Cis proline' 0 C--N 1.348 0.52 0 C-N-CA 124.013 -1.245 . . . . 0.0 113.168 2.096 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . 0.593 ' HG3' ' HA ' ' A' ' 106' ' ' ILE . 0.0 OUTLIER -113.15 141.5 46.85 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.41 -0.814 . . . . 0.0 109.764 -177.708 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . 0.487 ' O ' ' HA ' ' A' ' 125' ' ' ASN . 0.3 OUTLIER -97.95 124.99 42.65 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 114.935 -1.03 . . . . 0.0 112.116 -173.657 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.714 ' HB ' ' HB ' ' A' ' 35' ' ' ILE . 85.6 mt -136.01 148.2 27.87 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.487 0 CA-C-O 120.737 0.303 . . . . 0.0 110.8 178.442 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 33.5 tp -137.77 137.8 38.61 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 116.62 -0.264 . . . . 0.0 110.335 179.411 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.519 ' N ' HD12 ' A' ' 115' ' ' LEU . 0.3 OUTLIER -135.58 156.26 49.15 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-O 121.504 0.669 . . . . 0.0 111.41 -178.723 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . 0.703 ' HB3' ' HB2' ' A' ' 120' ' ' LYS . 11.2 t70 -75.77 162.67 27.99 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 114.572 -1.194 . . . . 0.0 110.876 179.695 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . 0.484 ' HA ' ' O ' ' A' ' 31' ' ' LYS . 17.0 mtm180 -49.94 -32.67 15.39 Favored 'General case' 0 N--CA 1.47 0.555 0 O-C-N 124.513 1.133 . . . . 0.0 112.703 -177.408 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . 0.769 ' HB3' ' HG3' ' A' ' 120' ' ' LYS . 19.8 t70 -77.97 -5.58 51.67 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-O 121.256 0.55 . . . . 0.0 110.948 -178.512 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 90.55 21.77 36.28 Favored Glycine 0 N--CA 1.438 -1.191 0 N-CA-C 110.459 -1.056 . . . . 0.0 110.459 -171.138 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . 0.769 ' HG3' ' HB3' ' A' ' 118' ' ' ASP . 35.9 mttp -87.22 105.29 17.11 Favored 'General case' 0 CA--C 1.515 -0.375 0 C-N-CA 120.304 -0.558 . . . . 0.0 110.342 -176.074 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . 0.636 ' H ' HD12 ' A' ' 121' ' ' ILE . 3.6 mp -47.23 108.61 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-O 121.147 0.498 . . . . 0.0 110.669 178.353 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 122' ' ' ILE . . . . . 0.493 ' H ' ' HA ' ' A' ' 115' ' ' LEU . 48.2 mt -83.56 -51.6 14.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 -177.952 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 15.0 m -136.01 126.3 26.51 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.189 -0.914 . . . . 0.0 109.988 -178.665 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -74.02 -18.74 60.81 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.386 0.612 . . . . 0.0 109.803 176.616 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . 0.487 ' HA ' ' O ' ' A' ' 112' ' ' PHE . 3.9 p30 -140.18 118.09 11.78 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.106 -0.952 . . . . 0.0 109.995 174.617 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 126' ' ' MET . . . . . 0.435 ' N ' ' HD1' ' A' ' 112' ' ' PHE . 15.9 tpt -110.94 -115.82 0.31 Allowed 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.686 -0.688 . . . . 0.0 109.859 179.084 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . 0.445 ' HB ' ' HB3' ' A' ' 131' ' ' ASP . 3.3 p -145.76 139.91 26.79 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 122.379 0.272 . . . . 0.0 110.321 178.571 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 65.7 mtt180 -62.87 161.5 28.96 Favored Pre-proline 0 N--CA 1.468 0.458 0 N-CA-C 112.876 0.695 . . . . 0.0 112.876 179.924 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -49.47 -31.25 23.26 Favored 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 123.862 3.041 . . . . 0.0 113.165 170.499 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 22.7 t -74.08 -26.34 60.32 Favored 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 111.543 0.201 . . . . 0.0 111.543 -179.264 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . 0.445 ' HB3' ' HB ' ' A' ' 127' ' ' THR . 8.7 t70 -81.9 128.1 69.78 Favored Pre-proline 0 C--N 1.331 -0.22 0 C-N-CA 120.236 -0.585 . . . . 0.0 110.734 179.64 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . 0.434 ' HD3' ' HA ' ' A' ' 131' ' ' ASP . 31.4 Cg_exo -61.86 -25.01 77.85 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 123.233 2.622 . . . . 0.0 113.671 -178.714 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . 0.561 ' O ' ' HB2' ' A' ' 137' ' ' LYS . 45.5 mmtm -61.04 -34.81 75.45 Favored 'General case' 0 CA--C 1.516 -0.357 0 CA-C-O 120.674 0.273 . . . . 0.0 110.926 -178.288 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 134' ' ' THR . . . . . 0.643 HG22 ' CZ ' ' A' ' 138' ' ' PHE . 1.2 m -59.56 -52.58 64.96 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.99 -0.55 . . . . 0.0 109.792 177.018 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . 0.558 ' HA ' ' CD2' ' A' ' 138' ' ' PHE . . . -60.44 -47.08 87.66 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.242 -0.89 . . . . 0.0 111.891 -179.481 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . 0.549 ' HG2' ' HA ' ' A' ' 133' ' ' LYS . 12.5 pt-20 -73.14 -23.19 60.43 Favored 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 120.444 -0.502 . . . . 0.0 110.852 -176.177 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . 0.561 ' HB2' ' O ' ' A' ' 133' ' ' LYS . 4.1 tmtm? -66.24 -43.01 87.76 Favored 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 109.492 -0.558 . . . . 0.0 109.492 175.855 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . 0.643 ' CZ ' HG22 ' A' ' 134' ' ' THR . 9.9 m-85 -56.37 -50.59 71.11 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.817 -0.629 . . . . 0.0 109.484 174.459 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 85.9 m-20 -54.66 -46.42 74.0 Favored 'General case' 0 C--O 1.222 -0.383 0 CA-C-N 115.795 -0.639 . . . . 0.0 109.881 176.984 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -53.88 -48.78 69.73 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.441 179.28 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.532 HD21 ' HE3' ' A' ' 137' ' ' LYS . 91.1 mt -58.48 -45.93 87.68 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.451 -177.594 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 2.9 mm? . . . . . 0 C--N 1.327 -0.399 0 CA-C-O 120.898 0.38 . . . . 0.0 111.053 -178.603 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.512 ' HB2' ' HZ ' ' A' ' 100' ' ' PHE . . . . . . . . 0 C--O 1.231 0.11 0 N-CA-C 110.482 -0.192 . . . . 0.0 110.482 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . 63.05 -69.36 0.07 Allowed 'General case' 0 N--CA 1.468 0.449 0 O-C-N 124.294 0.996 . . . . 0.0 111.996 -178.875 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 50.5 m -156.23 109.72 2.7 Favored 'General case' 0 C--N 1.311 -1.095 0 CA-C-N 115.223 -0.899 . . . . 0.0 109.615 179.938 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . 0.447 ' H ' ' HB2' ' A' ' 25' ' ' LEU . 12.7 p90 -124.57 176.43 6.53 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.753 -177.514 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . 0.561 ' HA ' ' HA ' ' A' ' 24' ' ' SER . 3.1 p -142.03 122.75 14.29 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.301 177.63 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 45.5 m-85 -132.09 145.67 58.38 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-O 120.819 0.342 . . . . 0.0 111.609 -177.685 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.607 ' HA ' ' O ' ' A' ' 21' ' ' LYS . 78.3 Cg_endo -81.69 128.19 5.92 Favored 'Trans proline' 0 N--CA 1.46 -0.48 0 C-N-CA 122.817 2.345 . . . . 0.0 113.931 179.692 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . 0.488 ' HB3' ' HB3' ' A' ' 21' ' ' LYS . 1.3 t70 -71.26 161.16 31.54 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 114.89 -1.05 . . . . 0.0 109.321 169.789 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.553 HG21 HG11 ' A' ' 82' ' ' VAL . 29.9 pt -46.76 -38.18 3.79 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.358 0 O-C-N 124.165 0.915 . . . . 0.0 112.849 -174.158 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 42.3 m-80 -75.88 -13.23 60.26 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-O 120.984 0.421 . . . . 0.0 111.357 -176.159 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 103.17 23.64 8.41 Favored Glycine 0 N--CA 1.449 -0.456 0 N-CA-C 111.182 -0.767 . . . . 0.0 111.182 -174.318 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.865 ' HE3' HG22 ' A' ' 23' ' ' VAL . 19.8 tptt -90.23 137.65 32.17 Favored 'General case' 0 C--O 1.219 -0.523 0 CA-C-O 121.081 0.467 . . . . 0.0 110.545 -176.063 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.493 ' N ' ' HD2' ' A' ' 21' ' ' LYS . 52.2 m -91.32 99.98 12.86 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-O 121.023 0.439 . . . . 0.0 110.163 -177.181 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.865 HG22 ' HE3' ' A' ' 21' ' ' LYS . 41.5 t -104.35 113.82 42.32 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 115.707 -0.679 . . . . 0.0 109.475 178.156 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . 0.561 ' HA ' ' HA ' ' A' ' 14' ' ' SER . 7.1 m -105.98 173.34 6.35 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.249 -177.984 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.552 HD11 ' HA3' ' A' ' 119' ' ' GLY . 3.4 tm? -59.01 -45.23 91.2 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.058 179.035 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -72.08 -17.9 61.96 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.973 0.416 . . . . 0.0 111.076 -177.851 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -73.8 -28.68 61.76 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.92 -0.582 . . . . 0.0 109.815 -178.91 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.501 HD11 HG21 ' A' ' 90' ' ' ILE . 97.6 mt -111.54 -1.18 15.91 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.316 179.25 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 85.2 tttt -67.51 146.29 54.09 Favored 'General case' 0 N--CA 1.448 -0.543 0 CA-C-O 121.104 0.478 . . . . 0.0 111.497 -174.119 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 116.9 -20.5 11.64 Favored Glycine 0 N--CA 1.445 -0.746 0 N-CA-C 111.139 -0.785 . . . . 0.0 111.139 -177.309 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.48 ' HB3' ' N ' ' A' ' 64' ' ' ILE . 64.3 mttm -126.11 149.38 48.98 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.727 -0.237 . . . . 0.0 110.656 178.746 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.547 ' CE1' ' HA ' ' A' ' 116' ' ' ASP . 22.4 m-85 -61.57 119.66 9.05 Favored 'General case' 0 CA--C 1.516 -0.341 0 CA-C-O 120.75 0.31 . . . . 0.0 110.707 -179.978 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 68.6 mt -100.29 115.35 41.39 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.921 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.057 -174.673 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 81.7 t80 -92.03 120.71 32.92 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 108.669 -0.864 . . . . 0.0 108.669 170.953 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.596 ' HA ' ' O ' ' A' ' 67' ' ' VAL . 49.8 mt -107.73 122.64 62.32 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-O 120.985 0.421 . . . . 0.0 110.616 -178.802 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.53 ' O ' ' HA ' ' A' ' 68' ' ' SER . 1.9 t70 -120.06 159.47 24.72 Favored 'General case' 0 C--N 1.315 -0.926 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 174.432 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.591 HG11 HG21 ' A' ' 109' ' ' ILE . 42.9 t -102.32 114.55 42.11 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.98 0 C-N-CA 119.651 -0.819 . . . . 0.0 111.822 178.882 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' TRP . . . . . 0.621 ' CE3' ' HZ2' ' A' ' 78' ' ' TRP . 0.8 OUTLIER -102.62 134.44 45.98 Favored 'General case' 0 C--O 1.225 -0.198 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 -179.994 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.646 ' HB3' ' SG ' ' A' ' 42' ' ' CYS . . . -146.94 164.68 32.15 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 112.285 0.476 . . . . 0.0 112.285 -175.474 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . 0.425 HG23 ' SD ' ' A' ' 81' ' ' MET . 1.4 m -78.64 -30.82 46.59 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.519 0.676 . . . . 0.0 110.383 178.117 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' TRP . . . . . 0.58 ' CH2' HD11 ' A' ' 109' ' ' ILE . 9.4 p-90 -106.48 21.83 16.8 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.234 -0.894 . . . . 0.0 112.116 -172.486 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' CYS . . . . . 0.646 ' SG ' ' HB3' ' A' ' 39' ' ' ALA . 25.7 p -116.99 88.98 3.01 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.477 0.656 . . . . 0.0 109.972 173.434 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -56.79 -53.97 40.05 Favored Glycine 0 CA--C 1.524 0.644 0 CA-C-N 115.486 -0.779 . . . . 0.0 113.912 -178.0 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 78.2 Cg_exo -52.41 -35.91 67.26 Favored 'Trans proline' 0 C--N 1.357 0.992 0 C-N-CA 122.818 2.345 . . . . 0.0 113.144 -178.333 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . 0.723 ' HB2' ' HD3' ' A' ' 110' ' ' PRO . 51.2 t -57.21 -30.82 64.88 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 121.041 0.448 . . . . 0.0 111.308 -177.564 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.577 ' HA ' HD12 ' A' ' 49' ' ' LEU . 41.9 mtp-105 -74.67 0.25 15.74 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.114 -0.493 . . . . 0.0 111.298 -174.162 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -84.45 -40.24 8.53 Favored Glycine 0 N--CA 1.446 -0.65 0 N-CA-C 111.539 -0.625 . . . . 0.0 111.539 174.22 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . 0.461 ' CD ' ' HE ' ' A' ' 128' ' ' ARG . 4.4 pm0 -93.92 -8.28 40.63 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 111.531 0.197 . . . . 0.0 111.531 -179.447 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.614 ' HG ' ' O ' ' A' ' 45' ' ' CYS . 48.6 mt -54.97 -51.47 79.17 Favored Pre-proline 0 CA--C 1.535 0.374 0 N-CA-C 111.773 0.286 . . . . 0.0 111.773 177.473 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.613 ' HD3' ' HB2' ' A' ' 49' ' ' LEU . 50.8 Cg_exo -57.77 -38.08 94.21 Favored 'Trans proline' 0 C--N 1.357 1.007 0 C-N-CA 122.007 1.805 . . . . 0.0 112.077 175.574 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -70.01 -33.26 71.78 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.009 0.433 . . . . 0.0 110.775 -179.921 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 9.3 tt -66.56 -48.67 68.93 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.59 -177.759 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.564 ' O ' ' HG3' ' A' ' 57' ' ' GLU . 12.4 ptmm? -62.58 -42.59 99.65 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 109.97 -0.381 . . . . 0.0 109.97 177.676 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -62.91 -34.47 77.51 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.323 179.687 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 18.2 mt -60.89 -48.02 83.74 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.931 175.42 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.453 ' HB2' ' HB2' ' A' ' 66' ' ' PHE . 7.8 tp10 -63.19 -41.78 99.23 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.572 -0.74 . . . . 0.0 109.999 178.615 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.564 ' HG3' ' O ' ' A' ' 53' ' ' LYS . 35.9 mt-10 -66.94 -21.38 65.98 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.827 177.627 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 61.7 tttp -86.21 -43.71 12.76 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.582 -179.267 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 80.3 m-85 -95.45 0.52 53.38 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 112.097 0.406 . . . . 0.0 112.097 -174.062 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -58.31 111.78 1.33 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.113 0.483 . . . . 0.0 110.829 176.349 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 150.69 -36.07 0.92 Allowed Glycine 0 N--CA 1.445 -0.718 0 N-CA-C 111.234 -0.746 . . . . 0.0 111.234 -178.597 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.551 ' HB3' HD22 ' A' ' 142' ' ' LEU . 2.2 mmmm -103.12 -160.64 0.79 Allowed 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.104 0.478 . . . . 0.0 110.695 175.93 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . 0.446 ' H ' ' HE2' ' A' ' 62' ' ' LYS . 23.0 m-20 -97.92 79.15 2.61 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 116.024 -0.534 . . . . 0.0 111.884 -174.988 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.588 ' HB ' HD21 ' A' ' 142' ' ' LEU . 14.7 tt -154.03 156.93 4.81 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 115.59 -0.732 . . . . 0.0 109.613 176.725 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' HIS . . . . . 0.464 ' CE1' ' HD2' ' A' ' 31' ' ' LYS . 47.6 m-70 -143.61 142.59 31.11 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 109.893 -0.41 . . . . 0.0 109.893 175.857 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . 0.453 ' HB2' ' HB2' ' A' ' 56' ' ' GLU . 87.5 m-85 -109.88 102.93 11.65 Favored 'General case' 0 C--N 1.314 -0.96 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 172.28 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.615 HG22 ' HB ' ' A' ' 90' ' ' ILE . 51.1 t -119.68 125.98 74.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 115.134 -0.939 . . . . 0.0 110.72 -171.85 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . 0.535 ' HB2' ' OE1' ' A' ' 91' ' ' GLN . 21.2 m -107.31 140.59 39.98 Favored 'General case' 0 C--N 1.312 -1.061 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.261 176.951 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 57.4 tp -117.76 133.52 55.85 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.089 179.388 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . 0.437 ' O ' ' HB3' ' A' ' 94' ' ' MET . 1.6 t -109.81 116.9 32.5 Favored 'General case' 0 C--O 1.221 -0.446 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.845 -172.303 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 42.6 m -85.55 19.85 2.27 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 120.827 0.346 . . . . 0.0 111.1 177.937 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.548 ' OD1' ' HA ' ' A' ' 39' ' ' ALA . 3.6 m-20 -73.95 147.83 42.72 Favored 'General case' 0 CA--C 1.517 -0.321 0 CA-C-O 121.261 0.553 . . . . 0.0 111.41 -177.228 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.48 ' HB2' ' HE3' ' A' ' 73' ' ' LYS . 28.1 ttmt -95.38 -32.61 12.85 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 115.415 -0.812 . . . . 0.0 109.912 177.734 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -78.86 73.74 5.4 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.703 -0.681 . . . . 0.0 109.722 -178.319 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 10.5 tttt -58.55 -50.8 72.46 Favored 'General case' 0 C--N 1.323 -0.575 0 C-N-CA 120.71 -0.396 . . . . 0.0 111.437 -175.116 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.446 ' HA ' ' OE1' ' A' ' 79' ' ' GLU . 1.6 tmtt? -57.49 -48.01 80.39 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.695 -177.795 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -67.38 -38.44 84.72 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-O 121.475 0.655 . . . . 0.0 110.126 -177.545 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' TRP . . . . . 0.621 ' HZ2' ' CE3' ' A' ' 38' ' ' TRP . 13.8 t-105 -71.28 -47.65 55.62 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 115.1 -0.955 . . . . 0.0 111.412 -178.348 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.446 ' OE1' ' HA ' ' A' ' 76' ' ' LYS . 3.1 pt-20 -62.23 -37.04 83.87 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-O 120.631 0.253 . . . . 0.0 111.405 -175.547 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 6.0 p30 -77.45 -31.29 53.72 Favored 'General case' 0 C--N 1.332 -0.181 0 C-N-CA 119.413 -0.915 . . . . 0.0 110.301 179.581 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' MET . . . . . 0.425 ' SD ' HG23 ' A' ' 40' ' ' THR . 16.3 ttt -64.67 -46.86 80.64 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.632 -0.258 . . . . 0.0 111.497 176.661 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.686 HG23 ' HB2' ' A' ' 87' ' ' LEU . 1.0 OUTLIER -60.44 -36.74 71.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 C-N-CA 120.373 -0.531 . . . . 0.0 110.389 175.982 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 31.3 m -64.13 -38.11 89.89 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.641 177.046 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . 0.47 ' HA ' ' HD3' ' A' ' 84' ' ' LYS . 35.3 mmtm -74.03 -47.44 36.89 Favored 'General case' 0 CA--C 1.519 -0.222 0 CA-C-O 121.214 0.531 . . . . 0.0 111.385 178.213 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -72.74 -8.12 53.89 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.319 -0.855 . . . . 0.0 111.918 -178.442 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 49.9 mt-30 69.23 26.06 5.52 Favored 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 112.634 0.605 . . . . 0.0 112.634 169.91 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.686 ' HB2' HG23 ' A' ' 82' ' ' VAL . 18.8 mt -67.77 108.54 3.0 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.719 0.295 . . . . 0.0 110.393 -178.091 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.417 ' HB2' ' HE2' ' A' ' 53' ' ' LYS . 39.7 mmtm -95.87 -177.44 4.03 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.388 -178.68 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 96.56 -162.57 22.44 Favored Glycine 0 N--CA 1.448 -0.556 0 N-CA-C 111.017 -0.833 . . . . 0.0 111.017 -174.632 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.615 ' HB ' HG22 ' A' ' 67' ' ' VAL . 49.4 mm -97.31 113.62 32.22 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 117.435 0.618 . . . . 0.0 109.693 176.885 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . 0.61 ' HB3' ' CZ2' ' A' ' 38' ' ' TRP . 60.4 mm-40 -123.98 106.77 10.67 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.45 -173.965 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 41.7 mt -104.67 145.61 30.09 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.095 -175.636 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' HIS . . . . . 0.518 ' O ' ' HD2' ' A' ' 16' ' ' PRO . 26.7 t-80 -113.22 139.76 48.52 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-O 121.502 0.668 . . . . 0.0 111.383 -177.929 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' MET . . . . . 0.634 ' HG3' ' HB2' ' A' ' 97' ' ' ASP . 27.1 ttm -107.72 94.18 4.94 Favored 'General case' 0 N--CA 1.442 -0.849 0 CA-C-N 114.905 -1.043 . . . . 0.0 108.629 179.075 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -68.93 78.12 0.28 Allowed Glycine 0 C--N 1.315 -0.592 0 CA-C-N 115.122 -0.945 . . . . 0.0 113.599 -178.669 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 5.3 m 71.87 5.13 5.27 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 123.148 0.579 . . . . 0.0 111.674 174.337 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . 0.634 ' HB2' ' HG3' ' A' ' 94' ' ' MET . 13.2 m-20 -79.02 32.06 0.21 Allowed 'General case' 0 N--CA 1.466 0.331 0 CA-C-O 121.036 0.446 . . . . 0.0 110.011 178.743 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . 0.586 ' HA ' ' SD ' ' A' ' 94' ' ' MET . 0.0 OUTLIER -78.59 14.06 1.41 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.129 -0.487 . . . . 0.0 112.225 -169.589 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -66.43 -28.09 68.34 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 168.082 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' PHE . . . . . 0.512 ' HZ ' ' HB2' ' A' ' 10' ' ' ALA . 55.1 t80 -70.95 -38.92 72.85 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.011 -0.995 . . . . 0.0 109.283 172.928 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' MET . . . . . 0.538 ' HG3' HG13 ' A' ' 106' ' ' ILE . 11.5 ttt -57.25 -44.9 84.29 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.296 -0.866 . . . . 0.0 110.333 172.702 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -67.61 -33.54 75.2 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.43 -0.805 . . . . 0.0 111.189 179.327 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -73.93 -39.91 63.45 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.925 0.393 . . . . 0.0 111.4 -179.589 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' TYR . . . . . 0.568 ' HB3' HG23 ' A' ' 106' ' ' ILE . 2.4 m-85 -83.64 -5.12 59.1 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.745 -178.917 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 93.8 mt 63.51 20.78 12.43 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.292 177.92 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . 0.614 HG22 ' HG3' ' A' ' 111' ' ' ARG . 39.0 pt -77.99 59.38 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 CA-C-O 121.586 0.708 . . . . 0.0 110.871 178.399 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 9.8 p30 -86.82 -38.5 16.77 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.928 179.505 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -85.12 76.72 2.18 Favored Glycine 0 N--CA 1.447 -0.6 0 N-CA-C 111.41 -0.676 . . . . 0.0 111.41 176.416 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.591 HG21 HG11 ' A' ' 37' ' ' VAL . 23.0 pt -94.78 156.46 38.18 Favored Pre-proline 0 C--N 1.323 -0.57 0 CA-C-N 115.973 -0.114 . . . . 0.0 110.955 -177.742 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . 0.723 ' HD3' ' HB2' ' A' ' 45' ' ' CYS . 29.2 Cg_endo -61.52 147.57 51.01 Favored 'Cis proline' 0 C--N 1.349 0.583 0 C-N-CA 124.348 -1.105 . . . . 0.0 114.049 2.117 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . 0.614 ' HG3' HG22 ' A' ' 106' ' ' ILE . 0.0 OUTLIER -118.54 137.87 52.92 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 179.125 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . 0.448 ' CD1' ' HA ' ' A' ' 128' ' ' ARG . 0.9 OUTLIER -103.2 120.96 41.7 Favored 'General case' 0 C--N 1.329 -0.285 0 O-C-N 123.908 0.755 . . . . 0.0 110.066 -175.366 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 87.3 mt -136.93 147.62 27.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-O 120.656 0.265 . . . . 0.0 110.307 -179.971 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.476 ' HB2' ' HG2' ' A' ' 126' ' ' MET . 54.7 tp -129.24 137.49 51.12 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.508 0.194 . . . . 0.0 110.546 -179.936 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.781 ' HG ' ' HA ' ' A' ' 121' ' ' ILE . 4.7 mp -129.56 151.12 50.52 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.127 0.489 . . . . 0.0 110.379 179.324 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . 0.547 ' HA ' ' CE1' ' A' ' 32' ' ' TYR . 22.4 t70 -70.88 164.33 25.58 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.243 -0.89 . . . . 0.0 110.205 176.564 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . 0.412 ' HG3' ' CD2' ' A' ' 32' ' ' TYR . 76.4 mtp180 -49.77 -31.71 12.18 Favored 'General case' 0 N--CA 1.466 0.369 0 O-C-N 124.068 0.855 . . . . 0.0 111.858 179.683 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . 0.475 ' HB3' ' HG2' ' A' ' 120' ' ' LYS . 6.4 t70 -71.77 -4.29 26.86 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.164 -178.906 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . 0.552 ' HA3' HD11 ' A' ' 25' ' ' LEU . . . 79.49 30.54 44.52 Favored Glycine 0 N--CA 1.439 -1.154 0 N-CA-C 110.286 -1.126 . . . . 0.0 110.286 -171.757 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . 0.475 ' HG2' ' HB3' ' A' ' 118' ' ' ASP . 40.6 mmtm -110.65 110.43 21.11 Favored 'General case' 0 CA--C 1.516 -0.333 0 C-N-CA 120.707 -0.397 . . . . 0.0 111.536 -175.418 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . 0.781 ' HA ' ' HG ' ' A' ' 115' ' ' LEU . 3.3 mp -42.15 112.22 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 115.272 -0.876 . . . . 0.0 111.94 -179.145 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 122' ' ' ILE . . . . . 0.503 HD11 ' HB2' ' A' ' 116' ' ' ASP . 27.3 mm -87.68 -46.8 15.94 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-N 115.275 -0.875 . . . . 0.0 109.281 176.096 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 12.4 m -134.7 114.4 12.66 Favored 'General case' 0 N--CA 1.447 -0.622 0 CA-C-N 115.142 -0.935 . . . . 0.0 110.03 179.559 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -76.12 -16.04 59.97 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.77 0.795 . . . . 0.0 109.714 175.735 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 12.2 p-10 -124.17 87.62 2.76 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 114.679 -1.146 . . . . 0.0 109.728 175.264 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 126' ' ' MET . . . . . 0.497 ' HG3' ' H ' ' A' ' 127' ' ' THR . 5.0 tpt -94.44 -170.18 2.21 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 108.936 -0.764 . . . . 0.0 108.936 -180.0 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . 0.551 ' HB ' ' OG1' ' A' ' 134' ' ' THR . 3.7 m -117.7 138.98 51.64 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 110.205 -0.295 . . . . 0.0 110.205 -177.914 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . 0.461 ' HE ' ' CD ' ' A' ' 48' ' ' GLU . 49.1 ttt180 -32.32 136.63 0.25 Allowed Pre-proline 0 C--O 1.237 0.401 0 C-N-CA 124.36 1.064 . . . . 0.0 112.686 173.314 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . 0.417 ' HD3' ' HA ' ' A' ' 128' ' ' ARG . 86.5 Cg_exo -50.56 -40.21 54.99 Favored 'Trans proline' 0 C--N 1.347 0.474 0 C-N-CA 123.731 2.954 . . . . 0.0 113.479 -178.016 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 8.8 p -84.27 18.2 2.27 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 112.219 0.452 . . . . 0.0 112.219 -175.716 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . 0.446 ' HA ' ' HD3' ' A' ' 132' ' ' PRO . 15.2 t70 -97.99 131.05 27.32 Favored Pre-proline 0 C--N 1.328 -0.328 0 C-N-CA 120.582 -0.447 . . . . 0.0 110.003 175.893 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . 0.446 ' HD3' ' HA ' ' A' ' 131' ' ' ASP . 56.5 Cg_exo -53.91 -35.43 80.09 Favored 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 123.139 2.56 . . . . 0.0 113.56 -177.988 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 35.5 mtmm -68.13 -36.48 79.77 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.046 0.451 . . . . 0.0 110.16 -178.33 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 134' ' ' THR . . . . . 0.7 HG22 ' CZ ' ' A' ' 138' ' ' PHE . 1.3 m -65.58 -48.54 71.97 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.128 178.26 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . 0.554 ' HA ' ' CD2' ' A' ' 138' ' ' PHE . . . -58.31 -46.77 85.51 Favored 'General case' 0 C--O 1.237 0.418 0 CA-C-N 115.494 -0.776 . . . . 0.0 112.099 -179.713 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -71.0 -24.33 62.36 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.832 0.348 . . . . 0.0 110.701 -178.567 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . 0.545 ' O ' ' HG ' ' A' ' 141' ' ' LEU . 44.6 tptt -65.95 -41.14 91.65 Favored 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 109.611 -0.514 . . . . 0.0 109.611 175.189 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . 0.7 ' CZ ' HG22 ' A' ' 134' ' ' THR . 12.1 m-85 -58.84 -51.87 68.16 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.504 177.726 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 19.3 p30 -69.95 -24.19 63.3 Favored 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 120.392 -0.523 . . . . 0.0 111.351 -175.35 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 51.0 tt0 -67.67 -48.51 66.42 Favored 'General case' 0 N--CA 1.45 -0.453 0 CA-C-O 120.826 0.346 . . . . 0.0 110.573 172.226 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.545 ' HG ' ' O ' ' A' ' 137' ' ' LYS . 86.9 mt -64.4 -35.05 79.63 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.972 -178.163 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 0.588 HD21 ' HB ' ' A' ' 64' ' ' ILE . 79.1 mt . . . . . 0 C--N 1.326 -0.444 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.228 -179.395 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.689 ' HB2' ' HA2' ' A' ' 6' ' ' GLY . 2.0 mpt? . . . . . 0 N--CA 1.482 1.165 0 N-CA-C 110.24 -0.281 . . . . 0.0 110.24 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 10.6 m -50.23 144.66 6.94 Favored 'General case' 0 C--O 1.24 0.569 0 N-CA-C 112.488 0.551 . . . . 0.0 112.488 -176.144 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER 73.46 -67.46 0.26 Allowed 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 115.134 -0.939 . . . . 0.0 109.43 -176.553 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 12.3 ptm180 -175.73 -38.0 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.81 -0.632 . . . . 0.0 109.375 174.407 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 3.3 m -89.97 -78.35 0.37 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.969 -0.56 . . . . 0.0 109.64 176.826 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . 0.689 ' HA2' ' HB2' ' A' ' 1' ' ' MET . . . 174.6 47.12 0.05 OUTLIER Glycine 0 N--CA 1.447 -0.599 0 N-CA-C 111.536 -0.626 . . . . 0.0 111.536 179.378 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 67.8 m-20 -104.09 137.26 19.18 Favored Pre-proline 0 C--N 1.325 -0.499 0 CA-C-O 120.61 0.243 . . . . 0.0 110.532 -175.832 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 69.8 Cg_endo -79.76 113.61 3.07 Favored 'Trans proline' 0 N--CA 1.458 -0.613 0 C-N-CA 122.698 2.266 . . . . 0.0 111.589 176.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.508 ' HB3' ' HE1' ' A' ' 100' ' ' PHE . 43.6 m -151.85 156.62 40.52 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.365 -177.477 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . 73.76 -34.97 0.3 Allowed 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 123.863 0.865 . . . . 0.0 112.458 175.847 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -80.55 78.9 7.24 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 120.9 0.381 . . . . 0.0 110.95 -177.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 53.6 m 68.65 95.5 0.07 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.032 -0.985 . . . . 0.0 111.899 176.613 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 33.9 p90 -98.1 165.99 11.63 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.416 178.067 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.502 ' HA ' ' HA ' ' A' ' 24' ' ' SER . 25.0 m -142.51 120.43 12.02 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.896 -0.409 . . . . 0.0 109.896 175.664 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . 0.42 ' CE2' ' HA ' ' A' ' 94' ' ' MET . 57.8 m-85 -128.19 161.72 54.62 Favored Pre-proline 0 C--N 1.324 -0.528 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.45 -177.407 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.459 ' HD2' ' O ' ' A' ' 93' ' ' HIS . 2.7 Cg_endo -86.18 124.95 2.54 Favored 'Trans proline' 0 N--CA 1.454 -0.846 0 C-N-CA 122.476 2.117 . . . . 0.0 112.567 174.008 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . 0.505 ' HB3' ' HB3' ' A' ' 21' ' ' LYS . 4.0 t70 -69.56 159.03 34.12 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.529 -0.759 . . . . 0.0 109.122 171.971 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.781 HG13 HG11 ' A' ' 82' ' ' VAL . 18.5 mm -40.94 -49.71 0.67 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.401 0 O-C-N 124.558 1.161 . . . . 0.0 112.898 -176.585 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 4.8 p30 -69.55 -16.49 63.43 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-O 121.126 0.488 . . . . 0.0 110.974 -174.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 107.73 33.83 2.98 Favored Glycine 0 N--CA 1.444 -0.781 0 CA-C-N 115.802 -0.636 . . . . 0.0 111.663 -177.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.646 ' HZ2' HG22 ' A' ' 23' ' ' VAL . 48.2 tttm -102.32 128.99 48.64 Favored 'General case' 0 CA--C 1.515 -0.381 0 C-N-CA 120.402 -0.519 . . . . 0.0 111.188 -177.617 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 8.3 m -64.75 104.88 0.89 Allowed 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 109.527 -0.546 . . . . 0.0 109.527 170.429 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 1.031 ' HB ' HD11 ' A' ' 92' ' ' LEU . 41.6 t -111.79 118.46 57.65 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 176.067 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . 0.502 ' HA ' ' HA ' ' A' ' 14' ' ' SER . 89.6 p -100.48 -173.81 2.5 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.563 -175.762 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.587 HD11 ' HA3' ' A' ' 119' ' ' GLY . 1.5 tm? -82.35 -1.02 48.47 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 176.219 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -95.99 -21.69 17.85 Favored 'General case' 0 CA--C 1.51 -0.563 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 -178.482 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -65.7 -22.38 66.61 Favored 'General case' 0 N--CA 1.437 -1.09 0 CA-C-N 113.755 -1.566 . . . . 0.0 110.208 173.354 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.62 HD13 HG21 ' A' ' 67' ' ' VAL . 37.1 mt -112.37 -15.67 13.08 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-N 115.407 -0.815 . . . . 0.0 111.008 -177.009 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.459 ' HB2' ' O ' ' A' ' 25' ' ' LEU . 62.2 tttp -69.75 133.38 47.4 Favored 'General case' 0 N--CA 1.445 -0.693 0 CA-C-N 115.694 -0.684 . . . . 0.0 111.455 -171.174 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 119.19 -18.9 10.2 Favored Glycine 0 N--CA 1.45 -0.387 0 N-CA-C 111.172 -0.771 . . . . 0.0 111.172 -176.896 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.601 ' HB3' ' NE2' ' A' ' 65' ' ' HIS . 24.5 ttmm -140.18 147.47 40.16 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 179.241 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.54 ' HB2' ' O ' ' A' ' 63' ' ' ASP . 81.8 m-85 -54.0 140.76 30.32 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-O 121.119 0.485 . . . . 0.0 111.659 -176.261 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 5.1 mp -112.18 132.25 61.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.634 -177.111 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 85.5 t80 -115.58 116.54 28.33 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 172.595 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.625 ' HB ' ' HB ' ' A' ' 113' ' ' ILE . 67.9 mt -103.33 109.73 27.81 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 CA-C-O 120.999 0.428 . . . . 0.0 110.671 -177.937 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.557 ' HA ' ' O ' ' A' ' 111' ' ' ARG . 5.7 p-10 -105.57 158.31 16.78 Favored 'General case' 0 C--N 1.316 -0.858 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 173.238 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.469 HG21 HG21 ' A' ' 106' ' ' ILE . 52.6 t -103.26 136.68 34.84 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.806 0 C-N-CA 120.485 -0.486 . . . . 0.0 111.447 179.068 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' TRP . . . . . 0.663 ' CZ2' ' HB2' ' A' ' 91' ' ' GLN . 0.2 OUTLIER -128.5 141.77 51.28 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 -179.95 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.505 ' HA ' ' OD1' ' A' ' 72' ' ' ASP . . . -146.15 158.11 43.86 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 112.445 0.535 . . . . 0.0 112.445 -176.67 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -76.35 -46.22 28.49 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.798 -0.637 . . . . 0.0 109.559 175.917 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 5.3 p-90 -80.77 -1.16 41.76 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 114.885 -1.052 . . . . 0.0 111.687 -175.352 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 43.6 t -95.31 110.89 22.84 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.252 0.549 . . . . 0.0 110.127 177.596 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.408 ' N ' ' CD ' ' A' ' 44' ' ' PRO . . . -85.31 -43.97 6.4 Favored Glycine 0 CA--C 1.528 0.859 0 CA-C-O 118.967 -0.907 . . . . 0.0 113.727 176.352 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.408 ' CD ' ' N ' ' A' ' 43' ' ' GLY . 71.2 Cg_exo -53.03 -38.34 80.07 Favored 'Trans proline' 0 C--N 1.362 1.274 0 C-N-CA 122.584 2.189 . . . . 0.0 113.221 -176.835 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . 0.691 ' O ' ' HG ' ' A' ' 49' ' ' LEU . 29.8 p -58.95 -32.51 69.67 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.8 0.333 . . . . 0.0 111.021 -179.653 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.593 ' HG2' HD12 ' A' ' 49' ' ' LEU . 52.0 mtt85 -69.38 -8.18 44.17 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.757 -176.412 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -78.26 -27.81 57.09 Favored Glycine 0 N--CA 1.444 -0.774 0 C-N-CA 120.53 -0.843 . . . . 0.0 111.658 175.687 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.462 ' OE2' ' HD3' ' A' ' 128' ' ' ARG . 15.7 pt-20 -114.53 -8.03 12.78 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 111.695 0.257 . . . . 0.0 111.695 -177.687 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.691 ' HG ' ' O ' ' A' ' 45' ' ' CYS . 68.8 mt -55.18 -47.13 99.27 Favored Pre-proline 0 CA--C 1.537 0.442 0 N-CA-C 112.248 0.462 . . . . 0.0 112.248 178.22 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.496 ' HD3' ' HB2' ' A' ' 49' ' ' LEU . 53.6 Cg_exo -54.97 -37.46 93.59 Favored 'Trans proline' 0 C--N 1.355 0.905 0 C-N-CA 121.688 1.592 . . . . 0.0 111.944 172.552 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -73.51 -28.64 62.01 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.619 179.544 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 8.2 tt -64.59 -39.62 94.06 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.009 -0.737 . . . . 0.0 109.009 175.096 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.437 ' HE2' ' O ' ' A' ' 88' ' ' LYS . 4.5 mmmp? -63.83 -46.99 82.58 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.486 174.59 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.41 ' O ' ' HB2' ' A' ' 58' ' ' LYS . 0.3 OUTLIER -53.09 -43.56 66.9 Favored 'General case' 0 C--O 1.222 -0.348 0 O-C-N 123.565 0.541 . . . . 0.0 111.082 173.944 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.479 HD21 ' HE2' ' A' ' 138' ' ' PHE . 21.7 tp -59.51 -44.42 93.13 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.951 0.405 . . . . 0.0 110.474 178.572 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.408 ' OE1' ' HD2' ' A' ' 66' ' ' PHE . 10.1 tp10 -65.5 -55.96 15.03 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.022 179.906 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 29.9 mt-10 -72.75 -19.24 61.41 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.561 -172.534 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.41 ' HB2' ' O ' ' A' ' 54' ' ' GLU . 18.1 ttmm -82.37 -31.6 29.65 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.139 0.495 . . . . 0.0 110.044 174.326 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.436 ' O ' ' HD2' ' A' ' 62' ' ' LYS . 25.8 m-85 -103.9 12.95 33.74 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.657 -0.702 . . . . 0.0 111.166 -178.552 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -47.16 113.8 0.74 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.077 0.465 . . . . 0.0 111.819 178.673 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 115.01 -12.19 20.11 Favored Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 120.88 -0.676 . . . . 0.0 112.254 -178.192 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.71 ' H ' ' HD2' ' A' ' 62' ' ' LYS . 0.0 OUTLIER -65.9 169.48 6.61 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-O 121.405 0.621 . . . . 0.0 111.599 -178.397 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.574 ' CG ' ' HG3' ' A' ' 31' ' ' LYS . 4.6 t70 -94.77 55.77 1.93 Allowed 'General case' 0 C--N 1.318 -0.773 0 CA-C-O 121.367 0.604 . . . . 0.0 109.992 178.786 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.477 ' HB ' ' HG2' ' A' ' 62' ' ' LYS . 4.0 mp -145.99 134.09 15.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.571 -0.74 . . . . 0.0 109.752 -178.698 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' HIS . . . . . 0.601 ' NE2' ' HB3' ' A' ' 31' ' ' LYS . 88.4 m-70 -101.55 120.81 40.88 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.511 -0.552 . . . . 0.0 109.511 173.623 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . 0.56 ' O ' ' HB ' ' A' ' 90' ' ' ILE . 63.5 m-85 -83.32 108.93 16.85 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 171.163 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.62 HG21 HD13 ' A' ' 28' ' ' LEU . 44.2 t -120.77 105.16 16.38 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.696 -174.188 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . 0.542 ' HA ' ' O ' ' A' ' 36' ' ' ASP . 13.3 m -88.09 124.53 33.87 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.531 -179.191 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 55.7 tp -110.0 129.98 55.6 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.777 0.322 . . . . 0.0 110.453 177.655 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . 0.504 ' O ' ' HB3' ' A' ' 94' ' ' MET . 1.0 OUTLIER -112.09 122.41 47.68 Favored 'General case' 0 C--O 1.221 -0.396 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.721 -175.147 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 12.9 t -85.41 9.31 15.97 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.403 177.674 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.505 ' OD1' ' HA ' ' A' ' 39' ' ' ALA . 3.0 m-20 -64.56 136.47 57.06 Favored 'General case' 0 CA--C 1.516 -0.343 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.592 -178.013 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 18.2 ttmm -82.83 -33.72 27.09 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-O 121.254 0.549 . . . . 0.0 109.846 177.451 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . 0.562 ' HB2' ' HB3' ' A' ' 77' ' ' ALA . 0.9 OUTLIER -77.9 85.84 4.14 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.477 -0.783 . . . . 0.0 111.217 -179.641 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.424 ' HB2' ' CE1' ' A' ' 93' ' ' HIS . 18.0 tttm -62.54 -62.95 1.39 Allowed 'General case' 0 C--O 1.218 -0.553 0 C-N-CA 120.024 -0.67 . . . . 0.0 111.782 -179.649 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.435 ' HA ' ' HD2' ' A' ' 76' ' ' LYS . 42.2 tptt -53.23 -37.7 62.29 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 123.279 0.362 . . . . 0.0 111.777 -174.445 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.562 ' HB3' ' HB2' ' A' ' 74' ' ' ASN . . . -66.47 -38.08 86.54 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.565 0.698 . . . . 0.0 110.466 177.217 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' TRP . . . . . 0.451 ' HZ3' HH22 ' A' ' 46' ' ' ARG . 7.5 t-105 -80.58 -41.89 23.25 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.313 -0.858 . . . . 0.0 111.229 -176.271 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.73 ' HB2' HG23 ' A' ' 18' ' ' ILE . 1.4 pt-20 -62.44 -39.11 92.27 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-O 120.711 0.291 . . . . 0.0 110.754 179.927 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 3.8 p30 -75.15 -28.55 60.18 Favored 'General case' 0 CA--C 1.518 -0.259 0 C-N-CA 119.784 -0.766 . . . . 0.0 109.65 177.188 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . 0.506 ' HG3' ' OD2' ' A' ' 85' ' ' ASP . 9.9 tpt -64.72 -51.97 59.57 Favored 'General case' 0 C--O 1.209 -1.068 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.362 176.822 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.781 HG11 HG13 ' A' ' 18' ' ' ILE . 3.2 p -61.24 -30.6 48.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 C-N-CA 120.744 -0.382 . . . . 0.0 110.746 178.869 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 71.8 m -64.41 -38.09 89.8 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.264 0.554 . . . . 0.0 110.08 173.471 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . 0.476 ' HZ2' ' HB2' ' A' ' 84' ' ' LYS . 3.1 ttmp? -77.55 -44.77 27.47 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.421 -0.809 . . . . 0.0 110.381 179.865 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . 0.724 ' HB3' ' HG ' ' A' ' 87' ' ' LEU . 1.2 m-20 -69.57 -16.37 63.4 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 114.68 -1.146 . . . . 0.0 111.007 179.949 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 18.8 mm-40 59.53 31.12 20.78 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-N 115.764 -0.653 . . . . 0.0 112.468 178.585 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.724 ' HG ' ' HB3' ' A' ' 85' ' ' ASP . 58.6 mt -85.01 39.84 0.78 Allowed 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.279 -177.739 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.437 ' O ' ' HE2' ' A' ' 53' ' ' LYS . 0.1 OUTLIER -65.56 150.53 48.25 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-O 121.407 0.623 . . . . 0.0 112.491 -178.801 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 166.4 -134.82 3.42 Favored Glycine 0 C--O 1.229 -0.172 0 N-CA-C 109.861 -1.296 . . . . 0.0 109.861 -172.587 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.56 ' HB ' ' O ' ' A' ' 66' ' ' PHE . 48.0 mm -111.22 114.09 46.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 170.073 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . 0.663 ' HB2' ' CZ2' ' A' ' 38' ' ' TRP . 0.4 OUTLIER -141.88 146.78 36.16 Favored 'General case' 0 C--N 1.314 -0.948 0 N-CA-C 113.232 0.827 . . . . 0.0 113.232 -168.643 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 1.031 HD11 ' HB ' ' A' ' 23' ' ' VAL . 2.5 mm? -134.13 153.86 51.57 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 114.853 -1.067 . . . . 0.0 110.581 179.161 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' HIS . . . . . 0.459 ' O ' ' HD2' ' A' ' 16' ' ' PRO . 25.5 t-80 -129.43 125.07 35.66 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.907 -179.724 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' MET . . . . . 0.529 ' SD ' ' HA ' ' A' ' 98' ' ' ARG . 24.5 ttm -76.26 -85.3 0.05 Allowed 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.38 -0.827 . . . . 0.0 110.313 179.393 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . 0.502 ' HA2' ' O ' ' A' ' 72' ' ' ASP . . . 117.78 -74.03 0.29 Allowed Glycine 0 N--CA 1.443 -0.869 0 C-N-CA 120.1 -1.048 . . . . 0.0 113.417 177.865 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 14.8 m -135.67 -8.12 2.16 Favored 'General case' 0 C--N 1.316 -0.861 0 C-N-CA 120.557 -0.457 . . . . 0.0 111.618 -174.956 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . 0.481 ' CG ' ' HG3' ' A' ' 94' ' ' MET . 8.2 p-10 -89.97 48.21 1.55 Allowed 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.883 0.849 . . . . 0.0 110.083 -176.091 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . 0.542 ' O ' ' HB3' ' A' ' 101' ' ' MET . 0.0 OUTLIER -75.91 20.52 0.18 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.133 -0.94 . . . . 0.0 112.614 -172.342 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 9.9 m -70.18 -30.17 67.23 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 171.24 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . 0.508 ' HE1' ' HB3' ' A' ' 9' ' ' SER . 1.3 t80 -73.59 -25.73 60.48 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.23 -0.895 . . . . 0.0 109.53 177.898 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' MET . . . . . 0.542 ' HB3' ' O ' ' A' ' 98' ' ' ARG . 13.4 tpt -58.81 -52.34 66.15 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 114.769 -1.105 . . . . 0.0 109.745 175.578 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 67.9 m-20 -73.38 -26.7 61.1 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.579 -0.737 . . . . 0.0 111.318 179.486 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -60.72 -26.82 67.45 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-O 121.025 0.44 . . . . 0.0 111.062 -179.224 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' TYR . . . . . 0.52 ' HB2' HG13 ' A' ' 106' ' ' ILE . 49.4 m-85 -108.52 -3.32 18.19 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.478 178.365 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 7.7 mp 60.36 32.19 20.59 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.147 0.499 . . . . 0.0 110.316 -174.547 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . 0.583 HG23 ' HB2' ' A' ' 111' ' ' ARG . 79.0 mt -64.2 131.14 29.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.737 176.505 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 16.3 t-20 -157.59 161.02 38.69 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 178.421 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 81.35 -60.88 4.67 Favored Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 121.242 -0.504 . . . . 0.0 112.991 178.092 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.471 HD13 ' HB2' ' A' ' 39' ' ' ALA . 44.3 mt 72.08 131.04 0.04 OUTLIER Pre-proline 0 CA--C 1.535 0.371 0 C-N-CA 122.971 0.508 . . . . 0.0 110.399 -176.22 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . 0.414 ' HB3' ' O ' ' A' ' 37' ' ' VAL . 2.2 Cg_endo -84.15 145.89 48.9 Favored 'Cis proline' 0 N--CA 1.461 -0.384 0 C-N-CA 124.153 -1.186 . . . . 0.0 112.963 0.3 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . 0.629 ' HD2' ' N ' ' A' ' 112' ' ' PHE . 0.0 OUTLIER -97.34 141.67 30.14 Favored 'General case' 0 N--CA 1.446 -0.626 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 173.093 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . 0.629 ' N ' ' HD2' ' A' ' 111' ' ' ARG . 0.7 OUTLIER -104.04 117.86 35.3 Favored 'General case' 0 C--N 1.324 -0.537 0 O-C-N 124.024 0.827 . . . . 0.0 111.714 -177.792 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.625 ' HB ' ' HB ' ' A' ' 35' ' ' ILE . 77.4 mt -129.22 149.41 33.65 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.428 0 C-N-CA 122.359 0.263 . . . . 0.0 110.38 177.106 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 21.4 tp -137.12 139.84 41.5 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.583 0.23 . . . . 0.0 110.621 178.041 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.515 ' HG ' ' HA ' ' A' ' 121' ' ' ILE . 1.0 OUTLIER -135.8 156.64 48.49 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.897 0.379 . . . . 0.0 110.207 -179.105 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . 0.58 ' HB3' ' HB2' ' A' ' 120' ' ' LYS . 23.0 t70 -73.04 160.74 31.58 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.571 -0.74 . . . . 0.0 110.786 176.91 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . 0.401 HH11 ' HD3' ' A' ' 117' ' ' ARG . 75.0 mtt-85 -44.81 -39.94 5.72 Favored 'General case' 0 N--CA 1.466 0.345 0 O-C-N 124.536 1.147 . . . . 0.0 112.18 179.838 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . 0.509 ' HB3' ' HG2' ' A' ' 120' ' ' LYS . 25.1 t70 -63.43 -23.55 67.45 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.335 0.588 . . . . 0.0 111.151 -178.03 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . 0.587 ' HA3' HD11 ' A' ' 25' ' ' LEU . . . 105.54 19.84 10.09 Favored Glycine 0 N--CA 1.432 -1.571 0 N-CA-C 110.001 -1.24 . . . . 0.0 110.001 -169.376 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . 0.58 ' HB2' ' HB3' ' A' ' 116' ' ' ASP . 32.8 mmtm -91.85 107.97 19.59 Favored 'General case' 0 C--O 1.221 -0.447 0 C-N-CA 120.71 -0.396 . . . . 0.0 111.207 -175.128 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 0.655 ' H ' HD12 ' A' ' 121' ' ' ILE . 3.5 mp -47.18 113.02 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 O-C-N 123.55 0.531 . . . . 0.0 110.651 177.553 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' ILE . . . . . 0.404 ' H ' ' HA ' ' A' ' 115' ' ' LEU . 38.5 mm -94.34 -53.79 7.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 115.678 -0.692 . . . . 0.0 109.773 179.98 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 6.1 m -127.04 114.46 17.81 Favored 'General case' 0 N--CA 1.446 -0.653 0 CA-C-N 115.504 -0.771 . . . . 0.0 109.911 179.832 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . 0.533 ' O ' HG12 ' A' ' 113' ' ' ILE . . . -65.0 -32.13 73.71 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 109.446 -0.576 . . . . 0.0 109.446 174.89 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 12.4 p-10 -127.33 106.92 9.54 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.08 -0.964 . . . . 0.0 109.019 173.586 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' MET . . . . . 0.451 ' N ' ' HD1' ' A' ' 112' ' ' PHE . 14.1 tpt -99.55 -101.3 0.23 Allowed 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.077 -175.469 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . 0.686 ' HB ' ' HB ' ' A' ' 134' ' ' THR . 0.2 OUTLIER -155.17 122.73 5.65 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.916 0.389 . . . . 0.0 110.885 -179.236 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . 0.462 ' HD3' ' OE2' ' A' ' 48' ' ' GLU . 30.1 ttm-85 -49.29 140.84 12.4 Favored Pre-proline 0 C--N 1.326 -0.454 0 CA-C-N 115.153 -0.931 . . . . 0.0 111.421 176.632 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -54.74 -38.77 91.58 Favored 'Trans proline' 0 C--N 1.35 0.615 0 C-N-CA 122.797 2.331 . . . . 0.0 113.14 178.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . 0.417 ' HB2' ' CB ' ' A' ' 48' ' ' GLU . 36.4 t -72.51 -2.22 18.88 Favored 'General case' 0 CA--C 1.535 0.395 0 N-CA-C 111.657 0.243 . . . . 0.0 111.657 177.981 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . 0.487 ' O ' HG22 ' A' ' 134' ' ' THR . 9.5 t70 -94.45 115.16 64.95 Favored Pre-proline 0 C--N 1.326 -0.417 0 N-CA-C 109.716 -0.476 . . . . 0.0 109.716 179.204 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . 0.403 ' HD3' ' HA ' ' A' ' 131' ' ' ASP . 51.3 Cg_exo -56.71 -25.46 60.38 Favored 'Trans proline' 0 N--CA 1.473 0.268 0 C-N-CA 123.041 2.494 . . . . 0.0 113.602 -176.425 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . 0.575 ' HZ2' ' HB2' ' A' ' 133' ' ' LYS . 9.7 mtmp? -70.02 -20.36 63.27 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 121.328 -0.149 . . . . 0.0 111.017 -177.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' THR . . . . . 0.686 ' HB ' ' HB ' ' A' ' 127' ' ' THR . 1.6 t -72.67 -40.7 66.11 Favored 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 177.348 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . 0.625 ' HA ' ' CD2' ' A' ' 138' ' ' PHE . . . -62.85 -41.53 99.4 Favored 'General case' 0 N--CA 1.453 -0.324 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.14 176.885 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -55.74 -42.34 75.24 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.417 -0.81 . . . . 0.0 110.649 175.014 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . 0.866 ' HE2' ' HA ' ' A' ' 137' ' ' LYS . 10.0 mmpt? -63.35 -42.8 98.93 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.144 179.559 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . 0.625 ' CD2' ' HA ' ' A' ' 135' ' ' ALA . 11.2 m-85 -57.88 -54.27 48.8 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-O 120.838 0.352 . . . . 0.0 110.366 -179.866 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 49.8 m-20 -56.34 -46.16 80.05 Favored 'General case' 0 C--O 1.223 -0.301 0 CA-C-N 115.918 -0.583 . . . . 0.0 109.966 179.743 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . 0.472 ' HB2' ' NE2' ' A' ' 149' ' ' HIS . 28.7 tt0 -57.65 -55.22 37.62 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.544 -0.753 . . . . 0.0 111.987 -177.897 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 4.6 pp -68.54 -20.12 64.54 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-O 120.722 0.296 . . . . 0.0 111.673 -174.913 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.41 HD11 ' HB2' ' A' ' 62' ' ' LYS . 95.7 mt -89.37 -11.87 42.02 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.789 0.328 . . . . 0.0 110.489 175.424 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 71.79 30.11 66.47 Favored Glycine 0 N--CA 1.449 -0.495 0 N-CA-C 110.72 -0.952 . . . . 0.0 110.72 -176.046 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.466 ' O ' ' HG ' ' A' ' 144' ' ' LEU . 58.1 tp -88.81 16.76 6.35 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 114.559 -0.821 . . . . 0.0 110.617 -174.741 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . 0.699 ' HB3' ' HA ' ' A' ' 148' ' ' HIS . 47.4 mt-10 -79.99 131.31 35.78 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.322 -178.786 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -76.49 73.7 1.81 Allowed Glycine 0 N--CA 1.454 -0.125 0 N-CA-C 110.661 -0.976 . . . . 0.0 110.661 174.035 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 7.1 t-160 77.2 -40.38 0.35 Allowed 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 124.197 0.999 . . . . 0.0 108.637 -167.21 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' HIS . . . . . 0.699 ' HA ' ' HB3' ' A' ' 145' ' ' GLU . 0.1 OUTLIER -171.84 166.41 6.43 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.399 -0.819 . . . . 0.0 109.188 167.934 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . 0.472 ' NE2' ' HB2' ' A' ' 140' ' ' GLU . 37.2 m80 -34.23 -63.54 0.28 Allowed 'General case' 0 N--CA 1.477 0.878 0 O-C-N 124.275 0.984 . . . . 0.0 112.5 -176.896 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 68.9 m-70 -102.49 112.43 25.15 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 177.02 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 59.4 t-80 -45.34 103.59 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.269 0 O-C-N 124.453 1.096 . . . . 0.0 113.214 -167.052 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 53.3 t60 . . . . . 0 C--O 1.245 0.862 0 CA-C-N 115.087 -0.96 . . . . 0.0 108.693 172.864 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.571 ' HG3' ' HG ' ' A' ' 3' ' ' LEU . 11.2 tpt . . . . . 0 N--CA 1.483 1.221 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 25.9 t -59.85 -34.06 72.62 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-O 120.998 0.428 . . . . 0.0 110.336 177.03 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.571 ' HG ' ' HG3' ' A' ' 1' ' ' MET . 2.8 pp -87.06 26.82 1.1 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.358 0.599 . . . . 0.0 110.448 176.188 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 17.7 tpp180 68.0 -87.82 0.03 OUTLIER 'General case' 0 C--O 1.233 0.19 0 CA-C-N 115.12 -0.945 . . . . 0.0 111.318 -176.866 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 69.9 p 40.75 -93.16 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.576 0 O-C-N 124.271 0.982 . . . . 0.0 111.731 -170.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -162.61 -78.6 0.03 OUTLIER Glycine 0 N--CA 1.442 -0.934 0 N-CA-C 111.159 -0.776 . . . . 0.0 111.159 176.554 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 27.9 p-10 -73.85 153.86 89.08 Favored Pre-proline 0 C--N 1.323 -0.578 0 CA-C-O 120.892 0.377 . . . . 0.0 110.686 -179.802 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 7.2 Cg_endo -86.53 107.37 0.79 Allowed 'Trans proline' 0 N--CA 1.453 -0.895 0 C-N-CA 122.901 2.401 . . . . 0.0 111.346 172.434 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.471 ' HA ' ' HE1' ' A' ' 100' ' ' PHE . 16.6 m -96.25 111.36 23.45 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.272 -178.8 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.474 ' HB1' HD11 ' A' ' 121' ' ' ILE . . . 73.94 -40.22 0.45 Allowed 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 123.595 0.758 . . . . 0.0 111.654 179.402 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -82.91 75.69 9.79 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.764 -179.214 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.514 ' HA ' ' HB3' ' A' ' 25' ' ' LEU . 15.9 m 68.74 79.0 0.21 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.004 -0.998 . . . . 0.0 111.482 176.433 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 23.6 p90 -101.3 -179.53 4.06 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.744 179.134 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.43 ' HA ' ' HA ' ' A' ' 24' ' ' SER . 21.0 t -142.37 132.09 24.1 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 109.338 -0.616 . . . . 0.0 109.338 177.537 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . 0.533 ' HB3' ' HB3' ' A' ' 92' ' ' LEU . 12.9 m-85 -138.42 154.67 73.77 Favored Pre-proline 0 C--N 1.326 -0.456 0 CA-C-O 120.608 0.242 . . . . 0.0 111.433 -176.873 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' A' ' 15' ' ' TYR . 1.1 Cg_endo -85.09 127.89 3.55 Favored 'Trans proline' 0 N--CA 1.457 -0.652 0 C-N-CA 123.196 2.597 . . . . 0.0 113.165 179.444 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . 0.693 ' HB3' ' HB3' ' A' ' 21' ' ' LYS . 0.5 OUTLIER -72.53 161.63 30.54 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.167 -0.924 . . . . 0.0 109.746 170.815 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.532 HD12 ' CG1' ' A' ' 82' ' ' VAL . 1.4 tt -46.59 -40.37 4.45 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 O-C-N 124.032 0.832 . . . . 0.0 112.083 -175.95 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.484 ' ND2' HG23 ' A' ' 18' ' ' ILE . 27.9 m-80 -79.53 9.93 4.41 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.228 -175.439 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 77.19 25.81 63.13 Favored Glycine 0 N--CA 1.445 -0.706 0 N-CA-C 110.758 -0.937 . . . . 0.0 110.758 -174.753 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.693 ' HB3' ' HB3' ' A' ' 17' ' ' ASP . 8.0 ttpm? -94.86 106.94 18.96 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.427 -0.386 . . . . 0.0 110.328 -174.694 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 24.7 m -69.29 111.54 5.27 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.154 -178.225 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.645 ' HB ' HD11 ' A' ' 92' ' ' LEU . 47.7 t -115.82 133.86 60.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 116.139 -0.482 . . . . 0.0 109.862 178.352 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . 0.43 ' HA ' ' HA ' ' A' ' 14' ' ' SER . 97.7 p -101.74 160.49 14.42 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.35 -178.434 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.586 HD12 ' HG ' ' A' ' 28' ' ' LEU . 20.8 tp -75.17 0.52 16.07 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.164 0.507 . . . . 0.0 109.961 175.45 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -75.68 -25.97 57.21 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.827 -179.734 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -74.87 -21.51 59.2 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-O 122.68 1.229 . . . . 0.0 108.87 177.137 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.586 ' HG ' HD12 ' A' ' 25' ' ' LEU . 3.9 mm? -82.7 -7.4 59.65 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 113.581 -1.645 . . . . 0.0 111.542 -170.941 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.762 ' HA ' ' O ' ' A' ' 117' ' ' ARG . 2.6 mptp? -73.65 175.92 6.7 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.239 0.542 . . . . 0.0 111.272 179.423 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 84.19 -44.51 3.34 Favored Glycine 0 N--CA 1.449 -0.49 0 CA-C-N 115.775 -0.648 . . . . 0.0 112.437 177.814 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.722 ' HD3' ' HA ' ' A' ' 63' ' ' ASP . 66.1 mttm -121.33 164.93 16.25 Favored 'General case' 0 C--N 1.323 -0.577 0 C-N-CA 122.226 0.211 . . . . 0.0 110.582 -177.848 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 44.1 m-85 -67.21 151.75 46.97 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.779 0.323 . . . . 0.0 111.24 -177.609 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.769 HD12 ' HA2' ' A' ' 119' ' ' GLY . 53.4 mt -121.5 132.63 70.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-O 120.832 0.349 . . . . 0.0 111.202 -174.623 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 86.0 t80 -121.37 125.35 46.74 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 109.071 -0.715 . . . . 0.0 109.071 172.74 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.557 HG12 ' HB ' ' A' ' 67' ' ' VAL . 64.2 mt -114.44 134.47 57.28 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-O 120.955 0.407 . . . . 0.0 110.718 -177.877 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.536 ' HA ' ' O ' ' A' ' 111' ' ' ARG . 24.3 t0 -126.68 158.55 36.12 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.372 -0.831 . . . . 0.0 109.0 177.121 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.575 ' HA ' ' O ' ' A' ' 69' ' ' LEU . 59.2 t -105.74 111.47 35.09 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.904 0 C-N-CA 120.228 -0.589 . . . . 0.0 110.816 173.164 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' TRP . . . . . 0.662 ' CZ2' ' HB2' ' A' ' 91' ' ' GLN . 0.6 OUTLIER -95.22 133.27 39.28 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.275 178.716 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.555 ' HB3' ' HB3' ' A' ' 42' ' ' CYS . . . -146.85 163.02 37.42 Favored 'General case' 0 N--CA 1.464 0.266 0 N-CA-C 111.7 0.259 . . . . 0.0 111.7 -175.722 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.715 ' HB ' ' CE3' ' A' ' 78' ' ' TRP . 8.2 t -98.34 -35.72 10.22 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-O 120.885 0.374 . . . . 0.0 110.762 176.693 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . 0.419 ' HE1' ' HA ' ' A' ' 72' ' ' ASP . 22.6 p-90 -86.39 16.27 4.66 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.164 0.507 . . . . 0.0 110.547 -178.994 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . 0.786 ' SG ' ' HB3' ' A' ' 45' ' ' CYS . 14.8 p -75.37 -56.55 4.6 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.611 -0.722 . . . . 0.0 111.791 -175.775 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 98.15 -99.37 2.19 Favored Glycine 0 CA--C 1.521 0.424 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.101 -176.161 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -55.32 -28.35 62.23 Favored 'Trans proline' 0 C--N 1.352 0.714 0 C-N-CA 123.331 2.688 . . . . 0.0 113.274 -179.635 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . 0.832 ' HB2' ' HD3' ' A' ' 110' ' ' PRO . 18.2 t -57.57 -22.85 47.34 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-O 120.979 0.419 . . . . 0.0 111.428 179.425 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.55 ' HA ' ' CD1' ' A' ' 49' ' ' LEU . 33.0 mtp-105 -70.9 -15.67 62.63 Favored 'General case' 0 C--N 1.324 -0.5 0 C-N-CA 120.577 -0.449 . . . . 0.0 111.301 -178.748 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -84.23 -12.97 75.1 Favored Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 120.678 -0.772 . . . . 0.0 111.67 176.08 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.68 ' HB3' ' HB2' ' A' ' 129' ' ' PRO . 0.5 OUTLIER -91.51 -26.34 18.83 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.135 0.493 . . . . 0.0 109.884 -179.342 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.809 HD23 HD12 ' A' ' 52' ' ' LEU . 54.9 mt -51.53 -45.27 90.77 Favored Pre-proline 0 CA--C 1.536 0.406 0 CA-C-N 115.315 -0.857 . . . . 0.0 113.147 -176.664 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.536 ' HD2' ' N ' ' A' ' 49' ' ' LEU . 10.3 Cg_endo -54.2 -36.42 85.79 Favored 'Trans proline' 0 C--N 1.354 0.818 0 C-N-CA 121.683 1.589 . . . . 0.0 112.048 174.426 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.53 ' HA ' ' HB2' ' A' ' 54' ' ' GLU . . . -82.21 -22.44 35.93 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.329 0.585 . . . . 0.0 110.106 -178.443 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.809 HD12 HD23 ' A' ' 49' ' ' LEU . 27.3 mt -64.74 -37.26 86.99 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.423 -0.808 . . . . 0.0 110.156 175.423 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.453 ' HE3' ' HB3' ' A' ' 53' ' ' LYS . 10.2 mtpp -75.2 -40.21 59.44 Favored 'General case' 0 CA--C 1.517 -0.322 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.951 173.567 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.53 ' HB2' ' HA ' ' A' ' 51' ' ' ALA . 6.4 mm-40 -47.16 -50.38 20.65 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.538 -0.755 . . . . 0.0 110.678 173.213 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 73.6 mt -59.01 -55.35 36.3 Favored 'General case' 0 N--CA 1.446 -0.631 0 CA-C-N 115.592 -0.731 . . . . 0.0 111.072 176.261 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.62 ' OE2' ' HB3' ' A' ' 88' ' ' LYS . 37.7 tt0 -45.01 -60.64 1.98 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.477 -0.783 . . . . 0.0 112.558 179.776 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 61.5 mt-10 -74.42 -31.99 62.5 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 111.96 0.356 . . . . 0.0 111.96 -169.86 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 49.5 mttp -78.38 -40.67 35.54 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.131 0.491 . . . . 0.0 111.081 -178.169 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.586 ' HB2' ' HE2' ' A' ' 66' ' ' PHE . 73.2 m-85 -102.78 8.43 39.38 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.497 -173.915 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.453 ' HB2' ' O ' ' A' ' 56' ' ' GLU . . . -59.53 131.41 50.85 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.657 172.156 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 77.13 11.01 85.95 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.962 -0.637 . . . . 0.0 113.027 176.147 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.416 ' HA ' ' HD3' ' A' ' 62' ' ' LYS . 33.5 mmtm -89.13 -136.11 0.11 Allowed 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.966 -0.383 . . . . 0.0 109.966 177.624 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.722 ' HA ' ' HD3' ' A' ' 31' ' ' LYS . 4.6 t0 -120.02 42.14 3.01 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 121.542 0.687 . . . . 0.0 109.778 179.008 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.438 HG21 ' HB3' ' A' ' 59' ' ' TYR . 7.3 tp -148.81 151.21 13.35 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 115.083 -0.962 . . . . 0.0 109.868 -171.624 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' HIS . . . . . 0.581 ' NE2' ' HB2' ' A' ' 31' ' ' LYS . 80.9 m-70 -126.99 137.8 53.16 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 175.128 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . 0.586 ' HE2' ' HB2' ' A' ' 59' ' ' TYR . 91.0 m-85 -110.43 109.98 20.57 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 120.624 0.249 . . . . 0.0 110.415 178.714 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.557 ' HB ' HG12 ' A' ' 35' ' ' ILE . 49.8 t -109.1 109.26 27.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.156 -177.115 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 50.2 m -91.68 114.0 26.41 Favored 'General case' 0 C--N 1.316 -0.884 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 174.144 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.575 ' O ' ' HA ' ' A' ' 37' ' ' VAL . 66.7 tp -109.83 130.02 55.57 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.555 -0.293 . . . . 0.0 110.266 178.649 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . 0.565 ' O ' ' HB3' ' A' ' 94' ' ' MET . 1.8 t -109.02 119.23 38.94 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 111.93 0.344 . . . . 0.0 111.93 -173.758 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' CYS . . . . . 0.559 ' HB3' ' SD ' ' A' ' 101' ' ' MET . 33.6 m -88.14 19.29 3.76 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.519 177.368 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.562 ' OD2' HG22 ' A' ' 40' ' ' THR . 2.2 m-20 -73.33 113.99 11.04 Favored 'General case' 0 CA--C 1.515 -0.403 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.705 -178.54 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.538 ' HA ' ' O ' ' A' ' 95' ' ' GLY . 47.3 tttm -71.63 -17.53 62.26 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-O 121.155 0.502 . . . . 0.0 110.312 177.812 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 4.6 m-20 -83.83 91.31 7.52 Favored 'General case' 0 CA--C 1.515 -0.392 0 N-CA-C 109.025 -0.731 . . . . 0.0 109.025 175.945 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.614 ' O ' ' HG2' ' A' ' 79' ' ' GLU . 13.0 tmtt? -64.98 -65.09 0.72 Allowed 'General case' 0 C--N 1.322 -0.629 0 C-N-CA 120.066 -0.654 . . . . 0.0 110.984 -176.69 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 11.1 tmtt? -52.24 -45.66 65.41 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.2 -0.909 . . . . 0.0 111.195 -176.357 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.695 ' HA ' ' ND2' ' A' ' 80' ' ' ASN . . . -61.77 -38.69 88.96 Favored 'General case' 0 C--O 1.246 0.881 0 CA-C-O 121.572 0.701 . . . . 0.0 110.644 -177.281 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' TRP . . . . . 0.715 ' CE3' ' HB ' ' A' ' 40' ' ' THR . 4.7 t-105 -70.14 -47.55 61.24 Favored 'General case' 0 N--CA 1.438 -1.042 0 CA-C-N 115.099 -0.955 . . . . 0.0 110.634 -176.798 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.614 ' HG2' ' O ' ' A' ' 75' ' ' LYS . 4.0 mm-40 -47.25 -44.78 23.13 Favored 'General case' 0 C--O 1.236 0.355 0 O-C-N 123.418 0.449 . . . . 0.0 111.774 175.347 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . 0.695 ' ND2' ' HA ' ' A' ' 77' ' ' ALA . 1.8 m-80 -59.83 -50.84 72.21 Favored 'General case' 0 CA--C 1.518 -0.288 0 C-N-CA 120.196 -0.601 . . . . 0.0 110.468 179.501 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 23.1 ttm -64.27 -42.32 96.49 Favored 'General case' 0 C--N 1.332 -0.156 0 N-CA-C 112.578 0.585 . . . . 0.0 112.578 -173.016 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.532 ' CG1' HD12 ' A' ' 18' ' ' ILE . 1.3 p -62.45 -37.43 78.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 C-N-CA 120.061 -0.656 . . . . 0.0 110.714 177.884 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 32.8 m -70.74 -35.75 72.82 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.221 0.534 . . . . 0.0 110.532 178.427 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 22.0 tttm -73.4 -52.29 14.31 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.721 -0.672 . . . . 0.0 111.571 -178.554 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -85.81 6.74 26.71 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.444 -0.798 . . . . 0.0 111.899 -173.404 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 89.8 mt-30 57.84 38.34 27.16 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 122.927 0.491 . . . . 0.0 111.605 175.237 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.646 HD22 HD22 ' A' ' 49' ' ' LEU . 44.4 mt -73.72 111.48 8.91 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.515 -177.08 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.62 ' HB3' ' OE2' ' A' ' 56' ' ' GLU . 3.9 mmmp? -105.51 -157.1 0.6 Allowed 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 112.537 0.569 . . . . 0.0 112.537 -177.346 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 97.04 176.76 34.89 Favored Glycine 0 N--CA 1.447 -0.591 0 N-CA-C 110.507 -1.037 . . . . 0.0 110.507 -169.254 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.405 ' HB ' ' O ' ' A' ' 66' ' ' PHE . 63.0 mt -83.22 110.94 18.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 N-CA-C 107.065 -1.457 . . . . 0.0 107.065 169.873 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . 0.662 ' HB2' ' CZ2' ' A' ' 38' ' ' TRP . 1.3 pt20 -122.78 123.21 40.52 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-O 121.666 0.746 . . . . 0.0 112.837 -164.114 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.645 HD11 ' HB ' ' A' ' 23' ' ' VAL . 2.5 mm? -121.23 149.93 42.12 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 114.937 -1.029 . . . . 0.0 109.318 178.272 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' HIS . . . . . 0.404 ' CE1' ' HA ' ' A' ' 75' ' ' LYS . 16.1 t-80 -120.33 135.23 55.08 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-O 121.642 0.734 . . . . 0.0 111.589 -176.113 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' MET . . . . . 0.784 ' HG3' ' HB2' ' A' ' 97' ' ' ASP . 25.7 ttm -103.21 91.96 4.31 Favored 'General case' 0 N--CA 1.442 -0.871 0 CA-C-N 114.391 -1.277 . . . . 0.0 108.16 178.933 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . 0.538 ' O ' ' HA ' ' A' ' 73' ' ' LYS . . . -57.76 -55.19 31.86 Favored Glycine 0 C--N 1.318 -0.426 0 CA-C-N 115.169 -0.923 . . . . 0.0 113.807 -175.256 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 10.9 m -146.94 13.0 1.12 Allowed 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 122.064 0.935 . . . . 0.0 109.49 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . 0.784 ' HB2' ' HG3' ' A' ' 94' ' ' MET . 0.7 OUTLIER -81.56 31.83 0.35 Allowed 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 114.838 -1.074 . . . . 0.0 110.462 -175.471 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . 0.549 ' HA ' ' SD ' ' A' ' 94' ' ' MET . 0.0 OUTLIER -67.52 0.03 3.42 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 113.362 0.875 . . . . 0.0 113.362 -170.619 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . 0.457 ' HA ' ' NH2' ' A' ' 98' ' ' ARG . 10.4 m -66.01 -19.23 65.79 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.66 0.743 . . . . 0.0 109.568 172.806 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . 0.471 ' HE1' ' HA ' ' A' ' 9' ' ' SER . 16.4 t80 -79.55 -24.14 42.34 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 115.317 -0.856 . . . . 0.0 110.135 177.773 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' MET . . . . . 0.559 ' SD ' ' HB3' ' A' ' 71' ' ' CYS . 88.6 mtp -60.17 -48.12 83.06 Favored 'General case' 0 CA--C 1.515 -0.395 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 174.357 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 67.5 m-20 -56.04 -40.89 74.17 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.224 -0.898 . . . . 0.0 111.088 176.577 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -63.25 -28.64 70.17 Favored 'General case' 0 N--CA 1.462 0.131 0 CA-C-N 116.198 -0.455 . . . . 0.0 112.075 -176.058 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' TYR . . . . . 0.94 ' HB3' HG23 ' A' ' 106' ' ' ILE . 2.8 m-85 -107.49 -6.36 17.08 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 111.937 0.347 . . . . 0.0 111.937 -178.602 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 3.4 mm? 57.94 33.06 22.77 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-O 121.425 0.631 . . . . 0.0 110.269 -174.049 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . 0.94 HG23 ' HB3' ' A' ' 104' ' ' TYR . 32.9 pt -88.93 36.18 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.248 -177.854 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 5.0 p-10 -67.28 -28.34 67.94 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.962 0.41 . . . . 0.0 110.376 179.266 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -92.06 103.5 3.06 Favored Glycine 0 N--CA 1.444 -0.769 0 N-CA-C 111.106 -0.798 . . . . 0.0 111.106 175.608 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.525 HG21 HG11 ' A' ' 37' ' ' VAL . 34.3 pt -110.79 153.46 43.69 Favored Pre-proline 0 C--N 1.324 -0.501 0 O-C-N 123.315 0.068 . . . . 0.0 110.943 -178.131 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . 0.832 ' HD3' ' HB2' ' A' ' 45' ' ' CYS . 42.2 Cg_endo -68.98 150.5 88.26 Favored 'Cis proline' 0 C--N 1.35 0.654 0 C-N-CA 123.547 -1.439 . . . . 0.0 112.428 0.982 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . 0.599 ' HG3' HG22 ' A' ' 106' ' ' ILE . 0.0 OUTLIER -114.52 127.9 56.05 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.209 -177.215 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . 0.556 ' HB2' ' HB3' ' A' ' 126' ' ' MET . 0.2 OUTLIER -102.47 114.35 28.48 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 114.701 -1.136 . . . . 0.0 110.608 -177.504 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 86.8 mt -130.75 143.51 40.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 120.85 0.357 . . . . 0.0 111.119 -178.244 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 48.2 tp -124.05 134.63 53.37 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.032 178.762 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.454 ' N ' HD12 ' A' ' 115' ' ' LEU . 1.6 mp -134.36 160.47 37.84 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.225 0.536 . . . . 0.0 110.615 -177.341 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . 0.51 ' HB2' HD11 ' A' ' 122' ' ' ILE . 28.5 t70 -77.17 167.96 20.87 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.193 -0.912 . . . . 0.0 110.351 177.288 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . 0.762 ' O ' ' HA ' ' A' ' 29' ' ' LYS . 81.9 mtt-85 -47.97 -37.66 15.06 Favored 'General case' 0 C--N 1.327 -0.382 0 O-C-N 124.402 1.064 . . . . 0.0 112.446 -177.524 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . 0.577 ' HA ' ' HG3' ' A' ' 29' ' ' LYS . 25.4 t0 -76.84 -0.1 22.77 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.532 0.682 . . . . 0.0 111.244 -178.922 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . 0.769 ' HA2' HD12 ' A' ' 33' ' ' ILE . . . 82.86 24.53 52.64 Favored Glycine 0 N--CA 1.431 -1.678 0 N-CA-C 110.058 -1.217 . . . . 0.0 110.058 -171.523 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . 0.485 ' HB2' ' HB3' ' A' ' 116' ' ' ASP . 44.9 mmtm -92.73 106.22 18.23 Favored 'General case' 0 C--O 1.222 -0.371 0 C-N-CA 120.601 -0.439 . . . . 0.0 111.466 -178.047 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 0.702 ' H ' HD12 ' A' ' 121' ' ' ILE . 4.4 mp -41.51 117.58 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.397 0 CA-C-N 115.416 -0.811 . . . . 0.0 112.273 -177.95 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' ILE . . . . . 0.51 HD11 ' HB2' ' A' ' 116' ' ' ASP . 45.6 mm -98.95 -43.62 11.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 115.392 -0.822 . . . . 0.0 109.313 176.288 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 16.2 m -135.6 114.32 11.9 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.305 -0.861 . . . . 0.0 109.917 178.428 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -77.49 -12.38 59.95 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.24 0.543 . . . . 0.0 110.555 179.681 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 6.5 t30 -143.65 98.58 3.27 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.186 -0.915 . . . . 0.0 108.573 175.686 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' MET . . . . . 0.556 ' HB3' ' HB2' ' A' ' 112' ' ' PHE . 17.6 tpt -77.79 -86.6 0.06 Allowed 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.649 -174.546 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 8.4 m -155.87 -73.01 0.11 Allowed 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.945 0.402 . . . . 0.0 110.055 -178.889 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . 0.775 ' HB3' ' HB2' ' A' ' 131' ' ' ASP . 44.9 ttt180 -178.35 143.17 0.45 Allowed Pre-proline 0 N--CA 1.44 -0.955 0 CA-C-N 115.508 -0.769 . . . . 0.0 109.159 -179.226 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . 0.68 ' HB2' ' HB3' ' A' ' 48' ' ' GLU . 57.3 Cg_exo -52.72 -45.45 40.35 Favored 'Trans proline' 0 C--N 1.346 0.431 0 C-N-CA 122.577 2.185 . . . . 0.0 112.856 178.405 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . 0.534 ' HB3' ' HA ' ' A' ' 48' ' ' GLU . 31.2 p -96.22 5.7 50.43 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 112.279 0.474 . . . . 0.0 112.279 -176.717 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . 0.796 ' OD1' ' HG2' ' A' ' 133' ' ' LYS . 11.3 t70 -89.3 128.43 51.36 Favored Pre-proline 0 C--O 1.235 0.312 0 C-N-CA 120.101 -0.64 . . . . 0.0 110.469 -178.658 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . 0.621 ' O ' ' HG3' ' A' ' 136' ' ' GLU . 82.6 Cg_exo -46.92 -41.23 25.71 Favored 'Trans proline' 0 C--N 1.344 0.325 0 C-N-CA 124.048 3.165 . . . . 0.0 114.944 -178.042 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . 0.796 ' HG2' ' OD1' ' A' ' 131' ' ' ASP . 27.7 mmtm -53.61 -37.71 63.29 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-O 121.209 0.528 . . . . 0.0 110.194 -172.097 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' THR . . . . . 0.722 HG22 ' CZ ' ' A' ' 138' ' ' PHE . 4.9 m -59.31 -59.62 5.16 Favored 'General case' 0 N--CA 1.446 -0.642 0 CA-C-N 115.23 -0.895 . . . . 0.0 110.657 178.0 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . 0.546 ' HA ' ' CD2' ' A' ' 138' ' ' PHE . . . -61.54 -41.21 97.0 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.862 -179.626 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . 0.891 ' HB3' ' HA3' ' A' ' 146' ' ' GLY . 19.9 mt-10 -66.92 -28.77 68.57 Favored 'General case' 0 CA--C 1.514 -0.423 0 CA-C-O 121.409 0.623 . . . . 0.0 110.511 -177.154 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . 0.548 ' O ' ' HG ' ' A' ' 141' ' ' LEU . 60.8 tttp -75.06 -31.23 61.2 Favored 'General case' 0 C--N 1.317 -0.848 0 CA-C-N 115.298 -0.865 . . . . 0.0 111.024 177.119 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . 0.722 ' CZ ' HG22 ' A' ' 134' ' ' THR . 12.2 m-30 -62.08 -41.06 97.79 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 173.69 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . 0.42 ' HB2' ' O ' ' A' ' 136' ' ' GLU . 5.7 m-20 -57.48 -53.15 61.37 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.02 -0.991 . . . . 0.0 110.157 172.901 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . 0.538 ' HB3' ' O ' ' A' ' 137' ' ' LYS . 8.0 tt0 -43.07 -51.55 5.75 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 123.14 0.576 . . . . 0.0 111.958 171.392 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.548 ' HG ' ' O ' ' A' ' 137' ' ' LYS . 94.2 mt -58.34 -37.92 76.14 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.9 -178.112 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 11.2 mp -84.95 -7.16 59.27 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.89 0.376 . . . . 0.0 111.163 -179.764 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 89.44 6.16 71.2 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 121.132 -0.556 . . . . 0.0 111.799 179.284 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 65.5 tp -86.71 -25.75 24.6 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.483 -0.359 . . . . 0.0 110.405 -179.458 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . 0.579 ' HB3' ' CE1' ' A' ' 147' ' ' HIS . 3.2 tt0 58.5 154.29 0.02 OUTLIER 'General case' 0 N--CA 1.452 -0.333 0 N-CA-C 114.524 1.305 . . . . 0.0 114.524 -177.8 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . 0.891 ' HA3' ' HB3' ' A' ' 136' ' ' GLU . . . -86.35 98.74 2.35 Favored Glycine 0 N--CA 1.444 -0.823 0 N-CA-C 110.252 -1.139 . . . . 0.0 110.252 169.682 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' HIS . . . . . 0.579 ' CE1' ' HB3' ' A' ' 145' ' ' GLU . 4.5 m-70 -82.22 28.31 0.45 Allowed 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 112.319 0.489 . . . . 0.0 112.319 -171.616 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' HIS . . . . . 0.58 ' HB2' ' OE1' ' A' ' 136' ' ' GLU . 0.0 OUTLIER -57.43 -30.32 64.88 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.288 0.566 . . . . 0.0 110.673 176.809 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 37.8 p-80 -126.76 21.53 6.98 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.343 -0.844 . . . . 0.0 109.687 -179.42 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 2.9 t-80 -126.23 103.99 7.98 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 -176.305 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 29.5 m170 -75.48 -0.47 20.28 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 111.848 0.314 . . . . 0.0 111.848 -174.554 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 25.3 t60 . . . . . 0 C--O 1.245 0.839 0 CA-C-O 118.149 -0.929 . . . . 0.0 109.136 173.795 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 85.8 mmm . . . . . 0 N--CA 1.481 1.109 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 14.6 m -66.73 117.41 8.83 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 123.281 0.363 . . . . 0.0 110.408 178.738 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 80.1 mt -149.86 102.33 3.12 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-N 116.328 -0.397 . . . . 0.0 110.651 179.107 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -166.25 28.71 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.31 0.576 . . . . 0.0 109.87 175.233 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . 0.62 ' HB2' ' O ' ' A' ' 7' ' ' ASN . 2.0 m -146.54 -179.11 6.54 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 -179.06 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -67.2 -20.18 70.93 Favored Glycine 0 C--N 1.331 0.271 0 N-CA-C 110.898 -0.881 . . . . 0.0 110.898 171.034 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . 0.62 ' O ' ' HB2' ' A' ' 5' ' ' SER . 41.7 m-80 -125.64 158.53 64.61 Favored Pre-proline 0 C--N 1.326 -0.432 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 173.332 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_exo -54.24 -35.88 84.46 Favored 'Trans proline' 0 CA--C 1.533 0.472 0 C-N-CA 122.5 2.134 . . . . 0.0 113.035 178.351 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 9.2 m -73.66 -172.79 1.32 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.083 0.468 . . . . 0.0 111.456 -178.389 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . 64.81 24.15 12.77 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-N 115.651 -0.704 . . . . 0.0 111.121 -179.104 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -155.24 101.45 2.22 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.98 177.83 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.477 ' HA ' HD23 ' A' ' 25' ' ' LEU . 36.9 m 65.01 103.85 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.474 0 CA-C-O 121.398 0.618 . . . . 0.0 112.128 178.128 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 36.5 p90 -125.81 171.03 11.02 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.426 178.487 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 30.7 m -140.91 129.21 22.34 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.899 -0.408 . . . . 0.0 109.899 178.227 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 45.8 m-85 -144.46 158.06 54.82 Favored Pre-proline 0 C--N 1.327 -0.372 0 CA-C-O 120.612 0.244 . . . . 0.0 110.841 -177.599 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_endo -87.09 128.5 2.71 Favored 'Trans proline' 0 N--CA 1.455 -0.751 0 C-N-CA 123.028 2.485 . . . . 0.0 113.023 178.882 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . 1.135 ' HB3' ' HB3' ' A' ' 21' ' ' LYS . 0.8 OUTLIER -66.32 162.77 19.5 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.409 -0.814 . . . . 0.0 109.735 170.687 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.842 HG13 HG11 ' A' ' 82' ' ' VAL . 24.5 mm -44.23 -45.43 2.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 O-C-N 124.27 0.981 . . . . 0.0 112.392 -177.367 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 33.2 m-80 -79.54 2.98 20.18 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.674 -172.941 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 87.5 35.79 9.17 Favored Glycine 0 N--CA 1.448 -0.557 0 N-CA-C 110.574 -1.011 . . . . 0.0 110.574 -174.526 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 1.135 ' HB3' ' HB3' ' A' ' 17' ' ' ASP . 35.5 ttmt -100.92 107.33 18.8 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.209 -0.495 . . . . 0.0 110.412 -174.835 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 25.2 m -74.34 105.73 5.64 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 120.924 0.392 . . . . 0.0 110.976 -177.137 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.629 ' HB ' HD11 ' A' ' 92' ' ' LEU . 45.8 t -117.99 138.07 49.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 116.064 -0.517 . . . . 0.0 109.668 179.192 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 80.3 p -113.6 156.5 23.55 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 116.316 -0.402 . . . . 0.0 109.93 179.263 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.519 ' O ' ' HB2' ' A' ' 29' ' ' LYS . 34.4 tp -70.42 -9.69 57.09 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.16 177.543 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -80.96 -26.98 36.2 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.494 177.288 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -74.15 -34.72 63.94 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.548 0.69 . . . . 0.0 110.107 175.795 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.496 HD11 HG21 ' A' ' 90' ' ' ILE . 66.6 mt -91.78 0.44 57.49 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.322 -0.854 . . . . 0.0 110.557 179.226 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.519 ' HB2' ' O ' ' A' ' 25' ' ' LEU . 60.2 tttp -74.54 150.63 39.69 Favored 'General case' 0 N--CA 1.443 -0.808 0 CA-C-N 115.134 -0.939 . . . . 0.0 110.633 -176.504 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 94.65 5.41 61.51 Favored Glycine 0 N--CA 1.447 -0.601 0 N-CA-C 110.576 -1.01 . . . . 0.0 110.576 -175.128 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 1.032 ' HD2' ' HA ' ' A' ' 63' ' ' ASP . 11.0 tppt? -146.0 151.44 37.78 Favored 'General case' 0 N--CA 1.446 -0.646 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 -177.982 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.41 ' HB2' HG22 ' A' ' 64' ' ' ILE . 61.3 m-85 -65.92 151.28 47.11 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 120.985 -0.286 . . . . 0.0 110.652 179.793 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.563 ' HB ' ' HB2' ' A' ' 115' ' ' LEU . 46.1 mm -127.08 125.86 67.13 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.975 -176.068 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . 0.445 ' CE2' ' HB2' ' A' ' 36' ' ' ASP . 59.0 t80 -105.43 112.01 24.95 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 170.554 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.57 ' HB ' ' HB ' ' A' ' 113' ' ' ILE . 40.3 mt -92.14 120.72 41.82 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-O 121.298 0.57 . . . . 0.0 110.461 179.77 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.561 ' O ' ' HA ' ' A' ' 68' ' ' SER . 15.9 t70 -120.24 125.03 47.11 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 115.133 -0.94 . . . . 0.0 109.231 178.919 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.661 HG11 HG21 ' A' ' 109' ' ' ILE . 21.5 t -82.5 113.92 22.53 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.913 0 C-N-CA 119.817 -0.753 . . . . 0.0 110.717 -178.981 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' TRP . . . . . 0.61 ' CZ2' ' HB2' ' A' ' 91' ' ' GLN . 0.5 OUTLIER -108.95 135.82 49.5 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.268 -0.878 . . . . 0.0 108.926 -177.967 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.624 ' HB3' ' HB3' ' A' ' 42' ' ' CYS . . . -145.04 172.36 13.17 Favored 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 120.433 -0.507 . . . . 0.0 111.96 -176.919 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -89.18 -43.17 11.21 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.661 0.743 . . . . 0.0 109.855 176.95 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . 0.551 ' CH2' HD11 ' A' ' 109' ' ' ILE . 11.1 p-90 -88.39 12.35 14.43 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 114.957 -1.02 . . . . 0.0 111.233 -176.056 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . 0.755 ' SG ' ' HB3' ' A' ' 45' ' ' CYS . 28.3 p -79.33 -17.86 53.68 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.154 -178.792 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 57.49 -107.06 0.88 Allowed Glycine 0 CA--C 1.522 0.508 0 CA-C-N 116.057 -0.519 . . . . 0.0 113.829 177.258 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_exo -51.6 -25.77 20.73 Favored 'Trans proline' 0 C--N 1.353 0.776 0 C-N-CA 123.746 2.964 . . . . 0.0 113.688 -177.348 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . 0.756 ' HB2' ' HD3' ' A' ' 110' ' ' PRO . 7.0 t -52.95 -30.68 36.11 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-O 120.844 0.354 . . . . 0.0 111.3 176.838 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.579 ' HA ' ' HG ' ' A' ' 49' ' ' LEU . 64.9 mtp180 -68.15 -11.42 59.14 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.835 -0.62 . . . . 0.0 111.677 -175.679 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -69.56 -33.23 71.75 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.919 -0.658 . . . . 0.0 112.595 179.802 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.551 ' OE2' ' HD3' ' A' ' 128' ' ' ARG . 28.0 mt-10 -93.6 -9.0 39.55 Favored 'General case' 0 C--N 1.328 -0.366 0 O-C-N 122.738 -0.272 . . . . 0.0 111.061 -177.561 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.617 ' HB3' HD22 ' A' ' 87' ' ' LEU . 81.4 mt -55.52 -46.69 99.68 Favored Pre-proline 0 C--N 1.326 -0.426 0 CA-C-N 116.558 -0.292 . . . . 0.0 111.455 179.331 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 1.004 ' HA ' ' HE3' ' A' ' 53' ' ' LYS . 51.5 Cg_exo -55.34 -43.95 53.56 Favored 'Trans proline' 0 C--N 1.356 0.956 0 C-N-CA 121.635 1.556 . . . . 0.0 111.895 170.781 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -69.02 -24.29 64.19 Favored 'General case' 0 N--CA 1.462 0.138 0 CA-C-O 121.13 0.49 . . . . 0.0 110.686 -174.483 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 8.7 tt -68.42 -39.28 81.65 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.486 -0.779 . . . . 0.0 109.252 178.015 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 1.004 ' HE3' ' HA ' ' A' ' 50' ' ' PRO . 8.4 mtmp? -62.84 -51.48 66.88 Favored 'General case' 0 CA--C 1.519 -0.248 0 CA-C-O 121.73 0.776 . . . . 0.0 109.375 177.302 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -57.82 -37.81 74.48 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 114.977 -1.01 . . . . 0.0 111.205 179.347 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.486 HD21 ' HE2' ' A' ' 138' ' ' PHE . 12.9 tp -73.98 -40.7 62.79 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.543 -0.299 . . . . 0.0 110.64 179.583 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.651 ' HG3' ' O ' ' A' ' 53' ' ' LYS . 0.0 OUTLIER -66.24 -39.52 89.6 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.711 -0.222 . . . . 0.0 110.473 -177.496 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 51.5 mt-10 -76.44 -28.27 56.53 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.009 0.433 . . . . 0.0 110.73 -179.255 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 63.7 tttm -70.21 -31.36 68.76 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.862 176.489 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.453 ' HB3' HD11 ' A' ' 64' ' ' ILE . 88.0 m-85 -112.17 5.71 18.65 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 112.0 0.37 . . . . 0.0 112.0 -176.099 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -62.93 142.97 58.11 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.618 175.687 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 95.11 -14.24 65.59 Favored Glycine 0 N--CA 1.446 -0.673 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.054 -179.743 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.764 ' HE2' ' HB3' ' A' ' 142' ' ' LEU . 18.7 mmmt -104.13 -169.86 1.69 Allowed 'General case' 0 N--CA 1.448 -0.532 0 CA-C-O 121.271 0.558 . . . . 0.0 111.463 178.859 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 1.032 ' HA ' ' HD2' ' A' ' 31' ' ' LYS . 28.0 m-20 -87.91 34.12 0.72 Allowed 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 113.401 0.889 . . . . 0.0 113.401 -165.848 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.453 HD11 ' HB3' ' A' ' 59' ' ' TYR . 27.6 pt -140.57 135.8 35.27 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-O 120.786 0.327 . . . . 0.0 110.639 176.213 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' HIS . . . . . 0.515 ' HB2' HD13 ' A' ' 33' ' ' ILE . 39.2 m-70 -109.61 144.25 38.2 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.074 175.889 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . 0.447 ' HE2' HD23 ' A' ' 55' ' ' LEU . 59.8 m-85 -100.78 114.6 28.53 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 173.468 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.64 ' HA ' ' O ' ' A' ' 90' ' ' ILE . 58.2 t -123.35 115.07 44.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-O 120.974 0.416 . . . . 0.0 111.125 -175.315 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . 0.561 ' HA ' ' O ' ' A' ' 36' ' ' ASP . 50.9 m -96.48 131.15 43.37 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.688 179.01 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.429 ' O ' ' HA ' ' A' ' 37' ' ' VAL . 84.8 mt -120.9 139.03 53.78 Favored 'General case' 0 N--CA 1.468 0.47 0 N-CA-C 110.51 -0.182 . . . . 0.0 110.51 178.062 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . 0.589 ' HB2' ' O ' ' A' ' 38' ' ' TRP . 0.8 OUTLIER -123.69 129.94 51.88 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 112.5 0.556 . . . . 0.0 112.5 -174.374 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 4.8 p -93.65 23.03 4.95 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.301 173.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.475 ' OD1' ' HA ' ' A' ' 39' ' ' ALA . 3.0 m-20 -79.47 108.02 12.68 Favored 'General case' 0 N--CA 1.467 0.382 0 O-C-N 122.339 -0.226 . . . . 0.0 111.013 -177.389 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 16.2 ptpt -68.12 -20.95 64.96 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 120.979 0.418 . . . . 0.0 110.658 178.09 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . 0.578 ' HB2' ' HB3' ' A' ' 77' ' ' ALA . 1.0 OUTLIER -79.42 69.09 5.61 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.394 174.122 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 11.9 tttt -58.73 -51.24 70.8 Favored 'General case' 0 C--O 1.218 -0.564 0 CA-C-N 116.63 -0.259 . . . . 0.0 111.649 -174.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.662 ' HA ' ' OE2' ' A' ' 79' ' ' GLU . 0.2 OUTLIER -58.11 -44.37 87.65 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 120.811 0.339 . . . . 0.0 110.442 -177.478 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.578 ' HB3' ' HB2' ' A' ' 74' ' ' ASN . . . -62.37 -43.29 99.18 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.683 0.754 . . . . 0.0 110.567 178.285 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' TRP . . . . . 0.464 ' O ' HG12 ' A' ' 82' ' ' VAL . 3.9 t-105 -73.34 -45.76 53.29 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 115.159 -0.928 . . . . 0.0 111.268 -176.731 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.662 ' OE2' ' HA ' ' A' ' 76' ' ' LYS . 0.6 OUTLIER -62.79 -35.29 79.39 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.001 -175.026 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 4.6 p30 -78.03 -33.51 51.06 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 119.657 -0.817 . . . . 0.0 110.339 178.772 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 45.4 tpp -61.96 -51.92 66.12 Favored 'General case' 0 C--O 1.222 -0.391 0 N-CA-C 111.462 0.171 . . . . 0.0 111.462 176.572 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.842 HG11 HG13 ' A' ' 18' ' ' ILE . 2.4 p -59.17 -37.03 66.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 C-N-CA 120.828 -0.349 . . . . 0.0 110.628 177.817 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 91.8 m -61.53 -39.09 89.8 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-O 120.894 0.378 . . . . 0.0 110.694 175.724 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . 0.445 ' HB3' ' HE3' ' A' ' 84' ' ' LYS . 0.2 OUTLIER -75.91 -44.94 37.85 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 179.717 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . 0.465 ' CG ' HH21 ' A' ' 46' ' ' ARG . 1.8 m-20 -69.6 -19.92 63.64 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.466 -0.788 . . . . 0.0 111.702 -176.387 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 73.1 mt-30 60.08 58.93 2.53 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-O 121.531 0.681 . . . . 0.0 110.936 176.853 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.617 HD22 ' HB3' ' A' ' 49' ' ' LEU . 81.9 mt -86.31 134.14 33.76 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.458 -0.792 . . . . 0.0 111.132 -177.068 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.582 ' HB3' ' OE2' ' A' ' 56' ' ' GLU . 11.7 mmmm -91.93 -168.99 2.14 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.934 177.249 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 84.49 160.25 31.35 Favored Glycine 0 N--CA 1.447 -0.612 0 C-N-CA 121.098 -0.573 . . . . 0.0 112.336 -177.436 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.64 ' O ' ' HA ' ' A' ' 67' ' ' VAL . 53.8 mt -77.68 113.0 16.29 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 175.405 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . 0.61 ' HB2' ' CZ2' ' A' ' 38' ' ' TRP . 1.6 pt20 -124.14 123.12 39.61 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-O 121.439 0.637 . . . . 0.0 112.074 -167.452 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.629 HD11 ' HB ' ' A' ' 23' ' ' VAL . 2.8 mm? -120.6 167.51 12.34 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.391 -0.822 . . . . 0.0 109.621 178.276 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 20.6 t-80 -138.66 126.89 22.82 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-O 121.201 0.524 . . . . 0.0 111.36 -173.084 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' MET . . . . . 0.446 ' HB3' ' HE2' ' A' ' 94' ' ' MET . 37.1 ttp -88.57 -67.05 0.86 Allowed 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 114.989 -1.005 . . . . 0.0 109.4 176.683 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . 0.441 ' HA2' ' O ' ' A' ' 72' ' ' ASP . . . 84.07 -77.5 2.11 Favored Glycine 0 N--CA 1.442 -0.901 0 C-N-CA 120.74 -0.743 . . . . 0.0 114.069 172.951 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 5.6 p -84.93 -19.57 32.0 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 113.247 0.832 . . . . 0.0 113.247 -169.75 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -101.54 154.77 18.55 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 119.723 -0.791 . . . . 0.0 111.023 -178.172 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . 0.515 ' HA ' ' HB3' ' A' ' 101' ' ' MET . 0.0 OUTLIER -140.66 9.05 2.19 Favored 'General case' 0 N--CA 1.446 -0.643 0 CA-C-N 115.511 -0.768 . . . . 0.0 109.789 173.083 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 4.5 m -78.32 -36.31 46.55 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.246 0.546 . . . . 0.0 109.793 178.426 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 70.5 t80 -74.78 -30.5 61.46 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 174.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' MET . . . . . 0.714 ' HG2' HG13 ' A' ' 106' ' ' ILE . 1.6 tmt? -64.2 -38.02 89.55 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 114.453 -1.249 . . . . 0.0 109.977 172.034 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -65.72 -44.44 86.05 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.468 -0.787 . . . . 0.0 110.483 177.61 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -62.88 -21.24 65.85 Favored 'General case' 0 CA--C 1.528 0.132 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.882 -177.604 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' TYR . . . . . 0.414 ' HB3' HG23 ' A' ' 106' ' ' ILE . 6.3 m-30 -100.39 -3.1 31.77 Favored 'General case' 0 C--O 1.237 0.419 0 CA-C-N 116.418 -0.355 . . . . 0.0 111.002 179.645 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 95.4 mt 59.05 25.94 14.49 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.108 -179.168 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . 0.714 HG13 ' HG2' ' A' ' 101' ' ' MET . 30.4 pt -86.64 66.14 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-O 121.664 0.745 . . . . 0.0 111.01 -177.693 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 44.2 t-20 -81.51 -59.72 2.52 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.364 -0.834 . . . . 0.0 109.81 179.786 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -82.93 90.2 1.53 Allowed Glycine 0 N--CA 1.446 -0.673 0 C-N-CA 120.634 -0.794 . . . . 0.0 111.482 176.931 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.661 HG21 HG11 ' A' ' 37' ' ' VAL . 46.5 pt -91.33 158.23 41.32 Favored Pre-proline 0 C--N 1.326 -0.448 0 N-CA-C 110.655 -0.128 . . . . 0.0 110.655 179.89 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . 0.756 ' HD3' ' HB2' ' A' ' 45' ' ' CYS . 40.9 Cg_endo -65.84 153.98 79.98 Favored 'Cis proline' 0 C--N 1.35 0.605 0 C-N-CA 124.006 -1.248 . . . . 0.0 113.691 1.939 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . 0.513 ' HG3' ' HA ' ' A' ' 106' ' ' ILE . 0.0 OUTLIER -125.8 138.14 53.82 Favored 'General case' 0 N--CA 1.446 -0.668 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.017 -179.302 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . 0.795 ' HD2' ' HB2' ' A' ' 128' ' ' ARG . 0.1 OUTLIER -102.05 117.53 34.99 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.358 -0.837 . . . . 0.0 110.633 -177.74 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.57 ' HB ' ' HB ' ' A' ' 35' ' ' ILE . 92.7 mt -131.15 145.13 35.87 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.283 0 CA-C-O 120.87 0.367 . . . . 0.0 111.128 -178.065 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.424 ' C ' HD12 ' A' ' 115' ' ' LEU . 42.0 tp -125.61 141.65 51.92 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.332 -0.395 . . . . 0.0 109.943 178.193 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.693 ' HG ' ' HA ' ' A' ' 121' ' ' ILE . 3.0 mp -134.87 153.98 51.84 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.061 0.458 . . . . 0.0 110.587 -178.018 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 27.8 t0 -79.72 166.49 21.74 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.221 -0.9 . . . . 0.0 110.765 178.596 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . 0.423 ' HA ' ' O ' ' A' ' 31' ' ' LYS . 5.6 mtm180 -53.57 -26.42 21.42 Favored 'General case' 0 N--CA 1.466 0.348 0 O-C-N 124.437 1.085 . . . . 0.0 111.956 -178.8 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -69.31 -16.72 63.61 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.302 0.573 . . . . 0.0 110.549 178.89 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 93.0 24.44 22.65 Favored Glycine 0 N--CA 1.436 -1.353 0 N-CA-C 109.762 -1.335 . . . . 0.0 109.762 -169.893 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 24.6 mmmt -111.7 114.34 27.29 Favored 'General case' 0 C--O 1.221 -0.403 0 N-CA-C 112.235 0.457 . . . . 0.0 112.235 -172.507 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 0.703 ' H ' HD12 ' A' ' 121' ' ' ILE . 4.1 mp -42.74 116.01 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 O-C-N 123.972 0.795 . . . . 0.0 111.761 178.576 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' ILE . . . . . 0.442 ' H ' ' HA ' ' A' ' 115' ' ' LEU . 69.3 mt -87.84 -47.69 15.52 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-N 115.21 -0.904 . . . . 0.0 108.726 174.94 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 15.1 m -128.52 114.53 16.87 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-N 115.003 -0.999 . . . . 0.0 109.944 179.631 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -70.98 -21.66 62.29 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.103 0.478 . . . . 0.0 110.577 178.509 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 6.9 t30 -139.57 101.53 4.24 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.539 -0.755 . . . . 0.0 109.009 176.399 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 13.1 tpt -105.48 -127.04 0.24 Allowed 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.2 -175.891 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 2.0 p -145.08 136.61 25.28 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 110.134 -0.321 . . . . 0.0 110.134 -178.062 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . 0.795 ' HB2' ' HD2' ' A' ' 112' ' ' PHE . 14.8 ttt180 -94.68 152.55 39.92 Favored Pre-proline 0 CA--C 1.535 0.401 0 CA-C-O 119.242 -0.408 . . . . 0.0 110.854 -177.978 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . 0.663 ' HD2' ' CG ' ' A' ' 128' ' ' ARG . 47.0 Cg_exo -24.4 -39.72 0.02 OUTLIER 'Trans proline' 0 C--N 1.366 1.469 1 C-N-CA 126.32 4.68 . . . . 0.0 117.275 175.771 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 66.6 m -50.33 -29.85 10.79 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-N 118.526 0.603 . . . . 0.0 111.129 175.302 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -92.2 121.36 66.77 Favored Pre-proline 0 C--N 1.323 -0.571 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.536 175.519 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . 0.471 ' O ' ' HG3' ' A' ' 136' ' ' GLU . 59.9 Cg_endo -72.16 -23.73 20.93 Favored 'Trans proline' 0 N--CA 1.462 -0.346 0 C-N-CA 122.492 2.128 . . . . 0.0 112.322 179.664 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . 0.476 ' HA ' ' HD3' ' A' ' 133' ' ' LYS . 57.3 mmtt -63.09 -30.25 71.45 Favored 'General case' 0 CA--C 1.518 -0.259 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.878 -177.771 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' THR . . . . . 0.773 HG22 ' CZ ' ' A' ' 138' ' ' PHE . 3.0 m -59.11 -54.81 42.83 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.742 -0.663 . . . . 0.0 109.718 175.234 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . 0.598 ' HA ' ' CD2' ' A' ' 138' ' ' PHE . . . -59.99 -43.56 95.09 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-N 115.67 -0.695 . . . . 0.0 112.045 177.817 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . 0.471 ' HG3' ' O ' ' A' ' 132' ' ' PRO . 50.8 mt-10 -55.72 -52.01 65.38 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-O 122.025 0.917 . . . . 0.0 110.269 177.47 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . 0.685 ' HE3' HD21 ' A' ' 141' ' ' LEU . 52.3 tptt -54.53 -40.63 68.83 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 113.956 -1.475 . . . . 0.0 111.319 179.113 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . 0.773 ' CZ ' HG22 ' A' ' 134' ' ' THR . 19.5 m-30 -55.49 -47.69 75.77 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 116.63 -0.259 . . . . 0.0 110.582 177.105 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . 0.623 ' HB3' ' HG3' ' A' ' 145' ' ' GLU . 39.5 m-20 -54.18 -55.03 31.86 Favored 'General case' 0 CA--C 1.521 -0.162 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 -179.254 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 8.8 tt0 -48.87 -57.71 5.99 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.403 -0.817 . . . . 0.0 111.968 174.95 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.685 HD21 ' HE3' ' A' ' 137' ' ' LYS . 90.2 mt -60.89 -37.3 81.74 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.799 -174.477 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.764 ' HB3' ' HE2' ' A' ' 62' ' ' LYS . 89.2 mt -79.14 -11.35 59.97 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.144 -178.387 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 86.9 19.67 55.47 Favored Glycine 0 N--CA 1.449 -0.454 0 N-CA-C 111.528 -0.629 . . . . 0.0 111.528 178.713 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 9.5 tt -80.15 -40.15 27.96 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 -179.594 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . 0.623 ' HG3' ' HB3' ' A' ' 139' ' ' ASN . 34.6 mt-10 -107.9 -171.56 1.89 Allowed 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.812 177.077 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 78.56 -119.59 5.16 Favored Glycine 0 N--CA 1.447 -0.614 0 C-N-CA 121.002 -0.618 . . . . 0.0 112.258 178.751 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 70.0 m80 -87.45 54.99 3.33 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.306 0.574 . . . . 0.0 110.594 -177.073 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 12.3 t60 -93.65 -5.4 48.73 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.006 -179.312 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -101.84 140.59 35.91 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.344 179.313 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 17.4 p80 -163.4 127.56 2.86 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.209 178.845 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 84.6 t60 -127.41 140.74 51.97 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 120.859 0.361 . . . . 0.0 110.799 -176.303 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 15.5 m170 . . . . . 0 C--O 1.242 0.661 0 CA-C-O 118.46 -0.781 . . . . 0.0 109.937 175.531 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.8 mtt . . . . . 0 N--CA 1.48 1.052 0 N-CA-C 110.164 -0.31 . . . . 0.0 110.164 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.731 ' HA ' ' HA ' ' A' ' 8' ' ' PRO . 27.9 m -78.83 131.54 36.51 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 109.738 -0.467 . . . . 0.0 109.738 175.876 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.616 HD22 ' H ' ' A' ' 3' ' ' LEU . 2.8 mm? -55.36 -58.36 8.05 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.988 0.423 . . . . 0.0 110.326 179.915 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 57.0 mtt180 -138.76 -68.75 0.44 Allowed 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 109.287 -0.635 . . . . 0.0 109.287 174.34 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 50.5 m -149.31 144.37 26.42 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.55 -0.75 . . . . 0.0 109.423 176.169 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 128.32 -94.16 0.37 Allowed Glycine 0 N--CA 1.447 -0.619 0 C-N-CA 120.811 -0.709 . . . . 0.0 111.84 -179.43 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . 0.892 ' HB2' ' HB2' ' A' ' 11' ' ' ALA . 78.7 m-20 -130.1 151.13 77.83 Favored Pre-proline 0 C--N 1.326 -0.451 0 N-CA-C 109.823 -0.436 . . . . 0.0 109.823 177.465 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.731 ' HA ' ' HA ' ' A' ' 2' ' ' SER . 9.7 Cg_exo -72.21 -62.61 0.04 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.368 0 C-N-CA 122.559 2.173 . . . . 0.0 111.484 174.084 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 16.2 m -102.08 165.39 11.19 Favored 'General case' 0 N--CA 1.447 -0.611 0 CA-C-N 115.952 -0.567 . . . . 0.0 109.897 179.296 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.644 ' HA ' ' CZ ' ' A' ' 100' ' ' PHE . . . 75.76 -44.65 0.52 Allowed 'General case' 0 N--CA 1.47 0.542 0 O-C-N 124.065 0.853 . . . . 0.0 112.667 174.896 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.892 ' HB2' ' HB2' ' A' ' 7' ' ' ASN . . . -56.67 -32.54 65.51 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 112.87 0.693 . . . . 0.0 112.87 -172.895 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 31.1 m -147.68 86.56 1.6 Allowed 'General case' 0 C--N 1.316 -0.873 0 CA-C-O 121.128 0.489 . . . . 0.0 111.362 179.188 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . 0.477 ' CE2' HD22 ' A' ' 25' ' ' LEU . 47.9 p90 -105.57 163.15 12.89 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 172.712 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.439 ' HA ' ' HA ' ' A' ' 24' ' ' SER . 14.0 m -139.71 122.03 15.99 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 109.805 -0.442 . . . . 0.0 109.805 178.852 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . 0.424 ' HA ' ' HD3' ' A' ' 16' ' ' PRO . 19.6 m-85 -137.11 149.32 65.84 Favored Pre-proline 0 C--N 1.327 -0.393 0 CA-C-O 120.678 0.275 . . . . 0.0 110.744 -177.262 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.471 ' HD2' ' O ' ' A' ' 93' ' ' HIS . 9.2 Cg_exo -72.35 124.37 9.87 Favored 'Trans proline' 0 N--CA 1.456 -0.678 0 C-N-CA 122.473 2.115 . . . . 0.0 112.54 178.02 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . 0.874 ' HB3' ' HB3' ' A' ' 21' ' ' LYS . 0.2 OUTLIER -68.97 162.95 25.65 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.132 -0.94 . . . . 0.0 109.765 172.769 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.668 HD12 HG13 ' A' ' 82' ' ' VAL . 0.8 OUTLIER -44.78 -43.42 2.49 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 O-C-N 124.147 0.904 . . . . 0.0 112.171 -177.227 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.52 ' ND2' HG23 ' A' ' 18' ' ' ILE . 21.8 m-80 -77.42 1.2 19.82 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.144 -175.349 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 85.84 30.61 23.08 Favored Glycine 0 N--CA 1.446 -0.663 0 N-CA-C 110.682 -0.967 . . . . 0.0 110.682 -173.626 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.874 ' HB3' ' HB3' ' A' ' 17' ' ' ASP . 2.0 ttmp? -98.09 116.04 29.48 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.481 -0.36 . . . . 0.0 110.902 -172.933 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 25.6 m -70.38 104.78 2.81 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 120.867 0.365 . . . . 0.0 110.905 178.799 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.472 ' HB ' HD21 ' A' ' 92' ' ' LEU . 61.0 t -121.32 146.16 26.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 178.741 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . 0.439 ' HA ' ' HA ' ' A' ' 14' ' ' SER . 86.7 p -121.52 -173.96 2.75 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 109.985 -0.376 . . . . 0.0 109.985 -178.666 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.698 ' O ' ' HB2' ' A' ' 29' ' ' LYS . 15.0 tp -98.84 0.69 44.78 Favored 'General case' 0 C--N 1.32 -0.685 0 C-N-CA 120.16 -0.616 . . . . 0.0 109.951 173.881 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -85.99 -32.71 21.37 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.398 -179.06 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -77.01 -17.98 58.47 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.367 0.603 . . . . 0.0 110.117 176.104 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 85.8 mt -100.12 -5.31 28.06 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.602 -0.727 . . . . 0.0 110.429 176.859 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.698 ' HB2' ' O ' ' A' ' 25' ' ' LEU . 58.4 tttm -81.7 140.98 34.0 Favored 'General case' 0 N--CA 1.443 -0.79 0 CA-C-N 115.582 -0.735 . . . . 0.0 110.705 -172.338 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 115.63 -13.58 17.88 Favored Glycine 0 N--CA 1.452 -0.239 0 N-CA-C 111.326 -0.71 . . . . 0.0 111.326 -175.389 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.502 ' HG3' ' OD1' ' A' ' 63' ' ' ASP . 25.0 ttmm -132.27 153.1 50.99 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 177.129 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.667 ' HB2' HG22 ' A' ' 64' ' ' ILE . 24.7 m-85 -51.92 141.85 16.78 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 118.328 0.513 . . . . 0.0 110.916 -176.491 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.589 HG21 HD11 ' A' ' 25' ' ' LEU . 67.3 mt -119.27 122.29 68.72 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.74 -174.545 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . 0.531 ' OH ' ' HG3' ' A' ' 128' ' ' ARG . 30.2 t80 -114.99 134.66 54.99 Favored 'General case' 0 C--N 1.316 -0.863 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 173.94 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.611 ' HA ' ' O ' ' A' ' 67' ' ' VAL . 82.1 mt -130.26 129.88 65.3 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.047 -176.651 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.635 ' O ' ' HA ' ' A' ' 68' ' ' SER . 4.6 p30 -130.6 160.29 34.64 Favored 'General case' 0 C--O 1.217 -0.614 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.418 172.71 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.544 ' HB ' ' HA ' ' A' ' 110' ' ' PRO . 47.8 t -95.56 137.94 22.44 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 CA-C-O 121.087 0.47 . . . . 0.0 111.779 -178.429 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' TRP . . . . . 0.936 ' HZ3' HG21 ' A' ' 82' ' ' VAL . 0.6 OUTLIER -122.34 132.91 54.62 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 174.244 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -148.43 154.14 39.48 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 120.767 -0.373 . . . . 0.0 111.655 -176.727 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.687 ' HB ' ' CE3' ' A' ' 78' ' ' TRP . 4.1 t -92.93 -28.68 16.31 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 121.203 -0.199 . . . . 0.0 110.785 173.516 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 11.5 p-90 -81.69 -8.32 59.69 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.939 0.4 . . . . 0.0 110.417 179.537 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . 0.56 ' O ' ' HD2' ' A' ' 44' ' ' PRO . 47.7 t -86.35 -71.33 0.55 Allowed 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 173.099 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 112.21 -77.53 0.24 Allowed Glycine 0 C--O 1.227 -0.293 0 C-N-CA 120.532 -0.842 . . . . 0.0 113.239 176.87 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.56 ' HD2' ' O ' ' A' ' 42' ' ' CYS . 9.7 Cg_endo -52.38 -31.79 49.08 Favored 'Trans proline' 0 C--N 1.353 0.815 0 C-N-CA 123.182 2.588 . . . . 0.0 112.431 -178.636 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . 0.56 ' HB3' ' HD3' ' A' ' 110' ' ' PRO . 26.9 p -61.41 -17.0 52.21 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.688 -179.899 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.514 ' HA ' HD23 ' A' ' 49' ' ' LEU . 61.7 mtp180 -83.27 -19.4 36.41 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.814 0.34 . . . . 0.0 111.075 -177.48 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -83.77 -7.68 85.5 Favored Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.479 -176.705 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -95.58 -10.44 29.55 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.513 0.197 . . . . 0.0 111.152 -177.283 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.991 ' HG ' ' HB3' ' A' ' 87' ' ' LEU . 4.2 mm? -55.25 -44.85 99.85 Favored Pre-proline 0 CA--C 1.538 0.487 0 CA-C-N 116.649 -0.251 . . . . 0.0 111.505 176.709 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.672 ' O ' ' HG2' ' A' ' 54' ' ' GLU . 76.0 Cg_exo -52.68 -37.37 75.1 Favored 'Trans proline' 0 C--N 1.357 0.981 0 C-N-CA 121.816 1.677 . . . . 0.0 112.131 170.606 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -71.51 -19.84 62.14 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.35 0.595 . . . . 0.0 110.704 -178.071 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 8.1 tt -72.88 -45.69 56.85 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.568 -0.742 . . . . 0.0 109.692 -179.83 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.509 ' HG3' ' N ' ' A' ' 54' ' ' GLU . 7.9 ptmm? -63.89 -42.04 97.57 Favored 'General case' 0 C--O 1.226 -0.15 0 N-CA-C 109.878 -0.415 . . . . 0.0 109.878 177.704 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.672 ' HG2' ' O ' ' A' ' 50' ' ' PRO . 55.2 mm-40 -51.22 -49.75 60.44 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-O 121.64 0.733 . . . . 0.0 110.224 177.932 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.769 HD13 ' HD2' ' A' ' 59' ' ' TYR . 0.2 OUTLIER -66.7 -39.21 87.98 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.068 -0.969 . . . . 0.0 110.755 -179.021 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 14.2 tp10 -61.23 -57.66 11.51 Favored 'General case' 0 N--CA 1.447 -0.591 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.045 -177.207 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 -67.97 -25.42 65.42 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 111.744 0.276 . . . . 0.0 111.744 -176.113 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.494 ' HD3' ' CE2' ' A' ' 59' ' ' TYR . 63.4 tttt -67.7 -34.12 76.25 Favored 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 120.759 -0.376 . . . . 0.0 110.51 174.064 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.769 ' HD2' HD13 ' A' ' 55' ' ' LEU . 68.3 m-85 -119.81 25.17 10.15 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.426 -176.327 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -49.63 116.51 1.79 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.059 0.457 . . . . 0.0 111.972 178.143 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 105.11 -0.73 40.96 Favored Glycine 0 N--CA 1.453 -0.214 0 C-N-CA 120.945 -0.645 . . . . 0.0 112.451 179.504 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.852 ' HG2' HG12 ' A' ' 64' ' ' ILE . 0.0 OUTLIER -67.32 174.9 2.98 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.523 0.678 . . . . 0.0 112.422 -178.299 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.502 ' OD1' ' HG3' ' A' ' 31' ' ' LYS . 32.3 t70 -101.28 51.45 0.85 Allowed 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.905 -177.317 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.852 HG12 ' HG2' ' A' ' 62' ' ' LYS . 19.4 pt -146.8 165.57 7.3 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.401 0 N-CA-C 110.113 -0.329 . . . . 0.0 110.113 177.546 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' HIS . . . . . 0.48 ' NE2' ' HB3' ' A' ' 31' ' ' LYS . 85.2 m-70 -122.9 140.42 52.99 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 175.922 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . 0.692 ' O ' ' HB ' ' A' ' 90' ' ' ILE . 79.6 m-85 -102.01 103.18 13.78 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 172.381 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.611 ' O ' ' HA ' ' A' ' 35' ' ' ILE . 39.0 t -119.12 113.6 41.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-O 120.967 0.413 . . . . 0.0 111.11 -175.465 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . 0.635 ' HA ' ' O ' ' A' ' 36' ' ' ASP . 0.7 OUTLIER -93.95 131.96 38.88 Favored 'General case' 0 C--N 1.317 -0.824 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 177.521 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.546 ' CD2' ' HB2' ' A' ' 92' ' ' LEU . 73.2 mt -118.2 137.7 52.83 Favored 'General case' 0 N--CA 1.468 0.463 0 O-C-N 122.072 -0.392 . . . . 0.0 110.426 176.918 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . 0.536 ' HB2' ' O ' ' A' ' 38' ' ' TRP . 1.3 t -118.06 123.5 45.81 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.188 0.518 . . . . 0.0 112.029 -176.209 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 49.7 t -89.85 14.14 12.75 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.75 176.417 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.574 ' O ' ' HA2' ' A' ' 95' ' ' GLY . 0.9 OUTLIER -65.53 133.11 50.53 Favored 'General case' 0 CA--C 1.516 -0.362 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 -178.292 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.48 ' HB2' ' NZ ' ' A' ' 73' ' ' LYS . 1.0 OUTLIER -87.45 -24.94 23.99 Favored 'General case' 0 C--N 1.316 -0.872 0 C-N-CA 120.084 -0.646 . . . . 0.0 110.571 -177.646 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . 0.571 ' HB2' ' HB3' ' A' ' 77' ' ' ALA . 0.7 OUTLIER -84.12 78.97 9.67 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.343 176.175 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.432 ' HG3' ' CE1' ' A' ' 93' ' ' HIS . 10.2 tttt -61.63 -56.58 18.31 Favored 'General case' 0 C--O 1.221 -0.443 0 C-N-CA 120.826 -0.35 . . . . 0.0 111.741 -173.763 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.557 ' HA ' ' OE1' ' A' ' 79' ' ' GLU . 17.3 tppt? -57.09 -40.62 77.32 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 111.882 0.327 . . . . 0.0 111.882 -177.903 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.571 ' HB3' ' HB2' ' A' ' 74' ' ' ASN . . . -62.79 -41.2 99.16 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.827 0.823 . . . . 0.0 110.188 177.393 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' TRP . . . . . 0.687 ' CE3' ' HB ' ' A' ' 40' ' ' THR . 5.2 t-105 -74.31 -47.57 33.81 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 114.698 -1.137 . . . . 0.0 111.202 -176.802 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.557 ' OE1' ' HA ' ' A' ' 76' ' ' LYS . 3.3 pt-20 -64.57 -35.52 81.24 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.938 -174.782 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 3.6 p30 -74.94 -37.13 62.07 Favored 'General case' 0 CA--C 1.523 -0.081 0 C-N-CA 119.995 -0.682 . . . . 0.0 110.114 179.053 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 34.4 ttm -64.1 -50.52 67.98 Favored 'General case' 0 C--O 1.219 -0.552 0 C-N-CA 120.65 -0.42 . . . . 0.0 110.784 175.914 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.936 HG21 ' HZ3' ' A' ' 38' ' ' TRP . 12.5 p -63.18 -23.23 32.75 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-O 121.086 0.469 . . . . 0.0 111.005 -178.158 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . 0.573 ' OG1' HD11 ' A' ' 18' ' ' ILE . 88.2 m -76.38 -46.82 25.65 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.566 -0.288 . . . . 0.0 110.453 171.98 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.32 -42.36 88.32 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.337 0.589 . . . . 0.0 110.384 -178.286 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -74.51 -5.61 43.66 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.186 -0.915 . . . . 0.0 111.282 -179.824 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 47.7 mt-30 63.52 17.74 10.57 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 115.867 -0.606 . . . . 0.0 112.368 174.556 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.991 ' HB3' ' HG ' ' A' ' 49' ' ' LEU . 29.2 mt -74.67 93.78 2.6 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.96 -0.385 . . . . 0.0 109.96 -179.986 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 9.0 mmtm -110.07 -178.84 3.62 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 113.006 0.743 . . . . 0.0 113.006 -176.261 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 130.88 -165.02 23.08 Favored Glycine 0 N--CA 1.449 -0.448 0 N-CA-C 109.71 -1.356 . . . . 0.0 109.71 -172.117 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.692 ' HB ' ' O ' ' A' ' 66' ' ' PHE . 60.9 mt -85.02 112.14 21.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 118.054 0.927 . . . . 0.0 108.508 172.808 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . 0.587 ' HB2' ' CZ2' ' A' ' 38' ' ' TRP . 2.1 pt20 -142.01 113.26 7.6 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 121.457 0.646 . . . . 0.0 111.69 -170.647 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.546 ' HB2' ' CD2' ' A' ' 69' ' ' LEU . 77.5 mt -110.42 154.23 23.87 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.495 -0.775 . . . . 0.0 109.902 -179.75 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' HIS . . . . . 0.471 ' O ' ' HD2' ' A' ' 16' ' ' PRO . 35.4 t-80 -121.93 126.81 49.47 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-O 121.455 0.645 . . . . 0.0 111.134 -175.254 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' MET . . . . . 0.436 ' HB3' ' HE2' ' A' ' 94' ' ' MET . 28.2 ttp -91.12 -72.62 0.57 Allowed 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 114.801 -1.09 . . . . 0.0 109.923 178.197 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . 0.574 ' HA2' ' O ' ' A' ' 72' ' ' ASP . . . 86.48 -75.26 2.26 Favored Glycine 0 N--CA 1.446 -0.648 0 C-N-CA 120.601 -0.809 . . . . 0.0 114.24 173.863 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -90.42 -34.59 15.57 Favored 'General case' 0 C--N 1.315 -0.928 0 N-CA-C 112.126 0.417 . . . . 0.0 112.126 -174.556 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -92.75 54.91 2.32 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.717 -163.833 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.71 4.94 0.94 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.952 -0.567 . . . . 0.0 112.405 -176.812 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 9.4 t -66.74 -19.44 65.75 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.126 0.489 . . . . 0.0 109.76 174.887 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . 0.644 ' CZ ' ' HA ' ' A' ' 10' ' ' ALA . 10.5 t80 -77.28 -23.87 51.09 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.174 177.652 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 93.6 mmm -62.41 -48.12 81.11 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 174.761 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -62.25 -22.49 66.03 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 115.405 -0.816 . . . . 0.0 111.649 176.603 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -70.42 -24.06 62.85 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.697 0.284 . . . . 0.0 111.115 179.544 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' TYR . . . . . 0.585 ' HB2' HD12 ' A' ' 106' ' ' ILE . 47.2 m-85 -106.28 -11.31 16.06 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.802 176.561 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 7.2 mp 67.14 14.59 9.83 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 115.61 -0.723 . . . . 0.0 112.071 179.181 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . 1.039 ' HB ' ' HG3' ' A' ' 111' ' ' ARG . 0.2 OUTLIER -82.84 149.95 4.45 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.428 0 CA-C-O 120.933 0.397 . . . . 0.0 110.804 -179.926 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 5.1 p30 -127.37 -57.65 1.29 Allowed 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.435 -179.289 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -76.38 116.1 4.62 Favored Glycine 0 N--CA 1.447 -0.601 0 C-N-CA 120.966 -0.635 . . . . 0.0 112.587 -179.389 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.454 ' HB ' ' HA ' ' A' ' 110' ' ' PRO . 40.2 pt -102.65 153.62 38.05 Favored Pre-proline 0 C--N 1.326 -0.441 0 N-CA-C 110.43 -0.211 . . . . 0.0 110.43 176.344 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . 0.56 ' HD3' ' HB3' ' A' ' 45' ' ' CYS . 49.5 Cg_endo -71.61 133.94 30.69 Favored 'Cis proline' 0 C--N 1.343 0.288 0 C-N-CA 123.175 -1.594 . . . . 0.0 113.236 1.312 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . 1.039 ' HG3' ' HB ' ' A' ' 106' ' ' ILE . 0.0 OUTLIER -95.22 146.41 24.35 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 173.975 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . 0.549 ' CE1' ' HB2' ' A' ' 128' ' ' ARG . 9.7 m-85 -119.35 119.44 34.0 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 -177.495 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.407 HD11 HG21 ' A' ' 106' ' ' ILE . 91.7 mt -131.13 138.19 53.96 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-O 121.015 0.436 . . . . 0.0 110.975 -177.283 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.72 HD21 HD11 ' A' ' 141' ' ' LEU . 30.6 tp -119.47 133.09 55.86 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.631 -0.713 . . . . 0.0 109.471 177.738 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.421 ' N ' HD12 ' A' ' 115' ' ' LEU . 0.7 OUTLIER -133.74 155.33 49.96 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.206 0.527 . . . . 0.0 110.61 -178.003 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . 0.637 ' HB3' ' HB2' ' A' ' 120' ' ' LYS . 17.6 t70 -71.21 166.82 20.71 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.176 -0.92 . . . . 0.0 110.804 176.76 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . 0.406 ' N ' ' CG ' ' A' ' 116' ' ' ASP . 69.4 mtt85 -51.55 -32.15 27.1 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 124.281 1.033 . . . . 0.0 112.974 -178.09 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . 0.684 ' HB3' ' HD3' ' A' ' 120' ' ' LYS . 25.4 t70 -81.25 4.48 20.24 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-O 121.474 0.654 . . . . 0.0 110.474 179.45 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 81.31 23.11 59.38 Favored Glycine 0 N--CA 1.438 -1.207 0 N-CA-C 110.466 -1.054 . . . . 0.0 110.466 -173.832 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . 0.684 ' HD3' ' HB3' ' A' ' 118' ' ' ASP . 19.8 mmmt -81.27 106.69 13.45 Favored 'General case' 0 CA--C 1.51 -0.566 0 C-N-CA 120.646 -0.422 . . . . 0.0 110.864 -176.028 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 0.637 ' H ' HD12 ' A' ' 121' ' ' ILE . 3.6 mp -47.05 106.58 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.315 -0.916 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.822 178.189 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 39.3 mm -88.34 -47.21 15.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 115.51 -0.768 . . . . 0.0 109.661 -179.75 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 13.6 m -144.95 114.64 7.26 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.721 178.576 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -74.52 -24.13 58.93 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.621 0.724 . . . . 0.0 109.782 174.774 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . 0.733 ' HA ' ' NH1' ' A' ' 111' ' ' ARG . 53.6 t30 -110.4 85.04 2.03 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.487 -0.779 . . . . 0.0 109.329 175.485 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' MET . . . . . 0.623 ' HG2' ' HB2' ' A' ' 114' ' ' LEU . 3.3 tpt -113.54 -166.91 1.13 Allowed 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 107.813 -1.18 . . . . 0.0 107.813 179.026 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . 0.561 ' O ' HG21 ' A' ' 134' ' ' THR . 2.1 p -132.11 161.53 33.07 Favored 'General case' 0 C--N 1.316 -0.882 0 N-CA-C 109.684 -0.487 . . . . 0.0 109.684 179.864 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . 0.636 ' CG ' ' HD2' ' A' ' 129' ' ' PRO . 19.2 ttt180 -86.76 158.01 54.23 Favored Pre-proline 0 C--N 1.316 -0.887 0 N-CA-C 109.795 -0.446 . . . . 0.0 109.795 179.387 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . 0.636 ' HD2' ' CG ' ' A' ' 128' ' ' ARG . 49.3 Cg_exo -42.81 -23.66 0.35 Allowed 'Trans proline' 0 C--N 1.356 0.945 0 C-N-CA 123.468 2.779 . . . . 0.0 113.908 170.906 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -55.85 -31.91 63.17 Favored 'General case' 0 CA--C 1.529 0.143 0 CA-C-O 121.092 0.472 . . . . 0.0 110.691 175.325 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 11.1 t0 -101.67 127.83 30.4 Favored Pre-proline 0 C--O 1.237 0.439 0 CA-C-N 115.852 -0.613 . . . . 0.0 109.92 179.51 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -58.35 -26.81 78.93 Favored 'Trans proline' 0 C--N 1.347 0.464 0 C-N-CA 123.299 2.666 . . . . 0.0 114.047 -178.385 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 42.3 mttp -56.15 -42.25 76.7 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-O 121.457 0.646 . . . . 0.0 110.842 -177.451 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' THR . . . . . 0.561 HG21 ' O ' ' A' ' 127' ' ' THR . 0.1 OUTLIER -69.14 -43.07 75.08 Favored 'General case' 0 N--CA 1.443 -0.821 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.539 178.883 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . 0.539 ' HA ' ' CD2' ' A' ' 138' ' ' PHE . . . -56.78 -46.92 81.22 Favored 'General case' 0 C--O 1.238 0.478 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.618 179.259 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . 0.647 ' HA ' ' OD1' ' A' ' 139' ' ' ASN . 14.7 pt-20 -71.15 -23.75 62.13 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.621 -179.559 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . 0.634 ' O ' ' HB3' ' A' ' 140' ' ' GLU . 60.9 tttp -79.28 -26.9 42.25 Favored 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 120.422 -0.511 . . . . 0.0 111.023 173.313 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . 0.637 ' HD2' HD11 ' A' ' 55' ' ' LEU . 21.5 m-85 -65.15 -43.2 92.57 Favored 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 120.469 -0.492 . . . . 0.0 110.213 177.138 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . 0.647 ' OD1' ' HA ' ' A' ' 136' ' ' GLU . 2.0 p-10 -70.01 -32.18 70.22 Favored 'General case' 0 C--O 1.224 -0.264 0 C-N-CA 120.006 -0.678 . . . . 0.0 110.128 175.099 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . 0.634 ' HB3' ' O ' ' A' ' 137' ' ' LYS . 4.4 tt0 -51.23 -55.13 19.69 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-O 120.823 0.344 . . . . 0.0 110.657 169.371 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.72 HD11 HD21 ' A' ' 114' ' ' LEU . 90.1 mt -58.42 -36.26 73.34 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.533 -178.918 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.506 ' HG ' ' O ' ' A' ' 138' ' ' PHE . 86.9 mt -77.32 -18.51 57.41 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.2 -179.671 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 86.05 13.83 68.19 Favored Glycine 0 N--CA 1.45 -0.417 0 N-CA-C 110.749 -0.94 . . . . 0.0 110.749 -175.625 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 37.4 tp -97.86 37.45 1.4 Allowed 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 -178.128 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . 0.471 ' HG2' ' HA ' ' A' ' 140' ' ' GLU . 0.0 OUTLIER -54.57 138.25 41.38 Favored 'General case' 0 N--CA 1.445 -0.71 0 CA-C-N 114.663 -1.153 . . . . 0.0 113.69 -176.325 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -115.2 -2.4 21.76 Favored Glycine 0 N--CA 1.446 -0.697 0 CA-C-N 114.797 -1.092 . . . . 0.0 112.283 -177.546 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 36.2 m80 -83.23 -2.29 55.2 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.25 0.547 . . . . 0.0 109.597 177.194 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 44.5 t-80 -78.01 110.33 12.85 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.551 -0.749 . . . . 0.0 111.478 -176.364 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 1.6 t60 -113.99 162.41 16.46 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 175.915 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 49.0 t-80 -101.3 108.87 20.62 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.783 0.325 . . . . 0.0 111.348 -178.162 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 78.4 t60 -124.36 -1.37 8.13 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.522 0.677 . . . . 0.0 109.223 172.026 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 26.8 t-80 . . . . . 0 C--O 1.244 0.786 0 CA-C-N 115.185 -0.916 . . . . 0.0 109.109 178.829 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 54.3 ttm . . . . . 0 N--CA 1.482 1.173 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 13.2 m -141.1 -175.41 4.31 Favored 'General case' 0 C--N 1.324 -0.523 0 O-C-N 123.21 0.319 . . . . 0.0 110.208 -175.518 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.923 HD13 ' H ' ' A' ' 3' ' ' LEU . 0.0 OUTLIER -79.53 13.16 2.12 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.293 0.568 . . . . 0.0 111.088 178.799 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . 0.511 ' HG3' ' O ' ' A' ' 7' ' ' ASN . 19.1 tpt180 -145.93 105.35 3.94 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.648 -0.705 . . . . 0.0 109.898 -173.848 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 15.6 m -75.4 140.31 42.87 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.013 176.856 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 87.23 54.15 2.64 Favored Glycine 0 N--CA 1.449 -0.44 0 N-CA-C 110.821 -0.912 . . . . 0.0 110.821 -174.783 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . 0.511 ' O ' ' HG3' ' A' ' 4' ' ' ARG . 10.1 m-20 68.26 141.18 0.07 OUTLIER Pre-proline 0 N--CA 1.467 0.394 0 C-N-CA 123.307 0.643 . . . . 0.0 111.162 -174.382 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.433 ' HD3' ' HA ' ' A' ' 7' ' ' ASN . 25.2 Cg_exo -62.66 -15.81 48.79 Favored 'Trans proline' 0 CA--C 1.527 0.149 0 C-N-CA 123.001 2.467 . . . . 0.0 112.651 -176.82 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 19.7 m 67.98 99.62 0.05 Allowed 'General case' 0 N--CA 1.464 0.233 0 O-C-N 123.784 0.677 . . . . 0.0 111.58 175.861 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . 73.72 -42.08 0.51 Allowed 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 123.991 0.917 . . . . 0.0 111.592 179.125 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -80.92 73.75 7.93 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.649 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.571 ' HA ' ' HB3' ' A' ' 25' ' ' LEU . 18.1 m 71.79 90.47 0.09 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.151 -0.931 . . . . 0.0 111.103 178.644 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 33.6 p90 -105.69 163.51 12.64 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.509 179.031 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.411 ' HA ' ' HA ' ' A' ' 24' ' ' SER . 11.9 p -137.45 128.27 27.18 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.276 -0.42 . . . . 0.0 109.902 178.053 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . 0.431 ' HA ' ' HD3' ' A' ' 16' ' ' PRO . 36.3 m-85 -140.91 149.63 56.78 Favored Pre-proline 0 C--N 1.326 -0.427 0 CA-C-N 116.532 -0.304 . . . . 0.0 110.248 -177.016 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.684 ' HA ' ' O ' ' A' ' 21' ' ' LYS . 3.8 Cg_exo -75.23 124.91 8.82 Favored 'Trans proline' 0 N--CA 1.453 -0.885 0 C-N-CA 122.201 1.934 . . . . 0.0 112.726 179.677 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . 0.769 ' HB3' ' HB3' ' A' ' 21' ' ' LYS . 0.0 OUTLIER -64.89 162.01 17.2 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.38 -0.827 . . . . 0.0 109.05 170.732 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.633 HG21 HG11 ' A' ' 82' ' ' VAL . 9.6 tp -62.42 -25.95 39.19 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.242 -171.656 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.502 HD22 HG23 ' A' ' 18' ' ' ILE . 0.9 OUTLIER -80.85 4.98 17.4 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.127 177.253 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 78.89 49.54 6.4 Favored Glycine 0 N--CA 1.449 -0.451 0 N-CA-C 110.809 -0.917 . . . . 0.0 110.809 -176.258 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.769 ' HB3' ' HB3' ' A' ' 17' ' ' ASP . 0.0 OUTLIER -114.84 140.85 48.61 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.531 -0.335 . . . . 0.0 110.521 -173.63 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 19.6 m -90.62 99.07 12.17 Favored 'General case' 0 C--N 1.318 -0.762 0 C-N-CA 120.512 -0.475 . . . . 0.0 110.078 178.207 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.415 ' HB ' ' CD2' ' A' ' 92' ' ' LEU . 48.7 t -115.34 137.79 47.78 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 116.069 -0.514 . . . . 0.0 109.735 -179.756 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . 0.411 ' HA ' ' HA ' ' A' ' 14' ' ' SER . 59.7 p -122.55 169.52 10.93 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.964 -175.786 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.8 HD12 HD12 ' A' ' 28' ' ' LEU . 32.5 tp -66.74 -16.1 64.0 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.026 174.87 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.409 ' HA ' ' HD3' ' A' ' 29' ' ' LYS . . . -62.4 -39.74 94.22 Favored 'General case' 0 C--N 1.333 -0.123 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.948 179.75 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -61.16 -33.81 74.02 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-O 121.772 0.796 . . . . 0.0 110.226 174.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.8 HD12 HD12 ' A' ' 25' ' ' LEU . 33.4 mt -79.64 -15.02 58.36 Favored 'General case' 0 N--CA 1.445 -0.688 0 CA-C-N 115.0 -1.0 . . . . 0.0 111.684 -173.008 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.67 ' HA ' ' O ' ' A' ' 117' ' ' ARG . 1.7 mptm? -66.46 160.83 24.11 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.392 0.615 . . . . 0.0 111.881 178.198 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 84.32 -14.83 43.25 Favored Glycine 0 N--CA 1.45 -0.374 0 CA-C-N 115.464 -0.789 . . . . 0.0 112.29 178.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.578 ' HG3' ' CG ' ' A' ' 63' ' ' ASP . 24.5 ttmm -144.15 143.15 30.96 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 109.311 -0.625 . . . . 0.0 109.311 -176.507 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 63.0 m-85 -56.2 155.04 7.11 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-O 120.681 0.277 . . . . 0.0 111.276 -177.689 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.557 HD12 ' HA2' ' A' ' 119' ' ' GLY . 43.3 mt -128.11 135.39 62.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-O 120.74 0.305 . . . . 0.0 111.565 -171.913 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . 0.541 ' HB2' HD11 ' A' ' 64' ' ' ILE . 88.1 t80 -120.04 116.47 25.79 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 173.532 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.538 ' HA ' ' O ' ' A' ' 67' ' ' VAL . 28.9 mm -101.7 132.21 48.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.566 -179.299 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.57 ' HA ' ' O ' ' A' ' 111' ' ' ARG . 1.2 t70 -140.77 162.76 34.65 Favored 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 176.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.555 ' HB ' ' HA ' ' A' ' 110' ' ' PRO . 46.8 t -102.06 131.22 50.5 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.919 0 C-N-CA 120.212 -0.595 . . . . 0.0 111.45 176.736 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' TRP . . . . . 0.685 ' CZ2' ' HB3' ' A' ' 91' ' ' GLN . 0.9 OUTLIER -126.14 132.75 51.78 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-O 120.822 0.344 . . . . 0.0 110.128 179.325 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.54 ' HB3' ' SG ' ' A' ' 42' ' ' CYS . . . -148.68 168.74 22.06 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-N 116.688 -0.233 . . . . 0.0 110.85 178.013 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.599 ' HB ' ' CE3' ' A' ' 78' ' ' TRP . 9.6 t -92.08 -18.68 23.24 Favored 'General case' 0 C--O 1.233 0.235 0 C-N-CA 120.868 -0.333 . . . . 0.0 111.667 179.265 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 1.5 p-90 -90.41 -13.46 34.9 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.788 0.328 . . . . 0.0 111.712 -177.44 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . 0.54 ' SG ' ' HB3' ' A' ' 39' ' ' ALA . 5.9 p -88.34 94.99 10.02 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.014 0.435 . . . . 0.0 110.515 177.723 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -54.17 -58.3 13.42 Favored Glycine 0 CA--C 1.524 0.647 0 CA-C-N 115.43 -0.804 . . . . 0.0 113.967 -179.309 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -53.95 -38.41 86.32 Favored 'Trans proline' 0 C--N 1.354 0.83 0 C-N-CA 122.721 2.28 . . . . 0.0 112.68 -178.31 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . 0.809 ' HB2' ' HD3' ' A' ' 110' ' ' PRO . 36.7 t -59.07 -38.54 79.69 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.184 0.516 . . . . 0.0 110.689 178.888 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.518 ' HA ' ' HG ' ' A' ' 49' ' ' LEU . 39.3 mtp180 -70.9 -15.83 62.64 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.911 -176.322 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -77.91 -26.48 60.28 Favored Glycine 0 N--CA 1.445 -0.701 0 C-N-CA 120.754 -0.736 . . . . 0.0 111.769 177.119 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.652 ' HB3' ' HB3' ' A' ' 130' ' ' SER . 14.2 pt-20 -107.03 0.99 24.01 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.841 0.353 . . . . 0.0 111.5 -179.854 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.538 ' N ' ' HD2' ' A' ' 50' ' ' PRO . 68.4 mt -59.94 -45.8 98.16 Favored Pre-proline 0 CA--C 1.537 0.456 0 CA-C-N 116.531 -0.304 . . . . 0.0 111.288 172.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.538 ' HD2' ' N ' ' A' ' 49' ' ' LEU . 11.9 Cg_endo -57.53 -35.16 98.89 Favored 'Trans proline' 0 C--N 1.356 0.965 0 C-N-CA 121.761 1.641 . . . . 0.0 111.913 171.323 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.586 ' HA ' ' HG2' ' A' ' 54' ' ' GLU . . . -67.3 -23.43 65.65 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-O 121.079 0.466 . . . . 0.0 110.806 179.042 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 10.0 tt -69.88 -34.08 73.08 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.944 -0.571 . . . . 0.0 109.554 176.073 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.486 ' HB3' ' O ' ' A' ' 50' ' ' PRO . 11.3 tttm -65.54 -46.71 78.5 Favored 'General case' 0 N--CA 1.425 -1.675 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 172.402 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.586 ' HG2' ' HA ' ' A' ' 51' ' ' ALA . 24.4 mm-40 -52.6 -44.65 66.11 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.05 -0.977 . . . . 0.0 110.001 176.688 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 47.8 mt -57.15 -53.55 56.8 Favored 'General case' 0 N--CA 1.452 -0.375 0 CA-C-N 115.433 -0.803 . . . . 0.0 111.249 175.418 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -48.87 -58.86 4.16 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.204 -0.907 . . . . 0.0 111.848 -179.052 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -71.11 -27.69 63.77 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 111.828 0.306 . . . . 0.0 111.828 -176.49 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 33.5 tttm -66.12 -25.04 66.81 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-O 121.01 0.433 . . . . 0.0 109.911 175.185 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.715 ' HD1' ' HG3' ' A' ' 62' ' ' LYS . 53.1 m-85 -124.26 18.34 9.06 Favored 'General case' 0 N--CA 1.453 -0.284 0 N-CA-C 112.766 0.654 . . . . 0.0 112.766 -176.522 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -62.03 110.23 1.52 Allowed 'General case' 0 C--N 1.323 -0.543 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 169.595 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 113.74 -13.27 22.57 Favored Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 120.802 -0.713 . . . . 0.0 111.758 -175.215 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.777 ' HD2' ' HG ' ' A' ' 142' ' ' LEU . 28.7 mmtp -84.82 -170.38 3.09 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-O 121.416 0.627 . . . . 0.0 110.809 177.418 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.578 ' CG ' ' HG3' ' A' ' 31' ' ' LYS . 16.9 t70 -116.95 82.96 1.89 Allowed 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.417 -179.217 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.541 HD11 ' HB2' ' A' ' 34' ' ' TYR . 17.2 tt -157.97 141.94 7.05 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.535 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.342 177.211 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' HIS . . . . . 0.527 ' NE2' ' HB3' ' A' ' 31' ' ' LYS . 84.5 m-70 -103.52 108.58 19.89 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 109.176 -0.676 . . . . 0.0 109.176 171.258 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 89.6 m-85 -78.78 103.54 8.79 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 172.783 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.701 ' HA ' ' O ' ' A' ' 90' ' ' ILE . 41.2 t -127.79 117.87 47.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-O 120.797 0.332 . . . . 0.0 111.068 -174.501 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . 0.533 ' HA ' ' O ' ' A' ' 36' ' ' ASP . 8.3 m -109.16 147.37 32.61 Favored 'General case' 0 C--N 1.318 -0.768 0 C-N-CA 120.687 -0.405 . . . . 0.0 110.597 178.03 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.56 HD13 ' HB2' ' A' ' 92' ' ' LEU . 3.8 mm? -110.96 132.91 53.81 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.476 178.355 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 27.5 t -112.95 117.33 31.78 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.106 0.479 . . . . 0.0 111.693 -179.118 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 71.7 m -91.81 33.24 1.05 Allowed 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.247 172.791 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.528 ' OD2' HG22 ' A' ' 40' ' ' THR . 0.4 OUTLIER -75.62 126.41 30.95 Favored 'General case' 0 CA--C 1.512 -0.514 0 C-N-CA 120.155 -0.618 . . . . 0.0 110.446 178.07 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.597 ' H ' ' HE3' ' A' ' 73' ' ' LYS . 0.0 OUTLIER -78.13 -14.56 59.43 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.224 -178.887 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . 0.603 ' HB2' ' HB3' ' A' ' 77' ' ' ALA . 0.6 OUTLIER -101.19 68.95 1.26 Allowed 'General case' 0 CA--C 1.512 -0.51 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 179.283 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.613 ' O ' ' HG3' ' A' ' 79' ' ' GLU . 11.8 tmtt? -54.66 -53.13 58.8 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.616 -173.779 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.451 ' HA ' ' CD ' ' A' ' 79' ' ' GLU . 18.2 tptp -52.87 -53.74 44.66 Favored 'General case' 0 C--N 1.327 -0.376 0 O-C-N 123.321 0.388 . . . . 0.0 110.847 179.018 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.603 ' HB3' ' HB2' ' A' ' 74' ' ' ASN . . . -56.53 -36.67 69.49 Favored 'General case' 0 C--O 1.24 0.565 0 CA-C-O 121.517 0.675 . . . . 0.0 110.505 179.358 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' TRP . . . . . 0.659 ' HZ2' ' CE3' ' A' ' 38' ' ' TRP . 8.0 t-105 -68.64 -34.21 75.35 Favored 'General case' 0 N--CA 1.435 -1.216 0 CA-C-N 114.807 -1.088 . . . . 0.0 110.606 -178.02 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.613 ' HG3' ' O ' ' A' ' 75' ' ' LYS . 52.7 mt-10 -53.66 -51.35 63.46 Favored 'General case' 0 CA--C 1.515 -0.39 0 CA-C-O 121.482 0.658 . . . . 0.0 110.822 173.766 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . 0.596 ' ND2' ' HA ' ' A' ' 77' ' ' ALA . 0.7 OUTLIER -66.23 -33.57 76.06 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.253 -0.885 . . . . 0.0 111.188 -173.282 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 1.4 tmt? -63.87 -59.12 4.92 Favored 'General case' 0 CA--C 1.517 -0.314 0 C-N-CA 120.849 -0.34 . . . . 0.0 111.306 177.731 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.633 HG11 HG21 ' A' ' 18' ' ' ILE . 5.7 p -58.52 -28.65 36.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-O 121.066 0.46 . . . . 0.0 110.873 -176.27 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 27.8 m -76.23 -40.43 52.12 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.927 -0.578 . . . . 0.0 110.954 176.902 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . 0.508 ' C ' ' HE2' ' A' ' 84' ' ' LYS . 0.0 OUTLIER -73.69 -49.0 27.92 Favored 'General case' 0 N--CA 1.456 -0.16 0 CA-C-O 121.338 0.589 . . . . 0.0 109.656 -178.096 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -76.27 0.49 19.09 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.129 -0.941 . . . . 0.0 111.211 -173.427 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 27.5 mt-30 61.41 34.21 18.34 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-N 115.79 -0.641 . . . . 0.0 112.575 168.853 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.596 ' HB2' HG23 ' A' ' 82' ' ' VAL . 72.0 mt -67.34 151.44 47.46 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.193 0.521 . . . . 0.0 111.548 -176.662 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 22.0 mmtm -117.75 -168.03 1.43 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.562 176.482 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 82.65 170.58 45.76 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 121.151 -0.547 . . . . 0.0 112.743 -177.719 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.701 ' O ' ' HA ' ' A' ' 67' ' ' VAL . 62.9 mt -85.64 112.11 21.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 N-CA-C 108.509 -0.922 . . . . 0.0 108.509 175.064 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . 0.685 ' HB3' ' CZ2' ' A' ' 38' ' ' TRP . 11.6 mm-40 -119.28 109.95 16.43 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-O 121.139 0.495 . . . . 0.0 111.181 -169.452 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.56 ' HB2' HD13 ' A' ' 69' ' ' LEU . 61.2 mt -106.55 149.46 27.12 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.465 0.65 . . . . 0.0 110.725 -177.64 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' HIS . . . . . 0.612 ' CE1' ' HA2' ' A' ' 95' ' ' GLY . 17.2 t-80 -119.95 111.59 18.11 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.662 -177.011 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 1.4 ttp -61.95 -49.64 75.3 Favored 'General case' 0 N--CA 1.448 -0.574 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.442 179.102 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . 0.612 ' HA2' ' CE1' ' A' ' 93' ' ' HIS . . . 118.68 -109.59 1.77 Allowed Glycine 0 N--CA 1.44 -1.076 0 CA-C-N 115.335 -0.848 . . . . 0.0 111.212 -177.997 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 1.7 m -126.94 24.17 6.48 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-O 120.731 0.3 . . . . 0.0 110.591 -179.255 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -87.32 142.65 27.73 Favored 'General case' 0 C--O 1.236 0.375 0 C-N-CA 119.656 -0.818 . . . . 0.0 111.276 -176.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . 0.807 ' HA ' ' HB2' ' A' ' 101' ' ' MET . 8.0 tpt180 -127.34 -3.42 6.19 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.039 -0.982 . . . . 0.0 110.163 178.057 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 1.5 m -66.49 -41.17 89.34 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 176.207 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . 0.403 ' CZ ' ' HE2' ' A' ' 104' ' ' TYR . 6.1 t80 -83.11 -24.34 32.66 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.433 -0.803 . . . . 0.0 109.707 176.298 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' MET . . . . . 0.807 ' HB2' ' HA ' ' A' ' 98' ' ' ARG . 0.0 OUTLIER -64.39 -55.49 20.69 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.432 -0.803 . . . . 0.0 109.078 178.125 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . 0.493 ' CG ' ' HE ' ' A' ' 98' ' ' ARG . 7.8 m-20 -65.02 -25.3 67.79 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.907 174.826 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -59.97 -32.24 70.64 Favored 'General case' 0 N--CA 1.466 0.33 0 N-CA-C 112.02 0.378 . . . . 0.0 112.02 -176.399 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' TYR . . . . . 0.403 ' HE2' ' CZ ' ' A' ' 100' ' ' PHE . 23.4 m-85 -101.04 8.55 42.89 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.619 0.247 . . . . 0.0 111.386 179.299 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 3.5 mm? 61.18 21.03 11.52 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.211 -179.831 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . 0.603 HG12 ' O ' ' A' ' 101' ' ' MET . 15.3 pt -79.98 150.55 4.91 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 176.013 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . 0.481 ' ND2' HH22 ' A' ' 98' ' ' ARG . 12.1 t-20 -160.82 -64.34 0.06 Allowed 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 -179.798 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -77.28 78.8 1.4 Allowed Glycine 0 N--CA 1.449 -0.498 0 N-CA-C 111.061 -0.815 . . . . 0.0 111.061 174.359 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.587 ' HB ' ' HA ' ' A' ' 110' ' ' PRO . 2.8 pp -75.68 161.1 77.48 Favored Pre-proline 0 C--N 1.323 -0.572 0 CA-C-N 115.719 -0.241 . . . . 0.0 111.546 -175.366 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . 0.809 ' HD3' ' HB2' ' A' ' 45' ' ' CYS . 40.1 Cg_endo -68.72 164.21 76.73 Favored 'Cis proline' 0 C--N 1.35 0.633 0 C-N-CA 124.029 -1.238 . . . . 0.0 113.504 0.983 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . 0.578 HH11 HG22 ' A' ' 106' ' ' ILE . 0.0 OUTLIER -129.54 137.59 50.85 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.728 -0.669 . . . . 0.0 109.43 179.314 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . 0.434 ' H ' ' HD3' ' A' ' 111' ' ' ARG . 0.2 OUTLIER -105.55 115.47 30.3 Favored 'General case' 0 C--N 1.323 -0.583 0 O-C-N 124.712 1.257 . . . . 0.0 111.413 -172.157 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.511 ' HB ' ' HB ' ' A' ' 35' ' ' ILE . 79.3 mt -131.16 146.15 34.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 120.936 0.398 . . . . 0.0 110.903 -178.956 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 42.0 tp -128.89 135.6 49.28 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.148 178.382 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.489 ' N ' HD12 ' A' ' 115' ' ' LEU . 1.3 mp -135.51 161.13 36.34 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.368 0.604 . . . . 0.0 110.892 -178.216 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . 0.867 ' HB3' ' HB2' ' A' ' 120' ' ' LYS . 17.8 t70 -74.22 165.35 25.31 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 114.874 -1.057 . . . . 0.0 110.443 175.728 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . 0.67 ' O ' ' HA ' ' A' ' 29' ' ' LYS . 53.8 mtt-85 -46.71 -39.35 11.35 Favored 'General case' 0 C--N 1.33 -0.271 0 O-C-N 124.308 1.005 . . . . 0.0 112.423 -178.562 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . 0.621 ' HA ' ' HG3' ' A' ' 29' ' ' LYS . 14.6 t0 -83.92 16.77 2.65 Favored 'General case' 0 C--O 1.237 0.423 0 CA-C-O 121.154 0.502 . . . . 0.0 111.253 -177.623 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . 0.557 ' HA2' HD12 ' A' ' 33' ' ' ILE . . . 72.85 25.26 74.32 Favored Glycine 0 N--CA 1.435 -1.416 0 C-N-CA 120.417 -0.897 . . . . 0.0 110.869 -175.712 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . 0.867 ' HB2' ' HB3' ' A' ' 116' ' ' ASP . 40.3 mmtm -85.7 104.17 15.17 Favored 'General case' 0 C--O 1.22 -0.462 0 C-N-CA 120.378 -0.529 . . . . 0.0 111.458 -179.196 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 0.647 ' H ' HD12 ' A' ' 121' ' ' ILE . 3.8 mp -44.81 113.22 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.678 -179.053 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' ILE . . . . . 0.42 ' H ' ' HA ' ' A' ' 115' ' ' LEU . 46.0 mm -95.75 -44.25 12.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.664 -0.698 . . . . 0.0 109.597 177.855 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 14.6 m -142.29 114.82 8.48 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.485 -0.78 . . . . 0.0 110.086 177.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . 0.407 ' HA ' HG23 ' A' ' 113' ' ' ILE . . . -78.06 -6.9 56.05 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.043 0.449 . . . . 0.0 110.832 179.276 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 5.9 t30 -150.81 100.59 2.83 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.83 -0.623 . . . . 0.0 109.416 179.456 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' MET . . . . . 0.633 ' HG2' HG23 ' A' ' 134' ' ' THR . 43.9 tpp -89.67 -91.04 0.14 Allowed 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 111.935 0.346 . . . . 0.0 111.935 -176.76 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . 0.527 ' O ' ' HG2' ' A' ' 128' ' ' ARG . 0.0 OUTLIER -152.67 -70.21 0.15 Allowed 'General case' 0 CA--C 1.531 0.235 0 N-CA-C 112.322 0.49 . . . . 0.0 112.322 -178.326 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . 0.527 ' HG2' ' O ' ' A' ' 127' ' ' THR . 3.5 mmt180 175.99 140.13 0.21 Allowed Pre-proline 0 N--CA 1.467 0.393 0 C-N-CA 124.351 1.06 . . . . 0.0 109.299 -173.474 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . 0.422 ' HG3' ' OD2' ' A' ' 36' ' ' ASP . 46.0 Cg_exo -56.44 -37.33 97.38 Favored 'Trans proline' 0 C--N 1.342 0.23 0 C-N-CA 122.339 2.026 . . . . 0.0 111.874 171.522 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . 0.652 ' HB3' ' HB3' ' A' ' 48' ' ' GLU . 13.3 p -78.06 -25.67 47.83 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.821 179.663 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . 0.501 ' OD2' ' HB2' ' A' ' 133' ' ' LYS . 29.7 t70 -78.49 117.6 67.31 Favored Pre-proline 0 C--N 1.327 -0.406 0 CA-C-O 120.832 0.348 . . . . 0.0 110.724 -175.336 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . 0.585 ' O ' ' HG2' ' A' ' 136' ' ' GLU . 49.6 Cg_exo -56.6 -29.49 79.47 Favored 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 123.469 2.78 . . . . 0.0 113.73 -175.233 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . 0.763 ' H ' ' HD3' ' A' ' 133' ' ' LYS . 0.0 OUTLIER -54.48 -35.36 62.99 Favored 'General case' 0 N--CA 1.456 -0.152 0 CA-C-O 120.578 0.227 . . . . 0.0 110.688 -177.824 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' THR . . . . . 0.633 HG23 ' HG2' ' A' ' 126' ' ' MET . 4.6 m -60.69 -48.81 80.13 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.482 0.658 . . . . 0.0 110.666 178.399 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . 0.626 ' HA ' ' CD2' ' A' ' 138' ' ' PHE . . . -61.78 -43.36 99.0 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.315 -0.857 . . . . 0.0 111.106 -178.228 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . 0.585 ' HG2' ' O ' ' A' ' 132' ' ' PRO . 10.8 mm-40 -72.05 -23.97 61.45 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.546 -177.279 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . 0.718 ' HG2' ' O ' ' A' ' 133' ' ' LYS . 17.8 mmtm -56.07 -49.77 72.85 Favored 'General case' 0 CA--C 1.515 -0.369 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 167.901 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . 0.626 ' CD2' ' HA ' ' A' ' 135' ' ' ALA . 7.0 m-30 -55.26 -36.91 66.58 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-N 115.163 -0.926 . . . . 0.0 110.57 -178.746 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . 0.558 ' ND2' ' HA ' ' A' ' 136' ' ' GLU . 72.8 m-20 -58.13 -56.41 22.38 Favored 'General case' 0 C--N 1.332 -0.179 0 C-N-CA 120.686 -0.406 . . . . 0.0 110.693 175.839 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -44.73 -59.91 2.28 Favored 'General case' 0 C--N 1.342 0.258 0 O-C-N 123.615 0.572 . . . . 0.0 111.675 178.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.434 HD13 ' O ' ' A' ' 137' ' ' LYS . 8.5 mp -50.69 -37.8 43.33 Favored 'General case' 0 CA--C 1.531 0.226 0 N-CA-C 112.595 0.591 . . . . 0.0 112.595 178.86 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.777 ' HG ' ' HD2' ' A' ' 62' ' ' LYS . 3.8 mm? -79.3 -29.2 42.34 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.623 0.249 . . . . 0.0 111.623 179.264 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 98.13 27.27 8.89 Favored Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 120.949 -0.643 . . . . 0.0 112.297 178.789 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.544 ' HB3' ' HB3' ' A' ' 139' ' ' ASN . 50.4 tp -75.25 -32.28 61.04 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.037 0.446 . . . . 0.0 110.46 -177.621 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 4.4 mp0 -54.76 -34.92 63.21 Favored 'General case' 0 C--O 1.238 0.449 0 CA-C-N 115.287 -0.869 . . . . 0.0 110.88 178.477 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 64.45 8.4 31.67 Favored Glycine 0 C--N 1.32 -0.335 0 CA-C-N 114.097 -1.41 . . . . 0.0 112.525 -178.791 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 74.4 m80 -151.5 -57.18 0.15 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.216 0.531 . . . . 0.0 109.587 -175.766 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' HIS . . . . . 0.535 ' O ' ' HB2' ' A' ' 149' ' ' HIS . 67.5 t60 -76.62 92.32 3.49 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.602 -0.727 . . . . 0.0 111.272 -178.514 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . 0.535 ' HB2' ' O ' ' A' ' 148' ' ' HIS . 4.5 t-160 172.41 -80.53 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 115.408 -0.815 . . . . 0.0 108.911 170.235 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' HIS . . . . . 0.408 ' H ' ' HB3' ' A' ' 149' ' ' HIS . 17.0 t60 65.33 -65.95 0.15 Allowed 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 123.651 0.78 . . . . 0.0 111.427 -179.837 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 54.1 t-80 -153.8 99.5 2.29 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 109.934 -0.395 . . . . 0.0 109.934 177.222 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' HIS . . . . . 0.415 ' HB3' ' CD2' ' A' ' 149' ' ' HIS . 11.0 t-80 . . . . . 0 C--N 1.318 -0.77 0 CA-C-O 118.175 -0.917 . . . . 0.0 109.268 179.545 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 58.1 tpp . . . . . 0 N--CA 1.479 0.99 0 CA-C-O 120.792 0.329 . . . . 0.0 110.219 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 14.8 m -96.2 86.23 4.19 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.006 0.431 . . . . 0.0 109.93 179.385 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 88.5 mt -67.47 112.68 4.79 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.646 -0.706 . . . . 0.0 111.063 -178.492 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 5.9 ptp180 -117.52 6.86 12.57 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.539 -0.755 . . . . 0.0 109.547 178.494 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 8.0 m -141.03 129.56 22.62 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-N 115.039 -0.982 . . . . 0.0 109.243 -178.838 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 109.1 -133.23 11.53 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.756 -0.735 . . . . 0.0 111.381 -178.164 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . 0.411 ' HA ' ' HD3' ' A' ' 8' ' ' PRO . 25.1 p-10 -114.93 149.79 43.06 Favored Pre-proline 0 C--N 1.325 -0.482 0 CA-C-N 116.994 0.397 . . . . 0.0 110.429 176.769 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.421 ' HB3' ' HA ' ' A' ' 13' ' ' PHE . 14.1 Cg_exo -68.16 146.72 71.12 Favored 'Trans proline' 0 N--CA 1.464 -0.219 0 C-N-CA 122.801 2.334 . . . . 0.0 112.279 179.521 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 51.0 m -103.12 174.01 6.05 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.18 -0.463 . . . . 0.0 109.968 176.524 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -76.45 71.08 3.09 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.136 0.493 . . . . 0.0 110.489 178.784 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -156.2 -43.44 0.08 Allowed 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.291 -0.868 . . . . 0.0 110.768 -179.35 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 23.5 p -149.91 33.49 0.68 Allowed 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 115.165 -0.925 . . . . 0.0 110.628 -178.256 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . 0.426 ' CE2' HD22 ' A' ' 25' ' ' LEU . 27.5 p90 -63.18 150.11 43.73 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.252 -177.278 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.42 ' HA ' ' HA ' ' A' ' 24' ' ' SER . 15.9 m -137.06 127.53 26.7 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 178.047 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . 0.42 ' CE2' ' HB2' ' A' ' 13' ' ' PHE . 77.6 m-85 -138.34 156.93 73.34 Favored Pre-proline 0 C--N 1.326 -0.436 0 CA-C-O 120.752 0.311 . . . . 0.0 111.356 -175.399 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.481 ' HD2' ' O ' ' A' ' 93' ' ' HIS . 1.6 Cg_endo -83.53 126.77 4.2 Favored 'Trans proline' 0 N--CA 1.459 -0.556 0 C-N-CA 123.183 2.588 . . . . 0.0 113.85 -178.488 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . 1.028 ' HB3' ' HB3' ' A' ' 21' ' ' LYS . 0.4 OUTLIER -65.08 166.14 9.99 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 114.88 -1.055 . . . . 0.0 109.584 169.47 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.579 ' HB ' ' HB2' ' A' ' 79' ' ' GLU . 40.0 pt -48.74 -33.36 5.01 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 C-N-CA 123.561 0.744 . . . . 0.0 112.803 -175.169 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 36.8 m-80 -83.7 -3.1 57.5 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.776 0.322 . . . . 0.0 111.599 -177.48 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 89.83 29.25 16.19 Favored Glycine 0 N--CA 1.45 -0.377 0 N-CA-C 110.212 -1.155 . . . . 0.0 110.212 -171.21 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 1.028 ' HB3' ' HB3' ' A' ' 17' ' ' ASP . 19.1 ttmt -92.23 111.74 23.42 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 114.872 -0.664 . . . . 0.0 110.639 -172.921 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 20.3 m -70.58 112.54 6.91 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 120.796 0.331 . . . . 0.0 111.376 -177.755 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.588 ' HB ' HD21 ' A' ' 92' ' ' LEU . 59.9 t -124.3 145.57 31.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 177.107 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . 0.42 ' HA ' ' HA ' ' A' ' 14' ' ' SER . 94.5 p -122.01 -175.46 3.12 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.084 0.468 . . . . 0.0 110.904 -175.784 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.471 ' O ' ' HB2' ' A' ' 29' ' ' LYS . 30.8 tp -93.68 -0.32 56.11 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.072 175.479 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.436 ' O ' ' HB3' ' A' ' 29' ' ' LYS . . . -88.94 -35.41 16.48 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.004 -179.196 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 3.9 p30 -78.18 -22.87 47.99 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.448 0.642 . . . . 0.0 110.062 176.7 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.426 HD13 HG21 ' A' ' 67' ' ' VAL . 85.7 mt -89.66 -8.79 51.69 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.105 175.311 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.471 ' HB2' ' O ' ' A' ' 25' ' ' LEU . 48.3 tttp -76.45 140.29 41.21 Favored 'General case' 0 N--CA 1.446 -0.654 0 CA-C-N 115.48 -0.782 . . . . 0.0 111.177 -176.254 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 110.54 2.32 29.16 Favored Glycine 0 N--CA 1.449 -0.481 0 N-CA-C 111.382 -0.687 . . . . 0.0 111.382 -177.153 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.597 ' HG3' ' CG ' ' A' ' 63' ' ' ASP . 24.6 ttmm -152.43 149.91 29.08 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 109.076 -0.712 . . . . 0.0 109.076 -179.758 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.449 ' HB2' ' O ' ' A' ' 63' ' ' ASP . 39.3 m-85 -49.11 144.92 4.53 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-O 121.044 0.45 . . . . 0.0 111.889 -177.307 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.511 ' HB ' ' HB2' ' A' ' 115' ' ' LEU . 35.3 mm -121.53 122.69 67.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.985 -177.234 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 78.6 t80 -116.96 112.01 20.4 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 108.782 -0.822 . . . . 0.0 108.782 171.701 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.716 ' HB ' ' CG2' ' A' ' 113' ' ' ILE . 78.8 mt -105.35 129.4 58.24 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 C-N-CA 120.563 -0.455 . . . . 0.0 110.446 -177.023 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.504 ' HA ' ' O ' ' A' ' 111' ' ' ARG . 1.8 t70 -123.34 159.72 28.26 Favored 'General case' 0 C--N 1.314 -0.938 0 N-CA-C 108.798 -0.815 . . . . 0.0 108.798 178.06 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.532 HG11 HG21 ' A' ' 109' ' ' ILE . 58.9 t -104.59 112.79 39.6 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.953 0 C-N-CA 120.258 -0.577 . . . . 0.0 110.49 176.24 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' TRP . . . . . 0.597 ' CZ2' ' HB3' ' A' ' 91' ' ' GLN . 0.6 OUTLIER -101.98 132.64 47.7 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.235 -176.055 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.427 ' HA ' ' OD1' ' A' ' 72' ' ' ASP . . . -147.05 156.25 42.87 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.885 -178.21 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.717 ' HB ' ' CE3' ' A' ' 78' ' ' TRP . 14.6 t -99.14 -23.46 15.23 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 120.898 -0.321 . . . . 0.0 110.808 175.418 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 8.8 p-90 -84.08 -8.0 59.23 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.076 0.465 . . . . 0.0 110.831 -179.94 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 42.5 t -91.99 105.29 17.57 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 175.713 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.406 ' N ' ' HD2' ' A' ' 44' ' ' PRO . . . -54.74 -61.68 7.05 Favored Glycine 0 CA--C 1.524 0.641 0 CA-C-N 115.712 -0.676 . . . . 0.0 113.837 -178.424 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.406 ' HD2' ' N ' ' A' ' 43' ' ' GLY . 12.3 Cg_endo -55.76 -34.33 90.66 Favored 'Trans proline' 0 C--N 1.352 0.755 0 C-N-CA 122.901 2.401 . . . . 0.0 112.66 -177.415 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . 0.706 ' O ' ' HG ' ' A' ' 49' ' ' LEU . 49.6 t -53.08 -39.75 63.57 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.178 179.481 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.678 HH12 ' HH2' ' A' ' 78' ' ' TRP . 20.1 mmm180 -65.92 -20.76 66.33 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.585 -174.409 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -80.56 -40.18 13.26 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.84 -0.695 . . . . 0.0 113.383 -174.126 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -95.72 -6.36 39.98 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 117.077 0.438 . . . . 0.0 111.604 -174.424 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.706 ' HG ' ' O ' ' A' ' 45' ' ' CYS . 39.7 mt -56.96 -47.42 99.12 Favored Pre-proline 0 C--N 1.327 -0.376 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.926 175.868 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.518 ' O ' ' HG2' ' A' ' 54' ' ' GLU . 75.4 Cg_exo -51.6 -40.39 64.14 Favored 'Trans proline' 0 C--N 1.358 1.051 0 C-N-CA 121.972 1.781 . . . . 0.0 112.113 173.906 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -69.86 -27.45 64.85 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.431 0.634 . . . . 0.0 110.695 -178.418 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.592 HD22 ' HE3' ' A' ' 88' ' ' LYS . 3.6 tt -73.36 -33.2 64.94 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.506 -0.77 . . . . 0.0 109.214 176.247 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.87 ' HE2' HD23 ' A' ' 87' ' ' LEU . 85.0 mttt -64.61 -50.37 67.44 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 108.933 -0.765 . . . . 0.0 108.933 174.905 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.518 ' HG2' ' O ' ' A' ' 50' ' ' PRO . 33.1 mm-40 -51.82 -41.75 62.0 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-N 114.822 -1.081 . . . . 0.0 110.836 175.797 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.594 HD21 ' CE2' ' A' ' 138' ' ' PHE . 17.6 tp -61.29 -44.41 97.26 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.05 -0.977 . . . . 0.0 111.057 -178.624 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.569 ' OE1' ' HB2' ' A' ' 88' ' ' LYS . 24.4 tt0 -65.17 -36.53 84.5 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-N 116.61 -0.268 . . . . 0.0 111.306 -178.192 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 17.2 mm-40 -54.07 -54.41 39.83 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.579 0.704 . . . . 0.0 109.832 173.851 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.491 ' HE3' ' CZ ' ' A' ' 59' ' ' TYR . 32.6 tttp -53.81 -33.88 57.47 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 114.58 -1.191 . . . . 0.0 112.333 177.334 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.491 ' CZ ' ' HE3' ' A' ' 58' ' ' LYS . 84.9 m-85 -111.16 16.95 20.78 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 112.335 0.494 . . . . 0.0 112.335 -175.88 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -64.1 131.68 48.22 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.868 0.366 . . . . 0.0 110.64 176.552 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 68.68 44.7 69.53 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.922 -0.656 . . . . 0.0 112.176 -179.506 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 40.2 mmtm -128.51 -154.11 0.61 Allowed 'General case' 0 N--CA 1.45 -0.432 0 CA-C-O 120.981 0.419 . . . . 0.0 109.981 177.2 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.597 ' CG ' ' HG3' ' A' ' 31' ' ' LYS . 10.4 t70 -111.77 69.46 0.69 Allowed 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 116.182 -0.463 . . . . 0.0 109.799 177.022 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.569 HG13 ' O ' ' A' ' 63' ' ' ASP . 15.1 mt -151.89 139.32 13.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.274 178.437 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' HIS . . . . . 0.509 ' NE2' ' HB3' ' A' ' 31' ' ' LYS . 92.0 m-70 -114.92 111.3 20.96 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.49 -0.777 . . . . 0.0 109.949 173.406 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . 0.506 ' HE1' HD23 ' A' ' 55' ' ' LEU . 89.4 m-85 -81.9 103.66 11.71 Favored 'General case' 0 C--N 1.318 -0.782 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 171.179 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.626 ' HA ' ' O ' ' A' ' 90' ' ' ILE . 41.9 t -116.28 122.12 69.03 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.436 -176.242 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . 0.76 ' HB2' ' HG2' ' A' ' 91' ' ' GLN . 50.7 m -110.54 134.94 51.93 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 116.544 -0.298 . . . . 0.0 110.932 -178.707 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.485 HD13 ' HB2' ' A' ' 92' ' ' LEU . 4.5 mm? -115.75 139.45 50.14 Favored 'General case' 0 N--CA 1.471 0.598 0 N-CA-C 110.081 -0.34 . . . . 0.0 110.081 175.6 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 3.5 t -118.11 124.87 49.08 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 112.926 0.713 . . . . 0.0 112.926 -172.882 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 10.6 m -87.1 13.07 10.03 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.876 174.217 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.59 ' O ' ' HA2' ' A' ' 95' ' ' GLY . 1.0 OUTLIER -71.45 136.31 47.58 Favored 'General case' 0 CA--C 1.516 -0.331 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 -178.476 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.468 ' H ' ' HG2' ' A' ' 73' ' ' LYS . 0.4 OUTLIER -99.98 -18.84 16.85 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-O 121.481 0.657 . . . . 0.0 110.034 178.92 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . 0.65 ' HB2' ' HB3' ' A' ' 77' ' ' ALA . 0.8 OUTLIER -80.8 61.05 4.3 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.026 -0.988 . . . . 0.0 109.785 174.369 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 9.5 tttt -50.67 -53.79 28.31 Favored 'General case' 0 C--O 1.222 -0.35 0 N-CA-C 112.647 0.61 . . . . 0.0 112.647 -171.177 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.506 ' HA ' ' OE1' ' A' ' 79' ' ' GLU . 40.3 tptt -61.7 -42.3 98.74 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.842 0.353 . . . . 0.0 110.989 -177.149 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.65 ' HB3' ' HB2' ' A' ' 74' ' ' ASN . . . -63.84 -33.76 76.4 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 121.746 0.784 . . . . 0.0 110.119 176.927 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' TRP . . . . . 0.717 ' CE3' ' HB ' ' A' ' 40' ' ' THR . 9.7 t-105 -76.72 -50.21 14.17 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 114.797 -1.092 . . . . 0.0 111.555 -177.463 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.579 ' HB2' ' HB ' ' A' ' 18' ' ' ILE . 4.1 pt-20 -60.38 -34.44 73.9 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-O 121.198 0.523 . . . . 0.0 110.357 -176.255 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . 0.63 ' O ' ' HD3' ' A' ' 84' ' ' LYS . 3.4 p30 -79.42 -29.97 42.15 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 119.67 -0.812 . . . . 0.0 110.668 177.622 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 13.6 tpt -61.4 -47.56 85.26 Favored 'General case' 0 C--O 1.225 -0.235 0 O-C-N 122.437 -0.164 . . . . 0.0 111.175 175.374 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.696 HG23 ' HB2' ' A' ' 87' ' ' LEU . 0.2 OUTLIER -61.1 -36.15 70.55 Favored 'Isoleucine or valine' 0 C--O 1.232 0.164 0 C-N-CA 120.386 -0.526 . . . . 0.0 110.17 175.602 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 76.3 m -61.51 -41.93 98.04 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.289 174.863 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . 0.63 ' HD3' ' O ' ' A' ' 80' ' ' ASN . 1.9 mptm? -72.9 -46.92 50.08 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-O 121.092 0.472 . . . . 0.0 110.912 179.684 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -66.03 -25.81 67.23 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.287 -0.869 . . . . 0.0 111.01 -176.477 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 29.2 mm-40 64.59 72.8 0.44 Allowed 'General case' 0 C--O 1.234 0.287 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.561 -175.843 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.87 HD23 ' HE2' ' A' ' 53' ' ' LYS . 89.8 mt -92.99 -179.46 5.11 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.05 177.007 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.592 ' HE3' HD22 ' A' ' 52' ' ' LEU . 0.0 OUTLIER -145.74 173.62 11.93 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 112.534 0.568 . . . . 0.0 112.534 -171.424 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 78.4 -170.71 54.95 Favored Glycine 0 N--CA 1.452 -0.24 0 CA-C-N 115.593 -0.731 . . . . 0.0 112.856 178.883 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.626 ' O ' ' HA ' ' A' ' 67' ' ' VAL . 5.0 mp -89.66 112.1 24.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 177.219 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . 0.76 ' HG2' ' HB2' ' A' ' 68' ' ' SER . 21.8 mt-30 -123.11 111.02 16.03 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-O 121.475 0.655 . . . . 0.0 111.061 -174.561 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.588 HD21 ' HB ' ' A' ' 23' ' ' VAL . 55.2 mt -105.98 164.36 12.02 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 114.979 -1.009 . . . . 0.0 109.668 -178.238 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' HIS . . . . . 0.481 ' O ' ' HD2' ' A' ' 16' ' ' PRO . 17.7 t-80 -131.46 124.67 30.67 Favored 'General case' 0 C--N 1.313 -1.015 0 CA-C-O 120.936 0.398 . . . . 0.0 111.357 -171.577 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 24.0 ttp -79.94 -58.02 3.37 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.241 179.39 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . 0.59 ' HA2' ' O ' ' A' ' 72' ' ' ASP . . . 101.34 -93.88 1.18 Allowed Glycine 0 N--CA 1.444 -0.789 0 C-N-CA 120.304 -0.951 . . . . 0.0 113.549 174.212 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 4.6 p -109.09 8.63 26.17 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 112.84 0.682 . . . . 0.0 112.84 -172.067 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -102.21 153.11 20.27 Favored 'General case' 0 CA--C 1.517 -0.309 0 C-N-CA 119.811 -0.756 . . . . 0.0 109.962 177.269 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.14 6.93 3.37 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.965 -0.561 . . . . 0.0 109.608 173.462 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 6.9 m -76.54 -32.7 58.39 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.044 -176.038 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 59.5 t80 -74.6 -37.49 62.85 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.546 -0.752 . . . . 0.0 111.014 178.938 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 5.2 ppp? -77.4 -26.17 51.52 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 176.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -68.05 -29.92 69.01 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.427 -0.806 . . . . 0.0 109.965 172.876 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -63.25 -18.61 63.74 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-N 115.991 -0.549 . . . . 0.0 111.37 179.181 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 72.3 m-85 -97.36 -5.43 36.43 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-O 120.837 0.351 . . . . 0.0 110.078 178.511 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 87.1 mt 60.19 17.04 6.55 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 115.35 -0.841 . . . . 0.0 111.345 179.349 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 11.1 tp -73.7 -45.15 51.29 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.35 0 N-CA-C 112.566 0.58 . . . . 0.0 112.566 -172.573 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 9.0 t30 67.66 -62.64 0.33 Allowed 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 123.158 0.583 . . . . 0.0 111.613 -176.909 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -91.77 111.05 3.95 Favored Glycine 0 N--CA 1.447 -0.579 0 C-N-CA 121.183 -0.532 . . . . 0.0 112.575 -176.537 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.532 HG21 HG11 ' A' ' 37' ' ' VAL . 43.2 pt -85.1 158.28 58.63 Favored Pre-proline 0 C--N 1.322 -0.595 0 N-CA-C 110.434 -0.21 . . . . 0.0 110.434 176.81 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . 0.531 ' HA ' ' HB ' ' A' ' 109' ' ' ILE . 3.0 Cg_exo -74.31 158.69 98.61 Favored 'Cis proline' 0 C--N 1.348 0.53 0 C-N-CA 124.132 -1.195 . . . . 0.0 113.426 1.473 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . 0.707 ' HD2' ' N ' ' A' ' 112' ' ' PHE . 0.1 OUTLIER -113.32 140.41 48.04 Favored 'General case' 0 N--CA 1.442 -0.874 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 175.979 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . 0.707 ' N ' ' HD2' ' A' ' 111' ' ' ARG . 4.2 m-85 -115.44 132.41 56.63 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 108.609 -0.885 . . . . 0.0 108.609 -177.953 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.716 ' CG2' ' HB ' ' A' ' 35' ' ' ILE . 7.5 tt -147.53 156.77 9.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 118.492 0.587 . . . . 0.0 111.278 -177.846 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 35.3 tp -136.29 132.56 35.89 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.837 0.351 . . . . 0.0 110.495 177.754 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.562 ' HG ' ' HA ' ' A' ' 121' ' ' ILE . 2.5 mp -130.97 151.54 51.26 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 178.979 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . 0.432 ' N ' HG13 ' A' ' 122' ' ' ILE . 9.7 t70 -73.1 164.56 26.51 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.965 -0.561 . . . . 0.0 109.792 179.044 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . 0.525 ' HG2' ' HA ' ' A' ' 31' ' ' LYS . 3.9 mtm180 -47.32 -33.96 6.27 Favored 'General case' 0 C--N 1.323 -0.554 0 O-C-N 124.519 1.137 . . . . 0.0 112.271 -179.645 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -71.24 -6.03 36.58 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.215 -177.883 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 84.69 22.61 52.95 Favored Glycine 0 N--CA 1.441 -1.027 0 N-CA-C 110.006 -1.238 . . . . 0.0 110.006 -172.542 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . 0.401 ' HA ' ' HD3' ' A' ' 120' ' ' LYS . 30.4 mmtp -102.75 111.13 23.31 Favored 'General case' 0 CA--C 1.518 -0.287 0 CA-C-N 115.521 -0.339 . . . . 0.0 111.267 -174.107 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 0.637 ' H ' HD12 ' A' ' 121' ' ' ILE . 3.8 mp -41.4 115.08 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 O-C-N 124.196 0.935 . . . . 0.0 111.817 179.883 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' ILE . . . . . 0.489 ' H ' ' HA ' ' A' ' 115' ' ' LEU . 63.8 mt -83.72 -41.5 16.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 175.92 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 49.4 m -146.55 125.36 12.66 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 114.843 -1.072 . . . . 0.0 109.164 176.091 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -61.34 -31.56 71.43 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-O 121.046 0.45 . . . . 0.0 111.584 -176.189 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 10.9 t30 -138.35 113.83 9.61 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.917 -0.583 . . . . 0.0 109.468 174.554 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' MET . . . . . 0.463 ' HG3' ' H ' ' A' ' 127' ' ' THR . 7.7 tpt -93.91 -148.03 0.26 Allowed 'General case' 0 C--N 1.317 -0.833 0 N-CA-C 108.917 -0.771 . . . . 0.0 108.917 -179.401 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . 0.463 ' H ' ' HG3' ' A' ' 126' ' ' MET . 1.1 p -135.94 143.09 44.72 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-O 120.707 0.289 . . . . 0.0 110.928 -177.497 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . 0.441 ' HA ' ' CD1' ' A' ' 112' ' ' PHE . 9.2 ptp180 -40.65 154.49 0.21 Allowed Pre-proline 0 C--N 1.327 -0.408 0 N-CA-C 113.536 0.939 . . . . 0.0 113.536 176.353 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_exo -54.81 -34.02 83.45 Favored 'Trans proline' 0 C--N 1.348 0.505 0 C-N-CA 123.503 2.802 . . . . 0.0 113.135 178.178 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 16.3 m -76.16 -1.86 28.29 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.655 -178.254 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . 0.455 ' HA ' ' HD3' ' A' ' 132' ' ' PRO . 9.8 t70 -90.3 124.82 61.99 Favored Pre-proline 0 C--N 1.324 -0.511 0 N-CA-C 109.974 -0.38 . . . . 0.0 109.974 178.757 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . 0.455 ' HD3' ' HA ' ' A' ' 131' ' ' ASP . 43.5 Cg_exo -58.77 -35.71 98.2 Favored 'Trans proline' 0 C--N 1.344 0.325 0 C-N-CA 123.173 2.582 . . . . 0.0 113.414 -177.827 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . 0.668 ' HZ2' ' HB2' ' A' ' 133' ' ' LYS . 10.0 mtmp? -62.88 -34.42 77.34 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-O 121.082 0.467 . . . . 0.0 111.031 -177.036 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' THR . . . . . 0.546 HG22 ' CZ ' ' A' ' 138' ' ' PHE . 0.3 OUTLIER -69.64 -51.49 34.39 Favored 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 109.765 -0.457 . . . . 0.0 109.765 177.168 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . 0.5 ' HA ' ' CD2' ' A' ' 138' ' ' PHE . . . -54.96 -49.95 70.14 Favored 'General case' 0 C--O 1.24 0.553 0 CA-C-N 115.605 -0.725 . . . . 0.0 112.25 179.653 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . 0.538 ' HG3' ' N ' ' A' ' 137' ' ' LYS . 2.0 pt-20 -60.57 -41.44 94.64 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-O 120.978 0.418 . . . . 0.0 110.268 -179.56 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . 0.538 ' N ' ' HG3' ' A' ' 136' ' ' GLU . 0.0 OUTLIER -66.53 -33.15 75.03 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.76 -177.217 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . 0.594 ' CE2' HD21 ' A' ' 55' ' ' LEU . 20.5 m-85 -58.52 -52.54 65.2 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.336 175.008 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . 0.862 ' HB3' ' HG3' ' A' ' 145' ' ' GLU . 56.6 m-20 -57.47 -54.55 45.59 Favored 'General case' 0 N--CA 1.464 0.26 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 177.718 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 23.3 tt0 -49.91 -60.5 2.86 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 114.798 -1.092 . . . . 0.0 113.204 179.868 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 84.7 mt -67.43 -28.89 68.27 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-O 120.644 0.259 . . . . 0.0 111.616 -173.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.424 HD23 ' HB2' ' A' ' 144' ' ' LEU . 66.8 tp -76.19 -21.77 56.1 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.335 0.588 . . . . 0.0 109.737 175.202 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 78.22 25.14 62.17 Favored Glycine 0 N--CA 1.445 -0.749 0 N-CA-C 110.588 -1.005 . . . . 0.0 110.588 -176.562 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.424 ' HB2' HD23 ' A' ' 142' ' ' LEU . 9.7 tt -73.47 -35.05 65.64 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-N 114.782 -0.709 . . . . 0.0 109.727 -176.461 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . 0.862 ' HG3' ' HB3' ' A' ' 139' ' ' ASN . 50.6 mt-10 -81.64 96.97 7.67 Favored 'General case' 0 N--CA 1.444 -0.732 0 CA-C-O 121.605 0.717 . . . . 0.0 110.709 178.683 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -74.9 64.66 2.29 Favored Glycine 0 C--N 1.311 -0.808 0 CA-C-N 114.693 -1.139 . . . . 0.0 110.848 175.175 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 11.9 t-80 -78.67 34.96 0.23 Allowed 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 122.83 0.452 . . . . 0.0 111.93 -170.756 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 22.5 p-80 -143.88 137.61 28.01 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.849 -0.426 . . . . 0.0 109.849 178.493 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 13.9 p-80 -58.92 115.73 3.31 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-O 121.121 0.486 . . . . 0.0 110.078 177.591 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 60.3 t60 -81.6 85.23 6.58 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.739 -0.664 . . . . 0.0 112.45 -170.042 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 34.6 t-80 -99.0 -8.55 25.21 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 106.713 -1.588 . . . . 0.0 106.713 161.374 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 32.0 p80 . . . . . 0 C--O 1.243 0.716 0 CA-C-N 113.536 -1.666 . . . . 0.0 108.057 173.217 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.443 ' SD ' ' N ' ' A' ' 1' ' ' MET . 1.4 mpt? . . . . . 0 N--CA 1.48 1.057 0 N-CA-C 109.901 -0.407 . . . . 0.0 109.901 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 22.3 t -174.11 101.03 0.1 Allowed 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 178.197 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 6.4 mp -96.28 84.38 3.74 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 120.954 0.407 . . . . 0.0 110.553 -176.76 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 35.2 mtp180 -73.69 -3.94 31.34 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.032 0.444 . . . . 0.0 110.698 178.834 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 10.3 p -91.83 -4.51 54.78 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.487 175.855 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -145.36 -85.54 0.07 OUTLIER Glycine 0 N--CA 1.447 -0.582 0 C-N-CA 120.883 -0.675 . . . . 0.0 112.041 -179.207 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . 0.421 ' HA ' ' HD3' ' A' ' 8' ' ' PRO . 45.8 m-80 -134.64 145.59 55.58 Favored Pre-proline 0 C--N 1.327 -0.388 0 N-CA-C 110.409 -0.219 . . . . 0.0 110.409 -179.157 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.421 ' HD3' ' HA ' ' A' ' 7' ' ' ASN . 21.3 Cg_exo -65.55 158.22 54.23 Favored 'Trans proline' 0 N--CA 1.464 -0.223 0 C-N-CA 122.924 2.416 . . . . 0.0 111.975 178.182 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 16.6 m -114.28 166.74 11.34 Favored 'General case' 0 N--CA 1.445 -0.707 0 CA-C-N 116.073 -0.512 . . . . 0.0 109.793 -179.254 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -77.81 72.99 4.38 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.554 0.692 . . . . 0.0 110.068 178.169 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -139.59 91.7 2.51 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.402 -0.817 . . . . 0.0 110.969 -178.355 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 1.026 ' HA ' ' HB3' ' A' ' 25' ' ' LEU . 67.2 m 59.06 77.09 0.32 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.702 -0.681 . . . . 0.0 112.105 178.154 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 31.4 p90 -82.3 -178.98 7.25 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.569 177.324 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.483 ' HA ' ' HA ' ' A' ' 24' ' ' SER . 23.2 t -142.53 134.64 27.36 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 175.469 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . 0.412 ' HA ' ' HD3' ' A' ' 16' ' ' PRO . 36.4 m-85 -146.07 150.3 41.55 Favored Pre-proline 0 C--N 1.325 -0.472 0 N-CA-C 109.999 -0.371 . . . . 0.0 109.999 179.835 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' A' ' 15' ' ' TYR . 3.9 Cg_exo -76.64 125.3 8.14 Favored 'Trans proline' 0 N--CA 1.455 -0.778 0 C-N-CA 122.458 2.106 . . . . 0.0 112.14 178.351 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . 0.811 ' HB3' ' HB3' ' A' ' 21' ' ' LYS . 0.0 OUTLIER -60.76 163.49 5.57 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.709 -0.678 . . . . 0.0 109.62 172.051 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.548 HG12 HG11 ' A' ' 82' ' ' VAL . 10.5 tp -61.33 -25.52 36.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.817 -170.9 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.488 ' HB2' ' OD2' ' A' ' 17' ' ' ASP . 0.9 OUTLIER -81.88 -5.37 58.19 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 120.932 0.396 . . . . 0.0 110.779 178.064 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 93.42 37.38 5.61 Favored Glycine 0 N--CA 1.447 -0.576 0 N-CA-C 110.888 -0.885 . . . . 0.0 110.888 -175.6 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.811 ' HB3' ' HB3' ' A' ' 17' ' ' ASP . 3.2 ttmp? -108.37 111.48 23.42 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.709 0.29 . . . . 0.0 110.89 -173.449 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 16.7 m -70.49 109.14 4.64 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 120.87 0.366 . . . . 0.0 111.095 -179.257 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.591 ' HB ' HD21 ' A' ' 92' ' ' LEU . 39.4 t -126.48 152.78 34.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 178.355 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . 0.483 ' HA ' ' HA ' ' A' ' 14' ' ' SER . 93.8 p -122.67 176.35 6.0 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.186 0.517 . . . . 0.0 110.718 -179.973 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 1.026 ' HB3' ' HA ' ' A' ' 12' ' ' SER . 21.0 tp -95.77 15.08 21.17 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 121.761 0.791 . . . . 0.0 108.882 173.435 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.528 ' HA ' ' HE2' ' A' ' 29' ' ' LYS . . . -100.05 -35.0 9.85 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 114.915 -1.038 . . . . 0.0 110.503 177.282 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -81.26 -17.7 48.54 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.458 177.69 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 72.4 mt -91.25 22.79 3.63 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.72 -179.911 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.528 ' HE2' ' HA ' ' A' ' 26' ' ' ALA . 1.1 mptp? -70.43 -169.64 0.32 Allowed 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 121.308 0.575 . . . . 0.0 111.348 176.469 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 89.23 -47.67 3.34 Favored Glycine 0 N--CA 1.45 -0.372 0 CA-C-N 115.83 -0.623 . . . . 0.0 112.616 173.328 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.723 ' HD3' ' HA ' ' A' ' 63' ' ' ASP . 72.6 mttt -127.05 167.72 15.56 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 110.0 -0.37 . . . . 0.0 110.0 -178.311 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.406 ' HD1' ' HA ' ' A' ' 116' ' ' ASP . 97.6 m-85 -64.95 154.12 38.47 Favored 'General case' 0 C--N 1.327 -0.4 0 O-C-N 123.197 0.311 . . . . 0.0 110.798 -176.579 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.468 HD13 ' HA2' ' A' ' 119' ' ' GLY . 4.6 mp -120.26 124.61 72.95 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-O 120.706 0.289 . . . . 0.0 110.475 -179.543 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 84.4 t80 -107.45 116.23 31.58 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 109.006 -0.738 . . . . 0.0 109.006 172.339 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.551 ' HA ' ' O ' ' A' ' 67' ' ' VAL . 67.8 mt -102.81 116.77 47.14 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.697 -178.239 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -109.93 158.82 17.82 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.503 -0.772 . . . . 0.0 109.14 174.112 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.452 HG11 ' CG2' ' A' ' 109' ' ' ILE . 57.5 t -101.25 125.55 55.21 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 C-N-CA 120.34 -0.544 . . . . 0.0 110.852 172.996 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' TRP . . . . . 0.661 ' HZ3' HG21 ' A' ' 82' ' ' VAL . 1.0 OUTLIER -118.95 135.11 54.77 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.04 -0.527 . . . . 0.0 109.778 -178.973 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.455 ' HA ' ' OD1' ' A' ' 72' ' ' ASP . . . -146.63 165.23 30.18 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.683 -0.235 . . . . 0.0 111.307 179.943 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.819 ' HB ' ' CE3' ' A' ' 78' ' ' TRP . 12.3 t -99.87 -29.55 12.53 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.946 0.403 . . . . 0.0 110.572 173.069 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 19.4 p-90 -80.42 11.15 3.84 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.117 0.484 . . . . 0.0 110.956 -179.138 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . 0.745 ' SG ' ' HB3' ' A' ' 45' ' ' CYS . 29.2 p -104.35 172.1 6.98 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.649 -177.044 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -123.03 -70.52 0.24 Allowed Glycine 0 N--CA 1.448 -0.549 0 CA-C-N 115.857 -0.611 . . . . 0.0 112.252 177.218 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -55.28 -35.53 91.56 Favored 'Trans proline' 0 C--N 1.351 0.676 0 C-N-CA 122.991 2.461 . . . . 0.0 112.882 178.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . 0.745 ' HB3' ' SG ' ' A' ' 42' ' ' CYS . 8.4 t -59.02 -34.41 71.86 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.872 0.368 . . . . 0.0 111.097 177.209 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.716 ' HA ' HD13 ' A' ' 49' ' ' LEU . 32.4 mtp180 -73.5 -4.66 35.17 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.33 -177.218 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -83.95 -19.73 60.71 Favored Glycine 0 N--CA 1.447 -0.62 0 C-N-CA 120.788 -0.72 . . . . 0.0 111.842 176.473 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.548 ' OE2' ' HD3' ' A' ' 128' ' ' ARG . 42.1 mm-40 -84.21 -16.87 41.78 Favored 'General case' 0 CA--C 1.515 -0.384 0 N-CA-C 110.401 -0.222 . . . . 0.0 110.401 -177.823 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.716 HD13 ' HA ' ' A' ' 46' ' ' ARG . 5.7 mp -45.44 -53.5 18.3 Favored Pre-proline 0 C--N 1.326 -0.424 0 CA-C-N 115.935 -0.575 . . . . 0.0 112.278 -178.744 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.588 ' HD3' ' HB2' ' A' ' 49' ' ' LEU . 31.7 Cg_exo -64.13 -37.55 41.38 Favored 'Trans proline' 0 C--N 1.353 0.799 0 C-N-CA 121.885 1.723 . . . . 0.0 112.842 175.868 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -77.34 -27.97 52.95 Favored 'General case' 0 CA--C 1.52 -0.193 0 CA-C-O 121.248 0.546 . . . . 0.0 110.6 -172.752 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 6.1 tt -64.13 -41.71 97.1 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 177.802 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 27.0 mmtm -70.64 -40.07 73.29 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.582 -0.735 . . . . 0.0 111.454 -179.731 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.401 ' O ' ' HB2' ' A' ' 58' ' ' LYS . 2.8 mm-40 -51.72 -53.64 37.06 Favored 'General case' 0 N--CA 1.455 -0.189 0 CA-C-O 121.341 0.591 . . . . 0.0 110.947 172.928 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.426 HD13 ' HE2' ' A' ' 138' ' ' PHE . 47.3 mt -61.5 -52.27 65.2 Favored 'General case' 0 N--CA 1.447 -0.611 0 CA-C-N 115.452 -0.795 . . . . 0.0 110.902 177.109 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.46 ' HA ' ' CE2' ' A' ' 66' ' ' PHE . 31.9 tt0 -45.09 -60.16 2.24 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 114.65 -1.159 . . . . 0.0 112.519 -179.308 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -69.7 -36.18 75.71 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-O 120.976 0.417 . . . . 0.0 111.045 -174.664 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.555 ' HB2' ' NZ ' ' A' ' 58' ' ' LYS . 0.7 OUTLIER -69.24 -35.2 75.9 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.21 0.528 . . . . 0.0 111.028 -175.482 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 83.3 m-85 -111.03 9.29 22.11 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.058 -178.285 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.416 ' HB2' ' O ' ' A' ' 56' ' ' GLU . . . -56.02 128.61 36.13 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.663 178.355 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 81.86 -4.16 76.26 Favored Glycine 0 N--CA 1.449 -0.44 0 CA-C-N 115.652 -0.704 . . . . 0.0 113.386 174.231 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.585 ' HD3' ' N ' ' A' ' 62' ' ' LYS . 0.0 OUTLIER -76.66 -89.8 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 117.104 0.452 . . . . 0.0 111.142 -174.896 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.723 ' HA ' ' HD3' ' A' ' 31' ' ' LYS . 10.9 p-10 -139.07 6.07 2.36 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.635 -175.463 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 16.0 tt -128.8 147.26 33.25 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-O 121.443 0.64 . . . . 0.0 112.623 -168.662 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 87.8 m-70 -112.86 125.8 54.76 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.203 -0.908 . . . . 0.0 108.807 170.697 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . 0.612 ' O ' ' HB ' ' A' ' 90' ' ' ILE . 96.4 m-85 -90.94 112.44 24.32 Favored 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 109.176 -0.675 . . . . 0.0 109.176 173.153 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.551 ' O ' ' HA ' ' A' ' 35' ' ' ILE . 45.9 t -123.58 106.32 17.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.662 -175.086 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . 0.45 ' HB3' ' CD1' ' A' ' 38' ' ' TRP . 15.0 m -88.11 139.55 30.39 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.107 179.069 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 61.4 tp -122.36 124.11 42.93 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-O 120.774 0.321 . . . . 0.0 110.459 176.868 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 1.2 t -104.62 122.05 44.82 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.691 0.758 . . . . 0.0 112.509 -173.219 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 4.2 m -86.81 11.19 13.82 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 114.956 -1.02 . . . . 0.0 111.539 177.05 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.51 ' O ' ' HA2' ' A' ' 95' ' ' GLY . 1.6 m-20 -69.07 125.76 27.67 Favored 'General case' 0 N--CA 1.464 0.266 0 N-CA-C 110.452 -0.203 . . . . 0.0 110.452 -176.521 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 86.0 tttt -76.27 -32.05 58.61 Favored 'General case' 0 C--N 1.321 -0.633 0 C-N-CA 120.344 -0.542 . . . . 0.0 109.708 175.343 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . 0.583 ' HB2' ' HB3' ' A' ' 77' ' ' ALA . 0.8 OUTLIER -76.21 71.23 2.92 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.481 -0.781 . . . . 0.0 110.856 177.771 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.532 ' O ' ' HG3' ' A' ' 79' ' ' GLU . 12.0 tmtt? -57.16 -56.61 19.57 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 120.992 -0.283 . . . . 0.0 111.596 -175.423 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.509 ' HA ' ' CD ' ' A' ' 79' ' ' GLU . 2.2 tptp -52.15 -57.44 9.61 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.097 -179.543 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.583 ' HB3' ' HB2' ' A' ' 74' ' ' ASN . . . -52.96 -31.59 41.39 Favored 'General case' 0 C--O 1.237 0.425 0 CA-C-O 121.356 0.598 . . . . 0.0 110.898 -179.766 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' TRP . . . . . 0.819 ' CE3' ' HB ' ' A' ' 40' ' ' THR . 2.1 t-105 -76.91 -34.63 57.69 Favored 'General case' 0 N--CA 1.442 -0.856 0 CA-C-N 115.146 -0.933 . . . . 0.0 110.546 -176.756 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.532 ' HG3' ' O ' ' A' ' 75' ' ' LYS . 29.9 mt-10 -51.19 -52.43 44.41 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-O 121.573 0.702 . . . . 0.0 110.326 172.496 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . 0.446 ' ND2' ' HA ' ' A' ' 77' ' ' ALA . 1.2 m-80 -64.17 -41.19 97.23 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.25 -0.886 . . . . 0.0 110.747 -175.987 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . 0.49 ' HG2' ' OG1' ' A' ' 40' ' ' THR . 14.4 tpt -67.29 -49.14 65.42 Favored 'General case' 0 N--CA 1.447 -0.601 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.938 -177.766 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.771 HG23 ' HB2' ' A' ' 87' ' ' LEU . 7.5 p -61.35 -30.89 48.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 121.068 0.461 . . . . 0.0 110.788 -179.543 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 45.8 m -74.61 -39.1 62.36 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.534 178.035 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . 0.748 ' HB3' ' HZ2' ' A' ' 84' ' ' LYS . 0.0 OUTLIER -74.08 -33.71 63.73 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 121.329 0.585 . . . . 0.0 109.843 179.48 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -82.81 4.29 25.98 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.216 -0.902 . . . . 0.0 111.329 -179.428 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 26.6 mt-30 60.38 28.24 17.86 Favored 'General case' 0 N--CA 1.47 0.545 0 N-CA-C 112.668 0.618 . . . . 0.0 112.668 171.904 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.771 ' HB2' HG23 ' A' ' 82' ' ' VAL . 97.6 mt -89.43 104.09 16.67 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 121.003 0.43 . . . . 0.0 111.523 -176.916 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.553 ' HA ' ' HE3' ' A' ' 88' ' ' LYS . 0.0 OUTLIER -106.95 -167.15 1.24 Allowed 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.031 172.515 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 109.44 -159.58 13.94 Favored Glycine 0 N--CA 1.452 -0.259 0 N-CA-C 111.023 -0.831 . . . . 0.0 111.023 -176.122 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.612 ' HB ' ' O ' ' A' ' 66' ' ' PHE . 62.9 mt -95.15 112.27 27.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 175.007 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . 0.644 ' HB2' ' CZ2' ' A' ' 38' ' ' TRP . 1.9 pt20 -139.14 123.04 17.73 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-O 121.348 0.594 . . . . 0.0 111.389 -173.098 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.591 HD21 ' HB ' ' A' ' 23' ' ' VAL . 70.4 mt -113.91 152.23 31.1 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.449 -0.796 . . . . 0.0 109.939 179.788 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' HIS . . . . . 0.454 ' CE1' ' HG3' ' A' ' 75' ' ' LYS . 20.6 t-80 -120.75 126.52 50.37 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.905 -177.416 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' MET . . . . . 0.453 ' SD ' ' HA ' ' A' ' 98' ' ' ARG . 18.6 ttp -84.13 -66.48 0.89 Allowed 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.227 -0.897 . . . . 0.0 110.61 178.567 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . 0.51 ' HA2' ' O ' ' A' ' 72' ' ' ASP . . . 108.56 -109.96 2.96 Favored Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 120.528 -0.844 . . . . 0.0 112.083 -178.29 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 8.9 t -112.45 11.18 19.84 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 120.727 0.299 . . . . 0.0 111.111 -177.147 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -97.5 46.46 1.03 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.126 0.489 . . . . 0.0 110.357 -175.371 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . 0.453 ' HA ' ' SD ' ' A' ' 94' ' ' MET . 0.0 OUTLIER -77.51 18.45 0.43 Allowed 'General case' 0 CA--C 1.52 -0.174 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.782 -172.812 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 5.2 m -61.0 -24.35 66.09 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 108.358 -0.979 . . . . 0.0 108.358 168.768 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 12.0 t80 -75.56 -29.93 59.52 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-N 114.766 -1.106 . . . . 0.0 110.118 176.172 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 71.2 mtp -63.08 -54.06 43.83 Favored 'General case' 0 CA--C 1.514 -0.42 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 171.307 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -57.16 -33.15 67.14 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.082 -0.963 . . . . 0.0 111.246 179.404 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -60.27 -39.82 88.19 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.793 0.33 . . . . 0.0 111.087 178.019 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' TYR . . . . . 0.478 ' HB2' HG13 ' A' ' 106' ' ' ILE . 42.9 m-85 -93.3 3.34 55.8 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.481 179.661 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 95.4 mt 65.47 22.02 11.85 Favored 'General case' 0 N--CA 1.464 0.242 0 O-C-N 123.755 0.659 . . . . 0.0 110.817 -176.234 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . 0.887 HG12 ' HG3' ' A' ' 111' ' ' ARG . 51.2 mt -71.08 112.5 6.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.627 176.036 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 50.9 t-20 -112.61 -68.85 0.9 Allowed 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 172.826 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -82.24 111.28 3.33 Favored Glycine 0 N--CA 1.446 -0.693 0 C-N-CA 120.83 -0.7 . . . . 0.0 111.802 178.5 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.556 ' HB ' ' HA ' ' A' ' 110' ' ' PRO . 34.5 pt -85.82 158.54 56.27 Favored Pre-proline 0 C--N 1.321 -0.633 0 N-CA-C 110.484 -0.191 . . . . 0.0 110.484 178.51 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . 0.556 ' HA ' ' HB ' ' A' ' 109' ' ' ILE . 86.8 Cg_endo -81.1 158.86 83.62 Favored 'Cis proline' 0 C--N 1.345 0.37 0 C-N-CA 123.768 -1.346 . . . . 0.0 113.391 1.995 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . 0.887 ' HG3' HG12 ' A' ' 106' ' ' ILE . 0.0 OUTLIER -108.58 148.45 30.3 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 108.712 -0.848 . . . . 0.0 108.712 173.215 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . 0.551 ' CE1' ' HB3' ' A' ' 128' ' ' ARG . 0.5 OUTLIER -119.11 116.72 26.96 Favored 'General case' 0 C--N 1.324 -0.532 0 O-C-N 123.96 0.788 . . . . 0.0 109.088 -175.008 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 91.6 mt -135.6 143.67 35.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 120.812 0.339 . . . . 0.0 111.261 -177.332 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.576 ' HB2' ' HG3' ' A' ' 126' ' ' MET . 39.3 tp -124.99 138.07 54.23 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.275 178.36 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.619 ' HG ' ' HA ' ' A' ' 121' ' ' ILE . 3.2 mp -131.97 153.45 50.31 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.079 -177.324 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . 0.549 ' HB2' HD11 ' A' ' 122' ' ' ILE . 37.4 t0 -68.37 166.81 15.87 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.564 -0.744 . . . . 0.0 110.212 177.308 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . 0.577 ' HA ' ' O ' ' A' ' 31' ' ' LYS . 8.3 mtm180 -48.87 -27.77 3.29 Favored 'General case' 0 N--CA 1.465 0.314 0 O-C-N 124.447 1.092 . . . . 0.0 112.615 -177.445 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . 0.447 ' HA ' ' HG3' ' A' ' 29' ' ' LYS . 33.0 t70 -83.44 2.31 37.3 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.478 0.656 . . . . 0.0 111.076 -178.835 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . 0.468 ' HA2' HD13 ' A' ' 33' ' ' ILE . . . 76.06 29.13 59.25 Favored Glycine 0 N--CA 1.434 -1.438 0 N-CA-C 110.247 -1.141 . . . . 0.0 110.247 -171.968 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . 0.405 ' HD3' ' HA ' ' A' ' 120' ' ' LYS . 41.0 mmtm -101.28 112.13 24.55 Favored 'General case' 0 C--O 1.222 -0.356 0 C-N-CA 120.794 -0.363 . . . . 0.0 111.791 -178.856 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 0.69 ' H ' HD12 ' A' ' 121' ' ' ILE . 3.9 mp -41.7 117.54 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 O-C-N 123.888 0.742 . . . . 0.0 112.327 -177.508 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' ILE . . . . . 0.549 HD11 ' HB2' ' A' ' 116' ' ' ASP . 35.6 mm -100.3 -44.54 11.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 115.345 -0.843 . . . . 0.0 109.555 175.983 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 15.9 m -135.2 114.47 12.36 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.503 -0.772 . . . . 0.0 110.343 178.716 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -81.53 -13.22 58.35 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.161 0.505 . . . . 0.0 110.606 179.439 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 3.4 p-10 -128.24 83.69 2.18 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.54 -0.755 . . . . 0.0 110.486 178.14 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' MET . . . . . 0.576 ' HG3' ' HB2' ' A' ' 114' ' ' LEU . 46.4 mmm -94.48 -165.13 1.26 Allowed 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.442 177.784 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . 0.412 HG21 ' NZ ' ' A' ' 133' ' ' LYS . 6.2 p -120.86 141.75 50.29 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.627 179.268 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . 0.551 ' HB3' ' CE1' ' A' ' 112' ' ' PHE . 13.0 ptp180 -48.96 154.28 1.31 Allowed Pre-proline 0 C--N 1.327 -0.385 0 CA-C-N 115.514 -0.766 . . . . 0.0 112.84 177.664 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_exo -51.58 -36.16 59.21 Favored 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 123.447 2.765 . . . . 0.0 113.627 177.275 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 18.8 m -72.79 -7.67 51.78 Favored 'General case' 0 N--CA 1.462 0.153 0 CA-C-O 120.935 0.398 . . . . 0.0 111.643 -178.784 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -90.51 121.39 68.44 Favored Pre-proline 0 C--N 1.327 -0.41 0 N-CA-C 109.751 -0.463 . . . . 0.0 109.751 179.668 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . 0.453 ' O ' ' HG2' ' A' ' 136' ' ' GLU . 51.9 Cg_exo -57.45 -31.73 92.15 Favored 'Trans proline' 0 C--N 1.343 0.284 0 C-N-CA 122.976 2.451 . . . . 0.0 113.268 -178.096 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . 0.531 ' HZ2' ' HB2' ' A' ' 133' ' ' LYS . 9.7 mtmp? -66.44 -19.24 65.74 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.846 0.355 . . . . 0.0 110.98 -176.908 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' THR . . . . . 0.64 HG22 ' CZ ' ' A' ' 138' ' ' PHE . 3.8 m -68.12 -51.25 48.34 Favored 'General case' 0 N--CA 1.447 -0.584 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 173.786 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . 0.649 ' HA ' ' CD2' ' A' ' 138' ' ' PHE . . . -59.96 -38.61 83.01 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.67 -0.696 . . . . 0.0 110.576 175.515 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . 0.453 ' HG2' ' O ' ' A' ' 132' ' ' PRO . 5.9 mm-40 -56.15 -41.62 75.71 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.203 177.111 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . 0.587 ' O ' ' HG ' ' A' ' 141' ' ' LEU . 21.3 ttmm -72.44 -26.33 61.8 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.56 -0.291 . . . . 0.0 111.043 179.745 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . 0.649 ' CD2' ' HA ' ' A' ' 135' ' ' ALA . 10.7 m-30 -66.27 -42.76 88.01 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 173.908 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 76.7 m-20 -58.62 -45.7 88.63 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.583 -0.735 . . . . 0.0 109.341 173.672 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . 0.54 ' HB3' ' O ' ' A' ' 137' ' ' LYS . 24.9 tt0 -50.79 -51.72 47.91 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 115.266 -0.879 . . . . 0.0 111.661 174.196 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.587 ' HG ' ' O ' ' A' ' 137' ' ' LYS . 95.2 mt -58.05 -44.46 87.46 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.472 -178.399 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 81.0 mt -73.12 -10.82 60.19 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.478 179.336 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 82.4 19.39 64.41 Favored Glycine 0 N--CA 1.447 -0.594 0 N-CA-C 111.196 -0.762 . . . . 0.0 111.196 -179.271 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.494 ' O ' ' HG ' ' A' ' 144' ' ' LEU . 52.4 tp -89.63 22.79 2.88 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.563 0.697 . . . . 0.0 109.907 -178.55 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -59.11 146.23 39.43 Favored 'General case' 0 N--CA 1.44 -0.932 0 CA-C-O 121.569 0.7 . . . . 0.0 111.67 177.323 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 96.84 -17.74 58.74 Favored Glycine 0 N--CA 1.443 -0.885 0 N-CA-C 110.115 -1.194 . . . . 0.0 110.115 -167.563 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' HIS . . . . . 0.402 ' NE2' ' OE2' ' A' ' 136' ' ' GLU . 0.4 OUTLIER 75.5 -70.22 0.15 Allowed 'General case' 0 N--CA 1.465 0.31 0 C-N-CA 123.966 0.907 . . . . 0.0 111.173 172.59 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 78.0 m-70 -146.17 14.86 1.31 Allowed 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.299 176.633 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 8.1 p80 -170.62 -73.15 0.02 OUTLIER 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.823 175.456 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER 176.01 139.65 0.06 Allowed 'General case' 0 N--CA 1.464 0.259 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 -178.494 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 4.6 p80 -99.24 -2.12 37.42 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-O 121.325 0.583 . . . . 0.0 109.652 174.098 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.242 0.668 0 CA-C-N 114.726 -1.125 . . . . 0.0 108.288 176.769 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.41 ' SD ' ' N ' ' A' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.481 1.103 0 N-CA-C 110.103 -0.332 . . . . 0.0 110.103 . . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 12.9 m -104.87 -66.82 0.94 Allowed 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.274 -179.393 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.707 ' H ' HD23 ' A' ' 3' ' ' LEU . 2.3 pt? -73.36 145.11 46.16 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.023 -0.535 . . . . 0.0 109.914 177.584 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 17.7 ptt180 -171.83 -44.26 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.39 -176.44 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 17.1 m -81.4 100.85 9.48 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.456 179.473 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 133.65 -104.09 0.52 Allowed Glycine 0 N--CA 1.447 -0.608 0 C-N-CA 120.882 -0.675 . . . . 0.0 112.087 178.889 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -128.01 146.02 57.58 Favored Pre-proline 0 C--N 1.324 -0.529 0 N-CA-C 110.246 -0.279 . . . . 0.0 110.246 179.246 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_endo -82.75 93.11 0.89 Allowed 'Trans proline' 0 N--CA 1.456 -0.682 0 C-N-CA 122.885 2.39 . . . . 0.0 112.148 177.269 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 16.3 m -84.5 95.63 8.87 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.632 -178.514 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.405 ' HB2' ' OH ' ' A' ' 104' ' ' TYR . . . 74.75 -37.89 0.37 Allowed 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 123.751 0.82 . . . . 0.0 112.225 176.355 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -76.09 82.61 2.93 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.76 -177.491 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.505 ' HA ' ' HB3' ' A' ' 25' ' ' LEU . 37.8 m 69.5 43.34 1.03 Allowed 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 114.674 -1.148 . . . . 0.0 111.267 174.759 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 55.7 p90 -68.06 161.98 25.6 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.606 177.909 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.553 ' HA ' ' HA ' ' A' ' 24' ' ' SER . 5.2 p -134.7 129.16 34.33 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.655 179.26 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . 0.447 ' OH ' ' HB2' ' A' ' 100' ' ' PHE . 24.6 m-85 -140.44 141.13 24.62 Favored Pre-proline 0 C--N 1.326 -0.414 0 CA-C-O 120.842 0.353 . . . . 0.0 111.119 178.709 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 63.3 Cg_endo -75.25 125.59 9.26 Favored 'Trans proline' 0 N--CA 1.461 -0.388 0 C-N-CA 122.399 2.066 . . . . 0.0 113.481 -177.442 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -69.35 159.13 33.73 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.131 -0.94 . . . . 0.0 109.252 170.379 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.546 HG13 ' OE1' ' A' ' 79' ' ' GLU . 2.6 tt -44.43 -44.56 2.37 Favored 'Isoleucine or valine' 0 C--O 1.24 0.567 0 O-C-N 124.445 1.091 . . . . 0.0 112.221 -176.207 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 43.8 m-80 -65.89 -12.93 58.29 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.375 -176.422 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 97.14 32.15 6.56 Favored Glycine 0 N--CA 1.444 -0.817 0 N-CA-C 111.248 -0.741 . . . . 0.0 111.248 -176.615 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.427 ' NZ ' HG22 ' A' ' 23' ' ' VAL . 23.4 ttpp -106.68 121.11 43.68 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 120.667 -0.413 . . . . 0.0 110.36 -176.815 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 14.1 m -63.0 99.32 0.16 Allowed 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.964 0.412 . . . . 0.0 110.385 176.65 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.427 HG22 ' NZ ' ' A' ' 21' ' ' LYS . 97.0 t -99.82 113.76 36.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 178.098 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . 0.553 ' HA ' ' HA ' ' A' ' 14' ' ' SER . 14.7 m -105.4 177.0 4.98 Favored 'General case' 0 C--N 1.311 -1.069 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.159 -179.218 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.545 ' O ' ' HB2' ' A' ' 29' ' ' LYS . 2.9 tm? -53.87 -38.0 64.27 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.619 178.718 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -89.66 10.13 24.36 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 112.287 0.477 . . . . 0.0 112.287 -176.596 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -87.43 -27.77 22.52 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-O 121.481 0.658 . . . . 0.0 110.319 -179.187 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.464 HD13 ' CD1' ' A' ' 33' ' ' ILE . 0.9 OUTLIER -132.88 15.91 4.27 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.487 -0.778 . . . . 0.0 110.592 -178.928 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.545 ' HB2' ' O ' ' A' ' 25' ' ' LEU . 17.1 tttt -67.02 150.47 49.18 Favored 'General case' 0 C--N 1.313 -0.979 0 CA-C-N 114.197 -1.365 . . . . 0.0 111.301 -177.063 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 113.49 -18.48 20.32 Favored Glycine 0 N--CA 1.448 -0.565 0 N-CA-C 111.193 -0.763 . . . . 0.0 111.193 -178.85 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.809 ' HD2' ' HA ' ' A' ' 63' ' ' ASP . 72.8 mmtt -117.11 154.72 30.53 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 179.218 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 69.4 m-85 -66.05 121.45 15.16 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 177.365 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.464 ' CD1' HD13 ' A' ' 28' ' ' LEU . 41.8 mm -94.6 115.73 34.14 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.896 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.73 -175.099 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . 0.68 ' HE2' ' HA ' ' A' ' 129' ' ' PRO . 59.4 t80 -107.01 111.23 23.62 Favored 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 173.755 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.543 ' HA ' ' O ' ' A' ' 67' ' ' VAL . 59.5 mt -97.01 132.6 41.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-O 121.152 0.501 . . . . 0.0 111.656 -173.392 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.507 ' O ' ' HA ' ' A' ' 68' ' ' SER . 5.3 p-10 -122.99 159.64 27.92 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.262 -0.881 . . . . 0.0 109.034 174.142 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.44 HG21 HG21 ' A' ' 106' ' ' ILE . 85.4 t -103.51 133.32 47.76 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.788 0 C-N-CA 120.5 -0.48 . . . . 0.0 110.805 174.078 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' TRP . . . . . 0.665 ' HZ3' HG21 ' A' ' 82' ' ' VAL . 0.9 OUTLIER -126.51 137.25 53.35 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.136 -0.483 . . . . 0.0 109.889 -178.303 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.556 ' HA ' ' OD1' ' A' ' 72' ' ' ASP . . . -145.55 164.68 30.91 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.64 -0.255 . . . . 0.0 110.666 177.665 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.714 ' HB ' ' CE3' ' A' ' 78' ' ' TRP . 4.9 t -81.55 -23.71 37.03 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.336 0.588 . . . . 0.0 109.671 172.822 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 12.7 p-90 -97.62 19.25 13.83 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.358 -0.837 . . . . 0.0 110.231 177.824 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . 0.644 ' SG ' ' HB3' ' A' ' 45' ' ' CYS . 24.8 p -78.27 -26.46 47.16 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.107 -177.437 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 66.47 -111.73 4.37 Favored Glycine 0 CA--C 1.519 0.337 0 CA-C-N 116.066 -0.515 . . . . 0.0 113.346 178.534 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -54.58 -28.16 54.24 Favored 'Trans proline' 0 C--N 1.351 0.666 0 C-N-CA 123.461 2.774 . . . . 0.0 113.292 -177.726 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . 0.644 ' HB3' ' SG ' ' A' ' 42' ' ' CYS . 30.7 t -52.6 -30.88 33.56 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.414 177.147 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.488 HH21 ' CG ' ' A' ' 85' ' ' ASP . 46.0 mtp180 -58.75 -21.42 55.46 Favored 'General case' 0 C--O 1.223 -0.292 0 N-CA-C 111.911 0.337 . . . . 0.0 111.911 -178.782 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -70.96 -23.88 77.64 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.829 -0.7 . . . . 0.0 112.831 -178.118 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.457 ' HB3' ' HB2' ' A' ' 130' ' ' SER . 35.7 mt-10 -99.3 -18.43 17.57 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.761 0.28 . . . . 0.0 111.317 -176.978 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.708 ' HB3' HD22 ' A' ' 87' ' ' LEU . 3.6 mm? -57.54 -43.91 99.21 Favored Pre-proline 0 C--N 1.325 -0.486 0 N-CA-C 112.911 0.708 . . . . 0.0 112.911 -179.166 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.516 ' HD2' ' N ' ' A' ' 49' ' ' LEU . 12.3 Cg_endo -58.48 -37.89 92.61 Favored 'Trans proline' 0 C--N 1.351 0.706 0 C-N-CA 121.275 1.317 . . . . 0.0 111.027 170.684 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -73.33 -19.09 61.1 Favored 'General case' 0 CA--C 1.519 -0.212 0 CA-C-O 121.415 0.626 . . . . 0.0 109.796 -176.638 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.442 ' O ' HD23 ' A' ' 52' ' ' LEU . 5.8 tt -65.13 -38.02 89.32 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-N 115.107 -0.951 . . . . 0.0 108.74 174.421 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.66 ' O ' ' HG2' ' A' ' 57' ' ' GLU . 8.9 mtmp? -59.01 -60.95 3.05 Favored 'General case' 0 CA--C 1.505 -0.783 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 171.809 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -45.17 -42.44 9.12 Favored 'General case' 0 C--O 1.224 -0.274 0 O-C-N 124.577 1.173 . . . . 0.0 111.256 -178.698 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.443 ' HB3' ' CE1' ' A' ' 66' ' ' PHE . 39.9 mt -61.41 -57.81 10.75 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.352 175.698 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 18.2 tp10 -65.45 -35.28 80.43 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.42 -174.391 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.66 ' HG2' ' O ' ' A' ' 53' ' ' LYS . 9.4 pt-20 -80.49 -29.05 37.36 Favored 'General case' 0 CA--C 1.532 0.25 0 O-C-N 121.906 -0.496 . . . . 0.0 111.141 179.4 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 75.9 tttt -63.36 -44.53 94.54 Favored 'General case' 0 C--O 1.237 0.426 0 CA-C-O 121.923 0.868 . . . . 0.0 109.11 170.484 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 61.2 m-85 -99.92 14.86 29.01 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.008 -0.997 . . . . 0.0 111.308 -176.414 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.432 ' HB2' ' HA ' ' A' ' 57' ' ' GLU . . . -57.66 126.44 27.38 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.037 170.584 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 85.43 -6.05 81.31 Favored Glycine 0 N--CA 1.445 -0.721 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.126 -179.151 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 30.7 mmtm -88.51 -155.67 0.34 Allowed 'General case' 0 CA--C 1.515 -0.374 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 178.89 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.809 ' HA ' ' HD2' ' A' ' 31' ' ' LYS . 36.1 m-20 -111.67 28.45 8.74 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 115.824 -0.626 . . . . 0.0 112.641 -175.793 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 4.7 mp -131.86 146.57 33.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-O 120.527 0.203 . . . . 0.0 110.799 179.925 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' HIS . . . . . 0.513 ' CD2' ' HB2' ' A' ' 31' ' ' LYS . 56.8 m-70 -124.91 145.65 49.72 Favored 'General case' 0 CA--C 1.514 -0.425 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 170.094 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . 0.443 ' CE1' ' HB3' ' A' ' 55' ' ' LEU . 77.0 m-85 -110.37 105.92 15.09 Favored 'General case' 0 C--N 1.315 -0.914 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 172.521 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.546 ' HA ' ' O ' ' A' ' 90' ' ' ILE . 48.0 t -112.63 114.07 45.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 115.374 -0.83 . . . . 0.0 111.232 -170.172 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . 0.507 ' HA ' ' O ' ' A' ' 36' ' ' ASP . 3.6 m -88.26 150.64 23.15 Favored 'General case' 0 C--N 1.314 -0.935 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.584 -179.379 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.516 HD11 ' HB2' ' A' ' 94' ' ' MET . 61.1 tp -133.92 121.62 21.96 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.984 0.421 . . . . 0.0 110.531 175.092 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . 0.473 ' O ' ' HB3' ' A' ' 94' ' ' MET . 0.7 OUTLIER -105.28 120.34 41.31 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.395 0.617 . . . . 0.0 112.379 -172.783 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' CYS . . . . . 0.475 ' HA ' ' HE3' ' A' ' 94' ' ' MET . 1.8 p -85.87 13.62 7.16 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.483 -0.78 . . . . 0.0 111.702 175.83 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.578 ' OD2' HG22 ' A' ' 40' ' ' THR . 2.6 m-20 -69.56 115.28 8.63 Favored 'General case' 0 CA--C 1.511 -0.537 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 -179.511 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -67.83 -28.86 67.92 Favored 'General case' 0 C--N 1.318 -0.763 0 C-N-CA 120.093 -0.643 . . . . 0.0 110.209 -179.924 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . 0.732 ' ND2' ' HB3' ' A' ' 77' ' ' ALA . 1.0 OUTLIER -77.27 116.28 17.75 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 171.73 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.683 ' HE2' ' CD ' ' A' ' 79' ' ' GLU . 19.9 tttt -81.45 -64.39 1.2 Allowed 'General case' 0 C--N 1.319 -0.745 0 C-N-CA 119.804 -0.759 . . . . 0.0 110.847 171.839 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.833 ' HE2' ' HA ' ' A' ' 76' ' ' LYS . 0.4 OUTLIER -44.25 -56.67 3.96 Favored 'General case' 0 N--CA 1.464 0.246 0 N-CA-C 113.383 0.883 . . . . 0.0 113.383 -172.057 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.841 ' HA ' ' ND2' ' A' ' 80' ' ' ASN . . . -61.28 -27.59 68.58 Favored 'General case' 0 C--O 1.242 0.689 0 CA-C-O 121.51 0.671 . . . . 0.0 111.233 -176.75 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' TRP . . . . . 0.714 ' CE3' ' HB ' ' A' ' 40' ' ' THR . 3.1 t-105 -81.61 -43.0 19.22 Favored 'General case' 0 N--CA 1.435 -1.188 0 CA-C-N 115.373 -0.83 . . . . 0.0 110.192 -173.921 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.683 ' CD ' ' HE2' ' A' ' 75' ' ' LYS . 6.0 mm-40 -49.34 -43.54 43.9 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-O 121.012 0.434 . . . . 0.0 110.747 171.649 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . 0.841 ' ND2' ' HA ' ' A' ' 77' ' ' ALA . 7.2 m-20 -56.93 -54.32 47.98 Favored 'General case' 0 CA--C 1.517 -0.315 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.583 179.269 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 37.5 ttm -64.61 -46.17 83.77 Favored 'General case' 0 C--O 1.223 -0.301 0 CA-C-N 116.248 -0.433 . . . . 0.0 112.073 -174.895 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.665 HG21 ' HZ3' ' A' ' 38' ' ' TRP . 5.7 p -63.44 -28.25 44.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 C-N-CA 120.622 -0.431 . . . . 0.0 111.407 -178.162 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 36.7 m -81.72 -34.95 30.27 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 120.87 0.367 . . . . 0.0 110.69 177.642 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 24.9 ttmm -77.48 -44.22 29.61 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.109 0.48 . . . . 0.0 111.059 -177.547 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . 0.745 ' HB3' ' HG ' ' A' ' 87' ' ' LEU . 5.4 t0 -77.36 -1.67 31.16 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.185 -0.916 . . . . 0.0 110.943 -176.247 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 48.3 mt-30 65.25 19.83 11.78 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 115.673 -0.694 . . . . 0.0 112.21 175.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.745 ' HG ' ' HB3' ' A' ' 85' ' ' ASP . 17.3 mt -74.03 87.81 1.87 Allowed 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.131 -179.119 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 4.2 mmpm? -101.76 -177.85 3.55 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 112.537 0.569 . . . . 0.0 112.537 -175.739 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 122.71 -176.23 16.53 Favored Glycine 0 N--CA 1.448 -0.545 0 N-CA-C 109.554 -1.418 . . . . 0.0 109.554 -171.948 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.546 ' O ' ' HA ' ' A' ' 67' ' ' VAL . 60.6 mt -83.34 112.7 21.3 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 118.063 0.932 . . . . 0.0 108.681 175.481 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . 0.481 ' HB2' ' CZ2' ' A' ' 38' ' ' TRP . 2.1 pt20 -137.98 110.71 7.61 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-O 121.834 0.826 . . . . 0.0 112.085 -168.565 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.422 HD22 ' HB ' ' A' ' 23' ' ' VAL . 26.0 mt -97.51 142.11 29.74 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.146 -0.934 . . . . 0.0 110.272 -177.83 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' HIS . . . . . 0.441 ' CE1' ' HG3' ' A' ' 75' ' ' LYS . 29.7 t-80 -110.56 117.04 32.47 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-O 121.35 0.595 . . . . 0.0 110.599 -179.643 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' MET . . . . . 0.636 ' SD ' ' HA ' ' A' ' 98' ' ' ARG . 13.6 ttp -79.81 -63.67 1.36 Allowed 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 114.964 -1.016 . . . . 0.0 110.482 -179.891 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . 0.554 ' HA2' ' O ' ' A' ' 72' ' ' ASP . . . 71.36 -79.1 0.55 Allowed Glycine 0 C--O 1.236 0.268 0 C-N-CA 120.967 -0.635 . . . . 0.0 114.466 174.463 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 1.3 p -88.72 -35.52 16.69 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-O 120.819 0.342 . . . . 0.0 111.57 -175.329 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -92.52 57.18 2.88 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.809 -166.793 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . 0.636 ' HA ' ' SD ' ' A' ' 94' ' ' MET . 0.0 OUTLIER -70.82 10.28 0.54 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.12 -0.946 . . . . 0.0 112.698 -172.888 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 8.6 m -73.6 -19.14 60.95 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 120.964 0.411 . . . . 0.0 111.079 -179.587 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . 0.447 ' HB2' ' OH ' ' A' ' 15' ' ' TYR . 3.2 t80 -79.63 -43.37 22.97 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 120.898 -0.321 . . . . 0.0 110.713 -178.459 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' MET . . . . . 0.556 ' HA ' HD12 ' A' ' 106' ' ' ILE . 5.1 ppp? -69.23 -24.91 64.07 Favored 'General case' 0 C--N 1.332 -0.178 0 N-CA-C 109.176 -0.676 . . . . 0.0 109.176 175.383 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . 0.405 ' HB2' ' NH1' ' A' ' 98' ' ' ARG . 11.4 t70 -66.41 -50.98 61.62 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.132 -0.94 . . . . 0.0 110.423 173.904 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -64.6 -18.94 65.36 Favored 'General case' 0 N--CA 1.461 0.095 0 CA-C-N 115.758 -0.655 . . . . 0.0 112.072 -175.29 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' TYR . . . . . 0.405 ' OH ' ' HB2' ' A' ' 10' ' ' ALA . 46.1 m-85 -108.45 2.43 22.33 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 111.844 0.313 . . . . 0.0 111.844 -179.319 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 8.8 tp 59.35 26.41 15.27 Favored 'General case' 0 C--N 1.328 -0.361 0 O-C-N 123.507 0.504 . . . . 0.0 110.423 -179.351 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . 0.652 HG12 ' HG3' ' A' ' 111' ' ' ARG . 69.9 mt -60.21 101.46 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.328 0 CA-C-N 115.673 -0.694 . . . . 0.0 111.456 178.769 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 8.7 p30 -134.21 148.88 50.95 Favored 'General case' 0 C--N 1.317 -0.808 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 173.945 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 76.3 84.91 0.41 Allowed Glycine 0 N--CA 1.446 -0.671 0 C-N-CA 120.469 -0.872 . . . . 0.0 111.775 -176.079 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 40.1 mt -69.57 139.16 88.84 Favored Pre-proline 0 C--N 1.325 -0.481 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 177.603 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . 0.487 ' HG3' ' SG ' ' A' ' 45' ' ' CYS . 10.0 Cg_endo -93.11 140.39 8.36 Favored 'Cis proline' 0 N--CA 1.459 -0.521 0 C-N-CA 124.455 -1.061 . . . . 0.0 113.974 0.952 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . 0.652 ' HG3' HG12 ' A' ' 106' ' ' ILE . 0.0 OUTLIER -83.82 144.18 29.45 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 172.933 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . 0.571 ' HD1' ' H ' ' A' ' 126' ' ' MET . 0.9 OUTLIER -118.7 116.83 27.38 Favored 'General case' 0 C--N 1.323 -0.547 0 O-C-N 123.724 0.64 . . . . 0.0 110.792 -176.788 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.497 ' HB ' ' HB ' ' A' ' 35' ' ' ILE . 83.0 mt -130.99 149.56 33.66 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.299 0 CA-C-N 116.703 -0.226 . . . . 0.0 110.908 -177.917 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.423 ' C ' HD12 ' A' ' 115' ' ' LEU . 62.4 tp -128.54 138.07 52.06 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.618 -0.265 . . . . 0.0 110.57 178.941 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.586 ' HG ' ' HA ' ' A' ' 121' ' ' ILE . 2.0 mp -135.19 152.1 51.26 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-O 121.334 0.588 . . . . 0.0 110.623 179.108 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . 0.427 ' N ' HG13 ' A' ' 122' ' ' ILE . 7.6 t70 -69.73 160.85 30.91 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 114.872 -1.058 . . . . 0.0 110.645 175.952 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . 0.452 ' HA ' ' O ' ' A' ' 31' ' ' LYS . 58.7 mtt-85 -48.51 -37.41 17.5 Favored 'General case' 0 N--CA 1.474 0.728 0 O-C-N 124.267 0.979 . . . . 0.0 111.368 -178.368 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . 0.632 ' HB3' ' HG3' ' A' ' 120' ' ' LYS . 29.1 t0 -67.82 -13.01 61.78 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 114.515 -1.221 . . . . 0.0 111.121 -177.069 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . 0.534 ' HA3' HD11 ' A' ' 25' ' ' LEU . . . 93.63 23.78 22.71 Favored Glycine 0 N--CA 1.439 -1.112 0 N-CA-C 110.553 -1.019 . . . . 0.0 110.553 -172.132 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . 0.632 ' HG3' ' HB3' ' A' ' 118' ' ' ASP . 36.6 mtmm -103.72 106.75 17.35 Favored 'General case' 0 C--O 1.223 -0.333 0 C-N-CA 120.564 -0.454 . . . . 0.0 111.365 -174.619 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 0.681 ' H ' HD12 ' A' ' 121' ' ' ILE . 3.3 mp -42.16 116.57 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 O-C-N 123.909 0.755 . . . . 0.0 111.692 -178.982 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' ILE . . . . . 0.459 ' H ' ' HA ' ' A' ' 115' ' ' LEU . 57.4 mt -89.04 -38.74 11.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 115.346 -0.843 . . . . 0.0 108.902 177.082 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 14.9 m -148.15 126.77 12.49 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.492 -0.776 . . . . 0.0 110.197 -179.812 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . 0.403 ' O ' HG12 ' A' ' 113' ' ' ILE . . . -74.24 -14.95 61.0 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-O 121.336 0.589 . . . . 0.0 110.593 178.53 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . 0.447 ' HA ' ' O ' ' A' ' 112' ' ' PHE . 5.1 p-10 -149.42 126.83 11.5 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.054 -0.975 . . . . 0.0 108.598 173.613 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' MET . . . . . 0.571 ' H ' ' HD1' ' A' ' 112' ' ' PHE . 15.9 tpt -108.95 -87.34 0.5 Allowed 'General case' 0 C--N 1.321 -0.653 0 C-N-CA 120.804 -0.358 . . . . 0.0 111.567 -176.941 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 7.6 p -141.61 -77.85 0.27 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.269 0.557 . . . . 0.0 110.774 -175.013 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . 0.894 ' HB3' ' HB2' ' A' ' 131' ' ' ASP . 43.3 ttm-85 -172.31 141.04 1.09 Allowed Pre-proline 0 N--CA 1.443 -0.807 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 177.5 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . 0.68 ' HA ' ' HE2' ' A' ' 34' ' ' TYR . 5.7 Cg_exo -38.48 -52.46 1.98 Allowed 'Trans proline' 0 C--N 1.348 0.551 0 C-N-CA 123.746 2.964 . . . . 0.0 113.455 -179.242 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . 0.457 ' HB2' ' HB3' ' A' ' 48' ' ' GLU . 36.1 t -109.01 26.16 10.94 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 111.734 0.272 . . . . 0.0 111.734 -177.378 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . 0.894 ' HB2' ' HB3' ' A' ' 128' ' ' ARG . 11.1 t0 -73.64 119.69 77.29 Favored Pre-proline 0 C--O 1.237 0.43 0 C-N-CA 120.108 -0.637 . . . . 0.0 109.458 176.598 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . 0.425 ' O ' ' HG2' ' A' ' 136' ' ' GLU . 51.5 Cg_exo -55.12 -33.08 82.61 Favored 'Trans proline' 0 C--N 1.349 0.579 0 C-N-CA 123.495 2.797 . . . . 0.0 113.737 -175.034 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 38.3 mttp -57.82 -45.86 85.55 Favored 'General case' 0 CA--C 1.519 -0.227 0 CA-C-O 121.33 0.586 . . . . 0.0 109.912 -177.936 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -63.36 -47.54 81.66 Favored 'General case' 0 N--CA 1.448 -0.538 0 CA-C-N 115.033 -0.985 . . . . 0.0 111.116 -178.881 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . 0.68 ' HA ' ' CD2' ' A' ' 138' ' ' PHE . . . -59.61 -50.75 72.67 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.606 -0.725 . . . . 0.0 111.072 -173.895 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . 0.686 ' O ' ' HB2' ' A' ' 139' ' ' ASN . 22.7 mm-40 -76.21 -23.16 54.6 Favored 'General case' 0 C--N 1.312 -1.028 0 CA-C-O 121.857 0.837 . . . . 0.0 110.084 -175.175 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . 1.05 ' HA ' ' HE3' ' A' ' 137' ' ' LYS . 0.1 OUTLIER -65.45 -39.34 91.9 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 115.522 -0.763 . . . . 0.0 109.655 170.995 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . 0.68 ' CD2' ' HA ' ' A' ' 135' ' ' ALA . 15.0 m-85 -55.59 -36.55 67.02 Favored 'General case' 0 N--CA 1.464 0.265 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 172.637 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . 0.686 ' HB2' ' O ' ' A' ' 136' ' ' GLU . 94.2 m-20 -51.16 -59.72 3.88 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.148 174.113 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . 0.469 ' HB2' ' OE2' ' A' ' 145' ' ' GLU . 33.8 tt0 -61.55 -36.12 79.7 Favored 'General case' 0 N--CA 1.463 0.179 0 C-N-CA 120.656 -0.418 . . . . 0.0 111.486 -179.262 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.501 ' HG ' ' O ' ' A' ' 137' ' ' LYS . 96.9 mt -61.48 -27.82 68.85 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.897 0.38 . . . . 0.0 110.841 178.348 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 41.7 tp -93.06 -18.08 23.07 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.597 178.172 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 97.78 22.05 17.07 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 121.179 -0.534 . . . . 0.0 111.88 -177.913 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 8.6 tt -89.56 -34.39 16.37 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.775 -0.213 . . . . 0.0 111.321 -175.7 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . 0.469 ' OE2' ' HB2' ' A' ' 140' ' ' GLU . 23.5 mt-10 -64.96 108.61 1.84 Allowed 'General case' 0 CA--C 1.516 -0.331 0 CA-C-O 121.784 0.802 . . . . 0.0 111.061 -179.694 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -84.23 66.13 3.95 Favored Glycine 0 C--N 1.312 -0.792 0 CA-C-N 114.682 -1.145 . . . . 0.0 112.053 -179.172 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 38.3 m170 -68.25 105.02 1.98 Allowed 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.849 0.357 . . . . 0.0 110.159 179.241 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 36.7 m80 -126.57 116.44 21.06 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.414 -179.087 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 31.0 t-80 -156.48 90.78 1.19 Allowed 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.088 177.826 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 45.4 t60 -146.05 6.07 1.01 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.938 0.399 . . . . 0.0 110.793 178.456 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 6.5 t60 -83.21 -33.73 26.06 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 109.333 -0.618 . . . . 0.0 109.333 177.484 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 61.7 t-80 . . . . . 0 C--O 1.24 0.583 0 CA-C-N 115.083 -0.962 . . . . 0.0 109.058 177.013 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.3 mpp? . . . . . 0 N--CA 1.483 1.183 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 25.0 m -92.8 134.44 35.06 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.931 0.396 . . . . 0.0 110.417 179.844 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.429 ' H ' HD23 ' A' ' 3' ' ' LEU . 2.1 pt? -134.19 171.54 14.1 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.064 -179.726 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . 0.468 ' HD2' ' N ' ' A' ' 4' ' ' ARG . 8.6 mpt_? -88.34 19.89 3.56 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.206 0.526 . . . . 0.0 110.548 -176.097 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 17.7 m -148.44 26.42 0.95 Allowed 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.643 -0.708 . . . . 0.0 109.737 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -159.44 -150.71 5.91 Favored Glycine 0 N--CA 1.446 -0.672 0 C-N-CA 120.633 -0.794 . . . . 0.0 112.514 -176.833 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 3.9 m-20 -82.96 150.42 61.64 Favored Pre-proline 0 C--N 1.323 -0.559 0 CA-C-O 120.943 0.401 . . . . 0.0 111.591 -175.331 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -80.38 -155.34 0.06 OUTLIER 'Trans proline' 0 C--N 1.346 0.441 0 C-N-CA 123.222 2.615 . . . . 0.0 111.879 175.102 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 19.2 p -149.58 -171.04 3.79 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.722 0.296 . . . . 0.0 110.726 -179.909 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -75.0 4.45 6.61 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.759 -178.403 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -89.6 -20.69 23.42 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.306 0.575 . . . . 0.0 110.36 177.817 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.576 ' HA ' ' HB3' ' A' ' 25' ' ' LEU . 67.6 m -161.24 91.43 0.86 Allowed 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.373 -0.83 . . . . 0.0 109.914 178.482 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . 0.504 ' CE2' HD22 ' A' ' 25' ' ' LEU . 25.4 p90 -103.55 178.81 4.45 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.655 -179.79 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.477 ' HA ' ' HA ' ' A' ' 24' ' ' SER . 25.1 p -142.35 119.72 11.6 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.119 -0.492 . . . . 0.0 109.948 176.578 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . 0.584 ' HB2' HD23 ' A' ' 92' ' ' LEU . 28.3 m-85 -134.8 155.3 79.48 Favored Pre-proline 0 C--N 1.324 -0.53 0 CA-C-N 116.652 -0.249 . . . . 0.0 110.675 -179.15 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -83.37 124.84 3.77 Favored 'Trans proline' 0 N--CA 1.453 -0.864 0 C-N-CA 122.016 1.811 . . . . 0.0 112.896 176.19 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . 1.001 ' HB3' ' HB3' ' A' ' 21' ' ' LYS . 0.9 OUTLIER -61.47 162.29 8.29 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.077 -0.965 . . . . 0.0 109.173 168.662 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.687 HD12 HG13 ' A' ' 82' ' ' VAL . 0.7 OUTLIER -42.46 -45.08 1.1 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.452 0 O-C-N 123.975 0.797 . . . . 0.0 112.072 -176.644 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.511 ' ND2' HG23 ' A' ' 18' ' ' ILE . 28.9 m-80 -77.23 8.54 3.92 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.825 -173.967 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 81.54 25.22 54.58 Favored Glycine 0 N--CA 1.449 -0.442 0 N-CA-C 110.769 -0.932 . . . . 0.0 110.769 -175.022 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 1.001 ' HB3' ' HB3' ' A' ' 17' ' ' ASP . 1.4 ttmp? -89.96 107.39 19.09 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.435 -0.383 . . . . 0.0 110.473 -173.744 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 23.6 m -67.37 108.29 2.72 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.84 -179.648 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 57.5 t -123.89 133.07 70.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 116.021 -0.536 . . . . 0.0 109.683 179.846 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . 0.477 ' HA ' ' HA ' ' A' ' 14' ' ' SER . 26.5 p -104.46 171.27 7.42 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.128 0.489 . . . . 0.0 110.031 178.6 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.576 ' HB3' ' HA ' ' A' ' 12' ' ' SER . 20.9 tp -91.18 11.86 21.95 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 121.257 0.551 . . . . 0.0 109.608 176.725 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.591 ' HA ' ' HD3' ' A' ' 29' ' ' LYS . . . -103.29 -25.63 13.25 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 -176.09 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 62.5 m-20 -70.29 -11.79 61.14 Favored 'General case' 0 N--CA 1.436 -1.154 0 CA-C-N 114.05 -1.432 . . . . 0.0 110.797 177.538 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 79.4 mt -110.3 3.19 19.67 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.575 -0.739 . . . . 0.0 112.317 -170.582 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.591 ' HD3' ' HA ' ' A' ' 26' ' ' ALA . 1.3 mptm? -61.98 150.07 38.97 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.192 0.52 . . . . 0.0 111.041 178.462 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 98.55 5.92 56.63 Favored Glycine 0 N--CA 1.445 -0.73 0 C-N-CA 120.807 -0.711 . . . . 0.0 111.731 -179.826 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.798 ' HD3' ' HA ' ' A' ' 63' ' ' ASP . 7.5 ttmm -161.79 148.39 13.99 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.958 -0.386 . . . . 0.0 109.958 179.45 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.491 ' HB2' ' O ' ' A' ' 63' ' ' ASP . 40.6 m-85 -56.28 149.57 16.14 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-O 121.266 0.555 . . . . 0.0 112.365 -173.765 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.697 ' HB ' ' HB2' ' A' ' 115' ' ' LEU . 31.4 mm -118.94 135.65 58.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 115.593 -0.731 . . . . 0.0 110.611 -176.139 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 87.8 t80 -123.32 112.08 17.18 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 109.583 -0.525 . . . . 0.0 109.583 172.197 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.702 ' HB ' ' HB ' ' A' ' 113' ' ' ILE . 39.4 mm -100.8 116.99 45.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.26 179.445 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -117.14 158.56 24.04 Favored 'General case' 0 C--N 1.315 -0.925 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 176.612 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.549 HG11 ' CG2' ' A' ' 109' ' ' ILE . 32.6 t -107.86 112.07 38.6 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.009 0 C-N-CA 120.171 -0.612 . . . . 0.0 109.888 175.315 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' TRP . . . . . 0.692 ' CE3' ' HZ2' ' A' ' 78' ' ' TRP . 0.9 OUTLIER -109.92 134.15 52.4 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 115.575 -0.739 . . . . 0.0 109.174 -175.461 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.546 ' HB3' ' HB3' ' A' ' 42' ' ' CYS . . . -147.07 165.62 29.36 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 116.477 -0.329 . . . . 0.0 110.702 -177.123 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.689 ' HB ' ' CE3' ' A' ' 78' ' ' TRP . 9.8 t -89.02 -24.96 22.22 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.271 0.558 . . . . 0.0 109.698 173.824 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . 0.453 ' HZ2' ' HG ' ' A' ' 71' ' ' CYS . 13.4 p-90 -94.86 8.81 41.49 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.108 179.782 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . 0.618 ' SG ' ' HB3' ' A' ' 45' ' ' CYS . 17.5 p -88.54 148.28 24.19 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 175.311 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -92.18 -65.69 1.12 Allowed Glycine 0 N--CA 1.448 -0.527 0 C-N-CA 120.277 -0.963 . . . . 0.0 113.087 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -56.12 -51.82 8.64 Favored 'Trans proline' 0 C--N 1.35 0.655 0 C-N-CA 122.743 2.295 . . . . 0.0 112.865 -175.328 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . 0.618 ' HB3' ' SG ' ' A' ' 42' ' ' CYS . 35.1 t -63.11 -39.75 95.61 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.874 0.369 . . . . 0.0 110.325 -175.846 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.537 ' HA ' ' HG ' ' A' ' 49' ' ' LEU . 62.3 ttt180 -71.14 -27.89 63.88 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.493 179.252 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -79.73 -37.75 22.13 Favored Glycine 0 N--CA 1.447 -0.609 0 C-N-CA 120.69 -0.767 . . . . 0.0 111.945 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.55 ' OE2' ' HD3' ' A' ' 128' ' ' ARG . 35.5 mt-10 -90.16 10.1 25.8 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 122.976 -0.132 . . . . 0.0 111.27 -178.495 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.632 ' O ' ' HG3' ' A' ' 53' ' ' LYS . 41.0 mt -46.23 -52.17 29.57 Favored Pre-proline 0 N--CA 1.468 0.465 0 N-CA-C 112.419 0.526 . . . . 0.0 112.419 -179.725 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.529 ' HD2' ' N ' ' A' ' 49' ' ' LEU . 10.3 Cg_endo -54.26 -41.33 77.1 Favored 'Trans proline' 0 C--N 1.355 0.876 0 C-N-CA 122.035 1.823 . . . . 0.0 112.46 179.077 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -80.46 -26.65 38.18 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.379 0.609 . . . . 0.0 110.172 -177.204 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 7.9 tt -66.71 -43.7 83.62 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.424 -0.807 . . . . 0.0 108.884 175.585 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.632 ' HG3' ' O ' ' A' ' 49' ' ' LEU . 88.5 mttt -57.83 -48.58 79.36 Favored 'General case' 0 CA--C 1.516 -0.335 0 O-C-N 123.589 0.556 . . . . 0.0 110.345 177.424 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -44.86 -59.09 2.72 Favored 'General case' 0 N--CA 1.452 -0.329 0 O-C-N 124.06 0.85 . . . . 0.0 111.018 175.16 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 60.1 mt -59.99 -51.71 68.48 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.27 177.789 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -44.14 -59.58 2.27 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 114.582 -1.19 . . . . 0.0 112.528 -179.056 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.556 ' HG2' ' O ' ' A' ' 53' ' ' LYS . 6.1 pt-20 -82.75 -29.27 29.82 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 112.154 0.427 . . . . 0.0 112.154 -173.868 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.533 ' HE3' ' HE1' ' A' ' 59' ' ' TYR . 32.4 ttpt -68.68 -36.65 78.78 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.236 0.541 . . . . 0.0 110.229 178.316 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.742 ' HB3' HD11 ' A' ' 64' ' ' ILE . 41.7 m-85 -99.45 -1.0 39.66 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.371 -178.857 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -63.83 142.09 58.53 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.538 -0.541 . . . . 0.0 109.538 169.19 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 84.86 9.72 80.33 Favored Glycine 0 N--CA 1.448 -0.521 0 C-N-CA 120.494 -0.86 . . . . 0.0 112.555 179.712 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.536 ' HD2' HD21 ' A' ' 142' ' ' LEU . 39.8 mmtm -100.61 -160.72 0.81 Allowed 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 174.532 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.798 ' HA ' ' HD3' ' A' ' 31' ' ' LYS . 2.6 t70 -90.66 52.04 2.11 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-O 121.271 0.558 . . . . 0.0 110.019 -179.688 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.742 HD11 ' HB3' ' A' ' 59' ' ' TYR . 9.2 pt -151.73 156.63 5.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 115.525 -0.761 . . . . 0.0 110.396 -178.418 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' HIS . . . . . 0.665 ' NE2' ' HB3' ' A' ' 31' ' ' LYS . 95.0 m-70 -126.28 113.64 17.21 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.165 -0.47 . . . . 0.0 109.779 175.397 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 88.7 m-85 -76.77 103.8 6.93 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 172.783 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.633 ' HB ' HD13 ' A' ' 35' ' ' ILE . 23.1 t -121.26 104.78 15.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 116.162 -0.472 . . . . 0.0 109.789 -178.928 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . 0.412 ' HB3' ' CD1' ' A' ' 38' ' ' TRP . 6.8 m -99.28 144.7 28.1 Favored 'General case' 0 C--N 1.313 -1.015 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.508 -177.063 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.435 HD23 ' HB2' ' A' ' 92' ' ' LEU . 78.5 mt -122.95 124.1 42.43 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-O 120.696 0.284 . . . . 0.0 111.49 177.564 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . 0.419 ' HA ' ' O ' ' A' ' 38' ' ' TRP . 40.6 m -96.0 119.71 34.98 Favored 'General case' 0 N--CA 1.464 0.272 0 N-CA-C 112.542 0.571 . . . . 0.0 112.542 -179.49 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' CYS . . . . . 0.453 ' HG ' ' HZ2' ' A' ' 41' ' ' TRP . 7.4 p -92.64 28.53 1.99 Allowed 'General case' 0 C--N 1.313 -1.008 0 CA-C-O 121.198 0.523 . . . . 0.0 110.118 175.03 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.514 ' OD2' HG22 ' A' ' 40' ' ' THR . 2.1 m-20 -81.77 112.79 19.25 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.312 178.255 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.452 ' HB3' ' HB ' ' A' ' 96' ' ' THR . 8.8 ptmm? -67.98 -28.6 67.58 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.078 0.466 . . . . 0.0 111.127 178.994 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -87.32 75.83 9.22 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 109.608 -0.515 . . . . 0.0 109.608 179.556 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.422 ' O ' ' HG2' ' A' ' 79' ' ' GLU . 8.5 tttm -55.06 -64.01 0.97 Allowed 'General case' 0 C--O 1.217 -0.655 0 CA-C-N 115.849 -0.614 . . . . 0.0 112.45 -175.711 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 64.2 tttp -43.94 -50.17 8.24 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 112.258 0.466 . . . . 0.0 112.258 -177.605 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.707 ' HA ' ' ND2' ' A' ' 80' ' ' ASN . . . -58.75 -41.6 86.91 Favored 'General case' 0 C--O 1.246 0.905 0 CA-C-O 122.142 0.972 . . . . 0.0 110.341 179.769 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' TRP . . . . . 0.692 ' HZ2' ' CE3' ' A' ' 38' ' ' TRP . 10.0 t-105 -65.55 -49.98 66.87 Favored 'General case' 0 C--N 1.312 -1.056 0 CA-C-N 114.012 -1.449 . . . . 0.0 110.988 -178.97 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.479 ' OE1' HG13 ' A' ' 18' ' ' ILE . 6.1 mm-40 -47.4 -44.07 24.12 Favored 'General case' 0 C--O 1.234 0.276 0 N-CA-C 112.069 0.396 . . . . 0.0 112.069 175.678 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . 0.717 ' O ' ' HG2' ' A' ' 84' ' ' LYS . 1.9 m-80 -60.64 -46.85 88.75 Favored 'General case' 0 CA--C 1.514 -0.41 0 C-N-CA 120.326 -0.55 . . . . 0.0 110.288 -179.243 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . 0.453 ' SD ' ' HZ3' ' A' ' 78' ' ' TRP . 19.0 ttt -63.07 -47.79 81.44 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 120.41 -0.516 . . . . 0.0 111.993 -177.214 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.687 HG13 HD12 ' A' ' 18' ' ' ILE . 7.2 p -64.17 -28.48 44.99 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 C-N-CA 120.308 -0.557 . . . . 0.0 111.41 -177.54 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . 0.435 HG23 HD11 ' A' ' 18' ' ' ILE . 5.0 p -81.17 -21.89 39.37 Favored 'General case' 0 N--CA 1.444 -0.749 0 O-C-N 121.941 -0.475 . . . . 0.0 111.757 176.406 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . 0.717 ' HG2' ' O ' ' A' ' 80' ' ' ASN . 27.1 mmtm -84.73 -38.39 19.75 Favored 'General case' 0 CA--C 1.519 -0.237 0 CA-C-O 121.249 0.547 . . . . 0.0 110.597 178.195 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -80.15 -22.76 41.67 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.241 -0.891 . . . . 0.0 110.305 179.393 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 26.4 mt-30 66.54 76.46 0.3 Allowed 'General case' 0 C--O 1.234 0.268 0 CA-C-N 115.188 -0.914 . . . . 0.0 111.96 177.085 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.543 ' HB2' HG23 ' A' ' 82' ' ' VAL . 89.4 mt -103.85 133.09 49.42 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.426 -0.806 . . . . 0.0 109.065 173.658 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.525 ' HD2' ' H ' ' A' ' 88' ' ' LYS . 0.0 OUTLIER -134.73 157.97 45.34 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.349 0.595 . . . . 0.0 111.96 -175.499 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 124.91 -132.75 8.24 Favored Glycine 0 N--CA 1.447 -0.626 0 N-CA-C 110.224 -1.15 . . . . 0.0 110.224 -173.278 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 57.7 mt -112.03 108.02 24.45 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 173.414 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . 0.657 ' HB3' ' CZ2' ' A' ' 38' ' ' TRP . 7.0 mm-40 -129.04 103.75 7.18 Favored 'General case' 0 N--CA 1.445 -0.708 0 N-CA-C 109.926 -0.398 . . . . 0.0 109.926 -175.828 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.584 HD23 ' HB2' ' A' ' 15' ' ' TYR . 5.1 mp -103.29 151.36 22.79 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-O 121.493 0.663 . . . . 0.0 110.87 -175.765 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 16.7 t-80 -120.77 119.59 33.17 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-N 115.613 -0.722 . . . . 0.0 110.425 -176.912 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 33.7 ttm -71.78 -75.78 0.12 Allowed 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.433 -0.803 . . . . 0.0 110.129 176.363 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 134.94 -95.15 0.26 Allowed Glycine 0 N--CA 1.442 -0.95 0 N-CA-C 111.114 -0.794 . . . . 0.0 111.114 -174.181 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.452 ' HB ' ' HB3' ' A' ' 73' ' ' LYS . 9.2 t -150.49 25.61 0.77 Allowed 'General case' 0 C--N 1.313 -0.981 0 CA-C-O 121.834 0.826 . . . . 0.0 109.287 177.831 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -81.55 72.61 8.6 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 114.86 -1.063 . . . . 0.0 109.766 -179.092 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . 0.591 ' HA ' ' HG3' ' A' ' 101' ' ' MET . 7.4 mmm180 -69.36 -10.91 60.03 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.724 -173.298 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 7.6 m -58.24 -36.81 73.76 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.165 0.507 . . . . 0.0 109.927 175.262 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 24.8 t80 -81.74 -25.43 35.38 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.184 178.782 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' MET . . . . . 0.591 ' HG3' ' HA ' ' A' ' 98' ' ' ARG . 1.3 mmt -58.92 -51.44 70.04 Favored 'General case' 0 CA--C 1.519 -0.245 0 CA-C-O 121.265 0.555 . . . . 0.0 109.507 175.451 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -77.02 -23.03 52.19 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.406 -0.815 . . . . 0.0 110.538 -177.793 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -64.8 -26.93 68.55 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-O 121.12 0.486 . . . . 0.0 111.043 176.931 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' TYR . . . . . 0.555 ' HB3' HG23 ' A' ' 106' ' ' ILE . 0.3 OUTLIER -96.38 -4.11 42.47 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.296 174.875 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 93.5 mt 58.59 32.21 21.91 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.356 -172.301 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . 0.997 HG21 HD11 ' A' ' 113' ' ' ILE . 40.8 pt -114.43 31.96 1.52 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.333 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.356 -178.622 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 15.3 p30 -56.47 -29.74 62.09 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.469 -0.787 . . . . 0.0 111.82 -178.699 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -89.48 108.95 3.54 Favored Glycine 0 N--CA 1.448 -0.525 0 C-N-CA 121.02 -0.61 . . . . 0.0 111.61 174.077 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.549 ' CG2' HG11 ' A' ' 37' ' ' VAL . 2.5 pp -100.43 153.81 37.54 Favored Pre-proline 0 C--N 1.325 -0.466 0 CA-C-O 120.344 0.116 . . . . 0.0 110.767 -177.528 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . 0.429 ' HG3' ' HB2' ' A' ' 42' ' ' CYS . 2.7 Cg_exo -76.82 152.51 95.43 Favored 'Cis proline' 0 C--N 1.344 0.326 0 C-N-CA 123.899 -1.292 . . . . 0.0 111.966 -0.068 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . 0.779 HH11 HG22 ' A' ' 106' ' ' ILE . 0.0 OUTLIER -125.17 138.45 54.14 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.365 0.603 . . . . 0.0 110.966 -179.0 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . 0.611 ' HD1' ' H ' ' A' ' 126' ' ' MET . 0.2 OUTLIER -106.74 114.97 29.39 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 114.341 -1.3 . . . . 0.0 110.354 -176.548 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.997 HD11 HG21 ' A' ' 106' ' ' ILE . 61.6 mt -123.57 142.54 39.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-O 120.858 0.361 . . . . 0.0 110.754 -178.483 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 23.0 tp -129.23 135.14 48.42 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.996 -0.547 . . . . 0.0 109.655 177.662 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.697 ' HB2' ' HB ' ' A' ' 33' ' ' ILE . 2.0 mp -132.57 153.44 51.0 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.878 0.37 . . . . 0.0 110.495 -177.054 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . 0.496 ' HB3' ' HB2' ' A' ' 120' ' ' LYS . 27.9 t0 -68.93 166.1 18.58 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.468 -0.787 . . . . 0.0 110.261 177.276 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . 0.513 ' HA ' ' C ' ' A' ' 31' ' ' LYS . 9.2 mtm180 -49.39 -27.64 4.28 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 124.335 1.054 . . . . 0.0 112.733 -177.076 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . 0.552 ' HB3' ' HG3' ' A' ' 120' ' ' LYS . 30.6 t70 -83.32 -0.97 52.1 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.257 0.551 . . . . 0.0 110.965 -178.784 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 81.26 22.5 60.61 Favored Glycine 0 N--CA 1.439 -1.16 0 N-CA-C 110.203 -1.159 . . . . 0.0 110.203 -170.513 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . 0.552 ' HG3' ' HB3' ' A' ' 118' ' ' ASP . 56.5 mttp -88.56 107.4 18.88 Favored 'General case' 0 C--O 1.223 -0.325 0 C-N-CA 120.478 -0.489 . . . . 0.0 111.052 -178.267 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 0.479 ' HA ' ' HG ' ' A' ' 115' ' ' LEU . 19.5 mt -42.74 116.27 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-O 121.725 0.774 . . . . 0.0 112.332 179.251 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' ILE . . . . . 0.461 HD11 ' HB2' ' A' ' 116' ' ' ASP . 39.2 mm -97.87 -50.87 10.94 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.927 0 CA-C-N 114.283 -1.326 . . . . 0.0 109.203 177.163 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 14.6 m -129.44 114.21 15.87 Favored 'General case' 0 N--CA 1.446 -0.664 0 CA-C-N 115.22 -0.9 . . . . 0.0 110.113 179.305 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -68.05 -20.38 64.97 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 121.807 0.813 . . . . 0.0 109.496 174.046 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 7.4 p30 -141.46 122.07 14.23 Favored 'General case' 0 N--CA 1.447 -0.586 0 CA-C-N 114.523 -1.217 . . . . 0.0 108.25 171.291 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' MET . . . . . 0.611 ' H ' ' HD1' ' A' ' 112' ' ' PHE . 17.3 tpt -92.76 -80.66 0.37 Allowed 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.915 -176.664 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 4.2 m -155.44 -61.91 0.11 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.576 -0.284 . . . . 0.0 110.48 179.605 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . 1.087 ' HB3' ' HB2' ' A' ' 131' ' ' ASP . 0.0 OUTLIER -179.82 142.1 0.35 Allowed Pre-proline 0 N--CA 1.453 -0.314 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 -176.467 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . 0.566 ' HD2' ' HG2' ' A' ' 128' ' ' ARG . 1.5 Cg_endo -43.19 -49.0 7.58 Favored 'Trans proline' 0 C--N 1.351 0.671 0 C-N-CA 123.431 2.754 . . . . 0.0 113.353 -178.626 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 25.3 t -113.24 29.72 7.76 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.821 0.343 . . . . 0.0 111.196 -177.561 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . 1.087 ' HB2' ' HB3' ' A' ' 128' ' ' ARG . 11.2 t70 -84.88 135.94 39.39 Favored Pre-proline 0 C--N 1.328 -0.341 0 C-N-CA 120.389 -0.525 . . . . 0.0 110.426 -179.975 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 80.8 Cg_exo -48.24 -37.82 32.34 Favored 'Trans proline' 0 C--N 1.344 0.303 0 C-N-CA 123.231 2.621 . . . . 0.0 113.258 176.66 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 28.9 mmtm -56.98 -36.22 70.1 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-O 120.866 0.365 . . . . 0.0 111.711 -177.336 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' THR . . . . . 0.684 HG22 ' CZ ' ' A' ' 138' ' ' PHE . 2.4 m -64.51 -51.19 64.22 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.284 0.564 . . . . 0.0 109.69 177.244 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . 0.672 ' HA ' ' CD2' ' A' ' 138' ' ' PHE . . . -61.56 -41.01 96.75 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.583 -0.735 . . . . 0.0 111.542 177.576 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -53.5 -52.1 60.67 Favored 'General case' 0 CA--C 1.511 -0.531 0 CA-C-O 121.44 0.638 . . . . 0.0 110.458 176.882 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . 0.707 ' HE2' ' HA ' ' A' ' 137' ' ' LYS . 0.3 OUTLIER -48.93 -46.56 43.26 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 114.333 -1.303 . . . . 0.0 111.261 175.614 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . 0.684 ' CZ ' HG22 ' A' ' 134' ' ' THR . 5.9 m-85 -63.1 -53.77 48.29 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 120.889 0.376 . . . . 0.0 109.991 178.4 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . 0.497 ' C ' ' H ' ' A' ' 145' ' ' GLU . 94.2 m-20 -50.9 -50.12 58.04 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.789 -179.886 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -49.41 -54.47 17.35 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.648 -0.705 . . . . 0.0 112.133 178.17 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.55 ' HG ' ' O ' ' A' ' 138' ' ' PHE . 3.2 pp -69.35 -19.38 63.85 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 120.953 -0.299 . . . . 0.0 111.206 -174.842 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.536 HD21 ' HD2' ' A' ' 62' ' ' LYS . 8.2 mp -82.64 -16.9 46.58 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.907 0.384 . . . . 0.0 110.56 173.418 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 94.14 8.47 60.17 Favored Glycine 0 N--CA 1.45 -0.387 0 N-CA-C 111.603 -0.599 . . . . 0.0 111.603 -178.135 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 60.7 tp -90.33 -52.11 5.09 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.476 -0.362 . . . . 0.0 110.258 -178.886 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . 0.497 ' H ' ' C ' ' A' ' 139' ' ' ASN . 2.6 mt-10 60.14 -76.36 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.446 0 O-C-N 124.348 1.03 . . . . 0.0 112.346 179.33 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 145.03 24.42 0.12 Allowed Glycine 0 C--N 1.306 -1.109 0 CA-C-N 113.771 -1.559 . . . . 0.0 109.696 -171.708 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 6.4 p-80 -58.04 118.13 5.09 Favored 'General case' 0 N--CA 1.458 -0.032 0 CA-C-O 121.388 0.613 . . . . 0.0 111.338 -177.062 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 14.8 t60 -102.29 2.48 37.0 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.589 -0.732 . . . . 0.0 109.554 -179.14 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 2.9 m-70 -133.52 141.29 47.68 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.648 -178.561 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 39.4 t-80 65.43 -98.97 0.06 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.109 -0.95 . . . . 0.0 111.902 172.383 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 70.1 t60 171.66 145.13 0.03 OUTLIER 'General case' 0 C--O 1.232 0.174 0 N-CA-C 109.754 -0.461 . . . . 0.0 109.754 -171.911 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 4.9 t60 . . . . . 0 C--O 1.241 0.642 0 N-CA-C 107.88 -1.156 . . . . 0.0 107.88 169.674 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.413 ' HG2' ' HB3' ' A' ' 8' ' ' PRO . 26.8 ptm . . . . . 0 N--CA 1.48 1.031 0 N-CA-C 110.262 -0.273 . . . . 0.0 110.262 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 23.0 m 68.71 -76.2 0.06 Allowed 'General case' 0 CA--C 1.532 0.275 0 O-C-N 124.111 0.882 . . . . 0.0 112.311 173.79 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.756 ' H ' HD23 ' A' ' 3' ' ' LEU . 1.8 pt? -82.65 110.25 17.55 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.902 0.382 . . . . 0.0 110.33 -178.949 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 27.1 mtm180 69.26 -170.68 0.18 Allowed 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 115.254 -0.885 . . . . 0.0 110.247 -179.037 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 34.4 m -111.2 93.29 4.4 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 174.44 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 167.74 -136.25 4.02 Favored Glycine 0 N--CA 1.446 -0.635 0 C-N-CA 120.531 -0.843 . . . . 0.0 112.689 -178.369 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . 0.472 ' HA ' ' HD3' ' A' ' 8' ' ' PRO . 4.7 p-10 -70.86 148.35 94.65 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-O 120.975 0.416 . . . . 0.0 111.874 -174.459 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.472 ' HD3' ' HA ' ' A' ' 7' ' ' ASN . 4.4 Cg_exo -74.32 165.93 30.69 Favored 'Trans proline' 0 C--O 1.234 0.279 0 C-N-CA 123.198 2.598 . . . . 0.0 111.708 175.089 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.528 ' HB2' HD11 ' A' ' 3' ' ' LEU . 66.2 m -156.15 176.09 13.12 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.559 -0.291 . . . . 0.0 110.481 179.0 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -77.61 76.29 4.14 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.542 0.687 . . . . 0.0 110.499 178.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -138.77 99.22 3.74 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 115.131 -0.94 . . . . 0.0 110.216 -179.752 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 49.0 m 64.7 80.02 0.24 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.405 -0.816 . . . . 0.0 111.454 179.463 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 53.5 p90 -96.08 155.32 16.81 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.116 178.014 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 5.4 p -142.1 112.92 7.35 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 120.98 0.419 . . . . 0.0 110.147 177.307 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . 0.559 ' HB2' HD13 ' A' ' 92' ' ' LEU . 35.8 m-85 -135.75 149.7 69.69 Favored Pre-proline 0 C--N 1.326 -0.431 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.413 -176.38 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.456 ' HA ' ' O ' ' A' ' 21' ' ' LYS . 97.3 Cg_endo -87.07 131.37 3.11 Favored 'Trans proline' 0 N--CA 1.452 -0.946 0 C-N-CA 122.528 2.152 . . . . 0.0 113.23 179.808 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . 0.506 ' HB3' ' HB3' ' A' ' 21' ' ' LYS . 12.1 t70 -67.95 154.49 41.49 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 114.958 -1.019 . . . . 0.0 108.63 170.403 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -53.21 -32.93 19.75 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.6 0 O-C-N 124.018 0.824 . . . . 0.0 110.883 -179.391 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 43.7 m-80 -76.29 -1.77 28.23 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 121.089 0.471 . . . . 0.0 110.82 179.051 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 86.05 42.11 6.83 Favored Glycine 0 N--CA 1.446 -0.647 0 CA-C-N 115.739 -0.664 . . . . 0.0 112.172 -179.619 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.506 ' HB3' ' HB3' ' A' ' 17' ' ' ASP . 56.8 tttm -107.71 124.2 49.66 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 120.173 -0.611 . . . . 0.0 111.252 -179.453 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 19.4 m -66.49 107.38 2.04 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.29 -0.414 . . . . 0.0 109.945 172.652 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.444 ' HB ' HD21 ' A' ' 92' ' ' LEU . 91.6 t -116.35 117.32 55.1 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-O 120.996 0.427 . . . . 0.0 109.909 178.342 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 17.6 m -122.77 179.47 4.62 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.288 -178.15 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.418 HD11 ' HA3' ' A' ' 119' ' ' GLY . 52.7 tp -56.4 -42.28 77.7 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.924 0.393 . . . . 0.0 111.027 -179.287 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -82.27 15.91 2.24 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.86 -177.793 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -102.18 -17.08 16.14 Favored 'General case' 0 CA--C 1.517 -0.294 0 N-CA-C 107.692 -1.225 . . . . 0.0 107.692 178.319 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -117.22 -20.81 9.07 Favored 'General case' 0 N--CA 1.445 -0.723 0 CA-C-N 113.973 -1.467 . . . . 0.0 110.494 -179.323 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 58.3 tttm -61.71 132.07 52.0 Favored 'General case' 0 N--CA 1.446 -0.662 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.273 -173.931 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 120.5 -8.59 11.03 Favored Glycine 0 N--CA 1.451 -0.328 0 N-CA-C 110.61 -0.996 . . . . 0.0 110.61 -174.496 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.687 ' HD3' ' HA ' ' A' ' 63' ' ' ASP . 25.2 ttmm -155.63 154.96 32.44 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 -178.784 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.445 ' HB2' ' O ' ' A' ' 63' ' ' ASP . 61.8 m-85 -59.07 147.1 36.12 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-O 121.094 0.473 . . . . 0.0 111.601 -174.482 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.553 HD12 ' HA2' ' A' ' 119' ' ' GLY . 40.0 mt -124.45 134.77 65.83 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.439 -175.633 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . 0.414 ' HE2' ' HB3' ' A' ' 36' ' ' ASP . 80.3 t80 -121.79 130.71 53.61 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 173.177 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.547 ' HA ' ' O ' ' A' ' 67' ' ' VAL . 62.5 mt -115.2 110.76 33.1 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-O 121.093 0.473 . . . . 0.0 110.577 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.582 ' O ' ' HA ' ' A' ' 68' ' ' SER . 7.1 p-10 -110.34 158.97 17.87 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-N 115.5 -0.773 . . . . 0.0 109.063 175.257 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.522 HG11 HG21 ' A' ' 109' ' ' ILE . 85.5 t -102.88 126.68 57.09 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.806 0 C-N-CA 120.144 -0.622 . . . . 0.0 111.119 176.598 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' TRP . . . . . 0.588 ' CE3' ' CZ2' ' A' ' 78' ' ' TRP . 0.7 OUTLIER -113.31 130.49 56.25 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 109.368 -0.605 . . . . 0.0 109.368 177.958 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -150.19 167.47 26.81 Favored 'General case' 0 C--N 1.328 -0.354 0 O-C-N 122.362 -0.211 . . . . 0.0 111.039 -178.497 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.601 HG22 ' OD2' ' A' ' 72' ' ' ASP . 13.8 t -108.85 -33.63 6.89 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 120.696 -0.401 . . . . 0.0 110.694 174.313 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . 0.726 ' HE1' ' HA ' ' A' ' 72' ' ' ASP . 65.6 p-90 -73.94 -9.24 58.44 Favored 'General case' 0 C--N 1.343 0.291 0 C-N-CA 120.319 -0.552 . . . . 0.0 111.002 178.489 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 25.5 t -63.55 -57.57 9.72 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.102 -179.917 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 107.28 -85.18 0.41 Allowed Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.642 -0.789 . . . . 0.0 112.493 -176.712 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_exo -53.42 -28.63 45.04 Favored 'Trans proline' 0 C--N 1.354 0.818 0 C-N-CA 123.134 2.556 . . . . 0.0 112.727 179.277 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 42.4 t -54.13 -29.15 44.06 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.055 176.963 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 54.8 mtp180 -83.65 -26.23 30.08 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-O 120.903 0.382 . . . . 0.0 110.695 -179.701 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -80.52 -36.67 22.65 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.865 -0.683 . . . . 0.0 111.689 -179.335 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.422 ' OE2' ' HD2' ' A' ' 128' ' ' ARG . 21.3 mt-10 -90.23 10.36 24.95 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.292 0.568 . . . . 0.0 109.985 177.95 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.546 ' N ' ' HD2' ' A' ' 50' ' ' PRO . 20.2 tp -69.05 -45.99 30.24 Favored Pre-proline 0 N--CA 1.441 -0.89 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.869 -177.936 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.546 ' HD2' ' N ' ' A' ' 49' ' ' LEU . 11.7 Cg_endo -56.83 -22.28 44.59 Favored 'Trans proline' 0 C--N 1.351 0.698 0 C-N-CA 121.565 1.51 . . . . 0.0 111.363 171.379 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -85.05 -31.38 23.44 Favored 'General case' 0 CA--C 1.515 -0.386 0 CA-C-O 121.924 0.869 . . . . 0.0 108.895 -179.233 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 6.0 tt -69.94 -48.07 59.88 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-N 114.443 -1.253 . . . . 0.0 108.573 178.228 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.687 ' HZ3' ' HB3' ' A' ' 53' ' ' LYS . 7.6 mtpm? -58.83 -49.37 77.99 Favored 'General case' 0 C--O 1.225 -0.193 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.751 179.119 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -46.03 -56.37 5.64 Favored 'General case' 0 C--N 1.332 -0.16 0 O-C-N 123.514 0.509 . . . . 0.0 111.586 176.397 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.598 HD21 ' HE2' ' A' ' 138' ' ' PHE . 38.8 tp -66.95 -48.7 67.75 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.255 -178.392 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.437 ' HA ' ' CE2' ' A' ' 66' ' ' PHE . 5.9 tm-20 -59.03 -55.1 39.47 Favored 'General case' 0 N--CA 1.448 -0.553 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.563 -175.998 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.674 ' HG2' ' NZ ' ' A' ' 88' ' ' LYS . 38.2 mt-10 -70.12 -30.43 67.62 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.724 0.297 . . . . 0.0 111.244 -174.73 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.482 ' HE3' ' HB2' ' A' ' 58' ' ' LYS . 34.3 ttmt -69.96 -41.77 74.07 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-O 121.198 0.523 . . . . 0.0 110.665 179.237 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 17.2 m-85 -100.3 7.82 44.12 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.473 -177.032 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -65.11 136.19 56.41 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.258 -0.428 . . . . 0.0 109.941 173.245 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 82.61 1.52 90.53 Favored Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.407 179.187 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.452 ' O ' ' HD3' ' A' ' 31' ' ' LYS . 34.8 mmtm -90.59 -154.16 0.33 Allowed 'General case' 0 CA--C 1.515 -0.395 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 176.601 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.687 ' HA ' ' HD3' ' A' ' 31' ' ' LYS . 2.6 t70 -95.1 47.26 1.14 Allowed 'General case' 0 C--N 1.318 -0.762 0 CA-C-O 121.35 0.595 . . . . 0.0 110.344 179.153 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 13.3 tt -155.16 135.31 4.18 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.721 0 CA-C-N 115.582 -0.735 . . . . 0.0 109.961 178.038 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' HIS . . . . . 0.659 ' NE2' ' HB3' ' A' ' 31' ' ' LYS . 75.3 m-70 -105.0 114.27 28.38 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 176.911 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . 0.453 ' CZ ' ' HG ' ' A' ' 55' ' ' LEU . 73.6 m-85 -78.4 104.81 9.23 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 172.442 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.547 ' O ' ' HA ' ' A' ' 35' ' ' ILE . 48.4 t -117.49 104.46 16.42 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.884 -178.359 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . 0.582 ' HA ' ' O ' ' A' ' 36' ' ' ASP . 23.3 p -89.26 146.03 25.0 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.169 -179.8 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.471 ' O ' HG13 ' A' ' 37' ' ' VAL . 64.8 tp -124.12 126.84 46.87 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 109.689 -0.486 . . . . 0.0 109.689 176.77 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . 0.487 ' HB3' ' HA ' ' A' ' 93' ' ' HIS . 19.3 t -103.94 109.03 20.62 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.435 0.636 . . . . 0.0 112.29 -174.301 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 6.8 m -81.02 25.11 0.48 Allowed 'General case' 0 C--N 1.314 -0.974 0 CA-C-N 115.067 -0.969 . . . . 0.0 110.188 169.553 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.726 ' HA ' ' HE1' ' A' ' 41' ' ' TRP . 2.9 t70 -72.79 129.74 38.89 Favored 'General case' 0 CA--C 1.51 -0.578 0 C-N-CA 119.899 -0.72 . . . . 0.0 110.174 -178.646 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.494 ' NZ ' ' HB3' ' A' ' 73' ' ' LYS . 3.0 ttpm? -88.02 -11.95 45.81 Favored 'General case' 0 C--N 1.313 -0.979 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.338 -177.856 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 -104.39 60.04 0.71 Allowed 'General case' 0 CA--C 1.51 -0.595 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 -176.779 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.64 ' O ' ' HG2' ' A' ' 79' ' ' GLU . 64.9 tttt -47.75 -51.33 22.59 Favored 'General case' 0 C--O 1.221 -0.414 0 O-C-N 123.644 0.59 . . . . 0.0 112.447 -170.029 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 23.6 tptm -48.3 -54.24 14.45 Favored 'General case' 0 C--O 1.245 0.855 0 CA-C-N 116.735 -0.211 . . . . 0.0 110.456 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.587 ' HA ' HD21 ' A' ' 80' ' ' ASN . . . -61.27 -39.86 91.95 Favored 'General case' 0 N--CA 1.452 -0.355 0 O-C-N 123.972 0.795 . . . . 0.0 110.034 -178.844 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' TRP . . . . . 0.588 ' CZ2' ' CE3' ' A' ' 38' ' ' TRP . 9.3 t-105 -61.43 -58.51 7.88 Favored 'General case' 0 N--CA 1.437 -1.088 0 CA-C-N 114.96 -1.018 . . . . 0.0 112.263 -179.458 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.64 ' HG2' ' O ' ' A' ' 75' ' ' LYS . 3.3 mm-40 -52.25 -48.04 65.43 Favored 'General case' 0 C--O 1.236 0.39 0 N-CA-C 112.426 0.528 . . . . 0.0 112.426 -175.669 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . 0.587 HD21 ' HA ' ' A' ' 77' ' ' ALA . 8.4 p30 -71.16 -28.82 64.53 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 118.859 -1.136 . . . . 0.0 110.852 -178.159 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 15.3 ttt -68.19 -47.81 66.93 Favored 'General case' 0 C--O 1.222 -0.359 0 C-N-CA 120.978 -0.289 . . . . 0.0 111.542 177.518 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.586 HG23 ' HB2' ' A' ' 87' ' ' LEU . 0.2 OUTLIER -58.69 -37.9 68.44 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.313 0 C-N-CA 120.429 -0.509 . . . . 0.0 110.205 178.72 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 25.3 m -67.34 -33.31 74.97 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.81 177.376 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 21.0 tttm -80.25 -49.97 10.86 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.699 -177.958 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 52.8 m-20 -84.37 6.79 21.78 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.633 -0.712 . . . . 0.0 111.406 -173.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 89.7 mt-30 64.28 41.72 5.8 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 115.72 -0.673 . . . . 0.0 112.745 171.007 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.586 ' HB2' HG23 ' A' ' 82' ' ' VAL . 7.9 mp -83.95 82.11 8.49 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 120.758 -0.377 . . . . 0.0 110.218 176.036 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.674 ' NZ ' ' HG2' ' A' ' 57' ' ' GLU . 0.0 OUTLIER -95.79 171.53 8.59 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.594 -0.276 . . . . 0.0 111.676 -179.852 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 128.07 -139.74 11.3 Favored Glycine 0 N--CA 1.452 -0.258 0 N-CA-C 110.286 -1.126 . . . . 0.0 110.286 -175.795 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 63.8 mt -111.44 109.05 27.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 N-CA-C 107.935 -1.135 . . . . 0.0 107.935 168.408 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . 0.541 ' HB3' ' CZ2' ' A' ' 38' ' ' TRP . 3.5 mm100 -127.73 100.22 5.87 Favored 'General case' 0 N--CA 1.442 -0.85 0 CA-C-O 120.838 0.351 . . . . 0.0 110.953 -167.669 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.559 HD13 ' HB2' ' A' ' 15' ' ' TYR . 27.0 mt -97.22 140.58 31.49 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 120.817 0.342 . . . . 0.0 110.787 -177.133 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' HIS . . . . . 0.547 ' CE1' ' HG3' ' A' ' 75' ' ' LYS . 30.0 t-80 -114.53 120.63 40.88 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 120.864 0.364 . . . . 0.0 110.896 178.301 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 19.7 ttp -79.0 -55.83 4.84 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.74 -0.664 . . . . 0.0 109.999 176.553 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . 0.453 ' HA2' ' NE2' ' A' ' 93' ' ' HIS . . . 111.19 -119.33 5.14 Favored Glycine 0 N--CA 1.438 -1.178 0 C-N-CA 120.557 -0.83 . . . . 0.0 111.879 -179.465 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 8.9 t -109.85 21.71 16.55 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-O 120.555 0.217 . . . . 0.0 110.994 -175.28 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -90.84 134.17 34.65 Favored 'General case' 0 CA--C 1.515 -0.383 0 C-N-CA 119.699 -0.8 . . . . 0.0 109.74 179.9 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . 0.598 ' HA ' ' HG3' ' A' ' 101' ' ' MET . 0.0 OUTLIER -113.71 6.08 16.69 Favored 'General case' 0 C--N 1.32 -0.676 0 C-N-CA 120.361 -0.536 . . . . 0.0 110.699 176.689 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 4.0 m -71.0 -39.68 72.29 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.373 -178.611 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 27.7 t80 -82.24 -30.61 30.65 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.585 -176.948 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' MET . . . . . 0.598 ' HG3' ' HA ' ' A' ' 98' ' ' ARG . 4.7 ppp? -74.68 -20.92 59.67 Favored 'General case' 0 C--N 1.332 -0.168 0 C-N-CA 120.144 -0.622 . . . . 0.0 109.495 177.554 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -68.0 -42.81 80.18 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.41 -0.814 . . . . 0.0 109.8 172.331 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -64.46 -16.99 63.4 Favored 'General case' 0 CA--C 1.529 0.158 0 CA-C-N 115.674 -0.694 . . . . 0.0 111.815 -177.621 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 9.0 m-85 -108.28 -2.32 19.35 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.402 178.212 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 7.8 mp 55.34 37.64 29.18 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.812 -176.793 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . 0.855 HG12 ' HG3' ' A' ' 111' ' ' ARG . 60.8 mt -59.41 106.51 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.006 177.906 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 7.1 m120 -73.79 -66.18 0.74 Allowed 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.626 0.727 . . . . 0.0 109.938 178.483 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -135.14 145.82 17.88 Favored Glycine 0 N--CA 1.438 -1.216 0 CA-C-N 114.971 -1.013 . . . . 0.0 111.12 178.979 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.522 HG21 HG11 ' A' ' 37' ' ' VAL . 40.2 pt -100.53 154.3 37.26 Favored Pre-proline 0 C--N 1.316 -0.85 0 N-CA-C 110.34 -0.244 . . . . 0.0 110.34 179.736 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . 0.487 ' HB3' ' O ' ' A' ' 37' ' ' VAL . 15.9 Cg_exo -69.1 131.73 19.34 Favored 'Cis proline' 0 C--N 1.348 0.515 0 C-N-CA 123.973 -1.261 . . . . 0.0 113.54 0.656 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . 0.855 ' HG3' HG12 ' A' ' 106' ' ' ILE . 0.0 OUTLIER -82.26 160.3 22.99 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 175.215 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . 0.429 ' HD2' ' HB2' ' A' ' 128' ' ' ARG . 0.2 OUTLIER -130.45 114.43 15.52 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.76 -0.654 . . . . 0.0 109.958 -177.445 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.516 ' HB ' ' HB ' ' A' ' 35' ' ' ILE . 81.5 mt -134.44 142.88 39.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-O 120.735 0.303 . . . . 0.0 111.142 -176.306 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.491 ' HB2' ' SD ' ' A' ' 126' ' ' MET . 41.2 tp -127.13 140.41 52.28 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.262 178.689 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.492 ' HB2' ' HB ' ' A' ' 33' ' ' ILE . 1.9 mp -133.29 150.0 51.91 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.302 0.572 . . . . 0.0 110.042 178.152 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . 0.624 ' HB3' ' HB2' ' A' ' 120' ' ' LYS . 14.1 t70 -70.29 164.3 24.7 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.029 -0.987 . . . . 0.0 110.604 178.905 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . 0.405 ' HA ' ' C ' ' A' ' 31' ' ' LYS . 84.5 mtt180 -48.13 -38.09 17.05 Favored 'General case' 0 N--CA 1.464 0.247 0 O-C-N 124.198 0.936 . . . . 0.0 112.613 -178.63 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -80.54 9.77 5.61 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.638 0.256 . . . . 0.0 111.607 -178.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . 0.553 ' HA2' HD12 ' A' ' 33' ' ' ILE . . . 79.04 28.81 53.34 Favored Glycine 0 N--CA 1.445 -0.744 0 N-CA-C 111.244 -0.743 . . . . 0.0 111.244 -176.988 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . 0.624 ' HB2' ' HB3' ' A' ' 116' ' ' ASP . 32.4 mtmm -99.47 104.29 16.11 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 120.674 -0.411 . . . . 0.0 110.742 -175.147 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 0.676 ' H ' HD12 ' A' ' 121' ' ' ILE . 4.0 mp -43.65 111.57 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-O 121.31 0.576 . . . . 0.0 111.396 -178.286 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' ILE . . . . . 0.451 ' H ' ' HA ' ' A' ' 115' ' ' LEU . 58.7 mt -85.59 -41.3 15.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 115.337 -0.847 . . . . 0.0 109.18 178.921 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 17.3 m -149.72 115.44 5.6 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.416 -0.811 . . . . 0.0 110.299 -179.522 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -69.92 -15.22 63.03 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.348 0.594 . . . . 0.0 110.307 174.937 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 18.1 p-10 -139.95 102.77 4.48 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.313 -0.858 . . . . 0.0 110.066 174.24 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' MET . . . . . 0.491 ' SD ' ' HB2' ' A' ' 114' ' ' LEU . 20.8 ttp -107.97 -133.4 0.33 Allowed 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.036 -0.529 . . . . 0.0 109.676 178.602 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 6.3 p -124.69 138.07 54.32 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 110.149 -0.315 . . . . 0.0 110.149 177.328 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . 0.43 ' CG ' ' HD2' ' A' ' 129' ' ' PRO . 37.9 ttm180 -67.78 147.36 98.59 Favored Pre-proline 0 C--N 1.325 -0.475 0 CA-C-N 116.198 -0.455 . . . . 0.0 109.874 177.565 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . 0.43 ' HD2' ' CG ' ' A' ' 128' ' ' ARG . 2.9 Cg_endo -42.62 -25.82 0.54 Allowed 'Trans proline' 0 C--N 1.356 0.966 0 C-N-CA 124.119 3.213 . . . . 0.0 114.226 177.095 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 1.4 m -57.76 -26.05 61.32 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 122.723 0.409 . . . . 0.0 111.708 178.432 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . 0.479 ' OD1' ' HG3' ' A' ' 133' ' ' LYS . 21.1 t0 -99.05 124.88 43.76 Favored Pre-proline 0 C--N 1.329 -0.32 0 N-CA-C 109.938 -0.393 . . . . 0.0 109.938 179.511 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 28.7 Cg_endo -61.0 -18.11 55.73 Favored 'Trans proline' 0 C--N 1.347 0.489 0 C-N-CA 123.273 2.648 . . . . 0.0 113.788 -178.081 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . 0.479 ' HG3' ' OD1' ' A' ' 131' ' ' ASP . 48.6 mttp -58.2 -23.93 57.31 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-O 120.833 0.349 . . . . 0.0 110.605 178.843 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 36.2 p -58.39 -59.32 5.53 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.235 175.494 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -56.75 -47.17 80.66 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.917 -177.907 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -56.63 -39.9 74.47 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.44 -0.8 . . . . 0.0 111.15 -179.633 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . 0.514 ' O ' ' HG ' ' A' ' 141' ' ' LEU . 75.5 tttt -74.08 -34.09 63.88 Favored 'General case' 0 N--CA 1.451 -0.396 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.883 -179.271 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . 0.598 ' HE2' HD21 ' A' ' 55' ' ' LEU . 11.1 m-30 -64.43 -40.22 95.33 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 109.689 -0.486 . . . . 0.0 109.689 177.747 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 75.6 m-20 -58.17 -45.74 86.96 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.69 -0.686 . . . . 0.0 109.66 174.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -60.58 -48.07 83.39 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.067 177.467 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.514 ' HG ' ' O ' ' A' ' 137' ' ' LYS . 95.5 mt -56.38 -45.59 80.46 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.776 -179.402 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.543 HD13 ' HB2' ' A' ' 63' ' ' ASP . 60.0 tp -67.71 -23.28 65.26 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.201 0.524 . . . . 0.0 110.811 -179.973 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 95.27 23.81 18.45 Favored Glycine 0 N--CA 1.442 -0.924 0 C-N-CA 120.719 -0.753 . . . . 0.0 111.383 -176.904 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 55.6 tp -82.26 -68.66 0.68 Allowed 'General case' 0 N--CA 1.446 -0.632 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 175.822 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 8.2 mm-40 -70.4 -22.44 62.74 Favored 'General case' 0 CA--C 1.505 -0.756 0 CA-C-O 122.086 0.946 . . . . 0.0 110.704 172.95 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -71.77 64.9 1.16 Allowed Glycine 0 C--N 1.305 -1.145 0 CA-C-N 113.974 -1.466 . . . . 0.0 110.078 166.272 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 88.9 m-70 -74.8 44.44 0.22 Allowed 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 122.754 0.421 . . . . 0.0 111.014 -174.544 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 27.3 p80 -78.97 48.43 0.84 Allowed 'General case' 0 N--CA 1.466 0.348 0 N-CA-C 112.366 0.506 . . . . 0.0 112.366 -173.486 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -166.7 174.36 8.78 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-N 116.46 -0.336 . . . . 0.0 110.718 175.594 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 15.2 t-80 66.97 22.39 10.08 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 123.509 0.723 . . . . 0.0 111.444 176.543 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 34.3 p-80 -166.94 -173.58 2.41 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 110.14 -0.318 . . . . 0.0 110.14 176.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 84.5 t60 . . . . . 0 C--O 1.246 0.914 0 CA-C-O 118.555 -0.736 . . . . 0.0 110.133 178.922 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.1 ptt? . . . . . 0 N--CA 1.481 1.125 0 CA-C-O 120.794 0.331 . . . . 0.0 111.035 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 18.7 p -154.88 178.29 10.33 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 110.153 -0.314 . . . . 0.0 110.153 -178.565 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 6.9 mp -71.96 98.28 2.02 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 176.204 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 38.9 ttm180 -62.46 -37.78 87.24 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.119 -175.704 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 37.1 m -110.89 101.49 10.08 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.33 -179.476 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 113.4 -39.37 2.86 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.552 177.693 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 53.5 m-80 68.41 162.91 0.14 Allowed Pre-proline 0 N--CA 1.469 0.493 0 C-N-CA 122.919 0.488 . . . . 0.0 110.789 -175.978 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -57.01 110.97 0.67 Allowed 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.008 1.806 . . . . 0.0 111.149 175.792 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.431 ' HA ' ' OG ' ' A' ' 12' ' ' SER . 5.5 m -70.23 -5.9 30.79 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.285 0.564 . . . . 0.0 111.775 -172.546 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.441 ' HA ' ' CZ ' ' A' ' 100' ' ' PHE . . . -79.0 -11.06 60.0 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 115.417 -0.81 . . . . 0.0 109.884 178.391 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -128.38 13.24 6.56 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.344 -0.844 . . . . 0.0 110.535 -178.644 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.431 ' OG ' ' HA ' ' A' ' 9' ' ' SER . 35.6 p -143.16 18.34 1.92 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.13 0.491 . . . . 0.0 110.852 -179.747 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 49.5 p90 -73.81 149.64 41.54 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.055 -0.521 . . . . 0.0 111.008 -176.958 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.466 ' HA ' ' HA ' ' A' ' 24' ' ' SER . 39.1 m -142.22 117.23 9.98 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.773 -0.649 . . . . 0.0 109.377 176.811 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . 0.538 ' HB2' HD22 ' A' ' 92' ' ' LEU . 57.5 m-85 -128.32 145.68 56.64 Favored Pre-proline 0 C--N 1.323 -0.55 0 CA-C-O 120.851 0.357 . . . . 0.0 111.236 -176.321 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 63.2 Cg_endo -76.07 125.39 8.58 Favored 'Trans proline' 0 N--CA 1.459 -0.553 0 C-N-CA 122.434 2.089 . . . . 0.0 113.449 -179.029 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . 0.68 ' HB3' ' HB3' ' A' ' 21' ' ' LYS . 3.3 t70 -64.15 157.36 25.79 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.044 -0.98 . . . . 0.0 108.528 168.007 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.526 HD12 ' CG1' ' A' ' 82' ' ' VAL . 3.4 tt -50.06 -39.04 15.41 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.519 0 O-C-N 123.959 0.787 . . . . 0.0 111.561 -173.867 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 37.8 m-80 -75.61 3.8 8.87 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.474 -175.407 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 82.59 37.77 13.42 Favored Glycine 0 N--CA 1.445 -0.719 0 N-CA-C 111.186 -0.765 . . . . 0.0 111.186 -176.739 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.68 ' HB3' ' HB3' ' A' ' 17' ' ' ASP . 4.2 tmmt? -110.72 120.9 43.92 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.723 0.297 . . . . 0.0 110.333 -177.786 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 26.0 m -70.68 101.66 2.11 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-O 120.956 0.407 . . . . 0.0 110.917 -177.039 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.518 ' HB ' HD23 ' A' ' 92' ' ' LEU . 41.5 t -92.61 109.26 21.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 175.703 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . 0.466 ' HA ' ' HA ' ' A' ' 14' ' ' SER . 57.4 p -106.16 175.86 5.36 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.204 -177.956 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.49 HD11 ' HA3' ' A' ' 119' ' ' GLY . 2.9 tm? -58.42 -33.7 69.98 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 109.662 -0.496 . . . . 0.0 109.662 176.098 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -74.32 -25.86 59.81 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.735 -178.456 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -69.17 -32.47 71.82 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-O 121.523 0.678 . . . . 0.0 110.472 -179.556 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.661 HD13 HG21 ' A' ' 67' ' ' VAL . 68.9 mt -100.35 -8.6 23.17 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.56 -0.745 . . . . 0.0 110.902 -178.623 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 56.1 tttp -70.75 138.45 50.49 Favored 'General case' 0 N--CA 1.443 -0.813 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.219 -173.874 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 109.22 -3.64 31.4 Favored Glycine 0 N--CA 1.446 -0.656 0 N-CA-C 111.203 -0.759 . . . . 0.0 111.203 -176.96 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.581 ' HD3' ' HA ' ' A' ' 63' ' ' ASP . 21.6 ttmm -154.1 150.25 27.98 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 -179.486 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.484 ' CD1' ' HA ' ' A' ' 116' ' ' ASP . 29.1 m-85 -59.99 148.68 34.53 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 121.145 0.498 . . . . 0.0 111.667 -175.829 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.488 ' HB ' ' HB2' ' A' ' 115' ' ' LEU . 55.3 mt -123.39 128.12 74.59 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.772 -175.602 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 91.7 t80 -118.16 110.19 17.29 Favored 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 108.72 -0.845 . . . . 0.0 108.72 173.395 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.563 ' HB ' ' HB ' ' A' ' 113' ' ' ILE . 68.0 mt -97.48 126.03 50.45 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-O 121.06 0.457 . . . . 0.0 111.135 -175.455 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.444 ' HA ' ' O ' ' A' ' 111' ' ' ARG . 3.2 p30 -113.04 159.33 19.27 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 173.18 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.522 HG21 HG21 ' A' ' 106' ' ' ILE . 61.6 t -105.05 131.19 54.83 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.933 0 C-N-CA 120.36 -0.536 . . . . 0.0 111.055 173.427 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' TRP . . . . . 0.575 ' CZ2' ' HB2' ' A' ' 91' ' ' GLN . 0.4 OUTLIER -125.05 134.17 52.63 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-O 120.748 0.308 . . . . 0.0 110.718 -179.014 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -147.74 162.04 40.01 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 116.646 -0.252 . . . . 0.0 110.588 178.377 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.727 ' HB ' ' CE3' ' A' ' 78' ' ' TRP . 12.2 t -99.6 -10.12 22.41 Favored 'General case' 0 N--CA 1.462 0.136 0 C-N-CA 120.537 -0.465 . . . . 0.0 111.528 179.845 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . 0.502 ' HE1' ' HA ' ' A' ' 72' ' ' ASP . 9.7 p-90 -99.02 15.88 24.37 Favored 'General case' 0 CA--C 1.51 -0.595 0 CA-C-O 122.56 1.171 . . . . 0.0 108.025 -177.381 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . 0.592 ' SG ' HD12 ' A' ' 109' ' ' ILE . 99.6 m -123.18 135.95 54.54 Favored 'General case' 0 N--CA 1.429 -1.505 0 CA-C-N 113.267 -1.788 . . . . 0.0 109.398 -178.212 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.716 ' H ' ' HD2' ' A' ' 44' ' ' PRO . . . -101.92 -49.86 1.22 Allowed Glycine 0 CA--C 1.525 0.671 0 CA-C-O 119.203 -0.776 . . . . 0.0 113.879 -177.945 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.716 ' HD2' ' H ' ' A' ' 43' ' ' GLY . 10.5 Cg_endo -53.38 -34.6 71.77 Favored 'Trans proline' 0 C--N 1.357 1.022 0 C-N-CA 122.8 2.333 . . . . 0.0 112.826 -176.661 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . 0.652 ' O ' ' HG ' ' A' ' 49' ' ' LEU . 18.4 p -58.42 -34.06 70.37 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.109 179.547 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.534 ' HG2' HD12 ' A' ' 49' ' ' LEU . 33.8 mtt85 -72.01 -8.01 52.04 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.787 -174.811 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -74.79 -33.87 54.49 Favored Glycine 0 N--CA 1.446 -0.677 0 C-N-CA 120.428 -0.892 . . . . 0.0 111.979 177.262 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.546 ' OE2' ' HD2' ' A' ' 129' ' ' PRO . 7.4 pt-20 -112.69 -0.49 15.05 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 112.198 0.444 . . . . 0.0 112.198 -177.478 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.652 ' HG ' ' O ' ' A' ' 45' ' ' CYS . 34.7 mt -55.05 -49.6 91.26 Favored Pre-proline 0 N--CA 1.468 0.443 0 N-CA-C 112.29 0.478 . . . . 0.0 112.29 177.069 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.563 ' HD3' ' HB2' ' A' ' 49' ' ' LEU . 77.2 Cg_exo -52.72 -44.33 48.73 Favored 'Trans proline' 0 C--N 1.357 1.016 0 C-N-CA 121.901 1.734 . . . . 0.0 112.161 176.483 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -73.61 -31.09 63.38 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.235 0.54 . . . . 0.0 110.563 -178.037 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.448 ' O ' ' HB2' ' A' ' 55' ' ' LEU . 6.5 tt -64.1 -53.44 49.7 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.264 -0.88 . . . . 0.0 109.885 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.689 ' O ' ' HG3' ' A' ' 57' ' ' GLU . 17.7 pttp -60.97 -39.64 90.36 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.121 179.71 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.472 ' HG3' ' O ' ' A' ' 50' ' ' PRO . 18.3 mt-10 -68.6 -29.06 67.5 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.469 -178.915 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.51 HD12 ' HB3' ' A' ' 129' ' ' PRO . 12.6 mt -59.32 -47.17 86.39 Favored 'General case' 0 N--CA 1.448 -0.55 0 N-CA-C 109.753 -0.462 . . . . 0.0 109.753 172.044 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 1.025 ' HG2' ' HA2' ' A' ' 89' ' ' GLY . 8.2 tp10 -65.18 -43.49 91.48 Favored 'General case' 0 C--O 1.218 -0.591 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.2 177.498 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.689 ' HG3' ' O ' ' A' ' 53' ' ' LYS . 37.1 mt-10 -61.42 -22.57 65.13 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.126 0.489 . . . . 0.0 110.776 179.773 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 63.2 tttp -85.45 -39.46 17.49 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.668 177.197 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.406 ' HB2' ' HE1' ' A' ' 66' ' ' PHE . 83.1 m-85 -110.48 18.29 19.92 Favored 'General case' 0 C--O 1.235 0.339 0 N-CA-C 111.859 0.318 . . . . 0.0 111.859 -173.556 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.409 ' HA ' ' OE2' ' A' ' 56' ' ' GLU . . . -56.48 117.16 3.58 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.914 -177.315 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 75.65 -3.5 49.01 Favored Glycine 0 N--CA 1.45 -0.428 0 CA-C-N 115.768 -0.651 . . . . 0.0 113.237 175.848 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.487 ' HA ' ' HD3' ' A' ' 62' ' ' LYS . 30.4 mmtm -66.56 -80.87 0.04 OUTLIER 'General case' 0 CA--C 1.515 -0.394 0 CA-C-O 120.956 0.408 . . . . 0.0 110.561 -178.082 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.581 ' HA ' ' HD3' ' A' ' 31' ' ' LYS . 14.5 t0 -156.87 28.89 0.31 Allowed 'General case' 0 C--N 1.313 -0.983 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.904 170.343 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 5.3 mp -142.53 133.89 24.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 115.888 -0.596 . . . . 0.0 109.528 178.667 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' HIS . . . . . 0.509 ' NE2' ' HB3' ' A' ' 31' ' ' LYS . 99.4 m-70 -107.21 116.43 31.91 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 109.241 -0.652 . . . . 0.0 109.241 172.312 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . 0.563 ' HB2' ' HB2' ' A' ' 56' ' ' GLU . 76.4 m-85 -87.85 103.32 15.54 Favored 'General case' 0 C--N 1.316 -0.866 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 174.286 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.722 ' HA ' ' O ' ' A' ' 90' ' ' ILE . 47.3 t -111.39 110.33 31.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 115.505 -0.77 . . . . 0.0 111.348 -169.641 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . 0.426 ' HB3' ' CG ' ' A' ' 38' ' ' TRP . 14.0 m -88.25 125.26 34.56 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 115.531 -0.758 . . . . 0.0 110.489 -179.642 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.493 HD11 ' HB2' ' A' ' 94' ' ' MET . 55.1 tp -113.57 121.19 43.46 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 122.784 0.433 . . . . 0.0 110.358 178.84 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . 0.482 ' HB2' ' CD1' ' A' ' 38' ' ' TRP . 10.2 t -109.15 116.9 32.82 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 112.488 0.551 . . . . 0.0 112.488 -174.188 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 42.8 t -86.09 21.93 1.87 Allowed 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.208 173.907 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.614 ' OD2' HG22 ' A' ' 40' ' ' THR . 5.4 t70 -66.51 131.48 46.13 Favored 'General case' 0 CA--C 1.513 -0.465 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 179.63 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.437 ' NZ ' ' HB3' ' A' ' 73' ' ' LYS . 3.7 ttpm? -82.63 -14.19 55.16 Favored 'General case' 0 C--N 1.315 -0.91 0 C-N-CA 120.427 -0.509 . . . . 0.0 110.642 -177.561 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . 0.545 ' HB2' ' HB3' ' A' ' 77' ' ' ALA . 0.2 OUTLIER -109.06 83.32 1.73 Allowed 'General case' 0 CA--C 1.51 -0.574 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 -176.766 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.641 ' HE2' ' CD ' ' A' ' 79' ' ' GLU . 18.0 tttt -56.41 -60.7 3.15 Favored 'General case' 0 C--O 1.22 -0.459 0 C-N-CA 120.742 -0.383 . . . . 0.0 111.346 -172.513 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 4.4 ttmp? -46.9 -43.99 19.32 Favored 'General case' 0 C--O 1.239 0.545 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.474 179.59 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.565 ' HA ' HD21 ' A' ' 80' ' ' ASN . . . -64.84 -38.56 91.38 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-O 121.347 0.594 . . . . 0.0 110.019 -177.804 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' TRP . . . . . 0.727 ' CE3' ' HB ' ' A' ' 40' ' ' THR . 5.6 t-105 -69.49 -47.71 63.01 Favored 'General case' 0 N--CA 1.44 -0.938 0 CA-C-N 115.015 -0.993 . . . . 0.0 111.515 -178.759 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.641 ' CD ' ' HE2' ' A' ' 75' ' ' LYS . 4.4 mm-40 -48.43 -54.01 15.69 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-O 121.165 0.507 . . . . 0.0 111.756 177.018 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . 0.565 HD21 ' HA ' ' A' ' 77' ' ' ALA . 9.2 p30 -72.88 -23.17 60.69 Favored 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 119.482 -0.887 . . . . 0.0 110.858 -176.518 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . 0.582 ' HG2' ' OG1' ' A' ' 40' ' ' THR . 10.9 tpt -70.02 -48.45 57.99 Favored 'General case' 0 C--O 1.21 -0.979 0 CA-C-O 119.488 -0.291 . . . . 0.0 111.242 176.152 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.619 HG23 ' HB2' ' A' ' 87' ' ' LEU . 2.3 p -62.92 -25.34 38.23 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 C-N-CA 120.474 -0.491 . . . . 0.0 110.355 177.79 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 29.7 m -64.32 -36.65 84.81 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-O 121.189 0.518 . . . . 0.0 110.294 171.611 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 80.6 mttt -82.88 -45.79 13.79 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.573 179.119 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . 0.526 ' OD2' ' HG3' ' A' ' 81' ' ' MET . 1.2 m-20 -64.55 -23.09 67.15 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 114.881 -1.054 . . . . 0.0 110.665 179.2 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 51.4 mt-30 57.59 61.62 2.4 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 115.517 -0.765 . . . . 0.0 111.483 178.298 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.619 ' HB2' HG23 ' A' ' 82' ' ' VAL . 79.3 mt -100.21 113.17 25.64 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.612 -178.709 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.548 ' HB2' ' HB2' ' A' ' 53' ' ' LYS . 11.8 mmmm -86.49 178.98 6.93 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.234 178.36 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . 1.025 ' HA2' ' HG2' ' A' ' 56' ' ' GLU . . . 105.19 -177.84 23.29 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.825 -0.702 . . . . 0.0 112.538 178.138 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.722 ' O ' ' HA ' ' A' ' 67' ' ' VAL . 45.6 mm -86.75 113.61 24.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 175.638 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . 0.575 ' HB2' ' CZ2' ' A' ' 38' ' ' TRP . 1.8 pt20 -130.72 142.11 50.41 Favored 'General case' 0 C--N 1.309 -1.162 0 C-N-CA 120.321 -0.551 . . . . 0.0 111.713 -170.207 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.538 HD22 ' HB2' ' A' ' 15' ' ' TYR . 1.0 OUTLIER -145.01 156.26 43.84 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.677 178.756 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' HIS . . . . . 0.558 ' CE1' ' HG3' ' A' ' 75' ' ' LYS . 19.0 t-80 -117.53 138.57 51.81 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-O 121.422 0.63 . . . . 0.0 111.471 -175.06 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' MET . . . . . 0.759 ' SD ' ' HA ' ' A' ' 98' ' ' ARG . 27.1 ttm -98.25 -76.68 0.52 Allowed 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 114.973 -1.012 . . . . 0.0 109.902 177.771 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . 0.509 ' HA2' ' O ' ' A' ' 72' ' ' ASP . . . 80.64 -85.41 1.36 Allowed Glycine 0 N--CA 1.447 -0.608 0 C-N-CA 121.065 -0.588 . . . . 0.0 113.207 178.474 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 7.6 p -82.47 -25.61 33.39 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 120.942 0.401 . . . . 0.0 112.063 -173.635 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . 0.52 ' HB2' ' HG3' ' A' ' 94' ' ' MET . 4.0 m-20 -87.85 38.05 0.82 Allowed 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.55 -173.307 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . 0.759 ' HA ' ' SD ' ' A' ' 94' ' ' MET . 0.0 OUTLIER -64.69 -12.42 46.36 Favored 'General case' 0 C--O 1.222 -0.35 0 N-CA-C 112.532 0.568 . . . . 0.0 112.532 -171.327 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 4.8 m -58.75 -20.61 51.02 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.385 0.612 . . . . 0.0 110.742 177.85 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . 0.441 ' CZ ' ' HA ' ' A' ' 10' ' ' ALA . 36.0 t80 -81.15 -32.0 33.87 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.096 179.932 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' MET . . . . . 0.689 ' HG3' ' O ' ' A' ' 98' ' ' ARG . 4.2 ppp? -77.08 -31.26 55.89 Favored 'General case' 0 C--O 1.235 0.321 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 177.919 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -59.84 -39.68 85.97 Favored 'General case' 0 CA--C 1.52 -0.177 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.145 170.875 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -62.96 -23.88 67.63 Favored 'General case' 0 N--CA 1.462 0.148 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.451 -178.617 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' TYR . . . . . 0.401 ' HB2' HG13 ' A' ' 106' ' ' ILE . 48.0 m-85 -100.38 -4.81 28.29 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.304 178.817 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 3.4 mm? 59.61 32.4 21.53 Favored 'General case' 0 C--O 1.234 0.271 0 O-C-N 123.417 0.448 . . . . 0.0 110.818 -176.874 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . 0.522 HG21 HG21 ' A' ' 37' ' ' VAL . 68.4 mt -65.8 88.95 0.1 OUTLIER 'Isoleucine or valine' 0 C--O 1.225 -0.221 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.179 177.316 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 31.1 m-80 -98.52 -13.8 20.3 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.125 0.488 . . . . 0.0 110.342 176.18 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -122.43 115.06 2.63 Favored Glycine 0 N--CA 1.442 -0.945 0 C-N-CA 120.571 -0.823 . . . . 0.0 112.192 -177.58 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.592 HD12 ' SG ' ' A' ' 42' ' ' CYS . 32.0 mt -97.2 131.39 27.59 Favored Pre-proline 0 C--N 1.32 -0.676 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 174.37 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -82.73 151.23 71.89 Favored 'Cis proline' 0 N--CA 1.459 -0.539 0 C-N-CA 123.769 -1.346 . . . . 0.0 112.935 1.729 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . 0.515 ' HG3' HG12 ' A' ' 106' ' ' ILE . 0.0 OUTLIER -102.77 140.18 37.38 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 173.596 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . 0.668 ' CE1' ' HB3' ' A' ' 128' ' ' ARG . 0.0 OUTLIER -105.1 118.03 35.51 Favored 'General case' 0 C--N 1.327 -0.371 0 O-C-N 124.102 0.876 . . . . 0.0 110.174 -175.102 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.563 ' HB ' ' HB ' ' A' ' 35' ' ' ILE . 90.8 mt -132.81 148.62 31.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.65 0.262 . . . . 0.0 110.904 -178.737 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.401 ' C ' HD12 ' A' ' 115' ' ' LEU . 42.5 tp -132.1 139.22 48.4 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.504 -0.316 . . . . 0.0 110.674 179.706 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.613 ' HG ' ' HA ' ' A' ' 121' ' ' ILE . 2.3 mp -136.09 153.83 51.2 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 178.768 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . 0.542 ' HB2' HD11 ' A' ' 122' ' ' ILE . 24.2 t70 -76.94 163.68 26.5 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.648 178.409 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 63.3 mtt180 -51.49 -30.05 18.71 Favored 'General case' 0 N--CA 1.464 0.256 0 O-C-N 124.354 1.034 . . . . 0.0 111.748 178.692 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -64.82 -17.86 64.61 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.077 0.465 . . . . 0.0 110.759 178.378 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . 0.49 ' HA3' HD11 ' A' ' 25' ' ' LEU . . . 93.97 25.16 17.99 Favored Glycine 0 N--CA 1.438 -1.173 0 N-CA-C 110.187 -1.165 . . . . 0.0 110.187 -172.438 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 30.3 mmtp -112.56 116.77 30.74 Favored 'General case' 0 C--O 1.223 -0.297 0 C-N-CA 120.304 -0.558 . . . . 0.0 112.097 -172.991 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 0.665 ' H ' HD12 ' A' ' 121' ' ' ILE . 3.8 mp -44.38 119.5 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.27 0 CA-C-N 115.436 -0.802 . . . . 0.0 111.984 179.698 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' ILE . . . . . 0.542 HD11 ' HB2' ' A' ' 116' ' ' ASP . 45.5 mm -98.62 -41.02 9.82 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-N 115.301 -0.863 . . . . 0.0 109.335 175.727 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 16.4 m -137.2 115.83 12.08 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.393 -0.821 . . . . 0.0 110.41 179.07 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -74.23 -16.01 60.97 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.06 0.457 . . . . 0.0 110.821 178.091 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 6.1 t30 -146.83 100.6 3.34 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.762 -0.654 . . . . 0.0 109.398 177.059 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 12.4 ttt -101.21 -139.0 0.34 Allowed 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.192 -177.978 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -124.96 127.25 46.75 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-O 121.039 0.447 . . . . 0.0 111.003 -175.733 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . 0.668 ' HB3' ' CE1' ' A' ' 112' ' ' PHE . 11.6 ptp180 -51.28 153.91 3.23 Favored Pre-proline 0 N--CA 1.468 0.473 0 N-CA-C 113.414 0.894 . . . . 0.0 113.414 178.778 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . 0.546 ' HD2' ' OE2' ' A' ' 48' ' ' GLU . 51.9 Cg_exo -55.69 -27.39 60.86 Favored 'Trans proline' 0 C--N 1.35 0.656 0 C-N-CA 123.575 2.85 . . . . 0.0 113.557 177.193 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . 0.523 ' OG ' ' HB3' ' A' ' 48' ' ' GLU . 67.9 m -62.95 -20.64 65.43 Favored 'General case' 0 N--CA 1.462 0.132 0 CA-C-O 120.919 0.39 . . . . 0.0 111.301 176.912 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . 0.43 ' OD2' ' HB2' ' A' ' 133' ' ' LYS . 7.3 t70 -85.32 122.1 73.73 Favored Pre-proline 0 C--N 1.325 -0.484 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.708 178.774 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . 0.406 ' O ' ' HG3' ' A' ' 136' ' ' GLU . 30.5 Cg_exo -63.97 -30.01 66.84 Favored 'Trans proline' 0 C--N 1.343 0.252 0 C-N-CA 122.922 2.415 . . . . 0.0 112.675 179.921 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . 0.43 ' HB2' ' OD2' ' A' ' 131' ' ' ASP . 26.7 mmmt -61.64 -37.64 84.76 Favored 'General case' 0 CA--C 1.519 -0.219 0 CA-C-O 121.007 0.432 . . . . 0.0 110.391 -176.801 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' THR . . . . . 0.738 HG22 ' CZ ' ' A' ' 138' ' ' PHE . 5.2 m -61.66 -53.25 58.66 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.238 176.255 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . 0.561 ' HA ' ' CD2' ' A' ' 138' ' ' PHE . . . -54.93 -46.52 74.94 Favored 'General case' 0 C--O 1.242 0.672 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.183 176.925 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . 0.406 ' HG3' ' O ' ' A' ' 132' ' ' PRO . 48.8 mt-10 -54.39 -55.74 25.61 Favored 'General case' 0 CA--C 1.509 -0.625 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.169 176.551 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . 0.569 ' HE2' ' HA ' ' A' ' 137' ' ' LYS . 0.1 OUTLIER -43.79 -42.88 5.81 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 114.221 -1.354 . . . . 0.0 111.774 179.825 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . 0.738 ' CZ ' HG22 ' A' ' 134' ' ' THR . 13.6 m-85 -63.74 -60.73 2.93 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-O 120.774 0.321 . . . . 0.0 110.921 179.961 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . 0.48 ' HB2' ' HB3' ' A' ' 144' ' ' LEU . 11.0 p30 -68.86 -23.7 64.26 Favored 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 120.313 -0.555 . . . . 0.0 110.989 -174.387 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 13.2 tt0 -60.47 -51.81 67.87 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.054 0.454 . . . . 0.0 110.454 173.568 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.53 ' HG ' ' O ' ' A' ' 137' ' ' LYS . 88.6 mt -64.56 -30.01 71.03 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.147 -177.906 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -82.16 -16.09 51.02 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.428 178.048 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 74.74 36.34 48.3 Favored Glycine 0 N--CA 1.45 -0.401 0 N-CA-C 110.705 -0.958 . . . . 0.0 110.705 -178.039 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.48 ' HB3' ' HB2' ' A' ' 139' ' ' ASN . 49.8 tp -106.63 12.46 29.32 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 114.862 -0.669 . . . . 0.0 110.32 -173.527 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . 0.419 ' HB2' ' CD2' ' A' ' 147' ' ' HIS . 0.0 OUTLIER -104.33 -32.77 8.91 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.516 0.674 . . . . 0.0 111.315 -179.492 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 99.67 7.0 54.23 Favored Glycine 0 C--N 1.315 -0.622 0 CA-C-N 114.827 -1.079 . . . . 0.0 113.262 175.773 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 147' ' ' HIS . . . . . 0.419 ' CD2' ' HB2' ' A' ' 145' ' ' GLU . 13.6 m-70 -95.55 56.48 1.81 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 117.428 0.614 . . . . 0.0 109.72 -176.99 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 19.6 p80 -73.25 63.72 0.75 Allowed 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 115.693 -0.685 . . . . 0.0 112.449 -174.714 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 23.8 t60 51.56 86.95 0.03 OUTLIER 'General case' 0 C--O 1.234 0.286 0 C-N-CA 124.034 0.934 . . . . 0.0 112.623 174.13 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 42.9 t-80 -62.74 108.97 1.28 Allowed 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.232 176.205 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 25.7 p80 -121.0 13.69 11.38 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.964 0.412 . . . . 0.0 110.367 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 41.6 t-80 . . . . . 0 C--O 1.242 0.691 0 CA-C-N 115.49 -0.777 . . . . 0.0 109.083 179.034 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 10.9 tpt . . . . . 0 N--CA 1.48 1.043 0 N-CA-C 110.023 -0.362 . . . . 0.0 110.023 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.485 ' HB2' HD22 ' A' ' 3' ' ' LEU . 1.2 m -57.9 -49.01 78.19 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.749 -174.77 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.494 ' O ' ' HG3' ' A' ' 4' ' ' ARG . 3.1 mm? -81.8 -4.03 55.38 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.353 -176.674 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . 0.494 ' HG3' ' O ' ' A' ' 3' ' ' LEU . 0.3 OUTLIER 37.08 -102.66 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 123.647 0.779 . . . . 0.0 112.365 -172.311 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 12.2 p -134.37 19.37 3.66 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.133 0.492 . . . . 0.0 110.387 179.328 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 142.53 73.78 0.03 OUTLIER Glycine 0 N--CA 1.448 -0.51 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.346 -178.022 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . 0.453 ' HA ' ' HD3' ' A' ' 8' ' ' PRO . 8.5 t30 -156.17 144.11 14.22 Favored Pre-proline 0 C--N 1.325 -0.479 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 178.207 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.453 ' HD3' ' HA ' ' A' ' 7' ' ' ASN . 39.6 Cg_exo -60.81 -67.17 0.05 OUTLIER 'Trans proline' 0 C--N 1.343 0.257 0 C-N-CA 123.047 2.498 . . . . 0.0 112.103 -176.39 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.81 ' HA ' HD11 ' A' ' 121' ' ' ILE . 18.3 m 57.88 -162.41 0.21 Allowed 'General case' 0 N--CA 1.453 -0.299 0 CA-C-O 121.803 0.811 . . . . 0.0 111.592 175.124 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -86.9 78.13 9.1 Favored 'General case' 0 C--N 1.314 -0.948 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 169.845 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -69.43 59.77 0.13 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 114.861 -1.063 . . . . 0.0 113.641 -172.445 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.535 ' HA ' ' HB3' ' A' ' 25' ' ' LEU . 26.4 m 53.58 33.4 16.3 Favored 'General case' 0 N--CA 1.465 0.28 0 N-CA-C 112.767 0.655 . . . . 0.0 112.767 170.493 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 34.7 p90 -60.77 147.92 40.82 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.893 0.378 . . . . 0.0 110.747 179.084 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.514 ' HA ' ' HA ' ' A' ' 24' ' ' SER . 28.2 t -139.81 117.96 11.93 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.111 -0.495 . . . . 0.0 109.707 -179.293 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . 0.438 ' HB2' ' HB3' ' A' ' 92' ' ' LEU . 92.1 m-85 -138.78 155.14 73.38 Favored Pre-proline 0 C--N 1.323 -0.562 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.322 -176.976 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -81.19 125.89 5.39 Favored 'Trans proline' 0 N--CA 1.454 -0.85 0 C-N-CA 122.015 1.81 . . . . 0.0 112.116 175.469 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . 0.503 ' HA ' ' HA ' ' A' ' 92' ' ' LEU . 12.5 t70 -62.32 152.95 32.36 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.196 -0.911 . . . . 0.0 108.894 172.127 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.646 HG22 ' HG3' ' A' ' 91' ' ' GLN . 12.1 tt -58.67 -25.81 29.63 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.435 0 O-C-N 123.781 0.675 . . . . 0.0 111.301 -178.287 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 44.7 m-80 -79.35 -2.17 40.32 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.321 0.582 . . . . 0.0 110.053 176.47 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 86.82 40.64 7.06 Favored Glycine 0 N--CA 1.447 -0.583 0 CA-C-N 115.401 -0.818 . . . . 0.0 112.371 179.244 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.542 ' NZ ' HG22 ' A' ' 23' ' ' VAL . 62.0 tttm -113.84 117.22 30.84 Favored 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 120.372 -0.531 . . . . 0.0 111.027 179.989 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 17.7 m -64.45 108.84 1.75 Allowed 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 109.938 -0.393 . . . . 0.0 109.938 174.384 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.542 HG22 ' NZ ' ' A' ' 21' ' ' LYS . 99.6 t -119.83 125.5 74.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-O 121.011 0.434 . . . . 0.0 110.201 -179.829 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . 0.514 ' HA ' ' HA ' ' A' ' 14' ' ' SER . 57.3 p -113.19 176.6 4.95 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 115.731 -0.668 . . . . 0.0 109.426 177.57 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.535 ' HB3' ' HA ' ' A' ' 12' ' ' SER . 2.7 tm? -60.98 -30.39 70.24 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 176.908 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -72.11 -24.42 61.47 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.66 -0.246 . . . . 0.0 111.325 -179.896 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -73.18 -21.75 60.61 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-O 121.924 0.868 . . . . 0.0 109.616 177.798 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.469 HD13 HG21 ' A' ' 67' ' ' VAL . 32.9 mt -104.5 -21.02 13.51 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-N 115.073 -0.967 . . . . 0.0 110.742 -179.492 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.41 ' HB2' HD13 ' A' ' 25' ' ' LEU . 52.9 tttp -71.41 149.32 46.06 Favored 'General case' 0 N--CA 1.445 -0.688 0 CA-C-N 115.459 -0.792 . . . . 0.0 110.909 -173.542 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 91.81 10.21 61.76 Favored Glycine 0 N--CA 1.452 -0.295 0 N-CA-C 111.066 -0.814 . . . . 0.0 111.066 -175.198 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.832 ' HD3' ' HA ' ' A' ' 63' ' ' ASP . 13.1 ttmm -162.12 157.48 23.35 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 108.196 -1.038 . . . . 0.0 108.196 179.73 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.532 ' CD2' HD13 ' A' ' 141' ' ' LEU . 82.3 m-85 -66.17 143.51 57.23 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 118.287 0.494 . . . . 0.0 110.808 -178.641 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.873 HD13 HD12 ' A' ' 115' ' ' LEU . 3.6 mp -126.04 146.37 31.95 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.226 0 CA-C-O 120.811 0.339 . . . . 0.0 110.561 -179.55 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . 0.737 ' HD1' ' HB3' ' A' ' 114' ' ' LEU . 75.2 t80 -129.7 121.64 27.35 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 173.224 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.697 HD13 ' HB ' ' A' ' 67' ' ' VAL . 25.9 mm -109.96 110.9 33.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 N-CA-C 112.156 0.428 . . . . 0.0 112.156 -173.253 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.589 ' O ' ' HA ' ' A' ' 68' ' ' SER . 33.7 m-20 -99.04 158.21 15.82 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 169.549 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.58 HG11 HG21 ' A' ' 109' ' ' ILE . 40.5 t -103.67 112.18 36.19 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.859 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 171.066 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' TRP . . . . . 0.791 ' CZ3' HG21 ' A' ' 82' ' ' VAL . 0.6 OUTLIER -103.29 132.55 49.46 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 -177.298 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.456 ' HB3' ' SG ' ' A' ' 42' ' ' CYS . . . -148.22 174.7 11.72 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.505 -0.316 . . . . 0.0 110.762 -178.551 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.553 HG22 ' OD2' ' A' ' 72' ' ' ASP . 5.9 t -104.27 -30.3 10.23 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 120.975 0.417 . . . . 0.0 110.379 171.618 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 21.0 p-90 -85.59 7.36 23.45 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.549 -178.108 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . 0.553 ' SG ' ' HB3' ' A' ' 45' ' ' CYS . 5.7 p -87.55 -2.21 58.47 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.677 -0.238 . . . . 0.0 111.41 -179.068 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.58 ' O ' ' HG2' ' A' ' 46' ' ' ARG . . . 64.94 -108.35 2.3 Favored Glycine 0 CA--C 1.523 0.579 0 N-CA-C 114.773 0.669 . . . . 0.0 114.773 171.736 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.41 ' HD2' ' O ' ' A' ' 42' ' ' CYS . 9.6 Cg_endo -50.75 -23.15 10.86 Favored 'Trans proline' 0 C--N 1.356 0.96 0 C-N-CA 124.342 3.361 . . . . 0.0 113.541 -174.647 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . 0.724 ' HB2' ' HD3' ' A' ' 110' ' ' PRO . 47.1 t -52.19 -15.97 0.71 Allowed 'General case' 0 C--N 1.323 -0.55 0 O-C-N 124.071 0.857 . . . . 0.0 112.924 178.533 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.58 ' HG2' ' O ' ' A' ' 43' ' ' GLY . 24.7 mmm180 -71.02 -6.64 40.49 Favored 'General case' 0 N--CA 1.448 -0.574 0 O-C-N 121.806 -0.559 . . . . 0.0 110.467 -179.43 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.454 ' O ' ' HD2' ' A' ' 50' ' ' PRO . . . -84.13 -23.44 51.87 Favored Glycine 0 N--CA 1.446 -0.643 0 CA-C-N 115.818 -0.628 . . . . 0.0 112.95 -178.478 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.56 ' HG3' ' HB3' ' A' ' 129' ' ' PRO . 2.0 mp0 -83.01 -4.49 58.38 Favored 'General case' 0 CA--C 1.516 -0.333 0 CA-C-N 117.2 0.5 . . . . 0.0 110.524 -179.379 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.797 ' HG ' HD21 ' A' ' 87' ' ' LEU . 7.3 mp -43.96 -55.23 9.61 Favored Pre-proline 0 CA--C 1.536 0.432 0 N-CA-C 112.487 0.551 . . . . 0.0 112.487 177.09 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.497 ' HD3' ' HB2' ' A' ' 49' ' ' LEU . 43.5 Cg_exo -58.45 -42.89 50.64 Favored 'Trans proline' 0 C--N 1.355 0.909 0 C-N-CA 121.874 1.716 . . . . 0.0 112.185 175.047 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -69.49 -21.75 63.66 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-O 121.476 0.655 . . . . 0.0 110.411 -174.226 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.556 HD13 HD22 ' A' ' 87' ' ' LEU . 7.6 tt -70.14 -55.44 9.4 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 114.974 -1.012 . . . . 0.0 108.643 178.673 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.694 ' HB3' ' NZ ' ' A' ' 53' ' ' LYS . 1.8 mtpm? -52.63 -63.01 1.28 Allowed 'General case' 0 C--O 1.219 -0.508 0 CA-C-N 115.503 -0.771 . . . . 0.0 111.365 175.826 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -52.39 -39.45 60.86 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 113.302 0.853 . . . . 0.0 113.302 -173.146 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.434 ' O ' ' HB2' ' A' ' 58' ' ' LYS . 14.4 mt -67.49 -44.77 77.69 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.174 0.512 . . . . 0.0 110.622 174.43 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -57.39 -42.68 82.68 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.145 -0.934 . . . . 0.0 111.582 176.538 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.618 ' HG2' ' O ' ' A' ' 53' ' ' LYS . 16.0 mm-40 -53.47 -52.01 60.88 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-O 121.714 0.768 . . . . 0.0 109.287 175.74 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.468 ' HB3' ' HE3' ' A' ' 58' ' ' LYS . 10.4 mmmt -53.01 -58.12 8.07 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-N 114.504 -1.225 . . . . 0.0 112.439 178.804 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.57 ' HB2' ' HE2' ' A' ' 66' ' ' PHE . 96.0 m-85 -106.71 21.6 17.23 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.047 -0.524 . . . . 0.0 112.322 -166.537 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -61.59 120.79 11.26 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.603 173.75 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 72.26 33.81 61.5 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.946 -0.645 . . . . 0.0 112.866 177.141 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.507 ' HB3' HD11 ' A' ' 142' ' ' LEU . 40.1 mmtm -109.03 -164.91 0.97 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.154 0.502 . . . . 0.0 110.128 175.623 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.832 ' HA ' ' HD3' ' A' ' 31' ' ' LYS . 3.7 t70 -89.87 54.95 2.99 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-O 121.792 0.806 . . . . 0.0 109.497 179.362 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.46 HG22 ' HB2' ' A' ' 62' ' ' LYS . 6.8 tp -157.0 129.98 1.15 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 CA-C-N 115.061 -0.972 . . . . 0.0 109.774 -178.114 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' HIS . . . . . 0.47 ' NE2' ' HB3' ' A' ' 31' ' ' LYS . 68.0 m-70 -103.3 106.58 17.13 Favored 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 175.773 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . 0.57 ' HE2' ' HB2' ' A' ' 59' ' ' TYR . 61.0 m-85 -79.01 103.13 8.74 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 171.082 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.697 ' HB ' HD13 ' A' ' 35' ' ' ILE . 29.6 t -122.26 126.53 74.4 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.476 -175.196 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . 0.589 ' HA ' ' O ' ' A' ' 36' ' ' ASP . 37.1 m -114.05 134.3 54.96 Favored 'General case' 0 C--N 1.311 -1.066 0 CA-C-N 116.106 -0.497 . . . . 0.0 109.855 177.191 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.516 HD22 ' HB2' ' A' ' 92' ' ' LEU . 26.6 mt -110.53 132.78 53.88 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 110.006 -0.368 . . . . 0.0 110.006 177.116 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . 0.471 ' O ' ' HB3' ' A' ' 94' ' ' MET . 0.9 OUTLIER -105.15 117.89 35.14 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.008 0.432 . . . . 0.0 111.348 -176.882 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 34.8 m -88.39 15.7 7.43 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.773 179.61 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.553 ' OD2' HG22 ' A' ' 40' ' ' THR . 1.3 m-20 -71.73 135.52 46.81 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.249 -0.648 . . . . 0.0 109.249 -179.867 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.416 ' O ' ' HD3' ' A' ' 73' ' ' LYS . 1.5 tmtp? -89.04 -30.1 18.95 Favored 'General case' 0 C--N 1.318 -0.784 0 C-N-CA 119.918 -0.713 . . . . 0.0 109.464 177.62 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . 0.586 ' HB2' ' HB3' ' A' ' 77' ' ' ALA . 0.8 OUTLIER -72.53 68.18 0.79 Allowed 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.135 -0.939 . . . . 0.0 110.434 174.127 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.483 ' O ' ' HG2' ' A' ' 79' ' ' GLU . 9.4 tttm -51.8 -64.5 0.79 Allowed 'General case' 0 C--O 1.22 -0.482 0 N-CA-C 112.489 0.551 . . . . 0.0 112.489 -175.984 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 51.9 tttm -49.77 -49.18 49.39 Favored 'General case' 0 C--N 1.329 -0.297 0 O-C-N 123.162 0.289 . . . . 0.0 111.204 -176.793 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.665 ' HA ' ' ND2' ' A' ' 80' ' ' ASN . . . -52.29 -44.05 64.79 Favored 'General case' 0 C--O 1.244 0.802 0 CA-C-O 121.886 0.85 . . . . 0.0 110.359 178.478 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' TRP . . . . . 0.548 ' CE3' ' HB ' ' A' ' 40' ' ' THR . 6.8 t-105 -66.92 -51.13 59.08 Favored 'General case' 0 N--CA 1.437 -1.114 0 CA-C-N 114.278 -1.328 . . . . 0.0 111.048 -179.438 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.522 ' OE1' HG13 ' A' ' 18' ' ' ILE . 5.3 mm-40 -46.22 -47.08 17.99 Favored 'General case' 0 CA--C 1.537 0.459 0 N-CA-C 111.87 0.322 . . . . 0.0 111.87 176.189 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . 0.665 ' ND2' ' HA ' ' A' ' 77' ' ' ALA . 0.6 OUTLIER -60.33 -49.23 78.42 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 120.823 -0.351 . . . . 0.0 110.526 -177.738 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 22.5 ttm -59.47 -48.47 81.53 Favored 'General case' 0 N--CA 1.466 0.341 0 N-CA-C 112.433 0.531 . . . . 0.0 112.433 -175.756 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.791 HG21 ' CZ3' ' A' ' 38' ' ' TRP . 0.9 OUTLIER -67.25 -26.05 35.24 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 C-N-CA 120.158 -0.617 . . . . 0.0 110.918 -178.046 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 90.6 m -72.78 -37.0 67.74 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.294 -0.412 . . . . 0.0 109.986 174.646 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . 0.4 ' HB3' ' HE3' ' A' ' 84' ' ' LYS . 1.2 tmmt? -71.26 -41.38 70.16 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.375 0.607 . . . . 0.0 110.018 177.513 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 15.6 m-20 -83.67 -1.72 54.64 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.225 -0.898 . . . . 0.0 111.881 -177.349 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 45.3 mt-30 62.0 23.63 13.95 Favored 'General case' 0 N--CA 1.468 0.466 0 N-CA-C 112.727 0.64 . . . . 0.0 112.727 172.074 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.797 HD21 ' HG ' ' A' ' 49' ' ' LEU . 94.1 mt -73.61 117.46 15.4 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 110.236 -0.283 . . . . 0.0 110.236 178.796 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.564 ' HA ' ' HE3' ' A' ' 88' ' ' LYS . 0.0 OUTLIER -119.61 -168.08 1.53 Allowed 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.693 -0.23 . . . . 0.0 111.581 177.314 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 112.75 -163.23 12.17 Favored Glycine 0 N--CA 1.451 -0.35 0 N-CA-C 110.241 -1.144 . . . . 0.0 110.241 -173.966 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.654 ' O ' ' HA ' ' A' ' 67' ' ' VAL . 52.5 mt -92.72 111.67 24.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 173.679 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . 0.693 ' HB2' ' CZ2' ' A' ' 38' ' ' TRP . 1.0 OUTLIER -143.24 103.59 4.15 Favored 'General case' 0 C--N 1.311 -1.086 0 CA-C-O 121.598 0.713 . . . . 0.0 111.789 -168.934 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.518 HD21 ' HB ' ' A' ' 23' ' ' VAL . 20.6 mt -96.79 151.28 19.81 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.275 -0.875 . . . . 0.0 110.622 -175.846 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 37.3 t-80 -113.47 127.87 56.25 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.081 178.847 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' MET . . . . . 0.471 ' HB3' ' O ' ' A' ' 70' ' ' SER . 35.9 ttm -81.06 -83.14 0.11 Allowed 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 115.053 -0.976 . . . . 0.0 110.279 -179.682 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 131.2 -83.72 0.31 Allowed Glycine 0 N--CA 1.444 -0.79 0 C-N-CA 120.396 -0.907 . . . . 0.0 112.245 -178.19 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 1.7 m -137.72 4.63 2.59 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.583 0.706 . . . . 0.0 109.964 179.472 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -87.16 53.03 2.68 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.248 -0.887 . . . . 0.0 110.448 -172.485 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . 0.498 ' HB3' ' OD1' ' A' ' 102' ' ' ASP . 4.0 mtm180 -63.35 -8.94 9.96 Favored 'General case' 0 CA--C 1.512 -0.5 0 N-CA-C 112.542 0.571 . . . . 0.0 112.542 -172.924 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 5.4 m -38.4 -33.09 0.09 Allowed 'General case' 0 C--N 1.313 -0.988 0 O-C-N 124.146 0.904 . . . . 0.0 112.376 179.197 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 80.2 t80 -81.27 -39.21 25.63 Favored 'General case' 0 CA--C 1.532 0.281 0 N-CA-C 112.356 0.502 . . . . 0.0 112.356 -179.822 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' MET . . . . . 0.459 ' SD ' ' HD2' ' A' ' 98' ' ' ARG . 24.9 ptm -78.66 -34.02 46.63 Favored 'General case' 0 CA--C 1.52 -0.185 0 C-N-CA 120.107 -0.637 . . . . 0.0 109.592 -177.268 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . 0.498 ' OD1' ' HB3' ' A' ' 98' ' ' ARG . 2.5 m-20 -75.57 -21.62 57.71 Favored 'General case' 0 N--CA 1.447 -0.604 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.186 176.581 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -64.95 -29.57 70.51 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-O 121.063 0.459 . . . . 0.0 110.701 174.88 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 59.7 m-85 -96.96 2.35 51.46 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.519 177.796 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 95.6 mt 65.89 5.21 3.33 Favored 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 113.386 0.884 . . . . 0.0 113.386 173.164 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . 0.545 ' CG1' ' HG3' ' A' ' 111' ' ' ARG . 1.2 pp -97.34 88.83 1.88 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.575 0 CA-C-O 121.509 0.671 . . . . 0.0 112.194 -179.277 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 4.0 p-10 -77.1 -11.73 59.85 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.609 -0.723 . . . . 0.0 109.812 175.642 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -89.75 98.56 2.46 Favored Glycine 0 N--CA 1.445 -0.716 0 CA-C-N 115.445 -0.798 . . . . 0.0 111.621 177.357 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.631 ' HB ' ' HA ' ' A' ' 110' ' ' PRO . 34.2 pt -104.88 162.79 18.72 Favored Pre-proline 0 C--N 1.321 -0.641 0 N-CA-C 110.088 -0.338 . . . . 0.0 110.088 179.823 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . 0.724 ' HD3' ' HB2' ' A' ' 45' ' ' CYS . 39.6 Cg_endo -70.11 143.74 75.39 Favored 'Cis proline' 0 C--N 1.349 0.567 0 C-N-CA 124.158 -1.184 . . . . 0.0 113.559 1.63 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . 0.545 ' HG3' ' CG1' ' A' ' 106' ' ' ILE . 0.0 OUTLIER -117.51 136.49 53.21 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.625 -0.716 . . . . 0.0 109.081 177.295 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . 0.571 ' CD2' ' HA ' ' A' ' 127' ' ' THR . 1.4 m-85 -105.7 117.23 33.5 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.789 -176.173 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.495 HD12 ' HA ' ' A' ' 124' ' ' ALA . 24.4 mm -128.53 164.0 31.61 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 N-CA-C 108.144 -1.058 . . . . 0.0 108.144 177.137 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.737 ' HB3' ' HD1' ' A' ' 34' ' ' TYR . 1.8 pt? -158.45 154.24 26.5 Favored 'General case' 0 C--N 1.316 -0.882 0 C-N-CA 120.573 -0.451 . . . . 0.0 110.978 173.455 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.873 HD12 HD13 ' A' ' 33' ' ' ILE . 0.0 OUTLIER -138.17 150.98 47.29 Favored 'General case' 0 N--CA 1.448 -0.569 0 CA-C-O 122.329 1.062 . . . . 0.0 113.377 -173.788 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 12.8 t0 -69.19 163.73 24.24 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 113.174 -1.83 . . . . 0.0 109.782 176.328 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . 0.482 ' HA ' ' O ' ' A' ' 31' ' ' LYS . 31.1 mtm180 -48.39 -28.05 2.99 Favored 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 124.503 1.121 . . . . 0.0 113.272 -174.877 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 26.6 t0 -82.52 -5.13 58.56 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.104 0.478 . . . . 0.0 111.44 -177.314 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 89.34 16.6 57.0 Favored Glycine 0 N--CA 1.441 -0.986 0 N-CA-C 110.013 -1.235 . . . . 0.0 110.013 -171.241 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 4.9 tttm -90.27 147.21 23.67 Favored 'General case' 0 C--O 1.204 -1.327 0 CA-C-N 115.034 -0.583 . . . . 0.0 110.766 -175.522 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 0.81 HD11 ' HA ' ' A' ' 9' ' ' SER . 3.8 mp -67.76 130.47 33.03 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.668 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.03 -174.775 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' ILE . . . . . 0.575 ' HB ' ' HG ' ' A' ' 114' ' ' LEU . 37.4 mm -100.53 -56.4 5.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 171.122 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . 0.475 ' HB3' ' CD2' ' A' ' 114' ' ' LEU . 42.9 t -135.14 142.72 46.22 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.481 174.375 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . 0.495 ' HA ' HD12 ' A' ' 113' ' ' ILE . . . -112.55 23.48 13.51 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.425 -0.807 . . . . 0.0 109.429 176.018 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 4.1 p-10 -161.67 38.63 0.13 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.349 -0.841 . . . . 0.0 110.108 -179.913 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' MET . . . . . 0.73 ' HG2' HD22 ' A' ' 114' ' ' LEU . 2.2 tpt -71.7 -168.72 0.37 Allowed 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 115.762 -0.654 . . . . 0.0 111.206 -176.949 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . 0.571 ' HA ' ' CD2' ' A' ' 112' ' ' PHE . 4.1 m -161.0 120.79 2.67 Favored 'General case' 0 C--O 1.223 -0.312 0 N-CA-C 110.108 -0.33 . . . . 0.0 110.108 -174.867 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . 0.569 ' HB2' ' OH ' ' A' ' 34' ' ' TYR . 21.8 ttt85 -88.94 -62.94 0.21 Allowed Pre-proline 0 CA--C 1.498 -1.039 0 CA-C-O 117.846 -1.073 . . . . 0.0 113.401 178.491 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . 0.56 ' HB3' ' HG3' ' A' ' 48' ' ' GLU . 1.0 OUTLIER -37.96 79.04 0.0 OUTLIER 'Trans proline' 0 C--N 1.372 1.784 0 C-N-CA 124.352 3.368 . . . . 0.0 113.814 -158.648 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . 0.471 ' N ' ' O ' ' A' ' 128' ' ' ARG . 43.5 p 54.73 26.72 7.86 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 114.299 -1.319 . . . . 0.0 110.67 -179.47 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -70.76 123.56 89.4 Favored Pre-proline 0 C--O 1.236 0.355 0 CA-C-N 115.513 -0.767 . . . . 0.0 111.041 -178.648 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_endo -63.92 -37.51 43.66 Favored 'Trans proline' 0 N--CA 1.46 -0.459 0 C-N-CA 122.505 2.136 . . . . 0.0 112.881 -178.343 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . 0.414 ' O ' ' HG2' ' A' ' 137' ' ' LYS . 26.1 mtmm -54.3 -50.11 68.09 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-O 121.599 0.714 . . . . 0.0 110.113 -177.036 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' THR . . . . . 0.652 HG22 ' CZ ' ' A' ' 138' ' ' PHE . 13.8 m -78.76 -35.52 44.47 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 114.977 -1.01 . . . . 0.0 111.221 -174.494 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . 0.736 ' HA ' ' CD2' ' A' ' 138' ' ' PHE . . . -62.31 -40.7 97.16 Favored 'General case' 0 C--O 1.242 0.658 0 CA-C-O 121.167 0.508 . . . . 0.0 110.372 178.269 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . 0.556 ' HA ' ' ND2' ' A' ' 139' ' ' ASN . 7.1 mm-40 -65.19 -41.4 94.6 Favored 'General case' 0 N--CA 1.447 -0.614 0 CA-C-N 115.254 -0.885 . . . . 0.0 111.062 176.486 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . 0.96 ' HE2' ' HA ' ' A' ' 137' ' ' LYS . 9.1 mmpt? -55.79 -41.71 74.51 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.554 175.975 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . 0.736 ' CD2' ' HA ' ' A' ' 135' ' ' ALA . 15.3 m-85 -56.81 -60.37 3.66 Favored 'General case' 0 N--CA 1.463 0.2 0 O-C-N 123.181 0.301 . . . . 0.0 110.783 178.556 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . 0.571 ' OD1' ' HA ' ' A' ' 145' ' ' GLU . 11.7 p30 -69.49 -27.03 64.85 Favored 'General case' 0 C--O 1.224 -0.249 0 C-N-CA 120.602 -0.439 . . . . 0.0 111.506 -173.326 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 21.7 tt0 -63.18 -60.66 3.13 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.597 0.237 . . . . 0.0 111.464 177.092 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.704 ' HG ' ' O ' ' A' ' 137' ' ' LYS . 3.0 pp -69.85 -19.86 63.43 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-O 120.845 0.355 . . . . 0.0 111.417 -175.69 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.507 HD11 ' HB3' ' A' ' 62' ' ' LYS . 0.8 OUTLIER -81.46 -21.38 38.82 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.065 175.039 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 73.57 27.51 67.33 Favored Glycine 0 N--CA 1.448 -0.548 0 N-CA-C 110.304 -1.118 . . . . 0.0 110.304 -176.231 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.415 ' HG ' ' O ' ' A' ' 144' ' ' LEU . 42.5 tp -109.66 27.15 9.85 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 114.308 -0.946 . . . . 0.0 108.987 -174.265 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . 0.571 ' HA ' ' OD1' ' A' ' 139' ' ' ASN . 51.3 mt-10 -54.31 -71.3 0.08 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 114.505 -1.225 . . . . 0.0 113.748 -173.659 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 78.73 -80.77 1.43 Allowed Glycine 0 C--N 1.31 -0.893 0 N-CA-C 109.424 -1.471 . . . . 0.0 109.424 -165.295 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 9.3 m170 63.92 -60.14 0.19 Allowed 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 115.061 1.504 . . . . 0.0 115.061 167.721 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 47.9 t-80 -70.96 75.94 0.64 Allowed 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 112.391 0.515 . . . . 0.0 112.391 -169.287 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 21.3 t-80 54.08 76.11 0.25 Allowed 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 115.561 -0.745 . . . . 0.0 111.994 173.663 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 150' ' ' HIS . . . . . 0.439 ' O ' ' HB3' ' A' ' 151' ' ' HIS . 52.4 m-70 -137.94 90.78 2.52 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.389 -0.368 . . . . 0.0 110.994 175.954 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 151' ' ' HIS . . . . . 0.439 ' HB3' ' O ' ' A' ' 150' ' ' HIS . 16.9 p80 172.19 -38.69 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.488 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 175.429 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 66.0 t-80 . . . . . 0 C--O 1.242 0.682 0 N-CA-C 107.598 -1.26 . . . . 0.0 107.598 178.458 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.738 ' HA ' ' O ' ' A' ' 11' ' ' ALA . 67.7 mtm . . . . . 0 N--CA 1.48 1.074 0 N-CA-C 109.999 -0.371 . . . . 0.0 109.999 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 16.8 t -140.99 156.77 45.99 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 179.888 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.683 HD22 ' HG3' ' A' ' 8' ' ' PRO . 2.6 pt? -137.73 161.47 36.43 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 120.712 0.291 . . . . 0.0 110.353 -177.837 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 63.4 mmt-85 -117.06 -19.37 9.77 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 172.396 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 19.0 t -173.03 153.75 2.63 Favored 'General case' 0 N--CA 1.451 -0.397 0 CA-C-N 115.399 -0.819 . . . . 0.0 108.979 178.324 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 76.89 -92.4 1.02 Allowed Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 120.917 -0.658 . . . . 0.0 112.722 178.721 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . 0.423 ' HA ' ' HD3' ' A' ' 8' ' ' PRO . 9.1 p30 -154.74 151.43 23.46 Favored Pre-proline 0 C--N 1.325 -0.473 0 N-CA-C 110.419 -0.215 . . . . 0.0 110.419 -176.766 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.683 ' HG3' HD22 ' A' ' 3' ' ' LEU . 3.1 Cg_exo -74.31 106.87 2.32 Favored 'Trans proline' 0 N--CA 1.462 -0.363 0 C-N-CA 122.649 2.233 . . . . 0.0 111.753 177.24 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 1.6 p -104.9 104.0 13.68 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.142 -177.586 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.627 ' O ' ' HG2' ' A' ' 1' ' ' MET . . . 70.53 -75.66 0.07 Allowed 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 115.134 -0.939 . . . . 0.0 111.181 178.762 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.738 ' O ' ' HA ' ' A' ' 1' ' ' MET . . . 11.97 74.54 0.01 OUTLIER 'General case' 0 N--CA 1.479 0.994 0 O-C-N 125.061 1.475 . . . . 0.0 113.807 -178.21 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 1.036 ' HA ' ' HB3' ' A' ' 25' ' ' LEU . 68.5 m 62.35 84.14 0.14 Allowed 'General case' 0 CA--C 1.534 0.362 0 CA-C-O 121.593 0.711 . . . . 0.0 111.354 -175.778 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 16.3 p90 -99.84 175.17 5.88 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.403 -0.817 . . . . 0.0 110.419 178.528 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 13.8 p -142.75 123.26 14.02 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.514 0.197 . . . . 0.0 110.57 178.963 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . 0.616 ' HB2' HD13 ' A' ' 92' ' ' LEU . 80.5 m-85 -134.65 150.05 72.51 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.655 -0.248 . . . . 0.0 110.483 179.24 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.41 ' HD2' ' O ' ' A' ' 93' ' ' HIS . 3.1 Cg_exo -80.83 124.85 5.21 Favored 'Trans proline' 0 N--CA 1.457 -0.636 0 C-N-CA 122.581 2.187 . . . . 0.0 112.805 178.638 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . 0.698 ' HB3' ' HB3' ' A' ' 21' ' ' LYS . 4.8 t70 -70.36 159.93 33.24 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.32 -0.855 . . . . 0.0 109.123 171.136 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.686 HD12 HG13 ' A' ' 82' ' ' VAL . 1.5 tt -50.24 -35.57 12.08 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.512 0 O-C-N 123.68 0.613 . . . . 0.0 111.651 -176.187 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 34.5 m-80 -77.54 11.93 1.83 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.411 -177.384 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 70.56 32.16 67.77 Favored Glycine 0 CA--C 1.505 -0.55 0 N-CA-C 110.335 -1.106 . . . . 0.0 110.335 -175.582 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.698 ' HB3' ' HB3' ' A' ' 17' ' ' ASP . 8.2 ttpm? -103.52 109.25 20.83 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.048 -0.576 . . . . 0.0 110.519 -173.997 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 20.9 m -65.19 106.94 1.42 Allowed 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.756 178.515 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.57 ' HB ' HD21 ' A' ' 92' ' ' LEU . 63.3 t -112.95 127.99 69.92 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 N-CA-C 109.176 -0.676 . . . . 0.0 109.176 179.028 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . 0.421 ' C ' ' H ' ' A' ' 26' ' ' ALA . 92.9 p -122.62 165.01 17.16 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.535 0.683 . . . . 0.0 111.757 -173.193 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 1.036 ' HB3' ' HA ' ' A' ' 12' ' ' SER . 20.8 tp -85.35 33.15 0.55 Allowed 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.894 0.854 . . . . 0.0 109.311 175.385 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.421 ' H ' ' C ' ' A' ' 24' ' ' SER . . . -118.73 -41.37 2.8 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 114.505 -1.225 . . . . 0.0 109.745 174.155 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -79.1 -31.77 44.37 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.337 0.589 . . . . 0.0 109.937 173.969 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.616 HD13 HG21 ' A' ' 67' ' ' VAL . 75.9 mt -78.97 -18.46 53.67 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.217 174.862 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.519 ' HB2' ' O ' ' A' ' 25' ' ' LEU . 44.7 tttp -71.48 131.66 43.63 Favored 'General case' 0 N--CA 1.444 -0.729 0 CA-C-N 115.317 -0.856 . . . . 0.0 110.817 -175.336 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 117.17 -8.74 15.8 Favored Glycine 0 N--CA 1.448 -0.512 0 N-CA-C 110.79 -0.924 . . . . 0.0 110.79 -174.655 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.424 ' C ' ' HA ' ' A' ' 117' ' ' ARG . 24.9 ttmm -143.47 147.94 35.3 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 179.637 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 54.9 m-85 -54.01 144.66 18.59 Favored 'General case' 0 N--CA 1.47 0.543 0 N-CA-C 112.562 0.578 . . . . 0.0 112.562 -174.223 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.519 HG13 HD11 ' A' ' 25' ' ' LEU . 39.2 mm -120.73 133.93 65.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.562 -0.745 . . . . 0.0 110.99 -175.04 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . 0.481 ' OH ' ' HD3' ' A' ' 129' ' ' PRO . 80.1 t80 -120.67 118.98 31.5 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 172.253 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.61 ' HB ' ' HB ' ' A' ' 113' ' ' ILE . 75.1 mt -99.98 126.78 53.39 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 N-CA-C 110.138 -0.319 . . . . 0.0 110.138 179.399 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.552 ' O ' ' HA ' ' A' ' 68' ' ' SER . 11.8 t70 -129.9 124.91 34.3 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.23 -178.924 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 26.5 t -81.78 121.77 35.63 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.913 0 C-N-CA 120.557 -0.457 . . . . 0.0 110.423 -179.598 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' TRP . . . . . 0.656 ' CE3' ' HZ2' ' A' ' 78' ' ' TRP . 0.7 OUTLIER -121.74 133.41 54.93 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.161 -0.472 . . . . 0.0 109.896 -176.618 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.505 ' HA ' ' OD1' ' A' ' 72' ' ' ASP . . . -148.27 158.28 44.0 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.577 -177.482 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.643 ' HB ' ' CE3' ' A' ' 78' ' ' TRP . 11.1 t -94.89 -25.59 16.52 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.114 0.483 . . . . 0.0 110.611 175.111 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . 0.431 ' HE1' ' HA ' ' A' ' 72' ' ' ASP . 14.9 p-90 -87.78 13.32 10.86 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.079 -177.742 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . 0.469 ' SG ' ' HB2' ' A' ' 45' ' ' CYS . 14.9 t -86.24 -60.69 1.93 Allowed 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.09 175.92 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 110.92 -91.37 0.61 Allowed Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.641 -179.269 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -53.62 -28.87 48.11 Favored 'Trans proline' 0 C--N 1.35 0.638 0 C-N-CA 123.302 2.668 . . . . 0.0 113.066 -178.59 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . 0.504 ' SG ' ' HG3' ' A' ' 110' ' ' PRO . 42.2 t -51.64 -30.05 20.09 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.66 178.594 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.558 ' HA ' ' HG ' ' A' ' 49' ' ' LEU . 55.8 mtp180 -65.44 -30.58 71.39 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.451 -0.341 . . . . 0.0 111.686 -176.592 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -68.9 -26.39 74.66 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.652 -0.785 . . . . 0.0 112.49 -176.65 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.456 ' OE2' ' HG2' ' A' ' 128' ' ' ARG . 14.6 mt-10 -94.49 -12.24 28.06 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.594 0.235 . . . . 0.0 111.005 -176.94 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.633 ' O ' ' HG3' ' A' ' 53' ' ' LYS . 73.2 mt -49.75 -49.19 74.74 Favored Pre-proline 0 C--N 1.331 -0.239 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.948 -178.598 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.55 ' HD3' ' HB2' ' A' ' 49' ' ' LEU . 71.3 Cg_exo -50.83 -37.82 56.04 Favored 'Trans proline' 0 C--N 1.357 1.003 0 C-N-CA 122.184 1.923 . . . . 0.0 112.767 176.984 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.513 ' O ' ' HB2' ' A' ' 55' ' ' LEU . . . -75.14 -25.4 58.36 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-O 121.617 0.722 . . . . 0.0 110.504 -176.114 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 6.8 tt -79.02 -48.34 14.6 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.0 -1.0 . . . . 0.0 108.419 -177.155 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.761 ' HB3' ' HG2' ' A' ' 88' ' ' LYS . 81.9 mttt -51.59 -55.71 17.67 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-N 114.655 -1.157 . . . . 0.0 109.909 176.893 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.473 ' HG2' ' O ' ' A' ' 50' ' ' PRO . 9.6 mm-40 -73.58 -23.32 59.93 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 114.074 -1.421 . . . . 0.0 112.55 -171.185 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.513 ' HB2' ' O ' ' A' ' 51' ' ' ALA . 0.4 OUTLIER -73.35 -34.0 65.4 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 120.302 -0.559 . . . . 0.0 109.588 176.408 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.447 ' OE2' ' HB2' ' A' ' 66' ' ' PHE . 5.1 tp10 -68.14 -37.13 80.74 Favored 'General case' 0 C--O 1.217 -0.63 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 175.686 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.463 ' HG2' ' O ' ' A' ' 53' ' ' LYS . 7.1 mm-40 -54.04 -53.96 45.8 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.391 0.615 . . . . 0.0 110.451 175.492 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 34.4 ttpt -55.57 -35.41 65.74 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.369 -0.832 . . . . 0.0 110.903 177.755 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.47 ' CZ ' ' HB2' ' A' ' 138' ' ' PHE . 38.3 m-85 -102.91 12.29 36.32 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 113.109 0.781 . . . . 0.0 113.109 -176.114 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -65.09 123.63 20.0 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 120.878 0.371 . . . . 0.0 110.352 176.516 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 83.52 7.68 85.94 Favored Glycine 0 N--CA 1.448 -0.541 0 C-N-CA 120.826 -0.702 . . . . 0.0 112.782 178.195 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 34.2 mmtm -89.92 -153.47 0.29 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.194 0.521 . . . . 0.0 109.821 177.997 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.403 ' H ' HD21 ' A' ' 142' ' ' LEU . 4.2 t70 -106.75 62.39 0.63 Allowed 'General case' 0 C--N 1.316 -0.878 0 CA-C-O 121.571 0.701 . . . . 0.0 110.021 176.853 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 17.8 tt -157.35 163.98 1.21 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.787 0 CA-C-N 115.12 -0.945 . . . . 0.0 109.174 177.503 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 96.8 m-70 -139.25 114.97 10.01 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 174.453 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . 0.452 ' HZ ' HD12 ' A' ' 55' ' ' LEU . 12.5 m-85 -80.47 103.0 10.04 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 171.998 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.616 HG21 HD13 ' A' ' 28' ' ' LEU . 46.8 t -115.82 104.54 16.9 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 CA-C-N 115.332 -0.849 . . . . 0.0 109.739 -176.566 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . 0.552 ' HA ' ' O ' ' A' ' 36' ' ' ASP . 28.9 m -88.1 148.26 24.54 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.531 -178.132 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.413 HD11 ' HB2' ' A' ' 94' ' ' MET . 63.7 tp -126.73 119.9 28.07 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 120.839 0.352 . . . . 0.0 110.664 178.139 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . 0.505 ' HB3' ' HA ' ' A' ' 93' ' ' HIS . 3.4 t -100.74 119.05 38.05 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.228 0.537 . . . . 0.0 112.095 -174.552 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 18.7 m -90.76 15.34 11.33 Favored 'General case' 0 C--N 1.31 -1.121 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.816 177.864 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.505 ' OD1' ' HA ' ' A' ' 39' ' ' ALA . 2.4 m-20 -68.2 127.26 32.25 Favored 'General case' 0 CA--C 1.516 -0.344 0 CA-C-O 121.049 0.452 . . . . 0.0 110.663 -177.957 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 38.5 ttmt -79.01 -31.65 44.81 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 121.413 0.625 . . . . 0.0 109.323 175.335 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . 0.561 ' HB2' ' HB3' ' A' ' 77' ' ' ALA . 0.8 OUTLIER -80.36 68.59 6.59 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.175 -0.92 . . . . 0.0 110.25 177.45 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.547 ' HG3' ' CE1' ' A' ' 93' ' ' HIS . 33.0 tttt -58.91 -49.54 77.43 Favored 'General case' 0 C--O 1.223 -0.338 0 C-N-CA 120.936 -0.306 . . . . 0.0 111.462 -173.862 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 64.7 tttp -52.43 -56.04 17.77 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 110.343 -0.243 . . . . 0.0 110.343 179.273 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.676 ' HA ' ' ND2' ' A' ' 80' ' ' ASN . . . -51.45 -35.66 40.63 Favored 'General case' 0 C--O 1.242 0.678 0 CA-C-O 122.03 0.919 . . . . 0.0 110.933 177.011 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' TRP . . . . . 0.656 ' HZ2' ' CE3' ' A' ' 38' ' ' TRP . 14.8 t-105 -74.25 -51.05 16.5 Favored 'General case' 0 N--CA 1.431 -1.377 0 CA-C-N 114.434 -1.257 . . . . 0.0 111.828 -173.045 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.498 ' HG2' ' O ' ' A' ' 75' ' ' LYS . 4.8 mm-40 -49.61 -41.06 41.17 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-O 121.082 0.468 . . . . 0.0 110.485 176.849 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . 0.676 ' ND2' ' HA ' ' A' ' 77' ' ' ALA . 6.0 m-20 -56.87 -54.26 48.53 Favored 'General case' 0 CA--C 1.518 -0.261 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.706 177.795 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . 0.539 ' SD ' ' HZ3' ' A' ' 78' ' ' TRP . 16.6 ttt -61.09 -48.42 81.75 Favored 'General case' 0 C--O 1.223 -0.316 0 N-CA-C 112.358 0.503 . . . . 0.0 112.358 -175.435 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.686 HG13 HD12 ' A' ' 18' ' ' ILE . 0.9 OUTLIER -60.91 -34.79 60.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 C-N-CA 120.386 -0.526 . . . . 0.0 111.069 -178.478 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 25.5 m -73.41 -29.79 62.82 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.106 0.479 . . . . 0.0 110.574 176.992 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 51.3 tttp -81.3 -41.97 21.33 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.179 0.514 . . . . 0.0 111.043 -177.905 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -77.24 -21.04 54.38 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.239 -0.891 . . . . 0.0 110.084 -176.126 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 17.8 mm-40 63.99 79.52 0.26 Allowed 'General case' 0 C--O 1.233 0.192 0 CA-C-N 115.375 -0.83 . . . . 0.0 111.229 -179.885 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.69 HD23 ' HE2' ' A' ' 53' ' ' LYS . 49.4 mt -96.55 140.93 30.45 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.422 -0.808 . . . . 0.0 111.001 179.402 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.761 ' HG2' ' HB3' ' A' ' 53' ' ' LYS . 30.6 mmtp -95.47 174.28 7.09 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.234 -0.439 . . . . 0.0 109.821 179.341 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . 0.425 ' CA ' ' HG2' ' A' ' 56' ' ' GLU . . . 86.33 -164.83 36.84 Favored Glycine 0 CA--C 1.517 0.184 0 C-N-CA 120.927 -0.654 . . . . 0.0 113.432 174.418 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.527 HG21 HG11 ' A' ' 23' ' ' VAL . 64.2 mt -103.51 113.45 40.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 178.297 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . 0.644 ' HB3' ' CZ2' ' A' ' 38' ' ' TRP . 8.1 mm100 -117.23 104.83 11.57 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 120.892 0.377 . . . . 0.0 111.022 -169.624 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.616 HD13 ' HB2' ' A' ' 15' ' ' TYR . 34.9 mt -100.04 147.94 25.07 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.146 0.498 . . . . 0.0 111.111 -176.51 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' HIS . . . . . 0.547 ' CE1' ' HG3' ' A' ' 75' ' ' LYS . 28.1 t-80 -115.08 127.86 55.87 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.144 0.497 . . . . 0.0 111.086 179.759 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' MET . . . . . 0.496 ' HB3' ' O ' ' A' ' 70' ' ' SER . 24.1 ttm -77.32 -74.95 0.22 Allowed 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.294 -0.866 . . . . 0.0 109.93 176.167 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 78.67 101.96 0.21 Allowed Glycine 0 N--CA 1.445 -0.734 0 C-N-CA 120.755 -0.735 . . . . 0.0 113.135 -179.689 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 64.9 p 61.17 16.29 7.08 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 114.221 1.193 . . . . 0.0 114.221 170.098 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -123.99 54.47 1.33 Allowed 'General case' 0 CA--C 1.518 -0.265 0 CA-C-O 121.502 0.667 . . . . 0.0 110.096 174.989 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . 0.491 ' HB2' ' SD ' ' A' ' 101' ' ' MET . 0.1 OUTLIER -77.3 5.62 8.26 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.27 -0.877 . . . . 0.0 111.911 -170.433 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 2.8 m -61.0 -29.95 70.0 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.294 0.569 . . . . 0.0 110.529 177.42 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 27.3 t80 -73.94 -24.83 59.71 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.567 -179.14 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' MET . . . . . 0.491 ' SD ' ' HB2' ' A' ' 98' ' ' ARG . 83.2 mtp -61.7 -51.58 67.8 Favored 'General case' 0 CA--C 1.515 -0.402 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 174.059 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -62.03 -25.36 67.61 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 114.649 -1.16 . . . . 0.0 111.424 -177.696 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -65.84 -28.97 69.37 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-O 121.074 0.464 . . . . 0.0 110.877 178.1 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 61.9 m-85 -109.27 10.81 25.61 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.495 179.766 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 95.4 mt 64.72 15.51 9.81 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.1 -177.24 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . 0.885 HG12 ' HG3' ' A' ' 111' ' ' ARG . 61.2 mt -67.03 112.92 2.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.271 175.111 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 16.2 t-20 -124.96 -53.85 1.63 Allowed 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 176.346 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -92.19 115.02 4.7 Favored Glycine 0 N--CA 1.442 -0.915 0 CA-C-N 115.29 -0.868 . . . . 0.0 111.979 178.339 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.507 ' CG2' ' HA ' ' A' ' 110' ' ' PRO . 41.9 mt -77.7 142.97 66.59 Favored Pre-proline 0 C--N 1.321 -0.655 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 175.383 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . 0.507 ' HA ' ' CG2' ' A' ' 109' ' ' ILE . 1.0 OUTLIER -86.13 170.67 42.16 Favored 'Cis proline' 0 C--N 1.348 0.553 0 C-N-CA 124.775 -0.927 . . . . 0.0 113.853 1.087 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . 0.885 ' HG3' HG12 ' A' ' 106' ' ' ILE . 0.0 OUTLIER -134.79 133.82 40.23 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.477 -0.783 . . . . 0.0 108.897 179.413 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . 0.491 ' CE1' ' HB2' ' A' ' 128' ' ' ARG . 0.0 OUTLIER -102.33 117.05 33.91 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 123.365 0.415 . . . . 0.0 110.502 -175.604 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.61 ' HB ' ' HB ' ' A' ' 35' ' ' ILE . 82.1 mt -129.16 141.81 45.64 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.326 0 CA-C-O 120.708 0.29 . . . . 0.0 111.004 179.559 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 40.4 tp -130.31 139.21 50.72 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.5 -179.775 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.468 ' N ' HD12 ' A' ' 115' ' ' LEU . 0.8 OUTLIER -136.03 155.77 49.73 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.04 0.447 . . . . 0.0 110.54 179.673 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . 0.692 ' HB3' ' HB2' ' A' ' 120' ' ' LYS . 19.2 t70 -71.94 162.55 29.29 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.221 -0.899 . . . . 0.0 110.568 176.684 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . 0.424 ' HA ' ' C ' ' A' ' 31' ' ' LYS . 33.0 mtt180 -46.53 -40.2 12.21 Favored 'General case' 0 N--CA 1.462 0.136 0 O-C-N 124.43 1.081 . . . . 0.0 111.895 -178.611 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . 0.85 ' HB3' ' HG3' ' A' ' 120' ' ' LYS . 38.4 t70 -66.09 -18.87 65.62 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.36 0.6 . . . . 0.0 111.173 -177.448 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 104.26 16.96 16.93 Favored Glycine 0 N--CA 1.436 -1.344 0 N-CA-C 110.288 -1.125 . . . . 0.0 110.288 -170.151 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . 0.85 ' HG3' ' HB3' ' A' ' 118' ' ' ASP . 60.0 mttm -86.03 107.35 17.75 Favored 'General case' 0 C--O 1.219 -0.528 0 C-N-CA 120.805 -0.358 . . . . 0.0 111.115 -173.929 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 0.65 ' H ' HD12 ' A' ' 121' ' ' ILE . 3.9 mp -48.18 111.67 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-O 121.02 0.438 . . . . 0.0 110.797 177.725 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' ILE . . . . . 0.412 HD11 ' HB2' ' A' ' 116' ' ' ASP . 45.5 mm -95.48 -50.38 11.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 115.659 -0.7 . . . . 0.0 109.9 -179.508 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 19.9 m -125.99 114.59 18.67 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.212 -177.86 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -72.08 -16.98 62.03 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.13 0.491 . . . . 0.0 110.091 176.694 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . 0.406 ' HA ' ' O ' ' A' ' 112' ' ' PHE . 7.7 t30 -149.8 101.18 3.03 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.299 -0.864 . . . . 0.0 109.159 173.909 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 12.6 tpt -91.48 -125.2 0.08 Allowed 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 -178.761 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . 0.463 ' OG1' ' HB ' ' A' ' 134' ' ' THR . 0.0 OUTLIER -140.82 131.72 26.01 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.879 0.371 . . . . 0.0 110.48 178.399 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . 0.651 ' HD2' ' HD2' ' A' ' 129' ' ' PRO . 17.7 tpt180 -51.52 138.03 30.83 Favored Pre-proline 0 C--N 1.323 -0.56 0 CA-C-N 115.252 -0.885 . . . . 0.0 111.073 176.04 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . 0.651 ' HD2' ' HD2' ' A' ' 128' ' ' ARG . 68.8 Cg_exo -48.49 -21.48 3.34 Favored 'Trans proline' 0 C--N 1.351 0.664 0 C-N-CA 123.496 2.797 . . . . 0.0 113.747 174.074 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . 0.455 ' H ' ' HG3' ' A' ' 128' ' ' ARG . 4.4 m -61.11 -28.06 68.82 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.762 0.315 . . . . 0.0 111.035 176.774 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . 0.65 ' OD1' ' HG2' ' A' ' 133' ' ' LYS . 24.1 t0 -100.64 117.35 62.93 Favored Pre-proline 0 N--CA 1.453 -0.321 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.162 179.736 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . 0.598 ' O ' ' HG2' ' A' ' 136' ' ' GLU . 14.1 Cg_endo -56.98 -21.18 40.19 Favored 'Trans proline' 0 CA--C 1.53 0.315 0 C-N-CA 123.196 2.597 . . . . 0.0 114.018 179.736 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . 0.65 ' HG2' ' OD1' ' A' ' 131' ' ' ASP . 31.1 mmtm -48.15 -55.31 10.68 Favored 'General case' 0 N--CA 1.474 0.73 0 CA-C-O 121.066 0.46 . . . . 0.0 110.724 -177.528 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' THR . . . . . 0.463 ' HB ' ' OG1' ' A' ' 127' ' ' THR . 15.1 t -65.15 -41.15 95.02 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.233 -0.894 . . . . 0.0 110.755 -175.069 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . 0.587 ' HA ' ' CD2' ' A' ' 138' ' ' PHE . . . -64.24 -47.87 78.0 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-O 121.402 0.62 . . . . 0.0 110.758 -176.801 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . 0.598 ' HG2' ' O ' ' A' ' 132' ' ' PRO . 8.6 mm-40 -77.12 -22.86 52.02 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-O 121.465 0.65 . . . . 0.0 109.821 -176.2 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . 0.583 ' O ' ' HG ' ' A' ' 141' ' ' LEU . 0.1 OUTLIER -57.68 -39.17 76.48 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.15 -0.932 . . . . 0.0 109.441 168.659 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . 0.587 ' CD2' ' HA ' ' A' ' 135' ' ' ALA . 9.3 m-85 -66.76 -40.59 88.31 Favored 'General case' 0 N--CA 1.462 0.15 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.373 177.596 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . 0.615 ' HB3' ' HG3' ' A' ' 145' ' ' GLU . 92.6 m-20 -47.53 -53.76 13.52 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 175.758 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 21.8 tt0 -53.85 -48.42 70.0 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.287 -0.869 . . . . 0.0 111.472 179.111 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.583 ' HG ' ' O ' ' A' ' 137' ' ' LYS . 83.4 mt -58.32 -29.35 65.84 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.899 -176.688 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.403 HD21 ' H ' ' A' ' 63' ' ' ASP . 10.0 mp -102.16 -5.66 24.16 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.678 -0.237 . . . . 0.0 111.442 -179.756 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 72.63 28.56 67.13 Favored Glycine 0 C--N 1.329 0.152 0 N-CA-C 110.827 -0.909 . . . . 0.0 110.827 -176.749 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.513 HD23 ' OD1' ' A' ' 139' ' ' ASN . 26.9 tp -76.14 -31.58 58.67 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 114.77 -0.715 . . . . 0.0 110.837 -173.139 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . 0.615 ' HG3' ' HB3' ' A' ' 139' ' ' ASN . 0.0 OUTLIER -86.4 -29.9 22.54 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.793 0.806 . . . . 0.0 110.372 178.477 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -76.93 28.79 1.6 Allowed Glycine 0 C--N 1.317 -0.484 0 CA-C-N 114.061 -1.427 . . . . 0.0 113.992 -174.93 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 18.9 p-80 -76.03 61.53 1.54 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.709 0.766 . . . . 0.0 110.232 176.263 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 12.3 m170 -92.0 100.0 12.73 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.69 -0.687 . . . . 0.0 109.573 -176.523 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 7.3 p80 -61.85 142.15 57.53 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.054 0.454 . . . . 0.0 111.367 -176.483 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 46.7 m80 -129.01 116.12 18.84 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.052 -0.522 . . . . 0.0 109.592 177.134 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 23.0 m170 69.39 103.6 0.06 Allowed 'General case' 0 N--CA 1.468 0.472 0 O-C-N 123.947 0.779 . . . . 0.0 111.503 -177.115 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 56.0 t-80 . . . . . 0 C--O 1.245 0.823 0 CA-C-O 118.318 -0.849 . . . . 0.0 109.515 177.98 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.5 mmt . . . . . 0 N--CA 1.479 0.986 0 N-CA-C 109.535 -0.543 . . . . 0.0 109.535 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 6.4 m -77.92 69.91 4.21 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.573 -0.528 . . . . 0.0 109.573 176.702 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 43.7 tp 69.52 -58.24 0.52 Allowed 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 115.268 -0.878 . . . . 0.0 110.367 -172.131 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 90.7 mtm180 -117.75 -179.72 3.82 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.115 -0.493 . . . . 0.0 109.706 176.913 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 16.3 m -78.4 -9.35 59.25 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.375 0.607 . . . . 0.0 110.577 178.183 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -165.85 143.85 8.74 Favored Glycine 0 N--CA 1.444 -0.788 0 N-CA-C 110.137 -1.185 . . . . 0.0 110.137 177.752 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . 0.612 ' HB3' ' HB2' ' A' ' 103' ' ' ALA . 8.9 m120 64.81 108.84 0.03 OUTLIER Pre-proline 0 N--CA 1.469 0.515 0 CA-C-O 121.171 0.51 . . . . 0.0 110.349 -177.094 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_exo -68.59 -75.34 0.01 OUTLIER 'Trans proline' 0 C--N 1.331 -0.362 0 C-N-CA 122.882 2.388 . . . . 0.0 112.367 -176.886 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 48.7 m 68.04 111.77 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.309 0 O-C-N 123.631 0.582 . . . . 0.0 111.271 -177.538 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.548 ' HB2' HD13 ' A' ' 121' ' ' ILE . . . 71.89 -40.95 0.49 Allowed 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 123.465 0.706 . . . . 0.0 112.823 178.077 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -76.2 69.35 2.73 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 112.281 0.474 . . . . 0.0 112.281 -175.598 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 42.5 m 62.6 102.86 0.03 OUTLIER 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 113.188 0.811 . . . . 0.0 113.188 172.042 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . 0.502 ' CE1' HD13 ' A' ' 25' ' ' LEU . 38.7 p90 -105.58 129.91 53.74 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.137 -0.483 . . . . 0.0 109.943 173.985 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 3.4 m -121.82 111.76 17.52 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.395 -177.841 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 63.9 m-85 -134.79 151.63 76.07 Favored Pre-proline 0 C--N 1.322 -0.597 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.605 -175.885 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -76.41 125.81 8.63 Favored 'Trans proline' 0 N--CA 1.46 -0.497 0 C-N-CA 122.569 2.18 . . . . 0.0 112.587 178.966 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . 0.544 ' HA ' ' HA ' ' A' ' 92' ' ' LEU . 10.5 t70 -70.51 159.16 34.79 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.484 -0.78 . . . . 0.0 108.926 172.114 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.559 HG13 HG11 ' A' ' 82' ' ' VAL . 0.0 OUTLIER -55.8 -25.64 19.01 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.487 0 O-C-N 123.722 0.639 . . . . 0.0 111.55 -176.947 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 42.8 m-80 -72.65 2.42 6.55 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.137 0.494 . . . . 0.0 110.91 176.065 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 73.67 36.35 53.73 Favored Glycine 0 N--CA 1.446 -0.639 0 N-CA-C 110.835 -0.906 . . . . 0.0 110.835 -179.501 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.461 ' HB2' ' NZ ' ' A' ' 21' ' ' LYS . 0.1 OUTLIER -119.56 134.07 55.39 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 110.273 -0.269 . . . . 0.0 110.273 -175.045 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 7.0 m -80.11 107.83 13.22 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-O 120.868 0.366 . . . . 0.0 110.619 -177.326 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.52 ' HB ' HD21 ' A' ' 92' ' ' LEU . 62.0 t -108.4 141.7 22.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 115.871 -0.604 . . . . 0.0 109.69 -179.969 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 82.3 p -120.53 -173.71 2.64 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 120.867 0.365 . . . . 0.0 110.716 -176.895 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.659 ' O ' ' HB2' ' A' ' 29' ' ' LYS . 65.0 tp -78.73 -26.52 44.72 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.465 -179.716 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -84.76 -30.58 24.54 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 112.8 0.667 . . . . 0.0 112.8 -169.709 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 3.4 p30 -81.04 -15.5 55.94 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.171 0.51 . . . . 0.0 110.849 -175.796 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 18.8 tp -118.36 21.87 12.42 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.756 0.788 . . . . 0.0 109.319 178.007 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.659 ' HB2' ' O ' ' A' ' 25' ' ' LEU . 57.6 tttm -94.18 163.27 13.52 Favored 'General case' 0 N--CA 1.44 -0.957 0 CA-C-N 114.813 -1.085 . . . . 0.0 109.961 -178.45 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 114.49 -31.33 6.45 Favored Glycine 0 CA--C 1.509 -0.301 0 C-N-CA 120.591 -0.814 . . . . 0.0 111.669 177.734 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 1.05 ' HD3' ' HA ' ' A' ' 63' ' ' ASP . 65.2 mttm -119.36 165.55 14.16 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 109.662 -0.496 . . . . 0.0 109.662 174.822 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 81.5 m-85 -60.89 149.15 37.18 Favored 'General case' 0 C--N 1.329 -0.311 0 O-C-N 123.323 0.39 . . . . 0.0 110.639 -177.87 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 71.1 mt -124.5 132.18 71.7 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 CA-C-O 120.853 0.359 . . . . 0.0 110.807 -174.737 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 88.3 t80 -117.12 121.05 40.19 Favored 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 173.013 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.533 ' HB ' ' HB ' ' A' ' 113' ' ' ILE . 57.1 mt -105.58 118.83 53.78 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-O 121.171 0.51 . . . . 0.0 110.736 -178.286 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -106.41 156.87 18.08 Favored 'General case' 0 C--N 1.316 -0.849 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 172.3 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.524 ' HB ' ' H ' ' A' ' 111' ' ' ARG . 62.0 t -110.46 112.1 39.08 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.877 0 C-N-CA 120.034 -0.666 . . . . 0.0 110.22 174.161 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' TRP . . . . . 0.655 ' CZ2' ' HB2' ' A' ' 91' ' ' GLN . 0.2 OUTLIER -98.02 132.86 43.2 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.097 -0.956 . . . . 0.0 109.516 -177.257 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.582 ' HA ' ' OD1' ' A' ' 72' ' ' ASP . . . -147.58 155.09 41.49 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.664 -178.714 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.675 ' HB ' ' CE3' ' A' ' 78' ' ' TRP . 13.3 t -100.34 -28.41 12.97 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.781 0.324 . . . . 0.0 110.704 174.601 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . 0.429 ' HE1' ' HA ' ' A' ' 72' ' ' ASP . 18.5 p-90 -81.31 11.03 4.69 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.785 -177.053 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . 0.777 ' HB3' ' SG ' ' A' ' 45' ' ' CYS . 44.5 t -91.55 -61.03 1.73 Allowed 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 109.912 -0.403 . . . . 0.0 109.912 174.854 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 111.0 -83.68 0.33 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.597 -179.629 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_exo -54.19 -26.86 44.32 Favored 'Trans proline' 0 C--N 1.351 0.704 0 C-N-CA 123.188 2.592 . . . . 0.0 112.854 179.463 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . 0.777 ' SG ' ' HB3' ' A' ' 42' ' ' CYS . 23.1 p -51.47 -35.49 40.1 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.399 176.797 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.589 ' HA ' HD13 ' A' ' 49' ' ' LEU . 33.6 mtp180 -67.9 -12.3 60.41 Favored 'General case' 0 N--CA 1.456 -0.157 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.21 -175.698 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -80.37 -19.93 67.93 Favored Glycine 0 N--CA 1.446 -0.654 0 C-N-CA 120.648 -0.786 . . . . 0.0 111.369 175.437 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 24.6 mt-10 -99.34 -12.81 19.97 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-O 120.606 0.241 . . . . 0.0 110.615 -179.282 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.589 HD13 ' HA ' ' A' ' 46' ' ' ARG . 7.5 mp -51.89 -48.57 87.52 Favored Pre-proline 0 CA--C 1.536 0.436 0 CA-C-N 116.561 -0.29 . . . . 0.0 111.701 172.279 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -57.04 -35.84 99.07 Favored 'Trans proline' 0 C--N 1.355 0.896 0 C-N-CA 121.791 1.661 . . . . 0.0 111.937 171.601 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.445 ' O ' ' HB2' ' A' ' 54' ' ' GLU . . . -72.0 -26.03 62.06 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-O 121.234 0.54 . . . . 0.0 110.574 -179.1 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 87.3 mt -67.6 -33.67 75.47 Favored 'General case' 0 N--CA 1.444 -0.74 0 CA-C-N 115.858 -0.61 . . . . 0.0 109.67 174.225 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 5.5 mtpm? -70.36 -39.19 74.76 Favored 'General case' 0 CA--C 1.519 -0.236 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.166 175.005 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.445 ' HB2' ' O ' ' A' ' 51' ' ' ALA . 28.1 mm-40 -50.7 -50.82 54.18 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.755 -0.657 . . . . 0.0 109.669 172.9 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 62.8 mt -62.23 -53.12 59.74 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.976 175.409 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 26.4 tt0 -43.41 -59.84 1.96 Allowed 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 114.575 -1.193 . . . . 0.0 112.427 179.522 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -78.67 -29.04 45.41 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 120.777 0.322 . . . . 0.0 111.598 -172.666 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 65.5 tttm -70.48 -27.69 64.41 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.884 0.374 . . . . 0.0 110.831 178.62 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.434 ' HB2' ' HE2' ' A' ' 66' ' ' PHE . 68.4 m-85 -122.58 13.7 10.13 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.46 -0.336 . . . . 0.0 111.845 -176.343 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -60.07 132.09 52.85 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.217 172.392 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 69.36 46.37 56.87 Favored Glycine 0 N--CA 1.447 -0.599 0 C-N-CA 120.854 -0.689 . . . . 0.0 112.169 -179.702 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.414 ' HB2' HG22 ' A' ' 64' ' ' ILE . 40.3 mmtm -126.6 -164.42 1.33 Allowed 'General case' 0 N--CA 1.45 -0.451 0 CA-C-O 121.216 0.531 . . . . 0.0 110.313 174.859 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 1.05 ' HA ' ' HD3' ' A' ' 31' ' ' LYS . 0.1 OUTLIER -97.85 44.32 1.04 Allowed 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.639 -0.71 . . . . 0.0 110.805 -179.41 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.414 HG22 ' HB2' ' A' ' 62' ' ' LYS . 18.2 tt -144.45 149.27 17.49 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.761 0 CA-C-N 114.929 -1.032 . . . . 0.0 109.761 -177.036 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' HIS . . . . . 0.55 ' NE2' ' HB2' ' A' ' 31' ' ' LYS . 89.4 m-70 -124.25 121.34 34.78 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 109.918 -0.401 . . . . 0.0 109.918 178.287 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . 0.434 ' HE2' ' HB2' ' A' ' 59' ' ' TYR . 91.8 m-85 -88.65 111.31 21.78 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 173.585 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.504 ' O ' ' HA ' ' A' ' 35' ' ' ILE . 27.4 t -118.58 109.37 26.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.459 -175.83 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . 0.426 ' HB3' ' CD1' ' A' ' 38' ' ' TRP . 10.9 m -88.07 143.73 26.91 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-N 115.918 -0.583 . . . . 0.0 109.856 178.844 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.48 ' O ' HG13 ' A' ' 37' ' ' VAL . 62.7 tp -131.88 124.0 28.63 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 174.652 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . 0.565 ' O ' ' HB3' ' A' ' 94' ' ' MET . 1.3 t -108.15 119.61 39.98 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.076 0.465 . . . . 0.0 112.046 -173.957 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 2.4 p -87.06 17.6 4.1 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.749 -0.659 . . . . 0.0 110.806 177.214 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.582 ' OD1' ' HA ' ' A' ' 39' ' ' ALA . 1.9 m-20 -69.64 121.3 16.86 Favored 'General case' 0 CA--C 1.515 -0.4 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.011 179.496 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 45.9 tttm -75.91 -25.86 56.42 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-O 121.146 0.498 . . . . 0.0 110.062 -179.874 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . 0.522 ' HB2' ' HB3' ' A' ' 77' ' ' ALA . 0.2 OUTLIER -78.7 96.87 5.67 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.747 -0.66 . . . . 0.0 109.788 174.027 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.55 ' O ' ' HG2' ' A' ' 79' ' ' GLU . 11.4 tmtt? -71.41 -66.33 0.64 Allowed 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 120.446 -0.502 . . . . 0.0 112.038 -173.863 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 36.0 ttpt -58.3 -43.28 88.04 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 121.009 -0.277 . . . . 0.0 110.819 -173.044 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.603 ' HA ' ' ND2' ' A' ' 80' ' ' ASN . . . -52.22 -38.82 59.09 Favored 'General case' 0 C--O 1.246 0.879 0 CA-C-O 121.86 0.838 . . . . 0.0 111.277 178.716 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' TRP . . . . . 0.675 ' CE3' ' HB ' ' A' ' 40' ' ' THR . 16.2 t-105 -79.02 -42.53 26.31 Favored 'General case' 0 N--CA 1.44 -0.959 0 CA-C-N 115.151 -0.931 . . . . 0.0 111.045 -173.175 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.55 ' HG2' ' O ' ' A' ' 75' ' ' LYS . 3.8 mm-40 -51.97 -40.72 61.33 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-O 121.473 0.654 . . . . 0.0 110.248 175.748 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . 0.603 ' ND2' ' HA ' ' A' ' 77' ' ' ALA . 7.2 m-20 -59.25 -54.07 51.02 Favored 'General case' 0 CA--C 1.513 -0.446 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.257 177.858 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 28.6 ttm -61.37 -45.99 92.05 Favored 'General case' 0 C--O 1.219 -0.507 0 CA-C-N 116.02 -0.536 . . . . 0.0 112.235 -174.209 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.567 ' CG2' ' HZ3' ' A' ' 38' ' ' TRP . 3.9 p -61.57 -32.82 54.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 C-N-CA 120.07 -0.652 . . . . 0.0 111.016 179.519 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 58.9 m -63.75 -40.34 96.48 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.979 0.419 . . . . 0.0 110.239 175.886 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 12.8 mptt -81.13 -29.96 34.66 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.495 -179.396 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . 0.406 ' CG ' HH21 ' A' ' 46' ' ' ARG . 1.5 m-20 -77.6 -6.8 55.02 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.142 0.496 . . . . 0.0 110.975 178.529 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 84.7 mt-30 66.18 18.26 10.92 Favored 'General case' 0 N--CA 1.468 0.43 0 N-CA-C 113.271 0.841 . . . . 0.0 113.271 170.357 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.554 ' HB2' HG23 ' A' ' 82' ' ' VAL . 71.0 mt -64.14 143.18 58.07 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.558 0.218 . . . . 0.0 110.89 -179.926 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 24.6 mmtm -123.15 -166.91 1.52 Allowed 'General case' 0 N--CA 1.451 -0.382 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.934 176.367 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 92.2 -157.01 23.83 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 121.002 -0.618 . . . . 0.0 111.685 -178.986 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 50.1 mm -107.26 117.48 53.12 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 N-CA-C 108.933 -0.766 . . . . 0.0 108.933 175.631 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . 0.655 ' HB2' ' CZ2' ' A' ' 38' ' ' TRP . 0.6 OUTLIER -135.2 102.59 5.23 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-O 121.916 0.865 . . . . 0.0 111.724 -169.4 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.544 ' HA ' ' HA ' ' A' ' 17' ' ' ASP . 38.6 mt -91.73 142.2 27.86 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 114.806 -1.088 . . . . 0.0 110.588 -175.982 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 23.2 t-80 -111.82 116.07 30.07 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-O 121.37 0.605 . . . . 0.0 110.443 179.544 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' MET . . . . . 0.733 ' SD ' ' HA ' ' A' ' 98' ' ' ARG . 10.7 ttm -69.47 -52.28 28.1 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.048 -0.978 . . . . 0.0 111.073 -178.899 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . 0.419 ' HA2' ' O ' ' A' ' 72' ' ' ASP . . . 77.86 -86.7 1.07 Allowed Glycine 0 N--CA 1.448 -0.557 0 C-N-CA 120.628 -0.796 . . . . 0.0 113.243 175.781 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 5.1 m -120.7 -5.45 9.7 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 120.843 0.354 . . . . 0.0 111.112 -176.173 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . 0.536 ' O ' ' HG3' ' A' ' 94' ' ' MET . 13.0 t70 -98.46 72.65 2.07 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 120.056 -0.657 . . . . 0.0 109.719 -177.907 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . 0.733 ' HA ' ' SD ' ' A' ' 94' ' ' MET . 0.0 OUTLIER -82.62 31.31 0.41 Allowed 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.384 -175.462 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 3.0 m -65.67 -43.45 89.31 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.489 179.837 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -71.73 -36.58 70.53 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.247 177.3 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' MET . . . . . 0.537 ' HG3' ' O ' ' A' ' 106' ' ' ILE . 15.1 ttt -56.08 -45.11 79.47 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.568 -0.742 . . . . 0.0 109.982 173.95 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . 0.476 ' HB2' ' CZ ' ' A' ' 98' ' ' ARG . 21.9 t70 -69.07 -49.56 56.29 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.242 -0.89 . . . . 0.0 110.919 179.462 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . 0.612 ' HB2' ' HB3' ' A' ' 7' ' ' ASN . . . -69.01 -21.71 64.12 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.957 -0.565 . . . . 0.0 112.344 -171.512 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 25.8 m-85 -109.08 2.63 21.28 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 111.752 0.279 . . . . 0.0 111.752 -178.441 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 9.0 mp 59.39 27.27 16.34 Favored 'General case' 0 N--CA 1.466 0.334 0 O-C-N 123.47 0.481 . . . . 0.0 111.09 -177.968 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . 0.537 ' O ' ' HG3' ' A' ' 101' ' ' MET . 53.6 mt -66.7 77.85 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.271 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.71 174.084 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 61.2 t30 -109.19 -46.47 3.57 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 175.427 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -77.77 91.95 1.1 Allowed Glycine 0 N--CA 1.446 -0.639 0 CA-C-N 115.455 -0.793 . . . . 0.0 111.222 174.575 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.47 HD13 ' HB2' ' A' ' 42' ' ' CYS . 2.4 pp -103.34 151.57 38.6 Favored Pre-proline 0 C--N 1.322 -0.609 0 CA-C-N 115.963 -0.118 . . . . 0.0 111.094 -178.829 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . 0.567 ' HD3' ' HB3' ' A' ' 45' ' ' CYS . 30.0 Cg_endo -68.51 153.49 89.39 Favored 'Cis proline' 0 C--N 1.349 0.573 0 C-N-CA 123.725 -1.365 . . . . 0.0 113.623 1.115 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . 0.524 ' H ' ' HB ' ' A' ' 37' ' ' VAL . 0.0 OUTLIER -113.57 144.41 42.93 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.727 -0.669 . . . . 0.0 109.519 -177.526 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . 0.651 ' HD2' ' HD3' ' A' ' 129' ' ' PRO . 0.9 OUTLIER -112.66 114.52 27.17 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.835 -177.873 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.533 ' HB ' ' HB ' ' A' ' 35' ' ' ILE . 85.6 mt -128.57 141.97 45.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.854 0.359 . . . . 0.0 110.801 -178.796 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.411 HD22 ' HE3' ' A' ' 126' ' ' MET . 41.2 tp -126.48 136.45 52.64 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.172 179.097 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.516 ' N ' HD12 ' A' ' 115' ' ' LEU . 0.7 OUTLIER -136.27 156.7 48.29 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.397 0.618 . . . . 0.0 110.553 -178.175 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . 0.645 ' HB3' ' HB2' ' A' ' 120' ' ' LYS . 9.6 t70 -77.96 168.2 20.28 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 114.88 -1.055 . . . . 0.0 111.351 177.722 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . 0.496 ' HA ' ' O ' ' A' ' 31' ' ' LYS . 88.1 mtt-85 -45.88 -40.55 10.15 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 124.569 1.148 . . . . 0.0 113.115 179.911 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . 0.788 ' HB2' ' HG3' ' A' ' 120' ' ' LYS . 40.2 m-20 -78.34 5.19 11.03 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.576 0.227 . . . . 0.0 111.502 -178.461 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . 0.454 ' HA3' HD11 ' A' ' 25' ' ' LEU . . . 80.63 26.6 53.71 Favored Glycine 0 N--CA 1.44 -1.09 0 N-CA-C 110.521 -1.032 . . . . 0.0 110.521 -173.268 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . 0.788 ' HG3' ' HB2' ' A' ' 118' ' ' ASP . 33.9 mtmm -94.17 103.98 16.01 Favored 'General case' 0 C--O 1.223 -0.332 0 C-N-CA 120.574 -0.45 . . . . 0.0 110.468 -173.511 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 0.558 ' H ' HD12 ' A' ' 121' ' ' ILE . 2.7 mp -45.0 112.72 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 115.566 -0.743 . . . . 0.0 111.651 -178.47 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' ILE . . . . . 0.446 HD11 ' HB2' ' A' ' 116' ' ' ASP . 46.3 mm -89.5 -40.1 12.83 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-N 115.216 -0.902 . . . . 0.0 109.126 176.504 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 14.8 m -142.66 117.49 9.9 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.338 -0.847 . . . . 0.0 110.497 178.237 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . 0.512 ' O ' HG12 ' A' ' 113' ' ' ILE . . . -68.29 -27.16 66.07 Favored 'General case' 0 C--N 1.334 -0.103 0 CA-C-O 121.409 0.623 . . . . 0.0 109.75 175.453 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 3.9 p-10 -136.82 109.25 7.37 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.044 -0.98 . . . . 0.0 108.646 171.103 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' MET . . . . . 0.422 ' N ' ' HD1' ' A' ' 112' ' ' PHE . 27.9 ttt -83.17 -87.83 0.1 Allowed 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.518 -174.728 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -137.03 -75.76 0.42 Allowed 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.574 -0.285 . . . . 0.0 111.579 -178.266 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . 0.936 ' HB3' ' HB2' ' A' ' 131' ' ' ASP . 3.6 tmm_? 177.88 139.06 0.24 Allowed Pre-proline 0 N--CA 1.453 -0.297 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 -178.128 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . 0.651 ' HD3' ' HD2' ' A' ' 112' ' ' PHE . 85.1 Cg_exo -48.65 -44.8 29.81 Favored 'Trans proline' 0 C--N 1.349 0.554 0 C-N-CA 122.869 2.379 . . . . 0.0 113.617 -176.649 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . 0.637 ' HB3' ' NH1' ' A' ' 128' ' ' ARG . 43.8 t -107.1 26.83 9.66 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.063 0.459 . . . . 0.0 110.863 -178.719 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . 0.936 ' HB2' ' HB3' ' A' ' 128' ' ' ARG . 13.6 t70 -92.09 134.06 29.25 Favored Pre-proline 0 C--N 1.325 -0.496 0 N-CA-C 109.781 -0.451 . . . . 0.0 109.781 177.686 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . 0.621 ' O ' ' HG3' ' A' ' 136' ' ' GLU . 18.8 Cg_endo -58.22 -40.87 72.51 Favored 'Trans proline' 0 C--N 1.343 0.269 0 C-N-CA 122.748 2.299 . . . . 0.0 113.142 -178.867 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 36.0 mtmm -61.17 -27.44 68.41 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 121.048 0.451 . . . . 0.0 110.69 -175.05 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' THR . . . . . 0.713 HG22 ' CZ ' ' A' ' 138' ' ' PHE . 1.3 m -60.94 -57.18 13.74 Favored 'General case' 0 N--CA 1.447 -0.595 0 CA-C-N 115.73 -0.668 . . . . 0.0 109.464 173.772 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . 0.643 ' HA ' ' CD2' ' A' ' 138' ' ' PHE . . . -60.09 -42.73 95.26 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.011 -0.995 . . . . 0.0 111.696 178.599 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . 0.621 ' HG3' ' O ' ' A' ' 132' ' ' PRO . 38.6 mt-10 -54.18 -52.45 61.15 Favored 'General case' 0 CA--C 1.512 -0.516 0 CA-C-O 121.382 0.61 . . . . 0.0 110.534 179.177 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . 0.51 ' O ' ' HB3' ' A' ' 140' ' ' GLU . 5.8 tmtm? -55.24 -43.61 74.73 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-N 114.792 -1.094 . . . . 0.0 111.148 -178.747 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . 0.713 ' CZ ' HG22 ' A' ' 134' ' ' THR . 14.8 m-85 -53.68 -60.54 3.18 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.07 -0.513 . . . . 0.0 111.44 177.674 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . 0.606 ' HB2' ' HB3' ' A' ' 144' ' ' LEU . 0.3 OUTLIER -72.28 -17.37 61.88 Favored 'General case' 0 C--O 1.224 -0.287 0 C-N-CA 120.423 -0.511 . . . . 0.0 111.2 -175.491 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . 0.51 ' HB3' ' O ' ' A' ' 137' ' ' LYS . 3.8 tt0 -59.21 -57.44 13.0 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.736 171.351 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.449 ' HG ' ' O ' ' A' ' 138' ' ' PHE . 4.5 pp -71.53 -19.58 62.15 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.965 -177.31 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 95.7 mt -81.05 -18.5 46.48 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.424 174.064 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 73.91 40.03 45.2 Favored Glycine 0 N--CA 1.45 -0.389 0 N-CA-C 110.848 -0.901 . . . . 0.0 110.848 -178.63 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.606 ' HB3' ' HB2' ' A' ' 139' ' ' ASN . 46.9 tp -117.38 20.39 13.63 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 114.882 -0.659 . . . . 0.0 110.398 -173.361 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -88.9 -32.37 17.76 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.332 0.587 . . . . 0.0 110.174 179.712 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -64.23 100.4 0.4 Allowed Glycine 0 C--N 1.317 -0.503 0 CA-C-N 114.659 -1.155 . . . . 0.0 112.46 179.613 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 28.0 m170 -110.85 145.23 38.6 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 110.489 -0.189 . . . . 0.0 110.489 -178.23 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER 65.36 129.94 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.701 0 O-C-N 124.455 1.097 . . . . 0.0 110.779 -173.841 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 9.6 p80 -68.43 153.94 42.79 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.873 -175.026 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 43.7 p-80 -148.02 121.14 8.87 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.095 -179.849 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 7.8 t-160 -103.62 79.26 1.66 Allowed 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 120.988 0.423 . . . . 0.0 110.028 179.763 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 55.6 t-80 . . . . . 0 C--O 1.243 0.728 0 CA-C-N 115.224 -0.898 . . . . 0.0 109.053 -178.726 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 93.6 mtp . . . . . 0 N--CA 1.482 1.14 0 CA-C-O 120.296 0.093 . . . . 0.0 110.76 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 50.8 m 61.93 -164.28 0.25 Allowed 'General case' 0 N--CA 1.463 0.176 0 O-C-N 123.587 0.554 . . . . 0.0 109.9 -174.916 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.46 ' HB3' ' HA ' ' A' ' 8' ' ' PRO . 92.6 mt 56.43 93.85 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.516 0 CA-C-O 121.357 0.599 . . . . 0.0 112.374 173.133 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 4.4 ptp180 -151.48 -171.46 3.94 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.959 -177.083 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 29.5 m 60.15 31.78 20.67 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-O 121.606 0.717 . . . . 0.0 110.113 -175.7 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 173.73 -97.35 0.11 Allowed Glycine 0 N--CA 1.444 -0.821 0 CA-C-N 115.131 -0.941 . . . . 0.0 111.316 -178.734 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . 0.499 ' HA ' ' HD3' ' A' ' 8' ' ' PRO . 15.0 t-20 -155.2 142.76 13.98 Favored Pre-proline 0 C--N 1.325 -0.481 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 178.904 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.499 ' HD3' ' HA ' ' A' ' 7' ' ' ASN . 12.2 Cg_exo -70.95 -25.23 23.34 Favored 'Trans proline' 0 N--CA 1.466 -0.135 0 C-N-CA 123.194 2.596 . . . . 0.0 112.688 -178.675 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 28.8 m -90.12 15.32 10.44 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.315 0.578 . . . . 0.0 110.863 -178.269 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -89.14 28.72 1.16 Allowed 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.153 178.879 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -159.79 117.31 2.64 Favored 'General case' 0 N--CA 1.447 -0.585 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.66 -175.526 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.661 ' H ' HD23 ' A' ' 25' ' ' LEU . 47.3 m 67.04 36.01 4.37 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.235 -0.893 . . . . 0.0 112.141 171.954 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 37.5 p90 -66.06 163.87 16.53 Favored 'General case' 0 N--CA 1.463 0.208 0 N-CA-C 110.093 -0.336 . . . . 0.0 110.093 174.672 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.43 ' HA ' ' HA ' ' A' ' 24' ' ' SER . 16.2 t -142.36 128.0 19.16 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 120.865 0.364 . . . . 0.0 110.802 179.843 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . 0.455 ' O ' HD22 ' A' ' 92' ' ' LEU . 75.7 m-85 -141.83 159.65 58.82 Favored Pre-proline 0 C--N 1.327 -0.402 0 CA-C-N 115.874 -0.603 . . . . 0.0 109.81 178.942 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.702 ' HA ' ' O ' ' A' ' 21' ' ' LYS . 85.9 Cg_endo -88.44 134.16 2.85 Favored 'Trans proline' 0 N--CA 1.459 -0.549 0 C-N-CA 122.557 2.172 . . . . 0.0 113.996 -178.896 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . 0.478 ' HA ' ' O ' ' A' ' 91' ' ' GLN . 8.3 m-20 -69.1 168.62 13.55 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.054 171.203 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.567 HD12 HG13 ' A' ' 82' ' ' VAL . 1.9 tt -41.69 -40.36 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 O-C-N 124.563 1.164 . . . . 0.0 112.238 175.539 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 40.4 m-80 -68.54 -3.99 13.59 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.484 -177.086 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 79.14 33.63 35.57 Favored Glycine 0 N--CA 1.442 -0.931 0 N-CA-C 110.561 -1.016 . . . . 0.0 110.561 -174.389 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.702 ' O ' ' HA ' ' A' ' 16' ' ' PRO . 15.9 tppt? -110.43 126.73 54.62 Favored 'General case' 0 C--O 1.22 -0.48 0 CA-C-N 115.607 -0.297 . . . . 0.0 110.853 -173.952 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 18.8 m -84.44 106.86 16.35 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.974 -174.392 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.421 ' HB ' HD21 ' A' ' 92' ' ' LEU . 71.7 t -112.81 144.65 20.07 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 115.646 -0.706 . . . . 0.0 109.748 179.837 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . 0.43 ' HA ' ' HA ' ' A' ' 14' ' ' SER . 95.7 p -113.98 162.01 16.96 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.912 -178.928 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.661 HD23 ' H ' ' A' ' 12' ' ' SER . 53.9 tp -66.98 -16.89 64.64 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.761 178.33 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -74.56 -18.95 60.51 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.825 0.345 . . . . 0.0 110.815 179.408 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -76.86 -39.1 52.33 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.629 0.728 . . . . 0.0 109.749 175.37 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.584 HD13 HG21 ' A' ' 67' ' ' VAL . 24.0 mt -84.69 -7.83 59.08 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 114.853 -1.067 . . . . 0.0 110.152 -179.402 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 32.9 tttp -73.78 130.2 39.48 Favored 'General case' 0 N--CA 1.439 -1.019 0 CA-C-N 114.847 -1.07 . . . . 0.0 110.496 -178.131 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 128.2 -31.14 3.72 Favored Glycine 0 N--CA 1.445 -0.747 0 N-CA-C 110.305 -1.118 . . . . 0.0 110.305 -173.985 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.857 ' HD3' ' HA ' ' A' ' 63' ' ' ASP . 61.4 mttm -122.56 174.31 7.15 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.526 -0.337 . . . . 0.0 110.154 175.518 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.962 ' HB2' HG22 ' A' ' 64' ' ' ILE . 92.4 m-85 -69.16 150.97 46.93 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 110.189 -0.3 . . . . 0.0 110.189 179.767 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.555 HD13 ' HA2' ' A' ' 119' ' ' GLY . 5.3 mp -124.59 134.47 66.69 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-O 120.79 0.328 . . . . 0.0 110.619 178.945 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 60.9 t80 -118.58 114.46 22.83 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 171.677 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.493 ' HA ' ' O ' ' A' ' 67' ' ' VAL . 67.4 mt -103.13 114.32 42.4 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 CA-C-O 121.134 0.493 . . . . 0.0 110.755 -177.791 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.486 ' O ' ' HA ' ' A' ' 68' ' ' SER . 5.5 p-10 -110.98 158.43 18.79 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 115.549 -0.75 . . . . 0.0 109.365 174.394 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.428 HG11 ' CG2' ' A' ' 109' ' ' ILE . 59.7 t -102.33 130.08 52.77 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.822 0 C-N-CA 120.779 -0.368 . . . . 0.0 110.421 178.359 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' TRP . . . . . 0.625 ' CZ2' ' HB2' ' A' ' 91' ' ' GLN . 0.6 OUTLIER -122.31 134.34 54.66 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 -179.223 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.55 ' HB3' ' HB3' ' A' ' 42' ' ' CYS . . . -145.03 162.23 37.47 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.548 -179.689 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.764 ' HB ' ' CE3' ' A' ' 78' ' ' TRP . 8.8 t -88.05 -22.19 24.34 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.226 0.536 . . . . 0.0 110.02 175.338 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 19.0 p-90 -96.71 18.0 15.3 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.674 -0.694 . . . . 0.0 109.848 176.045 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . 0.668 ' SG ' ' HB3' ' A' ' 45' ' ' CYS . 23.9 p -76.15 -19.38 58.53 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.542 -0.754 . . . . 0.0 111.089 -177.572 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 47.65 -98.31 0.01 OUTLIER Glycine 0 C--N 1.338 0.645 0 O-C-N 124.12 0.887 . . . . 0.0 114.261 176.602 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 81.6 Cg_exo -51.19 -26.11 19.02 Favored 'Trans proline' 0 C--N 1.354 0.821 0 C-N-CA 123.623 2.882 . . . . 0.0 113.502 178.217 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . 0.668 ' HB3' ' SG ' ' A' ' 42' ' ' CYS . 42.1 t -67.33 -41.14 85.75 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.286 0.565 . . . . 0.0 110.003 174.599 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.631 ' HA ' ' HG ' ' A' ' 49' ' ' LEU . 28.6 ttt-85 -67.49 -23.19 65.45 Favored 'General case' 0 N--CA 1.44 -0.953 0 CA-C-N 115.177 -0.92 . . . . 0.0 111.901 -173.487 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -63.2 -25.93 68.78 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.727 -0.749 . . . . 0.0 111.953 179.831 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.482 ' CD ' ' HE ' ' A' ' 128' ' ' ARG . 47.9 mt-10 -109.78 24.56 12.88 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 111.708 0.262 . . . . 0.0 111.708 -179.934 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.631 ' HG ' ' HA ' ' A' ' 46' ' ' ARG . 34.6 mt -59.29 -42.7 94.34 Favored Pre-proline 0 C--N 1.328 -0.369 0 C-N-CA 120.692 -0.403 . . . . 0.0 110.543 170.625 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.447 ' HD3' ' HB2' ' A' ' 49' ' ' LEU . 76.2 Cg_exo -51.94 -38.91 69.7 Favored 'Trans proline' 0 C--N 1.36 1.139 0 C-N-CA 122.02 1.813 . . . . 0.0 112.108 169.386 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -74.72 -26.76 60.03 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.146 0.498 . . . . 0.0 110.675 179.948 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 6.5 tt -67.01 -44.01 81.42 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 173.487 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 3.1 mmmp? -60.98 -42.63 98.74 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.558 176.353 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -47.76 -58.58 4.14 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.786 173.662 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.572 ' HG ' ' CZ ' ' A' ' 66' ' ' PHE . 18.0 tp -62.79 -44.24 96.68 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.538 -0.755 . . . . 0.0 110.479 179.169 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 23.7 tt0 -49.46 -60.41 2.87 Favored 'General case' 0 C--N 1.331 -0.212 0 C-N-CA 123.853 0.861 . . . . 0.0 111.876 -179.597 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 32.1 mt-10 -73.03 -35.51 66.77 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.767 -172.797 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 43.6 mtpt -68.14 -38.31 82.01 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.005 0.431 . . . . 0.0 111.609 179.714 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.641 ' HB3' HD11 ' A' ' 64' ' ' ILE . 51.7 m-85 -107.13 10.41 30.12 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.897 -175.769 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -70.45 150.3 46.35 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 109.773 -0.455 . . . . 0.0 109.773 170.478 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 68.72 38.78 86.12 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.574 178.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.691 ' HB2' HG12 ' A' ' 64' ' ' ILE . 47.6 mmtm -119.67 -163.53 1.0 Allowed 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.233 0.539 . . . . 0.0 109.933 176.154 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.857 ' HA ' ' HD3' ' A' ' 31' ' ' LYS . 0.6 OUTLIER -92.49 36.62 1.0 Allowed 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 115.265 -0.879 . . . . 0.0 110.127 178.165 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.962 HG22 ' HB2' ' A' ' 32' ' ' TYR . 30.4 pt -141.8 167.38 16.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.543 -174.507 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' HIS . . . . . 0.673 ' NE2' ' HB2' ' A' ' 31' ' ' LYS . 63.2 m-70 -136.45 119.03 15.93 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.172 -0.467 . . . . 0.0 109.919 177.02 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . 0.572 ' CZ ' ' HG ' ' A' ' 55' ' ' LEU . 11.8 m-85 -79.5 118.71 21.61 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 170.016 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.584 HG21 HD13 ' A' ' 28' ' ' LEU . 25.4 t -127.59 103.94 11.37 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-O 121.138 0.494 . . . . 0.0 110.707 -175.279 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . 0.486 ' HA ' ' O ' ' A' ' 36' ' ' ASP . 16.1 m -88.56 129.21 35.53 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-N 115.536 -0.757 . . . . 0.0 110.039 178.613 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.489 ' CD2' ' HB2' ' A' ' 92' ' ' LEU . 54.4 mt -114.33 132.21 56.27 Favored 'General case' 0 N--CA 1.465 0.303 0 O-C-N 122.147 -0.346 . . . . 0.0 110.287 174.988 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 1.4 t -112.34 120.33 41.35 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.17 0.51 . . . . 0.0 112.327 -174.586 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 4.7 p -88.76 18.49 4.69 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.842 177.014 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.531 ' OD2' HG22 ' A' ' 40' ' ' THR . 2.1 m-20 -72.34 136.55 46.2 Favored 'General case' 0 CA--C 1.519 -0.25 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.231 -179.497 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 51.4 tptt -79.16 -37.97 37.11 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 121.228 0.537 . . . . 0.0 110.045 177.936 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . 0.547 ' HB2' ' HB3' ' A' ' 77' ' ' ALA . 0.6 OUTLIER -79.42 82.96 5.49 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.759 -179.846 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.498 ' HB2' ' CE1' ' A' ' 93' ' ' HIS . 10.0 tttt -64.38 -51.9 60.96 Favored 'General case' 0 C--N 1.323 -0.545 0 C-N-CA 120.968 -0.293 . . . . 0.0 111.396 -177.129 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.489 ' HD3' ' C ' ' A' ' 76' ' ' LYS . 3.1 tmtm? -58.98 -51.27 70.79 Favored 'General case' 0 N--CA 1.444 -0.757 0 CA-C-N 116.103 -0.499 . . . . 0.0 109.715 -174.922 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.694 ' HA ' ' ND2' ' A' ' 80' ' ' ASN . . . -56.36 -38.48 71.46 Favored 'General case' 0 C--O 1.243 0.72 0 CA-C-O 121.959 0.885 . . . . 0.0 110.926 178.455 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' TRP . . . . . 0.764 ' CE3' ' HB ' ' A' ' 40' ' ' THR . 11.7 t-105 -75.83 -43.86 43.84 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 114.963 -1.017 . . . . 0.0 111.757 -174.169 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.55 ' HB2' HG13 ' A' ' 18' ' ' ILE . 4.0 pt-20 -60.49 -27.92 67.96 Favored 'General case' 0 CA--C 1.542 0.647 0 CA-C-O 121.047 0.451 . . . . 0.0 109.914 179.422 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . 0.694 ' ND2' ' HA ' ' A' ' 77' ' ' ALA . 8.9 m-20 -63.12 -52.98 60.42 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-O 120.795 0.331 . . . . 0.0 110.145 171.862 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . 0.411 ' HG2' ' HZ3' ' A' ' 78' ' ' TRP . 54.8 tpp -56.45 -47.84 78.28 Favored 'General case' 0 CA--C 1.518 -0.288 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.991 -175.83 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.572 HG23 ' HB2' ' A' ' 87' ' ' LEU . 1.6 p -61.16 -34.1 58.98 Favored 'Isoleucine or valine' 0 C--O 1.237 0.401 0 CA-C-O 120.939 0.4 . . . . 0.0 110.847 178.737 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 90.5 m -64.63 -42.53 95.41 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.82 0.343 . . . . 0.0 110.467 174.896 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . 0.761 ' HB3' ' HZ2' ' A' ' 84' ' ' LYS . 0.0 OUTLIER -76.79 -37.95 54.88 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.008 -176.535 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 55.8 m-20 -83.02 -0.1 47.31 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.49 -177.95 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 27.4 mt-30 66.08 11.56 7.87 Favored 'General case' 0 N--CA 1.467 0.391 0 N-CA-C 113.69 0.996 . . . . 0.0 113.69 170.724 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.572 ' HB2' HG23 ' A' ' 82' ' ' VAL . 84.9 mt -64.63 126.32 27.51 Favored 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 110.323 -0.251 . . . . 0.0 110.323 178.582 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 21.6 mmtm -123.33 -161.98 1.01 Allowed 'General case' 0 N--CA 1.45 -0.427 0 CA-C-O 120.768 0.318 . . . . 0.0 111.799 -179.217 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 96.13 -156.58 21.34 Favored Glycine 0 N--CA 1.448 -0.535 0 N-CA-C 111.416 -0.674 . . . . 0.0 111.416 -177.579 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.526 ' O ' ' HA ' ' A' ' 67' ' ' VAL . 45.8 mm -93.29 116.46 34.49 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 174.529 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . 0.625 ' HB2' ' CZ2' ' A' ' 38' ' ' TRP . 1.9 pt20 -141.64 95.17 2.78 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-O 121.813 0.816 . . . . 0.0 111.83 -168.854 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.489 ' HB2' ' CD2' ' A' ' 69' ' ' LEU . 37.9 mt -94.43 157.11 16.16 Favored 'General case' 0 N--CA 1.442 -0.844 0 CA-C-N 114.779 -1.101 . . . . 0.0 110.421 -176.647 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' HIS . . . . . 0.498 ' CE1' ' HB2' ' A' ' 75' ' ' LYS . 21.9 t-80 -123.98 127.17 47.53 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-N 115.498 -0.774 . . . . 0.0 110.248 -177.684 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' MET . . . . . 0.649 ' HG3' ' HB2' ' A' ' 97' ' ' ASP . 30.2 ttm -81.58 -65.93 0.95 Allowed 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 114.96 -1.018 . . . . 0.0 110.764 -177.289 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 106.53 -94.18 0.92 Allowed Glycine 0 N--CA 1.446 -0.688 0 C-N-CA 120.492 -0.861 . . . . 0.0 112.664 179.772 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -117.75 0.42 11.99 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 120.81 0.338 . . . . 0.0 111.399 -176.279 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . 0.649 ' HB2' ' HG3' ' A' ' 94' ' ' MET . 3.9 m-20 -83.89 41.55 0.81 Allowed 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.008 0.433 . . . . 0.0 110.658 -174.294 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.9 -6.74 9.04 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.789 -0.641 . . . . 0.0 112.399 -172.264 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 16.7 m -70.24 -19.27 63.15 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.347 0.594 . . . . 0.0 110.17 176.625 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 52.8 t80 -74.21 -37.94 63.72 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.839 -0.618 . . . . 0.0 109.463 175.069 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' MET . . . . . 0.408 ' HE1' HG21 ' A' ' 106' ' ' ILE . 71.4 mmm -63.37 -42.74 98.88 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 173.353 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -58.7 -47.5 84.33 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 114.422 -1.263 . . . . 0.0 110.701 178.711 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -67.85 -12.76 61.29 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.721 -177.503 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 7.7 m-85 -105.64 6.82 32.36 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.021 179.918 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 3.7 mm? 62.57 25.39 15.11 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.812 -179.097 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . 0.735 HG12 ' HG3' ' A' ' 111' ' ' ARG . 58.9 mt -83.61 86.3 2.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.004 174.267 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 13.9 m120 -84.76 -51.41 6.81 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.045 177.274 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -107.73 130.67 10.23 Favored Glycine 0 N--CA 1.441 -1.019 0 CA-C-N 115.448 -0.796 . . . . 0.0 111.676 -179.933 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.428 ' CG2' HG11 ' A' ' 37' ' ' VAL . 2.9 pp -98.98 154.95 37.09 Favored Pre-proline 0 C--N 1.319 -0.751 0 N-CA-C 110.43 -0.211 . . . . 0.0 110.43 177.988 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . 0.624 ' HG3' ' SG ' ' A' ' 45' ' ' CYS . 71.8 Cg_endo -82.89 149.5 67.82 Favored 'Cis proline' 0 N--CA 1.46 -0.449 0 C-N-CA 123.523 -1.449 . . . . 0.0 113.036 0.199 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . 0.735 ' HG3' HG12 ' A' ' 106' ' ' ILE . 0.0 OUTLIER -103.99 153.17 21.15 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.902 -0.59 . . . . 0.0 109.658 177.657 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 11.9 m-85 -119.72 127.69 53.09 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 108.89 -0.782 . . . . 0.0 108.89 -178.231 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.428 ' HB ' ' HB ' ' A' ' 35' ' ' ILE . 89.6 mt -138.26 144.8 29.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-O 120.685 0.279 . . . . 0.0 110.764 -175.769 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 28.5 tp -128.58 139.78 52.12 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 109.879 -0.415 . . . . 0.0 109.879 178.494 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.691 ' HG ' ' HA ' ' A' ' 121' ' ' ILE . 2.1 mp -133.75 158.83 42.33 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 109.947 -0.39 . . . . 0.0 109.947 -177.796 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . 0.54 ' OD2' ' HB2' ' A' ' 120' ' ' LYS . 3.9 p30 -86.12 175.31 8.6 Favored 'General case' 0 CA--C 1.516 -0.349 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.023 177.73 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . 0.603 ' HA ' ' O ' ' A' ' 31' ' ' LYS . 21.9 mtp85 -58.17 -26.98 63.42 Favored 'General case' 0 N--CA 1.465 0.298 0 O-C-N 124.36 1.038 . . . . 0.0 112.384 -173.124 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -76.29 -6.91 53.56 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.529 0.68 . . . . 0.0 109.356 -179.239 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . 0.555 ' HA2' HD13 ' A' ' 33' ' ' ILE . . . 89.47 23.48 33.85 Favored Glycine 0 N--CA 1.434 -1.463 0 N-CA-C 110.319 -1.113 . . . . 0.0 110.319 -174.857 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . 0.54 ' HB2' ' OD2' ' A' ' 116' ' ' ASP . 10.1 mmmm -102.96 118.38 36.7 Favored 'General case' 0 C--O 1.223 -0.295 0 C-N-CA 119.792 -0.763 . . . . 0.0 112.045 -172.96 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 0.691 ' HA ' ' HG ' ' A' ' 115' ' ' LEU . 3.6 mp -46.79 114.69 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.55 -0.75 . . . . 0.0 111.681 178.618 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' ILE . . . . . 0.406 HD11 ' HB3' ' A' ' 116' ' ' ASP . 40.0 mm -92.68 -44.4 13.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 115.229 -0.896 . . . . 0.0 109.659 176.519 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 20.8 m -127.63 114.79 17.83 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.386 -0.824 . . . . 0.0 110.024 177.774 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -72.31 -17.72 61.84 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.074 0.464 . . . . 0.0 110.774 178.971 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 7.2 t30 -142.3 98.84 3.39 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.62 -0.718 . . . . 0.0 109.828 175.969 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' MET . . . . . 0.47 ' HG3' ' H ' ' A' ' 127' ' ' THR . 7.7 tpt -92.73 -150.49 0.27 Allowed 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 178.135 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . 0.626 ' OG1' ' HB ' ' A' ' 134' ' ' THR . 1.3 p -133.37 131.47 40.09 Favored 'General case' 0 N--CA 1.446 -0.642 0 CA-C-O 121.593 0.711 . . . . 0.0 112.356 -175.053 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . 0.482 ' HE ' ' CD ' ' A' ' 48' ' ' GLU . 34.4 ttt85 -31.89 139.2 0.2 Allowed Pre-proline 0 N--CA 1.471 0.588 0 CA-C-N 113.753 -1.567 . . . . 0.0 113.316 170.169 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_exo -40.54 -39.96 3.09 Favored 'Trans proline' 0 C--N 1.352 0.727 0 C-N-CA 124.682 3.588 . . . . 0.0 115.338 179.028 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -72.36 -7.0 47.27 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 112.22 0.452 . . . . 0.0 112.22 -175.589 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . 0.554 ' O ' HG22 ' A' ' 134' ' ' THR . 4.5 t70 -85.18 130.09 53.28 Favored Pre-proline 0 C--N 1.324 -0.542 0 CA-C-O 120.829 0.347 . . . . 0.0 110.887 178.468 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -68.6 -22.77 37.56 Favored 'Trans proline' 0 C--N 1.343 0.239 0 C-N-CA 122.648 2.232 . . . . 0.0 113.111 -179.907 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . 0.622 ' HA ' ' HG2' ' A' ' 136' ' ' GLU . 0.8 OUTLIER -73.76 -35.38 64.99 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.114 0.483 . . . . 0.0 110.7 -175.87 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' THR . . . . . 0.626 ' HB ' ' OG1' ' A' ' 127' ' ' THR . 4.2 t -71.2 -40.25 71.3 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 176.048 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . 0.514 ' HA ' ' CD2' ' A' ' 138' ' ' PHE . . . -62.48 -49.12 76.63 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 115.78 -0.645 . . . . 0.0 111.462 179.162 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . 0.622 ' HG2' ' HA ' ' A' ' 133' ' ' LYS . 5.2 pt-20 -58.91 -38.22 78.43 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 121.215 0.531 . . . . 0.0 109.818 179.56 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . 0.558 ' O ' ' HG ' ' A' ' 141' ' ' LEU . 0.0 OUTLIER -65.4 -41.52 93.55 Favored 'General case' 0 N--CA 1.448 -0.547 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.014 -177.913 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . 0.514 ' CD2' ' HA ' ' A' ' 135' ' ' ALA . 15.3 m-85 -54.5 -52.48 61.81 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-O 121.012 0.434 . . . . 0.0 109.996 176.524 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . 0.569 ' HB3' ' HG3' ' A' ' 145' ' ' GLU . 66.2 m-20 -59.37 -50.42 74.02 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.01 179.32 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -52.04 -56.25 15.55 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.242 -0.89 . . . . 0.0 112.768 179.547 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.558 ' HG ' ' O ' ' A' ' 137' ' ' LYS . 4.1 pp -68.87 -21.8 64.24 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 120.816 0.341 . . . . 0.0 111.336 -175.962 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.407 ' N ' HD12 ' A' ' 141' ' ' LEU . 0.2 OUTLIER -78.22 -18.82 54.92 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 175.22 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 87.17 17.72 58.7 Favored Glycine 0 N--CA 1.446 -0.644 0 N-CA-C 111.005 -0.838 . . . . 0.0 111.005 -178.066 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 9.8 tt -80.97 -39.17 26.41 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-N 115.201 -0.499 . . . . 0.0 109.664 -179.355 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . 0.569 ' HG3' ' HB3' ' A' ' 139' ' ' ASN . 30.7 mt-10 -101.67 -172.03 2.08 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.248 179.544 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 127.66 63.76 0.13 Allowed Glycine 0 N--CA 1.444 -0.769 0 N-CA-C 111.119 -0.792 . . . . 0.0 111.119 -177.403 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 46.2 t-80 -76.46 64.88 2.23 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-O 121.29 0.567 . . . . 0.0 111.32 -174.682 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 41.6 t60 -135.57 7.31 3.28 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 108.558 -0.904 . . . . 0.0 108.558 172.875 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . 0.403 ' HD1' ' C ' ' A' ' 152' ' ' HIS . 16.5 m170 -104.55 -179.87 4.07 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 114.928 -1.033 . . . . 0.0 109.146 179.038 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 50.9 m-70 -110.22 2.6 19.39 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.803 0.335 . . . . 0.0 111.414 -179.407 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 58.2 m-70 -152.67 -63.67 0.16 Allowed 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 173.954 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 152' ' ' HIS . . . . . 0.403 ' C ' ' HD1' ' A' ' 149' ' ' HIS . 53.0 t-80 . . . . . 0 C--O 1.25 1.091 0 CA-C-O 117.454 -1.26 . . . . 0.0 107.689 173.272 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.448 ' HG3' ' HB3' ' A' ' 10' ' ' ALA . 93.1 mtp . . . . . 0 N--CA 1.481 1.112 0 N-CA-C 110.007 -0.368 . . . . 0.0 110.007 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 9.9 m -83.9 120.55 26.22 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.808 -0.441 . . . . 0.0 109.808 177.041 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -76.44 73.93 3.19 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.117 0.484 . . . . 0.0 110.762 -178.822 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 35.1 tpt85 -109.21 -22.66 11.99 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.256 177.287 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 13.2 p -79.48 -25.17 41.92 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.997 -178.459 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 88.38 -6.14 83.91 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.797 -0.716 . . . . 0.0 111.652 -178.008 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . 0.479 HD22 ' N ' ' A' ' 7' ' ' ASN . 0.8 OUTLIER -97.03 156.1 36.74 Favored Pre-proline 0 C--N 1.325 -0.48 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 178.865 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.564 ' HG2' HG21 ' A' ' 99' ' ' THR . 2.3 Cg_endo -48.31 -56.01 3.53 Favored 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 123.39 2.727 . . . . 0.0 112.892 -177.34 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 13.7 m 61.28 -171.25 0.15 Allowed 'General case' 0 C--O 1.233 0.184 0 CA-C-O 121.475 0.655 . . . . 0.0 111.158 176.96 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.448 ' HB3' ' HG3' ' A' ' 1' ' ' MET . . . -79.28 68.64 5.33 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.937 -0.574 . . . . 0.0 109.672 174.18 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -154.47 -34.7 0.1 Allowed 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.49 -0.777 . . . . 0.0 111.193 -178.836 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 22.8 t -169.54 153.42 5.11 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 178.521 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . 0.427 ' CD2' ' HZ ' ' A' ' 100' ' ' PHE . 52.3 p90 -154.98 152.82 30.14 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-O 120.81 0.338 . . . . 0.0 110.938 179.405 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 19.3 m -143.75 106.56 4.47 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 169.701 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . 0.776 ' HB2' HD12 ' A' ' 92' ' ' LEU . 24.8 m-85 -128.35 154.7 79.13 Favored Pre-proline 0 C--N 1.325 -0.483 0 CA-C-N 116.762 -0.199 . . . . 0.0 110.963 -174.716 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -81.89 125.43 4.79 Favored 'Trans proline' 0 CA--C 1.532 0.386 0 C-N-CA 122.6 2.2 . . . . 0.0 113.87 -178.479 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . 0.671 ' HB3' ' HB3' ' A' ' 21' ' ' LYS . 0.4 OUTLIER -69.53 163.62 25.01 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.009 -0.996 . . . . 0.0 109.918 171.212 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.65 HD12 HG13 ' A' ' 82' ' ' VAL . 0.9 OUTLIER -43.85 -44.99 1.94 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.662 0 O-C-N 123.858 0.724 . . . . 0.0 112.252 -177.883 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.486 ' ND2' HG23 ' A' ' 18' ' ' ILE . 29.2 m-80 -77.24 3.81 12.0 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.495 -174.792 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 83.62 32.57 24.31 Favored Glycine 0 N--CA 1.446 -0.683 0 N-CA-C 110.662 -0.975 . . . . 0.0 110.662 -174.289 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.671 ' HB3' ' HB3' ' A' ' 17' ' ' ASP . 8.0 ttpm? -104.94 105.97 16.25 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.758 0.313 . . . . 0.0 110.796 -174.549 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 19.3 m -67.68 117.33 9.46 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.147 -179.935 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.452 HG11 HD22 ' A' ' 92' ' ' LEU . 7.1 p -117.77 143.49 28.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 115.939 -0.573 . . . . 0.0 109.475 177.396 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 60.4 p -122.48 -173.19 2.63 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.02 0.438 . . . . 0.0 110.579 -175.621 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 64.8 tp -85.91 -19.89 29.83 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.775 177.973 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.901 ' HA ' ' HD3' ' A' ' 29' ' ' LYS . . . -78.46 -35.23 46.97 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.568 -0.287 . . . . 0.0 111.423 -172.593 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -78.24 -11.79 59.95 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.36 0.6 . . . . 0.0 110.543 179.783 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.528 HD13 HG21 ' A' ' 67' ' ' VAL . 92.8 mt -92.78 -9.18 41.46 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.632 177.324 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.901 ' HD3' ' HA ' ' A' ' 26' ' ' ALA . 13.4 mtpp -75.98 153.59 36.44 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.266 0.555 . . . . 0.0 111.537 -179.07 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 101.7 -3.12 52.96 Favored Glycine 0 N--CA 1.45 -0.385 0 CA-C-N 115.357 -0.838 . . . . 0.0 111.747 -178.227 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.617 ' HB3' ' NE2' ' A' ' 65' ' ' HIS . 24.2 ttmm -157.97 145.89 18.62 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 -179.108 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.44 ' HB2' ' O ' ' A' ' 63' ' ' ASP . 34.6 m-85 -53.63 149.37 8.28 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-O 120.906 0.384 . . . . 0.0 111.424 -177.861 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.468 HD12 ' HA2' ' A' ' 119' ' ' GLY . 55.1 mt -125.28 138.69 53.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.554 -175.581 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 59.4 t80 -127.45 123.74 36.75 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 174.677 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.602 ' HB ' ' HB ' ' A' ' 113' ' ' ILE . 66.4 mt -109.59 123.13 65.23 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-O 121.074 0.464 . . . . 0.0 111.189 -177.028 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.432 ' HA ' ' O ' ' A' ' 111' ' ' ARG . 4.7 p-10 -116.37 159.32 22.13 Favored 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 173.216 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.553 HG11 HG21 ' A' ' 109' ' ' ILE . 60.7 t -105.22 115.47 47.13 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.839 0 C-N-CA 120.203 -0.599 . . . . 0.0 111.235 176.241 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' TRP . . . . . 0.644 ' HZ3' HG21 ' A' ' 82' ' ' VAL . 0.6 OUTLIER -98.12 132.79 43.36 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 179.358 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.568 ' HA ' ' OD1' ' A' ' 72' ' ' ASP . . . -147.05 152.99 39.47 Favored 'General case' 0 C--O 1.236 0.368 0 N-CA-C 112.268 0.47 . . . . 0.0 112.268 -173.837 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.557 HG23 ' SD ' ' A' ' 81' ' ' MET . 0.5 OUTLIER -83.68 -48.06 10.56 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.703 0.763 . . . . 0.0 110.182 176.561 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . 0.428 ' HE1' ' HA ' ' A' ' 72' ' ' ASP . 17.4 p-90 -81.73 20.08 0.99 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 114.654 -1.157 . . . . 0.0 112.283 -171.309 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . 0.687 ' HB3' ' SG ' ' A' ' 45' ' ' CYS . 40.5 t -88.39 -64.03 1.21 Allowed 'General case' 0 C--N 1.322 -0.613 0 C-N-CA 120.541 -0.464 . . . . 0.0 110.38 -179.672 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 108.46 -84.1 0.36 Allowed Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.611 -0.804 . . . . 0.0 112.232 -178.736 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_exo -53.91 -22.6 24.69 Favored 'Trans proline' 0 C--N 1.352 0.736 0 C-N-CA 123.244 2.63 . . . . 0.0 112.946 177.57 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . 0.687 ' SG ' ' HB3' ' A' ' 42' ' ' CYS . 26.3 p -52.45 -31.87 36.84 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.26 177.843 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.573 ' HA ' ' HG ' ' A' ' 49' ' ' LEU . 64.9 mtp180 -72.91 -14.39 61.46 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.121 -175.617 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -84.26 -25.56 43.43 Favored Glycine 0 N--CA 1.448 -0.535 0 N-CA-C 111.244 -0.742 . . . . 0.0 111.244 174.484 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -87.12 -20.95 26.34 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.952 -0.388 . . . . 0.0 109.952 -179.186 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.687 ' HB2' ' HD3' ' A' ' 50' ' ' PRO . 79.4 mt -52.74 -50.61 80.09 Favored Pre-proline 0 CA--C 1.534 0.365 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.4 -179.225 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.687 ' HD3' ' HB2' ' A' ' 49' ' ' LEU . 52.8 Cg_exo -57.73 -34.91 98.85 Favored 'Trans proline' 0 C--N 1.355 0.875 0 C-N-CA 121.905 1.737 . . . . 0.0 112.552 173.476 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -75.48 -31.82 60.36 Favored 'General case' 0 N--CA 1.454 -0.236 0 CA-C-O 121.274 0.559 . . . . 0.0 109.889 -176.948 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 6.9 tt -68.0 -40.2 83.09 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.326 -0.852 . . . . 0.0 108.934 177.097 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.862 ' HA ' ' HG2' ' A' ' 56' ' ' GLU . 12.3 mtpp -60.13 -43.99 95.27 Favored 'General case' 0 CA--C 1.517 -0.298 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.857 176.198 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.596 ' O ' ' HB2' ' A' ' 58' ' ' LYS . 23.5 mm-40 -50.2 -47.82 54.53 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.814 173.365 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 6.0 mp -66.27 -51.77 54.14 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 111.873 0.324 . . . . 0.0 111.873 179.074 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.862 ' HG2' ' HA ' ' A' ' 53' ' ' LYS . 10.2 pt-20 -58.11 -46.48 85.49 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 120.571 0.224 . . . . 0.0 111.436 -173.964 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.726 ' HG3' ' HG3' ' A' ' 56' ' ' GLU . 62.4 mt-10 -80.88 -25.53 37.55 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.819 0.342 . . . . 0.0 111.024 -174.173 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.596 ' HB2' ' O ' ' A' ' 54' ' ' GLU . 16.2 ttmm -75.84 -34.53 60.09 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.343 0.592 . . . . 0.0 110.25 178.099 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.469 ' HD1' ' HG3' ' A' ' 62' ' ' LYS . 97.9 m-85 -108.63 8.54 27.09 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.488 -176.45 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -60.9 112.08 1.91 Allowed 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 170.467 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 111.27 -8.42 28.81 Favored Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 120.641 -0.79 . . . . 0.0 111.822 -177.763 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.469 ' HG3' ' HD1' ' A' ' 59' ' ' TYR . 45.8 mmtm -84.65 -157.72 0.3 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.465 0.65 . . . . 0.0 109.892 176.371 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.522 ' CG ' ' HG3' ' A' ' 31' ' ' LYS . 9.1 t70 -108.46 75.1 0.96 Allowed 'General case' 0 C--N 1.314 -0.955 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.026 176.387 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 17.1 tt -157.4 143.54 9.22 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.64 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.01 178.084 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' HIS . . . . . 0.617 ' NE2' ' HB3' ' A' ' 31' ' ' LYS . 93.1 m-70 -111.14 108.94 18.79 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 171.663 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 73.3 m-85 -77.05 107.75 9.63 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 173.211 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.56 HG13 HD21 ' A' ' 92' ' ' LEU . 98.1 t -120.28 104.68 15.83 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-N 115.211 -0.904 . . . . 0.0 110.843 -173.086 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . 0.693 ' HB2' ' HG2' ' A' ' 91' ' ' GLN . 11.0 m -91.25 130.97 37.06 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.815 178.152 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.717 HD11 ' HB2' ' A' ' 94' ' ' MET . 62.3 tp -121.66 131.95 54.38 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 110.05 -0.352 . . . . 0.0 110.05 177.537 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 1.7 t -112.89 120.78 42.6 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.318 0.58 . . . . 0.0 112.297 -173.013 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 9.9 m -82.71 9.61 9.27 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.58 -0.736 . . . . 0.0 111.398 175.251 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.697 ' O ' ' HA2' ' A' ' 95' ' ' GLY . 2.2 m-20 -66.02 132.81 49.43 Favored 'General case' 0 CA--C 1.517 -0.307 0 CA-C-O 120.917 0.389 . . . . 0.0 111.766 -174.78 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 21.0 ttpp -76.12 -30.63 58.29 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 121.367 0.603 . . . . 0.0 110.051 175.16 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -84.62 105.32 15.34 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 108.933 -0.766 . . . . 0.0 108.933 -179.949 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 14.3 tttt -78.01 -57.25 3.9 Favored 'General case' 0 C--N 1.319 -0.735 0 C-N-CA 118.834 -1.146 . . . . 0.0 111.055 177.996 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.675 ' HA ' ' OE2' ' A' ' 79' ' ' GLU . 12.5 ttmm -55.56 -50.41 70.13 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 112.535 0.568 . . . . 0.0 112.535 -175.298 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -60.58 -33.2 72.36 Favored 'General case' 0 CA--C 1.522 -0.104 0 CA-C-O 121.545 0.688 . . . . 0.0 110.297 -178.09 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' TRP . . . . . 0.564 ' CZ2' ' CE3' ' A' ' 38' ' ' TRP . 10.9 t-105 -80.47 -43.88 20.14 Favored 'General case' 0 N--CA 1.442 -0.827 0 CA-C-N 115.236 -0.893 . . . . 0.0 110.937 -178.285 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.675 ' OE2' ' HA ' ' A' ' 76' ' ' LYS . 1.3 pt-20 -64.09 -36.51 84.25 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.405 -178.953 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . 0.541 HD22 ' N ' ' A' ' 81' ' ' MET . 0.2 OUTLIER -78.11 -27.61 48.43 Favored 'General case' 0 C--N 1.332 -0.189 0 C-N-CA 120.111 -0.636 . . . . 0.0 110.636 178.652 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . 0.557 ' SD ' HG23 ' A' ' 40' ' ' THR . 19.5 ttt -68.17 -50.06 56.86 Favored 'General case' 0 C--O 1.218 -0.605 0 C-N-CA 121.031 -0.268 . . . . 0.0 111.021 173.946 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.65 HG13 HD12 ' A' ' 18' ' ' ILE . 5.6 p -59.91 -31.99 48.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 C-N-CA 120.306 -0.558 . . . . 0.0 110.598 179.491 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 60.5 m -67.25 -41.47 85.53 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-O 120.952 0.406 . . . . 0.0 110.762 173.734 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 51.2 tptt -70.0 -46.19 65.65 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.912 179.738 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . 0.419 ' CG ' HH21 ' A' ' 46' ' ' ARG . 0.9 OUTLIER -73.85 -8.62 56.75 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.184 -0.916 . . . . 0.0 111.045 179.511 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 88.0 mt-30 61.56 32.82 18.61 Favored 'General case' 0 C--O 1.238 0.454 0 N-CA-C 113.328 0.862 . . . . 0.0 113.328 169.388 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.569 ' HB2' HG23 ' A' ' 82' ' ' VAL . 75.9 mt -67.86 152.37 45.68 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.632 0.253 . . . . 0.0 110.582 177.85 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.453 ' HB2' ' OE1' ' A' ' 56' ' ' GLU . 28.9 mmtm -125.03 -162.46 1.1 Allowed 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.998 178.352 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 86.53 -155.29 28.01 Favored Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 120.918 -0.658 . . . . 0.0 111.944 -178.797 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 63.0 mt -109.98 110.94 34.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 176.342 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . 0.693 ' HG2' ' HB2' ' A' ' 68' ' ' SER . 21.9 mt-30 -128.53 111.57 13.39 Favored 'General case' 0 N--CA 1.441 -0.883 0 CA-C-O 121.33 0.586 . . . . 0.0 111.131 -175.541 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.776 HD12 ' HB2' ' A' ' 15' ' ' TYR . 0.4 OUTLIER -109.1 146.08 34.63 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.238 -179.0 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 18.9 t-80 -110.27 119.14 38.28 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.783 -175.585 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' MET . . . . . 0.717 ' HB2' HD11 ' A' ' 69' ' ' LEU . 26.2 ttp -83.11 -56.88 3.53 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 114.929 -1.032 . . . . 0.0 110.838 -177.343 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . 0.697 ' HA2' ' O ' ' A' ' 72' ' ' ASP . . . 86.78 -90.43 1.67 Allowed Glycine 0 N--CA 1.445 -0.703 0 C-N-CA 120.214 -0.993 . . . . 0.0 113.296 176.126 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 1.7 p -103.56 -20.24 14.09 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 112.33 0.493 . . . . 0.0 112.33 -174.125 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -93.09 54.15 2.09 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-O 121.185 0.517 . . . . 0.0 111.033 -165.627 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . 0.696 ' HA ' ' SD ' ' A' ' 94' ' ' MET . 0.0 OUTLIER -81.24 40.26 0.55 Allowed 'General case' 0 CA--C 1.516 -0.363 0 N-CA-C 112.845 0.683 . . . . 0.0 112.845 -172.243 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . 0.564 HG21 ' HG2' ' A' ' 8' ' ' PRO . 7.3 t -60.9 -17.71 52.3 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 169.77 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . 0.427 ' HZ ' ' CD2' ' A' ' 13' ' ' PHE . 2.8 m-85 -72.91 -37.14 67.34 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-N 115.218 -0.901 . . . . 0.0 111.377 174.392 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' MET . . . . . 0.93 ' HA ' ' HB ' ' A' ' 106' ' ' ILE . 83.8 mtp -63.67 -48.47 77.06 Favored 'General case' 0 CA--C 1.517 -0.313 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 178.717 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -62.77 -37.87 88.37 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.824 -0.625 . . . . 0.0 111.112 177.053 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -71.68 -47.35 54.76 Favored 'General case' 0 N--CA 1.463 0.197 0 N-CA-C 112.367 0.506 . . . . 0.0 112.367 -175.071 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' TYR . . . . . 0.704 ' HB2' HG12 ' A' ' 106' ' ' ILE . 67.3 m-85 -96.95 0.48 49.0 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 112.069 0.396 . . . . 0.0 112.069 -174.491 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 9.6 mp 64.57 26.34 13.28 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.309 0.576 . . . . 0.0 110.006 -173.104 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . 0.93 ' HB ' ' HA ' ' A' ' 101' ' ' MET . 33.8 mm -55.67 108.96 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.155 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.188 172.933 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 48.5 t-20 -139.65 -66.61 0.45 Allowed 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 178.328 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -72.03 100.1 0.91 Allowed Glycine 0 N--CA 1.446 -0.699 0 C-N-CA 120.62 -0.8 . . . . 0.0 111.188 174.366 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.553 HG21 HG11 ' A' ' 37' ' ' VAL . 2.7 pp -106.2 154.22 39.81 Favored Pre-proline 0 C--N 1.323 -0.587 0 C-N-CA 121.544 -0.062 . . . . 0.0 110.986 -178.74 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . 0.502 ' C ' ' HA ' ' A' ' 109' ' ' ILE . 22.7 Cg_exo -65.52 138.38 36.19 Favored 'Cis proline' 0 C--N 1.349 0.561 0 C-N-CA 124.224 -1.156 . . . . 0.0 113.392 1.016 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . 0.505 ' HD3' ' H ' ' A' ' 112' ' ' PHE . 0.0 OUTLIER -96.1 150.49 20.44 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.842 -0.617 . . . . 0.0 109.56 178.46 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . 0.579 ' HB2' ' HB2' ' A' ' 126' ' ' MET . 0.1 OUTLIER -116.35 114.36 24.2 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.279 -0.873 . . . . 0.0 110.583 -174.97 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.658 HD11 HD11 ' A' ' 106' ' ' ILE . 67.6 mt -128.86 144.46 38.04 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.354 0 CA-C-O 120.819 0.343 . . . . 0.0 111.064 -179.187 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 45.6 tp -128.71 134.08 48.35 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.064 -0.516 . . . . 0.0 109.987 176.717 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.48 HD23 HG13 ' A' ' 121' ' ' ILE . 0.4 OUTLIER -135.47 152.69 51.6 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.453 0.644 . . . . 0.0 110.601 -178.959 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . 0.827 ' HB3' ' HB2' ' A' ' 120' ' ' LYS . 43.0 t0 -70.61 164.5 24.79 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 114.735 -1.12 . . . . 0.0 110.36 179.707 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . 0.42 ' HA ' ' O ' ' A' ' 31' ' ' LYS . 40.0 mtm180 -51.56 -20.99 2.19 Favored 'General case' 0 C--N 1.323 -0.578 0 C-N-CA 124.589 1.155 . . . . 0.0 113.515 -173.98 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . 0.511 ' HB3' ' HG3' ' A' ' 120' ' ' LYS . 26.6 t70 -96.91 1.9 51.02 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-O 121.471 0.653 . . . . 0.0 110.262 -175.966 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . 0.468 ' HA2' HD12 ' A' ' 33' ' ' ILE . . . 88.17 16.93 58.46 Favored Glycine 0 N--CA 1.44 -1.034 0 N-CA-C 110.504 -1.038 . . . . 0.0 110.504 -171.752 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . 0.827 ' HB2' ' HB3' ' A' ' 116' ' ' ASP . 6.2 mtpm? -85.02 102.85 13.53 Favored 'General case' 0 C--O 1.221 -0.419 0 C-N-CA 121.047 -0.261 . . . . 0.0 110.953 -175.955 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 0.684 ' H ' HD12 ' A' ' 121' ' ' ILE . 4.1 mp -45.8 115.94 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 O-C-N 123.728 0.643 . . . . 0.0 111.561 -176.546 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' ILE . . . . . 0.469 ' H ' ' HA ' ' A' ' 115' ' ' LEU . 56.3 mt -89.77 -39.27 12.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 178.404 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 17.1 m -154.4 125.11 7.07 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.369 -0.832 . . . . 0.0 109.77 176.932 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . 0.447 ' O ' HG12 ' A' ' 113' ' ' ILE . . . -72.5 -18.74 61.64 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.33 0.586 . . . . 0.0 110.21 177.982 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 16.2 p-10 -142.03 121.69 13.41 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.402 -0.817 . . . . 0.0 110.445 176.668 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' MET . . . . . 0.579 ' HB2' ' HB2' ' A' ' 112' ' ' PHE . 92.3 mmm -95.65 -117.86 0.11 Allowed 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.048 174.197 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . 0.603 ' HB ' ' CG ' ' A' ' 131' ' ' ASP . 4.0 m -132.36 -50.38 0.93 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.877 0.37 . . . . 0.0 110.768 -179.482 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . 0.972 ' HB3' ' HB3' ' A' ' 131' ' ' ASP . 46.9 ttt180 -165.76 151.18 8.05 Favored Pre-proline 0 N--CA 1.444 -0.746 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 -178.674 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 20.5 Cg_exo -64.98 7.78 0.25 Allowed 'Trans proline' 0 CA--C 1.532 0.417 0 C-N-CA 122.141 1.894 . . . . 0.0 112.797 175.589 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . 0.427 ' H ' ' C ' ' A' ' 128' ' ' ARG . 11.4 p -158.77 21.15 0.21 Allowed 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 111.808 0.299 . . . . 0.0 111.808 -178.895 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . 0.972 ' HB3' ' HB3' ' A' ' 128' ' ' ARG . 1.2 p30 -75.97 152.76 84.64 Favored Pre-proline 0 N--CA 1.444 -0.77 0 O-C-N 122.151 -0.343 . . . . 0.0 110.412 179.7 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -65.65 -28.01 52.69 Favored 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.842 2.361 . . . . 0.0 114.042 -175.028 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . 0.802 ' HA ' ' HG2' ' A' ' 136' ' ' GLU . 36.0 mttm -79.24 -28.92 42.48 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.019 0.437 . . . . 0.0 111.041 -176.289 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 134' ' ' THR . . . . . 0.701 HG22 ' CZ ' ' A' ' 138' ' ' PHE . 96.9 m -71.89 -38.82 69.92 Favored 'General case' 0 C--N 1.317 -0.838 0 N-CA-C 109.611 -0.514 . . . . 0.0 109.611 171.48 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . 0.439 ' HA ' ' CD2' ' A' ' 138' ' ' PHE . . . -61.59 -49.8 75.16 Favored 'General case' 0 C--O 1.236 0.39 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.659 174.742 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . 0.802 ' HG2' ' HA ' ' A' ' 133' ' ' LYS . 11.9 pt-20 -63.65 -28.32 69.83 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 120.961 0.41 . . . . 0.0 110.111 179.104 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . 0.638 ' O ' ' HG ' ' A' ' 141' ' ' LEU . 0.7 OUTLIER -60.09 -48.27 82.41 Favored 'General case' 0 N--CA 1.446 -0.654 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.406 175.866 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . 0.701 ' CZ ' HG22 ' A' ' 134' ' ' THR . 8.6 m-85 -54.46 -47.12 73.31 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.012 177.566 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 85.3 m-20 -56.63 -47.71 79.12 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.262 177.147 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . 0.538 ' HA ' ' HB2' ' A' ' 145' ' ' GLU . 43.6 tt0 -60.15 -43.01 96.08 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.553 179.103 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.638 ' HG ' ' O ' ' A' ' 137' ' ' LYS . 94.0 mt -57.39 -44.82 84.84 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.409 -178.646 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 10.0 mp -81.64 -14.96 56.03 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.819 0.342 . . . . 0.0 111.032 -179.667 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 89.27 20.05 47.19 Favored Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 120.829 -0.7 . . . . 0.0 111.733 -179.852 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 10.3 tt -82.23 -24.77 34.67 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.43 -0.581 . . . . 0.0 109.43 -179.643 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . 0.538 ' HB2' ' HA ' ' A' ' 140' ' ' GLU . 1.8 mm-40 -56.52 145.18 28.78 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 115.435 -0.802 . . . . 0.0 111.553 176.261 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -159.99 -140.71 2.96 Favored Glycine 0 N--CA 1.445 -0.718 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.092 -178.759 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 54.3 t-80 -80.47 63.68 5.0 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 109.705 -0.48 . . . . 0.0 109.705 179.501 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 2.3 p80 -74.7 -13.88 60.67 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.102 -177.809 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 4.1 t-80 -168.51 -81.68 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.166 -0.47 . . . . 0.0 109.815 172.272 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -155.2 130.78 9.82 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 110.1 -0.333 . . . . 0.0 110.1 179.904 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 20.3 p-80 -95.85 -22.78 17.25 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 172.253 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 60.1 t-80 . . . . . 0 C--O 1.248 0.984 0 CA-C-N 114.5 -1.227 . . . . 0.0 108.319 175.125 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 51.1 ttm . . . . . 0 N--CA 1.484 1.228 0 N-CA-C 109.98 -0.378 . . . . 0.0 109.98 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 20.3 m 59.35 -166.57 0.17 Allowed 'General case' 0 CA--C 1.53 0.173 0 O-C-N 123.736 0.647 . . . . 0.0 110.262 -177.078 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.461 ' O ' HD22 ' A' ' 3' ' ' LEU . 0.0 OUTLIER -137.56 132.96 33.91 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.129 0.49 . . . . 0.0 110.577 176.558 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . 0.443 ' HB2' ' O ' ' A' ' 3' ' ' LEU . 40.7 ttm180 170.01 -45.49 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 -179.159 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 23.1 t -149.01 143.62 26.21 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 114.51 -1.223 . . . . 0.0 108.129 174.899 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 82.12 -111.34 3.33 Favored Glycine 0 N--CA 1.446 -0.691 0 C-N-CA 120.469 -0.872 . . . . 0.0 111.641 -176.083 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 32.0 p30 -168.25 159.69 9.05 Favored Pre-proline 0 C--O 1.238 0.482 0 CA-C-O 120.953 0.406 . . . . 0.0 111.372 -178.961 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 15.4 Cg_exo -69.43 145.28 58.55 Favored 'Trans proline' 0 N--CA 1.462 -0.377 0 C-N-CA 122.54 2.16 . . . . 0.0 110.663 171.083 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 27.6 m -73.08 87.33 1.38 Allowed 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.633 0.254 . . . . 0.0 110.805 -177.169 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.692 ' HA ' ' CE1' ' A' ' 100' ' ' PHE . . . 63.01 10.81 4.67 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 115.562 -0.744 . . . . 0.0 111.839 178.4 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.621 ' HB1' ' HE3' ' A' ' 120' ' ' LYS . . . -89.77 -6.07 56.33 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.582 -175.142 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 50.1 m -158.12 129.83 6.77 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.557 179.908 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . 0.442 ' CE2' HD13 ' A' ' 25' ' ' LEU . 52.4 p90 -157.65 159.46 37.01 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.481 -0.327 . . . . 0.0 110.295 176.451 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.561 ' HA ' ' HA ' ' A' ' 24' ' ' SER . 19.2 m -142.46 124.97 15.71 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.215 -0.448 . . . . 0.0 109.801 177.785 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 77.7 m-85 -139.25 154.18 71.8 Favored Pre-proline 0 C--N 1.326 -0.425 0 CA-C-O 120.516 0.198 . . . . 0.0 110.869 -178.002 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.514 ' HA ' ' O ' ' A' ' 21' ' ' LYS . 6.8 Cg_endo -85.15 127.93 3.53 Favored 'Trans proline' 0 N--CA 1.452 -0.92 0 C-N-CA 122.478 2.118 . . . . 0.0 112.928 179.437 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . 0.52 ' HA ' ' O ' ' A' ' 91' ' ' GLN . 11.7 t70 -67.18 154.65 40.74 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 169.409 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.497 HD12 ' CG1' ' A' ' 82' ' ' VAL . 5.9 tt -52.06 -33.3 16.26 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.435 0 O-C-N 123.729 0.643 . . . . 0.0 111.431 -176.338 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 40.3 m-80 -69.09 -9.68 53.88 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.027 -179.627 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 92.93 36.83 5.9 Favored Glycine 0 N--CA 1.446 -0.656 0 CA-C-N 115.802 -0.636 . . . . 0.0 111.802 -179.382 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.514 ' O ' ' HA ' ' A' ' 16' ' ' PRO . 62.3 tttm -107.04 121.79 45.18 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 120.573 -0.451 . . . . 0.0 110.617 -178.306 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 12.9 m -67.35 99.76 0.76 Allowed 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 109.651 -0.5 . . . . 0.0 109.651 173.566 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.431 ' HB ' ' CD2' ' A' ' 92' ' ' LEU . 96.6 t -107.57 115.43 48.77 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-N 115.888 -0.596 . . . . 0.0 109.905 -178.77 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . 0.561 ' HA ' ' HA ' ' A' ' 14' ' ' SER . 77.9 p -98.75 171.08 8.32 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 115.878 -0.601 . . . . 0.0 109.712 179.411 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.503 HD21 ' O ' ' A' ' 119' ' ' GLY . 27.0 tp -66.99 -22.27 65.92 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.087 0.47 . . . . 0.0 110.435 177.113 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -79.94 -31.48 40.01 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.092 176.593 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.428 ' OD2' HG13 ' A' ' 23' ' ' VAL . 20.6 t70 -66.69 -21.95 66.09 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 115.511 -0.768 . . . . 0.0 110.005 176.813 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.647 HD13 HG21 ' A' ' 67' ' ' VAL . 96.0 mt -105.96 3.22 28.17 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.456 -0.793 . . . . 0.0 111.779 -179.446 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.47 ' HG2' ' HA ' ' A' ' 118' ' ' ASP . 18.8 mtpt -75.08 162.01 28.91 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 121.377 0.608 . . . . 0.0 112.063 -177.6 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 113.84 -41.82 2.1 Favored Glycine 0 N--CA 1.447 -0.6 0 CA-C-N 115.332 -0.849 . . . . 0.0 111.459 179.809 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.478 ' O ' ' HA ' ' A' ' 117' ' ' ARG . 60.7 mttm -125.79 165.4 18.72 Favored 'General case' 0 N--CA 1.447 -0.623 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 177.48 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -63.68 134.82 56.08 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 177.667 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.462 HD13 ' HA2' ' A' ' 119' ' ' GLY . 5.0 mp -102.49 132.31 48.82 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.914 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 179.289 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 18.6 t80 -113.49 107.61 16.05 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 174.711 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.708 ' HA ' ' O ' ' A' ' 67' ' ' VAL . 62.6 mt -91.56 120.45 40.64 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.746 -176.251 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.495 ' O ' ' HA ' ' A' ' 68' ' ' SER . 3.8 t70 -118.13 125.96 51.28 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 177.176 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.661 HG11 HG21 ' A' ' 109' ' ' ILE . 42.5 t -79.49 112.38 17.46 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.761 0 CA-C-O 121.507 0.67 . . . . 0.0 111.57 -175.572 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' TRP . . . . . 0.579 ' HZ3' ' CG2' ' A' ' 82' ' ' VAL . 0.8 OUTLIER -101.36 134.31 44.64 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.092 -0.958 . . . . 0.0 109.629 178.651 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -146.54 170.46 16.85 Favored 'General case' 0 C--N 1.321 -0.661 0 O-C-N 122.072 -0.393 . . . . 0.0 110.316 -179.592 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.701 ' HB ' ' CE3' ' A' ' 78' ' ' TRP . 8.8 t -91.05 1.44 57.08 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.508 0.671 . . . . 0.0 110.109 178.369 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 8.4 p-90 -126.6 17.93 7.47 Favored 'General case' 0 N--CA 1.448 -0.568 0 CA-C-N 115.613 -0.721 . . . . 0.0 111.411 -179.237 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 26.4 p -105.83 108.36 19.83 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-O 121.302 0.572 . . . . 0.0 109.973 175.764 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.449 ' N ' ' HD2' ' A' ' 44' ' ' PRO . . . -72.56 -62.83 3.09 Favored Glycine 0 CA--C 1.525 0.71 0 CA-C-N 115.563 -0.744 . . . . 0.0 114.446 -174.502 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.449 ' HD2' ' N ' ' A' ' 43' ' ' GLY . 10.4 Cg_endo -52.1 -32.53 49.64 Favored 'Trans proline' 0 C--N 1.356 0.936 0 C-N-CA 123.523 2.815 . . . . 0.0 113.687 -171.364 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . 0.68 ' HB2' ' CG ' ' A' ' 110' ' ' PRO . 37.1 t -57.37 -31.17 65.51 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.657 -177.544 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.5 ' HA ' ' HG ' ' A' ' 49' ' ' LEU . 1.7 mpt_? -63.96 -43.29 96.26 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 112.478 0.548 . . . . 0.0 112.478 -172.501 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -69.17 -8.32 58.48 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.89 -0.671 . . . . 0.0 113.291 -174.82 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.474 ' CD ' ' HE ' ' A' ' 128' ' ' ARG . 24.4 mt-10 -119.21 3.62 11.36 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.649 0.261 . . . . 0.0 111.14 -177.719 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.57 ' HB2' ' HD3' ' A' ' 50' ' ' PRO . 87.2 mt -53.97 -46.88 98.45 Favored Pre-proline 0 CA--C 1.534 0.354 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.451 176.584 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.57 ' HD3' ' HB2' ' A' ' 49' ' ' LEU . 75.0 Cg_exo -51.34 -44.22 44.62 Favored 'Trans proline' 0 C--N 1.358 1.07 0 C-N-CA 121.93 1.753 . . . . 0.0 111.994 172.518 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -69.92 -32.42 70.69 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.024 0.44 . . . . 0.0 110.942 -176.329 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 7.6 tt -63.94 -50.44 68.67 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.344 -178.34 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.583 ' O ' ' HG3' ' A' ' 57' ' ' GLU . 24.9 pttm -71.56 -30.14 65.53 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 120.38 -0.528 . . . . 0.0 110.586 -177.398 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -68.28 -37.98 81.24 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-O 121.017 0.437 . . . . 0.0 110.795 177.028 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.469 HD22 ' O ' ' A' ' 129' ' ' PRO . 14.7 tp -63.78 -40.11 95.87 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 177.469 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -64.39 -47.65 78.41 Favored 'General case' 0 N--CA 1.443 -0.785 0 CA-C-N 115.987 -0.551 . . . . 0.0 109.934 177.931 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.583 ' HG3' ' O ' ' A' ' 53' ' ' LYS . 42.1 mt-10 -50.2 -40.1 46.09 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-O 121.199 0.523 . . . . 0.0 110.942 178.533 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.806 ' HE3' ' CE2' ' A' ' 59' ' ' TYR . 34.6 ttpt -73.11 -43.03 62.28 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.532 -0.758 . . . . 0.0 112.327 -177.159 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.806 ' CE2' ' HE3' ' A' ' 58' ' ' LYS . 97.6 m-85 -102.66 -2.5 28.18 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 112.561 0.578 . . . . 0.0 112.561 -172.279 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -57.66 122.75 13.53 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.09 0.471 . . . . 0.0 111.61 179.755 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 99.58 -20.71 48.43 Favored Glycine 0 N--CA 1.445 -0.716 0 CA-C-N 115.536 -0.757 . . . . 0.0 113.263 174.036 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.53 ' N ' ' HD2' ' A' ' 62' ' ' LYS . 10.8 mptt -78.69 -97.57 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 117.204 0.502 . . . . 0.0 111.657 -176.25 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.413 ' HB3' HD21 ' A' ' 142' ' ' LEU . 12.3 p-10 -119.68 -3.4 10.32 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.537 -0.301 . . . . 0.0 111.73 -173.029 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.473 HG12 ' N ' ' A' ' 65' ' ' HIS . 16.7 tt -144.64 164.65 13.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-O 120.731 0.3 . . . . 0.0 111.086 -170.893 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' HIS . . . . . 0.473 ' N ' HG12 ' A' ' 64' ' ' ILE . 0.1 OUTLIER -156.83 141.36 16.74 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.111 171.497 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . 0.4 ' CE2' HD23 ' A' ' 55' ' ' LEU . 74.9 m-85 -94.67 132.27 39.58 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.223 0.535 . . . . 0.0 110.983 -174.257 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.708 ' O ' ' HA ' ' A' ' 35' ' ' ILE . 56.9 t -132.52 118.57 35.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.176 -178.401 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . 0.495 ' HA ' ' O ' ' A' ' 36' ' ' ASP . 49.7 m -88.38 136.51 32.95 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.542 -179.692 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.551 ' O ' ' HA ' ' A' ' 37' ' ' VAL . 64.2 tp -121.84 128.93 52.19 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 110.304 -0.258 . . . . 0.0 110.304 177.279 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . 0.457 ' HB2' ' CD1' ' A' ' 38' ' ' TRP . 44.2 t -109.7 114.87 28.83 Favored 'General case' 0 C--O 1.216 -0.684 0 N-CA-C 112.102 0.408 . . . . 0.0 112.102 -172.901 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 3.3 m -84.64 21.49 1.51 Allowed 'General case' 0 C--N 1.312 -1.048 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.805 175.672 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -71.76 143.95 49.4 Favored 'General case' 0 CA--C 1.515 -0.396 0 C-N-CA 120.069 -0.652 . . . . 0.0 109.916 178.372 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.655 ' HB3' ' HZ2' ' A' ' 73' ' ' LYS . 0.0 OUTLIER -96.68 -15.23 21.57 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.179 -177.277 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . 0.559 ' HB2' ' HB3' ' A' ' 77' ' ' ALA . 0.0 OUTLIER -104.2 79.84 1.65 Allowed 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 -177.736 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.551 ' HA ' ' CE1' ' A' ' 93' ' ' HIS . 21.1 tttm -51.6 -63.5 1.11 Allowed 'General case' 0 CA--C 1.513 -0.451 0 N-CA-C 112.782 0.66 . . . . 0.0 112.782 -173.544 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 26.3 tptp -46.51 -51.46 15.32 Favored 'General case' 0 C--N 1.323 -0.556 0 O-C-N 123.431 0.457 . . . . 0.0 110.726 -178.359 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.702 ' HA ' ' ND2' ' A' ' 80' ' ' ASN . . . -58.95 -42.81 90.72 Favored 'General case' 0 C--O 1.239 0.551 0 CA-C-O 121.198 0.523 . . . . 0.0 110.826 179.619 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' TRP . . . . . 0.701 ' CE3' ' HB ' ' A' ' 40' ' ' THR . 6.9 t-105 -64.35 -51.98 60.65 Favored 'General case' 0 N--CA 1.435 -1.188 0 CA-C-N 115.51 -0.768 . . . . 0.0 112.489 -179.94 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.466 ' CD ' ' HE2' ' A' ' 75' ' ' LYS . 19.2 mm-40 -48.14 -40.1 22.71 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-O 120.948 0.404 . . . . 0.0 111.39 178.278 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . 0.702 ' ND2' ' HA ' ' A' ' 77' ' ' ALA . 3.6 m-20 -60.66 -50.19 74.52 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-O 120.846 0.355 . . . . 0.0 110.614 177.146 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 16.2 tpt -63.5 -37.7 88.29 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 112.164 0.431 . . . . 0.0 112.164 -175.183 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.579 ' CG2' ' HZ3' ' A' ' 38' ' ' TRP . 0.6 OUTLIER -68.58 -36.9 76.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 C-N-CA 119.965 -0.694 . . . . 0.0 111.13 179.053 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 12.7 t -78.69 -21.39 48.28 Favored 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 120.127 -0.629 . . . . 0.0 110.512 178.051 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 60.9 tttp -80.94 -53.68 6.24 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-O 120.973 0.416 . . . . 0.0 110.379 177.537 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -77.29 -20.04 55.59 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.143 -177.204 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 26.5 mt-30 65.16 78.42 0.28 Allowed 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 115.147 -0.933 . . . . 0.0 112.244 177.304 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.546 HD13 ' HA ' ' A' ' 82' ' ' VAL . 5.5 mp -104.45 118.42 36.57 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.116 -0.947 . . . . 0.0 108.61 174.101 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 72.9 mmtt -103.04 179.17 4.35 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 112.706 0.632 . . . . 0.0 112.706 -177.323 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 105.84 179.17 23.63 Favored Glycine 0 N--CA 1.45 -0.383 0 CA-C-N 115.096 -0.956 . . . . 0.0 111.172 -175.972 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.465 ' O ' ' HA ' ' A' ' 67' ' ' VAL . 63.4 mt -76.82 116.36 19.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 173.242 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . 0.556 ' HB2' ' CZ2' ' A' ' 38' ' ' TRP . 3.0 pt20 -136.81 107.42 6.54 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 121.793 0.806 . . . . 0.0 112.646 -166.075 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.431 ' CD2' ' HB ' ' A' ' 23' ' ' VAL . 21.9 mt -99.15 144.31 28.43 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.012 -0.994 . . . . 0.0 110.117 -178.618 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' HIS . . . . . 0.551 ' CE1' ' HA ' ' A' ' 75' ' ' LYS . 10.3 t-160 -115.83 131.34 56.97 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 121.69 0.757 . . . . 0.0 111.334 178.725 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' MET . . . . . 0.755 ' HG3' ' HB2' ' A' ' 97' ' ' ASP . 34.4 ttp -108.84 90.2 3.22 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 114.059 -1.428 . . . . 0.0 108.491 179.626 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . 0.51 ' O ' ' HA ' ' A' ' 73' ' ' LYS . . . -64.25 -65.53 2.96 Favored Glycine 0 C--N 1.318 -0.45 0 CA-C-N 115.319 -0.855 . . . . 0.0 113.513 -173.387 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 7.4 p -121.02 7.19 10.32 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-O 121.438 0.637 . . . . 0.0 110.393 -178.135 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . 0.755 ' HB2' ' HG3' ' A' ' 94' ' ' MET . 0.6 OUTLIER -90.56 12.73 17.86 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.32 -0.854 . . . . 0.0 110.663 -170.998 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . 0.686 ' HA ' ' SD ' ' A' ' 94' ' ' MET . 0.0 OUTLIER -72.19 14.03 0.26 Allowed 'General case' 0 C--O 1.222 -0.356 0 N-CA-C 113.068 0.766 . . . . 0.0 113.068 -170.704 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 9.8 t -70.52 -21.98 62.68 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 169.234 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . 0.692 ' CE1' ' HA ' ' A' ' 10' ' ' ALA . 88.9 t80 -79.31 -24.42 42.85 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.52 -0.764 . . . . 0.0 109.653 174.255 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' MET . . . . . 0.653 ' HB3' ' O ' ' A' ' 98' ' ' ARG . 14.8 tpt -59.69 -38.14 80.76 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.321 -0.854 . . . . 0.0 110.177 175.102 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 78.6 m-20 -65.21 -21.43 66.75 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.6 -0.727 . . . . 0.0 111.401 179.207 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -66.29 -14.52 62.13 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-O 120.592 0.234 . . . . 0.0 111.502 178.465 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 65.5 m-85 -95.69 -13.27 24.38 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 110.195 -0.298 . . . . 0.0 110.195 176.427 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 98.3 mt 71.17 -24.36 0.17 Allowed 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 123.791 0.836 . . . . 0.0 112.864 176.811 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . 0.428 HG21 HH11 ' A' ' 111' ' ' ARG . 14.4 mt -98.1 93.72 3.43 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-O 120.875 0.369 . . . . 0.0 110.721 -175.871 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . 0.497 ' HA ' ' HE3' ' A' ' 101' ' ' MET . 67.0 t30 -82.62 -1.33 50.65 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.857 -178.282 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -81.46 98.46 1.89 Allowed Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.802 -0.713 . . . . 0.0 111.742 177.813 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.661 HG21 HG11 ' A' ' 37' ' ' VAL . 44.8 pt -104.56 161.11 23.83 Favored Pre-proline 0 C--N 1.325 -0.475 0 CA-C-N 116.473 0.137 . . . . 0.0 111.062 -177.156 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . 0.68 ' CG ' ' HB2' ' A' ' 45' ' ' CYS . 23.4 Cg_exo -64.26 134.44 18.44 Favored 'Cis proline' 0 C--N 1.35 0.657 0 C-N-CA 123.928 -1.28 . . . . 0.0 113.178 0.89 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . 0.951 ' HE ' ' HA ' ' A' ' 111' ' ' ARG . 0.0 OUTLIER -102.28 141.78 34.57 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-N 116.246 -0.434 . . . . 0.0 109.964 174.263 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . 0.42 ' CE1' ' HD3' ' A' ' 128' ' ' ARG . 0.6 OUTLIER -113.93 113.74 25.25 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.301 -0.863 . . . . 0.0 108.739 -174.949 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.478 ' HB ' ' HB ' ' A' ' 35' ' ' ILE . 81.0 mt -123.97 138.16 54.58 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-O 121.249 0.547 . . . . 0.0 111.488 -173.024 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.471 ' HG ' HD12 ' A' ' 122' ' ' ILE . 58.8 tp -112.96 134.31 54.53 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 115.415 -0.811 . . . . 0.0 109.062 175.916 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.462 ' N ' HD12 ' A' ' 115' ' ' LEU . 2.3 mp -131.58 147.04 52.49 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 -179.831 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 23.6 t0 -65.75 164.8 13.91 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.119 176.409 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . 0.478 ' HA ' ' O ' ' A' ' 31' ' ' LYS . 0.6 OUTLIER -53.84 -21.71 8.18 Favored 'General case' 0 N--CA 1.471 0.586 0 O-C-N 124.2 0.937 . . . . 0.0 112.376 -176.15 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . 0.509 ' HB3' ' HG2' ' A' ' 120' ' ' LYS . 6.0 t70 -88.46 6.21 38.75 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.557 0.694 . . . . 0.0 110.075 -178.974 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . 0.503 ' O ' HD21 ' A' ' 25' ' ' LEU . . . 75.82 24.78 68.76 Favored Glycine 0 N--CA 1.437 -1.26 0 N-CA-C 110.833 -0.907 . . . . 0.0 110.833 -173.859 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . 0.621 ' HE3' ' HB1' ' A' ' 11' ' ' ALA . 43.6 mmtm -99.76 106.35 18.24 Favored 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 120.317 -0.553 . . . . 0.0 111.351 -175.803 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 0.611 ' H ' HD12 ' A' ' 121' ' ' ILE . 3.0 mp -39.84 115.78 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 114.852 -1.067 . . . . 0.0 112.419 -177.648 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' ILE . . . . . 0.471 HD12 ' HG ' ' A' ' 114' ' ' LEU . 57.4 mt -86.88 -41.14 14.58 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 114.957 -1.02 . . . . 0.0 108.797 173.978 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 19.8 m -153.53 121.55 6.09 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.444 179.019 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -79.19 -17.03 55.66 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-O 121.488 0.661 . . . . 0.0 110.497 177.407 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 45.6 t30 -128.26 98.83 5.21 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 108.477 -0.935 . . . . 0.0 108.477 174.457 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 17.1 tpt -100.77 -97.43 0.26 Allowed 'General case' 0 C--N 1.322 -0.616 0 C-N-CA 120.696 -0.402 . . . . 0.0 111.409 -174.999 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . 0.568 ' O ' ' HB2' ' A' ' 128' ' ' ARG . 3.4 p -152.01 -73.81 0.14 Allowed 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 111.534 0.198 . . . . 0.0 111.534 -173.42 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . 0.626 ' HD2' ' HD2' ' A' ' 129' ' ' PRO . 20.2 tpt180 157.0 136.27 0.0 OUTLIER Pre-proline 0 N--CA 1.456 -0.151 0 C-N-CA 124.196 0.999 . . . . 0.0 108.514 -172.424 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . 0.626 ' HD2' ' HD2' ' A' ' 128' ' ' ARG . 84.2 Cg_exo -49.45 -44.13 35.91 Favored 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 122.285 1.99 . . . . 0.0 112.6 172.166 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . 0.455 ' H ' ' HG3' ' A' ' 128' ' ' ARG . 0.0 OUTLIER -78.6 3.03 17.34 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 112.263 0.468 . . . . 0.0 112.263 -177.54 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . 0.429 ' HB2' ' HB3' ' A' ' 128' ' ' ARG . 10.5 t70 -89.23 123.76 66.34 Favored Pre-proline 0 C--O 1.236 0.363 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 177.291 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -55.43 -37.06 95.14 Favored 'Trans proline' 0 C--N 1.342 0.236 0 C-N-CA 123.345 2.696 . . . . 0.0 113.653 -176.069 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . 0.528 ' HA ' ' HG2' ' A' ' 136' ' ' GLU . 36.4 mtmm -61.11 -33.21 73.01 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 121.357 0.598 . . . . 0.0 110.964 -175.367 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 134' ' ' THR . . . . . 0.591 HG22 ' CZ ' ' A' ' 138' ' ' PHE . 0.2 OUTLIER -67.13 -53.05 34.26 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.885 176.843 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . 0.493 ' HA ' ' CD2' ' A' ' 138' ' ' PHE . . . -60.64 -47.3 86.84 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.41 -0.814 . . . . 0.0 111.555 -178.999 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . 0.528 ' HG2' ' HA ' ' A' ' 133' ' ' LYS . 12.9 pt-20 -63.29 -30.39 71.54 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.395 -178.205 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . 1.083 ' HA ' ' HE3' ' A' ' 137' ' ' LYS . 0.4 OUTLIER -65.43 -44.64 86.71 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-N 116.573 -0.285 . . . . 0.0 110.405 177.709 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . 0.591 ' CZ ' HG22 ' A' ' 134' ' ' THR . 7.2 m-85 -60.51 -57.58 12.14 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-O 121.056 0.455 . . . . 0.0 110.694 -179.708 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . 0.496 HD22 ' N ' ' A' ' 140' ' ' GLU . 0.3 OUTLIER -67.68 -18.28 64.88 Favored 'General case' 0 C--O 1.222 -0.354 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.811 -175.514 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . 0.496 ' N ' HD22 ' A' ' 139' ' ' ASN . 24.6 tt0 -66.35 -50.36 63.81 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 172.595 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.475 ' HG ' ' O ' ' A' ' 137' ' ' LYS . 60.8 mt -61.17 -33.55 73.61 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.659 -179.783 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.413 HD21 ' HB3' ' A' ' 63' ' ' ASP . 94.6 mt -80.48 -24.13 39.68 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.255 178.896 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 74.51 41.49 36.22 Favored Glycine 0 N--CA 1.45 -0.415 0 N-CA-C 110.41 -1.076 . . . . 0.0 110.41 -173.958 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.445 ' O ' ' HG ' ' A' ' 144' ' ' LEU . 35.2 tp -120.85 20.33 11.64 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 114.916 -0.642 . . . . 0.0 111.226 -169.678 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -80.43 -178.63 6.75 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 120.519 -0.472 . . . . 0.0 110.566 -179.557 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -77.4 21.74 2.83 Favored Glycine 0 CA--C 1.519 0.343 0 C-N-CA 121.101 -0.571 . . . . 0.0 112.791 -179.603 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -64.97 144.34 57.35 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-O 120.804 0.335 . . . . 0.0 111.432 178.806 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 20.5 t-80 60.59 38.14 18.96 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 115.402 -0.817 . . . . 0.0 110.684 177.398 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 33.5 m80 -136.88 163.61 30.25 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.092 178.201 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 47.8 t60 -74.85 116.51 15.65 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 179.13 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 88.8 m-70 -84.37 149.15 26.22 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 121.101 0.477 . . . . 0.0 111.496 -173.518 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 25.1 p-80 . . . . . 0 C--O 1.244 0.779 0 N-CA-C 108.485 -0.931 . . . . 0.0 108.485 175.749 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.0 ptp . . . . . 0 N--CA 1.481 1.116 0 CA-C-O 120.621 0.248 . . . . 0.0 111.103 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 10.5 m -81.28 87.45 6.12 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.948 0.404 . . . . 0.0 110.619 -177.872 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.612 HD22 ' N ' ' A' ' 4' ' ' ARG . 0.0 OUTLIER -70.7 -37.25 73.56 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.498 178.053 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . 0.612 ' N ' HD22 ' A' ' 3' ' ' LEU . 29.3 mtm180 68.75 -24.54 0.14 Allowed 'General case' 0 N--CA 1.474 0.772 0 N-CA-C 113.429 0.9 . . . . 0.0 113.429 172.57 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . 0.408 ' H ' ' C ' ' A' ' 3' ' ' LEU . 8.0 m -46.1 -67.9 0.24 Allowed 'General case' 0 C--O 1.233 0.228 0 C-N-CA 123.008 0.523 . . . . 0.0 111.44 -178.142 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . 0.415 ' O ' ' HB2' ' A' ' 7' ' ' ASN . . . -93.29 36.74 3.6 Favored Glycine 0 N--CA 1.448 -0.551 0 C-N-CA 120.488 -0.863 . . . . 0.0 112.215 177.843 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . 0.554 ' HB3' ' HD2' ' A' ' 8' ' ' PRO . 52.6 m-80 70.28 169.48 0.12 Allowed Pre-proline 0 N--CA 1.471 0.619 0 C-N-CA 122.863 0.465 . . . . 0.0 110.836 -179.051 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.554 ' HD2' ' HB3' ' A' ' 7' ' ' ASN . 19.3 Cg_endo -62.23 -60.23 0.21 Allowed 'Trans proline' 0 C--N 1.35 0.626 0 C-N-CA 121.811 1.674 . . . . 0.0 111.656 173.04 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 15.1 m -73.06 161.71 30.32 Favored 'General case' 0 N--CA 1.444 -0.745 0 CA-C-N 116.04 -0.527 . . . . 0.0 109.633 176.361 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . 73.7 -50.45 0.69 Allowed 'General case' 0 N--CA 1.471 0.589 0 O-C-N 124.007 0.817 . . . . 0.0 111.161 -177.345 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.405 ' HA ' ' HE3' ' A' ' 120' ' ' LYS . . . -70.55 -29.3 65.72 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.977 0.418 . . . . 0.0 110.683 176.926 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 26.6 t -164.75 83.56 0.4 Allowed 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.244 -0.889 . . . . 0.0 109.906 176.396 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 41.1 p90 -101.43 164.46 11.76 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.416 179.985 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.541 ' HA ' ' HA ' ' A' ' 24' ' ' SER . 20.2 m -142.24 126.03 17.05 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 109.905 -0.406 . . . . 0.0 109.905 178.258 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . 0.412 ' HA ' ' HD3' ' A' ' 16' ' ' PRO . 59.2 m-85 -141.04 144.96 37.03 Favored Pre-proline 0 C--N 1.325 -0.465 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.834 -178.602 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.485 ' HA ' ' O ' ' A' ' 21' ' ' LYS . 4.2 Cg_exo -77.68 125.65 7.64 Favored 'Trans proline' 0 N--CA 1.461 -0.412 0 C-N-CA 122.87 2.38 . . . . 0.0 113.018 -179.846 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . 0.608 ' HA ' ' HA ' ' A' ' 92' ' ' LEU . 11.2 t70 -65.37 158.42 26.63 Favored 'General case' 0 C--O 1.238 0.457 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 172.228 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.479 HG12 HG11 ' A' ' 82' ' ' VAL . 11.0 tp -55.03 -27.38 19.16 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 O-C-N 123.669 0.606 . . . . 0.0 112.248 -170.281 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.584 HD21 ' HB2' ' A' ' 21' ' ' LYS . 3.3 p-10 -78.78 -13.27 59.9 Favored 'General case' 0 N--CA 1.456 -0.16 0 CA-C-O 121.2 0.524 . . . . 0.0 110.189 -178.177 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 104.36 31.61 4.57 Favored Glycine 0 N--CA 1.445 -0.732 0 CA-C-N 115.712 -0.676 . . . . 0.0 112.154 -177.29 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.584 ' HB2' HD21 ' A' ' 19' ' ' ASN . 62.3 tttt -101.9 115.03 29.64 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 120.439 -0.504 . . . . 0.0 110.805 179.354 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 14.7 m -64.83 99.69 0.35 Allowed 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 120.892 0.377 . . . . 0.0 110.157 174.579 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 92.9 t -103.3 119.16 51.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.46 -178.457 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . 0.541 ' HA ' ' HA ' ' A' ' 14' ' ' SER . 88.2 p -97.45 171.51 8.34 Favored 'General case' 0 C--N 1.316 -0.878 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 177.082 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.464 ' O ' ' HB2' ' A' ' 29' ' ' LYS . 37.8 tp -63.83 -24.66 67.84 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.72 0.295 . . . . 0.0 111.128 179.709 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -75.61 -24.85 56.57 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.533 -0.303 . . . . 0.0 111.013 -179.312 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -66.33 -25.07 66.65 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-O 121.489 0.661 . . . . 0.0 110.326 179.839 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.659 HD11 HG21 ' A' ' 90' ' ' ILE . 85.7 mt -122.75 15.66 10.18 Favored 'General case' 0 N--CA 1.449 -0.52 0 CA-C-N 115.663 -0.699 . . . . 0.0 111.237 -177.145 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.504 ' HE2' ' O ' ' A' ' 118' ' ' ASP . 61.1 tttm -83.82 157.51 22.01 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.572 -175.38 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 114.72 -34.65 4.78 Favored Glycine 0 N--CA 1.449 -0.433 0 C-N-CA 120.756 -0.735 . . . . 0.0 111.73 179.383 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.732 ' HB2' ' NE2' ' A' ' 65' ' ' HIS . 63.6 mttm -120.52 170.03 9.79 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.733 -0.233 . . . . 0.0 110.683 177.67 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 87.3 m-85 -65.81 155.56 35.87 Favored 'General case' 0 C--N 1.329 -0.296 0 O-C-N 123.298 0.374 . . . . 0.0 110.272 178.52 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.583 ' HB ' ' HB2' ' A' ' 115' ' ' LEU . 70.9 mt -129.38 140.68 48.52 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-O 120.87 0.366 . . . . 0.0 111.163 -175.684 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 93.3 t80 -125.56 110.69 14.15 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 174.001 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.605 ' HB ' ' HB ' ' A' ' 113' ' ' ILE . 59.2 mt -98.01 130.03 47.35 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.07 -176.346 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.47 ' O ' ' HA ' ' A' ' 68' ' ' SER . 5.7 p-10 -116.38 150.33 37.92 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.761 -0.654 . . . . 0.0 109.519 174.762 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.424 ' HB ' ' H ' ' A' ' 111' ' ' ARG . 38.2 t -102.65 130.55 52.47 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.801 0 C-N-CA 120.487 -0.485 . . . . 0.0 110.148 174.927 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' TRP . . . . . 0.661 ' CZ2' ' HB2' ' A' ' 91' ' ' GLN . 0.6 OUTLIER -132.66 135.81 46.07 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.771 -0.65 . . . . 0.0 109.623 -173.569 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.463 ' HB3' ' SG ' ' A' ' 42' ' ' CYS . . . -147.06 161.7 40.31 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 122.257 -0.277 . . . . 0.0 111.092 178.664 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.712 ' HB ' ' CE3' ' A' ' 78' ' ' TRP . 3.0 t -85.52 -4.84 59.28 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.012 0.434 . . . . 0.0 110.925 178.025 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . 0.447 ' HE1' ' HA ' ' A' ' 72' ' ' ASP . 10.2 p-90 -115.86 16.51 16.23 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.442 -176.855 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . 0.463 ' SG ' ' HB3' ' A' ' 39' ' ' ALA . 19.8 p -120.93 95.46 4.71 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.228 0.537 . . . . 0.0 110.755 178.675 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -63.39 -51.12 57.07 Favored Glycine 0 CA--C 1.527 0.805 0 CA-C-O 119.184 -0.787 . . . . 0.0 113.894 -179.778 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -54.45 -38.7 89.71 Favored 'Trans proline' 0 C--N 1.357 0.999 0 C-N-CA 122.483 2.122 . . . . 0.0 112.632 -179.111 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . 0.504 ' SG ' ' HB3' ' A' ' 110' ' ' PRO . 16.8 t -59.01 -40.86 86.25 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.303 0.573 . . . . 0.0 110.634 177.35 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.598 ' HA ' ' CD1' ' A' ' 49' ' ' LEU . 23.2 ttt180 -72.57 -3.74 26.49 Favored 'General case' 0 N--CA 1.447 -0.621 0 CA-C-N 115.309 -0.859 . . . . 0.0 111.409 -175.847 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -66.59 -48.36 63.03 Favored Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 121.055 -0.593 . . . . 0.0 112.693 179.857 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.543 ' OE1' ' HB2' ' A' ' 128' ' ' ARG . 11.9 pt-20 -115.29 17.28 16.64 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 112.179 0.437 . . . . 0.0 112.179 -176.441 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.949 HD13 HD21 ' A' ' 87' ' ' LEU . 37.7 mt -52.41 -50.72 78.32 Favored Pre-proline 0 C--N 1.324 -0.54 0 N-CA-C 112.248 0.462 . . . . 0.0 112.248 175.987 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.519 ' HD2' ' N ' ' A' ' 49' ' ' LEU . 10.3 Cg_endo -55.2 -36.08 92.46 Favored 'Trans proline' 0 C--N 1.356 0.96 0 C-N-CA 122.0 1.8 . . . . 0.0 112.305 176.601 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -71.87 -23.29 61.48 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.021 0.439 . . . . 0.0 111.08 -178.707 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 6.7 tt -70.01 -44.09 70.04 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 177.532 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.573 ' HD2' ' N ' ' A' ' 53' ' ' LYS . 3.2 mptp? -68.82 -40.02 79.71 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.396 177.638 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.614 ' O ' ' HG3' ' A' ' 58' ' ' LYS . 0.2 OUTLIER -48.2 -49.37 33.17 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.395 0.617 . . . . 0.0 110.72 168.568 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.601 HD21 ' HE2' ' A' ' 138' ' ' PHE . 21.7 tp -60.11 -40.03 88.27 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.151 176.97 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.6 ' HG2' ' CG ' ' A' ' 66' ' ' PHE . 44.4 mt-10 -57.67 -48.45 79.46 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.527 -0.76 . . . . 0.0 111.332 178.137 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -61.13 -36.84 80.83 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.846 0.355 . . . . 0.0 110.954 -179.703 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.614 ' HG3' ' O ' ' A' ' 54' ' ' GLU . 53.1 mttm -62.47 -43.8 97.93 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-O 121.41 0.624 . . . . 0.0 110.535 177.387 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 96.1 m-85 -101.93 16.38 26.14 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.434 -175.126 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -64.7 135.57 56.02 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.118 172.749 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 80.75 9.37 86.44 Favored Glycine 0 N--CA 1.449 -0.487 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.762 178.985 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 37.7 mmtm -94.7 -151.59 0.33 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.345 0.593 . . . . 0.0 110.164 177.764 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.728 ' HA ' ' HD3' ' A' ' 31' ' ' LYS . 4.0 t70 -111.82 64.89 0.62 Allowed 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.731 -0.668 . . . . 0.0 109.789 178.517 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 19.9 tt -156.53 156.28 4.68 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.446 0 CA-C-N 115.857 -0.611 . . . . 0.0 110.537 -175.035 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' HIS . . . . . 0.732 ' NE2' ' HB2' ' A' ' 31' ' ' LYS . 81.1 m-70 -134.97 115.05 13.1 Favored 'General case' 0 CA--C 1.515 -0.377 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 175.631 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . 0.6 ' CG ' ' HG2' ' A' ' 56' ' ' GLU . 71.0 m-85 -79.67 118.95 21.96 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 172.05 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.587 ' O ' ' HA ' ' A' ' 35' ' ' ILE . 40.5 t -128.94 111.36 22.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.674 -174.256 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . 0.548 ' HB3' ' CD1' ' A' ' 38' ' ' TRP . 8.2 m -87.81 146.97 25.36 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.145 179.655 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.468 ' HA ' ' O ' ' A' ' 92' ' ' LEU . 7.2 mp -131.45 122.78 26.81 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-O 120.762 0.315 . . . . 0.0 110.338 171.81 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 14.7 t -110.09 114.62 28.28 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.135 0.493 . . . . 0.0 112.106 -175.782 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 64.0 m -79.19 19.09 0.59 Allowed 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.328 175.798 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.447 ' HA ' ' HE1' ' A' ' 41' ' ' TRP . 0.1 OUTLIER -61.58 152.72 29.72 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-O 120.676 0.274 . . . . 0.0 110.79 176.428 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 21.9 pttp -108.06 -21.99 12.58 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.182 -178.351 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . 0.433 ' HB2' ' HB3' ' A' ' 77' ' ' ALA . 0.0 OUTLIER -100.88 67.97 1.26 Allowed 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 -179.087 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.547 ' O ' ' HG3' ' A' ' 79' ' ' GLU . 9.7 tttt -48.06 -52.78 18.76 Favored 'General case' 0 C--N 1.331 -0.237 0 O-C-N 123.782 0.676 . . . . 0.0 112.795 -168.606 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.464 ' HA ' ' HD2' ' A' ' 76' ' ' LYS . 35.1 tptt -52.67 -50.03 64.06 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 123.397 0.435 . . . . 0.0 110.646 -179.067 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.568 ' HA ' ' ND2' ' A' ' 80' ' ' ASN . . . -58.15 -37.53 74.84 Favored 'General case' 0 C--O 1.245 0.834 0 CA-C-O 121.492 0.663 . . . . 0.0 110.405 -179.152 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' TRP . . . . . 0.712 ' CE3' ' HB ' ' A' ' 40' ' ' THR . 5.8 t-105 -68.41 -35.94 78.39 Favored 'General case' 0 N--CA 1.438 -1.03 0 CA-C-N 115.051 -0.977 . . . . 0.0 110.306 -178.642 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.547 ' HG3' ' O ' ' A' ' 75' ' ' LYS . 55.9 mt-10 -51.07 -48.85 61.5 Favored 'General case' 0 CA--C 1.52 -0.189 0 CA-C-O 121.328 0.585 . . . . 0.0 110.965 173.435 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . 0.568 ' ND2' ' HA ' ' A' ' 77' ' ' ALA . 2.7 m-80 -64.85 -42.76 94.63 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.544 -175.504 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . 0.43 ' SD ' ' HZ3' ' A' ' 78' ' ' TRP . 34.8 ttm -66.82 -47.25 72.59 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 119.892 -0.723 . . . . 0.0 111.667 -177.844 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.545 ' CG2' ' HZ3' ' A' ' 38' ' ' TRP . 4.4 p -62.18 -32.39 54.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 C-N-CA 120.49 -0.484 . . . . 0.0 110.93 179.947 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 89.3 m -70.72 -40.72 72.63 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.707 178.406 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . 0.542 ' HD3' ' O ' ' A' ' 80' ' ' ASN . 1.3 mptm? -81.78 -32.47 31.36 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.579 -0.282 . . . . 0.0 111.394 -175.866 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . 0.515 ' HB3' HD13 ' A' ' 87' ' ' LEU . 1.2 t0 -81.71 -3.77 54.54 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.438 0.637 . . . . 0.0 110.164 -179.718 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . 0.49 ' HA ' ' OE1' ' A' ' 86' ' ' GLN . 13.6 mm-40 68.88 16.77 8.81 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 115.017 -0.992 . . . . 0.0 113.444 172.757 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.949 HD21 HD13 ' A' ' 49' ' ' LEU . 10.6 mp -66.58 103.81 1.15 Allowed 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 110.326 -0.25 . . . . 0.0 110.326 173.867 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 43.6 mmtm -108.72 -178.8 3.69 Favored 'General case' 0 C--N 1.323 -0.548 0 O-C-N 122.431 -0.168 . . . . 0.0 110.698 176.168 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 122.2 -153.24 16.82 Favored Glycine 0 N--CA 1.452 -0.278 0 N-CA-C 110.762 -0.935 . . . . 0.0 110.762 -177.069 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.659 HG21 HD11 ' A' ' 28' ' ' LEU . 48.5 mm -104.67 116.03 47.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 N-CA-C 108.369 -0.974 . . . . 0.0 108.369 171.356 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . 0.661 ' HB2' ' CZ2' ' A' ' 38' ' ' TRP . 2.2 pt20 -141.41 100.19 3.73 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-O 122.099 0.952 . . . . 0.0 112.57 -165.55 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.608 ' HA ' ' HA ' ' A' ' 17' ' ' ASP . 22.9 mt -89.89 149.29 22.69 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 114.623 -1.171 . . . . 0.0 110.366 -176.93 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' HIS . . . . . 0.414 ' O ' ' HD2' ' A' ' 16' ' ' PRO . 15.0 t-80 -121.11 134.14 55.24 Favored 'General case' 0 C--N 1.31 -1.132 0 CA-C-N 115.585 -0.734 . . . . 0.0 109.402 177.619 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' MET . . . . . 0.566 ' SD ' ' HA ' ' A' ' 98' ' ' ARG . 48.3 ttm -78.98 -83.8 0.09 Allowed 'General case' 0 N--CA 1.435 -1.203 0 CA-C-N 115.302 -0.863 . . . . 0.0 110.349 -175.423 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 125.08 42.11 0.34 Allowed Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.102 -1.047 . . . . 0.0 113.045 178.99 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.411 ' C ' ' H ' ' A' ' 98' ' ' ARG . 3.7 m 78.03 0.35 2.72 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 123.021 0.528 . . . . 0.0 111.378 -179.329 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -79.3 34.75 0.26 Allowed 'General case' 0 N--CA 1.467 0.409 0 CA-C-O 121.405 0.622 . . . . 0.0 109.52 178.577 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . 0.566 ' HA ' ' SD ' ' A' ' 94' ' ' MET . 0.1 OUTLIER -76.24 20.24 0.21 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.4 -0.818 . . . . 0.0 112.773 -167.106 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 14.3 m -70.38 -24.3 62.93 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.732 0.777 . . . . 0.0 108.916 169.832 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 17.1 t80 -75.83 -23.95 55.78 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.367 -0.833 . . . . 0.0 109.506 175.354 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' MET . . . . . 0.493 ' HB3' ' O ' ' A' ' 98' ' ' ARG . 16.6 tpt -64.43 -33.77 76.63 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.482 -0.781 . . . . 0.0 109.407 175.035 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 46.1 m-20 -70.55 -22.73 62.57 Favored 'General case' 0 N--CA 1.461 0.104 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.819 177.177 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -71.73 -14.59 62.06 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.892 0.377 . . . . 0.0 111.013 -179.004 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' TYR . . . . . 0.607 ' O ' ' HG ' ' A' ' 105' ' ' LEU . 65.1 m-85 -96.47 -4.06 42.26 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 174.563 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.607 ' HG ' ' O ' ' A' ' 104' ' ' TYR . 2.9 pp 51.52 14.37 0.26 Allowed 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 125.108 1.363 . . . . 0.0 113.605 178.818 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . 0.558 ' HB ' ' CG ' ' A' ' 111' ' ' ARG . 17.2 mm -120.1 95.27 3.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 N-CA-C 109.025 -0.732 . . . . 0.0 109.025 172.665 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . 0.518 ' ND2' HH22 ' A' ' 98' ' ' ARG . 4.6 m-20 -86.32 20.49 2.37 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.903 -173.067 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -113.76 123.42 6.11 Favored Glycine 0 N--CA 1.447 -0.629 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.06 -179.626 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.432 ' CG2' ' HA ' ' A' ' 110' ' ' PRO . 21.8 mt -87.85 137.45 31.69 Favored Pre-proline 0 C--N 1.325 -0.469 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 176.838 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . 0.519 ' HG2' ' CZ ' ' A' ' 112' ' ' PHE . 95.1 Cg_endo -88.96 144.2 19.84 Favored 'Cis proline' 0 N--CA 1.456 -0.681 0 C-N-CA 123.522 -1.449 . . . . 0.0 113.496 1.188 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . 0.558 ' CG ' ' HB ' ' A' ' 106' ' ' ILE . 0.0 OUTLIER -100.2 133.25 44.88 Favored 'General case' 0 N--CA 1.444 -0.761 0 N-CA-C 108.879 -0.786 . . . . 0.0 108.879 172.587 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . 0.59 ' CZ ' ' HB3' ' A' ' 128' ' ' ARG . 13.1 m-85 -102.44 124.84 48.72 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 108.52 -0.919 . . . . 0.0 108.52 179.616 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.605 ' HB ' ' HB ' ' A' ' 35' ' ' ILE . 74.7 mt -133.46 147.07 31.15 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-O 120.981 0.419 . . . . 0.0 111.135 -175.276 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 37.1 tp -127.76 135.99 50.89 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.923 -0.581 . . . . 0.0 109.725 179.108 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.583 ' HB2' ' HB ' ' A' ' 33' ' ' ILE . 2.8 mp -133.81 154.87 50.7 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 179.264 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . 0.42 ' OD2' ' HB2' ' A' ' 120' ' ' LYS . 2.7 p30 -84.92 178.1 7.72 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.664 -179.956 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . 0.557 ' HG2' ' HA ' ' A' ' 31' ' ' LYS . 79.7 mtt180 -58.82 -20.48 50.89 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 114.538 -1.21 . . . . 0.0 112.927 -174.434 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . 0.504 ' O ' ' HE2' ' A' ' 29' ' ' LYS . 22.4 t70 -85.27 1.77 46.84 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.741 0.781 . . . . 0.0 109.137 179.506 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 77.87 25.08 63.07 Favored Glycine 0 N--CA 1.431 -1.7 0 N-CA-C 110.221 -1.151 . . . . 0.0 110.221 -173.366 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . 0.42 ' HB2' ' OD2' ' A' ' 116' ' ' ASP . 46.1 mmtm -108.45 120.8 43.47 Favored 'General case' 0 C--O 1.22 -0.451 0 C-N-CA 119.246 -0.982 . . . . 0.0 112.326 -172.369 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 0.558 ' HA ' ' HG ' ' A' ' 115' ' ' LEU . 33.3 mt -42.62 117.83 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-N 115.079 -0.964 . . . . 0.0 113.159 -179.363 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' ILE . . . . . 0.413 HD11 ' HB3' ' A' ' 116' ' ' ASP . 59.4 mt -93.0 -37.13 8.18 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.828 0 CA-C-N 113.863 -1.517 . . . . 0.0 108.862 174.286 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 11.1 m -146.61 115.58 6.92 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.406 -0.815 . . . . 0.0 110.44 179.346 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -69.41 -30.47 68.44 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.52 0.676 . . . . 0.0 109.429 172.647 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . 0.428 ' HA ' ' NH1' ' A' ' 111' ' ' ARG . 11.0 t30 -111.07 95.77 5.74 Favored 'General case' 0 N--CA 1.449 -0.519 0 CA-C-N 115.245 -0.888 . . . . 0.0 109.675 175.985 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' MET . . . . . 0.496 ' HG3' ' H ' ' A' ' 127' ' ' THR . 10.5 tpt -105.98 -175.72 2.87 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 107.742 -1.206 . . . . 0.0 107.742 177.592 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . 0.496 ' H ' ' HG3' ' A' ' 126' ' ' MET . 4.1 p -115.95 139.07 50.61 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-O 121.441 0.638 . . . . 0.0 112.387 -173.025 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . 0.59 ' HB3' ' CZ ' ' A' ' 112' ' ' PHE . 0.0 OUTLIER -41.2 146.84 0.48 Allowed Pre-proline 0 N--CA 1.468 0.452 0 CA-C-N 114.472 -1.24 . . . . 0.0 113.558 171.593 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 26.0 Cg_endo -61.85 -31.35 85.12 Favored 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 123.464 2.776 . . . . 0.0 113.293 -178.593 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . 0.423 ' HB3' ' CZ ' ' A' ' 128' ' ' ARG . 47.1 t -74.93 -2.38 26.75 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.698 0.285 . . . . 0.0 111.164 -179.125 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . 0.481 ' HB2' ' CD ' ' A' ' 128' ' ' ARG . 14.5 t70 -91.59 129.25 43.39 Favored Pre-proline 0 C--N 1.327 -0.377 0 N-CA-C 110.059 -0.349 . . . . 0.0 110.059 176.289 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -67.85 -26.59 38.11 Favored 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 122.774 2.316 . . . . 0.0 113.414 -176.668 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . 0.561 ' O ' ' HG3' ' A' ' 137' ' ' LYS . 13.7 mmmm -70.44 -28.92 65.41 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.862 0.363 . . . . 0.0 110.238 -178.48 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 134' ' ' THR . . . . . 0.784 HG22 ' CZ ' ' A' ' 138' ' ' PHE . 2.8 m -59.04 -50.91 72.27 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.662 -0.699 . . . . 0.0 109.899 175.004 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . 0.625 ' HA ' ' CD2' ' A' ' 138' ' ' PHE . . . -56.41 -43.78 79.7 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.288 -0.869 . . . . 0.0 111.383 176.567 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 7.6 mt-10 -54.8 -49.16 71.63 Favored 'General case' 0 CA--C 1.516 -0.364 0 CA-C-O 121.316 0.579 . . . . 0.0 110.724 177.793 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . 0.561 ' HG3' ' O ' ' A' ' 133' ' ' LYS . 39.3 mtpt -55.63 -41.65 73.84 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.239 -0.892 . . . . 0.0 111.142 -179.705 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . 0.784 ' CZ ' HG22 ' A' ' 134' ' ' THR . 13.7 m-85 -61.36 -61.2 2.72 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.728 179.35 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . 0.563 HD22 ' N ' ' A' ' 140' ' ' GLU . 0.3 OUTLIER -69.43 -18.91 63.78 Favored 'General case' 0 C--O 1.224 -0.285 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.819 -172.711 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . 0.563 ' N ' HD22 ' A' ' 139' ' ' ASN . 36.1 tt0 -75.39 -51.07 13.98 Favored 'General case' 0 C--N 1.321 -0.64 0 C-N-CA 120.97 -0.292 . . . . 0.0 110.688 175.616 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.41 ' HG ' ' O ' ' A' ' 137' ' ' LYS . 89.3 mt -66.92 -27.11 67.22 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.318 -177.562 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 96.9 mt -85.86 -17.57 35.22 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.653 177.031 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 72.06 30.55 65.27 Favored Glycine 0 N--CA 1.45 -0.368 0 N-CA-C 110.42 -1.072 . . . . 0.0 110.42 -176.202 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.419 ' O ' ' HG ' ' A' ' 144' ' ' LEU . 50.5 tp -95.75 6.29 49.27 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 114.374 -0.913 . . . . 0.0 110.244 -173.912 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -64.14 158.63 22.42 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.742 -0.663 . . . . 0.0 112.305 -179.09 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . 0.48 ' HA2' ' O ' ' A' ' 149' ' ' HIS . . . -104.44 12.12 51.04 Favored Glycine 0 N--CA 1.445 -0.728 0 CA-C-N 115.013 -0.994 . . . . 0.0 111.103 172.5 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 3.5 t-160 -56.64 -57.56 11.86 Favored 'General case' 0 N--CA 1.464 0.232 0 C-N-CA 123.17 0.588 . . . . 0.0 111.039 -177.925 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 16.6 t-80 -90.62 -3.87 57.23 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.751 -176.273 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . 0.48 ' O ' ' HA2' ' A' ' 146' ' ' GLY . 53.6 t-80 178.18 112.5 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 -178.083 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 95.9 m-70 -48.52 113.39 0.75 Allowed 'General case' 0 N--CA 1.467 0.408 0 O-C-N 123.728 0.643 . . . . 0.0 109.671 179.229 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -77.58 123.32 26.47 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.668 -0.696 . . . . 0.0 112.455 -164.129 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 29.9 p-80 . . . . . 0 C--O 1.251 1.181 0 CA-C-O 117.05 -1.452 . . . . 0.0 107.34 172.351 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.48 1.028 0 CA-C-O 120.792 0.329 . . . . 0.0 110.25 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 16.2 p -89.07 -6.38 57.15 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.219 0.533 . . . . 0.0 110.877 179.34 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -84.48 86.69 7.25 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.194 -178.705 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 13.6 ptt180 -132.83 12.43 4.37 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.791 0.805 . . . . 0.0 109.356 172.845 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 51.4 m -156.86 -163.2 1.37 Allowed 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 114.788 -1.097 . . . . 0.0 108.215 -179.251 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -68.54 -74.7 0.58 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.027 -1.082 . . . . 0.0 111.017 176.016 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 93.9 m-20 -110.01 156.4 40.07 Favored Pre-proline 0 C--N 1.321 -0.672 0 N-CA-C 109.203 -0.665 . . . . 0.0 109.203 172.059 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 12.9 Cg_endo -59.25 98.65 0.11 Allowed 'Trans proline' 0 C--O 1.234 0.322 0 C-N-CA 122.4 2.066 . . . . 0.0 112.121 -179.2 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 22.1 m -80.06 140.38 36.53 Favored 'General case' 0 N--CA 1.443 -0.813 0 CA-C-N 115.624 -0.716 . . . . 0.0 109.853 -177.791 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.564 ' HA ' ' CZ ' ' A' ' 100' ' ' PHE . . . 74.78 -39.91 0.43 Allowed 'General case' 0 N--CA 1.47 0.537 0 O-C-N 124.108 0.88 . . . . 0.0 111.312 -177.864 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.429 ' O ' HD23 ' A' ' 25' ' ' LEU . . . -74.89 -11.65 60.18 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.223 178.971 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.722 ' HA ' ' HB3' ' A' ' 25' ' ' LEU . 18.3 p -159.67 93.36 1.09 Allowed 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.857 174.427 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 38.2 p90 -97.76 159.85 14.68 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.437 174.8 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 13.2 p -134.59 115.18 13.56 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.642 0.258 . . . . 0.0 111.117 -178.908 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 65.3 m-85 -138.88 159.62 66.32 Favored Pre-proline 0 N--CA 1.465 0.288 0 CA-C-N 116.451 -0.34 . . . . 0.0 111.3 -177.487 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 79.4 Cg_endo -84.86 134.15 5.23 Favored 'Trans proline' 0 C--N 1.351 0.676 0 C-N-CA 122.683 2.255 . . . . 0.0 113.406 177.895 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . 0.524 ' HB3' ' HB3' ' A' ' 21' ' ' LYS . 7.4 t70 -80.0 160.12 26.0 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 114.826 -1.079 . . . . 0.0 109.428 174.96 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 2.2 tt -46.94 -38.19 4.0 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 O-C-N 124.151 0.907 . . . . 0.0 112.105 -178.392 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 45.0 m-80 -71.82 -13.2 61.62 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.097 0.475 . . . . 0.0 111.056 -178.389 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 95.28 34.43 6.11 Favored Glycine 0 N--CA 1.446 -0.654 0 N-CA-C 110.949 -0.86 . . . . 0.0 110.949 -175.027 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.524 ' HB3' ' HB3' ' A' ' 17' ' ' ASP . 25.7 tptp -106.08 131.05 53.82 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.121 0.486 . . . . 0.0 111.012 -176.241 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 7.6 m -80.76 99.06 8.05 Favored 'General case' 0 C--N 1.314 -0.97 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 179.618 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.756 ' HB ' HD11 ' A' ' 92' ' ' LEU . 25.2 t -109.43 134.52 51.22 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-O 121.321 0.581 . . . . 0.0 109.728 178.848 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . 0.461 ' H ' ' CB ' ' A' ' 27' ' ' ASP . 13.7 m -122.52 166.47 14.75 Favored 'General case' 0 C--N 1.306 -1.287 0 CA-C-N 115.59 -0.732 . . . . 0.0 109.184 178.334 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.722 ' HB3' ' HA ' ' A' ' 12' ' ' SER . 19.6 tp -66.35 -22.51 66.26 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.083 0.468 . . . . 0.0 110.298 179.472 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.498 ' HA ' ' HB2' ' A' ' 29' ' ' LYS . . . -91.29 0.69 57.48 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.746 175.583 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.461 ' CB ' ' H ' ' A' ' 24' ' ' SER . 35.7 t70 -91.73 -33.44 15.02 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 179.415 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.702 HD11 HG21 ' A' ' 90' ' ' ILE . 76.9 mt -105.37 10.3 33.47 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.635 176.166 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.498 ' HB2' ' HA ' ' A' ' 26' ' ' ALA . 64.0 tttt -65.94 148.13 52.28 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 115.443 -0.799 . . . . 0.0 111.12 -176.825 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 121.04 -23.59 7.68 Favored Glycine 0 N--CA 1.447 -0.622 0 N-CA-C 111.185 -0.766 . . . . 0.0 111.185 -177.092 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.529 ' HD3' ' HA ' ' A' ' 63' ' ' ASP . 43.7 mttm -128.49 166.72 18.23 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 109.527 -0.546 . . . . 0.0 109.527 177.574 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.912 ' HB2' HG22 ' A' ' 64' ' ' ILE . 67.9 m-85 -66.55 144.87 56.18 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.83 0.348 . . . . 0.0 110.54 -179.644 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 47.0 mm -117.13 128.67 74.45 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-N 116.301 -0.408 . . . . 0.0 110.838 -176.31 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 84.6 t80 -110.57 121.54 45.57 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 171.774 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.714 ' HB ' ' HB ' ' A' ' 113' ' ' ILE . 54.5 mt -107.78 128.59 62.91 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-O 120.905 0.383 . . . . 0.0 110.569 -178.995 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.455 ' O ' ' HA ' ' A' ' 68' ' ' SER . 4.5 t70 -132.77 141.62 48.6 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 176.693 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.502 ' HA ' ' O ' ' A' ' 69' ' ' LEU . 39.1 t -89.5 112.82 24.94 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 C-N-CA 120.531 -0.468 . . . . 0.0 111.675 -176.289 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' TRP . . . . . 0.682 ' CZ2' ' HB2' ' A' ' 91' ' ' GLN . 0.7 OUTLIER -102.72 132.91 48.54 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.642 -0.708 . . . . 0.0 109.353 178.905 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -147.71 164.57 33.15 Favored 'General case' 0 N--CA 1.464 0.252 0 N-CA-C 111.689 0.255 . . . . 0.0 111.689 -175.03 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.597 HG22 ' OD2' ' A' ' 72' ' ' ASP . 4.2 t -99.22 -33.08 10.9 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-O 120.856 0.36 . . . . 0.0 110.794 172.037 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 21.2 p-90 -82.94 21.21 1.07 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.158 0.504 . . . . 0.0 110.531 -178.947 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . 0.816 ' SG ' ' HB3' ' A' ' 45' ' ' CYS . 12.7 p -87.51 -69.88 0.66 Allowed 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.35 -176.649 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.439 ' N ' ' SG ' ' A' ' 42' ' ' CYS . . . 110.35 -92.36 0.68 Allowed Glycine 0 N--CA 1.448 -0.565 0 C-N-CA 121.111 -0.566 . . . . 0.0 111.949 -175.511 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.439 ' HD2' ' O ' ' A' ' 42' ' ' CYS . 12.2 Cg_endo -55.97 -29.57 74.11 Favored 'Trans proline' 0 C--N 1.349 0.602 0 C-N-CA 123.464 2.776 . . . . 0.0 112.747 -178.65 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . 0.993 ' HB2' ' HD3' ' A' ' 110' ' ' PRO . 43.6 t -54.33 -33.49 59.04 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.729 -0.669 . . . . 0.0 111.445 178.978 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.526 ' HA ' ' HG ' ' A' ' 49' ' ' LEU . 56.8 mtp180 -68.31 -18.0 64.4 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.712 0.291 . . . . 0.0 110.937 -176.396 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -82.02 -22.47 59.28 Favored Glycine 0 N--CA 1.448 -0.512 0 C-N-CA 120.713 -0.756 . . . . 0.0 111.865 177.135 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -104.63 -5.67 21.19 Favored 'General case' 0 C--N 1.329 -0.313 0 O-C-N 122.783 -0.245 . . . . 0.0 111.043 179.488 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.717 HD13 HD11 ' A' ' 87' ' ' LEU . 65.0 mt -53.64 -48.04 94.54 Favored Pre-proline 0 C--O 1.235 0.295 0 CA-C-N 116.677 -0.238 . . . . 0.0 110.975 174.401 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.687 ' O ' ' HG2' ' A' ' 54' ' ' GLU . 54.2 Cg_exo -54.57 -40.91 81.68 Favored 'Trans proline' 0 C--N 1.356 0.949 0 C-N-CA 121.824 1.682 . . . . 0.0 112.029 171.724 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -69.29 -31.56 70.14 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-O 121.26 0.552 . . . . 0.0 110.571 -176.728 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 6.6 tt -67.04 -48.25 68.89 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.364 -0.834 . . . . 0.0 109.916 -179.395 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.566 ' O ' ' HG3' ' A' ' 57' ' ' GLU . 6.2 ptmm? -67.58 -32.45 73.21 Favored 'General case' 0 C--N 1.333 -0.134 0 C-N-CA 121.009 -0.276 . . . . 0.0 110.48 -179.909 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.687 ' HG2' ' O ' ' A' ' 50' ' ' PRO . 51.6 mm-40 -59.51 -47.38 85.76 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.904 0.383 . . . . 0.0 110.394 176.493 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 29.6 mt -61.9 -53.41 56.17 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.683 175.598 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.566 ' HA ' ' CD2' ' A' ' 66' ' ' PHE . 4.5 tm-20 -44.7 -59.87 2.29 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 114.872 -1.058 . . . . 0.0 112.039 179.957 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.566 ' HG3' ' O ' ' A' ' 53' ' ' LYS . 20.1 mt-10 -71.78 -35.6 70.08 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.77 0.319 . . . . 0.0 111.664 -173.082 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.402 ' HD3' ' CE2' ' A' ' 59' ' ' TYR . 83.5 tttt -67.09 -39.48 86.78 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.224 0.535 . . . . 0.0 110.771 -178.875 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.475 ' HB3' HD11 ' A' ' 64' ' ' ILE . 96.9 m-85 -105.32 10.27 33.58 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.241 -176.141 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -68.19 157.41 35.47 Favored 'General case' 0 C--O 1.239 0.516 0 CA-C-O 120.795 0.331 . . . . 0.0 110.427 172.215 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 77.9 8.49 87.3 Favored Glycine 0 N--CA 1.447 -0.633 0 C-N-CA 120.98 -0.629 . . . . 0.0 112.583 178.421 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.524 ' HB2' HG12 ' A' ' 64' ' ' ILE . 43.6 mmtm -98.77 -161.17 0.85 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.129 0.49 . . . . 0.0 110.029 177.99 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.529 ' HA ' ' HD3' ' A' ' 31' ' ' LYS . 21.5 m-20 -91.16 32.69 1.01 Allowed 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 115.352 -0.84 . . . . 0.0 110.556 179.267 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.912 HG22 ' HB2' ' A' ' 32' ' ' TYR . 31.7 pt -141.67 165.59 18.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.129 -176.955 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 87.1 m-70 -136.44 137.72 40.73 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 175.118 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . 0.566 ' CD2' ' HA ' ' A' ' 56' ' ' GLU . 93.4 m-85 -94.69 110.11 21.98 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.624 -0.51 . . . . 0.0 109.624 174.172 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.601 ' O ' ' HA ' ' A' ' 35' ' ' ILE . 57.1 t -116.81 106.17 19.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.713 -175.581 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . 0.455 ' HA ' ' O ' ' A' ' 36' ' ' ASP . 34.5 m -88.96 133.41 34.33 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.171 177.302 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.502 ' O ' ' HA ' ' A' ' 37' ' ' VAL . 79.2 mt -117.24 135.18 53.99 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.735 0.302 . . . . 0.0 110.42 176.712 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . 0.436 ' O ' ' HB3' ' A' ' 94' ' ' MET . 1.4 t -113.87 120.73 41.73 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.279 -0.418 . . . . 0.0 111.63 -176.247 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 1.8 p -89.14 16.4 7.27 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.908 177.142 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.597 ' OD2' HG22 ' A' ' 40' ' ' THR . 1.4 m-20 -68.23 132.75 47.69 Favored 'General case' 0 CA--C 1.518 -0.266 0 N-CA-C 109.919 -0.4 . . . . 0.0 109.919 178.923 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 38.7 ttpt -76.85 -35.37 57.55 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-O 121.18 0.514 . . . . 0.0 109.862 177.86 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . 0.548 ' HB2' ' HB3' ' A' ' 77' ' ' ALA . 0.9 OUTLIER -74.29 102.07 4.23 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.538 -0.755 . . . . 0.0 110.216 176.553 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 10.8 tttt -78.19 -55.68 5.07 Favored 'General case' 0 C--N 1.319 -0.732 0 C-N-CA 120.521 -0.472 . . . . 0.0 111.282 -178.343 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 47.4 tptt -60.43 -48.6 81.04 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.254 -174.986 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.548 ' HB3' ' HB2' ' A' ' 74' ' ' ASN . . . -58.31 -36.38 73.27 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.972 178.714 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' TRP . . . . . 0.524 ' O ' HG12 ' A' ' 82' ' ' VAL . 12.2 t-105 -76.9 -48.6 17.8 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.197 -177.714 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.405 ' O ' HG13 ' A' ' 82' ' ' VAL . 4.6 pt-20 -62.15 -32.91 73.57 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-O 120.938 0.399 . . . . 0.0 110.919 -176.326 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . 0.597 HD22 ' N ' ' A' ' 81' ' ' MET . 0.2 OUTLIER -79.99 -27.3 39.64 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 119.717 -0.793 . . . . 0.0 111.149 177.866 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . 0.597 ' N ' HD22 ' A' ' 80' ' ' ASN . 15.4 ttt -65.91 -48.47 71.32 Favored 'General case' 0 C--O 1.22 -0.495 0 C-N-CA 120.45 -0.5 . . . . 0.0 111.068 173.481 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.645 HG23 ' HB2' ' A' ' 87' ' ' LEU . 0.6 OUTLIER -58.88 -37.59 67.83 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 C-N-CA 120.408 -0.517 . . . . 0.0 110.518 177.832 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 58.7 m -63.33 -41.96 98.94 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.84 175.241 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 1.3 tmtp? -71.81 -45.17 62.4 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.435 -178.873 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -72.36 -10.91 60.4 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.461 -0.79 . . . . 0.0 111.627 -178.026 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 22.5 mt-30 67.67 49.27 0.98 Allowed 'General case' 0 N--CA 1.464 0.267 0 O-C-N 123.517 0.511 . . . . 0.0 111.855 173.731 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.717 HD11 HD13 ' A' ' 49' ' ' LEU . 21.2 mt -104.67 130.66 52.66 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 176.687 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.545 ' C ' ' HD3' ' A' ' 88' ' ' LYS . 0.0 OUTLIER -135.53 165.51 25.35 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.8 0.333 . . . . 0.0 111.847 -179.112 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 140.3 -142.08 12.1 Favored Glycine 0 N--CA 1.449 -0.448 0 N-CA-C 109.998 -1.241 . . . . 0.0 109.998 -176.208 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.702 HG21 HD11 ' A' ' 28' ' ' LEU . 45.9 mm -108.79 113.18 43.39 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 169.792 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . 0.682 ' HB2' ' CZ2' ' A' ' 38' ' ' TRP . 1.7 pt20 -141.48 104.17 4.53 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-O 121.836 0.827 . . . . 0.0 112.207 -169.33 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.756 HD11 ' HB ' ' A' ' 23' ' ' VAL . 3.0 mm? -99.04 163.31 12.63 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 114.905 -1.043 . . . . 0.0 110.766 -177.439 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 25.2 t-80 -131.68 121.73 24.78 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.93 -174.95 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' MET . . . . . 0.436 ' HB3' ' O ' ' A' ' 70' ' ' SER . 25.3 ttm -73.07 -61.11 1.93 Allowed 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 114.901 -1.045 . . . . 0.0 110.697 -179.169 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 95.04 -101.62 2.74 Favored Glycine 0 N--CA 1.446 -0.671 0 C-N-CA 120.661 -0.78 . . . . 0.0 112.712 178.14 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 19.2 p -110.91 16.68 21.12 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 111.884 0.327 . . . . 0.0 111.884 -175.508 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -102.06 48.18 0.88 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.051 0.453 . . . . 0.0 110.452 -179.133 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -68.55 -6.82 27.54 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.516 -174.471 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 28.9 m -64.49 -30.99 72.02 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.113 0.482 . . . . 0.0 110.025 173.082 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . 0.564 ' CZ ' ' HA ' ' A' ' 10' ' ' ALA . 20.5 t80 -74.2 -36.79 64.01 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 176.442 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' MET . . . . . 0.699 ' HG3' HG13 ' A' ' 106' ' ' ILE . 12.9 ttt -59.07 -45.55 90.53 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.063 -0.971 . . . . 0.0 110.311 172.138 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -67.09 -35.14 79.15 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.985 179.733 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -61.26 -38.19 85.8 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-O 120.997 0.427 . . . . 0.0 111.167 -179.504 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 39.7 m-85 -87.44 -7.66 57.41 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.533 179.316 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 80.0 mt 61.05 30.49 19.56 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.956 -179.696 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . 0.699 HG13 ' HG3' ' A' ' 101' ' ' MET . 22.9 pt -77.79 77.79 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 121.685 0.755 . . . . 0.0 110.901 179.008 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 17.6 p-10 -88.28 -54.26 4.29 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.613 -0.721 . . . . 0.0 111.542 -177.878 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -81.53 63.22 4.39 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 121.103 -0.57 . . . . 0.0 112.379 -176.559 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.593 ' HA ' ' C ' ' A' ' 110' ' ' PRO . 44.9 pt -71.43 147.46 92.72 Favored Pre-proline 0 C--N 1.324 -0.509 0 N-CA-C 110.496 -0.187 . . . . 0.0 110.496 -179.363 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . 0.993 ' HD3' ' HB2' ' A' ' 45' ' ' CYS . 24.9 Cg_endo -62.57 136.05 19.57 Favored 'Cis proline' 0 C--N 1.348 0.52 0 C-N-CA 124.013 -1.245 . . . . 0.0 113.168 2.096 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . 0.593 ' HG3' ' HA ' ' A' ' 106' ' ' ILE . 0.0 OUTLIER -113.15 141.5 46.85 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.41 -0.814 . . . . 0.0 109.764 -177.708 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . 0.487 ' O ' ' HA ' ' A' ' 125' ' ' ASN . 0.3 OUTLIER -97.95 124.99 42.65 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 114.935 -1.03 . . . . 0.0 112.116 -173.657 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.714 ' HB ' ' HB ' ' A' ' 35' ' ' ILE . 85.6 mt -136.01 148.2 27.87 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.487 0 CA-C-O 120.737 0.303 . . . . 0.0 110.8 178.442 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 33.5 tp -137.77 137.8 38.61 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 116.62 -0.264 . . . . 0.0 110.335 179.411 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.519 ' N ' HD12 ' A' ' 115' ' ' LEU . 0.3 OUTLIER -135.58 156.26 49.15 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-O 121.504 0.669 . . . . 0.0 111.41 -178.723 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . 0.703 ' HB3' ' HB2' ' A' ' 120' ' ' LYS . 11.2 t70 -75.77 162.67 27.99 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 114.572 -1.194 . . . . 0.0 110.876 179.695 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . 0.484 ' HA ' ' O ' ' A' ' 31' ' ' LYS . 17.0 mtm180 -49.94 -32.67 15.39 Favored 'General case' 0 N--CA 1.47 0.555 0 O-C-N 124.513 1.133 . . . . 0.0 112.703 -177.408 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . 0.769 ' HB3' ' HG3' ' A' ' 120' ' ' LYS . 19.8 t70 -77.97 -5.58 51.67 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-O 121.256 0.55 . . . . 0.0 110.948 -178.512 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 90.55 21.77 36.28 Favored Glycine 0 N--CA 1.438 -1.191 0 N-CA-C 110.459 -1.056 . . . . 0.0 110.459 -171.138 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . 0.769 ' HG3' ' HB3' ' A' ' 118' ' ' ASP . 35.9 mttp -87.22 105.29 17.11 Favored 'General case' 0 CA--C 1.515 -0.375 0 C-N-CA 120.304 -0.558 . . . . 0.0 110.342 -176.074 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 0.636 ' H ' HD12 ' A' ' 121' ' ' ILE . 3.6 mp -47.23 108.61 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-O 121.147 0.498 . . . . 0.0 110.669 178.353 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' ILE . . . . . 0.493 ' H ' ' HA ' ' A' ' 115' ' ' LEU . 48.2 mt -83.56 -51.6 14.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 -177.952 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 15.0 m -136.01 126.3 26.51 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.189 -0.914 . . . . 0.0 109.988 -178.665 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -74.02 -18.74 60.81 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.386 0.612 . . . . 0.0 109.803 176.616 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . 0.487 ' HA ' ' O ' ' A' ' 112' ' ' PHE . 3.9 p30 -140.18 118.09 11.78 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.106 -0.952 . . . . 0.0 109.995 174.617 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' MET . . . . . 0.435 ' N ' ' HD1' ' A' ' 112' ' ' PHE . 15.9 tpt -110.94 -115.82 0.31 Allowed 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.686 -0.688 . . . . 0.0 109.859 179.084 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . 0.445 ' HB ' ' HB3' ' A' ' 131' ' ' ASP . 3.3 p -145.76 139.91 26.79 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 122.379 0.272 . . . . 0.0 110.321 178.571 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 65.7 mtt180 -62.87 161.5 28.96 Favored Pre-proline 0 N--CA 1.468 0.458 0 N-CA-C 112.876 0.695 . . . . 0.0 112.876 179.924 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -49.47 -31.25 23.26 Favored 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 123.862 3.041 . . . . 0.0 113.165 170.499 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 22.7 t -74.08 -26.34 60.32 Favored 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 111.543 0.201 . . . . 0.0 111.543 -179.264 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . 0.445 ' HB3' ' HB ' ' A' ' 127' ' ' THR . 8.7 t70 -81.9 128.1 69.78 Favored Pre-proline 0 C--N 1.331 -0.22 0 C-N-CA 120.236 -0.585 . . . . 0.0 110.734 179.64 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . 0.434 ' HD3' ' HA ' ' A' ' 131' ' ' ASP . 31.4 Cg_exo -61.86 -25.01 77.85 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 123.233 2.622 . . . . 0.0 113.671 -178.714 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . 0.561 ' O ' ' HB2' ' A' ' 137' ' ' LYS . 45.5 mmtm -61.04 -34.81 75.45 Favored 'General case' 0 CA--C 1.516 -0.357 0 CA-C-O 120.674 0.273 . . . . 0.0 110.926 -178.288 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 134' ' ' THR . . . . . 0.643 HG22 ' CZ ' ' A' ' 138' ' ' PHE . 1.2 m -59.56 -52.58 64.96 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.99 -0.55 . . . . 0.0 109.792 177.018 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . 0.558 ' HA ' ' CD2' ' A' ' 138' ' ' PHE . . . -60.44 -47.08 87.66 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.242 -0.89 . . . . 0.0 111.891 -179.481 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . 0.549 ' HG2' ' HA ' ' A' ' 133' ' ' LYS . 12.5 pt-20 -73.14 -23.19 60.43 Favored 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 120.444 -0.502 . . . . 0.0 110.852 -176.177 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . 0.561 ' HB2' ' O ' ' A' ' 133' ' ' LYS . 4.1 tmtm? -66.24 -43.01 87.76 Favored 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 109.492 -0.558 . . . . 0.0 109.492 175.855 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . 0.643 ' CZ ' HG22 ' A' ' 134' ' ' THR . 9.9 m-85 -56.37 -50.59 71.11 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.817 -0.629 . . . . 0.0 109.484 174.459 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 85.9 m-20 -54.66 -46.42 74.0 Favored 'General case' 0 C--O 1.222 -0.383 0 CA-C-N 115.795 -0.639 . . . . 0.0 109.881 176.984 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -53.88 -48.78 69.73 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.441 179.28 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.532 HD21 ' HE3' ' A' ' 137' ' ' LYS . 91.1 mt -58.48 -45.93 87.68 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.451 -177.594 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -86.27 -3.38 58.97 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.898 0.38 . . . . 0.0 111.053 -178.603 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 75.53 26.33 65.75 Favored Glycine 0 N--CA 1.452 -0.278 0 N-CA-C 111.753 -0.539 . . . . 0.0 111.753 177.81 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 49.7 tp -86.59 3.49 44.18 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 114.879 -0.661 . . . . 0.0 111.083 -174.619 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -70.03 165.37 21.99 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.21 0.529 . . . . 0.0 111.253 178.839 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -144.3 83.76 0.2 Allowed Glycine 0 N--CA 1.445 -0.72 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.626 178.264 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 85.1 m-70 -111.42 112.12 23.64 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 109.641 -0.504 . . . . 0.0 109.641 -179.715 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 8.7 p-80 -99.03 161.67 13.49 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 120.76 0.314 . . . . 0.0 110.379 179.112 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 68.5 m-70 -103.76 178.47 4.55 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.071 -0.513 . . . . 0.0 109.75 -179.245 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 26.3 t-80 -126.06 133.7 51.63 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 179.664 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 45.7 t-80 -62.45 120.69 11.56 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.22 -178.311 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 11.8 t-160 . . . . . 0 C--O 1.245 0.845 0 CA-C-N 115.658 -0.701 . . . . 0.0 109.461 176.195 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 72.0 mtm . . . . . 0 N--CA 1.479 1.009 0 CA-C-O 120.547 0.213 . . . . 0.0 110.651 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 20.2 m -112.31 94.32 4.87 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.745 0.307 . . . . 0.0 111.094 -177.906 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -168.42 98.48 0.42 Allowed 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 109.117 -0.697 . . . . 0.0 109.117 175.637 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . 0.438 ' H ' ' HD2' ' A' ' 4' ' ' ARG . 0.0 OUTLIER -72.26 2.97 5.12 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 112.338 0.495 . . . . 0.0 112.338 -173.841 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 9.4 m -106.23 4.8 29.24 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 120.987 0.422 . . . . 0.0 110.766 -179.138 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 82.17 -68.8 3.44 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.919 -0.657 . . . . 0.0 112.694 178.986 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 10.2 p30 -88.32 159.03 48.34 Favored Pre-proline 0 C--N 1.324 -0.54 0 N-CA-C 109.392 -0.595 . . . . 0.0 109.392 177.523 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -75.64 89.69 1.19 Allowed 'Trans proline' 0 N--CA 1.453 -0.906 0 C-N-CA 121.748 1.632 . . . . 0.0 111.819 178.597 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 16.2 m -77.03 94.91 4.07 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.159 -0.928 . . . . 0.0 109.978 179.248 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.512 ' HB2' ' HZ ' ' A' ' 100' ' ' PHE . . . 68.49 -75.44 0.07 Allowed 'General case' 0 C--O 1.231 0.11 0 CA-C-N 115.178 -0.919 . . . . 0.0 110.482 -177.473 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . 63.05 -69.36 0.07 Allowed 'General case' 0 N--CA 1.468 0.449 0 O-C-N 124.294 0.996 . . . . 0.0 111.996 -178.875 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 50.5 m -156.23 109.72 2.7 Favored 'General case' 0 C--N 1.311 -1.095 0 CA-C-N 115.223 -0.899 . . . . 0.0 109.615 179.938 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . 0.447 ' H ' ' HB2' ' A' ' 25' ' ' LEU . 12.7 p90 -124.57 176.43 6.53 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.753 -177.514 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.561 ' HA ' ' HA ' ' A' ' 24' ' ' SER . 3.1 p -142.03 122.75 14.29 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.301 177.63 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 45.5 m-85 -132.09 145.67 58.38 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-O 120.819 0.342 . . . . 0.0 111.609 -177.685 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.607 ' HA ' ' O ' ' A' ' 21' ' ' LYS . 78.3 Cg_endo -81.69 128.19 5.92 Favored 'Trans proline' 0 N--CA 1.46 -0.48 0 C-N-CA 122.817 2.345 . . . . 0.0 113.931 179.692 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . 0.488 ' HB3' ' HB3' ' A' ' 21' ' ' LYS . 1.3 t70 -71.26 161.16 31.54 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 114.89 -1.05 . . . . 0.0 109.321 169.789 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.553 HG21 HG11 ' A' ' 82' ' ' VAL . 29.9 pt -46.76 -38.18 3.79 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.358 0 O-C-N 124.165 0.915 . . . . 0.0 112.849 -174.158 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 42.3 m-80 -75.88 -13.23 60.26 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-O 120.984 0.421 . . . . 0.0 111.357 -176.159 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 103.17 23.64 8.41 Favored Glycine 0 N--CA 1.449 -0.456 0 N-CA-C 111.182 -0.767 . . . . 0.0 111.182 -174.318 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.865 ' HE3' HG22 ' A' ' 23' ' ' VAL . 19.8 tptt -90.23 137.65 32.17 Favored 'General case' 0 C--O 1.219 -0.523 0 CA-C-O 121.081 0.467 . . . . 0.0 110.545 -176.063 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.493 ' N ' ' HD2' ' A' ' 21' ' ' LYS . 52.2 m -91.32 99.98 12.86 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-O 121.023 0.439 . . . . 0.0 110.163 -177.181 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.865 HG22 ' HE3' ' A' ' 21' ' ' LYS . 41.5 t -104.35 113.82 42.32 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 115.707 -0.679 . . . . 0.0 109.475 178.156 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . 0.561 ' HA ' ' HA ' ' A' ' 14' ' ' SER . 7.1 m -105.98 173.34 6.35 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.249 -177.984 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.552 HD11 ' HA3' ' A' ' 119' ' ' GLY . 3.4 tm? -59.01 -45.23 91.2 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.058 179.035 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -72.08 -17.9 61.96 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.973 0.416 . . . . 0.0 111.076 -177.851 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -73.8 -28.68 61.76 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.92 -0.582 . . . . 0.0 109.815 -178.91 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.501 HD11 HG21 ' A' ' 90' ' ' ILE . 97.6 mt -111.54 -1.18 15.91 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.316 179.25 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 85.2 tttt -67.51 146.29 54.09 Favored 'General case' 0 N--CA 1.448 -0.543 0 CA-C-O 121.104 0.478 . . . . 0.0 111.497 -174.119 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 116.9 -20.5 11.64 Favored Glycine 0 N--CA 1.445 -0.746 0 N-CA-C 111.139 -0.785 . . . . 0.0 111.139 -177.309 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.48 ' HB3' ' N ' ' A' ' 64' ' ' ILE . 64.3 mttm -126.11 149.38 48.98 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.727 -0.237 . . . . 0.0 110.656 178.746 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.547 ' CE1' ' HA ' ' A' ' 116' ' ' ASP . 22.4 m-85 -61.57 119.66 9.05 Favored 'General case' 0 CA--C 1.516 -0.341 0 CA-C-O 120.75 0.31 . . . . 0.0 110.707 -179.978 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 68.6 mt -100.29 115.35 41.39 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.921 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.057 -174.673 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 81.7 t80 -92.03 120.71 32.92 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 108.669 -0.864 . . . . 0.0 108.669 170.953 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.596 ' HA ' ' O ' ' A' ' 67' ' ' VAL . 49.8 mt -107.73 122.64 62.32 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-O 120.985 0.421 . . . . 0.0 110.616 -178.802 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.53 ' O ' ' HA ' ' A' ' 68' ' ' SER . 1.9 t70 -120.06 159.47 24.72 Favored 'General case' 0 C--N 1.315 -0.926 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 174.432 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.591 HG11 HG21 ' A' ' 109' ' ' ILE . 42.9 t -102.32 114.55 42.11 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.98 0 C-N-CA 119.651 -0.819 . . . . 0.0 111.822 178.882 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' TRP . . . . . 0.621 ' CE3' ' HZ2' ' A' ' 78' ' ' TRP . 0.8 OUTLIER -102.62 134.44 45.98 Favored 'General case' 0 C--O 1.225 -0.198 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 -179.994 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.646 ' HB3' ' SG ' ' A' ' 42' ' ' CYS . . . -146.94 164.68 32.15 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 112.285 0.476 . . . . 0.0 112.285 -175.474 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.425 HG23 ' SD ' ' A' ' 81' ' ' MET . 1.4 m -78.64 -30.82 46.59 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.519 0.676 . . . . 0.0 110.383 178.117 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . 0.58 ' CH2' HD11 ' A' ' 109' ' ' ILE . 9.4 p-90 -106.48 21.83 16.8 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.234 -0.894 . . . . 0.0 112.116 -172.486 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . 0.646 ' SG ' ' HB3' ' A' ' 39' ' ' ALA . 25.7 p -116.99 88.98 3.01 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.477 0.656 . . . . 0.0 109.972 173.434 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -56.79 -53.97 40.05 Favored Glycine 0 CA--C 1.524 0.644 0 CA-C-N 115.486 -0.779 . . . . 0.0 113.912 -178.0 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 78.2 Cg_exo -52.41 -35.91 67.26 Favored 'Trans proline' 0 C--N 1.357 0.992 0 C-N-CA 122.818 2.345 . . . . 0.0 113.144 -178.333 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . 0.723 ' HB2' ' HD3' ' A' ' 110' ' ' PRO . 51.2 t -57.21 -30.82 64.88 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 121.041 0.448 . . . . 0.0 111.308 -177.564 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.577 ' HA ' HD12 ' A' ' 49' ' ' LEU . 41.9 mtp-105 -74.67 0.25 15.74 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.114 -0.493 . . . . 0.0 111.298 -174.162 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -84.45 -40.24 8.53 Favored Glycine 0 N--CA 1.446 -0.65 0 N-CA-C 111.539 -0.625 . . . . 0.0 111.539 174.22 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.461 ' CD ' ' HE ' ' A' ' 128' ' ' ARG . 4.4 pm0 -93.92 -8.28 40.63 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 111.531 0.197 . . . . 0.0 111.531 -179.447 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.614 ' HG ' ' O ' ' A' ' 45' ' ' CYS . 48.6 mt -54.97 -51.47 79.17 Favored Pre-proline 0 CA--C 1.535 0.374 0 N-CA-C 111.773 0.286 . . . . 0.0 111.773 177.473 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.613 ' HD3' ' HB2' ' A' ' 49' ' ' LEU . 50.8 Cg_exo -57.77 -38.08 94.21 Favored 'Trans proline' 0 C--N 1.357 1.007 0 C-N-CA 122.007 1.805 . . . . 0.0 112.077 175.574 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -70.01 -33.26 71.78 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.009 0.433 . . . . 0.0 110.775 -179.921 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 9.3 tt -66.56 -48.67 68.93 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.59 -177.759 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.564 ' O ' ' HG3' ' A' ' 57' ' ' GLU . 12.4 ptmm? -62.58 -42.59 99.65 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 109.97 -0.381 . . . . 0.0 109.97 177.676 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -62.91 -34.47 77.51 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.323 179.687 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 18.2 mt -60.89 -48.02 83.74 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.931 175.42 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.453 ' HB2' ' HB2' ' A' ' 66' ' ' PHE . 7.8 tp10 -63.19 -41.78 99.23 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.572 -0.74 . . . . 0.0 109.999 178.615 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.564 ' HG3' ' O ' ' A' ' 53' ' ' LYS . 35.9 mt-10 -66.94 -21.38 65.98 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.827 177.627 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 61.7 tttp -86.21 -43.71 12.76 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.582 -179.267 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 80.3 m-85 -95.45 0.52 53.38 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 112.097 0.406 . . . . 0.0 112.097 -174.062 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -58.31 111.78 1.33 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.113 0.483 . . . . 0.0 110.829 176.349 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 150.69 -36.07 0.92 Allowed Glycine 0 N--CA 1.445 -0.718 0 N-CA-C 111.234 -0.746 . . . . 0.0 111.234 -178.597 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.551 ' HB3' HD22 ' A' ' 142' ' ' LEU . 2.2 mmmm -103.12 -160.64 0.79 Allowed 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.104 0.478 . . . . 0.0 110.695 175.93 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.446 ' H ' ' HE2' ' A' ' 62' ' ' LYS . 23.0 m-20 -97.92 79.15 2.61 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 116.024 -0.534 . . . . 0.0 111.884 -174.988 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.588 ' HB ' HD21 ' A' ' 142' ' ' LEU . 14.7 tt -154.03 156.93 4.81 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 115.59 -0.732 . . . . 0.0 109.613 176.725 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' HIS . . . . . 0.464 ' CE1' ' HD2' ' A' ' 31' ' ' LYS . 47.6 m-70 -143.61 142.59 31.11 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 109.893 -0.41 . . . . 0.0 109.893 175.857 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . 0.453 ' HB2' ' HB2' ' A' ' 56' ' ' GLU . 87.5 m-85 -109.88 102.93 11.65 Favored 'General case' 0 C--N 1.314 -0.96 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 172.28 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.615 HG22 ' HB ' ' A' ' 90' ' ' ILE . 51.1 t -119.68 125.98 74.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 115.134 -0.939 . . . . 0.0 110.72 -171.85 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . 0.535 ' HB2' ' OE1' ' A' ' 91' ' ' GLN . 21.2 m -107.31 140.59 39.98 Favored 'General case' 0 C--N 1.312 -1.061 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.261 176.951 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 57.4 tp -117.76 133.52 55.85 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.089 179.388 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . 0.437 ' O ' ' HB3' ' A' ' 94' ' ' MET . 1.6 t -109.81 116.9 32.5 Favored 'General case' 0 C--O 1.221 -0.446 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.845 -172.303 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 42.6 m -85.55 19.85 2.27 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 120.827 0.346 . . . . 0.0 111.1 177.937 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.548 ' OD1' ' HA ' ' A' ' 39' ' ' ALA . 3.6 m-20 -73.95 147.83 42.72 Favored 'General case' 0 CA--C 1.517 -0.321 0 CA-C-O 121.261 0.553 . . . . 0.0 111.41 -177.228 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.48 ' HB2' ' HE3' ' A' ' 73' ' ' LYS . 28.1 ttmt -95.38 -32.61 12.85 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 115.415 -0.812 . . . . 0.0 109.912 177.734 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -78.86 73.74 5.4 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.703 -0.681 . . . . 0.0 109.722 -178.319 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 10.5 tttt -58.55 -50.8 72.46 Favored 'General case' 0 C--N 1.323 -0.575 0 C-N-CA 120.71 -0.396 . . . . 0.0 111.437 -175.116 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.446 ' HA ' ' OE1' ' A' ' 79' ' ' GLU . 1.6 tmtt? -57.49 -48.01 80.39 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.695 -177.795 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -67.38 -38.44 84.72 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-O 121.475 0.655 . . . . 0.0 110.126 -177.545 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' TRP . . . . . 0.621 ' HZ2' ' CE3' ' A' ' 38' ' ' TRP . 13.8 t-105 -71.28 -47.65 55.62 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 115.1 -0.955 . . . . 0.0 111.412 -178.348 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.446 ' OE1' ' HA ' ' A' ' 76' ' ' LYS . 3.1 pt-20 -62.23 -37.04 83.87 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-O 120.631 0.253 . . . . 0.0 111.405 -175.547 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 6.0 p30 -77.45 -31.29 53.72 Favored 'General case' 0 C--N 1.332 -0.181 0 C-N-CA 119.413 -0.915 . . . . 0.0 110.301 179.581 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . 0.425 ' SD ' HG23 ' A' ' 40' ' ' THR . 16.3 ttt -64.67 -46.86 80.64 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.632 -0.258 . . . . 0.0 111.497 176.661 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.686 HG23 ' HB2' ' A' ' 87' ' ' LEU . 1.0 OUTLIER -60.44 -36.74 71.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 C-N-CA 120.373 -0.531 . . . . 0.0 110.389 175.982 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 31.3 m -64.13 -38.11 89.89 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.641 177.046 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . 0.47 ' HA ' ' HD3' ' A' ' 84' ' ' LYS . 35.3 mmtm -74.03 -47.44 36.89 Favored 'General case' 0 CA--C 1.519 -0.222 0 CA-C-O 121.214 0.531 . . . . 0.0 111.385 178.213 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -72.74 -8.12 53.89 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.319 -0.855 . . . . 0.0 111.918 -178.442 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 49.9 mt-30 69.23 26.06 5.52 Favored 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 112.634 0.605 . . . . 0.0 112.634 169.91 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.686 ' HB2' HG23 ' A' ' 82' ' ' VAL . 18.8 mt -67.77 108.54 3.0 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.719 0.295 . . . . 0.0 110.393 -178.091 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.417 ' HB2' ' HE2' ' A' ' 53' ' ' LYS . 39.7 mmtm -95.87 -177.44 4.03 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.388 -178.68 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 96.56 -162.57 22.44 Favored Glycine 0 N--CA 1.448 -0.556 0 N-CA-C 111.017 -0.833 . . . . 0.0 111.017 -174.632 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.615 ' HB ' HG22 ' A' ' 67' ' ' VAL . 49.4 mm -97.31 113.62 32.22 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 117.435 0.618 . . . . 0.0 109.693 176.885 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . 0.61 ' HB3' ' CZ2' ' A' ' 38' ' ' TRP . 60.4 mm-40 -123.98 106.77 10.67 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.45 -173.965 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 41.7 mt -104.67 145.61 30.09 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.095 -175.636 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' HIS . . . . . 0.518 ' O ' ' HD2' ' A' ' 16' ' ' PRO . 26.7 t-80 -113.22 139.76 48.52 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-O 121.502 0.668 . . . . 0.0 111.383 -177.929 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' MET . . . . . 0.634 ' HG3' ' HB2' ' A' ' 97' ' ' ASP . 27.1 ttm -107.72 94.18 4.94 Favored 'General case' 0 N--CA 1.442 -0.849 0 CA-C-N 114.905 -1.043 . . . . 0.0 108.629 179.075 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -68.93 78.12 0.28 Allowed Glycine 0 C--N 1.315 -0.592 0 CA-C-N 115.122 -0.945 . . . . 0.0 113.599 -178.669 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 5.3 m 71.87 5.13 5.27 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 123.148 0.579 . . . . 0.0 111.674 174.337 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . 0.634 ' HB2' ' HG3' ' A' ' 94' ' ' MET . 13.2 m-20 -79.02 32.06 0.21 Allowed 'General case' 0 N--CA 1.466 0.331 0 CA-C-O 121.036 0.446 . . . . 0.0 110.011 178.743 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . 0.586 ' HA ' ' SD ' ' A' ' 94' ' ' MET . 0.0 OUTLIER -78.59 14.06 1.41 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.129 -0.487 . . . . 0.0 112.225 -169.589 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -66.43 -28.09 68.34 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 168.082 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . 0.512 ' HZ ' ' HB2' ' A' ' 10' ' ' ALA . 55.1 t80 -70.95 -38.92 72.85 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.011 -0.995 . . . . 0.0 109.283 172.928 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' MET . . . . . 0.538 ' HG3' HG13 ' A' ' 106' ' ' ILE . 11.5 ttt -57.25 -44.9 84.29 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.296 -0.866 . . . . 0.0 110.333 172.702 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -67.61 -33.54 75.2 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.43 -0.805 . . . . 0.0 111.189 179.327 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -73.93 -39.91 63.45 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.925 0.393 . . . . 0.0 111.4 -179.589 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' TYR . . . . . 0.568 ' HB3' HG23 ' A' ' 106' ' ' ILE . 2.4 m-85 -83.64 -5.12 59.1 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.745 -178.917 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 93.8 mt 63.51 20.78 12.43 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.292 177.92 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . 0.614 HG22 ' HG3' ' A' ' 111' ' ' ARG . 39.0 pt -77.99 59.38 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 CA-C-O 121.586 0.708 . . . . 0.0 110.871 178.399 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 9.8 p30 -86.82 -38.5 16.77 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.928 179.505 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -85.12 76.72 2.18 Favored Glycine 0 N--CA 1.447 -0.6 0 N-CA-C 111.41 -0.676 . . . . 0.0 111.41 176.416 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.591 HG21 HG11 ' A' ' 37' ' ' VAL . 23.0 pt -94.78 156.46 38.18 Favored Pre-proline 0 C--N 1.323 -0.57 0 CA-C-N 115.973 -0.114 . . . . 0.0 110.955 -177.742 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . 0.723 ' HD3' ' HB2' ' A' ' 45' ' ' CYS . 29.2 Cg_endo -61.52 147.57 51.01 Favored 'Cis proline' 0 C--N 1.349 0.583 0 C-N-CA 124.348 -1.105 . . . . 0.0 114.049 2.117 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . 0.614 ' HG3' HG22 ' A' ' 106' ' ' ILE . 0.0 OUTLIER -118.54 137.87 52.92 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 179.125 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . 0.448 ' CD1' ' HA ' ' A' ' 128' ' ' ARG . 0.9 OUTLIER -103.2 120.96 41.7 Favored 'General case' 0 C--N 1.329 -0.285 0 O-C-N 123.908 0.755 . . . . 0.0 110.066 -175.366 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 87.3 mt -136.93 147.62 27.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-O 120.656 0.265 . . . . 0.0 110.307 -179.971 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.476 ' HB2' ' HG2' ' A' ' 126' ' ' MET . 54.7 tp -129.24 137.49 51.12 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.508 0.194 . . . . 0.0 110.546 -179.936 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.781 ' HG ' ' HA ' ' A' ' 121' ' ' ILE . 4.7 mp -129.56 151.12 50.52 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.127 0.489 . . . . 0.0 110.379 179.324 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . 0.547 ' HA ' ' CE1' ' A' ' 32' ' ' TYR . 22.4 t70 -70.88 164.33 25.58 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.243 -0.89 . . . . 0.0 110.205 176.564 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . 0.412 ' HG3' ' CD2' ' A' ' 32' ' ' TYR . 76.4 mtp180 -49.77 -31.71 12.18 Favored 'General case' 0 N--CA 1.466 0.369 0 O-C-N 124.068 0.855 . . . . 0.0 111.858 179.683 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . 0.475 ' HB3' ' HG2' ' A' ' 120' ' ' LYS . 6.4 t70 -71.77 -4.29 26.86 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.164 -178.906 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . 0.552 ' HA3' HD11 ' A' ' 25' ' ' LEU . . . 79.49 30.54 44.52 Favored Glycine 0 N--CA 1.439 -1.154 0 N-CA-C 110.286 -1.126 . . . . 0.0 110.286 -171.757 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . 0.475 ' HG2' ' HB3' ' A' ' 118' ' ' ASP . 40.6 mmtm -110.65 110.43 21.11 Favored 'General case' 0 CA--C 1.516 -0.333 0 C-N-CA 120.707 -0.397 . . . . 0.0 111.536 -175.418 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 0.781 ' HA ' ' HG ' ' A' ' 115' ' ' LEU . 3.3 mp -42.15 112.22 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 115.272 -0.876 . . . . 0.0 111.94 -179.145 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' ILE . . . . . 0.503 HD11 ' HB2' ' A' ' 116' ' ' ASP . 27.3 mm -87.68 -46.8 15.94 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-N 115.275 -0.875 . . . . 0.0 109.281 176.096 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 12.4 m -134.7 114.4 12.66 Favored 'General case' 0 N--CA 1.447 -0.622 0 CA-C-N 115.142 -0.935 . . . . 0.0 110.03 179.559 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -76.12 -16.04 59.97 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.77 0.795 . . . . 0.0 109.714 175.735 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 12.2 p-10 -124.17 87.62 2.76 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 114.679 -1.146 . . . . 0.0 109.728 175.264 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' MET . . . . . 0.497 ' HG3' ' H ' ' A' ' 127' ' ' THR . 5.0 tpt -94.44 -170.18 2.21 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 108.936 -0.764 . . . . 0.0 108.936 -180.0 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . 0.551 ' HB ' ' OG1' ' A' ' 134' ' ' THR . 3.7 m -117.7 138.98 51.64 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 110.205 -0.295 . . . . 0.0 110.205 -177.914 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . 0.461 ' HE ' ' CD ' ' A' ' 48' ' ' GLU . 49.1 ttt180 -32.32 136.63 0.25 Allowed Pre-proline 0 C--O 1.237 0.401 0 C-N-CA 124.36 1.064 . . . . 0.0 112.686 173.314 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . 0.417 ' HD3' ' HA ' ' A' ' 128' ' ' ARG . 86.5 Cg_exo -50.56 -40.21 54.99 Favored 'Trans proline' 0 C--N 1.347 0.474 0 C-N-CA 123.731 2.954 . . . . 0.0 113.479 -178.016 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 8.8 p -84.27 18.2 2.27 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 112.219 0.452 . . . . 0.0 112.219 -175.716 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . 0.446 ' HA ' ' HD3' ' A' ' 132' ' ' PRO . 15.2 t70 -97.99 131.05 27.32 Favored Pre-proline 0 C--N 1.328 -0.328 0 C-N-CA 120.582 -0.447 . . . . 0.0 110.003 175.893 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . 0.446 ' HD3' ' HA ' ' A' ' 131' ' ' ASP . 56.5 Cg_exo -53.91 -35.43 80.09 Favored 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 123.139 2.56 . . . . 0.0 113.56 -177.988 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 35.5 mtmm -68.13 -36.48 79.77 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.046 0.451 . . . . 0.0 110.16 -178.33 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 134' ' ' THR . . . . . 0.7 HG22 ' CZ ' ' A' ' 138' ' ' PHE . 1.3 m -65.58 -48.54 71.97 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.128 178.26 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . 0.554 ' HA ' ' CD2' ' A' ' 138' ' ' PHE . . . -58.31 -46.77 85.51 Favored 'General case' 0 C--O 1.237 0.418 0 CA-C-N 115.494 -0.776 . . . . 0.0 112.099 -179.713 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -71.0 -24.33 62.36 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.832 0.348 . . . . 0.0 110.701 -178.567 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . 0.545 ' O ' ' HG ' ' A' ' 141' ' ' LEU . 44.6 tptt -65.95 -41.14 91.65 Favored 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 109.611 -0.514 . . . . 0.0 109.611 175.189 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . 0.7 ' CZ ' HG22 ' A' ' 134' ' ' THR . 12.1 m-85 -58.84 -51.87 68.16 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.504 177.726 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 19.3 p30 -69.95 -24.19 63.3 Favored 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 120.392 -0.523 . . . . 0.0 111.351 -175.35 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 51.0 tt0 -67.67 -48.51 66.42 Favored 'General case' 0 N--CA 1.45 -0.453 0 CA-C-O 120.826 0.346 . . . . 0.0 110.573 172.226 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.545 ' HG ' ' O ' ' A' ' 137' ' ' LYS . 86.9 mt -64.4 -35.05 79.63 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.972 -178.163 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.588 HD21 ' HB ' ' A' ' 64' ' ' ILE . 79.1 mt -85.33 -15.96 41.55 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.228 -179.395 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 76.84 35.51 39.52 Favored Glycine 0 N--CA 1.451 -0.344 0 N-CA-C 111.236 -0.746 . . . . 0.0 111.236 179.565 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.449 ' O ' ' HG ' ' A' ' 144' ' ' LEU . 46.1 tp -103.51 15.45 28.95 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.391 0.615 . . . . 0.0 110.192 -174.39 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -63.06 141.53 58.73 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.755 178.208 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -121.16 67.58 0.43 Allowed Glycine 0 N--CA 1.448 -0.56 0 C-N-CA 120.907 -0.663 . . . . 0.0 112.026 179.397 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 30.1 t60 -76.55 -27.41 55.91 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.001 0.429 . . . . 0.0 110.208 -179.087 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 53.4 m80 -99.23 118.38 35.79 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.256 -179.935 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 33.2 m170 -107.99 98.4 7.97 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.084 179.819 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 4.8 t60 -65.88 -31.15 71.92 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.231 0.539 . . . . 0.0 110.124 178.764 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 19.2 t-80 -173.52 -24.47 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 179.853 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 63.8 t60 . . . . . 0 C--O 1.244 0.796 0 CA-C-N 114.846 -1.07 . . . . 0.0 108.937 171.281 . . . . . . . . 0 0 . 1 stop_ save_